PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Leto, D; Uhm, M; Williams, A; Chen, XW; Saltiel, AR				Leto, Dara; Uhm, Maeran; Williams, Anja; Chen, Xiao-wei; Saltiel, Alan R.			Negative Regulation of the RalGAP Complex by 14-3-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; MEDIATED PHOSPHORYLATION; GLUT4 TRANSLOCATION; TUMOR-SUPPRESSOR; PLASMA-MEMBRANE; INSULIN; RAS; RALA; TSC2; BINDING	RGC1 and RGC2 comprise a functional RalGAP complex (RGC) that suppresses RalA activity. The PI3-kinase/Akt signaling pathway activates RalA through phosphorylation-mediated inhibition of the RGC. Here we identify a novel phosphorylation-dependent interaction between 14-3-3 and the RGC. 14-3-3 binds to the complex through an Akt-phosphorylated residue, threonine 715, on RGC2. Interaction with 14-3-3 does not alter in vitro activity of the GTPase-activating protein complex. However, blocking the interaction between 14-3-3 and RGC2 in cells increases suppression of RalA activity by the RGC, suggesting that 14-3-3 inhibits the complex through a non-catalytic mechanism. Together, these data show that 14-3-3 negatively regulates the RGC downstream of the PI3-kinase/Akt signaling pathway.	[Uhm, Maeran; Saltiel, Alan R.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Saltiel, Alan R.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Saltiel, AR (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	saltiel@umich.edu	Chen, Xiaowei/F-7026-2014; Saltiel, Alan/L-3632-2019	Chen, Xiao-Wei/0000-0001-6466-6248; Saltiel, Alan/0000-0002-9726-9828	National Institutes of Health Grant [DK076906]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076906, P30DK020572, R01DK061618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076906 (to A.R.S.).	Alan JK, 2010, MOL CELL BIOL, V30, P4324, DOI 10.1128/MCB.01646-09; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chen S, 2011, TRENDS ENDOCRIN MET, V22, P429, DOI 10.1016/j.tem.2011.07.005; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2011, CELL CYCLE, V10, P2299, DOI 10.4161/cc.10.14.16524; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Csepanyi-Komi R, 2012, MOL CELL ENDOCRINOL, V353, P10, DOI 10.1016/j.mce.2011.11.005; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; EMKEY R, 1991, J BIOL CHEM, V266, P9703; Feng LP, 2004, FEBS LETT, V557, P275, DOI 10.1016/S0014-5793(03)01507-2; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gotoh T, 2000, J BIOL CHEM, V275, P30118, DOI 10.1074/jbc.M003074200; Gridley S, 2005, CELL SIGNAL, V17, P59, DOI 10.1016/j.cellsig.2004.05.013; Hernandez-Munoz I, 2000, ONCOGENE, V19, P2745, DOI 10.1038/sj.onc.1203586; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kishida S, 1997, ONCOGENE, V15, P2899, DOI 10.1038/sj.onc.1201473; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Liu J, 2000, BIOCHEM J, V346, P77, DOI 10.1042/0264-6021:3460077; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Matsubara K, 1999, ONCOGENE, V18, P1303, DOI 10.1038/sj.onc.1202425; O'Toole TE, 2011, J CELL PHYSIOL, V226, P2965, DOI 10.1002/jcp.22644; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Rebhun JF, 2000, J BIOL CHEM, V275, P13406, DOI 10.1074/jbc.C000085200; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Shirakawa R, 2009, J BIOL CHEM, V284, P21580, DOI 10.1074/jbc.M109.012112; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Tian XJ, 2002, EMBO J, V21, P1327, DOI 10.1093/emboj/21.6.1327; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	52	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9272	9283		10.1074/jbc.M112.426106	http://dx.doi.org/10.1074/jbc.M112.426106			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386617	Green Published, hybrid			2022-12-25	WOS:000316862200045
J	Phillips, DD; Fattah, RJ; Crown, D; Zhang, Y; Liu, SH; Moayeri, M; Fischer, ER; Hansen, BT; Ghirlando, R; Nestorovich, EM; Wein, AN; Simons, L; Leppla, SH; Leysath, CE				Phillips, Damilola D.; Fattah, Rasem J.; Crown, Devorah; Zhang, Yi; Liu, Shihui; Moayeri, Mahtab; Fischer, Elizabeth R.; Hansen, Bryan T.; Ghirlando, Rodolfo; Nestorovich, Ekaterina M.; Wein, Alexander N.; Simons, Lacy; Leppla, Stephen H.; Leysath, Clinton E.			Engineering Anthrax Toxin Variants That Exclusively Form Octamers and Their Application to Targeting Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL ALPHA-HEMOLYSIN; PROTECTIVE ANTIGEN; LETHAL FACTOR; SEDIMENTATION-VELOCITY; MAMMALIAN-CELLS; PORE FORMATION; KINASE-KINASE; OLIGOMERIZATION; ULTRACENTRIFUGATION; INTERNALIZATION	Anthrax toxin protective antigen (PA) delivers its effector proteins into the host cell cytosol through formation of an oligomeric pore, which can assume heptameric or octameric states. By screening a highly directed library of PA mutants, we identified variants that complement each other to exclusively form octamers. These PA variants were individually nontoxic and demonstrated toxicity only when combined with their complementary partner. We then engineered requirements for activation by matrix metalloproteases and urokinase plasminogen activator into two of these variants. The resulting therapeutic toxin specifically targeted cells expressing both tumor associated proteases and completely stopped tumor growth in mice when used at a dose far below that which caused toxicity. This scheme for obtaining intercomplementing subunits can be employed with other oligomeric proteins and potentially has wide application.	[Phillips, Damilola D.; Fattah, Rasem J.; Crown, Devorah; Zhang, Yi; Liu, Shihui; Moayeri, Mahtab; Wein, Alexander N.; Simons, Lacy; Leppla, Stephen H.; Leysath, Clinton E.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Fischer, Elizabeth R.; Hansen, Bryan T.] NIAID, Electron Microscopy Unit, Res Technol Branch, NIH, Hamilton, MT 59840 USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Nestorovich, Ekaterina M.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Catholic University of America	Leysath, CE (corresponding author), NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	leysathce@niaid.nih.gov		Moayeri, Mahtab/0000-0002-4448-8883; Wein, Alex/0000-0002-8813-3523; Phillips, Damilola/0000-0002-3643-7111; Liu, Shihui/0000-0003-3444-1069	Intramural Research Program of NIAID from the National Institutes of Health; Intramural Research Program of NIDDK from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001031, ZICAI001052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER	Intramural Research Program of NIAID from the National Institutes of Health; Intramural Research Program of NIDDK from the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Programs of NIAID and NIDDK from the National Institutes of Health.	Ahuja N, 2001, BIOCHEM BIOPH RES CO, V287, P542, DOI 10.1006/bbrc.2001.5613; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Boukari H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098106; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Czajkowsky DM, 1998, J MOL BIOL, V276, P325, DOI 10.1006/jmbi.1997.1535; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Dumetz F, 2011, AM J PATHOL, V178, P2523, DOI 10.1016/j.ajpath.2011.02.027; Feld GK, 2012, J MOL BIOL, V415, P159, DOI 10.1016/j.jmb.2011.10.035; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kintzer AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013888; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu SH, 2000, CANCER RES, V60, P6061; Liu SH, 2005, NAT BIOTECHNOL, V23, P725, DOI 10.1038/nbt1091; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; Mogridge J, 2001, J BACTERIOL, V183, P2111, DOI 10.1128/JB.183.6.2111-2116.2001; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Singh Y, 1999, INFECT IMMUN, V67, P1853; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Varughese M, 1998, MOL MED, V4, P87, DOI 10.1007/BF03401732; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	32	28	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9058	9065		10.1074/jbc.M113.452110	http://dx.doi.org/10.1074/jbc.M113.452110			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393143	Green Published, hybrid			2022-12-25	WOS:000316862200025
J	Scopelliti, AJ; Ryan, RM; Vandenberg, RJ				Scopelliti, Amanda J.; Ryan, Renae M.; Vandenberg, Robert J.			Molecular Determinants for Functional Differences between Alanine-Serine-Cysteine Transporter 1 and Other Glutamate Transporter Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; SUBSTRATE; EXPRESSION; BINDING; CLONING; MECHANISM; MUTATION; SYSTEM; ASCT1; SITE	The ASCTs (alanine, serine, and cysteine transporters) belong to the solute carrier family 1 (SLC1), which also includes the human glutamate transporters (excitatory amino acid transporters, EAATs) and the prokaryotic aspartate transporter Glt(Ph). Despite the high degree of amino acid sequence identity between family members, ASCTs function quite differently from the EAATs and GltPh. The aim of this study was to mutate ASCT1 to generate a transporter with functional properties of the EAATs and GltPh, to further our understanding of the structural basis for the different transport mechanisms of the SLC1 family. We have identified three key residues involved in determining differences between ASCT1, the EAATs and Glt(Ph). ASCT1 transporters containing the mutations A382T, T459R, and Q386E were expressed in Xenopus laevis oocytes, and their transport and anion channel functions were investigated. A382T and T459R altered the substrate selectivity of ASCT1 to allow the transport of acidic amino acids, particularly L-aspartate. The combination of A382T and T459R within ASCT1 generates a transporter with a similar profile to that of Glt(Ph), with preference for L-aspartate over L-glutamate. Interestingly, the amplitude of the anion conductance activated by the acidic amino acids does not correlate with rates of transport, highlighting the distinction between these two processes. Q386E impaired the ability of ASCT1 to bind acidic amino acids at pH 5.5; however, this was reversed by the additional mutation A382T. We propose that these residues differences in TM7 and TM8 combine to determine differences in substrate selectivity between members of the SLC1 family.	[Scopelliti, Amanda J.; Ryan, Renae M.; Vandenberg, Robert J.] Univ Sydney, Discipline Pharmacol, Bosch Inst, Sch Med Sci, Sydney, NSW 2006, Australia	University of Sydney	Vandenberg, RJ (corresponding author), Univ Sydney, Discipline Pharmacol, Bosch Inst, Sch Med Sci, Sydney, NSW 2006, Australia.	robert.vandenberg@sydney.edu.au	Ryan, Renae/AAC-3540-2021; Vandenberg, Robert John/E-6018-2016	Ryan, Renae/0000-0002-8680-4610; Vandenberg, Robert John/0000-0003-1523-4814	Australian Research Council [DP1092729]; University of Sydney; John Lamberton scholarship; National Health and Medical Research Council [571093]	Australian Research Council(Australian Research Council); University of Sydney(University of Sydney); John Lamberton scholarship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Discovery Grant DP1092729 from the Australian Research Council.; Supported by a University of Sydney postgraduate award and a John Lamberton scholarship.; Supported by a National Health and Medical Research Council Career Development Fellowship 571093.	ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Broer A, 1999, J NEUROCHEM, V73, P2184; CHRISTENSEN HN, 1967, J BIOL CHEM, V242, P5237; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; CONRADT M, 1995, J BIOL CHEM, V270, P25207, DOI 10.1074/jbc.270.42.25207; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Howard A, 2004, J NUTR, V134, P2957, DOI 10.1093/jn/134.11.2957; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Poulsen MV, 2001, J PHYSIOL-LONDON, V534, P159, DOI 10.1111/j.1469-7793.2001.00159.x; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Sakai K, 2003, J NEUROSCI, V23, P550; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; SHAFQAT S, 1993, J BIOL CHEM, V268, P15351; Tamarappoo BK, 1996, BBA-BIOMEMBRANES, V1279, P131, DOI 10.1016/0005-2736(95)00259-6; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Watzke N, 2000, J GEN PHYSIOL, V116, P609, DOI 10.1085/jgp.116.5.609; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	32	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8250	8257		10.1074/jbc.M112.441022	http://dx.doi.org/10.1074/jbc.M112.441022			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23393130	hybrid, Green Published			2022-12-25	WOS:000316564500025
J	Arsenault, D; Brochu-Gaudreau, K; Charbonneau, M; Dubois, CM				Arsenault, Dominique; Brochu-Gaudreau, Karine; Charbonneau, Martine; Dubois, Claire M.			HDAC6 Deacetylase Activity Is Required for Hypoxia-Induced Invadopodia Formation and Cell Invasion	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX DEGRADATION; SUBEROYLANILIDE HYDROXAMIC ACID; BREAST-CANCER CELLS; TGF-BETA; HISTONE DEACETYLASES; MESENCHYMAL TRANSITION; SMAD PROTEINS; TUMOR-CELLS; SIGNALING PATHWAYS; EPITHELIAL-CELLS	Despite significant progress in the cancer field, tumor cell invasion and metastasis remain a major clinical challenge. Cell invasion across tissue boundaries depends largely on extracellular matrix degradation, which can be initiated by formation of actin-rich cell structures specialized in matrix degradation called invadopodia. Although the hypoxic microenvironment within solid tumors has been increasingly recognized as an important driver of local invasion and metastasis, little is known about how hypoxia influences invadopodia biogenesis. Here, we show that histone deacetylase 6 (HDAC6), a cytoplasmic member of the histone deacetylase family, is a novel modulator of hypoxia-induced invadopodia formation. Hypoxia was found to enhance HDAC6 tubulin deacetylase activity through activation of the EGFR pathway. Activated HDAC6, in turn, triggered Smad3 phosphorylation resulting in nuclear accumulation. Inhibition of HDAC6 activity or knockdown of the protein inhibited both hypoxia-induced Smad3 activation and invadopodia formation. Our data provide evidence that hypoxia influences invadopodia formation in a biphasic manner, which involves the activation of HDAC6 deacetylase activity by EGFR, resulting in enhanced Smad phosphorylation and nuclear accumulation. The identification of HDAC6 as a key participant of hypoxia-induced cell invasion may have important therapeutic implications for the treatment of metastasis in cancer patients.	[Arsenault, Dominique; Brochu-Gaudreau, Karine; Charbonneau, Martine; Dubois, Claire M.] Univ Sherbrooke, Div Immunol, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Dubois, CM (corresponding author), Univ Sherbrooke, Div Immunol, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada.	Claire.Dubois@usherbrooke.ca	Brochu-Gaudreau, Karine/GWC-1767-2022; Dubois, Claire M/K-1985-2013	Brochu-Gaudreau, Karine/0000-0003-1163-2196; 	Canadian Institutes for Health Research [MOP-89810]; Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institutes for Health Research (grant MOP-89810 to C. M. Dubois). C. M. Dubois is a member of the Fonds de la Recherche en Sante du Quebec (FRSQ)-funded Centre de Recherche Clinique Etienne-LeBel. D. Arsenault is a recipient of a scolarship from the Canadian Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M., 2012, DNA CELL BIOL; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Akman HO, 2001, BLOOD, V98, P3324, DOI 10.1182/blood.V98.12.3324; Arsenault D, 2011, J CELL PHYSL; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Baldassarre M, 2006, EUR J CELL BIOL, V85, P1217, DOI 10.1016/j.ejcb.2006.08.003; Basu RK, 2011, AM J PHYSIOL-RENAL, V300, pF898, DOI 10.1152/ajprenal.00335.2010; Bazzaro M, 2008, CLIN CANCER RES, V14, P7340, DOI 10.1158/1078-0432.CCR-08-0642; Behzadian MA, 1998, GLIA, V24, P216, DOI 10.1002/(SICI)1098-1136(199810)24:2<216::AID-GLIA6>3.3.CO;2-D; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Bruserud O, 2007, CURR PHARM BIOTECHNO, V8, P388, DOI 10.2174/138920107783018417; Chae KS, 2011, ONCOGENE, V30, P1213, DOI 10.1038/onc.2010.498; Chen WT, 1999, ANN NY ACAD SCI, V878, P361, DOI 10.1111/j.1749-6632.1999.tb07695.x; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Dallavalle S, 2012, BIOCHEM PHARMACOL, V84, P756, DOI 10.1016/j.bcp.2012.06.014; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fukuda Hiroki, 2006, Briefings in Functional Genomics & Proteomics, V5, P190, DOI 10.1093/bfgp/ell032; Gong KZ, 2011, MOL ENDOCRINOL, V25, P1794, DOI 10.1210/me.2011-1009; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hess-Stumpp H, 2005, EUR J CELL BIOL, V84, P109, DOI 10.1016/j.ejcb.2004.12.010; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Inoue A, 2002, J MOL ENDOCRINOL, V29, P175, DOI 10.1677/jme.0.0290175; ITO N, 1991, CANCER RES, V51, P4080; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kaluza D, 2011, EMBO J, V30, P4142, DOI 10.1038/emboj.2011.298; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kimura F, 2010, CANCER SCI, V101, P1133, DOI 10.1111/j.1349-7006.2010.01527.x; Krasagakis K, 1998, BRIT J CANCER, V77, P1492, DOI 10.1038/bjc.1998.245; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Krishnamachary B, 2003, CANCER RES, V63, P1138; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Lin HH, 2012, MOL CELL BIOL, V32, P1124, DOI 10.1128/MCB.06053-11; Lin HY, 2006, MED RES REV, V26, P397, DOI 10.1002/med.20056; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Lucien F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028851; Luu TH, 2008, CLIN CANCER RES, V14, P7138, DOI 10.1158/1078-0432.CCR-08-0122; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mandal S, 2008, EXP CELL RES, V314, P3478, DOI 10.1016/j.yexcr.2008.09.013; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McMahon S, 2005, J BIOL CHEM, V280, P6561, DOI 10.1074/jbc.M413248200; Mishra OP, 2010, NEUROCHEM RES, V35, P1471, DOI 10.1007/s11064-010-0208-1; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Mottet D, 2005, INT J CANCER, V117, P764, DOI 10.1002/ijc.21268; Munoz-Najar UM, 2006, ONCOGENE, V25, P2379, DOI 10.1038/sj.onc.1209273; Nascimento CF, 2010, MICROSC RES TECHNIQ, V73, P99, DOI 10.1002/jemt.20761; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Park SY, 2011, ONCOL REP, V25, P1677, DOI 10.3892/or.2011.1236; Piek E, 1999, J CELL SCI, V112, P4557; Rey M, 2011, EUR J CELL BIOL, V90, P128, DOI 10.1016/j.ejcb.2010.09.004; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; Sakuma T, 2006, INT J ONCOL, V29, P117; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Sasseville M, 2010, J CELL SCI, V123, P3166, DOI 10.1242/jcs.063834; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Shi YF, 2007, FEBS LETT, V581, P203, DOI 10.1016/j.febslet.2006.12.010; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Tsunoda K, 2011, J INVEST DERMATOL; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wang J, 2010, INVEST OPHTH VIS SCI, V51, P2943, DOI 10.1167/iovs.09-4639; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Wang X, 2010, CARCINOGENESIS, V31, P1202, DOI 10.1093/carcin/bgq078; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wiercinska E, 2010, BREAST CANC RES TREA; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Yoon SO, 2005, CANCER RES, V65, P2761, DOI 10.1158/0008-5472.CAN-04-4122; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	92	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55529	10.1371/journal.pone.0055529	http://dx.doi.org/10.1371/journal.pone.0055529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405166	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400111
J	Liu, Y; Yang, XS; Guo, CY; Nie, P; Liu, Y; Ma, J				Liu, Yong; Yang, Xuesen; Guo, Chenying; Nie, Pan; Liu, Yan; Ma, Jie			Essential Role of MFG-E8 for Phagocytic Properties of Microglial Cells	PLOS ONE			English	Article							GLOBULE-EGF FACTOR-8; SYSTEMIC-LUPUS-ERYTHEMATOSUS; APOPTOTIC CELLS; NEURONAL DEATH; MACROPHAGE CLEARANCE; LENTIVIRUS VECTOR; VIABLE NEURONS; PHOSPHATIDYLSERINE; DISEASE; IDENTIFICATION	Milk fat globule factor-E8 (MFG-E8) has been regarded as a key factor involved in the phagocytosis of apoptotic cells. We induced a lentivirus into the microglial cells for the augmentation or abrogation of MFG-E8 expression in mouse microglial cells, and investigated phagocytosis of phosphatidylserine tagged human red blood cells (hRBCs) in co-cultures. Increased MFG-E8 levels were associated with a significant increase in phagocytic activity compared to the controls. Conversely, phagocytosis dramitically decreased due to the abrogation of MFG-E8. In addition, the expression of the inflammatory cytokines, TNF-alpha and IL-1 beta, also increased or decreased in the microglial cells with the augmentation or abrogation of MFG-E8, respectively. Our findings indicate that the enhanced expression of MFG-E8 could increase phagocytosis of apoptotic cells; conversely, the rate of phagocytosis and the expression of inflammatory cytokines decreased when MFG-E8 expression was knocked down. Our results confirm that MFG-E8 plays an important role in phagocytosis, and possibly serves as an essential signal molecule for microglial cells.	[Liu, Yong] Third Mil Med Univ, SW Eye Hosp, Southwest Hosp, Chongqing, Peoples R China; [Yang, Xuesen] Third Mil Med Univ, Inst Trop Med, Chongqing, Peoples R China; [Guo, Chenying; Ma, Jie] Harvard Univ, Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Dept Ophthalmol,Med Sch, Boston, MA USA; [Nie, Pan; Liu, Yan] Southwest Univ, Coll Life Sci, Chongqing, Peoples R China	Army Medical University; Army Medical University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Southwest University - China	Liu, Y (corresponding author), Third Mil Med Univ, SW Eye Hosp, Southwest Hosp, Chongqing, Peoples R China.	liu_yong2012@yahoo.com			National Natural Science Foundation of China [30700931, 30970672]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30700931 to Yong Liu and No. 30970672 to Xuesen Yang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; Aziz M, 2011, APOPTOSIS, V16, P1077, DOI 10.1007/s10495-011-0630-0; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196; Fricker M, 2012, J NEUROSCI, V32, P2657, DOI 10.1523/JNEUROSCI.4837-11.2012; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Leonardi-Essmann F, 2005, J NEUROIMMUNOL, V160, P92, DOI 10.1016/j.jneuroim.2004.11.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Miksa M, 2006, SHOCK, V25, P586, DOI 10.1097/01.shk.0000209533.22941.d0; Mochizuki H, 1996, J NEUROL SCI, V137, P120, DOI 10.1016/0022-510X(95)00336-Z; Neher JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00027; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Skalamera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020057; THOMAS LB, 1995, EXP NEUROL, V133, P265, DOI 10.1006/exnr.1995.1029; Tyurina YY, 2004, J BIOL CHEM, V279, P6056, DOI 10.1074/jbc.M309929200; Yamaguchi H, 2008, J LEUKOCYTE BIOL, V83, P1300, DOI 10.1189/jlb.1107730; Yamaguchi H, 2010, EUR J IMMUNOL, V40, P1778, DOI 10.1002/eji.200940096; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; ZHANG L, 1995, BRAIN RES, V677, P177, DOI 10.1016/0006-8993(95)00197-X; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	38	23	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55754	10.1371/journal.pone.0055754	http://dx.doi.org/10.1371/journal.pone.0055754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405209	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400154
J	Shu, MY; Wang, YH; Yu, JH; Kuo, S; Coda, A; Jiang, Y; Gallo, RL; Huang, CM				Shu, Muya; Wang, Yanhan; Yu, Jinghua; Kuo, Sherwin; Coda, Alvin; Jiang, Yong; Gallo, Richard L.; Huang, Chun-Ming			Fermentation of Propionibacterium acnes, a Commensal Bacterium in the Human Skin Microbiome, as Skin Probiotics against Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; INFECTIONS; GLYCEROL; CELLS; SUSCEPTIBILITY; ANTIMICROBIALS; INTERFERENCE; INFLAMMATION; METABOLISM; PREDICTION	Bacterial interference creates an ecological competition between commensal and pathogenic bacteria. Through fermentation of milk with gut-friendly bacteria, yogurt is an excellent aid to balance the bacteriological ecosystem in the human intestine. Here, we demonstrate that fermentation of glycerol with Propionibacterium acnes (P. acnes), a skin commensal bacterium, can function as a skin probiotic for in vitro and in vivo growth suppression of USA300, the most prevalent community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). We also promote the notion that inappropriate use of antibiotics may eliminate the skin commensals, making it more difficult to fight pathogen infection. This study warrants further investigation to better understand the role of fermentation of skin commensals in infectious disease and the importance of the human skin microbiome in skin health.	[Shu, Muya; Wang, Yanhan; Kuo, Sherwin; Coda, Alvin; Gallo, Richard L.; Huang, Chun-Ming] Univ Calif San Diego, Dept Med, Div Dermatol, La Jolla, CA 92093 USA; [Yu, Jinghua] Sanford Burnham Inst Med Res, La Jolla, CA USA; [Jiang, Yong] Surface Bioadv Inc, San Diego, CA USA; [Huang, Chun-Ming] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Huang, CM (corresponding author), Univ Calif San Diego, Dept Med, Div Dermatol, La Jolla, CA 92093 USA.	chunming@ucsd.edu	Gallo, Richard L/A-8931-2009; , Chun-Ming/AAM-1856-2020	Gallo, Richard L/0000-0002-1401-7861; , Chun-Ming/0000-0002-3352-5394; Coda, Alvin/0000-0002-8509-8590	NIH [STTR, 1R21AI088147]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088147, R01AI083358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grants (STTR and 1R21AI088147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CY, 1996, PLAST RECONSTR SURG, V98, P1225, DOI 10.1097/00006534-199612000-00016; Bashir A, 2007, PAK J PHARM SCI, V20, P299; Chitarra LG, 2000, J APPL MICROBIOL, V88, P809, DOI 10.1046/j.1365-2672.2000.01014.x; Cohen AL, 2007, EMERG INFECT DIS, V13, P1707, DOI 10.3201/eid1311.070148; CUMMINS CS, 1975, J CLIN MICROBIOL, V2, P104; CUMMINS CS, 1974, J GEN MICROBIOL, V80, P433, DOI 10.1099/00221287-80-2-433; Curry JL, 2003, ARCH PATHOL LAB MED, V127, P289; DEMAEREL P, 1994, LANCET, V344, P1234, DOI 10.1016/S0140-6736(94)90552-5; Dishisha T, 2012, BIORESOURCE TECHNOL, V118, P553, DOI 10.1016/j.biortech.2012.05.079; EVANS CA, 1975, J INVEST DERMATOL, V64, P42, DOI 10.1111/1523-1747.ep12540897; EVANS CA, 1984, J INVEST DERMATOL, V82, P294, DOI 10.1111/1523-1747.ep12260391; Falagas ME, 2008, INT J ANTIMICROB AG, V31, P518, DOI 10.1016/j.ijantimicag.2008.01.024; Fluhr JW, 2008, BRIT J DERMATOL, V159, P23, DOI 10.1111/j.1365-2133.2008.08643.x; Fujita T, 2011, J INVEST DERMATOL, V131, P1660, DOI 10.1038/jid.2011.123; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Gilbert M, 2006, CAN MED ASSOC J, V175, P149, DOI 10.1503/cmaj.051565; Goetghebeur M, 2007, CAN J INFECT DIS MED, V18, P27, DOI 10.1155/2007/253947; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Higaki S, 2004, INT J DERMATOL, V43, P103, DOI 10.1111/j.1365-4632.2004.01887.x; Higaki S, 1990, Nihon Hifuka Gakkai Zasshi, V100, P883; INGRAM LO, 1984, ADV MICROB PHYSIOL, V25, P253; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kidd DA, 2007, TOXICOL IN VITRO, V21, P1292, DOI 10.1016/j.tiv.2007.08.018; Kitagawa H, 2011, EXP DERMATOL, V20, P157, DOI 10.1111/j.1600-0625.2010.01180.x; Kwon YM, 1998, APPL ENVIRON MICROB, V64, P3458; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lind H., 2010, INT J MICROBIOL, V2010, DOI [10.1155/2010/430873, DOI 10.1155/2010/430873]; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Malani PN, 2008, J AM GERIATR SOC, V56, P1485, DOI 10.1111/j.1532-5415.2008.01823.x; McDowell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041480; Millet S, 2010, CRIT REV FOOD SCI, V50, P605, DOI 10.1080/10408390802565939; MUAMBA MLK, 1982, CAN J MICROBIOL, V28, P758, DOI 10.1139/m82-115; Odell CA, 2010, CURR OPIN PEDIATR, V22, P273, DOI 10.1097/MOP.0b013e328339421b; OSTLING CE, 1993, J APPL BACTERIOL, V75, P18, DOI 10.1111/j.1365-2672.1993.tb03402.x; Park JS, 2007, INT IMMUNOPHARMACOL, V7, P70, DOI 10.1016/j.intimp.2006.08.015; Raftari M, 2009, Open Microbiol J, V3, P121, DOI 10.2174/1874285800903010121; Ramage G, 2003, BIOMATERIALS, V24, P3221, DOI 10.1016/S0142-9612(03)00173-X; Ramstad S, 1997, J PHOTOCH PHOTOBIO B, V40, P141, DOI 10.1016/S1011-1344(97)00039-0; Ricke SC, 2003, POULTRY SCI, V82, P632, DOI 10.1093/ps/82.4.632; Saleh K, 2011, DERMATOL SURG, V37, P1014, DOI 10.1111/j.1524-4725.2011.02040.x; Slonczewski JL, 1992, ASM NEWS, V58, P140; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; USHIJIMA T, 1984, CAN J MICROBIOL, V30, P647, DOI 10.1139/m84-096; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wang ZX, 2001, BIOTECHNOL ADV, V19, P201, DOI 10.1016/S0734-9750(01)00060-X; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Wu Ling, 2009, Weishengwu Xuebao, V49, P168; Zhang H, 2009, INT J FOOD MICROBIOL, V135, P211, DOI 10.1016/j.ijfoodmicro.2009.08.015; Zheng XJ, 2003, J INVEST DERMATOL, V121, P1487, DOI 10.1111/j.1523-1747.2003.12614.x	53	164	187	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55380	10.1371/journal.pone.0055380	http://dx.doi.org/10.1371/journal.pone.0055380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405142	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400087
J	Vermeulen, C; Lejeune, P; Lisein, J; Sawadogo, P; Bouche, P				Vermeulen, Cedric; Lejeune, Philippe; Lisein, Jonathan; Sawadogo, Prosper; Bouche, Philippe			Unmanned Aerial Survey of Elephants	PLOS ONE			English	Article								The use of a UAS (Unmanned Aircraft System) was tested to survey large mammals in the Nazinga Game Ranch in the south of Burkina Faso. The Gatewing x 100 (TM) equipped with a Ricoh GR III camera was used to test animal reaction as the UAS passed, and visibility on the images. No reaction was recorded as the UAS passed at a height of 100 m. Observations, made on a set of more than 7000 images, revealed that only elephants (Loxodonta africana) were easily visible while medium and small sized mammals were not. The easy observation of elephants allows experts to enumerate them on images acquired at a height of 100 m. We, therefore, implemented an aerial strip sample count along transects used for the annual wildlife foot count. A total of 34 elephants were recorded on 4 transects, each overflown twice. The elephant density was estimated at 2.47 elephants/km(2) with a coefficient of variation (CV%) of 36.10%. The main drawback of our UAS was its low autonomy (45 min). Increased endurance of small UAS is required to replace manned aircraft survey of large areas (about 1000 km of transect per day vs 40 km for our UAS). The monitoring strategy should be adapted according to the sampling plan. Also, the UAS is as expensive as a second-hand light aircraft. However the logistic and flight implementation are easier, the running costs are lower and its use is safer. Technological evolution will make civil UAS more efficient, allowing them to compete with light aircraft for aerial wildlife surveys.	[Vermeulen, Cedric; Lejeune, Philippe; Lisein, Jonathan; Bouche, Philippe] Univ Liege Gembloux Agrobio Tech, Unite Gest Ressources Forestieres & Milieux Nat, Gembloux, Belgium; [Sawadogo, Prosper] Off Natl Aires Protegees, Ouagadougou, Burkina Faso	University of Liege	Vermeulen, C (corresponding author), Univ Liege Gembloux Agrobio Tech, Unite Gest Ressources Forestieres & Milieux Nat, Gembloux, Belgium.	cvermeulen@ulg.ac.be			Department of Forest Nature and Landscape of the University of Liege Gembloux Agro-Bio Tech.	Department of Forest Nature and Landscape of the University of Liege Gembloux Agro-Bio Tech.	This operation was funded by the Department of Forest Nature and Landscape of the University of Liege Gembloux Agro-Bio Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouche P, 2012, THESIS U LIEGE; Bouche P, 2012, ENV MONITOR IN PRESS; Bouche P, 2012, BIOTECHNOL AGRON SOC, V16, P77; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Croze H., 1972, East African Wildlife Journal, V10, P91; Dekker AJFM, 1985, DPBKF82008 PNUDFAO; Dunham KM, 2012, AFR J ECOL IN PRESS; Ferreira SM, 2009, S AFR J WILDL RES, V39, P181, DOI 10.3957/056.039.0205; Israel M, 2011, INT ARCH PHOTOGRAMME, VXXXVIII-1/C22; JACHMANN H, 1991, AFR J ECOL, V29, P188, DOI 10.1111/j.1365-2028.1991.tb01001.x; Jachmann H., 2001, ESTIMATING ABUNDANCE, DOI 10.1007/978-1-4615-1381-0; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Koh LP, 2012, TROP CONSERV SCI, V5, P121, DOI 10.1177/194008291200500202; Marchal A, 2012, BIOTECHNOL AGRON SOC, V16, P307; Martin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038882; National Oceanic and Atmospheric Administration, 2009, NOAA UNM AIRCR HELP; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Norton-Griffiths, 1978, AWF HDB, V1; Sarda-Palomera F, 2012, IBIS, V154, P177, DOI 10.1111/j.1474-919X.2011.01177.x; Trimble MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026614; Watts AC, 2010, J WILDLIFE MANAGE, V74, P1614, DOI 10.2193/2009-425; Wilkinson BE, 2009, PHOTOGRAMM ENG REM S, V75, P1415, DOI 10.14358/PERS.75.12.1415	22	165	181	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54700	10.1371/journal.pone.0054700	http://dx.doi.org/10.1371/journal.pone.0054700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405088	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400032
J	Xu, XY; Zhao, MD; Liu, XB; Jiang, YZ; Zhang, HX; Zhai, XY; Zhang, L; Hu, XM				Xu, Xiaoyan; Zhao, Mingdong; Liu, Xianbing; Jiang, Yuzhu; Zhang, Haixia; Zhai, Xiaoyu; Zhang, Ling; Hu, Xuemei			Toxoplasma gondii Infection Regulates the Balance of Activating and Inhibitory Receptors on Decidual Natural Killer Cells	PLOS ONE			English	Article							NK CELL	Inhibitory receptors and activating receptor expressed on decidual natural killer (dNK) cells are generally believed to be important in abnormal pregnancy outcomes and induced adverse pregnancy. However, if Toxoplasma gondii (T. gondii) infection induced abnormal pregnancy was related to dNK cells changes is not clear. In this study, we used human dNK cells co-cultured with human extravillous cytotrophoblast (EVT) cells following YFP-Toxoplasma gondii (YFP-T. gondii) infection in vitro and established animal pregnant infection model. Levels of inhibitory receptors KIR2DL4 and ILT-2, their ligand HLA-G, and activating receptor NKG2D in human decidua, and NKG2A and its ligand Qa-1 and NKG2D in mice uterine were analyzed by real-time PCR and flow cytometry with levels of NKG2D significantly higher than those of KIR2DL4 and ILT-2 in vitro and in invo. The level of NKG2D was positively correlated with cytotoxic activity of dNK cells in vitro. Numbers of abnormal pregnancies were significantly greater in the infected group than in the control group. This result demonstrated that the increased NKG2D expression and imbalance between inhibitory receptors of dNK cells and HLA-G may contribute to abnormal pregnancy outcomes observed upon maternal infection with T. gondii.	[Xu, Xiaoyan; Liu, Xianbing; Jiang, Yuzhu; Zhang, Haixia; Zhai, Xiaoyu; Zhang, Ling; Hu, Xuemei] Binzhou Med Univ, Dept Immunol, Binzhou, Shandong, Peoples R China; [Zhao, Mingdong] Binzhou Med Univ, Yantai Affiliated Hosp, Dept Radiol, Binzhou, Shandong, Peoples R China	Binzhou Medical University; Binzhou Medical University	Hu, XM (corresponding author), Binzhou Med Univ, Dept Immunol, Binzhou, Shandong, Peoples R China.	xue-mei-hu@163.com			National Natural Science Foundation of China [81171591, 81273243]; Science and Technology Development Planning Project of Shandong Province [2012GSF11809]; Natural Science Foundation of Shandong Province [ZR2010HM012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning Project of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported in part by funds from the National Natural Science Foundation of China 81171591 and 81273243, Science and Technology Development Planning Project of Shandong Province 2012GSF11809, Natural Science Foundation of Shandong Province ZR2010HM012. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI K, 1995, LANCET, V345, P1340, DOI 10.1016/S0140-6736(95)92539-2; Biassoni R, 2003, J CELL MOL MED, V7, P376, DOI 10.1111/j.1582-4934.2003.tb00240.x; Chao KH, 1999, HUM IMMUNOL, V60, P791, DOI 10.1016/S0198-8859(99)00049-X; Commodaro AG, 2009, MEM I OSWALDO CRUZ, V104, P345, DOI 10.1590/S0074-02762009000200030; Emmer PM, 2002, HUM REPROD, V17, P1072, DOI 10.1093/humrep/17.4.1072; Faridi RM, 2009, HUM REPROD, V24, P1758, DOI 10.1093/humrep/dep047; Gonen-Gross T, 2003, HUM IMMUNOL, V64, P1011, DOI 10.1016/j.humimm.2003.08.355; Johansson SE, 2011, VIRAL IMMUNOL, V24, P359, DOI 10.1089/vim.2011.0025; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Leng J, 2009, PARASITE IMMUNOL, V31, P717, DOI 10.1111/j.1365-3024.2009.01122.x; Loke Y.W., 1995, HUMAN IMPLANTATION C; Moffett-King Ashley, 2002, Trends in Immunology, V23, P332, DOI 10.1016/S1471-4906(02)02261-5; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Ornoy A, 2006, REPROD TOXICOL, V21, P399, DOI 10.1016/j.reprotox.2005.02.002; Perussia B, 2005, MOL IMMUNOL, V42, P385, DOI 10.1016/j.molimm.2004.07.017; Rajagopalan S, 2001, J IMMUNOL, V167, P1877, DOI 10.4049/jimmunol.167.4.1877; Trundley A, 2006, METH MOLEC MED, V122, P109; Vargas-Inchaustegui DA, 2011, IMMUNOLOGY, V134, P326, DOI 10.1111/j.1365-2567.2011.03493.x; Varla-Leftherioti M, 2005, CHEM IMMUNOL ALLERGY, V89, P84, DOI 10.1159/000087915; Wold ASD, 2005, CURR OPIN OBSTET GYN, V17, P237; Yamada H, 2005, MOL HUM REPROD, V11, P451, DOI 10.1093/molehr/gah181; Yamada H, 2001, AM J REPROD IMMUNOL, V46, P132, DOI 10.1111/j.8755-8920.2001.460203.x; Yang X, 2008, IMMUOLOGY, V90, P490; [杨新 Yang Xin], 2008, [现代免疫学, Current Immunology], V28, P208; YOKOYAMA WM, 1993, CURR OPIN IMMUNOL, V5, P67, DOI 10.1016/0952-7915(93)90083-5	26	18	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55432	10.1371/journal.pone.0055432	http://dx.doi.org/10.1371/journal.pone.0055432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393578	gold, Green Published, Green Submitted			2022-12-25	WOS:000314692800032
J	Sun, XL; Jones, HP; Dobbs, N; Bodhankar, S; Simecka, JW				Sun, Xiangle; Jones, Harlan P.; Dobbs, Nicole; Bodhankar, Sheetal; Simecka, Jerry W.			Dendritic Cells Are the Major Antigen Presenting Cells in Inflammatory Lesions of Murine Mycoplasma Respiratory Disease	PLOS ONE			English	Article							EOSINOPHILIC AIRWAY INFLAMMATION; MACROPHAGE POPULATIONS; INHALED ANTIGEN; FLOW-CYTOMETRY; TH2 RESPONSES; T-CELLS; MICE; PULMONIS; INFECTION; IMMUNITY	Mycoplasmas cause chronic respiratory diseases in animals and humans, and to date, development of vaccines have been problematic. Using a murine model of mycoplasma pneumonia, lymphocyte responses, specifically T cells, were shown to confer protection as well as promote immunopathology in mycoplasma disease. Because T cells play such a critical role, it is important to define the role of antigen presenting cells (APC) as these cells may influence either exacerbation of mycoplasma disease pathogenesis or enhancement of protective immunity. The roles of APC, such as dendritic cells and/or macrophages, and their ability to modulate adaptive immunity in mycoplasma disease are currently unknown. Therefore, the purpose of this study was to identify individual pulmonary APC populations that may contribute to the activation of T cell responses during mycoplasma disease pathogenesis. The present study indeed demonstrates increasing numbers of CD11c(-) F4/80(+) cells, which contain macrophages, and more mature/activated CD11c(+) F4/80(-) cells, containing DC, in the lungs after infection. CD11c(-) F4/80(+) macrophage-enriched cells and CD11c(+) F4/80(-) dendritic cell-enriched populations showed different patterns of cytokine mRNA expression, supporting the idea that these cells have different impacts on immunity in response to infection. In fact, DC containing CD11c(+) F4/80(-) cell populations from the lungs of infected mice were most capable of stimulating mycoplasma-specific CD4(+) Th cell responses in vitro. In vivo, these CD11c(+) F4/80(-) cells were co-localized with CD4(+) Th cells in inflammatory infiltrates in the lungs of mycoplasma-infected mice. Thus, CD11c(+)F4/80(-) dendritic cells appear to be the major APC population responsible for pulmonary T cell stimulation in mycoplasma-infected mice, and these dendritic cells likely contribute to responses impacting disease pathogenesis.	[Sun, Xiangle; Jones, Harlan P.; Dobbs, Nicole; Bodhankar, Sheetal; Simecka, Jerry W.] Univ N Texas, Hlth Sci Ctr Ft Worth, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Simecka, JW (corresponding author), Univ N Texas, Hlth Sci Ctr Ft Worth, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA.	jerry.simecka@unthsc.edu	Jones, Harlan/ABC-9920-2020		Public Health Service Grant [HL 69431, AI 55907]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI055907] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grants HL 69431 and AI 55907 (to J.W.S.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bertorelli G, 2000, ALLERGY, V55, P449, DOI 10.1034/j.1398-9995.2000.055005449.x; BILYK N, 1995, IMMUNOLOGY, V86, P231; Bjorck P, 2001, BLOOD, V98, P3520, DOI 10.1182/blood.V98.13.3520; Bodhankar S, 2010, J INFECT DIS, V202, P39, DOI 10.1086/653121; CARTNER SC, 1995, INFECT IMMUN, V63, P4138, DOI 10.1128/IAI.63.10.4138-4142.1995; Cartner SC, 1996, INFECT IMMUN, V64, P5326, DOI 10.1128/IAI.64.12.5326-5331.1996; Cartner SC, 1998, INFECT IMMUN, V66, P3485, DOI 10.1128/IAI.66.8.3485-3491.1998; CASSELL GH, 1973, ANN NY ACAD SCI, V225, P395, DOI 10.1111/j.1749-6632.1973.tb45665.x; CASSELL GH, 1982, REV INFECT DIS, V4, pS18; Cochand L, 1999, AM J RESP CELL MOL, V21, P547, DOI 10.1165/ajrcmb.21.5.3785; DAJANI AS, 1965, J EXP MED, V121, P1071, DOI 10.1084/jem.121.6.1071; DAVIDSON MK, 1988, INFECT IMMUN, V56, P2156, DOI 10.1128/IAI.56.8.2156-2162.1988; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; EVENGARD B, 1994, CLIN EXP IMMUNOL, V98, P388; Faulkner L, 2000, IMMUNOLOGY, V99, P523, DOI 10.1046/j.1365-2567.2000.00018.x; FOY HM, 1993, CLIN INFECT DIS, V17, pS37, DOI 10.1093/clinids/17.Supplement_1.S37; Hammad H, 2000, LAB INVEST, V80, P605, DOI 10.1038/labinvest.3780065; HOROWITZ SA, 1987, INFECT IMMUN, V55, P1314, DOI 10.1128/IAI.55.5.1314-1320.1987; Jones HP, 2003, FRONT BIOSCI-LANDMRK, V8, pD930, DOI 10.2741/1098; Jones HP, 2002, J IMMUNOL, V168, P3493, DOI 10.4049/jimmunol.168.7.3493; KEYSTONE EC, 1980, INFECT IMMUN, V27, P192, DOI 10.1128/IAI.27.1.192-196.1980; KRAUSE DC, 1993, MYCOPLASMAS MOL BIOL, P417; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Lambrecht BN, 1999, AM J RESP CELL MOL, V20, P1165, DOI 10.1165/ajrcmb.20.6.3484; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Masten BJ, 1999, J IMMUNOL, V162, P1310; Masten BJ, 1997, AM J RESP CELL MOL, V16, P335, DOI 10.1165/ajrcmb.16.3.9070619; MCWILLIAM AS, 1995, IMMUNOL CELL BIOL, V73, P405, DOI 10.1038/icb.1995.63; Moller GM, 1996, CLIN EXP ALLERGY, V26, P517, DOI 10.1111/j.1365-2222.1996.tb00571.x; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; NICOD LP, 1987, AM REV RESPIR DIS, V136, P818, DOI 10.1164/ajrccm/136.4.818; Osterholzer JJ, 2009, INFECT IMMUN, V77, P3749, DOI 10.1128/IAI.00454-09; POLLARD AM, 1990, J EXP MED, V172, P159, DOI 10.1084/jem.172.1.159; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Sandstedt K, 1997, CLIN EXP IMMUNOL, V108, P490, DOI 10.1046/j.1365-2249.1997.3981294.x; SIMECKA J W, 1992, Regional Immunology, V4, P18; Simecka JW, 2005, MYCOPLASMAS: MOLECULAR BIOLOGY PATHOGENICITY AND STRATEGIES FOR CONTROL, P485; Simecka JW, 2003, RRD INF IMM, V1, P203; SIMECKA JW, 1987, INFECT IMMUN, V55, P731, DOI 10.1128/IAI.55.3.731-735.1987; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Sun XG, 2006, INFECT IMMUN, V74, P5943, DOI 10.1128/IAI.00082-06; Sung SSJ, 2001, J IMMUNOL, V166, P1261, DOI 10.4049/jimmunol.166.2.1261; TAYLOR G, 1974, J MED MICROBIOL, V7, P343, DOI 10.1099/00222615-7-3-343; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Woolard MD, 2004, J IMMUNOL, V172, P6875, DOI 10.4049/jimmunol.172.11.6875; Yancey AL, 2001, INFECT IMMUN, V69, P2865, DOI 10.1128/IAI.69.5.2865-2871.2001	53	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55984	10.1371/journal.pone.0055984	http://dx.doi.org/10.1371/journal.pone.0055984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390557	Green Submitted, Green Published, gold			2022-12-25	WOS:000314691100073
J	Zhou, L; Oh, SY; Zhou, YQ; Yuan, BJ; Wu, F; Oh, MH; Wang, YF; Takemoto, C; Van Rooijen, N; Zheng, T; Zhu, Z				Zhou, Li; Oh, Sun Young; Zhou, Yuqi; Yuan, Baojun; Wu, Fan; Oh, Min Hee; Wang, Yefu; Takemoto, Cliff; Van Rooijen, Nico; Zheng, Tao; Zhu, Zhou			SHP-1 Regulation of Mast Cell Function in Allergic Inflammation and Anaphylaxis	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE SHP-1; MULTIPLE-SCLEROSIS PATIENTS; AIRWAY SMOOTH-MUSCLE; IMMUNODEFICIENT MUTANT; OXIDATIVE STRESS; MOTH-EATEN; ASTHMA; EXPRESSION; LIPOPOLYSACCHARIDE; RESPONSES	Allergic inflammation and severe allergic reactions (anaphylaxis) are important in allergen induced diseases. Bacterial products such as lipopolysaccharide (LPS) are ubiquitous and can facilitate allergen induced Th2 immune responses. Phosphatase SHP-1 is critical in regulating immunological homeostasis and in allergen induced Th2 immune responses in the lung. However, the mechanisms underlying the initiation of allergic inflammation and allergen induced anaphylaxis are still not completely elucidated and it is unclear whether SHP-1 plays any role in LPS-induced airway inflammation and in allergen-induced anaphylaxis. In this study we tested the hypothesis that phosphatase SHP-1 plays an important role in allergic inflammation and anaphylaxis and determined whether its effects are through regulation of mast cell functions. SHP-1 deficient (mev/+ and mev/mev) and mast cell deficient (Kit(W-sh)) mice were examined in their responses to LPS airway stimulation and to ovalbumin (OVA) allergen induced systemic anaphylaxis. Compared to wild type mice, mev/+ mice had significantly enhanced LPS induced airway inflammation and OVA induced anaphylactic responses, including hypothermia and clinical symptoms. These changes were mast cell dependent as Kit(W-sh) mice had reduced responses whereas adoptive transfer of mast cells restored the responses. However, T and B cells were not involved and macrophages did not play a significant role in LPS induced airway inflammation. Interestingly, basophil differentiation from SHP-1 deficient bone marrow cells was significantly reduced. These findings provided evidence that through regulation of mast cell functions SHP-1 plays a critical role as a negative regulator in allergic inflammation and in allergen induced anaphylaxis. In addition, SHP-1 seems to be required for normal basophil development.	[Zhou, Li; Oh, Sun Young; Zhou, Yuqi; Yuan, Baojun; Wu, Fan; Oh, Min Hee; Zheng, Tao; Zhu, Zhou] Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, Baltimore, MD USA; [Takemoto, Cliff] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Hematol, Baltimore, MD 21205 USA; [Wang, Yefu] Wuhan Univ, Ctr Expt Anim, ABSL Lab 3, Wuhan 430072, Peoples R China; [Wang, Yefu] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China; [Van Rooijen, Nico] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Wuhan University; Wuhan University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Zhu, Z (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, Baltimore, MD USA.	zzhu@jhmi.edu	Van Rooijen, Nico/Z-1578-2019; Takemoto, Clifford M/Y-7558-2018	Oh, Min-Hee/0000-0003-1581-4288	National Institutes of Health (NIH) [R01HL079349, P01HL107151, R01AI075025, AI 075025-03S1]; China Scholarship Council grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079349, P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075025] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council grant(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants R01HL079349 and P01HL107151 to ZZ, R01AI075025 and AI 075025-03S1 to TZ, and a China Scholarship Council grant to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias K, 2011, J ALLERGY CLIN IMMUN, V127, P1552, DOI 10.1016/j.jaci.2011.03.044; Bem RA, 2008, AM J PHYSIOL-LUNG C, V295, pL314, DOI 10.1152/ajplung.00210.2007; Branum Amy M, 2008, NCHS Data Brief, P1; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Brightling CE, 2003, CLIN EXP ALLERGY, V33, P1711, DOI 10.1111/j.1365-2222.2003.01827.x; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Chiba N, 2007, J CELL PHYSIOL, V213, P126, DOI 10.1002/jcp.21101; Cho YS, 2008, AM J RESP CELL MOL, V39, P412, DOI 10.1165/rcmb.2007-0229OC; Christophi GP, 2008, LAB INVEST, V88, P243, DOI 10.1038/labinvest.3700720; Christophi GP, 2009, LAB INVEST, V89, P742, DOI 10.1038/labinvest.2009.32; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Jang MK, 2010, BIOCHEM BIOPH RES CO, V393, P137, DOI 10.1016/j.bbrc.2010.01.102; Kamata T, 2003, J CLIN INVEST, V111, P109, DOI 10.1172/JCI200315719; Kim YK, 2007, J IMMUNOL, V178, P5375, DOI 10.4049/jimmunol.178.8.5375; Kumagai C, 2012, J NEUROIMMUNOL, V246, P51, DOI 10.1016/j.jneuroim.2012.03.003; Masuda A, 2002, J IMMUNOL, V169, P3801, DOI 10.4049/jimmunol.169.7.3801; Matsubara S, 2006, AM J RESP CRIT CARE, V173, P56, DOI 10.1164/rccm.200503-361OC; Moorman Jeanne E., 2011, Morbidity and Mortality Weekly Report, V60, P84; National Institute of Allergy and Infectious Diseases, 2003, NIH PUBL; Oh SY, 2009, AM J RESP CELL MOL, V40, P568, DOI 10.1165/rcmb.2008-0225OC; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Reuter S, 2008, EUR RESPIR J, V31, P773, DOI 10.1183/09031936.00058907; Roongapinun S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014174; SHULTZ LD, 1984, AM J PATHOL, V116, P179; SHULTZ LD, 1976, J IMMUNOL, V116, P936; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Sun JF, 2007, J IMMUNOL, V179, P6696, DOI 10.4049/jimmunol.179.10.6696; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang L, 2010, J IMMUNOL, V184, P1180, DOI 10.4049/jimmunol.0901972; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu Z, 2010, CLIN EXP ALLERGY, V40, P536, DOI 10.1111/j.1365-2222.2010.03477.x	38	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55763	10.1371/journal.pone.0055763	http://dx.doi.org/10.1371/journal.pone.0055763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390550	Green Submitted, gold, Green Published			2022-12-25	WOS:000314691100066
J	Hamann, S; Metrailler, S; Schorderet, DF; Cottet, S				Hamann, Severine; Metrailler, Sylviane; Schorderet, Daniel F.; Cottet, Sandra			Analysis of the Cytoprotective Role of alpha-Crystallins in Cell Survival and Implication of the alpha A-Crystallin C-Terminal Extension Domain in Preventing Bax-Induced Apoptosis	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; RETINAL-PIGMENT EPITHELIUM; LEBERS CONGENITAL AMAUROSIS; STAUROSPORINE-INDUCED APOPTOSIS; RPE65(-/-) MOUSE MODEL; B-CRYSTALLIN; IN-VIVO; MITOCHONDRIAL DYSFUNCTION; MACULAR DEGENERATION; MOLECULAR CHAPERONE	alpha-Crystallins, initially described as the major structural proteins of the lens, belong to the small heat shock protein family. Apart from their function as chaperones, alpha-crystallins are involved in the regulation of intracellular apoptotic signals. alpha A- and alpha B-crystallins have been shown to interfere with the mitochondrial apoptotic pathway triggering Bax pro-apoptotic activity and downstream activation of effector caspases. Differential regulation of alpha-crystallins has been observed in several eye diseases such as age-related macular degeneration and stress-induced and inherited retinal degenerations. Although the function of alpha-crystallins in healthy and diseased retina remains poorly understood, their altered expression in pathological conditions argue in favor of a role in cellular defensive response. In the Rpe65(-/-) mouse model of Leber's congenital amaurosis, we previously observed decreased expression of alpha A- and alpha B-crystallins during disease progression, which was correlated with Bax pro-death activity and photoreceptor apoptosis. In the present study, we demonstrated that alpha-crystallins interacted with pro-apoptotic Bax and displayed cytoprotective action against Bax-triggered apoptosis, as assessed by TUNEL and caspase assays. We further observed in staurosporine-treated photoreceptor-like 661W cells stably overexpressing alpha A- or alpha B-crystallin that Bax-dependent apoptosis and caspase activation were inhibited. Finally, we reported that the C-terminal extension domain of alpha A- crystallin was sufficient to provide protection against Bax-triggered apoptosis. Altogether, these data suggest that alpha-crystallins interfere with Bax-induced apoptosis in several cell types, including the cone-derived 661W cells. They further suggest that alpha A-crystallin-derived peptides might be sufficient to promote cytoprotective action in response to apoptotic cell death.	[Hamann, Severine; Metrailler, Sylviane; Schorderet, Daniel F.; Cottet, Sandra] IRO, Sion, Switzerland; [Hamann, Severine; Schorderet, Daniel F.] Swiss Fed Inst Technol EPFL, Sch Life Sci, Lausanne, Switzerland; [Schorderet, Daniel F.; Cottet, Sandra] Univ Lausanne, Dept Ophthalmol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Cottet, S (corresponding author), IRO, Sion, Switzerland.	sandra.cottet@irovision.ch			Swiss National Science Foundation (SNSF) [31003A-138313]; Fondation Telethon Action Suisse (FTAS)	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Fondation Telethon Action Suisse (FTAS)	This research was supported by the Swiss National Science Foundation (SNSF) Grant 31003A-138313 (www.snf.ch) and the Fondation Telethon Action Suisse (FTAS) (www.telethon.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alge CS, 2002, INVEST OPHTH VIS SCI, V43, P3575; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Andley UP, 1998, J BIOL CHEM, V273, P31252, DOI 10.1074/jbc.273.47.31252; Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; Asomugha CO, 2011, MOL VIS, V17, P2356; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Cavusoglu N, 2003, MOL CELL PROTEOMICS, V2, P494, DOI 10.1074/mcp.M300029-MCP200; Cottet S, 2008, APOPTOSIS, V13, P329, DOI 10.1007/s10495-008-0180-2; Cottet S, 2006, FASEB J, V20, P2036, DOI 10.1096/fj.06-6211com; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Dou GR, 2012, FREE RADICAL BIO MED, V53, P1111, DOI 10.1016/j.freeradbiomed.2012.06.042; Dufour EM, 2003, NEUROBIOL DIS, V14, P166, DOI 10.1016/S0969-9961(03)00102-5; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Ghosh JG, 2007, BIOCHEMISTRY-US, V46, P6308, DOI 10.1021/bi700149h; Hamann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006616; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hu WF, 2012, CURR MOL MED, V12, P177, DOI 10.2174/156652412798889036; Johnson PT, 2005, INVEST OPHTH VIS SCI, V46, P4788, DOI 10.1167/iovs.05-0767; Jones SE, 1998, NEUROREPORT, V9, P4161, DOI 10.1097/00001756-199812210-00030; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kannan R, 2012, PROG RETIN IN PRESS; KANTOROW M, 1994, P NATL ACAD SCI USA, V91, P3112, DOI 10.1073/pnas.91.8.3112; Kapphahn RJ, 2003, BIOCHEMISTRY-US, V42, P15310, DOI 10.1021/bi034774e; Kashkar H, 2002, CELL DEATH DIFFER, V9, P750, DOI 10.1038/sj.cdd.4401024; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Maeda A, 1999, INVEST OPHTH VIS SCI, V40, P2788; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; McGreal RS, 2012, BBA-GEN SUBJECTS, V1820, P921, DOI 10.1016/j.bbagen.2012.04.004; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Metrailler S, 2012, EXP EYE RES, V96, P70, DOI 10.1016/j.exer.2011.12.019; Munemasa Y, 2009, INVEST OPHTH VIS SCI, V50, P3869, DOI 10.1167/iovs.08-3138; Murphy KM, 2000, CELL DEATH DIFFER, V7, P102, DOI 10.1038/sj.cdd.4400597; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Pasupuleti N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.3; Rao NA, 2008, INVEST OPHTH VIS SCI, V49, P1161, DOI 10.1167/iovs.07-1259; Rao NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033582; Reddy GB, 2006, IUBMB LIFE, V58, P632, DOI 10.1080/15216540601010096; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; Santhoshkumar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019291; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xi JH, 2003, MOL VIS, V9, P410; Yaung J, 2008, EXP EYE RES, V86, P355, DOI 10.1016/j.exer.2007.11.007; Yaung J, 2007, MOL VIS, V13, P566; Ying X, 2008, J MOL NEUROSCI, V35, P253, DOI 10.1007/s12031-007-9010-1; Yoshimura N, 2003, INVEST OPHTH VIS SCI, V44, P2211, DOI 10.1167/iovs.02-0704; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	61	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55372	10.1371/journal.pone.0055372	http://dx.doi.org/10.1371/journal.pone.0055372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383327	gold, Green Published, Green Submitted			2022-12-25	WOS:000314597900034
J	Bartasun, P; Cieslinski, H; Bujacz, A; Wierzbicka-Wos, A; Kur, J				Bartasun, Paulina; Cieslinski, Hubert; Bujacz, Anna; Wierzbicka-Wos, Anna; Kur, Jozef			A Study on the Interaction of Rhodamine B with Methylthioadenosine Phosphorylase Protein Sourced from an Antarctic Soil Metagenomic Library	PLOS ONE			English	Article							5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE; FLUORESCENCE; IDENTIFICATION; LIPASE; PURIFICATION; REFINEMENT; RESOLUTION; CRYSTAL; BINDING	The presented study examines the phenomenon of the fluorescence under UV light excitation (312 nm) of E. coli cells expressing a novel metagenomic-derived putative methylthioadenosine phosphorylase gene, called rsfp, grown on LB agar supplemented with a fluorescent dye rhodamine B. For this purpose, an rsfp gene was cloned and expressed in an LMG194 E. coli strain using an arabinose promoter. The resulting RSFP protein was purified and its UV-VIS absorbance spectrum and emission spectrum were assayed. Simultaneously, the same spectroscopic studies were carried out for rhodamine B in the absence or presence of RSFP protein or native E. coli proteins, respectively. The results of the spectroscopic studies suggested that the fluorescence of E. coli cells expressing rsfp gene under UV illumination is due to the interaction of rhodamine B molecules with the RSFP protein. Finally, this interaction was proved by a crystallographic study and then by site-directed mutagenesis of rsfp gene sequence. The crystal structures of RSFP apo form (1.98 angstrom) and complex RSFP/RB (1.90 angstrom) show a trimer of RSFP molecules located on the crystallographic six fold screw axis. The RSFP complex with rhodamine B revealed the binding site for RB, in the pocket located on the interface between symmetry related monomers.	[Bartasun, Paulina; Cieslinski, Hubert; Kur, Jozef] Gdansk Univ Technol, Fac Chem, Dept Microbiol, Gdansk, Poland; [Bujacz, Anna] Lodz Univ Technol, Inst Tech Biochem, Lodz, Poland; [Wierzbicka-Wos, Anna] Univ Szczecin, Fac Biol, Dept Microbiol, Szczecin, Poland	Fahrenheit Universities; Gdansk University of Technology; Lodz University of Technology; University of Szczecin	Cieslinski, H (corresponding author), Gdansk Univ Technol, Fac Chem, Dept Microbiol, Gdansk, Poland.	hcieslin@pg.gda.pl	Wierzbicka-Woś, Anna/AAI-9544-2020; Bujacz, Anna/M-4464-2018; Wierzbicka-Woś, Anna/E-1089-2012	Wierzbicka-Woś, Anna/0000-0002-8416-5077; Bujacz, Anna/0000-0002-0808-1349; Wierzbicka-Woś, Anna/0000-0002-8416-5077; , Hubert/0000-0002-3504-2257; Cieslinski, Hubert/0000-0003-0573-0830				Afonine PV, 2007, ACTA CRYSTALLOGR D, V63, P1194, DOI 10.1107/S0907444907046148; Appleby TC, 2001, J BIOL CHEM, V276, P39232, DOI 10.1074/jbc.M105694200; Appleby TC, 1999, STRUCTURE, V7, P629, DOI 10.1016/S0969-2126(99)80084-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai HH, 2010, COLLOID SURFACE A, V372, P35, DOI 10.1016/j.colsurfa.2010.09.017; Castro-Ochoa LD, 2005, ENZYME MICROB TECH, V37, P648, DOI 10.1016/j.enzmictec.2005.06.003; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; Cieslinski H, 2009, POL J MICROBIOL, V58, P199; Cieslinski H, 2009, FEMS MICROBIOL LETT, V299, P232, DOI 10.1111/j.1574-6968.2009.01756.x; Deyl Z, 1998, J CHROMATOGR LIBR, V60, P465, DOI 10.1016/S0301-4770(08)60310-3; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faoro H, 2011, ENV MICROBIOL REP, V3, P750, DOI 10.1111/j.1758-2229.2011.00295.x; GOLLNICK K, 1981, TETRAHEDRON LETT, V22, P4049, DOI 10.1016/S0040-4039(01)82062-1; KEMNITZ K, 1986, J PHYS CHEM-US, V90, P5094, DOI 10.1021/j100412a043; KEMNITZ K, 1983, CHEM PHYS LETT, V101, P337, DOI 10.1016/0009-2614(83)87489-2; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muthuraman G, 2009, J IND ENG CHEM, V15, P841, DOI 10.1016/j.jiec.2009.09.010; Oplatowska M, 2011, ANALYST, V136, P2403, DOI 10.1039/c0an00934b; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAMETTE RW, 1956, J AM CHEM SOC, V78, P4872, DOI 10.1021/ja01600a017; SHAPIRO SH, 1988, ANN CLIN LAB SCI, V18, P451; TRUANT J P, 1962, Henry Ford Hosp Med Bull, V10, P287; VANDERAUWERAER M, 1988, LANGMUIR, V4, P583, DOI 10.1021/la00081a016; WESSELY Z, 1981, STAIN TECHNOL, V56, P169, DOI 10.3109/10520298109067305; Whitehead KA, 2009, INT J FOOD MICROBIOL, V135, P75, DOI 10.1016/j.ijfoodmicro.2009.07.003; Wierzbicka-Wos A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-108; Winn MD, 2002, ACTA CRYSTALLOGR D, V58, P1929, DOI 10.1107/S0907444902016116; Zhang Y, 2006, J MOL BIOL, V357, P252, DOI 10.1016/j.jmb.2005.12.040; Zhao X, 2009, DYES PIGMENTS, V80, P212, DOI 10.1016/j.dyepig.2008.07.003; Zhu J, 2009, SENSOR ACTUAT B-CHEM, V138, P9, DOI 10.1016/j.snb.2009.02.054	35	21	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55697	10.1371/journal.pone.0055697	http://dx.doi.org/10.1371/journal.pone.0055697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383268	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600148
J	Krishnaiah, SY; Dodia, C; Feinstein, SI; Fisher, AB				Krishnaiah, Saikumari Y.; Dodia, Chandra; Feinstein, Sheldon I.; Fisher, Aron B.			p67(phox) terminates the phospholipase A(2)-derived signal for activation of NADPH oxidase (NOX2)	FASEB JOURNAL			English	Article						peroxiredoxin 6; reactive oxygen species; protein-protein interactions; pulmonary microvascular endothelium	A(2) ACTIVITY; PEROXIREDOXIN 6; COMPONENT P67(PHOX); ENDOTHELIAL-CELLS; PROTEIN; PHOSPHORYLATION; PEROXIDASE; STRESS; ENZYME	The phospholipase A(2) (PLA(2)) activity of phosphorylated peroxiredoxin 6 (Prdx6) is required for activation of NADPH oxidase (NOX2). We investigated the interaction of Prdx6 with p67(phox) and its effect on NOX2 activity. With the use of specific antibodies, coimmunoprecipitation of p67(phox) and phosphorylated Prdx6 was demonstrated with lysates of mouse pulmonary microvascular endothelial cells (MPMVECs) that were stimulated with angiotensin II; the interaction of p67(phox) with nonphosphorylated Prdx6 was relatively weak. Association of p67(phox) and phosphoPrdx6 in intact MPMVECs after angiotensin II stimulation was demonstrated by proximity ligation assay and was abolished by U0126, a MAP kinase inhibitor. By isothermal titration calorimetry, p67(phox) bound strongly to phosphoPrdx6 but bound poorly to Prdx6; phosphorylated p67(phox) did not bind to either Prdx6 or phosphoPrdx6. PLA(2) activity of recombinant phosphoPrdx6 was decreased by > 98% in the presence of p67(phox); the calculated dissociation constant (K-d) of the p67phox: phosphoPrdx6 complex was 65 nM. PLA(2) activity (MJ33 sensitive) in cell lysates following angiotensin II treatment of MPMVECs was increased by 85% following knockdown of p67(phox) with siRNA. These data indicate that p67(phox) binds to phosphoPrdx6 and inhibits its PLA(2) activity, an interaction that could function to terminate the PLA(2)-mediated NOX2 activation signal.-Krishnaiah, S. Y., Dodia, C., Feinstein, S. I., and Fisher, A. B. p67(phox) terminates the phospholipase A(2)-derived signal for activation of NADPH oxidase (NOX2). FASEB J. 27, 2066-2073 (2013). www.fasebj.org	[Krishnaiah, Saikumari Y.; Dodia, Chandra; Feinstein, Sheldon I.; Fisher, Aron B.] Univ Penn, Inst Environm Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Fisher, AB (corresponding author), Univ Penn, Inst Environm Med, 3620 Hamilton Walk,1 John Morgan Bldg, Philadelphia, PA 19104 USA.	abf@mail.med.upenn.edu	Krishnaiah, Saikumari/I-7140-2016		U.S. National Institutes of Health [HL 105509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105509] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank David Speicher, Shampa Chatterjee, Luis Ralat, Suiping Zhao, and Sandy Harper for helpful advice, and Yu-Chin Lien for assistance with the Duolink assay. The authors thank Molly McGoey for typing the manuscript. This research has been presented, in part, as a poster at the 2012 Experimental Biology meeting in San Diego, CA, USA. Grant support was provided by HL 105509 from the U.S. National Institutes of Health. The authors declare no conflicts of interest.	Ambruso DR, 2012, BIOCHIM BIOPHYS ACTA, V1823, P306, DOI [10.1016/j.bbamcr.2011.11.014, DOI 10.1016/J.BBAMCR.2011.11.014]; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; Chatterjee S, 2011, J BIOL CHEM, V286, P11696, DOI 10.1074/jbc.M110.206623; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Dang PMC, 2003, BIOCHEMISTRY-US, V42, P4520, DOI 10.1021/bi0205754; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; Ellison MA, 2012, EUR J IMMUNOL, V42, P1609, DOI 10.1002/eji.201142157; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Fisher AB, 1996, J LIPID RES, V37, P1057; Forbes LV, 1999, BIOCHEM J, V338, P99, DOI 10.1042/0264-6021:3380099; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Leavey PJ, 2002, J BIOL CHEM, V277, P45181, DOI 10.1074/jbc.M202869200; Lien YC, 2012, ANTIOXID REDOX SIGN, V16, P440, DOI 10.1089/ars.2011.3950; Milovanova T, 2008, BBA-MOL CELL RES, V1783, P1866, DOI 10.1016/j.bbamcr.2008.05.010; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P841, DOI [10.1089/ars.2008.2231, 10.1089/ARS.2008.2231]; Rahaman H, 2012, BIOCHEMISTRY-US, V51, P5521, DOI 10.1021/bi300380h; SEGAL AW, 1989, BIOCHEM SOC T, V17, P427, DOI 10.1042/bst0170427; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Wu Y, 2009, BIOCHEM J, V419, P669, DOI 10.1042/BJ20082061; Wu YZ, 2006, J BIOL CHEM, V281, P7515, DOI 10.1074/jbc.M504525200	24	19	19	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2013	27	5					2066	2073		10.1096/fj.12-222133	http://dx.doi.org/10.1096/fj.12-222133			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23401562	Green Published			2022-12-25	WOS:000318226100026
J	Boiko, N; Kucher, V; Eaton, BA; Stockand, JD				Boiko, Nina; Kucher, Volodymyr; Eaton, Benjamin A.; Stockand, James D.			Inhibition of Neuronal Degenerin/Epithelial Na+ Channels by the Multiple Sclerosis Drug 4-Aminopyridine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; GATED POTASSIUM CHANNELS; FUNCTIONAL EXPRESSION; SYMPTOMATIC TREATMENT; AXONAL DEGENERATION; K+ CHANNEL; ACID; BLOCK; RECEPTORS; ISCHEMIA	The voltage-gated K+ (Kv) channel blocker 4-aminopyridine (4-AP) is used to target symptoms of the neuroinflammatory disease multiple sclerosis (MS). By blocking Kv channels, 4-AP facilitates action potential conduction and neurotransmitter release in presynaptic neurons, lessening the effects of demyelination. Because they conduct inward Na+ and Ca2(+) currents that contribute to axonal degeneration in response to inflammatory conditions, acid-sensing ion channels (ASICs) contribute to the pathology of MS. Consequently, ASICs are emerging as disease-modifying targets in MS. Surprisingly, as first demonstrated here, 4-AP inhibits neuronal degenerin/epithelial Na+ (Deg/ENaC) channels, including ASIC and BLINaC. This effect is specific for 4-AP compared with its heterocyclic base, pyridine, and the related derivative, 4-methylpyridine; and akin to the actions of 4-AP on the structurally unrelated Kv channels, dose- and voltage-dependent. 4-AP has differential actions on distinct ASICs, strongly inhibiting ASIC1a channels expressed in central neurons but being without effect on ASIC3, which is enriched in peripheral sensory neurons. The voltage dependence of the 4-AP block and the single binding site for this inhibitor are consistent with 4-AP binding in the pore of Deg/ENaC channels as it does Kv channels, suggesting a similar mechanism of inhibition in these two classes of channels. These findings argue that effects on both Kv and Deg/ENaC channels should be considered when evaluating the actions of 4-AP. Importantly, the current results are consistent with 4-AP influencing the symptoms of MS as well as the course of the disease because of inhibitory actions on Kv and ASIC channels, respectively.	[Boiko, Nina; Kucher, Volodymyr; Eaton, Benjamin A.; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Stockand, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	stockand@uthscsa.edu		Stockand, James/0000-0002-3817-4319	National Institutes of Health Grant [R01 DK059594]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062811] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK059594 (to J. D. S.).	Armstrong CM, 2001, BIOPHYS J, V81, P895, DOI 10.1016/S0006-3495(01)75749-9; Berdiev BK, 2002, J BIOL CHEM, V277, P45734, DOI 10.1074/jbc.M208995200; Boiko N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.411736; Bolshakov KV, 2002, NEUROSCIENCE, V110, P723, DOI 10.1016/S0306-4522(01)00582-6; CAMPBELL DL, 1993, J GEN PHYSIOL, V101, P603, DOI 10.1085/jgp.101.4.603; CHOQUET D, 1992, J GEN PHYSIOL, V99, P217, DOI 10.1085/jgp.99.2.217; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Filippova N, 2001, J PHYSIOL-LONDON, V535, P145, DOI 10.1111/j.1469-7793.2001.00145.x; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HEINEMANN SH, 1988, BIOPHYS J, V54, P757, DOI 10.1016/S0006-3495(88)83013-3; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hunt T, 2012, BIOORG MED CHEM LETT, V22, P929, DOI 10.1016/j.bmcl.2011.12.016; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; Kalia J, 2011, MOL PHARMACOL, V80, P1085, DOI 10.1124/mol.111.074989; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; KIRSCH GE, 1993, J GEN PHYSIOL, V102, P797, DOI 10.1085/jgp.102.5.797; Korenke AR, 2008, ANN PHARMACOTHER, V42, P1458, DOI 10.1345/aph.1L028; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Kucher V, 2011, BIOPHYS J, V100, P1930, DOI 10.1016/j.bpj.2011.02.046; Lassmann H, 2007, J NEUROL SCI, V259, P3, DOI 10.1016/j.jns.2006.08.016; Leng TD, 2013, ACTA PHARMACOL SIN, V34, P33, DOI 10.1038/aps.2012.81; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Nikolaeva MA, 2005, J NEUROSCI, V25, P9960, DOI 10.1523/JNEUROSCI.2003-05.2005; O'Dowd D. K., 2007, JOVE-J VIS EXP, V5, P226, DOI [10.3791/226, DOI 10.3791/226]; Petrescu N, 2007, MUSCLE NERVE, V35, P451, DOI 10.1002/mus.20731; Pietra F, 2012, CHEM BIODIVERS, V9, P331, DOI 10.1002/cbdv.201100260; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Solari A, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001330; Staruschenko A, 2007, DEV NEUROBIOL, V67, P97, DOI 10.1002/dneu.20338; Stys PK, 2005, J NEUROL SCI, V233, P3, DOI 10.1016/j.jns.2005.03.031; THOMPSON S, 1982, J GEN PHYSIOL, V80, P1, DOI 10.1085/jgp.80.1.1; VANDIEMEN HAM, 1993, CLIN NEUROPHARMACOL, V16, P195, DOI 10.1097/00002826-199306000-00002; Vergo S, 2011, BRAIN, V134, P571, DOI 10.1093/brain/awq337; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; Wiemuth D, 2011, MOL PHARMACOL, V80, P911, DOI 10.1124/mol.111.073726; Wu ZZ, 2009, J BIOL CHEM, V284, P36453, DOI 10.1074/jbc.M109.075523; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; YELLEN G, 1984, J GEN PHYSIOL, V84, P157, DOI 10.1085/jgp.84.2.157; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	53	29	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9418	9427		10.1074/jbc.M112.449413	http://dx.doi.org/10.1074/jbc.M112.449413			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404498	Green Published, hybrid			2022-12-25	WOS:000316862200058
J	Higashi, S; Hirose, T; Takeuchi, T; Miyazaki, K				Higashi, Shouichi; Hirose, Tomokazu; Takeuchi, Tomoka; Miyazaki, Kaoru			Molecular Design of a Highly Selective and Strong Protein Inhibitor against Matrix Metalloproteinase-2 (MMP-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; AMINO-ACID-RESIDUES; TISSUE INHIBITOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; EXTRACELLULAR-MATRIX; IV COLLAGENASE; CELL-MIGRATION; BINDING; CANCER	Synthetic inhibitors of matrix metalloproteinases (MMPs), designed previously, as well as tissue inhibitors of metalloproteinases (TIMPs) lack enzyme selectivity, which has been a major obstacle for developing inhibitors into safe and effective MMP-targeted drugs. Here we designed a fusion protein named APP-IP-TIMP-2, in which the ten amino acid residue sequence of APP-derived MMP-2 selective inhibitory peptide (APP-IP) is added to the N terminus of TIMP-2. The APP-IP and TIMP-2 regions of the fusion protein are designed to interact with the active site and the hemopexin-like domain of MMP-2, respectively. The reactive site of the TIMP-2 region, which has broad specificity against MMPs, is blocked by the APP-IP adduct. The recombinant APP-IP-TIMP-2 showed strong inhibitory activity toward MMP-2 (K-i(app) = 0.68 pM), whereas its inhibitory activity toward MMP-1, MMP-3, MMP-7, MMP-8, MMP-9, or MT1-MMP was six orders of magnitude or more weaker (IC50 > 1 mu M). The fusion protein inhibited the activation of pro-MMP-2 in the concanavalin A-stimulated HT1080 cells, degradation of type IV collagen by the cells, and the migration of stimulated cells. Compared with the decapeptide APP-IP (t(1/2) = 30 min), APP-IP-TIMP-2 (t(1/2) >> 96 h) showed a much longer half-life in cultured tumor cells. Therefore, the fusion protein may be a useful tool to evaluate contributions of proteolytic activity of MMP-2 in various pathophysiological processes. It may also be developed as an effective anti-tumor drug with restricted side effects.	[Higashi, Shouichi; Hirose, Tomokazu; Takeuchi, Tomoka; Miyazaki, Kaoru] Yokohama City Univ, Grad Sch Nanobiosci, Dept Genome Syst Sci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan	Yokohama City University	Higashi, S (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	shigashi@yokohama-cu.ac.jp			Strategic Research Promotion of Yokohama City University, Japan, JST (Research for Promoting Technological Seeds) [T2401]; Extramural Collaborative Research Grant from the Cancer Research Institute, Kanazawa University, Japan	Strategic Research Promotion of Yokohama City University, Japan, JST (Research for Promoting Technological Seeds); Extramural Collaborative Research Grant from the Cancer Research Institute, Kanazawa University, Japan	This work was supported in part by Grant No. T2401 (to S. H.) from the 2012 Strategic Research Promotion of Yokohama City University, Japan, JST (Research for Promoting Technological Seeds, to S. H.), and an Extramural Collaborative Research Grant from the Cancer Research Institute, Kanazawa University, Japan (to S. H.).	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Betz M, 1997, EUR J BIOCHEM, V247, P356, DOI 10.1111/j.1432-1033.1997.00356.x; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Dublanchet AC, 2005, BIOORG MED CHEM LETT, V15, P3787, DOI 10.1016/j.bmcl.2005.05.079; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Finzel BC, 1998, PROTEIN SCI, V7, P2118, DOI 10.1002/pro.5560071008; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Gooyit M, 2011, J MED CHEM, V54, P6676, DOI 10.1021/jm200566e; Hashimoto H, 2011, J BIOL CHEM, V286, P33236, DOI 10.1074/jbc.M111.264176; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Higashi S, 2008, J BIOL CHEM, V283, P10068, DOI 10.1074/jbc.M709509200; Higashi S, 2008, J BIOL CHEM, V283, P35735, DOI 10.1074/jbc.M806285200; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Jia MC, 2000, ADV EXP MED BIOL, V476, P181; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; LIOTTA LA, 1986, CANCER RES, V46, P1; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; MIYAZAKI K, 1990, CANCER RES, V50, P7758; Momi S, 2009, J EXP MED, V206, P2365, DOI 10.1084/jem.20090687; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Murphy DJ, 2004, ANAL BIOCHEM, V327, P61, DOI 10.1016/j.ab.2003.12.018; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Pochetti G, 2009, J MED CHEM, V52, P1040, DOI 10.1021/jm801166j; Rosenblum G, 2003, J BIOL CHEM, V278, P27009, DOI 10.1074/jbc.M301139200; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shofuda K, 1998, J BIOCHEM-TOKYO, V124, P462, DOI 10.1093/oxfordjournals.jbchem.a022136; Soejima K, 2003, BLOOD, V102, P3232, DOI 10.1182/blood-2003-03-0908; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Takeda S, 2012, BBA-PROTEINS PROTEOM, V1824, P164, DOI 10.1016/j.bbapap.2011.04.009; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; Williams J W, 1979, Methods Enzymol, V63, P437; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Yana I, 2002, CLIN EXP METASTAS, V19, P209, DOI 10.1023/A:1015527220537; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644	53	19	20	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9066	9076		10.1074/jbc.M112.441758	http://dx.doi.org/10.1074/jbc.M112.441758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23395821	Green Published, hybrid			2022-12-25	WOS:000316862200026
J	Wei, JJ; Zhang, Y; Ivanov, IP; Sachs, MS				Wei, Jiajie; Zhang, Ying; Ivanov, Ivaylo P.; Sachs, Matthew S.			The Stringency of Start Codon Selection in the Filamentous Fungus Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUG TRANSLATION INITIATION; MODULATES AUTOREGULATION; REGULATORY SEQUENCES; RNA-POLYMERASE; IN-VIVO; CONTEXT; RECOGNITION; GENES; ARABIDOPSIS; UPSTREAM	In eukaryotic cells initiation may occur from near-cognate codons that differ from AUG by a single nucleotide. The stringency of start codon selection impacts the efficiency of initiation at near-cognate codons and the efficiency of initiation at AUG codons in different contexts. We used a codon-optimized firefly luciferase reporter initiated with AUG or each of the nine near-cognate codons in preferred context to examine the stringency of start codon selection in the model filamentous fungus Neurospora crassa. In vivo results indicated that the hierarchy of initiation at start codons in N. crassa (AUG >> CUG > GUG > ACG > AUA approximate to UUG > AUU > AUC) is similar to that in human cells. Similar results were obtained by translating mRNAs in a homologous N. crassa in vitro translation system or in rabbit reticulocyte lysate. We next examined the efficiency of initiation at AUG, CUG, and UUG codons in different contexts in vitro. The preferred context was more important for efficient initiation from near-cognate codons than from AUG. These studies demonstrated that near-cognate codons are used for initiation in N. crassa. Such events could provide additional coding capacity or have regulatory functions. Analyses of the 5'-leader regions in the N. crassa transcriptome revealed examples of highly conserved near-cognate codons in preferred contexts that could extend the N termini of the predicted polypeptides.	[Wei, Jiajie; Zhang, Ying; Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Ivanov, Ivaylo P.] Univ Coll Cork, Dept Biochem, Cork, Ireland	Texas A&M University System; Texas A&M University College Station; University College Cork	Sachs, MS (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	msachs@bio.tamu.edu		Ivanov, Ivaylo/0000-0002-4793-5466; Sachs, Matthew/0000-0001-9891-9223; Zhang, Ying/0000-0002-1238-0456; Ivanov, Ivaylo/0000-0002-6008-3261	National Institutes of Health [GM47498, GM068087]; Science Foundation Ireland Grant [08/IN.1/B1889]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087, R01GM047498, R29GM047498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland Grant(Science Foundation Ireland); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM47498 and GM068087 (to M. S. S.).; Supported by Science Foundation Ireland Grant 08/IN.1/B1889 to J.F. Atkins.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Chang CP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-188; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; Christensen AC, 2005, PLANT CELL, V17, P2805, DOI 10.1105/tpc.105.035287; CLEMENTS JM, 1988, MOL CELL BIOL, V8, P4533, DOI 10.1128/MCB.8.10.4533; Conlon H, 2001, MOL MICROBIOL, V40, P361, DOI 10.1046/j.1365-2958.2001.02399.x; Dementhon K, 2004, MOL MICROBIOL, V53, P1625, DOI 10.1111/j.1365-2958.2004.04235.x; DONAHUE TF, 1988, MOL CELL BIOL, V8, P2955, DOI 10.1128/MCB.8.7.2955; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Fang P, 2000, J BIOL CHEM, V275, P26710; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; GORDON K, 1992, PLANT J, V2, P809, DOI 10.1046/j.1365-313X.1992.t01-17-00999.x; Grundemann D, 1996, BIOTECHNIQUES, V21, P898; GUTIERREZ S, 1991, J BACTERIOL, V173, P2354; Hedtke B, 2002, PLANT J, V30, P625, DOI 10.1046/j.1365-313X.2002.01318.x; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Ivanov IP, 2010, P NATL ACAD SCI USA, V107, P18056, DOI 10.1073/pnas.1009269107; Jacobs GH, 2009, NUCLEIC ACIDS RES, V37, pD72, DOI 10.1093/nar/gkn763; Johansson MJO, 2010, GENE DEV, V24, P1491, DOI 10.1101/gad.1930710; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kobayashi Y, 2002, BIOCHEM BIOPH RES CO, V299, P57, DOI 10.1016/S0006-291X(02)02579-2; Kochetov AV, 2013, J BIOMOL STRUCT DYN, V31, P103, DOI 10.1080/07391102.2012.691367; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Loughran G, 2012, NUCLEIC ACIDS RES, V40, P2898, DOI 10.1093/nar/gkr1192; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; LUO ZG, 1995, MOL CELL BIOL, V15, P5235; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Martin-Marcos P, 2011, MOL CELL BIOL, V31, P4814, DOI 10.1128/MCB.05819-11; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Nakagawa S, 2008, NUCLEIC ACIDS RES, V36, P861, DOI 10.1093/nar/gkm1102; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Park EH, 2011, EMBO J, V30, P302, DOI 10.1038/emboj.2010.312; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; PORTIS JL, 1994, J VIROL, V68, P3879, DOI 10.1128/JVI.68.6.3879-3887.1994; Riechmann JL, 1999, MOL CELL BIOL, V19, P8505; Robert F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005428; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; SACHS MS, 1991, DEV BIOL, V148, P117, DOI 10.1016/0012-1606(91)90322-T; Simpson GG, 2010, PLANT CELL, V22, P3764, DOI 10.1105/tpc.110.077990; Singh CR, 2012, MOL CELL BIOL, V32, P3978, DOI 10.1128/MCB.00376-12; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Takahashi K, 2005, GENOMICS, V85, P360, DOI 10.1016/j.ygeno.2004.11.012; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; Vaughn JN, 2012, RNA, V18, P368, DOI 10.1261/rna.031179.111; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang Z, 1998, MOL CELL BIOL, V18, P7528, DOI 10.1128/MCB.18.12.7528; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; Wei JJ, 2012, MOL CELL BIOL, V32, P2396, DOI 10.1128/MCB.00136-12; Wilke CO, 2010, CURR OPIN STRUC BIOL, V20, P385, DOI 10.1016/j.sbi.2010.03.004; Wu C, 2007, METHOD ENZYMOL, V429, P203, DOI 10.1016/S0076-6879(07)29010-X; Xie WB, 2012, P NATL ACAD SCI USA, V109, P8161, DOI 10.1073/pnas.1201262109; Zhang A, 1997, CELL MOL LIFE SCI, V53, P69, DOI 10.1007/PL00000581; Zhang F, 2011, NUCLEIC ACIDS RES, V39, P3128, DOI 10.1093/nar/gkq1251; Zhou M., 2013, NATURE IN PRESS; [No title captured]	73	28	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9549	9562		10.1074/jbc.M112.447177	http://dx.doi.org/10.1074/jbc.M112.447177			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396971	Green Published, hybrid			2022-12-25	WOS:000316862200069
J	Aswendt, M; Adamczak, J; Couillard-Despres, S; Hoehn, M				Aswendt, Markus; Adamczak, Joanna; Couillard-Despres, Sebastien; Hoehn, Mathias			Boosting Bioluminescence Neuroimaging: An Optimized Protocol for Brain Studies	PLOS ONE			English	Article							FIREFLY LUCIFERASE INHIBITION; IN-VIVO; MAMMALIAN-CELLS; GENE-EXPRESSION; LIVING MICE; STEM-CELL; REPORTER GENE; LONG-TERM; ANESTHETICS; MODEL	Bioluminescence imaging is widely used for optical cell tracking approaches. However, reliable and quantitative bioluminescence of transplanted cells in the brain is highly challenging. In this study we established a new bioluminescence imaging protocol dedicated for neuroimaging, which increases sensitivity especially for noninvasive tracking of brain cell grafts. Different D-Luciferin concentrations (15, 150, 300 and 750 mg/kg), injection routes (iv, ip, sc), types of anesthesia (Isoflurane, Ketamine/Xylazine, Pentobarbital) and timing of injection were compared using DCX-Luc transgenic mice for brain specific bioluminescence. Luciferase kinetics was quantitatively evaluated for maximal photon emission, total photon emission and time-to-peak. Photon emission followed a D-Luciferin dose-dependent relation without saturation, but with delay in time-to-peak increasing for increasing concentrations. The comparison of intravenous, subcutaneous and intraperitoneal substrate injection reflects expected pharmacokinetics with fastest and highest photon emission for intravenous administration. Ketamine/Xylazine and Pentobarbital anesthesia showed no significant beneficial effect on maximal photon emission. However, a strong difference in outcome was observed by injecting the substrate pre Isoflurane anesthesia. This protocol optimization for brain specific bioluminescence imaging comprises injection of 300 mg/kg D-Luciferin pre Isoflurane anesthesia as an efficient and stable method with a signal gain of approx. 200% (compared to 150 mg/kg post Isoflurane). Gain in sensitivity by the novel imaging protocol was quantitatively assessed by signal-to-noise calculations of luciferase-expressing neural stem cells grafted into mouse brains (transplantation of 3,000-300,000 cells). The optimized imaging protocol lowered the detection limit from 6,000 to 3,000 cells by a gain in signal-to-noise ratio.	[Aswendt, Markus; Adamczak, Joanna; Hoehn, Mathias] Max Planck Inst Neurol Res, In Vivo NMR Lab, D-50931 Cologne, Germany; [Couillard-Despres, Sebastien] Paracelsus Med Univ, Inst Mol Regenerat Med, Salzburg, Austria; [Couillard-Despres, Sebastien] Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria	Max Planck Society; Paracelsus Private Medical University	Hoehn, M (corresponding author), Max Planck Inst Neurol Res, In Vivo NMR Lab, Gleueler Str 50, D-50931 Cologne, Germany.	mathias@nf.mpg.de	Aswendt, Markus/L-2743-2019	Aswendt, Markus/0000-0003-1423-0934; Hummer, Joanna/0000-0002-0329-2892; Couillard-Despres, Sebastien/0000-0002-8486-6412	Volkswagen Foundation [I/83443]; EU-FP7 program ENCITE [HEALTH-F5-2008-201842, HEALTH-F2-2012-279017]	Volkswagen Foundation(Volkswagen); EU-FP7 program ENCITE	This work was financially supported by grants from the Volkswagen Foundation (I/83443) and the EU-FP7 program ENCITE (HEALTH-F5-2008-201842) and TargetBraIn (HEALTH-F2-2012-279017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger F, 2008, EUR J NUCL MED MOL I, V35, P2275, DOI 10.1007/s00259-008-0870-6; Choy G, 2003, BIOTECHNIQUES, V35, P1022, DOI 10.2144/03355rr02; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Couillard-Despres S, 2008, MOL IMAGING, V7, P28, DOI 10.2310/7290.2008.0004; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Edinger M, 2002, EUR J CANCER, V38, P2128, DOI 10.1016/S0959-8049(02)00410-0; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; Gerbino P. P., 2005, REMINGTON SCI PRACTI; Gissel C, 2005, THROMB HAEMOSTASIS, V94, P719, DOI 10.1160/TH05-05-0338; Hasan MT, 2001, GENESIS, V29, P116, DOI 10.1002/gene.1014; Hildebrandt IJ, 2008, ILAR J, V49, P17, DOI 10.1093/ilar.49.1.17; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Keyaerts M, 2008, EUR J NUCL MED MOL I, V35, P999, DOI 10.1007/s00259-007-0664-2; Keyaerts M, 2012, PLOS ONE, V7, P374, DOI 10.1371/journal.pone.0030061; Keyaerts M, 2012, TRENDS MOL MED, V18, P164, DOI 10.1016/j.molmed.2012.01.005; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Lee KH, 2003, NUCL MED COMMUN, V24, P1003, DOI 10.1097/00006231-200309000-00009; Leitao JMM, 2010, J PHOTOCH PHOTOBIO B, V101, P1, DOI 10.1016/j.jphotobiol.2010.06.015; LEMBERT N, 1995, BIOCHEM J, V305, P929, DOI 10.1042/bj3050929; Lipshutz GS, 2001, MOL THER, V3, P284, DOI 10.1006/mthe.2001.0267; Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NGUYEN VT, 1988, ANAL BIOCHEM, V171, P404, DOI 10.1016/0003-2697(88)90505-2; Pawson P, 2008, SMALL ANIMAL CLIN PH; Pendharkar AV, 2010, STROKE, V41, P2064, DOI 10.1161/STROKEAHA.109.575993; Pesnel S, 2011, MOL IMAGING BIOL, V13, P646, DOI 10.1007/s11307-010-0387-9; Pichler A, 2004, P NATL ACAD SCI USA, V101, P1702, DOI 10.1073/pnas.0304326101; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Sher F, 2009, STEM CELLS, V27, P1582, DOI 10.1002/stem.76; Sutton EJ, 2008, EUR RADIOL, V18, P2021, DOI 10.1007/s00330-008-0984-z; Szarecka A, 2007, BIOPHYS J, V93, P1895, DOI 10.1529/biophysj.106.102780; Tang Y, 2003, HUM GENE THER, V14, P1247, DOI 10.1089/104303403767740786; Wang WG, 2003, CANCER BIOL THER, V2, P196, DOI 10.4161/cbt.2.2.347; Zuurbier CJ, 2002, AM J PHYSIOL-HEART C, V282, pH2099, DOI 10.1152/ajpheart.01002.2001	39	58	58	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55662	10.1371/journal.pone.0055662	http://dx.doi.org/10.1371/journal.pone.0055662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405190	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400135
J	Hornung, C; Poehlein, A; Haack, FS; Schmidt, M; Dierking, K; Pohlen, A; Schulenburg, H; Blokesch, M; Plener, L; Jung, K; Bonge, A; Krohn-Molt, I; Utpatel, C; Timmermann, G; Spieck, E; Pommerening-Roser, A; Bode, E; Bode, HB; Daniel, R; Schmeisser, C; Streit, WR				Hornung, Claudia; Poehlein, Anja; Haack, Frederike S.; Schmidt, Martina; Dierking, Katja; Pohlen, Andrea; Schulenburg, Hinrich; Blokesch, Melanie; Plener, Laure; Jung, Kirsten; Bonge, Andreas; Krohn-Molt, Ines; Utpatel, Christian; Timmermann, Gabriele; Spieck, Eva; Pommerening-Roeser, Andreas; Bode, Edna; Bode, Helge B.; Daniel, Rolf; Schmeisser, Christel; Streit, Wolfgang R.			The Janthinobacterium sp HH01 Genome Encodes a Homologue of the V. cholerae CqsA and L. pneumophila LqsA Autoinducer Synthases	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; CHROMOBACTERIUM-VIOLACEUM; VIBRIO-CHOLERAE; IV PILI; TWITCHING MOTILITY; VI SECRETION; IN-VITRO; BACTERIAL; SEQUENCE; COMMUNICATION	Janthinobacteria commonly form biofilms on eukaryotic hosts and are known to synthesize antibacterial and antifungal compounds. Janthinobacterium sp. HH01 was recently isolated from an aquatic environment and its genome sequence was established. The genome consists of a single chromosome and reveals a size of 7.10 Mb, being the largest janthinobacterial genome so far known. Approximately 80% of the 5,980 coding sequences (CDSs) present in the HH01 genome could be assigned putative functions. The genome encodes a wealth of secretory functions and several large clusters for polyketide biosynthesis. HH01 also encodes a remarkable number of proteins involved in resistance to drugs or heavy metals. Interestingly, the genome of HH01 apparently lacks the N-acylhomoserine lactone (AHL)-dependent signaling system and the AI-2-dependent quorum sensing regulatory circuit. Instead it encodes a homologue of the Legionella-and Vibrio-like autoinducer (lqsA/cqsA) synthase gene which we designated jqsA. The jqsA gene is linked to a cognate sensor kinase (jqsS) which is flanked by the response regulator jqsR. Here we show that a jqsA deletion has strong impact on the violacein biosynthesis in Janthinobacterium sp. HH01 and that a jqsA deletion mutant can be functionally complemented with the V. cholerae cqsA and the L. pneumophila lqsA genes.	[Hornung, Claudia; Haack, Frederike S.; Schmidt, Martina; Bonge, Andreas; Krohn-Molt, Ines; Utpatel, Christian; Timmermann, Gabriele; Spieck, Eva; Pommerening-Roeser, Andreas; Schmeisser, Christel; Streit, Wolfgang R.] Univ Hamburg, Biozentrum Klein Flottbek, Abt Mikrobiol & Biotechnol, Hamburg, Germany; [Poehlein, Anja; Daniel, Rolf] Univ Gottingen, Inst Mikrobiol & Genet, Lab Genomanal, D-37073 Gottingen, Germany; [Dierking, Katja; Pohlen, Andrea; Schulenburg, Hinrich] Univ Kiel, Dept Evolutionary Ecol & Genet, Kiel, Germany; [Blokesch, Melanie] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Mol Microbiol Lab, Lausanne, Switzerland; [Plener, Laure; Jung, Kirsten] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biol 1, Martinsried, Germany; [Bode, Edna; Bode, Helge B.] Goethe Univ Frankfurt, Inst Mol Biowissensch, Frankfurt, Germany	University of Hamburg; University of Gottingen; University of Kiel; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Munich; Goethe University Frankfurt	Streit, WR (corresponding author), Univ Hamburg, Biozentrum Klein Flottbek, Abt Mikrobiol & Biotechnol, Hamburg, Germany.	wolfgang.streit@uni-hamburg.de	Schulenburg, Hinrich/A-3886-2009; Streit, Wolfgang R/K-1366-2012; Ziegler, Katja/GPT-0482-2022; Dierking, Katja/E-1050-2011; Daniel, Rolf/AAQ-5933-2021; Blokesch, Melanie/A-4057-2013; Bode, Helge B/F-7022-2014; Streit, Wolfgang/S-3049-2019	Dierking, Katja/0000-0002-5129-346X; Daniel, Rolf/0000-0002-8646-7925; Blokesch, Melanie/0000-0002-7024-1489; Bode, Helge B/0000-0001-6048-5909; Streit, Wolfgang/0000-0001-7617-7396; Poehlein, Anja/0000-0002-2473-6202	German Federal Ministry of Education and Research (BMBF)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was kindly funded by the German Federal Ministry of Education and Research (BMBF) within the framework GenomikTransfer and in relation to the ExpressSys and ChemBiofilm network projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Antonio Regina Vasconcellos, 2004, Genet Mol Res, V3, P85; Aranda S, 2011, MICROB ECOL, V62, P446, DOI 10.1007/s00248-011-9840-9; Audic S, 2007, PLOS GENET, V3, P1454, DOI 10.1371/journal.pgen.0030138; August PR, 2000, J MOL MICROB BIOTECH, V2, P513; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Blosser RS, 2000, J MICROBIOL METH, V40, P47, DOI 10.1016/S0167-7012(99)00136-0; BRENNER S, 1974, GENETICS, V77, P71; Bromberg N, 2005, J ENZYM INHIB MED CH, V20, P449, DOI 10.1080/14756360500273052; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cazoto LL, 2011, J ANTIBIOT, V64, P395, DOI 10.1038/ja.2011.13; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; de Carvalho DD, 2006, TOXICOL IN VITRO, V20, P1514, DOI 10.1016/j.tiv.2006.06.007; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; DELEY J, 1978, INT J SYST BACTERIOL, V28, P154, DOI 10.1099/00207713-28-2-154; Driessen AJM, 1998, CURR OPIN MICROBIOL, V1, P216, DOI 10.1016/S1369-5274(98)80014-3; DUCEY TF, 2002, EPICENTRE FORUM, V9, P6; Federle MJ, 2009, CONTRIB MICROBIOL, V16, P18, DOI 10.1159/000219371; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Galloway WRJD, 2011, CHEM REV, V111, P28, DOI 10.1021/cr100109t; Ganin H, 2012, ACS CHEM BIOL, V7, P659, DOI 10.1021/cb2004675; GONZALEZ C, 1987, CAN J MICROBIOL, V33, P1120, DOI 10.1139/m87-196; Hakvag S, 2009, MAR DRUGS, V7, P576, DOI 10.3390/md7040576; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Hoshino T, 2011, APPL MICROBIOL BIOT, V91, P1463, DOI 10.1007/s00253-011-3468-z; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Kelly RC, 2009, NAT CHEM BIOL, V5, P891, DOI 10.1038/nchembio.237; Kim SJ, 2012, J BACTERIOL, V194, P2096, DOI 10.1128/JB.00096-12; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Lee YM, 2011, J MICROBIOL, V49, P355, DOI 10.1007/s12275-011-0232-0; Lo Scrudato M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002778; Lopes SCP, 2009, ANTIMICROB AGENTS CH, V53, P2149, DOI 10.1128/AAC.00693-08; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Mashburn-Warren L, 2008, GEOBIOLOGY, V6, P214, DOI 10.1111/j.1472-4669.2008.00157.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Matz C, 2004, APPL ENVIRON MICROB, V70, P1593, DOI 10.1128/AEM.70.3.1593-1599.2004; Matz C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002744; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Meiser P, 2008, CHEMBIOCHEM, V9, P1549, DOI 10.1002/cbic.200800077; Mojib N, 2011, INT J DERMATOL, V50, P1223, DOI 10.1111/j.1365-4632.2010.04825.x; Mojib N, 2010, ANTON LEEUW INT J G, V98, P531, DOI 10.1007/s10482-010-9470-0; Molnar I, 2000, CHEM BIOL, V7, P97, DOI 10.1016/S1074-5521(00)00075-2; Momen AZMR, 2000, BIOSCI BIOTECH BIOCH, V64, P539, DOI 10.1271/bbb.64.539; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Morohoshi T, 2008, FEMS MICROBIOL LETT, V279, P124, DOI 10.1111/j.1574-6968.2007.01016.x; Morohoshi T, 2010, BIOSCI BIOTECH BIOCH, V74, P2116, DOI 10.1271/bbb.100385; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ng WL, 2011, MOL MICROBIOL, V79, P1407, DOI 10.1111/j.1365-2958.2011.07548.x; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Pantanella F, 2007, J APPL MICROBIOL, V102, P992, DOI 10.1111/j.1365-2672.2006.03155.x; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Robbel L, 2010, J BIOL CHEM, V285, P27501, DOI 10.1074/jbc.R110.128181; Rodrigues AL, 2012, BIOTECHNOL LETT, V34, P717, DOI 10.1007/s10529-011-0827-x; Rossolini GM, 2001, ANTIMICROB AGENTS CH, V45, P837, DOI 10.1128/AAC.45.3.837-844.2001; Ryan KS, 2008, J BIOL CHEM, V283, P6467, DOI 10.1074/jbc.M708573200; Sambrook J, 2001, MOL CLONING LAB MANU; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Schiex T, 2003, NUCLEIC ACIDS RES, V31, P3738, DOI 10.1093/nar/gkg610; Schmeisser C, 2009, APPL ENVIRON MICROB, V75, P4035, DOI 10.1128/AEM.00515-09; Shinoda K, 2007, CHEM COMMUN, P4140, DOI 10.1039/b705358d; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SNEATH PHA, 1956, J GEN MICROBIOL, V15, P70, DOI 10.1099/00221287-15-1-70; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stauff DL, 2011, J BACTERIOL, V193, P3871, DOI 10.1128/JB.05125-11; Stiernagle Theresa, 2006, WormBook, P1; Suckow G, 2011, J BACTERIOL, V193, P4914, DOI 10.1128/JB.05396-11; Swem LR, 2009, MOL CELL, V35, P143, DOI 10.1016/j.molcel.2009.05.029; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tech Maike, 2003, In Silico Biology, V3, P441; Tiaden A, 2010, TRENDS MICROBIOL, V18, P288, DOI 10.1016/j.tim.2010.03.004; Tiaden A, 2010, ENVIRON MICROBIOL, V12, P1243, DOI 10.1111/j.1462-2920.2010.02167.x; Voget S, 2003, APPL ENVIRON MICROB, V69, P6235, DOI 10.1128/AEM.69.10.6235-6242.2003; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x; Yada S, 2008, MAR BIOTECHNOL, V10, P128, DOI 10.1007/s10126-007-9046-9; Yang LH, 2007, LETT APPL MICROBIOL, V44, P625, DOI 10.1111/j.1472-765X.2007.02125.x; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8	98	43	45	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55045	10.1371/journal.pone.0055045	http://dx.doi.org/10.1371/journal.pone.0055045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405110	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400054
J	Katsamenis, OL; Jenkins, T; Quinci, F; Michopoulou, S; Sinclair, I; Thurner, PJ				Katsamenis, Orestis L.; Jenkins, Thomas; Quinci, Federico; Michopoulou, Sofia; Sinclair, Ian; Thurner, Philipp J.			A Novel Videography Method for Generating Crack-Extension Resistance Curves in Small Bone Samples	PLOS ONE			English	Article							HUMAN CORTICAL BONE; AGE-RELATED-CHANGES; FRACTURE-TOUGHNESS; GROWTH-RESISTANCE; MICRODAMAGE; PLASTICITY; MECHANICS; BEHAVIOR; FAILURE	Assessment of bone quality is an emerging solution for quantifying the effects of bone pathology or treatment. Perhaps one of the most important parameters characterising bone quality is the toughness behaviour of bone. Particularly, fracture toughness, is becoming a popular means for evaluating bone quality. The method is moving from a single value approach that models bone as a linear-elastic material (using the stress intensity factor, K) towards full crack extension resistance curves (R-curves) using a non-linear model (the strain energy release rate in J-R curves). However, for explanted human bone or small animal bones, there are difficulties in measuring crack-extension resistance curves due to size constraints at the millimetre and sub-millimetre scale. This research proposes a novel "whitening front tracking'' method that uses videography to generate full fracture resistance curves in small bone samples where crack propagation cannot typically be observed. Here we present this method on sharp edge notched samples (<1 mmx1 mmxLength) prepared from four human femora tested in three-point bending. Each sample was loaded in a mechanical tester with the crack propagation recorded using videography and analysed using an algorithm to track the whitening (damage) zone. Using the "whitening front tracking'' method, full R-curves and J-R curves could be generated for these samples. The curves for this antiplane longitudinal orientation were similar to those found in the literature, being between the published longitudinal and transverse orientations. The proposed technique shows the ability to generate full "crack'' extension resistance curves by tracking the whitening front propagation to overcome the small size limitations and the single value approach.	[Katsamenis, Orestis L.; Jenkins, Thomas; Thurner, Philipp J.] Univ Southampton, Fac Engn & Environm, Bioengn Sci Res Grp, Southampton, Hants, England; [Quinci, Federico] Univ Southampton, Fac Engn & Environm, Natl Ctr Adv Tribol Southampton, Southampton, Hants, England; [Michopoulou, Sofia] Univ Coll London Hosp NHS Fdn Trust, Inst Nucl Med, London, England; [Sinclair, Ian] Univ Southampton, Fac Engn & Environm, Engn Mat Res Grp, Southampton, Hants, England	University of Southampton; University of Southampton; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Southampton	Katsamenis, OL (corresponding author), Univ Southampton, Fac Engn & Environm, Bioengn Sci Res Grp, Southampton, Hants, England.	O.Katsamenis@soton.ac.uk; p.thurner@soton.ac.uk	Thurner, Philipp J/A-3887-2012; Sinclair, Ian/ABB-5502-2021	Katsamenis, Orestis/0000-0003-4367-4147; Thurner, Philipp/0000-0001-7588-9041; Michopoulou, Sofia/0000-0003-1974-8388				[Anonymous], 2004, E11210 ASTM INT, V4, P1, DOI [DOI 10.1520/E0112-96R04, DOI 10.1520/E0112-10]; Chamis CC, 1974, D7572 NASA TN; EVANS AG, 1984, J AM CERAM SOC, V67, P255, DOI 10.1111/j.1151-2916.1984.tb18842.x; GOODMAN HM, 1988, BASIC MED ENDOCRINOL; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221; Kruzic JJ, 2005, J BIOMED MATER RES A, V74A, P461, DOI 10.1002/jbm.a.30380; Launey ME, 2010, ANNU REV MATER RES, V40, P25, DOI [10.1146/annurev-matsci-070909-104427, 10.1146/annurev-matsci-070909-10442]; Leng HJ, 2008, J MECH BEHAV BIOMED, V1, P68, DOI 10.1016/j.jmbbm.2007.06.002; Malik CL, 2003, J BIOMECH, V36, P191, DOI 10.1016/S0021-9290(02)00362-7; Nalla RK, 2005, BIOMATERIALS, V26, P217, DOI 10.1016/j.biomaterials.2004.02.017; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; NORMAN TL, 1995, J BIOMECH, V28, P309, DOI 10.1016/0021-9290(94)00069-G; Phelps JB, 2000, J BIOMED MATER RES, V51, P735, DOI 10.1002/1097-4636(20000915)51:4<735::AID-JBM23>3.0.CO;2-G; Rau C, 2011, PHYS STATUS SOLIDI A; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Ritchie RO, 2008, BONE, V43, P798, DOI 10.1016/j.bone.2008.04.027; Ritchie RO, 2005, FATIGUE FRACT ENG M, V28, P345, DOI 10.1111/j.1460-2695.2005.00878.x; Ritchie RO, 2009, PHYS TODAY, V62, P41, DOI 10.1063/1.3156332; Sun XH, 2010, J BIOMECH, V43, P1989, DOI 10.1016/j.jbiomech.2010.03.011; Thurner PJ, 2007, ENG FRACT MECH, V74, P1928, DOI 10.1016/j.engfracmech.2006.05.024; Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8; Vashishth D, 2004, J BIOMECH, V37, P943, DOI 10.1016/j.jbiomech.2003.11.003; Vashishth D, 2007, INT J FATIGUE, V29, P1024, DOI 10.1016/j.ijfatigue.2006.09.010; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Yan JH, 2007, BONE, V40, P479, DOI 10.1016/j.bone.2006.08.013; Yang QD, 2006, BONE, V38, P878, DOI 10.1016/j.bone.2005.10.014; Zimmermann EA, 2011, P NATL ACAD SCI USA, V108, P14416, DOI 10.1073/pnas.1107966108; Zimmermann EA, 2010, BIOMATERIALS, V31, P5297, DOI 10.1016/j.biomaterials.2010.03.056; Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7	30	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55641	10.1371/journal.pone.0055641	http://dx.doi.org/10.1371/journal.pone.0055641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405186	Green Accepted, Green Published, gold			2022-12-25	WOS:000315153400131
J	Liang, HY; Luo, L; Yang, ZC; Di, B; Bai, ZJ; He, P; Jing, QL; Zheng, XL				Liang, Huiying; Luo, Lei; Yang, Zhicong; Di, Biao; Bai, Zhijun; He, Peng; Jing, Qinlong; Zheng, Xueli			Re-Emergence of Dengue Virus Type 3 in Canton, China, 2009-2010, Associated with Multiple Introductions through Different Geographical Routes	PLOS ONE			English	Article							SUBTYPE-III; GUANGDONG PROVINCE; SEROTYPE 3; EMERGENCE; GUANGZHOU; OUTBREAK; FEVER; EPIDEMIOLOGY; INFECTIONS; GENOTYPE	Background: Endemic dengue virus type 3 (DENV-3) infections have not been reported in Canton, China, since 1980. In March 2009, DENV-3 was isolated for the second time, occurring about 30 years after the previous circulation. In August, 3 other cases emerged. One much larger outbreak occurred again in 2010. To address the origin and particularly to determine whether the outbreaks were caused by the same viral genotype, we investigated the epidemiological and molecular characteristics of the introduction, spread and genetic microevolution of DENV-3 involved. Methodology/Principal Findings: Three imported cases (index-1,2,3) separately traveled back from Vietnam, India and Tanzania, resulted in 1, 3 and 60 secondary autochthonous cases, respectively. In autochthonous cases, 64.6% positive in IgM anti-DENV and 18.6% in IgG from a total of 48 submitted serum samples, accompanied by 7 DENV-3 isolates. With 99.8%, 99.7%, and 100% envelope gene nucleotidic identity, 09/GZ/1081 from index-1 and endemic strain (09/GZ/1483) belonged to genotype V; 09/GZ/10616 from index-2 and endemic strains (09/GZ/11144 and 09/GZ/11194) belonged to genotype III Clade-A; and 10/GZ/4898 from index-3 and all four 2010 endemic DENV-3 strains belonged to genotype III Clade-B, respectively. Conclusions/Significance: Both epidemiological and phylogenetic analyses showed that the 2010 outbreak of dengue was not a reemergence of the 2009 strain. Introductions of different genotypes following more than one route were important contributory factors for the 2009-2010 dengue epidemics/outbreaks in Canton. These findings underscore the importance of early detection and case management of imported case in preventing large-scale dengue epidemics among indigenous peoples of Canton.	[Liang, Huiying] Canton Ctr Dis Control & Prevent, Dept Primary Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Luo, Lei; Yang, Zhicong; Di, Biao; Bai, Zhijun; He, Peng; Jing, Qinlong] Canton Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Zheng, Xueli] So Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Yang, ZC (corresponding author), Canton Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	yangzc@gzcdc.org.cn		Liang, Huiying/0000-0002-9987-8002	National Institutes of Health (NIH) [1R01A1083202-01A1]; National Natural Science Foundation of China (NSFC) [30972566]; Guangzhou Medical Science Program [20121A011120, 20121A011124]; Guangzhou Municipal Science & Technology Bureau [2009J-c161]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangzhou Medical Science Program; Guangzhou Municipal Science & Technology Bureau	This study was supported by the National Institutes of Health (NIH) Research Project (No.1R01A1083202-01A1), the National Natural Science Foundation of China (NSFC) grant (No.30972566), Guangzhou Medical Science Program grant (20121A011120 and 20121A011124), and the Guangzhou Municipal Science & Technology Bureau grant (No.2009J-c161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007299; Bitar D, 2009, EUROSURVEILLANCE, V14; Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555; Chen SP, 2011, INFECT GENET EVOL, V11, P1183, DOI 10.1016/j.meegid.2011.03.025; Dash PK, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-55; Gubler DJ, 2004, NAT MED, V10, P129, DOI 10.1038/nm0204-129; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Halstead SB, 2005, EMERG INFECT DIS, V11, P740, DOI 10.3201/eid1105.050346; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908; Jiang Tao, 2012, Virol J, V9, P125, DOI 10.1186/1743-422X-9-125; Jing QL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-87; Jones TF, 1999, CLIN INFECT DIS, V28, P853, DOI 10.1086/515213; LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luo L, 2012, J VECTOR ECOL, V37, P230, DOI 10.1111/j.1948-7134.2012.00221.x; [罗雷 LUO Lei], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P490; Massad E, 2011, LANCET, V377, P1630, DOI 10.1016/S0140-6736(11)60470-4; McBride WJH, 2000, MICROBES INFECT, V2, P1041, DOI 10.1016/S1286-4579(00)01258-2; Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Palacio M, 1995, MMWR-MORBID MORTAL W, V44, P21; Papa A, 2002, EUR J CLIN MICROBIOL, V21, P603, DOI 10.1007/s10096-002-0770-9; Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83; QIU FX, 1993, B WORLD HEALTH ORGAN, V71, P349; Ramos MM, 2009, T ROY SOC TROP MED H, V103, P878, DOI 10.1016/j.trstmh.2008.11.009; Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753; Sharma S, 2011, J GEN VIROL, V92, P1595, DOI 10.1099/vir.0.030437-0; Shu PY, 2003, CLIN DIAGN LAB IMMUN, V10, P622, DOI 10.1128/CDLI.10.4.622-630.2003; Shu PY, 2005, EMERG INFECT DIS, V11, P460, DOI 10.3201/eid1103.040420; Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thai KTD, 2010, EPIDEMIOL INFECT, V138, P585, DOI 10.1017/S095026880999046X; Usuku S, 2001, ARCH VIROL, V146, P1381, DOI 10.1007/s007050170098; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Xu GZ, 2007, AM J TROP MED HYG, V76, P1182, DOI 10.4269/ajtmh.2007.76.1182; Yan Zi-qiang, 2010, Zhonghua Weisheng Shachong Yaoxie, V16, P42; Zheng K, 2009, EPIDEMIOL INFECT, V137, P73, DOI 10.1017/S0950268808000617	39	17	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55353	10.1371/journal.pone.0055353	http://dx.doi.org/10.1371/journal.pone.0055353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405138	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400083
J	Wang, L; Lv, XQ; Li, H; Zhang, M; Wang, H; Jin, B; Chen, T				Wang, Li; Lv, Xueqin; Li, Hong; Zhang, Min; Wang, Hong; Jin, Biao; Chen, Tong			Inhibition of Apoplastic Calmodulin Impairs Calcium Homeostasis and Cell Wall Modeling during Cedrus deodara Pollen Tube Growth	PLOS ONE			English	Article							EXTRACELLULAR CALMODULIN; SIGNAL-TRANSDUCTION; HIGHER-PLANTS; CARROT CELLS; GERMINATION; PROTEIN; GRADIENT; PECTIN; CA2+; POLYPEPTIDE	Calmodulin (CaM) is one of the most well-studied Ca2+ transducers in eukaryotic cells. It is known to regulate the activity of numerous proteins with diverse cellular functions; however, the functions of apoplastic CaM in plant cells are still poorly understood. By combining pharmacological analysis and microscopic techniques, we investigated the involvement of apoplastic CaM in pollen tube growth of Cedrus deodara (Roxb.) Loud. It was found that the tip-focused calcium gradient was rapidly disturbed as one of the early events after application of pharmacological agents, while the cytoplasmic organization was not significantly affected. The deposition and distribution of acidic pectins and esterified pectins were also dramatically changed, further perturbing the normal modeling of the cell wall. Several protein candidates from different functional categories may be involved in the responses to inhibition of apoplastic CaM. These results revealed that apoplastic CaM functions to maintain the tip-focused calcium gradient and to modulate the distribution/transformation of pectins during pollen tube growth.	[Wang, Li; Lv, Xueqin; Li, Hong; Zhang, Min; Wang, Hong; Chen, Tong] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China; [Wang, Li; Zhang, Min; Jin, Biao] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China; [Lv, Xueqin; Li, Hong] Yangzhou Univ, Coll Biol Sci & Technol, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Yangzhou University; Yangzhou University	Chen, T (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China.	chentong@ibcas.ac.cn	Chen, Tong/C-5684-2014	Chen, Tong/0000-0002-2456-7170; Wang, Li/0000-0003-1688-064X	Natural Science Foundation of China [31000092, 31200145, 30870436]; National Natural Science Foundation of Jiangsu Province [BK2011444]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the Natural Science Foundation of China (no. 31000092, 31200145 and 30870436) and the National Natural Science Foundation of Jiangsu Province (no. BK2011444). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRO RL, 1984, PLANT PHYSIOL, V75, P382, DOI 10.1104/pp.75.2.382; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; BOWLER C, 1994, PLANT CELL, V6, P1529, DOI 10.1105/tpc.6.11.1529; BOYNTON AL, 1980, BIOCHEM BIOPH RES CO, V95, P745, DOI 10.1016/0006-291X(80)90849-9; Chebli Y., 2007, FUNCT PLANT SCI BIOT, V1, P232; Chen T, 2007, PLANT CELL PHYSIOL, V48, P19, DOI 10.1093/pcp/pcl036; Chen T, 2009, PLANT PHYSIOL, V149, P1111, DOI 10.1104/pp.108.127514; CROCKER G, 1988, BIOCHEM J, V253, P877, DOI 10.1042/bj2530877; Cui SJ, 2005, J BIOL CHEM, V280, P31420, DOI 10.1074/jbc.M501349200; CYR RJ, 1991, J CELL SCI, V100, P311; Derksen J, 1999, PROTOPLASMA, V208, P26, DOI 10.1007/BF01279072; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Feijo JA, 2004, CURR OPIN PLANT BIOL, V7, P589, DOI 10.1016/j.pbi.2004.07.014; Fernando DD, 2005, SEX PLANT REPROD, V18, P149, DOI 10.1007/s00497-005-0008-y; Franklin-Tong VE, 1999, PLANT CELL, V11, P727, DOI 10.1105/tpc.11.4.727; Geitmann A, 2006, PLANT CELL MONOGR, V3, P177, DOI 10.1007/7089_049; Hao HQ, 2005, NEW PHYTOL, V165, P721, DOI 10.1111/j.1469-8137.2004.01290.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; JENA PK, 1989, P NATL ACAD SCI USA, V86, P3644, DOI 10.1073/pnas.86.10.3644; Jurgen Z, 1999, PLANTA, V209, P537; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Konno H, 2002, PHYSIOL PLANTARUM, V114, P213, DOI 10.1034/j.1399-3054.2002.1140207.x; Konrad KR, 2011, CURR OPIN PLANT BIOL, V14, P721, DOI 10.1016/j.pbi.2011.09.005; Krichevsky A, 2007, DEV BIOL, V303, P405, DOI 10.1016/j.ydbio.2006.12.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazzaro MD, 2005, J EXP BOT, V56, P2619, DOI 10.1093/jxb/eri256; LI YQ, 1994, SEX PLANT REPROD, V7, P145; Ma LG, 1997, PLANTA, V202, P336, DOI 10.1007/s004250050135; Ma LG, 1999, PLANT CELL, V11, P1351, DOI 10.1105/tpc.11.7.1351; Ma LG, 2000, PLANT CELL PHYSIOL, V41, P372; Malho R, 2006, PROTOPLASMA, V228, P21, DOI 10.1007/s00709-006-0162-6; MALHO R, 1995, PLANT CELL, V7, P1173, DOI 10.1105/tpc.7.8.1173; MCCANN MC, 1993, J CELL SCI, V106, P1347; MCCANN MC, 1992, PLANT PHYSIOL, V100, P1940, DOI 10.1104/pp.100.4.1940; MILLER DD, 1992, J CELL SCI, V101, P7; MORIKAWA H, 1978, PLANT CELL PHYSIOL, V19, P1151; MORRIS ER, 1982, J MOL BIOL, V155, P507, DOI 10.1016/0022-2836(82)90484-3; Moutinho A, 1998, SEX PLANT REPROD, V11, P131, DOI 10.1007/s004970050130; OBERMEYER G, 1991, EUR J CELL BIOL, V56, P319; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Parre E, 2005, PLANTA, V220, P582, DOI 10.1007/s00425-004-1368-5; RATHORE KS, 1991, DEV BIOL, V148, P612, DOI 10.1016/0012-1606(91)90278-B; Rato C, 2004, PLANT J, V38, P887, DOI 10.1111/j.1365-313X.2004.02091.x; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; STINEMETZ CL, 1987, PLANT PHYSIOL, V84, P1337, DOI 10.1104/pp.84.4.1337; SUN DY, 1995, PLANT CELL PHYSIOL, V36, P133; Sun DY, 2001, SCI CHINA SER C, V44, P449, DOI 10.1007/BF02882387; Sun Y, 2003, PLANT CELL ENVIRON, V26, P887, DOI 10.1046/j.1365-3040.2003.01021.x; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Williams DH, 1980, SPECTROSCOPIC METHOD, P125; Yan A, 2009, P NATL ACAD SCI USA, V106, P22002, DOI 10.1073/pnas.0910811106; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Yokota E, 2004, PLANTA, V218, P1008, DOI 10.1007/s00425-003-1177-2	55	8	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55411	10.1371/journal.pone.0055411	http://dx.doi.org/10.1371/journal.pone.0055411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405148	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400093
J	White, O; Diedrichsen, J				White, Olivier; Diedrichsen, Joern			Flexible Switching of Feedback Control Mechanisms Allows for Learning of Different Task Dynamics	PLOS ONE			English	Article							INTERNAL-MODELS; MOTOR; ADAPTATION; RESPONSES; MOVEMENT; SYSTEM; REACH; LIMB; CUES; ARM	To produce skilled movements, the brain flexibly adapts to different task requirements and movement contexts. Two core abilities underlie this flexibility. First, depending on the task, the motor system must rapidly switch the way it produces motor commands and how it corrects movements online, i.e. it switches between different (feedback) control policies. Second, it must also adapt to environmental changes for different tasks separately. Here we show these two abilities are related. In a bimanual movement task, we show that participants can switch on a movement-by-movement basis between two feedback control policies, depending only on a static visual cue. When this cue indicates that the hands control separate objects, reactions to force field perturbations of each arm are purely unilateral. In contrast, when the visual cue indicates a commonly controlled object, reactions are shared across hands. Participants are also able to learn different force fields associated with a visual cue. This is however only the case when the visual cue is associated with different feedback control policies. These results indicate that when the motor system can flexibly switch between different control policies, it is also able to adapt separately to the dynamics of different environmental contexts. In contrast, visual cues that are not associated with different control policies are not effective for learning different task dynamics.	[White, Olivier] INSERM, Cognit Act & Sensorimotor Plast U1093, Dijon, France; [White, Olivier] Univ Bourgogne, Unite Format & Rech Sci & Tech Act Phys & Sport, Dijon, France; [Diedrichsen, Joern] UCL, Inst Cognit Neurosci, London, England; [White, Olivier; Diedrichsen, Joern] Bangor Univ, Wolfson Ctr Clin & Cognit Neurosci, Bangor, Gwynedd, Wales	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; University of London; University College London; Bangor University	White, O (corresponding author), INSERM, Cognit Act & Sensorimotor Plast U1093, Dijon, France.	olivier.white@u-bourgogne.fr	White, Olivier/AAJ-6914-2020; Diedrichsen, Jörn/AAQ-2242-2020; Diedrichsen, Jörn/A-7789-2010	White, Olivier/0000-0002-9119-1329; Diedrichsen, Jörn/0000-0003-0264-8532; Diedrichsen, Jörn/0000-0003-0264-8532	Biotechnology and Biological Science Research Council [BB/J009458/1]; INSERM (Institut National de la Sante et de la Recherche Medicale); Conseil General de Bourgogne; BBSRC [BB/E009174/2, BB/J009458/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009458/1, BB/E009174/2] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Conseil General de Bourgogne; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by a grant from the Biotechnology and Biological Science Research Council (BB/J009458/1) to JD and by INSERM (Institut National de la Sante et de la Recherche Medicale) and the Conseil General de Bourgogne to OW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Cothros N, 2006, EXP BRAIN RES, V173, P689, DOI 10.1007/s00221-006-0411-0; Cothros N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001990; Diedrichsen J, 2010, J NEUROSCI, V30, P5159, DOI 10.1523/JNEUROSCI.5406-09.2010; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Diedrichsen J, 2009, HUM MOVEMENT SCI, V28, P334, DOI 10.1016/j.humov.2008.10.003; Diedrichsen J, 2007, CURR BIOL, V17, P1675, DOI 10.1016/j.cub.2007.08.051; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Hirashima M, 2012, CURR BIOL, V22, P432, DOI 10.1016/j.cub.2012.01.042; Howard IS, 2008, J NEUROSCI, V28, P10531, DOI 10.1523/JNEUROSCI.3473-08.2008; Kluzik J, 2008, J NEUROPHYSIOL, V100, P1455, DOI 10.1152/jn.90334.2008; MARSDEN CD, 1981, BRAIN, V104, P513, DOI 10.1093/brain/104.3.513; Mutha PK, 2009, J NEUROPHYSIOL, V102, P3142, DOI 10.1152/jn.91335.2008; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Pruszynski JA, 2008, J NEUROPHYSIOL, V100, P224, DOI 10.1152/jn.90262.2008; ROTHWELL JC, 1980, NATURE, V286, P496, DOI 10.1038/286496a0; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Shadmehr R, 2004, HUM MOVEMENT SCI, V23, P543, DOI 10.1016/j.humov.2004.04.003; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Wainscott SK, 2005, J NEUROPHYSIOL, V93, P786, DOI 10.1152/jn.00240.2004	25	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54771	10.1371/journal.pone.0054771	http://dx.doi.org/10.1371/journal.pone.0054771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405093	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400037
J	Wu, M; Yu, Q; Li, XL; Zheng, J; Huang, JF; Kwoh, CK				Wu, Min; Yu, Qi; Li, Xiaoli; Zheng, Jie; Huang, Jing-Fei; Kwoh, Chee-Keong			Benchmarking Human Protein Complexes to Investigate Drug-Related Systems and Evaluate Predicted Protein Complexes	PLOS ONE			English	Article							TRANSLATIONAL BIOINFORMATICS; GENOME; DATABASE; MODULES	Protein complexes are key entities to perform cellular functions. Human diseases are also revealed to associate with some specific human protein complexes. In fact, human protein complexes are widely used for protein function annotation, inference of human protein interactome, disease gene prediction, and so on. Therefore, it is highly desired to build an up-to-date catalogue of human complexes to support the research in these applications. Protein complexes from different databases are as expected to be highly redundant. In this paper, we designed a set of concise operations to compile these redundant human complexes and built a comprehensive catalogue called CHPC2012 (Catalogue of Human Protein Complexes). CHPC2012 achieves a higher coverage for proteins and protein complexes than those individual databases. It is also verified to be a set of complexes with high quality as its co-complex protein associations have a high overlap with protein-protein interactions (PPI) in various existing PPI databases. We demonstrated two distinct applications of CHPC2012, that is, investigating the relationship between protein complexes and drug-related systems and evaluating the quality of predicted protein complexes. In particular, CHPC2012 provides more insights into drug development. For instance, proteins involved in multiple complexes (the overlapping proteins) are potential drug targets; the drug-complex network is utilized to investigate multi-target drugs and drug-drug interactions; and the disease-specific complex-drug networks will provide new clues for drug repositioning. With this up-to-date reference set of human protein complexes, we believe that the CHPC2012 catalogue is able to enhance the studies for protein interactions, protein functions, human diseases, drugs, and related fields of research. CHPC2012 complexes can be downloaded from http://www1.i2r.a-star.edu.sg/xlli/CHPC2012/CHPC2012.htm.	[Wu, Min; Zheng, Jie; Kwoh, Chee-Keong] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore; [Yu, Qi; Huang, Jing-Fei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Beijing 100864, Peoples R China; [Li, Xiaoli] Inst Infocomm Res, Data Min Dept, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Chinese Academy of Sciences; Kunming Institute of Zoology; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R)	Huang, JF (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Beijing 100864, Peoples R China.	huangjf@mail.kiz.ac.cn; asckkwoh@ntu.edu.sg	Zheng, Jie/C-1356-2011; Wu, Min/AAB-2446-2022; Li, Xiaoli/GYQ-7384-2022; Zheng, Jie/AAX-1454-2021; Li, Xiaoli/C-9739-2012; Yu, Qi/I-2427-2019	Zheng, Jie/0000-0001-6774-9786; Wu, Min/0000-0003-0977-3600; Li, Xiaoli/0000-0002-0762-6562; Yu, Qi/0000-0002-2110-244X	Nanyang Technological University, Singapore [M58020030]; Tier 1 AcRF Grant from Ministry of Education, Singapore [RG32/11 (M4010977.020)]; Tier 2 AcRF Grant from Ministry of Education, Singapore [MOE2008-T2-1-074]; National Basic Research Program of China [2009CB941300]; National Natural Science Foundation of China [31123005]	Nanyang Technological University, Singapore(Nanyang Technological University); Tier 1 AcRF Grant from Ministry of Education, Singapore(Ministry of Education, Singapore); Tier 2 AcRF Grant from Ministry of Education, Singapore(Ministry of Education, Singapore); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research has been supported by Startup Grant M58020030 from Nanyang Technological University, Singapore; Tier 1 AcRF Grant RG32/11 (M4010977.020) from Ministry of Education, Singapore; Tier 2 AcRF Grant MOE2008-T2-1-074 from Ministry of Education, Singapore; the National Basic Research Program of China (Grant No. 2009CB941300); and the National Natural Science Foundation of China (Grant No. 31123005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Agarwal P, 2008, BRIEF BIOINFORM, V9, P479, DOI 10.1093/bib/bbn035; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bin Goh WW, 2012, J PROTEOME RES, V11, P1571, DOI 10.1021/pr200698c; Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P443, DOI 10.1177/0091270003252519; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Butte AJ, 2008, J AM MED INFORM ASSN, V15, P709, DOI 10.1197/jamia.M2824; Chua Hon Nian, 2008, Journal of Bioinformatics and Computational Biology, V6, P435, DOI 10.1142/S0219720008003497; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Cramer P, 2001, SCIENCE, V292, P1844; Farkas IJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001950; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu HY, 2005, BIOINFORMATICS, V21, pI213, DOI 10.1093/bioinformatics/bti1049; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lee HS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-80; Li J, 2009, PLOS COMPUTATIONAL B, V5; Li M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-398; Li Xiao-Li, 2007, Comput Syst Bioinformatics Conf, V6, P157; Li XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S3; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Luc PV, 2004, BIOINFORMATICS, V20, P1413, DOI 10.1093/bioinformatics/bth114; Lussier YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-319; Nacher JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030028; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wegener E., 2008, V186, P237, DOI 10.1007/978-3-540-72843-6_10; Wu M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S8; Wu M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-169; Xie ZP, 2011, BIOINFORMATICS, V27, pI159, DOI 10.1093/bioinformatics/btr212; Yan Q, 2010, METHODS MOL BIOL, V662, P167, DOI 10.1007/978-1-60761-800-3_8; Yang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021502; Yu Q, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/103702	45	10	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53197	10.1371/journal.pone.0053197	http://dx.doi.org/10.1371/journal.pone.0053197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405067	Green Published, gold			2022-12-25	WOS:000315153400010
J	Rakobowchuk, M; Parsloe, ER; Gibbins, SE; Harris, E; Birch, KM				Rakobowchuk, Mark; Parsloe, Emily R.; Gibbins, Sarah E.; Harris, Emma; Birch, Karen M.			Prolonged Low Flow Reduces Reactive Hyperemia and Augments Low Flow Mediated Constriction in the Brachial Artery Independent of the Menstrual Cycle	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ATP CHANNEL ACTIVATION; HUMANS IN-VIVO; POSTCONDITIONING PROTECTS; VASCULAR FUNCTION; PROGENITOR CELLS; DILATION; INFORMATION; EXERCISE	Non-invasive forearm ischemia-reperfusion injury and low flow induced vascular dysfunction models provide methods to evaluate vascular function. The role of oestrogen, an endogenous anti-oxidant on recovery from ischemia-reperfusion injury has not been evaluated nor has the impact of prolonged low flow on vascular function been established. Eight healthy women (33610 yr) attended the lab during the follicular, ovulatory and mid-luteal phases of their menstrual cycles. After 30 minutes of rest, brachial artery vascular function was assessed by ultrasound measurements of diameter changes during 5 minutes of forearm ischemia and 3 minutes after. Subsequently, a 20-minute forearm ischemia period was completed. Further, vascular function assessments were completed 15, 30 and 45 minutes into recovery. Flow-mediated dilation, low-flow-mediated constriction, and reactive hyperaemia proximal to the area of ischemia were determined. Flow-mediated dilation was reduced at 15 minutes of recovery but recovered at 30 and 45 minutes (PRE:7.1 +/- 1.0%, POST15:4.5 +/- 0.6%, POST30:5.5 +/- 0.7% POST45:5.9 +/- 0.4%, p<0.01). Conversely, low-flow mediated constriction increased (PRE:-1.3 +/- 0.4%, POST15:-3.3 +/- 0.6%, POST30:-2.5 +/- 0.5% POST45:-1.5 +/- 0.12%, p<0.01). Reactive hyperaemia was reduced throughout recovery (p, 0.05). Data were unaffected by menstrual phase. Prolonged low flow altered vascular function and may relate as much to increased vasoconstriction as with decreased vasodilation. Reductions in anterograde shear and greater retrograde shear likely modulate the brachial artery response, but the reduced total shear also plays an important role. The data suggest substantial alterations in vascular function proximal to areas of ischemia with potential clinical implications following reperfusion.	[Rakobowchuk, Mark] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; [Parsloe, Emily R.] Univ Cambridge, Cambridge, England; [Gibbins, Sarah E.; Harris, Emma; Birch, Karen M.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England	University of Essex; University of Cambridge; University of Leeds	Rakobowchuk, M (corresponding author), Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England.	merako@essex.ac.uk	Harris, Emma/AAJ-8194-2020	Harris, Emma/0000-0002-7649-9763; Birch, Karen/0000-0001-7796-8640	British Heart Foundation [PG/08/060/25340]; Physiological Society summer studentship; Wellcome Trust Vacation Studentship	British Heart Foundation(British Heart Foundation); Physiological Society summer studentship; Wellcome Trust Vacation Studentship(Wellcome Trust)	This work was supported by the British Heart Foundation (PG/08/060/25340), a Physiological Society summer studentship to SG, and a Wellcome Trust Vacation Studentship to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broadhead MW, 2004, CIRCULATION, V110, P2077, DOI 10.1161/01.CIR.0000144304.91010.F0; DeVan AE, 2011, AM J PHYSIOL-HEART C, V300, pH813, DOI 10.1152/ajpheart.00845.2010; Fadini GP, 2008, ARTERIOSCL THROM VAS, V28, P997, DOI 10.1161/ATVBAHA.107.159558; Gori T, 2005, CIRCULATION, V111, P742, DOI 10.1161/01.CIR.0000155252.23933.2D; Gori T, 2010, HEART, V96, P141, DOI 10.1136/hrt.2009.167213; Gori T, 2008, J AM COLL CARDIOL, V51, P1953, DOI 10.1016/j.jacc.2008.01.049; Gori T, 2012, EUR HEART J, V33, P363, DOI 10.1093/eurheartj/ehr361; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; Jiang BY, 2011, HYPERTENSION, V57, P1145, DOI 10.1161/HYPERTENSIONAHA.110.163113; Kharbanda RK, 2001, CIRCULATION, V103, P1624, DOI 10.1161/01.CIR.103.12.1624; Loukogeorgakis SP, 2006, CIRCULATION, V113, P1015, DOI 10.1161/CIRCULATIONAHA.105.590398; Loukogeorgakis SP, 2005, J AM COLL CARDIOL, V46, P450, DOI 10.1016/j.jacc.2005.04.044; Loukogeorgakis SP, 2010, CIRCULATION, V121, P2310, DOI 10.1161/CIRCULATIONAHA.108.814731; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Okorie MI, 2011, EUR HEART J, V32, P1266, DOI 10.1093/eurheartj/ehr041; Pedersen CM, 2012, EUR HEART J, V33, P1920, DOI 10.1093/eurheartj/ehr380; Pleiner J, 2008, ATHEROSCLEROSIS, V197, P383, DOI 10.1016/j.atherosclerosis.2007.06.011; Pyke KE, 2007, J APPL PHYSIOL, V102, P1510, DOI 10.1152/japplphysiol.01024.2006; Rakobowchuk M, 2012, EXP PHYSIOL, V97, P375, DOI 10.1113/expphysiol.2011.062836; Spieker LE, 2003, J CARDIOVASC PHARM, V42, P315, DOI 10.1097/00005344-200309000-00001; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Weissgerber TL, 2010, J APPL PHYSIOL, V108, P1097, DOI 10.1152/japplphysiol.00815.2009	22	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55385	10.1371/journal.pone.0055385	http://dx.doi.org/10.1371/journal.pone.0055385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393572	Green Published, gold, Green Accepted			2022-12-25	WOS:000314692800026
J	Chujo, D; Foucat, E; Nguyen, TS; Chaussabel, D; Banchereau, J; Ueno, H				Chujo, Daisuke; Foucat, Emile; Thien-Son Nguyen; Chaussabel, Damien; Banchereau, Jacques; Ueno, Hideki			ZnT8-Specific CD4(+) T Cells Display Distinct Cytokine Expression Profiles between Type 1 Diabetes Patients and Healthy Adults	PLOS ONE			English	Article							CLASS-II TETRAMERS; GLUTAMATE-DECARBOXYLASE; PERIPHERAL-BLOOD; RESPONSES; INSULIN; AUTOANTIGEN; EPITOPE; AUTOIMMUNITY; ASSAY; IDDM	Determination of antigen-specific T cell repertoires in human blood has been a challenge. Here, we show a novel integrated approach that permits determination of multiple parameters of antigen-specific T cell repertoires. The approach consists of two assays: the Direct assay and the Cytokine-driven assay. Briefly, human PBMCs are first stimulated with overlapping peptides encoding a given antigen for 48 hours to measure cytokine secretion (Direct assay). Peptide-reactive T cells are further expanded by IL-2 for 5 days; and after overnight starvation, expanded cells are stimulated with the same peptides from the initial culture to analyze cytokine secretion (Cytokine-driven assay). We first applied this integrated approach to determine the type of islet-antigen-specific T cells in healthy adults. Out of ten donors, the Direct assay identified GAD65-specific CD4(+) T cells in three adults and zinc transporter 8 (ZnT8)-specific CD4(+) T cells in five adults. The intracytoplasmic cytokine staining assay showed that these islet-antigen-specific CD4(+) T cells belonged to the CD45RO(+) memory compartment. The Cytokine-driven assay further revealed that islet-antigen-specific CD4(+) T cells in healthy adults were capable of secreting various types of cytokines including type 1 and type 2 cytokines as well as IL-10. We next applied our integrated assay to determine whether the type of ZnT8-specific CD4(+) T cells is different between Type 1 diabetes patients and age/gender/HLA-matched healthy adults. We found that ZnT8-specific CD4(+) T cells were skewed towards Th1 cells in T1D patients, while Th2 and IL-10-producing cells were prevalent in healthy adults. In conclusion, the Direct assay and the Cytokine-driven assay complement each other, and the combination of the two assays provides information of antigen-specific T cell repertoires on the breadth, type, and avidity. This strategy is applicable to determine the differences in the quality of antigen-specific T cells between health and disease.	[Chujo, Daisuke; Foucat, Emile; Banchereau, Jacques; Ueno, Hideki] Baylor Inst Immunol Res, Dallas, TX USA; [Thien-Son Nguyen; Chaussabel, Damien] Virginia Mason, Benaroya Res Inst, Seattle, WA USA	Baylor Scott & White Health; Benaroya Research Institute; Virginia Mason Medical Center	Ueno, H (corresponding author), Baylor Inst Immunol Res, Dallas, TX USA.	HidekiU@baylorhealth.edu	Ueno, Hideki/L-1237-2016; Chaussabel, Damien/AAX-1909-2020	Ueno, Hideki/0000-0001-7747-0738; Chaussabel, Damien/0000-0002-6131-7242	Juvenile Diabetes Research Foundation [17-2010-406]; Baylor Health Care System	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Baylor Health Care System	This study was supported by funding from Juvenile Diabetes Research Foundation (grant number: 17-2010-406; http://www.jdrf.org) and Baylor Health Care System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleva DG, 2001, J CLIN INVEST, V107, P173, DOI 10.1172/JCI8525; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; ATKINSON MA, 1994, J CLIN INVEST, V94, P2125, DOI 10.1172/JCI117567; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Boehm BO, 2009, MOL IMMUNOL, V46, P2576, DOI 10.1016/j.molimm.2009.05.007; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Chattopadhyay PK, 2006, NAT PROTOC, V1, P1, DOI 10.1038/nprot.2006.1; Chujo D, 2012, CELL TRANSPLANTATION; Chujo D, 2012, CELL TRANSP IN PRESS; Coppieters KT, 2012, J EXP MED; Dang M, 2011, J IMMUNOL, V186, P6056, DOI 10.4049/jimmunol.1003815; Danke NA, 2005, J AUTOIMMUN, V25, P303, DOI 10.1016/j.jaut.2005.08.007; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Durinovic-Bello I, 2002, J AUTOIMMUN, V18, P55, DOI 10.1006/jaut.2001.0566; Durinovic-Bello I, 2006, P NATL ACAD SCI USA, V103, P11683, DOI 10.1073/pnas.0603682103; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Gianani R, 2005, IMMUNOL REV, V204, P232, DOI 10.1111/j.0105-2896.2005.00248.x; Herold KC, 2009, DIABETES, V58, P2588, DOI 10.2337/db09-0249; Jarchum I, 2008, CLIN IMMUNOL, V127, P359, DOI 10.1016/j.clim.2008.01.015; Jasinski J M, 2005, Clin Dev Immunol, V12, P181, DOI 10.1080/17402520500078204; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Mallone R, 2007, DIABETES, V56, P613, DOI 10.2337/db06-1419; Mannering SI, 2010, CLIN EXP IMMUNOL, V162, P197, DOI 10.1111/j.1365-2249.2010.04237.x; Monti P, 2007, J IMMUNOL, V179, P5785, DOI 10.4049/jimmunol.179.9.5785; Nepom GT, 2002, ARTHRITIS RHEUM, V46, P5, DOI 10.1002/1529-0131(200201)46:1<5::AID-ART10063>3.0.CO;2-S; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Peakman M, 1999, J CLIN INVEST, V104, P1449, DOI 10.1172/JCI7936; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Reijonen H, 2002, DIABETES, V51, P1375, DOI 10.2337/diabetes.51.5.1375; Reijonen H, 2004, DIABETES, V53, P1987, DOI 10.2337/diabetes.53.8.1987; Roep BO, 1996, DIABETES, V45, P1147, DOI 10.2337/diabetes.45.9.1147; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Schloot NC, 2003, J AUTOIMMUN, V21, P365, DOI 10.1016/S0896-8411(03)00111-2; Schloot NC, 1997, DIABETOLOGIA, V40, P332, DOI 10.1007/s001250050683; Seyfert-Margolis V, 2006, DIABETES, V55, P2588, DOI 10.2337/db05-1378; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Tian JD, 1996, J EXP MED, V183, P1561, DOI 10.1084/jem.183.4.1561; Tree TIM, 2010, DIABETES, V59, P1451, DOI 10.2337/db09-0503; Vence L, 2007, P NATL ACAD SCI USA, V104, P20884, DOI 10.1073/pnas.0710557105; Viglietta V, 2002, J CLIN INVEST, V109, P895, DOI 10.1172/JCI14114; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wong FS, 1999, J AUTOIMMUN, V13, P290, DOI 10.1006/jaut.1999.0322; Yang JB, 2006, J IMMUNOL, V176, P2781, DOI 10.4049/jimmunol.176.5.2781; Zaccone P, 1999, DIABETES, V48, P1522, DOI 10.2337/diabetes.48.8.1522	47	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55595	10.1371/journal.pone.0055595	http://dx.doi.org/10.1371/journal.pone.0055595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390544	gold, Green Published, Green Submitted			2022-12-25	WOS:000314691100060
J	Scholling, M; Thurner, S; Hanel, R				Schoelling, Manuel; Thurner, Stefan; Hanel, Rudolf			Protein Complex Formation: Computational Clarification of the Sequential versus Probabilistic Recruitment Puzzle	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; RNA; INITIATION; PROMOTER	Our current view on how protein complexes assemble and disassemble at promoter sites is based on experimental data. For instance this data is provided by biochemical methods (e.g. ChIP-on-chip assays) or GFP-based assays. These two approaches suggest very different characteristics for protein recruitment processes that regulate and initiate gene transcription. Biochemical methods suggest a strictly ordered and consecutive protein recruitment while GFP-based assays draw a picture much closer to chaotic or stochastic recruitment. To understand the reason for these conflicting results, we design a generalized recruitment model (GRM) that allows to simulate all possible scenarios between strictly sequential recruitment and completely probabilistic recruitment. With this model we show that probabilistic, transient binding events that are visible in GFP experiments can not be detected by ChIP experiments. We demonstrate that sequential recruitment processes and probabilistic recruitment processes that contain "shortcuts'' exhibit periodic dynamics and are hard to distinguish with standard ChIP measurements. Therefore we propose a simple experimental method that can be used to discriminate sequential from probabilistic recruitment processes. We discuss the limitations of this method.	[Schoelling, Manuel; Thurner, Stefan; Hanel, Rudolf] Med Univ Vienna, Sect Sci Complex Syst CeMSIIS, Vienna, Austria; [Thurner, Stefan] Santa Fe Inst, Santa Fe, NM 87501 USA	Medical University of Vienna; The Santa Fe Institute	Thurner, S (corresponding author), Med Univ Vienna, Sect Sci Complex Syst CeMSIIS, Vienna, Austria.	stefan.thurner@meduniwien.ac.at		Hanel, Rudolf/0000-0002-4045-9532	Forum Integrativmedizin; Hilde Umdasch Privatstiftung	Forum Integrativmedizin; Hilde Umdasch Privatstiftung	The project has been funded by "Forum Integrativmedizin'', an initiative of the "Hilde Umdasch Privatstiftung'' (http://www.integrativmedizin.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100007; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; D'Orsogna MR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.170603; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hanel R, 2011, PLOS ONE, V7; Hanel R, 2010, PHILOS T R SOC A, V368, P5583, DOI 10.1098/rsta.2010.0267; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Lemaire V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198102; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Stasevich TJ, 2011, CHROMOSOMA, V120, P533, DOI 10.1007/s00412-011-0340-y; Stasevich TJ, 2010, BIOPHYS J, V99, P3093, DOI 10.1016/j.bpj.2010.08.059	27	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55046	10.1371/journal.pone.0055046	http://dx.doi.org/10.1371/journal.pone.0055046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383305	Green Published, gold, Green Submitted			2022-12-25	WOS:000314597900012
J	Tironi-Farinati, C; Geoghegan, PA; Cangelosi, A; Pinto, A; Loidl, CF; Goldstein, J				Tironi-Farinati, Carla; Geoghegan, Patricia A.; Cangelosi, Adriana; Pinto, Alipio; Fabian Loidl, C.; Goldstein, Jorge			A Translational Murine Model of Sub-Lethal Intoxication with Shiga Toxin 2 Reveals Novel Ultrastructural Findings in the Brain Striatum	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI O157-H7; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; BASAL GANGLIA; NEUROLOGICAL COMPLICATIONS; MAST-CELLS; DNA FRAGMENTATION; ORAL INFECTION; PRIMATE MODEL	Infection by Shiga toxin-producing Escherichia coli causes hemorrhagic colitis, hemolytic uremic syndrome (HUS), acute renal failure, and also central nervous system complications in around 30% of the children affected. Besides, neurological deficits are one of the most unrepairable and untreatable outcomes of HUS. Study of the striatum is relevant because basal ganglia are one of the brain areas most commonly affected in patients that have suffered from HUS and since the deleterious effects of a sub-lethal dose of Shiga toxin have never been studied in the striatum, the purpose of this study was to attempt to simulate an infection by Shiga toxin-producing E. coli in a murine model. To this end, intravenous administration of a sub-lethal dose of Shiga toxin 2 (0.5 eta g per mouse) was used and the correlation between neurological manifestations and ultrastructural changes in striatal brain cells was studied in detail. Neurological manifestations included significant motor behavior abnormalities in spontaneous motor activity, gait, pelvic elevation and hind limb activity eight days after administration of the toxin. Transmission electron microscopy revealed that the toxin caused early perivascular edema two days after administration, as well as significant damage in astrocytes four days after administration and significant damage in neurons and oligodendrocytes eight days after administration. Interrupted synapses and mast cell extravasation were also found eight days after administration of the toxin. We thus conclude that the chronological order of events observed in the striatum could explain the neurological disorders found eight days after administration of the toxin.	[Tironi-Farinati, Carla; Pinto, Alipio; Goldstein, Jorge] Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Neurofisiopatol, RA-1425 Buenos Aires, DF, Argentina; [Geoghegan, Patricia A.; Cangelosi, Adriana] Ctr Nacl Control Calidad Biol CNCCB ANLIS Dr Carl, Buenos Aires, DF, Argentina; [Fabian Loidl, C.] Univ Buenos Aires, Fac Med, Inst Biol Celular & Neurociencia Prof E De Robert, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Goldstein, J (corresponding author), Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Neurofisiopatol, RA-1425 Buenos Aires, DF, Argentina.	jogol@fmed.uba.ar		Goldstein, Jorge/0000-0002-9488-0074	CONICET (National Research Council, Argentina) [PIP114-200801-00497]; Universidad de Buenos Aires (UBA) [UBACYT 20020090200634]	CONICET (National Research Council, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBA)(University of Buenos Aires)	These studies were supported by CONICET (National Research Council, Argentina) Grant PIP114-200801-00497 (http://www.conicet.gov.ar/web/conicet/inicio) and Universidad de Buenos Aires (UBA) grant UBACYT 20020090200634 (http://www.uba.ar/secyt/contenido.php?id=42&s=50) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BARNETT NDP, 1995, PEDIATR NEUROL, V12, P155, DOI 10.1016/0887-8994(94)00121-H; BARRON KD, 1990, BRAIN RES, V523, P219, DOI 10.1016/0006-8993(90)91490-8; Bast DJ, 1997, INFECT IMMUN, V65, P2019, DOI 10.1128/IAI.65.6.2019-2028.1997; Berciano MT, 1999, J NEUROPATH EXP NEUR, V58, P1234, DOI 10.1097/00005072-199912000-00004; Boccoli J, 2008, BRAIN RES, V1230, P320, DOI 10.1016/j.brainres.2008.07.052; Boyd SG, 2001, ARCH DIS CHILD, V84, P434; Bruyn GW, 1987, ACTA NEUROPATHOL, V5, P21; Burdet J, 2013, BRIT J PHARMACOL, V168, P946, DOI 10.1111/j.1476-5381.2012.02239.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; Cimolai N, 1998, ACTA PAEDIATR, V87, P593, DOI 10.1080/08035259850158353; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dean-Nystrom EA, 2000, INFECT IMMUN, V68, P2356, DOI 10.1128/IAI.68.4.2356-2358.2000; DIMARIO FJ, 1987, CLIN PEDIATR, V26, P586, DOI 10.1177/000992288702601106; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donohue-Rolfe A, 2000, J INFECT DIS, V181, P1825, DOI 10.1086/315421; Florenzano F, 2000, J COMP NEUROL, V424, P651; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; FUJII J, 1994, INFECT IMMUN, V62, P3447, DOI 10.1128/IAI.62.8.3447-3453.1994; Fujii J, 1996, INFECT IMMUN, V64, P5053, DOI 10.1128/IAI.64.12.5053-5060.1996; Garbuzova-Davis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016601; Gerfen C.R., 2004, RAT NERVOUS SYSTEM, P455, DOI DOI 10.1016/B978-012547638-6/50019-5; Goldstein J, 2007, BRAIN RES, V1161, P106, DOI 10.1016/j.brainres.2007.05.067; Grundmann K, 2012, NEUROBIOL DIS, V47, P61, DOI 10.1016/j.nbd.2012.03.024; Hager A, 1999, NEUROPEDIATRICS, V30, P210, DOI 10.1055/s-2007-973492; HAHN JS, 1989, J CHILD NEUROL, V4, P108, DOI 10.1177/088307388900400206; Isogai E, 1998, INFECT IMMUN, V66, P197, DOI 10.1128/IAI.66.1.197-202.1998; JEONG YK, 1994, PEDIATR RADIOL, V24, P585, DOI 10.1007/BF02012739; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; Karpman D, 1997, J INFECT DIS, V175, P611, DOI 10.1093/infdis/175.3.611; Kita E, 2000, INFECT IMMUN, V68, P1207, DOI 10.1128/IAI.68.3.1207-1214.2000; Kohutnicka M, 1998, IMMUNOPHARMACOLOGY, V39, P167, DOI 10.1016/S0162-3109(98)00022-8; Kurioka T, 1998, INFECT IMMUN, V66, P1726, DOI 10.1128/IAI.66.4.1726-1734.1998; Lei M, 2008, BIOCHEM BIOPH RES CO, V369, P1082, DOI 10.1016/j.bbrc.2008.02.151; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; Malamud N, 1974, ATLAS NEUROPATHOLOGY, P36; Matise I, 2000, VET PATHOL, V37, P318, DOI 10.1354/vp.37-4-318; Meichtri L, 2004, INT J FOOD MICROBIOL, V96, P189, DOI 10.1016/j.ijfoodmicro.2004.03.018; Mizuguchi M, 2001, ACTA NEUROPATHOL, V102, P306; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; MURATA F, 1974, AM J ANAT, V139, P335, DOI 10.1002/aja.1001390304; Nishikawa K, 2002, P NATL ACAD SCI USA, V99, P7669, DOI 10.1073/pnas.112058999; Noris M, 2005, J AM SOC NEPHROL, V16, P1035, DOI 10.1681/ASN.2004100861; Northington FJ, 2007, NEUROSCIENCE, V149, P822, DOI 10.1016/j.neuroscience.2007.06.060; O'Brien AD, 1998, ESCHERICHIA COLI O15, P1; Obata F, 2008, J INFECT DIS, V198, P1398, DOI 10.1086/591911; Obata F, 2010, ADV APPL MICROBIOL, V71, P1, DOI 10.1016/S0065-2164(10)71001-7; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; Pastor AM, 1997, NEUROSCIENCE, V81, P457, DOI 10.1016/S0306-4522(97)00200-5; PETITO CK, 1982, J NEUROPATH EXP NEUR, V41, P423, DOI 10.1097/00005072-198207000-00005; Priestley J.V., 1992, ELECT MICROSCOPIC IM, P89; Proulx F, 2001, PEDIATR RES, V50, P163, DOI 10.1203/00006450-200108000-00002; RICHARDSON SE, 1992, INFECT IMMUN, V60, P4154, DOI 10.1128/IAI.60.10.4154-4167.1992; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; ROOS RAC, 1983, J NEUROL SCI, V61, P37, DOI 10.1016/0022-510X(83)90053-9; Ruan YW, 2003, BRAIN RES, V982, P228, DOI 10.1016/S0006-8993(03)03021-X; SHETH KJ, 1986, ANN NEUROL, V19, P90, DOI 10.1002/ana.410190120; Siegler RL, 2001, J AM SOC NEPHROL, V12, P1458, DOI 10.1681/ASN.V1271458; Signorini E, 2000, PEDIATR NEPHROL, V14, P990, DOI 10.1007/s004670050059; Steinborn M, 2004, PEDIATR RADIOL, V34, P805, DOI 10.1007/s00247-004-1289-2; Strbian D, 2006, J CEREBR BLOOD F MET, V26, P605, DOI 10.1038/sj.jcbfm.9600228; Struelens MJ, 2011, EUROSURVEILLANCE, V16, P2; Sugatani J, 2000, THROMB RES, V100, P61, DOI 10.1016/S0049-3848(00)00305-4; Taguchi H, 2002, J MED MICROBIOL, V51, P336, DOI 10.1099/0022-1317-51-4-336; Takahashi K, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-11; Taylor FB, 1999, AM J PATHOL, V154, P1285, DOI 10.1016/S0002-9440(10)65380-1; Tironi-Farinati C, 2010, J NEUROIMMUNOL, V222, P48, DOI 10.1016/j.jneuroim.2010.03.001; Trachtman H, 2012, NAT REV NEPHROL, V8, P658, DOI 10.1038/nrneph.2012.196; TZIPORI S, 1988, J CLIN PATHOL, V41, P1099, DOI 10.1136/jcp.41.10.1099; TZIPORI S, 1995, INFECT IMMUN, V63, P3621, DOI 10.1128/IAI.63.9.3621-3627.1995; UPADHYAYA K, 1980, PEDIATRICS, V65, P115; Uranova N, 2001, BRAIN RES BULL, V55, P597, DOI 10.1016/S0361-9230(01)00528-7; Watanabe M, 2004, J INFECT DIS, V189, P360, DOI 10.1086/381124; WEST MO, 1990, J NEUROPHYSIOL, V64, P1233, DOI 10.1152/jn.1990.64.4.1233; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wood NI, 2007, NEUROBIOL DIS, V25, P342, DOI 10.1016/j.nbd.2006.09.015; ZOJA C, 1992, J LAB CLIN MED, V120, P229	81	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55812	10.1371/journal.pone.0055812	http://dx.doi.org/10.1371/journal.pone.0055812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383285	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600162
J	Guttman, C; Davidov, G; Shaked, H; Kolusheva, S; Bitton, R; Ganguly, A; Miller, JF; Chill, JH; Zarivach, R				Guttman, Chen; Davidov, Geula; Shaked, Hadassa; Kolusheva, Sofiya; Bitton, Ronit; Ganguly, Atish; Miller, Jeff F.; Chill, Jordan H.; Zarivach, Raz			Characterization of the N-Terminal Domain of BteA: A Bordetella Type III Secreted Cytotoxic Effector	PLOS ONE			English	Article							DIFFUSION MEASUREMENTS; FIELD GRADIENT; PSEUDOMONAS-SYRINGAE; VIRULENCE FACTORS; SYSTEM; ASSOCIATION; CHAPERONES; PREDICTION; SCREEN; MOTIF	BteA, a 69-kDa cytotoxic protein, is a type III secretion system (T3SS) effector in the classical Bordetella, the etiological agents of pertussis and related mammalian respiratory diseases. Currently there is limited information regarding the structure of BteA or its subdomains, and no insight as to the identity of its eukaryotic partners(s) and their modes of interaction with BteA. The mechanisms that lead to BteA dependent cell death also remain elusive. The N-terminal domain of BteA is multifunctional, acting as a docking platform for its cognate chaperone (BtcA) in the bacterium, and targeting the protein to lipid raft microdomains within the eukaryotic host cell. In this study we describe the biochemical and biophysical characteristics of this domain (BteA287) and determine its architecture. We characterize BteA287 as being a soluble and highly stable domain which is rich in alpha helical content. Nuclear magnetic resonance (NMR) experiments combined with size exclusion and analytical ultracentrifugation measurements confirm these observations and reveal BteA287 to be monomeric in nature with a tendency to oligomerize at concentrations above 200 mu M. Furthermore, diffusion-NMR demonstrated that the first 31 residues of BteA287 are responsible for the apparent aggregation behavior of BteA287. Light scattering analyses and small angle X-ray scattering experiments reveal a prolate ellipsoidal bi-pyramidal dumb-bell shape. Thus, our biophysical characterization is a first step towards structure determination of the BteA N-terminal domain.	[Guttman, Chen; Davidov, Geula; Zarivach, Raz] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Guttman, Chen; Davidov, Geula; Zarivach, Raz] Ben Gurion Univ Negev, NIBN, IL-84105 Beer Sheva, Israel; [Kolusheva, Sofiya; Bitton, Ronit] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel; [Bitton, Ronit] Ben Gurion Univ Negev, Dept Chem Engn, IL-84105 Beer Sheva, Israel; [Shaked, Hadassa; Chill, Jordan H.] Bar Ilan Univ, Dept Chem, Ramat Gan, Israel; [Ganguly, Atish; Miller, Jeff F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Bar Ilan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chill, JH (corresponding author), Bar Ilan Univ, Dept Chem, Ramat Gan, Israel.	Jordan.Chill@biu.ac.il; zarivach@bgu.ac.il	Chill, Jordan/W-5048-2018; ZARIVACH, RAZ/F-1671-2012	Chill, Jordan/0000-0002-9518-824X; ZARIVACH, RAZ/0000-0001-6543-0296; Bitton, Ronit/0000-0001-9601-9926; Davidov, Geula/0000-0001-5153-4940; Kolusheva, Sofiya/0000-0002-4406-2241	EU [239182, 227764]	EU(European Commission)	The research leading to these results has received funding from the EU Seventh Framework Programme (FP7/2007-2013 under grant agreement no 239182 and no 227764 (P-CUBE)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja U, BMC MICROBIOL, V12, P167; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Ambrus A, 2007, ANAL BIOCHEM, V367, P56, DOI 10.1016/j.ab.2007.04.025; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; Guinier A., 1955, SMALL ANGLE SCATTERI; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Han HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017797; Ilyina E, 1997, BIOCHEMISTRY-US, V36, P3383, DOI 10.1021/bi9622229; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Kuwae A, 2006, J BIOL CHEM, V281, P6589, DOI 10.1074/jbc.M512711200; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; McDermott JE, 2011, INFECT IMMUN, V79, P23, DOI 10.1128/IAI.00537-10; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mooij WTM, 2009, NUCLEIC ACIDS RES, V37, pW402, DOI 10.1093/nar/gkp256; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Price WS, 1999, J AM CHEM SOC, V121, P11503, DOI 10.1021/ja992265n; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; WHO, 2005, PERT VACC WHO POS PA, V44; William SP, 2006, CURRENT OPINION COLL, V11, P19; Winn MD, ACTA CRYSTALLOGR D, V67, P235; Wurtele M, 2001, NAT STRUCT BIOL, V8, P23; Yuk MH, 2000, MOL MICROBIOL, V35, P991, DOI 10.1046/j.1365-2958.2000.01785.x	39	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55650	10.1371/journal.pone.0055650	http://dx.doi.org/10.1371/journal.pone.0055650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383256	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800181
J	Monty, A; Bizoux, JP; Escarre, J; Mahy, G				Monty, Arnaud; Bizoux, Jean-Philippe; Escarre, Jose; Mahy, Gregory			Rapid Plant Invasion in Distinct Climates Involves Different Sources of Phenotypic Variation	PLOS ONE			English	Article							SENECIO-INAEQUIDENS; LOCAL ADAPTATION; GENETIC DIVERSITY; INVADED RANGE; ALPINE PLANT; PLASTICITY; WEED; DISPERSAL; EVOLUTION; TRAITS	When exotic species spread over novel environments, their phenotype will depend on a combination of different processes, including phenotypic plasticity (PP), local adaptation (LA), environmental maternal effects (EME) and genetic drift (GD). Few attempts have been made to simultaneously address the importance of those processes in plant invasion. The present study uses the well-documented invasion history of Senecio inaequidens (Asteraceae) in southern France, where it was introduced at a single wool-processing site. It gradually invaded the Mediterranean coast and the Pyrenean Mountains, which have noticeably different climates. We used seeds from Pyrenean and Mediterranean populations, as well as populations from the first introduction area, to explore the phenotypic variation related to climatic variation. A reciprocal sowing experiment was performed with gardens under Mediterranean and Pyrenean climates. We analyzed climatic phenotypic variation in germination, growth, reproduction, leaf physiology and survival. Genetic structure in the studied invasion area was characterized using AFLP. We found consistent genetic differentiation in growth traits but no home-site advantage, so weak support for LA to climate. In contrast, genetic differentiation showed a relationship with colonization history. PP in response to climate was observed for most traits, and it played an important role in leaf trait variation. EME mediated by seed mass influenced all but leaf traits in a Pyrenean climate. Heavier, earlier-germinating seeds produced larger individuals that produced more flower heads throughout the growing season. However, in the Mediterranean garden, seed mass only influenced the germination rate. The results show that phenotypic variation in response to climate depends on various ecological and evolutionary processes associated with geographical zone and life history traits. Seeing the relative importance of EME and GD, we argue that a "local adaptation vs. phenotypic plasticity" approach is therefore not sufficient to fully understand what shapes phenotypic variation and genetic architecture of invasive populations.	[Monty, Arnaud; Bizoux, Jean-Philippe; Mahy, Gregory] Univ Liege, Gembloux Agrobio Tech, Biodivers & Landscape Unit, B-5030 Gembloux, Belgium; [Escarre, Jose] Ctr Ecol Fonct & Evolut, UMR 5175, F-5000 Montpellier, France	University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Monty, A (corresponding author), Univ Liege, Gembloux Agrobio Tech, Biodivers & Landscape Unit, Passage Deportes 2, B-5030 Gembloux, Belgium.	arnaud.monty@ulg.ac.be		mahy, gregory/0000-0003-3094-8620; Monty, Arnaud/0000-0003-1910-6748	Belgian Fonds National de la Recherche Scientifique [FRFC 2.4605.06]; Belgian FONDS NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FNRS) [FRFC 2.4556.05]	Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian FONDS NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the project FRFC 2.4605.06 from the Belgian Fonds National de la Recherche Scientifique (www1.frs-fnrs.be). J-P.B. has a postdoctoral position at the Fonds National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Guy Buchet, Christian Collin and Gerard Malot's team (Office National des Forets, ONF) who provided technical assistance during the research project. Bernard Kazandjian and Jean-Luc Martin helped us find a suitable experimental site in the Pyrenean region. This research was supported by the project FRFC 2.4556.05 from the Belgian FONDS NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FNRS).	[Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Austerlitz F, 2000, GENETICS, V154, P1309; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Bossdorf O, 2008, DIVERS DISTRIB, V14, P676, DOI 10.1111/j.1472-4642.2008.00471.x; Cano L, 2008, J ECOL, V96, P468, DOI 10.1111/j.1365-2745.2008.01363.x; COTTREL V, 1998, P 6 MED S E W R S EN, P41; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dijkstra P., 1989, CAUSES CONSEQUENCES, P125; Donohue K., 1998, MATERNAL EFFECTS ADA; Dybdahl MF, 2005, ECOLOGY, V86, P1592, DOI 10.1890/04-0898; Ebeling SK, 2011, J PLANT ECOL-UK, V4, P209, DOI 10.1093/jpe/rtr007; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Ernst WHO, 1998, ACTA BOT NEERL, V47, P131; Excoffier L, 2006, ARLEQUIN VER 3 01 IN; Faraway J.J., 2005, LINEAR MODELS R; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Galloway LF, 1995, EVOLUTION, V49, P1095, DOI 10.1111/j.1558-5646.1995.tb04436.x; Garcia-Serrano H, 2004, CAN J BOT, V82, P1346, DOI [10.1139/B04-097, 10.1139/b04-097]; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Gaudeul M, 2000, MOL ECOL, V9, P1625, DOI 10.1046/j.1365-294x.2000.01063.x; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; Godoy O, 2011, BIOL INVASIONS, V13, P1615, DOI 10.1007/s10530-010-9919-0; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Guillerm J. L., 1990, Biological invasions in Europe and the Mediterranean Basin., P61; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kollmann J, 2004, DIVERS DISTRIB, V10, P377, DOI 10.1111/j.1366-9516.2004.00126.x; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; LACEY EP, 1988, ECOLOGY, V69, P220, DOI 10.2307/1943178; Lachmuth S, 2011, NEW PHYTOL, V192, P529, DOI 10.1111/j.1469-8137.2011.03808.x; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Lafuma L, 2003, PLANT SYST EVOL, V243, P59, DOI 10.1007/s00606-003-0075-0; Lafuma L, 2007, OIKOS, V116, P201, DOI 10.1111/j.0030-1299.2007.15220.x; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; Lopez-Garcia MC, 2005, BIOL INVASIONS, V7, P181, DOI 10.1007/s10530-004-8978-5; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Montague JL, 2008, J EVOLUTION BIOL, V21, P234, DOI 10.1111/j.1420-9101.2007.01456.x; Monty A, 2009, J EVOLUTION BIOL, V22, P917, DOI 10.1111/j.1420-9101.2009.01728.x; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; Monty A, 2008, BELG J BOT, V141, P51; Monty A, 2010, BIOTECHNOL AGRON SOC, V14, P627; Monty A, 2010, OIKOS, V119, P1563, DOI 10.1111/j.1600-0706.2010.17769.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palacio-Lopez K, 2011, OIKOS, V120, P1393, DOI 10.1111/j.1600-0706.2010.19114.x; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Paz H, 2003, ECOLOGY, V84, P439, DOI 10.1890/0012-9658(2003)084[0439:SMASPW]2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; RICE KJ, 1991, OECOLOGIA, V88, P91, DOI 10.1007/BF00328408; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Ross CA, 2009, BIOL INVASIONS, V11, P441, DOI 10.1007/s10530-008-9261-y; SCHMITT J, 1992, AM NAT, V139, P451, DOI 10.1086/285338; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Senay P, 1944, B SOC BOT FRANCE, V91, P111; STRATTON DA, 1989, AM J BOT, V76, P1646, DOI 10.2307/2444402; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344	62	33	33	2	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55627	10.1371/journal.pone.0055627	http://dx.doi.org/10.1371/journal.pone.0055627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383251	gold, Green Published			2022-12-25	WOS:000315563800177
J	Patel, RA; Liu, Y; Wang, B; Li, R; Sebti, SM				Patel, R. A.; Liu, Y.; Wang, B.; Li, R.; Sebti, S. M.			Identification of novel ROCK inhibitors with anti-migratory and anti-invasive activities	ONCOGENE			English	Article						RKI-18; ROCK1; ROCK2; invasion; migration; MLC-2	RHO-ASSOCIATED KINASE; BREAST-CANCER CELLS; TUMOR-CELLS; GTPASES; PROTEINS; OVEREXPRESSION; INVOLVEMENT; PROGRESSION; EXPRESSION; DISEASE	ROCK1 and ROCK2 mediate important processes such as cell migration, invasion and metastasis, making them good targets for the development of antitumor agents. Recently, using a fragment-based approach and X-ray crystallography, we reported on the design and synthesis of novel Rho-kinase inhibitors (RKIs). Here, we selected a pair of RKIs, the closely related structural analogs RKI-18 (potent; IC50 values of 397 nM (ROCK1) and 349 nM (ROCK2)) and RKI-11 (weak/inactive; IC50 values of 38 mu M (ROCK1) and 45 mu M (ROCK2)), as chemical probes and determined their effects on cytoskeleton organization, signaling, apoptosis, anchorage-dependent and independent growth, migration and invasion. RKI-18 but not RKI-11 suppresses potently the phosphorylation of the ROCK substrate myosin light chain 2 (MLC2) in intact human breast, lung, colon and prostate cancer cells. Furthermore, RKI-18 is highly selective at decreasing the levels of P-MLC2 over those of P-Akt, P-S6 and P-Erk 1/2. RKI-18 suppresses ROCK-mediated actin fiber formation, following stimulation with LPA as well as p21-activated kinase (PAK)-mediated lamellipodia and filopodia formation following bradykinin or PDGF stimulation. Furthermore, RKI-18 but not RKI-11 inhibits migration, invasion and anchorage-independent growth of human breast cancer cells. The fact that the active ROCK inhibitor RKI-18, but not the inactive closely related structural analog RKI-11 is effective at suppressing malignant transformation suggests that inhibition of ROCK with RKI-18 results in preventing migration, invasion and anchorage-independent growth. The potential of this class of RKIs as anti-tumor agents warrants further advanced preclinical studies.	[Patel, R. A.; Liu, Y.; Wang, B.; Li, R.; Sebti, S. M.] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; [Sebti, S. M.] Univ S Florida, Dept Oncol Sci, Tampa, FL USA; [Sebti, S. M.] Univ S Florida, Dept Mol Med, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Sebti, SM (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, SRB3-DRDIS,12902 Magnolia Dr, Tampa, FL 33612 USA.	said.sebti@moffitt.org			NCI [U19 CA 067771]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA098473, U19CA067771] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Nan Sun (Moffitt Cancer Center) and the following Moffitt Cancer Center core facilities: the Chemical Biology Core, the Analytical Microscopy Core and Comparative Medicine Core facility. This work was supported by NCI grant U19 CA 067771.	Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Balasis ME, 2011, CLIN CANCER RES, V17, P2852, DOI 10.1158/1078-0432.CCR-10-2544; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5; Burbelo P, 2004, BREAST CANCER RES TR, V84, P43, DOI 10.1023/B:BREA.0000018422.02237.f9; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Imamura F, 2000, JPN J CANCER RES, V91, P811, DOI 10.1111/j.1349-7006.2000.tb01018.x; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kleer CG, 2002, AM J PATHOL, V160, P579, DOI 10.1016/S0002-9440(10)64877-8; Lane J, 2008, INT J ONCOL, V33, P585, DOI 10.3892/ijo_00000044; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; Li RS, 2012, J MED CHEM, V55, P2474, DOI 10.1021/jm201289r; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Patel RA, 2012, CANCER RES, V72, P5025, DOI 10.1158/0008-5472.CAN-12-0954; Redowicz MJ, 1999, ARCH BIOCHEM BIOPHYS, V364, P122, DOI 10.1006/abbi.1999.1112; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Routhier A, 2010, ONCOL REP, V23, P861, DOI 10.3892/or_00000708; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Vigil D, 2012, CANCER RES, V72, P5338, DOI 10.1158/0008-5472.CAN-11-2373; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Ying H, 2006, MOL CANCER THER, V5, P2158, DOI 10.1158/1535-7163.MCT-05-0440; Yoshioka K, 1999, CANCER RES, V59, P2004; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	33	47	50	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					550	555		10.1038/onc.2012.634	http://dx.doi.org/10.1038/onc.2012.634			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23396364	Green Accepted			2022-12-25	WOS:000331125100003
J	Zhang, J; Chen, C; Hou, XX; Gao, YY; Lin, F; Yang, J; Gao, ZM; Pan, LN; Tao, LQ; Wen, CJ; Yao, ZJ; Tsun, A; Shi, GC; Li, B				Zhang, Jing; Chen, Chen; Hou, Xiaoxia; Gao, Yayi; Lin, Fang; Yang, Jing; Gao, Zhimei; Pan, Lina; Tao, Lianqin; Wen, Chijun; Yao, Zhengju; Tsun, Andy; Shi, Guochao; Li, Bin			Identification of the E3 Deubiquitinase Ubiquitin-specific Peptidase 21 (USP21) as a Positive Regulator of the Transcription Factor GATA3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELLS; TGF-BETA; HISTONE ACETYLTRANSFERASE; FOXP3 EXPRESSION; DIFFERENTIATION; PROGRAMS; IL-4	The expression of the transcription factor GATA 3 in FOXP3(+) regulatory T (Treg) cells is crucial for their physiological function in limiting inflammatory responses. Although other studies have shown how T cell receptor (TcR) signals induce the up-regulation of GATA3 expression in Treg cells, the underlying mechanism that maintains GATA3 expression in Treg cells remains unclear. Here, we show how USP21 interacts with and stabilizes GATA3 by mediating its deubiquitination. In a T cell line model, we found that TcR stimulation promoted USP21 expression, which was further up-regulated in the presence of FOXP3. The USP21 mutant C221A reduced its capacity to stabilize GATA3 expression, and its knockdown led to the down-regulation of GATA3 protein expression in Treg cells. Furthermore, we found that FOXP3 could directly bind to the USP21 gene promoter and activated its transcription upon TcR stimulation. Finally, USP21, GATA3, and FOXP3 were found up-regulated in Treg cells that were isolated from asthmatic subjects. In summary, we have identified a USP21-mediated pathway that promotes GATA3 stabilization and expression at the post-translational level. We propose that this pathway forms an important signaling loop that stabilizes the expression of GATA3 in Treg cells.	[Zhang, Jing; Chen, Chen; Gao, Yayi; Lin, Fang; Yang, Jing; Gao, Zhimei; Yao, Zhengju; Tsun, Andy; Li, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol,Unit Mol Immunol, Shanghai 200025, Peoples R China; [Hou, Xiaoxia; Pan, Lina; Tao, Lianqin; Shi, Guochao] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Pneumol, Shanghai 200025, Peoples R China; [Wen, Chijun] Shanghai Second Peoples Hosp, Dept Resp Med, Shanghai 200011, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Shanghai Jiao Tong University	Shi, GC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Pneumol Med, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China.	shiguochao@hotmail.com; binli@sibs.ac.cn	lI, Bin/AAR-4966-2021	lI, Bin/0000-0002-7640-8884	National Natural Science Foundation of China, NSFC [30972702, 31170825, 81270083, 31150110337, 31200647, 81271835]; National Institutes of Health-NSFC Collaborative Grant [81161120417]; Shanghai "Rising Star" Program Grant [10QA1407900]; Novo Nordisk-Chinese Academy of Sciences Foundation; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2010KIP205, 2012KIP204]	National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); National Institutes of Health-NSFC Collaborative Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai "Rising Star" Program Grant; Novo Nordisk-Chinese Academy of Sciences Foundation; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported by (National Natural Science Foundation of China, NSFC) Grants 30972702, 31170825, 81270083, 31150110337, 31200647, and 81271835; National Institutes of Health-NSFC Collaborative Grant 81161120417; Shanghai "Rising Star" Program Grant 10QA1407900; and the Novo Nordisk-Chinese Academy of Sciences Foundation. This work was also supported by the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grants 2010KIP205 and 2012KIP204.	Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chapoval S, 2010, J LEUKOCYTE BIOL, V87, P1011, DOI 10.1189/jlb.1209772; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wang YQ, 2010, J IMMUNOL, V185, P5983, DOI 10.4049/jimmunol.1001255; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei J, 2007, P NATL ACAD SCI USA, V104, P18169, DOI 10.1073/pnas.0703642104; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Xiao Y, 2010, CURR OPIN IMMUNOL, V22, P583, DOI 10.1016/j.coi.2010.08.013; Xu GF, 2010, J BIOL CHEM, V285, P969, DOI 10.1074/jbc.M109.042689; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	35	55	58	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9373	9382		10.1074/jbc.M112.374744	http://dx.doi.org/10.1074/jbc.M112.374744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23395819	Green Published, hybrid			2022-12-25	WOS:000316862200054
J	Vu, NT; Park, MA; Shultz, JC; Goehe, RW; Hoeferlin, LA; Shultz, MD; Smith, SA; Lynch, KW; Chalfant, CE				Vu, Ngoc T.; Park, Margaret A.; Shultz, Jacqueline C.; Goehe, Rachel W.; Hoeferlin, L. Alexis; Shultz, Michael D.; Smith, Sarah A.; Lynch, Kristen W.; Chalfant, Charles E.			hnRNP U Enhances Caspase-9 Splicing and Is Modulated by AKT-dependent Phosphorylation of hnRNP L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NUCLEAR-MATRIX PROTEIN; DOUBLE-STRAND BREAKS; PRE-MESSENGER-RNA; CELL LUNG-CANCER; U/SAF-A; SAF-A; APOPTOSIS; DNA; TRANSCRIPTION	Caspase-9 has two splice variants, pro-apoptotic caspase-9a and anti-apoptotic caspase-9b, which are regulated by RNA trans-factors associated with exon 3 of caspase-9 pre-mRNA (C9/E3). In this study, we identified hnRNP U as an RNA trans-factor associated with C9/E3. Down-regulation of hnRNP U led to a decrease in the caspase-9a/9bmRNAratio, demonstrating a novel enhancing function. Importantly, hnRNP U bound specifically to C9/E3 at an RNA cis-element previously reported as the binding site for the splicing repressor, hnRNP L. Phosphorylated hnRNP L interfered with hnRNP U binding to C9/E3, and our results demonstrate the importance of the phosphoinositide 3-kinase/AKT pathway in modulating the association of hnRNP U to C9/E3. Taken together, these findings show that hnRNP U competes with hnRNP L for binding to C9/E3 to enhance the inclusion of the four-exon cassette, and this splice-enhancing function is blocked by the AKT pathway via phosphorylation of hnRNP L.	[Vu, Ngoc T.; Park, Margaret A.; Shultz, Jacqueline C.; Goehe, Rachel W.; Hoeferlin, L. Alexis; Shultz, Michael D.; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Vu, Ngoc T.] Vietnam Educ Fdn, Arlington, VA 22201 USA; [Chalfant, Charles E.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA 23249 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Smith, Sarah A.; Lynch, Kristen W.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; University of Pennsylvania	Chalfant, CE (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Sanger Hall,Rm 2-016,1101 E Marshall St, Richmond, VA 23298 USA.	cechalfant@vcu.edu		Hoeferlin, L. Alexis/0000-0001-7569-8712	National Institutes of Health [CA154314, R01 GM067719]; Department of Veterans Affairs; Vietnam Education Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA154314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067719] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Vietnam Education Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants CA154314 (to C. E. C.) and R01 GM067719 (to K. W. L.). This work was also supported by a merit review and research career scientist award from the Department of Veterans Affairs (to C. E. C.), a fellowship from the Vietnam Education Foundation (to N. T. V.), and a fellowship from the American Heart Association (to S. A. S.).	Berglund FM, 2009, BIOCHEM BIOPH RES CO, V381, P59, DOI 10.1016/j.bbrc.2009.02.019; Britton S, 2009, CELL CYCLE, V8, P3717, DOI 10.4161/cc.8.22.10025; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Eggert M, 1997, J BIOL CHEM, V272, P28471, DOI 10.1074/jbc.272.45.28471; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Helbig R, 2003, CHROMOSOMA, V112, P173, DOI 10.1007/s00412-003-0258-0; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Obrdlik A, 2008, MOL CELL BIOL, V28, P6342, DOI 10.1128/MCB.00766-08; Seol DW, 1999, J BIOL CHEM, V274, P2072, DOI 10.1074/jbc.274.4.2072; Shultz JC, 2011, MOL CANCER RES, V9, P889, DOI 10.1158/1541-7786.MCR-11-0061; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; Srinivasula SM, 1999, CANCER RES, V59, P999; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; Yugami M, 2007, FEBS LETT, V581, P1, DOI 10.1016/j.febslet.2006.11.062	24	55	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8575	8584		10.1074/jbc.M112.443333	http://dx.doi.org/10.1074/jbc.M112.443333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23396972	Green Published, hybrid			2022-12-25	WOS:000316564500058
J	de Hoef, DLV; Coppens, I; Holowka, T; Ben Mamoun, C; Branch, O; Rodriguez, A				de Hoef, Diana L. van; Coppens, Isabelle; Holowka, Thomas; Ben Mamoun, Choukri; Branch, OraLee; Rodriguez, Ana			Plasmodium falciparum-Derived Uric Acid Precipitates Induce Maturation of Dendritic Cells	PLOS ONE			English	Article							EXPERIMENTAL CEREBRAL MALARIA; DANGER SIGNAL; ANTIGEN PRESENTATION; GALLSTONE FORMATION; URATE OXIDASE; PLASMA; RESPONSES; HEMOZOIN; IDENTIFICATION; INFLAMMASOME	Malaria is characterized by cyclical fevers and high levels of inflammation, and while an early inflammatory response contributes to parasite clearance, excessive and persistent inflammation can lead to severe forms of the disease. Here, we show that Plasmodium falciparum-infected erythrocytes contain uric acid precipitates in the cytoplasm of the parasitophorous vacuole, which are released when erythrocytes rupture. Uric acid precipitates are highly inflammatory molecules that are considered a danger signal for innate immunity and are the causative agent in gout. We determined that P. falciparum-derived uric acid precipitates induce maturation of human dendritic cells, increasing the expression of cell surface co-stimulatory molecules such as CD80 and CD86, while decreasing human leukocyte antigen-DR expression. In accordance with this, uric acid accounts for a significant proportion of the total stimulatory activity induced by parasite-infected erythrocytes. Moreover, the identification of uric acid precipitates in P. falciparum-and P. vivax-infected erythrocytes obtained directly from malaria patients underscores the in vivo and clinical relevance of our findings. Altogether, our data implicate uric acid precipitates as a potentially important contributor to the innate immune response to Plasmodium infection and may provide a novel target for adjunct therapies.	[de Hoef, Diana L. van; Branch, OraLee; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA; [Coppens, Isabelle] Johns Hopkins Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Holowka, Thomas; Ben Mamoun, Choukri] Yale Univ, Infect Dis Sect, Sch Med, New Haven, CT USA; [Holowka, Thomas; Ben Mamoun, Choukri] Yale Univ, Dept Microbial Pathogenesis, Sch Med, New Haven, CT USA	New York University; Johns Hopkins University; Yale University; Yale University	Rodriguez, A (corresponding author), NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA.	Ana.Rodriguez@nyumc.org	Rodríguez, Ana/GQR-0554-2022	Rodriguez, Ana/0000-0002-0060-3405	Burroughs Wellcome Fund Award for Investigators in the Pathogenesis of Infectious Disease; NIH [R56-AI070907]; Irma T. Hirschl Trust Career Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007404, R56AI070907, R01AI064831] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Award for Investigators in the Pathogenesis of Infectious Disease; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Trust Career Investigator Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Burroughs Wellcome Fund Award for Investigators in the Pathogenesis of Infectious Disease (http://www.bwfund.org/pages/105/Investigators-in-the-Pathogenesis-of-Infectious-Disease/), NIH grant R56-AI070907 (http://grants.nih.gov/grants/funding/r56.htm) and the Irma T. Hirschl Trust Career Investigator Award (http://www.mssm.edu/static_files/Test2/06081716/www.mssm.edu/grants/pdfs/Hirschl_applic_guidelines.pdf) to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Becker MA, 2009, J RHEUMATOL, V36, P1273, DOI 10.3899/jrheum.080814; Bertrand Kouam Eric, 2008, Pak J Biol Sci, V11, P1646, DOI 10.3923/pjbs.2008.1646.1649; Bettiol E, MALAR J, V9, P64; BOULIEU R, 1983, ANAL BIOCHEM, V129, P398, DOI 10.1016/0003-2697(83)90568-7; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; Clark EH, 2012, INFECT IMMUN; Clark IA, 2003, PHARMACOL THERAPEUT, V99, P221, DOI 10.1016/S0163-7258(03)00060-3; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; DAS BS, 1993, AM J TROP MED HYG, V49, P720, DOI 10.4269/ajtmh.1993.49.720; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; Della Bella S, 2008, J IMMUNOL METHODS, V339, P153, DOI 10.1016/j.jim.2008.09.009; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; El Bissati K, 2008, MOL BIOCHEM PARASIT, V161, P130, DOI 10.1016/j.molbiopara.2008.06.012; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Elandalloussi Laurence M, 2002, Malar J, V1, P6, DOI 10.1186/1475-2875-1-6; Erdman LK, 2008, MOL BIOCHEM PARASIT, V162, P105, DOI 10.1016/j.molbiopara.2008.08.006; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; Gowda NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020398; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Haldar K, 2009, HEMATOL-AM SOC HEMAT, V2009, P87, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.87; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hu DE, 2004, CANCER RES, V64, P5059, DOI 10.1158/0008-5472.CAN-04-1586; Iwalokun BA, 2006, APMIS, V114, P842, DOI 10.1111/j.1600-0463.2006.apm_457.x; Iwama M, 2012, BIOL PHARM BULL, V35, P1367, DOI 10.1248/bpb.b12-00198; Johnson RJ, 2011, SEMIN NEPHROL, V31, P394, DOI 10.1016/j.semnephrol.2011.08.002; Khan SR, 2002, KIDNEY INT, V62, P2062, DOI 10.1046/j.1523-1755.2002.00676.x; Kim CC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-17; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; Kono H, J CLIN INVEST, V120, P1939; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kordes M, 2011, INFECT IMMUN, V79, P3633, DOI 10.1128/IAI.05459-11; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Labbe K, 2010, J IMMUNOL, V185, P5495, DOI 10.4049/jimmunol.1002517; Lopera-Mesa T.MM-MNK, 2012, PLOS ONE, V7; Luah YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010252; Lundie RJ, 2010, EUR J IMMUNOL, V40, P1674, DOI 10.1002/eji.200939265; MCCARTY DJ, 1961, ANN INTERN MED, V54, P452, DOI 10.7326/0003-4819-54-3-452; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; MOSER AJ, 1994, DIGEST DIS SCI, V39, P1313; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Nguansangiam S, 2007, TROP MED INT HEALTH, V12, P1037, DOI 10.1111/j.1365-3156.2007.01881.x; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Orengo JM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-254; Orengo JM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000013; Orengo JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005194; Overgaard-Hansen K, 1959, NATURE S8, P553; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Reimer T, 2010, EUR J IMMUNOL, V40, P764, DOI 10.1002/eji.200939996; ROSLYN JJ, 1987, DIGEST DIS SCI, V32, P609, DOI 10.1007/BF01296161; Saliba KJ, 2003, J BIOL CHEM, V278, P5605, DOI 10.1074/jbc.M208648200; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Sarma PSA, 1998, AM J TROP MED HYG, V58, P454, DOI 10.4269/ajtmh.1998.58.454; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; Selvam R., 1992, Indian Journal of Malariology, V29, P103; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; STOCKER R, 1986, BIOCHEM BIOPH RES CO, V134, P152, DOI 10.1016/0006-291X(86)90540-1; Terkeltaub R, 2007, J RHEUMATOL, V34, P1955; Urban BC, 2001, BLOOD, V98, P2859, DOI 10.1182/blood.V98.9.2859; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; ZOLG JW, 1982, J PARASITOL, V68, P1072, DOI 10.2307/3281094	72	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55584	10.1371/journal.pone.0055584	http://dx.doi.org/10.1371/journal.pone.0055584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405174	Green Published, gold			2022-12-25	WOS:000315153400119
J	Fisson, S; Ouakrim, H; Touitou, V; Baudet, S; Ben Abdelwahed, R; Donnou, S; Miloudi, A; Galand, C; Bodaghi, B; LeHoang, P; Brissard, M; Le Garff-Tavernier, M; Fridman, WH; Sautes-Fridman, C; Cassoux, N; Merle-Beral, H				Fisson, Sylvain; Ouakrim, Hanane; Touitou, Valerie; Baudet, Sylvie; Ben Abdelwahed, Rym; Donnou, Sabrina; Miloudi, Amine; Galand, Claire; Bodaghi, Bahram; Phuc LeHoang; Brissard, Martine; Le Garff-Tavernier, Magali; Fridman, Wolf Herman; Sautes-Fridman, Catherine; Cassoux, Nathalie; Merle-Beral, Helene			Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis between Intraocular Lymphoma or Uveitis	PLOS ONE			English	Article							NERVOUS-SYSTEM LYMPHOMA; VITREORETINAL LYMPHOMA; AQUEOUS-HUMOR; INTERLEUKIN-10	Primary intraocular lymphoma (PIOL), also called primary vitreoretinal lymphomas, often masquerades as uveitis. This misdiagnosis can result in subsequent brain involvement and oculocerebral lymphoma (OCL). In this study, we sought to characterize the helper T-cell type 1 (Th1)/Th2 cytokine profile in vitreous samples from patients with PIOL, OCL, uveitis and controls with non-inflammatory disease. Vitreous and aqueous humor samples from 87 patients with PIOL (n = 30), OCL (n = 12), uveitis (n = 34), and retinal detachment (RD) without hemorrhage (n = 11) were analyzed and their concentrations of interleukin (IL)-2, IL-4, IL-6, IL-10, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha were determined by flow cytometric bead arrays (CBA). The IL-10 levels determined by CBA were compared with those by ELISA. IL-10 concentrations measured by CBA and ELISA were highly correlated. IL-2, IL-4, and TNF alpha were not detected in any sample. The only cytokine detected at a significant level in samples from RD vitreous was IL-6. The IL-10/IL-6 ratio, as previously reported, was slightly higher in PIOL than in uveitis samples, but not for all patients. Cytokine profiles from PIOL and OCL samples did not differ. The combination of the IL-10/IL-6 and IL-10/IFN gamma ratios was highly informative for discriminating PIOL/OCL from uveitis samples and for therapeutic follow up of PIOL. This strategy might be very helpful as an initial screening to rule out PIOL in patients thought to have uveitis.	[Fisson, Sylvain; Ouakrim, Hanane; Ben Abdelwahed, Rym; Donnou, Sabrina; Miloudi, Amine; Galand, Claire; Fridman, Wolf Herman; Sautes-Fridman, Catherine; Merle-Beral, Helene] INSERM, UMRS872, Ctr Rech Cordeliers, Paris, France; [Fisson, Sylvain; Ouakrim, Hanane; Touitou, Valerie; Baudet, Sylvie; Ben Abdelwahed, Rym; Donnou, Sabrina; Miloudi, Amine; Galand, Claire; Bodaghi, Bahram; Phuc LeHoang; Fridman, Wolf Herman; Sautes-Fridman, Catherine; Merle-Beral, Helene] Univ Paris 06, UMRS 872, Paris, France; [Fisson, Sylvain; Ouakrim, Hanane; Ben Abdelwahed, Rym; Donnou, Sabrina; Miloudi, Amine; Galand, Claire; Fridman, Wolf Herman; Sautes-Fridman, Catherine] Univ Paris 05, UMRS 872, Paris, France; [Fisson, Sylvain; Donnou, Sabrina] Genethon, Evry, France; [Fisson, Sylvain; Donnou, Sabrina] INSERM, U951, Evry, France; [Fisson, Sylvain; Donnou, Sabrina] Univ Evry Val dEssonne, UMRS 951, Evry, France; [Touitou, Valerie; Bodaghi, Bahram; Phuc LeHoang] Hop La Pitie Salpetriere, AP HP, Serv Ophtalmol, Paris, France; [Baudet, Sylvie; Brissard, Martine; Le Garff-Tavernier, Magali; Merle-Beral, Helene] Hop La Pitie Salpetriere, AP HP, Serv Hematol Biol, Paris, France; [Cassoux, Nathalie] Inst Curie, Serv Oncoophtalmol, Dept Oncol Chirurg, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Fisson, S (corresponding author), INSERM, UMRS872, Ctr Rech Cordeliers, Paris, France.	sylvain.fisson@univ-evry.fr	Bodaghi, Bahram/AAS-1160-2021; Cassoux, Nathalie/D-6844-2015; FISSON, Sylvain/J-8003-2013	Cassoux, Nathalie/0000-0002-5535-9649; FISSON, Sylvain/0000-0002-0057-363X; sautes-fridman, catherine/0000-0003-1735-8722; Galand, Claire/0000-0001-8005-4831; LeHoang, Phuc/0000-0003-4722-1831; fridman, wolf herman/0000-0002-1332-0973; Merle-Beral, Helene/0000-0002-7430-1143; Bodaghi, Bahram/0000-0002-0962-5301; Le Garff-Tavernier, Magali/0000-0002-3131-3240	Institut National du Cancer [RC013-C06N631-2005, C06N748-2006]; Association pour la Recherche contre le Cancer; Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Pierre and Marie Curie; Universite Paris-Descartes; pole de competitivite Ile de France (ImmuCan project); Tunisian Direction Generale de la Recherche Scientifique; French-Tunisian CMCU "(Egide-PHC Utique)" project; DGRS-INSERM; CMCU; Institut National du Cancer; Federation des Aveugles de France; Fondation de France (Fouassier)	Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre and Marie Curie; Universite Paris-Descartes; pole de competitivite Ile de France (ImmuCan project); Tunisian Direction Generale de la Recherche Scientifique; French-Tunisian CMCU "(Egide-PHC Utique)" project; DGRS-INSERM; CMCU; Institut National du Cancer(Institut National du Cancer (INCA) France); Federation des Aveugles de France; Fondation de France (Fouassier)	This work was supported by the Institut National du Cancer (Grants RC013-C06N631-2005 and C06N748-2006), the Association pour la Recherche contre le Cancer, the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite Pierre and Marie Curie, the Universite Paris-Descartes, the pole de competitivite Ile de France (ImmuCan project), the Tunisian Direction Generale de la Recherche Scientifique, and the French-Tunisian CMCU "(Egide-PHC Utique)" project. R. B. A. was a recipient of grants from the DGRS-INSERM and the CMCU. S. D. was recipient of a grant from the Institut National du Cancer. V. T. was a beneficiary of study grants from the Federation des Aveugles de France and the Fondation de France (Fouassier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpek EK, 1999, OPHTHALMOLOGY, V106, P2291; Buggage RR, 1999, INVEST OPHTH VIS SCI, V40, P2462; Cassoux N, 2000, OCUL IMMUNOL INFLAMM, V8, P243, DOI 10.1076/ocii.8.4.243.6463; Cassoux N, 2007, INVEST OPHTH VIS SCI, V48, P3253, DOI 10.1167/iovs.06-0031; Chan Chi-Chao, 2003, Trans Am Ophthalmol Soc, V101, P275; Chan CC, 2011, ONCOLOGIST, V16, P1589, DOI 10.1634/theoncologist.2011-0210; Chan CC, 2009, OCUL IMMUNOL INFLAMM, V17, P375, DOI 10.3109/09273940903434804; Corn BW, 1997, CANCER, V79, P2409; Davis JL, 2004, OCUL IMMUNOL INFLAMM, V12, P7, DOI 10.1076/ocii.12.1.7.28072; Ecker SM, 2011, MOL VIS, V17, P2856; HOCHBERG FH, 1988, J NEUROSURG, V68, P835, DOI 10.3171/jns.1988.68.6.0835; Jahnke K, 2007, CLIN OPHTHALMOL, V1, P247; Kawamura H, 2009, OPHTHAL RES, V42, P172, DOI 10.1159/000230879; Merle-Beral H, 2004, BRIT J HAEMATOL, V124, P469, DOI 10.1046/j.1365-2141.2003.04800.x; Sen HN, 2009, OCUL IMMUNOL INFLAMM, V17, P133, DOI 10.1080/09273940903108544; Vosganian GS, 2011, J NEURO-ONCOL, V105, P127, DOI 10.1007/s11060-011-0618-1; Whitcup SM, 1997, ARCH OPHTHALMOL-CHIC, V115, P1157, DOI 10.1001/archopht.1997.01100160327010; WHITCUP SM, 1993, OPHTHALMOLOGY, V100, P1399; Wolf LA, 2003, OPHTHALMOLOGY, V110, P1671, DOI 10.1016/S0161-6420(03)00811-X	19	45	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e52385	10.1371/journal.pone.0052385	http://dx.doi.org/10.1371/journal.pone.0052385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405064	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400007
J	Hostage, CA; Choudhury, KR; Doraiswamy, PM; Petrella, JR				Hostage, Christopher A.; Choudhury, Kingshuk Roy; Doraiswamy, Pudugramam Murali; Petrella, Jeffrey R.		Alzheimer's Dis Neuroimaging Initi	Dissecting the Gene Dose-Effects of the APOE epsilon 4 and epsilon 2 Alleles on Hippocampal Volumes in Aging and Alzheimer's Disease	PLOS ONE			English	Article							NEUROIMAGING INITIATIVE ADNI; APOLIPOPROTEIN-E GENOTYPE; GRAY-MATTER VOLUME; GEOMETRICALLY ACCURATE; CORTICAL THICKNESSES; MRI; ATROPHY; LOAD; SEGMENTATION; FREQUENCY	Objective: To investigate whether there is a specific dose-dependent effect of the Apolipoprotein E (APOE) epsilon 4 and epsilon 2 alleles on hippocampal volume, across the cognitive spectrum, from normal aging to Alzheimer's Disease (AD). Materials and Methods: We analyzed MR and genetic data on 662 patients from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database-198 cognitively normal controls (CN), 321 mild-cognitive impairment (MCI) subjects, and 143 AD subjects-looking for dose-dependent effects of the epsilon 4 and epsilon 2 alleles on hippocampal volumes. Volumes were measured using a fully-automated algorithm applied to high resolution T1-weighted MR images. Statistical analysis consisted of a multivariate regression with repeated-measures model. Results: There was a dose-dependent effect of the epsilon 4 allele on hippocampal volume in AD (p = 0.04) and MCI (p = 0.02)-in both cases, each allele accounted for loss of >150 mm(3) (approximately 4%) of hippocampal volume below the mean volume for AD and MCI subjects with no such alleles (Cohen's d = -0.16 and -0.19 for AD and MCI, respectively). There was also a dose-dependent, main effect of the epsilon 2 allele (p<0.0001), suggestive of a moderate protective effect on hippocampal volume-an approximately 20% per allele volume increase as compared to CN with no epsilon 2 alleles (Cohen's d = 0.23). Conclusion: Though no effect of epsilon 4 was seen in CN subjects, our findings confirm and extend prior data on the opposing effects of the APOE epsilon 4 and epsilon 2 alleles on hippocampal morphology across the spectrum of cognitive aging.	[Hostage, Christopher A.; Choudhury, Kingshuk Roy; Petrella, Jeffrey R.] Duke Univ, Dept Radiol, Sch Med, Durham, NC 27710 USA; [Doraiswamy, Pudugramam Murali] Duke Univ, Dept Psychiat, Sch Med, Durham, NC 27706 USA; [Doraiswamy, Pudugramam Murali] Duke Univ, Sch Med, Duke Inst Brain Sci, Durham, NC USA	Duke University; Duke University; Duke University	Petrella, JR (corresponding author), Duke Univ, Dept Radiol, Sch Med, Durham, NC 27710 USA.	jeffrey.petrella@duke.edu			RSNA Research Medical Student Grant [RMS1213]; NATIONAL INSTITUTE ON AGING [U19AG010483] Funding Source: NIH RePORTER	RSNA Research Medical Student Grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a 2012 RSNA Research Medical Student Grant, grant #RMS1213 (http://www.rsna.org/Grants_and_Awards.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, ADNI MRI PROTOCOLS; Barber R, 2000, NEUROLOGY, V54, P1304, DOI 10.1212/WNL.54.6.1304; Basso M, 2006, NEUROBIOL AGING, V27, P1416, DOI 10.1016/j.neurobiolaging.2005.08.002; BENJAMIN R, 1994, LANCET, V344, P473, DOI 10.1016/S0140-6736(94)91804-X; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Cherbuin N, 2008, J GERONTOL A-BIOL, V63, P501, DOI 10.1093/gerona/63.5.501; Chiang GC, 2010, NEUROLOGY, V75, P1976, DOI 10.1212/WNL.0b013e3181ffe4d1; Crivello F, 2010, NEUROIMAGE, V53, P1064, DOI 10.1016/j.neuroimage.2009.12.116; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Farlow MR, 1997, NEUROLOGY, V48, pS30, DOI 10.1212/WNL.48.5_Suppl_6.30S; Farlow MR, 2004, NEUROLOGY, V63, P1898, DOI 10.1212/01.WNL.0000144279.21502.B7; Filippini N, 2009, NEUROIMAGE, V44, P724, DOI 10.1016/j.neuroimage.2008.10.003; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Holland D, 2012, HUM BRAIN MAPP, V33, P2586, DOI 10.1002/hbm.21386; Holland D, 2011, MED IMAGE ANAL, V15, P489, DOI 10.1016/j.media.2011.02.005; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 1998, ANN NEUROL, V43, P303, DOI 10.1002/ana.410430307; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Lemaitre H, 2005, NEUROIMAGE, V24, P1205, DOI 10.1016/j.neuroimage.2004.10.016; Liu YW, 2010, DEMENT GERIATR COGN, V30, P229, DOI 10.1159/000320136; Liu YW, 2010, J ALZHEIMERS DIS, V21, P947, DOI 10.3233/JAD-2010-100201; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; NAGY Z, 1995, NEUROSCIENCE, V69, P757, DOI 10.1016/0306-4522(95)00331-C; Petersen R, 2008, ALZHEIMERS DIS NEURO; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Rebeck GW, 2002, J ALZHEIMERS DIS, V4, P145, DOI 10.3233/JAD-2002-4304; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Serra-Grabulosa JM, 2003, NEUROGENETICS, V4, P141, DOI 10.1007/s10048-002-0142-8; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Teter B, 2002, J ALZHEIMERS DIS, V4, P155, DOI 10.3233/JAD-2002-4305; Thompson PM, 1997, J COMPUT ASSIST TOMO, V21, P567, DOI 10.1097/00004728-199707000-00008; Tupler LA, 2007, NEUROBIOL AGING, V28, P1644, DOI 10.1016/j.neurobiolaging.2006.07.001; WEST HL, 1994, NEUROSCI LETT, V175, P46, DOI 10.1016/0304-3940(94)91074-X	45	43	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54483	10.1371/journal.pone.0054483	http://dx.doi.org/10.1371/journal.pone.0054483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405083	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400027
J	Spry, C; Macuamule, C; Lin, ZY; Virga, KG; Lee, RE; Strauss, E; Saliba, KJ				Spry, Christina; Macuamule, Cristiano; Lin, Zhiyang; Virga, Kristopher G.; Lee, Richard E.; Strauss, Erick; Saliba, Kevin J.			Pantothenamides Are Potent, On-Target Inhibitors of Plasmodium falciparum Growth When Serum Pantetheinase Is Inactivated	PLOS ONE			English	Article							N-SUBSTITUTED PANTOTHENAMIDES; COENZYME-A BIOSYNTHESIS; IN-VITRO; MALARIA; KINASE; ASSAY; ACID; DERIVATIVES; ENZYME; PENTYLPANTOTHENAMIDE	Growth of the virulent human malaria parasite Plasmodium falciparum is dependent on an extracellular supply of pantothenate (vitamin B5) and is susceptible to inhibition by pantothenate analogues that hinder pantothenate utilization. In this study, on the hunt for pantothenate analogues with increased potency relative to those reported previously, we screened a series of pantothenamides (amide analogues of pantothenate) against P. falciparum and show for the first time that analogues of this type possess antiplasmodial activity. Although the active pantothenamides in this series exhibit only modest potency under standard in vitro culture conditions, we show that the potency of pantothenamides is selectively enhanced when the parasite culture medium is pre-incubated at 37 degrees C for a prolonged period. We present evidence that this finding is linked to the presence in Albumax II (a serum-substitute routinely used for in vitro cultivation of P. falciparum) of pantetheinase activity: the activity of an enzyme that hydrolyzes the pantothenate metabolite pantetheine, for which pantothenamides also serve as substrates. Pantetheinase activity, and thereby pantothenamide degradation, is reduced following incubation of Albumax II-containing culture medium for a prolonged period at 37 degrees C, revealing the true, sub-micromolar potency of pantothenamides. Importantly we show that the potent antiplasmodial effect of pantothenamides is attenuated with pantothenate, consistent with the compounds inhibiting parasite proliferation specifically by inhibiting pantothenate and/or CoA utilization. Additionally, we show that the pantothenamides interact with P. falciparum pantothenate kinase, the first enzyme involved in converting pantothenate to coenzyme A. This is the first demonstration of on-target antiplasmodial pantothenate analogues with sub-micromolar potency, and highlights the potential of pantetheinase-resistant pantothenamides as antimalarial agents.	[Spry, Christina; Lin, Zhiyang; Saliba, Kevin J.] Australian Natl Univ, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia; [Saliba, Kevin J.] Australian Natl Univ, Sch Med, Coll Med Biol & Environm, Canberra, ACT, Australia; [Macuamule, Cristiano; Strauss, Erick] Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa; [Virga, Kristopher G.] Presbyterian Coll, Sch Pharm, Dept Pharmaceut & Adm Sci, Clinton, SC USA; [Virga, Kristopher G.; Lee, Richard E.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Lee, Richard E.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	Australian National University; Australian National University; Stellenbosch University; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Saliba, KJ (corresponding author), Australian Natl Univ, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia.	kevin.saliba@anu.edu.au	Lee, Richard/J-4997-2013; Saliba, Kevin J/C-9166-2009; Strauss, Erick/G-1783-2010; Lee, Richard/AAX-3996-2021	Lee, Richard/0000-0002-2397-0443; Saliba, Kevin J/0000-0003-3345-8440; Strauss, Erick/0000-0002-9898-8226; Lee, Richard/0000-0002-2397-0443; Spry, Christina/0000-0002-8156-7070; Lin, Zhiyang Jace/0000-0003-1857-0303; MACUAMULE, Cristiano Joao/0000-0003-0551-3772	South African Malaria Initiative (SAMI); American Lebanese Syrian Associated Charities (ALSAC), St. Jude Children's Research Hospital	South African Malaria Initiative (SAMI); American Lebanese Syrian Associated Charities (ALSAC), St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC))	Aspects of this work were supported by grants from the South African Malaria Initiative (SAMI) to ES and KJS and the American Lebanese Syrian Associated Charities (ALSAC), St. Jude Children's Research Hospital, to REL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinnusi TO, 2011, BIOORGAN MED CHEM, V19, P2696, DOI 10.1016/j.bmc.2011.02.053; Allen RJW, 2010, MOL BIOCHEM PARASIT, V169, P63, DOI 10.1016/j.molbiopara.2009.09.005; Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Asahi H, 2005, EXP PARASITOL, V109, P7, DOI 10.1016/j.exppara.2004.10.002; Bracchi-Ricard V, 2000, BIOCHEM J, V347, P255, DOI 10.1042/0264-6021:3470255; Choudhry AE, 2003, ANTIMICROB AGENTS CH, V47, P2051, DOI 10.1128/AAC.47.6.2051-2055.2003; CLIFTON G, 1970, ARCH BIOCHEM BIOPHYS, V137, P523, DOI 10.1016/0003-9861(70)90470-4; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; DUPRE S, 1984, ANAL BIOCHEM, V142, P175, DOI 10.1016/0003-2697(84)90534-7; Harmse L, 2001, BIOCHEM PHARMACOL, V62, P341, DOI 10.1016/S0006-2952(01)00644-X; Huang XY, 2011, ANAL BIOCHEM, V414, P278, DOI 10.1016/j.ab.2011.04.001; Ivey RA, 2004, J BIOL CHEM, V279, P35622, DOI 10.1074/jbc.M403152200; Lamprecht DA, 2012, ORG BIOMOL CHEM, V10, P5278, DOI 10.1039/c2ob25429h; Lehane AM, 2007, J BIOL CHEM, V282, P25395, DOI 10.1074/jbc.M704610200; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Martin F, 2001, IMMUNOGENETICS, V53, P296, DOI 10.1007/s002510100327; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; Mercer AC, 2008, BIOORG MED CHEM LETT, V18, P5991, DOI 10.1016/j.bmcl.2008.07.078; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Mitamura T, 2000, PARASITOL INT, V49, P219, DOI 10.1016/S1383-5769(00)00048-9; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Pace HC, 2001, GENOME BIOL, V2; Patani GA, 1996, CHEM REV, V96, P3147, DOI 10.1021/cr950066q; Perez-Sacau E, 2005, CHEM BIODIVERS, V2, P264, DOI 10.1002/cbdv.200590009; Ruan BH, 2010, ANAL BIOCHEM, V399, P284, DOI 10.1016/j.ab.2009.12.010; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Saliba KJ, 2005, MOL BIOCHEM PARASIT, V141, P129, DOI 10.1016/j.molbiopara.2005.02.003; Saliba KJ, 2005, ANTIMICROB AGENTS CH, V49, P632, DOI 10.1128/AAC.49.2.632-637.2005; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; SOMOGYI M, 1945, J BIOL CHEM, V160, P69; Spry C, 2005, ANTIMICROB AGENTS CH, V49, P4649, DOI 10.1128/AAC.49.11.4649-4657.2005; Spry C., 2010, Infectious Disorders - Drug Targets, V10, P200; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; Strauss E, 2002, J BIOL CHEM, V277, P48205, DOI 10.1074/jbc.M204560200; Thomas J, 2010, ANTIMICROB AGENTS CH, V54, P1374, DOI 10.1128/AAC.01473-09; van Schalkwyk DA, 2008, J PHARMACOL EXP THER, V327, P511, DOI 10.1124/jpet.108.141929; van Wyk M, 2008, ORG BIOMOL CHEM, V6, P4348, DOI 10.1039/b811086g; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Virga KG, 2006, BIOORGAN MED CHEM, V14, P1007, DOI 10.1016/j.bmc.2005.09.021; WEIGELE M, 1972, J AM CHEM SOC, V94, P5927, DOI 10.1021/ja00771a084; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WITTWER CT, 1983, J BIOL CHEM, V258, P9733; WITTWER CT, 1989, AM J CLIN NUTR, V50, P1072, DOI 10.1093/ajcn/50.5.1072; WITTWER CT, 1985, J CLIN INVEST, V76, P1665, DOI 10.1172/JCI112152; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Zhang YM, 2004, J BIOL CHEM, V279, P50969, DOI 10.1074/jbc.M409607200	48	61	62	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54974	10.1371/journal.pone.0054974	http://dx.doi.org/10.1371/journal.pone.0054974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405100	Green Published, gold			2022-12-25	WOS:000315153400044
J	Wang, JH; Zhang, CS; Wei, XF; Blagosklonov, O; Lv, GD; Lu, XM; Mantion, G; Vuitton, DA; Wen, H; Lin, RY				Wang, Junhua; Zhang, Chuanshan; Wei, Xufa; Blagosklonov, Oleg; Lv, Guodong; Lu, Xiaomei; Mantion, Georges; Vuitton, Dominique A.; Wen, Hao; Lin, Renyong			TGF-beta and TGF-beta/Smad Signaling in the Interactions between Echinococcus multilocularis and Its Hosts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HUMAN ALVEOLAR ECHINOCOCCOSIS; HUMAN LIVER FIBROSIS; PERIPARASITIC GRANULOMA; EXTRACELLULAR-MATRIX; TNF-ALPHA; CELLS; MICE; EXPRESSION; KINASE	Alveolar echinococcosis (AE) is characterized by the development of irreversible fibrosis and of immune tolerance towards Echinococcus multilocularis (E. multilocularis). Very little is known on the presence of transforming growth factor-beta (TGF-beta) and other components of TGF-beta/Smad pathway in the liver, and on their possible influence on fibrosis, over the various stages of infection. Using Western Blot, qRT-PCR and immunohistochemistry, we measured the levels of TGF-beta 1, TGF-beta receptors, and down-stream Smads activation, as well as fibrosis marker expression in both a murine AE model from day 2 to 360 post-infection (p.i.) and in AE patients. TGF-beta 1, its receptors, and down-stream Smads were markedly expressed in the periparasitic infiltrate and also in the hepatocytes, close to and distant from AE lesions. Fibrosis was significant at 180 days p.i. in the periparasitic infiltrate and was also present in the liver parenchyma, even distant from the lesions. Over the time course after infection TGF-beta 1 expression was correlated with CD4/CD8 T-cell ratio long described as a hallmark of AE severity. The time course of the various actors of the TGF-beta/Smad system in the in vivo mouse model as well as down-regulation of Smad7 in liver areas close to the lesions in human cases highly suggest that TGF-beta plays an important role in AE both in immune tolerance against the parasite and in liver fibrosis.	[Wang, Junhua; Zhang, Chuanshan; Wei, Xufa; Lv, Guodong; Lu, Xiaomei; Wen, Hao; Lin, Renyong] Xinjiang Med Univ, State Key Lab Incubat Base Xinjiang Major Dis Res, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China; [Wang, Junhua; Zhang, Chuanshan; Wei, Xufa; Lv, Guodong; Lu, Xiaomei; Wen, Hao; Lin, Renyong] Xinjiang Med Univ, Xinjiang Key Lab Echinococcosis, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China; [Wang, Junhua; Blagosklonov, Oleg] Univ Franche Comte, Dept Nucl Med, F-25030 Besancon, Franche Comte, France; [Wang, Junhua; Blagosklonov, Oleg] Jean Minjoz Univ Hosp, Besancon, Franche Comte, France; [Blagosklonov, Oleg; Mantion, Georges; Vuitton, Dominique A.] Univ Franche Comte, WHO Collaborating Ctr Prevent & Treatment Human E, F-25030 Besancon, Franche Comte, France; [Blagosklonov, Oleg; Mantion, Georges; Vuitton, Dominique A.] Univ Hosp, Besancon, Franche Comte, France	Xinjiang Medical University; Xinjiang Medical University; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon	Wen, H (corresponding author), Xinjiang Med Univ, State Key Lab Incubat Base Xinjiang Major Dis Res, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China.	Dr.wenhao@163.com; renyongl@yahoo.com.cn	Wang, Junhua/ABB-6324-2021	Wang, Junhua/0000-0002-6110-3711	Xinjiang Young Scientist Foundation [2010211B19]; Program for Changjiang Scholars and Innovative Research Team in Universities [IRT1181]; NSFC [30960342, 81260452, 81260252]; Xinjiang Key-Lab Projects [XJDX0202-2009-03]	Xinjiang Young Scientist Foundation; Program for Changjiang Scholars and Innovative Research Team in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NSFC(National Natural Science Foundation of China (NSFC)); Xinjiang Key-Lab Projects	This work was supported by the Xinjiang Young Scientist Foundation (2010211B19), the Program for Changjiang Scholars and Innovative Research Team in Universities (IRT1181), NSFC Grant Projects (30960342, 81260452, 81260252), and Xinjiang Key-Lab Projects (XJDX0202-2009-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SS, 2008, HAEMOPHILIA, V14, P1151, DOI 10.1111/j.1365-2516.2008.01831.x; Alatorre-Carranza MD, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-81; Allen JT, 2001, RESP RES, V3, DOI 10.1186/rr162; Amiot F, 1999, PARASITE IMMUNOL, V21, P475, DOI 10.1046/j.1365-3024.1999.00245.x; Anthony B, 2010, EXP PARASITOL, V124, P409, DOI 10.1016/j.exppara.2009.12.009; Banas MC, 2007, J HISTOCHEM CYTOCHEM, V55, P275, DOI 10.1369/jhc.6A7083.2006; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Brehm K, 2006, PARASITOL INT, V55, pS15, DOI 10.1016/j.parint.2005.11.003; BRESSONHADNI S, 1994, EUR CYTOKINE NETW, V5, P461; Cufi S, 2010, CELL CYCLE, V9, P4461, DOI 10.4161/cc.9.22.14048; Emery I, 1996, PARASITE IMMUNOL, V18, P463, DOI 10.1111/j.1365-3024.1996.tb01030.x; Feng M, 2012, INT IMMUNOPHARMACOL, V12, P189, DOI 10.1016/j.intimp.2011.11.010; Gelmedin V, 2008, BIOCHEM PHARMACOL, V76, P1068, DOI 10.1016/j.bcp.2008.08.020; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; Guerret S, 1998, PARASITOL RES, V84, P657, DOI 10.1007/s004360050466; Harraga S, 2003, ACTA TROP, V85, P231, DOI 10.1016/S0001-706X(02)00218-8; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Higashiyama H, 2007, J CLIN PATHOL, V60, P283, DOI 10.1136/jcp.2006.037606; Itoh S, 2007, MOL CANCER RES, V5, P667, DOI 10.1158/1541-7786.MCR-06-0282; JETTEN AM, 1986, EXP CELL RES, V167, P539, DOI 10.1016/0014-4827(86)90193-X; Kamiya Y, 2010, J BIOL CHEM, V285, P30804, DOI 10.1074/jbc.M110.166140; LIANCE M, 1984, EXPERIENTIA, V40, P1436, DOI 10.1007/BF01951932; Lin RY, 2009, WORLD J GASTROENTERO, V15, P2116, DOI 10.3748/wjg.15.2116; Maille E, 2011, AM J PHYSIOL-LUNG C, V301, pL945, DOI 10.1152/ajplung.00149.2011; Mondragon-De-la-Pena C, 2002, PARASITE, V9, P351, DOI 10.1051/parasite/2002094351; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nono JK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001516; Ouellette MJ, 1997, AM J REPROD IMMUNOL, V37, P125; Przybyszewska M, 2011, ARCH IMMUNOL THER EX, V59, P315, DOI 10.1007/s00005-011-0133-2; RicardBlum S, 1996, GASTROENTEROLOGY, V111, P172, DOI 10.1053/gast.1996.v111.pm8698196; RICARDBLUM S, 1992, HEPATOLOGY, V15, P599, DOI 10.1002/hep.1840150408; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Singh P, 2011, INDIAN J CANCER, V48, P351, DOI 10.4103/0019-509X.84939; Sobral LM, 2011, J PERIODONTOL, V82, P642, DOI 10.1902/jop.2010.100510; Spiliotis M, 2006, INT J PARASITOL, V36, P1097, DOI 10.1016/j.ijpara.2006.05.008; Vuitton DA, 2006, PARASITOL INT, V55, pS51, DOI 10.1016/j.parint.2005.11.007; Vuitton DA, 2003, PARASITOLOGY, V127, pS87, DOI 10.1017/S0031182003004153; Vuitton DA, 2003, ACTA TROP, V85, P119, DOI 10.1016/S0001-706X(02)00230-9; VUITTON DA, 1986, Z PARASITENKD, V72, P97, DOI 10.1007/BF00927740; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wu Xiang-wei, 2004, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V22, P1; Yang YZ, 2010, DIABETES, V59, pA590; Zhang CS, 2012, PLOS ONE, V7, P436, DOI 10.1371/journal.pone.0030127; Zhang S, 2008, J INFECT DIS, V197, P1341, DOI 10.1086/586709; Zhou L, 2011, CANCER RES, V71, P955, DOI 10.1158/0008-5472.CAN-10-2933	45	27	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55379	10.1371/journal.pone.0055379	http://dx.doi.org/10.1371/journal.pone.0055379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405141	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400086
J	Lee, YJ; Jeong, BH; Choi, EK; Carp, RI; Kim, YS				Lee, Yun-Jung; Jeong, Byung-Hoon; Choi, Eun-Kyoung; Carp, Richard I.; Kim, Yong-Sun			Complete Genome Sequences of New Xenotropic Murine Leukemia Viruses from the Senescence-Accelerated Mouse (SAM): Molecular and Phylogenetic Analyses	PLOS ONE			English	Article							CELL-SURFACE RECEPTOR; GENE; GAMMARETROVIRUSES; INDUCTION; INFECTION; PROTEIN; MICE; XMRV	Approximately 10% of the mouse genome is constituted by endogenous retroviruses (ERVs), and a number of mouse ERVs remain active. Many copies of endogenous murine leukemia viruses (MuLVs) are detected in the genomes of inbred mouse strains. Some of these MuLVs are transcriptionally active or produce infectious virus particles. Previously, we identified partial env sequences of new xenotropic MuLVs (X-MuLVs) from a senescence-accelerated mouse (SAM) strain. In the present study, we investigated and characterized the complete sequences of the X-MuLVs. The complete genomes and open reading frames (ORFs) of two X-MuLVs, designated xmlv15 and xmlv18 (accession nos. HQ154630 and HQ154631, respectively), were molecularly cloned from the genome of the SAM mice. We confirmed that the xmlv15 and xmlv18 sequences are distinct from all known MuLV genomes and are most similar to DG-75 MuLV. Moreover, we found that common strains of laboratory mice carry our newly identified xmlvs. Additionally, the expression levels of xmlv15-related sequences were much higher in C57BL and ICR mice than in the SAM strains without any stimulators. Our findings suggest that a specific group of endogenous MuLVs is constitutively expressed in the brain and that they may participate in normal functions and/or pathogenic conditions.	[Lee, Yun-Jung; Jeong, Byung-Hoon; Choi, Eun-Kyoung; Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea; [Lee, Yun-Jung; Kim, Yong-Sun] Hallym Univ, Coll Med, Dept Microbiol, Chunchon, Kangwon Do, South Korea; [Carp, Richard I.] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA	Hallym University; Hallym University; Institute for Basic Research in Developmental Disabilities	Kim, YS (corresponding author), Hallym Univ, Ilsong Inst Life Sci, Anyang, Gyeonggi Do, South Korea.	yskim@hallym.ac.kr	Jeong, Byung-Hoon/AAA-3425-2020	Jeong, Byung-Hoon/0000-0002-4525-9994	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012-0000308]; National Research Foundation of Korea Grant; Korean Government [NRF-2011-619E0001]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea Grant(National Research Foundation of Korea); Korean Government(Korean Government)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012-0000308) and by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2011-619E0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON SA, 1971, SCIENCE, V174, P157, DOI 10.1126/science.174.4005.157; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Baliji S, 2010, J VIROL, V84, P12841, DOI 10.1128/JVI.01863-10; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; BATTINI JL, 1992, J VIROL, V66, P1468, DOI 10.1128/JVI.66.3.1468-1475.1992; Boeke JD, 1997, RETROVIRUSES; DATTA SK, 1977, VIROLOGY, V83, P449, DOI 10.1016/0042-6822(77)90193-3; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRANKEL WN, 1989, J VIROL, V63, P1763, DOI 10.1128/JVI.63.4.1763-1774.1989; GREENBERGER JS, 1975, J IMMUNOL, V115, P317; Groom HCT, 2012, J GEN VIROL, V93, P915, DOI 10.1099/vir.0.041038-0; GROSS L, 1951, P SOC EXP BIOL MED, V76, P27; HEARD JM, 1991, J VIROL, V65, P4026, DOI 10.1128/JVI.65.8.4026-4032.1991; Jeong BH, 2002, J NEUROPATH EXP NEUR, V61, P1001, DOI 10.1093/jnen/61.11.1001; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; KRIEG AM, 1988, J VIROL, V62, P3545, DOI 10.1128/JVI.62.10.3545-3550.1988; Lee KH, 2006, BIOCHEM BIOPH RES CO, V349, P122, DOI 10.1016/j.bbrc.2006.08.016; LEVY JA, 1970, SCIENCE, V170, P326, DOI 10.1126/science.170.3955.326; LOWY DR, 1971, SCIENCE, V174, P155, DOI 10.1126/science.174.4005.155; MORSE HC, 1982, J VIROL, V43, P1; Mouse Genome Sequencing Consortium, 2001, NATURE, V420, P520; ONEILL RR, 1986, J VIROL, V58, P359, DOI 10.1128/JVI.58.2.359-366.1986; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PORTIS JL, 1987, J VIROL, V61, P1037, DOI 10.1128/JVI.61.4.1037-1044.1987; RISSER R, 1983, ANNU REV GENET, V17, P85, DOI 10.1146/annurev.ge.17.120183.000505; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; SHERR CJ, 1974, CELL, V1, P55, DOI 10.1016/0092-8674(74)90155-X; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; STOYE JP, 1987, J VIROL, V61, P2659, DOI 10.1128/JVI.61.9.2659-2669.1987; Stoye JP, 2001, CURR BIOL, V11, pR914, DOI 10.1016/S0960-9822(01)00553-X; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; VOGT M, 1986, VIROLOGY, V154, P420, DOI 10.1016/0042-6822(86)90470-8; WEBER WJ, 1982, DIS TRANSMITTED RATS; Yang YL, 1999, NAT GENET, V21, P216, DOI 10.1038/6005	41	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55669	10.1371/journal.pone.0055669	http://dx.doi.org/10.1371/journal.pone.0055669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393596	Green Submitted, Green Published, gold			2022-12-25	WOS:000314692800050
J	Siljamaki, E; Rintanen, N; Kirsi, M; Upla, P; Wang, W; Karjalainen, M; Ikonen, E; Marjomaki, V				Siljamaki, Elina; Rintanen, Nina; Kirsi, Maija; Upla, Paula; Wang, Wei; Karjalainen, Mikko; Ikonen, Elina; Marjomaki, Varpu			Cholesterol Dependence of Collagen and Echovirus 1 Trafficking along the Novel alpha 2 beta 1 Integrin Internalization Pathway	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GPI-ANCHORED PROTEINS; LOW-DENSITY-LIPOPROTEIN; LIPID RAFTS; RNA REPLICATION; CELL-MEMBRANES; TRANSPORT; ENTRY; REQUIRES; BINDING	We have previously shown that soluble collagen and a human pathogen, echovirus 1 (EV1) cluster alpha 2 beta 1 integrin on the plasma membrane and cause their internalization into cytoplasmic endosomes. Here we show that cholesterol plays a major role not only in the uptake of a2b1 integrin and its ligands but also in the formation of alpha 2 integrin-specific multivesicular bodies (alpha 2-MVBs) and virus infection. EV1 infection and alpha 2 beta 1 integrin internalization were totally halted by low amounts of the cholesterol-aggregating drugs filipin or nystatin. Inhibition of cholesterol synthesis and accumulation of lanosterol after ketoconazole treatment inhibited uptake of collagen, virus and clustered integrin, and prevented formation of multivesicular bodies and virus infection. Loading of lipid starved cells with cholesterol increased infection to some extent but could not completely restore EV1 infection to control levels. Cold Triton X-100 treatment did not solubilize the alpha 2-MVBs suggesting, together with cholesterol labeling, that the cytoplasmic endosomes were enriched in detergent-resistant lipids in contrast to alpha V integrin labeled control endosomes in the clathrin pathway. Cholesterol aggregation leading to increased ion permeability caused a significant reduction in EV1 uncoating in endosomes as judged by sucrose gradient centrifugation and by neutral red-based uncoating assay. In contrast, the replication step was not dependent on cholesterol in contrast to the reports on several other viruses. In conclusion, our results showed that the integrin internalization pathway is dependent on cholesterol for uptake of collagen, EV1 and integrin, for maturation of endosomal structures and for promoting EV1 uncoating. The results thus provide novel information for developing anti-viral strategies and more insight into collagen and integrin trafficking.	[Siljamaki, Elina; Rintanen, Nina; Kirsi, Maija; Upla, Paula; Karjalainen, Mikko; Marjomaki, Varpu] Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, Jyvaskyla, Finland; [Wang, Wei; Ikonen, Elina] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Wang, Wei; Ikonen, Elina] Minerva Fdn, Helsinki, Finland	University of Jyvaskyla; University of Helsinki	Marjomaki, V (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, Jyvaskyla, Finland.	varpu.s.marjomaki@jyu.fi		Marjomaki, Varpu/0000-0002-4592-5926; Ikonen, Elina/0000-0001-8382-1135	Academy of Finland [131429, 131489/Elina Ikonen, 140756, 218109/Varpu Marjomaki]; National graduate school in Nanoscience	Academy of Finland(Academy of Finland); National graduate school in Nanoscience	This work was supported by grants from Academy of Finland (http://www.aka.fi/eng, grant numbers: 131429, 131489/Elina Ikonen; 140756, 218109/Varpu Marjomaki) and National graduate school in Nanoscience (https://www.jyu.fi/science/muut_yksikot/nsc/en/studies/ngs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; ARCHER DB, 1975, J GEN MICROBIOL, V90, P187, DOI 10.1099/00221287-90-1-187; Axelsson MAB, 2004, MOL BIOL CELL, V15, P1843, DOI 10.1091/mbc.E03-07-0459; BABCOCK DF, 1976, J BIOL CHEM, V251, P3881; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Beh CT, 2001, GENETICS, V157, P1117; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chatterjee S, 2001, EMBO J, V20, P1583, DOI 10.1093/emboj/20.7.1583; Chemello ME, 2002, J VIROL, V76, P13083, DOI 10.1128/JVI.76.24.13083-13087.2002; Chung CS, 2005, J VIROL, V79, P1623, DOI 10.1128/JVI.79.3.1623-1634.2005; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gopalakrishna P, 2000, J CELL BIOCHEM, V77, P517, DOI 10.1002/(SICI)1097-4644(20000615)77:4<517::AID-JCB1>3.3.CO;2-Y; Green JM, 1999, J CELL BIOL, V146, P673, DOI 10.1083/jcb.146.3.673; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Johansson M, 2003, MOL BIOL CELL, V14, P903, DOI 10.1091/mbc.E02-08-0459; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Karjalainen M, 2008, MOL BIOL CELL, V19, P2857, DOI 10.1091/mbc.E07-10-1094; Karjalainen M, 2011, CELL MICROBIOL, V13, P1975, DOI 10.1111/j.1462-5822.2011.01685.x; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; KOTLERBRAJTBURG J, 1979, ANTIMICROB AGENTS CH, V15, P716, DOI 10.1128/AAC.15.5.716; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Pietiainen V, 2004, MOL BIOL CELL, V15, P4911, DOI 10.1091/mbc.E04-01-0070; Rintanen N, 2012, MOL BIOL CELL, V23, P448, DOI 10.1091/mbc.E11-06-0548; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Upla P, 2008, J VIROL, V82, P1581, DOI 10.1128/JVI.01375-07; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; WETZ K, 1991, J GEN VIROL, V72, P2541, DOI 10.1099/0022-1317-72-10-2541; Xing L, 2004, J BIOL CHEM, V279, P11632, DOI 10.1074/jbc.M312441200; Zerenturk EJ, 2011, BIOCH BIOPHYSICA ACT	54	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55465	10.1371/journal.pone.0055465	http://dx.doi.org/10.1371/journal.pone.0055465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393580	gold, Green Published, Green Submitted			2022-12-25	WOS:000314692800034
J	Couldrey, C; Wells, DN				Couldrey, Christine; Wells, David N.			DNA Methylation at a Bovine Alpha Satellite I Repeat CpG Site during Development following Fertilization and Somatic Cell Nuclear Transfer	PLOS ONE			English	Article							CLONED EMBRYOS; TRANSFER BLASTOCYSTS; FETUSES; PATTERNS; CATTLE; GENE; DEMETHYLATION; ABNORMALITIES; EXPRESSION; SEQUENCES	Incomplete epigenetic reprogramming is postulated to contribute to the low developmental success following somatic cell nuclear transfer (SCNT). Here, we describe the epigenetic reprogramming of DNA methylation at an alpha satellite I CpG site (alpha satI-5) during development of cattle generated either by artificial insemination (AI) or in vitro fertilization (IVF) and SCNT. Quantitative methylation analysis identified that SCNT donor cells were highly methylated at alpha satI-5 and resulting SCNT blastocysts showed significantly more methylation than IVF blastocysts. At implantation, no difference in methylation was observed between SCNT and AI in trophoblast tissue at alpha satI-5, however, SCNT embryos were significantly hyper-methylated compared to AI controls at this time point. Following implantation, DNA methylation at alpha satI-5 decreased in AI but not SCNT placental tissues. In contrast to placenta, the proportion of methylation at alpha satI-5 remained high in adrenal, kidney and muscle tissues during development. Differences in the average proportion of methylation were smaller in somatic tissues than placental tissues but, on average, SCNT somatic tissues were hyper-methylated at alpha satI-5. Although sperm from all bulls was less methylated than somatic tissues at alpha satI-5, on average this site remained hyper-methylated in sperm from cloned bulls compared with control bulls. This developmental time course confirms that epigenetic reprogramming does occur, at least to some extent, following SCNT. However, the elevated methylation levels observed in SCNT blastocysts and cellular derivatives implies that there is either insufficient time or abundance of appropriate reprogramming factors in oocytes to ensure complete reprogramming. Incomplete reprogramming at this CpG site may be a contributing factor to low SCNT success rates, but more likely represents the tip of the iceberg in terms of incompletely reprogramming. Until protocols ensure the epigenetic signature of a differentiated somatic cell is reset to a state resembling totipotency, the efficiency of SCNT is likely to remain low.	[Couldrey, Christine; Wells, David N.] AgRes Ruakura Res Ctr, Hamilton, New Zealand	AgResearch - New Zealand	Couldrey, C (corresponding author), AgRes Ruakura Res Ctr, Hamilton, New Zealand.	Christine.Couldrey@agresearch.co.nz		Wells, David/0000-0002-8729-4958	New Zealand Foundation for Research, Science, and Technology [C10X0303]; AgResearch Curiosity Fund	New Zealand Foundation for Research, Science, and Technology(New Zealand Foundation for Research, Science and Technology); AgResearch Curiosity Fund	This work was supported by a grant from the New Zealand Foundation for Research, Science, and Technology (C10X0303) and the AgResearch Curiosity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburatani Hiroyuki, 2011, Gan To Kagaku Ryoho, V38, P1; Alonso-Gonzalez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035619; Bourc'his D, 2001, CURR BIOL, V11, P1542, DOI 10.1016/S0960-9822(01)00480-8; Cezar GG, 2003, BIOL REPROD, V68, P1009, DOI 10.1095/biolreprod.102.010181; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Chavatte-Palmer P, 2002, BIOL REPROD, V66, P1596, DOI 10.1095/biolreprod66.6.1596; Chavatte-Palmer PM, 2009, CLONING STEM CELLS, V11, P309, DOI 10.1089/clo.2008.0080; Chaves R, 2000, CHROMOSOME RES, V8, P621, DOI 10.1023/A:1009290125305; Chen T, 2005, FRONT BIOSCI-LANDMRK, V10, P3002, DOI 10.2741/1756; Chu L, 2012, J MOL CELL BIOL; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Couldrey C, 2011, CELL REPROGRAM, V13, P171, DOI 10.1089/cell.2010.0065; Couldrey C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-27; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Dindot SV, 2004, BIOL REPROD, V71, P470, DOI 10.1095/biolreprod.103.025775; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Hiendleder S, 2004, BIOL REPROD, V71, P217, DOI 10.1095/biolreprod.103.026062; Hori N, 2010, ANIM REPROD SCI, V122, P303, DOI 10.1016/j.anireprosci.2010.09.008; Kaneda Masahiro, 2011, BMC Proc, V5 Suppl 4, pS3, DOI 10.1186/1753-6561-5-S4-S3; Kang YK, 2002, EMBO J, V21, P1092, DOI 10.1093/emboj/21.5.1092; Kang YK, 2003, MOL REPROD DEV, V66, P32, DOI 10.1002/mrd.10330; Lanza RP, 2001, SCIENCE, V294, P1893, DOI 10.1126/science.1063440; Ledgard A, 2009, J REPROD DEVELOP, V55, P467, DOI 10.1262/jrd.20142; Lee RSF, 2004, BIOL REPROD, V70, P1, DOI 10.1095/biolreprod.103.020982; Lucifero D, 2006, BIOL REPROD, V75, P531, DOI 10.1095/biolreprod.106.051722; Mizutani E, 2012, DEV BIOL, V364, P56, DOI 10.1016/j.ydbio.2012.01.001; Ng RK, 2005, P NATL ACAD SCI USA, V102, P1957, DOI 10.1073/pnas.0409813102; Prada D, 2012, MUTAT RES-FUND MOL M, V729, P100, DOI 10.1016/j.mrfmmm.2011.10.007; Reik W, 2003, PHILOS T R SOC B, V358, P1403, DOI 10.1098/rstb.2003.1326; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Smith C, 2007, REPRODUCTION, V133, P231, DOI 10.1530/rep.1.0966; Somers J, 2006, REPRODUCTION, V131, P1073, DOI 10.1530/rep.1.00967; Su H, 2011, ANIM REPROD SCI, V127, P23, DOI 10.1016/j.anireprosci.2011.07.002; Suzuki T, 2002, EXP GERONTOL, V37, P1005, DOI 10.1016/S0531-5565(02)00061-X; Wilmut I, 2006, METH MOL B, V348, P307; Yamanaka K, 2011, ANIM SCI J, V82, P523, DOI 10.1111/j.1740-0929.2011.00881.x	36	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55153	10.1371/journal.pone.0055153	http://dx.doi.org/10.1371/journal.pone.0055153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383311	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900018
J	Liu, YW; Mattila, JP; Schmid, SL				Liu, Ya-Wen; Mattila, Juha-Pekka; Schmid, Sandra L.			Dynamin-Catalyzed Membrane Fission Requires Coordinated GTP Hydrolysis	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; COATED PITS; IN-VIVO; VESICLE FORMATION; RECEPTOR; MUTANT; MECHANISM; ACTIN; CELLS	Dynamin is the most-studied membrane fission machinery and has served as a paradigm for studies of other fission GTPases; however, several critical questions regarding its function remain unresolved. In particular, because most dynamin GTPase domain mutants studied to date equally impair both basal and assembly-stimulated GTPase activities, it has been difficult to distinguish their respective roles in clathrin-mediated endocytosis (CME) or in dynamin catalyzed membrane fission. Here we compared a new dynamin mutant, Q40E, which is selectively impaired in assembly-stimulated GTPase activity with S45N, a GTP-binding mutant equally defective in both basal and assembly-stimulated GTPase activities. Both mutants potently inhibit CME and effectively recruit other endocytic accessory proteins to stalled coated pits. However, the Q40E mutant blocks at a later step than S45N, providing additional evidence that GTP binding and/or basal GTPase activities of dynamin are required throughout clathrin coated pit maturation. Importantly, using in vitro assays for assembly-stimulated GTPase activity and membrane fission, we find that the latter is much more potently inhibited by both dominant-negative mutants than the former. These studies establish that efficient fission from supported bilayers with excess membrane reservoir (SUPER) templates requires coordinated GTP hydrolysis across two rungs of an assembled dynamin collar.	[Liu, Ya-Wen; Mattila, Juha-Pekka; Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schmid, SL (corresponding author), UT SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	Sandra.Schmid@UTSouthwestern.edu		LIU, YA-WEN/0000-0003-0180-4142; Schmid, Sandra/0000-0002-1690-7024	Muscular Dystrophy Association Grant [MDA-114824]; Academy of Finland;  [GM42455]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER	Muscular Dystrophy Association Grant(Muscular Dystrophy Association); Academy of Finland(Academy of Finland); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Y-WL was supported by Muscular Dystrophy Association Grant MDA-114824, J-PM was supported by a postdoctoral research grant from the Academy of Finland. This work was supported by GM42455 to SLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Binns DD, 2000, BIOCHEMISTRY-US, V39, P7188, DOI 10.1021/bi000033r; Binns DD, 1999, J PROTEIN CHEM, V18, P277, DOI 10.1023/A:1021083211267; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Ceresa BP, 2001, J BIOL CHEM, V276, P9649, DOI 10.1074/jbc.M010387200; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Faelber K, 2012, STRUCTURE, V20, P1621, DOI 10.1016/j.str.2012.08.028; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Lee A, 1999, CURR BIOL, V9, P261, DOI 10.1016/S0960-9822(99)80115-8; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Narayanan R, 2005, J CELL BIOL, V169, P117, DOI 10.1083/jcb.200502042; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2010, BIOPHYS J, V99, P517, DOI 10.1016/j.bpj.2010.04.036; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shen HY, 2011, MOL BIOL CELL, V22, P493, DOI 10.1091/mbc.E10-07-0637; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	44	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55691	10.1371/journal.pone.0055691	http://dx.doi.org/10.1371/journal.pone.0055691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383266	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600147
J	Fonoudi, H; Yeganeh, M; Fattahi, F; Ghazizadeh, Z; Rassouli, H; Alikhani, M; Mojarad, BA; Baharvand, H; Salekdeh, GH; Aghdami, N				Fonoudi, Hananeh; Yeganeh, Meghdad; Fattahi, Faranak; Ghazizadeh, Zaniar; Rassouli, Hassan; Alikhani, Mehdi; Mojarad, Bahareh Adhami; Baharvand, Hossein; Salekdeh, Ghasem Hosseini; Aghdami, Nasser			ISL1 Protein Transduction Promotes Cardiomyocyte Differentiation from Human Embryonic Stem Cells	PLOS ONE			English	Article							SCALABLE EXPANSION; PROGENITOR CELLS; SMOOTH-MUSCLE; TAT; PEPTIDE; HEART; MANIPULATION; ENDOCYTOSIS; DELIVERY; PATHWAY	Background: Human embryonic stem cells (hESCs) have the potential to provide an unlimited source of cardiomyocytes, which are invaluable resources for drug or toxicology screening, medical research, and cell therapy. Currently a number of obstacles exist such as the insufficient efficiency of differentiation protocols, which should be overcome before hESC-derived cardiomyocytes can be used for clinical applications. Although the differentiation efficiency can be improved by the genetic manipulation of hESCs to over-express cardiac-specific transcription factors, these differentiated cells are not safe enough to be applied in cell therapy. Protein transduction has been demonstrated as an alternative approach for increasing the efficiency of hESCs differentiation toward cardiomyocytes. Methods: We present an efficient protocol for the differentiation of hESCs in suspension by direct introduction of a LIM homeodomain transcription factor, Islet1 (ISL1) recombinant protein into the cells. Results: We found that the highest beating clusters were derived by continuous treatment of hESCs with 40 mu g/ml recombinant ISL1 protein during days 1-8 after the initiation of differentiation. The treatment resulted in up to a 3-fold increase in the number of beating areas. In addition, the number of cells that expressed cardiac specific markers (cTnT, CONNEXIN 43, ACTININ, and GATA4) doubled. This protocol was also reproducible for another hESC line. Conclusions: This study has presented a new, efficient, and reproducible procedure for cardiomyocytes differentiation. Our results will pave the way for scaled up and controlled differentiation of hESCs to be used for biomedical applications in a bioreactor culture system.	[Fonoudi, Hananeh; Fattahi, Faranak; Ghazizadeh, Zaniar; Mojarad, Bahareh Adhami; Baharvand, Hossein; Aghdami, Nasser] Acad Ctr Educ Culture & Res, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran; [Fonoudi, Hananeh; Fattahi, Faranak; Mojarad, Bahareh Adhami] Univ Tehran, Dept Biotechnol, Coll Sci, Tehran, Iran; [Yeganeh, Meghdad; Rassouli, Hassan; Alikhani, Mehdi; Salekdeh, Ghasem Hosseini] Acad Ctr Educ Culture & Res, Royan Inst Stem Cell Biol & Technol, Dept Mol Syst Biol Biol, Cell Sci Res Ctr, Tehran, Iran; [Baharvand, Hossein] Univ Sci & Culture, Acad Ctr Educ Culture & Res, Dept Dev Biol, Tehran, Iran; [Salekdeh, Ghasem Hosseini] Agr Biotechnol Res Inst Iran, Dept Syst Biol, Karaj, Iran; [Aghdami, Nasser] Acad Ctr Educ Culture & Res, Royan Inst Stem Cell Biol & Technol, Dept Regenerat Med, Cell Sci Res Ctr, Tehran, Iran	Academic Center for Education, Culture & Research (ACECR); University of Tehran; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Baharvand, H (corresponding author), Acad Ctr Educ Culture & Res, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran.	Baharvand@RoyanInstitute.Org; Salekdeh@RoyanInstitute.Org; Nasser.Aghdami@RoyanInstitute.Org	Alikhani, Mehdi/AAZ-7970-2020; Aghdami, Nasser/ABH-7238-2020; Salekdeh, Ghasem Hosseini/E-4198-2012	Alikhani, Mehdi/0000-0002-8808-9577; Salekdeh, Ghasem Hosseini/0000-0002-5124-4721; Fonoudi, Hananeh/0000-0001-5888-9306	Royan Institute; Iranian Council of Stem Cell Research and Technology	Royan Institute; Iranian Council of Stem Cell Research and Technology	This study was funded by grants provided from Royan Institute and the Iranian Council of Stem Cell Research and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2011, NAT PROTOC, V6, P572, DOI 10.1038/nprot.2011.325; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; Baharvand H, 2004, IN VITRO CELL DEV-AN, V40, P76, DOI 10.1290/1543-706X(2004)040<0076:CCDFEO>2.0.CO;2; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Do Kwon Y, 2005, MOL THER, V12, P28, DOI 10.1016/y.ymthe.2005.03.01; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Fijnvandraat AC, 2003, J MUSCLE RES CELL M, V24, P211, DOI 10.1023/A:1026063409656; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Moore JC, 2005, REPROD TOXICOL, V20, P377, DOI 10.1016/j.reprotox.2005.04.012; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Rezaei Larijani M, 2011, STEM CELLS DEV; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Serra M, 2009, ANN ANAT, V191, P104, DOI 10.1016/j.aanat.2008.09.005; Stock K, 2010, CELL MOL LIFE SCI, V67, P2439, DOI 10.1007/s00018-010-0347-1; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Zhu Wei-Zhong, 2009, Transplant Rev (Orlando), V23, P53, DOI 10.1016/j.trre.2008.05.005; Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604; Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318	35	29	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55577	10.1371/journal.pone.0055577	http://dx.doi.org/10.1371/journal.pone.0055577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383231	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800170
J	Tempe, D; Vives, E; Brockly, F; Brooks, H; De Rossi, S; Piechaczyk, M; Bossis, G				Tempe, D.; Vives, E.; Brockly, F.; Brooks, H.; De Rossi, S.; Piechaczyk, M.; Bossis, G.			SUMOylation of the inducible (c-Fos:c-Jun)/AP-1 transcription complex occurs on target promoters to limit transcriptional activation	ONCOGENE			English	Article						AP-1; SUMO; transcription; c-Fos	JUN PROTEINS; SUMO; AP-1; SPECIFICITY; PATHWAY; GENES	The inducible proto-oncogenic (c-Fos:c-Jun)/AP-1 transcription complex binds 12-O-tetradecanoylphorbol 13-acetate (TPA)-responsive elements (TRE) in its target genes. It is tightly controlled at multiple levels to avoid the deleterious effects of its inappropriate activation. In particular, SUMOylation represses its transactivation capacity in transient reporter assays using constitutively expressed proteins. This led to the presumption that (c-Fos:c-Jun)/AP-1 SUMOylation would be required to turn-off transcription of its target genes, as proposed for various transcription factors. Instead, thanks to the generation of an antibody specific for SUMO-modified c-Fos, we provide here direct evidence that SUMOylated c-Fos is present on a stably integrated reporter TPA-inducible promoter at the onset of transcriptional activation and colocalizes with RNA polymerase II within chromatin. Interestingly, (c-Fos:c-Jun)/AP-1 SUMOylation limits reporter gene induction, as well as the appearance of active transcription-specific histone marks on its promoter. Moreover, non-SUMOylatable mutant (c-Fos:c-Jun)/AP-1 dimers accumulate to higher levels on their target promoter, suggesting that SUMOylation might facilitate the release of (c-Fos:c-Jun)/AP-1 from promoters. Finally, activation of GADD153, an AP-1 target gene, is also associated with a rapid increase in SUMOylation at the level of its TRE and c-Fos SUMOylation dampens its induction by TPA. Taken together, our data suggest that SUMOylation could serve to buffer transcriptional activation of AP-1 target genes.	[Tempe, D.; Brockly, F.; Brooks, H.; Piechaczyk, M.; Bossis, G.] CNRS, UMR 5535, Inst Genet Mol Montpellier, Equipe Labellisee Ligue Canc, Montpellier 5, France; [Tempe, D.; Brockly, F.; Brooks, H.; Piechaczyk, M.; Bossis, G.] Univ Montpellier 2, Montpellier, France; [Tempe, D.; Brockly, F.; Brooks, H.; Piechaczyk, M.; Bossis, G.] Univ Montpellier I, Montpellier, France; [Vives, E.] IRCM, Montpellier, France; [Vives, E.] Univ Montpellier I, INSERM, U896, Montpellier, France; [Vives, E.] CRLC Val dAurelle Paul Lamarque, Montpellier, France; [De Rossi, S.] BIOCAMPUS Montpellier, Montpellier RIO Imaging, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Montpellier	Piechaczyk, M (corresponding author), CNRS, UMR 5535, Inst Genet Mol Montpellier, Equipe Labellisee Ligue Canc, 1919 Route Mende, Montpellier 5, France.	marc.piechaczyk@igmm.cnrs.fr; guillaume.bossis@igmm.cnrs.fr	PIECHACZYK, Marc/E-7896-2013; Bossis, Guillaume/C-7172-2012; VIVES, Eric/AAG-6569-2020	PIECHACZYK, Marc/0000-0003-1367-2597; VIVES, Eric/0000-0001-5391-9641; bossis, guillaume/0000-0002-3349-8250	CNRS; Association pour la Recherche sur le Cancer (ARC); Agence Nationale de la Recherche [BLAN08-3_310119]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR))	We are grateful to Drs R Hipskind, I Jariel-Encontre, T Salem and G Moquet-Torcy for fruitful discussions and critical reading of the manuscript. MP's laboratory is an 'Equipe Labellisee of the French Ligue Nationale contre le Cancer. This work was also supported by the CNRS, the Association pour la Recherche sur le Cancer (ARC), and the Agence Nationale de la Recherche (BLAN08-3_310119).	Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Barry J, 2011, INT J BIOCHEM CELL B, V43, P37, DOI 10.1016/j.biocel.2010.09.022; Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fluhmann B, 1998, MOL CELL ENDOCRINOL, V139, P89, DOI 10.1016/S0303-7207(98)00070-7; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Gomard T, 2010, PLOS ONE, V5, pA178, DOI 10.1371/journal.pone.0009585; Guo BQ, 2011, NUCLEIC ACIDS RES, V39, P6403, DOI 10.1093/nar/gkr267; Guyton KZ, 1996, BIOCH J 2, V314; Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kubota Y, 2011, NAT CELL BIOL, V13, P282, DOI 10.1038/ncb2169; Liu HW, 2012, NUCLEIC ACIDS RES, V40, P10172, DOI 10.1093/nar/gks819; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Maison C, 2011, NAT GENET, V43, P220, DOI 10.1038/ng.765; Malnou CE, 2010, J BIOL CHEM, V285, P6552, DOI 10.1074/jbc.M109.032680; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Rosonina E, 2012, GENE DEV, V26, P350, DOI 10.1101/gad.184689.111; Rosonina E, 2010, GENE DEV, V24, P1242, DOI 10.1101/gad.1917910; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Ubeda M, 1999, MOL CELL BIOL, V19, P7589	33	37	39	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					921	927		10.1038/onc.2013.4	http://dx.doi.org/10.1038/onc.2013.4			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23396363				2022-12-25	WOS:000331626900013
J	Stalin, J; Harhouri, K; Hubert, L; Subrini, C; Lafitte, D; Lissitzky, JC; Elganfoud, N; Robert, S; Foucault-Bertaud, A; Kaspi, E; Sabatier, F; Aurrand-Lions, M; Bardin, N; Holmgren, L; Dignat-George, F; Blot-Chabaud, M				Stalin, Jimmy; Harhouri, Karim; Hubert, Lucas; Subrini, Caroline; Lafitte, Daniel; Lissitzky, Jean-Claude; Elganfoud, Nadia; Robert, Stephane; Foucault-Bertaud, Alexandrine; Kaspi, Elise; Sabatier, Florence; Aurrand-Lions, Michel; Bardin, Nathalie; Holmgren, Lars; Dignat-George, Francoise; Blot-Chabaud, Marcel			Soluble Melanoma Cell Adhesion Molecule (sMCAM/sCD146) Promotes Angiogenic Effects on Endothelial Progenitor Cells through Angiomotin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS ANGIOGENESIS; ANGIOSTATIN; CD146; MIGRATION; PROTEIN; ACTIVATION; EXPRESSION; DOMAINS; DISPLAY; GROWTH	The melanoma cell adhesion molecule (CD146) contains a circulating proteolytic variant (sCD146), which is involved in inflammation and angiogenesis. Its circulating level is modulated in different pathologies, but its intracellular transduction pathways are still largely unknown. Using peptide pulldown and mass spectrometry, we identified angiomotin as a sCD146-associated protein in endothelial progenitor cells (EPC). Interaction between angiomotin and sCD146 was confirmed by enzyme-linked immunosorbent assay (ELISA), homogeneous time-resolved fluorescence, and binding of sCD146 on both immobilized recombinant angiomotin and angiomotin-transfected cells. Silencing angiomotin in EPC inhibited sCD146 angiogenic effects, i.e. EPC migration, proliferation, and capacity to form capillary-like structures in Matrigel. In addition, sCD146 effects were inhibited by the angiomotin inhibitor angiostatin and competition with recombinant angiomotin. Finally, binding of sCD146 on angiomotin triggered the activation of several transduction pathways that were identified by antibody array. These results delineate a novel signaling pathway where sCD146 binds to angiomotin to stimulate a proangiogenic response. This result is important to find novel target cells of sCD146 and for the development of therapeutic strategies based on EPC in the treatment of ischemic diseases.	[Stalin, Jimmy; Harhouri, Karim; Hubert, Lucas; Subrini, Caroline; Elganfoud, Nadia; Robert, Stephane; Foucault-Bertaud, Alexandrine; Kaspi, Elise; Sabatier, Florence; Bardin, Nathalie; Dignat-George, Francoise; Blot-Chabaud, Marcel] Aix Marseille Univ, INSERM, UMR S 1076, Format & Res Unit Pharm, F-13005 Marseille, France; [Lafitte, Daniel] Aix Marseille Univ, INSERM, UMR 911, Res Ctr Biol Oncol & Oncopharmacol, F-13005 Marseille, France; [Lissitzky, Jean-Claude; Aurrand-Lions, Michel] Aix Marseille Univ, Res Ctr Cancerol Marseille, INSERM, U1068, F-13009 Marseille, France; [Holmgren, Lars] Karolinska Inst, Canc Ctr Karolinska, Dept Pathol & Oncol, SE-17176 Stockholm, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Karolinska Institutet	Blot-Chabaud, M (corresponding author), Aix Marseille Univ, INSERM, UMR S 1076, Lab Hematol & Immunol,UFR Pharm, 27 Bd J Moulin, F-13005 Marseille, France.	marcel.blot-chabaud@laposte.net	Harhouri, Karim/M-3399-2016; Bardin, Nathalie/AAL-3663-2020; Blot-Chabaud, Marcel/D-4064-2017; Aurrand-Lions, Michel/O-9953-2016; DIGNAT-GEORGE, Françoise/R-1129-2016; Kaspi, Elise/I-4936-2016	Harhouri, Karim/0000-0003-2904-5221; Bardin, Nathalie/0000-0003-3680-082X; Aurrand-Lions, Michel/0000-0002-8361-3034; DIGNAT-GEORGE, Françoise/0000-0001-7006-4462; Kaspi, Elise/0000-0003-0458-5109; lafitte, daniel/0000-0001-9921-7522; Stalin, Jimmy/0000-0001-8092-7057	INSERM; Aix-Marseille University; Region Provence-Alpes-Cote d'Azur; Association for Research on Cancer; canceropole Provence-Alpes-Cote d'Azur; University Foundation Sport Sante et developpement durable	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Aix-Marseille University; Region Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'Azur); Association for Research on Cancer; canceropole Provence-Alpes-Cote d'Azur; University Foundation Sport Sante et developpement durable	This work was supported by INSERM and Aix-Marseille University.; Both authors contributed equally to this work. J. Stalin was supported by a grant from Region Provence-Alpes-Cote d'Azur.; The proteomic platform was supported by Association for Research on Cancer, canceropole Provence-Alpes-Cote d'Azur, and University Foundation Sport Sante et developpement durable. We thank Biocytex company for providing rsCD146.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Almeras L, 2007, PROTEOMICS, V7, P769, DOI 10.1002/pmic.200600392; Anfosso F, 1998, J BIOL CHEM, V273, P26852, DOI 10.1074/jbc.273.41.26852; Bardin N, 2006, INFLAMM BOWEL DIS, V12, P16, DOI 10.1097/01.MIB.0000194181.46930.88; Bardin N, 2003, THROMB HAEMOSTASIS, V90, P915, DOI 10.1160/TH02-11-0285; Bardin N, 2009, ARTERIOSCL THROM VAS, V29, P746, DOI 10.1161/ATVBAHA.108.183251; Basile DP, 2004, AM J PHYSIOL-RENAL, V286, pF893, DOI 10.1152/ajprenal.00328.2003; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Bu PC, 2006, MOL CANCER THER, V5, P2872, DOI 10.1158/1535-7163.MCT-06-0260; Causey LD, 1996, NAT BIOTECHNOL, V14, P348, DOI 10.1038/nbt0396-348; Claesson-Welsh L, 1998, P NATL ACAD SCI USA, V95, P5579, DOI 10.1073/pnas.95.10.5579; Cochrane D, 2000, J MOL BIOL, V297, P89, DOI 10.1006/jmbi.2000.3561; Daugherty PS, 1998, PROTEIN ENG, V11, P825, DOI 10.1093/protein/11.9.825; Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Flanagan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040443; Harhouri K, 2010, BLOOD, V115, P3843, DOI 10.1182/blood-2009-06-229591; Holmgren L, 2006, P NATL ACAD SCI USA, V103, P9208, DOI 10.1073/pnas.0603110103; Ji WDR, 1998, FASEB J, V12, P1731, DOI 10.1096/fasebj.12.15.1731; Jiang TX, 2012, BLOOD, V120, P2330, DOI 10.1182/blood-2012-01-406108; Jouve N, 2013, J BIOL CHEM, V288, P2571, DOI 10.1074/jbc.M112.418848; Kang HT, 2004, J BIOCHEM MOL BIOL, V37, P159; Kebir A, 2010, CIRC RES, V107, P66, DOI 10.1161/CIRCRESAHA.109.213827; Li G, 2003, ONCOGENE, V22, P6891, DOI 10.1038/sj.onc.1206819; Lucas R, 1998, BLOOD, V92, P4730; Matsunaga T, 2005, AM J PHYSIOL-HEART C, V288, pH2042, DOI 10.1152/ajpheart.00669.2004; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Pasquier E, 2005, THROMB HAEMOSTASIS, V94, P1280, DOI 10.1160/TH05-04-0253; Pearson JD, 2009, J THROMB HAEMOST, V7, P255, DOI 10.1111/j.1538-7836.2008.03214.x; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wajih N, 2003, BLOOD, V101, P1857, DOI 10.1182/blood-2002-02-0582; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zheng CG, 2009, INT J BIOCHEM CELL B, V41, P2163, DOI 10.1016/j.biocel.2009.03.014	36	36	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8991	9000		10.1074/jbc.M112.446518	http://dx.doi.org/10.1074/jbc.M112.446518			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23389031	Green Published, hybrid			2022-12-25	WOS:000316862200018
J	Jeon, JY; Jeong, DH; Park, MG; Lee, JW; Chu, SH; Park, JH; Lee, MK; Sato, K; Ligibel, JA; Meyerhardt, JA; Kim, NK				Jeon, Justin Y.; Jeong, Duck Hyoun; Park, Min Geun; Lee, Ji-Won; Chu, Sang Hui; Park, Ji-Hye; Lee, Mi Kyung; Sato, Kaori; Ligibel, Jennifer A.; Meyerhardt, Jeffrey A.; Kim, Nam Kyu			Impact of Diabetes on Oncologic Outcome of Colorectal Cancer Patients: Colon vs. Rectal Cancer	PLOS ONE			English	Article							INDEPENDENT RISK-FACTOR; IGF-BINDING-PROTEINS; BODY-MASS INDEX; SERUM C-PEPTIDE; MELLITUS; TYPE-2; MORTALITY; INSULIN; SURVIVAL; METAANALYSIS	Background: To evaluate the impact of diabetes on outcomes in colorectal cancer patients and to examine whether this association varies by the location of tumor (colon vs. rectum). Patients and methods: This study includes 4,131 stage I-III colorectal cancer patients, treated between 1995 and 2007 (12.5% diabetic, 53% colon, 47% rectal) in South Korea. Cox proportional hazards modeling was used to determine the prognostic influence of DM on survival endpoints. Results: Colorectal cancer patients with DM had significantly worse disease-free survival (DFS) [hazard ratio (HR) 1.17, 95% confidence interval (CI): 1.00-1.37] compared with patients without DM. When considering colon and rectal cancer independently, DM was significantly associated with worse overall survival (OS) (HR: 1.46, 95% CI: 1.11-1.92), DFS (HR: 1.45, 95% CI: 1.15-1.84) and recurrence-free survival (RFS) (HR: 1.32, 95% CI: 0.98-1.76) in colon cancer patients. No association for OS, DFS or RFS was observed in rectal cancer patients. There was significant interaction of location of tumor (colon vs. rectal cancer) with DM on OS (P = 0.009) and DFS (P = 0.007). Conclusions: This study suggests that DM negatively impacts survival outcomes of patients with colon cancer but not rectal cancer.	[Jeong, Duck Hyoun; Park, Min Geun; Kim, Nam Kyu] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Jeon, Justin Y.; Sato, Kaori; Ligibel, Jennifer A.; Meyerhardt, Jeffrey A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jeon, Justin Y.; Park, Ji-Hye; Lee, Mi Kyung] Yonsei Univ, Sports Med Lab, Seoul 120749, South Korea; [Lee, Ji-Won] Yonsei Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Chu, Sang Hui] Yonsei Univ, Coll Nursing, Biobehav Res Ctr, Dept Clin Nursing Sci, Seoul 120749, South Korea; [Chu, Sang Hui] Yonsei Univ, Coll Nursing, Biobehav Res Ctr, Nursing Policy & Res Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Meyerhardt, JA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	jmeyerhardt@partners.org; namkyuk@yuhs.ac		Kim, Nam-Kyu/0000-0003-0639-5632; CHU, Sang Hui/0000-0001-6877-5599; Jeon, Justin/0000-0001-7978-4271; LEE, JI WON/0000-0002-2666-4249	NATIONAL CANCER INSTITUTE [R01CA149222] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA149222] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BACH LA, 1992, DIABETES METAB REV, V8, P229, DOI 10.1002/dmr.5610080304; Berster Jutta M., 2008, Archives of Physiology and Biochemistry, V114, P84, DOI [10.1080/13813450802008455, 10.1080/13813450802008455 ]; Bowker SL, 2010, DIABETOLOGIA, V53, P1631, DOI 10.1007/s00125-010-1750-8; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Breivik J, 1997, INT J CANCER, V74, P664, DOI 10.1002/(SICI)1097-0215(19971219)74:6<664::AID-IJC18>3.0.CO;2-5; Carmona FJ, 2011, CLIN CANCER RES, V17, P1215, DOI 10.1158/1078-0432.CCR-10-3446; Caudle AS, 2008, ANN SURG ONCOL, V15, P1931, DOI 10.1245/s10434-008-9873-6; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Dehal AN, 2012, J CLIN ONCOL, V30, P53, DOI 10.1200/JCO.2011.38.0303; Dehal AN, 2011, J CLIN ONCOLOGY OFFI; Deng LY, 2012, DIGEST DIS SCI, V57, P1576, DOI 10.1007/s10620-012-2055-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giouleme O, 2011, WORLD J GASTROENTERO, V17, P444, DOI 10.3748/wjg.v17.i4.444; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Harriss DJ, 2009, COLORECTAL DIS, V11, P547, DOI 10.1111/j.1463-1318.2009.01766.x; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; Huang YC, 2011, J CANCER RES CLIN, V137, P211, DOI 10.1007/s00432-010-0879-7; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jenab M, 2007, INT J CANCER, V121, P368, DOI 10.1002/ijc.22697; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Kaczka Aleksandra, 2007, Pol Merkur Lekarski, V22, P373; Korea TS, 2010, STAT CAUSE DEATH; Larsson SC, 2006, EUR J CANCER, V42, P2590, DOI 10.1016/j.ejca.2006.04.015; Li M, 2007, ONCOLOGY-BASEL, V73, P52, DOI 10.1159/000120628; Li Q, 2011, EPIGENETICS-US, V6, P849, DOI 10.4161/epi.6.7.16314; Lim E, 2005, CANCER EPIDEM BIOMAR, V14, P1579, DOI 10.1158/1055-9965.EPI-05-0176; Limburg PJ, 2005, CANCER EPIDEM BIOMAR, V14, P133; Lindblom A, 2001, CURR OPIN ONCOL, V13, P63, DOI 10.1097/00001622-200101000-00013; Meyerhardt JA, 2004, J CLIN ONCOL, V22, P648, DOI 10.1200/JCO.2004.07.121; Meyerhardt JA, 2008, J CLIN ONCOL, V26, P4109, DOI 10.1200/JCO.2007.15.6687; Meyerkardt JA, 2003, J CLIN ONCOL, V21, P433, DOI 10.1200/JCO.2003.07.125; Moore Malcolm A, 2005, Asian Pac J Cancer Prev, V6, P412; Morrison DS, 2011, J EPIDEMIOL COMMUN H, V65, P1053, DOI 10.1136/jech.2010.127555; Noh Geum Youb, 2010, J Korean Soc Coloproctol, V26, P424, DOI 10.3393/jksc.2010.26.6.424; Polednak AP, 2006, CANCER DETECT PREV, V30, P466, DOI 10.1016/j.cdp.2006.07.003; Salageanu Aurora, 2010, J Med Life, V3, P416; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Shonka NA, 2006, MED ONCOL, V23, P515, DOI 10.1385/MO:23:4:515; Song YM, 2008, J CLIN ONCOL, V26, P3395, DOI 10.1200/JCO.2007.15.7867; Sun L, 2012, DIGEST DIS SCI, V57, P1586, DOI 10.1007/s10620-012-2059-x; Tavani A, 2005, CANCER EPIDEM BIOMAR, V14, P2277, DOI 10.1158/1055-9965.EPI-05-0331; van de Poll-Franse LV, 2007, INT J CANCER, V120, P1986, DOI 10.1002/ijc.22532; WILLIAMS JC, 1984, CANCER, V54, P3070, DOI 10.1002/1097-0142(19841215)54:12<3070::AID-CNCR2820541243>3.0.CO;2-N; Xu XT, 2011, J DIGEST DIS, V12, P234, DOI 10.1111/j.1751-2980.2011.00504.x; Yu J, 2004, CLIN IMMUNOL, V113, P318, DOI 10.1016/j.clim.2004.08.009; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512	51	62	64	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55196	10.1371/journal.pone.0055196	http://dx.doi.org/10.1371/journal.pone.0055196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405123	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400068
J	McDonough, PM; Maciejewski-Lenoir, D; Hartig, SM; Hanna, RA; Whittaker, R; Heisel, A; Nicoll, JB; Buehrer, BM; Christensen, K; Mancini, MG; Mancini, MA; Edwards, DP; Price, JH				McDonough, Patrick M.; Maciejewski-Lenoir, Dominique; Hartig, Sean M.; Hanna, Rita A.; Whittaker, Ross; Heisel, Andrew; Nicoll, James B.; Buehrer, Benjamin M.; Christensen, Kurt; Mancini, Maureen G.; Mancini, Michael A.; Edwards, Dean P.; Price, Jeffrey H.			Differential Phosphorylation of Perilipin 1A at the Initiation of Lipolysis Revealed by Novel Monoclonal Antibodies and High Content Analysis	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; DEPENDENT PROTEIN-KINASE; LIPID STORAGE DROPLETS; A-STIMULATED LIPOLYSIS; PROGESTERONE-RECEPTOR; ADIPOCYTE LIPOLYSIS; BREAST-CANCER; TRANSLOCATION; ACTIVATION; REGULATOR	Lipolysis in adipocytes is regulated by phosphorylation of lipid droplet-associated proteins, including perilipin 1A and hormone-sensitive lipase (HSL). Perilipin 1A is potentially phosphorylated by cAMP(adenosine 3',5'-cyclic monophosphate)dependent protein kinase (PKA) on several sites, including conserved C-terminal residues, serine 497 (PKA-site 5) and serine 522 (PKA-site 6). To characterize perilipin 1A phosphorylation, novel monoclonal antibodies were developed, which selectively recognize perilipin 1A phosphorylation at PKA-site 5 and PKA-site 6. Utilizing these novel antibodies, as well as antibodies selectively recognizing HSL phosphorylation at serine 563 or serine 660, we used high content analysis to examine the phosphorylation of perilipin 1A and HSL in adipocytes exposed to lipolytic agents. We found that perilipin PKA-site 5 and HSL-serine 660 were phosphorylated to a similar extent in response to forskolin (FSK) and L-gamma-melanocyte stimulating hormone (L-gamma-MSH). In contrast, perilipin PKA-site 6 and HSL-serine 563 were phosphorylated more slowly and L-gamma-MSH was a stronger agonist for these sites compared to FSK. When a panel of lipolytic agents was tested, including multiple concentrations of isoproterenol, FSK, and L-gamma-MSH, the pattern of results was virtually identical for perilipin PKA-site 5 and HSL-serine 660, whereas a distinct pattern was observed for perilipin PKA-site 6 and HSL-serine 563. Notably, perilipin PKA-site 5 and HSL-serine 660 feature two arginine residues upstream from the phospho-acceptor site, which confers high affinity for PKA, whereas perilipin PKA-site 6 and HSL-serine 563 feature only a single arginine. Thus, we suggest perilipin 1A and HSL are differentially phosphorylated in a similar manner at the initiation of lipolysis and arginine residues near the target serines may influence this process.	[McDonough, Patrick M.; Maciejewski-Lenoir, Dominique; Hanna, Rita A.; Whittaker, Ross; Heisel, Andrew; Price, Jeffrey H.] Vala Sci Inc, San Diego, CA USA; [Hartig, Sean M.; Christensen, Kurt; Mancini, Maureen G.; Mancini, Michael A.; Edwards, Dean P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Nicoll, James B.; Buehrer, Benjamin M.] Zen Bio Inc, Res Triangle Pk, NC USA; [Price, Jeffrey H.] Sanford Burnham Inst Med Res, Signal Transduct Program, La Jolla, CA USA	Baylor College of Medicine; Sanford Burnham Prebys Medical Discovery Institute	McDonough, PM (corresponding author), Vala Sci Inc, San Diego, CA USA.	pmcdonough@valasciences.com		Buehrer, Benjamin/0000-0001-6654-4367	United States National Institutes of Health (NIH)/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) [5R44DK074333]; NIH/NIDDK [1F32DK85979]; John S. Dunn Gulf Coast Consortium for Chemical Genomics; Specialized Cooperative Centers for Reproduction Grant NIH/NICHD (National Institute of Child Health and Human Development) [U54 HD-007495]; Texas Gulf Coast Digestive Diseases Center [NIH/NIDDK P30 DK-56338]; Public Health Services Cancer Center [NIH/NCI P30 CA-125123]; Dan L. Duncan Cancer Center of Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK074333, F32DK085970, P30DK056338] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); John S. Dunn Gulf Coast Consortium for Chemical Genomics; Specialized Cooperative Centers for Reproduction Grant NIH/NICHD (National Institute of Child Health and Human Development); Texas Gulf Coast Digestive Diseases Center; Public Health Services Cancer Center; Dan L. Duncan Cancer Center of Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in part, by United States National Institutes of Health (NIH)/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) 5R44DK074333 (P. M. McDonough). S. M. Hartig was supported by NIH/NIDDK 1F32DK85979. Imaging resources were supported by the John S. Dunn Gulf Coast Consortium for Chemical Genomics (M. A. Mancini), Specialized Cooperative Centers for Reproduction Grant NIH/NICHD (National Institute of Child Health and Human Development) U54 HD-007495 (B. W. O'Malley), Texas Gulf Coast Digestive Diseases Center Grant NIH/NIDDK P30 DK-56338 (M. K. Estes), Public Health Services Cancer Center Support Grant NIH/NCI P30 CA-125123 (C. K. Osborne), and the Dan L. Duncan Cancer Center of Baylor College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shimon A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002288; Bicknell KA, 2009, MOL CELL ENDOCRINOL, V300, P71, DOI 10.1016/j.mce.2008.09.032; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2010, CELL METAB, V11, P173, DOI 10.1016/j.cmet.2010.02.008; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11; Clemm DL, 2000, MOL ENDOCRINOL, V14, P52, DOI 10.1210/me.14.1.52; Galello F, 2010, J BIOL CHEM, V285, P29770, DOI 10.1074/jbc.M110.120378; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; Harmer SC, 2008, J ENDOCRINOL, V196, P149, DOI 10.1677/JOE-07-0391; Hilhorst R, 2009, ANAL BIOCHEM, V387, P150, DOI 10.1016/j.ab.2009.01.022; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martin S, 2009, J BIOL CHEM, V284, P32097, DOI 10.1074/jbc.M109.002675; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; McDonough PM, 2011, ASSAY DRUG DEV TECHN, V9, P262, DOI 10.1089/adt.2010.0302; McDonough PM, 2009, ASSAY DRUG DEV TECHN, V7, P440, DOI 10.1089/adt.2009.0196; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Press M, 2002, STEROIDS, V67, P799, DOI 10.1016/S0039-128X(02)00039-9; Rapold RA, 2012, J LIPID RES; Ruppelt A.O., 2009, HDB CELLULAR SIGNALL, P1497; Sasano H, 2005, J STEROID BIOCHEM, V95, P35, DOI 10.1016/j.jsbmb.2005.04.027; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Whittaker R, 2010, J BIOMOL SCREEN; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yamaguchi T, 2006, MOL CELL BIOCHEM, V284, P167, DOI 10.1007/s11010-005-9045-y; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200; Zhang XD, 2010, BIOCHEM BIOPH RES CO, V396, P1054, DOI 10.1016/j.bbrc.2010.05.064; Zhou DQ, 2012, FASEB J, V26, P4733, DOI 10.1096/fj.12-206862	41	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55511	10.1371/journal.pone.0055511	http://dx.doi.org/10.1371/journal.pone.0055511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405163	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400108
J	Yamazaki, T; Yamamoto, M; Ishihara, Y; Komatsu, S; Munetsuna, E; Onizaki, M; Ishida, A; Kawato, S; Mukuda, T				Yamazaki, Takeshi; Yamamoto, Megumi; Ishihara, Yasuhiro; Komatsu, Shota; Munetsuna, Eiji; Onizaki, Masahiro; Ishida, Atsuhiko; Kawato, Suguru; Mukuda, Takao			De Novo Synthesized Estradiol Protects against Methylmercury-Induced Neurotoxicity in Cultured Rat Hippocampal Slices	PLOS ONE			English	Article							SEX STEROID-HORMONES; MINAMATA DISEASE; OXIDATIVE STRESS; NEUROPROTECTIVE ACTIONS; ESTROGEN SYNTHESIS; PROPIDIUM IODIDE; NERVOUS-SYSTEM; CELL-DEATH; BRAIN; MERCURY	Background: Estrogen, a class of female sex steroids, is neuroprotective. Estrogen is synthesized in specific areas of the brain. There is a possibility that the de novo synthesized estrogen exerts protective effect in brain, although direct evidence for the neuroprotective function of brain-synthesized estrogen has not been clearly demonstrated. Methylmercury (MeHg) is a neurotoxin that induces neuronal degeneration in the central nervous system. The neurotoxicity of MeHg is region-specific, and the molecular mechanisms for the selective neurotoxicity are not well defined. In this study, the protective effect of de novo synthesized 17 beta-estradiol on MeHg-induced neurotoxicity in rat hippocampus was examined. Methodology/Principal Findings: Neurotoxic effect of MeHg on hippocampal organotypic slice culture was quantified by propidium iodide fluorescence imaging. Twenty-four-hour treatment of the slices with MeHg caused cell death in a dose-dependent manner. The toxicity of MeHg was attenuated by pre-treatment with exogenously added estradiol. The slices de novo synthesized estradiol. The estradiol synthesis was not affected by treatment with 1 mu M MeHg. The toxicity of MeHg was enhanced by inhibition of de novo estradiol synthesis, and the enhancement of toxicity was recovered by the addition of exogenous estradiol. The neuroprotective effect of estradiol was inhibited by an estrogen receptor (ER) antagonist, and mimicked by pre-treatment of the slices with agonists for ER alpha and ER beta, indicating the neuroprotective effect was mediated by ERs. Conclusions/Significance: Hippocampus de novo synthesized estradiol protected hippocampal cells from MeHg-induced neurotoxicity via ER alpha- and ER beta-mediated pathways. The self-protective function of de novo synthesized estradiol might be one of the possible mechanisms for the selective sensitivity of the brain to MeHg toxicity.	[Yamazaki, Takeshi; Ishihara, Yasuhiro; Komatsu, Shota; Munetsuna, Eiji; Onizaki, Masahiro; Ishida, Atsuhiko] Hiroshima Univ, Lab Mol Brain Sci, Grad Sch Integrated Arts & Sci, Higashihiroshima 724, Japan; [Yamamoto, Megumi] Natl Inst Minamata Dis, Physiol Sect, Dept Basic Med Sci, Minamata, Kumamoto, Japan; [Kawato, Suguru] Univ Tokyo Komaba, Dept Biophys & Life Sci, Grad Sch Arts & Sci, Tokyo, Japan; [Mukuda, Takao] Hiroshima Univ, Lab Integrat Physiol, Grad Sch Integrated Arts & Sci, Higashihiroshima 724, Japan	Hiroshima University; University of Tokyo; Hiroshima University	Yamazaki, T (corresponding author), Hiroshima Univ, Lab Mol Brain Sci, Grad Sch Integrated Arts & Sci, Higashihiroshima 724, Japan.	takey@hiroshima-u.ac.jp	Ishihara, Yasuhiro/U-6511-2017	Ishihara, Yasuhiro/0000-0001-9751-7660	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschner M, 2005, THER DRUG MONIT, V27, P278, DOI 10.1097/01.ftd.0000160275.85450.32; BAKIR F, 1973, SCIENCE, V181, P230, DOI 10.1126/science.181.4096.230; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Ceccatelli S, 2010, CHEM-BIOL INTERACT, V188, P301, DOI 10.1016/j.cbi.2010.04.007; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Dare E, 2000, J NEUROSCI RES, V62, P557, DOI 10.1002/1097-4547(20001115)62:4<557::AID-JNR10>3.0.CO;2-9; Eto K, 2000, NEUROPATHOLOGY, V20, pS14; Eto K, 1997, TOXICOL PATHOL, V25, P614, DOI 10.1177/019262339702500612; Falluel-Morel A, 2007, J NEUROCHEM, V103, P1968, DOI 10.1111/j.1471-4159.2007.04882.x; Fester L, 2011, CELL TISSUE RES, V345, P285, DOI 10.1007/s00441-011-1221-7; Fujimura M, 2009, NEUROTOXICOLOGY, V30, P1000, DOI 10.1016/j.neuro.2009.08.001; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Garcia-Segura LM, 2003, PROG NEUROBIOL, V71, P31, DOI 10.1016/j.pneurobio.2003.09.005; Haynes LE, 2003, NEUROSCIENCE, V120, P799, DOI 10.1016/S0306-4522(03)00167-2; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Hojo Y, 2009, ENDOCRINOLOGY, V150, P5106, DOI 10.1210/en.2009-0305; Ishihara Y, 2012, NEUROCHEM INT, V60, P782, DOI 10.1016/j.neuint.2012.03.004; Konkle ATM, 2011, ENDOCRINOLOGY, V152, P223, DOI 10.1210/en.2010-0607; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; Kretz O, 2004, J NEUROSCI, V24, P5913, DOI 10.1523/JNEUROSCI.5186-03.2004; Lee ESY, 2009, TOXICOL SCI, V110, P156, DOI 10.1093/toxsci/kfp081; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Malagutti KS, 2009, ENVIRON TOXICOL PHAR, V27, P293, DOI 10.1016/j.etap.2008.11.005; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Munetsuna E, 2009, ENDOCRINOLOGY, V150, P4260, DOI 10.1210/en.2008-1644; Nagashima K, 1997, TOXICOL PATHOL, V25, P624, DOI 10.1177/019262339702500613; OKABE M, 1980, NEUROTOXICOLOGY, V1, P607; PARDRIDGE WM, 1979, J CLIN INVEST, V64, P145, DOI 10.1172/JCI109433; Pike CJ, 2009, FRONT NEUROENDOCRIN, V30, P239, DOI 10.1016/j.yfrne.2009.04.015; Rune GM, 2006, NEUROCHEM RES, V31, P145, DOI 10.1007/s11064-005-9004-8; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Sarafian TA, 1999, AM J RESP CELL MOL, V20, P1286, DOI 10.1165/ajrcmb.20.6.3424; Sasano H, 1998, CLIN ENDOCRINOL, V48, P325, DOI 10.1046/j.1365-2265.1998.00390.x; Singh M, 2006, EXP BIOL MED, V231, P514; Suzuki S, 2009, FRONT NEUROENDOCRIN, V30, P201, DOI 10.1016/j.yfrne.2009.04.007; Takeuchi T, 1982, Acta Pathol Jpn, V32 Suppl 1, P73; TAKEUCHI T, 1989, NEUROTOXICOLOGY, V10, P651; Tan SW, 2009, CRIT REV TOXICOL, V39, P228, DOI 10.1080/10408440802233259; VITALE M, 1993, HISTOCHEMISTRY, V100, P223, DOI 10.1007/BF00269095; Wakabayashi K, 1995, BRAIN RES, V705, P267, DOI 10.1016/0006-8993(95)01208-7; Yee S, 1996, NEUROTOXICOLOGY, V17, P17; Yi KD, 2009, J NEUROCHEM, V108, P732, DOI 10.1111/j.1471-4159.2008.05805.x; Zhao LQ, 2004, BRAIN RES, V1010, P22, DOI 10.1016/j.brainres.2004.02.066; Zimmer J, 2000, AMINO ACIDS, V19, P7, DOI 10.1007/s007260070029	47	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55559	10.1371/journal.pone.0055559	http://dx.doi.org/10.1371/journal.pone.0055559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405170	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400115
J	Ji, K; Akgul, G; Wollmuth, LP; Tsirka, SE				Ji, Kyungmin; Akgul, Gulcan; Wollmuth, Lonnie P.; Tsirka, Stella E.			Microglia Actively Regulate the Number of Functional Synapses	PLOS ONE			English	Article							HIPPOCAMPAL SLICE CULTURES; IN-VIVO; BRAIN; CELLS; MACROPHAGES; STRENGTH; RECEPTOR; INJURY; ALPHA	Microglia are the immunocompetent cells of the central nervous system. In the physiological setting, their highly motile processes continually survey the local brain parenchyma and transiently contact synaptic elements. Although recent work has shown that the interaction of microglia with synapses contributes to synaptic remodeling during development, the role of microglia in synaptic physiology is just starting to get explored. To assess this question, we employed an electrophysiological approach using two methods to manipulate microglia in culture: organotypic hippocampal brain slices in which microglia were depleted using clodronate liposomes, and cultured hippocampal neurons to which microglia were added. We show here that the frequency of excitatory postsynaptic current increases in microglia-depleted brain slices, consistent with a higher synaptic density, and that this enhancement ensures from the loss of microglia since it is reversed when the microglia are replenished. Conversely, the addition of microglia to neuronal cultures decreases synaptic activity and reduces the density of synapses, spine numbers, surface expression of AMPA receptor (GluA1), and levels of synaptic adhesion molecules. Taken together, our findings demonstrate that non-activated microglia acutely modulate synaptic activity by regulating the number of functional synapses in the central nervous system.	[Ji, Kyungmin; Tsirka, Stella E.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Akgul, Gulcan] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA; [Akgul, Gulcan; Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wollmuth, LP (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	lwollmuth@notes.cc.sunysb.edu; stella@pharm.stonybrook.edu	Tsirka, Stella/AAD-4018-2019; Akgül, Gülcan/AAE-1418-2019	Akgül, Gülcan/0000-0003-1590-6350	 [NS42168];  [MH066892]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was partially funded by NS42168 (SET) and MH066892 (LPW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AURIAULT C, 1983, FEBS LETT, V153, P11, DOI 10.1016/0014-5793(83)80109-4; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dehghani F, 2004, EXP NEUROL, V189, P241, DOI 10.1016/j.expneurol.2004.06.010; Hailer NP, 1997, EUR J NEUROSCI, V9, P863, DOI 10.1111/j.1460-9568.1997.tb01436.x; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Tyler CM, 2012, NEURON, V74, P597, DOI 10.1016/j.neuron.2012.05.002; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009	28	169	173	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e56293	10.1371/journal.pone.0056293	http://dx.doi.org/10.1371/journal.pone.0056293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393609	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800064
J	Wen, YD; Wang, H; Kho, SH; Rinkiko, S; Sheng, X; Shen, HM; Zhu, YZ				Wen, Ya-Dan; Wang, Hong; Kho, Sok-Hong; Rinkiko, Suguro; Sheng, Xiong; Shen, Han-Ming; Zhu, Yi-Zhun			Hydrogen Sulfide Protects HUVECs against Hydrogen Peroxide Induced Mitochondrial Dysfunction and Oxidative Stress	PLOS ONE			English	Article							PERMEABILITY TRANSITION; ENDOTHELIAL-CELLS; ATHEROSCLEROSIS; DISEASE; DEATH; H2S; MECHANISMS; INHIBITOR; APOPTOSIS; CYSTEINE	Background: Hydrogen sulfide (H2S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H2S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H2O2) induced endothelial cells damage. Methodology and Principal Findings: H2S, at non-cytotoxic levels, exerts a concentration dependent protective effect in human umbilical vein endothelial cells (HUVECs) exposed to H2O2. Analysis of ATP synthesis, mitochondrial membrane potential (Delta Psi m) and cytochrome c release from mitochondria indicated that mitochondrial function was preserved by pretreatment with H2S. In contrast, in H2O2 exposed endothelial cells mitochondria appeared swollen or ruptured. In additional experiments, H2S was also found to preserve the activities and protein expressions levels of the antioxidants enzymes, superoxide dismutase, catalase, glutathione peroxidase and glutathione-S-transferase in H2O2 exposed cells. ROS and lipid peroxidation, as assessed by measuring H(2)DCFDA, dihydroethidium (DHE), diphenyl-l-pyrenylphosphine (DPPP) and malonaldehyde (MDA) levels, were also inhibited by H2S treatment. Interestingly, in the current model, D, L-propargylglycine (PAG), a selective inhibitor of cystathionine gamma-lyase (CSE), abolished the protective effects of H2S donors. Innovation: This study is the first to show that H2S can inhibit H2O2 mediated mitochondrial dysfunction in human endothelial cells by preserving antioxidant defences. Significance: H2S may protect against atherosclerosis by preventing H2O2 induced injury to endothelial cells. These effects appear to be mediated via the preservation of mitochondrial function and by reducing the deleterious effects of oxidative stress.	[Wen, Ya-Dan; Wang, Hong; Kho, Sok-Hong; Zhu, Yi-Zhun] Natl Univ Singapore, Sch Med, Dept Pharmacol, Singapore 117548, Singapore; [Rinkiko, Suguro; Sheng, Xiong] Jinan Univ, Inst Biomed, Guangzhou, Guangdong, Peoples R China; [Shen, Han-Ming] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	National University of Singapore; Jinan University; National University of Singapore	Zhu, YZ (corresponding author), Natl Univ Singapore, Sch Med, Dept Pharmacol, Singapore 117548, Singapore.	yizhunzhu@gmail.com	SHEN, Han-Ming/B-5942-2011; Zhu, Yi Zhun/ABG-8449-2021	SHEN, Han-Ming/0000-0001-7369-5227; Zhu, Yi Zhun/0000-0001-7700-8041	National Medical Research Council [NMRC/EDG/0053/2009]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by National Medical Research Council (http://www.nmrc.gov.sg/content/nmrc_internet/home.html), fund number NMRC/EDG/0053/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Laggner H, 2007, FREE RADICAL RES, V41, P741, DOI 10.1080/10715760701263265; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Mitsuhashi H, 2005, SHOCK, V24, P529, DOI 10.1097/01.shk.0000183393.83272.de; Mourier A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001129; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Recchioni R, 2002, METABOLISM, V51, P1384, DOI 10.1053/meta.2002.35579; Singh Raja B, 2002, Exp Clin Cardiol, V7, P40; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Thorburn DR, 2004, NAT GENET, V36, P13, DOI 10.1038/ng0104-13; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33; Violi F, 2007, NUTR FOOD SCI, V3, P200; Wang Q, 2010, ANTIOXID REDOX SIGN, V12, P1155, DOI 10.1089/ars.2009.2947; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yan SK, 2006, BIOCHEM BIOPH RES CO, V351, P485, DOI 10.1016/j.bbrc.2006.10.058; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao X, 2008, HYPERTENS RES, V31, P1619, DOI 10.1291/hypres.31.1619	27	138	141	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e53147	10.1371/journal.pone.0053147	http://dx.doi.org/10.1371/journal.pone.0053147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393548	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800002
J	Yang, FL; Zhou, GS				Yang, Fulin; Zhou, Guangsheng			Sensitivity of Temperate Desert Steppe Carbon Exchange to Seasonal Droughts and Precipitation Variations in Inner Mongolia, China	PLOS ONE			English	Article							NET ECOSYSTEM EXCHANGE; GAP FILLING STRATEGIES; SOIL CO2 FLUX; DIOXIDE EXCHANGE; INTERANNUAL VARIABILITY; PRIMARY PRODUCTIVITY; ANNUAL GRASSLAND; RESPIRATION; WATER; HEAT	Arid grassland ecosystems have significant interannual variation in carbon exchange; however, it is unclear how environmental factors influence carbon exchange in different hydrological years. In this study, the eddy covariance technique was used to investigate the seasonal and interannual variability of CO2 flux over a temperate desert steppe in Inner Mongolia, China from 2008 to 2010. The amounts and times of precipitation varied significantly throughout the study period. The precipitation in 2009 (186.4 mm) was close to the long-term average (183.9 +/- 47.6 mm), while the precipitation in 2008 (136.3 mm) and 2010 (141.3 mm) was approximately a quarter below the long-term average. The temperate desert steppe showed carbon neutrality for atmospheric CO2 throughout the study period, with a net ecosystem carbon dioxide exchange (NEE) of -7.2, -22.9, and 26.0 g C m(-2) yr(-1) in 2008, 2009, and 2010, not significantly different from zero. The ecosystem gained more carbon in 2009 compared to other two relatively dry years, while there was significant difference in carbon uptake between 2008 and 2010, although both years recorded similar annual precipitation. The results suggest that summer precipitation is a key factor determining annual NEE. The apparent quantum yield and saturation value of NEE (NEEsat) and the temperature sensitivity coefficient of ecosystem respiration (R-eco) exhibited significant variations. The values of NEEsat were -2.6, -2.9, and -1.4 mu mol CO2 m(-2) s(-1) in 2008, 2009, and 2010, respectively. Drought suppressed both the gross primary production (GPP) and R-eco, and the drought sensitivity of GPP was greater than that of R-eco. The soil water content sensitivity of GPP was high during the dry year of 2008 with limited soil moisture availability. Our results suggest the carbon balance of this temperate desert steppe was not only sensitive to total annual precipitation, but also to its seasonal distribution.	[Yang, Fulin] CMA, Key Lab Arid Climat Change & Reducing Disaster Ga, Key Open Lab Arid Climat Change & Disaster Reduct, Inst Arid Meteorol, Lanzhou, Peoples R China; [Yang, Fulin; Zhou, Guangsheng] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Zhou, Guangsheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China	China Meteorological Administration; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Meteorological Sciences (CAMS)	Zhou, GS (corresponding author), Chinese Acad Meteorol Sci, Beijing, Peoples R China.	gszhou@cams.cma.gov.cn	郭, 青霞/GZH-2618-2022	Yang, Fulin/0000-0002-5530-0954	National Basic Research Program of China [2010CB951303]; National Natural Science Foundation of China [40830957]; China Postdoctoral Science Foundation [2012M512044]; Natural Science Foundation of Gansu Province [1208RJYA025]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Gansu Province	This research was jointly supported by the National Basic Research Program of China (2010CB951303), National Natural Science Foundation of China (40830957), China Postdoctoral Science Foundation (2012M512044), and Natural Science Foundation of Gansu Province (1208RJYA025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires LMI, 2008, GLOBAL CHANGE BIOL, V14, P539, DOI 10.1111/j.1365-2486.2007.01507.x; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Baldocchi D, 2011, NATURE, V476, P160, DOI 10.1038/476160a; Burba GG, 2008, GLOBAL CHANGE BIOL, V14, P1854, DOI 10.1111/j.1365-2486.2008.01606.x; Chou WW, 2008, GLOBAL CHANGE BIOL, V14, P1382, DOI 10.1111/j.1365-2486.2008.01572.x; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Craine JM, 1999, PLANT SOIL, V207, P77, DOI 10.1023/A:1004417419288; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Falge E, 2001, AGR FOREST METEOROL, V107, P71, DOI 10.1016/S0168-1923(00)00235-5; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Fan JW, 2008, CLIMATIC CHANGE, V86, P375, DOI 10.1007/s10584-007-9316-6; Flanagan LB, 2002, GLOBAL CHANGE BIOL, V8, P599, DOI 10.1046/j.1365-2486.2002.00491.x; Fu Y, 2009, BIOGEOSCIENCES, V6, P2879, DOI 10.5194/bg-6-2879-2009; Gilmanov TG, 2007, AGR ECOSYST ENVIRON, V121, P93, DOI 10.1016/j.agee.2006.12.008; Gu LH, 2005, AGR FOREST METEOROL, V128, P179, DOI 10.1016/j.agrformet.2004.11.006; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Hunt JE, 2002, AGR FOREST METEOROL, V111, P65, DOI 10.1016/S0168-1923(02)00006-0; Hussain MZ, 2011, AGR ECOSYST ENVIRON, V141, P67, DOI 10.1016/j.agee.2011.02.013; Jongen M, 2011, AGR FOREST METEOROL, V151, P595, DOI 10.1016/j.agrformet.2011.01.008; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kato T, 2006, GLOBAL CHANGE BIOL, V12, P1285, DOI 10.1111/j.1365-2486.2006.01153.x; Klumpp K, 2011, GLOBAL CHANGE BIOL, V17, P3534, DOI 10.1111/j.1365-2486.2011.02490.x; Koehler AK, 2011, GLOBAL CHANGE BIOL, V17, P309, DOI 10.1111/j.1365-2486.2010.02180.x; Krishnan P, 2012, AGR FOREST METEOROL, V153, P31, DOI 10.1016/j.agrformet.2011.09.017; Li SG, 2005, GLOBAL CHANGE BIOL, V11, P1941, DOI 10.1111/j.1365-2486.2005.01047.x; [李晓兵 Li Xiaobing], 2002, [地球科学进展, Advance in Earth Sciences], V17, P254; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Ma SY, 2007, AGR FOREST METEOROL, V147, P157, DOI 10.1016/j.agrformet.2007.07.008; Meir P, 2008, PHILOS T R SOC B, V363, P1849, DOI 10.1098/rstb.2007.0021; Meyers TP, 2001, AGR FOREST METEOROL, V106, P205, DOI 10.1016/S0168-1923(00)00213-6; Monteith J.L., 1990, PRINCIPLES ENV PHYS, V2nd; Nagy Z, 2007, AGR ECOSYST ENVIRON, V121, P21, DOI 10.1016/j.agee.2006.12.003; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Oliphant AJ, 2004, AGR FOREST METEOROL, V126, P185, DOI 10.1016/j.agrformet.2004.07.003; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; PARTON WJ, 1995, GLOBAL CHANGE BIOL, V1, P13, DOI 10.1111/j.1365-2486.1995.tb00002.x; Ping XY, 2010, GEODERMA, V155, P262, DOI 10.1016/j.geoderma.2009.12.009; Polley HW, 2008, GLOBAL CHANGE BIOL, V14, P1620, DOI 10.1111/j.1365-2486.2008.01599.x; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2002, GLOBAL CHANGE BIOL, V8, P999, DOI 10.1046/j.1365-2486.2002.00530.x; Richardson AD, 2006, AGR FOREST METEOROL, V136, P1, DOI 10.1016/j.agrformet.2006.01.007; Saigusa N, 1998, AGR FOREST METEOROL, V89, P131, DOI 10.1016/S0168-1923(97)00060-9; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Scott RL, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001348; Shen WJ, 2009, GLOBAL CHANGE BIOL, V15, P2274, DOI 10.1111/j.1365-2486.2009.01857.x; SIMS PL, 2001, AGR FOREST METEOROL, V109, P117, DOI DOI 10.1016/S0168-1923(01)00264-7; Smart AJ, 2007, RANGELAND ECOL MANAG, V60, P146, DOI 10.2111/05-099R4.1; Sottocornola M, 2010, AGR FOREST METEOROL, V150, P287, DOI 10.1016/j.agrformet.2009.11.013; Sun H., 2005, ECOSYSTEMS CHINA; Suyker AE, 2001, GLOBAL CHANGE BIOL, V7, P279, DOI 10.1046/j.1365-2486.2001.00407.x; Suyker AE, 2003, GLOBAL CHANGE BIOL, V9, P255, DOI 10.1046/j.1365-2486.2003.00567.x; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Thomey ML, 2011, GLOBAL CHANGE BIOL, V17, P1505, DOI 10.1111/j.1365-2486.2010.02363.x; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang YF, 2011, SCI TOTAL ENVIRON, V410, P182, DOI 10.1016/j.scitotenv.2011.09.067; Wang YL, 2008, AGR FOREST METEOROL, V148, P714, DOI 10.1016/j.agrformet.2008.01.013; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wolf S, 2011, GLOBAL CHANGE BIOL, V17, P2763, DOI 10.1111/j.1365-2486.2011.02460.x; Xu LK, 2004, AGR FOREST METEOROL, V123, P79, DOI 10.1016/j.agrformet.2003.10.004; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Yang FL, 2011, AGR ECOSYST ENVIRON, V142, P318, DOI 10.1016/j.agee.2011.05.032; Yang FL, 2011, J HYDROL, V396, P139, DOI 10.1016/j.jhydrol.2010.11.001; Zhao L, 2006, GLOBAL CHANGE BIOL, V12, P1940, DOI 10.1111/j.1365-2486.2006.01197.x; Zhu ZL, 2006, SCI CHINA SER D, V49, P36, DOI 10.1007/s11430-006-8036-5	69	20	24	11	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55418	10.1371/journal.pone.0055418	http://dx.doi.org/10.1371/journal.pone.0055418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393576	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800030
J	Mitchell, KM; Cox, AP; Mabey, D; Tucker, JD; Peeling, RW; Vickerman, P				Mitchell, Kate M.; Cox, Andrew P.; Mabey, David; Tucker, Joseph D.; Peeling, Rosanna W.; Vickerman, Peter			The Impact of Syphilis Screening among Female Sex Workers in China: A Modelling Study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; CONDOM USE; TRANSMISSION DYNAMICS; COST-EFFECTIVENESS; MASS TREATMENT; HIGH-RISK; HIV; TESTS; INFECTIONS; CLIENTS	Background: In China, female sex workers (FSWs) are at high risk of syphilis infection, but are hard to reach for interventions. Point-of-care testing introduces opportunities for expanding syphilis control measures. Modelling is used to estimate the impact of using rapid tests to screen FSWs for syphilis. In other settings, modelling has predicted large rebounds in infectious syphilis following screening, which may undermine any impact achieved. Methods: A deterministic syphilis transmission model among FSWs and clients was fitted to data from Yunnan Province (FSW syphilis prevalence = 7.5%), and used to estimate the impact of rapid syphilis testing and treatment for FSWs. Impact projections were compared for different model structures that included risk heterogeneity amongst FSWs, incoming syphilis infections amongst new FSWs and clients and re-infection from FSWs' regular non-commercial partners. The rebound in syphilis prevalence after screening ceased was explored. Results: All model structures suggest yearly syphilis screening could substantially reduce (by 72-88%) syphilis prevalence amongst FSWs in this setting over five years. However, incoming syphilis infections amongst new FSWs and clients or re-infections from regular non-commercial partners of FSWs can considerably reduce (>30%) the proportion of infections averted. Including heterogeneity in risk amongst FSWs had little effect upon the proportion of infections averted. In this setting, the rebound in syphilis prevalence after screening ceased is predicted to be slight, but it could be large in high prevalence settings. Conclusions: Rapid test screening could dramatically reduce syphilis prevalence amongst hard-to-reach groups, but strategies to reduce re-infection from regular non-commercial partners are needed to maximise impact.	[Mitchell, Kate M.; Vickerman, Peter] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Cox, Andrew P.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Mabey, David; Tucker, Joseph D.; Peeling, Rosanna W.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Tucker, Joseph D.] Univ N Carolina, Sch Med, Chapel Hill, NC USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Mitchell, KM (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	Kate.Mitchell@lshtm.ac.uk	Mitchell, Kate/ABE-5796-2020	Tucker, Joseph/0000-0003-2804-1181; Mabey, David/0000-0002-0031-8276; Vickerman, Peter/0000-0002-8291-5890	Bill and Melinda Gates Foundation [OPP47697]; FOGARTY INTERNATIONAL CENTER [K01TW008200] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Bill and Melinda Gates Foundation (www.gatesfoundation.org), grant number OPP47697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Boily MC, 2002, SEX TRANSM INFECT, V78, pI78, DOI 10.1136/sti.78.suppl_1.i78; Briggs A, 2006, DECISION MODELLING H; Bruusgaard E, 1929, ARCH DERMATOL SYPH-G, V157, P309, DOI 10.1007/BF01959543; CDC, 1968, SYPH A SYN; Chen XS, 2011, SEX TRANSM INFECT, V87, pA2, DOI 10.1136/sextrans-2011-050102.7; China Centre for Disease Prevention and Control, 2004, NAT EP REP SEX TRANS; CLARK E G, 1955, J Chronic Dis, V2, P311, DOI 10.1016/0021-9681(55)90139-9; Ferguson NM, 2000, SEX TRANSM DIS, V27, P600, DOI 10.1097/00007435-200011000-00008; Foss AM, 2009, SEX TRANSM INFECT, V85, P276, DOI 10.1136/sti.2008.032458; Garnett GP, 1996, J INFECT DIS, V174, pS150, DOI 10.1093/infdis/174.Supplement_2.S150; Garnett GP, 1997, SEX TRANSM DIS, V24, P185, DOI 10.1097/00007435-199704000-00002; Gil VE, 1996, SOC SCI MED, V42, P141, DOI 10.1016/0277-9536(95)00064-X; Grassly NC, 2005, NATURE, V433, P417, DOI 10.1038/nature03072; Heijne JCM, 2011, J INFECT DIS, V203, P372, DOI 10.1093/infdis/jiq050; Herring A, 2006, NAT REV MICROBIOL, pS33, DOI 10.1038/nrmicro1563; Indian Council of Medical Research & Family Health International, 2007, NAT INT SUMM REP IND; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; Kretzschmar M, 1998, MATH BIOSCI, V148, P83, DOI 10.1016/S0025-5564(97)10008-6; Lau JTF, 2009, SEX TRANSM INFECT, V85, P376, DOI 10.1136/sti.2008.035162; Lau JTF, 2002, AIDS CARE, V14, P219, DOI 10.1080/09540120220104721; Lin CC, 2006, SEX TRANSM DIS, V33, P726, DOI 10.1097/01.olq.0000222703.12018.58; LIU Dalin, 1997, SEXUAL BEHAV MODERN; Lowndes CM, 2000, AIDS, V14, P2523, DOI 10.1097/00002030-200011100-00015; Lukehart SA, 2008, SEXUALLY TRANSMITTED, P648; Mabey D, 2006, SEX TRANSM INFECT, V82, pV13, DOI 10.1136/sti.2006.022467; MAGNUSON HJ, 1956, MEDICINE, V35, P33, DOI 10.1097/00005792-195602000-00002; Mandell, 2005, PRINCIPLES PRACTICE; Mishra S, 2010, SEX TRANSM INFECT, V86, P193, DOI 10.1136/sti.2009.038778; MOORE MB, 1963, PUBLIC HEALTH REP, V78, P966, DOI 10.2307/4591989; Mukenge-Tshibaka L, 2002, SEX TRANSM DIS, V29, P324, DOI 10.1097/00007435-200206000-00003; Myer L, 2003, SEX TRANSM INFECT, V79, P208, DOI 10.1136/sti.79.3.208; Pirkle C, 2007, SEX TRANSM DIS, V34, P695, DOI 10.1097/01.olq.0000260989.70866.94; Pourbohloul B, 2003, SEX TRANSM DIS, V30, P297, DOI 10.1097/00007435-200304000-00005; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; SCHROETER AL, 1972, J AMER MED ASSOC, V221, P471, DOI 10.1001/jama.221.5.471; Sparling PF., 2008, SEX TRANSM DIS, V4th ed, pp. 661; The Sexually Transmitted Diseases Diagnostics Initiative (SDI) Special Programme for Research and Training in Tropical Diseases (TDR), 2006, US RAP SYPH TESTS; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Vickerman P, 2006, SEX TRANSM INFECT, V82, pV38, DOI 10.1136/sti.2006.021824; Vickerman P, 2006, SEX TRANSM INFECT, V82, P403, DOI 10.1136/sti.2006.020107; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663; Vickerman P, 2010, SEX TRANSM INFECT, V86, P163, DOI 10.1136/sti.2008.034678; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Weller S, 2002, Cochrane Database Syst Rev, pCD003255; West B, 2002, SEX TRANSM INFECT, V78, P282, DOI 10.1136/sti.78.4.282; Williams JR, 2006, SEX TRANSM INFECT, V82, P372, DOI 10.1136/sti.2006.020875; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b; Yang C, 2010, SEX TRANSM INFECT, V86, P559, DOI 10.1136/sti.2009.041731; Yang HM, 2005, SEX TRANSM DIS, V32, P572, DOI 10.1097/01.olq.0000175418.48665.95; Zhong N, 2002, CHIN TROPICAL MED, P2100	51	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55622	10.1371/journal.pone.0055622	http://dx.doi.org/10.1371/journal.pone.0055622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383249	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000315563800176
J	Silvius, D; Pitstick, R; Ahn, M; Meishery, D; Oehler, A; Barsh, GS; DeArmond, SJ; Carlson, GA; Gunn, TM				Silvius, Derek; Pitstick, Rose; Ahn, Misol; Meishery, Delisha; Oehler, Abby; Barsh, Gregory S.; DeArmond, Stephen J.; Carlson, George A.; Gunn, Teresa M.			Levels of the Mahogunin Ring Finger 1 E3 Ubiquitin Ligase Do Not Influence Prion Disease	PLOS ONE			English	Article							CELL-DEATH; PROTEIN; NEURODEGENERATION; DEGENERATION; EXPRESSION; PRP	Prion diseases are rare but invariably fatal neurodegenerative disorders. They are associated with spongiform encephalopathy, a histopathology characterized by the presence of large, membrane-bound vacuolar structures in the neuropil of the brain. While the primary cause is recognized as conversion of the normal form of prion protein (PrPC) to a conformationally distinct, pathogenic form (PrPSc), the cellular pathways and mechanisms that lead to spongiform change, neuronal dysfunction and death are not known. Mice lacking the Mahogunin Ring Finger 1 (MGRN1) E3 ubiquitin ligase develop spongiform encephalopathy by 9 months of age but do not become ill. In cell culture, PrP aberrantly present in the cytosol was reported to interact with and sequester MGRN1. This caused endo-lysosomal trafficking defects similar to those observed when Mgrn1 expression is knocked down, implicating disrupted MGRN1-dependent trafficking in the pathogenesis of prion disease. As these defects were rescued by over-expression of MGRN1, we investigated whether reduced or elevated Mgrn1 expression influences the onset, progression or pathology of disease in mice inoculated with PrPSc. No differences were observed, indicating that disruption of MGRN1-dependent pathways does not play a significant role in the pathogenesis of transmissible spongiform encephalopathy.	[Silvius, Derek; Pitstick, Rose; Meishery, Delisha; Carlson, George A.; Gunn, Teresa M.] McLaughlin Res Inst, Great Falls, MT USA; [Ahn, Misol; Oehler, Abby; DeArmond, Stephen J.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Ahn, Misol; Oehler, Abby; DeArmond, Stephen J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Barsh, Gregory S.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	McLaughlin Research Institute for Biomedical Sciences, Inc.; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University	Gunn, TM (corresponding author), McLaughlin Res Inst, Great Falls, MT USA.	tmg@mri.montana.edu		Ahn, Misol/0000-0002-6088-8481; Gunn, Teresa/0000-0003-2688-6420	National Institutes of Health [NS41997]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health program project grant NS41997. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Azouz A, 2007, EXP CELL RES, V313, P761, DOI 10.1016/j.yexcr.2006.11.018; Bajsarowicz K, 2012, J NEUROPATH EXP NEUR, V71, P449, DOI 10.1097/NEN.0b013e3182544680; Bouzamondo-Bernstein E, 2004, J NEUROPATH EXP NEUR, V63, P882, DOI 10.1093/jnen/63.8.882; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; DEARMOND SJ, 1993, P NATL ACAD SCI USA, V90, P6449, DOI 10.1073/pnas.90.14.6449; DeArmond SJ, 1996, COLD SPRING HARB SYM, V61, P531; Fioriti L, 2005, J BIOL CHEM, V280, P11320, DOI 10.1074/jbc.M412441200; Giese A, 1998, BRAIN PATHOL, V8, P449; Gunn TM, 2001, GENETICS, V158, P1683; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Imran M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-559; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Jayadev S, 2011, ANN NEUROL, V69, P712, DOI 10.1002/ana.22264; Jiao J, 2009, BBA-MOL BASIS DIS, V1792, P1027, DOI 10.1016/j.bbadis.2009.08.009; Jiao J, 2009, GENESIS, V47, P524, DOI 10.1002/dvg.20529; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; KRISTENSSON K, 1993, NEUROLOGY, V43, P2335, DOI 10.1212/WNL.43.11.2335; LAMPERT P, 1971, ACTA NEUROPATHOL, V19, P81, DOI 10.1007/BF00688486; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Miesbauer M, 2010, CURR ISSUES MOL BIOL, V12, P109; Norstrom EM, 2007, J VIROL, V81, P2831, DOI 10.1128/JVI.02157-06; Restelli E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013725; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Spilman P, 2008, P NATL ACAD SCI USA, V105, P10595, DOI 10.1073/pnas.0803671105; Wong K, 1996, NEUROLOGY, V47, P741, DOI 10.1212/WNL.47.3.741	31	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55575	10.1371/journal.pone.0055575	http://dx.doi.org/10.1371/journal.pone.0055575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383230	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800169
J	Datta, D; McClendon, CL; Jacobson, MP; Wells, JA				Datta, Debajyoti; McClendon, Christopher L.; Jacobson, Matthew P.; Wells, James A.			Substrate and Inhibitor-induced Dimerization and Cooperativity in Caspase-1 but Not Caspase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; COMBINATORIAL APPROACH; PROTEIN INTERACTIONS; MECHANISM; ACTIVATION; SPECIFICITIES; STABILITY; SECRETION; APOPTOSIS; PROTEASES	Caspases are intracellular cysteine-class proteases with aspartate specificity that is critical for driving processes as diverse as the innate immune response and apoptosis, exemplified by caspase-1 and caspase-3, respectively. Interestingly, caspase-1 cleaves far fewer cellular substrates than caspase-3 and also shows strong positive cooperativity between the two active sites of the homodimer, unlike caspase-3. Biophysical and kinetic studies here present a molecular basis for this difference. Analytical ultracentrifugation experiments show that mature caspase-1 exists predominantly as a monomer under physiological concentrations that undergoes dimerization in the presence of substrate; specifically, substrate binding shifts the K-D for dimerization by 20-fold. We have created a hemi-active site-labeled dimer of caspase-1, where one site is blocked with the covalent active site inhibitor, benzyloxycarbonyl-Val-Ala-Aspfluoromethylketone. This hemi-labeled enzyme is about 9-fold more active than the apo-dimer of caspase-1. These studies suggest that substrate not only drives dimerization but also, once bound to one site in the dimer, promotes an active conformation in the other monomer. Steady-state kinetic analysis and modeling independently support this model, where binding of one substrate molecule not only increases substrate binding in preformed dimers but also drives the formation of heterodimers. Thus, the cooperativity in caspase-1 is driven both by substrate-induced dimerization as well as substrate-induced activation. Substrate-induced dimerization and activation seen in caspase-1 and not in caspase-3 may reflect their biological roles. Whereas caspase-1 cleaves a dramatically smaller number of cellular substrates that need to be concentrated near inflammasomes, caspase-3 is a constitutively active dimer that cleaves many more substrates located diffusely throughout the cell.	[Datta, Debajyoti; McClendon, Christopher L.; Jacobson, Matthew P.; Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wells, JA (corresponding author), UCSF Mission Bay, MC 2552 Byers Hall S504,1700 4th St, San Francisco, CA 94158 USA.	Jim.Wells@ucsf.edu	Jacobson, Matthew/Y-5161-2018; Wells, Jim A/O-9854-2016	Jacobson, Matthew/0000-0001-6262-655X; 	National Institutes of Health [R01-AI070292, GMO7618]; PhRMA Foundation fellowship; National Science Foundation East Asia and Pacific Summer Institutes grant; National Institutes of Health Postdoctoral Fellowship [F32-GM099197]; National Science Foundation Teragrid program at the Texas Advanced Supercomputing Center [TG-MCB090109]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation fellowship; National Science Foundation East Asia and Pacific Summer Institutes grant; National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Teragrid program at the Texas Advanced Supercomputing Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI070292 (to J. A. W.) and GMO7618 (to D. D.). This work was also supported by a PhRMA Foundation fellowship and a National Science Foundation East Asia and Pacific Summer Institutes grant (to C. L. M., who is currently funded by National Institutes of Health Postdoctoral Fellowship F32-GM099197). This work was also supported by supercomputer time provided by the National Science Foundation Teragrid program at the Texas Advanced Supercomputing Center (Project TG-MCB090109 to M. P. J., a consultant for Schrodinger, Inc.).	Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; BLACK RA, 1989, J BIOL CHEM, V264, P5323; Bose K, 2005, PROTEIN SCI, V14, P24; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Datta D, 2008, J MOL BIOL, V381, P1157, DOI 10.1016/j.jmb.2008.06.040; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; Denault JB, 2006, MOL CELL, V23, P523, DOI 10.1016/j.molcel.2006.06.020; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Hauske P, 2008, CHEMBIOCHEM, V9, P2920, DOI 10.1002/cbic.200800528; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; MADSEN NB, 1967, J BIOL CHEM, V242, P3301; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rano TA, 1997, CHEM BIOL, V4, P149, DOI 10.1016/S1074-5521(97)90258-1; Romanowski MJ, 2004, STRUCTURE, V12, P1361, DOI 10.1016/j.str.2004.05.010; Scheer JM, 2005, PROTEIN EXPRES PURIF, V41, P148, DOI 10.1016/j.pep.2005.01.008; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Stennicke HR, 1999, METHODS, V17, P313, DOI 10.1006/meth.1999.0745; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Talanian RV, 1996, J BIOL CHEM, V271, P21853, DOI 10.1074/jbc.271.36.21853; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; THORNBERRY NA, 1994, METHOD ENZYMOL, V244, P615; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0	39	27	27	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9971	9981		10.1074/jbc.M112.426460	http://dx.doi.org/10.1074/jbc.M112.426460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23386603	Green Published, hybrid			2022-12-25	WOS:000317114000036
J	Mardones, GA; Burgos, PV; Lin, Y; Kloer, DP; Magadan, JG; Hurley, JH; Bonifacino, JS				Mardones, Gonzalo A.; Burgos, Patricia V.; Lin, Yimo; Kloer, Daniel P.; Magadan, Javier G.; Hurley, James H.; Bonifacino, Juan S.			Structural Basis for the Recognition of Tyrosine-based Sorting Signals by the mu 3A Subunit of the AP-3 Adaptor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-ASSOCIATED PROTEINS; LYSOSOMAL MEMBRANE-PROTEINS; HERMANSKY-PUDLAK-SYNDROME; MEDIUM CHAINS; ENDOCYTIC MACHINERY; CYTOPLASMIC TAIL; BETA-3A SUBUNIT; AP2 COMPLEX; RECEPTOR; BINDING	Tyrosine-based signals fitting the YXX empty set motif mediate sorting of transmembrane proteins to endosomes, lysosomes, the basolateral plasma membrane of polarized epithelial cells, and the somatodendritic domain of neurons through interactions with the homologous mu 1, mu 2, mu 3, and mu 4 subunits of the corresponding AP-1, AP-2, AP-3, and AP-4 complexes. Previous x-ray crystallographic analyses identified distinct binding sites for YXX empty set signals on mu 2 and mu 4, which were located on opposite faces of the proteins. To elucidate the mode of recognition of YXX empty set signals by other members of the mu family, we solved the crystal structure at 1.85 angstrom resolution of the C-terminal domain of the mu 3 subunit of AP-3 (isoform A) in complex with a peptide encoding a YXX empty set signal (SDYQRL) from the trans-Golgi network protein TGN38. The mu 3A C-terminal domain consists of an immunoglobulin-like beta-sandwich organized into two sub-domains, A and B. The YXX empty set signal binds in an extended conformation to a site on mu 3A subdomain A, at a location similar to the YXX empty set -binding site on mu 2 but not mu 4. The binding sites on mu 3A and mu 2 exhibit similarities and differences that account for the ability of both proteins to bind distinct sets of YXX empty set signals. Biochemical analyses confirm the identification of the mu 3A site and show that this protein binds YXX empty set signals with 14-19 mu M affinity. The surface electrostatic potential of mu 3A is less basic than that of mu 2, in part explaining the association of AP-3 with intracellular membranes having less acidic phosphoinositides.	[Mardones, Gonzalo A.; Burgos, Patricia V.] Univ Austral Chile, Inst Fisiol, Fac Med, Valdivia 5110566, Chile; [Mardones, Gonzalo A.; Burgos, Patricia V.] Univ Austral Chile, Ctr Invest Sur Austral Enfermedades Sistema Nervi, Valdivia 5110566, Chile; [Mardones, Gonzalo A.; Burgos, Patricia V.; Lin, Yimo; Magadan, Javier G.; Bonifacino, Juan S.] NICHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Kloer, Daniel P.; Hurley, James H.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Universidad Austral de Chile; Universidad Austral de Chile; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Mardones, GA (corresponding author), Univ Austral Chile, Inst Fisiol, Fac Med, Valdivia 5110566, Chile.	gonzalo.mardones@uach.cl; hurley@helix.nih.gov; juan@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile [1100896]; Intramural Program of NICHD, National Institutes of Health; Intramural Program of NIDDK, National Institutes of Health; U. S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036130] Funding Source: NIH RePORTER	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile; Intramural Program of NICHD, National Institutes of Health; Intramural Program of NIDDK, National Institutes of Health; U. S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant 1100896 from Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (to G. A. M.), and the Intramural Programs of NICHD (to J. S. B.) and NIDDK (to J. H. H.), National Institutes of Health. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Basic Energy Sciences, Office of Science under Contract W-31-109-Eng-38.	Aguilar RC, 1997, J BIOL CHEM, V272, P27160, DOI 10.1074/jbc.272.43.27160; Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Carvajal-Gonzalez JM, 2012, P NATL ACAD SCI USA, V109, P3820, DOI 10.1073/pnas.1117949109; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cosson P, 1996, EMBO J, V15, P1792, DOI 10.1002/j.1460-2075.1996.tb00528.x; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; HONING S, 1995, J CELL BIOL, V128, P321, DOI 10.1083/jcb.128.3.321; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Mullins C, 1999, MOL GEN GENET, V262, P401, DOI 10.1007/s004380051099; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Stephens DJ, 1998, BIOCHEM J, V335, P567, DOI 10.1042/bj3350567; Umasankar PK, 2012, NAT CELL BIOL, V14, P488, DOI 10.1038/ncb2473; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walther K, 2001, EMBO REP, V2, P634, DOI 10.1093/embo-reports/kve134; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2	48	28	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9563	9571		10.1074/jbc.M113.450775	http://dx.doi.org/10.1074/jbc.M113.450775			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404500	Green Published, hybrid			2022-12-25	WOS:000316862200070
J	McCoy, F; Darbandi, R; Chen, SI; Eckard, L; Dodd, K; Jones, K; Baucum, AJ; Gibbons, JA; Lin, SH; Colbran, RJ; Nutt, LK				McCoy, Francis; Darbandi, Rashid; Chen, Si-Ing; Eckard, Laura; Dodd, Keela; Jones, Kelly; Baucum, Anthony J., II; Gibbons, Jennifer A.; Lin, Sue-Hwa; Colbran, Roger J.; Nutt, Leta K.			Metabolic Regulation of CaMKII Protein and Caspases in Xenopus laevis Egg Extracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-II; CELL-DEATH; PHOSPHATASES; APOPTOSIS; OOCYTE; ACTIVATION; EXPRESSION; PP1	The metabolism of the Xenopus laevis egg provides a cell survival signal. We found previously that increased carbon flux from glucose-6-phosphate (G6P) through the pentose phosphate pathway in egg extracts maintains NADPH levels and calcium/calmodulin regulated protein kinase II (CaMKII) activity to phosphorylate caspase 2 and suppress cell death pathways. Here we show that the addition of G6P to oocyte extracts inhibits the dephosphorylation/inactivation of CaMKII bound to caspase 2 by protein phosphatase 1. Thus, G6P sustains the phosphorylation of caspase 2 by CaMKII at Ser-135, preventing the induction of caspase 2-mediated apoptotic pathways. These findings expand our understanding of oocyte biology and clarify mechanisms underlying the metabolic regulation of CaMKII and apoptosis. Furthermore, these findings suggest novel approaches to disrupt the suppressive effects of the abnormal metabolism on cell death pathways.	[McCoy, Francis; Darbandi, Rashid; Chen, Si-Ing; Eckard, Laura; Dodd, Keela; Jones, Kelly; Nutt, Leta K.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Baucum, Anthony J., II; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Baucum, Anthony J., II; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA; [Gibbons, Jennifer A.] Qiagen Inc, Frederick, MD 21703 USA; [Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	St Jude Children's Research Hospital; Vanderbilt University; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center	Nutt, LK (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, MS 340,262 Danny Thomas Pl, Memphis, TN 38105 USA.	leta.nutt@stjude.org	Colbran, Roger/AAU-7708-2021; Baucum, Anthony/I-5109-2013	Colbran, Roger/0000-0001-7401-8244; Baucum, Anthony/0000-0002-4756-9865; Darbandi, Rashid/0000-0002-1239-6191	National Cancer Institute, National Institutes of Health [P30CA021765]; V Foundation and by the American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation and by the American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Cancer Institute, National Institutes of Health Award Number P30CA021765. This work was also supported by the V Foundation and by the American Lebanese Syrian Associated Charities (ALSAC).	Baucum AJ, 2013, J NEUROCHEM, V124, P490, DOI 10.1111/jnc.12101; Baucum AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031554; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; Carmody LC, 2008, FASEB J, V22, P1660, DOI 10.1096/fj.07-092841; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Colbran RJ, 2004, J NEUROSCI, V24, P8404, DOI 10.1523/JNEUROSCI.3602-04.2004; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; DWORKIN MB, 1989, DEV BIOL, V132, P512, DOI 10.1016/0012-1606(89)90246-7; Evans EK, 1998, ADV ENZYME REGUL, V38, P265, DOI 10.1016/S0065-2571(97)00020-4; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; ICHINOSE M, 1990, BRAIN RES, V533, P137, DOI 10.1016/0006-8993(90)91806-R; Jalan-Sakrikar N, 2012, J BIOL CHEM, V287, P15275, DOI 10.1074/jbc.M112.351817; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; MOORHEAD G, 1994, FEBS LETT, V356, P46, DOI 10.1016/0014-5793(94)01232-6; Newgard CB, 2010, NAT MED, V16, P388, DOI 10.1038/nm0410-388; Nutt LK, 2012, SEMIN CELL DEV BIOL, V23, P412, DOI 10.1016/j.semcdb.2012.03.015; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Rokhlin OW, 2007, CANCER BIOL THER, V6, P732, DOI 10.4161/cbt.6.5.3975; Rokhlin OW, 2010, CANCER BIOL THER, V9, P223, DOI 10.4161/cbt.9.3.10747; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Strack S, 1997, J NEUROCHEM, V68, P2119; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weiser D. C., 2003, CURR PROTOC PROTEIN	33	9	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8838	8848		10.1074/jbc.M112.437186	http://dx.doi.org/10.1074/jbc.M112.437186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23400775	hybrid, Green Published			2022-12-25	WOS:000316862200006
J	Guida, VG; Valentine, PC; Gallea, LB				Guida, Vincent G.; Valentine, Page C.; Gallea, Leslie B.			Semidiurnal Temperature Changes Caused by Tidal Front Movements in the Warm Season in Seabed Habitats on the Georges Bank Northern Margin and Their Ecological Implications	PLOS ONE			English	Article							PROGNOSTIC NUMERICAL-MODEL; HORIZONTAL TRANSPORT; CYCLIC TEMPERATURE; CONTINENTAL-SHELF; SEDIMENT; STRATIFICATION; POPULATIONS; PHYSIOLOGY; COMMUNITY; ECOSYSTEM	Georges Bank is a large, shallow feature separating the Gulf of Maine from the Atlantic Ocean. Previous studies demonstrated a strong tidal-mixing front during the warm season on the northern bank margin between thermally stratified water in the Gulf of Maine and mixed water on the bank. Tides transport warm water off the bank during flood tide and cool gulf water onto the bank during ebb tide. During 10 days in August 2009, we mapped frontal temperatures in five study areas along similar to 100 km of the bank margin. The seabed "frontal zone", where temperature changed with frontal movment, experienced semidiurnal temperature maxima and minima. The tidal excursion of the frontal boundary between stratified and mixed water ranged 6 to 10 km. This "frontal boundary zone" was narrower than the frontal zone. Along transects perpendicular to the bank margin, seabed temperature change at individual sites ranged from 7.0 degrees C in the frontal zone to 0.0 degrees C in mixed bank water. At time series in frontal zone stations, changes during tidal cycles ranged from 1.2 to 6.1 degrees C. The greatest rate of change (-2.48 degrees C hr(-1)) occurred at mid-ebb. Geographic plots of seabed temperature change allowed the mapping of up to 8 subareas in each study area. The magnitude of temperature change in a subarea depended on its location in the frontal zone. Frontal movement had the greatest effect on seabed temperature in the 40 to 80 m depth interval. Subareas experiencing maximum temperature change in the frontal zone were not in the frontal boundary zone, but rather several km gulfward (off-bank) of the frontal boundary zone. These results provide a new ecological framework for examining the effect of tidally-driven temperature variability on the distribution, food resources, and reproductive success of benthic invertebrate and demersal fish species living in tidal front habitats.	[Guida, Vincent G.] NOAA, NE Fisheries Sci Ctr, JJ Howard Lab, Natl Marine Fisheries Serv, Highlands, NJ 07732 USA; [Valentine, Page C.; Gallea, Leslie B.] US Geol Survey, Woods Hole Coastal & Marine Sci Ctr, Woods Hole, MA 02543 USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; United States Geological Survey	Guida, VG (corresponding author), NOAA, NE Fisheries Sci Ctr, JJ Howard Lab, Natl Marine Fisheries Serv, Highlands, NJ 07732 USA.	Vincent.Guida@noaa.gov			Northeast Fisheries Science Center (NEFSC); United States Geological Survey Woods Hole Coastal and Marine Science Center (USGS WH CMSC); NEFSC	Northeast Fisheries Science Center (NEFSC); United States Geological Survey Woods Hole Coastal and Marine Science Center (USGS WH CMSC); NEFSC	This study was supported by salary funds from the regular annual salary budget from Northeast Fisheries Science Center (NEFSC) and United States Geological Survey Woods Hole Coastal and Marine Science Center (USGS WH C&MSC), respectively; ship time funds from the NEFSC annual budget for days-at-sea ship operations; equipment from the NEFSC and USGS WH C&MSC annual equipment budgets. The funding offices (NEFSC and USGS WH C& MSC) played the following roles in this study: approval of research plans and allocation of assets, e.g. ship time and personnel travel and overtime payments, and review and approval of manuscript release for publication. This is standard agency practice in both cases.	Asch RG, 2008, FISH B-NOAA, V106, P438; Blackwood D, 2000, SEABED CONSERVATION; BRICKMAN D, 1993, J PHYS OCEANOGR, V23, P409, DOI 10.1175/1520-0485(1993)023<0409:EOTITO>2.0.CO;2; Brink KH, 2009, PROG OCEANOGR, V82, P191, DOI 10.1016/j.pocean.2009.07.004; BUTMAN B, 1987, GEORGES BANK, P125; Callaway R, 2002, ICES J MAR SCI, V59, P1199, DOI 10.1006/jmsc.2002.1288; Chen CS, 1998, J MAR RES, V56, P1163, DOI 10.1357/002224098765093607; Chen CS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000390; Chen CS, 2001, DEEP-SEA RES PT II, V48, P419, DOI 10.1016/S0967-0645(00)00124-7; CHRISTIANSEN ME, 1975, MAR BIOL, V32, P215, DOI 10.1007/BF00399201; CLAIREAUX G, 1995, J EXP BIOL, V198, P49; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; CREUTZBERG F, 1986, NETH J SEA RES, V20, P305, DOI 10.1016/0077-7579(86)90052-9; Dale AC, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001327; Dewicke A, 2002, J SEA RES, V47, P121, DOI 10.1016/S1385-1101(02)00106-5; FEARNHEAD PG, 1975, DEEP-SEA RES, V22, P311, DOI 10.1016/0011-7471(75)90072-8; Flagg C.N., 1987, GEORGES BANK, P108; Franks PJS, 2001, DEEP-SEA RES PT II, V48, P457, DOI 10.1016/S0967-0645(00)00125-9; Hannah CG, 1997, CONT SHELF RES, V17, P1887, DOI 10.1016/S0278-4343(97)00048-4; Harris BP, 2010, CONT SHELF RES, V30, P1840, DOI 10.1016/j.csr.2010.08.011; Hermsen JM, 2003, MAR ECOL PROG SER, V260, P97, DOI 10.3354/meps260097; Horne E.P.W., 1989, Scientia Marina, V153, P145; Horne EPW, 1996, DEEP-SEA RES PT II, V43, P1683, DOI 10.1016/S0967-0645(96)00037-9; Hu S, 2008, J MARINE SYST, V74, P528, DOI 10.1016/j.jmarsys.2008.04.007; International Hydrographic Organization, 1994, SPEC PUBL INT HYDR B, V1; Ji RB, 2008, J MARINE SYST, V73, P31, DOI 10.1016/j.jmarsys.2007.08.002; JOHNS DM, 1981, MAR BIOL, V63, P301, DOI 10.1007/BF00396000; Kostylev V., 2007, SPEC PAP GEOL ASS CA, V47, P171; Kostylev VE, 2005, AM FISH S S, V41, P141; LODER JW, 1985, J MAR RES, V43, P581, DOI 10.1357/002224085788440367; LODER JW, 1992, J GEOPHYS RES-OCEANS, V97, P14331, DOI 10.1029/92JC01342; Lough RG, 2010, FISH OCEANOGR, V19, P159, DOI 10.1111/j.1365-2419.2010.00535.x; LOUGH RG, 1989, J MAR RES, V47, P343, DOI 10.1357/002224089785076334; Lough RG, 2001, DEEP-SEA RES PT II, V48, P631; Manuel JL, 1997, J PLANKTON RES, V19, P1949, DOI 10.1093/plankt/19.12.1949; MCLEESE DW, 1958, J FISH RES BOARD CAN, V15, P1345, DOI 10.1139/f58-073; National Oceanic and Atmospheric Administration, 2009, TID CURR G SHOAL; National Oceanic and Atmospheric Administration, 2009, TID CURR CURR STAT L; OREILLY JE, 1987, GEORGES BANK, P220; Packer D.B., 1999, SUMMER FLOUNDER PARA; PINGREE RD, 1978, J GEOPHYS RES-OCEANS, V83, P4615, DOI 10.1029/JC083iC09p04615; Pringle JM, 2001, LIMNOL OCEANOGR, V46, P381, DOI 10.4319/lo.2001.46.2.0381; SIMPSON JH, 1974, NATURE, V250, P404, DOI 10.1038/250404a0; SIMPSON JH, 1981, DEEP-SEA RES, V28, P727, DOI 10.1016/0198-0149(81)90132-1; SIMPSON JH, 1978, J GEOPHYS RES-OC ATM, V83, P4607, DOI 10.1029/JC083iC09p04607; SIMPSON JH, 1971, DEEP-SEA RES, V18, P309, DOI 10.1016/0011-7471(71)90036-2; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Steele JH, 2007, PROG OCEANOGR, V74, P423, DOI 10.1016/j.pocean.2007.05.003; THORP JH, 1981, ARCH ENVIRON CON TOX, V10, P69, DOI 10.1007/BF01057576; THORP JH, 1975, J EXP MAR BIOL ECOL, V18, P19, DOI 10.1016/0022-0981(75)90013-1; Tian RC, 2009, MAR ECOL PROG SER, V380, P147, DOI 10.3354/meps07916; Trimmer M, 2003, ESTUAR COAST SHELF S, V56, P1011, DOI 10.1016/S0272-7714(02)00312-8; Ullman DS, 1999, J GEOPHYS RES-OCEANS, V104, P23459, DOI 10.1029/1999JC900133; Ullman DS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001328; Ullman DS, 2001, CONT SHELF RES, V21, P1139, DOI 10.1016/S0278-4343(00)00107-2; WOLCOTT TG, 1973, BIOL BULL, V145, P389, DOI 10.2307/1540048; Yoshida J, 1996, DEEP-SEA RES PT II, V43, P1713, DOI 10.1016/S0967-0645(96)00056-2	57	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55273	10.1371/journal.pone.0055273	http://dx.doi.org/10.1371/journal.pone.0055273			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405129	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400074
J	Guillemet, E; Tran, SL; Cadot, C; Rognan, D; Lereclus, D; Ramarao, N				Guillemet, Elisabeth; Tran, Seav-Ly; Cadot, Celine; Rognan, Didier; Lereclus, Didier; Ramarao, Nalini			Glucose 6P Binds and Activates HlyIIR to Repress Bacillus cereus Haemolysin hlyII Gene Expression	PLOS ONE			English	Article							ENVIRONMENTAL-CONDITIONS; REGULATES EXPRESSION; IRON-METABOLISM; TOXIN GENE; II GENE; THURINGIENSIS; VIRULENCE; PROTEIN; BACTERIA; PORE	Bacillus cereus is a Gram-positive spore-forming bacterium causing food poisoning and serious opportunistic infections. These infections are characterized by bacterial accumulation despite the recruitment of phagocytic cells. We have previously shown that B. cereus Haemolysin II (HlyII) induces macrophage cell death by apoptosis. In this work, we investigated the regulation of the hlyII gene. We show that HlyIIR, the negative regulator of hlyII expression in B. cereus, is especially active during the early bacterial growth phase. We demonstrate that glucose 6P directly binds to HlyIIR and enhances its activity at a post-transcriptional level. Glucose 6P activates HlyIIR, increasing its capacity to bind to its DNA-box located upstream of the hlyII gene, inhibiting its expression. Thus, hlyII expression is modulated by the availability of glucose. As HlyII induces haemocyte and macrophage death, two cell types that play a role in the sequestration of nutrients upon infection, HlyII may induce host cell death to allow the bacteria to gain access to carbon sources that are essential components for bacterial growth.	[Guillemet, Elisabeth; Tran, Seav-Ly; Cadot, Celine; Lereclus, Didier; Ramarao, Nalini] INRA, Unite MICALIS UMR 1319, La Miniere, Guyancourt, France; [Rognan, Didier] CNRS, UMR 7200, Lab Therapeut Innovat, Illkirch Graffenstaden, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Ramarao, N (corresponding author), INRA, Unite MICALIS UMR 1319, La Miniere, Guyancourt, France.	nalini.ramarao@jouy.inra.fr	Rama Rao, Nalini/GRR-7800-2022; Lereclus, Didier/AAD-8293-2019; Rognan, Didier/B-9939-2014	Lereclus, Didier/0000-0001-9047-9104; Tran, Seav-ly/0000-0001-7014-6601				AGAISSE H, 1994, J BACTERIOL, V176, P4734, DOI 10.1128/JB.176.15.4734-4741.1994; Andreeva ZI, 2007, BBA-BIOMEMBRANES, V1768, P253, DOI 10.1016/j.bbamem.2006.11.004; Andreeva ZI, 2006, PROTEIN EXPRES PURIF, V47, P186, DOI 10.1016/j.pep.2005.10.030; Andreeva-Kovalevskaya ZI, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1473, DOI 10.1134/S0006297908130087; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arnaout MK, 1999, J PEDIAT HEMATOL ONC, V21, P431, DOI 10.1097/00043426-199909000-00018; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Auger S, 2009, APPL ENVIRON MICROB, V75, P6616, DOI 10.1128/AEM.00155-09; Baida G, 1999, FEMS MICROBIOL LETT, V180, P7, DOI 10.1016/S0378-1097(99)00455-3; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Bouillaut L, 2005, APPL ENVIRON MICROB, V71, P8903, DOI 10.1128/AEM.71.12.8903-8910.2005; Brillard J, 2010, APPL ENVIRON MICROB, V76, P2562, DOI 10.1128/AEM.02348-09; Brillard J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-183; Budarina ZI, 2004, MICROBIOL-SGM, V150, P3691, DOI 10.1099/mic.0.27142-0; Cadot C, 2010, J CLIN MICROBIOL, V48, P1358, DOI 10.1128/JCM.02123-09; Callegan MC, 2005, INVEST OPHTH VIS SCI, V46, P3233, DOI 10.1167/iovs.05-0410; Chiang C, 2011, J BACTERIOL, V193, P52, DOI 10.1128/JB.01656-09; Clair G, 2010, MOL CELL PROTEOMICS, V9, P1486, DOI 10.1074/mcp.M000027-MCP201; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Eckert DT, 2008, BIOCHEM BIOPH RES CO, V372, P131, DOI 10.1016/j.bbrc.2008.05.002; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Halbedel S, 2007, J MOL MICROB BIOTECH, V12, P147, DOI 10.1159/000096470; Harvie DR, 2005, MICROBIOL-SGM, V151, P569, DOI 10.1099/mic.0.27744-0; Hernandez E, 1998, J CLIN MICROBIOL, V36, P2138, DOI 10.1128/JCM.36.7.2138-2139.1998; Hilliard NJ, 2003, J CLIN MICROBIOL, V41, P3441, DOI 10.1128/JCM.41.7.3441-3444.2003; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Kovalevskiy OV, 2007, J MOL BIOL, V365, P825, DOI 10.1016/j.jmb.2006.10.074; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; LERECLUS D, 1992, BIO-TECHNOL, V10, P418, DOI 10.1038/nbt0492-418; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Maniatis T., 1982, MOL CLONING LAB MANU; Meugnier E, 2007, CURR OPIN CLIN NUTR, V10, P518, DOI 10.1097/MCO.0b013e3281298fef; Miles G, 2002, PROTEIN SCI, V11, P1813, DOI 10.1110/ps.0204002; Porcheron G, 2011, MOL MICROBIOL, V81, P717, DOI 10.1111/j.1365-2958.2011.07725.x; Ramarao N, 2005, CELL MICROBIOL, V7, P1357, DOI 10.1111/j.1462-5822.2005.00562.x; Ramarao N, 2006, MICROBES INFECT, V8, P1483, DOI 10.1016/j.micinf.2006.01.005; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rodikova EA, 2007, FEBS LETT, V581, P1190, DOI 10.1016/j.febslet.2007.02.035; Sanchis V, 1996, J BIOTECHNOL, V48, P81, DOI 10.1016/0168-1656(96)01404-6; Sineva E, 2012, J BACTERIOL, V194, P3327, DOI 10.1128/JB.00199-12; Sineva EV, 2009, FEMS MICROBIOL LETT, V299, P110, DOI 10.1111/j.1574-6968.2009.01742.x; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Tran SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022876; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; Tran SL, 2010, J BACTERIOL, V192, P2638, DOI 10.1128/JB.01315-09; van der Voort M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-62; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; 2009, EFSA J, V271	57	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55085	10.1371/journal.pone.0055085	http://dx.doi.org/10.1371/journal.pone.0055085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405113	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400057
J	He, P; Cheng, X; Staufenbiel, M; Li, R; Shen, Y				He, Ping; Cheng, Xin; Staufenbiel, Matthias; Li, Rena; Shen, Yong			Long-Term Treatment of Thalidomide Ameliorates Amyloid-Like Pathology through Inhibition of beta-Secretase in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TRANSGENIC TG2576 MICE; FACTOR-ALPHA; PRECURSOR PROTEIN; TNF-ALPHA; INFLAMMATORY RESPONSES; NEURONAL DEATH; MESSENGER-RNA; ANIMAL-MODEL; EXPRESSION	Thalidomide is a tumor necrosis factor alpha (TNF alpha) inhibitor which has been found to have abilities against tumor growth, angiogenesis and inflammation. Recently, it has been applied in clinic for the treatment of multiple myeloma as well as some inflammatory diseases. However, whether thalidomide has any therapeutic effects on neurodegenerative disorders, i.e. Alzheimer's disease (AD) is not clear. AD is characterized by excessive amount of amyloid beta peptides (A beta), which results in a significant release of inflammatory factors, including TNF alpha in the brain. Studies have shown that inhibition of TNF alpha reduces amyloid-associated pathology, prevents neuron loss and improves cognition. Our recent report showed that genetic inhibition of TNF alpha/TNF receptor signal transduction down-regulates beta amyloid cleavage enzyme 1 (BACE1) activity, reduces A beta generation and improves learning and memory deficits. However, the mechanism of thalidomide involving in the mitigation of AD neuropathological features remains unclear. Here, we chronically administrated thalidomide on human APPswedish mutation transgenic (APP23) mice from 9 months old (an onset of A beta deposits and early stage of AD-like changes) to 12 months old. We found that, in addition of dramatic decrease in the activation of both astrocytes and microglia, thalidomide significantly reduces Ab load and plaque formation. Furthermore, we found a significant decrease in BACE1 level and activity with long-term thalidomide application. Interestingly, these findings cannot be observed in the brains of 12-month-old APP23 mice with short-term treatment of thalidomide (3 days). These results suggest that chronic thalidomide administration is an alternative approach for AD prevention and therapeutics.	[He, Ping; Shen, Yong] Roskamp Inst, Ctr Adv Therapeut Strategies Brain Disorders, Sarasota, FL 34243 USA; [Cheng, Xin; Shen, Yong] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Cheng, Xin; Shen, Yong] Fudan Univ, Inst Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Staufenbiel, Matthias] Novartis Pharm Ltd, Nervous Syst Res, Basel, Switzerland; [Li, Rena] Roskamp Inst, Ctr Hormone Adv Sci & Educ, Sarasota, FL USA	Fudan University; Fudan University; Novartis	Shen, Y (corresponding author), Roskamp Inst, Ctr Adv Therapeut Strategies Brain Disorders, Sarasota, FL 34243 USA.	yshen@rfdn.org	Cheng, Xin/AAF-4744-2019	Cheng, Xin/0000-0001-7816-0547	National Institutes of Health [NIA025888, NIAR01AG032441]; Alzheimer Association [IIRG-09-61521, IIRG-07-59510]; AHAF [G2006-118, A2008-642]; NSFC [81100861]; NATIONAL INSTITUTE ON AGING [R01AG025888, R01AG034155, R01AG032441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); AHAF; NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by grants from National Institutes of Health: NIA025888 (YS) and NIAR01AG032441 (RL), Alzheimer Association: IIRG-09-61521 (YS) and IIRG-07-59510 (RL); AHAF: G2006-118 (RL) and A2008-642 (PH); and NSFC 81100861 (XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alkam T, 2008, BEHAV BRAIN RES, V189, P100, DOI 10.1016/j.bbr.2007.12.014; Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; Aragon-Ching JB, 2007, RECENT PAT ANTI-CANC, V2, P167, DOI 10.2174/157489207780832478; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Boddapati S, 2011, J MOL BIOL, V405, P436, DOI 10.1016/j.jmb.2010.10.054; Cai J, 2012, EMBO MOL MED, V4, P980, DOI 10.1002/emmm.201101084; Cheng X, 2010, J ALZHEIMERS DIS, V19, P621, DOI 10.3233/JAD-2010-1253; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Daruwalla J, 2005, J SURG ONCOL, V91, P134, DOI 10.1002/jso.20289; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Frid P, 2007, BRAIN RES REV, V53, P135, DOI 10.1016/j.brainresrev.2006.08.001; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hong HS, 2003, BIOCHEM BIOPH RES CO, V307, P922, DOI 10.1016/S0006-291X(03)01270-1; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Janelsins MC, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-23; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Kaicker S, 2003, INT J ONCOL, V23, P1651; Kenyon BM, 1997, EXP EYE RES, V64, P971, DOI 10.1006/exer.1997.0292; Kiaei M, 2006, J NEUROSCI, V26, P2467, DOI 10.1523/JNEUROSCI.5253-05.2006; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Matsuoka Y, 2001, AM J PATHOL, V158, P1345, DOI 10.1016/S0002-9440(10)64085-0; Mazzoccoli L, 2012, BIOMED PHARMACOTHER, V66, P323, DOI 10.1016/j.biopha.2012.05.001; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; McCusker SM, 2001, LANCET, V357, P436, DOI 10.1016/S0140-6736(00)04008-3; Mehlhorn G, 2000, INT J DEV NEUROSCI, V18, P423, DOI 10.1016/S0736-5748(00)00012-5; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Munch G, 2003, J NEUROCHEM, V86, P283, DOI 10.1046/j.1471-4159.2003.01837.x; Nair RR, 2012, ADV PHARMACOL, V65, P143, DOI 10.1016/B978-0-12-397927-8.00006-3; Paganelli R, 2002, EXP GERONTOL, V37, P257, DOI 10.1016/S0531-5565(01)00191-7; Pak T, 2005, MED SCI MONITOR, V11, pBR357; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Patel NS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-9; Ryu JK, 2008, NEUROBIOL DIS, V29, P254, DOI 10.1016/j.nbd.2007.08.019; Sabbagh MN, 2010, ALZHEIMERS DEMENTIA, V6; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shen Y, 2006, TRENDS MOL MED, V12, P574, DOI 10.1016/j.molmed.2006.10.002; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sly LM, 2001, BRAIN RES BULL, V56, P581, DOI 10.1016/S0361-9230(01)00730-4; Sommer B, 1998, MOL PSYCHIATR, V3, P284, DOI 10.1038/sj.mp.4000397; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Van Dooren T, 2006, AM J PATHOL, V168, P245, DOI 10.2353/ajpath.2006.050752; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walker SL, 2007, LEPROSY REV, V78, P197; Weber D, 2003, J CLIN ONCOL, V21, P16, DOI 10.1200/JCO.2003.03.139; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Yan Q, 2003, J NEUROSCI, V23, P7504; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yang LB, 2002, J NEUROSCI, V22, P3025, DOI 10.1523/JNEUROSCI.22-08-03025.2002; Zhang C, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-15	74	58	62	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55091	10.1371/journal.pone.0055091	http://dx.doi.org/10.1371/journal.pone.0055091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405115	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400059
J	Hummler, E; Dousse, A; Rieder, A; Stehle, JC; Rubera, I; Osterheld, MC; Beermann, F; Frateschi, S; Charles, RP				Hummler, Edith; Dousse, Aline; Rieder, Audrey; Stehle, Jean-Christophe; Rubera, Isabelle; Osterheld, Maria-Chiara; Beermann, Friedrich; Frateschi, Simona; Charles, Roch-Philippe			The Channel-Activating Protease CAP1/Prss8 Is Required for Placental Labyrinth Maturation	PLOS ONE			English	Article							PROSTASIN SERINE-PROTEASE; SODIUM-CHANNEL; MESSENGER-RNA; EXPRESSION; MATRIPTASE; GROWTH; CANCER; INHIBITION; CLEARANCE; CARCINOMA	The serine protease CAP1/Prss8 is crucial for skin barrier function, lung alveolar fluid clearance and has been unveiled as diagnostic marker for specific cancer types. Here, we show that a constitutive knockout of CAP1/Prss8 leads to embryonic lethality. These embryos presented no specific defects, but it is during this period, and in particular at E13.5, that wildtype placentas show an increased expression of CAP1/Prss8, thus suggesting a placental defect in the knockout situation. The placentas of knockout embryos exhibited significantly reduced vascular development and incomplete cellular maturation. In contrary, epiblast-specific deletion of CAP1/Prss8 allowed development until birth. These CAP1/Prss8-deficient newborns presented abnormal epidermis, and died soon after birth due to impaired skin function. We thus conclude that a late placental insufficiency might be the primary cause of embryonic lethality in CAP1/Prss8 knockouts. This study highlights a novel and crucial role for CAP1/Prss8 in placental development and function.	[Hummler, Edith; Dousse, Aline; Rieder, Audrey; Rubera, Isabelle; Frateschi, Simona; Charles, Roch-Philippe] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Stehle, Jean-Christophe; Osterheld, Maria-Chiara] Univ Lausanne, Univ Inst Pathol, Lausanne, Switzerland; [Beermann, Friedrich] Ecole Polytech Fed Lausanne, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland	University of Lausanne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Hummler, E (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	Edith.Hummler@unil.ch		Charles, Roch-Philippe/0000-0002-5243-3866; RUBERA, Isabelle/0000-0002-4267-6207	Swiss National Science Foundation [3100A0-102125/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (grant 3100A0-102125/1 to EH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen LM, 2001, PROSTATE, V48, P93, DOI 10.1002/pros.1085; Chen LM, 2004, PROSTATE, V59, P1, DOI 10.1002/pros.10346; Chen LM, 2002, INT J CANCER, V97, P323, DOI 10.1002/ijc.1601; Chen M, 2008, BBA-MOL CELL RES, V1783, P896, DOI 10.1016/j.bbamcr.2007.10.019; Chen MQ, 2010, MOL CELL BIOCHEM, V337, P259, DOI 10.1007/s11010-009-0307-y; Cross JC, 2002, RECENT PROG HORM RES, V57, P221, DOI 10.1210/rp.57.1.221; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Forbs D, 2005, INT J ONCOL, V27, P1061; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Frateschi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1162; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Hayashi Shigemi, 2002, Gene Expression Patterns, V2, P93, DOI 10.1016/S0925-4773(02)00292-7; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin HY, 2006, J HISTOCHEM CYTOCHEM, V54, P1139, DOI 10.1369/jhc.6A7005.2006; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Ma XJ, 2009, HISTOCHEM CELL BIOL, V132, P639, DOI 10.1007/s00418-009-0652-7; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; Rubera I, 2002, GENESIS, V32, P173, DOI 10.1002/gene.10040; Sakashita K, 2008, J SURG ONCOL, V98, P559, DOI 10.1002/jso.21158; Santin AD, 2003, CANCER, V98, P1898, DOI 10.1002/cncr.11753; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483	40	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55796	10.1371/journal.pone.0055796	http://dx.doi.org/10.1371/journal.pone.0055796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405214	Green Published, gold			2022-12-25	WOS:000315153400159
J	Keita, AK; Socolovschi, C; Ahuka-Mundeke, S; Ratmanov, P; Butel, C; Ayouba, A; Inogwabini, BI; Muyembe-Tamfum, JJ; Mpoudi-Ngole, E; Delaporte, E; Peeters, M; Fenollar, F; Raoult, D				Keita, Alpha Kabinet; Socolovschi, Cristina; Ahuka-Mundeke, Steve; Ratmanov, Pavel; Butel, Christelle; Ayouba, Ahidjo; Inogwabini, Bila-Isia; Muyembe-Tamfum, Jean-Jacques; Mpoudi-Ngole, Eitel; Delaporte, Eric; Peeters, Martine; Fenollar, Florence; Raoult, Didier			Molecular Evidence for the Presence of Rickettsia Felis in the Feces of Wild-living African Apes	PLOS ONE			English	Article							PHYLOGENY; FLEAS; SEQUENCES	Background: Rickettsia felis is a common emerging pathogen detected in mosquitoes in sub-Saharan Africa. We hypothesized that, as with malaria, great apes may be exposed to the infectious bite of infected mosquitoes and release R. felis DNA in their feces. Methods: We conducted a study of 17 forest sites in Central Africa, testing 1,028 fecal samples from 313 chimpanzees, 430 gorillas and 285 bonobos. The presence of rickettsial DNA was investigated by specific quantitative real-time PCR. Positive results were confirmed by a second PCR using primers and a probe targeting a specific gene for R. felis. All positive samples were sequenced. Results: Overall, 113 samples (11%) were positive for the Rickettsia-specific gltA gene, including 25 (22%) that were positive for R. felis. The citrate synthase (gltA) sequence and outer membrane protein A (ompA) sequence analysis indicated 99% identity at the nucleotide level to R. felis. The 88 other samples (78%) were negative using R. felis-specific qPCR and were compatible with R. felis-like organisms. Conclusion: For the first time, we detected R. felis in wild-living ape feces. This non invasive detection of human pathogens in endangered species opens up new possibilities in the molecular epidemiology and evolutionary analysis of infectious diseases, beside HIV and malaria.	[Keita, Alpha Kabinet; Socolovschi, Cristina; Ratmanov, Pavel; Fenollar, Florence; Raoult, Didier] Aix Marseille Univ, CNRS 7278, IRD 198, URMITE,UM63,Inserm 1095, Marseille, France; [Keita, Alpha Kabinet; Ahuka-Mundeke, Steve; Butel, Christelle; Ayouba, Ahidjo; Delaporte, Eric; Peeters, Martine] IRD, TransVIHMI, UMI 233, Montpellier, France; [Keita, Alpha Kabinet; Ahuka-Mundeke, Steve; Butel, Christelle; Ayouba, Ahidjo; Delaporte, Eric; Peeters, Martine] Univ Montpellier I, Montpellier, France; [Inogwabini, Bila-Isia] WWF, Projet Lac Tumba, Mbandaka, DEM REP CONGO; [Muyembe-Tamfum, Jean-Jacques] Clin Univ Kinshasa, Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Muyembe-Tamfum, Jean-Jacques] Clin Univ Kinshasa, Microbiol Serv, Kinshasa, DEM REP CONGO; [Mpoudi-Ngole, Eitel] Projet PRESICA, Yaounde, Cameroon; [Mpoudi-Ngole, Eitel] Virol Lab IMPM IRD, Yaounde, Cameroon	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; World Wildlife Fund; Institute Nacional de Recherche Biomedical; Universite de Kinshasa; Universite de Kinshasa	Raoult, D (corresponding author), Aix Marseille Univ, CNRS 7278, IRD 198, URMITE,UM63,Inserm 1095, Marseille, France.	didier.raoult@gmail.com	Keita, Alpha/A-9454-2015; Ayouba, Ahidjo/G-8775-2017; KEITA, Alpha Kabinet/AAR-1586-2020; Ratmanov, Pavel/K-8952-2019; Ratmanov, Pavel E/A-9301-2016; Delaporte, Eric/J-5397-2018; RAOULT, Didier/A-8434-2008	Keita, Alpha/0000-0003-4377-341X; Ayouba, Ahidjo/0000-0002-5081-1632; KEITA, Alpha Kabinet/0000-0003-4377-341X; Ratmanov, Pavel/0000-0002-6292-8758; Ratmanov, Pavel E/0000-0002-6292-8758; Delaporte, Eric/0000-0002-1822-9853; RAOULT, Didier/0000-0002-0633-5974; Inogwabini, Bila-Isia/0000-0002-6897-2477	NIAID NIH HHS [R37 AI050529] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050529] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berrelha J, 2009, CLIN MICROBIOL INFEC, V15, P251, DOI 10.1111/j.1469-0691.2008.02273.x; Bitam I, 2006, AM J TROP MED HYG, V74, P532, DOI 10.4269/ajtmh.2006.74.532; Calvignac-Spencer S, 2012, CLIN MICROBIOL INFEC, V18, P521, DOI 10.1111/j.1469-0691.2012.03816.x; Duval L, 2012, CLIN MICROBIOL INFEC, V18, P528, DOI 10.1111/j.1469-0691.2012.03825.x; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Horta MC, 2006, APPL ENVIRON MICROB, V72, P1705, DOI 10.1128/AEM.72.2.1705-1707.2006; La Scola B, 2002, INT J SYST EVOL MICR, V52, P2035, DOI [10.1099/ijs.0.02070-0, 10.1099/00207713-52-6-2035]; Li YY, 2012, J VIROL, V86, P10776, DOI 10.1128/JVI.01498-12; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Mediannikov O, 2012, COMP IMMUNOL MICROB, V35, P145, DOI 10.1016/j.cimid.2011.12.011; Mediannikov O, 2012, EMERG INFECT DIS, V18, P1385, DOI 10.3201/eid1808.111243; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Neel C, 2010, J VIROL, V84, P1464, DOI 10.1128/JVI.02129-09; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; Peeters M, 2012, CLIN MICROBIOL INFEC, V18, P514, DOI 10.1111/j.1469-0691.2012.03843.x; Raoult D, 2012, CLIN MICROBIOL INFEC, V18, P513, DOI 10.1111/j.1469-0691.2012.03810.x; Richards AL, 2010, EMERG INFECT DIS, V16, P1081, DOI 10.3201/eid1607.091885; Rolain JM, 2005, EMERG INFECT DIS, V11, P1742, DOI 10.3201/eid1111.050861; Sackal C, 2008, EMERG INFECT DIS, V14, P1972, DOI 10.3201/eid1412.080610; SIBLEY CG, 1990, J MOL EVOL, V30, P202, DOI 10.1007/BF02099992; SIBLEY CG, 1984, J MOL EVOL, V20, P2, DOI 10.1007/BF02101980; Socolovschi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048254; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1687, DOI 10.3201/eid1810.120178; Socolovschi C, 2010, EMERG INFECT DIS, V16, P1140, DOI 10.3201/eid1607.100070; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thepparit C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016396; Van Heuverswyn Fran, 2007, Curr Infect Dis Rep, V9, P338, DOI 10.1007/s11908-007-0052-x; VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111	28	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54679	10.1371/journal.pone.0054679	http://dx.doi.org/10.1371/journal.pone.0054679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405087	Green Submitted, gold, Green Published			2022-12-25	WOS:000315153400031
J	Lin, T; Yu, YJ; Bai, XM; Feng, L; Wang, J				Lin, Tao; Yu, Yunjun; Bai, Xuemei; Feng, Ling; Wang, Jin			Greenhouse Gas Emissions Accounting of Urban Residential Consumption: A Household Survey Based Approach	PLOS ONE			English	Article							ENERGY USE; GHG EMISSIONS; CO2 EMISSION; LIFE-STYLES; CITY; OPPORTUNITIES; SCALE; CYCLE	Devising policies for a low carbon city requires a careful understanding of the characteristics of urban residential lifestyle and consumption. The production-based accounting approach based on top-down statistical data has a limited ability to reflect the total greenhouse gas (GHG) emissions from residential consumption. In this paper, we present a survey-based GHG emissions accounting methodology for urban residential consumption, and apply it in Xiamen City, a rapidly urbanizing coastal city in southeast China. Based on this, the main influencing factors determining residential GHG emissions at the household and community scale are identified, and the typical profiles of low, medium and high GHG emission households and communities are identified. Up to 70% of household GHG emissions are from regional and national activities that support household consumption including the supply of energy and building materials, while 17% are from urban level basic services and supplies such as sewage treatment and solid waste management, and only 13% are direct emissions from household consumption. Housing area and household size are the two main factors determining GHG emissions from residential consumption at the household scale, while average housing area and building height were the main factors at the community scale. Our results show a large disparity in GHG emissions profiles among different households, with high GHG emissions households emitting about five times more than low GHG emissions households. Emissions from high GHG emissions communities are about twice as high as from low GHG emissions communities. Our findings can contribute to better tailored and targeted policies aimed at reducing household GHG emissions, and developing low GHG emissions residential communities in China.	[Lin, Tao; Yu, Yunjun; Feng, Ling; Wang, Jin] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China; [Lin, Tao; Yu, Yunjun; Feng, Ling; Wang, Jin] Xiamen Key Lab Urban Metab, Xiamen, Peoples R China; [Bai, Xuemei] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Chinese Academy of Sciences; Institute of Urban Environment, CAS; Australian National University	Lin, T (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	tlin@iue.ac.cn	CAS, KLUEH/T-5743-2019; Bai, Xuemei/A-5443-2012; Lin, Tao/B-7256-2009; yu, yunjun/AAA-6254-2022	Bai, Xuemei/0000-0001-6556-8041; Lin, Tao/0000-0002-7479-2333; 	National Natural Science Foundation of China [41201598]; Fujian Provincial department of Science and Technology [2011R0093, 2010I0014]; China Postdoctoral Science Foundation [20110490614]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial department of Science and Technology; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Funding was provided by the National Natural Science Foundation of China (41201598), http://www.nsfc.gov.cn; Fujian Provincial department of Science and Technology (2011R0093,2010I0014), http://xmgl.fjkjt.gov.cn/; and China Postdoctoral Science Foundation (20110490614), http://www.chinapostdoctor.org.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X. M, 2012, ENERGIZING SUSTAINAB; Bai XM, 2007, J IND ECOL, V11, P15, DOI 10.1162/jie.2007.1202; Baynes T, 2011, ENERG POLICY, V39, P7298, DOI 10.1016/j.enpol.2011.08.053; Baynes TM, 2012, CURR OPIN ENV SUST, V4, P458, DOI 10.1016/j.cosust.2012.09.003; Bin S, 2005, ENERG POLICY, V33, P197, DOI 10.1016/S0301-4215(03)00210-6; Dhakal S, 2010, CURR OPIN ENV SUST, V2, P277, DOI 10.1016/j.cosust.2010.05.007; Dhakal S, 2009, ENERG POLICY, V37, P4208, DOI 10.1016/j.enpol.2009.05.020; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Druckman A, 2008, ENERG POLICY, V36, P3177, DOI 10.1016/j.enpol.2008.03.021; Druckman A, 2009, ECOL ECON, V68, P2066, DOI 10.1016/j.ecolecon.2009.01.013; Feng L, 2011, CHINA POPUL RESOURC, V21, P93; Feng ZH, 2011, ENERGY, V36, P656, DOI 10.1016/j.energy.2010.09.049; Gao L., 2010, J GEOINFORMATION SCI, V2, P364; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grubler A., 2012, GLOBAL ENERGY ASSESS; HM Government, 2006, UK CLIM CHANG PROGR; IPCC, 2006, 2006 IPCC GUIDELINES, V3, P1; Jones CM, 2011, ENVIRON SCI TECHNOL, V45, P4088, DOI 10.1021/es102221h; Kanemoto K, 2012, ENVIRON SCI TECHNOL, V46, P172, DOI 10.1021/es202239t; Kaye JP, 2006, TRENDS ECOL EVOL, V21, P192, DOI 10.1016/j.tree.2005.12.006; Kennedy C, 2010, ENERG POLICY, V38, P4828, DOI 10.1016/j.enpol.2009.08.050; Lenzen M, 2006, ENERGY, V31, P181, DOI 10.1016/j.energy.2005.01.009; Lenzen M, 2011, J IND ECOL, V15, P650, DOI 10.1111/j.1530-9290.2011.00397.x; Lin JY, 2010, ENERG POLICY, V38, P5123, DOI 10.1016/j.enpol.2010.04.042; [刘晶茹 Liu Jingru], 2003, [城市环境与城市生态, Urban Environment and Urban Ecology], V16, P34; Martinsson J, 2011, ENERG POLICY, V39, P5182, DOI 10.1016/j.enpol.2011.05.046; National Development And Reform Commission, 2009, CHIN GRID BAS EM FAC; Ngnikam E, 2002, WASTE MANAGE RES, V20, P501, DOI 10.1177/0734242X0202000604; Pataki DE, 2006, GLOBAL CHANGE BIOL, V12, P2092, DOI 10.1111/j.1365-2486.2006.01242.x; Ramaswami A, 2008, ENVIRON SCI TECHNOL, V42, P6455, DOI 10.1021/es702992q; Ramaswami A, 2011, ENVIRON SCI TECHNOL, V45, P4205, DOI 10.1021/es201166n; Ruhl C., 2008, BP STAT REV WORLD EN; SCHIPPER L, 1989, ANNU REV ENERGY, V14, P273, DOI 10.1146/annurev.eg.14.110189.001421; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Wang J, 2002, INT J REMOTE SENS, V23, P263, DOI 10.1080/01431160010025998; Wang Y, 2009, CHIN J POPUL RESOUR, V7, P11, DOI 10.1080/10042857.2009.10684933; Wei YM, 2007, ENERG POLICY, V35, P247, DOI 10.1016/j.enpol.2005.11.020; Weisz H, 2010, CURR OPIN ENV SUST, V2, P185, DOI 10.1016/j.cosust.2010.05.010; Xiamen Statistics Bureau, 2009, YB XIAM SPEC EC ZON; Yang YX., 2009, CHINA FOOD COMPOSITI; You F, 2011, ECOL COMPLEX, V8, P201, DOI 10.1016/j.ecocom.2011.02.003; Zhao JZ, 2011, ENVIRON SCI TECHNOL, V45, P8607, DOI 10.1021/es203138c; [智静 ZHI Jing], 2009, [地理科学进展, Progress in Geography], V28, P429	43	49	51	1	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55642	10.1371/journal.pone.0055642	http://dx.doi.org/10.1371/journal.pone.0055642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405187	gold, Green Published			2022-12-25	WOS:000315153400132
J	Nguyen, HD; Tomitaka, Y; Ho, SYW; Duchene, S; Vetten, HJ; Lesemann, D; Walsh, JA; Gibbs, AJ; Ohshima, K				Nguyen, Huy D.; Tomitaka, Yasuhiro; Ho, Simon Y. W.; Duchene, Sebastian; Vetten, Heinrich-Josef; Lesemann, Dietrich; Walsh, John A.; Gibbs, Adrian J.; Ohshima, Kazusato			Turnip Mosaic Potyvirus Probably First Spread to Eurasian Brassica Crops from Wild Orchids about 1000 Years Ago	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; MOLECULAR CHARACTERIZATION; DNA-SEQUENCES; VIRUS; RECOMBINATION; RNA; DETERMINANT; P3; IDENTIFICATION; PHYLOGENETICS	Turnip mosaic potyvirus (TuMV) is probably the most widespread and damaging virus that infects cultivated brassicas worldwide. Previous work has indicated that the virus originated in western Eurasia, with all of its closest relatives being viruses of monocotyledonous plants. Here we report that we have identified a sister lineage of TuMV-like potyviruses (TuMV-OM) from European orchids. The isolates of TuMV-OM form a monophyletic sister lineage to the brassica-infecting TuMVs (TuMV-BIs), and are nested within a clade of monocotyledon-infecting viruses. Extensive host-range tests showed that all of the TuMV-OMs are biologically similar to, but distinct from, TuMV-BIs and do not readily infect brassicas. We conclude that it is more likely that TuMV evolved from a TuMV-OM-like ancestor than the reverse. We did Bayesian coalescent analyses using a combination of novel and published sequence data from four TuMV genes [helper component-proteinase protein (HC-Pro), protein 3(P3), nuclear inclusion b protein (NIb), and coat protein (CP)]. Three genes (HC-Pro, P3, and NIb), but not the CP gene, gave results indicating that the TuMV-BI viruses diverged from TuMV-OMs around 1000 years ago. Only 150 years later, the four lineages of the present global population of TuMV-BIs diverged from one another. These dates are congruent with historical records of the spread of agriculture in Western Europe. From about 1200 years ago, there was a warming of the climate, and agriculture and the human population of the region greatly increased. Farming replaced woodlands, fostering viruses and aphid vectors that could invade the crops, which included several brassica cultivars and weeds. Later, starting 500 years ago, inter-continental maritime trade probably spread the TuMV-BIs to the remainder of the world.	[Nguyen, Huy D.; Tomitaka, Yasuhiro; Ohshima, Kazusato] Saga Univ, Fac Agr, Lab Plant Virol, Saga 840, Japan; [Nguyen, Huy D.; Tomitaka, Yasuhiro; Ohshima, Kazusato] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Ho, Simon Y. W.; Duchene, Sebastian] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Vetten, Heinrich-Josef; Lesemann, Dietrich] Fed Res Ctr Cultivated Plants JKI, Julius Kuehn Inst, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Germany; [Walsh, John A.] Univ Warwick, Wellesbourne, Warwick, England; [Gibbs, Adrian J.] Australian Natl Univ, Canberra, ACT, Australia	Saga University; Kagoshima University; University of Sydney; Julius Kuhn-Institut; University of Warwick; Australian National University	Ohshima, K (corresponding author), Saga Univ, Fac Agr, Lab Plant Virol, Saga 840, Japan.	ohshimak@cc.saga-u.ac.jp	Walsh, John/K-9791-2015; Ho, Simon YW/A-8417-2008	Ho, Simon YW/0000-0002-0361-2307; Duchene, Sebastian/0000-0002-2863-0907	Saga University; JSPS KAKENHI [18405022, 24405026]; BBSRC [BB/E00668X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E00668X/1] Funding Source: researchfish	Saga University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was in part funded by Saga University and supported by JSPS KAKENHI Grant Number 18405022 and 24405026 (http://www.saga-u.ac.jp/and http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 1994, MAKING EUROPE CONQUE; Bellwood Peter S, 2005, 1 FARMERS ORIGINS AG; Chen CC, 2003, PLANT DIS, V87, P901, DOI 10.1094/PDIS.2003.87.8.901; Chen J, 2003, J PHYTOPATHOL, V151, P26, DOI 10.1046/j.1439-0434.2003.00674.x; Chen J, 2002, ARCH VIROL, V147, P683, DOI 10.1007/s007050200018; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Crisp P., 1995, EVOLUTION CROP PLANT, P86; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Farzadfar S, 2009, EUR J PLANT PATHOL, V124, P45, DOI 10.1007/s10658-008-9390-2; Felsenstein J, 1993, PHYLIP PHYLOGENY INT; Fuji S, 1999, ARCH VIROL, V144, P231, DOI 10.1007/s007050050500; Fuji S, 2000, ARCH VIROL, V145, P635, DOI 10.1007/s007050050052; Gardner MW, 1921, J AGRIC RES, V22, P0123; Gibbs A., 2000, AUST ORCHID REV, V65, P10; Gibbs AJ, 2010, J GEN VIROL, V91, P13, DOI 10.1099/vir.0.015925-0; Gibbs A, 2008, ARCH VIROL, V153, P2177, DOI 10.1007/s00705-008-0256-x; Gibbs A, 2010, ANNU REV PHYTOPATHOL, V48, P205, DOI 10.1146/annurev-phyto-073009-114404; Gibbs AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002523; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harlan J.R., 1998, ORIGINS AGR CROP DOM, P1; Hemingway JS, 1995, EVOLUTION CROP PLANT, P82; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2011, SYST BIOL, V60, P366, DOI 10.1093/sysbio/syq099; Hodgkin T, 1995, EVOLUTION CROP PLANT, P76; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jenner CE, 2003, MOL PLANT MICROBE IN, V16, P777, DOI 10.1094/MPMI.2003.16.9.777; Jenner CE, 2002, VIROLOGY, V300, P50, DOI 10.1006/viro.2002.1519; Jenner CE, 2000, MOL PLANT MICROBE IN, V13, P1102, DOI 10.1094/MPMI.2000.13.10.1102; King AM, 2012, 9 REPORT INT COMMITT, P770; Korkmaz S, 2008, PLANT PATHOL, V57, P1155, DOI 10.1111/j.1365-3059.2008.01902.x; Kozubek E, 2007, J APPL GENET, V48, P295, DOI 10.1007/BF03195226; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lesemann D. E., 1985, ACTA HORTIC, V164, P45; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; MacNaughton IH, 1995, EVOLUTION CROP PLANT, P62; MacNaughton IH, 1995, EVOLUTION CROP PLANT, P68; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; NICOLAS O, 1992, J GEN VIROL, V73, P2785, DOI 10.1099/0022-1317-73-11-2785; Ohshima K, 2002, J GEN VIROL, V83, P1511, DOI 10.1099/0022-1317-83-6-1511; Ohshima K, 1996, ARCH VIROL, V141, P1991, DOI 10.1007/BF01718209; Ohshima K, 2007, J GEN VIROL, V88, P298, DOI 10.1099/vir.0.82335-0; Pagan I, 2010, J MOL EVOL, V71, P298, DOI 10.1007/s00239-010-9385-4; Pagan I, 2010, J VIROL, V84, P6177, DOI 10.1128/JVI.02160-09; Pallett DW, 2008, PLANT PATHOL, V57, P401, DOI 10.1111/j.1365-3059.2007.01764.x; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Sanjuan R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002685; Sawyer S, 1999, GENECONV COMPUTER PA; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Simmonds NW., 1976, EVOLUTION CROP PLANT; Simmons HE, 2008, J GEN VIROL, V89, P1081, DOI 10.1099/vir.0.83543-0; SMARRT J, 1995, EVOLUTION CROP PLANT; SMITH JM, 1992, J MOL EVOL, V34, P126; Suehiro N, 2004, J GEN VIROL, V85, P2087, DOI 10.1099/vir.0.79825-0; Tan ZY, 2005, J GEN VIROL, V86, P501, DOI 10.1099/vir.0.80540-0; Tomimura K, 2004, VIROLOGY, V330, P408, DOI 10.1016/j.virol.2004.09.040; Tomimura K, 2003, MOL ECOL, V12, P2099, DOI 10.1046/j.1365-294X.2003.01881.x; Vavilov, 1926, ORIGIN CULTIVATED PL; Wang HY, 2009, VIRUS GENES, V38, P421, DOI 10.1007/s11262-009-0335-4; Ward C. W., 1995, MOL BASIS VIRUS EVOL, P477; Weiller GF, 1998, MOL BIOL EVOL, V15, P326, DOI 10.1093/oxfordjournals.molbev.a025929	69	79	82	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55336	10.1371/journal.pone.0055336	http://dx.doi.org/10.1371/journal.pone.0055336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405136	Green Published, gold			2022-12-25	WOS:000315153400081
J	Twomey, E; Yeager, J; Brown, JL; Morales, V; Cummings, M; Summers, K				Twomey, Evan; Yeager, Justin; Brown, Jason Lee; Morales, Victor; Cummings, Molly; Summers, Kyle			Phenotypic and Genetic Divergence among Poison Frog Populations in a Mimetic Radiation	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; MULLERIAN MIMICRY; MIGRATION RATES; WARNING-COLOR; INFERENCE; SELECTION; SPECIATION; EVOLUTION; PATTERN; LOCI	The evolution of Mullerian mimicry is, paradoxically, associated with high levels of diversity in color and pattern. In a mimetic radiation, different populations of a species evolve to resemble different models, which can lead to speciation. Yet there are circumstances under which initial selection for divergence under mimicry may be reversed. Here we provide evidence for the evolution of extensive phenotypic divergence in a mimetic radiation in Ranitomeya imitator, the mimic poison frog, in Peru. Analyses of color hue (spectral reflectance) and pattern reveal substantial divergence between morphs. However, we also report that there is a "transition-zone'' with mixed phenotypes. Analyses of genetic structure using microsatellite variation reveals some differentiation between populations, but this does not strictly correspond to color pattern divergence. Analyses of gene flow between populations suggest that, while historical levels of gene flow were low, recent levels are high in some cases, including substantial gene flow between some color pattern morphs. We discuss possible explanations for these observations.	[Twomey, Evan; Yeager, Justin; Brown, Jason Lee; Summers, Kyle] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Yeager, Justin] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Brown, Jason Lee] Duke Univ, Dept Biol, Durham, NC USA; [Morales, Victor] Univ Ricardo Palma, Fac Ciencias Biol, Lima, Peru; [Cummings, Molly] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of North Carolina; East Carolina University; Tulane University; Duke University; Universidad Ricardo Palma; University of Texas System; University of Texas Austin	Summers, K (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	summersk@ecu.edu		Yeager, Justin/0000-0001-8692-6311	National Science Foundation; National Geographic Society	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society)	Work was supported by the National Science Foundation and the National Geographic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerli P, 1999, GENETICS, V152, P763; Brown JL, 2008, BEHAVIOUR, V145, P1139, DOI 10.1163/156853908785387647; Brown JL, 2011, ZOOTAXA, P1; Brown JL, 2009, CONSERV GENET RESOUR, V1, P149, DOI 10.1007/s12686-009-9036-5; Brown JL, 2010, AM NAT, V175, P436, DOI 10.1086/650727; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Chouteau M, 2011, AM NAT, V178, P810, DOI 10.1086/662667; Chouteau M, 2011, BIOL LETTERS, V7, P796, DOI 10.1098/rsbl.2011.0039; Cooley WW, 1971, MULTIVARIATE DATA AN; Cummings ME, 2008, ANIM BEHAV, V75, P175, DOI 10.1016/j.anbehav.2007.04.016; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Friendly M, 2007, J COMPUT GRAPH STAT, V16, P421, DOI 10.1198/106186007x208407; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Jiggins CD, 2008, BIOSCIENCE, V58, P541, DOI 10.1641/B580610; Kronforst MR, 2007, J EVOLUTION BIOL, V20, P278, DOI 10.1111/j.1420-9101.2006.01198.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Muller F., 1879, T ENTOMOL SOC LOND, V1879, P20, DOI DOI 10.1093/beheco/arw009; Naisbit RE, 2001, P ROY SOC B-BIOL SCI, V268, P1849, DOI 10.1098/rspb.2001.1753; Pritchard JK, 2000, GENETICS, V155, P945; Rasband W., 2006, IMAGEJ; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowland HM, 2010, BEHAV ECOL, V21, P851, DOI 10.1093/beheco/arq071; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SCHULTE R, 1999, PFEILGIFTFROSCHE, V2; Spande TF, 1999, J NAT PROD, V62, P5, DOI 10.1021/np980298v; Symula R, 2003, MOL PHYLOGENET EVOL, V26, P452, DOI 10.1016/S1055-7903(02)00367-6; Symula R, 2001, P ROY SOC B-BIOL SCI, V268, P2415, DOI 10.1098/rspb.2001.1812; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Wilson GA, 2003, GENETICS, V163, P1177; Yeager J., 2009, THESIS E CAROLINA U; Yeager J, 2012, CURR ZOOL, V58, P668, DOI 10.1093/czoolo/58.4.668	36	24	24	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55443	10.1371/journal.pone.0055443	http://dx.doi.org/10.1371/journal.pone.0055443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405150	Green Published, gold			2022-12-25	WOS:000315153400095
J	Ziske, J; Kunz, A; Sewangi, J; Lau, I; Dugange, F; Hauser, A; Kirschner, W; Harms, G; Theuring, S				Ziske, Judith; Kunz, Andrea; Sewangi, Julius; Lau, Inga; Dugange, Festo; Hauser, Andrea; Kirschner, Wolf; Harms, Gundel; Theuring, Stefanie			Hematological Changes in Women and Infants Exposed to an AZT-Containing Regimen for Prevention of Mother-to-Child-Transmission of HIV in Tanzania	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BREAST-FEEDING POPULATIONS; SINGLE-DOSE NEVIRAPINE; PERINATAL ZIDOVUDINE; FOLLOW-UP; EFFICACY; PROGRAM; SAFETY; HEMATOPOIESIS; INTERVENTIONS	Introduction: Tanzanian guidelines for prevention of mother-to-child-transmission of HIV (PMTCT) recommend an antiretroviral combination regimen involving zidovudine (AZT) during pregnancy, single-dosed nevirapine at labor onset, AZT plus Lamivudine (3TC) during delivery, and AZT/3TC for 1-4 weeks postpartum. As drug toxicities are a relevant concern, we assessed hematological alterations in AZT-exposed women and their infants. Methods and Materials: A cohort of HIV-positive women, either with AZT intake (n = 82, group 1) or without AZT intake (n = 62, group 2) for PMTCT during pregnancy, was established at Kyela District Hospital, Tanzania. The cohort also included the infants of group 1 with an in-utero AZT exposure >= 4 weeks, receiving AZT for 1 week postpartum (n = 41), and infants of group 2 without in-utero AZT exposure, receiving a prolonged 4-week AZT tail (n = 58). Complete blood counts were evaluated during pregnancy, birth, weeks 4-6 and 12. Results: For women of group 1 with antenatal AZT intake, we found a statistically significant decrease in hemoglobin level, red blood cells, white blood cells, granulocytes, as well as an increase in red cell distribution width and platelet count. At delivery, the median red blood cell count was significantly lower and the median platelet count was significantly higher in women of group 1 compared to group 2. At birth, infants from group 1 showed a lower median hemoglobin level and granulocyte count and a higher frequency of anemia and granulocytopenia. At 4-6 weeks postpartum, the mean neutrophil granulocyte count was significantly lower and neutropenia was significantly more frequent in infants of group 2. Conclusions: AZT exposure during pregnancy as well as after birth resulted in significant hematological alterations for women and their newborns, although these changes were mostly mild and transient in nature. Research involving larger cohorts is needed to further analyze the impact of AZT-containing regimens on maternal and infant health.	[Ziske, Judith; Kunz, Andrea; Lau, Inga; Hauser, Andrea; Harms, Gundel; Theuring, Stefanie] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Sewangi, Julius] Minist Hlth & Social Welf, Reg AIDS Control Program Mbeya Reg, Mbeya, Tanzania; [Dugange, Festo] Kyela Dist Hosp, Minist Hlth & Social Welf, Kyela, Tanzania; [Kirschner, Wolf] Forsch Beratung Evaluat, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Theuring, S (corresponding author), Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany.	stefanie.theuring@charite.de			German Ministry of Economic Cooperation through the GIZ Sector Project	German Ministry of Economic Cooperation through the GIZ Sector Project	The study was supported by the German Ministry of Economic Cooperation through the GIZ Sector Project "Strengthening the German Contribution to the Global AIDS Response". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahoua L, 2010, J TROP PEDIATRICS, V56, P43, DOI 10.1093/tropej/fmp054; Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; Alioum A, 2001, STAT MED, V20, P3539, DOI 10.1002/sim.1076; [Anonymous], 2011, PROGRESS REPORT 2011; Briand Nelly, 2007, PLoS Clin Trials, V2, pe11, DOI 10.1371/journal.pctr.0020011; Briand N, 2010, AIDS RES HUM RETROV, V26, P1163, DOI 10.1089/aid.2010.0034; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cordoba A, 2018, ALAMBIQUE REV ACAD M, V6, P1; Dabis F, 2005, AIDS, V19, P309; Dao H, 2007, AM J OBSTET GYNECOL, V197, pS42, DOI 10.1016/j.ajog.2007.03.001; Eshleman SH, 2005, JAIDS-J ACQ IMM DEF, V39, P593; Feiterna-Sperling C, 2007, JAIDS-J ACQ IMM DEF, V45, P43, DOI 10.1097/QAI.0b013e318042d5e3; Kirsten I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021020; Le Chenadec J, 2003, AIDS, V17, P2053, DOI 10.1097/00002030-200309260-00006; Leroy V, 2002, AIDS, V16, P631, DOI 10.1097/00002030-200203080-00016; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; McIntyre JA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000172; Mirkuzie AH, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-50; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; National Institute for Allergy and Infectious Disease (NIAID) Division of AIDS, 2009, TABL GRAD SEV AD PED; Pacheco SE, 2006, J INFECT DIS, V194, P1089, DOI 10.1086/507645; Shah MM, 1996, AIDS, V10, P1239, DOI 10.1097/00002030-199609000-00010; SILL PR, 1985, BRIT J OBSTET GYNAEC, V92, P480, DOI 10.1111/j.1471-0528.1985.tb01352.x; Sinha G, 2007, JAIDS-J ACQ IMM DEF, V45, P210, DOI 10.1097/QAI.0b013e3180556000; Sperling RS, 1998, AIDS, V12, P1805, DOI 10.1097/00002030-199814000-00012; Tanzania Commission for AIDS (TACAIDS) National Bureau of Statistics (NBS), 2008, TANZANIA HIV AIDS AN; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2008, UNITED REPUBLIC OF T; United Nations Development Programme, 2011, HUMAN DEVELOPMENT RE	28	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55633	10.1371/journal.pone.0055633	http://dx.doi.org/10.1371/journal.pone.0055633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405185	Green Published, gold			2022-12-25	WOS:000315153400130
J	Qian, XF; Cao, SY; Yang, GH; Pan, Y; Yin, CY; Chen, X; Zhu, Y; Zhuang, Y; Shen, YF; Hu, ZB				Qian, Xifeng; Cao, Songyu; Yang, Guohua; Pan, Yun; Yin, Chenyu; Chen, Xiang; Zhu, Ying; Zhuang, Yun; Shen, Yunfeng; Hu, Zhibin			Potentially Functional Polymorphism in IL-23 Receptor and Risk of Acute Myeloid Leukemia in a Chinese Population	PLOS ONE			English	Article							INTERLEUKIN-23 RECEPTOR; ANTITUMOR IMMUNITY; CANCER; GENE; CYTOKINE; IL23R	The interleukin-23 (IL-23) and its receptor (IL-23R) mediate the direct antitumor activities in human hematologic malignancies including pediatric acute leukemia. Two potentially functional genetic variants (IL-23R rs1884444 T > G and rs6682925 T > C) have been found to contribute to solid cancer susceptibility. In this study, we conducted a case-control study including 545 acute myeloid leukemia (AML) patients and 1,146 cancer-free controls in a Chinese population to assess the association between these two SNPs and the risk of AML. We found that IL-23R rs1884444 TG/GG and rs6682925 TC/CC variant genotypes were associated with significantly increased risk of AML [rs1884444: adjusted odds ratio (OR) = 1.28, 95% confidence interval (CI) = 1.01-1.62; rs6682925: adjusted OR = 1.30, 95% CI = 1.01-1.67], compared to their corresponding wild-type homozygotes, respectively. These findings indicated that genetic variants in IL-23R may contribute to AML risk in our Chinese population.	[Qian, Xifeng; Yang, Guohua; Zhuang, Yun; Shen, Yunfeng] Nanjing Med Univ, Dept Hematol, Wuxi Peoples Hosp, Wuxi, Peoples R China; [Cao, Songyu; Pan, Yun; Hu, Zhibin] Nanjing Med Univ, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Cao, Songyu; Pan, Yun; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Yin, Chenyu; Chen, Xiang; Zhu, Ying] Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi, Peoples R China; [Qian, Xifeng; Cao, Songyu; Hu, Zhibin] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China	Jiangnan University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Jiangnan University; Nanjing Medical University; Nanjing Medical University	Hu, ZB (corresponding author), Nanjing Med Univ, Dept Hematol, Wuxi Peoples Hosp, Wuxi, Peoples R China.	yfshen21cn@yahoo.com.cn; zhibin_hu@njmu.edu.cn			National Natural Science Foundation for Young Scholars of China [81200361]; Nanjing Medical University Foundation for Development of Science and Technology [2011NJMU203]	National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Nanjing Medical University Foundation for Development of Science and Technology	This work was supported in part by the National Natural Science Foundation for Young Scholars of China (81200361)(http://kjc.njmu.edu.cn/); Nanjing Medical University Foundation for Development of Science and Technology (2011NJMU203)(http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossard P, 1998, DEVELOPMENT, V125, P4909; Chen JJ, 2010, MOL CARCINOGEN, V49, P862, DOI 10.1002/mc.20661; Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Chu HJ, 2012, INT J CANCER, V130, P1093, DOI 10.1002/ijc.26130; Cocco C, 2011, J LEUKOCYTE BIOL, V89, P729, DOI 10.1189/jlb.1210660; Cocco C, 2010, BLOOD, V116, P3887, DOI 10.1182/blood-2009-10-248245; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; EVANS DIK, 1972, LANCET, V2, P1322; Farago B, 2008, ANN RHEUM DIS, V67, P248, DOI 10.1136/ard.2007.072819; Ferretti E, 2010, IMMUNOL LETT, V133, P99, DOI 10.1016/j.imlet.2010.08.002; GUNZ FW, 1969, J NATL CANCER I, V42, P517; Hu JW, 2006, CANCER RES, V66, P8887, DOI 10.1158/0008-5472.CAN-05-3448; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Jiang L, 2011, CANCER SCI, V102, P1462, DOI 10.1111/j.1349-7006.2011.01965.x; Kaiga T, 2007, J IMMUNOL, V178, P7571, DOI 10.4049/jimmunol.178.12.7571; Kan SH, 2008, GENES IMMUN, V9, P631, DOI 10.1038/gene.2008.64; Kim ES, 2012, LIFE SCI, V90, P740, DOI 10.1016/j.lfs.2012.03.017; Langowski JL, 2007, TRENDS IMMUNOL, V28, P207, DOI 10.1016/j.it.2007.03.006; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; LEBEAU MM, 1986, J CLIN ONCOL, V4, P325, DOI 10.1200/JCO.1986.4.3.325; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Overwijk WW, 2006, J IMMUNOL, V176, P5213, DOI 10.4049/jimmunol.176.9.5213; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Safrany E, 2012, INFLAMM RES; Tartour E, 1999, CANCER RES, V59, P3698; THIRMAN MJ, 1993, NEW ENGL J MED, V329, P909, DOI 10.1056/NEJM199309233291302; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Ugai S, 2003, CANCER GENE THER, V10, P771, DOI 10.1038/sj.cgt.7700630; Xu Y, 2012, J GASTROENTEROL; Yuan XP, 2006, CANCER RES, V66, P2630, DOI 10.1158/0008-5472.CAN-05-1682	31	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55473	10.1371/journal.pone.0055473	http://dx.doi.org/10.1371/journal.pone.0055473			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393581	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800035
J	Setz, C; Friedrich, M; Hahn, S; Dorrie, J; Schaft, N; Schuler, G; Schubert, U				Setz, Christian; Friedrich, Melanie; Hahn, Sabine; Doerrie, Jan; Schaft, Niels; Schuler, Gerold; Schubert, Ulrich			Just One Position-Independent Lysine Residue Can Direct MelanA into Proteasomal Degradation following N-Terminal Fusion of Ubiquitin	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; MULTIUBIQUITIN CHAIN; ANTIGEN PRESENTATION; VIRUS NUCLEOPROTEIN; CROSS-PRESENTATION; DNA IMMUNIZATION; T-LYMPHOCYTES; PROTEIN; PATHWAY	N-terminal stable in frame fusion of ubiquitin (Ub) has been shown to target the fusion protein for proteasomal degradation. This pathway, called the Ub fusion degradation (UFD), might also elevate MHC class I (MHC-I) antigen presentation of specific antigens. The UFD, mainly studied on cytosolic proteins, has been described to be mediated by polyubiquitination of specific lysine residues within the fused Ub moiety. Using the well characterized melanoma-specific antigen MelanA as a model protein, we analyzed the requirements of the UFD for ubiquitination and proteasomal degradation of a transmembrane protein. Here we show that fusion of the non-cleavable Ub(G76V) variant to the N-terminus of MelanA results in rapid proteasomal degradation via the endoplasmic reticulum-associated degradation (ERAD) pathway and, consequently, leads to an increased MHC-I antigen presentation. While lysine residues within Ub are dispensable for these effects, the presence of one single lysine residue, irrespectively of its location along the fusion protein, is sufficient to induce degradation of MelanA. These results show that the ubiquitination, ER to cytosol relocation and proteasomal degradation of a transmembrane protein can be increased by N-terminal fusion of Ub at the presence of at least one, position independent lysine residue. These findings are in contrast to the conventional wisdom concerning the UFD and indicate a new concept to target a protein into the ubiquitin-proteasome system (UPS) and thus for enhanced MHC-I antigen presentation, and might open up new possibilities in the development of tumor vaccines.	[Setz, Christian; Friedrich, Melanie; Hahn, Sabine; Schubert, Ulrich] Univ Klinikum Erlangen, Inst Clin & Mol Virol, Erlangen, Germany; [Doerrie, Jan; Schaft, Niels; Schuler, Gerold] Univ Klinikum Erlangen, Dept Dermatol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schubert, U (corresponding author), Univ Klinikum Erlangen, Inst Clin & Mol Virol, Erlangen, Germany.	ulrich.schubert@viro.med.uni-erlangen.de	Dörrie, Jan/H-3678-2011; Schaft, Niels/H-3713-2011	Dörrie, Jan/0000-0002-3478-0741; Schaft, Niels/0000-0001-8236-9298	German Human Genome Research Project [IE-S08T06]; German Research Council [SFB 643-A1]; National Institutes of Health [R01DK81553]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081553] Funding Source: NIH RePORTER	German Human Genome Research Project; German Research Council(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant IE-S08T06 from the German Human Genome Research Project, by the grant SFB 643-A1 from the German Research Council as well as by National Institutes of Health grant R01DK81553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Andersson HA, 2004, MOL THER, V10, P432, DOI 10.1016/j.ymthe.2004.05.035; Basta S, 2007, SCAND J IMMUNOL, V65, P311, DOI 10.1111/j.1365-3083.2007.01909.x; Basta S, 2005, J IMMUNOL, V175, P796, DOI 10.4049/jimmunol.175.2.796; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; De Maziere AM, 2002, TRAFFIC, V3, P678, DOI 10.1034/j.1600-0854.2002.30909.x; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Fu TM, 1998, VACCINE, V16, P1711, DOI 10.1016/S0264-410X(98)00134-0; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Goldwich A, 2008, J IMMUNOL, V180, P372, DOI 10.4049/jimmunol.180.1.372; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DH, 2007, FEBS LETT, V581, P265, DOI 10.1016/j.febslet.2006.12.024; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kohler G, 1981, CHARACTERIZATION MON; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Levy F, 2005, MOL BIOL CELL, V16, P1777, DOI 10.1091/mbc.E04-09-0803; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Madsen L, 2009, INT J BIOCHEM CELL B, V41, P2380, DOI 10.1016/j.biocel.2009.05.017; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rimoldi D, 2001, J BIOL CHEM, V276, P43189, DOI 10.1074/jbc.M103221200; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rodriguez F, 1997, J VIROL, V71, P8497, DOI 10.1128/JVI.71.11.8497-8503.1997; Saeki Y, 2004, BIOCHEM BIOPH RES CO, V320, P840, DOI 10.1016/j.bbrc.2004.05.216; Schliehe C, 2012, J VIROL, V86, P9782, DOI 10.1128/JVI.00694-12; Schlosser E, 2007, EMBO REP, V8, P945, DOI 10.1038/sj.embor.7401065; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sijts A., 2001, Current Molecular Medicine (Hilversum), V1, P665, DOI 10.2174/1566524013363230; Stack JH, 2000, NAT BIOTECHNOL, V18, P1298, DOI 10.1038/82422; Tellam J, 2003, BLOOD, V102, P4535, DOI 10.1182/blood-2003-03-0870; Tobery TW, 1997, J EXP MED, V185, P909, DOI 10.1084/jem.185.5.909; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Wu YQ, 1997, J IMMUNOL, V159, P6037; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zhang MX, 2004, IMMUNOLOGY, V112, P567, DOI 10.1111/j.1365-2567.2004.01916.x; Zhao G, 2009, P NATL ACAD SCI USA, V106, P16197, DOI 10.1073/pnas.0908321106	56	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55567	10.1371/journal.pone.0055567	http://dx.doi.org/10.1371/journal.pone.0055567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393593	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800047
J	Thornton, RB; Wiertsema, SP; Kirkham, LAS; Rigby, PJ; Vijayasekaran, S; Coates, HL; Richmond, PC				Thornton, Ruth B.; Wiertsema, Selma P.; Kirkham, Lea-Ann S.; Rigby, Paul J.; Vijayasekaran, Shyan; Coates, Harvey L.; Richmond, Peter C.			Neutrophil Extracellular Traps and Bacterial Biofilms in Middle Ear Effusion of Children with Recurrent Acute Otitis Media - A Potential Treatment Target	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CYSTIC-FIBROSIS PATIENTS; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; MORAXELLA-CATARRHALIS; RAPID IDENTIFICATION; DNA; COLONIZATION; TRACT; PATHOGENESIS	Background: Bacteria persist within biofilms on the middle ear mucosa of children with recurrent and chronic otitis media however the mechanisms by which these develop remain to be elucidated. Biopsies can be difficult to obtain from children and their small size limits analysis. Methods: In this study we aimed to investigate biofilm presence in middle ear effusion (MEE) from children with recurrent acute otitis media (rAOM) and to determine if these may represent infectious reservoirs similarly to those on the mucosa. We examined this through culture, viability staining and fluorescent in situ hybridisation (FISH) to determine bacterial species present. Most MEEs had live bacteria present using viability staining (32/36) and all effusions had bacteria present using the universal FISH probe (26/26). Of these, 70% contained 2 or more otopathogenic species. Extensive DNA stranding was also present. This DNA was largely host derived, representing neutrophil extracellular traps (NETs) within which live bacteria in biofilm formations were present. When treated with the recombinant human deoxyribonuclease 1, Dornase alfa, these strands were observed to fragment. Conclusions: Bacterial biofilms, composed of multiple live otopathogenic species can be demonstrated in the MEEs of children with rAOM and that these contain extensive DNA stranding from NETs. The NETs contribute to the viscosity of the effusion, potentially contributing to its failure to clear as well as biofilm development. Our data indicates that Dornase alfa can fragment these strands and may play a role in future chronic OM treatment.	[Thornton, Ruth B.; Wiertsema, Selma P.; Kirkham, Lea-Ann S.; Vijayasekaran, Shyan; Coates, Harvey L.; Richmond, Peter C.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Thornton, Ruth B.; Wiertsema, Selma P.; Kirkham, Lea-Ann S.; Richmond, Peter C.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Rigby, Paul J.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [Vijayasekaran, Shyan; Coates, Harvey L.] Princess Margaret Hosp Children, Dept Otolaryngol Head & Neck Surg, Perth, WA, Australia; [Vijayasekaran, Shyan; Coates, Harvey L.] Univ Western Australia, Dept Otolaryngol Head & Neck Surg, Perth, WA 6009, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Thornton, RB (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia.	ruth.thornton@uwa.edu.au	Richmond, Peter C/G-3379-2012; vijayasekaran, shyan/AAB-7538-2022; Thornton, Ruth/GOP-2314-2022; Kirkham, Lea-Ann S/A-5847-2013; Coates, Harvey Larry Charles/AAR-2846-2020	Richmond, Peter C/0000-0001-7562-7228; vijayasekaran, shyan/0000-0001-7990-6742; Kirkham, Lea-Ann S/0000-0001-5421-8126; Thornton, Ruth/0000-0001-9852-8310	GlaxoSmithKline Australia; University of Western Australia Priming Grant; University of Western Australia near miss safety net grant; Telethon Trust Research Grant	GlaxoSmithKline Australia(GlaxoSmithKline); University of Western Australia Priming Grant; University of Western Australia near miss safety net grant; Telethon Trust Research Grant	GlaxoSmithKline Australia, University of Western Australia Priming Grant, University of Western Australia near miss safety net grant and Telethon Trust Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Bluestone CD, 2003, EVIDENCE BASED OTITI, V2nd; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Casselbrant M.L., 2003, EVIDENCE BASED OTITI; Coates H, 2004, ADV THERAPY OTITIS M, P299; Coates H, 2008, OTOLARYNG HEAD NECK, V138, P778, DOI 10.1016/j.otohns.2007.02.009; Dagan R, 1998, PEDIATR INFECT DIS J, V17, P776, DOI 10.1097/00006454-199809000-00005; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; Gok U, 2001, INT J PEDIATR OTORHI, V60, P49, DOI 10.1016/S0165-5876(01)00510-9; Goodman SD, 2011, MUCOSAL IMMUNOL; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Heiniger N, 2007, J INFECT DIS, V196, P1080, DOI 10.1086/521194; Henke MO, 2007, PAEDIATR RESPIR REV, V8, P24, DOI 10.1016/j.prrv.2007.02.009; Hogardt M, 2000, J CLIN MICROBIOL, V38, P818, DOI 10.1128/JCM.38.2.818-825.2000; Homoe P, 2009, EUR ARCH OTORHINOLAR; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Juneau RA, 2011, INFECT IMMUN, V79, P431, DOI 10.1128/IAI.00660-10; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Kobayashi H, 2009, J INFECT CHEMOTHER, V15, P125, DOI 10.1007/s10156-008-0691-3; Krishnamurthy A, 2009, MICROBES INFECT, V11, P545, DOI 10.1016/j.micinf.2009.03.001; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parks QM, 2009, J MED MICROBIOL, V58, P492, DOI 10.1099/jmm.0.005728-0; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Post J Christopher, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P185, DOI 10.1097/01.moo.0000124936.46948.6a; Ratjen F, 2005, PEDIATR PULM, V39, P1, DOI 10.1002/ppul.20134; Ratner AJ, 2005, P NATL ACAD SCI USA, V102, P3429, DOI 10.1073/pnas.0500599102; Reid SD, 2009, J INFECT DIS; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Smith-Vaughan H, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-10; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Thornton RB, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-94; Trebesius K, 2000, MED MICROBIOL IMMUN, V188, P169, DOI 10.1007/s004300000035; Walker TS, 2005, INFECT IMMUN, V73, P3693, DOI 10.1128/IAI.73.6.3693-3701.2005; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Wiertsema SP, 2011, VACCINE	45	66	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e53837	10.1371/journal.pone.0053837	http://dx.doi.org/10.1371/journal.pone.0053837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393551	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800005
J	Arntz, R; Rutten-Jacobs, L; Maaijwee, N; Schoonderwaldt, H; Dorresteijn, L; van Dijk, E; de Leeuw, FE				Arntz, Renate; Rutten-Jacobs, Loes; Maaijwee, Noortje; Schoonderwaldt, Hennie; Dorresteijn, Lucille; van Dijk, Ewoud; de Leeuw, Frank-Erik			Post-Stroke Epilepsy in Young Adults: A Long-Term Follow-Up Study	PLOS ONE			English	Article							ACUTE CEREBROVASCULAR-DISEASE; TRANSIENT ISCHEMIC ATTACKS; NIH STROKE SCALE; CEREBRAL INFARCTION; EARLY SEIZURES; PREDICTORS; MULTICENTER; PROGNOSIS; RATIONALE; MORTALITY	Background: Little is known about the incidence and risk of seizures after stroke in young adults. Especially in the young seizures might dramatically influence prognosis and quality of life. We therefore investigated the long-term incidence and risk of post-stroke epilepsy in young adults with a transient ischemic attack (TIA), ischemic stroke (IS) or intracerebral hemorrhage (ICH). Methods and Findings: We performed a prospective cohort study among 697 consecutive patients with a first-ever TIA, IS or ICH, aged 18-50 years, admitted to our hospital between 1-1-1980 till 1-11-2010. The occurrence of epilepsy was assessed by standardized questionnaires and verified by a neurologist. Cumulative risks were estimated with Kaplan-Meier analysis. Cox proportional hazard models were used to calculate relative risks. After mean follow-up of 9.1 years (SD 8.2), 79 (11.3%) patients developed post-stroke epilepsy and 39 patients (5.6%) developed epilepsy with recurrent seizures. Patients with an initial late seizure more often developed recurrent seizures than patients with an initial early seizure. Cumulative risk of epilepsy was 31%, 16% and 5% for patients with an ICH, IS and TIA respectively (Logrank test ICH and IS versus TIA p<0.001). Cumulative risk of epilepsy with recurrent seizures was 23%, 8% and 4% respectively (Logrank ICH versus IS p = 0.05, ICH versus TIA p<0.001, IS versus TIA p = 0.01). In addition a high NIHSS was a significant predictor of both epilepsy and epilepsy with recurrent seizures (HR 1.07, 95% CI 1.03-1.11 and 1.08, 95% CI 1.02-1.14). Conclusions: Post-stroke epilepsy is much more common than previously thought. Especially patients with an ICH and a high NIHSS are at high risk. This calls upon the question whether a subgroup could be identified which benefits from the use of prophylactic antiepileptic medication. Future studies should be executed to investigate risk factors and the effect of post-stroke epilepsy on quality of life.	[Arntz, Renate; Rutten-Jacobs, Loes; Maaijwee, Noortje; Schoonderwaldt, Hennie; van Dijk, Ewoud; de Leeuw, Frank-Erik] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Dorresteijn, Lucille] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands	Radboud University Nijmegen; Medical Spectrum Twente	de Leeuw, FE (corresponding author), Radboud Univ Nijmegen, Dept Neurol, Med Ctr, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	h.deleeuw@neuro.umcn.nl	van Dijk, Ewoud J/J-7951-2012; Rutten-Jacobs, Loes/C-7746-2013; de Leeuw, Frank-Erik/E-4795-2012; de Leeuw, H.F./L-4479-2015	Rutten-Jacobs, Loes/0000-0003-3223-885X; Rutten-Jacobs, Loes/0000-0001-6275-0462	Dutch Epilepsy Fund [2010-18]	Dutch Epilepsy Fund	This manuscript was supported by the "Dutch Epilepsy Fund" (grantnumber 2010-18). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, Stroke, V6, P564; [Anonymous], 1993, EPILEPSIA, V34, P592; Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; Arboix A, 1996, NEUROLOGY, V47, P1429, DOI 10.1212/WNL.47.6.1429; Beghi E, 2011, NEUROLOGY, V77, P1785, DOI 10.1212/WNL.0b013e3182364878; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Bousser MG, 2009, CEREBROVASC DIS, V27, P509, DOI 10.1159/000212671; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; Burneo JG, 2010, EUR J NEUROL, V17, P52, DOI 10.1111/j.1468-1331.2009.02739.x; Camilo O, 2004, STROKE, V35, P1769, DOI 10.1161/01.STR.0000130989.17100.96; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; De Herdt V, 2011, NEUROLOGY, V77, P1794, DOI 10.1212/WNL.0b013e31823648a6; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; HANKEY GJ, 1991, J NEUROL NEUROSUR PS, V54, P793, DOI 10.1136/jnnp.54.9.793; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Kammersgaard Lars Peter, 2005, J Stroke Cerebrovasc Dis, V14, P210, DOI 10.1016/j.jstrokecerebrovasdis.2005.07.001; Kasner SE, 1999, STROKE, V30, P1534, DOI 10.1161/01.STR.30.8.1534; Krakow K, 2010, CEREBROVASC DIS, V30, P584, DOI 10.1159/000319777; Labovitz DL, 2001, NEUROLOGY, V57, P200, DOI 10.1212/WNL.57.2.200; Lamy C, 2003, NEUROLOGY, V60, P400, DOI 10.1212/WNL.60.3.400; Leys D, 2002, NEUROLOGY, V59, P26, DOI 10.1212/WNL.59.1.26; Lossius MI, 2005, EPILEPSIA, V46, P1246, DOI 10.1111/j.1528-1167.2005.57904.x; Luhmann HJ, 1996, PROG NEUROBIOL, V48, P131, DOI 10.1016/0301-0082(95)00042-9; Naess H, 2004, ACTA NEUROL SCAND, V110, P107, DOI 10.1111/j.1600-0404.2004.00273.x; Neau JP, 1998, CEREBROVASC DIS, V8, P296, DOI 10.1159/000015869; Paolucci S, 1997, EPILEPSIA, V38, P266, DOI 10.1111/j.1528-1157.1997.tb01115.x; Putaala J, 2010, ANN NEUROL, V68, P661, DOI 10.1002/ana.22091; Reith J, 1997, STROKE, V28, P1585, DOI 10.1161/01.STR.28.8.1585; Rutten-Jacobs LCA, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-109; Schulz UGR, 2002, POSTGRAD MED J, V78, P246, DOI 10.1136/pmj.78.918.246; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; Szaflarski JP, 2008, EPILEPSIA, V49, P974, DOI 10.1111/j.1528-1167.2007.01513.x; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Varona JF, 2004, J NEUROL, V251, P1507, DOI 10.1007/s00415-004-0583-0; Williams LS, 2000, STROKE, V31, P858, DOI 10.1161/01.STR.31.4.858	37	62	66	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55498	10.1371/journal.pone.0055498	http://dx.doi.org/10.1371/journal.pone.0055498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390537	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100053
J	Chen, SC; Hung, CC; Kuo, MC; Lee, JJ; Chiu, YW; Chang, JM; Hwang, SJ; Chen, HC				Chen, Szu-Chia; Hung, Chi-Chih; Kuo, Mei-Chuan; Lee, Jia-Jung; Chiu, Yi-Wen; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun			Association of Dyslipidemia with Renal Outcomes in Chronic Kidney Disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; URINARY ALBUMIN EXCRETION; FIBRONECTIN PRODUCTION; REVERSE EPIDEMIOLOGY; BLOOD-PRESSURE; CHOLESTEROL; DYSFUNCTION; PROGRESSION; PRAVASTATIN; RISK	Dyslipidemia is highly prevalent in patients with chronic kidney disease (CKD) and the relationship between dyslipidemia with renal outcomes in patients with moderate to advanced CKD remains controversial. Hence, our objective is to determine whether dyslipidemia is independently associated with rapid renal progression and progression to renal replacement therapy (RRT) in CKD patients. The study analyzed the association between lipid profile, RRT, and rapid renal progression (estimated glomerular filtration rate [eGFR] slope <-6 ml/min/1.73 m(2)/yr) in 3303 patients with stages 3 to 5 CKD. During a median 2.8-year follow-up, 1080 (32.3%) participants commenced RRT and 841 (25.5%) had rapid renal progression. In the adjusted models, the lowest quintile (hazard ratios [HR], 1.23; 95% confidence interval [Cl], 1.01 to 1.49) and the highest two quintiles of total cholesterol (HR, 1.25; 95% Cl, 1.02 to 1.52 and HR, 1.35; 95% Cl, 1.11 to 1.65 respectively) increased risks for RRT (vs. quintile 2). Besides, the highest quintile of total cholesterol was independently associated with rapid renal progression (odds ratio, 1.36; 95% Cl, 1.01 to 1.83). Our study demonstrated that certain levels of dyslipidemia were independently associated with RRT and rapid renal progression in CKD stage 3-5. Assessment of lipid profile may help identify high risk groups with adverse renal outcomes.	[Chen, Szu-Chia; Hung, Chi-Chih; Kuo, Mei-Chuan; Lee, Jia-Jung; Chiu, Yi-Wen; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Div Nephrol, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Chen, Szu-Chia; Chang, Jer-Ming] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung Municipal Hsiao Kang Hosp, Kaohsiung, Taiwan; [Kuo, Mei-Chuan; Chiu, Yi-Wen; Chang, Jer-Ming; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan; [Chen, Szu-Chia; Hung, Chi-Chih; Lee, Jia-Jung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chang, JM (corresponding author), Kaohsiung Med Univ, Div Nephrol, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan.	jemich@kmu.edu.tw	蘇, 河名/AAE-9843-2019					Abrass CK, 2004, AM J NEPHROL, V24, P46, DOI 10.1159/000075925; Atthobari J, 2006, NEPHROL DIAL TRANSPL, V21, P3106, DOI 10.1093/ndt/gfl244; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Chawla V, 2010, CLIN J AM SOC NEPHRO, V5, P1582, DOI 10.2215/CJN.01450210; Chen HC, 2002, KIDNEY BLOOD PRESS R, V25, P2, DOI 10.1159/000049428; Chen HC, 2002, ATHEROSCLEROSIS, V160, P141, DOI 10.1016/S0021-9150(01)00545-7; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P2750, DOI 10.2215/CJN.04660511; Chen SC, 2011, HYPERTENS RES, V34, P1052, DOI 10.1038/hr.2011.95; Contreras G, 2010, J AM SOC NEPHROL, V21, P2131, DOI 10.1681/ASN.2009121285; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hattori M, 1999, KIDNEY INT, V56, pS47, DOI 10.1046/j.1523-1755.1999.07112.x; Hovind P, 2001, KIDNEY INT, V60, P277, DOI 10.1046/j.1523-1755.2001.00797.x; Iseki K, 2002, KIDNEY INT, V61, P1887, DOI 10.1046/j.1523-1755.2002.00324.x; Kopple JD, 2005, AM J CLIN NUTR, V81, P1257; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin NW, 2007, SEMIN DIALYSIS, V20, P586, DOI 10.1111/j.1525-139X.2007.00366.x; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nakamura T, 2001, AM J NEPHROL, V21, P449, DOI 10.1159/000046648; Panichi V, 2001, RENAL FAILURE, V23, P551, DOI 10.1081/JDI-100104737; Rahman M, 2008, AM J KIDNEY DIS, V52, P412, DOI 10.1053/j.ajkd.2008.05.027; ROVIN BH, 1993, KIDNEY INT, V43, P218, DOI 10.1038/ki.1993.35; Sandhu S, 2006, J AM SOC NEPHROL, V17, P2006, DOI 10.1681/ASN.2006010012; Schaeffner ES, 2003, J AM SOC NEPHROL, V14, P2084, DOI 10.1681/ASN.V1482084; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Vaziri ND, 2006, INT J HAEMODIALYSIS, V10, P1; Vaziri ND, 2011, BLOOD PURIFICAT, V31, P189, DOI 10.1159/000321845; Vazquez-Perez S, 2001, NEPHROL DIAL TRANSPL, V16, P40, DOI 10.1093/ndt/16.suppl_1.40	31	27	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55643	10.1371/journal.pone.0055643	http://dx.doi.org/10.1371/journal.pone.0055643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390545	Green Submitted, Green Published, gold			2022-12-25	WOS:000314691100061
J	Martirosyan, A; Ohne, Y; Degos, C; Gorvel, L; Moriyon, I; Oh, S; Gorvel, JP				Martirosyan, Anna; Ohne, Yoichiro; Degos, Clara; Gorvel, Laurent; Moriyon, Ignacio; Oh, Sangkon; Gorvel, Jean-Pierre			Lipopolysaccharides with Acylation Defects Potentiate TLR4 Signaling and Shape T Cell Responses	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; DENDRITIC CELLS; LYMPH-NODES; IMMUNITY; ANTIGEN; SUBSETS; RECOGNITION; TOLERANCE; INFECTION; ENDOTOXIN	Lipopolysaccharides or endotoxins are components of Gram-negative enterobacteria that cause septic shock in mammals. However, a LPS carrying hexa-acyl lipid A moieties is highly endotoxic compared to a tetra-acyl LPS and the latter has been considered as an antagonist of hexa-acyl LPS-mediated TLR4 signaling. We investigated the relationship between the structure and the function of bacterial LPS in the context of human and mouse dendritic cell activation. Strikingly, LPS with acylation defects were capable of triggering a strong and early TLR4-dependent DC activation, which in turn led to the activation of the proteasome machinery dampening the pro-inflammatory cytokine secretion. Upon activation with tetraacyl LPS both mouse and human dendritic cells triggered CD4(+) T and CD8(+) T cell responses and, importantly, human myeloid dendritic cells favored the induction of regulatory T cells. Altogether, our data suggest that LPS acylation controlled by pathogenic bacteria might be an important strategy to subvert adaptive immunity.	[Martirosyan, Anna; Degos, Clara; Gorvel, Laurent; Gorvel, Jean-Pierre] Aix Marseille Univ UM 2, Ctr Immunol Marseille Luminy, Marseille, France; [Martirosyan, Anna; Degos, Clara; Gorvel, Laurent; Gorvel, Jean-Pierre] INSERM, U1104, F-13258 Marseille, France; [Martirosyan, Anna; Degos, Clara; Gorvel, Laurent; Gorvel, Jean-Pierre] CNRS, UMR 7280, Marseille, France; [Ohne, Yoichiro; Oh, Sangkon] Baylor Inst Immunol Res, Dallas, TX USA; [Moriyon, Ignacio] Univ Navarra, Inst Trop Hlth, E-31080 Pamplona, Spain; [Moriyon, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Baylor Scott & White Health; University of Navarra; University of Navarra	Gorvel, JP (corresponding author), Aix Marseille Univ UM 2, Ctr Immunol Marseille Luminy, Marseille, France.	gorvel@ciml.univ-mrs.fr	Gorvel, Jean-Pierre/O-1332-2018; GORVEL, Laurent/AAB-1749-2020; Ohne, Yoichiro/AGE-6061-2022; Moriyon, Ignacio/N-4764-2016	Gorvel, Jean-Pierre/0000-0002-2829-9804; GORVEL, Laurent/0000-0001-7526-261X; Moriyon, Ignacio/0000-0002-4288-0195; Degos, Clara/0000-0002-1359-1669	Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale, France; Foundation de la Recherche Medicale (FRM), France; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [U19 AI057234]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Foundation de la Recherche Medicale (FRM), France; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale, France. AM was a recipient of the Foundation de la Recherche Medicale (FRM), France. This work was also supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) - U19 AI057234. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Backhed F, 2003, MICROBES INFECT, V5, P1057, DOI 10.1016/S1286-4579(03)00207-7; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lapaque N, 2006, CELL MICROBIOL, V8, P401, DOI 10.1111/j.1462-5822.2005.00629.x; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Mills KHG, 2004, SEMIN IMMUNOL, V16, P107, DOI 10.1016/j.smim.2003.12.006; Mueller M, 2004, J BIOL CHEM, V279, P26307, DOI 10.1074/jbc.M401231200; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; Pierre P, 2009, CURR OPIN IMMUNOL, V21, P70, DOI 10.1016/j.coi.2009.03.003; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Seydel U, 2003, EUR J IMMUNOL, V33, P1586, DOI 10.1002/eji.200323649; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343	34	13	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55117	10.1371/journal.pone.0055117	http://dx.doi.org/10.1371/journal.pone.0055117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390517	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100033
J	Nabte, MJ; Marino, AI; Rodriguez, MV; Monjeau, A; Saba, SL				Nabte, Marcela J.; Marino, Andrea I.; Victoria Rodriguez, Maria; Monjeau, Adrian; Saba, Sergio L.			Range Management Affects Native Ungulate Populations in Peninsula Valdes, a World Natural Heritage	PLOS ONE			English	Article							PATAGONIAN MONTE; HETEROGENEITY; SHEEP; CONSERVATION; COMPETITION; LIVESTOCK; GUANACOS	Sheep rearing is the main productive activity in Patagonian rangelands, where guanacos are the only native ungulate. Ranchers perceive a decrease in range carrying capacity as guanaco numbers increase, therefore guanaco conservation within private lands becomes a considerable challenge. This issue is particularly evident in the World Natural Heritage Peninsula Valdes (PV), where there is a need to harmonize livestock production and biodiversity conservation. While sheep rearing prevails as the primary land use in the area, some ecotourism initiatives have been implemented to complement livestock production. In order to study how land use affected guanaco distribution, we characterized PV's ranches in terms of land subdivision, primary productivity, stocking-rate and management type, and assess how these variables affected guanaco encounter rates. Smaller ranches were composed of smaller paddocks (mean size 4.8 km(2)), which showed higher values of the remote-sensing derived Enhance Vegetation Index (EVI) (mean 0.14) and held higher sheep densities (mean 108.0 sheep/km(2)), while larger management units (mean size 23.8 km(2)), showed lower EVI values (mean 0.12) and lower stocking-rates (mean 36.7 sheep/km(2)). This pattern suggests that primary productivity has been a decisive factor to determine the minimal paddock size set by ranchers in PV, apparently precluding excessive land-subdivision in less productive areas. Guanaco encounter rate, expressed as number of guanacos per travelled kilometre, was inversely related to EVI and stocking-rate. However, land subdivision was the better predictor of guanaco encounter-rate within only sheep ranches, finding more guanacos per kilometre as paddock size increased. In contrast, in ranches where ecotourism was implemented as a complementary activity, guanaco encounter-rates were greater, regardless of paddock size. Our results suggest that the implementation of an additional activity by which landowners derive benefits from wildlife has prompted a beneficial outcome for guanacos, presumably through a decrease in harassment intensity. Finally, we propose possible mechanisms by which land subdivision may affect guanaco distribution and potential alternatives for the inclusion of wildlife conservation in a context of extensive livestock production.	[Nabte, Marcela J.; Marino, Andrea I.; Victoria Rodriguez, Maria; Saba, Sergio L.] Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Nabte, Marcela J.; Saba, Sergio L.] Univ Nacl Patagonia San Juan Bosco, Fac Ciencias Nat, Puerto Madryn, Chubut, Argentina; [Monjeau, Adrian] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Monjeau, Adrian] Fdn Bariloche, Programa Ecofilosofia, Dept Filosofia, San Carlos De Bariloche, Rio Negro, Argentina	Centro Nacional Patagonico (CENPAT); Universidad Nacional de la Patagonia San Juan Bosco; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Marino, AI (corresponding author), Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina.	marino@cenpat.edu.ar			Rufford Small Grant Foundation; Universidad Nacional de la Patagonia San Juan Bosco; Administracion del Area Natural Protegida Peninsula Valdes	Rufford Small Grant Foundation; Universidad Nacional de la Patagonia San Juan Bosco; Administracion del Area Natural Protegida Peninsula Valdes	The field work was possible thanks to the financial support of The Rufford Small Grant Foundation, Universidad Nacional de la Patagonia San Juan Bosco and Administracion del Area Natural Protegida Peninsula Valdes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi R, 2004, J WILDLIFE MANAGE, V68, P924, DOI 10.2193/0022-541X(2004)068[0924:HPFCBG]2.0.CO;2; Baldi R, 2001, OECOLOGIA, V129, P561, DOI 10.1007/s004420100770; Barnes MK, 2008, RANGELAND ECOL MANAG, V61, P380, DOI 10.2111/06-155.1; Barros V, 1983, CONTRIBUCION CTR NAC; Barros VR, 1981, MAPAS PROBABILIAD PR; Bertiller MB, 1981, CONTRIBUCION CTR NAC; Bertiller Monica B., 1998, Ecologia Austral, V8, P191; Bisigato AJ, 1997, J ARID ENVIRON, V36, P639, DOI 10.1006/jare.1996.0247; Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Campanella MV, 2008, J VEG SCI, V19, P75, DOI 10.3170/2007-8-18333; Chaikina N.A., 2006, RANGELANDS, V28, P8, DOI DOI 10.2111/1551-501X(2006)28[8:TEOCGO]2.0.CO;2; Cheli GH, 2009, THESIS U NACL COMAHU; Comerford E, 2004, CHOOSING INCENTIVE M; Cramps S, 1977, HDB BIRDS EUROPE MID, V1; Crawley MJ., 2007, R BOOK; de Leeuw J, 2001, BIOL CONSERV, V100, P297, DOI 10.1016/S0006-3207(01)00034-9; De Lucca ER, 2010, PRESENCIA PUMA PUMA; Derner JD, 2009, RANGELAND ECOL MANAG, V62, P111, DOI 10.2111/08-008.1; du Toit Johan T., 2010, P30, DOI 10.1002/9781444317091.ch3; Fernandez T, 2008, CUAD HIST PATAGON, V2, P17; Folch A, 1992, HDB BIRDS WORLD, V1; Fuhlendorf SD, 2006, ECOL APPL, V16, P1706, DOI 10.1890/1051-0761(2006)016[1706:SHBTBF]2.0.CO;2; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Fulbright TE, 2006, WHITE TAILED DEER HA; Gallardo Giovana, 2009, Mastozool. neotrop., V16, P59; Golluscio Rodolfo A., 1998, Ecologia Austral, V8, P265; Hobbs NT, 2008, GLOBAL ENVIRON CHANG, V18, P776, DOI 10.1016/j.gloenvcha.2008.07.011; LANGE RT, 1969, J RANGE MANAGE, V22, P396, DOI 10.2307/3895849; Menedin F, 2008, INFORME SECTORIAL SE; Nabte MJ, 2010, DESARROLLO CRITERIOS; Nebel G, 2005, FOREST POLICY ECON, V7, P175, DOI 10.1016/S1389-9341(03)00030-3; Niroula GS, 2005, LAND USE POLICY, V22, P358, DOI 10.1016/j.landusepol.2004.10.001; Novaro Andres J., 1995, Oryx, V29, P18; Ottichilo Wilber K., 2000, Conservation Biology Series (Dordrecht), V12, P203; Pedrana J, 2010, BIODIVERS CONSERV, V19, P3499, DOI 10.1007/s10531-010-9910-1; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Prins Herbert H.T., 2000, Conservation Biology Series (Dordrecht), V12, P51; Rodriguez MV, 2007, J ARID ENVIRON, V70, P137, DOI 10.1016/j.jaridenv.2006.12.010; Saba SL, 1995, NATURALIA PATAGONICA, V3, P153; Secretaria de Medio Ambiente y Desarrollo Sustentable de la Nacion, 2012, SECRETARIA MEDIO AMB; Travaini A, 2000, MASTOZOOL NEOTROP, V7, P117; Victurine R, 2010, WILD RANGELANDS CONS, P152; Burgi MV, 2012, ORYX, V46, P99, DOI 10.1017/S0030605311000214; Wrobel ML, 2010, WILD RANGELANDS CONS, P1, DOI [10.1002/9781444317091.ch1, DOI 10.1002/9781444317091.CH1]	45	21	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55655	10.1371/journal.pone.0055655	http://dx.doi.org/10.1371/journal.pone.0055655			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390546	Green Submitted, Green Published, gold			2022-12-25	WOS:000314691100062
J	Porwal, C; Kaushik, A; Makkar, N; Banavaliker, JN; Hanif, M; Singla, R; Bhatnagar, AK; Behera, D; Pande, JN; Singh, UB				Porwal, Chhavi; Kaushik, Amit; Makkar, Nayani; Banavaliker, Jayant N.; Hanif, Mahmud; Singla, Rupak; Bhatnagar, Anuj K.; Behera, Digambar; Pande, Jitendra Nath; Singh, Urvashi B.			Incidence and Risk Factors for Extensively Drug-Resistant Tuberculosis in Delhi Region	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANT; 2ND-LINE DRUGS; XDR-TB; SOUTH-AFRICA; INDIA; PREVALENCE; SYSTEM	Background: India with a major burden of multidrug-resistant tuberculosis (MDR-TB) does not have national level data on this hazardous disease. Since 2006, emergence of extensively drug-resistant TB (XDR-TB) is considered a serious threat to global TB control. This study highlights the demographic and clinical risk factors associated with XDR-TB in Delhi. Methods: The study was conducted during April 2007 to May 2010. Six hundred eleven MDR-TB suspects were enrolled from four tertiary care hospitals, treating TB patients in Delhi and the demographic details recorded. Sputum samples were cultured using rapid, automated liquid culture system (MGIT 960). Drug susceptibility testing (DST) for Rifampicin (RIF) and Isoniazid (INH) was performed for all positive M. tuberculosis (M.tb) cultures. All MDR-TB isolates were tested for sensitivity to second-line drugs [Amikacin (AMK), Capreomycin (CAP), Ofloxacin (OFX), Ethionamide (ETA)]. Results/Findings: Of 611, 483 patients were infected with MDR M. tuberculosis (M. tb) strains. Eighteen MDR-TB isolates (3.7%) were XDR M.tb strains. Family history of TB (p 0.045), socioeconomic status (p 0.013), concomitant illness (p 0.001) and previous intake of 2nd line injectable drugs (p 0.001) were significantly associated with occurrence of XDR-TB. Only two of the patients enrolled were HIV seropositive, but had a negative culture for M. tuberculosis. 56/483 isolates were pre-XDR M. tuberculosis, though the occurrence of pre-XDR-TB did not show any significant demographical associations. Conclusions: The actual incidence and prevalence rate of XDR-TB in India is not available, although some scattered data is available. This study raises a concern about existence of XDR-TB in India, though small, signaling a need to strengthen the TB control program for early diagnosis of both tuberculosis and drug resistance in order to break the chains of transmission.	[Porwal, Chhavi; Kaushik, Amit; Makkar, Nayani; Singh, Urvashi B.] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India; [Banavaliker, Jayant N.; Bhatnagar, Anuj K.] Rajan Babu Inst Pulm Med & TB, Delhi, India; [Hanif, Mahmud] New Delhi TB Ctr, New Delhi, India; [Singla, Rupak; Behera, Digambar] Lala Ram Sarup Inst TB & Resp Dis, New Delhi, India; [Pande, Jitendra Nath] Sitaram Bhartia Inst Sci & Res, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Sitaram Bhartia Institute of Science & Research	Singh, UB (corresponding author), All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India.	drurvashi@gmail.com	Kaushik, Amit/J-8836-2019	Kaushik, Amit/0000-0002-5622-1721	Indian Council of Medical Research (ICMR), New Delhi; Council of Scientific and Industrial Research (CSIR), New Delhi	Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Chhavi Porwal and Amit Kaushik gratefully acknowledge the research fellowships from the Indian Council of Medical Research (ICMR) and Council of Scientific and Industrial Research (CSIR), New Delhi respectively.	Ajbani K, 2011, J CLIN MICROBIOL, V49, P1588, DOI 10.1128/JCM.00113-11; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; [Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; Balaji V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009527; Banerjee R, 2008, CLIN INFECT DIS, V47, P450, DOI 10.1086/590009; Centers for Disease Control and Prevention, 2006, JAMA J AM MED ASS AM, V296, P2792; Chan ED, 2009, CLIN INFECT DIS, V48, pE50, DOI 10.1086/597010; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Jain A, 2008, J BIOSCIENCES, V33, P605, DOI 10.1007/s12038-008-0078-8; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Jeon CY, 2008, CLIN INFECT DIS, V46, P42, DOI 10.1086/524017; Kent PT, 1985, GUIDE LEVEL 3 LAB; Khanna A, 2010, ANTIMICROB AGENTS CH, V54, P4789, DOI 10.1128/AAC.00661-10; Lin SYG, 2009, J CLIN MICROBIOL, V47, P3630, DOI 10.1128/JCM.00803-09; Martin A, 2008, J CLIN MICROBIOL, V46, P3952, DOI 10.1128/JCM.01171-08; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P3192, DOI 10.1128/AAC.49.8.3192-3197.2005; Migliori GB, 2007, EUR RESPIR J, V29, P423, DOI 10.1183/09031936.00001307; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Mondal R, 2007, EMERG INFECT DIS, V13, P1429, DOI 10.3201/eid1309.070443; Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P243; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Rodrigues C, 2008, INT J TUBERC LUNG D, V12, P1449; Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006; Sharma SK, 2009, INDIAN J MED RES, V130, P392; Siddiqi SH, 2006, MGIT PROCEDURE MANUA; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; Singh S, 2007, AIDS, V21, P2345, DOI 10.1097/QAD.0b013e3282f125c9; World Health Organization, 2008, WHOHTMTB2008392; World Health Organization, 2010, WHOHTMTB20103	29	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55299	10.1371/journal.pone.0055299	http://dx.doi.org/10.1371/journal.pone.0055299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390524	gold, Green Submitted, Green Published			2022-12-25	WOS:000314691100040
J	Sandvik, EL; McLeod, BR; Parker, AE; Stewart, PS				Sandvik, Elizabeth L.; McLeod, Bruce R.; Parker, Albert E.; Stewart, Philip S.			Direct Electric Current Treatment under Physiologic Saline Conditions Kills Staphylococcus epidermidis Biofilms via Electrolytic Generation of Hypochlorous Acid	PLOS ONE			English	Article							CURRENT-INDUCED DETACHMENT; SURGICAL STAINLESS-STEEL; PSEUDOMONAS-AERUGINOSA BIOFILMS; ESCHERICHIA-COLI; SALMONELLA-ENTERITIDIS; INFECTIONS; BACTERIAL; EFFICACY; ENHANCEMENT; IMPLANTS	The purpose of this study was to investigate the mechanism by which a direct electrical current reduced the viability of Staphylococcus epidermidis biofilms in conjunction with ciprofloxacin at physiologic saline conditions meant to approximate those in an infected artificial joint. Biofilms grown in CDC biofilm reactors were exposed to current for 24 hours in 1/10th strength tryptic soy broth containing 9 g/L total NaCl. Dose-dependent log reductions up to 6.7 log(10) CFU/cm(2) were observed with the application of direct current at all four levels (0.7 to 1.8 mA/cm(2)) both in the presence and absence of ciprofloxacin. There were no significant differences in log reductions for wells with ciprofloxacin compared to those without at the same current levels. When current exposures were repeated without biofilm or organics in the medium, significant generation of free chlorine was measured. Free chlorine doses equivalent to the 24 hour endpoint concentration for each current level were shown to mimic killing achieved by current application. Current exposure (1.8 mA/cm(2)) in medium lacking chloride and amended with sulfate, nitrate, or phosphate as alternative electrolytes produced diminished kills of 3, 2, and 0 log reduction, respectively. Direct current also killed Pseudomonas aeruginosa biofilms when NaCl was present. Together these results indicate that electrolysis reactions generating hypochlorous acid from chloride are likely a main contributor to the efficacy of direct current application. A physiologically relevant NaCl concentration is thus a critical parameter in experimental design if direct current is to be investigated for in vivo medical applications.	[Sandvik, Elizabeth L.; McLeod, Bruce R.; Parker, Albert E.; Stewart, Philip S.] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA; [Sandvik, Elizabeth L.; Stewart, Philip S.] Montana State Univ, Dept Chem & Biol Engn, Bozeman, MT 59717 USA; [McLeod, Bruce R.] Montana State Univ, Dept Elect & Comp Engn, Bozeman, MT 59717 USA; [Parker, Albert E.] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Stewart, PS (corresponding author), Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA.	phil_s@erc.montana.edu		Stewart, Philip/0000-0001-7773-8570	Montana State University College of Engineering; Peter Ewing Capital Management LLC; Allegheny-Singer Research Institute; Montana Board of Research and Commercialization Technology [08-03]; M.J. Murdock Charitable Trust; NSF Major Research Instrumentation Program	Montana State University College of Engineering; Peter Ewing Capital Management LLC; Allegheny-Singer Research Institute; Montana Board of Research and Commercialization Technology; M.J. Murdock Charitable Trust; NSF Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by Montana State University College of Engineering, Peter Ewing Capital Management LLC, The Allegheny-Singer Research Institute, and The Montana Board of Research and Commercialization Technology Grant Agreement No. 08-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Betsey Pitts at the Center for Biofilm Engineering for providing expert assistance with confocal microscopy. Microscopy equipment at the facility was purchased with funds provided by the M.J. Murdock Charitable Trust and the NSF Major Research Instrumentation Program.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, E589507 ASTM INT, DOI [10.1520/E2562-07.www.astm.org, DOI 10.1520/E2562-07]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGER TJ, 1976, ANTIMICROB AGENTS CH, V9, P357, DOI 10.1128/AAC.9.2.357; BERGER TJ, 1976, ANTIMICROB AGENTS CH, V10, P856, DOI 10.1128/AAC.10.5.856; BLENKINSOPP SA, 1992, APPL ENVIRON MICROB, V58, P3770, DOI 10.1128/AEM.58.11.3770-3773.1992; Brezonik P.L., 1994, CHEM KINETICS PROCES; Buckingham-Meyer K, 2007, J MICROBIOL METH, V70, P236, DOI 10.1016/j.mimet.2007.04.010; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Chapman JS, 2003, INT BIODETER BIODEGR, V51, P133, DOI 10.1016/S0964-8305(02)00097-5; COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; DAVIS CP, 1989, ANTIMICROB AGENTS CH, V33, P442, DOI 10.1128/AAC.33.4.442; DAVIS CP, 1992, ANTIMICROB AGENTS CH, V36, P2552, DOI 10.1128/AAC.36.11.2552; DAVIS CP, 1982, J CLIN MICROBIOL, V15, P891, DOI 10.1128/JCM.15.5.891-894.1982; Davison WM, 2010, ANTIMICROB AGENTS CH, V54, P2920, DOI 10.1128/AAC.01734-09; del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P35, DOI 10.1128/AAC.00237-08; Ehrlich GD, 2004, ASM NEWS, V70, P127; FOOTE CS, 1983, NATURE, V301, P715, DOI 10.1038/301715a0; Hong SH, 2008, BIOTECHNOL BIOENG, V100, P379, DOI 10.1002/bit.21760; Jass J, 1996, J ANTIMICROB CHEMOTH, V38, P987, DOI 10.1093/jac/38.6.987; JASS J, 1995, J IND MICROBIOL, V15, P234, DOI 10.1007/BF01569830; Khoury A E, 1992, ASAIO J, V38, pM174, DOI 10.1097/00002480-199207000-00013; King CC, 1997, J LEUKOCYTE BIOL, V61, P293, DOI 10.1002/jlb.61.3.293; Konig DP, 2001, ARCH ORTHOP TRAUM SU, V121, P297, DOI 10.1007/s004020000242; Li XY, 2004, J ENVIRON ENG, V130, P1217, DOI 10.1061/(ASCE)0733-9372(2004)130:10(1217); Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687; McLeod BR, 1999, METHOD ENZYMOL, V310, P656; Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/fmb.11.117, 10.2217/FMB.11.117]; Pavoni GL, 2004, CLIN MICROBIOL INFEC, V10, P831, DOI 10.1111/j.1469-0691.2004.00928.x; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Poortinga AT, 2001, BIOTECHNOL BIOENG, V76, P395, DOI 10.1002/bit.10129; Poortinga AT, 2001, COLLOID SURFACE B, V20, P189, DOI 10.1016/S0927-7765(00)00184-3; Rabinovitch C, 2006, APPL ENVIRON MICROB, V72, P6364, DOI 10.1128/AEM.00442-06; Saginur R, 2006, ANTIMICROB AGENTS CH, V50, P55, DOI 10.1128/AAC.50.1.55-61.2006; Sam CH, 2009, J DENT SCI, V4, P45, DOI 10.1016/S1991-7902(09)60008-8; Secinti KD, 2008, J CLIN NEUROSCI, V15, P434, DOI 10.1016/j.jocn.2007.03.010; Shirtliff ME, 2005, APPL ENVIRON MICROB, V71, P6379, DOI 10.1128/AEM.71.10.6379-6382.2005; Stewart PS, 1999, ANTIMICROB AGENTS CH, V43, P292, DOI 10.1128/AAC.43.2.292; Stoodley P, 1997, ANTIMICROB AGENTS CH, V41, P1876, DOI 10.1128/AAC.41.9.1876; Sun JL, 2012, CAN J MICROBIOL, V58, P448, DOI 10.1139/w2012-005; Ueda Shigeko, 2007, Biocontrol Science, V12, P149; van der Borden AJ, 2005, BIOMATERIALS, V26, P6731, DOI 10.1016/j.biomaterials.2004.04.052; van der Borden AJ, 2004, APPL ENVIRON MICROB, V70, P6871, DOI 10.1128/AEM.70.11.6871-6874.2004; van der Borden AJ, 2004, J BIOMED MATER RES B, V68B, P160, DOI 10.1002/jbm.b.20015; van der Borden AJ, 2007, BIOMATERIALS, V28, P2122, DOI 10.1016/j.biomaterials.2007.01.001; Venkitanarayanan KS, 1999, APPL ENVIRON MICROB, V65, P4276; Vergidis P, 2012, INFECT DIS CLIN N AM, V26, P173, DOI 10.1016/j.idc.2011.09.012; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Wattanakaroon W, 2000, ARCH ORAL BIOL, V45, P167, DOI 10.1016/S0003-9969(99)00132-6; Wellman N, 1996, ANTIMICROB AGENTS CH, V40, P2012, DOI 10.1128/AAC.40.9.2012; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X; Xulu BA, 2010, BIOCHEMISTRY-US, V49, P2068, DOI 10.1021/bi902089w; Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537	54	57	64	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55118	10.1371/journal.pone.0055118	http://dx.doi.org/10.1371/journal.pone.0055118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390518	Green Submitted, Green Published, gold			2022-12-25	WOS:000314691100034
J	van den Brand, BT; Vermeij, EA; Waterborg, CEJ; Arntz, OJ; Kracht, M; Bennink, MB; van den Berg, WB; van de Loo, FAJ				van den Brand, Ben T.; Vermeij, Eline A.; Waterborg, Claire E. J.; Arntz, Onno J.; Kracht, Michael; Bennink, Miranda B.; van den Berg, Wim B.; van de Loo, Fons A. J.			Intravenous Delivery of HIV-Based Lentiviral Vectors Preferentially Transduces F4/80+and Ly-6C+Cells in Spleen, Important Target Cells in Autoimmune Arthritis	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; IN-VIVO; IMMUNE-RESPONSE; DEFICIENT MICE; GENE DELIVERY; TH17 CELLS; EXPRESSION; HEPATOCYTES; TRANSGENE; ANTAGONIST	Antigen presenting cells (APCs) play an important role in arthritis and APC specific gene therapeutic targeting will enable intracellular modulation of cell activity. Viral mediated overexpression is a potent approach to achieve adequate transgene expression levels and lentivirus (LV) is useful for sustained expression in target cells. Therefore, we studied the feasibility of lentiviral mediated targeting of APCs in experimental arthritis. Third generation VSV-G pseudotyped self-inactivating (SIN)-LV were injected intravenously and spleen cells were analyzed with flow cytometry for green fluorescent protein (GFP) transgene expression and cell surface markers. Collagen-induced arthritis (CIA) was induced by immunization with bovine collagen type II in complete Freund's adjuvant. Effect on inflammation was monitored macroscopically and T-cell subsets in spleen were analyzed by flow cytometry. Synovium from arthritic knee joints were analyzed for proinflammatory cytokine expression. Lentiviruses injected via the tail vein preferentially infected the spleen and transduction peaks at day 10. A dose escalating study showed that 8% of all spleen cells were targeted and further analysis showed that predominantly Ly6C+ and F4/80+ cells in spleen were targeted by the LV. To study the feasibility of blocking TAK1-dependent pathways by this approach, a catalytically inactive mutant of TAK1 (TAK1-K63W) was overexpressed during CIA. LV-TAK1-K63W significantly reduced incidence and arthritis severity macroscopically. Further histological analysis showed a significant decrease in bone erosion in LV-TAK1-K63W treated animals. Moreover, systemic Th17 levels were decreased by LV-TAK1-K63W treatment in addition to diminished IL-6 and KC production in inflamed synovium. In conclusion, systemically delivered LV efficiently targets monocytes and macrophages in spleen that are involved in autoimmune arthritis. Moreover, this study confirms efficacy of TAK1 targeting in arthritis. This approach may provide a valuable tool in targeting splenic APCs, to unravel their role in autoimmune arthritis and to identify and validate APC specific therapeutic targets.	[van den Brand, Ben T.; Vermeij, Eline A.; Waterborg, Claire E. J.; Arntz, Onno J.; Bennink, Miranda B.; van den Berg, Wim B.; van de Loo, Fons A. J.] Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmacol, D-35390 Giessen, Germany	Radboud University Nijmegen; Justus Liebig University Giessen	van de Loo, FAJ (corresponding author), Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	a.vandeloo@reuma.umcn.nl	Arntz, Onno J/A-2354-2016; van de Loo, Fons AJ/A-3425-2014; Waterborg, Claire/P-9245-2015; van den Berg, W.B./H-8010-2014	Arntz, Onno J/0000-0001-7064-6067; van de Loo, Fons AJ/0000-0002-5851-099X; Kracht, Michael/0000-0002-8501-043X	Top Institute Pharma [D1-101]; VIDI grant from the Netherlands Organization for Scientific Research [917.46.363]; Dutch Arthritis Association [RF 11-1-409]	Top Institute Pharma; VIDI grant from the Netherlands Organization for Scientific Research; Dutch Arthritis Association	This work was supported by: Top Institute Pharma, project D1-101; VIDI grant (917.46.363) from the Netherlands Organization for Scientific Research; and Dutch Arthritis Association (RF 11-1-409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Anderson R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3089; Annoni A, 2007, BLOOD, V110, P1788, DOI 10.1182/blood-2006-11-059873; Arce F, 2009, MOL THER, V17, P1643, DOI 10.1038/mt.2009.149; Arntz OJ, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2974; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Courties G, 2010, BLOOD, V116, P3505, DOI 10.1182/blood-2010-02-269605; de Vries TJ, 2009, J LEUKOCYTE BIOL, V85, P919, DOI 10.1189/jlb.0708402; Dimitrova P, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3926; Eftychi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031550; Follenzi A, 2004, BLOOD, V103, P3700, DOI 10.1182/blood-2003-09-3217; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Gjertsson I, 2009, MOL THER, V17, P632, DOI 10.1038/mt.2009.299; Hofkens W, 2011, J CONTROL RELEASE, V152, P363, DOI 10.1016/j.jconrel.2011.03.001; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kimura T, 2007, MOL THER, V15, P1390, DOI 10.1038/sj.mt.6300180; Koenders MI, 2008, ARTHRITIS RHEUM-US, V58, P3461, DOI 10.1002/art.23957; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Lloyd CM, 2008, J IMMUNOL METHODS, V334, P70, DOI 10.1016/j.jim.2008.02.005; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; van Lent PLEM, 2009, INT J RADIAT BIOL, V85, P860, DOI [10.3109/09553000903072454, 10.1080/09553000903072454]; VandenDriessche T, 2002, BLOOD, V100, P813, DOI 10.1182/blood.V100.3.813; Veenbergen S, 2008, ARTHRITIS RHEUM-US, V58, P3742, DOI 10.1002/art.24072	25	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55356	10.1371/journal.pone.0055356	http://dx.doi.org/10.1371/journal.pone.0055356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390530	gold, Green Published, Green Submitted			2022-12-25	WOS:000314691100046
J	Wang, X; Liu, DM; Li, AL; Sun, XL; Zhang, RZ; Wu, L; Liang, YC; Mao, L				Wang, Xiang; Liu, Danmei; Li, Aili; Sun, Xiuli; Zhang, Rongzhi; Wu, Liang; Liang, Yanchun; Mao, Long			Transcriptome Analysis of Tomato Flower Pedicel Tissues Reveals Abscission Zone-Specific Modulation of Key Meristem Activity Genes	PLOS ONE			English	Article							FLORAL ORGAN ABSCISSION; CELL-SEPARATION; ARABIDOPSIS; ETHYLENE; EXPRESSION; JOINTLESS; ENCODES; DEHISCENCE; IDENTITY; LEAVES	Tomato flower abscises at the anatomically distinct abscission zone that separates the pedicel into basal and apical portions. During abscission, cell separation occurs only at the abscission zone indicating distinctive molecular regulation in its cells. We conducted a transcriptome analysis of tomato pedicel tissues during ethylene promoted abscission. We found that the abscission zone was the most active site with the largest set of differentially expressed genes when compared with basal and apical portions. Gene Ontology analyses revealed enriched transcription regulation and hydrolase activities in the abscission zone. We also demonstrate coordinated responses of hormone and cell wall related genes. Besides, a number of ESTs representing homologs of key Arabidopsis shoot apical meristem activity genes were found to be preferentially expressed in the abscission zone, including WUSCHEL (WUS), KNAT6, LATERAL ORGAN BOUNDARIES DOMAIN PROTEIN 1(LBD1), and BELL-like homeodomain protein 1 (BLH1), as well as tomato axillary meristem genes BLIND (Bl) and LATERAL SUPPRESSOR (Ls). More interestingly, the homologs of WUS and the potential functional partner OVATE FAMILIY PROTEIN (OFP) were subsequently down regulated during abscission while Bl and AGL12 were continuously and specifically induced in the abscission zone. The expression patterns of meristem activity genes corroborate the idea that cells of the abscission zone confer meristem-like nature and coincide with the course of abscission and post-abscission cell differentiation. Our data therefore propose a possible regulatory scheme in tomato involving meristem genes that may be required not only for the abscission zone development, but also for abscission.	[Wang, Xiang] Henan Agr Univ, Natl Ctr Wheat Res, Zhengzhou, Peoples R China; [Wang, Xiang; Liu, Danmei; Li, Aili; Sun, Xiuli; Zhang, Rongzhi; Wu, Liang; Mao, Long] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, MOA Key Lab Germplasm & Biotechnol, Beijing 100193, Peoples R China; [Sun, Xiuli; Liang, Yanchun] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Henan Agricultural University; Chinese Academy of Agricultural Sciences; Jilin University	Mao, L (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, MOA Key Lab Germplasm & Biotechnol, Beijing 100193, Peoples R China.	maolong@caas.net.cn			Natural Science Foundation of China [31070260]; National Transgenic Key project of MOA of China [2013ZX08009-001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Key project of MOA of China	This work is supported in part by Natural Science Foundation of China (number 31070260) and National Transgenic Key project of MOA of China (number 2013ZX08009-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk BJ, 2007, PLANT J, V50, P1007, DOI 10.1111/j.1365-313X.2007.03105.x; Addicott F.T, 1982, ABSCISSION; Belles-Boix E, 2006, PLANT CELL, V18, P1900, DOI 10.1105/tpc.106.041988; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder B. M., 2009, Stewart Postharvest Review, V5, P1, DOI 10.2212/spr.2009.1.1; Bleecker AB, 1997, PLANT CELL, V9, P1169, DOI 10.1105/tpc.9.7.1169; Butenko MA, 2012, PLANT SIGNAL BEHAV, V7, P135, DOI 10.4161/psb.7.1.18379; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; Chen XB, 2010, J INTEGR PLANT BIOL, V52, P946, DOI 10.1111/j.1744-7909.2010.00987.x; Cho HT, 2000, P NATL ACAD SCI USA, V97, P9783, DOI 10.1073/pnas.160276997; Cho SK, 2008, P NATL ACAD SCI USA, V105, P15629, DOI 10.1073/pnas.0805539105; Cosgrove DJ, 2002, PLANT CELL PHYSIOL, V43, P1436, DOI 10.1093/pcp/pcf180; delCampillo E, 1996, PLANT PHYSIOL, V111, P813, DOI 10.1104/pp.111.3.813; GAWADI AG, 1950, AM J BOT, V37, P172, DOI 10.2307/2437968; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hake S, 2004, ANNU REV CELL DEV BI, V20, P125, DOI 10.1146/annurev.cellbio.20.031803.093824; Hamant O, 2010, CR BIOL, V333, P371, DOI 10.1016/j.crvi.2010.01.015; Hong SB, 2000, PLANT PHYSIOL, V123, P869, DOI 10.1104/pp.123.3.869; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACKSON MB, 1970, NATURE, V225, P1019, DOI 10.1038/2251019a0; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; LASHBROOK CC, 1994, PLANT CELL, V6, P1485, DOI 10.1105/tpc.6.10.1485; Lee J, 2007, PLANT MOL BIOL, V65, P487, DOI 10.1007/s11103-007-9196-1; Lee Y, 2001, CURR OPIN PLANT BIOL, V4, P527, DOI 10.1016/S1369-5266(00)00211-9; Li EY, 2011, PLANT J, V67, P328, DOI 10.1111/j.1365-313X.2011.04595.x; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Majer C, 2011, TRENDS PLANT SCI, V16, P47, DOI 10.1016/j.tplants.2010.09.009; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; McManus MT, 2008, ANN BOT-LONDON, V101, P285, DOI 10.1093/aob/mcm269; Meir S, 2010, PLANT PHYSIOL, V154, P1929, DOI 10.1104/pp.110.160697; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; Muller D, 2006, PLANT CELL, V18, P586, DOI 10.1105/tpc.105.038745; Nakano T, 2012, PLANT PHYSIOL, V158, P439, DOI 10.1104/pp.111.183731; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OSBORNE DJ, 1989, CRIT REV PLANT SCI, V8, P103, DOI 10.1080/07352688909382272; OSBORNE DJ, 1976, PLANTA, V132, P197, DOI 10.1007/BF00388903; Osborne DJ, 2005, HORMONES SIGNALS TAR; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Patterson SE, 2001, PLANT PHYSIOL, V126, P494, DOI 10.1104/pp.126.2.494; Preston JC, 2010, PLANT J, V62, P704, DOI 10.1111/j.1365-313X.2010.04184.x; Quinet M, 2011, PHYSIOL PLANTARUM, V141, P166, DOI 10.1111/j.1399-3054.2010.01426.x; ROBERTS JA, 1984, PLANTA, V160, P159, DOI 10.1007/BF00392864; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Rolland-Lagan AG, 2008, CURR OPIN GENET DEV, V18, P348, DOI 10.1016/j.gde.2008.05.002; Rossini L, 2006, THEOR APPL GENET, V112, P1073, DOI 10.1007/s00122-006-0209-2; Rutjens B, 2009, PLANT J, V58, P641, DOI 10.1111/j.1365-313X.2009.03809.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Szymkowiak EJ, 2006, PLANTA, V223, P646, DOI 10.1007/s00425-005-0115-x; Taylor JE, 2001, NEW PHYTOL, V151, P323, DOI 10.1046/j.0028-646x.2001.00194.x; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; van Nocker S, 2007, PLANT REV; van Nocker SJSPR., 2009, STEWART POSTHARVEST, V5, P5, DOI DOI 10.2212/SPR.2009.1.5; Wang XQ, 2006, J INTEGR PLANT BIOL, V48, P15, DOI 10.1111/j.1744-7909.2005.00085.x-i1; Yang TJ, 2005, CHROMOSOMA, V114, P103, DOI 10.1007/s00412-005-0342-8; Zenoni S, 2011, NEW PHYTOL, V191, P662, DOI 10.1111/j.1469-8137.2011.03726.x	60	47	47	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55238	10.1371/journal.pone.0055238	http://dx.doi.org/10.1371/journal.pone.0055238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390523	Green Submitted, gold, Green Published			2022-12-25	WOS:000314691100039
J	Ali, BH; Al-Husseni, I; Beegam, S; Al-Shukaili, A; Nemmar, A; Schierling, S; Queisser, N; Schupp, N				Ali, Badreldin H.; Al-Husseni, Isehaq; Beegam, Sumyia; Al-Shukaili, Ahmed; Nemmar, Abderrahim; Schierling, Simone; Queisser, Nina; Schupp, Nicole			Effect of Gum Arabic on Oxidative Stress and Inflammation in Adenine-Induced Chronic Renal Failure in Rats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ACACIA GUM; INDUCED NEPHROTOXICITY; MULTIPLE-ANTIOXIDANTS; NITROGEN-EXCRETION; HYPERTENSION; OXYGEN; BIOMARKERS; UREMIA; CANCER	Inflammation and oxidative stress are known to be involved in the pathogenesis of chronic kidney disease in humans, and in chronic renal failure (CRF) in rats. The aim of this work was to study the role of inflammation and oxidative stress in adenine-induced CRF and the effect thereon of the purported nephroprotective agent gum arabic (GA). Rats were divided into four groups and treated for 4 weeks as follows: control, adenine in feed (0.75%, w/w), GA in drinking water (15%, w/v) and adenine+GA, as before. Urine, blood and kidneys were collected from the rats at the end of the treatment for analysis of conventional renal function tests (plasma creatinine and urea concentration). In addition, the concentrations of the pro-inflammatory cytokine TNF-alpha and the oxidative stress markers glutathione and superoxide dismutase, renal apoptosis, superoxide formation and DNA double strand break frequency, detected by immunohistochemistry for gamma-H2AX, were measured. Adenine significantly increased the concentrations of urea and creatinine in plasma, significantly decreased the creatinine clearance and induced significant increases in the concentration of the measured inflammatory mediators. Further, it caused oxidative stress and DNA damage. Treatment with GA significantly ameliorated these actions. The mechanism of the reported salutary effect of GA in adenine-induced CRF is associated with mitigation of the adenine-induced inflammation and generation of free radicals.	[Ali, Badreldin H.; Beegam, Sumyia] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Pharmacol & Clin Pharm, Muscat, Oman; [Al-Husseni, Isehaq] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Physiol, Muscat, Oman; [Al-Shukaili, Ahmed] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Muscat, Oman; [Nemmar, Abderrahim] UAE Univ, Dept Physiol, Fac Med, Al Ain, U Arab Emirates; [Schierling, Simone; Queisser, Nina; Schupp, Nicole] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany	Sultan Qaboos University; Sultan Qaboos University; Sultan Qaboos University; United Arab Emirates University; University of Wurzburg	Schupp, N (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany.	nicole.schupp@toxi.uni-wuerzburg.de	Alhusseni, Isehaq/C-6160-2013	Alhusseni, Isehaq/0000-0002-6037-3146; Schupp, Nicole/0000-0002-1836-6348; Al-Shukaili, Ahmed/0000-0002-4476-2395	Research Council of Oman [RC/Med/Phar/10/01]; Sultan Qaboos University (SQU); Deutsche Forschungsgemeinschaft [SCHU 2367/1-2]; University of Wurzburg; German Research Foundation (DFG)	Research Council of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); Sultan Qaboos University (SQU); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was financially supported by a grant from the Research Council of Oman (RC/Med/Phar/10/01), and the Sultan Qaboos University (SQU), by the Deutsche Forschungsgemeinschaft, grant SCHU 2367/1-2 und the University of Wurzburg. The publication of this work was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mosawi AJ, 2007, J TROP PEDIATRICS, V53, P362, DOI 10.1093/tropej/fmm033; Al-Majed AA, 2003, J BIOCHEM MOL TOXIC, V17, P146, DOI 10.1002/jbt.10072; Al-Majed AA, 2002, PHARMACOL RES, V46, P445, DOI 10.1016/S1043661802001251; Al-Yahya AA, 2009, OXID MED CELL LONGEV, V2, P207, DOI 10.4161/oxim.2.4.8878; Ali AA, 2008, NAT PROD RES, V22, P12, DOI 10.1080/14786410500463544; Ali BH, 2013, PHYSIOL RES, V62, P47, DOI 10.33549/physiolres.932383; Ali BH, 2011, PHYTOMEDICINE, V18, P1176, DOI 10.1016/j.phymed.2011.03.005; Ali BH, 2011, EXP BIOL MED, V236, P107, DOI 10.1258/ebm.2010.010163; Ali BH, 2010, EXP BIOL MED, V235, P373, DOI 10.1258/ebm.2009.009214; Ali BH, 2009, FOOD CHEM TOXICOL, V47, P1, DOI 10.1016/j.fct.2008.07.001; Ali BH, 2003, RENAL FAILURE, V25, P15, DOI 10.1081/JDI-120017439; Annuk M, 2001, J AM SOC NEPHROL, V12, P2747, DOI 10.1681/ASN.V12122747; Aviles-Gomez R, 2006, ETHNIC DIS, V16; Bassaganya-Riera J, 2011, J NUTR, V141, P1318, DOI 10.3945/jn.111.139022; Batista ML, 2009, ARQ BRAS CARDIOL, V93, P692, DOI 10.1590/S0066-782X2009001200021; Bliss DZ, 1996, AM J CLIN NUTR, V63, P392, DOI 10.1093/ajcn/63.3.392; Bolton CH, 2001, NEPHROL DIAL TRANSPL, V16, P1189, DOI 10.1093/ndt/16.6.1189; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Cheung WW, 2010, PEDIATR NEPHROL, V25, P711, DOI 10.1007/s00467-009-1427-z; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Dounousi E, 2006, AM J KIDNEY DIS, V48, P752, DOI 10.1053/j.ajkd.2006.08.015; DUARTE CG, 1993, CLIN LAB MED, V13, P33, DOI 10.1016/S0272-2712(18)30459-1; ELDIN AMG, 2003, PHARM RES, V48, P631; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Filiopoulos Vasilis, 2009, Inflammation & Allergy Drug Targets, V8, P369; Goux A, 2011, FREE RADICAL RES, V45, P454, DOI 10.3109/10715762.2010.541455; Himmelfarb J, 2004, SEMIN DIALYSIS, V17, P449, DOI 10.1111/j.0894-0959.2004.17605.x; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Kim HJ, 2010, CLIN EXP NEPHROL, V14, P536, DOI 10.1007/s10157-010-0340-x; Kinugasa E, CONTRIB NEPHROL, V168, P134; Korish AA, 2010, RENAL FAILURE, V32, P203, DOI 10.3109/08860221003592820; Korish AA, 2009, SAUDI MED J, V30, P1150; Locatelli F, 2006, J NEPHROL, V19, P6; Mahmoud MF, 2012, RENAL FAILURE, V34, P73, DOI 10.3109/0886022X.2011.623563; Manning RD, 2005, AM J NEPHROL, V25, P311, DOI 10.1159/000086411; Matsumoto N, 2006, KIDNEY INT, V69, P257, DOI 10.1038/sj.ki.5000028; Morena Marion, 2005, Hemodial Int, V9, P37, DOI 10.1111/j.1492-7535.2005.01116.x; ORMROD D, 1980, NEPHRON, V26, P249, DOI 10.1159/000181994; Perazella MA, 2010, SEMIN NEPHROL, V30, P570, DOI 10.1016/j.semnephrol.2010.09.005; Pradeep AR, 2010, AUST DENT J, V55, P65, DOI 10.1111/j.1834-7819.2009.01180.x; Schupp N, 2011, FASEB J, V25, P968, DOI 10.1096/fj.10-173286; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sener G, 2007, PROSTAG OTH LIPID M, V83, P257, DOI 10.1016/j.prostaglandins.2007.01.013; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; Standage SW, 2011, EXPERT REV ANTI-INFE, V9, P71, DOI [10.1586/eri.10.154, 10.1586/ERI.10.154]; Suliman S. M., 2000, SUD ASS PHYS 17 C KH; Touyz RM, 2004, HISTOCHEM CELL BIOL, V122, P339, DOI 10.1007/s00418-004-0696-7; Tyler V.B., 1977, PHARMACOGNOSY, P64; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Vaziri ND, 2004, SEMIN NEPHROL, V24, P469, DOI 10.1016/j.semnephrol.2004.06.026; Welch WJ, 2006, CLIN EXP PHARMACOL P, V33, P1002, DOI 10.1111/j.1440-1681.2006.04478.x; Westhoff JH, 2008, HYPERTENSION, V52, P123, DOI 10.1161/HYPERTENSIONAHA.107.099432; Winchester JF, 2010, J AM SOC NEPHROL, V21, P209, DOI 10.1681/ASN.2008080899; Xuan NT, 2010, CELL PHYSIOL BIOCHEM, V25, P641, DOI 10.1159/000315083; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; YOUNES H, 1995, J NUTR, V125, P1010; Zhao MM, 2011, KIDNEY INT, V79, P1071, DOI 10.1038/ki.2011.18	59	92	93	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55242	10.1371/journal.pone.0055242	http://dx.doi.org/10.1371/journal.pone.0055242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383316	Green Published, gold			2022-12-25	WOS:000314597900023
J	Khunti, K; Morris, DH; Weston, CL; Gray, LJ; Webb, DR; Davies, MJ				Khunti, Kamlesh; Morris, Danielle H.; Weston, Claire L.; Gray, Laura J.; Webb, David R.; Davies, Melanie J.			Joint Prevalence of Diabetes, Impaired Glucose Regulation, Cardiovascular Disease Risk and Chronic Kidney Disease in South Asians and White Europeans	PLOS ONE			English	Article							ADULTS	Background: Multiple vascular risk factors may confer very high risk, but the degree of commonality between risk factors is unclear, particularly among ethnic minorities. Furthermore, it is unknown what impact this commonality will have on the UK-based NHS Health Check Programme; a vascular disease prevention programme that screens individuals aged 40-74 years. We estimated the joint prevalence of diabetes, impaired glucose regulation (IGR), high cardiovascular disease (CVD) risk and chronic kidney disease (CKD) among White Europeans and South Asians who would be eligible for the Programme. Methods: Cross-sectional data were analysed for 3707 participants (23.6% South Asian) in a screening study set in Leicestershire, UK. Diabetes and IGR were screen-detected. CKD may have been diagnosed previously. IGR was defined as impaired fasting glucose and/or impaired glucose tolerance, and high CVD risk as 10 year risk greater than 20%. Results: Among males, South Asians had higher prevalence than White Europeans of diabetes (9.0% vs. 3.9%, respectively, p<0.001), IGR (12.5% vs. 9.2%, p = 0.06), and high CVD risk (39.1% vs. 33.1%, p = 0.03), but lower prevalence of CKD (1.5% vs. 4.6%, p<0.01). Among females, South Asians had higher prevalence than White Europeans of diabetes (7.4% vs. 3.3%, p<0.001), but lower prevalence of CKD (3.7% vs. 13.0%, p<0.001) and CVD risk (2.4% vs. 4.6%, p = 0.03), and a nonsignificant difference in IGR prevalence. At least one risk factor was diagnosed in 34% of participants, and all of them in 0.4%, suggesting that 723,589-734,589 more individuals each year will require monitoring following implementation of the Health Check Programme. Conclusions: The collective prevalence of risk factors for vascular disease in this population was high, but there was little overlap between the risk factors, and prevalence differed by ethnicity. This has implications for service delivery and resources, and should be considered when planning screening and intervention programmes.	[Khunti, Kamlesh; Weston, Claire L.; Gray, Laura J.] Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester Diabet Ctr, Leicester, Leics, England; [Morris, Danielle H.; Webb, David R.; Davies, Melanie J.] Univ Leicester, Dept Cardiovasc Sci, Leicester Gen Hosp, Leicester Diabet Ctr, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Khunti, K (corresponding author), Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester Diabet Ctr, Leicester, Leics, England.	kk22@le.ac.uk	/ABC-9527-2021	Khunti, Kamlesh/0000-0003-2343-7099; Webb, David/0000-0002-3932-3339; Davies, Melanie/0000-0002-9987-9371; Gray, Laura/0000-0002-9284-9321	Department of Health; University Hospitals of Leicester Diabetes Research Fund; Diabetes UK; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire; Northamptonshire and Rutland (NIHR CLAHRC - LNR); NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit, University Hospitals of Leicester NHS Trust; Loughborough University; University of Leicester; National Institute for Health Research [RP-PG-0606-1272, RP-DG-1210-10183] Funding Source: researchfish	Department of Health; University Hospitals of Leicester Diabetes Research Fund; Diabetes UK(Diabetes UK); National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - Leicestershire; Northamptonshire and Rutland (NIHR CLAHRC - LNR); NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit, University Hospitals of Leicester NHS Trust; Loughborough University; University of Leicester; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by funding from the Department of Health (www.dh.gov.uk), the University Hospitals of Leicester Diabetes Research Fund (www.leicestershospitals.nhs.uk) and Diabetes UK (www.diabetes.org.uk) and was conducted as part of activities supported by the National Institute for Health Research (www.nihr.ac.uk) Collaboration for Leadership in Applied Health Research and Care - Leicestershire, Northamptonshire and Rutland (NIHR CLAHRC - LNR) and The NIHR Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit which is a partnership between University Hospitals of Leicester NHS Trust, Loughborough University and the University of Leicester. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Audit Commission, 2000, TEST TIM REV DIAB SE; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Brindle P, 2006, HEART, V92, P1595, DOI 10.1136/hrt.2006.092346; Dalton ARH, 2011, J PUBLIC HEALTH-UK, V33, P422, DOI 10.1093/pubmed/fdr034; Dalton AR, 2011, EUR J CARDIOVASC PRE; DH Renal NSF Team, 2005, NAT SERV FRAM REN SE; Fischbacher CM, 2004, J PUBLIC HEALTH-UK, V26, P250, DOI 10.1093/pubmed/fdh158; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Jafar TH, 2005, J AM SOC NEPHROL, V16, P1413, DOI 10.1681/ASN.2004121100; Khunti K, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c6312; Middleton RJ, 2006, NEPHROL DIAL TRANSPL, V21, P88, DOI 10.1093/ndt/gfi163; NHS Diabetes and Kidney Care, 2010, NHS HLTH CHECK FREQ; NHS The Information Centre for Health and Social Care, 2011, DIS PREV QUAL OUTC F; Office for National Statistics, 2011, PEEG CURR EST POP ES; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Sandbaek A, 2008, DIABETOLOGIA, V51, P1127, DOI 10.1007/s00125-008-1013-0; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Stevens LA, 2005, J AM SOC NEPHROL, V16, P2439, DOI 10.1681/ASN.2005020192; Vascular Checks Programme, 2008, VASC CHECKS RISK ASS; Webb DR, 2011, DIABETOLOGIA, V54, P2237, DOI 10.1007/s00125-011-2189-2; Webb DR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-16; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	25	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55580	10.1371/journal.pone.0055580	http://dx.doi.org/10.1371/journal.pone.0055580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383233	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800171
J	Sasaki, Y; Hagiwara, K; Kakisaka, M; Yamada, K; Murakami, T; Aida, Y				Sasaki, Yutaka; Hagiwara, Kyoji; Kakisaka, Michinori; Yamada, Kazunori; Murakami, Tomoyuki; Aida, Yoko			Importin alpha 3/Qip1 Is Involved in Multiplication of Mutant Influenza Virus with Alanine Mutation at Amino Acid 9 Independently of Nuclear Transport Function	PLOS ONE			English	Article							A VIRUS; LOCALIZATION SIGNAL; POLYMERASE PROTEINS; ALPHA FAMILY; NUCLEOPROTEIN; REPLICATION; CELLS; RNA; MEMBRANE; RIBONUCLEOPROTEINS	The nucleoprotein (NP) of influenza A virus is transported into the nucleus via the classical importin alpha/beta pathway, and proceeds via nuclear localization signals (NLSs) recognized by importin a molecules. Although NP binds to importin a isoforms Rch1, Qip1 and NPI-1, the role of each individual isoform during the nuclear transport of NP and replication of the influenza virus remains unknown. In this study, we examined the contribution of importin a isoforms for nuclear localization of NP and viral growth using a panel of NP mutants containing serial alanine replacements within an unconventional NLS of NP. Alanine mutation at amino acid 8 (R8A) caused a significant reduction in the nuclear localization and binding to the three importin isoforms. The R8A NP mutant virus did not generate by reverse-genetics approach. This indicates that position 8 is the main site that mediates nuclear localization via interactions with Rch1, Qip1 and NPI-1, and subsequent viral production. This was confirmed by the finding that the conservation of amino acid 8 in human-and avian-origin influenza virus NP was necessary for virus propagation. By contrast, another mutant, S9A NP, which localized in the nucleus, caused a reduction in viral growth and vRNA transcription, suggesting that the unconventional NLS within NP may be associated with nuclear transport, vRNA transcription and viral replication through independent pathways. Interestingly, the N-terminal 110-amino acid region, which contained the unconventional NLS with S9A mutation, mainly bound to Qip1. Furthermore, activities of vRNA transcription and replication of S9A NP mutants were decreased by silencing Qip1 in without changing nuclear localization, indicating that Qip1 involves in multiplication of S9A mutant virus independently of nuclear transport function. Collectively, our results demonstrate the unconventional NLS within NP might have the additional ability to regulate the viral replication that is independent of nuclear localization activity via interactions with Qip1.	[Sasaki, Yutaka; Hagiwara, Kyoji; Kakisaka, Michinori; Yamada, Kazunori; Murakami, Tomoyuki; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan; [Yamada, Kazunori; Murakami, Tomoyuki; Aida, Yoko] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Viral Infect Dis, Wako, Saitama, Japan	RIKEN; University of Tokyo	Aida, Y (corresponding author), RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan.	aida@riken.jp			RIKEN Program for Drug Discovery and Medical Technology Platforms	RIKEN Program for Drug Discovery and Medical Technology Platforms	This study was supported in part by a RIKEN Program for Drug Discovery and Medical Technology Platforms. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AKKINA RK, 1987, J VIROL, V61, P2217, DOI 10.1128/JVI.61.7.2217-2224.1987; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Cros JF, 2005, TRAFFIC, V6, P205, DOI 10.1111/j.1600-0854.2005.00263.x; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Hagiwara K, 2010, BIOCHEM BIOPH RES CO, V394, P721, DOI 10.1016/j.bbrc.2010.03.058; HERZ C, 1981, CELL, V26, P391, DOI 10.1016/0092-8674(81)90208-7; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 1997, THESIS JUSTUS LIEBIG; Hu JJ, 2010, J BIOL CHEM, V285, P33113, DOI 10.1074/jbc.M110.117044; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; JONES IM, 1986, EMBO J, V5, P2371, DOI 10.1002/j.1460-2075.1986.tb04506.x; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Ketha KMV, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-22; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Kohler M, 2002, CELL PHYSIOL BIOCHEM, V12, P335; Kohler M, 2001, VIROLOGY, V289, P186, DOI 10.1006/viro.2001.1151; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; MARTIN K, 1991, J VIROL, V65, P232, DOI 10.1128/JVI.65.1.232-244.1991; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Sieczkarski SB, 2005, ARCH VIROL, V150, P1783, DOI 10.1007/s00705-005-0558-1; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; Takeda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027815; Wang P, 1997, J VIROL, V71, P1850, DOI 10.1128/JVI.71.3.1850-1856.1997; Weber F, 1998, VIROLOGY, V250, P9, DOI 10.1006/viro.1998.9329; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003; Zhang J, 1996, VIROLOGY, V225, P255, DOI 10.1006/viro.1996.0599	43	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55765	10.1371/journal.pone.0055765	http://dx.doi.org/10.1371/journal.pone.0055765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383277	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800186
J	Richter, S; Gorny, X; Machts, J; Behnisch, G; Wustenberg, T; Herbort, MC; Munte, TF; Seidenbecher, CI; Schott, BH				Richter, Sylvia; Gorny, Xenia; Machts, Judith; Behnisch, Gusalija; Wuestenberg, Torsten; Herbort, Maike C.; Muente, Thomas F.; Seidenbecher, Constanze I.; Schott, Bjoern H.			Effects of AKAP5 Pro100Leu Genotype on Working Memory for Emotional Stimuli	PLOS ONE			English	Article							GENETIC-VARIATION; SEROTONIN TRANSPORTER; NEURAL MECHANISMS; AMYGDALA RESPONSIVENESS; REPETITION SUPPRESSION; INDIVIDUAL-DIFFERENCES; FACIAL EXPRESSIONS; BRAIN ACTIVATION; FACES; RESPONSES	Recent investigations addressing the role of the synaptic multiadaptor molecule AKAP5 in human emotion and behavior suggest that the AKAP5 Pro100Leu polymorphism (rs2230491) contributes to individual differences in affective control. Carriers of the less common Leu allele show a higher control of anger as indicated by behavioral measures and dACC brain response on emotional distracters when compared to Pro homozygotes. In the current fMRI study we used an emotional working memory task according to the n-back scheme with neutral and negative emotional faces as target stimuli. Pro homozygotes showed a performance advantage at the behavioral level and exhibited enhanced activation of the amygdala and fusiform face area during working memory for emotional faces. On the other hand, Leu carriers exhibited increased activation of the dACC during performance of the 2-back condition. Our results suggest that AKAP5 Pro100Leu effects on emotion processing might be task-dependent with Pro homozygotes showing lower control of emotional interference, but more efficient processing of task-relevant emotional stimuli.	[Richter, Sylvia] Salzburg Univ, Dept Clin Psychol, A-5020 Salzburg, Austria; [Richter, Sylvia; Gorny, Xenia; Behnisch, Gusalija; Herbort, Maike C.; Seidenbecher, Constanze I.; Schott, Bjoern H.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Machts, Judith; Schott, Bjoern H.] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany; [Wuestenberg, Torsten; Herbort, Maike C.; Schott, Bjoern H.] Charite, Dept Psychiat, D-13353 Berlin, Germany; [Muente, Thomas F.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	Salzburg University; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck	Schott, BH (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	bschott@neuro2.med.uni-magdeburg.de	Schott, Björn H/U-5626-2017; Münte, Thomas/C-2077-2014; Machts, Judith/J-2508-2019	Schott, Björn H/0000-0002-8237-4481; Machts, Judith/0000-0002-8660-095X; Seidenbecher, Constanze/0000-0002-7433-2716; Wustenberg, Torsten/0000-0001-8408-2864	Deutsche Forschungsgemeinschaft [SFB 779]; Leibniz Society (Leibniz Graduate School Synaptogenetics); State of Saxony-Anhalt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Society (Leibniz Graduate School Synaptogenetics); State of Saxony-Anhalt	The present project is supported by the Deutsche Forschungsgemeinschaft (SFB 779, TP A8), the "Pakt fur Forschung und Innovation" of the Leibniz Society (Leibniz Graduate School Synaptogenetics), and the State of Saxony-Anhalt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia-Klein N, 2009, EMOTION, V9, P385, DOI 10.1037/a0015904; Braver TS, 2010, CURR OPIN NEUROBIOL, V20, P242, DOI 10.1016/j.conb.2010.03.002; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Buckholtz JW, 2008, TRENDS NEUROSCI, V31, P120, DOI 10.1016/j.tins.2007.12.006; Calder AJ, 2011, PHILOS T R SOC B, V366, P1684, DOI 10.1098/rstb.2010.0362; Canli T, 2009, NEUROSCIENCE, V164, P43, DOI 10.1016/j.neuroscience.2009.06.049; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Dalton KM, 2007, BIOL PSYCHIAT, V61, P512, DOI 10.1016/j.biopsych.2006.05.019; De Martino B, 2008, PSYCHOPHARMACOLOGY, V197, P127, DOI 10.1007/s00213-007-1015-5; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146; Dekowska M, 2008, ACTA NEUROBIOL EXP, V68, P229; Domschke K, 2012, NEUROIMAGE, V60, P2222, DOI 10.1016/j.neuroimage.2012.02.039; Druzgal TJ, 2001, COGNITIVE BRAIN RES, V10, P355, DOI 10.1016/S0926-6410(00)00056-2; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Erk S, 2007, NEUROIMAGE, V37, P623, DOI 10.1016/j.neuroimage.2007.05.006; Erk S, 2006, EUR J NEUROSCI, V24, P1227, DOI 10.1111/j.1460-9568.2006.04976.x; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Furmark T, 2009, J PSYCHIATR NEUROSCI, V34, P30; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Greene CM, 2008, BIOL PSYCHOL, V79, P30, DOI 10.1016/j.biopsycho.2007.11.009; Haas BW, 2009, J NEUROSCI, V29, P1132, DOI 10.1523/JNEUROSCI.5324-08.2009; Hariri AR, 2009, ANNU REV NEUROSCI, V32, P225, DOI 10.1146/annurev.neuro.051508.135335; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Heinz A, 2006, REV NEUROSCIENCE, V17, P359; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kienast T, 2008, NAT NEUROSCI, V11, P1381, DOI 10.1038/nn.2222; Kilpatrick LA, 2011, GASTROENTEROLOGY, V140, P1943, DOI 10.1053/j.gastro.2011.03.011; Ladouceur CD, 2009, EMOTION, V9, P855, DOI 10.1037/a0017747; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Liu LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009790; Lonsdorf TB, 2011, BIOL PSYCHOL, V87, P106, DOI 10.1016/j.biopsycho.2011.02.014; Lundqvist D., 1998, KAROLINSKA DIRECTED; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Moita MAP, 2002, NAT NEUROSCI, V5, P837, DOI 10.1038/nn901; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; O'Nions EJP, 2011, J COGNITIVE NEUROSCI, V23, P3681, DOI 10.1162/jocn_a_00055; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005; Perlman SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005952; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Rasch B, 2010, NEUROIMAGE, V53, P870, DOI 10.1016/j.neuroimage.2010.01.001; Richter S, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00175; Said CP, 2010, NEUROPSYCHOLOGIA, V48, P3596, DOI 10.1016/j.neuropsychologia.2010.08.009; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Schardt DM, 2010, NEUROIMAGE, V53, P943, DOI 10.1016/j.neuroimage.2009.11.078; Schott BH, 2011, HUM BRAIN MAPP; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schubert R, 2008, CEREB CORTEX, V18, P2686, DOI 10.1093/cercor/bhn029; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Sharpe JP, 2001, PERS INDIV DIFFER, V31, P505, DOI 10.1016/S0191-8869(00)00155-0; Shin LM, 2011, AM J PSYCHIAT, V168, P979, DOI 10.1176/appi.ajp.2011.09121812; Sik A, 2000, EUR J NEUROSCI, V12, P1155, DOI 10.1046/j.1460-9568.2000.00002.x; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Smolka MN, 2005, J NEUROSCI, V25, P836, DOI 10.1523/JNEUROSCI.1792-04.2005; Stelzel C, 2010, J NEUROSCI, V30, P14205, DOI 10.1523/JNEUROSCI.1062-10.2010; Strange BA, 2003, P NATL ACAD SCI USA, V100, P13626, DOI 10.1073/pnas.1635116100; Swayze RD, 2004, NEUROPHARMACOLOGY, V47, P764, DOI 10.1016/j.neuropharm.2004.07.014; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Ulfig N, 1999, MICROSC RES TECHNIQ, V46, P48, DOI 10.1002/(SICI)1097-0029(19990701)46:1<48::AID-JEMT4>3.0.CO;2-1; Ulfig N, 2001, CELLS TISSUES ORGANS, V168, P319, DOI 10.1159/000047848; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wager TD, 2009, NEUROIMAGE, V47, P836, DOI 10.1016/j.neuroimage.2009.05.044; Walter H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006726; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Wolfensberger SPA, 2008, NEUROIMAGE, V41, P544, DOI 10.1016/j.neuroimage.2008.01.053; Yang TT, 2002, NEUROREPORT, V13, P1737, DOI 10.1097/00001756-200210070-00009; Zweynert S, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00144	82	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e55613	10.1371/journal.pone.0055613	http://dx.doi.org/10.1371/journal.pone.0055613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23383244	Green Submitted, gold, Green Published			2022-12-25	WOS:000315483200023
J	Stepanchick, A; Zhi, HJ; Cavanaugh, AH; Rothblum, K; Schneider, DA; Rothblum, LI				Stepanchick, Ann; Zhi, Huijun; Cavanaugh, Alice H.; Rothblum, Katrina; Schneider, David A.; Rothblum, Lawrence I.			DNA Binding by the Ribosomal DNA Transcription Factor Rrn3 Is Essential for Ribosomal DNA Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-I; SACCHAROMYCES-CEREVISIAE ENCODES; RDNA TRANSCRIPTION; FACTOR UBF; FACTOR SL1; NUCLEOLAR TRANSCRIPTION; CORE PROMOTER; TIF-IA; INITIATION; PHOSPHORYLATION	The human homologue of yeast Rrn3 is an RNA polymerase I-associated transcription factor that is essential for ribosomal DNA (rDNA) transcription. The generally accepted model is that Rrn3 functions as a bridge between RNA polymerase I and the transcription factors bound to the committed template. In this model Rrn3 would mediate an interaction between the mammalian Rrn3-polymerase I complex and SL1, the rDNA transcription factor that binds to the core promoter element of the rDNA. In the course of studying the role of Rrn3 in recruitment, we found that Rrn3 was in fact a DNA-binding protein. Analysis of the sequence of Rrn3 identified a domain with sequence similarity to the DNA binding domain of heat shock transcription factor 2. Randomization, or deletion, of the amino acids in this region in Rrn3, amino acids 382-400, abrogated its ability to bind DNA, indicating that this domain was an important contributor to DNA binding by Rrn3. Control experiments demonstrated that these mutant Rrn3 constructs were capable of interacting with both rpa43 and SL1, two other activities demonstrated to be essential for Rrn3 function. However, neither of these Rrn3 mutants was capable of functioning in transcription in vitro. Moreover, although wild-type human Rrn3 complemented a yeast rrn3-ts mutant, the DNA-binding site mutant did not. These results demonstrate that DNA binding by Rrn3 is essential for transcription by RNA polymerase I.	[Stepanchick, Ann; Zhi, Huijun; Cavanaugh, Alice H.] Geisinger Med Clin, Sigfried & Janet Weis Ctr Res, Danville, PA 17821 USA; [Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Rothblum, Katrina; Rothblum, Lawrence I.] Univ Oklahoma, Coll Med, Dept Cell Biol, Oklahoma City, OK 73104 USA	Geisinger Medical Center; University of Alabama System; University of Alabama Birmingham; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rothblum, LI (corresponding author), Univ Oklahoma, Coll Med, Dept Cell Biol, 940 Stanton L Young,BMSB 553C, Oklahoma City, OK 73104 USA.	lrothblu@OUHSC.edu		Schneider, David/0000-0003-0635-5091	National Institutes of Health [GM069841, HL077814, GM084946]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946, R01GM069841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069841 and HL077814 (to L. I. R.) and GM084946 (to D. A. S.).	BAZETTJONES DP, 1994, SCIENCE, V264, P1134, DOI 10.1126/science.8178172; BECKMANN H, 1995, SCIENCE, V270, P1506, DOI 10.1126/science.270.5241.1506; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Bodem J, 2000, EMBO REP, V1, P171, DOI 10.1093/embo-reports/kvd032; Cavanaugh A., RIBOSOMAL DNA TRANSC; Cavanaugh AH, 2002, J BIOL CHEM, V277, P27423, DOI 10.1074/jbc.M201232200; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; CAVANAUGH AH, 1984, P NATL ACAD SCI-BIOL, V81, P718, DOI 10.1073/pnas.81.3.718; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; COMAI L, 1994, SCIENCE, V266, P1966, DOI 10.1126/science.7801123; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; COPENHAVER GP, 1994, NUCLEIC ACIDS RES, V22, P2651, DOI 10.1093/nar/22.13.2651; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; GOKAL PK, 1986, J BIOL CHEM, V261, P2536; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; HAGLUND RE, 1987, MOL CELL BIOCHEM, V73, P11; Hanada K, 1996, EMBO J, V15, P2217, DOI 10.1002/j.1460-2075.1996.tb00575.x; Hannan RD, 1999, NUCLEIC ACIDS RES, V27, P3720, DOI 10.1093/nar/27.18.3720; Hannan RD, 1998, J BIOL CHEM, V273, P1257, DOI 10.1074/jbc.273.2.1257; Heix J, 1998, EMBO J, V17, P7373, DOI 10.1093/emboj/17.24.7373; Hirschler-Laszkiewicz I, 2001, NUCLEIC ACIDS RES, V29, P4114, DOI 10.1093/nar/29.20.4114; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; KEYS DA, 1994, GENE DEV, V8, P2349, DOI 10.1101/gad.8.19.2349; Keys DA, 1996, GENE DEV, V10, P887, DOI 10.1101/gad.10.7.887; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; Lin CW, 1996, MOL CELL BIOL, V16, P6436; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; MILLER KG, 1985, MOL CELL BIOL, V5, P554, DOI 10.1128/MCB.5.3.554; Moorefield B, 2000, P NATL ACAD SCI USA, V97, P4724, DOI 10.1073/pnas.080063997; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; NAGAMINE M, 1987, MOL CELL BIOL, V7, P1486, DOI 10.1128/MCB.7.4.1486; OMAHONY DJ, 1992, NUCLEIC ACIDS RES, V20, P1301; OMAHONY DJ, 1992, J BIOL CHEM, V267, P35; Pelletier G, 2000, MOL CELL, V6, P1059, DOI 10.1016/S1097-2765(00)00104-0; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; PIKAARD CS, 1990, MOL CELL BIOL, V10, P3810, DOI 10.1128/MCB.10.7.3810; ROTHBLUM LI, 1982, NUCLEIC ACIDS RES, V10, P7345, DOI 10.1093/nar/10.22.7345; SMITH SD, 1990, MOL CELL BIOL, V10, P3105, DOI 10.1128/MCB.10.6.3105; Steffan JS, 1996, GENE DEV, V10, P2551, DOI 10.1101/gad.10.20.2551; THURIAUX P, 1995, J BIOL CHEM, V270, P24252, DOI 10.1074/jbc.270.41.24252; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Yamamoto K, 2000, NUCLEIC ACIDS RES, V28, P1199, DOI 10.1093/nar/28.5.1199; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V281, P1001, DOI 10.1006/bbrc.2001.4457; Yamamoto RT, 1996, EMBO J, V15, P3964, DOI 10.1002/j.1460-2075.1996.tb00770.x; YANGYEN HF, 1988, MOL CELL BIOL, V8, P3406, DOI 10.1128/MCB.8.8.3406; Zhai WG, 1997, GENE DEV, V11, P1605, DOI 10.1101/gad.11.12.1605; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220; Zhao J, 2003, MOL CELL, V11, P405, DOI 10.1016/S1097-2765(03)00036-4; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130	53	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9135	9144		10.1074/jbc.M112.444265	http://dx.doi.org/10.1074/jbc.M112.444265			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393135	Green Published, hybrid			2022-12-25	WOS:000316862200033
J	Chi, XJ; Lu, YX; Zhao, P; Li, CG; Wang, XJ; Wang, M				Chi, Xiao-Jing; Lu, Yi-Xin; Zhao, Peng; Li, Chuan-Gen; Wang, Xiao-Jia; Wang, Ming			Interaction Domain of Glycoproteins gB and gH of Marek's Disease Virus and Identification of an Antiviral Peptide with Dual Functions	PLOS ONE			English	Article							VIRAL MEMBRANE-FUSION; CELL-FUSION; FUSOGENIC DOMAINS; CRYSTAL-STRUCTURE; B GB; TYPE-1; ENTRY; GL; PROTEIN; GD	Our previous study reported that both glycoproteins gB and gH of the herpesvirus Marek's disease virus (MDV) contain eleven potential heptad repeat domains. These domains overlap with a-helix-enriched hydrophobic regions, including the gH-derived HR1 (gHH1) and HR3 (gHH3) and gB-derived HR1 (gBH1) regions, which demonstrate effective antiviral activity, with 50% inhibitory concentrations (IC50) of less than 12 mu M. Plaque formation and chicken embryo infection assays confirmed these results. In this study, biochemical and biophysical analyses detected potential interactions between these peptides. gHH1, gHH3, and gBH1 were found to interact with each other in pairs. The complex formed by gHH3 and gBH1 showed the most stable interaction at a molar ratio of 1: 3, the binding between gHH1 and gBH1 was relatively weak, and no interaction was observed between the three HR peptides. These results indicate that gHH3 and gBH1 are likely the key contributors to the interaction between gB and gH. Furthermore, each HR peptide from herpesvirus glycoproteins did not effectively inhibit virus infection compared with peptides from a class I enveloped virus. In this report, the HR mimic peptide modified with a double glutamic acid (EE) or a double lysine (KK) at the non-interactive sites (i.e., solvent-accessible sites) did not noticeably affect the antiviral activity compared with the wild-type HR peptide, whereas tandem peptides from gH-derived gHH1 and gB-derived gBH1 (i.e., gBH1-Linker-gHH1) produced efficient antiviral effects, unlike the individual peptides. The proposed interpretation of inhibition of entry has been addressed. Our results support the hypothesis that the interaction domain between glycoproteins gH and gB is a critical target in the design of inhibitors of herpesvirus infection.	[Chi, Xiao-Jing; Lu, Yi-Xin; Li, Chuan-Gen; Wang, Xiao-Jia; Wang, Ming] China Agr Univ, Coll Vet Med, Minist Agricultrure, Key Lab Zoonosis, Beijing 100094, Peoples R China; [Zhao, Peng] Shandong Agr Univ, Coll Vet Med, Dept Vet Prevent Med, Tai An, Shandong, Peoples R China	China Agricultural University; Shandong Agricultural University	Wang, XJ (corresponding author), China Agr Univ, Coll Vet Med, Minist Agricultrure, Key Lab Zoonosis, Beijing 100094, Peoples R China.	wangxj@cau.edu.cn; vetdean@cau.edu.cn	Zhao, Peng/HDO-7507-2022		National Natural Science Foundation of China [31101819]; program of Education Ministry of China for New Century Excellent Talents in University [NCET-11-0486]; Foundation for the Authors of National Excellent Doctoral Dissertations of PR China [2006079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program of Education Ministry of China for New Century Excellent Talents in University; Foundation for the Authors of National Excellent Doctoral Dissertations of PR China	This work was supported by grants from The National Natural Science Foundation of China (31101819), the program of Education Ministry of China for New Century Excellent Talents in University (NCET-11-0486), and the Foundation for the Authors of National Excellent Doctoral Dissertations of PR China (2006079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajithdoss DK, 2009, VIRUS RES, V142, P57, DOI 10.1016/j.virusres.2009.01.008; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Atanasiu D, 2010, J VIROL, V84, P12292, DOI 10.1128/JVI.01700-10; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; BISSELL MJ, 1977, J SUPRAMOL STR CELL, V6, P1, DOI 10.1002/jss.400060102; Browne HM, 2009, PROTEIN PEPTIDE LETT, V16, P760, DOI 10.2174/092986609788681850; Burgess SC, 2004, P NATL ACAD SCI USA, V101, P13879, DOI 10.1073/pnas.0305789101; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Falanga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032186; Falanga A, 2009, PROTEIN PEPTIDE LETT, V16, P751, DOI 10.2174/092986609788681760; Farnsworth A, 2007, P NATL ACAD SCI USA, V104, P10187, DOI 10.1073/pnas.0703790104; FUKUCHI K, 1985, P NATL ACAD SCI USA, V82, P751, DOI 10.1073/pnas.82.3.751; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; Galdiero S, 2008, J BIOL CHEM, V283, P29993, DOI 10.1074/jbc.M803092200; Galdiero S, 2008, PEPTIDES, V29, P1461, DOI 10.1016/j.peptides.2008.04.022; Galdiero S, 2008, CHEMBIOCHEM, V9, P758, DOI 10.1002/cbic.200700457; Galdiero S, 2007, CHEMBIOCHEM, V8, P885, DOI 10.1002/cbic.200700044; Gianni T, 2006, J VIROL, V80, P2216, DOI 10.1128/JVI.80.5.2216-2224.2006; Gianni T, 2006, J VIROL, V80, P8190, DOI 10.1128/JVI.00504-06; Gimeno IM, 2001, VET PATHOL, V38, P491, DOI 10.1354/vp.38-5-491; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heldwein EE, 2008, CELL MOL LIFE SCI, V65, P1653, DOI 10.1007/s00018-008-7570-z; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Kato K, 1999, J VET MED SCI, V61, P1161, DOI 10.1292/jvms.61.1161; Lee SI, 2001, J VET MED SCI, V63, P427, DOI 10.1292/jvms.63.427; Li Yanpeng, 2010, Weishengwu Xuebao, V50, P942; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lopper M, 2004, J VIROL, V78, P8333, DOI 10.1128/jvi.78.15.8333-8341.2004; Maresova L, 2001, J VIROL, V75, P9483, DOI 10.1128/JVI.75.19.9483-9492.2001; Maurer UE, 2008, P NATL ACAD SCI USA, V105, P10559, DOI 10.1073/pnas.0801674105; Muggeridge MI, 2000, J GEN VIROL, V81, P2017, DOI 10.1099/0022-1317-81-8-2017; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Pertel PE, 2002, J VIROL, V76, P4390, DOI 10.1128/JVI.76.9.4390-4400.2002; Silva RF, 2010, AVIAN DIS, V54, P862, DOI 10.1637/9048-090409-Reg.1; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; Tulman ER, 2000, J VIROL, V74, P7980, DOI 10.1128/JVI.74.17.7980-7988.2000; Wang XJ, 2011, VIROLOGY, V416, P65, DOI 10.1016/j.virol.2011.05.001; Wang XJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-190; Wu P, 1999, ACTA VIROL, V43, P152; YOSHIDA S, 1994, GENE, V150, P303, DOI 10.1016/0378-1119(94)90442-1	46	4	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54761	10.1371/journal.pone.0054761	http://dx.doi.org/10.1371/journal.pone.0054761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405092	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400036
J	Davidson, Z; Valeix, M; Van Kesteren, F; Loveridge, AJ; Hunt, JE; Murindagomo, F; Macdonald, DW				Davidson, Zeke; Valeix, Marion; Van Kesteren, Freya; Loveridge, Andrew J.; Hunt, Jane E.; Murindagomo, Felix; Macdonald, David W.			Seasonal Diet and Prey Preference of the African Lion in a Waterhole-Driven Semi-Arid Savanna	PLOS ONE			English	Article							PHOTOGRAPHIC REFERENCE SYSTEM; KRUGER-NATIONAL-PARK; POPULATION-DYNAMICS; CARNIVORE DIET; SELECTION; HAIR; SIZE; MICROSTRUCTURE; HERBIVORES; PATTERNS	Large carnivores inhabiting ecosystems with heterogeneously distributed environmental resources with strong seasonal variations frequently employ opportunistic foraging strategies, often typified by seasonal switches in diet. In semi-arid ecosystems, herbivore distribution is generally more homogeneous in the wet season, when surface water is abundant, than in the dry season when only permanent sources remain. Here, we investigate the seasonal contribution of the different herbivore species, prey preference and distribution of kills (i.e. feeding locations) of African lions in Hwange National Park, Zimbabwe, a semi-arid African savanna structured by artificial waterholes. We used data from 245 kills and 74 faecal samples. Buffalo consistently emerged as the most frequently utilised prey in all seasons by both male (56%) and female (33%) lions, contributing the most to lion dietary biomass. Jacobs' index also revealed that buffalo was the most intensively selected species throughout the year. For female lions, kudu and to a lesser extent the group "medium Bovidae" are the most important secondary prey. This study revealed seasonal patterns in secondary prey consumption by female lions partly based on prey ecology with browsers, such as giraffe and kudu, mainly consumed in the early dry season, and grazers, such as zebra and suids, contributing more to female diet in the late dry season. Further, it revealed the opportunistic hunting behaviour of lions for prey as diverse as elephants and mice, with elephants taken mostly as juveniles at the end of the dry season during droughts. Jacobs' index finally revealed a very strong preference for kills within 2 km from a waterhole for all prey species, except small antelopes, in all seasons. This suggested that surface-water resources form passive traps and contribute to the structuring of lion foraging behaviour.	[Davidson, Zeke; Valeix, Marion; Van Kesteren, Freya; Loveridge, Andrew J.; Hunt, Jane E.; Macdonald, David W.] Univ Oxford, Dept Zool, Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Abingdon, Oxon, England; [Valeix, Marion] Univ Lyon 1, CNRS UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Murindagomo, Felix] Zimbabwe Parks & Wildlife Management Author, Harare, Zimbabwe	University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Davidson, Z (corresponding author), Colden Common, Marwell Wildlife, Winchester, Hants, England.	zeked@marwell.org.uk	Valeix, Marion/A-5110-2010		Darwin Initiative for Biodiversity; Disney Wildlife Conservation Foundation; SAVE Foundation; Regina B. Frankenberg Foundation; Rufford Maurice Laing Foundation; Instalite Contracting Bulawayo; Eppley Foundation; Panthera Foundation; Dete Animal Rescue Trust (DART)	Darwin Initiative for Biodiversity; Disney Wildlife Conservation Foundation; SAVE Foundation; Regina B. Frankenberg Foundation; Rufford Maurice Laing Foundation; Instalite Contracting Bulawayo; Eppley Foundation; Panthera Foundation; Dete Animal Rescue Trust (DART)	The work was supported by the Darwin Initiative for Biodiversity, Disney Wildlife Conservation Foundation, SAVE Foundation, Regina B. Frankenberg Foundation the Rufford Maurice Laing Foundation and Instalite Contracting Bulawayo. The Project was supported by the Eppley Foundation, Panthera Foundation and the kind generosity of Rivington and Joan Winant, Adrian Gardiner and the Lilian Jean Kaplan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Zimbabwe Parks and Wildlife Management Authority is acknowledged for approving this research and for permission to publish this manuscript. The field assistance of Dr. Daniel Parker, B. Stapelkamp, Nicholas Elliot, Jaelle Claypole, Agrippa Moyo, Lowani Mpofu and the rangers of the Hwange National Park was invaluable. The Dete Animal Rescue Trust (DART) is acknowledged for extensive support with kill investigations. We owe thanks to Wilderness Safaris, The Hide Safaris, Touch the Wild Safaris, Zimbabwe Sun international and the Gwaai ICA for permission to work on their concessions. We thank Matt Hayward, Craig Tambling and two anonymous reviewers for helpful comments on a previous draft.	Bacon MM, 2011, WILDLIFE SOC B, V35, P409, DOI 10.1002/wsb.85; BUYS D, 1984, S AFR J WILDL RES, V14, P111; Campbell Ken, 1995, P117; Chamaille-Jammes S, 2009, AFR J ECOL, V47, P804, DOI 10.1111/j.1365-2028.2009.01077.x; Cumming DHM, 2003, OECOLOGIA, V134, P560, DOI 10.1007/s00442-002-1149-4; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; de Boer WF, 2010, J MAMMAL, V91, P1280, DOI 10.1644/09-MAMM-A-392.1; de Leeuw J, 2001, BIOL CONSERV, V100, P297, DOI 10.1016/S0006-3207(01)00034-9; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fritz H, 2011, ECOGRAPHY, V34, P196, DOI 10.1111/j.1600-0587.2010.06537.x; Fritz Herve, 2006, Conservation Biology Series (Cambridge), V11, P19; Funston PJ, 2006, S AFR J WILDL RES, V36, P9; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2011, ACTA OECOL, V37, P314, DOI 10.1016/j.actao.2011.03.003; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Holdo RM, 2003, J TROP ECOL, V19, P189, DOI 10.1017/S0266467403003213; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; KEOGH HJ, 1985, S AFR J WILDL RES, V15, P109; KEOGH HJ, 1983, S AFR J WILDL RES, V13, P89; Lehmann MB, 2008, S AFR J WILDL RES, V38, P66, DOI 10.3957/0379-4369-38.1.66; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge AJ, 2006, J ZOOL, V270, P523, DOI 10.1111/j.1469-7998.2006.00181.x; Loveridge AJ, 2009, ECOGRAPHY, V32, P953, DOI 10.1111/j.1600-0587.2009.05745.x; Marker LL, 2003, S AFR J WILDL RES, V33, P43; Marucco F, 2008, J MAMMAL, V89, P665, DOI 10.1644/07-MAMM-A-005R3.1; Mills M. G. L., 1995, Koedoe, V38, P95; Mosser A, 2009, ECOL LETT, V12, P1050, DOI 10.1111/j.1461-0248.2009.01359.x; Owen-Smith N, 2008, ECOLOGY, V89, P1120, DOI 10.1890/07-0970.1; Owen-Smith N, 2008, OIKOS, V117, P602, DOI 10.1111/j.0030-1299.2008.16309.x; OWENSMITH N, 1982, ECOL STUD, V42, P359; PERRIN MR, 1980, S AFR J WILDL RES, V10, P1; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Rogers CML, 1993, WODDY VEGETATION SUR; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Tambling CJ, 2012, J ZOOL, V286, P102, DOI 10.1111/j.1469-7998.2011.00856.x; Tambling CJ, 2010, J WILDLIFE MANAGE, V74, P549, DOI 10.2193/2009-010; THRASH I, 1995, J ARID ENVIRON, V29, P213, DOI 10.1016/S0140-1963(05)80091-6; Valeix M, 2011, AM NAT, V178, P269, DOI 10.1086/660824; Valeix M, 2011, J TROP ECOL, V27, P163, DOI 10.1017/S0266467410000647; Valeix M, 2010, LANDSCAPE ECOL, V25, P337, DOI 10.1007/s10980-009-9425-x; Van Kesteren F, 2006, THESIS U OXFORD OXFO; WALKER BH, 1987, J APPL ECOL, V24, P381, DOI 10.2307/2403882; WESTERN D, 1975, East African Wildlife Journal, V13, P265	50	82	84	2	188	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55182	10.1371/journal.pone.0055182	http://dx.doi.org/10.1371/journal.pone.0055182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405121	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400065
J	Leisegang, R; Maartens, G; Hislop, M; Sargent, J; Darkoh, E; Cleary, S				Leisegang, Rory; Maartens, Gary; Hislop, Michael; Sargent, John; Darkoh, Ernest; Cleary, Susan			A Novel Markov Model Projecting Costs and Outcomes of Providing Antiretroviral Therapy to Public Patients in Private Practices versus Public Clinics in South Africa	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; HIV TREATMENT; DISEASE; STRATEGIES; EFFICIENCY; BENEFITS; CARE	Introduction: Providing private antiretroviral therapy (ART) care for public sector patients could increase access to ART in low-and middle-income countries. We compared the costs and outcomes of a private-care and a public-care ART program in South Africa. Methods: A novel Markov model was developed from the public-care program. Patients were first tunneled for 6 months in their baseline CD4 category before being distributed into a dynamic CD4 and viral load model. Patients were allowed to return to ART care from loss to follow up (LTFU). We then populated this modeling framework with estimates derived from the private-care program to externally validate the model. Results: Baseline characteristics were similar in the two programs. Clinic visit utilization was higher and death rates were lower in the first few years on ART in the public-care program. After 10 years on ART we estimated the following outcomes in the public-care and private-care programs respectively: viral load <1000 copies/ml 89% and 84%, CD4 >500 cells/ml 33% and 37%, LTFU 14% and 14%, and death 27% and 32%. Lifetime undiscounted survival estimates were 14.1 (95% CI 13.2-14.9) and (95% CI 12.7-14.5) years with costs of 18,734 (95% CI 12,588-14,022) and 13,062 (95% CI 12,077-14,047) USD in the private-care and public-care programs respectively. When clinic visit utilization in the public-care program was reduced by two thirds after the initial 6 months on ART, which is similar to their current practice, the costs were comparable between the programs. Conclusions: Using a novel Markov model, we determined that the private-care program had similar outcomes but lower costs than the public-care program, largely due to lower visit frequencies. These findings have important implications for increasing and sustaining coverage of patients in need of ART care in resource-limited settings.	[Leisegang, Rory; Maartens, Gary] Univ Cape Town, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Hislop, Michael] Medscheme Pty Ltd, Aid AIDS, Cape Town, South Africa; [Sargent, John; Darkoh, Ernest] BroadReach Healthcare, Cape Town, South Africa; [Cleary, Susan] Univ Cape Town, Hlth Econ Unit, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Maartens, G (corresponding author), Univ Cape Town, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa.	gary.maartens@uct.ac.za	Cleary, Susan/AHE-7259-2022; Maartens, Gary/F-3836-2014; Sargent, James D/I-2773-2013; Maartens, Gary/S-2788-2019	Cleary, Susan/0000-0002-9071-7958; Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606	Wellcome Trust CIDRI grant; Tibotec's Research and Education in HIV/AIDS for Resource-Poor Countries initiative; Doris Duke Charitable Foundation	Wellcome Trust CIDRI grant; Tibotec's Research and Education in HIV/AIDS for Resource-Poor Countries initiative; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	This research was supported in part by the Wellcome Trust CIDRI grant, Tibotec's Research and Education in HIV/AIDS for Resource-Poor Countries initiative, and the Doris Duke Charitable Foundation. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analysis SD, 2011, STATA 11 0; Ananworanich J, 2006, LANCET, V368, P459, DOI 10.1016/S0140-6736(06)69153-8; Bachmann MO, 2006, AIDS CARE, V18, P109, DOI 10.1080/09540120500159334; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Boulle A, 2008, POSTGRAD MED J, V84, P225, DOI 10.1136/sti.2007.027748; Boulle A, 2010, AIDS; Cleary S, 2011, HEALTH POLICY, V99, P261, DOI 10.1016/j.healthpol.2010.10.016; Cleary S, 2010, CURR OPIN HIV AIDS, V5, P210, DOI 10.1097/COH.0b013e3283384a6f; Cleary SM, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327621.24232.71; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Consumer Price Index (CPI), 2010, CONS PRIC IND CPI; Dreesch Norbert, 2007, Hum Resour Health, V5, P25, DOI 10.1186/1478-4491-5-25; Freedberg K, 2007, AIDS; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kranzer K, 2011, TROP MED INT HLTH; Leisegang R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S3; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; Marseille E, 2006, AIDS, V20, P907, DOI 10.1097/01.aids.0000218556.36661.47; Nachega JB, 2010, ANN INTERN MED, V152, P18, DOI 10.7326/0003-4819-152-1-201001050-00006; Ndiaye B, 2009, AIDS, V23, P1786, DOI 10.1097/QAD.0b013e32832e3469; Rosen S, 2006, MUCH DOES IT COST PR; Rosen S, 2007, SAMJ, V97; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Sendi PP, 1999, J EVAL CLIN PRACT, V5, P283, DOI 10.1046/j.1365-2753.1999.00174.x; Treeage Software I, 2009, TREEAG SOFTW I; Vijayaraghavan A, 2007, JAIDS-J ACQ IMM DEF, V46, P91; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; WHO, 2010, UNAIDS REP GLOB AIDS; WHO, 2004, COST COST EFF PUBL P; Wolf LL, 2007, JAIDS-J ACQ IMM DEF, V46, P463, DOI 10.1097/QAI.0b013e3181594c38; World Health Organization, 2003, SCAL ANT THER RES LT	35	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53570	10.1371/journal.pone.0053570	http://dx.doi.org/10.1371/journal.pone.0053570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405073	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400016
J	McCarthy, JK; Brockerhoff, EG; Didham, RK				McCarthy, James K.; Brockerhoff, Eckehard G.; Didham, Raphael K.			An Experimental Test of Insect-Mediated Colonisation of Damaged Pinus radiata Trees by Sapstain Fungi	PLOS ONE			English	Article							HYLASTES-ATER COLEOPTERA; SPHAEROPSIS-SAPINEA; BARK BEETLES; STORM DAMAGE; HOST; OPHIOSTOMA; PATHOGEN; PINES; CERATOCYSTIOPSIS; ASSOCIATION	Vector-pathogen dynamics play a central role in understanding tree health and forest dynamics. There is substantial evidence that bark beetles act as spore vectors for many species of fungi that cause 'sapstain' discolouration of damaged trees and timber. However, the direct quantitative link between vector-mediated spore dispersal and subsequent sapstain colonisation of wood is not fully understood. Here, we used caged versus uncaged experimental logs to test whether the exclusion of bark beetles quantitatively alters the distribution and intensity of sapstain fungal spread within damaged trees. Using generalised linear mixed models, we tested the effect of bark beetle exclusion on sapstain intensity within and among cut logs at two plantation forest sites. Overall, sapstain was found on all logs regardless of caging treatment, indicating that sapstain colonisation can occur (to some degree) without arthropod vectors, probably via wind, rain-splash and, potentially, latent endophytic development. This was supported by the dominance of Diplodia pinea in fungal isolations taken from trees felled at the site, as this fungal species is known to disperse independently of bark beetles. However, the intensity of sapstain within and among experimental logs was significantly greater in uncaged than in caged logs, where beetle colonisation was significantly greater. This appeared to be driven by a significant within-log association between the intensity of staining and the intensity of beetle, and other arthropod, tunnelling and feeding activities. Taken together, these results strongly suggest that the dominant mechanism underlying the role of bark beetles in sapstain development in this study system is not vector-mediated spore dispersal, per se, but rather the facilitation of spore entry and hyphal development through tunnelling and feeding activities. We discuss the implications of these findings for forest management and the effective salvage-harvest of trees damaged by stochastic climate events such as storm and fire damage.	[McCarthy, James K.; Brockerhoff, Eckehard G.] Scion New Zealand Forest Res Inst, Christchurch, New Zealand; [McCarthy, James K.; Brockerhoff, Eckehard G.; Didham, Raphael K.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Didham, Raphael K.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Didham, Raphael K.] Ctr Environm & Life Sci, CSIRO Ecosyst Serv, Perth, WA, Australia	University of Canterbury; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	McCarthy, JK (corresponding author), Scion New Zealand Forest Res Inst, Christchurch, New Zealand.	james.k.mccarthy@me.com	Brockerhoff, Eckehard Gustav/C-1528-2009; McCarthy, James K./E-9801-2010; Didham, Raphael K/B-5953-2011	Brockerhoff, Eckehard Gustav/0000-0002-5962-3208; McCarthy, James K./0000-0003-3060-1678; 	Foundation for Research, Science and Technology [C04X0807]; New Zealand Forest Health Research Collaborative; Brian Mason Scientific and Technical Trust; University of Canterbury; Tertiary Education Commission Enterprise Scholarship	Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); New Zealand Forest Health Research Collaborative; Brian Mason Scientific and Technical Trust; University of Canterbury; Tertiary Education Commission Enterprise Scholarship	Funding was provided by the Foundation for Research, Science and Technology (contract C04X0807 to Scion), the New Zealand Forest Health Research Collaborative, the Brian Mason Scientific and Technical Trust, the University of Canterbury, and a Tertiary Education Commission Enterprise Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; BALLARD RG, 1982, CAN J BOT, V60, P2334, DOI 10.1139/b82-285; Bates D., 2011, LINEAR MIXED EFFECTS; Bihon W, 2011, FOREST PATHOL, V41, P370, DOI 10.1111/j.1439-0329.2010.00691.x; Brockerhoff Eckehard G., 2003, New Zealand Entomologist, V26, P29; Brockerhoff EG, 2006, FOREST ECOL MANAG, V228, P234, DOI 10.1016/j.foreco.2006.02.046; BROOKHOUSER LW, 1971, PHYTOPATHOLOGY, V61, P409, DOI 10.1094/Phyto-61-409; Bueno A, 2010, SILVA FENN, V44, P387, DOI 10.14214/sf.137; Cudmore TJ, 2010, J APPL ECOL, V47, P1036, DOI 10.1111/j.1365-2664.2010.01848.x; Eagen R, 1997, CAN J MICROBIOL, V43, P592, DOI 10.1139/m97-084; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Feci E, 2003, FOREST PATHOL, V33, P7, DOI 10.1046/j.1439-0329.2003.00304.x; Grulke NE, 2011, NEW PHYTOL, V189, P8, DOI 10.1111/j.1469-8137.2010.03568.x; HARRINGTON TC, 1981, MYCOLOGIA, V73, P1123, DOI 10.2307/3759682; Hood I.A., 1997, Australian Forestry, V60, P7; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; Kerr J, 2010, OLFACTORY VISUAL CUE; Leach JG, 1934, J AGRIC RES, V49, P0315; Liese W., 1984, New Zealand Journal of Forestry, V29, P119; Lu M, 2010, NEW PHYTOL, V187, P859, DOI 10.1111/j.1469-8137.2010.03316.x; Luchi N, 2012, FOREST PATHOL, V42, P246, DOI 10.1111/j.1439-0329.2011.00750.x; Madar Z, 2005, PHYTOPARASITICA, V33, P28, DOI 10.1007/BF02980922; Mausel DL, 2007, CAN J FOREST RES, V37, P156, DOI 10.1139/X06-215; McCarthy JK, 2010, FOREST ECOL MANAG, V260, P1456, DOI 10.1016/j.foreco.2010.07.044; McCarthy JK, 2012, FOREST ECOL MANAG, V277, P81, DOI 10.1016/j.foreco.2012.04.018; McCarthy JK, 2011, ROLE BARK BEETLES VE; Oblinger BW, 2011, FOREST ECOL MANAG, V262, P663, DOI 10.1016/j.foreco.2011.04.038; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; PALMER MA, 1987, PHYTOPATHOLOGY, V77, P944, DOI 10.1094/Phyto-77-944; PALMER MA, 1988, PHYTOPATHOLOGY, V78, P831, DOI 10.1094/Phyto-78-831; POWELL MA, 1995, CAN J FOREST RES, V25, P1148, DOI 10.1139/x95-127; R Core Team, 2016, R FDN STAT COMP; Reay S.D., 2006, New Zealand Entomologist, V29, P21; Reay SD, 2002, FOREST ECOL MANAG, V165, P47, DOI 10.1016/S0378-1127(01)00628-4; Rornn P, 2007, CAN J MICROBIOL, V53, P756, DOI 10.1139/W07-001; Santini A, 2008, FOREST ECOL MANAG, V256, P502, DOI 10.1016/j.foreco.2008.05.010; Seifert K. A., 1999, TAXONOMY ECOLOGY PAT, P141; Stanosz GR, 2001, NEW PHYTOL, V149, P531, DOI 10.1046/j.1469-8137.2001.00052.x; Suckling DM, 1999, 2 NZ SAPST S, P117; SWART WJ, 1987, PLANT DIS, V71, P1038, DOI 10.1094/PD-71-1038; Thwaites JM, 2005, NEW ZEAL J BOT, V43, P653, DOI 10.1080/0028825X.2005.9512982; Uzunovic A, 1999, CAN J FOREST RES, V29, P242, DOI 10.1139/cjfr-29-2-242; Whitehill JGA, 2007, ENVIRON ENTOMOL, V36, P114, DOI 10.1603/0046-225X(2007)36[114:IPCSIA]2.0.CO;2; Wingfield M. J., 1980, Phytophylactica, V12, P57; Wylie F. R., 1999, Australian Forestry, V62, P148; Zeff C, 1999, FORESTRY PRACTISES M, P31; Zhou XD, 2004, FUNGAL DIVERS, V15, P261; Zimmerman WC, 1995, MYCOLOGIA, V87, P857, DOI 10.2307/3760861; Zipfel RD, 2006, STUD MYCOL, P75, DOI 10.3114/sim.55.1.75; ZWOLINSKI JB, 1995, FOREST ECOL MANAG, V72, P293, DOI 10.1016/0378-1127(94)03459-A	52	8	8	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55692	10.1371/journal.pone.0055692	http://dx.doi.org/10.1371/journal.pone.0055692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405198	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400143
J	Muth, CA; Steinl, C; Klein, G; Lee-Thedieck, C				Muth, Christine Anna; Steinl, Carolin; Klein, Gerd; Lee-Thedieck, Cornelia			Regulation of Hematopoietic Stem Cell Behavior by the Nanostructured Presentation of Extracellular Matrix Components	PLOS ONE			English	Article							COPOLYMER MICELLE NANOLITHOGRAPHY; BONE-MARROW NICHE; PROGENITOR CELLS; SUBSTRATE ELASTICITY; INTEGRIN LIGANDS; STEM/PROGENITOR CELLS; IN-VITRO; FIBRONECTIN; ADHESION; THROMBOSPONDIN-2	Hematopoietic stem cells (HSCs) are maintained in stem cell niches, which regulate stem cell fate. Extracellular matrix (ECM) molecules, which are an essential part of these niches, can actively modulate cell functions. However, only little is known on the impact of ECM ligands on HSCs in a biomimetic environment defined on the nanometer-scale level. Here, we show that human hematopoietic stem and progenitor cell (HSPC) adhesion depends on the type of ligand, i.e., the type of ECM molecule, and the lateral, nanometer-scaled distance between the ligands (while the ligand type influenced the dependency on the latter). For small fibronectin (FN)-derived peptide ligands such as RGD and LDV the critical adhesive interligand distance for HSPCs was below 45 nm. FN-derived (FN type III 7-10) and osteopontin-derived protein domains also supported cell adhesion at greater distances. We found that the expression of the ECM protein thrombospondin-2 (THBS2) in HSPCs depends on the presence of the ligand type and its nanostructured presentation. Functionally, THBS2 proved to mediate adhesion of HSPCs. In conclusion, the present study shows that HSPCs are sensitive to the nanostructure of their microenvironment and that they are able to actively modulate their environment by secreting ECM factors.	[Muth, Christine Anna; Lee-Thedieck, Cornelia] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Muth, Christine Anna; Lee-Thedieck, Cornelia] Heidelberg Univ, Dept Biophys Chem, Heidelberg, Germany; [Steinl, Carolin; Klein, Gerd] Univ Tubingen, Med Res Ctr, Sect Transplantat Immunol & Immunohematol, Tubingen, Germany; [Lee-Thedieck, Cornelia] Karlsruhe Inst Technol, Inst Funct Interfaces, Eggenstein Leopoldshafen, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Helmholtz Association; Karlsruhe Institute of Technology	Lee-Thedieck, C (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany.	cornelia.lee-thedieck@kit.edu	Klein, Gerd/C-8499-2013; Lee-Thedieck, Cornelia/H-2835-2013	Lee-Thedieck, Cornelia/0000-0001-8863-5403; Muth, Anna Christine/0000-0001-6161-6085	Baden-Wurttemberg Stiftung [P-LS-Biomat/22]; Brigitte Schlieben-Lange-Programme; Kathe und Josef Klinz-Stiftung	Baden-Wurttemberg Stiftung; Brigitte Schlieben-Lange-Programme; Kathe und Josef Klinz-Stiftung	The project was supported by contract research 'Biomaterialien/Biokompatibilitat' of the Baden-Wurttemberg Stiftung (P-LS-Biomat/22). CL-T gratefully acknowledges support by the Brigitte Schlieben-Lange-Programme and the 'Kathe und Josef Klinz-Stiftung'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D; Alford AI, 2010, BONE, V46, P464, DOI 10.1016/j.bone.2009.08.058; Altrock E, 2012, BIOMATERIALS, V33, P3107, DOI 10.1016/j.biomaterials.2012.01.002; AOTA S, 1994, J BIOL CHEM, V269, P24756; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Aydin D, 2010, LANGMUIR, V26, P15472, DOI 10.1021/la103065x; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038; Bornstein P, 2000, MATRIX BIOL, V19, P557, DOI 10.1016/S0945-053X(00)00104-9; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011; Cavalcanti-Adam EA, 2008, HFSP J, V2, P276, DOI 10.2976/1.2976662; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Choi JS, 2012, BIOMATERIALS, V33, P4460, DOI 10.1016/j.biomaterials.2012.03.010; Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829; Franke K, 2007, BIOMATERIALS, V28, P836, DOI 10.1016/j.biomaterials.2006.09.031; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gillette Jennifer M, 2009, Commun Integr Biol, V2, P305; Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314; Graeter SV, 2007, NANO LETT, V7, P1413, DOI 10.1021/nl070098g; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Hankenson KD, 2002, J BONE MINER RES, V17, P415, DOI 10.1359/jbmr.2002.17.3.415; Hines M, 2008, J CHEM TECHNOL BIOT, V83, P421, DOI 10.1002/jctb.1856; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Hirschfeld-Warneken VC, 2008, EUR J CELL BIOL, V87, P743, DOI 10.1016/j.ejcb.2008.03.011; Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; HURLEY RW, 1995, J CLIN INVEST, V96, P511, DOI 10.1172/JCI118063; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126; Jung Y, 2005, CYTOKINE, V32, P155, DOI 10.1016/j.cyto.2005.09.001; KERST JM, 1993, BLOOD, V81, P344; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KLEIN G, 1995, EXPERIENTIA, V51, P914, DOI 10.1007/BF01921741; Kramer A, 1999, P NATL ACAD SCI USA, V96, P2087, DOI 10.1073/pnas.96.5.2087; Kurth I, 2011, MACROMOL BIOSCI, V11, P739, DOI 10.1002/mabi.201000432; Kurth I, 2009, INTEGR BIOL-UK, V1, P427, DOI 10.1039/b903711j; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Lee-Thedieck C, 2012, J CELL SCI, V125, P3765, DOI 10.1242/jcs.095596; Lee-Thedieck C, 2012, MACROMOL RAPID COMM, V33, P1432, DOI 10.1002/marc.201200219; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Lepzelter D, 2012, LANGMUIR, V28, P5379, DOI 10.1021/la203725a; LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805; Liao JH, 2011, J ORTHOP RES, V29, P1544, DOI 10.1002/jor.21436; Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003; Lohmuller T, 2011, BIOINTERPHASES, V6, pMR1, DOI 10.1116/1.3536839; Melikova S, 2004, EXP HEMATOL, V32, P1051, DOI 10.1016/j.exphem.2004.07.018; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MOULD AP, 1991, J BIOL CHEM, V266, P3579; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Papayannopoulou T, 2001, BLOOD, V98, P2403, DOI 10.1182/blood.V98.8.2403; PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schofield KP, 1998, BLOOD, V91, P3230, DOI 10.1182/blood.V91.9.3230.3230_3230_3238; Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006; Sigal GB, 1996, ANAL CHEM, V68, P490, DOI 10.1021/ac9504023; Spatz JP, 2000, LANGMUIR, V16, P407, DOI 10.1021/1a990070n; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693; VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9; WAYNER EA, 1992, J CELL BIOL, V116, P489, DOI 10.1083/jcb.116.2.489; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Wolfram T, 2007, BIOINTERPHASES, V2, P44, DOI 10.1116/1.2713991; Yokota T, 1998, BLOOD, V91, P3263, DOI 10.1182/blood.V91.9.3263.3263_3263_3272; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R	83	36	37	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54778	10.1371/journal.pone.0054778	http://dx.doi.org/10.1371/journal.pone.0054778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405094	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400038
J	Ratan, A; Miller, W; Guillory, J; Stinson, J; Seshagiri, S; Schuster, SC				Ratan, Aakrosh; Miller, Webb; Guillory, Joseph; Stinson, Jeremy; Seshagiri, Somasekar; Schuster, Stephan C.			Comparison of Sequencing Platforms for Single Nucleotide Variant Calls in a Human Sample	PLOS ONE			English	Article							GENOME SEQUENCE	Next-generation sequencings platforms coupled with advanced bioinformatic tools enable re-sequencing of the human genome at high-speed and large cost savings. We compare sequencing platforms from Roche/454(GS FLX), Illumina/HiSeq (HiSeq 2000), and Life Technologies/SOLiD (SOLiD 3 ECC) for their ability to identify single nucleotide substitutions in whole genome sequences from the same human sample. We report on significant GC-related bias observed in the data sequenced on Illumina and SOLiD platforms. The differences in the variant calls were investigated with regards to coverage, and sequencing error. Some of the variants called by only one or two of the platforms were experimentally tested using mass spectrometry; a method that is independent of DNA sequencing. We establish several causes why variants remained unreported, specific to each platform. We report the indel called using the three sequencing technologies and from the obtained results we conclude that sequencing human genomes with more than a single platform and multiple libraries is beneficial when high level of accuracy is required.	[Ratan, Aakrosh; Miller, Webb; Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Guillory, Joseph; Stinson, Jeremy; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Roche Holding; Genentech	Schuster, SC (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA.	scs@bx.psu.edu			Roche [454]; Pennsylvania Department of Health	Roche(Roche Holding); Pennsylvania Department of Health	This study is based on sequencing data generated for the Southern African genomes Project [5]. The 454 data was generated at Penn State University and supported by Roche/454 via the donation of sequencing reagents. We like to thank Timothy Harkins and Kevin McCarren for making SOLiD data for the KB1 genome available to this group of investigators. The sequence data for Illumina GA IIx and HiSeq 2000 was generated at Penn State University and supported through internal funds. The funders had no role in study design, data collection (other than what has been stated above) and analysis, decision to publish, or preparation of the manuscript. This project is funded, in part, under a grant by the Pennsylvania Department of Health using Tobacco CURE Funds to AR. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations or conclusions.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Koehler R, 2011, BIOINFORMATICS, V27, P272, DOI 10.1093/bioinformatics/btq640; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lassmann T, 2011, BIOINFORMATICS, V27, P130, DOI 10.1093/bioinformatics/btq614; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Shen YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004012; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Tong P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r91; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	24	57	58	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55089	10.1371/journal.pone.0055089	http://dx.doi.org/10.1371/journal.pone.0055089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405114	Green Published, gold			2022-12-25	WOS:000315153400058
J	Sawaya, S; Bagshaw, A; Buschiazzo, E; Kumar, P; Chowdhury, S; Black, MA; Gemmell, N				Sawaya, Sterling; Bagshaw, Andrew; Buschiazzo, Emmanuel; Kumar, Pankaj; Chowdhury, Shantanu; Black, Michael A.; Gemmell, Neil			Microsatellite Tandem Repeats Are Abundant in Human Promoters and Are Associated with Regulatory Elements	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; HEME OXYGENASE-1 GENE; NITRIC-OXIDE SYNTHASE; G4 DNA; G-QUADRUPLEX; DINUCLEOTIDE REPEATS; GENOME; POLYMORPHISM; EXPRESSION; TRANSCRIPTION	Tandem repeats are genomic elements that are prone to changes in repeat number and are thus often polymorphic. These sequences are found at a high density at the start of human genes, in the gene's promoter. Increasing empirical evidence suggests that length variation in these tandem repeats can affect gene regulation. One class of tandem repeats, known as microsatellites, rapidly alter in repeat number. Some of the genetic variation induced by microsatellites is known to result in phenotypic variation. Recently, our group developed a novel method for measuring the evolutionary conservation of microsatellites, and with it we discovered that human microsatellites near transcription start sites are often highly conserved. In this study, we examined the properties of microsatellites found in promoters. We found a high density of microsatellites at the start of genes. We showed that microsatellites are statistically associated with promoters using a wavelet analysis, which allowed us to test for associations on multiple scales and to control for other promoter related elements. Because promoter microsatellites tend to be G/C rich, we hypothesized that G/C rich regulatory elements may drive the association between microsatellites and promoters. Our results indicate that CpG islands, G-quadruplexes (G4) and untranslated regulatory regions have highly significant associations with microsatellites, but controlling for these elements in the analysis does not remove the association between microsatellites and promoters. Due to their intrinsic lability and their overlap with predicted functional elements, these results suggest that many promoter microsatellites have the potential to affect human phenotypes by generating mutations in regulatory elements, which may ultimately result in disease. We discuss the potential functions of human promoter microsatellites in this context.	[Sawaya, Sterling; Gemmell, Neil] Univ Otago, Dept Anat, Ctr Reprod & Genom, Dunedin, New Zealand; [Sawaya, Sterling; Gemmell, Neil] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand; [Bagshaw, Andrew] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Buschiazzo, Emmanuel] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Kumar, Pankaj; Chowdhury, Shantanu] GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India; [Chowdhury, Shantanu] CSIR, Inst Genom & Integrat Biol, Prote & Struct Biol Unit, Delhi, India; [Black, Michael A.] Univ Otago, Dept Biochem, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago; University of California System; University of California Merced; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Otago	Sawaya, S (corresponding author), Univ Otago, Dept Anat, Ctr Reprod & Genom, Dunedin, New Zealand.	sterlingsawaya@gmail.com	Gemmell, Neil J/C-6774-2009; Black, Michael/F-1484-2010	Gemmell, Neil J/0000-0003-0671-3637; Black, Michael/0000-0003-1174-6054; Bagshaw, Andrew/0000-0002-2930-7298; KUMAR, PANKAJ/0000-0002-8411-1634	Royal Society of New Zealand Marsden [UOO 0721, UOO 085]; Minority Health International Research Training grant (National Institutes of Health); Indian Council of Medical Research	Royal Society of New Zealand Marsden(Royal Society of New ZealandMarsden Fund (NZ)); Minority Health International Research Training grant (National Institutes of Health); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	SS and NG were partially funded by Royal Society of New Zealand Marsden Grant (UOO 0721) and Minority Health International Research Training grant (National Institutes of Health). AB was funded by a Royal Society of New Zealand Marsden Grant (UOO 085). PK was funded by a Sr. Research Fellowship from the Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2000, HYPERTENSION, V36, P187, DOI 10.1161/01.HYP.36.2.187; Akai J, 1999, GENE, V239, P65, DOI 10.1016/S0378-1119(99)00380-7; Allayee H, 2008, AM J CLIN NUTR, V88, P934, DOI 10.1093/ajcn/88.4.934; Arneodo A, 1996, PHYSICA D, V96, P291, DOI 10.1016/0167-2789(96)00029-2; Bacolla A, 2001, J BIOL CHEM, V276, P18605, DOI 10.1074/jbc.M100404200; Bacolla A, 2008, GENOME RES, V18, P1545, DOI 10.1101/gr.078303.108; Baral A, 2012, NUCLEIC ACIDS RES, V40, P3800, DOI 10.1093/nar/gkr1258; Beaulieu M, 1997, ANTISENSE NUCLEIC A, V7, P125, DOI 10.1089/oli.1.1997.7.125; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Borel C, 2012, HUM MUTAT, V33, P1302, DOI 10.1002/humu.22115; BRAHMACHARI SK, 1995, ELECTROPHORESIS, V16, P1705, DOI 10.1002/elps.11501601283; Brandstrom M, 2008, MOL BIOL EVOL, V25, P2579, DOI 10.1093/molbev/msn201; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Buschiazzo E, 2010, GENOME BIOL EVOL, V2, P153, DOI 10.1093/gbe/evq007; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Darlow JM, 1998, J MOL BIOL, V275, P3, DOI 10.1006/jmbi.1997.1453; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dodin G, 2000, J THEOR BIOL, V206, P323, DOI 10.1006/jtbi.2000.2127; Domart MC, 2012, ADDICT BIOL, V17, P783, DOI 10.1111/j.1369-1600.2011.00321.x; Du Z, 2008, GENOME RES, V18, P233, DOI 10.1101/gr.6905408; Du Z, 2009, NUCLEIC ACIDS RES, V37, P6784, DOI 10.1093/nar/gkp710; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Eddy J, 2011, NUCLEIC ACIDS RES, V39, P4975, DOI 10.1093/nar/gkr079; Eddy J, 2009, MOL CARCINOGEN, V48, P319, DOI 10.1002/mc.20496; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Fujita P. A., 2010, NUCL ACIDS RES; Funke-Kaiser H, 2003, J HYPERTENS, V21, P2111, DOI 10.1097/00004872-200311000-00021; Gao PS, 2004, J MED GENET, V41, P535, DOI 10.1136/jmg.2003.015842; Gebhardt F, 1999, J BIOL CHEM, V274, P13176, DOI 10.1074/jbc.274.19.13176; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Halder R, 2010, MOL BIOSYST, V6, P2439, DOI 10.1039/c0mb00009d; Han YJ, 2008, MOL CELL BIOL, V28, P863, DOI 10.1128/MCB.00960-07; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Herdewyn S., 2012, HUMAN MOL GENETICS; Hough C, 2008, J THROMB HAEMOST, V6, P1183, DOI 10.1111/j.1538-7836.2008.03011.x; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Itokawa M, 2003, PHARMACOGENETICS, V13, P271, DOI 10.1097/00008571-200305000-00006; Kelkar YD, 2011, GENOME RES; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; King DG, 2007, HEREDITY, V99, P123, DOI 10.1038/sj.hdy.6800998; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kopf J, 2011, NEUROIMAGE, V57, P1617, DOI 10.1016/j.neuroimage.2011.05.034; Koren S, 2012, NAT BIOTECHNOL; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lawson MJ, 2008, GENE, V407, P54, DOI 10.1016/j.gene.2007.09.017; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; McIver LJ, 2011, GENOMICS, V97, P193, DOI 10.1016/j.ygeno.2011.01.001; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nason GP, 2008, USE R, P1; Ng TK, 2009, MOL VIS, V15, P2239; Nithianantharajah J, 2007, BIOESSAYS, V29, P525, DOI 10.1002/bies.20589; Okladnova O, 1998, BIOCHEM BIOPH RES CO, V248, P402, DOI 10.1006/bbrc.1998.8972; Payseur BA, 2011, MOL BIOL EVOL, V28, P303, DOI 10.1093/molbev/msq198; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Reif A, 2009, ARCH GEN PSYCHIAT, V66, P41, DOI 10.1001/archgenpsychiatry.2008.510; Rife T, 2009, J NEUROSCI RES, V87, P2319, DOI 10.1002/jnr.22045; Riley DE, 2009, GENE, V429, P74, DOI 10.1016/j.gene.2008.09.025; Riley DE, 2009, GENE, V429, P80, DOI 10.1016/j.gene.2008.09.030; Roberts RL, 2008, PHARMACOGENET GENOM, V18, P434, DOI 10.1097/FPC.0b013e3282f85e47; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Rothenburg S, 2001, IMMUNOL REV, V184, P286, DOI 10.1034/j.1600-065x.2001.1840125.x; Rustighi A, 2002, BIOCHEMISTRY-US, V41, P1229, DOI 10.1021/bi011666o; Sawaya S, 2012, TANDEM REPEAT POLYMO; Sawaya SM, 2012, GENOME BIOL EVOL, V4, P748, DOI 10.1093/gbe/evs050; Searle S, 1999, J MED GENET, V36, P295; Shimajiri S, 1999, FEBS LETT, V455, P70, DOI 10.1016/S0014-5793(99)00863-7; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Todd AK, 2008, NUCLEIC ACIDS RES, V36, P2700, DOI 10.1093/nar/gkn078; Todur SP, 2012, CLIN TRANSLATIONAL S; Tracey M, 2001, CROAT MED J, V42, P233; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Valverde P, 1999, CIRC RES, V84, P937; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Verma A, 2009, NUCLEIC ACIDS RES, V37, P4194, DOI 10.1093/nar/gkn1076; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Wang BS, 2005, ONCOGENE, V24, P3999, DOI 10.1038/sj.onc.1208550; Wang GL, 2007, FRONT BIOSCI-LANDMRK, V12, P4424, DOI 10.2741/2399; Wang SY, 2008, MUTAT RES-FUND MOL M, V638, P26, DOI 10.1016/j.mrfmmm.2007.08.011; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Whetstine JR, 2002, J BIOL CHEM, V277, P43873, DOI 10.1074/jbc.M208296200; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Xu G, 1998, ARCH BIOCHEM BIOPHYS, V358, P83, DOI 10.1006/abbi.1998.0852; Yadav VK, 2008, NUCLEIC ACIDS RES, V36, pD381, DOI 10.1093/nar/gkm781; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729	97	97	104	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54710	10.1371/journal.pone.0054710	http://dx.doi.org/10.1371/journal.pone.0054710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405090	Green Submitted, gold, Green Published			2022-12-25	WOS:000315153400034
J	Becker, D; Wimmers, K; Luther, H; Hofer, A; Leeb, T				Becker, Doreen; Wimmers, Klaus; Luther, Henning; Hofer, Andreas; Leeb, Tosso			A Genome-Wide Association Study to Detect QTL for Commercially Important Traits in Swiss Large White Boars	PLOS ONE			English	Article							QUANTITATIVE TRAIT; CARCASS COMPOSITION; GENETIC-PARAMETERS; MEAT QUALITY; WILD BOAR; REPRODUCTION TRAITS; LOCI; PIG; GROWTH; IDENTIFICATION	The improvement of meat quality and production traits has high priority in the pork industry. Many of these traits show a low to moderate heritability and are difficult and expensive to measure. Their improvement by targeted breeding programs is challenging and requires knowledge of the genetic and molecular background. For this study we genotyped 192 artificial insemination boars of a commercial line derived from the Swiss Large White breed using the PorcineSNP60 BeadChip with 62,163 evenly spaced SNPs across the pig genome. We obtained 26 estimated breeding values (EBVs) for various traits including exterior, meat quality, reproduction, and production. The subsequent genome-wide association analysis allowed us to identify four QTL with suggestive significance for three of these traits (p-values ranging from 4.99 x 10(-6) to 2.73 x 10(-5)). Single QTL for the EBVs pH one hour post mortem (pH1) and carcass length were on pig chromosome (SSC) 14 and SSC 2, respectively. Two QTL for the EBV rear view hind legs were on SSC 10 and SSC 16.	[Becker, Doreen; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Wimmers, Klaus] Leibniz Inst Farm Anim Biol, Dummerstorf, Germany; [Luther, Henning; Hofer, Andreas] SUISAG, Sempach, Switzerland	University of Bern; Forschungsinstitut fur Nutztierbiologie (FBN)	Leeb, T (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Becker, Doreen/AAF-9108-2020; Leeb, Tosso/G-3187-2014; Wimmers, Klaus/AAF-9434-2020	Becker, Doreen/0000-0003-0425-6284; Leeb, Tosso/0000-0003-0553-4880; Wimmers, Klaus/0000-0002-9523-6790	German Research Council (DFG) [LE 1032/23-1]	German Research Council (DFG)(German Research Foundation (DFG))	This study was funded by a grant from the German Research Council (DFG LE 1032/23-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Andersson-Eklund L, 1998, J ANIM SCI, V76, P694; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; de Koning DJ, 2001, LIVEST PROD SCI, V72, P185, DOI 10.1016/S0301-6226(01)00226-3; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Estrada K, 2009, HUM MOL GENET, V18, P3516, DOI 10.1093/hmg/ddp296; Evans GJ, 2003, GENETICS, V164, P621; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Fontanesi L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-583; Geldermann H, 2003, J ANIM BREED GENET, V120, P363, DOI 10.1046/j.0931-2668.2003.00408.x; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gregersen VR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-22; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hermesch S, 2000, LIVEST PROD SCI, V65, P239, DOI 10.1016/S0301-6226(00)00150-0; Karlskov-Mortensen P, 2006, ANIM GENET, V37, P156, DOI 10.1111/j.1365-2052.2005.01405.x; Knott SA, 1998, GENETICS, V149, P1069; Lee GJ, 2003, ANIM SCI, V76, P155, DOI 10.1017/S1357729800053418; Lee SS, 2003, J ANIM BREED GENET, V120, P11, DOI 10.1046/j.0931-2668.2003.00419.x; Malek M, 2001, MAMM GENOME, V12, P630, DOI 10.1007/s003350020018; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Nezer C, 2002, GENET SEL EVOL, V34, P371, DOI [10.1051/gse:2002013, 10.1186/1297-9686-34-3-371]; Onteru SK, 2012, ANIM GENET, V43, P18, DOI 10.1111/j.1365-2052.2011.02213.x; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rohrer GA, 1998, J ANIM SCI, V76, P2255; Schneider JF, 2012, J ANIM SCI, V90, P3360, DOI 10.2527/jas.2011-4759; Sonesson AK, 1998, LIVEST PROD SCI, V57, P23, DOI 10.1016/S0301-6226(98)00163-8; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Uemoto Y, 2010, ANIM SCI J, V81, P28, DOI 10.1111/j.1740-0929.2009.00713.x; Uimari P, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-42; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; van Wijk HJ, 2005, J ANIM SCI, V83, P324; Wang JY, 2013, ANIM GENET, V44, P34, DOI 10.1111/j.1365-2052.2012.02366.x; Wilson K, 2012, J APPL GENET, V53, P449, DOI 10.1007/s13353-012-0112-2	37	27	30	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55951	10.1371/journal.pone.0055951	http://dx.doi.org/10.1371/journal.pone.0055951			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393604	Green Submitted, Green Published, gold			2022-12-25	WOS:000314692800059
J	Bull, SC; Muldoon, MR; Doig, AJ				Bull, Simon C.; Muldoon, Mark R.; Doig, Andrew J.			Maximising the Size of Non-Redundant Protein Datasets Using Graph Theory	PLOS ONE			English	Article							MAXIMUM CLIQUE PROBLEM	Analysis of protein data sets often requires prior removal of redundancy, so that data is not biased by containing similar proteins. This is usually achieved by pairwise comparison of sequences, followed by purging so that no two pairs have similarities above a chosen threshold. From a starting set, such as the PDB or a genome, one should remove as few sequences as possible, to give the largest possible non-redundant set for subsequent analysis. Protein redundancy can be represented as a graph, with proteins as nodes connected by undirected edges, if they have a pairwise similarity above the chosen threshold. The problem is then equivalent to finding the maximum independent set (MIS), where as few nodes are removed as possible to remove all edges. We tested seven MIS algorithms, three of which are new. We applied the methods to the PDB, subsets of the PDB, various genomes and the BHOLSIB benchmark datasets. For PDB subsets of up to 1000 proteins, we could compare to the exact MIS, found by the Cliquer algorithm. The best algorithm was the new method, Leaf. This works by adding clique members that have no edges to nodes outside the clique to the MIS, starting with the smallest cliques. For PDB subsets of up to 1000 members, it usually finds the MIS and is fast enough to apply to data sets of tens of thousands of proteins. Leaf gives sets that are around 10% larger than the commonly used PISCES algorithm, that are of identical quality. We therefore suggest that Leaf should be the method of choice for generating non-redundant protein data sets, though it is ineffective on dense graphs, such as the BHOLSIB benchmarks. The Leaf algorithm is available at: https://github.com/SimonCB765/Leaf, and sets from genomes and the PDB are available at: http://www.bioinf.manchester.ac.uk/leaf/.	[Bull, Simon C.; Doig, Andrew J.] Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, Manchester, Lancs, England; [Muldoon, Mark R.] Univ Manchester, Sch Math, Manchester, Lancs, England	University of Manchester; University of Manchester	Doig, AJ (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Fac Life Sci, Manchester, Lancs, England.	andrew.doig@manchester.ac.uk	Muldoon, Mark/T-9192-2019; Muldoon, Mark R/C-7505-2009; Doig, Andrew/AAD-7456-2019	Doig, Andrew/0000-0003-0346-2270; Muldoon, Mark/0000-0002-5004-7195	BBSRC (UK)	BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The BBSRC (UK) supported this work with a PhD studentship to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Balaji S., 2010, ADV MODEL OPTIM, V12, P107; Barton GJ, 1996, PROTEIN STRUCTURE PR; Grosso A, 2008, J HEURISTICS, V14, P587, DOI 10.1007/s10732-007-9055-x; HOBOHM U, 1994, PROTEIN SCI, V3, P522; Liu P, 2009, BIOINFORMATICS BIOME, P1; Niskanen S, 2003, CLIQUER USERS GUIDE; Ostergard PRJ, 2002, DISCRETE APPL MATH, V120, P197, DOI 10.1016/S0166-218X(01)00290-6; Thain D, 2005, CONCURR COMP-PRACT E, V17, P323, DOI 10.1002/cpe.938; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224	11	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55484	10.1371/journal.pone.0055484	http://dx.doi.org/10.1371/journal.pone.0055484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393584	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000314692800038
J	Hodul, PJ; Dong, YB; Husain, K; Pimiento, JM; Chen, JD; Zhang, AY; Francois, R; Pledger, WJ; Coppola, D; Sebti, SM; Chen, DT; Malafa, MP				Hodul, Pamela J.; Dong, Yanbin; Husain, Kazim; Pimiento, Jose M.; Chen, Jiandong; Zhang, Anying; Francois, Rony; Pledger, Warren J.; Coppola, Domenico; Sebti, Said M.; Chen, Dung-Tsa; Malafa, Mokenge P.			Vitamin E delta-Tocotrienol Induces p27(Kip1) -Dependent Cell-Cycle Arrest in Pancreatic Cancer Cells via an E2F-1-Dependent Mechanism	PLOS ONE			English	Article							P27 EXPRESSION; POOR-PROGNOSIS; PROLIFERATION; RAS; PHOSPHORYLATION; LOCALIZATION; MUTATIONS; P21(CIP1); TUMOR; CHEMOPREVENTION	Vitamin E delta-tocotrienol has been shown to have antitumor activity, but the precise molecular mechanism by which it inhibits the proliferation of cancer cells remains unclear. Here, we demonstrated that delta-tocotrienol exerted significant cell growth inhibition pancreatic ductal cancer (PDCA) cells without affecting normal human pancreatic ductal epithelial cell growth. We also showed that delta-tocotrienol-induced growth inhibition occurred concomitantly with G(1) cell-cycle arrest and increased p27(Kip1) nuclear accumulation. This finding is significant considering that loss of nuclear p27(Kip1) expression is a well-established adverse prognostic factor in PDCA. Furthermore, delta-tocotrienol inactivated RAF-MEK-ERK signaling, a pathway known to suppress p27(Kip1) expression. To determine whether p27(Kip1) induction is required for delta-tocotrienol inhibition of PDCA cell proliferation, we stably silenced the CDKN1B gene, encoding p27(Kip1), in MIAPaCa-2 PDCA cells and demonstrated that p27(Kip1) silencing suppressed cell-cycle arrest induced by delta-tocotrienol. Furthermore, delta-tocotrienol induced p27(Kip1) mRNA expression but not its protein degradation. p27(Kip1) gene promoter activity was induced by delta-tocotrienol through the promoter's E2F-1 binding site, and this activity was attenuated by E2F-1 depletion using E2F-1 small interfering RNA. Finally, decreased proliferation, mediated by Ki67 and p27(Kip1) expression by delta-tocotrienol, was confirmed in vivo in a nude mouse xenograft pancreatic cancer model. Our findings reveal a new mechanism, dependent on p27(Kip1) induction, by which delta-tocotrienol can inhibit proliferation in PDCA cells, providing a new rationale for p27(Kip1) as a biomarker for delta-tocotrienol efficacy in pancreatic cancer prevention and therapy.	[Hodul, Pamela J.; Dong, Yanbin; Husain, Kazim; Pimiento, Jose M.; Malafa, Mokenge P.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA; [Chen, Jiandong; Pledger, Warren J.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Coppola, Domenico] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA; [Sebti, Said M.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Chen, Dung-Tsa] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Biostat Core, Tampa, FL 33612 USA; [Zhang, Anying] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Francois, Rony] Univ Florida, Coll Med, Gainesville, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Electronic Science & Technology of China; State University System of Florida; University of Florida	Malafa, MP (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA.	mokenge.malafa@moffitt.org	Zhang, An/GRS-5852-2022; Pimiento, Jose M./AAA-8284-2021	Francois, Rony/0000-0003-4699-6336	National Institutes of Health (NIH) [1R01 CA-129227-01A1, 5RO1 CA-098473-05, DAVOS 69-15099-99-01, Bankhead-Coley 08BR-02]; Moffitt Foundation [Kurtz Pledge 09-33412-06-01, GI Cancer Research 09-33412-07-01, Steinmann Family Foundation 09-33412-08-05]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA098473, R01CA129227] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moffitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Institutes of Health (NIH) grant K12 Clinical Scholar in Oncology grant (to PJ Hodul) and by Moffitt Foundation grants (Kurtz Pledge 09-33412-06-01, GI Cancer Research 09-33412-07-01, and Steinmann Family Foundation 09-33412-08-05). This work was also supported by NIH grants 1R01 CA-129227-01A1, 5RO1 CA-098473-05, DAVOS 69-15099-99-01 (to MP Malafa), and Bankhead-Coley 08BR-02. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021573; Bagui TK, 2003, MOL CELL BIOL, V23, P7285, DOI 10.1128/MCB.23.20.7285-7290.2003; Bagui TK, 2000, MOL CELL BIOL, V20, P8748, DOI 10.1128/MCB.20.23.8748-8757.2000; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Chan JM, 2005, CANCER EPIDEM BIOMAR, V14, P2093, DOI 10.1158/1055-9965.EPI-05-0226; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; ELSON CE, 1995, J NUTR, V125, pS1666; ELSON CE, 1994, J NUTR, V124, P607, DOI 10.1093/jn/124.5.607; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; Furukawa T, 1996, AM J PATHOL, V148, P1763; GOULD MN, 1991, AM J CLIN NUTR, V53, pS1068, DOI 10.1093/ajcn/53.4.1068S; GRUNEWALD K, 1989, INT J CANCER, V43, P1037, DOI 10.1002/ijc.2910430614; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Hu YX, 2000, PANCREAS, V21, P226, DOI 10.1097/00006676-200010000-00002; Husain K, 2011, MOL CANCER THER, V10, P2363, DOI 10.1158/1535-7163.MCT-11-0424; Husain K, 2009, PHARMACOLOGY, V83, P157, DOI 10.1159/000190792; Hussein D, 2009, PANCREAS, V38, pE124, DOI 10.1097/MPA.0b013e3181a20f9c; Ishimura N, 2003, CANCER LETT, V199, P169, DOI 10.1016/S0304-3835(03)00384-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Juuti A, 2003, ONCOLOGY-BASEL, V65, P371, DOI 10.1159/000074651; Kawa S, 2005, J STEROID BIOCHEM, V97, P173, DOI 10.1016/j.jsbmb.2005.06.021; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lu CD, 1999, CANCER, V85, P1250, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1250::AID-CNCR6>3.3.CO;2-R; MILLS PK, 1988, CANCER-AM CANCER SOC, V61, P2578, DOI 10.1002/1097-0142(19880615)61:12&lt;2578::AID-CNCR2820611232&gt;3.0.CO;2-0; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; MOTOJIMA K, 1993, ANN SURG, V217, P138, DOI 10.1097/00000658-199302000-00007; NGAH WZW, 1991, AM J CLIN NUTR, V53, pS1076, DOI 10.1093/ajcn/53.4.1076S; Orend G, 1998, ONCOGENE, V16, P2575, DOI 10.1038/sj.onc.1201791; PARKER RA, 1993, J BIOL CHEM, V268, P11230; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Reynisdottir I, 1997, GENE DEV, V11, P492, DOI 10.1101/gad.11.4.492; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; Sen CK, 2007, MOL ASPECTS MED, V28, P692, DOI 10.1016/j.mam.2007.03.001; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P5039, DOI 10.2741/2446; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Silverman DT, 1998, JNCI-J NATL CANCER I, V90, P1710, DOI 10.1093/jnci/90.22.1710; Springett GM, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-1299; Sylvester PW, 2005, FRONT BIOSCI, V10, P699, DOI 10.2741/1565; Viglietto G, 2002, CELL CYCLE, V1, P394, DOI 10.4161/cc.1.6.263; Wada S, 2005, CANCER LETT, V229, P181, DOI 10.1016/j.canlet.2005.06.036; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; Wiseman DA, 2007, J PHARMACOL EXP THER, V320, P1163, DOI 10.1124/jpet.106.111666; Xu WL, 2009, NUTRITION, V25, P555, DOI 10.1016/j.nut.2008.10.019; Zhou XH, 2009, ANAT REC, V292, P1122, DOI 10.1002/ar.20938	50	33	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e52526	10.1371/journal.pone.0052526	http://dx.doi.org/10.1371/journal.pone.0052526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393547	gold, Green Published, Green Submitted			2022-12-25	WOS:000314692800001
J	Jetha, NN; Semenchenko, V; Wishart, DS; Cashman, NR; Marziali, A				Jetha, Nahid N.; Semenchenko, Valentyna; Wishart, David S.; Cashman, Neil R.; Marziali, Andre			Nanopore Analysis of Wild-Type and Mutant Prion Protein (PrPC): Single Molecule Discrimination and PrPC Kinetics	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; HIDDEN MARKOV-MODELS; FATAL FAMILIAL INSOMNIA; DNA HAIRPIN MOLECULES; CONFORMATIONAL CONVERSION; DYNAMICS SIMULATIONS; ION-CHANNEL; SCRAPIE; PORE; POLYMORPHISM	Prion diseases are fatal neurodegenerative diseases associated with the conversion of cellular prion protein (PrPC) in the central nervous system into the infectious isoform (PrPSc). The mechanics of conversion are almost entirely unknown, with understanding stymied by the lack of an atomic-level structure for PrPSc. A number of pathogenic PrPC mutants exist that are characterized by an increased propensity for conversion into PrPSc and that differ from wild-type by only a single amino-acid point mutation in their primary structure. These mutations are known to perturb the stability and conformational dynamics of the protein. Understanding of how this occurs may provide insight into the mechanism of PrPC conversion. In this work we sought to explore wild-type and pathogenic mutant prion protein structure and dynamics by analysis of the current fluctuations through an organic alpha-hemolysin nanometer-scale pore (nanopore) in which a single prion protein has been captured electrophoretically. In doing this, we find that wild-type and D178N mutant PrPC, (a PrPC mutant associated with both Fatal Familial Insomnia and Creutzfeldt-Jakob disease), exhibit easily distinguishable current signatures and kinetics inside the pore and we further demonstrate, with the use of Hidden Markov Model signal processing, accurate discrimination between these two proteins at the single molecule level based on the kinetics of a single PrPC capture event. Moreover, we present a four-state model to describe wild-type PrPC kinetics in the pore as a first step in our investigation on characterizing the differences in kinetics and conformational dynamics between wild-type and D178N mutant PrPC. These results demonstrate the potential of nanopore analysis for highly sensitive, real-time protein and small molecule detection based on single molecule kinetics inside a nanopore, and show the utility of this technique as an assay to probe differences in stability between wild-type and mutant prion proteins at the single molecule level.	[Jetha, Nahid N.; Marziali, Andre] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada; [Semenchenko, Valentyna; Wishart, David S.] Natl Inst Nanotechnol, Edmonton, AB, Canada; [Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Wishart, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Cashman, Neil R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; National Research Council Canada; University of Alberta; University of Alberta; University of British Columbia	Jetha, NN (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada.	nahid@phas.ubc.ca	Wishart, David Scott/ABI-3181-2020	Wishart, David S/0000-0002-3207-2434	PrioNet Canada; Natural Sciences and Engineering Research Council of Canada	PrioNet Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by PrioNet Canada (http://www.prionetcanada.ca/). NNJ received scholarship funding from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Alonso DOV, 2001, P NATL ACAD SCI USA, V98, P2985, DOI 10.1073/pnas.061555898; Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; Barducci A, 2005, BIOPHYS J, V88, P1334, DOI 10.1529/biophysj.104.049882; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Caughey B, 1997, J VIROL, V71, P4107, DOI 10.1128/JVI.71.5.4107-4110.1997; Caughey B, 1995, CHEM BIOL, V2, P807, DOI 10.1016/1074-5521(95)90087-X; CHUNG SH, 1990, PHILOS T R SOC B, V329, P265, DOI 10.1098/rstb.1990.0170; Churbanov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S13; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Coulthart MB, 2001, CAN MED ASSOC J, V165, P51; DeGuzman VS, 2006, NUCLEIC ACIDS RES, V34, P6425, DOI 10.1093/nar/gkl754; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Hatlo MM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.068101; Jetha NN, 2009, METHODS MOL BIOL, V544, P129, DOI 10.1007/978-1-59745-483-4_10; Jetha NN, 2009, METHODS MOL BIOL, V544, P113, DOI 10.1007/978-1-59745-483-4_9; Julien O, 2011, BIOCHEMISTRY-US, V50, P7536, DOI 10.1021/bi200731e; Lin JX, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.158101; Ma L, 2010, CHEMBIOCHEM, V11, P25, DOI 10.1002/cbic.200900526; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Meli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019093; Merstorf C, 2012, ACS CHEM BIOL, V7, P652, DOI 10.1021/cb2004737; Mohammad MM, 2008, EUR BIOPHYS J BIOPHY, V37, P913, DOI 10.1007/s00249-008-0309-9; Mohammad MM, 2008, J AM CHEM SOC, V130, P4081, DOI 10.1021/ja710787a; MONARI L, 1994, P NATL ACAD SCI USA, V91, P2839, DOI 10.1073/pnas.91.7.2839; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Movileanu L, 2001, J GEN PHYSIOL, V117, P239, DOI 10.1085/jgp.117.3.239; Nandi PK, 2002, BIOCHEMISTRY-US, V41, P11017, DOI 10.1021/bi025886t; Pastoriza-Gallego M, 2011, J AM CHEM SOC, V133, P2923, DOI 10.1021/ja1073245; Payet L, 2012, ANAL CHEM, V84, P4071, DOI 10.1021/ac300129e; Perez-Pineiro R, 2011, FEBS J, V278, P4002, DOI 10.1111/j.1742-4658.2011.08304.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Soskine M, 2012, NANO LETT, V12, P4895, DOI 10.1021/nl3024438; van der Kamp MW, 2010, J MOL BIOL, V404, P732, DOI 10.1016/j.jmb.2010.09.060; Vanik DL, 2002, J BIOL CHEM, V277, P49065, DOI 10.1074/jbc.M207511200; Venkataramanan L, 2002, BIOPHYS J, V82, P1930, DOI 10.1016/S0006-3495(02)75542-2; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; Vercoutere WA, 2003, NUCLEIC ACIDS RES, V31, P1311, DOI 10.1093/nar/gkg218; Wanunu M, 2010, NAT NANOTECHNOL, V5, P160, DOI [10.1038/nnano.2009.379, 10.1038/NNANO.2009.379]; Winters-Hilt S, 2003, BIOPHYS J, V84, P967, DOI 10.1016/S0006-3495(03)74913-3; Zuegg J, 1999, BIOCHEMISTRY-US, V38, P13862, DOI 10.1021/bi991469d	45	12	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54982	10.1371/journal.pone.0054982	http://dx.doi.org/10.1371/journal.pone.0054982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393562	Green Submitted, Green Published, gold			2022-12-25	WOS:000314692800016
J	Kaur, K; Zarzoso, M; Ponce-Balbuena, D; Guerrero-Serna, G; Hou, LQ; Musa, H; Jalife, J				Kaur, Kuljeet; Zarzoso, Manuel; Ponce-Balbuena, Daniela; Guerrero-Serna, Guadalupe; Hou, Luqia; Musa, Hassan; Jalife, Jose			TGF-beta 1, Released by Myofibroblasts, Differentially Regulates Transcription and Function of Sodium and Potassium Channels in Adult Rat Ventricular Myocytes	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CARDIAC FIBROBLASTS; MYOCARDIAL-INFARCTION; ANGIOTENSIN-II; IN-VITRO; EXPRESSION; CELL; HYPERTROPHY; PHENOTYPE; CARDIOMYOCYTES	Cardiac injury promotes fibroblasts activation and differentiation into myofibroblasts, which are hypersecretory of multiple cytokines. It is unknown whether any of such cytokines are involved in the electrophysiological remodeling of adult cardiomyocytes. We cultured adult cardiomyocytes for 3 days in cardiac fibroblast conditioned medium (FCM) from adult rats. In whole-cell voltage-clamp experiments, FCM-treated myocytes had 41% more peak inward sodium current (I-Na) density at -40 mV than myocytes in control medium (p<0.01). In contrast, peak transient outward current (I-to) was decreased by similar to 55% at 60 mV (p<0.001). Protein analysis of FCM demonstrated that the concentration of TGF-beta 1 was >3 fold greater in FCM than control, which suggested that FCM effects could be mediated by TGF-beta 1. This was confirmed by pre-treatment with TGF-beta 1 neutralizing antibody, which abolished the FCM-induced changes in both I-Na and I-to. In current-clamp experiments TGF-beta 1 (10 ng/ml) prolonged the action potential duration at 30, 50, and 90 repolarization (p<0.05); at 50 ng/ml it gave rise to early afterdepolarizations. In voltage-clamp experiments, TGF-beta 1 increased I-Na density in a dose-dependent manner without affecting voltage dependence of activation or inactivation. I-Na density was -36.25 +/- 2.8 pA/pF in control, -59.17 +/- 6.2 pA/pF at 0.1 ng/ml (p<0.01), and -58.22 +/- 6.6 pA/pF at 1 ng/ml (p<0.01). In sharp contrast, I-to density decreased from 22.2 +/- 1.2 pA/pF to 12.7 +/- 0.98 pA/pF (p<0.001) at 10 ng/ml. At 1 ng/ml TGF-beta 1 significantly increased SCN5A (Na(V)1.5) (+73%; p<0.01), while reducing KCNIP2 (Kchip2; -77%; p<0.01) and KCND2 (K(V)4.2; -50% p<0.05) mRNA levels. Further, the TGF-beta 1-induced increase in I-Na was mediated through activation of the PI3K-AKT pathway via phosphorylation of FOXO1 (a negative regulator of SCN5A). TGF-beta 1 released by myofibroblasts differentially regulates transcription and function of the main cardiac sodium channel and of the channel responsible for the transient outward current. The results provide new mechanistic insight into the electrical remodeling associated with myocardial injury.	[Kaur, Kuljeet; Zarzoso, Manuel; Ponce-Balbuena, Daniela; Guerrero-Serna, Guadalupe; Hou, Luqia; Musa, Hassan; Jalife, Jose] Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jalife, J (corresponding author), Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA.	jjalife@umich.edu	Jalife, Jose/L-4833-2015; Musa, Hassan/AAQ-1548-2021; Kaur, Kuljeet/R-4564-2017; Jalife, Jose/AAJ-9156-2021; Zarzoso, Manuel/AAA-6129-2019	Jalife, Jose/0000-0003-0080-3500; Kaur, Kuljeet/0000-0002-8075-5678; Jalife, Jose/0000-0003-0080-3500; Zarzoso, Manuel/0000-0003-3372-4497	National Institutes of Health Heart, Blood, and Lung Institute (NHLBI) [P01HL039707, P01HL087226]; Fondation Leducq; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087226, P01HL039707] Funding Source: NIH RePORTER	National Institutes of Health Heart, Blood, and Lung Institute (NHLBI); Fondation Leducq(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Heart, Blood, and Lung Institute (NHLBI) Grants P01HL039707, P01HL087226, and by a Transatlantic Network of Excellence Program grant from Fondation Leducq (http://www.fondationleducq.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach DS, 2011, J PHYSIOL-LONDON, V589, P2363, DOI 10.1113/jphysiol.2010.200576; Azhar M, 2003, CYTOKINE GROWTH F R, V14, P391, DOI 10.1016/S1359-6101(03)00044-3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; Dobaczewski M, 2010, CIRC RES, V107, P418, DOI 10.1161/CIRCRESAHA.109.216101; Dobaczewski Marcin, 2009, Front Biosci (Schol Ed), V1, P391, DOI 10.2741/e33; Duffy HS, 2011, J CARDIOVASC PHARM, V57, P373, DOI 10.1097/FJC.0b013e3182155a38; EGHBALI M, 1991, CIRC RES, V69, P483, DOI 10.1161/01.RES.69.2.483; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Guo W, 1999, CARDIOVASC RES, V41, P157, DOI 10.1016/S0008-6363(98)00157-6; Harada M, 1997, CIRCULATION, V96, P3737; HEIMER R, 1995, J MOL CELL CARDIOL, V27, P2191, DOI 10.1016/S0022-2828(95)91479-X; Horio T, 2005, REGUL PEPTIDES, V124, P65, DOI 10.1016/j.regpep.2004.06.029; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Jia Y, 2006, CIRC RES, V98, P386, DOI 10.1161/01.RES.0000201956.86258.e1; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; King KL, 1996, ENDOCRINE, V5, P85, DOI 10.1007/BF02738660; Kupershmidt S, 1998, CIRC RES, V83, P441, DOI 10.1161/01.RES.83.4.441; LaFramboise WA, 2007, AM J PHYSIOL-CELL PH, V292, pC1799, DOI 10.1152/ajpcell.00166.2006; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li X, 2008, AM J PHYSIOL-HEART C, V295, pH416, DOI 10.1152/ajpheart.91446.2007; Mann DL, 2003, NEW ENGL J MED, V349, P1963, DOI 10.1056/NEJMe038163; Mao WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032738; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Nakazato Kazuhiko, 2010, Fukushima J Med Sci, V56, P1, DOI 10.5387/fms.56.1; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Panama BK, 2011, CIRC RES, V108, P537, DOI 10.1161/CIRCRESAHA.110.229112; Pathak M, 2001, HYPERTENSION, V37, P833, DOI 10.1161/01.HYP.37.3.833; Pedrotty DM, 2009, CARDIOVASC RES, V83, P688, DOI 10.1093/cvr/cvp164; Ramos-Mondragon R, 2011, PFLUG ARCH EUR J PHY, V461, P235, DOI 10.1007/s00424-010-0912-3; Ramos-Mondragon R, 2008, VASC HEALTH RISK MAN, V4, P1289; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shang LL, 2008, AM J PHYSIOL-CELL PH, V294, pC372, DOI 10.1152/ajpcell.00186.2007; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Trepanier-Boulay V, 2004, CARDIOVASC RES, V64, P84, DOI 10.1016/j.cardiores.2004.06.002; Vasquez C, 2010, CIRC RES, V107, P1011, DOI 10.1161/CIRCRESAHA.110.227421; Villarreal FJ, 1996, J MOL CELL CARDIOL, V28, P735, DOI 10.1006/jmcc.1996.0068; Wang JG, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-38; Zhang TT, 2001, CIRC RES, V88, P476, DOI 10.1161/01.RES.88.5.476	46	46	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55391	10.1371/journal.pone.0055391	http://dx.doi.org/10.1371/journal.pone.0055391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393573	Green Submitted, Green Published, gold			2022-12-25	WOS:000314692800027
J	Kim, HJ; Woo, HM; Ryu, J; Bok, J; Kim, JW; Choi, SB; Park, MH; Park, HY; Koo, SK				Kim, Hyung Jin; Woo, Hae-Mi; Ryu, Jihee; Bok, Jinwoong; Kim, Jin Woo; Choi, Sang Back; Park, Mi-Hyun; Park, Hyun-Young; Koo, Soo Kyung			Conditional Deletion of Pten Leads to Defects in Nerve Innervation and Neuronal Survival in Inner Ear Development	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; TUMOR-SUPPRESSOR; SENSORY NEURONS; OTIC PLACODE; GROWTH; MOUSE; MICE; PROLIFERATION; COCHLEA; BRAIN	All cellular phenomena and developmental events, including inner ear development, are modulated through harmonized signaling networks. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a tumor suppressor, is a major signaling component involved in cross talk with key regulators of development; i.e., Wnt, Notch, and bone morphogenetic proteins. Although Pten function has been studied in various systems, its role in inner ear development is poorly understood. Here, we used inner ear-specific Pten conditional knockout mice and examined the characteristics of the inner ear. In a detailed analysis of the phenotype, reduced cochlear turning and widened epithelia were observed. Phalloidin staining of sensory epithelium revealed that hair cell patterns were disturbed; i.e., additional rows of hair cells were discovered. The neural abnormality revealed a reduction in and disorganization of nerve fibers, including apoptosis at the neural precursor stage. Pten deficiency induced increased phosphorylation of Akt at Ser473. The elevation of inhibitory glycogen synthase kinase 3 beta Ser9 phosphorylation (pGSK3 beta) was sustained until the neuronal differentiation stage at embryonic day 14.5, instead of pGSK3 beta downregulation. This is the first report on the influence of Pten/Akt/GSK3 beta signaling on the development of spiral ganglia. These results suggest that Pten is required for the maintenance of neuroblast number, neural precursors, and differentiation in the inner ear.	[Kim, Hyung Jin; Woo, Hae-Mi; Ryu, Jihee; Choi, Sang Back; Park, Mi-Hyun; Park, Hyun-Young; Koo, Soo Kyung] Natl Inst Hlth, Ctr Biomed Sci, Cheongwon Gun, Chungcheongbuk, South Korea; [Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Anat, Project Med Sci BK21, Seoul, South Korea; [Kim, Jin Woo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST)	Koo, SK (corresponding author), Natl Inst Hlth, Ctr Biomed Sci, Osong Hlth Technol Adm Complex 643, Cheongwon Gun, Chungcheongbuk, South Korea.	skkoo@nih.go.kr	KIM, JIN WOO/C-1655-2011; Bok, Jinwoong/M-2834-2019	KIM, JIN WOO/0000-0003-0767-1918; Bok, Jinwoong/0000-0003-1958-1872; Park, Hyun-Young/0000-0002-6698-7368	Korea National Institute of Health [4800-4845-300-210, 2100-N63005-00, 4800-4845-302-210, 2012-N61001-00]	Korea National Institute of Health	This study was supported by a Korea National Institute of Health intramural research grant 4800-4845-300-210 (no. 2100-N63005-00) and 4800-4845-302-210 (no. 2012-N61001-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030790; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; Chang W, 2002, DEV BIOL, V251, P380, DOI 10.1006/dbio.2002.0822; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dong YY, 2010, NEUROREPORT, V21, P731, DOI 10.1097/WNR.0b013e32833bfb5e; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; Fritzsch B, 1997, J NEUROSCI, V17, P6213; FRITZSCH B, 1993, HEARING RES, V65, P51, DOI 10.1016/0378-5955(93)90200-K; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Iwata T, 2009, DEV GROWTH DIFFER, V51, P299, DOI 10.1111/j.1440-169X.2009.01104.x; Kazdoba TM, 2012, DEV NEUROSCI-BASEL, V34, P198, DOI 10.1159/000337229; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kim WY, 2001, DEVELOPMENT, V128, P417; Kini V, 2010, J BIOL CHEM, V285, P33082, DOI 10.1074/jbc.M110.142034; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li L, 2002, MOL CELL NEUROSCI, V20, P21, DOI 10.1006/mcne.2002.1115; Liu B, 2009, BBA-BIOMEMBRANES, V1788, P2174, DOI 10.1016/j.bbamem.2009.07.016; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marino S, 2002, DEVELOPMENT, V129, P3513; Monet M, 2012, J BIOL CHEM, V287, P17672, DOI 10.1074/jbc.M112.341354; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; Morsli H, 1998, J NEUROSCI, V18, P3327; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Okano T, 2011, J NEUROSCI, V31, P18104, DOI 10.1523/JNEUROSCI.3619-11.2011; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Sha SH, 2010, HEARING RES, V264, P86, DOI 10.1016/j.heares.2009.09.002; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Wangemann P, 2011, CELL PHYSIOL BIOCHEM, V28, P527, DOI 10.1159/000335113; Wu DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008409; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	47	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55609	10.1371/journal.pone.0055609	http://dx.doi.org/10.1371/journal.pone.0055609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393595	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800049
J	Schechter, SP; Bruns, TD				Schechter, Shannon P.; Bruns, Thomas D.			A Common Garden Test of Host-Symbiont Specificity Supports a Dominant Role for Soil Type in Determining AMF Assemblage Structure in Collinsia sparsiflora	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; EVOLUTIONARY ECOLOGY; LOCAL ADAPTATION; PLANT HOST; SERPENTINE; DIVERSITY; COMMUNITIES; POPULATION; MUTUALISTS; SELECTION	Specialization in plant host-symbiont-soil interactions may help mediate plant adaptation to edaphic stress. Our previous field study showed ecological evidence for host-symbiont specificity between serpentine and non-serpentine adapted ecotypes of Collinsia sparsiflora and arbuscular mycorrrhizal fungi (AMF). To test for adapted plant ecotype-AMF specificity between C. sparsiflora ecotypes and field AMF taxa, we conducted an AMF common garden greenhouse experiment. We grew C. sparsiflora ecotypes individually in a common pool of serpentine and non-serpentine AMF then identified the root AMF by amplifying rDNA, cloning, and sequencing and compared common garden AMF associates to serpentine and non-serpentine AMF controls. Mixing of serpentine and non-serpentine AMF soil inoculum resulted in an intermediate soil classified as non-serpentine soil type. Within this common garden both host ecotypes associated with AMF assemblages that resembled those seen in a non-serpentine soil. ANOSIM analysis and MDS ordination showed that common garden AMF assemblages differed significantly from those in the serpentine-only controls (R = 0.643, P < 0.001), but were similar the non-serpentine-only control AMF assemblages (R = 0.081, P < 0.31). There was no evidence of adapted host ecotype-AMF specificity. Instead soil type accounted for most of the variation AM fungi association patterns, and some differences between field and greenhouse behavior of individual AM fungi were found.	[Schechter, Shannon P.; Bruns, Thomas D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schechter, SP (corresponding author), US EPA, Robert S Kerr Environm Res Ctr, Ada, OK USA.	Schechter.Shannon@epa.gov			U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program; University of California Natural Reserve System; Mycological Society of San Francisco; NSF [2036096]	U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program(United States Environmental Protection Agency); University of California Natural Reserve System; Mycological Society of San Francisco; NSF(National Science Foundation (NSF))	This research has been supported by a grant from the U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program (http://www.epa.gov/ncer/rfa/2012/2012_star_gradfellow.html), by a grant from the University of California Natural Reserve System (http://nrs.ucop.edu/), a grant from the Mycological Society of San Francisco (http://www.mssf.org/), and NSF Grant #2036096 (T.D. Bruns). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; Bidartondo MI, 2002, NATURE, V419, P389, DOI 10.1038/nature01054; Bonfante P, 2008, TRENDS PLANT SCI, V13, P492, DOI 10.1016/j.tplants.2008.07.001; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Clarke K. R., 2001, CHANGES MARINE COMMU; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Croll D, 2008, NEW PHYTOL, V178, P672, DOI 10.1111/j.1469-8137.2008.02381.x; Douds DD, 1998, NEW PHYTOL, V138, P27, DOI 10.1046/j.1469-8137.1998.00876.x; Ehinger M, 2009, NEW PHYTOL, V184, P412, DOI 10.1111/j.1469-8137.2009.02983.x; Gonzalez-Chavez C, 2002, NEW PHYTOL, V155, P163, DOI 10.1046/j.1469-8137.2002.00430.x; Hausmann NT, 2010, ECOLOGY, V91, P2333, DOI 10.1890/09-0924.1; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Helgason T, 2002, J ECOL, V90, P371, DOI 10.1046/j.1365-2745.2001.00674.x; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Ji BM, 2010, ECOLOGY, V91, P3037, DOI 10.1890/09-1451.1; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kruckeberg A.R., 1984, CALIFORNIA SERPENTIN; Linderman RG, 2004, SCI HORTIC-AMSTERDAM, V99, P67, DOI 10.1016/S0304-4238(03)00081-5; MADDISON D, 2005, MACCLADE ANAL PHYLOG; Mangan SA, 2010, ECOLOGY, V91, P2594, DOI 10.1890/09-0396.1; Merckx V, 2008, P ROY SOC B-BIOL SCI, V275, P1029, DOI 10.1098/rspb.2007.1622; Peters SM, 2001, ARID LAND RES MANAG, V15, P359, DOI 10.1080/153249801753127642; Poisot T, 2011, ECOL LETT, V14, P841, DOI 10.1111/j.1461-0248.2011.01645.x; Pringle A, 2002, AM J BOT, V89, P1439, DOI 10.3732/ajb.89.9.1439; Rajakaruna N, 2004, INT GEOL REV, V46, P471, DOI 10.2747/0020-6814.46.5.471; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Renker C, 2006, MYCORRHIZA, V16, P525, DOI 10.1007/s00572-006-0067-4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; Schechter SP, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00059.1; Schultz PA, 2001, AM J BOT, V88, P1650, DOI 10.2307/3558410; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sykorova Z, 2007, MYCORRHIZA, V18, P1, DOI 10.1007/s00572-007-0147-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thrall PH, 2008, J ECOL, V96, P746, DOI 10.1111/j.1365-2745.2008.01381.x; Thrall PH, 2007, TRENDS ECOL EVOL, V22, P120, DOI 10.1016/j.tree.2006.11.007; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Walker C, 2007, MYCOL RES, V111, P137, DOI 10.1016/j.mycres.2006.11.008; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wright JW, 2007, NEW PHYTOL, V173, P354, DOI 10.1111/j.1469-8137.2006.01925.x; Wright JW, 2006, ECOLOGY, V87, P2433, DOI 10.1890/0012-9658(2006)87[2433:EVOENM]2.0.CO;2; Wright JW, 2006, EVOL ECOL RES, V8, P1; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	48	18	18	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55507	10.1371/journal.pone.0055507	http://dx.doi.org/10.1371/journal.pone.0055507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393588	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800042
J	Stefanaki, I; Panagiotou, OA; Kodela, E; Gogas, H; Kypreou, KP; Chatzinasiou, F; Nikolaou, V; Plaka, M; Kalfa, I; Antoniou, C; Ioannidis, JPA; Evangelou, E; Stratigos, AJ				Stefanaki, Irene; Panagiotou, Orestis A.; Kodela, Elisavet; Gogas, Helen; Kypreou, Katerina P.; Chatzinasiou, Foteini; Nikolaou, Vasiliki; Plaka, Michaela; Kalfa, Iro; Antoniou, Christina; Ioannidis, John P. A.; Evangelou, Evangelos; Stratigos, Alexander J.			Replication and Predictive Value of SNPs Associated with Melanoma and Pigmentation Traits in a Southern European Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR MC1R GENE; CUTANEOUS MALIGNANT-MELANOMA; MELANOCORTIN-1 RECEPTOR; RISK-FACTORS; SKIN-CANCER; SUSCEPTIBILITY GENES; SEQUENCE VARIANTS; GREEK PATIENTS; IDENTIFIES 3	Background: Genetic association studies have revealed numerous polymorphisms conferring susceptibility to melanoma. We aimed to replicate previously discovered melanoma-associated single-nucleotide polymorphisms (SNPs) in a Greek case-control population, and examine their predictive value. Methods: Based on a field synopsis of genetic variants of melanoma (MelGene), we genotyped 284 patients and 284 controls at 34 melanoma-associated SNPs of which 19 derived from GWAS. We tested each one of the 33 SNPs passing quality control for association with melanoma both with and without accounting for the presence of well-established phenotypic risk factors. We compared the risk allele frequencies between the Greek population and the HapMap CEU sample. Finally, we evaluated the predictive ability of the replicated SNPs. Results: Risk allele frequencies were significantly lower compared to the HapMap CEU for eight SNPs (rs16891982 - SLC45A2, rs12203592 - IRF4, rs258322 - CDK10, rs1805007 - MC1R, rs1805008 - MC1R, rs910873 - PIGU, rs17305573 - PIGU, and rs1885120 - MTAP) and higher for one SNP (rs6001027 - PLA2G6) indicating a different profile of genetic susceptibility in the studied population. Previously identified effect estimates modestly correlated with those found in our population (r = 0.72, P<0.0001). The strongest associations were observed for rs401681-T in CLPTM1L (odds ratio [OR] 1.60, 95% CI 1.22-2.10; P = 0.001), rs16891982-C in SCL45A2 (OR 0.51, 95% CI 0.34-0.76; P = 0.001), and rs1805007-T in MC1R (OR 4.38, 95% CI 2.03-9.43; P = 2610 25). Nominally statistically significant associations were seen also for another 5 variants (rs258322-T in CDK10, rs1805005-T in MC1R, rs1885120-C in MYH7B, rs2218220-T in MTAP and rs4911442-G in the ASIP region). The addition of all SNPs with nominal significance to a clinical non-genetic model did not substantially improve melanoma risk prediction (AUC for clinical model 83.3% versus 83.9%, p = 0.66). Conclusion: Overall, our study has validated genetic variants that are likely to contribute to melanoma susceptibility in the Greek population.	[Stefanaki, Irene; Kodela, Elisavet; Kypreou, Katerina P.; Chatzinasiou, Foteini; Nikolaou, Vasiliki; Plaka, Michaela; Antoniou, Christina; Stratigos, Alexander J.] Univ Athens, Sch Med, Andreas Sygros Hosp, Dept Dermatol, GR-11527 Athens, Greece; [Panagiotou, Orestis A.; Ioannidis, John P. A.; Evangelou, Evangelos] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Gogas, Helen] Univ Athens, Laikon Hosp, Dept Internal Med, Athens, Greece; [Kalfa, Iro] Laikon Gen Hosp, Blood Donat Unit, Athens, Greece; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA; [Evangelou, Evangelos] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England	Athens Medical School; National & Kapodistrian University of Athens; University of Ioannina; Laiko General Hospital; National & Kapodistrian University of Athens; Laiko General Hospital; Stanford University; Stanford University; Stanford University; University of London; King's College London	Stratigos, AJ (corresponding author), Univ Athens, Sch Med, Andreas Sygros Hosp, Dept Dermatol, GR-11527 Athens, Greece.	alstrat@hol.gr	Stefanaki, Irene/AAT-2771-2021; Evangelou, Evangelos/C-3033-2013; Ioannidis, John P. A./G-9836-2011; Panagiotou, Orestis A/I-5934-2015; Panagiotou, Orestis/AAI-1268-2021; Nikolaou, Vasiliki/AAQ-7874-2021	Stefanaki, Irene/0000-0002-2964-370X; Evangelou, Evangelos/0000-0002-5488-2999; Panagiotou, Orestis A/0000-0001-9604-8380; Nikolaou, Vasiliki/0000-0001-9340-9152	Aristeia Program; European Social Fund and National Resources [1094]	Aristeia Program; European Social Fund and National Resources(European Social Fund (ESF))	The present work was funded by Aristeia Program. This Program is co-funded by the European Social Fund and National Resources (Project code: 1094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bastiaens M, 2001, HUM MOL GENET, V10, P1701, DOI 10.1093/hmg/10.16.1701; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Bataille V, 2003, EUR J CANCER, V39, P1341, DOI 10.1016/S0959-8049(03)00313-7; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Berwick M, 2006, CANCER EPIDEM BIOMAR, V15, P1520, DOI 10.1158/1055-9965.EPI-06-0270; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Chatzinasiou F, 2011, JNCI-J NATL CANCER I, V103, P1227, DOI 10.1093/jnci/djr219; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Fargnoli MC, 2006, EXPERT REV ANTICANC, V6, P657, DOI 10.1586/14737140.6.5.657; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; Ioannidis JPA, 2012, ARCH INTERN MED, V172, P744, DOI 10.1001/archinternmed.2012.931; Kefford RF, 1999, J CLIN ONCOL, V17, P3245, DOI 10.1200/JCO.1999.17.10.3245; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Lasithiotakis K, 2006, INT J DERMATOL, V45, P397, DOI 10.1111/j.1365-4632.2006.02492.x; Lasithiotakis K, 2004, EUR J CANCER, V40, P2502, DOI 10.1016/j.ejca.2004.06.032; Law MH, 2012, J INVEST DERMATOL, V132, P1763, DOI 10.1038/jid.2012.75; MacGregor S, 2011, NAT GENET, V43, P1114, DOI 10.1038/ng.958; Matichard E, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011536; Nan HM, 2011, HUM GENET, V129, P247, DOI 10.1007/s00439-010-0921-5; Nan HM, 2009, INT J CANCER, V125, P909, DOI 10.1002/ijc.24327; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Nikolaou V, 2011, BRIT J DERMATOL, V165, P1219, DOI 10.1111/j.1365-2133.2011.10551.x; Nikolaou VA, 2008, CANCER CAUSE CONTROL, V19, P671, DOI 10.1007/s10552-008-9130-0; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Shekar SN, 2009, J INVEST DERMATOL, V129, P2211, DOI 10.1038/jid.2009.48; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Stratigos AJ, 2006, J INVEST DERMATOL, V126, P399, DOI 10.1038/sj.jid.5700078; Stratigos AJ, 2006, J INVEST DERMATOL, V126, P1842, DOI 10.1038/sj.jid.5700292; Titus-Ernstoff L, 2005, INT J CANCER, V116, P144, DOI 10.1002/ijc.21001; Tucker MA, 2003, ONCOGENE, V22, P3042, DOI 10.1038/sj.onc.1206444; Wacholder S, 2012, AM J EPIDEMIOL, V176, P495, DOI 10.1093/aje/kws255; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630	51	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55712	10.1371/journal.pone.0055712	http://dx.doi.org/10.1371/journal.pone.0055712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393597	gold, Green Submitted, Green Published			2022-12-25	WOS:000314692800051
J	Takasaki, K; Miura, T; Kanno, M; Tamaki, H; Hanada, S; Kamagata, Y; Kimura, N				Takasaki, Kazuto; Miura, Takamasa; Kanno, Manabu; Tamaki, Hideyuki; Hanada, Satoshi; Kamagata, Yoichi; Kimura, Nobutada			Discovery of Glycoside Hydrolase Enzymes in an AvicelAdapted Forest Soil Fungal Community by a Metatranscriptomic Approach	PLOS ONE			English	Article							CELL-WALLS; DIVERSITY; EXPANSIN; GENES; RNA; HYDROLYSIS; DISRUPTION; PROTEIN	To discover the structural and functional novel glycoside hydrolase enzymes from soil fungal communities that decompose cellulosic biomass, transcripts of functional genes in a forest soil were analyzed. Pyrosequencing of the Avicel and wheat-amended soil cDNAs produced 56,084 putative protein-coding sequence (CDS) fragments, and the most dominant group of putative CDSs based on the taxonomic analysis was assigned to the domain Eukarya, which accounted for 99% of the total number of the putative CDSs. Of 9,449 eukaryotic CDSs whose functions could be categorized, approximately 40% of the putative CDSs corresponded to metabolism-related genes, including genes involved in carbohydrate, amino acid, and energy metabolism. Among the carbohydrate-metabolism genes, 129 sequences encoded glycoside hydrolase enzymes, with 47 sequences being putative cellulases belonging to 13 GH families. To characterize the function of glycoside hydrolase enzymes, we synthesized the putative CelA gene with codon optimization for heterologous expression in Escherichia coli, which was shown to be similar to the structure of plant expansins, and observed stimulation for cellulase activity on Avicel degradation. This study demonstrated that fungal communities adapt to Avicel and wheat decomposition and that metatranscriptomic sequence data can be reference data for identifying a novel gene.	[Takasaki, Kazuto; Miura, Takamasa; Kanno, Manabu; Tamaki, Hideyuki; Hanada, Satoshi; Kamagata, Yoichi; Kimura, Nobutada] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kimura, N (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan.	n-kimura@aist.go.jp	Tamaki, Hideyuki/M-9863-2016; Kanno, Manabu/M-4244-2016	Kanno, Manabu/0000-0003-2410-8756	New Energy and industrial technology Development Organization (NEDO) in Japan	New Energy and industrial technology Development Organization (NEDO) in Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported by the New Energy and industrial technology Development Organization (NEDO) in Japan (http://www.nedo.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Botero LM, 2005, APPL ENVIRON MICROB, V71, P1267, DOI 10.1128/AEM.71.3.1267-1275.2005; Bouzarelou D, 2008, FUNGAL GENET BIOL, V45, P839, DOI 10.1016/j.fgb.2008.03.001; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Cosgrove DJ, 2000, CURR OPIN PLANT BIOL, V3, P73, DOI 10.1016/S1369-5266(99)00039-4; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Cowan DA, 2000, TRENDS BIOTECHNOL, V18, P14, DOI 10.1016/S0167-7799(99)01395-5; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; GOODAY GW, 1977, J GEN MICROBIOL, V99, P1; Grant S, 2006, APPL ENVIRON MICROB, V72, P135, DOI 10.1128/AEM.72.1.135-143.2006; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; Lara E, 2007, FEMS MICROBIOL ECOL, V62, P365, DOI 10.1111/j.1574-6941.2007.00387.x; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; McGrath KC, 2008, J MICROBIOL METH, V75, P172, DOI 10.1016/j.mimet.2008.05.019; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; MCQUEENMASON SJ, 1995, PLANT PHYSIOL, V107, P87, DOI 10.1104/pp.107.1.87; Moon-van der Staay SY, 2006, FEMS MICROBIOL ECOL, V57, P420, DOI 10.1111/j.1574-6941.2006.00130.x; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Voget S, 2003, APPL ENVIRON MICROB, V69, P6235, DOI 10.1128/AEM.69.10.6235-6242.2003; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Zachow C, 2009, ISME J, V3, P79, DOI 10.1038/ismej.2008.87	37	23	24	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55485	10.1371/journal.pone.0055485	http://dx.doi.org/10.1371/journal.pone.0055485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393585	Green Submitted, gold, Green Published			2022-12-25	WOS:000314692800039
J	Uchida, Y; Maezawa, Y; Uchida, Y; Hiruta, N; Shimoyama, E; Kawai, S				Uchida, Yasumi; Maezawa, Yuko; Uchida, Yasuto; Hiruta, Nobuyuki; Shimoyama, Ei; Kawai, Seiji			Localization of Oxidized Low-Density Lipoprotein and Its Relation to Plaque Morphology in Human Coronary Artery	PLOS ONE			English	Article							ATHEROSCLEROTIC LESIONS; MACROPHAGES; LDL; OXIDATION; VISUALIZATION; ACCUMULATION; CELLS	Objectives: Oxidized low-density lipoprotein (oxLDL) plays a key role in the formation of atherosclerotic plaques. However, its localization in human coronary arterial wall is not well understood. The present study was performed to visualize deposition sites and patterns of native oxLDL and their relation to plaque morphology in human coronary artery. Methods: Evans blue dye (EB) elicits a violet fluorescence by excitation at 345-nm and emission at 420-nm, and a reddish-brown fluorescence by excitation at 470-nm and emission at 515-nm characteristic of oxLDL only. Therefore, native oxLDL in excised human coronary artery were investigated by color fluorescent microscopy (CFM) using EB as a biomarker. Results: (1) By luminal surface scan with CFM, the % incidence of oxLDL in 38 normal segments, 41 white plaques and 32 yellow plaques that were classified by conventional angioscopy, was respectively 26, 44 and 94, indicating significantly (p<0.05) higher incidence in the latter than the former two groups. Distribution pattern was classified as patchy, diffuse and web-like. Web-like pattern was observed only in yellow plaques with necrotic core. (2) By transected surface scan, oxLDL deposited within superficial layer in normal segments and diffusely within both superficial and deep layers in white and yellow plaques. In yellow plaques with necrotic core, oxLDL deposited not only in the marginal zone of the necrotic core but also in the fibrous cap. Conclusion: Taken into consideration of the well-known process of coronary plaque growth, the results suggest that oxLDL begins to deposit in human coronary artery wall before plaque formation and increasingly deposits with plaque growth, exhibiting different deposition sites and patterns depending on morphological changes.	[Uchida, Yasumi] Japan Fdn Cardiovasc Res, Funabashi, Chiba, Japan; [Maezawa, Yuko] Chiba Univ, Dept Cellular Therapy, Chiba, Japan; [Uchida, Yasuto] Toho Univ, Ohmori Hosp, Dept Cardiol, Tokyo, Japan; [Hiruta, Nobuyuki] Toho Univ, Sakura Hosp, Dept Pathol, Sakura, Japan; [Shimoyama, Ei] Funabashi Futawa Hosp, Dept Pathol, Funabashi, Chiba, Japan; [Kawai, Seiji] Chiba Kensei Hosp, Dept Surg, Chiba, Japan	Chiba University; Toho University; Toho University	Uchida, Y (corresponding author), Japan Fdn Cardiovasc Res, Funabashi, Chiba, Japan.	uchiy@ta2.so-net.ne.jp		Maezawa, Yoshiro/0000-0001-5567-9901				Al Gadban MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012534; BALL RY, 1995, ATHEROSCLEROSIS, V114, P45, DOI 10.1016/0021-9150(94)05463-S; Briley-Saebo KC, 2008, CIRCULATION, V117, P3206, DOI 10.1161/CIRCULATIONAHA.107.757120; Chen JH, 2009, ARTERIOSCL THROM VAS, V29, P92, DOI 10.1161/ATVBAHA.108.174599; Fang LH, 2011, J CLIN INVEST, V121, P4861, DOI 10.1172/JCI57755; Fukuchi M, 2002, LAB INVEST, V82, P1437, DOI 10.1097/01.LAB.0000032546.01658.5D; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Harvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183; Itabe H, 2000, BBA-MOL CELL BIOL L, V1487, P233, DOI 10.1016/S1388-1981(00)00098-6; Iuliano L, 1996, ATHEROSCLEROSIS, V126, P131; Kayo S, 2004, AM HEART J, V148, P818, DOI 10.1016/j.ahj.2004.05.042; Li W, 1998, ARTERIOSCL THROM VAS, V18, P177, DOI 10.1161/01.ATV.18.2.177; Matsuura E, 2008, AUTOIMMUN REV, V7, P558, DOI 10.1016/j.autrev.2008.04.018; Okura Y, 2000, CIRCULATION, V102, P2680, DOI 10.1161/01.CIR.102.22.2680; Ovchinnikova O, 2009, ARTERIOSCL THROM VAS, V29, P1478, DOI 10.1161/ATVBAHA.109.188185; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; SHAH PK, 1995, CIRCULATION, V92, P1565; Shah PK, 2009, CARDIOVASC DRUG THER, V23, P31, DOI 10.1007/s10557-008-6147-2; Sigala F, 2010, J VASC SURG, V52, P704, DOI 10.1016/j.jvs.2010.03.047; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; TERASAWA K, 2000, J JPN COLL ANGIOL, V40, P159; Tsimikas S, 1999, J NUCL CARDIOL, V6, P41, DOI 10.1016/S1071-3581(99)90064-8; UCHIDA Y, 1995, AM HEART J, V130, P1114, DOI 10.1016/0002-8703(95)90216-3; UCHIDA Y, 2006, Patent No. 7025981; Uchida Y, 2001, CORONARY ANGIOSCOPY, P71; Uchida Y, 2012, MOL IMAGING, P247; Uchida Y, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/JOURNAL.PONE.0031530; Uchida Y, 2001, CORONARY ANGIOSCOPY, P51; Uchida Y, 2001, CORONARY ANGIOSCOPY, P14; Uchida Y, 2011, CIRC J, V75, P1913, DOI 10.1253/circj.CJ-10-1286; Uchida Y, 2011, ARTERIOSCL THROM VAS, V31, P1452, DOI 10.1161/ATVBAHA.110.221671; Uchida Y, 2010, CIRC J, V74, P2181, DOI 10.1253/circj.CJ-10-0451; Uchida Y, 2010, JACC-CARDIOVASC IMAG, V3, P398, DOI 10.1016/j.jcmg.2009.09.030; Vickers KC, 2009, J LIPID RES, V50, P1735, DOI 10.1194/jlr.M800342-JLR200; Yamada Nobuhiro, 2002, Nihon Rinsho, V60 Suppl 10, P87; Yancey PG, 1998, J LIPID RES, V39, P1349; Zaima N, 2011, ATHEROSCLEROSIS, V217, P427, DOI 10.1016/j.atherosclerosis.2011.03.044	37	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55188	10.1371/journal.pone.0055188	http://dx.doi.org/10.1371/journal.pone.0055188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393566	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800020
J	Gao, XN; Lin, J; Ning, QY; Gao, L; Yao, YS; Zhou, JH; Li, YH; Wang, LL; Yu, L				Gao, Xiao-ning; Lin, Ji; Ning, Qiao-yang; Gao, Li; Yao, Yu-shi; Zhou, Ji-hao; Li, Yong-hui; Wang, Li-li; Yu, Li			A Histone Acetyltransferase p300 Inhibitor C646 Induces Cell Cycle Arrest and Apoptosis Selectively in AML1-ETO-Positive AML Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MONOCYTIC LEUKEMIA; G1/S TRANSITION; FUSION PROTEIN; AML1-ETO; CBP/P300; AML1/ETO; TRANSCRIPTION; PATHWAYS; KINASE	AML1-ETO fusion protein (AE) is generated by t(8;21)(q22;q22) chromosomal translocation, which is one of the most frequently observed structural abnormalities in acute myeloid leukemia (AML) and displays a pivotal role in leukemogenesis. The histone acetyltransferase p300 promotes self-renewal of leukemia cells by acetylating AE and facilitating its downstream gene expression as a transcriptional coactivator, suggesting that p300 may be a potential therapeutic target for AE-positive AML. However, the effects of p300 inhibitors on leukemia cells and the underlying mechanisms have not been extensively investigated. In the current study, we analyzed the anti-leukemia effects of C646, a selective and competitive p300 inhibitor, on AML cells. Results showed that C646 inhibited cellular proliferation, reduced colony formation, evoked partial cell cycle arrest in G1 phase, and induced apoptosis in AE-positive AML cell lines and primary blasts isolated from leukemic mice and AML patients. Nevertheless, no significant inhibitory effects were observed in granulocyte colony-stimulating factor-mobilized normal peripheral blood stem cells. Notably, AE-positive AML cells were more sensitive to lower C646 doses than AE-negative ones. And C646-induced growth inhibition on AE-positive AML cells was associated with reduced global histone H3 acetylation and declined c-kit and bcl-2 levels. Therefore, C646 may be a potential candidate for treating AE-positive AML.	[Gao, Xiao-ning; Ning, Qiao-yang; Gao, Li; Yao, Yu-shi; Zhou, Ji-hao; Li, Yong-hui; Wang, Li-li; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Lin, Ji] Chinese Peoples Liberat Army Gen Hosp, Cent Lab, Hainan Branch, Sanya, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Yu, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China.	chunhuiliyu@yahoo.com	wang, lili/HDL-7210-2022	Yu, Li/0000-0001-6872-2665	National Natural Science Foundation of China [81000221, 81171820, 90919044, 30971297]; Beijing Natural Science Foundation [7122169, 7112126]; Beijing New Stars Program of Science and Technology [2010B075]; National Public Health Grand Research Foundation [201202017]; Capital Public Health Project [Z111107067311070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing New Stars Program of Science and Technology; National Public Health Grand Research Foundation; Capital Public Health Project	This work was supported by the National Natural Science Foundation of China (No. 81000221, No. 81171820, No. 90919044 and No. 30971297), the Beijing Natural Science Foundation (No. 7122169, No. 7112126), the Beijing New Stars Program of Science and Technology (No. 2010B075), the National Public Health Grand Research Foundation (No. 201202017) and the Capital Public Health Project (No. Z111107067311070). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Bandyopadhyay D, 2002, CANCER RES, V62, P6231; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Chan HM, 2001, J CELL SCI, V114, P2363; Elagib KE, 2007, CANCER LETT, V251, P179, DOI 10.1016/j.canlet.2006.10.010; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Fazi F, 2007, BLOOD, V109, P4432, DOI 10.1182/blood-2006-09-045781; Feng LX, 2000, J BIOL CHEM, V275, P25572, DOI 10.1074/jbc.M002218200; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Goodman RH, 2000, GENE DEV, V14, P1553; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Grisolano JL, 2003, P NATL ACAD SCI USA, V100, P9506, DOI 10.1073/pnas.1531730100; Iyer NG, 2007, ONCOGENE, V26, P21, DOI 10.1038/sj.onc.1209771; Katsumoto T, 2008, CANCER SCI, V99, P1523, DOI 10.1111/j.1349-7006.2008.00865.x; Kitabayashi I, 2001, LEUKEMIA, V15, P89, DOI 10.1038/sj.leu.2401983; Klampfer L, 1996, P NATL ACAD SCI USA, V93, P14059, DOI 10.1073/pnas.93.24.14059; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; Santer FR, 2011, MOL CANCER THER, V10, P1644, DOI 10.1158/1535-7163.MCT-11-0182; Wang L, 2011, SCIENCE, V333, P765, DOI 10.1126/science.1201662; Wang YY, 2011, P NATL ACAD SCI USA, V108, P2450, DOI 10.1073/pnas.1019625108; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443	22	72	74	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55481	10.1371/journal.pone.0055481	http://dx.doi.org/10.1371/journal.pone.0055481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390536	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100052
J	Hou, JY; Rodriguez-Gabin, A; Samaweera, L; Hazan, R; Goldberg, GL; Horwitz, SB; McDaid, HM				Hou, June Y.; Rodriguez-Gabin, Alicia; Samaweera, Leleesha; Hazan, Rachel; Goldberg, Gary L.; Horwitz, Susan Band; McDaid, Hayley M.			Exploiting MEK Inhibitor-Mediated Activation of ER alpha for Therapeutic Intervention in ER-Positive Ovarian Carcinoma	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; TREFOIL FACTOR-1; LOW-GRADE; PROGESTERONE-RECEPTOR; SEROUS CARCINOMA; PHASE-II; PHOSPHORYLATION; EXPRESSION; LETROZOLE	While the clinical benefit of MEK inhibitor (MEKi)-based therapy is well established in Raf mutant malignancies, its utility as a suppressor of hyperactive MAPK signaling in the absence of mutated Raf or Ras, is an area of ongoing research. MAPK activation is associated with loss of ER alpha expression and hormonal resistance in numerous malignancies. Herein, we demonstrate that MEKi induces a feedback response that results in ER alpha overexpression, phosphorylation and transcriptional activation of ER-regulated genes. Mechanistically, MEKi-mediated ER alpha overexpression is largely independent of erbB2 and AKT feedback activation, but is ERK-dependent. We subsequently exploit this phenomenon therapeutically by combining the ER-antagonist, fulvestrant with MEKi. This results in synergistic suppression of tumor growth, in vitro and potentiation of single agent activity in vivo in nude mice bearing xenografts. Thus, we demonstrate that exploiting adaptive feedback after MEKi can be used to sensitize ER alpha-positive tumors to hormonal therapy, and propose that this strategy may have broader clinical utility in ER alpha-positive ovarian carcinoma.	[Hou, June Y.; Goldberg, Gary L.] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Obstet & Gynecol & Womens Hlth, Div Gynecol Oncol, Bronx, NY 10467 USA; [Rodriguez-Gabin, Alicia; Samaweera, Leleesha; Horwitz, Susan Band] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Hazan, Rachel] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [McDaid, Hayley M.] Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McDaid, HM (corresponding author), Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA.	hayley.mcdaid@einstein.yu.edu	Hou, June/L-6992-2019		National Cancer Institute Grant [CA077263]; Breast Cancer Research Foundation; National Foundation for Cancer Research; National Institutes of Health Grant [K12CA132783-01A1]; Young Clinical Investigators award from Montefiore Medical Center; NATIONAL CANCER INSTITUTE [K12CA132783, R01CA135061, R01CA136854, R01CA077263] Funding Source: NIH RePORTER	National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; National Foundation for Cancer Research; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Young Clinical Investigators award from Montefiore Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Grant CA077263, the Breast Cancer Research Foundation (HMD and SBH), the National Foundation for Cancer Research (SBH), National Institutes of Health Grant K12CA132783-01A1 (HMD and JYH). JYH was the recipient of a Young Clinical Investigators award from Montefiore Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenta PA, 2009, GYNECOL ONCOL, V113, P205, DOI 10.1016/j.ygyno.2009.01.012; Arias-Pulido H, 2009, GYNECOL ONCOL, V114, P480, DOI 10.1016/j.ygyno.2009.05.045; Atsriku C, 2009, MOL CELL PROTEOMICS, V8, P467, DOI 10.1074/mcp.M800282-MCP200; Ayhan A, 2009, AM J SURG PATHOL, V33, P1220, DOI 10.1097/PAS.0b013e3181a24354; Bayliss J, 2007, CLIN CANCER RES, V13, P7029, DOI 10.1158/1078-0432.CCR-07-0587; Bindels EMJ, 2002, ONCOGENE, V21, P8158, DOI 10.1038/sj.onc.1206012; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bowman A, 2002, CLIN CANCER RES, V8, P2233; Buache E, 2011, ONCOGENE, V30, P3261, DOI 10.1038/onc.2011.41; Clarkl DE, 2001, EMBO J, V20, P3484, DOI 10.1093/emboj/20.13.3484; Covens AL, 2011, GYNECOL ONCOL, V120, P185, DOI 10.1016/j.ygyno.2010.10.015; Cunat S, 2004, GYNECOL ONCOL, V94, P25, DOI 10.1016/j.ygyno.2004.03.026; de Leeuw R., 2012, ONCOGENE; de Leeuw R, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/232435; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Gross AL, 2010, J ONCOL, V2010, DOI 10.1155/2010/126295; Ho CL, 2004, CANCER RES, V64, P6915, DOI 10.1158/0008-5472.CAN-04-2067; Houtman R, 2012, MOL CANCER THER, V11, P805, DOI 10.1158/1535-7163.MCT-11-0855; Howlader NNA, 2011, SEER CANC STAT REV, P1975; Hsu CY, 2004, CLIN CANCER RES, V10, P6432, DOI 10.1158/1078-0432.CCR-04-0893; Huang GS, 2006, CLIN CANCER RES, V12, P298, DOI 10.1158/1078-0432.CCR-05-0229; Joel PB, 1998, J BIOL CHEM, V273, P13317, DOI 10.1074/jbc.273.21.13317; Karam SM, 2008, CELL PROLIFERAT, V41, P923, DOI 10.1111/j.1365-2184.2008.00562.x; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; LANGDON SP, 1993, INT J CANCER, V55, P459, DOI 10.1002/ijc.2910550323; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Lau KM, 1999, P NATL ACAD SCI USA, V96, P5722, DOI 10.1073/pnas.96.10.5722; Legrier M-E, 2007, P 98 ANN M AM ASS CA; Legrier ME, 2007, CANCER RES, V67, P11300, DOI 10.1158/0008-5472.CAN-07-0702; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Markman M, 1996, GYNECOL ONCOL, V62, P4, DOI 10.1006/gyno.1996.0181; O'Donnell AJM, 2005, ENDOCR-RELAT CANCER, V12, P851, DOI 10.1677/erc.1.01039; Papadimitriou CA, 2004, ONCOLOGY-BASEL, V66, P112, DOI 10.1159/000077436; PETRANGELI E, 1994, J STEROID BIOCHEM, V49, P327, DOI 10.1016/0960-0760(94)90275-5; RAO BR, 1991, ENDOCR REV, V12, P14, DOI 10.1210/edrv-12-1-14; Regalo G, 2005, CELL MOL LIFE SCI, V62, P2910, DOI 10.1007/s00018-005-5478-4; Ribieras S, 1998, BBA-REV CANCER, V1378, pF61, DOI 10.1016/S0304-419X(98)00016-X; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Schmeler KM, 2008, GYNECOL ONCOL, V108, P510, DOI 10.1016/j.ygyno.2007.11.013; Seidman JD, 2006, GYNECOL ONCOL, V103, P703, DOI 10.1016/j.ygyno.2006.05.030; SHELLING AN, 1995, BRIT J CANCER, V72, P521, DOI 10.1038/bjc.1995.367; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smyth JF, 2007, CLIN CANCER RES, V13, P3617, DOI 10.1158/1078-0432.CCR-06-2878; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Song RXD, 2010, J STEROID BIOCHEM, V118, P219, DOI 10.1016/j.jsbmb.2009.09.018; Suga S, 2007, GYNECOL ONCOL, V105, P341, DOI 10.1016/j.ygyno.2006.12.030; Vereczkey I, 2011, PATHOL ONCOL RES, V17, P551, DOI 10.1007/s12253-010-9345-8; Walker G, 2007, GYNECOL ONCOL, V106, P461, DOI 10.1016/j.ygyno.2007.05.009; Yamnik RL, 2010, FEBS LETT, V584, P124, DOI 10.1016/j.febslet.2009.11.041; Yan L, 2009, 100 AACR ANN M; Yoon J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004560; Yoon YK, 2009, MOL CANCER THER, V8, P2526, DOI 10.1158/1535-7163.MCT-09-0300	54	19	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54103	10.1371/journal.pone.0054103	http://dx.doi.org/10.1371/journal.pone.0054103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390495	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100011
J	Seo, HJ; Kim, HC; Klein, TA; Ramey, AM; Lee, JH; Kyung, SG; Park, JY; Cho, YS; Cho, IS; Yeh, JY				Seo, Hyun-Ji; Kim, Heung Chul; Klein, Terry A.; Ramey, Andrew M.; Lee, Ji-Hye; Kyung, Soon-Goo; Park, Jee-Yong; Cho, Yun Sang; Cho, In-Soo; Yeh, Jung-Yong			Molecular Detection and Genotyping of Japanese Encephalitis Virus in Mosquitoes during a 2010 Outbreak in the Republic of Korea	PLOS ONE			English	Article							WEST-NILE-VIRUS; LABORATORY TRANSMISSION; FREQUENT INTRODUCTIONS; SOUTH-KOREA; EAST-ASIA; CHINA; CULICIDAE; DIPTERA; IDENTIFICATION; IMMUNIZATION	Japanese encephalitis virus (JEV), a mosquito-borne zoonotic pathogen, is one of the major causes of viral encephalitis. To reduce the impact of Japanese encephalitis among children in the Republic of Korea (ROK), the government established a mandatory vaccination program in 1967. Through the efforts of this program only 0-7 (mean 2.1) cases of Japanese encephalitis were reported annually in the ROK during the period of 1984-2009. However, in 2010 there was an outbreak of 26 confirmed cases of Japanese encephalitis, including 7 deaths. This represented a >12-fold increase in the number of confirmed cases of Japanese encephalitis in the ROK as compared to the mean number reported over the last 26 years and a 3.7-fold increase over the highest annual number of cases during this same period (7 cases). Surveillance of adult mosquitoes was conducted during the 2010 outbreak of Japanese encephalitis in the ROK. A total of 6,328 culicine mosquitoes belonging to 12 species from 5 genera were collected at 6 survey sites from June through October 2010 and assayed by reverse-transcription polymerase chain reaction (RT-PCR) for the presence of JEV. A total of 34/371 pooled samples tested positive for JEV (29/121 Culex tritaeniorhynchus, 4/64 Cx. pipiens, and 1/26 Cx. bitaeniorhynchus) as confirmed by sequencing of the pre-membrane and envelope protein coding genes. The maximum likelihood estimates of JEV positive individuals per 1,000 culicine vectors for Cx. tritaeniorhynchus, Cx. pipiens, and Cx. bitaeniorhynchus were 11.8, 5.6, and 2.8, respectively. Sequences of the JEV pre-membrane and envelope protein coding genes amplified from the culicine mosquitoes by RT-PCR were compared with those of JEV genotypes I-V. Phylogenetic analyses support the detection of a single genotype (I) among samples collected from the ROK in 2010.	[Seo, Hyun-Ji; Lee, Ji-Hye; Park, Jee-Yong; Cho, Yun Sang; Cho, In-Soo; Yeh, Jung-Yong] Anim Plant & Fisheries Quarantine & Inspect Agcy, Foreign Anim Dis Div, Anyang Si, South Korea; [Kim, Heung Chul] 5th Med Detachment, Unit 15247, Multifunct Med Battal 168, Med Brigade 65, Seoul, South Korea; [Klein, Terry A.] Force Hlth Protect & Prevent Med, Med Brigade USAMEDDAC Korea 65, Unit 15281, Seoul, South Korea; [Ramey, Andrew M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Kyung, Soon-Goo] Korea Racing Author, Gwacheon, South Korea; [Yeh, Jung-Yong] Univ Incheon, Div Life Sci, Coll Life Sci & Bioengn, Inchon, South Korea	Animal & Plant Quarantine Agency; United States Department of the Interior; United States Geological Survey; Incheon National University	Yeh, JY (corresponding author), Anim Plant & Fisheries Quarantine & Inspect Agcy, Foreign Anim Dis Div, Anyang Si, South Korea.	malvab2848@gmail.com		Yeh, Jung-Yong/0000-0002-0939-7783; Cho, Yun Sang/0000-0003-1346-7067; Ramey, Andrew/0000-0002-3601-8400	Korea National Veterinary Research and Quarantine Service (NVRQS) [N-AD13-2011-13-01]; Korean Horse Racing Authority, Seoul, ROK; Uniformed Services University, Bethesda, MD; Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS), Silver Spring, MD; National Center for Medical Intelligence	Korea National Veterinary Research and Quarantine Service (NVRQS); Korean Horse Racing Authority, Seoul, ROK; Uniformed Services University, Bethesda, MD; Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS), Silver Spring, MD; National Center for Medical Intelligence	This work was supported by Korea National Veterinary Research and Quarantine Service (NVRQS) grant N-AD13-2011-13-01. This work was also supported through a joint partnership between the Korean Horse Racing Authority, Seoul, ROK; the Uniformed Services University, Bethesda, MD; the Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System (AFHSC-GEIS), Silver Spring, MD; and the National Center for Medical Intelligence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE K, 1978, INDIAN J MED RES, V67, P889; BHATTACHARYA S, 1986, TROP GEOGR MED, V38, P46; Cao QS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-472; CHEN WR, 1992, AM J TROP MED HYG, V47, P61, DOI 10.4269/ajtmh.1992.47.61; CHEN WR, 1990, J GEN VIROL, V71, P2915, DOI 10.1099/0022-1317-71-12-2915; Cho YJ, 2007, J BACTERIOLOGY VIROL, V37, P161; GRASCENKOV N. I., 1964, BULL WORLD HLTH ORGAN, V30, P161; Hanna JN, 1996, MED J AUSTRALIA, V165, P256, DOI 10.5694/j.1326-5377.1996.tb124960.x; IGARASHI A, 1994, MICROBIOL IMMUNOL, V38, P827, DOI 10.1111/j.1348-0421.1994.tb01866.x; Jeong YE, 2011, ACTIVITY JAPANESE EN; Johansen CA, 2002, AM J TROP MED HYG, V67, P656, DOI 10.4269/ajtmh.2002.67.656; K-CDC, 2010, INF DIS SURV YB REP, P51; Kim HC, 2011, J MED ENTOMOL, V48, P1250, DOI 10.1603/ME11091; Kim Heung Chul, 2007, Entomological Research, V37, P267, DOI 10.1111/j.1748-5967.2007.00124.x; Kim JO, 2009, ESTABLISHMENT IN VIT; Lee H.W., 1971, J KOREAN MED ASSOC, V14, P871; LEWIS L, 1947, ARCH NEURO PSYCHIATR, V57, P430, DOI 10.1001/archneurpsyc.1947.02300270048004; Li YX, 2011, EMERG INFECT DIS, V17, P934, DOI 10.3201/eid1705.101417; Nabeshima T, 2009, J GEN VIROL, V90, P827, DOI 10.1099/vir.0.007617-0; Nga PT, 2004, J GEN VIROL, V85, P1625, DOI 10.1099/vir.0.79797-0; Nitatpattana N, 2008, EMERG INFECT DIS, V14, P1762, DOI 10.3201/eid1411.080542; ROSEN L, 1986, ANNU REV MICROBIOL, V40, P395, DOI 10.1146/annurev.mi.40.100186.002143; Saito M, 2007, AM J TROP MED HYG, V77, P737, DOI 10.4269/ajtmh.2007.77.737; Sohn YM, 2000, EMERG INFECT DIS, V6, P17; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; SUCHARIT S, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P611; Takasaki T, 2003, VACCINE, V21, P4514, DOI 10.1016/S0264-410X(03)00507-3; Takhampunya R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-449; Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2; Turell MJ, 2006, J MED ENTOMOL, V43, P1076, DOI 10.1603/0022-2585(2006)43[1076:LTOJEW]2.0.CO;2; Turell MJ, 2006, J MED ENTOMOL, V43, P296, DOI 10.1603/0022-2585(2006)043[0296:LTOJEA]2.0.CO;2; Turell MJ, 2003, J MED ENTOMOL, V40, P580, DOI 10.1603/0022-2585-40.4.580; United Nations, 2005, UN URB PROSP 2005 RE; VYTHILINGAM I, 1995, J AM MOSQUITO CONTR, V11, P94; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; Wang HY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-73; Wang LH, 2007, EMERG INFECT DIS, V13, P1123, DOI 10.3201/eid1307.070010; Wang LH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-345; Weng MH, 2000, J MED ENTOMOL, V37, P780, DOI 10.1603/0022-2585-37.5.780; Williams DT, 2001, AM J TROP MED HYG, V65, P379, DOI 10.4269/ajtmh.2001.65.379; World Health Organization, 2008, WORLD HLTH REP YEARS; Yamshchikov G, 2005, VACCINE, V23, P4785, DOI 10.1016/j.vaccine.2005.04.036; Yang Dong Kun, 2004, J Vet Sci, V5, P125; Yun SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-127; Zhang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016418; Zheng YY, 2012, REV MED VIROL, V22, P301, DOI 10.1002/rmv.1710	46	53	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55165	10.1371/journal.pone.0055165	http://dx.doi.org/10.1371/journal.pone.0055165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390520	Green Submitted, Green Published, gold			2022-12-25	WOS:000314691100036
J	Garcia, RA; Search, DJ; Lupisella, JA; Ostrowski, J; Guan, B; Chen, J; Yang, WP; Truong, A; He, AQ; Zhang, RG; Yan, MJ; Hellings, SE; Gargalovic, PS; Ryan, CS; Watson, LM; Langish, RA; Shipkova, PA; Carson, NL; Taylor, JR; Yang, R; Psaltis, GC; Harrity, TW; Robl, JA; Gordon, DA				Garcia, Ricardo A.; Search, Debra J.; Lupisella, John A.; Ostrowski, Jacek; Guan, Bo; Chen, Jian; Yang, Wen-Pin; Amy Truong; He, Aiqing; Zhang, Rongan; Yan, Mujing; Hellings, Samuel E.; Gargalovic, Peter S.; Ryan, Carol S.; Watson, Linda M.; Langish, Robert A.; Shipkova, Petia A.; Carson, Nancy L.; Taylor, Joseph R.; Yang, Richard; Psaltis, George C.; Harrity, Thomas W.; Robl, Jeffrey A.; Gordon, David A.			11 beta-Hydroxysteroid Dehydrogenase Type 1 Gene Knockout Attenuates Atherosclerosis and In Vivo Foam Cell Formation in Hyperlipidemic apoE(-/-) Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TOLL-LIKE RECEPTOR-4; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; VISCERAL OBESITY; OXIDIZED LDL; MACROPHAGES; INHIBITION; ACCUMULATION; APOPTOSIS	Background: Chronic glucocorticoid excess has been linked to increased atherosclerosis and general cardiovascular risk in humans. The enzyme 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta HSD1) increases active glucocorticoid levels within tissues by catalyzing the conversion of cortisone to cortisol. Pharmacological inhibition of 11 beta HSD1 has been shown to reduce atherosclerosis in murine models. However, the cellular and molecular details for this effect have not been elucidated. Methodology/Principal Findings: To examine the role of 11 beta HSD1 in atherogenesis, 11 beta HSD1 knockout mice were created on the pro-atherogenic apoE(-/-) background. Following 14 weeks of Western diet, aortic cholesterol levels were reduced 50% in 11 beta HSD1(-/-)/apoE(-/-) mice vs. 11 beta HSD1(+/+)/apoE(-/-) mice without changes in plasma cholesterol. Aortic 7-ketocholesterol content was reduced 40% in 11 beta HSD1(-/-)/apoE(-/-) mice vs. control. In the aortic root, plaque size, necrotic core area and macrophage content were reduced similar to 30% in 11 beta HSD1(-/-)/apoE(-/-) mice. Bone marrow transplantation from 11 beta HSD1(-/-)/apoE(-/-) mice into apoE(-/-) recipients reduced plaque area 39-46% in the thoracic aorta. In vivo foam cell formation was evaluated in thioglycollate-elicited peritoneal macrophages from 11 beta HSD1(+/+)/apoE(-/-) and 11 beta HSD1(-/-)/apoE(-/-) mice fed a Western diet for similar to 5 weeks. Foam cell cholesterol levels were reduced 48% in 11 beta HSD1(-/-)/apoE(-/-) mice vs. control. Microarray profiling of peritoneal macrophages revealed differential expression of genes involved in inflammation, stress response and energy metabolism. Several toll-like receptors (TLRs) were downregulated in 11 beta HSD1(-/-)/apoE(-/-) mice including TLR 1, 3 and 4. Cytokine release from 11 beta HSD1(-/-)/apoE(-/-)-derived peritoneal foam cells was attenuated following challenge with oxidized LDL. Conclusions: These findings suggest that 11 beta HSD1 inhibition may have the potential to limit plaque development at the vessel wall and regulate foam cell formation independent of changes in plasma lipids. The diminished cytokine response to oxidized LDL stimulation is consistent with the reduction in TLR expression and suggests involvement of 11 beta HSD1 in modulating binding of pro-atherogenic TLR ligands.	[Garcia, Ricardo A.; Search, Debra J.; Lupisella, John A.; Ostrowski, Jacek; Zhang, Rongan; Yan, Mujing; Hellings, Samuel E.; Gargalovic, Peter S.; Ryan, Carol S.; Carson, Nancy L.; Yang, Richard; Harrity, Thomas W.; Gordon, David A.] Bristol Myers Squibb Co, Cardiovasc Drug Discovery, Pennington, NJ 08534 USA; [Guan, Bo; Chen, Jian; Yang, Wen-Pin; Amy Truong; He, Aiqing] Bristol Myers Squibb Co, Appl Genom, Pennington, NJ USA; [Watson, Linda M.] Bristol Myers Squibb Co, Pharmaceut Compound Optimizat Discovery Toxicol, Lawrenceville, NJ USA; [Langish, Robert A.; Shipkova, Petia A.] Bristol Myers Squibb Co, Pharmaceut Compound Optimizat Discovery Analyt Sc, Pennington, NJ USA; [Taylor, Joseph R.] Bristol Myers Squibb Co, Metab Dis, Pennington, NJ USA; [Psaltis, George C.] Bristol Myers Squibb Co, Vet Sci, Pennington, NJ USA; [Robl, Jeffrey A.] Bristol Myers Squibb Co, Discovery Chem, Pennington, NJ USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Gordon, DA (corresponding author), Bristol Myers Squibb Co, Cardiovasc Drug Discovery, Pennington, NJ 08534 USA.	david.gordon@bms.com		Lupisella, John/0000-0003-1343-6412	Bristol-Myers Squibb Company	Bristol-Myers Squibb Company(Bristol-Myers Squibb)	Studies described in this report were funded by Bristol-Myers Squibb Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker L, 2010, CELL METAB, V11, P125, DOI 10.1016/j.cmet.2010.01.003; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown AJ, 1997, J LIPID RES, V38, P1730; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Deuchar GA, 2011, ENDOCRINOLOGY, V152, P236, DOI 10.1210/en.2010-0925; Du Q, 2012, J SURG RES, V173, P354, DOI 10.1016/j.jss.2010.10.016; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Fantidis P, 2010, CURR VASC PHARMACOL, V8, P517, DOI 10.2174/157016110791330889; Feng B, 2003, P NATL ACAD SCI USA, V100, P10423, DOI 10.1073/pnas.1732494100; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Garedew A, 2008, J CELL SCI, V121, P3468, DOI 10.1242/jcs.034660; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; Gilmour JS, 2006, J IMMUNOL, V176, P7605, DOI 10.4049/jimmunol.176.12.7605; Hadoke PWF, 2009, BRIT J PHARMACOL, V156, P689, DOI 10.1111/j.1476-5381.2008.00047.x; Hadoke PWF, 2001, CIRCULATION, V104, P2832, DOI 10.1161/hc4801.100077; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Higashimori M, 2011, ARTERIOSCL THROM VAS, V31, P50, DOI 10.1161/ATVBAHA.110.210971; Howell KW, 2011, J SURG RES, V171, pE27, DOI 10.1016/j.jss.2011.06.033; Hult M, 2004, CELL MOL LIFE SCI, V61, P992, DOI 10.1007/s00018-003-3476-y; Jaffe IZ, 2010, J CLIN INVEST, V120, P3891, DOI 10.1172/JCI40205; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Miller YI, 2009, TRENDS CARDIOVAS MED, V19, P227, DOI 10.1016/j.tcm.2010.02.001; Morgan SA, 2010, EXPERT OPIN INV DRUG, V19, P1067, DOI 10.1517/13543784.2010.504713; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Nuotio-Antar AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1517, DOI 10.1152/ajpendo.00522.2007; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Preusch MR, 2008, ARTERIOSCL THROM VAS, V28, P2158, DOI 10.1161/ATVBAHA.108.174128; Rickard AJ, 2009, J MOL ENDOCRINOL, V42, P449, DOI 10.1677/JME-08-0144; Salvayre R, 2002, BBA-MOL CELL BIOL L, V1585, P213, DOI 10.1016/S1388-1981(02)00343-8; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Thieringer R, 2001, J IMMUNOL, V167, P30, DOI 10.4049/jimmunol.167.1.30; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Tsukamoto Kayo, 2002, J Atheroscler Thromb, V9, P57; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wake DJ, 2006, ENDOCRINE, V29, P101, DOI 10.1385/ENDO:29:1:101; Wamil M, 2008, ENDOCRINOLOGY, V149, P5909, DOI 10.1210/en.2008-0420; Wamil M, 2007, DRUG DISCOV TODAY, V12, P504, DOI 10.1016/j.drudis.2007.06.001; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200	48	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e53192	10.1371/journal.pone.0053192	http://dx.doi.org/10.1371/journal.pone.0053192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383297	gold, Green Submitted, Green Published			2022-12-25	WOS:000314597900004
J	Zhang, JQ; Tao, R; You, ZL; Dai, YM; Fan, Y; Cui, JG; Mao, Q; Wang, J				Zhang, Jiuquan; Tao, Ran; You, Zhonglan; Dai, Yongming; Fan, Yi; Cui, Jinguo; Mao, Qing; Wang, Jian			Gamna-Gandy Bodies of the Spleen Detected with Susceptibility Weighted Imaging: Maybe a New Potential Non-Invasive Marker of Esophageal Varices	PLOS ONE			English	Article							CHARACTERIZING IRON DEPOSITION; PORTAL-HYPERTENSION; SIDEROTIC NODULES; LIVER-CIRRHOSIS; MR; PRESSURE; PREVENTION; DIAGNOSIS	Background/Objectives: Portal hypertension (PH) is a clinical sequelae of liver cirrhosis, and bleeding from esophageal varices (EV) is a serious complication of PH with significant morbidity and mortality. The aims of this study were to assess the ability of 2D multislice breath-hold susceptibility weighted imaging (SWI) to detect Gamna-Gandy bodies (GGBs) in the spleens of patients with PH and to evaluate the potential role of GGB number as a non-invasive marker of PH and EV. Materials and Methods: T1-, T2- and T2* - weighted imaging and SWI were performed on 135 patients with PH and on 37 control individuals. Platelet counts were collected from all PH patients. Two radiologists analyzed all magnetic resonance imaging (MRI) data, and measured the portal vein diameter, splenic index (SI), and platelet count/spleen diameter ratio. The numbers of patients with GGBs in the spleen were determined, and the numbers of GGB were counted in the four MRI sequences in GGB-positive patients. The portal vein diameter, SI, platelet count, and platelet count/spleen diameter ratio of control individuals were compared with those of GGB-negative and GGB-positive patients on SWI images. The correlations among GGB numbers, the portal vein diameter, the SI, the platelet count, and the platelet count/spleen diameter ratio were analyzed. Results: The GGB detection rate and the detected GGB number by using SWI were significantly greater than those by using T1-, T2-, and T2* -weighted images. The number of GGBs in the SWI images correlated positively with the portal vein diameter and SI and correlated negatively with the platelet count and platelet count/spleen diameter ratio. Conclusion: SWI provided more accurate information of GGBs in patients with PH. The number of GGB may be a non-invasive predictor of improving the selection for endoscopic screening of PH patients at risk of EV.	[Zhang, Jiuquan; Tao, Ran; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Dai, Yongming] Siemens Healthcare, MR Collaborat NE Asia, Shanghai, Peoples R China; [You, Zhonglan; Fan, Yi; Mao, Qing] Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China; [Tao, Ran; Cui, Jinguo] Peoples Liberty Army, Dept Radiol, Bethune Int Peace Hosp, Shijiazhuang, Peoples R China	Army Medical University; Siemens AG; Army Medical University	Mao, Q (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China.	qingmao@yahoo.com; wangjian_811@yahoo.com	ZHANG, JIUQUAN/X-8389-2019					Berzigotti A, 2008, CLIN GASTROENTEROL H, V6, P1129, DOI 10.1016/j.cgh.2008.05.004; Bhatt S, 2006, J ULTRAS MED, V25, P1625, DOI 10.7863/jum.2006.25.12.1625; Bosch J, 2003, LANCET, V361, P952, DOI 10.1016/S0140-6736(03)12778-X; BOYER TD, 1977, GASTROENTEROLOGY, V72, P584; Cheng YCN, 2001, NMR BIOMED, V14, P468, DOI 10.1002/nbm.727; D'Amico G, 1999, SEMIN LIVER DIS, V19, P475, DOI 10.1055/s-2007-1007133; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; de Franchis R, 2008, DIGEST LIVER DIS, V40, P312, DOI 10.1016/j.dld.2007.12.007; Dib N, 2005, GASTROEN CLIN BIOL, V29, P975, DOI 10.1016/S0399-8320(05)88170-9; Dobritz M, 2001, MAGN RESON IMAGING, V19, P1249, DOI 10.1016/S0730-725X(01)00451-9; Elsayes KM, 2005, RADIOGRAPHICS, V25, P967, DOI 10.1148/rg.254045154; FEU F, 1995, LANCET, V346, P1056, DOI 10.1016/S0140-6736(95)91740-3; Giannini E, 2003, GUT, V52, P1200, DOI 10.1136/gut.52.8.1200; GIBSON PR, 1990, AUST NZ J MED, V20, P771, DOI 10.1111/j.1445-5994.1990.tb00421.x; Gluud LL, 2007, AM J GASTROENTEROL, V102, P2842, DOI 10.1111/j.1572-0241.2007.01564.x; Groszmann RJ, 2005, J CLIN GASTROENTEROL, V39, pS125, DOI 10.1097/01.mcg.0000155552.14396.3d; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haag K, 1999, AM J ROENTGENOL, V172, P631, DOI 10.2214/ajr.172.3.10063849; Laurent O, 2011, J RADIOL, V92, P909, DOI 10.1016/j.jradio.2011.05.010; Luo T Y, 1998, Radiat Med, V16, P473; MINAMI M, 1989, RADIOLOGY, V172, P681, DOI 10.1148/radiology.172.3.2672092; Robinson RJ, 2011, J NEUROIMAGING; SAGOH T, 1989, RADIOLOGY, V172, P685, DOI 10.1148/radiology.172.3.2672093; Schepis F, 2001, HEPATOLOGY, V33, P333, DOI 10.1053/jhep.2001.21410; Sharma SK, 2007, J GASTROEN HEPATOL, V22, P1909, DOI 10.1111/j.1440-1746.2006.04501.x; Thomopoulos KC, 2003, DIGEST LIVER DIS, V35, P473, DOI 10.1016/S1590-8658(03)00219-6; Unsal Nuray Haliloglu, 2006, Diagn Interv Radiol, V12, P125; Watanabe S, 2000, J COMPUT ASSIST TOMO, V24, P788, DOI 10.1097/00004728-200009000-00022; WITTE CL, 1983, LYMPHOLOGY, V16, P60; Yilmaz S, 2007, J GASTROEN HEPATOL, V22, P758, DOI 10.1111/j.1440-1746.2007.04965.x; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036	33	12	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55626	10.1371/journal.pone.0055626	http://dx.doi.org/10.1371/journal.pone.0055626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383250	gold, Green Submitted, Green Published			2022-12-25	WOS:000314610600139
J	Heinemeier, KM; Schjerling, P; Heinemeier, J; Magnusson, SP; Kjaer, M				Heinemeier, Katja Maria; Schjerling, Peter; Heinemeier, Jan; Magnusson, Stig Peter; Kjaer, Michael			Lack of tissue renewal in human adult Achilles tendon is revealed by nuclear bomb C-14	FASEB JOURNAL			English	Article						collagen fibril; turnover; synthesis rate; skeletal muscle; carbon-14	COLLAGEN-SYNTHESIS; TURNOVER; RADIOCARBON; MICRODIALYSIS; TENDINOPATHY; HYPERTROPHY; EXERCISE; AGE	Tendons are often injured and heal poorly. Whether this is caused by a slow tissue turnover is unknown, since existing data provide diverging estimates of tendon protein half-life that range from 2 mo to 200 yr. With the purpose of determining life-long turnover of human tendon tissue, we used the C-14 bomb-pulse method. This method takes advantage of the dramatic increase in atmospheric levels of C-14, produced by nuclear bomb tests in 1955-1963, which is reflected in all living organisms. Levels of C-14 were measured in 28 forensic samples of Achilles tendon core and 4 skeletal muscle samples (donor birth years 1945-1983) with accelerator mass spectrometry (AMS) and compared to known atmospheric levels to estimate tissue turnover. We found that Achilles tendon tissue retained levels of C-14 corresponding to atmospheric levels several decades before tissue sampling, demonstrating a very limited tissue turnover. The tendon concentrations of C-14 approximately reflected the atmospheric levels present during the first 17 yr of life, indicating that the tendon core is formed during height growth and is essentially not renewed thereafter. In contrast, C-14 levels in muscle indicated continuous turnover. Our observation provides a fundamental premise for understanding tendon function and pathology, and likely explains the poor regenerative capacity of tendon tissue.-Heinemeier, K. M., Schjerling, P., Heinemeier, J., Magnusson, S. P., Kjaer, M. Lack of tissue renewal in human adult Achilles tendon is revealed by nuclear bomb C-14. FASEB J. 27, 2074-2079 (2013). www.fasebj.org	[Heinemeier, Katja Maria; Schjerling, Peter; Magnusson, Stig Peter; Kjaer, Michael] Bispebjerg Hosp, Inst Sport Med, Dept Orthoped Surg M, DK-2400 Copenhagen NV, Denmark; [Heinemeier, Katja Maria; Schjerling, Peter; Magnusson, Stig Peter; Kjaer, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, DK-1168 Copenhagen, Denmark; [Heinemeier, Jan] Aarhus Univ, Dept Phys & Astron, AMS Dating Ctr 14C, Aarhus, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Aarhus University	Heinemeier, KM (corresponding author), Bispebjerg Hosp, Inst Sport Med, Bldg 8,1 Floor,Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.	katjaheinemeier@gmail.com	Magnusson, Peter/AAN-1631-2020; Kjaer, Michael/W-6842-2019; Schjerling, Peter/F-6194-2011; Magnusson, S. Peter/AAD-5903-2022	Kjaer, Michael/0000-0002-4582-8755; Schjerling, Peter/0000-0001-7138-3211; Magnusson, S. Peter/0000-0002-4308-5484	Danish Medical Research Council [11-107595]; Danish Rheumatism Association [A1698]; Weimann Foundation; Lundbeck Foundation; Novo Nordisk Foundation; Nordea Foundation (Healthy Ageing grant); Danish Research Council for Natural Sciences	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Rheumatism Association; Weimann Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Nordea Foundation (Healthy Ageing grant); Danish Research Council for Natural Sciences(Danish Natural Science Research Council)	The authors are thankful for the reliable and prompt service from Dr. Ugo Zoppi (Accium Biosciences, Seattle, WA, USA) with <SUP>14</SUP>C measurements and for help from Patrick Hanson with tissue sampling and Professor Niels Lynnerup with grant applications. Financial support from the Danish Medical Research Council (11-107595), Danish Rheumatism Association (A1698), Weimann Foundation, Lundbeck Foundation, Novo Nordisk Foundation, Nordea Foundation (Healthy Ageing grant) and the Danish Research Council for Natural Sciences is greatly appreciated. The authors declare no conflicts of interest.	Babraj JA, 2005, AM J PHYSIOL-ENDOC M, V289, pE864, DOI 10.1152/ajpendo.00243.2005; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Couppe C, 2008, J APPL PHYSIOL, V105, P805, DOI 10.1152/japplphysiol.90361.2008; Goodsite ME, 2001, RADIOCARBON, V43, P495; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Heinemeier KM, 2013, SCAND J MED SCI SPOR, V23, pe150, DOI 10.1111/j.1600-0838.2011.01414.x; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Kongsgaard M, 2007, ACTA PHYSIOL, V191, P111, DOI 10.1111/j.1748-1716.2007.01714.x; Kuczmarski RJ, 2000, ADV DATA, P1; Kueppers LM, 2004, OECOLOGIA, V141, P641, DOI 10.1007/s00442-004-1689-x; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; Langberg H, 2001, J PHYSIOL-LONDON, V534, P297, DOI 10.1111/j.1469-7793.2001.00297.x; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; LIBBY WF, 1964, SCIENCE, V146, P1171; Lynnerup N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001529; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Riley G, 2008, NAT CLIN PRACT RHEUM, V4, P82, DOI 10.1038/ncprheum0700; Rosager S, 2002, SCAND J MED SCI SPOR, V12, P90, DOI 10.1034/j.1600-0838.2002.120205.x; Spalding KL, 2005, NATURE, V437, P333, DOI 10.1038/437333a; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Sullivan BE, 2009, J APPL PHYSIOL, V106, P468, DOI 10.1152/japplphysiol.91341.2008; Svensson RB, 2011, CONNECT TISSUE RES, V52, P415, DOI 10.3109/03008207.2010.551569; Thorpe CT, 2010, J BIOL CHEM, V285, P15674, DOI 10.1074/jbc.M109.077503; Zoppi U, 2007, RADIOCARBON, V49, P173, DOI 10.1017/S0033822200041990	26	190	191	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					2074	2079		10.1096/fj.12-225599	http://dx.doi.org/10.1096/fj.12-225599			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23401563	hybrid, Green Published			2022-12-25	WOS:000318226100027
J	Pozdnyakov, N; Murrey, HE; Crump, CJ; Pettersson, M; Ballard, TE; Ende, CWA; Ahn, K; Li, YM; Bales, KR; Johnson, DS				Pozdnyakov, Nikolay; Murrey, Heather E.; Crump, Christina J.; Pettersson, Martin; Ballard, T. Eric; Ende, Christopher W. Am; Ahn, Kwangwook; Li, Yue-Ming; Bales, Kelly R.; Johnson, Douglas S.			gamma-Secretase Modulator (GSM) Photoaffinity Probes Reveal Distinct Allosteric Binding Sites on Presenilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMER-DISEASE; AMYLOID PRECURSOR PROTEIN; ACTIVE-SITE; TRANSMEMBRANE DOMAIN; CLICK CHEMISTRY; MOUSE MODEL; IN-VIVO; INHIBITOR; TARGET; MECHANISM	gamma-Secretase is an intramembrane aspartyl protease that cleaves the amyloid precursor protein to produce neurotoxic beta-amyloid peptides (i.e. A beta 42) that have been implicated in the pathogenesis of Alzheimer disease. Small molecule gamma-secretase modulators (GSMs) have emerged as potential disease-modifying treatments for Alzheimer disease because they reduce the formation of A beta 42 while not blocking the processing of gamma-secretase substrates. We developed clickable GSM photoaffinity probes with the goal of identifying the target of various classes of GSMs and to better understand their mechanism of action. Here, we demonstrate that the photoaffinity probe E2012-BPyne specifically labels the N-terminal fragment of presenilin-1 (PS1-NTF) in cell membranes as well as in live cells and primary neuronal cultures. The labeling is competed in the presence of the parent imidazole GSM E2012, but not with acid GSM-1, allosteric GSI BMS-708163, or substrate docking site peptide inhibitor pep11, providing evidence that these compounds have distinct binding sites. Surprisingly, we found that the cross-linking of E2012-BPyne to PS1-NTF is significantly enhanced in the presence of the active site-directed GSI L-685,458 (L458). In contrast, L458 does not affect the labeling of the acid GSM photoprobe GSM-5. We also observed that E2012-BPyne specifically labels PS1-NTF (active gamma-secretase) but not full-length PS1 (inactive gamma-secretase) in ANP.24 cells. Taken together, our results support the hypothesis that multiple binding sites within the gamma-secretase complex exist, each of which may contribute to different modes of modulatory action. Furthermore, the enhancement of PS1-NTF labeling by E2012-BPyne in the presence of L458 suggests a degree of cooperativity between the active site of gamma-secretase and the modulatory binding site of certain GSMs.	[Pozdnyakov, Nikolay; Murrey, Heather E.; Pettersson, Martin; Ballard, T. Eric; Ende, Christopher W. Am; Bales, Kelly R.; Johnson, Douglas S.] Pfizer Worldwide Res & Dev, Cambridge, MA 02139 USA; [Crump, Christina J.; Ahn, Kwangwook; Li, Yue-Ming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Crump, Christina J.; Ahn, Kwangwook; Li, Yue-Ming] Cornell Univ, Dept Pharmacol, Weill Grad Sch Med Sci, New York, NY 10021 USA	Pfizer; Memorial Sloan Kettering Cancer Center; Cornell University	Bales, KR (corresponding author), Pfizer Worldwide Res & Dev, Cambridge, MA 02139 USA.	kelly.bales@pfizer.com; doug.johnson@pfizer.com	LI, Yue/GRS-8071-2022		National Institutes of Health [1R01NS076117-01]; Alzheimer Association [IIRG-08-90824]; Institutional Training Grant [T32 GM073546-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Institutional Training Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01NS076117-01 (to Y. M. L.). This work was also supported by Alzheimer Association Grant IIRG-08-90824 (to Y. M. L.).; Supported by Institutional Training Grant T32 GM073546-01A1.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Barrett PJ, 2011, BIOCHEMISTRY-US, V50, P10328, DOI 10.1021/bi201371j; Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726; Borgegard T, 2012, J BIOL CHEM, V287, P11810, DOI 10.1074/jbc.M111.305227; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Chau DM, 2012, J BIOL CHEM, V287, P17288, DOI 10.1074/jbc.M111.300483; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Coan KED, 2009, J MED CHEM, V52, P2067, DOI 10.1021/jm801605r; Crump CJ, 2012, BIOCHEMISTRY-US, V51, P7209, DOI 10.1021/bi301137h; Crump CJ, 2012, BIOORG MED CHEM LETT, V22, P2997, DOI 10.1016/j.bmcl.2012.02.027; Crump CJ, 2011, ACS CHEM NEUROSCI, V2, P705, DOI 10.1021/cn200098p; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Eirich J, 2011, J AM CHEM SOC, V133, P12144, DOI 10.1021/ja2039979; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Gillman KW, 2010, ACS MED CHEM LETT, V1, P120, DOI 10.1021/ml1000239; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawkins J, 2011, NEURODEGENER DIS, V8, P455, DOI 10.1159/000324511; Jumpertz T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030484; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kreft AF, 2009, J MED CHEM, V52, P6169, DOI 10.1021/jm900188z; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; MacKinnon AL, 2007, J AM CHEM SOC, V129, P14560, DOI 10.1021/ja076250y; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Miller DL, 2007, AMYLOID, V14, P39, DOI 10.1080/13506120601116500; Oborski C. E., 2012, NEUROSCI MED, V3, P149; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Pettersson M, 2011, EXPERT OPIN THER PAT, V21, P205, DOI 10.1517/13543776.2011.547479; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Sagi SA, 2011, J BIOL CHEM, V286, P39794, DOI 10.1074/jbc.M111.277228; Salisbury CM, 2008, J AM CHEM SOC, V130, P2184, DOI 10.1021/ja074138u; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shi HB, 2011, CHEM COMMUN, V47, P11306, DOI 10.1039/c1cc14824a; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Uemura K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1129; Van Broeck B, 2011, BRIT J PHARMACOL, V163, P375, DOI 10.1111/j.1476-5381.2011.01207.x; Weggen S, 2003, J BIOL CHEM, V278, P30748, DOI 10.1074/jbc.M304824200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591	50	83	84	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9710	9720		10.1074/jbc.M112.398602	http://dx.doi.org/10.1074/jbc.M112.398602			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23396974	Green Published, hybrid			2022-12-25	WOS:000317114000013
J	Bektas, M; Jolly, PS; Berkowitz, P; Amagai, M; Rubenstein, DS				Bektas, Meryem; Jolly, Puneet S.; Berkowitz, Paula; Amagai, Masayuki; Rubenstein, David S.			A Pathophysiologic Role for Epidermal Growth Factor Receptor in Pemphigus Acantholysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CARCINOMA-CELL LINE; EGF RECEPTOR; MONOCLONAL-ANTIBODY; HUMAN AUTOANTIBODIES; SIGNAL-TRANSDUCTION; VULGARIS; P38; DESMOGLEIN; INHIBITION	The pemphigus family of autoimmune bullous disorders is characterized by autoantibody binding to desmoglein 1 and/or 3 (dsg1/dsg3). In this study we show that EGF receptor (EGFR) is activated following pemphigus vulgaris (PV) IgG treatment of primary human keratinocytes and that EGFR activation is downstream of p38 mitogen-activated protein kinase (p38). Inhibition of EGFR blocked PV IgG-triggered dsg3 endocytosis, keratin intermediate filament retraction, and loss of cell-cell adhesion in vitro. Significantly, inhibiting EGFR prevented PV IgG-induced blister formation in the passive transfer mouse model of pemphigus. These data demonstrate cross-talk between dsg3 and EGFR, that this cross-talk is regulated by p38, and that EGFR is a potential therapeutic target for pemphigus. Small-molecule inhibitors and monoclonal antibodies directed against EGFR are currently used to treat several types of solid tumors. This study provides the experimental rationale for investigating the use of EGFR inhibitors in pemphigus.	[Bektas, Meryem; Jolly, Puneet S.; Berkowitz, Paula; Rubenstein, David S.] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo 1608582, Japan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Keio University	Rubenstein, DS (corresponding author), Univ N Carolina, Sch Med, Dept Dermatol, Suite 405 Mary Ellen Jones CB 7287, Chapel Hill, NC 27599 USA.	druben@med.unc.edu	Amagai, Masayuki/K-5325-2013	Amagai, Masayuki/0000-0003-3314-7052; Bektas, Meryem/0000-0001-8080-7557	National Institutes of Health Grant [RO1 AI49427]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049427] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI49427 (to D. S. R.).	Adachi S, 2009, CANCER LETT, V277, P108, DOI 10.1016/j.canlet.2008.11.034; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Aoyama Y, 1999, J INVEST DERMATOL, V112, P67, DOI 10.1046/j.1523-1747.1999.00463.x; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Berkowitz P, 2008, AM J PATHOL, V173, P1628, DOI 10.2353/ajpath.2008.080391; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Cirillo N, 2007, J CELL PHYSIOL, V210, P411, DOI 10.1002/jcp.20856; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; EYRE RW, 1988, J CLIN INVEST, V81, P807, DOI 10.1172/JCI113387; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; Gaudry CA, 2001, J BIOL CHEM, V276, P24871, DOI 10.1074/jbc.M102731200; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Heupel WM, 2009, AM J PATHOL, V174, P475, DOI 10.2353/ajpath.2009.080392; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Jans R, 2004, J INVEST DERMATOL, V123, P564, DOI 10.1111/j.0022-202X.2004.23221.x; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Kawasaki Y, 2006, AUTOIMMUNITY, V39, P587, DOI 10.1080/08916930600971943; Keely SJ, 1998, J BIOL CHEM, V273, P27111, DOI 10.1074/jbc.273.42.27111; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; KOULU L, 1984, J EXP MED, V160, P1509, DOI 10.1084/jem.160.5.1509; Lee HE, 2009, J BIOL CHEM, V284, P12524, DOI 10.1074/jbc.M808204200; Li X, 1998, EMBO J, V17, P2574, DOI 10.1093/emboj/17.9.2574; Lorch JH, 2004, J BIOL CHEM, V279, P37191, DOI 10.1074/jbc.M405123200; Lorch JH, 2007, CANCER RES, V67, P727, DOI 10.1158/0008-5472.CAN-06-2162; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Pretel M, 2009, EXP DERMATOL, V18, P771, DOI 10.1111/j.1600-0625.2009.00893.x; Schmidt E, 2009, AM J PHYSIOL-CELL PH, V296, pC162, DOI 10.1152/ajpcell.00161.2008; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Seishima M, 1999, ARCH DERMATOL RES, V291, P606, DOI 10.1007/s004030050462; Sloss CM, 2010, ONCOGENE, V29, P3146, DOI 10.1038/onc.2010.52; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; STANLEY JR, 1986, J IMMUNOL, V136, P1227; Tsai W, 1997, EMBO J, V16, P4597, DOI 10.1093/emboj/16.15.4597; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Vergarajauregui S, 2006, TRAFFIC, V7, P686, DOI 10.1111/j.1600-0854.2006.00420.x; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Yin TF, 2005, J BIOL CHEM, V280, P40355, DOI 10.1074/jbc.M506692200; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	44	45	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9447	9456		10.1074/jbc.M112.438010	http://dx.doi.org/10.1074/jbc.M112.438010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404504	Green Published, hybrid			2022-12-25	WOS:000316862200061
J	Shah, NB; Hutcheon, ML; Haarer, BK; Duncan, TM				Shah, Naman B.; Hutcheon, Marcus L.; Haarer, Brian K.; Duncan, Thomas M.			F-1-ATPase of Escherichia coli THE epsilon-INHIBITED STATE FORMS AFTER ATP HYDROLYSIS, IS DISTINCT FROM THE ADP-INHIBITED STATE, AND RESPONDS DYNAMICALLY TO CATALYTIC SITE LIGANDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING SITES; C-TERMINAL DOMAIN; SUBUNIT-EPSILON; GAMMA-SUBUNIT; F1 ATPASE; ADENOSINE-TRIPHOSPHATASE; MITOCHONDRIAL F1-ATPASE; CRYSTAL-STRUCTURE; BETA-SUBUNIT; F-1 MOTOR	F-1-ATPase is the catalytic complex of rotary nanomotor ATP synthases. Bacterial ATP synthases can be autoinhibited by the C-terminal domain of subunit epsilon, which partially inserts into the enzyme's central rotor cavity to block functional subunit rotation. Using a kinetic, optical assay of F-1.epsilon binding and dissociation, we show that formation of the extended, inhibitory conformation of epsilon (epsilon(X)) initiates after ATP hydrolysis at the catalytic dwell step. Prehydrolysis conditions prevent formation of the epsilon(X) state, and post-hydrolysis conditions stabilize it. We also show that epsilon inhibition and ADP inhibition are distinct, competing processes that can follow the catalytic dwell. We show that the N-terminal domain of epsilon is responsible for initial binding to F-1 and provides most of the binding energy. Without the C-terminal domain, partial inhibition by the epsilon N-terminal domain is due to enhanced ADP inhibition. The rapid effects of catalytic site ligands on conformational changes of F-1-bound epsilon suggest dynamic conformational and rotational mobility in F-1 that is paused near the catalytic dwell position.	[Shah, Naman B.; Hutcheon, Marcus L.; Haarer, Brian K.; Duncan, Thomas M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Duncan, TM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	duncant@upstate.edu		Duncan, Thomas/0000-0002-6432-4958	National Institutes of Health Grant [R01GM083088]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083088] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM083088 (to T. M. D.).	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Bhardwaj A, 2008, PROTEIN SCI, V17, P1475, DOI 10.1110/ps.036111.108; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Bulygin VV, 2009, BBA-BIOENERGETICS, V1787, P1016, DOI 10.1016/j.bbabio.2009.02.025; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; COX GB, 1992, MOL MECHANISMS BIOEN, P283; DALLMANN HG, 1992, J BIOL CHEM, V267, P18953; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; DROBINSKAYA IY, 1985, FEBS LETT, V182, P419, DOI 10.1016/0014-5793(85)80346-X; Duncan T. M., 2004, ENZYMES, VXXIII, P203; Duncan TM, 1995, BIOCHEM SOC T, V23, P736, DOI 10.1042/bst0230736; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; DUNN SD, 1987, BIOCHEMISTRY-US, V26, P4488, DOI 10.1021/bi00388a047; DUNN SD, 1982, J BIOL CHEM, V257, P7354; DUNN SD, 1986, ANAL BIOCHEM, V159, P35, DOI 10.1016/0003-2697(86)90304-0; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Fischer S, 2000, J BIOL CHEM, V275, P30157, DOI 10.1074/jbc.275.39.30157; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; GUERRERO KJ, 1990, J BIOL CHEM, V265, P16280; Haagsma AC, 2010, FEMS MICROBIOL LETT, V313, P68, DOI 10.1111/j.1574-6968.2010.02123.x; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; JAULT JM, 1993, J BIOL CHEM, V268, P20762; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; KATO Y, 1995, BBA-BIOENERGETICS, V1231, P275, DOI 10.1016/0005-2728(95)00087-Y; Kinosita K, 2012, ADV EXP MED BIOL, V726, P5, DOI 10.1007/978-1-4614-0980-9_2; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Konno H, 2011, J BIOL CHEM, V286, P13423, DOI 10.1074/jbc.M110.155986; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; MENDELHARTVIG J, 1991, BIOCHEMISTRY-US, V30, P1278, DOI 10.1021/bi00219a017; MENDELHARTVIG J, 1991, BIOCHEMISTRY-US, V30, P10987, DOI 10.1021/bi00109a025; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; MILGROM YM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P43, DOI 10.1016/0005-2728(90)90091-H; MILGROM YM, 1993, J BIOL CHEM, V268, P23179; MURATALIEV MB, 1991, BIOCHEMISTRY-US, V30, P8305, DOI 10.1021/bi00098a004; MURATALIEV MB, 1992, EUR J BIOCHEM, V209, P681, DOI 10.1111/j.1432-1033.1992.tb17336.x; Nakanishi-Matsui M, 2007, J BIOL CHEM, V282, P20698, DOI 10.1074/jbc.M700551200; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 2011, CHEM SCI, V2, P2086, DOI 10.1039/c1sc00276g; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pu JZ, 2008, P NATL ACAD SCI USA, V105, P1192, DOI 10.1073/pnas.0708746105; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Rees DM, 2012, P NATL ACAD SCI USA, V109, P11139, DOI 10.1073/pnas.1207587109; Richter ML, 2004, PHOTOSYNTH RES, V79, P319, DOI 10.1023/B:PRES.0000017157.08098.36; Saita E, 2010, J BIOL CHEM, V285, P11411, DOI 10.1074/jbc.M109.099143; Schulenberg B, 1999, J BIOL CHEM, V274, P28351, DOI 10.1074/jbc.274.40.28351; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Shimo-Kon R, 2010, BIOPHYS J, V98, P1227, DOI 10.1016/j.bpj.2009.11.050; Sielaff H, 2008, BIOPHYS J, V95, P4979, DOI 10.1529/biophysj.108.139782; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Spetzler D, 2012, ADV PHOTOSYNTH RESP, V34, P561, DOI 10.1007/978-94-007-1579-0_22; STERNWEIS PC, 1980, BIOCHEMISTRY-US, V19, P526, DOI 10.1021/bi00544a021; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; TOZER RG, 1986, EUR J BIOCHEM, V161, P513, DOI 10.1111/j.1432-1033.1986.tb10472.x; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8; Tsumuraya M, 2009, FEBS LETT, V583, P1121, DOI 10.1016/j.febslet.2009.02.038; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WILKENS S, 1994, BIOL CHEM H-S, V375, P43; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; Xiong H, 1998, BIOCHEMISTRY-US, V37, P16423, DOI 10.1021/bi981522i; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682	81	38	39	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9383	9395		10.1074/jbc.M113.451583	http://dx.doi.org/10.1074/jbc.M113.451583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23400782	Green Published, hybrid			2022-12-25	WOS:000316862200055
J	Ding, Y; Zhang, Y; Xu, C; Tao, QH; Chen, YG				Ding, Yi; Zhang, Yan; Xu, Chao; Tao, Qing-Hua; Chen, Ye-Guang			HECT Domain-containing E3 Ubiquitin Ligase NEDD4L Negatively Regulates Wnt Signaling by Targeting Dishevelled for Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; PATHWAY; CANCER; XENOPUS; FAMILY; GENE; ITCH	Wnt signaling plays a pivotal role in embryogenesis and tissue homeostasis. Dishevelled (Dvl) is a central mediator for both Wnt/beta-catenin and Wnt/planar cell polarity pathways. NEDD4L, an E3 ubiquitin ligase, has been shown to regulate ion channel activity, cell signaling, and cell polarity. Here, we report a novel role of NEDD4L in the regulation of Wnt signaling. NEDD4L induces Dvl2 polyubiquitination and targets Dvl2 for proteasomal degradation. Interestingly, the NEDD4L-mediated ubiquitination of Dvl2 is Lys-6, Lys-27, and Lys-29 linked but not typical Lys-48-linked ubiquitination. Consistent with the role of Dvl in both Wnt/beta-catenin and Wnt/planar cell polarity signaling, NEDD4L regulates the cellular beta-catenin level and Rac1, RhoA, and JNK activities. We have further identified a hierarchical regulation that Wnt5a induces JNK-mediated phosphorylation of NEDD4L, which in turn promotes its ability to degrade Dvl2. Finally, we show that NEDD4L inhibits Dvl2-induced axis duplication in Xenopus embryos. Our work thus demonstrates that NEDD4L is a negative feedback regulator of Wnt signaling.	[Ding, Yi; Xu, Chao; Chen, Ye-Guang] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Zhang, Yan; Tao, Qing-Hua] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Tao, QH (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	qhtaolab@tsinghua.edu.cn; ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019	Ding, Yi/0000-0001-7525-7124	National Key Basic Research Program of China (973 Program) [2011CB943800]; National Natural Science Foundation of China [30930050, 30921004, 30930012]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program of China (973 Program) Grants 2011CB943800 (to Y. G. C. and Q. H. T.) and National Natural Science Foundation of China Grants 30930050 and 30921004 (to Y. G. C.) and 30930012 (to Q. H. T.).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Boase NA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1284; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dibbens LM, 2007, GENES BRAIN BEHAV, V6, P750, DOI 10.1111/j.1601-183X.2007.00305.x; Dwyer Jessica L, 2012, Spermatogenesis, V2, P104; Feng J, 2004, NEOPLASIA, V6, P623, DOI 10.1593/neo.04142; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Fouladkou F, 2010, J BIOL CHEM, V285, P6770, DOI 10.1074/jbc.M109.082347; Ganner A, 2009, P NATL ACAD SCI USA, V106, P17799, DOI 10.1073/pnas.0909465106; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Gray RS, 2011, DEV CELL, V21, P120, DOI 10.1016/j.devcel.2011.06.011; Hallows KR, 2010, J BIOL CHEM, V285, P21671, DOI 10.1074/jbc.M109.084731; He SM, 2012, JPN J CLIN ONCOL, V42, P196, DOI 10.1093/jjco/hyr195; Hu XY, 2009, EJSO-EUR J SURG ONC, V35, P527, DOI 10.1016/j.ejso.2008.09.015; Kamnasaran D, 2003, CLIN INVEST MED, V26, P285; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Mizutani K, 2005, TUMORI J, V91, P546, DOI 10.1177/030089160509100616; Nandadasa S, 2009, DEVELOPMENT, V136, P1327, DOI 10.1242/dev.031203; Nethe M, 2012, J CELL SCI, V125, P3430, DOI 10.1242/jcs.100925; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Pulvirenti T, 2011, CANCER RES, V71, P7280, DOI 10.1158/0008-5472.CAN-11-1531; Rao L, 2010, J PEDIATR NEUROSCI, V5, P64, DOI 10.4103/1817-1745.66686; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sharma J, 2012, J BIOL CHEM, V287, P6830, DOI 10.1074/jbc.M111.315135; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Van Campenhout CA, 2011, DEV CELL, V21, P479, DOI 10.1016/j.devcel.2011.08.003; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Wen J, 2010, J BIOL CHEM, V285, P11023, DOI 10.1074/jbc.M109.085381; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Zhang L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/831092	47	83	87	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8289	8298		10.1074/jbc.M112.433185	http://dx.doi.org/10.1074/jbc.M112.433185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23396981	Green Published, hybrid			2022-12-25	WOS:000316564500029
J	Kujala, H; Moilanen, A; Araujo, MB; Cabeza, M				Kujala, Heini; Moilanen, Atte; Araujo, Miguel B.; Cabeza, Mar			Conservation Planning with Uncertain Climate Change Projections	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; DISPERSAL CORRIDORS; RESERVE NETWORKS; PROTECTED AREAS; CHANGE IMPACTS; GLOBAL CHANGE; BIODIVERSITY; VULNERABILITY; PERSISTENCE; SCENARIOS	Climate change is affecting biodiversity worldwide, but conservation responses are constrained by considerable uncertainty regarding the magnitude, rate and ecological consequences of expected climate change. Here we propose a framework to account for several sources of uncertainty in conservation prioritization. Within this framework we account for uncertainties arising from (i) species distributions that shift following climate change, (ii) basic connectivity requirements of species, (iii) alternative climate change scenarios and their impacts, (iv) in the modelling of species distributions, and (v) different levels of confidence about present and future. When future impacts of climate change are uncertain, robustness of decision-making can be improved by quantifying the risks and trade-offs associated with climate scenarios. Sensible prioritization that accounts simultaneously for the present and potential future distributions of species is achievable without overly jeopardising present-day conservation values. Doing so requires systematic treatment of uncertainties and testing of the sensitivity of results to assumptions about climate. We illustrate the proposed framework by identifying priority areas for amphibians and reptiles in Europe.	[Kujala, Heini; Moilanen, Atte; Cabeza, Mar] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland; [Araujo, Miguel B.] CSIC, Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, Madrid, Spain; [Araujo, Miguel B.] Univ Evora, Rui Nabeiro Biodivers Chair, Ctr Invest Biodiversidade & Recursos Genet, Evora, Portugal; [Araujo, Miguel B.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark	University of Helsinki; Consejo Superior de Investigaciones Cientificas (CSIC); University of Evora; University of Copenhagen	Cabeza, M (corresponding author), Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland.	cabeza@cc.helsinki.fi	Moilanen, Atte/A-5005-2011; Cabeza, Mar/ABC-4297-2020; Araújo, Miguel B/B-6117-2008	Cabeza, Mar/0000-0002-7410-7631; Araújo, Miguel B/0000-0002-5107-7265; KUJALA, HEINI/0000-0001-9772-3202	Academy of Finland Centre of Excellence Programme [213457, 129636]; Luonnonvaraisten elioiden kestavan kayton ja suojelun tutkijakoulu Graduate School fellowship; Finnish Cultural Foundation [SKR-00070832]; ERC-StG (European Research Council Starting Grant) [260393]; European Commission [244092]; Spanish Research Council; 'Rui Nabeiro' Biodiversity Chair; Danish National Research Foundation	Academy of Finland Centre of Excellence Programme(Academy of Finland); Luonnonvaraisten elioiden kestavan kayton ja suojelun tutkijakoulu Graduate School fellowship; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); ERC-StG (European Research Council Starting Grant); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Research Council; 'Rui Nabeiro' Biodiversity Chair; Danish National Research Foundation(Danmarks Grundforskningsfond)	For financial support HK and AM thank the Academy of Finland Centre of Excellence Programme 2006-2011, grants 213457 and 129636 (URL: http://www.aka.fi/en-GB/A/Centres-of-Excellence-/). HK was also funded by a Luonnonvaraisten elioiden kestavan kayton ja suojelun tutkijakoulu Graduate School fellowship (URL: http://www.helsinki.fi/luova) and by Finnish Cultural Foundation, grant SKR-00070832 (URL: http://www.skr.fi). AM acknowledges the support by the ERC-StG (European Research Council Starting Grant, URL: http://erc.europa.eu/starting-grants) project Global Environmental Decision Analysis (GEDA), grant 260393. MC and MBA were funded by the European Commission Seventh Framework Program project European RESPONSES to climate change (grant agreement number 244092, URL: http://www.responsesproject.eu/). MBA also acknowledges the Spanish Research Council (URL: http://www.csic.es/web/guest/home), the 'Rui Nabeiro' Biodiversity Chair (URL: http://www.catedra.uevora.pt/rui-nabeiro/), and the Danish National Research Foundation (URL: http://www.dg.dk/en/) for support of his research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasyan A, 2009, IUCN 2011 IUCN RED L; Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2004, BIOL CONSERV, V118, P533, DOI 10.1016/j.biocon.2003.10.006; Araujo MB, 2009, CONSERV BIOL, V23, P1332; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P3, DOI 10.1016/j.gloenvcha.2003.10.004; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Ben-Haim Y., 2006, INFO GAP DECISION TH, V2; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Burns CE, 2003, P NATL ACAD SCI USA, V100, P11474, DOI 10.1073/pnas.1635115100; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; Carr LW, 2001, CONSERV BIOL, V15, P1071, DOI 10.1046/j.1523-1739.2001.0150041071.x; Carroll C, 2010, GLOBAL CHANGE BIOL, V16, P891, DOI 10.1111/j.1365-2486.2009.01965.x; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Forman RTT, 2000, CONSERV BIOL, V14, P31, DOI 10.1046/j.1523-1739.2000.99299.x; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Gasc J.P., 1997, P1; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Hannah L, 2002, CONSERV BIOL, V16, P264, DOI 10.1046/j.1523-1739.2002.00465.x; Hastie T.J., 2017, STAT SCI; Henle K, 2010, BIODIVERSITY CLIMATE, P225; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; IPCC, 2000, SPECIAL REPORT EMISS; IUCN, 2008, AN AMPH 2008 IUCN RE; Kharouba HM, 2010, BIOL CONSERV, V143, P1094, DOI 10.1016/j.biocon.2010.02.002; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kujala H, 2011, BIOL CONSERV, V144, P2450, DOI 10.1016/j.biocon.2011.06.023; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; Lek S, 1996, ECOL MODEL, V90, P39, DOI 10.1016/0304-3800(95)00142-5; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; Masson-Delmotte V, 2018, SPEC REP GLOB WARM 1; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mitchell TD, 2003, COMPREHENSIVE SET HI, V55, P55; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A, 2008, ZONATION SOFTWARE SP; Moilanen A, 2006, CONSERV BIOL, V20, P1688, DOI 10.1111/j.1523-1739.2006.00560.x; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; O'Neill BC, 2004, INT STAT REV, V72, P167; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillips SJ, 2008, ECOL APPL, V18, P1200, DOI 10.1890/07-0507.1; Porter KR, 1972, HERPETOLOGY; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; PRESSEY RL, 1994, BIODIVERS CONSERV, V3, P242, DOI 10.1007/BF00055941; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Rayfield B, 2009, ECOL MODEL, V220, P725, DOI 10.1016/j.ecolmodel.2008.11.016; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; SINSCH U, 1990, ETHOL ECOL EVOL, V2, P65, DOI 10.1080/08927014.1990.9525494; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Thomson JR, 2009, ECOL APPL, V19, P817, DOI 10.1890/08-0915.1; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P759, DOI 10.1111/j.1365-2486.2006.01140.x; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9; Wintle BA, 2011, NAT CLIM CHANGE, V1, P355, DOI 10.1038/NCLIMATE1227	73	108	109	1	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53315	10.1371/journal.pone.0053315	http://dx.doi.org/10.1371/journal.pone.0053315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405068	Green Published, gold			2022-12-25	WOS:000315153400011
J	Thomas, M; Kienast, Y; Scheuer, W; Bahner, M; Kaluza, K; Gassner, C; Herting, F; Brinkmann, U; Seeber, S; Kavlie, A; Welschof, M; Ries, S; Weidner, KM; Regula, JT; Klein, C				Thomas, Markus; Kienast, Yvonne; Scheuer, Werner; Baehner, Monika; Kaluza, Klaus; Gassner, Christian; Herting, Frank; Brinkmann, Ulrich; Seeber, Stefan; Kavlie, Anita; Welschof, Martin; Ries, Stefan; Weidner, K. Michael; Regula, Joerg T.; Klein, Christian			A Novel Angiopoietin-2 Selective Fully Human Antibody with Potent Anti-Tumoral and Anti-Angiogenic Efficacy and Superior Side Effect Profile Compared to Pan-Angiopoietin-1/-2 Inhibitors	PLOS ONE			English	Article							ENDOTHELIAL-CELL SURVIVAL; ADVANCED SOLID TUMORS; AMG 386; OVARIAN-CANCER; TIE2 RECEPTOR; IN-VIVO; OCULAR ANGIOGENESIS; ANTITUMOR-ACTIVITY; BLOOD-VESSELS; SHORT-TERM	There is increasing experimental evidence for an important role of Angiopoietin-2 (Ang-2) in tumor angiogenesis and progression. In addition, Ang-2 is up-regulated in many cancer types and correlated with poor prognosis. To investigate the functional role of Ang-2 inhibition in tumor development and progression, we generated novel fully human antibodies that neutralize specifically the binding of Ang-2 to its receptor Tie2. The selected antibodies LC06 and LC08 recognize both rodent and human Ang-2 with high affinity, but LC06 shows a higher selectivity for Ang-2 over Ang-1 compared to LC08 which can be considered an Ang-2/Ang-1 cross-reactive antibody. Our data demonstrate that Ang-2 blockade results in potent tumor growth inhibition and pronounced tumor necrosis in subcutaneous and orthotopic tumor models. These effects are attended with a reduction of intratumoral microvessel density and tumor vessels characterized by fewer branches and increased pericyte coverage. Furthermore, anti-Ang-2 treatment strongly inhibits the dissemination of tumor cells to the lungs. Interestingly, in contrast to the Ang-2/Ang-1 cross-reactive antibody LC08 that leads to a regression of physiological vessels in the mouse trachea, the inhibition with the selective anti-Ang-2 antibody LC06 appears to be largely restricted to tumor vasculature without obvious effects on normal vasculature. Taken together, these data provide strong evidence for the selective Ang-2 antibody LC06 as promising new therapeutic agent for the treatment of various cancers.	[Thomas, Markus; Kienast, Yvonne; Scheuer, Werner; Herting, Frank; Weidner, K. Michael; Klein, Christian] Roche Diagnost GmbH, Pharma Res & Early Dev, Discovery Oncol, Penzberg, Germany; [Baehner, Monika; Kaluza, Klaus; Gassner, Christian; Brinkmann, Ulrich; Seeber, Stefan; Ries, Stefan; Regula, Joerg T.] Roche Diagnost GmbH, Pharma Res & Early Dev, Biol Res, Penzberg, Germany; [Kavlie, Anita; Welschof, Martin] Affitech Res AS, Oslo, Norway	Roche Holding; Roche Holding	Thomas, M (corresponding author), Roche Diagnost GmbH, Pharma Res & Early Dev, Discovery Oncol, Penzberg, Germany.	markus.thomas@roche.com	Brinkmann, Ulrich/AAF-8216-2019; Klein, Christian/G-1336-2010	Brinkmann, Ulrich/0000-0002-5558-0212; Klein, Christian/0000-0001-7594-7280; Regula, Joerg Thomas/0000-0002-7343-1077				Ahmad SA, 2001, CANCER, V92, P1138, DOI 10.1002/1097-0142(20010901)92:5<1138::AID-CNCR1431>3.0.CO;2-L; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Brown JL, 2010, MOL CANCER THER, V9, P145, DOI 10.1158/1535-7163.MCT-09-0554; Burger RA, 2012, GYNECOL ONCOL, V124, P5, DOI 10.1016/j.ygyno.2011.11.011; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Coxon A, 2010, MOL CANCER THER, V9, P2641, DOI 10.1158/1535-7163.MCT-10-0213; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; Franco M, 2006, CANCER RES, V66, P3639, DOI 10.1158/0008-5472.CAN-05-3295; Hatfield KJ, 2008, LEUKEMIA, V22, P287, DOI 10.1038/sj.leu.2404985; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; Herbst RS, 2009, J CLIN ONCOL, V27, P3557, DOI 10.1200/JCO.2008.19.6683; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Hu B, 2003, P NATL ACAD SCI USA, V100, P8904, DOI 10.1073/pnas.1533394100; Huang H, 2011, CLIN CANC RES; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Joussen AM, 2001, GRAEF ARCH CLIN EXP, V239, P972, DOI 10.1007/s004170100365; Karlan BY, 2012, J CLIN ONCOL, V30, P362, DOI 10.1200/JCO.2010.34.3178; Kesisis G, 2007, CURR PHARM DESIGN, V13, P2795, DOI 10.2174/138161207781757033; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Kurebayashi J, 1999, BRIT J CANCER, V79, P707, DOI 10.1038/sj.bjc.6690114; Leow CC, 2012, INT J ONCOL, V40, P1321, DOI 10.3892/ijo.2012.1366; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Mita AC, 2010, CLIN CANCER RES, V16, P3044, DOI 10.1158/1078-0432.CCR-09-3368; Mochizuki Y, 2002, J CELL SCI, V115, P175; Nasarre P, 2009, CANCER RES, V69, P1324, DOI 10.1158/0008-5472.CAN-08-3030; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park JH, 2007, CHEST, V132, P200, DOI 10.1378/chest.06-2915; Pfaff D, 2006, J LEUKOCYTE BIOL, V80, P719, DOI 10.1189/jlb.1105652; Pietila R, 2012, J CELL SCI, V125, P2212, DOI 10.1242/jcs.098020; Rennel ES, 2011, MICROCIRCULATION, V18, P598, DOI 10.1111/j.1549-8719.2011.00120.x; Rini B, 2012, CANCER; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Sarraf-Yazdi S, 2008, J SURG RES, V146, P16, DOI 10.1016/j.jss.2007.04.028; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Schneider T, 2002, CLIN EXP METASTAS, V19, P571, DOI 10.1023/A:1020992411420; Stoeltzing O, 2003, CANCER RES, V63, P3370; Stratmann A, 1998, AM J PATHOL, V153, P1459, DOI 10.1016/S0002-9440(10)65733-1; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tsutsui S, 2006, BREAST CANCER RES TR, V98, P261, DOI 10.1007/s10549-005-9157-9; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Wurmbach JH, 2000, ANTICANCER RES, V20, P5217; Zagzag D, 1999, EXP NEUROL, V159, P391, DOI 10.1006/exnr.1999.7162; Zhang L, 2003, CANCER RES, V63, P3403	55	50	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54923	10.1371/journal.pone.0054923	http://dx.doi.org/10.1371/journal.pone.0054923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405099	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400043
J	Wang, W; Collinger, JL; Degenhart, AD; Tyler-Kabara, EC; Schwartz, AB; Moran, DW; Weber, DJ; Wodlinger, B; Vinjamuri, RK; Ashmore, RC; Kelly, JW; Boninger, ML				Wang, Wei; Collinger, Jennifer L.; Degenhart, Alan D.; Tyler-Kabara, Elizabeth C.; Schwartz, Andrew B.; Moran, Daniel W.; Weber, Douglas J.; Wodlinger, Brian; Vinjamuri, Ramana K.; Ashmore, Robin C.; Kelly, John W.; Boninger, Michael L.			An Electrocorticographic Brain Interface in an Individual with Tetraplegia	PLOS ONE			English	Article							MOTOR CORTICAL REPRESENTATION; MOVEMENT TRAJECTORIES; COMPUTER INTERFACE; CORTEX; SIGNALS; EXECUTION; DIRECTION; IMAGERY; ARM	Brain-computer interface (BCI) technology aims to help individuals with disability to control assistive devices and reanimate paralyzed limbs. Our study investigated the feasibility of an electrocorticography (ECoG)-based BCI system in an individual with tetraplegia caused by C4 level spinal cord injury. ECoG signals were recorded with a high-density 32-electrode grid over the hand and arm area of the left sensorimotor cortex. The participant was able to voluntarily activate his sensorimotor cortex using attempted movements, with distinct cortical activity patterns for different segments of the upper limb. Using only brain activity, the participant achieved robust control of 3D cursor movement. The ECoG grid was explanted 28 days post-implantation with no adverse effect. This study demonstrates that ECoG signals recorded from the sensorimotor cortex can be used for real-time device control in paralyzed individuals.	[Wang, Wei; Collinger, Jennifer L.; Tyler-Kabara, Elizabeth C.; Schwartz, Andrew B.; Weber, Douglas J.; Wodlinger, Brian; Vinjamuri, Ramana K.; Ashmore, Robin C.; Boninger, Michael L.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Wang, Wei; Collinger, Jennifer L.; Degenhart, Alan D.; Tyler-Kabara, Elizabeth C.; Schwartz, Andrew B.; Weber, Douglas J.; Boninger, Michael L.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Wang, Wei; Boninger, Michael L.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Wang, Wei; Degenhart, Alan D.; Schwartz, Andrew B.; Weber, Douglas J.; Wodlinger, Brian] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Wang, Wei; Degenhart, Alan D.; Schwartz, Andrew B.; Weber, Douglas J.; Wodlinger, Brian] Univ Pittsburgh, Pittsburgh, PA USA; [Collinger, Jennifer L.; Weber, Douglas J.; Boninger, Michael L.] Dept Vet Affairs, Human Engn Res Labs, Pittsburgh, PA USA; [Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Schwartz, Andrew B.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Moran, Daniel W.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Moran, Daniel W.] Washington Univ, Dept Neurobiol, St Louis, MO USA; [Kelly, John W.] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Washington University (WUSTL); Carnegie Mellon University	Wang, W (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.	wangwei3@pitt.edu	Tyler-Kabara, Elizabeth/H-4930-2013	Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Degenhart, Alan/0000-0002-8369-8517; Wodlinger, Brian/0000-0001-6808-4448; Vinjamuri, Ramana Kumar/0000-0003-1650-5524; Collinger, Jennifer/0000-0002-4517-5395; Boninger, Michael/0000-0001-6966-919X	University of Pittsburgh Medical Center (UPMC); UPMC Rehabilitation Institute; National Institutes of Health (NIH) [3R01NS050256-05S1, 1R01EB009103-01, 8KL2TR000146-07]; SPAWAR [N66001-10-C-4056 20100630]; Telemedicine and Advanced Technology Research Center of the US Army Medical Research and Materiel Command Agreement [W81XWH-07-1-0716]; Craig H. Neilsen Foundation; Office of Research and Development, Rehabilitation Research & Development Service, VA Center of Excellence in Wheelchairs and Associated Rehab Engineering [B6789C]; Hopkins University Applied Physics Laboratory; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050256] Funding Source: NIH RePORTER	University of Pittsburgh Medical Center (UPMC); UPMC Rehabilitation Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPAWAR; Telemedicine and Advanced Technology Research Center of the US Army Medical Research and Materiel Command Agreement; Craig H. Neilsen Foundation; Office of Research and Development, Rehabilitation Research & Development Service, VA Center of Excellence in Wheelchairs and Associated Rehab Engineering; Hopkins University Applied Physics Laboratory; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the University of Pittsburgh Medical Center (UPMC) (www.upmc.com), UPMC Rehabilitation Institute (www.upmc.com/Services/rehab/rehab-institute), and the National Institutes of Health (NIH)(www.nih.gov) Grants 3R01NS050256-05S1, 1R01EB009103-01, and 8KL2TR000146-07. This material is based upon work supported by the SPAWAR (www.spawar.navy.mil) under Contract No. N66001-10-C-4056 20100630, Telemedicine and Advanced Technology Research Center of the US Army Medical Research and Materiel Command Agreement (www.tatrc.org) W81XWH-07-1-0716, and the Craig H. Neilsen Foundation (chnfoundation.org). This material is supported in part by the Office of Research and Development, Rehabilitation Research & Development Service, VA Center of Excellence in Wheelchairs and Associated Rehab Engineering (www.herl.research.va.gov), Grant# B6789C. The contents of this publication do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the participant for his commitment and effort for this study and for his insightful discussion with the study team. We thank the contribution and support from clinicians and researchers at the University of Pittsburgh and University of Pittsburgh Medical Center (UPMC). Specifically, we thank Dr. Joseph Ricker at Department of Physical Medicine and Rehabilitation (PM&R) for conducting presurgical neuropsychological screening with the study participant, Dr. Timothy Verstynen at the Learning Research and Development Center for his help with presurgical fMRI protocol development, Dr. Donald Crammond at the Department of Neurological Surgery for intra-operative neurophysiology monitoring, Dr. Ferenc Gyulai at the Department of Anesthesiology for directing general anesthesia for the grid implantation surgery, and Dr. Richard Barbara at the Department of PM&R for post-BCI-experiment neuropsychological consultation with the participant. We thank Ms. Elizabeth (Betsy) Harchick at the Department of PM&R for helping with regulatory compliance, subject recruitment, presurgical functional neuroimaging studies, and BCI sessions. We thank Dr. Stephen Foldes at the Department of PM&R and Ms. Leah Helou at the Department of communication science and disorders for helping with BCI sessions. We thank the University of Pittsburgh Clinical and Translational Science Institute for important help with human subject protocol development and regulatory approval and compliance. We thank Mr. Jesse Wheeler at the Department of Biomedical Engineering, Washington University in St. Louis, for pre-clinical testing of the custom ECoG array and discussions on neural decoding schemes. We thank the Johns Hopkins University Applied Physics Laboratory for their support of the project, especially the prosthetic arm control experiment.	Acharya S, 2010, J NEURAL ENG, V7, DOI [10.1088/1741-2560/7/4/046002, 10.2202/1553-3840.1324]; American Spinal Injury Association/International Medical Society of Paraplegia, 2001, INT STAND NEUR FUNCT; Ashmore RC, 2012, STABLE ONLINE CONTRO; Blakely T, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0977; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chao ZC, 2011, FRONT NEUROENGINEERI, V3, P3; Christensen MS, 2007, PREMOTOR CORTEX MODU; Crapse TB, 2008, CURR OPIN NEUROBIOL, V18, P552, DOI 10.1016/j.conb.2008.09.017; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Degenhart AD, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/363565; Donoghue JP, 2008, NEURON, V60, P511, DOI 10.1016/j.neuron.2008.10.037; Edwards E, 2009, NEUROIMAGE; Felton EA, 2007, ELECTROCORTICOGRAPHI; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Gritsenko V, 2007, AFFERENT INPUT EFFER; Harris A, 2011, IEEE SYS MAN CYBERN, P2877, DOI 10.1109/ICSMC.2011.6084102; Hermes D, 2010, J NEUROSCI METH, V185, P293, DOI 10.1016/j.jneumeth.2009.10.005; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Kellis S, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056007; Kennedy PR, 2004, IEEE T NEUR SYS REH, V12, P339, DOI 10.1109/TNSRE.2004.834629; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Miller KJ, 2009, J NEUROSCI, V29, P3132, DOI 10.1523/JNEUROSCI.5506-08.2009; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Miller KJ, 2007, J NEUROSCI METH, V162, P303, DOI 10.1016/j.jneumeth.2007.01.019; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Porro CA, 1996, PRIMARY MOTOR SENSOR; Ray S, 2008, CLIN NEUROPHYSIOL, V119, P116, DOI 10.1016/j.clinph.2007.09.136; Rouse AG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036018; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Schalk G, 2012, BRAIN COMPUTER INTER, P251; Schalk Gerwin, 2011, IEEE Rev Biomed Eng, V4, P140, DOI 10.1109/RBME.2011.2172408; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Shoham S, 2001, NATURE, V413, P793, DOI 10.1038/35101651; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; Stoica P., 1997, SPECTRAL ANAL SIGNAL; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Wang W, 2009, HUMAN MOTOR CORTICAL; Wang W, 2007, J NEUROPHYSIOL, V97, P4258, DOI 10.1152/jn.01180.2006; Wang Wei, 2010, Phys Med Rehabil Clin N Am, V21, P157, DOI 10.1016/j.pmr.2009.07.003; Wheeler JJ, 2011, PERSONAL COMMUNICATI; Wodlinger B, 2012, CLIN NEUROP IN PRESS, P3083; Yanagisawa T, 2011, ANN NEUROL	54	223	224	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55344	10.1371/journal.pone.0055344	http://dx.doi.org/10.1371/journal.pone.0055344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405137	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000315153400082
J	Yeh, CY; Yeh, TH; Jung, CJ; Chen, PL; Lien, HT; Chia, JS				Yeh, Chiou-Yueh; Yeh, Te-Huei; Jung, Chiau-Jing; Chen, Pei-Lin; Lien, Huei-Ting; Chia, Jean-San			Activated Human Nasal Epithelial Cells Modulate Specific Antibody Response against Bacterial or Viral Antigens	PLOS ONE			English	Article							IN-VITRO IMMUNIZATION; NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; GEM PARTICLES; STREPTOCOCCUS-MUTANS; LACTOCOCCUS-LACTIS; B-CELLS; EXPRESSION; INDUCE; INTERFACE	Nasal mucosa is an immune responsive organ evidenced by eliciting both specific local secretory IgA and systemic IgG antibody responses with intra-nasal administration of antigens. Nevertheless, the role of nasal epithelial cells in modulating such responses is unclear. Human nasal epithelial cells (hNECs) obtained from sinus mucosa of patients with chronic rhinosinusitis were cultured in vitro and firstly were stimulated by Lactococcus lactis bacterium-like particles (BLPs) in order to examine their role on antibody production. Secondly, both antigens of immunodominant protein IDG60 from oral Streptococcus mutans and hemagglutinin (HA) from influenza virus were tested to evaluate the specific antibody response. Stimulated hNECs by BLPs exhibited a significant increase in the production of interleukin-6 (IL-6), and thymic stromal lymphopoietin (TSLP). Conditioned medium of stimulated hNECs has effects on enhancing the proliferation of CD4+ T cells together with interferon-gamma and IL-5 production, increasing the costimulatory molecules on dendritic cells and augmenting the production of IDG60 specific IgA, HA specific IgG, IgA by human peripheral blood lymphocytes. Such production of antigen specific IgG and IgA is significantly counteracted in the presence of IL-6 and TSLP neutralizing antibodies. In conclusion, properly stimulated hNECs may impart immuno-modulatory effects on the antigen-specific antibody response at least through the production of IL-6 and TSLP.	[Yeh, Chiou-Yueh; Lien, Huei-Ting; Chia, Jean-San] Natl Taiwan Univ, Grad Inst Immunol, Coll Med, Taipei 10764, Taiwan; [Yeh, Te-Huei] Natl Taiwan Univ, Dept Otolaryngol, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Jung, Chiau-Jing; Chen, Pei-Lin; Chia, Jean-San] Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chia, JS (corresponding author), Natl Taiwan Univ, Grad Inst Immunol, Coll Med, Taipei 10764, Taiwan.	chiajs@ntu.edu.tw		CHIA, JEAN-SAN/0000-0002-5431-0712	National Science Council [NSC 95-2320-B-002-086-MY3, NSC 97-2314-B-002-091-MY3, 98-2320-B-002-047-MY3, NSC 100-2314-B-002-044, NSC 101-2321-B-002-074, NSC 101-2321-B-002-016]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council (NSC 95-2320-B-002-086-MY3, NSC 97-2314-B-002-091-MY3, 98-2320-B-002-047-MY3, NSC 100-2314-B-002-044, NSC 101-2321-B-002-074 and NSC 101-2321-B-002-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audouy SAL, 2006, VACCINE, V24, P5434, DOI 10.1016/j.vaccine.2006.03.054; BORREBAECK CAK, 1987, BIOCHEM BIOPH RES CO, V148, P941, DOI 10.1016/S0006-291X(87)80223-1; Bosma T, 2006, APPL ENVIRON MICROB, V72, P880, DOI 10.1128/AEM.72.1.880-889.2006; Brandtzaeg P, 2011, AM J RESP CRIT CARE, V183, P1595, DOI 10.1164/rccm.201011-1783OC; BROMANDER A, 1991, J IMMUNOL, V146, P2908; BROMANDER AK, 1993, SCAND J IMMUNOL, V37, P452, DOI 10.1111/j.1365-3083.1993.tb03318.x; Chia JS, 2000, ORAL MICROBIOL IMMUN, V15, P131, DOI 10.1034/j.1399-302x.2000.150210.x; Chia JS, 2001, INFECT IMMUN, V69, P6987, DOI 10.1128/IAI.69.11.6987-6998.2001; Chua BY, 2011, J IMMUNOL, V187, P1692, DOI 10.4049/jimmunol.1100486; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Fujiki T, 2010, BIOSCI BIOTECH BIOCH, V74, P1836, DOI 10.1271/bbb.100243; GASSON MJ, 1983, J BACTERIOL, V154, P1; Ichikawa A, 1999, CYTOTECHNOLOGY, V31, P131, DOI 10.1023/A:1008063903946; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kalinski P, 2000, J IMMUNOL, V165, P1877, DOI 10.4049/jimmunol.165.4.1877; Kamekura R, 2008, INFLAMMATION REGENER, V28, P160; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kato A, 2006, J IMMUNOL, V177, P7164, DOI 10.4049/jimmunol.177.10.7164; Krzysiek R, 2000, BLOOD, V96, P2338, DOI 10.1182/blood.V96.7.2338.h8002338_2338_2345; Lin CF, 2007, ACTA OTO-LARYNGOL, V127, P395, DOI 10.1080/00016480601089416; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Matsumoto S, 2006, CYTOTECHNOLOGY, V52, P227, DOI 10.1007/s10616-006-9003-x; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Ramasamy R, 2006, VACCINE, V24, P3900, DOI 10.1016/j.vaccine.2006.02.040; Ramirez K, 2010, MUCOSAL IMMUNOL, V3, P159, DOI 10.1038/mi.2009.131; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Saluja V, 2010, EUR J PHARM BIOPHARM, V76, P470, DOI 10.1016/j.ejpb.2010.08.003; Saluja V, 2010, VACCINE, V28, P7963, DOI 10.1016/j.vaccine.2010.09.066; Saluja V, 2010, AAPS J, V12, P109, DOI 10.1208/s12248-009-9168-2; Tanaka J, 2010, DIGEST DIS SCI, V55, P1896, DOI 10.1007/s10620-009-0979-x; van Roosmalen ML, 2006, METHODS, V38, P144, DOI 10.1016/j.ymeth.2005.09.015; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Yeh CY, 2006, INFECT IMMUN, V74, P1273, DOI 10.1128/IAI.74.2.1273-1283.2006; Yeh TH, 2007, LARYNGOSCOPE, V117, P1439, DOI 10.1097/MLG.0b013e318063e84f; Yeh TH, 2005, ACTA OTO-LARYNGOL, V125, P1091, DOI 10.1080/00016480510037906; Zeng WG, 2012, VACCINE, V30, P4800, DOI 10.1016/j.vaccine.2012.05.017	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55472	10.1371/journal.pone.0055472	http://dx.doi.org/10.1371/journal.pone.0055472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405156	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400101
J	Ishikawa, T; Sakaguchi, Y				Ishikawa, Takumi; Sakaguchi, Yutaka			Both Movement-End and Task-End Are Critical for Error Feedback in Visuomotor Adaptation: A Behavioral Experiment	PLOS ONE			English	Article							PRISM ADAPTATION; SENSORY PREDICTION; BASAL GANGLIA; CEREBELLUM; SPECIFICITY; DEPRESSION; SIGNALS; LOOKING; LESIONS; CORTEX	An important issue in motor learning/adaptation research is how the brain accepts the error information necessary for maintaining and improving task performance in a changing environment. The present study focuses on the effect of timing of error feedback. Previous research has demonstrated that adaptation to displacement of the visual field by prisms in a manual reaching task is significantly slowed by delayed visual feedback of the endpoint, suggesting that error feedback is most effective when given at the end of a movement. To further elucidate the brain mechanism by which error information is accepted in visuomotor adaptation, we tested whether error acceptance is linked to the end of a given task or to the end of an executed movement. We conducted a behavioral experiment using a virtual shooting task in which subjects controlled their wrist movements to meet a target with a cursor as accurately as possible. We manipulated the timing of visual feedback of the impact position so that it occurred either ahead of or behind the true time of impact. In another condition, the impact timing was explicitly indicated by an additional cue. The magnitude of the aftereffect significantly varied depending on the timing of feedback (p < 0.05, Friedman's Test). Interestingly, two distinct peaks of aftereffect were observed around movement-end and around task-end, irrespective of the existence of the timing cue. However, the peak around task-end was sharper when the timing cue was given. Our results demonstrate that the brain efficiently accepts error information at both movement-end and task-end, suggesting that two different learning mechanisms may underlie visuomotor transformation.	[Ishikawa, Takumi; Sakaguchi, Yutaka] Univ Electrocommun, Dept Informat Media Syst, Tokyo, Japan	University of Electro-Communications - Japan	Ishikawa, T (corresponding author), Univ Electrocommun, Dept Informat Media Syst, Tokyo, Japan.	g.burafuma@gmail.com		Sakaguchi, Yutaka/0000-0002-5573-8462	Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)	Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This research was partially supported by Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST) (http://www.jst.go.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960, DOI 10.1152/jn.1999.81.4.1960; BINGHAM GP, 1989, J EXP PSYCHOL HUMAN, V15, P507, DOI 10.1037/0096-1523.15.3.507; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Cressman EK, 2010, J NEUROPHYSIOL, V103, P1888, DOI 10.1152/jn.01002.2009; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Fernandez-Ruiz J, 2004, COGNITIVE BRAIN RES, V20, P92, DOI 10.1016/j.cogbrainres.2004.01.007; Fernandez-Ruiz J, 1999, LEARN MEMORY, V6, P47; Fernandez-Ruiz J, 2006, J NEUROSCI, V26, P1986, DOI 10.1523/JNEUROSCI.4023-05.2006; Fernandez-Ruiz J, 2003, EUR J NEUROSCI, V18, P689, DOI 10.1046/j.1460-9568.2003.02785.x; Fernandez-Ruiz J, 2007, NEUROPSYCHOLOGIA, V45, P2692, DOI 10.1016/j.neuropsychologia.2007.04.006; Honda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037900; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P719, DOI 10.1037/0096-1523.21.4.719; Ishikawa T, 2010, NEURO2010; Ishikawa T, 2011, LECT NOTES COMPU III, P95; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Kawato M., 1990, ADV NEURAL COMPUTERS, V6, P365; Kitazawa S, 1997, J NEUROSCI, V17, P1481; KITAZAWA S, 1995, J NEUROSCI, V15, P7644; Kitazawa S, 2002, EXP BRAIN RES, V144, P258, DOI 10.1007/s00221-002-1089-6; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Miall RC, 2007, PLOS BIOL, V5, P2733, DOI 10.1371/journal.pbio.0050316; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Newport R, 2006, NEUROPSYCHOLOGIA, V44, P2757, DOI 10.1016/j.neuropsychologia.2006.01.007; Rao SM, 1997, J NEUROSCI, V17, P5528; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Stratton GM, 1896, PSYCHOL REV, V3, P611, DOI DOI 10.1037/H0072918; Tanaka H, 2011, EXP BRAIN RES, V208, P257, DOI 10.1007/s00221-010-2476-z; Thach WT, 1998, NEUROBIOL LEARN MEM, V70, P177, DOI 10.1006/nlme.1998.3846; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wong AL, 2011, J NEUROPHYSIOL, V105, P1130, DOI 10.1152/jn.00394.2010; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Yin PB, 2001, EXP BRAIN RES, V141, P250, DOI 10.1007/s002210100892	38	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55801	10.1371/journal.pone.0055801	http://dx.doi.org/10.1371/journal.pone.0055801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086NV	23393602	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800057
J	Wallrabenstein, I; Kuklan, J; Weber, L; Zborala, S; Werner, M; Altmuller, J; Becker, C; Schmidt, A; Hatt, H; Hummel, T; Gisselmann, G				Wallrabenstein, Ivonne; Kuklan, Jonas; Weber, Lea; Zborala, Sandra; Werner, Markus; Altmueller, Janine; Becker, Christian; Schmidt, Anna; Hatt, Hanns; Hummel, Thomas; Gisselmann, Guenter			Human Trace Amine-Associated Receptor TAAR5 Can Be Activated by Trimethylamine	PLOS ONE			English	Article							MAMMALIAN ODORANT RECEPTORS; FUNCTIONAL EXPRESSION; OLFACTORY SUBSYSTEM; IDENTIFICATION; SENSITIVITY; EXCRETION; AGONISTS; ANOSMIA; STRESS; FAMILY	In addition to the canonical olfactory receptors, TAARs were currently suggested to be a second class of chemosensory receptors in the olfactory epithelium of vertebrates. In contrast to several deorphanized murine TAARs, agonists for the intact human TAAR genes 2, 5, 6, 8 and 9 that are potentially expressed in the human olfactory epithelium have not been determined so far. Moreover, the physiological relevance of TAARs still remains elusive. We present the first successful functional expression of a human TAAR and agonists of human TAAR5. We performed a ligand screening using recombinantly expressed human TAAR5 in HANA3A cells and Xenopus laevis oocytes. In order to measure receptor activity, we used a cAMP-dependent reporter gene assay and two-electrode voltage clamp technique. As a result, human TAAR5 can be activated in a concentration-dependent manner by trimethylamine and with less efficacy by dimethylethylamine. It could neither be activated by any other of the tested single amines with a related chemical structure (42 in total), nor by any of the tested odorant mixtures. The hypothesis that Single Nucleotide Polymorphisms (SNP) within the reading frame of an olfactory receptor gene can cause a specific anosmia, formed the basis for clarifying the question, if anosmia for trimethylamine is caused by a SNP in a TAAR coding sequence. All functional human TAAR gene reading frames of subjects with specific anosmia for trimethylamine were amplified and products analyzed regarding SNP distribution. We demonstrated that the observed specific anosmia for trimethylamine is not correlated with a SNP in the coding sequence of one of the putatively functional human TAAR genes.	[Wallrabenstein, Ivonne; Kuklan, Jonas; Weber, Lea; Zborala, Sandra; Werner, Markus; Hatt, Hanns; Gisselmann, Guenter] Ruhr Univ Bochum, Bochum, Germany; [Schmidt, Anna; Hummel, Thomas] Tech Univ Dresden, Univ Dresden Med Sch, Dept Otorhinolaryngol, Smell & Taste Clin, D-01062 Dresden, Germany; [Altmueller, Janine; Becker, Christian] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany	Ruhr University Bochum; Technische Universitat Dresden; University of Cologne	Wallrabenstein, I (corresponding author), Ruhr Univ Bochum, Univ Str 150, Bochum, Germany.	Ivonne.Wallrabenstein@rub.de		Altmuller, Janine/0000-0003-4372-1521	Deutsche Forschungsgemeinschaft [SPP1393]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (SPP1393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; AMOORE JE, 1977, CHEM SENS FLAV, V2, P267, DOI 10.1093/chemse/2.3.267; AMOORE JE, 1979, CHEM SENS FLAV, V4, P153, DOI 10.1093/chemse/4.2.153; Amoore JE, 1976, J CHEM ECOL, V2, P49, DOI 10.1007/BF00988023; Bansal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018353; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Carnicelli V, 2010, CHEMOSENS PERCEPT, V3, P99, DOI 10.1007/s12078-010-9075-z; Ferrero DM, 2012, ACS CHEM BIOL, V7, P1184, DOI 10.1021/cb300111e; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Johnson MA, 2012, P NATL ACAD SCI USA, V109, P13410, DOI 10.1073/pnas.1206724109; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Keydar I, 2012, HUM MUTAT; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; McKee CLG, 2006, J PROTEOME RES, V5, P378, DOI 10.1021/pr050255h; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Mitchell SC, 2001, DRUG METAB DISPOS, V29, P517; Navarrete-Palacios E, 2003, BIOL PSYCHOL, V63, P269, DOI 10.1016/S0301-0511(03)00076-0; NISHIMURA K, 1989, J EXP ZOOL, V251, P300, DOI 10.1002/jez.1402510306; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; PAULOS MA, 1982, SCIENCE, V215, P1127, DOI 10.1126/science.7063846; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Saras A, 2008, J BIOL CHEM, V283, P10470, DOI 10.1074/jbc.M709993200; Shimizu M, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-2; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; SNODDY AM, 1985, PHARMACOL BIOCHEM BE, V22, P497, DOI 10.1016/0091-3057(85)90054-1; Staubert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011133; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zucchi R, 2006, BRIT J PHARMACOL, V149, P967, DOI 10.1038/sj.bjp.0706948	37	81	83	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54950	10.1371/journal.pone.0054950	http://dx.doi.org/10.1371/journal.pone.0054950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393561	Green Submitted, Green Published, gold			2022-12-25	WOS:000314692800015
J	Alvarez-Lacalle, E; Cantalapiedra, IR; Penaranda, A; Cinca, J; Hove-Madsen, L; Echebarria, B				Alvarez-Lacalle, Enric; Cantalapiedra, Inma R.; Penaranda, Angelina; Cinca, Juan; Hove-Madsen, Leif; Echebarria, Blas			Dependency of Calcium Alternans on Ryanodine Receptor Refractoriness	PLOS ONE			English	Article							CA2+-INDUCED CA2+ RELEASE; SARCOPLASMIC-RETICULUM; TERMINATION; MECHANISMS; FIBRILLATION; ACTIVATION; MUTATIONS; STABILITY; TRANSIENT; DYNAMICS	Background: Rapid pacing rates induce alternations in the cytosolic calcium concentration caused by fluctuations in calcium released from the sarcoplasmic reticulum (SR). However, the relationship between calcium alternans and refractoriness of the SR calcium release channel (RyR2) remains elusive. Methodology/Principal Findings: To investigate how ryanodine receptor (RyR2) refractoriness modulates calcium handling on a beat-to-beat basis using a numerical rabbit cardiomyocyte model. We used a mathematical rabbit cardiomyocyte model to study the beat-to-beat calcium response as a function of RyR2 activation and inactivation. Bi-dimensional maps were constructed depicting the beat-to-beat response. When alternans was observed, a novel numerical clamping protocol was used to determine whether alternans was caused by oscillations in SR calcium loading or by RyR2 refractoriness. Using this protocol, we identified regions of RyR2 gating parameters where SR calcium loading or RyR2 refractoriness underlie the induction of calcium alternans, and we found that at the onset of alternans both mechanisms contribute. At low inactivation rates of the RyR2, calcium alternans was caused by alternation in SR calcium loading, while at low activation rates it was caused by alternation in the level of available RyR2s. Conclusions/Significance: We have mapped cardiomyocyte beat-to-beat responses as a function of RyR2 activation and inactivation, identifying domains where SR calcium load or RyR2 refractoriness underlie the induction of calcium alternans. A corollary of this work is that RyR2 refractoriness due to slow recovery from inactivation can be the cause of calcium alternans even when alternation in SR calcium load is present.	[Alvarez-Lacalle, Enric; Cantalapiedra, Inma R.; Penaranda, Angelina; Echebarria, Blas] Univ Politecn Catalunya Barcelona Tech, Dept Fis Aplicada, Barcelona, Spain; [Cinca, Juan] Hosp Santa Creu & Sant Pau, Cardiol Serv IIB St Pau, Barcelona, Spain; [Hove-Madsen, Leif] Hosp Santa Creu & Sant Pau, Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain	Universitat Politecnica de Catalunya; Hospital of Santa Creu i Sant Pau; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Echebarria, B (corresponding author), Univ Politecn Catalunya Barcelona Tech, Dept Fis Aplicada, Barcelona, Spain.	blas.echebarria@upc.edu	Alvarez Lacalle, Enrique/M-1031-2014; Echebarria, Blas/K-5247-2014; Alvarez-Lacalle, Enrique/ADA-6394-2022; Rodriguez Cantalapiedra, Inmaculada/L-6394-2014; Echebarria, Blas/AAE-4135-2021; echebarria, blas/ABD-6811-2020; Peñaranda, Angelina/L-5120-2014	Alvarez Lacalle, Enrique/0000-0001-6824-6857; Echebarria, Blas/0000-0003-0503-1781; Alvarez-Lacalle, Enrique/0000-0001-6824-6857; Rodriguez Cantalapiedra, Inmaculada/0000-0002-0070-8979; Peñaranda, Angelina/0000-0002-0162-2851; Hove-Madsen, Leif/0000-0001-5493-3998	Spanish Ministry of Science and Innovation [CNIC-2007-12, FIS2008-06335-C02-01, FIS2011-28820-C02-01, FIS2009-13360-C03-03, SAF2011-30312]; Redes de Investigacion corporative, Instituto de Salud Carlos III, red REDINSCOR [RD06-0003-0000]; Generalitat of Catalonia [2009SGR878]; Spanish Ministry of Health and Consume	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Redes de Investigacion corporative, Instituto de Salud Carlos III, red REDINSCOR; Generalitat of Catalonia; Spanish Ministry of Health and Consume	Financial support from the Spanish Ministry of Science and Innovation is acknowledged CNIC-2007-12 (to BE, JC, and LHM), FIS2008-06335-C02-01 and FIS2011-28820-C02-01 (to BE), FIS2009-13360-C03-03 and SAF2011-30312 (to LHM). L. Hove-Madsen and J. Cinca were also supported by the Spanish Ministry of Health and Consume; Redes de Investigacion corporative, Instituto de Salud Carlos III, red REDINSCOR [RD06-0003-0000]. IRC also acknowledges financial support from the Generalitat of Catalonia under Project 2009SGR878. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belevych AE, 2009, CARDIOVASC RES, V84, P387, DOI 10.1093/cvr/cvp246; Chudin E, 1999, BIOPHYS J, V77, P2930, DOI 10.1016/S0006-3495(99)77126-2; Diaz ME, 2004, CIRC RES, V94, P650, DOI 10.1161/01.RES.0000119923.64774.72; Diaz ME, 2002, CIRC RES, V91, P585, DOI 10.1161/01.RES.0000035527.53514.C2; Diaz ME, 1997, J PHYSIOL-LONDON, V501, P3, DOI 10.1111/j.1469-7793.1997.003bo.x; Domeier TL, 2009, J PHYSIOL-LONDON, V587, P5197, DOI 10.1113/jphysiol.2009.177576; Dumitrescu C, 2002, AM J PHYSIOL-HEART C, V282, pH1320, DOI 10.1152/ajpheart.00466.2001; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; Hilliard FA, 2010, J MOL CELL CARDIOL, V48, P293, DOI 10.1016/j.yjmcc.2009.10.005; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; Huser J, 2000, J PHYSIOL-LONDON, V524, P795, DOI 10.1111/j.1469-7793.2000.00795.x; Jiang D, 2007, P NATL ACAD SCI USA, V104, P18309, DOI 10.1073/pnas.0706573104; Kameyama M, 2003, J ELECTROCARDIOL, V36, P125, DOI 10.1054/jelc.2003.50021; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Laver DR, 2011, J MOL CELL CARDIOL, V51, P357, DOI 10.1016/j.yjmcc.2011.05.009; Lehnart SE, 2004, CIRCULATION, V109, P3208, DOI 10.1161/01.CIR.0000132472.98675.EC; Llach A, 2011, J PHYSIOL-LONDON, V589, P3247, DOI 10.1113/jphysiol.2010.197715; Lukyanenko V, 1998, J PHYSIOL-LONDON, V507, P667, DOI 10.1111/j.1469-7793.1998.667bs.x; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; MATTIAZZI A, 1994, AM J PHYSIOL, V267, pH812, DOI 10.1152/ajpheart.1994.267.2.H812; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; Penaranda A, 2012, COMPUT CARDIOL CONF, V39, P297; Picht E, 2006, CIRC RES, V99, P740, DOI 10.1161/01.RES.0000244002.88813.91; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Restrepo JG, 2008, BIOPHYS J, V95, P3767, DOI 10.1529/biophysj.108.130419; Rovetti R, 2010, CIRC RES, V106, P1582, DOI 10.1161/CIRCRESAHA.109.213975; Sham JSK, 1998, P NATL ACAD SCI USA, V95, P15096, DOI 10.1073/pnas.95.25.15096; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shiferaw Y, 2003, BIOPHYS J, V85, P3666, DOI 10.1016/S0006-3495(03)74784-5; Shkryl VM, 2012, AM J PHYSIOL-HEART C, V302, pH2310, DOI 10.1152/ajpheart.00079.2012; Sobie EA, 2005, J PHYSIOL-LONDON, V565, P441, DOI 10.1113/jphysiol.2005.086496; Szentesi P, 2004, CIRC RES, V95, P807, DOI 10.1161/01.RES.0000146029.80463.7d; Terentyev D, 2002, CIRC RES, V91, P414, DOI 10.1161/01.RES.0000032490.04207.BD; Thomas NL, 2005, BIOCHEM BIOPH RES CO, V331, P231, DOI 10.1016/j.bbrc.2005.02.194; Vest JA, 2005, CIRCULATION, V111, P2025, DOI 10.1161/01.CIR.0000162461.67140.4C; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	38	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55042	10.1371/journal.pone.0055042	http://dx.doi.org/10.1371/journal.pone.0055042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390511	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100027
J	Findlay, B; Mookherjee, N; Schweizer, F				Findlay, Brandon; Mookherjee, Neeloffer; Schweizer, Frank			Ultrashort Cationic Lipopeptides and Lipopeptoids Selectively Induce Cytokine Production in Macrophages	PLOS ONE			English	Article							DEFENSE PEPTIDE LL-37; ANTIMICROBIAL PEPTIDES; BACTERIAL-INFECTIONS; IMMUNE-RESPONSES; HUMAN CAP18; IN-VITRO; RECEPTOR; RESISTANCE; DISCOVERY; DISEASE	A series of ultrashort lipopeptides and lipopeptoids were tested for their ability to induce cytokine production in macrophages. Fourteen compounds were found to strongly induce production of chemokines Gro alpha and IL-8, with a structural bias that was absent from previous antibacterial activity investigations. Compounds based on LysGlyLys and NLysGlyNLys sequences did not induce cytokine production, whereas those based on LysLysLys and NLysNLysNLys were active only when linked to a lipid tail at least sixteen carbons long. Three lipopeptides induced high levels of IL-8 production, above that of equivalent concentrations of cathelicidin LL-37, while no compound induced production of the pro-inflammatory cytokine TNF-alpha at or below 100 mu M. Two compounds, peptoids C16OH-NLysNLysNLys and C16OH-NHarNHarNHar, were selective for IL-8 production and did not induce TNF-alpha or IL-1 beta. These compounds may prove beneficial for in vivo treatment of infectious disease, with improved bioavailability over LL-37 due to their protease-resistant scaffold.	[Findlay, Brandon; Schweizer, Frank] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Mookherjee, Neeloffer] Univ Manitoba, Dept Internal Med & Immunol, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada; [Schweizer, Frank] Univ Manitoba, Dept Med Microbiol, Hlth Sci Ctr, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Mookherjee, N (corresponding author), Univ Manitoba, Dept Internal Med & Immunol, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada.	mookherj@cc.umanitoba.ca; schweize@cc.umanitoba.ca		Mookherjee, Neeloffer/0000-0002-9350-4157	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri G, 2011, J MED CHEM, V54, P8148, DOI 10.1021/jm201071e; Baker TJ, 2000, J ORG CHEM, V65, P9054, DOI 10.1021/jo001142e; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Choi KY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00149; Czihal P, 2012, ACS CHEM BIOL, V7, P1281, DOI 10.1021/cb300063v; Findlay B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041141; Findlay B, 2012, INT J ANTIMICROB AG, V40, P36, DOI 10.1016/j.ijantimicag.2012.03.013; Findlay B, 2010, ANTIMICROB AGENTS CH, V54, P4049, DOI 10.1128/AAC.00530-10; Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782; Hammerum AM, 2007, EMERG INFECT DIS, V13, P1632, DOI 10.3201/eid1311.070421; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017; Kaoud TS, 2011, ACS CHEM BIOL, V6, P658, DOI 10.1021/cb200017n; Khandelia H, 2008, BBA-BIOMEMBRANES, V1778, P1528, DOI 10.1016/j.bbamem.2008.02.009; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; LARRICK JW, 1995, IMMUNOTECHNOLOGY, V1, P65, DOI 10.1016/1380-2933(95)00006-2; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Makovitzki A, 2008, BIOCHEMISTRY-US, V47, P10630, DOI 10.1021/bi8011675; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Mookherjee N, 2009, MOL BIOSYST, V5, P483, DOI 10.1039/b813787k; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Tadesse DA, 2012, EMERG INFECT DIS, V18, P741, DOI 10.3201/eid1805.111153; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Thaker HD, 2012, J AM CHEM SOC, V134, P11088, DOI 10.1021/ja303304j; Thwaite JE, 2006, ANTIMICROB AGENTS CH, V50, P2316, DOI 10.1128/AAC.01488-05; Turner-Brannen E, 2011, J IMMUNOL, V186, P7127, DOI 10.4049/jimmunol.1002306; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang LH, 2008, P NATL ACAD SCI USA, V105, P20595, DOI 10.1073/pnas.0806456105; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yu J, 2007, J IMMUNOL, V179, P7684, DOI 10.4049/jimmunol.179.11.7684; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	40	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54280	10.1371/journal.pone.0054280	http://dx.doi.org/10.1371/journal.pone.0054280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390497	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100013
J	Srour, N; LeBlanc, C; King, J; McKim, DA				Srour, Nadim; LeBlanc, Carole; King, Judy; McKim, Douglas A.			Lung Volume Recruitment in Multiple Sclerosis	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; RESPIRATORY MUSCLE FUNCTION; PULMONARY-FUNCTION; NEUROMUSCULAR WEAKNESS; COUGH; VENTILATION; DYSFUNCTION; EXTUBATION; DISABILITY; CLEARANCE	Introduction: Pulmonary function abnormalities have been described in multiple sclerosis including reductions in forced vital capacity (FVC) and cough but the time course of this impairment is unknown. Peak cough flow (PCF) is an important parameter for patients with respiratory muscle weakness and a reduced PCF has a direct impact on airway clearance and may therefore increase the risk of respiratory tract infections. Lung volume recruitment is a technique that improves PCF by inflating the lungs to their maximal insufflation capacity. Objectives: Our goals were to describe the rate of decline of pulmonary function and PCF in patients with multiple sclerosis and describe the use of lung volume recruitment in this population. Methods: We reviewed all patients with multiple sclerosis referred to a respiratory neuromuscular rehabilitation clinic from February 1999 until December 2010. Lung volume recruitment was attempted in patients with FVC<80% predicted. Regular twice daily lung volume recruitment was prescribed if it resulted in a significant improvement in the laboratory. Results: There were 79 patients included, 35 of whom were seen more than once. A baseline FVC,80% predicted was present in 82% of patients and 80% of patients had a PCF insufficient for airway clearance. There was a significant decline in FVC (122.6 mL/y, 95% CI 54.9-190.3) and PCF (192 mL/s/y, 95% 72-311) over a median follow-up time of 13.4 months. Lung volume recruitment was associated with a slower decline in FVC (p<0.0001) and PCF (p=0.042). Conclusion: Pulmonary function and cough decline significantly over time in selected patients with multiple sclerosis and lung volume recruitment is associated with a slower rate of decline in lung function and peak cough flow. Given design limitations, additional studies are needed to assess the role of lung volume recruitment in patients with multiple sclerosis.	[Srour, Nadim; McKim, Douglas A.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [McKim, Douglas A.] Ottawa Hosp, Dept Med, Ottawa, ON, Canada; [King, Judy; McKim, Douglas A.] Univ Ottawa, Ottawa, ON, Canada; [LeBlanc, Carole; McKim, Douglas A.] Ottawa Hosp Rehabil Ctr, CANVent Program Canadian Alternat Noninvas Ventil, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Srour, N (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	nsrour@ohri.ca	King, Judy/L-1070-2018	King, Judy/0000-0003-4530-9987				Aiello M, 2008, RESPIRATION, V76, P311, DOI 10.1159/000119641; Altintas A, 2007, CLIN NEUROL NEUROSUR, V109, P242, DOI 10.1016/j.clineuro.2006.09.004; Bach JR, 2007, AM J PHYS MED REHAB, V86, P295, DOI 10.1097/PHM.0b013e318038d1ce; Bach JR, 2010, CHEST, V137, P1033, DOI 10.1378/chest.09-2144; Bach JR, 1997, CHEST, V112, P1024, DOI 10.1378/chest.112.4.1024; Bach JR, 2000, CHEST, V117, P301, DOI 10.1378/chest.117.2.301; Bach JR, 1996, CHEST, V110, P1566, DOI 10.1378/chest.110.6.1566; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; Buyse B, 1997, EUR RESPIR J, V10, P139, DOI 10.1183/09031936.97.10010139; Chiara T, 2006, ARCH PHYS MED REHAB, V87, P468, DOI 10.1016/j.apmr.2005.12.035; Edwards YS, 2001, COMP BIOCHEM PHYS A, V129, P245, DOI 10.1016/S1095-6433(01)00321-X; Finder JD, 2004, AM J RESP CRIT CARE, V170, P456, DOI 10.1164/rccm.200307-885ST; FOGLIO K, 1994, EUR RESPIR J, V7, P23, DOI 10.1183/09031936.94.07010023; Fry Donna K, 2007, J Neurol Phys Ther, V31, P162, DOI 10.1097/NPT.0b013e31815ce136; Gauld LM, 2009, DEV MED CHILD NEUROL, V51, P350, DOI 10.1111/j.1469-8749.2008.03260.x; Gosselink R, 1999, EUR RESPIR J, V13, P449, DOI 10.1183/09031936.99.13244999; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Kang SW, 2000, CHEST, V118, P61, DOI 10.1378/chest.118.1.61; KING M, 1985, J APPL PHYSIOL, V58, P1776, DOI 10.1152/jappl.1985.58.6.1776; McKim DA, 2012, ARCH PHYS MED REHABI; McKim DA, 2011, CAN RESPIR J, V18, P197, DOI 10.1155/2011/139769; Misuri G, 2000, CHEST, V117, P447, DOI 10.1378/chest.117.2.447; Mutluay FK, 2005, CLIN REHABIL, V19, P426, DOI 10.1191/0269215505cr782oa; Sancho J, 2007, AM J RESP CRIT CARE, V175, P1266, DOI 10.1164/rccm.200612-1841OC; SMELTZER SC, 1992, CHEST, V101, P479, DOI 10.1378/chest.101.2.479; SMELTZER SC, 1988, ARCH NEUROL-CHICAGO, V45, P1245, DOI 10.1001/archneur.1988.00520350083020	26	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e56676	10.1371/journal.pone.0056676	http://dx.doi.org/10.1371/journal.pone.0056676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383293	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600168
J	Weng, TT; Karmouty-Quintana, H; Garcia-Morales, LJ; Molina, JG; Pedroza, M; Bunge, RR; Bruckner, BA; Loebe, M; Seethamraju, H; Blackburn, MR				Weng, Tingting; Karmouty-Quintana, Harry; Garcia-Morales, Luis J.; Molina, Jose G.; Pedroza, Mesias; Bunge, Raquel R.; Bruckner, Brian A.; Loebe, Matthias; Seethamraju, Harish; Blackburn, Michael R.			Hypoxia-induced deoxycytidine kinase expression contributes to apoptosis in chronic lung disease	FASEB JOURNAL			English	Article						COPD; deoxyadenosine; emphysema; adenosine deaminase	ADENOSINE-DEAMINASE DEFICIENCY; CHRONIC LYMPHOCYTIC-LEUKEMIA; HIF-DEPENDENT INDUCTION; ACTIVATION; PULMONARY; GEMCITABINE; CANCER; INHIBITION; CELLS; CD73	Chronic obstructive pulmonary disease (COPD) is characterized by persistent inflammation and tissue remodeling and is a leading cause of death in the United States. Increased apoptosis of pulmonary epithelial cells is thought to play a role in COPD development and progression. Identification of signaling pathways resulting in increased apoptosis in COPD can be used in the development of novel therapeutic interventions. Deoxyadenosine (dAdo) is a DNA breakdown product that amplifies lymphocyte apoptosis by being phosphorylated to deoxyadenosine triphosphate (dATP). dAdo is maintained at low levels by adenosine deaminase (ADA). This study demonstrated that mice lacking ADA developed COPD manifestations in association with elevated dAdo and dATP levels and increased apoptosis in the lung. Deoxycitidine kinase (DCK), a major enzyme for dAdo phosphorylation, was up-regulated in mouse and human airway epithelial cells in association with air-space enlargement. Hypoxia was identified as a novel regulator of DCK, and inhibition of DCK resulted in diminished dAdo-mediated apoptosis in the lungs. Our results suggest that activating the dAdo-DCK-dATP pathway directly results in increased apoptosis in the lungs of mice with air-space enlargement and suggests a novel therapeutic target for the treatment of COPD.	[Weng, Tingting; Karmouty-Quintana, Harry; Molina, Jose G.; Pedroza, Mesias; Blackburn, Michael R.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Garcia-Morales, Luis J.; Bunge, Raquel R.; Bruckner, Brian A.; Loebe, Matthias] Methodist Hosp, Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA; [Bruckner, Brian A.; Loebe, Matthias; Seethamraju, Harish] Methodist Hosp, Methodist JC Walter Jr Transplant Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; The Methodist Hospital System; The Methodist Hospital - Houston	Blackburn, MR (corresponding author), Univ Texas Houston, Sch Med, 6431 Fannin, Houston, TX 77030 USA.	michael.r.blackburn@uth.tmc.edu	Karmouty-Quintana, Harry/ABC-9144-2020	Karmouty-Quintana, Harry/0000-0003-4753-9823; Blackburn, Michael/0000-0002-1394-9966	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070952, P01HL114457] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL114457, R01 HL070952] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Blackburn MR, 1996, PROG NUCLEIC ACID RE, V55, P195, DOI 10.1016/S0079-6603(08)60194-4; Chen Y, 2012, BIOINFORMATICS, V28, P1, DOI 10.1093/bioinformatics/btr619; COHEN A, 1983, J BIOL CHEM, V258, P2334; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Csapo Z, 2003, BIOCHEM PHARMACOL, V65, P2031, DOI 10.1016/S0006-2952(03)00182-5; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P699, DOI 10.1006/bbrc.1999.1888; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Ge YB, 2003, J BIOL CHEM, V278, P49901, DOI 10.1074/jbc.M305085200; Geutjes EJ, 2012, BREAST CANCER RES TR, V131, P809, DOI 10.1007/s10549-011-1477-3; Girard N, 2007, B CANCER, V94, pS127; Grenz A, 2011, ANTIOXID REDOX SIGN, V15, P2221, DOI 10.1089/ars.2010.3665; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hilbig A, 2008, EXPERT REV ANTICANC, V8, P511, DOI 10.1586/14737140.8.4.511; Jiang H, 2010, ACTA BIOCH BIOPH SIN, V42, P483, DOI 10.1093/abbs/gmq041; Joachims ML, 2008, NUCLEOS NUCLEOT NUCL, V27, P816, DOI 10.1080/15257770802146270; Joachims ML, 2008, J IMMUNOL, V181, P8153, DOI 10.4049/jimmunol.181.11.8153; Jones J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13suppl2/01; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Keszler G, 2004, NUCLEOS NUCLEOT NUCL, V23, P1335, DOI 10.1081/NCN-200027586; Koeppen M, 2011, CURR OPIN ANESTHESIO, V24, P363, DOI 10.1097/ACO.0b013e32834873fd; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Li XB, 2006, MICROVASC RES, V72, P48, DOI 10.1016/j.mvr.2006.04.005; Minet E, 2000, INT J MOL MED, V5, P253; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Robak T, 2005, DRUG AGING, V22, P983, DOI 10.2165/00002512-200522120-00002; Sebastiani V, 2006, CLIN CANCER RES, V12, P2492, DOI 10.1158/1078-0432.CCR-05-2655; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Sigmond J, 2010, ANTI-CANCER DRUG, V21, P591, DOI 10.1097/CAD.0b013e32833a3543; Spasokoukotskaja T, 1998, ADV EXP MED BIOL, V431, P641; SPASOKOUKOTSKAJA T, 1995, EUR J CANCER, V31A, P202, DOI 10.1016/0959-8049(94)00435-8; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Toy G, 2010, P NATL ACAD SCI USA, V107, P5551, DOI 10.1073/pnas.0913900107; Van den Neste E, 2003, BIOCHEM PHARMACOL, V65, P573, DOI 10.1016/S0006-2952(02)01559-9; WAKAMIYA M, 1995, P NATL ACAD SCI USA, V92, P3673, DOI 10.1073/pnas.92.9.3673; Yang MX, 2010, IMMUNOL CELL BIOL, V88, P165, DOI 10.1038/icb.2009.77; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224; Zhou Y, 2009, PHARMACOL THERAPEUT, V123, P105, DOI 10.1016/j.pharmthera.2009.04.003	46	14	14	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					2013	2026		10.1096/fj.12-222067	http://dx.doi.org/10.1096/fj.12-222067			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23392349	Green Published			2022-12-25	WOS:000318226100021
J	Nadanaka, S; Zhou, SB; Kagiyama, S; Shoji, N; Sugahara, K; Sugihara, K; Asano, M; Kitagawa, H				Nadanaka, Satomi; Zhou, Shaobo; Kagiyama, Shoji; Shoji, Naoko; Sugahara, Kazuyuki; Sugihara, Kazushi; Asano, Masahide; Kitagawa, Hiroshi			EXTL2, a Member of the EXT Family of Tumor Suppressors, Controls Glycosaminoglycan Biosynthesis in a Xylose Kinase-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; CHONDROITIN N-ACETYLGALACTOSAMINYLTRANSFERASE; HEPARAN-SULFATE; GENOMIC STRUCTURE; GENE; IDENTIFICATION; EXPRESSION; INITIATION; PROTEOGLYCANS; LOCALIZATION	Mutant alleles of EXT1 or EXT2, two members of the EXT gene family, are causative agents in hereditary multiple exostoses, and their gene products function together as a polymerase in the biosynthesis of heparan sulfate. EXTL2, one of three EXT-like genes in the human genome that are homologous to EXT1 and EXT2, encodes a transferase that adds not only GlcNAc but also N-acetylgalactosamine to the glycosaminoglycan (GAG)-protein linkage region via an alpha 1,4-linkage. However, both the role of EXTL2 in the biosynthesis of GAGs and the biological significance of EXTL2 remain unclear. Here we show that EXTL2 transfers a GlcNAc residue to the tetrasaccharide linkage region that is phosphorylated by a xylose kinase 1 (FAM20B) and thereby terminates chain elongation. We isolated an oligosaccharide from the mouse liver, which was not detected in EXTL2 knock-out mice. Based on structural analysis by a combination of glycosidase digestion and 500-MHz H-1 NMR spectroscopy, the oligosaccharide was found to be GlcNAc alpha 1-4GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl(2-O-phosphate), which was considered to be a biosynthetic intermediate of an immature GAG chain. Indeed, EXTL2 specifically transferred a GlcNAc residue to a phosphorylated linkage tetrasaccharide, GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl(2-O-phosphate). Remarkably, the phosphorylated linkage pentasaccharide generated by EXTL2 was not used as an acceptor for heparan sulfate or chondroitin sulfate polymerases. Moreover, production of GAGs was significantly higher in EXTL2 knock-out mice than in wild-type mice. These results indicate that EXTL2 functions to suppress GAG biosynthesis that is enhanced by a xylose kinase and that the EXTL2-dependent mechanism that regulates GAG biosynthesis might be a "quality control system" for proteoglycans.	[Nadanaka, Satomi; Zhou, Shaobo; Kagiyama, Shoji; Shoji, Naoko; Sugahara, Kazuyuki; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Sugihara, Kazushi; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa 9208640, Japan	Kobe Pharmaceutical University; Kanazawa University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Program for the Strategic Research Foundation at Private Universities; MEXT, Japan [23110002]; Grants-in-Aid for Scientific Research [23500493] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for the Strategic Research Foundation at Private Universities; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)-supported Program for the Strategic Research Foundation at Private Universities, 2012-2017 (to H. K.) and was supported in part by a Grant-in-Aid for Scientific Research in Innovative Areas 23110002 (Deciphering Sugar Chain-based Signals Regulating Integrative Neuronal Functions (to H. K.)) from MEXT, Japan.	Arai T, 1999, INT J ONCOL, V15, P915; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; DEWAARD P, 1992, J BIOL CHEM, V267, P6036; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Fansson LA, 2000, MATRIX BIOL, V19, P367, DOI 10.1016/S0945-053X(00)00083-4; HECHT JT, 1995, AM J HUM GENET, V56, P1125; HEINEGAR.D, 1972, BIOCHIM BIOPHYS ACTA, V285, P193, DOI 10.1016/0005-2795(72)90191-2; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; KITAGAWA H, 1995, J BIOL CHEM, V270, P22190, DOI 10.1074/jbc.270.38.22190; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; KITAGAWA H, 1995, J BIOCHEM-TOKYO, V117, P1083, DOI 10.1093/oxfordjournals.jbchem.a124810; Kitagawa H, 2001, BIOCHEM J, V358, P539, DOI 10.1042/0264-6021:3580539; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; Kitagawa H, 1999, GLYCOBIOLOGY, V9, P697, DOI 10.1093/glycob/9.7.697; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okada M, 2010, BIOCHEM J, V428, P463, DOI 10.1042/BJ20100101; Prante C, 2006, STEM CELLS, V24, P2252, DOI 10.1634/stemcells.2005-0508; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; Saito T, 1998, BIOCHEM BIOPH RES CO, V243, P61, DOI 10.1006/bbrc.1997.8062; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; VanHul W, 1997, AM J HUM GENET, V61, P363, DOI 10.1086/514844; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; Wise CA, 1997, GENOME RES, V7, P10, DOI 10.1101/gr.7.1.10; Wuyts W, 1997, EUR J HUM GENET, V5, P382, DOI 10.1159/000484796; Wuyts W, 1999, CYTOGENET CELL GENET, V86, P267, DOI 10.1159/000015317	36	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9321	9333		10.1074/jbc.M112.416909	http://dx.doi.org/10.1074/jbc.M112.416909			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23395820	Green Published, hybrid			2022-12-25	WOS:000316862200050
J	Reed, JH; Jain, M; Lee, K; Kandimalla, ER; Faridi, MH; Buyon, JP; Gupta, V; Clancy, RM				Reed, Joanne H.; Jain, Manish; Lee, Kristen; Kandimalla, Ekambar R.; Faridi, Mohd Hafeez; Buyon, Jill P.; Gupta, Vineet; Clancy, Robert M.			Complement Receptor 3 Influences Toll-like Receptor 7/8-Dependent Inflammation IMPLICATIONS FOR AUTOIMMUNE DISEASES CHARACTERIZED BY ANTIBODY REACTIVITY TO RIBONUCLEOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CARDIAC MANIFESTATIONS; FUNCTIONAL VARIANT; ITGAM; TOLL-LIKE-RECEPTOR-7; ASSOCIATION; AUTOANTIGEN; PATHWAY; CELLS; RISK	Toll-like receptor (TLR) signaling is an important component in the inflammatory response generated in diseases characterized by autoantibody reactivity to proteins such as SSA/Ro in complex with endogenous nucleic acids. Complement receptor 3 (CR3), a genetic variant of which has been identified as a risk factor in systemic lupus erythematosus, has been shown to induce tolerogenic responses in dendritic cells and suppress TLR4 responses in a murine sepsis model. Accordingly, this study addressed the hypothesis that activation of CR3, influenced by genotype of CD11b, negatively regulates TLR7/8-dependent effector function. Allosteric activation of CD11b via pretreatment with the small molecule, leukadhedrin 1 (LA1), significantly attenuated TLR7/8-induced (hY3 RNA, R848) secretion of TNF alpha in THP-1 cells and human macrophages isolated from donors homozygous for the ancestral common ITGAM allele at rs1143679. This inhibition was accompanied by profound degradation of the adaptor protein MyD88, an effect not observed with direct inhibition of TLR ligation by an antagonist oligonucleotide. In contrast, the addition of LA1 after incubation with the TLR agonists did not result in MyD88 degradation and subsequent attenuation of TNF alpha secretion. In TLR7/8-stimulated macrophages isolated from donors heterozygous for the CD11b variant, pretreatment with LA1 did not down-regulate TNF alpha release. These novel findings support a negative cross-talk between CR3 and TLR pathways likely to be induced by antibodies reactive with ribonucleoproteins and point to the development of CR3-specific agonists as potential therapeutics for diseases such as neonatal lupus.	[Reed, Joanne H.; Jain, Manish; Lee, Kristen; Buyon, Jill P.; Clancy, Robert M.] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY 10016 USA; [Kandimalla, Ekambar R.] Idera Pharmaceut Inc, Cambridge, MA 02139 USA; [Faridi, Mohd Hafeez; Gupta, Vineet] Univ Miami, Div Nephrol & Hypertens, Dept Med, Peggy & Harold Katz Family Drug Discovery Ctr, Miami, FL 33136 USA	New York University; University of Miami	Reed, JH (corresponding author), NYU, Sch Med, Dept Med, 560 1st Ave,TCH 407, New York, NY 10016 USA.	Joanne.Reed@nyumc.org		Reed, Joanne/0000-0002-7585-7848; Lee, Kristen/0000-0002-6837-9569; Buyon, Jill/0000-0002-3852-7129; Gupta, Vineet/0000-0001-6987-2550	Alliance for Lupus Research grant; American Heart Association; Arthritis Foundation grant; National Institutes of Health [AR-42455, DK-084195]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR042455, R01AR042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084195] Funding Source: NIH RePORTER	Alliance for Lupus Research grant; American Heart Association(American Heart Association); Arthritis Foundation grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an Alliance for Lupus Research grant (to R. C.), American Heart Association grants (to J. R. and V. G.), Arthritis Foundation grant (to J. R.), and National Institutes of Health Grants AR-42455 (to J. B.) and DK-084195 (to V. G.).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Alvarez D., 2011, J BIOL CHEM; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Clancy RM, 2010, J IMMUNOL, V184, P2148, DOI 10.4049/jimmunol.0902248; Fan Y, 2011, J EUR ACAD DERMATOL, V25, P271, DOI 10.1111/j.1468-3083.2010.03776.x; Faridi MH, 2009, BIOORG MED CHEM LETT, V19, P6902, DOI 10.1016/j.bmcl.2009.10.077; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Han SZ, 2009, HUM MOL GENET, V18, P1171, DOI 10.1093/hmg/ddp007; Hoffmann MH, 2010, J AUTOIMMUN, V34, pJ178, DOI 10.1016/j.jaut.2009.11.013; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Izmirly PM, 2012, CIRCULATION, V126, P76, DOI 10.1161/CIRCULATIONAHA.111.089268; Izmirly PM, 2010, ANN RHEUM DIS, V69, P1827, DOI 10.1136/ard.2009.119263; Lan T, 2007, P NATL ACAD SCI USA, V104, P13750, DOI 10.1073/pnas.0706059104; Lan T, 2009, J MED CHEM, V52, P6871, DOI 10.1021/jm901145s; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; MacPherson M, 2011, J BIOL CHEM, V286, P17303, DOI 10.1074/jbc.M110.182998; Maess MB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-90; Maiguel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001811; Marth T, 1997, J EXP MED, V185, P1987, DOI 10.1084/jem.185.11.1987; MERRILL JT, 1990, J IMMUNOL, V145, P2608; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; OBRIEN CA, 1994, GENE DEV, V8, P2891, DOI 10.1101/gad.8.23.2891; Rhodes B, 2012, ANN RHEUM DIS, V71, P2028, DOI 10.1136/annrheumdis-2012-201390; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; Yu D, 2009, J MED CHEM, V52, P5108, DOI 10.1021/jm900730r	28	36	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9077	9083		10.1074/jbc.M112.403303	http://dx.doi.org/10.1074/jbc.M112.403303			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386618	hybrid, Green Published			2022-12-25	WOS:000316862200027
J	Vallabhaneni, S; McConnell, JJ; Loeb, L; Hartogensis, W; Hecht, FM; Grant, RM; Pilcher, CD				Vallabhaneni, Snigdha; McConnell, J. Jeff; Loeb, Lisa; Hartogensis, Wendy; Hecht, Fredrick M.; Grant, Robert M.; Pilcher, Christopher D.			Changes in Seroadaptive Practices from before to after Diagnosis of Recent HIV Infection among Men Who Have Sex with Men	PLOS ONE			English	Article							TRANSMISSION RISK BEHAVIORS; UNPROTECTED ANAL INTERCOURSE; POSITIVE MEN; UNITED-STATES; PREVENTION; PREVALENCE; INCREASE; DISEASE; COHORT	Objective: We assessed changes in sexual behavior among men who have sex with men (MSM), before and for several years after HIV diagnosis, accounting for adoption of a variety of seroadaptive practices. Methods: We collected self-reported sexual behavior data every 3 months from HIV-positive MSM at various stages of HIV infection. To establish population level trends in sexual behavior, we used negative binomial regression to model the relationship between time since diagnosis and several sexual behavior variables: numbers of (a) total partners, (b) potentially discordant partners (PDP; i.e., HIV-negative or unknown-status partners), (c) PDPs with whom unprotected anal intercourse (UAI) occurred, and (d) PDPs with whom unprotected insertive anal intercourse (uIAI) occurred. Results: A total of 237 HIV-positive MSM contributed 502 interviews. UAI with PDPs occurred with a mean of 4.2 partners in the 3 months before diagnosis. This declined to 0.9 partners/3 months at 12 months after diagnosis, and subsequently rose to 1.7 partners/3 months at 48 months, before falling again to 1.0 partners/3 months at 60 months. The number of PDPs with whom uIAI occurred dropped from 2.4 in the pre-diagnosis period to 0.3 partners/3 months (an 87.5% reduction) by 12 months after enrollment, and continued to decline over time. Conclusion: Within months after being diagnosed with HIV, MSM adopted seroadaptive practices, especially seropositioning, where the HIV-positive partner was not in the insertive position during UAI, resulting in a sustained decline in the sexual activity associated with the highest risk of HIV transmission.	[Vallabhaneni, Snigdha] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [McConnell, J. Jeff; Grant, Robert M.] Gladstone Inst, San Francisco, CA USA; [Loeb, Lisa; Hartogensis, Wendy; Hecht, Fredrick M.; Grant, Robert M.; Pilcher, Christopher D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Vallabhaneni, S (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	snigdhav@gmail.com		Loeb Stanga, Lisa/0000-0001-7471-5381; Grant, Robert/0000-0002-0851-7085; Hecht, Frederick/0000-0002-5782-1171	NIH NIAID [5 P01 A1071713]; National Center for Complementary & Integrative Health [K24AT007827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246, T32MH019105, R34MH096606] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from NIH NIAID 5 P01 A1071713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidala AA, 2006, AIDS EDUC PREV, V18, P12, DOI 10.1521/aeap.2006.18.1.12; Bachmann LH, 2005, SEX TRANSM DIS, V32, P20, DOI 10.1097/01.olq.0000148293.81774.e4; Butler DM, 2007, AIDS, V21, P1218, DOI 10.1097/QAD.0b013e32814db7bf; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; Crepaz N, 2009, AIDS, V23, P1617, DOI 10.1097/QAD.0b013e32832effae; Denning PH, 2005, AM J PUBLIC HEALTH, V95, P152, DOI 10.2105/AJPH.2003.017814; Eaton LA, 2009, J ASSOC NURSE AIDS C, V20, P39, DOI 10.1016/j.jana.2008.10.005; Gates GJ., MANY PEOPLE ARE LESB; Glick SN, 2012, JAIDS-J ACQ IMM DEF, V60, P83, DOI 10.1097/QAI.0b013e318247925e; Gorbach Pamina M, 2011, J Acquir Immune Defic Syndr, V56, P176, DOI 10.1097/QAI.0b013e3181ff9750; Gorbach PM, 2006, JAIDS-J ACQ IMM DEF, V42, P80, DOI 10.1097/01.qai.0000196665.78497.f1; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harrell FE, 2001, REGRESSION MODELING; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Kalichman SC, 2010, AM J PUBLIC HEALTH, V100, P714, DOI 10.2105/AJPH.2009.162602; Le Talec J, SEROADAPTATION INSTE; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McConnell JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008831; McFarland W, 2012, AIDS BEHAV, V16, P121, DOI 10.1007/s10461-011-9936-8; McGowan JP, 2004, CLIN INFECT DIS, V38, P122, DOI 10.1086/380128; Metsch LR, 2008, CLIN INFECT DIS, V47, P577, DOI 10.1086/590153; Morin SF, 2005, JAIDS-J ACQ IMM DEF, V40, P226, DOI 10.1097/01.qai.0000166375.16222.eb; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pinkerton SD, 2008, AM J PREV MED, V35, P184, DOI 10.1016/j.amepre.2008.04.012; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; Van de Ven P, 2002, AIDS CARE, V14, P471, DOI 10.1080/09540120208629666; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	30	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55397	10.1371/journal.pone.0055397	http://dx.doi.org/10.1371/journal.pone.0055397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405145	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400090
J	Bruun, CS; Jaderlund, KH; Berendt, M; Jensen, KB; Spodsberg, EH; Gredal, H; Shelton, GD; Mickelson, JR; Minor, KM; Lohi, H; Bjerkas, I; Stigen, O; Espenes, A; Rohdin, C; Edlund, R; Ohlsson, J; Cizinauskas, S; Leifsson, PS; Drogemuller, C; Moe, L; Cirera, S; Fredholm, M				Bruun, Camilla S.; Jaderlund, Karin H.; Berendt, Mette; Jensen, Kristine B.; Spodsberg, Eva H.; Gredal, Hanne; Shelton, G. Diane; Mickelson, James R.; Minor, Katie M.; Lohi, Hannes; Bjerkas, Inge; Stigen, Oyvind; Espenes, Arild; Rohdin, Cecilia; Edlund, Rebecca; Ohlsson, Jennie; Cizinauskas, Sigitas; Leifsson, Pall S.; Droegemueller, Cord; Moe, Lars; Cirera, Susanna; Fredholm, Merete			A Gly98Val Mutation in the N-Myc Downstream Regulated Gene 1 (NDRG1) in Alaskan Malamutes with Polyneuropathy	PLOS ONE			English	Article							MARIE-TOOTH DISEASE; SENSORY NEUROPATHY-LOM; HEREDITARY MOTOR; DEMYELINATING NEUROPATHY; GYPSIES; BRAIN	The first cases of early-onset progressive polyneuropathy appeared in the Alaskan Malamute population in Norway in the late 1970s. Affected dogs were of both sexes and were ambulatory paraparetic, progressing to non-ambulatory tetraparesis. On neurologic examination, affected dogs displayed predominantly laryngeal paresis, decreased postural reactions, decreased spinal reflexes and muscle atrophy. The disease was considered eradicated through breeding programmes but recently new cases have occurred in the Nordic countries and the USA. The N-myc downstream-regulated gene (NDRG1) is implicated in neuropathies with comparable symptoms or clinical signs both in humans and in Greyhound dogs. This gene was therefore considered a candidate gene for the polyneuropathy in Alaskan Malamutes. The coding sequence of the NDRG1 gene derived from one healthy and one affected Alaskan Malamute revealed a non-synonymous G>T mutation in exon 4 in the affected dog that causes a Gly98Val amino acid substitution. This substitution was categorized to be "probably damaging'' to the protein function by PolyPhen2 (score: 1.000). Subsequently, 102 Alaskan Malamutes from the Nordic countries and the USA known to be either affected (n = 22), obligate carriers (n = 7) or healthy (n = 73) were genotyped for the SNP using TaqMan. All affected dogs had the T/T genotype, the obligate carriers had the G/T genotype and the healthy dogs had the G/G genotype except for 13 who had the G/T genotype. A protein alignment showed that residue 98 is conserved in mammals and also that the entire NDRG1 protein is highly conserved (94.7%) in mammals. We conclude that the G>T substitution is most likely the mutation that causes polyneuropathy in Alaskan Malamutes. Our characterization of a novel candidate causative mutation for polyneuropathy offers a new canine model that can provide further insight into pathobiology and therapy of human polyneuropathy. Furthermore, selection against this mutation can now be used to eliminate the disease in Alaskan Malamutes.	[Bruun, Camilla S.; Berendt, Mette; Jensen, Kristine B.; Spodsberg, Eva H.; Gredal, Hanne; Edlund, Rebecca; Ohlsson, Jennie; Cirera, Susanna; Fredholm, Merete] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark; [Jaderlund, Karin H.; Stigen, Oyvind; Moe, Lars] Norwegian Sch Vet Sci, Dept Compan Anim Clin Sci, Oslo, Norway; [Shelton, G. Diane] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Mickelson, James R.; Minor, Katie M.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Lohi, Hannes; Cizinauskas, Sigitas] Univ Helsinki, Res Programs Unit, Dept Vet Biosci, Helsinki, Finland; [Lohi, Hannes; Cizinauskas, Sigitas] Folkhalsen Res Ctr, Helsinki, Finland; [Espenes, Arild] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Rohdin, Cecilia] Swedish Univ Agr Sci, Univ Anim Hosp, Uppsala, Sweden; [Leifsson, Pall S.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Droegemueller, Cord] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland	University of Copenhagen; Norwegian University of Life Sciences; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; University of Helsinki; Folkhalsan Research Center; Norwegian University of Life Sciences; Swedish University of Agricultural Sciences; University of Copenhagen; University of Bern	Bruun, CS (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark.	cvb@sund.ku.dk; mf@sund.ku.dk	Lohi, Hannes/F-4596-2011; Cirera, Susanna/K-8540-2017; Jäderlund, Karin Hultin/AAL-8211-2020; Rohdin, Cecilia/E-5590-2016	Lohi, Hannes/0000-0003-1087-5532; Rohdin, Cecilia/0000-0002-7698-550X; Leifsson, Pall S/0000-0003-1539-9491; Fredholm, Merete/0000-0002-3563-7648; Minor, Katie/0000-0002-5472-5088; Berendt, Mette/0000-0003-0636-449X; Gredal, Hanne/0000-0001-5582-1816; Mickelson, James/0000-0001-6951-0234; Drogemuller, Cord/0000-0001-9773-522X; Cirera, Susanna/0000-0001-8105-1579	Agria Insurance Foundation for Research; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; European Commission [LUPA-GA-201370]	Agria Insurance Foundation for Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	Agria Insurance Foundation for Research (http://www.agria.se) has financially supported investigations performed in Norway and Sweden. Veterinarian Peter Juul Kristensen has financially supported the diagnostic tests in one Danish dog. The Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation) and the Jane and Aatos Erkko Foundation (http://www.jaes.fi) have financially supported work in HL's laboratory. Work in MF's laboratory was supported by European Commission (LUPA-GA-201370) (http://www.eurolupa.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Berger P, 2004, NEUROBIOL DIS, V17, P290, DOI 10.1016/j.nbd.2004.07.014; Braund KG, 1997, J VET INTERN MED, V11, P243, DOI 10.1111/j.1939-1676.1997.tb00098.x; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Drogemuller C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011258; Dubowitz V, 2007, MUSCLE BIOPSY PRACTI, P21; Granger N, 2011, VET J, V188, P274, DOI 10.1016/j.tvjl.2010.06.003; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Kalaydjieva L, 1998, BRAIN, V121, P399, DOI 10.1093/brain/121.3.399; King RHM, 2011, NEUROBIOL DIS, V42, P368, DOI 10.1016/j.nbd.2011.01.030; Matiasek K, 2011, VET J, V188, P254, DOI 10.1016/j.tvjl.2011.03.002; Moe, 1989, P 3 ANN S EUR SOC VE, P28; Moe L., 1982, Proceedings of the 14th Nordic Veterinary Congress, 6-9 July, 1982, Copenhagen, Denmark., P171; Moe L., 1992, KIRKS CURRENT VET TH, P1038; Patzko A, 2011, CURR NEUROL NEUROSCI, V11, P78, DOI 10.1007/s11910-010-0158-7; Reilly MM, 2011, J PERIPHER NERV SYST, V16, P1, DOI 10.1111/j.1529-8027.2011.00324.x; Rentmeister K, 2012, TIERAERZTL PRAX K H, V40, P26; Rozen S, 2000, Methods Mol Biol, V132, P365; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	21	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54547	10.1371/journal.pone.0054547	http://dx.doi.org/10.1371/journal.pone.0054547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393557	Green Submitted, Green Published, gold			2022-12-25	WOS:000314692800011
J	Hou, LQ; Hu, B; Jalife, J				Hou, Luqia; Hu, Bin; Jalife, Jose			Genetically Engineered Excitable Cardiac Myofibroblasts Coupled to Cardiomyocytes Rescue Normal Propagation and Reduce Arrhythmia Complexity in Heterocellular Monolayers	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BIOLOGICAL PACEMAKER; PURKINJE NEURONS; FIBROBLASTS; CHANNELS; MODULATION; EXPRESSION; CONDUCTION; MYOCYTES; THERAPY	Rationale and Objective: The use of genetic engineering of unexcitable cells to enable expression of gap junctions and inward rectifier potassium channels has suggested that cell therapies aimed at establishing electrical coupling of unexcitable donor cells to host cardiomyocytes may be arrhythmogenic. Whether similar considerations apply when the donor cells are electrically excitable has not been investigated. Here we tested the hypothesis that adenoviral transfer of genes coding Kir2.1 (I-K1), Na(V)1.5 (I-Na) and connexin-43 (Cx43) proteins into neonatal rat ventricular myofibroblasts (NRVF) will convert them into fully excitable cells, rescue rapid conduction velocity (CV) and reduce the incidence of complex reentry arrhythmias in an in vitro model. Methods and Results: We used adenoviral (Ad-) constructs encoding Kir2.1, Na(V)1.5 and Cx43 in NRVF. In single NRVF, Ad-Kir2.1 or Ad- Na(V)1.5 infection enabled us to regulate the densities of I-K1 and I-Na, respectively. At varying MOI ratios of 10/10, 5/10 and 5/20, NRVF co-infected with Ad-Kir2.1+ Na(V)1.5 were hyperpolarized and generated action potentials (APs) with upstroke velocities >100 V/s. However, when forming monolayers only the addition of Ad-Cx43 made the excitable NRVF capable of conducting electrical impulses (CV = 20.71 +/- 0.79 cm/s). When genetically engineered excitable NRVF overexpressing Kir2.1, Na(V)1.5 and Cx43 were used to replace normal NRVF in heterocellular monolayers that included neonatal rat ventricular myocytes (NRVM), CV was significantly increased (27.59 +/- 0.76 cm/s vs. 21.18 +/- 0.65 cm/s, p<0.05), reaching values similar to those of pure myocytes monolayers (27.27 +/- 0.72 cm/s). Moreover, during reentry, propagation was faster and more organized, with a significantly lower number of wavebreaks in heterocellular monolayers formed by excitable compared with unexcitable NRVF. Conclusion: Viral transfer of genes coding Kir2.1, Na(V)1.5 and Cx43 to cardiac myofibroblasts endows them with the ability to generate and propagate APs. The results provide proof of concept that cell therapies with excitable donor cells increase safety and reduce arrhythmogenic potential.	[Hou, Luqia; Hu, Bin; Jalife, Jose] Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [Hou, Luqia; Jalife, Jose] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jalife, J (corresponding author), Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA.	jjalife@umich.edu	Jalife, Jose/L-4833-2015; Jalife, Jose/AAJ-9156-2021	Jalife, Jose/0000-0003-0080-3500; Jalife, Jose/0000-0003-0080-3500	National Heart, Lung and Blood Institute [P01-HL039707, P01-HL087226]; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL039707, P01HL087226] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by P01-HL039707 and P01-HL087226 from the National Heart, Lung and Blood Institute and by the Leducq Foundation (JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaci Muriel, 2007, Biotechnology Journal, V2, P50, DOI 10.1002/biot.200600092; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Auerbach DS, 2011, J PHYSIOL-LONDON, V589, P2363, DOI 10.1113/jphysiol.2010.200576; Camelliti P, 2004, CARDIOVASC RES, V62, P415, DOI 10.1016/j.cardiores.2004.01.027; Cho HC, 2007, CIRC RES, V100, P1112, DOI 10.1161/01.RES.0000265845.04439.78; Cho HC, 2010, CIRC RES, V106, P674, DOI 10.1161/CIRCRESAHA.109.212936; Choudry Fizzah Aziz, 2011, Regen Med, V6, P17, DOI 10.2217/rme.11.57; DELMAR M, 1989, CIRC RES, V65, P775, DOI 10.1161/01.RES.65.3.775; DEMAZIERE AMGL, 1992, J MOL CELL CARDIOL, V24, P567, DOI 10.1016/0022-2828(92)91041-3; Feld Y, 2002, CIRCULATION, V105, P522, DOI 10.1161/hc0402.102661; Fozzard HA, 1996, PHYSIOL REV, V76, P887, DOI 10.1152/physrev.1996.76.3.887; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Greener I, 2011, J MOL CELL CARDIOL, V50, P759, DOI 10.1016/j.yjmcc.2010.07.022; He YS, 2008, FEBS LETT, V582, P2338, DOI 10.1016/j.febslet.2008.05.023; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kirkton RD, 2012, EUROPACE, V14, pV40, DOI 10.1093/europace/eus269; Kirkton RD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1302; Kohl P, 2005, J ELECTROCARDIOL, V38, P45, DOI 10.1016/j.jelectrocard.2005.06.096; KOHL P, 1994, EXP PHYSIOL, V79, P943, DOI 10.1113/expphysiol.1994.sp003819; McSpadden LC, 2012, CIRC ARRHYTHM ELECTR; Milstein ML, 2012, P NATL ACAD SCI US; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Munoz V, 2007, CIRC RES, V101, P475, DOI 10.1161/CIRCRESAHA.107.149617; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; PERTSOV AM, 1993, CIRC RES, V72, P631, DOI 10.1161/01.RES.72.3.631; Plotnikov AN, 2007, CIRCULATION, V116, P706, DOI 10.1161/CIRCULATIONAHA.107.703231; Potapova I, 2004, CIRC RES, V94, P952, DOI 10.1161/01.RES.0000123827.60210.72; Raizman JE, 2007, J CELL PHYSIOL, V213, P540, DOI 10.1002/jcp.21134; Rosker C, 2011, CIRC RES, V109, P1120, DOI 10.1161/CIRCRESAHA.111.244798; Walsh KB, 2008, AM J PHYSIOL-HEART C, V294, pH1010, DOI 10.1152/ajpheart.01195.2007; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Yankelson L, 2008, CIRCULATION, V117, P720, DOI 10.1161/CIRCULATIONAHA.106.671776; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	35	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55400	10.1371/journal.pone.0055400	http://dx.doi.org/10.1371/journal.pone.0055400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393574	gold, Green Published, Green Submitted			2022-12-25	WOS:000314692800028
J	Engle, JR; Tinling, S; Recanzone, GH				Engle, James R.; Tinling, Steve; Recanzone, Gregg H.			Age-Related Hearing Loss in Rhesus Monkeys Is Correlated with Cochlear Histopathologies	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; AUDITORY BRAIN-STEM; HUMAN TEMPORAL BONE; MACACA-MULATTA; AUDIOMETRIC PATTERNS; HAIR-CELLS; PRESBYCUSIS; DEGENERATION; PATHOLOGY; NOISE	Audiometric hearing deficits are a common symptom of age-related hearing loss (ARHL), as are specific histopathological changes in the cochlea; however, very little data have been collected in non-human primates. To examine this relationship further, we collected auditory brainstem responses (ABRs) from rhesus monkeys spanning in age from 10 to 35 years old, and examined four different morphological features of their cochleae. We found significant correlations between ABR thresholds and the loss of outer hair cells and spiral ganglion cells, but not with the loss of inner hair cells or a reduced thickness of the stria vascularis. The strongest correlation with ABR thresholds was the number of different pathologies present. These findings show that while aged rhesus monkeys experience audiometric hearing deficits similar to that seen in humans, they are not correlated with a single peripheral deficit, but instead with a number of different underlying cochlear histopathologies, indicating that similar histopathologies may exist in geriatric humans as well.	[Engle, James R.] Univ Arizona, Evelyn F McKnight Brain Inst, Tucson, AZ USA; [Engle, James R.] Univ Arizona, ARL Div Neural Syst Memory & Aging, Tucson, AZ USA; [Tinling, Steve] Univ Calif Davis, Dept Otolaryngol, Davis, CA 95616 USA; [Engle, James R.; Recanzone, Gregg H.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Recanzone, Gregg H.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of Arizona; University of Arizona; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Recanzone, GH (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	ghrecanzone@ucdavis.edu			National Institute on Aging (NIA) [R21AG024372, R01AG034137]; National Institute on Deafness and Other Communication Disorders (NIDCD) [T32DC008072, R01DC008649]; NATIONAL INSTITUTE ON AGING [R21AG024372, R01AG034137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008649, T32DC008072] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funded by National Institute on Aging (NIA) R21AG024372, R01AG034137 (GHR), and National Institute on Deafness and Other Communication Disorders (NIDCD) T32DC008072 (JRE) and R01DC008649 (ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel SM, 2000, J ACOUST SOC AM, V108, P743, DOI 10.1121/1.429607; ALLEN AR, 1978, ELECTROEN CLIN NEURO, V45, P53, DOI 10.1016/0013-4694(78)90341-3; Bao JX, 2010, HEARING RES, V264, P93, DOI 10.1016/j.heares.2009.10.009; BENNETT CL, 1983, BEHAV NEUROSCI, V97, P602, DOI 10.1037/0735-7044.97.4.602; Chen MA, 2006, OTOL NEUROTOL, V27, P316, DOI 10.1097/00129492-200604000-00005; Clark J G, 1981, ASHA, V23, P493; Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003; Fowler CG, 2002, HEARING RES, V169, P24, DOI 10.1016/S0378-5955(02)00335-0; Fowler CG, 2010, HEARING RES, V261, P75, DOI 10.1016/j.heares.2010.01.006; Frisina DR, 1997, HEARING RES, V106, P95, DOI 10.1016/S0378-5955(97)00006-3; Gates GA, 1999, ARCH OTOLARYNGOL, V125, P654, DOI 10.1001/archotol.125.6.654; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; HAWKINS JE, 1976, ACTA OTO-LARYNGOL, V81, P337, DOI 10.3109/00016487609119971; HAWKINS JE, 1968, ANN OTO RHINOL LARYN, V77, P608, DOI 10.1177/000348946807700403; Hawkins JE, 1986, BEHAV PATHOLOGY AGIN; Heffner RS, 2004, ANAT REC PART A, V281A, P1111, DOI 10.1002/ar.a.20117; Juarez-Salinas DL, 2010, J NEUROSCI, V30, P14795, DOI 10.1523/JNEUROSCI.3393-10.2010; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Linthicum FH, 2009, OTOL NEUROTOL, V30, P418, DOI 10.1097/MAO.0b013e31819a8827; Miller LM, 2009, P NATL ACAD SCI USA, V106, P5931, DOI 10.1073/pnas.0901023106; MOODY DB, 1978, ARCH OTO-RHINO-LARYN, V220, P47, DOI 10.1007/BF00456301; Navarro XO, 2008, SOC NEUR ABSTR, V34; Nelson EG, 2003, LARYNGOSCOPE, V113, P1672, DOI 10.1097/00005537-200310000-00006; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; Ohlemiller KK, 2008, HEARING RES, V244, P85, DOI 10.1016/j.heares.2008.08.001; Ohlemiller KK, 2004, J COMP NEUROL, V479, P103, DOI 10.1002/cne.20326; RAMADAN HH, 1989, OTOLARYNG HEAD NECK, V100, P30, DOI 10.1177/019459988910000105; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Recanzone GH, 2011, HEARING RES, V271, P115, DOI 10.1016/j.heares.2010.03.084; SCHUKNECHT H F, 1955, Laryngoscope, V65, P402; SCHUKNECHT HF, 1964, ARCHIV OTOLARYNGOL, V80, P369; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; SUGA F, 1976, ANN OTO RHINOL LARYN, V85, P169, DOI 10.1177/000348947608500201; SUZUKA Y, 1988, ACTA OTO-LARYNGOL, P1; Tinling SP, 2004, J MICROSC-OXFORD, V215, P230, DOI 10.1111/j.0022-2720.2004.01382.x; Torre P, 2004, NEUROBIOL AGING, V25, P945, DOI 10.1016/j.neurobiolaging.2003.09.006; Torre P, 2000, HEARING RES, V142, P131, DOI 10.1016/S0378-5955(00)00025-3; WILLOTT JF, 1988, EXP NEUROL, V99, P615, DOI 10.1016/0014-4886(88)90178-1; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006; Xing YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034500; Zilberstein Y, 2012, J NEUROSCI, V32, P405, DOI 10.1523/JNEUROSCI.4678-11.2012	43	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55092	10.1371/journal.pone.0055092	http://dx.doi.org/10.1371/journal.pone.0055092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390514	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100030
J	Slayton, RB; Turabelidze, G; Bennett, SD; Schwensohn, CA; Yaffee, AQ; Khan, F; Butler, C; Trees, E; Ayers, TL; Davis, ML; Laufer, AS; Gladbach, S; Williams, I; Gieraltowski, LB				Slayton, Rachel B.; Turabelidze, George; Bennett, Sarah D.; Schwensohn, Colin A.; Yaffee, Anna Q.; Khan, Faisal; Butler, Cindy; Trees, Eija; Ayers, Tracy L.; Davis, Marjorie L.; Laufer, Alison S.; Gladbach, Stephen; Williams, Ian; Gieraltowski, Laura B.			Outbreak of Shiga Toxin-Producing Escherichia coli (STEC) O157:H7 Associated with Romaine Lettuce Consumption, 2011	PLOS ONE			English	Article							FOODBORNE ILLNESS; UNITED-STATES; CALIFORNIA; O157-H7	Background: Shiga toxin-producing Escherichia coli (STEC) O157:H7 is the causal agent for more than 96,000 cases of diarrheal illness and 3,200 infection-attributable hospitalizations annually in the United States. Materials and Methods: We defined a confirmed case as a compatible illness in a person with the outbreak strain during 10/07/2011-11/30/2011. Investigation included hypothesis generation, a case-control study utilizing geographically-matched controls, and a case series investigation. Environmental inspections and tracebacks were conducted. Results: We identified 58 cases in 10 states; 67% were hospitalized and 6.4% developed hemolytic uremic syndrome. Any romaine consumption was significantly associated with illness (matched Odds Ratio (mOR) = 10.0, 95% Confidence Interval (CI) = 2.1-97.0). Grocery Store Chain A salad bar was significantly associated with illness (mOR = 18.9, 95% CI = 4.5-176.8). Two separate traceback investigations for romaine lettuce converged on Farm A. Case series results indicate that cases (64.9%) were more likely than the FoodNet population (47%) to eat romaine lettuce (p-value = 0.013); 61.3% of cases reported consuming romaine lettuce from the Grocery Store Chain A salad bar. Conclusions: This multistate outbreak of STEC O157:H7 infections was associated with consumption of romaine lettuce. Traceback analysis determined that a single common lot of romaine lettuce harvested from Farm A was used to supply Grocery Store Chain A and a university campus linked to a case with the outbreak strain. An investigation at Farm A did not identify the source of contamination. Improved ability to trace produce from the growing fields to the point of consumption will allow more timely prevention and control measures to be implemented.	[Slayton, Rachel B.; Bennett, Sarah D.; Laufer, Alison S.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Slayton, Rachel B.; Bennett, Sarah D.; Schwensohn, Colin A.; Yaffee, Anna Q.; Trees, Eija; Ayers, Tracy L.; Laufer, Alison S.; Williams, Ian; Gieraltowski, Laura B.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Turabelidze, George; Butler, Cindy; Gladbach, Stephen] Missouri Dept Hlth & Senior Serv, Eastern Dist Off, St Louis, MO USA; [Khan, Faisal] St Louis Cty Dept Hlth, Communicable Dis Control Serv, St Louis, MO USA; [Davis, Marjorie L.] US FDA, Coordinated Outbreak Response & Evaluat Team, College Pk, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Slayton, RB (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	RSlayton@cdc.gov	Yaffee, Anna/AAQ-3559-2021; Trees, Eija/AAY-7538-2020	Trees, Eija/0000-0001-6694-2445; Ayers, Tracy/0000-0003-4140-3263; Slayton, Rachel/0000-0003-4699-8040; Yaffee, Anna/0000-0002-4495-6587				Aruscavage D, 2008, J FOOD PROTECT, V71, P2384, DOI 10.4315/0362-028X-71.12.2384; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Ethelberg S., 2010, EURO SURVEILL, V15; Friesema I, 2008, EURO SURVEILL, V13; Hyytia-Trees E, 2010, FOODBORNE PATHOG DIS, V7, P129, DOI 10.1089/fpd.2009.0371; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Soderstrom A, 2008, FOODBORNE PATHOG DIS, V5, P339, DOI 10.1089/fpd.2007.0065; Sodha SV, 2011, EPIDEMIOL INFECT, V139, P309, DOI 10.1017/S0950268810000920; U.S. Centers for Disease Control and Prevention, 2007, FOODB DIS ACT SURV N	12	56	56	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55300	10.1371/journal.pone.0055300	http://dx.doi.org/10.1371/journal.pone.0055300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390525	gold, Green Published, Green Submitted			2022-12-25	WOS:000314691100041
J	Chaparro, JM; Badri, DV; Bakker, MG; Sugiyama, A; Manter, DK; Vivanco, JM				Chaparro, Jacqueline M.; Badri, Dayakar V.; Bakker, Matthew G.; Sugiyama, Akifumi; Manter, Daniel K.; Vivanco, Jorge M.			Root Exudation of Phytochemicals in Arabidopsis Follows Specific Patterns That Are Developmentally Programmed and Correlate with Soil Microbial Functions	PLOS ONE			English	Article							AGROBACTERIUM-TUMEFACIENS; GENE-EXPRESSION; PSEUDOMONAS-FLUORESCENS; SINORHIZOBIUM-MELILOTI; RHIZOSPHERE MICROBIOME; SECONDARY METABOLITES; BACILLUS-SUBTILIS; CHEMOTAXIS; ACID; SECRETION	Plant roots constantly secrete compounds into the soil to interact with neighboring organisms presumably to gain certain functional advantages at different stages of development. Accordingly, it has been hypothesized that the phytochemical composition present in the root exudates changes over the course of the lifespan of a plant. Here, root exudates of in vitro grown Arabidopsis plants were collected at different developmental stages and analyzed using GC-MS. Principle component analysis revealed that the composition of root exudates varied at each developmental stage. Cumulative secretion levels of sugars and sugar alcohols were higher in early time points and decreased through development. In contrast, the cumulative secretion levels of amino acids and phenolics increased over time. The expression in roots of genes involved in biosynthesis and transportation of compounds represented in the root exudates were consistent with patterns of root exudation. Correlation analyses were performed of the in vitro root exudation patterns with the functional capacity of the rhizosphere microbiome to metabolize these compounds at different developmental stages of Arabidopsis grown in natural soils. Pyrosequencing of rhizosphere mRNA revealed strong correlations (p<0.05) between microbial functional genes involved in the metabolism of carbohydrates, amino acids and secondary metabolites with the corresponding compounds released by the roots at particular stages of plant development. In summary, our results suggest that the root exudation process of phytochemicals follows a developmental pattern that is genetically programmed.	[Chaparro, Jacqueline M.; Badri, Dayakar V.; Bakker, Matthew G.; Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Sugiyama, Akifumi] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Manter, Daniel K.] USDA ARS, Soil Plant Nutrient Res Unit, Ft Collins, CO 80522 USA	Colorado State University; Kyoto University; United States Department of Agriculture (USDA)	Vivanco, JM (corresponding author), Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA.	j.vivanco@colostate.edu	Bakker, Matthew/B-8610-2013	Bakker, Matthew/0000-0003-0345-0587; Sugiyama, Akifumi/0000-0002-9643-6639	National Science Foundation [MCB-0950857]; Div Of Molecular and Cellular Bioscience [0950857] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Work was supported by a grant from the National Science Foundation to J.M.V. (MCB-0950857). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Nada Y, 2007, EUR J PLANT PATHOL, V118, P375, DOI 10.1007/s10658-007-9150-8; [Anonymous], 2010, COMMUN INTEGR BIOL, DOI DOI 10.4161/CIB.3.1.10118; Badri DV, 2008, PLANT PHYSIOL, V146, P762, DOI 10.1104/pp.107.109587; Badri Dayakar V, 2012, Front Plant Sci, V3, P149, DOI 10.3389/fpls.2012.00149; Badri DV, 2010, MOL PLANT, V3, P491, DOI 10.1093/mp/ssq004; Badri DV, 2009, PLANT PHYSIOL, V151, P2006, DOI 10.1104/pp.109.147462; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; BEHERA B, 1974, SOIL SCI SOC AM J, V38, P591, DOI 10.2136/sssaj1974.03615995003800040021x; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Blencke HM, 2003, METAB ENG, V5, P133, DOI 10.1016/S1096-7176(03)00009-0; BOWRA BJ, 1981, J GEN MICROBIOL, V126, P231; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; De-La-Pena C, 2008, J BIOL CHEM, V283, P25247, DOI 10.1074/jbc.M801967200; De-la-Pena C, 2010, J BIOL CHEM, V285, P30654, DOI 10.1074/jbc.M110.119040; Edreva A., 2008, General and Applied Plant Physiology, V34, P67; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Flores HE, 1999, TRENDS PLANT SCI, V4, P220, DOI 10.1016/S1360-1385(99)01411-9; Hamer U, 2005, SOIL BIOL BIOCHEM, V37, P445, DOI 10.1016/j.soilbio.2004.07.037; Haudecoeur E, 2009, P NATL ACAD SCI USA, V106, P14587, DOI 10.1073/pnas.0808005106; Horiuchi J, 2005, PLANTA, V222, P848, DOI 10.1007/s00425-005-0025-y; JimenezZurdo JI, 1997, MOL MICROBIOL, V23, P85, DOI 10.1046/j.1365-2958.1997.1861555.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Lambert JD, 2010, INTEGR COMP BIOL, V50, P768, DOI 10.1093/icb/icq121; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li Y, 2009, APPL ENVIRON MICROB, V75, P1223, DOI 10.1128/AEM.02015-08; LOAKE GJ, 1988, J GEN MICROBIOL, V134, P1427; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Micallef SA, 2009, PLANT SIGNAL BEHAV, V4, P777, DOI 10.1093/jxb/erp053; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Naher U. A., 2008, Research Journal of Microbiology, V3, P580; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Oku S, 2012, MICROBES ENV; Omrane S, 2009, PLANT SIGNAL BEHAV, V4, P1066, DOI 10.4161/psb.4.11.9735; ORDAL GW, 1979, J GEN MICROBIOL, V115, P167, DOI 10.1099/00221287-115-1-167; Ortiz-Castro R, 2009, PLANT SIGNAL BEHAV, V4, P701, DOI 10.4161/psb.4.8.9047; Phillips DA, 2004, PLANT PHYSIOL, V136, P2887, DOI 10.1104/pp.104.044222; Pillai BVS, 2002, APPL ENVIRON MICROB, V68, P143, DOI 10.1128/AEM.68.1.143-151.2002; Poysti NJ, 2007, MICROBIOL-SGM, V153, P727, DOI 10.1099/mic.0.29148-0; Ramos-Gonzalez MI, 2005, J BACTERIOL, V187, P4033, DOI 10.1128/JB.187.12.4033-4041.2005; ROVIRA AD, 1969, BOT REV, V35, P35, DOI 10.1007/BF02859887; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Sana TR, 2010, METABOLOMICS, V6, P451, DOI 10.1007/s11306-010-0218-7; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHMULLING T, 1988, EMBO J, V7, P2621, DOI 10.1002/j.1460-2075.1988.tb03114.x; Selvakumar G., 2012, BACTERIAL MEDIATED A, P205; SHAW CH, 1991, BIOESSAYS, V13, P25, DOI 10.1002/bies.950130105; Shcheglov Alex S., 2007, P97, DOI 10.1007/978-1-4020-6040-3_5; Simons M, 1997, MOL PLANT MICROBE IN, V10, P102, DOI 10.1094/MPMI.1997.10.1.102; Steinkellner S, 2007, MOLECULES, V12, P1290, DOI 10.3390/12071290; TANG CS, 1995, ACS SYM SER, V582, P142; Volkers RJM, 2009, EXTREMOPHILES, V13, P283, DOI 10.1007/s00792-008-0216-0; Williams MA, 2010, SOIL BIOL BIOCHEM, V42, P1148, DOI 10.1016/j.soilbio.2010.03.021; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yamada T, 2011, NUCLEIC ACIDS RES, V39, pW412, DOI 10.1093/nar/gkr313; Zamioudis C, 2012, MOL PLANT MICROBE IN, V25, P139, DOI 10.1094/MPMI-06-11-0179; Zhang J, 2009, PLANT J, V57, P171, DOI 10.1111/j.1365-313X.2008.03676.x	68	361	386	18	401	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55731	10.1371/journal.pone.0055731	http://dx.doi.org/10.1371/journal.pone.0055731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383346	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900053
J	Ko, SC; Huang, CR; Shieh, JM; Yang, JH; Chang, WC; Chen, BK				Ko, Shian-Chin; Huang, Chi-Ruei; Shieh, Jiunn-Min; Yang, Jhen-Hong; Chang, Wen-Chang; Chen, Ben-Kuen			Epidermal Growth Factor Protects Squamous Cell Carcinoma against Cisplatin-Induced Cytotoxicity through Increased Interleukin-1 beta Expression	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN BREAST-CANCER; FACTOR-RECEPTOR; PROINFLAMMATORY CYTOKINE; DYNAMIC REGULATION; SUPPRESSOR-CELLS; EPITHELIAL-CELLS; ENDOTOXIC-SHOCK; MESSENGER-RNA; FACTOR-ALPHA	The expression of cytokines, such as IL-1 beta, and the activation of the epidermal growth factor receptor (EGFR) are crucial regulators in the process of carcinogenesis. The correlation between growth factor and activated cytokine signals in the control of tumor development is a critical issue to be clarified. In our study, we found that the IL-1 beta gene and protein expression were induced by EGF in squamous cell carcinoma. To clarify the mechanism involved in EGF-regulated IL-1 beta expression, we examined the transcriptional activity and mRNA stability of IL-1 beta in EGF-treated cells. We found that EGF induced the expression of IL-1 beta and was mediated through transcriptional activation, but not through mRNA stability. The involvement of Akt and NF-kappa B signaling pathways in the EGF-induced IL-1 beta gene expression was confirmed by knockdown of RelA and Akt in cells or treating cells with Akt and NF-kappa B inhibitors, LY294002 and parthenolide, respectively. The expression of dominant negative I kappa B also repressed the activation of NF-kappa B and inhibited EGF-induced IL-1 beta expression. Using immunofluorescence staining assay, the EGF-stimulated nuclear translocation of NF-kappa B (p65) was inhibited by pretreating cells with LY294002 and parthenolide. Furthermore, EGF increased the binding of NF-kappa B to the NF-kappa B binding site of the IL-1 beta promoter through the activation of the Akt/NF-kappa B pathway, which resulted in activating IL-1 beta promoter activity. The expression and secretion of IL-1 beta induced by EGF considerably reduced chemotherapeutic drug cisplatin-induced cell death. These results showed that EGF enhanced the expression of IL-1 beta, which was mediated by the Akt/NF-kappa B pathway. The activation of EGF signaling and increase of IL-1 beta contributed to chemotherapeutic resistance of cancer cells, suggesting that the expression of IL-1 beta may be used as a biomarker to evaluate successful cancer treatment.	[Ko, Shian-Chin; Shieh, Jiunn-Min] Chi Mei Med Ctr, Dept Chest Med, Tainan, Taiwan; [Huang, Chi-Ruei; Chen, Ben-Kuen] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 70101, Taiwan; [Yang, Jhen-Hong; Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Chang, Wen-Chang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Chen, BK (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 70101, Taiwan.	bkchen58@mail.ncku.edu.tw		Huang, Chi-Ruei/0000-0001-9646-8852	National Science Council of the Republic of China [NSC 99-2320-B-006-006-MY3]; National Cheng Kung University Project of Promoting Academic Excellence and Developing World-Class Research Centers	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); National Cheng Kung University Project of Promoting Academic Excellence and Developing World-Class Research Centers	This work was supported by grant NSC 99-2320-B-006-006-MY3 from the National Science Council of the Republic of China and by the National Cheng Kung University Project of Promoting Academic Excellence and Developing World-Class Research Centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2003, J BIOL CHEM, V278, P20077, DOI 10.1074/jbc.M208619200; Ahsan A, 2010, CANCER RES, V70, P2862, DOI 10.1158/0008-5472.CAN-09-4294; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Apte RN, 2002, ADV EXP MED BIOL, P277; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Cenni B, 2001, CANCER CHEMOTH PHARM, V47, P397, DOI 10.1007/s002800000244; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Chang KY, 2009, J BIOL CHEM, V284, P9908, DOI 10.1074/jbc.M806210200; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gao HW, 2007, EXPERT OPIN THER TAR, V11, P869, DOI 10.1517/14728222.11.7.869; Grandis JR, 1996, CANCER-AM CANCER SOC, V78, P1284, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X; GRANDIS JR, 1993, CANCER RES, V53, P3579; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kerpedjieva SS, 2012, STEM CELLS DEV; KONDO Y, 1994, J PHARMACOL EXP THER, V270, P1313; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; LE PT, 1991, J EXP MED, V174, P1147, DOI 10.1084/jem.174.5.1147; Liu YW, 1997, BIOCHEM J, V324, P133, DOI 10.1042/bj3240133; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Miller LJ, 2000, CANCER INVEST, V18, P293, DOI 10.3109/07357900009012171; Molina-Holgado E, 2000, BRIT J PHARMACOL, V131, P152, DOI 10.1038/sj.bjp.0703557; Nakamura H, 2007, CLIN EXP RHEUMATOL, V25, P831; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; NETA R, 1986, J IMMUNOL, V136, P2483; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Noordhuis MG, 2009, CLIN CANCER RES, V15, P7389, DOI 10.1158/1078-0432.CCR-09-1149; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Pantschenko AG, 2003, INT J ONCOL, V23, P269; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Poppenborg H, 1999, CYTOKINE, V11, P689, DOI 10.1006/cyto.1998.0473; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schlosser S, 1999, CANCER RES, V59, P4551; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; Sheehan M, 2002, MOL PHARMACOL, V61, P953, DOI 10.1124/mol.61.5.953; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Sriuranpong V, 2003, CANCER RES, V63, P2948; Watkins LR, 1999, LIFE SCI, V65, P449, DOI 10.1016/S0024-3205(99)00095-8; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	51	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55795	10.1371/journal.pone.0055795	http://dx.doi.org/10.1371/journal.pone.0055795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383347	gold, Green Published, Green Submitted			2022-12-25	WOS:000314597900054
J	Watzlawik, JO; Warrington, AE; Rodriguez, M				Watzlawik, Jens O.; Warrington, Arthur E.; Rodriguez, Moses			PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; LYSOLECITHIN-INDUCED DEMYELINATION; TYROSINE KINASE LYN; SRC FAMILY KINASES; SPINAL-CORD; SCHWANN-CELLS; RAT-BRAIN; IN-VIVO; MONOCLONAL AUTOANTIBODY	Background: Promotion of remyelination is a major goal in treating demyelinating diseases such as multiple sclerosis (MS). The recombinant human monoclonal IgM, rHIgM22, targets myelin and oligodendrocytes (OLs) and promotes remyelination in animal models of MS. It is unclear whether rHIgM22-mediated stimulation of lesion repair is due to promotion of oligodendrocyte progenitor cell (OPC) proliferation and survival, OPC differentiation into myelinating OLs or protection of mature OLs. It is also unknown whether astrocytes or microglia play a functional role in IgM-mediated lesion repair. Methods: We assessed the effect of rHIgM22 on cell proliferation in mixed CNS glial and OPC cultures by tritiated-thymidine uptake and by double-label immunocytochemistry using the proliferation marker, Ki-67. Antibody-mediated signaling events, OPC differentiation and OPC survival were investigated and quantified by Western blots. Results: rHIgM22 stimulates OPC proliferation in mixed glial cultures but not in purified OPCs. There is no proliferative response in astrocytes or microglia. rHIgM22 activates PDGF alpha R in OPCs in mixed glial cultures. Blocking PDGFR-kinase inhibits rHIgM22-mediated OPC proliferation in mixed glia. We confirm in isolated OPCs that rHIgM22-mediated antiapoptotic signaling and inhibition of OPC differentiation requires PDGF and FGF-2. We observed no IgM-mediated effect in mature OLs in the absence of PDGF and FGF-2. Conclusion: Stimulation of OPC proliferation by rHIgM22 depends on co-stimulatory astrocytic and/or microglial factors. We demonstrate that rHIgM22-mediated activation of PDGF alpha R is required for stimulation of OPC proliferation. We propose that rHIgM22 lowers the PDGF threshold required for OPC proliferation and protection, which can result in remyelination of CNS lesions.	Mayo Clin, Coll Med, Dept Immunol, Rochester, MN USA; [Rodriguez, Moses] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Rodriguez, M (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA.	rodriguez.moses@mayo.edu		Rodriguez, Moses/0000-0001-6328-6497; Watzlawik, Jens/0000-0003-0610-0267	National Institutes of Health (NIH) [R01 GM092993, R01 NS024180, R01 NS032129, R01 NS048357, R21 NS073684]; National Multiple Sclerosis Society [CA 1060A11]; NIH CTSA (Center for Translational Science Activities - HIPFA); Applebaum; Hilton; Peterson Foundations; Minnesota Partnership Award for Biotechnology and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024180, R01NS032129, R01NS048357, R21NS073684] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH CTSA (Center for Translational Science Activities - HIPFA); Applebaum; Hilton; Peterson Foundations; Minnesota Partnership Award for Biotechnology and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH) (R01 GM092993, R01 NS024180, R01 NS032129, R01 NS048357 and R21 NS073684) and the National Multiple Sclerosis Society (CA 1060A11). This work was also supported by a grant from the NIH CTSA (Center for Translational Science Activities - HIPFA). The authors also acknowledge with thanks support from the Applebaum, Hilton and Peterson Foundations, the Minnesota Partnership Award for Biotechnology and Medical Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAUJO DM, 1992, J NEUROSCI, V12, P1668; Asakura K, 1996, J NEUROSCI RES, V43, P273, DOI 10.1002/(SICI)1097-4547(19960201)43:3<273::AID-JNR2>3.0.CO;2-G; Asakura K, 1996, J NEUROIMMUNOL, V65, P11, DOI 10.1016/0165-5728(95)00175-1; Asakura K, 1998, J NEUROSCI, V18, P7700; BALACI L, 1994, NEUROREPORT, V6, P197, DOI 10.1097/00001756-199412300-00050; Bansal R, 1997, J NEUROSCI RES, V50, P215; Bansal R, 1999, J NEUROSCI, V19, P7913; Bansal R, 2003, J NEUROSCI RES, V74, P486, DOI 10.1002/jnr.10773; Bansal R, 1997, ADV EXP MED BIOL, V429, P69; Bansal R, 1996, MOL CELL NEUROSCI, V7, P263, DOI 10.1006/mcne.1996.0020; BANSAL R, 1994, DEV BIOL, V162, P511, DOI 10.1006/dbio.1994.1105; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; Baron W, 2005, GLIA, V49, P467, DOI 10.1002/glia.20132; Baron W, 2002, EMBO J, V21, P1957, DOI 10.1093/emboj/21.8.1957; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; BARRES BA, 1993, DEVELOPMENT, V118, P283; Becker-Catania SG, ASN NEURO, V3; Bieber AJ, 2002, GLIA, V37, P241, DOI 10.1002/glia.10033; BLAKEMORE WF, 1985, J NEUROL SCI, V70, P207, DOI 10.1016/0022-510X(85)90088-7; BLAKEMORE WF, 1984, J NEUROL SCI, V64, P265, DOI 10.1016/0022-510X(84)90175-8; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; BOTTENSTEIN JE, 1986, P NATL ACAD SCI USA, V83, P1955, DOI 10.1073/pnas.83.6.1955; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; CARROLL WM, 1994, BRAIN, V117, P563, DOI 10.1093/brain/117.3.563; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Decker L, 2004, BIOCHEM SOC T, V32, P426, DOI 10.1042/BST0320426; FANTL WJ, 1989, MOL CELL BIOL, V9, P4473, DOI 10.1128/MCB.9.10.4473; FERRARA N, 1988, BRAIN RES, V462, P223, DOI 10.1016/0006-8993(88)90550-1; Frost EE, 1999, CURR BIOL, V9, P1251, DOI 10.1016/S0960-9822(99)80506-5; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Fruttiger M, 2000, CURR BIOL, V10, P1283, DOI 10.1016/S0960-9822(00)00757-0; Gamas P, 2009, LEUKEMIA, V23, P1500, DOI 10.1038/leu.2009.60; GARD AL, 1993, DEV BIOL, V159, P618, DOI 10.1006/dbio.1993.1269; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; Guan H, 2008, MOL CANCER THER, V7, P1807, DOI 10.1158/1535-7163.MCT-08-0058; Hammang JP, 1997, EXP NEUROL, V147, P84, DOI 10.1006/exnr.1997.6592; HART IK, 1989, DEVELOPMENT, V105, P595; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Honmou O, 1996, J NEUROSCI, V16, P3199; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jiang FJ, 2001, DEV BIOL, V232, P414, DOI 10.1006/dbio.2001.0208; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; Luciano F, 2003, FASEB J, V17, P711, DOI 10.1096/fj.02-0716fje; MAYER M, 1993, GLIA, V8, P12, DOI 10.1002/glia.440080103; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mi S, 2009, ANN NEUROL, V65, P304, DOI 10.1002/ana.21581; MILLER DJ, 1994, J NEUROSCI, V14, P6230; Milner R, 1997, GLIA, V19, P85, DOI 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Osterhout DJ, 1997, J NEUROSCI, V17, P9122; Pavelko KD, 1998, J NEUROSCI, V18, P2498; PETTMANN B, 1986, NEUROSCI LETT, V68, P175, DOI 10.1016/0304-3940(86)90137-0; Pirko I, 2004, FASEB J, V18, P1577, DOI 10.1096/fj.04-2026fje; PRESTA M, 1995, INT J DEV NEUROSCI, V13, P29, DOI 10.1016/0736-5748(94)00065-B; PRINGLE N, 1989, EMBO J, V8, P1049, DOI 10.1002/j.1460-2075.1989.tb03472.x; Pul R, 2002, CLIN NEUROPHARMACOL, V25, P254, DOI 10.1097/00002826-200209000-00005; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Robinson S, 1998, J NEUROSCI, V18, P10457; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; SHIMOJO M, 1991, NEUROSCI LETT, V123, P229, DOI 10.1016/0304-3940(91)90937-O; Silberstein FC, 1996, J NEUROCHEM, V66, P1409; Soldan MMP, 2003, MOL CELL NEUROSCI, V22, P14, DOI 10.1016/S1044-7431(02)00018-0; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Stangel M, 2003, J NEUROIMMUNOL, V138, P25, DOI 10.1016/S0165-5728(03)00087-0; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; UMEMORI H, 1992, MOL BRAIN RES, V16, P303, DOI 10.1016/0169-328X(92)90239-8; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; Vana AC, 2007, J NEUROPATH EXP NEUR, V66, P975, DOI 10.1097/NEN.0b013e3181587d46; Warrington AE, 2000, P NATL ACAD SCI USA, V97, P6820, DOI 10.1073/pnas.97.12.6820; Warrington AE, 2007, J NEUROSCI RES, V85, P967, DOI 10.1002/jnr.21217; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; Watzlawik J, 2010, GLIA, V58, P1782, DOI 10.1002/glia.21048; Wei S, 1996, J IMMUNOL, V157, P5155; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Windrem MS, 2002, J NEUROSCI RES, V69, P966, DOI 10.1002/jnr.10397; Yim SH, 2001, J NEUROCHEM, V76, P1925, DOI 10.1046/j.1471-4159.2001.00199.x; Zhang SC, 1999, P NATL ACAD SCI USA, V96, P4089, DOI 10.1073/pnas.96.7.4089	92	45	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55149	10.1371/journal.pone.0055149	http://dx.doi.org/10.1371/journal.pone.0055149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383310	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900017
J	Ying, J; Rahbar, MH; Hallman, DM; Hernandez, LM; Spitz, MR; Forman, MR; Gorlova, OY				Ying, Jun; Rahbar, Mohammad H.; Hallman, D. Michael; Hernandez, Ladia M.; Spitz, Margret R.; Forman, Michele R.; Gorlova, Olga Y.			Associations between Dietary Intake of Choline and Betaine and Lung Cancer Risk	PLOS ONE			English	Article							DNA METHYLATION; FOLATE INTAKE; PROMOTER HYPERMETHYLATION; BREAST-CANCER; SMOKING; METABOLISM; METHIONINE; SMOKERS; HEALTH; HYPOMETHYLATION	Evidence from human and animal research indicates that choline metabolic pathways may be activated during a variety of diseases, including cancer. We report results of a case-control study of 2821 lung cancer cases and 2923 controls that assessed associations of choline and betaine dietary intakes with lung cancer. Using multivariable logistic regression analyses, we report a significant association between higher betaine intake and lower lung cancer risk that varied by smoking status. Specifically, no significant association was observed between betaine intake and lung cancer among never-smokers. However, higher betaine intake was significantly associated with reduced lung cancer risk among smokers, and the protective effect was more evident among current than former smokers: for former and current smokers, the ORs (95% CI) of lung cancer for individuals with highest as compared to lowest quartiles of intake were 0.70(0.55-0.88) and 0.51(0.39-0.66) respectively. Significant linear trend of higher betaine intake and lower lung cancer risk was observed among both former (p(trend)=0.002) and current (p(trend)<0.0001) smokers. A similar protective effect was also observed with choline intake both in overall analysis as well as among current smokers, with p-values for chi-square tests being 0.001 and 0.004 respectively, but the effect was less evident, as no linear trend was observed. Our results suggest that choline and betaine intake, especially higher betaine intake, may be protective against lung cancer through mitigating the adverse effect of smoking.	[Ying, Jun; Gorlova, Olga Y.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Rahbar, Mohammad H.; Hallman, D. Michael] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol, Houston, TX USA; [Hernandez, Ladia M.; Forman, Michele R.] Univ Texas Austin, Dell Pediat Res Inst, Coll Nat Sci, Dept Nutr Sci, Austin, TX 78712 USA; [Spitz, Margret R.] Baylor Coll Med, Duncan Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Austin; Baylor College of Medicine	Ying, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	jying@mdanderson.org			NIH [RO1 CA149462, RO1 CA55769, RO1 CA127219]; NIH Centers for Translational Science Award (NIH CTSA) by the National Center for Research Resources (NCRR) [UL1 RR024148]; NATIONAL CANCER INSTITUTE [R01CA127219, R01CA149462, R01CA055769] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Centers for Translational Science Award (NIH CTSA) by the National Center for Research Resources (NCRR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was supported in part by the NIH RO1 CA149462 and FAMRI Young Clinical Scientist Award (YCSA) to OYG and RO1 CA55769 and CA127219 to MRS, as well as by the NIH Centers for Translational Science Award (NIH CTSA) grant (UL1 RR024148), awarded to the University of Texas Health Science Center at Houston in 2006 by the National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BARAK AJ, 1993, ALCOHOL CLIN EXP RES, V17, P552, DOI 10.1111/j.1530-0277.1993.tb00798.x; Barak AJ, 1996, ALCOHOL, V13, P483, DOI 10.1016/0741-8329(96)00040-7; BLOCK G, 1992, J AM DIET ASSOC, V92, P686; BLOCK G, 1994, AM J EPIDEMIOL, V139, P1190, DOI 10.1093/oxfordjournals.aje.a116965; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Cho E, 2007, JNCI-J NATL CANCER I, V99, P1224, DOI 10.1093/jnci/djm082; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; de Vogel S, 2011, CANCER CAUSE CONTROL, V22, P1, DOI 10.1007/s10552-010-9659-6; Dueck DA, 1996, MOL CELL BIOCHEM, V162, P97; Enokida H, 2006, CANCER-AM CANCER SOC, V106, P79, DOI 10.1002/cncr.21577; Esteller M, 1999, CANCER RES, V59, P67; Feinberg AP, 2010, VIRCHOWS ARCH, V456, P13, DOI 10.1007/s00428-009-0847-2; Furniss CS, 2008, CANCER EPIDEM BIOMAR, V17, P966, DOI 10.1158/1055-9965.EPI-07-2775; Futscher BW, 2004, NEOPLASIA, V6, P380, DOI 10.1593/neo.04115; Henning SM, 1996, ADV EXP MED BIOL, V399, P143; HOFSTETTER A, 1986, NEW ENGL J MED, V314, P79, DOI 10.1056/NEJM198601093140204; Hudmon KS, 1997, CANCER EPIDEM BIOMAR, V6, P565; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Katz-Brull R, 2002, CANCER RES, V62, P1966; KIM YI, 1994, J NUTR, V124, P2197, DOI 10.1093/jn/124.11.2197; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Kondo Y, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001559; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Kotsopoulos J, 2010, EUR J CLIN NUTR, V64, P111, DOI 10.1038/ejcn.2009.109; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mar M-H., 2004, USDA DATABASE CHOLIN; Marsit CJ, 2007, CARCINOGENESIS, V28, P1745, DOI 10.1093/carcin/bgm116; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Osler M, 1998, PREV MED, V27, P438, DOI 10.1006/pmed.1998.0289; Palaniappan U, 2001, J NUTR, V131, P1952, DOI 10.1093/jn/131.7.1952; Patterson KY, 2008, USDA DATABASE CHOLIN; PIERETTI M, 1995, HUM PATHOL, V26, P398, DOI 10.1016/0046-8177(95)90140-X; Schabath MB, 2005, AM J EPIDEMIOL, V161, P412, DOI 10.1093/aje/kwi063; Schatzkin A, 2003, INT J EPIDEMIOL, V32, P1054, DOI 10.1093/ije/dyg264; Schwartz AG, 2009, J THORAC ONCOL, V4, P1195, DOI 10.1097/JTO.0b013e3181b244ef; Shao CB, 2011, CLIN CANCER RES, V17, P4320, DOI 10.1158/1078-0432.CCR-10-2992; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Teixido N, 2005, LETT APPL MICROBIOL, V41, P248, DOI 10.1111/j.1472-765X.2005.01757.x; THORNTON A, 1994, J CLIN EPIDEMIOL, V47, P1143, DOI 10.1016/0895-4356(94)90101-5; U.S. Department of Agriculture Agricultural Research Service USDA Nutrient Data Laboratory, 2008, COMP FOODS RAW PROC; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; van der Maarel SM, 2008, ANN RHEUM DIS, V67, P97, DOI 10.1136/ard.2008.098392; VARELAMOREIRAS G, 1995, J AM COLL NUTR, V14, P480; Voorrips LE, 2000, CANCER EPIDEM BIOMAR, V9, P357; Wei QY, 2003, CANCER EPIDEM BIOMAR, V12, P963; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wu JY, 2008, ANN SURG ONCOL, V15, P3272, DOI 10.1245/s10434-008-0078-9; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; Xu XR, 2009, FASEB J, V23, P4022, DOI 10.1096/fj.09-136507	55	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e54561	10.1371/journal.pone.0054561	http://dx.doi.org/10.1371/journal.pone.0054561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383301	gold, Green Published, Green Submitted			2022-12-25	WOS:000314597900008
J	Brannmark, C; Nyman, E; Fagerholm, S; Bergenholm, L; Ekstrand, EM; Cedersund, G; Stralfors, P				Brannmark, Cecilia; Nyman, Elin; Fagerholm, Siri; Bergenholm, Linnea; Ekstrand, Eva-Maria; Cedersund, Gunnar; Stralfors, Peter			Insulin Signaling in Type 2 Diabetes EXPERIMENTAL AND MODELING ANALYSES REVEAL MECHANISMS OF INSULIN RESISTANCE IN HUMAN ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR SUBSTRATE-1; FAT-CELLS; GLUCOSE-TRANSPORT; PHOSPHORYLATION; ADIPOCYTES; IRS1; EXPRESSION; TRANSLOCATION; CONTRIBUTES; SENSITIVITY	Type 2 diabetes originates in an expanding adipose tissue that for unknown reasons becomes insulin resistant. Insulin resistance reflects impairments in insulin signaling, but mechanisms involved are unclear because current research is fragmented. We report a systems level mechanistic understanding of insulin resistance, using systems wide and internally consistent data from human adipocytes. Based on quantitative steady-state and dynamic time course data on signaling intermediaries, normally and in diabetes, we developed a dynamic mathematical model of insulin signaling. The model structure and parameters are identical in the normal and diabetic states of the model, except for three parameters that change in diabetes: (i) reduced concentration of insulin receptor, (ii) reduced concentration of insulin-regulated glucose transporter GLUT4, and (iii) changed feedback from mammalian target of rapamycin in complex with raptor (mTORC1). Modeling reveals that at the core of insulin resistance in human adipocytes is attenuation of a positive feedback from mTORC1 to the insulin receptor substrate-1, which explains reduced sensitivity and signal strength throughout the signaling network. Model simulations with inhibition of mTORC1 are comparable with experimental data on inhibition of mTORC1 using rapamycin in human adipocytes. We demonstrate the potential of the model for identification of drug targets, e. g. increasing the feedback restores insulin signaling, both at the cellular level and, using a multilevel model, at the whole body level. Our findings suggest that insulin resistance in an expanded adipose tissue results from cell growth restriction to prevent cell necrosis.	[Brannmark, Cecilia; Nyman, Elin; Fagerholm, Siri; Bergenholm, Linnea; Ekstrand, Eva-Maria; Cedersund, Gunnar; Stralfors, Peter] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Cedersund, Gunnar] Linkoping Univ, Dept Biomed Engn, SE-58185 Linkoping, Sweden	Linkoping University; Linkoping University	Stralfors, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.	peter.stralfors@liu.se	Nyman, Elin/I-3363-2019; Ekstrand, Eva-Maria/AAI-8504-2020	Nyman, Elin/0000-0002-4261-0291; Ekstrand, Eva-Maria/0000-0001-5260-1826	Swedish Diabetes Fund; Novo Nordic Foundation; University of Linkoping; Swedish Research Council	Swedish Diabetes Fund; Novo Nordic Foundation(Novo Nordisk Foundation); University of Linkoping; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Diabetes Fund, Novo Nordic Foundation, University of Linkoping, and the Swedish Research Council.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Brannmark C, 2010, J BIOL CHEM, V285, P20171, DOI 10.1074/jbc.M110.106849; Carvalho E, 1999, FASEB J, V13, P2173, DOI 10.1096/fasebj.13.15.2173; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Danielsson A, 2005, FEBS J, V272, P141, DOI 10.1111/j.1432-1033.2004.04396.x; Danielsson A, 2009, MOL MED, V15, P228, DOI 10.2119/molmed.2009.00037; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Franck N, 2007, DIABETOLOGIA, V50, P1716, DOI 10.1007/s00125-007-0713-1; FROST SC, 1987, J BIOL CHEM, V262, P9872; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hussey SE, 2011, DIABETES OBES METAB, V13, P959, DOI 10.1111/j.1463-1326.2011.01426.x; Im SS, 2006, BIOCHEM J, V399, P131, DOI 10.1042/BJ20060696; Kampmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027854; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laurencikiene J, 2011, J CLIN ENDOCR METAB, V96, pE2045, DOI 10.1210/jc.2011-1702; Lonn M, 2010, FASEB J, V24, P326, DOI 10.1096/fj.09-133058; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Nyman E, 2012, TRENDS ENDOCRIN MET, V23, P107, DOI 10.1016/j.tem.2011.12.007; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; OLEFSKY JM, 1976, J CLIN INVEST, V57, P1165, DOI 10.1172/JCI108384; Ost A, 2007, FASEB J, V21, P3696, DOI 10.1096/fj.07-8173com; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Pereira MJ, 2012, MOL CELL ENDOCRINOL, V355, P96, DOI 10.1016/j.mce.2012.01.024; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; STRALFORS P, 1989, EUR J BIOCHEM, V182, P379, DOI 10.1111/j.1432-1033.1989.tb14842.x; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhou LJ, 2009, MOL PHARMACOL, V76, P596, DOI 10.1124/mol.109.057067	48	72	73	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9867	9880		10.1074/jbc.M112.432062	http://dx.doi.org/10.1074/jbc.M112.432062			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23400783	hybrid, Green Published			2022-12-25	WOS:000317114000027
J	Rawat, SJ; Creasy, CL; Peterson, JR; Chernoff, J				Rawat, Sonali Jalan; Creasy, Caretha L.; Peterson, Jeffrey R.; Chernoff, Jonathan			The Tumor Suppressor Mst1 Promotes Changes in the Cellular Redox State by Phosphorylation and Inactivation of Peroxiredoxin-1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; MAMMALIAN PEROXIREDOXIN; HYDROGEN-PEROXIDE; KINASE; APOPTOSIS; PATHWAY; ISOFORMS; GROWTH; CELLS; H2O2	The serine/threonine protein kinases Mst1 and Mst2 can be activated by cellular stressors including hydrogen peroxide. Using two independent protein interaction screens, we show that these kinases associate, in an oxidation-dependent manner, with Prdx1, an enzyme that regulates the cellular redox state by reducing hydrogen peroxide to water and oxygen. Mst1 inactivates Prdx1 by phosphorylating it at Thr-90 and Thr-183, leading to accumulation of hydrogen peroxide in cells. These results suggest that hydrogen peroxide-stimulated Mst1 activates a positive feedback loop to sustain an oxidizing cellular state.	[Rawat, Sonali Jalan; Creasy, Caretha L.; Peterson, Jeffrey R.; Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Rawat, Sonali Jalan] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19102 USA	Fox Chase Cancer Center; Drexel University	Chernoff, J (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Jonathan.Chernoff@fccc.edu	Chernoff, Jonathan/I-7631-2014; Rawat, Sonali/N-7827-2014	Chernoff, Jonathan/0000-0002-4803-7836; Peterson, Jeffrey/0000-0002-0604-718X	National Institutes of Health [R01 CA58836, R01 CA098830, P30 CA006927]; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA098830, R01CA058836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA58836 and R01 CA098830 (to J. C.), as well as by an appropriation from the state of Pennsylvania.; We thank Carola Neumann for Prdx1 plasmids and Prdx1<SUP>-/-</SUP> MEFs, Matthias Gstaiger for the tap-tagging vector pcDNA5/FRT/TO/SH/GW, and Steven Gygi and the Taplin Mass Spectrometry Facility for assistance with analysis of protein complexes and phosphorylation site determinations. The Fox Chase Cancer Center was supported by a grant from the National Institutes of Health (Grant P30 CA006927).	Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Chae HZ, 1999, METHOD ENZYMOL, V300, P219; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Goyal MM, 2010, PROTEIN CELL, V1, P888, DOI 10.1007/s13238-010-0113-z; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Guo C, 2011, J BIOL CHEM, V286, P6253, DOI 10.1074/jbc.M110.178210; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Hsu JL, 1996, J BIOL CHEM, V271, P17687, DOI 10.1074/jbc.271.30.17687; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Kakeya H, 1998, CANCER RES, V58, P4888; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Luo XL, 2009, INT J MOL MED, V23, P357, DOI 10.3892/ijmm_00000139; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Morinaka A, 2011, ONCOGENE, V30, P4208, DOI 10.1038/onc.2011.139; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; O'Neill AK, 2013, FEBS J, V280, P572, DOI 10.1111/j.1742-4658.2012.08537.x; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Song H, 2010, BIOCHEM BIOPH RES CO, V391, P969, DOI 10.1016/j.bbrc.2009.11.175; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Wen WH, 2010, J BIOL CHEM, V285, P39108, DOI 10.1074/jbc.M110.151753; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; You B, 2009, BIOCHEM J, V418, P93, DOI 10.1042/BJ20081340; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zykova TA, 2010, J BIOL CHEM, V285, P29138, DOI 10.1074/jbc.M110.135905	45	44	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8762	8771		10.1074/jbc.M112.414524	http://dx.doi.org/10.1074/jbc.M112.414524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386615	Green Published, hybrid			2022-12-25	WOS:000316564500075
J	Ghosh, S; DeCoffe, D; Brown, K; Rajendiran, E; Estaki, M; Dai, CB; Yip, A; Gibson, DL				Ghosh, Sanjoy; DeCoffe, Daniella; Brown, Kirsty; Rajendiran, Ethendhar; Estaki, Mehrbod; Dai, Chuanbin; Yip, Ashley; Gibson, Deanna L.			Fish Oil Attenuates Omega-6 Polyunsaturated Fatty Acid-Induced Dysbiosis and Infectious Colitis but Impairs LPS Dephosphorylation Activity Causing Sepsis	PLOS ONE			English	Article							INTESTINAL ALKALINE-PHOSPHATASE; ULCERATIVE-COLITIS; ESCHERICHIA-COLI; CROHNS-DISEASE; LINOLEIC-ACID; LIPOPOLYSACCHARIDE; INFLAMMATION; MICROBIOTA; DEFENSE; SUSCEPTIBILITY	Clinically, excessive omega-6 polyunsaturated fatty acid (PUFA) and inadequate omega-3 PUFA have been associated with enhanced risks for developing ulcerative colitis. In rodent models, omega-3 PUFAs have been shown to either attenuate or exacerbate colitis in different studies. We hypothesized that a high omega-6: omega-3 PUFA ratio would increase colitis susceptibility through the microbe-immunity nexus. To address this, we fed post-weaned mice diets rich in omega-6 PUFA (corn oil) and diets supplemented with omega-3 PUFA (corn oil+fish oil) for 5 weeks. We evaluated the intestinal microbiota, induced colitis with Citrobacter rodentium and followed disease progression. We found that omega-6 PUFA enriched the microbiota with Enterobacteriaceae, Segmented Filamentous Bacteria and Clostridia spp., all known to induce inflammation. During infection-induced colitis, omega-6 PUFA fed mice had exacerbated intestinal damage, immune cell infiltration, prostaglandin E2 expression and C. rodentium translocation across the intestinal mucosae. Addition of omega-3 PUFA on a high omega-6 PUFA diet, reversed inflammatory-inducing microbial blooms and enriched beneficial microbes like Lactobacillus and Bifidobacteria, reduced immune cell infiltration and impaired cytokine/chemokine induction during infection. While, omega-3 PUFA supplementation protected against severe colitis, these mice suffered greater mortality associated with sepsis-related serum factors such as LPS binding protein, IL-15 and TNF-alpha. These mice also demonstrated decreased expression of intestinal alkaline phosphatase and an inability to dephosphorylate LPS. Thus, the colonic microbiota is altered differentially through varying PUFA composition, conferring altered susceptibility to colitis. Overall, omega-6 PUFA enriches pro-inflammatory microbes and augments colitis; but prevents infection-induced systemic inflammation. In contrast, omega-3 PUFA supplementation reverses the effects of the omega-6 PUFA diet but impairs infection-induced responses resulting in sepsis. We conclude that as an anti-inflammatory agent, omega-3 PUFA supplementation during infection may prove detrimental when host inflammatory responses are critical for survival.	[Ghosh, Sanjoy; DeCoffe, Daniella; Brown, Kirsty; Rajendiran, Ethendhar; Estaki, Mehrbod; Dai, Chuanbin; Yip, Ashley; Gibson, Deanna L.] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada	University of British Columbia; University of British Columbia Okanagan	Gibson, DL (corresponding author), Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada.	deanna.gibson@ubc.ca	Gibson, Deanna L/CAF-4166-2022	Gibson, Deanna L/0000-0003-0052-7550; Brown, Kirsty/0000-0003-1410-4532	Intestinal Disease Education and Awareness Society; Bill & Melinda Gates Foundation; Crohn's and Colitis Foundation of Canada; Canadian Association of Gastroenterology	Intestinal Disease Education and Awareness Society; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Crohn's and Colitis Foundation of Canada; Canadian Association of Gastroenterology	Grant Support was provided by the Intestinal Disease Education and Awareness Society; Bill & Melinda Gates Foundation; and Crohn's and Colitis Foundation of Canada. D. D. and K. B were funded through scholarships from the Canadian Association of Gastroenterology. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andoh A, 2003, INT J MOL MED, V12, P721; Baker J, 2012, AM J PHYSIOL-GASTR L, V303, pG825, DOI 10.1152/ajpgi.00327.2011; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2002, CLIN NUTR, V21, P451, DOI 10.1054/clnu.2002.0594; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Belluzzi A, 2004, Eur Rev Med Pharmacol Sci, V8, P225; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; Brown K, 2012, NUTRIENTS, V4, P1552, DOI [10.3390/nu4081095, 10.3390/nu4111552]; Chapkin RS, 2007, J NUTR, V137, p200S, DOI 10.1093/jn/137.1.200S; Chen KT, 2010, AM J PHYSIOL-GASTR L, V299, pG467, DOI 10.1152/ajpgi.00364.2009; Dong L, 2011, J GASTROENTEROL HEPA; Duck LW, 2007, INFLAMM BOWEL DIS, V13, P1191, DOI 10.1002/ibd.20237; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; GALLAY P, 1993, INFECT IMMUN, V61, P378, DOI 10.1128/IAI.61.2.378-383.1993; Gareau MG, 2010, J INFECT DIS, V201, P81, DOI 10.1086/648614; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Ghosh S, 2011, AM J PHYSIOL-GASTR L, V301, pG39, DOI 10.1152/ajpgi.00509.2010; Gibson DL, 2008, CELL MICROBIOL, V10, P618, DOI 10.1111/j.1462-5822.2007.01071.x; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Gibson DL, 2010, GASTROENTEROLOGY, V139, P1277, DOI 10.1053/j.gastro.2010.06.057; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Gravaghi C, 2011, J NUTR BIOCHEM, V22, P360, DOI 10.1016/j.jnutbio.2010.03.003; Gray-Donald K, 2000, CAN J PUBLIC HEALTH, V91, P381, DOI 10.1007/BF03404812; Hummel S, 2012, APPL ENVIRON MICROB, V78, P1140, DOI 10.1128/AEM.06983-11; Innis SM, 2010, AM J PHYSIOL-GASTR L, V299, pG1376, DOI 10.1152/ajpgi.00258.2010; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ma CX, 2006, CELL MICROBIOL, V8, P1669, DOI 10.1111/j.1462-5822.2006.00741.x; Ma X, 2008, CLIN EXP IMMUNOL, V151, P130, DOI 10.1111/j.1365-2249.2007.03530.x; Mane J, 2009, J NUTR, V139, P603, DOI 10.3945/jn.108.101170; Matsunaga H, 2008, INFLAMM BOWEL DIS, V14, P1348, DOI 10.1002/ibd.20491; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Monteleone I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-122; Natividad JMM, 2012, INFLAMM BOWEL DIS, V18, P1434, DOI 10.1002/ibd.22848; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Ramsden CE, 2010, BRIT J NUTR, V104, P1586, DOI 10.1017/S0007114510004010; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Simopoulos Artemis P., 1999, Annals of Nutrition and Metabolism, V43, P127, DOI 10.1159/000012777; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Statistics C, 2006, FOOD STAT 2005; Tjonneland A, 2009, GUT, V58, P1606, DOI 10.1136/gut.2008.169078; Todorov SD, 2011, J APPL MICROBIOL; Uchiyama K, 2010, INFLAMM BOWEL DIS, V16, P1696, DOI 10.1002/ibd.21251; Villar J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006818; WAN JM, 1987, CLIN SCI, V72, P383, DOI 10.1042/cs0720383; Ward PA, 2007, NAT MED, V13, P903, DOI 10.1038/nm0807-903; Woodworth HL, 2010, CANCER RES, V70, P7960, DOI 10.1158/0008-5472.CAN-10-1396	49	130	132	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55468	10.1371/journal.pone.0055468	http://dx.doi.org/10.1371/journal.pone.0055468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405155	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400100
J	Kriticos, DJ; Leriche, A; Palmer, DJ; Cook, DC; Brockerhoff, EG; Stephens, AEA; Watt, MS				Kriticos, Darren J.; Leriche, Agathe; Palmer, David J.; Cook, David C.; Brockerhoff, Eckehard G.; Stephens, Andrea E. A.; Watt, Michael S.			Linking Climate Suitability, Spread Rates and Host-Impact When Estimating the Potential Costs of Invasive Pests	PLOS ONE			English	Article							PINE PROCESSIONARY MOTH; THAUMETOPOEA-PITYOCAMPA DEN.; GEOGRAPHIC RANGE; SCHIFF. LEP.; ECONOMIC-IMPACT; FRUIT-FLY; TEMPERATURE; DEFOLIATION; SURVIVAL; FOREST	Biosecurity agencies need robust bioeconomic tools to help inform policy and allocate scarce management resources. They need to estimate the potential for each invasive alien species (IAS) to create negative impacts, so that relative and absolute comparisons can be made. Using pine processionary moth (Thaumetopoea pityocampa sensu lato) as an example, these needs were met by combining species niche modelling, dispersal modelling, host impact and economic modelling. Within its native range (the Mediterranean Basin and adjacent areas), T. pityocampa causes significant defoliation of pines and serious urticating injuries to humans. Such severe impacts overseas have fuelled concerns about its potential impacts, should it be introduced to New Zealand. A stochastic bioeconomic model was used to estimate the impact of PPM invasion in terms of pine production value lost due to a hypothetical invasion of New Zealand by T. pityocampa. The bioeconomic model combines a semi-mechanistic niche model to develop a climate-related damage function, a climate-related forest growth model, and a stochastic spread model to estimate the present value (PV) of an invasion. Simulated invasions indicate that Thaumetopoea pityocampa could reduce New Zealand's merchantable and total pine stem volume production by 30%, reducing forest production by between NZ$1,550 M to NZ$2,560 M if left untreated. Where T. pityocampa is controlled using aerial application of an insecticide, projected losses in PV were reduced, but still significant (NZ$30 M to NZ$2,210 M). The PV estimates were more sensitive to the efficacy of the spray program than the potential rate of spread of the moth. Our novel bioeconomic method provides a refined means of estimating potential impacts of invasive alien species, taking into account climatic effects on asset values, the potential for pest impacts, and pest spread rates.	[Kriticos, Darren J.; Leriche, Agathe; Cook, David C.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Kriticos, Darren J.; Leriche, Agathe] Univ Minnesota, Dept Appl Econ, InSTePP, St Paul, MN 55108 USA; [Kriticos, Darren J.; Leriche, Agathe; Cook, David C.] CRC Natl Plant Biosecur, Bruce, Australia; [Kriticos, Darren J.; Palmer, David J.] Scion New Zealand Forest Res Inst, Rotorua, New Zealand; [Cook, David C.] Dept Agr & Food Western Australia, Bunbury, Australia; [Cook, David C.] Univ Western Australia, Crawley, Australia; [Brockerhoff, Eckehard G.; Watt, Michael S.] Scion New Zealand Forest Res Inst, Christchurch, New Zealand; [Stephens, Andrea E. A.] HortResearch, Lincoln, New Zealand	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Minnesota System; University of Minnesota Twin Cities; University of Western Australia; New Zealand Institute for Plant & Food Research Ltd	Kriticos, DJ (corresponding author), CSIRO Ecosyst Sci, Canberra, ACT, Australia.	Darren.Kriticos@csiro.au	Brockerhoff, Eckehard Gustav/C-1528-2009; Leriche, Agathe/C-3151-2008; Watt, Michael S/C-3813-2009; Kriticos, Darren J/A-4170-2008; Cook, David C/C-1064-2009	Brockerhoff, Eckehard Gustav/0000-0002-5962-3208; Leriche, Agathe/0000-0001-9646-5344; Kriticos, Darren J/0000-0003-2599-8105; Cook, David C/0000-0002-2954-7697; Stephens, Andrea/0000-0003-0595-4623; Watt, Michael/0000-0001-6752-9134	New Zealand Foundation for Research, Science Technology [C02X0501, C09X0905]; New Zealand Ministry of Agriculture and Forestry	New Zealand Foundation for Research, Science Technology(New Zealand Foundation for Research, Science and Technology); New Zealand Ministry of Agriculture and Forestry	This work was partly funded by the New Zealand Foundation for Research, Science & Technology through contract C02X0501 [the Better Border Biosecurity (B3) programme (www.b3nz.org)], and contract C09X0905 (Beating Environmental Weeds II) and the New Zealand Ministry of Agriculture and Forestry. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOW DA, 1990, LANDSCAPE ECOL, V4, P177, DOI 10.1007/BF00132860; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Astiaso Gallart F, 1992, B SERVICIO PLAGAS FO, V4, P122; Battisti A, 2005, ECOL APPL, V15, P2084, DOI 10.1890/04-1903; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; BREUER M, 1990, J APPL ENTOMOL, V109, P331, DOI 10.1111/j.1439-0418.1990.tb00060.x; Brockerhoff EG, 2007, 12216 NZ FOR HLTH RE; Buffo E, 2007, AGR FOREST ENTOMOL, V9, P65, DOI 10.1111/j.1461-9563.2006.00321.x; BUXTON RD, 1983, OUTLOOK AGR, V12, P34, DOI 10.1177/003072708301200106; Carus S, 2004, PHYTOPARASITICA, V32, P459, DOI 10.1007/BF02980440; Cobos Suarez J. M., 1990, Boletin de Sanidad Vegetal, Plagas, V16, P37; Cook DC, 2008, AUST FORESTRY, V71, P107, DOI 10.1080/00049158.2008.10676277; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; CTGREF-INRA, 1980, CHEN PROC PIN ORG SU; De Villiers M., 2012, B ENTOMOLOGICAL RES; De Wolf ED, 2007, ANNU REV PHYTOPATHOL, V45, P203, DOI 10.1146/annurev.phyto.44.070505.143329; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; EPPO/CABI, 1996, THAUM PIT, P532; FAO, 2006, INT STAND PHYT MEAS; Fraser RW, 2006, INT J PEST MANAGE, V52, P261, DOI 10.1080/09670870600795930; Gatto P, 2009, J ENVIRON MANAGE, V90, P683, DOI 10.1016/j.jenvman.2008.01.007; Hengeveld R., 1989, DYNAMICS BIOL INVASI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoch G, 2009, AGR FOREST ENTOMOL, V11, P313, DOI 10.1111/j.1461-9563.2009.00431.x; Hodar JA, 2004, ACTA OECOL, V26, P203, DOI 10.1016/j.actao.2004.05.004; Huchon H, 1970, REV FORESTIERE FRANC, P220; Kanat M, 2005, ANN FOREST SCI, V62, P91, DOI 10.1051/forest:2004095; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kerdelhue C, 2006, HEREDITY, V97, P38, DOI 10.1038/sj.hdy.6800836; Kimberley Mark, 2005, New Zealand Journal of Forestry, V50, P13; Kriticos D. J., 2005, New Zealand Plant Protection, V58, P1; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; LAURENTHERVOUET N, 1986, ANN SCI FOREST, V43, P239, DOI 10.1051/forest:19860209; LEMOINE B, 1977, ANN SCI FOREST, V34, P205, DOI 10.1051/forest/19770302; Lewis M., 1997, SPATIAL ECOLOGY ROLE, P46; Markalas S, 1998, POPULATION DYNAMICS, IMPACTS, AND INTEGRATED MANAGEMENT OF FOREST DEFOLIATING INSECTS - PROCEEDINGS, P292; Melbourne BA, 2009, SCIENCE, V325, P1536, DOI 10.1126/science.1176138; Ministry for Environment, LAND COV DAT VERS 2; Ministry of Agriculture and Forestry, 2010, NAT EX FOR DESCR; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Palmer DJ, 2009, FOREST ECOL MANAG, V258, P2046, DOI 10.1016/j.foreco.2009.07.057; Palmeri V, 2005, FOREST, V2, P345; Pimentel C, 2006, FOREST ECOL MANAG, V233, P108, DOI 10.1016/j.foreco.2006.06.005; Pimentel C, 2010, BIOL J LINN SOC, V100, P224, DOI 10.1111/j.1095-8312.2010.01413.x; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pitt JPW, 2011, ECOL MODEL, V222, P1880, DOI 10.1016/j.ecolmodel.2011.03.023; Plant Health Australia, 2009, PLANTPLAN AUSTR EM P; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Robinet C, 2008, J ANIM ECOL, V77, P966, DOI 10.1111/j.1365-2656.2008.01417.x; Robinet C, 2007, GLOBAL ECOL BIOGEOGR, V16, P460, DOI 10.1111/j.1466-8238.2006.00302.x; Salvato P, 2002, MOL ECOL, V11, P2435, DOI 10.1046/j.1365-294X.2002.01631.x; Schmidt GH, 1997, PHYTOPARASITICA, V25, P275; Sharov AA, 2004, RISK ANAL, V24, P879, DOI 10.1111/j.0272-4332.2004.00486.x; Shigesada N, 1997, BIOL INVASIONS THEOR; Standards Australia, 2006, NAT POSTB WEED RISK; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Waggoner PE, 1950, PLANT DIS REP      S, V190, P19; Watt MS, 2009, WEED RES, V49, P381, DOI 10.1111/j.1365-3180.2009.00704.x; Watt MS, 2009, FOREST ECOL MANAG, V257, P1505, DOI 10.1016/j.foreco.2008.12.026; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Wilby, 2005, NEW AGENDA BIOSECURI; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152; Zhang QH, 1998, J APPL ENTOMOL, V122, P353, DOI 10.1111/j.1439-0418.1998.tb01512.x	69	25	26	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54861	10.1371/journal.pone.0054861	http://dx.doi.org/10.1371/journal.pone.0054861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405097	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400041
J	Onorato, M; Proment, D; Clauss, G; Klein, M				Onorato, Miguel; Proment, Davide; Clauss, Guenther; Klein, Marco			Rogue Waves: From Nonlinear Schrodinger Breather Solutions to Sea-Keeping Test	PLOS ONE			English	Article							WATER; EQUATION	Under suitable assumptions, the nonlinear dynamics of surface gravity waves can be modeled by the one-dimensional nonlinear Schrodinger equation. Besides traveling wave solutions like solitons, this model admits also breather solutions that are now considered as prototypes of rogue waves in ocean. We propose a novel technique to study the interaction between waves and ships/structures during extreme ocean conditions using such breather solutions. In particular, we discuss a state of the art sea-keeping test in a 90-meter long wave tank by creating a Peregrine breather solution hitting a scaled chemical tanker and we discuss its potential devastating effects on the ship.	[Onorato, Miguel] Univ Turin, Dipartimento Fis, Turin, Italy; [Onorato, Miguel] Ist Nazl Fis Nucl, Sez Torino, I-10125 Turin, Italy; [Proment, Davide] Univ E Anglia, Sch Math, Norwich NR4 7TJ, Norfolk, England; [Clauss, Guenther; Klein, Marco] Tech Univ Berlin, Ocean Engn Div, Berlin, Germany	University of Turin; Istituto Nazionale di Fisica Nucleare (INFN); University of East Anglia; Technical University of Berlin	Proment, D (corresponding author), Univ E Anglia, Sch Math, Norwich NR4 7TJ, Norfolk, England.	davideproment@gmail.com	Proment, Davide/R-2463-2017; Onorato, Miguel/AAE-8793-2021; Onorato, Miguel/G-7104-2012	Proment, Davide/0000-0002-9472-0097; Onorato, Miguel/0000-0001-9141-2147; Onorato, Miguel/0000-0001-9141-2147; Klein, Marco/0000-0003-2867-7534	E.U. project EXTREME SEAS [SCP8-GA-2009-234175]	E.U. project EXTREME SEAS	The authors were supported by the E.U. project EXTREME SEAS (SCP8-GA-2009-234175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHMEDIEV NN, 1987, THEOR MATH PHYS+, V72, P809, DOI 10.1007/BF01017105; AKHMEDIEV NN, 1985, ZH EKSP TEOR FIZ+, V89, P1542; Baldock TE, 1996, PHILOS T R SOC A, V354, P649, DOI 10.1098/rsta.1996.0022; Bludov YV, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.033610; Chabchoub A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016311; Chabchoub A, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007636; Chabchoub A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.204502; Clauss G., 2011, P ASME 2011 30 INT C, P1; Clauss GF, 2002, APPL OCEAN RES, V24, P147, DOI 10.1016/S0141-1187(02)00026-3; Clauss GF, 2005, 24 INT C OFFSH MECH, V129, P61; Clauss GF, 1996, 96552 OMAE, V1, P41; Dysthe KB, 1999, PHYS SCRIPTA, VT82, P48, DOI 10.1238/Physica.Topical.082a00048; Haver S, 2004, P ROG WAV 2004; Kharif C, 2009, ADV GEOPHYS ENV MECH, P1, DOI 10.1007/978-3-540-88419-4_1; Kibler B, 2010, NAT PHYS, V6, P790, DOI 10.1038/NPHYS1740; Kuznetsov E A, 1977, AKAD NAUK SSSR DOKLA, V236, P575; MA YC, 1979, STUD APPL MATH, V60, P43; Mei C. C., 1989, APPL DYNAMICS OCEAN, V1; Newell A.C., 1992, NONLINEAR OPTICS; Osborne AR, 2000, PHYS LETT A, V275, P386, DOI 10.1016/S0375-9601(00)00575-2; PEREGRINE DH, 1983, J AUST MATH SOC B, V25, P16, DOI 10.1017/S0334270000003891; Sulem P.-L., 1999, NONLINEAR SCHRODINGE, V139; Toffoli A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041771; Zakharov, 1968, J APPL MECH TECH PHY, V9, P190, DOI [10.1007/BF00913182, DOI 10.1007/BF00913182]	24	93	95	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54629	10.1371/journal.pone.0054629	http://dx.doi.org/10.1371/journal.pone.0054629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405086	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000315153400030
J	Williams, SA; Jasarevic, E; Vandas, GM; Warzak, DA; Geary, DC; Ellersieck, MR; Roberts, RM; Rosenfeld, CS				Williams, Scott A.; Jasarevic, Eldin; Vandas, Gregory M.; Warzak, Denise A.; Geary, David C.; Ellersieck, Mark R.; Roberts, R. Michael; Rosenfeld, Cheryl S.			Effects of Developmental Bisphenol A Exposure on Reproductive-Related Behaviors in California Mice (Peromyscus californicus): A Monogamous Animal Model	PLOS ONE			English	Article							TERRITORIAL MARKING; SEX-DIFFERENCES; SOCIAL STRESS; URINE-MARKING; TESTOSTERONE; ENDOCRINE; ESTRADIOL; DIFFERENTIATION; EXPLORATION; INTERFERES	Bisphenol A (BPA), a pervasive, endocrine disrupting compound (EDC), acts as a mixed agonist-antagonist with respect to estrogens and other steroid hormones. We hypothesized that sexually selected traits would be particularly sensitive to EDC. Consistent with this concept, developmental exposure of males from the polygynous deer mouse, Peromyscus maniculatus, to BPA resulted in compromised spatial navigational ability and exploratory behaviors, while there was little effect on females. Here, we have examined a related, monogamous species, the California mouse (Peromyscus californicus), where we predicted that males would be less sensitive to BPA in terms of navigational and exploratory behaviors, while displaying other traits related to interactions with females and territorial marking that might be vulnerable to disruption. As in the deer mouse experiments, females were fed either a phytoestrogen-free CTL diet through pregnancy and lactation or the same diet supplemented with BPA (50 mg/kg feed weight) or ethinyl estradiol (EE) (0.1 part per billion) to provide a "pure'' estrogen control. After weaning, pups were maintained on CTL diet until they had reached sexual maturity, at which time behaviors were evaluated. In addition, territorial marking was assessed in BPA-exposed males housed alone and when a control male was visible in the testing arena. In contrast to deer mice, BPA and EE exposure had no effect on spatial navigational skills in either male or female California mice. While CTL females exhibited greater exploratory behavior than CTL males, BPA exposure abolished this sex difference. BPA-exposed males, however, engaged in less territorial marking when CTL males were present. These studies demonstrate that developmental BPA exposure can disrupt adult behaviors in a sex- and species-dependent manner and are consistent with the hypothesis that sexually selected traits are particularly vulnerable to endocrine disruption and should be a consideration in risk assessment studies.	[Williams, Scott A.; Vandas, Gregory M.; Warzak, Denise A.; Roberts, R. Michael; Rosenfeld, Cheryl S.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65212 USA; [Williams, Scott A.; Jasarevic, Eldin; Vandas, Gregory M.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Jasarevic, Eldin; Geary, David C.] Univ Missouri, Ctr Translat Neurosci, Interdisciplinary Neurosci Program, Columbia, MO USA; [Jasarevic, Eldin; Geary, David C.] Univ Missouri, Dept Psychol Sci, Columbia, MO USA; [Jasarevic, Eldin] Univ Missouri, Thompson Ctr Autism & Neurodev Disorder, Columbia, MO USA; [Warzak, Denise A.; Roberts, R. Michael] Univ Missouri, Dept Anim Sci, Columbia, MO USA; [Ellersieck, Mark R.] Univ Missouri, Coll Agr Food & Nat Resources Statistician, Columbia, MO USA; [Roberts, R. Michael] Univ Missouri, Dept Biochem, Columbia, MO USA; [Roberts, R. Michael; Rosenfeld, Cheryl S.] Univ Missouri, Genet Area Program, Columbia, MO USA; [Rosenfeld, Cheryl S.] Univ Missouri, Dept Biomed Sci, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Rosenfeld, CS (corresponding author), Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65212 USA.	rosenfeldc@missouri.edu		Jasarevic, Eldin/0000-0001-8174-0710	National Institutes of Health Challenge Grant [RC1 ES018195]; Mizzou Advantage grant; Food for the 21th Century Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC1ES018195] Funding Source: NIH RePORTER	National Institutes of Health Challenge Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizzou Advantage grant; Food for the 21th Century Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a National Institutes of Health Challenge Grant RC1 ES018195 (to CSR), a Mizzou Advantage grant (to CSR, DCG and RMR), and support from Food for the 21th Century Program to RMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; ARNOLD AP, 1985, HORM BEHAV, V19, P469, DOI 10.1016/0018-506X(85)90042-X; ASA CS, 1990, HORM BEHAV, V24, P497, DOI 10.1016/0018-506X(90)90038-Y; Bailin P.D., 2008, PUBLIC AWARENESS DRI, P37; Balakrishnan B, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.025; Bartolomucci A, 2001, PHYSIOL BEHAV, V73, P401, DOI 10.1016/S0031-9384(01)00453-X; Becker EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032002; Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Chang YM, 2000, J COMP PSYCHOL, V114, P401, DOI 10.1037/0735-7036.114.4.401; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cox KH, 2010, HORM BEHAV, V58, P754, DOI 10.1016/j.yhbeh.2010.07.008; D'Amato FR, 2001, PHYSIOL BEHAV, V73, P421, DOI 10.1016/S0031-9384(01)00460-7; Darwin G., 1871, P423; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; Eichmann F, 1999, PHYSIOL BEHAV, V65, P785; EISENBERG JOHN F., 1962, BEHAVIOUR, V19, P177, DOI 10.1163/156853962X00014; Fountain ED, 2008, BIOL REPROD, V78, P211, DOI 10.1095/biolreprod.107.065003; Frazier CRM, 2006, HORM BEHAV, V50, P699, DOI 10.1016/j.yhbeh.2006.06.035; Frye CA, 2012, J NEUROENDOCRINOL, V24, P144, DOI 10.1111/j.1365-2826.2011.02229.x; Galea LAM, 1996, J EXP BIOL, V199, P195; Galea LAM, 1999, NEUROSCIENCE, V89, P955, DOI 10.1016/S0306-4522(98)00345-5; Galloway T, 2010, ENV HLTH PERSPECT; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Gleason ED, 2009, FRONT NEUROENDOCRIN, V30, P460, DOI 10.1016/j.yfrne.2009.04.009; GUBERNICK DJ, 1987, J COMP PSYCHOL, V101, P169, DOI 10.1037/0735-7036.101.2.169; Gubernick DJ, 2000, P ROY SOC B-BIOL SCI, V267, P147, DOI 10.1098/rspb.2000.0979; Hajszan T, 2010, FRONT NEUROENDOCRIN, V31, P519, DOI 10.1016/j.yfrne.2010.06.004; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; He YH, 2009, ENVIRON RES, V109, P629, DOI 10.1016/j.envres.2009.04.003; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; JACOBS LF, 1990, P NATL ACAD SCI USA, V87, P6349, DOI 10.1073/pnas.87.16.6349; Jasarevic E, 2012, J COMP PSYCHOL; Jasarevic E, 2013, HORM BEHAV, V63, P180, DOI 10.1016/j.yhbeh.2012.09.009; Jasarevic E, 2012, ANIM BEHAV, V84, P1141, DOI 10.1016/j.anbehav.2012.08.015; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Kawamoto Y, 2007, TOXICOL APPL PHARM, V224, P182, DOI 10.1016/j.taap.2007.06.023; Kim ME, 2011, FOOD CHEM TOXICOL, V49, P3383, DOI 10.1016/j.fct.2011.09.017; KIMURA T, 1985, HORM BEHAV, V19, P64, DOI 10.1016/0018-506X(85)90006-6; Lambert KG, 2011, BRAIN BEHAV EVOLUT, V77, P159, DOI 10.1159/000326054; Layne JN, 1968, BIOL PEROMYSCUS RODE; Leranth C, 2008, P NATL ACAD SCI USA, V105, P14187, DOI 10.1073/pnas.0806139105; Leranth C, 2008, ENDOCRINOLOGY, V149, P988, DOI 10.1210/en.2007-1053; Littell RC, 1998, J ANIM SCI, V76, P1216; Marler CA, 2008, NEUROBIOLOGY OF THE PARENTAL BRAIN, P435, DOI 10.1016/B978-012374285-8.00028-7; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Nakamura K, 2012, BRAIN DEV-JPN, V34, P57, DOI 10.1016/j.braindev.2010.12.011; Nishikawa M, 2010, ENVIRON HEALTH PERSP, V118, P1196, DOI 10.1289/ehp.0901575; Perera F, 2012, ENVIRON HEALTH PERSP, V120, P1190, DOI 10.1289/ehp.1104492; Pyter LM, 2006, EUR J NEUROSCI, V23, P3056, DOI 10.1111/j.1460-9568.2006.04821.x; Pyter LM, 2005, J NEUROSCI, V25, P4521, DOI 10.1523/JNEUROSCI.0795-05.2005; Razzoli M, 2005, BRAIN RES BULL, V65, P249, DOI 10.1016/j.brainresbull.2004.11.013; Ribble DO, 1990, POPULATION SOCIAL DY; Rubin BS, 2011, J STEROID BIOCH MOL; Ryan BC, 2010, TOXICOL SCI, V114, P133, DOI 10.1093/toxsci/kfp266; Saal FSV, 2005, BIRTH DEFECTS RES A, V73, P140, DOI 10.1002/bdra.20120; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Stump DG, 2010, TOXICOL SCI, V115, P167, DOI 10.1093/toxsci/kfq025; THIESSEN DD, 1971, J COMP PHYSIOL PSYCH, V77, P38, DOI 10.1037/h0031570; THIESSEN DD, 1968, SCIENCE, V160, P432, DOI 10.1126/science.160.3826.432; TURNER JW, 1979, PHYSIOL BEHAV, V23, P845, DOI 10.1016/0031-9384(79)90188-4; TURNER JW, 1984, PHYSIOL BEHAV, V33, P173, DOI 10.1016/0031-9384(84)90096-9; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; VOMSAAL FS, 1995, TOXICOL LETT, V77, P343, DOI 10.1016/0378-4274(95)03316-5; Walton JC, 2011, NEUROSCIENCE, V175, P127, DOI 10.1016/j.neuroscience.2010.12.004; Yamaguchi H, 2005, HORM BEHAV, V47, P549, DOI 10.1016/j.yhbeh.2004.12.009	70	56	57	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55698	10.1371/journal.pone.0055698	http://dx.doi.org/10.1371/journal.pone.0055698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405200	Green Submitted, gold, Green Published			2022-12-25	WOS:000315153400145
J	Breme, C; Heslot, F				Breme, Camille; Heslot, Francois			Mapping of Single-Base Differences between Two DNA Strands in a Single Molecule Using Holliday Junction Nanomechanics	PLOS ONE			English	Article							FORCE SPECTROSCOPY; HELICAL JUNCTIONS; BRANCH MIGRATION; ELASTICITY; TWEEZERS; TORQUE	Objective: The aim of this work is to demonstrate a novel single-molecule DNA sequence comparison assay that is purely based on DNA mechanics. Methods: A molecular construct that contained the two homologous but non-identical DNA sequences that were to be compared was prepared such that a four-way (Holliday) junction could be formed by the formation of heteroduplexes through the inter-recombination of the strands. Magnetic tweezers were used to manipulate the force and the winding applied to this construct for inducing both the formation and the migration of a Holliday junction. The end-to-end distance of the construct was measured as a function of the winding and was used to monitor the behavior of the Holliday junction in different regions of the intra-molecular recombination. Main Results: In the appropriate buffer, the magnet rotation induces the migration of the Holliday junction in the regions where there is no sequence difference between the recombining sequences. In contrast, even a single-base difference between the recombining sequences leads to a long-lasting blockage of the migration in the same buffer; this effect was obtained when the junction was positioned near this locus (the site of the single-base difference) and forced toward the formation of heteroduplexes that comprise the locus. The migration blockages were detected through the identification of the formation of plectonemes. The detection of the presence of sequence differences and their respective mappings were obtained from the series of blockages that were detected. Significance: This work presents a novel single-molecule sequence comparison assay that is based on the use of a Holliday junction as an ultra-sensitive nanomechanism; the mismatches act as blocking grains of sand in the Holliday "DNA gearbox''. This approach will potentially have future applications in biotechnology.	[Breme, Camille; Heslot, Francois] Ecole Normale Super, Lab Pierre Aigrain, UMR 8551, F-75231 Paris, France; [Breme, Camille; Heslot, Francois] Univ Paris 06, Lab Pierre Aigrain, Paris, France; [Breme, Camille; Heslot, Francois] Univ Paris 07, Lab Pierre Aigrain, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Heslot, F (corresponding author), Ecole Normale Super, Lab Pierre Aigrain, UMR 8551, 24 Rue Lhomond, F-75231 Paris, France.	heslot@lpa.ens.fr	heslot, françois/AAF-9406-2021		Centre national de la recherche scientifique (CNRS); Universite Pierre et Marie Curie (UPMC)	Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie (UPMC)	The funders for the study were Centre national de la recherche scientifique (CNRS) and Universite Pierre et Marie Curie (UPMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas I, 1998, J MOL BIOL, V279, P795, DOI 10.1006/jmbi.1998.1769; Bockelmann U, 2002, BIOPHYS J, V82, P1537, DOI 10.1016/S0006-3495(02)75506-9; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Dawid A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.188102; De Vlaminck I, 2011, NANO LETT, V11, P5489, DOI 10.1021/nl203299e; Forth S, 2011, BIOPHYS J, V101, pL5, DOI 10.1016/j.bpj.2011.05.066; Gomez A, 2005, APPL ENVIRON MICROB, V71, P7607, DOI 10.1128/AEM.71.11.7607-7609.2005; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Lilley DMJ, 2009, IMA VOL MATH APPL, V150, P213, DOI 10.1007/978-1-4419-0670-0_11; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; Marko JF, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021926; McKinney SA, 2005, P NATL ACAD SCI USA, V102, P5715, DOI 10.1073/pnas.0409328102; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; Moroz JD, 1998, MACROMOLECULES, V31, P6333, DOI 10.1021/ma971804a; Mosconi F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.078301; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; PANYUTIN IG, 1995, EMBO J, V14, P1819, DOI 10.1002/j.1460-2075.1995.tb07170.x; PANYUTIN IG, 1993, J MOL BIOL, V230, P413, DOI 10.1006/jmbi.1993.1159; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Ramreddy T, 2011, NUCLEIC ACIDS RES, V39, P4275, DOI 10.1093/nar/gkr008; SCOULICA E, 1995, ANTIMICROB AGENTS CH, V39, P1379, DOI 10.1128/AAC.39.6.1379; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TAYLOR WH, 1990, J MOL BIOL, V212, P363, DOI 10.1016/0022-2836(90)90131-5; Treffer R, 2010, CURR OPIN BIOTECH, V21, P4, DOI 10.1016/j.copbio.2010.02.009; Venkatesan BM, 2011, NAT NANOTECHNOL, V6, P615, DOI [10.1038/NNANO.2011.129, 10.1038/nnano.2011.129]; VIOVY JL, 1994, CR ACAD SCI III-VIE, V317, P795; Voulgarakis NK, 2006, NANO LETT, V6, P1483, DOI 10.1021/nl0608801; Zhao Q, 2007, NANO LETT, V7, P1680, DOI 10.1021/nl070668c	31	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55154	10.1371/journal.pone.0055154	http://dx.doi.org/10.1371/journal.pone.0055154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393565	gold, Green Submitted, Green Published			2022-12-25	WOS:000314692800019
J	Papadimitriou, KI; Stan, GBV; Drakakis, EM				Papadimitriou, Konstantinos I.; Stan, Guy-Bart V.; Drakakis, Emmanuel M.			Systematic Computation of Nonlinear Cellular and Molecular Dynamics with Low-Power CytoMimetic Circuits: A Simulation Study	PLOS ONE			English	Article							CA2+-INDUCED CA2+ RELEASE; CALCIUM OSCILLATIONS; PROTEIN-PHOSPHORYLATION; INTRACELLULAR CALCIUM; MODEL; VLSI	This paper presents a novel method for the systematic implementation of low-power microelectronic circuits aimed at computing nonlinear cellular and molecular dynamics. The method proposed is based on the Nonlinear Bernoulli Cell Formalism (NBCF), an advanced mathematical framework stemming from the Bernoulli Cell Formalism (BCF) originally exploited for the modular synthesis and analysis of linear, time-invariant, high dynamic range, logarithmic filters. Our approach identifies and exploits the striking similarities existing between the NBCF and coupled nonlinear ordinary differential equations (ODEs) typically appearing in models of naturally encountered biochemical systems. The resulting continuous-time, continuous-value, low-power CytoMimetic electronic circuits succeed in simulating fast and with good accuracy cellular and molecular dynamics. The application of the method is illustrated by synthesising for the first time microelectronic CytoMimetic topologies which simulate successfully: 1) a nonlinear intracellular calcium oscillations model for several Hill coefficient values and 2) a gene-protein regulatory system model. The dynamic behaviours generated by the proposed CytoMimetic circuits are compared and found to be in very good agreement with their biological counterparts. The circuits exploit the exponential law codifying the low-power subthreshold operation regime and have been simulated with realistic parameters from a commercially available CMOS process. They occupy an area of a fraction of a square-millimetre, while consuming between 1 and 12 microwatts of power. Simulations of fabrication-related variability results are also presented.	[Papadimitriou, Konstantinos I.; Stan, Guy-Bart V.; Drakakis, Emmanuel M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Stan, Guy-Bart V.] Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, London, England	Imperial College London; Imperial College London	Drakakis, EM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, S Kensington Campus, London, England.	e.drakakis@imperial.ac.uk	Papadimitriou, Konstantinos/G-1214-2013	Stan, Guy-Bart/0000-0002-5560-902X; Papadimitriou, Konstantinos I./0000-0002-0995-4834	Engineering and Physical Sciences Research Council [EP/G036004/1] Funding Source: researchfish; EPSRC [EP/G036004/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Andreou AG, 1996, ANALOG INTEGR CIRC S, V9, P141, DOI 10.1007/BF00166411; Andronov A.A, 1973, THEORY BIFURCATIONS; Ascoli A, 2007, INT J CIRC THEOR APP, V35, P33, DOI 10.1002/cta.379; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; CAPOGROSSI MC, 1987, CIRC RES, V61, P498, DOI 10.1161/01.RES.61.4.498; Carafoli E., 1978, CURR TOP MEMBR TRANS, V10, P151; Cauwenberghs G, 1997, ANALOG INTEGR CIRC S, V13, P195, DOI 10.1023/A:1008252532342; Chen H, 2010, IEEE T NEURAL NETWOR, V21, P1511, DOI 10.1109/TNN.2010.2049028; Chen LN, 2002, IEEE T CIRCUITS-I, V49, P1429, DOI 10.1109/TCSI.2002.803354; Drakakis EM, 1999, IEEE T CIRCUITS-I, V46, P559, DOI 10.1109/81.762921; Drakakis EM, 1999, IEEE T CIRCUITS-II, V46, P290, DOI 10.1109/82.754862; Drakakis EM, 1997, ISCAS '97 - PROCEEDINGS OF 1997 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS I - IV, P501, DOI 10.1109/ISCAS.1997.608784; Drazin P, 1992, NONLINEAR SYSTEMS, V10; DUPONT G, 1994, BIOPHYS J, V67, P2191, DOI 10.1016/S0006-3495(94)80705-2; DUPONT G, 1991, CELL CALCIUM, V12, P73, DOI 10.1016/0143-4160(91)90010-C; DUPONT G, 1992, BIOPHYS CHEM, V42, P257, DOI 10.1016/0301-4622(92)80018-Z; DUPONT G, 1993, CELL CALCIUM, V14, P311, DOI 10.1016/0143-4160(93)90052-8; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Enz C, 1999, IEEE T CIRCUITS-II, V46, P279, DOI 10.1109/82.754861; GOLDBETER A, 1990, BIOPHYS CHEM, V37, P341, DOI 10.1016/0301-4622(90)88033-O; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; Goldbeter A., 1996, BIOCH OSCILLATIONS B; Guckenheimer J, 1997, NONLINEAR OSCILLATIO, V42; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Indiveri G., 2011, FRONTIERS NEUROSCIEN, V5; JACOB R, 1988, NATURE, V335, P40, DOI 10.1038/335040a0; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Marhl M, 1997, BIOPHYS CHEM, V63, P221, DOI 10.1016/S0301-4622(96)02248-X; Marsden J.E., 1976, HOPF BIFURCATION ITS, V19; MEAD C, 1990, P IEEE, V78, P1629, DOI 10.1109/5.58356; Mees A.I., 1981, DYNAMICS FEEDBACK SY; Panasonic Industry, 2022, ULTRA LOW POWER BIOE, DOI 10.1017/CBO9780511841446; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Reissig R, 1967, ZAMM-Z ANGEW MATH ME, V4, P480; ROONEY TA, 1990, J BIOL CHEM, V265, P10792; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Serrano-Gotarredona T, 1998, CIRC SYST 1998 ISCAS, V2, P466; Serrano-Gotarredona T, 2003, SOL STAT CIRC C 2003, P627; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Takahashi K, 2002, IEEE INTELL SYST, V17, P64, DOI 10.1109/MIS.2002.1039834; Tenore F, 2004, CIRC SYST 2004 ISCAS, V5, pV; Toth L, 2000, IEEE T CIRCUITS-II, V47, P1365, DOI 10.1109/82.899629; Tsividis Y, 1997, IEEE T CIRCUITS-II, V44, P65, DOI 10.1109/82.554425; Zhang W.L., 2011, SYST BIOL ISB 2011 I, P190, DOI [10.1109/ISB.2011.6033154, DOI 10.1109/ISB.2011.6033154]	45	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e53591	10.1371/journal.pone.0053591	http://dx.doi.org/10.1371/journal.pone.0053591			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393550	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000314692800004
J	Andersson, K; Pokrzywa, M; Dacklin, I; Lundgren, E				Andersson, Karin; Pokrzywa, Malgorzata; Dacklin, Ingrid; Lundgren, Erik			Inhibition of TTR Aggregation-Induced Cell Death-A New Role for Serum Amyloid P Component	PLOS ONE			English	Article							DNA-BINDING PROTEIN; C-REACTIVE PROTEIN; SYSTEMIC AMYLOIDOSIS; ALZHEIMERS-DISEASE; APOPTOTIC CELLS; IN-VITRO; TRANSTHYRETIN; TOXICITY; PEPTIDE; POLYNEUROPATHY	Background: Serum amyloid P component (SAP) is a glycoprotein that is universally found associated with different types of amyloid deposits. It has been suggested that it stabilizes amyloid fibrils and therefore protects them from proteolytic degradation. Methodology/Principal Findings: In this paper, we show that SAP binds not only to mature amyloid fibrils but also to early aggregates of amyloidogenic mutants of the plasma protein transthyretin (TTR). It does not inhibit fibril formation of TTR mutants, which spontaneously form amyloid in vitro at physiological pH. We found that SAP prevents cell death induced by mutant TTR, while several other molecules that are also known to decorate amyloid fibrils do not have such effect. Using a Drosophila model for TTR-associated amyloidosis, we found a new role for SAP as a protective factor in inhibition of TTR-induced toxicity. Overexpression of mutated TTR leads to a neurological phenotype with changes in wing posture. SAP-transgenic flies were crossed with mutated TTR-expressing flies and the results clearly confirmed a protective effect of SAP on TTR-induced phenotype, with an almost complete reduction in abnormal wing posture. Furthermore, we found in vivo that binding of SAP to mutated TTR counteracts the otherwise detrimental effects of aggregation of amyloidogenic TTR on retinal structure. Conclusions/Significance: Together, these two approaches firmly establish the protective effect of SAP on TTR-induced cell death and degenerative phenotypes, and suggest a novel role for SAP through which the toxicity of early amyloidogenic aggregates is attenuated.	[Andersson, Karin; Dacklin, Ingrid; Lundgren, Erik] Umea Univ, Dept Mol Biol, Umea, Sweden; [Pokrzywa, Malgorzata] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden	Umea University; University of Gothenburg	Pokrzywa, M (corresponding author), Univ Gothenburg, Inst Biomed, Gothenburg, Sweden.	malgorzata.pokrzywa@gu.se; Erik.Lundgren@molbiol.umu.se	Pokrzywa, Małgorzata/GQA-6257-2022		European Commission (EURAMY); European Commission (Systemic Amyloidosis Network); Swedish Research Council; Swedish Agency for Animal Protection; Medical Faculty of Umea University; Swedish Society for Medical Research; Lennander Foundation; FAMY patient associations; Amyl Foundation, Norrbotten, Sweden	European Commission (EURAMY)(European CommissionEuropean Commission Joint Research Centre); European Commission (Systemic Amyloidosis Network)(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Agency for Animal Protection; Medical Faculty of Umea University; Swedish Society for Medical Research; Lennander Foundation; FAMY patient associations; Amyl Foundation, Norrbotten, Sweden	This work was supported by grants from the European Commission (EURAMY, Systemic Amyloidosis Network), the Swedish Research Council, the Swedish Agency for Animal Protection, the Medical Faculty of Umea University, the Swedish Society for Medical Research, the Lennander Foundation, the FAMY patient associations, and the Amyl Foundation, Norrbotten, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JK, 1982, ANN NY ACAD SCI, V389, P216, DOI 10.1111/j.1749-6632.1982.tb22139.x; Andersson K, 2002, BIOCHEM BIOPH RES CO, V294, P309, DOI 10.1016/S0006-291X(02)00465-5; Aslund Andreas, 2009, J Chem Biol, V2, P161, DOI 10.1007/s12154-009-0024-8; BARTALENA L, 1993, CLIN LAB MED, V13, P583, DOI 10.1016/S0272-2712(18)30427-X; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Benson MD, 1996, AMYLOID, V3, P44, DOI 10.3109/13506129609014354; Berg I, 2010, NAT PROTOC, V5, P935, DOI 10.1038/nprot.2010.41; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bijl M, 2003, ARTHRITIS RHEUM, V48, P248, DOI 10.1002/art.10737; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BUTLER PJG, 1990, J EXP MED, V172, P13, DOI 10.1084/jem.172.1.13; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Cohen A S, 1993, Curr Opin Rheumatol, V5, P62; Colon W, 1996, CIBA F SYMP, V199, P228; ELLIS MC, 1993, DEVELOPMENT, V119, P855; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Familian A, 2001, J IMMUNOL, V167, P647, DOI 10.4049/jimmunol.167.2.647; Goldsteins G, 1997, BIOCHEMISTRY-US, V36, P5346, DOI 10.1021/bi961649c; Goldsteins G, 1999, P NATL ACAD SCI USA, V96, P3108, DOI 10.1073/pnas.96.6.3108; HAMAZAKI H, 1995, BIOCHEM BIOPH RES CO, V211, P349, DOI 10.1006/bbrc.1995.1819; HAWKINS PN, 1995, EUR J NUCL MED, V22, P595, DOI 10.1007/BF01254559; JANCIAUSKIENE S, 1995, J BIOL CHEM, V270, P26041, DOI 10.1074/jbc.270.44.26041; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Kruman I, 1997, J NEUROSCI, V17, P5089; Lundgren E, 1999, METHOD ENZYMOL, V309, P591; MURAKAMI T, 1992, AM J PATHOL, V141, P451; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Olofsson A, 2002, CLIN CHEM LAB MED, V40, P1266, DOI 10.1515/CCLM.2002.219; Olofsson A, 2001, J BIOL CHEM, V276, P39592, DOI 10.1074/jbc.M103599200; OSMAND AP, 1977, P NATL ACAD SCI USA, V74, P739, DOI 10.1073/pnas.74.2.739; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; PEPYS MB, 1987, BIOCHEM BIOPH RES CO, V148, P308, DOI 10.1016/0006-291X(87)91111-9; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; PITKANEN P, 1984, AM J PATHOL, V117, P391; Pokrzywa M, 2007, EUR J NEUROSCI, V26, P913, DOI 10.1111/j.1460-9568.2007.05728.x; Pokrzywa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014343; Rapezzi C, 2010, NAT REV CARDIOL, V7, P398, DOI 10.1038/nrcardio.2010.67; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Schreiber G, 1997, COMP BIOCHEM PHYS B, V116, P137, DOI 10.1016/S0305-0491(96)00212-X; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; SNOW AD, 1987, LAB INVEST, V56, P120; Soma M, 2001, BIOCHEM BIOPH RES CO, V286, P200, DOI 10.1006/bbrc.2001.5364; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sousa MM, 2002, AM J PATHOL, V161, P1935, DOI 10.1016/S0002-9440(10)64469-0; Sousa MM, 2000, LAB INVEST, V80, P1101, DOI 10.1038/labinvest.3780116; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; SRINIVASAN N, 1994, STRUCTURE, V2, P1017, DOI 10.1016/S0969-2126(94)00105-7; Suhr OB, 2001, SCAND J CLIN LAB INV, V61, P11; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; Veerhuis R, 2003, ACTA NEUROPATHOL, V105, P135, DOI 10.1007/s00401-002-0624-7; Webster S, 1996, J NEUROSCI RES, V46, P58, DOI 10.1002/(SICI)1097-4547(19961001)46:1<58::AID-JNR8>3.0.CO;2-E; Wiseman RL, 2005, BIOCHEMISTRY-US, V44, P16612, DOI 10.1021/bi0511484	61	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55766	10.1371/journal.pone.0055766	http://dx.doi.org/10.1371/journal.pone.0055766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390551	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100067
J	Rodriguez-Jato, S; Shan, JX; Khadake, J; Heggestad, AD; Ma, XJ; Johnstone, KA; Resnick, JL; Yang, TP				Rodriguez-Jato, Sara; Shan, Jixiu; Khadake, Jyoti; Heggestad, Arnold D.; Ma, Xiaojie; Johnstone, Karen A.; Resnick, James L.; Yang, Thomas P.			Regulatory Elements Associated with Paternally-Expressed Genes in the Imprinted Murine Angelman/Prader-Willi Syndrome Domain	PLOS ONE			English	Article							BETA-GLOBIN LOCUS; MAMMALIAN MITOCHONDRIAL BIOGENESIS; TRANSCRIPTION FACTOR GABP; SNRPN MINIMAL PROMOTER; DELETION MOUSE MODEL; PRADER-WILLI; IN-VIVO; CONTROL REGION; CHROMOSOME CONFORMATION; SPATIAL-ORGANIZATION	The Angelman/Prader-Willi syndrome (AS/PWS) domain contains at least 8 imprinted genes regulated by a bipartite imprinting center (IC) associated with the SNRPN gene. One component of the IC, the PWS-IC, governs the paternal epigenotype and expression of paternal genes. The mechanisms by which imprinting and expression of paternal genes within the AS/PWS domain-such as MKRN3 and NDN-are regulated by the PWS-IC are unclear. The syntenic region in the mouse is organized and imprinted similarly to the human domain with the murine PWS-IC defined by a 6 kb interval within the Snrpn locus that includes the promoter. To identify regulatory elements that may mediate PWS-IC function, we mapped the location and allele-specificity of DNase I hypersensitive (DH) sites within the PWS-IC in brain cells, then identified transcription factor binding sites within a subset of these DH sites. Six major paternal-specific DH sites were detected in the Snrpn gene, five of which map within the 6 kb PWS-IC. We postulate these five DH sites represent functional components of the murine PWS-IC. Analysis of transcription factor binding within multiple DH sites detected nuclear respiratory factors (NRF's) and YY1 specifically on the paternal allele. NRF's and YY1 were also detected in the paternal promoter region of the murine Mrkn3 and Ndn genes. These results suggest that NRF's and YY1 may facilitate PWS-IC function and coordinately regulate expression of paternal genes. The presence of NRF's also suggests a link between transcriptional regulation within the AS/PWS domain and regulation of respiration. 3C analyses indicated Mkrn3 lies in close proximity to the PWS-IC on the paternal chromosome, evidence that the PWS-IC functions by allele-specific interaction with its distal target genes. This could occur by allele-specific co-localization of the PWS-IC and its target genes to transcription factories containing NRF's and YY1.	[Rodriguez-Jato, Sara; Shan, Jixiu; Khadake, Jyoti; Heggestad, Arnold D.; Ma, Xiaojie; Yang, Thomas P.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Johnstone, Karen A.; Resnick, James L.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Yang, Thomas P.] Univ Florida, Coll Med, Ctr Epigenet, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Yang, TP (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	tpyang@ufl.edu			National Institutes of Health [HD057026, HD037872]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057026, R01HD037872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health grants HD057026 to TPY and HD037872 JLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARR JA, 1995, MAMM GENOME, V6, P405, DOI 10.1007/BF00355641; Bielinska B, 2000, NAT GENET, V25, P74, DOI 10.1038/75629; Bittel DC, 2007, AM J MED GENET A, V143A, P422, DOI 10.1002/ajmg.a.31504; Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; Buiting K, 1999, HUM GENET, V105, P665, DOI 10.1007/s004390051160; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chen C, 2001, MOL CELL BIOL, V21, P7682, DOI 10.1128/MCB.21.22.7682-7695.2001; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dhar SS, 2009, J BIOL CHEM, V284, P18644, DOI 10.1074/jbc.M109.019976; Do Kim J, 2006, GENOME RES, V16, P901, DOI 10.1101/gr.5091406; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Dubose AJ, 2011, HUM MOL GENET; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Eskiw CH, 2010, COLD SH Q B, V75, P501, DOI 10.1101/sqb.2010.75.046; Finberg YG, 2003, GENE, V304, P201, DOI 10.1016/S0378-1119(02)01212-X; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; Glenn CC, 1996, AM J HUM GENET, V58, P335; Gray TA, 2000, GENOMICS, V66, P76, DOI 10.1006/geno.2000.6199; Greally JM, 1999, P NATL ACAD SCI USA, V96, P14430, DOI 10.1073/pnas.96.25.14430; Hanel ML, 2005, J CELL BIOCHEM, V94, P1046, DOI 10.1002/jcb.20365; Hershko AY, 2001, GENES CELLS, V6, P967, DOI 10.1046/j.1365-2443.2001.00474.x; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; HORNSTRA IK, 1993, ANAL BIOCHEM, V213, P179, DOI 10.1006/abio.1993.1407; HORNSTRA IK, 1993, HUM MOL GENET, V2, P1659; HORNSTRA IK, 1992, MOL CELL BIOL, V12, P5345, DOI 10.1128/MCB.12.12.5345; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Jong MTC, 1999, HUM MOL GENET, V8, P795, DOI 10.1093/hmg/8.5.795; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; Kang SHL, 2003, MOL CELL BIOL, V23, P4150, DOI 10.1128/MCB.23.12.4150-4161.2003; Kantor B, 2004, HUM MOL GENET, V13, P751, DOI 10.1093/hmg/ddh085; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim JD, 2007, GENOMICS, V89, P262, DOI 10.1016/j.ygeno.2006.09.009; LAMARCO KL, 1989, GENE DEV, V3, P1372, DOI 10.1101/gad.3.9.1372; Lau JCY, 2004, NUCLEIC ACIDS RES, V32, P3376, DOI 10.1093/nar/gkh671; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lee S, 2003, GENE EXPR PATTERNS, V3, P599, DOI 10.1016/S1567-133X(03)00113-3; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Murrell A, 2011, BIOCHEM CELL BIOL, V89, P469, DOI [10.1139/o11-043, 10.1139/O11-043]; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; O'Leary DA, 2007, MOL CELL BIOL, V27, P3470, DOI 10.1128/MCB.00659-06; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Perk J, 2002, EMBO J, V21, P5807, DOI 10.1093/emboj/cdf570; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rabinovitz S, 2012, P NATL ACAD SCI US; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Rodriguez-Jato S, 2005, NUCLEIC ACIDS RES, V33, P4740, DOI 10.1093/nar/gki786; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Saitoh S, 2000, AM J HUM GENET, V66, P1958, DOI 10.1086/302917; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schweizer J, 1999, HUM MOL GENET, V8, P555, DOI 10.1093/hmg/8.4.555; Smith EY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002422; Smith KT, 2006, NUCLEIC ACIDS RES, V34, P1205, DOI 10.1093/nar/gkj521; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stefan M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-157; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034348; Xin ZH, 2001, AM J HUM GENET, V69, P1389, DOI 10.1086/324469; Xue HH, 2007, IMMUNITY, V26, P421, DOI 10.1016/j.immuni.2007.03.010; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548	75	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e52390	10.1371/journal.pone.0052390	http://dx.doi.org/10.1371/journal.pone.0052390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390487	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100003
J	Ronholm, J; van Faassen, H; MacKenzie, R; Zhang, ZY; Cao, XD; Lin, M				Ronholm, Jennifer; van Faassen, Henk; MacKenzie, Roger; Zhang, Zhiyi; Cao, Xudong; Lin, Min			Monoclonal Antibodies Recognizing the Surface Autolysin IspC of Listeria monocytogenes Serotype 4b: Epitope Localization, Kinetic Characterization, and Cross-Reaction Studies	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; GRAM-POSITIVE BACTERIA; PEPTIDOGLYCAN HYDROLASE; ESCHERICHIA-COLI; PROTEINS; VIRULENCE; EXPRESSION; CHALLENGE; INFECTION; AFFINITY	Listeria monocytogenes serotype 4b is responsible for a high percentage of fatal cases of food-borne infection. In a previous study, we created 15 monoclonal antibodies (MAbs) against a similar to 77 kDa antigen that is associated with the cell surface of live L. monocytogenes serotype 4b cells. Here we report an extensive characterization of these MAbs to further their development as diagnostic reagents. The similar to 77 kDa target antigen was identified by mass spectrometry and N-terminal sequencing to be IspC, a novel surface associated autolysin. Epitope localization experiments revealed that each of the 15 MAbs recognized the C-terminal cell-wall binding domain of IspC. The presence of IspC was shown to be highly conserved within L. monocytogenes serotype 4b, as evidenced by a strong reaction between anti-IspC MAbs and all 4b isolates. To determine the range of cross-reactivity with other L. monocytogenes serotypes ELISA was used to test each MAb against multiple isolates from each of the L. monocytogenes serotypes. Of the 15 MAbs, five: M2774, M2775, M2780, M2790 and M2797, showed specificity for L. monocytogenes serotype 4b and only cross reacted with serotype 4ab isolates. The kinetics of the interaction between each of the MAbs and IspC was measured using surface plasmon resonance. The MAbs M2773, M2792, M2775, M2797 and M2781 each had very low dissociation constants (4.5 x 10(-9) to 1.2 x 10(-8) M). While several of these antibodies have properties which could be useful in diagnostic tests, the combined high fidelity and affinity of M2775 for the IspC protein and serotype 4b isolates, makes it a particularly promising candidate for use in the development of a specific L. monocytogenes serotype 4b diagnostic test.	[Ronholm, Jennifer; Lin, Min] Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Ottawa, ON, Canada; [Ronholm, Jennifer; Lin, Min] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [van Faassen, Henk; MacKenzie, Roger] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [MacKenzie, Roger] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Zhang, Zhiyi] Natl Res Council Canada, Inst Microstruct Sci, Ottawa, ON, Canada; [Cao, Xudong] Univ Ottawa, Dept Chem & Biol Engn, Ottawa, ON, Canada	Canadian Food Inspection Agency; University of Ottawa; National Research Council Canada; University of Guelph; National Research Council Canada; University of Ottawa	Lin, M (corresponding author), Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Ottawa, ON, Canada.	Min.Lin@inspection.gc.ca	Ronholm, Jennifer/ABD-6240-2020		Canadian Institutes of Health Research (CIHR) through a Banting and Best Doctoral Canadian Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR) through a Banting and Best Doctoral Canadian Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	JR is supported by the Canadian Institutes of Health Research (CIHR) through a Banting and Best Doctoral Canadian Graduate Scholarship (http://www.cihr-irsc.gc.ca/). This study is supported, in part, by a Strategic Grant from Natural Sciences and Engineering Research Council of Canada (NSERC) to XC and ML (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhunia AK, 1997, CRIT REV MICROBIOL, V23, P77, DOI 10.3109/10408419709115131; Donnelly CW, 2001, NUTR REV, V59, P183, DOI 10.1111/j.1753-4887.2001.tb07011.x; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Gerner-Smidt P, 2005, CLIN MICROBIOL INFEC, V11, P618, DOI 10.1111/j.1469-0691.2005.01171.x; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Jung YS, 2003, J FOOD PROTECT, V66, P1283, DOI 10.4315/0362-028X-66.7.1283; KATHARIOU S, 1994, APPL ENVIRON MICROB, V60, P3548, DOI 10.1128/AEM.60.10.3548-3552.1994; Kerdahi KF, 2000, J AOAC INT, V83, P86; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li GX, 2010, HYBRIDOMA, V29, P283, DOI 10.1089/hyb.2010.0021; Lin M, 2006, J MED MICROBIOL, V55, P291, DOI 10.1099/jmm.0.46305-0; Lin M, 2009, J APPL MICROBIOL, V106, P1705, DOI 10.1111/j.1365-2672.2008.04140.x; Makino S, 1998, MICROB PATHOGENESIS, V25, P101, DOI 10.1006/mpat.1998.0216; Milohanic E, 2004, INFECT IMMUN, V72, P4401, DOI 10.1128/IAI.72.8.4401-4409.2004; Monte LG, 2011, COMP IMMUNOL MICROB, V34, P441, DOI 10.1016/j.cimid.2011.08.003; NIMMO GR, 1984, J IMMUNOL METHODS, V72, P177, DOI 10.1016/0022-1759(84)90446-0; Norton DM, 2002, J AOAC INT, V85, P505; Nuttall SD, 2011, PROTEINS, V79, P1306, DOI 10.1002/prot.22971; Paton JC, 1998, TRENDS MICROBIOL, V6, P85, DOI 10.1016/S0966-842X(98)01220-7; Ralovich B., 1993, Acta Microbiologica Hungarica, V40, P3; Ronholm J, 2012, APPL ENVIRON MICROB, V78, P7833, DOI 10.1128/AEM.02065-12; Ronholm J, 2012, GLYCOBIOLOGY, V22, P1311, DOI 10.1093/glycob/cws100; Sambrook J. G., 2001, MOL CLONING LAB MANU; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Seeliger H.P.R., 1986, BERGEYS MANUAL SYSTE, P1235; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Van Blarcom TJ, 2010, GENE THER, V17, P913, DOI 10.1038/gt.2010.42; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wang LR, 2008, MICROBIOL-SGM, V154, P1900, DOI 10.1099/mic.0.2007/015172-0; Wang LR, 2007, J BACTERIOL, V189, P2046, DOI 10.1128/JB.01375-06; Wang L, 2007, BIOCHEM BIOPH RES CO, V354, P403, DOI 10.1016/j.bbrc.2006.12.218; Yu WL, 2007, J MED MICROBIOL, V56, P888, DOI 10.1099/jmm.0.46977-0	33	11	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55098	10.1371/journal.pone.0055098	http://dx.doi.org/10.1371/journal.pone.0055098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390515	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100031
J	Storm, P; Tibiletti, T; Hall, M; Funk, C				Storm, Patrik; Tibiletti, Tania; Hall, Michael; Funk, Christiane			Refolding and Enzyme Kinetic Studies on the Ferrochelatase of the Cyanobacterium Synechocystis sp. PCC 6803	PLOS ONE			English	Article							CAB-LIKE-PROTEINS; TETRAPYRROLE BIOSYNTHESIS; SUBCELLULAR-LOCALIZATION; CHLOROPHYLL SYNTHESIS; GENE-EXPRESSION; SP PCC-6803; METAL-ION; ARABIDOPSIS; HEME; PATHWAY	Heme is a cofactor for proteins participating in many important cellular processes, including respiration, oxygen metabolism and oxygen binding. The key enzyme in the heme biosynthesis pathway is ferrochelatase (protohaem ferrolyase, EC 4.99.1.1), which catalyzes the insertion of ferrous iron into protoporphyrin IX. In higher plants, the ferrochelatase enzyme is localized not only in mitochondria, but also in chloroplasts. The plastidic type II ferrochelatase contains a C-terminal chlorophyll a/b (CAB) motif, a conserved hydrophobic stretch homologous to the CAB domain of plant light harvesting proteins and light-harvesting like proteins. This type II ferrochelatase, found in all photosynthetic organisms, is presumed to have evolved from the cyanobacterial ferrochelatase. Here we describe a detailed enzymological study on recombinant, refolded and functionally active type II ferrochelatase (FeCh) from the cyanobacterium Synechocystis sp. PCC 6803. A protocol was developed for the functional refolding and purification of the recombinant enzyme from inclusion bodies, without truncation products or soluble aggregates. The refolded FeCh is active in its monomeric form, however, addition of an N-terminal His(6)-tag has significant effects on its enzyme kinetics. Strikingly, removal of the C-terminal CAB-domain led to a greatly increased turnover number, k(cat), compared to the full length protein. While pigments isolated from photosynthetic membranes decrease the activity of FeCh, direct pigment binding to the CAB domain of FeCh was not evident.	[Funk, Christiane] Umea Univ, Deptartment Chem, Umea, Sweden; Umea Univ, Umea Plant Sci Ctr, Umea, Sweden	Umea University; Umea University	Funk, C (corresponding author), Umea Univ, Deptartment Chem, Umea, Sweden.	Christiane.Funk@chem.umu.se	Funk, Christiane/AAO-6041-2021	Funk, Christiane/0000-0002-7897-4038; Tibiletti, Tania/0000-0002-1875-798X	Swedish Energy Agency; Umea University	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Umea University	The authors are thankful to the Royal Swedish Academy (to C.F.) and the Kempe foundation (to P.S.) for granting their positions. The work was supported by the Swedish Energy Agency and Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS A, 1993, J BIOL CHEM, V268, P8541; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; CAMADRO JM, 1988, J BIOL CHEM, V263, P11675; CASTELFRANCO PA, 1975, PLANT PHYSIOL, V55, P485, DOI 10.1104/pp.55.3.485; Chow KS, 1997, J BIOL CHEM, V272, P27565, DOI 10.1074/jbc.272.44.27565; Chow KS, 1998, PLANT J, V15, P531, DOI 10.1046/j.1365-313X.1998.00235.x; Cornah JE, 2002, BIOCHEM J, V362, P423, DOI 10.1042/0264-6021:3620423; Dailey HA, 2002, BIOCHEM SOC T, V30, P590, DOI 10.1042/bst0300590; Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672; Dupuy C, 1997, LANGMUIR, V13, P3965, DOI 10.1021/la9604285; Evers TH, 2008, PROTEIN ENG DES SEL, V21, P529, DOI 10.1093/protein/gzn029; Falk JE, 1964, PORPHYRINS METALLOPO, P236; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; Hansson MD, 2007, BIOCHEMISTRY-US, V46, P87, DOI 10.1021/bi061760a; Hansson MD, 2006, J BIOL INORG CHEM, V11, P325, DOI 10.1007/s00775-006-0080-2; Hernandez-Prieto MA, 2011, BBA-BIOENERGETICS, V1807, P1143, DOI 10.1016/j.bbabio.2011.05.002; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Hunter GA, 2008, J BIOL CHEM, V283, P23685, DOI 10.1074/jbc.M803372200; Iyer JK, 2003, MOL MED, V9, P175, DOI 10.1007/BF03402182; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Lipfert J, 2007, J PHYS CHEM B, V111, P12427, DOI 10.1021/jp073016l; Lister R, 2001, FEBS LETT, V506, P291, DOI 10.1016/S0014-5793(01)02925-8; Masuda T, 2003, PLANTA, V217, P602, DOI 10.1007/s00425-003-1019-2; Matsumoto F, 2004, PLANT PHYSIOL, V135, P2379, DOI 10.1104/pp.104.042408; Moulin M, 2005, BIOCHEM SOC T, V33, P737, DOI 10.1042/BST0330737; Papenbrock J, 1999, PLANTA, V208, P264, DOI 10.1007/s004250050558; Shi Z, 2004, J BIOL CHEM, V279, P19977, DOI 10.1074/jbc.M313821200; Shi Z, 2003, ANAL BIOCHEM, V318, P18, DOI 10.1016/S0003-2697(03)00175-1; Singh DP, 2002, PLANT MOL BIOL, V50, P773, DOI 10.1023/A:1019959224271; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; Sobotka R, 2011, PLANT PHYSIOL, V155, P1735, DOI 10.1104/pp.110.167528; Stephenson PG, 2008, PHOTOCH PHOTOBIO SCI, V7, P1243, DOI 10.1039/b802596g; Storm P, 2008, PHOTOSYNTH RES, V98, P479, DOI 10.1007/s11120-008-9368-0; Suzuki T, 2002, J BIOL CHEM, V277, P4731, DOI 10.1074/jbc.M105613200; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; van Lis R, 2005, PLANT PHYSIOL, V139, P1946, DOI 10.1104/pp.105.069732; Vavilin DV, 2002, PHYSIOL PLANTARUM, V115, P9, DOI 10.1034/j.1399-3054.2002.1150102.x; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Xu H, 2002, PLANT MOL BIOL, V49, P149, DOI 10.1023/A:1014900806905; Yao DCI, 2012, J BIOL CHEM, V287, P682, DOI 10.1074/jbc.M111.320994	42	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55569	10.1371/journal.pone.0055569	http://dx.doi.org/10.1371/journal.pone.0055569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390541	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100057
J	Park, JW; Piknova, B; Huang, PL; Noguchi, CT; Schechter, AN				Park, Ji Won; Piknova, Barbora; Huang, Paul L.; Noguchi, Constance T.; Schechter, Alan N.			Effect of Blood Nitrite and Nitrate Levels on Murine Platelet Function	PLOS ONE			English	Article							OXIDE SYNTHASE; XANTHINE OXIDOREDUCTASE; DIETARY NITRATE; HYPOXIC CONDITIONS; RELAXING FACTOR; REDUCTION; ENDOTHELIUM; AGGREGATION; HUMANS; MICE	Nitric oxide (NO) appears to play an important role in the regulation of thrombosis and hemostasis by inhibiting platelet function. The discovery of NO generation by reduction of nitrite (NO2-) and nitrate (NO3-) in mammals has led to increased attention to these anions with respect to potential beneficial effects in cardiovascular diseases. We have previously shown that nitrite anions at 0.1 mu M inhibit aggregation and activation of human platelet preparations in vitro in the presence of red blood cells and this effect was enhanced by deoxygenation, an effect likely due to NO generation. In the present study, we hypothesized that nitrite and nitrate derived from the diet could also alter platelet function upon their conversion to NO in vivo. To manipulate the levels of nitrite and nitrate in mouse blood, we used antibiotics, NOS inhibitors, low nitrite/nitrate (NOx) diets, endothelial NOS knock-out mice and also supplementation with high levels of nitrite or nitrate in the drinking water. We found that all of these perturbations affected nitrite and nitrate levels but that the lowest whole blood values were obtained by dietary restriction. Platelet aggregation and ATP release were measured in whole blood and the results show an inverse correlation between nitrite/nitrate levels and platelet activity in aggregation and ATP release. Furthermore, we demonstrated that nitrite-supplemented group has a prolonged bleeding time compared with control or low NOx diet group. These results show that diet restriction contributes greatly to blood nitrite and nitrate levels and that platelet reactivity can be significantly affected by these manipulations. Our study suggests that endogenous levels of nitrite and nitrate may be used as a biomarker for predicting platelet function and that dietary manipulation may affect thrombotic processes.	[Park, Ji Won; Piknova, Barbora; Noguchi, Constance T.; Schechter, Alan N.] NIDDKD, Mol Med Branch, NIH, Bethesda, MD 20892 USA; [Huang, Paul L.] Massachusetts Gen Hosp, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Massachusetts General Hospital	Schechter, AN (corresponding author), NIDDKD, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	alans@intra.niddk.nih.gov		Schechter, Alan N/0000-0002-5235-9408; Huang, Paul/0000-0002-5436-8658	National Institue of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025093, ZIADK025104, ZIADK025061, ZIADK025021] Funding Source: NIH RePORTER	National Institue of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the intramural program of the National Institue of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHEID U, 1987, THROMB RES, V47, P561, DOI 10.1016/0049-3848(87)90361-6; AZUMA H, 1986, BRIT J PHARMACOL, V88, P411, DOI 10.1111/j.1476-5381.1986.tb10218.x; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Bryan NS, 2008, FREE RADICAL BIO MED, V45, P468, DOI 10.1016/j.freeradbiomed.2008.04.040; Bryan NS, 2007, P NATL ACAD SCI USA, V104, P19144, DOI 10.1073/pnas.0706579104; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; BULT H, 1988, BRIT J PHARMACOL, V95, P1308, DOI 10.1111/j.1476-5381.1988.tb11769.x; Carlsson S, 2001, NITRIC OXIDE-BIOL CH, V5, P580, DOI 10.1006/niox.2001.0371; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Freedman JE, 1999, CIRC RES, V84, P1416; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; Govoni M, 2008, NITRIC OXIDE-BIOL CH, V19, P333, DOI 10.1016/j.niox.2008.08.003; Huang LY, 2010, NITRIC OXIDE-BIOL CH, V22, P191, DOI 10.1016/j.niox.2010.01.004; Jansson EA, 2008, NAT CHEM BIOL, V4, P411, DOI 10.1038/nchembio.92; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; LUNDBERG JON, 1994, GUT, V35, P1543, DOI 10.1136/gut.35.11.1543; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2010, BIOCHEM BIOPH RES CO, V396, P39, DOI 10.1016/j.bbrc.2010.02.136; Lundberg JO, 2010, NITRIC OXIDE-BIOL CH, V22, P61, DOI 10.1016/j.niox.2009.11.004; Machha A, 2011, EUR J NUTR, V50, P293, DOI 10.1007/s00394-011-0192-5; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Milsom AB, 2012, ANTIOXID REDOX SIGN, V17, P422, DOI 10.1089/ars.2011.4156; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Naseem KM, 2011, PLATELETS, V22, P148, DOI 10.3109/09537104.2010.522629; Raat NJH, 2009, FREE RADICAL BIO MED, V47, P510, DOI 10.1016/j.freeradbiomed.2009.05.015; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Richardson G, 2002, NITRIC OXIDE-BIOL CH, V7, P24, DOI 10.1016/S1089-8603(02)00010-1; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Srihirun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030380; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Tymvios C, 2009, BRIT J PHARMACOL, V158, P1735, DOI 10.1111/j.1476-5381.2009.00408.x; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Weitzberg E, 1998, NITRIC OXIDE-BIOL CH, V2, P1, DOI 10.1006/niox.1997.0162; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Zhang Zhi, 1997, Biochemical Society Transactions, V25, p524S; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3	42	52	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55699	10.1371/journal.pone.0055699	http://dx.doi.org/10.1371/journal.pone.0055699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383344	Green Submitted, gold, Green Published			2022-12-25	WOS:000314597900051
J	Varghese, B; Supply, P; Allix-Beguec, C; Shoukri, M; Al-Omari, R; Herbawi, M; Al-Hajoj, S				Varghese, Bright; Supply, Philip; Allix-Beguec, Caroline; Shoukri, Mohammed; Al-Omari, Ruba; Herbawi, Mais; Al-Hajoj, Sahal			Admixed Phylogenetic Distribution of Drug Resistant Mycobacterium tuberculosis in Saudi Arabia	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; BEIJING GENOTYPE; HAJJ PILGRIMAGE; MIRU-VNTRPLUS; STRAINS; INFECTION; PATTERNS; IDENTIFICATION; IMMIGRATION; DIVERSITY	Background: The phylogeographical structure of Mycobacterium tuberculosis is generally bimodal in low tuberculosis (TB) incidence countries, where genetic lineages of the isolates generally differ with little strain clustering between autochthonous and foreign-born TB patients. However, less is known on this structure in Saudi Arabia-the most important hub of human migration as it hosts a total population of expatriates and pilgrims from all over the world which is equal to that of its citizens. Methodology: We explored the mycobacterial phylogenetic structure and strain molecular clustering in Saudi Arabia by genotyping 322 drug-resistant clinical isolates collected over a 12-month period in a national drug surveillance survey, using 24 locus-based MIRU-VNTR typing and spoligotyping. Principal Findings: In contrast to the cosmopolitan population of the country, almost all the known phylogeographic lineages of M. tuberculosis complex (with noticeable exception of Mycobacterium africanum/West-African 1 and 2) were detected, with Delhi/CAS (21.1%), EAI (11.2%), Beijing (11.2%) and main branches of the Euro-American super-lineage such as Ghana (14.9%), Haarlem (10.6%) and Cameroon (7.8%) being represented. Statistically significant associations of strain lineages were observed with poly-drug resistance and multi drug resistance especially among previously treated cases (p value of < = 0.001 for both types of resistance), with relative over-representation of Beijing strains in the latter category. However, there was no significant difference among Saudi and non-Saudi TB patients regarding distribution of phylogenetic lineages (p = 0.311). Moreover, 59.5% (22/37) of the strain molecular clusters were shared between the Saudi born and immigrant TB patients. Conclusions: Specific distribution of M. tuberculosis phylogeographic lineages is not observed between the autochthonous and foreign-born populations. These observations might reflect both socially favored ongoing TB transmission between the two population groups, and historically deep-rooted, prolonged contacts and trade relations of the peninsula with other world regions. More vigorous surveillance and strict adherence to tuberculosis control policies are urgently needed in the country.	[Varghese, Bright; Al-Omari, Ruba; Herbawi, Mais; Al-Hajoj, Sahal] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Supply, Philip; Allix-Beguec, Caroline] Genoscreen, Lille, France; [Supply, Philip] INSERM, U1019, F-59045 Lille, France; [Supply, Philip] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Supply, Philip] Ctr Infect & Immun Lille, Inst Pasteur Lille, Lille, France; [Supply, Philip] Univ Lille Nord France, Lille, France; [Shoukri, Mohammed] King Faisal Specialist Hosp & Res Ctr, Natl Biotechnol Ctr, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; King Faisal Specialist Hospital & Research Center	Al-Hajoj, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia.	hajoj@kfshrc.edu.sa	Allix-Béguec, Caroline/AAI-4645-2021; Supply, Philip/A-9580-2019	Allix-Béguec, Caroline/0000-0001-7642-4844; Supply, Philip/0000-0003-3690-3853	Institute (King Faisal Specialist Hospital and Research Center) [RAC 2030017]	Institute (King Faisal Specialist Hospital and Research Center)	The authors received no current external funding sources for this study. This study was supported by the authors' Institute (King Faisal Specialist Hospital and Research Center) under project: RAC #2030017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, as the authors received an institutional fund.	Abouzeid MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039478; Al-Hajoj SAM, 2007, J CLIN MICROBIOL, V45, P2467, DOI 10.1128/JCM.02293-06; Al-Jasser FS, 2012, SAUDI MED J, V33, P879; Allix-Beguec C, 2008, EUR RESPIR J, V31, P1077, DOI 10.1183/09031936.00053307; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Alothman AF, 2011, BMC P S6, V5, P252, DOI 10,1186/1753-6561-5-S6-P252; Alrabiaah AA, 2012, ANN SAUDI MED, V32, P4, DOI 10.5144/0256-4947.2012.4; Alzeer A, 1998, J INFECTION, V36, P303, DOI 10.1016/S0163-4453(98)94315-8; Alzeer AH, 2009, ANN THORAC MED, V4, P50, DOI 10.4103/1817-1737.49412; [Anonymous], 2009, GUID SURV DRUG RES T; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Arora J, 2009, INFECT GENET EVOL, V9, P832, DOI 10.1016/j.meegid.2009.05.008; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Curtin P., 1984, CROSS CULTURAL TRADE; Dale JW, 1999, J CLIN MICROBIOL, V37, P1265, DOI 10.1128/JCM.37.5.1265-1268.1999; Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garzelli C, 2010, CLIN MICROBIOL INFEC, V16, P1691, DOI [10.1111/j.1469-0691.2009.03149.x, 10.1111/j.1469-0691.2010.03149.x]; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Mandourah Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-117; Omran A R, 1993, Popul Today, V21, P1; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Parwati I, 2010, J INFECT DIS, V201, P553, DOI 10.1086/650311; Rajapaksa US, 2008, T ROY SOC TROP MED H, V102, P997, DOI 10.1016/j.trstmh.2008.04.025; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Ritz N, 2009, ANTIMICROB AGENTS CH, V53, P316, DOI 10.1128/AAC.01302-08; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tanveer M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-171; Weniger T, 2012, INFECT GENET EVOL, V12, P748, DOI 10.1016/j.meegid.2012.01.021; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2011, WHO GLOBAL TUBERCULO; Wilder-Smith A, 2005, TROP MED INT HEALTH, V10, P336, DOI 10.1111/j.1365-3156.2005.01395.x	40	20	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55598	10.1371/journal.pone.0055598	http://dx.doi.org/10.1371/journal.pone.0055598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383340	Green Submitted, Green Published, gold			2022-12-25	WOS:000314597900047
J	Teraa, M; Sprengers, RW; Westerweel, PE; Gremmels, H; Goumans, MJTH; Teerlink, T; Moll, FL; Verhaar, MC				Teraa, Martin; Sprengers, Ralf W.; Westerweel, Peter E.; Gremmels, Hendrik; Goumans, Marie-Jose T. H.; Teerlink, Tom; Moll, Frans L.; Verhaar, Marianne C.		JUVENTAS Study Grp	Bone Marrow Alterations and Lower Endothelial Progenitor Cell Numbers in Critical Limb Ischemia Patients	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ASYMMETRIC DIMETHYLARGININE; INDUCED NEOVASCULARIZATION; THERAPEUTIC IMPLICATIONS; RHEUMATOID-ARTHRITIS; MONONUCLEAR-CELLS; RISK-FACTORS; T-CELLS; MOBILIZATION; DISEASE	Background: Critical limb ischemia (CLI) is characterized by lower extremity artery obstruction and a largely unexplained impaired ischemic neovascularization response. Bone marrow (BM) derived endothelial progenitor cells (EPC) contribute to neovascularization. We hypothesize that reduced levels and function of circulating progenitor cells and alterations in the BM contribute to impaired neovascularization in CLI. Methods: Levels of primitive (CD34(+) and CD133(+)) progenitors and CD34(+) KDR+ EPC were analyzed using flow cytometry in blood and BM from 101 CLI patients in the JUVENTAS-trial (NCT00371371) and healthy controls. Blood levels of markers for endothelial injury (sE-selectin, sICAM-1, sVCAM-1, and thrombomodulin), and progenitor cell mobilizing and inflammatory factors were assessed by conventional and multiplex ELISA. BM levels and activity of the EPC mobilizing protease MMP-9 were assessed by ELISA and zymography. Circulating angiogenic cells (CAC) were cultured and their paracrine function was assessed. Results: Endothelial injury markers were higher in CLI (P<0.01). CLI patients had higher levels of VEGF, SDF-1 alpha, SCF, G-CSF (P<0.05) and of IL-6, IL-8 and IP-10 (P<0.05). Circulating EPC and BM CD34(+) cells (P<0.05), lymphocytic expression of CXCR4 and CD26 in BM (P<0.05), and BM levels and activity of MMP-9 (P<0.01) were lower in CLI. Multivariate regression analysis showed an inverse association between IL-6 and BM CD34(+) cell levels (P = 0.007). CAC from CLI patients had reduced paracrine function (P<0.0001). Conclusion: CLI patients have reduced levels of circulating EPC, despite profound endothelial injury and an EPC mobilizing response. Moreover, CLI patients have lower BM CD34(+)-cell levels, which were inversely associated with the inflammatory marker IL-6, and lower BM MMP-9 levels and activity. The results of this study suggest that inflammation-induced BM exhaustion and a disturbed progenitor cell mobilization response due to reduced levels and activity of MMP-9 in the BM and alterations in the SDF-1 alpha/CXCR4 interaction contribute to the attenuated neovascularization in CLI patients.	[Teraa, Martin; Gremmels, Hendrik; Verhaar, Marianne C.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Teraa, Martin; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Sprengers, Ralf W.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Westerweel, Peter E.] Univ Med Ctr Utrecht, Dept Haematol, Utrecht, Netherlands; [Goumans, Marie-Jose T. H.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Teerlink, Tom] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Verhaar, MC (corresponding author), Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands.	m.c.verhaar@umcutrecht.nl	Goumans, Marie-José/AAG-4994-2021; Goumans, Marie Jose/U-1455-2019; Verhaar, Marianne/AAM-6788-2020; Gremmels, Hendrik/G-3185-2012; Teraa, Martin/A-2508-2012; Mali, Willem PThM/I-1123-2014; Stefanadis, Christodoulos/ABH-2232-2020	Goumans, Marie Jose/0000-0001-9344-6746; Verhaar, Marianne/0000-0002-3276-6428; Gremmels, Hendrik/0000-0002-7818-620X; Teraa, Martin/0000-0002-6751-6752; Mali, Willem PThM/0000-0003-4391-0904; Stefanadis, Christodoulos/0000-0001-5974-6454	"Stichting Vrienden UMC Utrecht" of Dirkzwager-Assink foundation (The Netherlands) [CS 06.007]; Dutch Heart Foundation (The Netherlands) [2008B094]; the Netherlands Organisation for Scientific Research (The Netherlands) [116001026]; foundation "De Drie Lichten" (The Netherlands) [10/06]; the Netherlands Organisation for Scientific Research (NWO) (The Netherlands) [016.096.359]	"Stichting Vrienden UMC Utrecht" of Dirkzwager-Assink foundation (The Netherlands)(Netherlands Government); Dutch Heart Foundation (The Netherlands)(Netherlands Heart FoundationNetherlands Government); the Netherlands Organisation for Scientific Research (The Netherlands); foundation "De Drie Lichten" (The Netherlands)(Netherlands Government); the Netherlands Organisation for Scientific Research (NWO) (The Netherlands)	The reported work was supported by the "Stichting Vrienden UMC Utrecht" on behalf of the Dirkzwager-Assink foundation (The Netherlands, grant CS 06.007, www.vriendenumcutrecht.nl), The Dutch Heart Foundation (The Netherlands, grant 2008B094, www.hartstichting.nl), the Netherlands Organisation for Scientific Research (The Netherlands, ZonMw-TAS grant 116001026, www.zonmw.nl) and foundation "De Drie Lichten" (The Netherlands, grant 10/06). M.C. Verhaar is supported by the Netherlands Organisation for Scientific Research (NWO) (The Netherlands, Vidi grant 016.096.359, www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Belotti D, 2008, MOL CANCER RES, V6, P525, DOI 10.1158/1541-7786.MCR-07-0366; Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714, DOI 10.1160/TH07-01-0036; Chen MC, 2009, DIABETIC MED, V26, P134, DOI 10.1111/j.1464-5491.2008.02649.x; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Christopherson KW, 2003, BLOOD, V101, P4680, DOI 10.1182/blood-2002-12-3893; Cobellis G, 2010, CELL TRANSPLANT, V19, P1425, DOI 10.3727/096368910X509068; de Jong S, 2006, ANAL BIOCHEM, V353, P287, DOI 10.1016/j.ab.2006.03.010; de Kleijn DPV, 2001, FEBS LETT, V501, P37, DOI 10.1016/S0014-5793(01)02622-9; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fox A, 2008, BRIT J SURG, V95, P244, DOI 10.1002/bjs.5913; Grisar J, 2007, ANN RHEUM DIS, V66, P1284, DOI 10.1136/ard.2006.066605; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Herder C, 2011, ATHEROSCLEROSIS, V216, P244, DOI 10.1016/j.atherosclerosis.2011.01.041; Hirata Y, 2010, INT HEART J, V51, P1, DOI 10.1536/ihj.51.1; Hirsch AT, 2001, VASC MED, V6, P87, DOI 10.1191/135886301701568756; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Hung HS, 2009, CELL TRANSPLANT, V18, P1003, DOI 10.3727/096368909X12483162196683; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Iyer V, 2012, CANCER RES, V72, P2705, DOI 10.1158/0008-5472.CAN-11-3287; Jie KE, 2010, NEPHROL DIAL TRANSPL, V25, P1875, DOI 10.1093/ndt/gfp749; Kissel CK, 2007, J AM COLL CARDIOL, V49, P2341, DOI 10.1016/j.jacc.2007.01.095; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Morishita T, 2012, J ATHEROSCLER THROMB, V19, P149, DOI 10.5551/jat.10074; Nikolaisen C, 2008, J RHEUMATOL, V35, P380; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Oda M, 2012, HEART VESSELS, V27, P38, DOI 10.1007/s00380-011-0125-5; Palombo C, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-88; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286; Scheubel RJ, 2010, INT J CARDIOL, V139, P134, DOI 10.1016/j.ijcard.2008.10.009; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Sprengers RW, 2010, J VASC SURG, V51, P1564, DOI 10.1016/j.jvs.2010.02.020; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; Tousoulis D, 2008, ATHEROSCLEROSIS, V201, P236, DOI 10.1016/j.atherosclerosis.2008.05.034; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P2310, DOI 10.1161/ATVBAHA.107.151407; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang CH, 2008, AM J PHYSIOL-REG I, V294, pR811, DOI 10.1152/ajpregu.00543.2007; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Westerweel PE, 2007, ANN RHEUM DIS, V66, P865, DOI 10.1136/ard.2006.065631; Zhu JH, 2008, RESP MED, V102, P1073, DOI 10.1016/j.rmed.2007.12.030	52	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55592	10.1371/journal.pone.0055592	http://dx.doi.org/10.1371/journal.pone.0055592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383236	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600131
J	dos Santos, MG; Muxel, SM; Zampieri, RA; Pomorski, TG; Floeter-Winter, LM				dos Santos, Marcos Gonzaga; Muxel, Sandra Marcia; Zampieri, Ricardo Andrade; Pomorski, Thomas Gunther; Floeter-Winter, Lucile Maria			Transbilayer Dynamics of Phospholipids in the Plasma Membrane of the Leishmania Genus	PLOS ONE			English	Article							MILTEFOSINE TRANSPORTER; DRUG-RESISTANCE; LIPID MOVEMENT; PHOSPHATIDYLSERINE; PROMASTIGOTES; TRANSLOCATION; DONOVANI; OVEREXPRESSION; TRAFFICKING; ASYMMETRY	Protozoans of the Leishmania genus are the etiological agents of a wide spectrum of diseases commonly known as leishmaniases. Lipid organization of the plasma membrane of the parasite may mimic the lipid organization of mammalian apoptotic cells and play a role in phagocytosis and parasite survival in the mammal host. Here, we analyzed the phospholipid dynamics in the plasma membrane of both the L. (Leishmania) and the L. (Viannia) subgenera. We found that the activity and substrate specificity of the inward translocation machinery varied between Leishmania species. The differences in activity of inward phospholipid transport correlated with the different sensitivities of the various species towards the alkyl-phospholipid analogue miltefosine. Furthermore, all species exhibited a phospholipid scramblase activity in their plasma membranes upon stimulation with calcium ionophores. However, binding of annexin V to the parasite surface was only detected for a subpopulation of parasites during the stationary growth phase and only marginally enhanced by scramblase activation.	[dos Santos, Marcos Gonzaga; Muxel, Sandra Marcia; Zampieri, Ricardo Andrade; Floeter-Winter, Lucile Maria] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil; [Pomorski, Thomas Gunther] Univ Copenhagen, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Dept Plant Biol & Biotechnol, Frederiksberg, Denmark	Universidade de Sao Paulo; Danmarks Grundforskningsfond; University of Copenhagen	Pomorski, TG (corresponding author), Univ Copenhagen, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Dept Plant Biol & Biotechnol, Frederiksberg, Denmark.	tgp@life.ku.dk; lucile@ib.usp.br	Floeter-Winter, Lucile Maria/K-2618-2012; Zampieri, Ricardo/D-3706-2018; Floeter-Winter, Lucile Maria/AAE-7629-2019; Muxel, Sandra/F-7464-2012; Santos, Marcos/E-1993-2013; Pomorski, Thomas Günther/G-4804-2014	Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Muxel, Sandra/0000-0003-0118-5361; Pomorski, Thomas Günther/0000-0002-4889-0829	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Carlsberg Foundation; Deutsche Forschungsgemeinschaft	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlsberg Foundation(Carlsberg Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Carlsberg Foundation (TGP) and the Deutsche Forschungsgemeinschaft (TGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Araujo-Santos JM, 2005, BIOCHEM BIOPH RES CO, V330, P349, DOI 10.1016/j.bbrc.2005.02.176; Araujo-Santos JM, 2003, BIOCHEM BIOPH RES CO, V306, P250, DOI 10.1016/S0006-291X(03)00947-1; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Castanys-Munoz E, 2008, ANTIMICROB AGENTS CH, V52, P3573, DOI 10.1128/AAC.00587-08; Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; CRONIN T M, 1987, Paleontological Society Memoir, P1; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Farias LH, 2012, J INFECT DIS; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; HOWARD MK, 1991, T ROY SOC TROP MED H, V85, P477, DOI 10.1016/0035-9203(91)90226-O; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Parodi-Talice A, 2003, BBA-BIOMEMBRANES, V1612, P195, DOI 10.1016/S0005-2736(03)00131-7; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Perez-Victoria FJ, 2003, J BIOL CHEM, V278, P49965, DOI 10.1074/jbc.M308352200; Saraiva EM, 2005, EXP PARASITOL, V110, P39, DOI 10.1016/j.exppara.2005.01.004; Sims PJ, 2001, THROMB HAEMOSTASIS, V86, P266; SMEETS EF, 1994, BBA-BIOMEMBRANES, V1195, P281, DOI 10.1016/0005-2736(94)90268-2; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Tripathi A, 2003, MOL BIOCHEM PARASIT, V128, P1, DOI 10.1016/S0166-6851(03)00024-0; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Weingartner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042070; Weingartner A, 2011, MOL BIOCHEM PARASIT, V179, P59, DOI 10.1016/j.molbiopara.2011.05.006; Weingartner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012443; Weingartner A, 2011, MOL BIOCH PARASITOL; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565; Zheng LA, 2010, RAPID COMMUN MASS SP, V24, P2074, DOI 10.1002/rcm.4618; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55604	10.1371/journal.pone.0055604	http://dx.doi.org/10.1371/journal.pone.0055604			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383240	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800174
J	Tripp, EA; Fatimah, S; Darbyshire, I; McDade, LA				Tripp, Erin A.; Fatimah, Siti; Darbyshire, Iain; McDade, Lucinda A.			Origin of African Physacanthus (Acanthaceae) via Wide Hybridization	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; CYTOPLASMIC INHERITANCE; SENECIO-VULGARIS; GENE-TRANSFER; SEQUENCE DATA; DNA; RECOMBINATION; HYBRID; HETEROPLASMY; MECHANISMS	Gene flow between closely related species is a frequent phenomenon that is known to play important roles in organismal evolution. Less clear, however, is the importance of hybridization between distant relatives. We present molecular and morphological evidence that support origin of the plant genus Physacanthus via ``wide hybridization'' between members of two distantly related lineages in the large family Acanthaceae. These two lineages are well characterized by very different morphologies yet, remarkably, Physacanthus shares features of both. Chloroplast sequences from six loci indicate that all three species of Physacanthus contain haplotypes from both lineages, suggesting that heteroplasmy likely predated speciation in the genus. Although heteroplasmy is thought to be unstable and thus transient, multiple haplotypes have been maintained through time in Physacanthus. The most likely scenario to explain these data is that Physacanthus originated via an ancient hybridization event that involved phylogenetically distant parents. This wide hybridization has resulted in the establishment of an independently evolving clade of flowering plants.	[Tripp, Erin A.; Fatimah, Siti; McDade, Lucinda A.] Rancho Santa Ana Bot Garden, Claremont, CA USA; [Tripp, Erin A.] Univ Colorado, Boulder, CO 80309 USA; [Tripp, Erin A.] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Darbyshire, Iain] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Royal Botanic Gardens, Kew	Tripp, EA (corresponding author), Rancho Santa Ana Bot Garden, Claremont, CA USA.	erin.tripp@colorado.edu	Isa, Siti Fatimah Md/P-1483-2018	Isa, Siti Fatimah Md/0000-0002-6334-8915; TRIPP, ERIN/0000-0001-9340-8723	United States National Science Foundation [DEB-0919594]	United States National Science Foundation(National Science Foundation (NSF))	Financial support was provided by a United States National Science Foundation grant to EAT & LAM (DEB-0919594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 1984, P1; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Anderson E., 1949, INTROGRESSIVE HYBRID; Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; BREMEKAMP C. E. B., 1965, BULL BOT SURV INDIA, V7, P21; Cidade FW, 2010, AM J BOT, V97, pE107, DOI 10.3732/ajb.1000207; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; COYNE JA, 1989, EVOLUTION, V43, P362, DOI 10.1111/j.1558-5646.1989.tb04233.x; Darwin C., 1877, DIFFERENT FORMS FLOW; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; Doublet V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002938; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; Etherington GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/bioinformatics/bth500; Evans RC, 2002, AM J BOT, V89, P1478, DOI 10.3732/ajb.89.9.1478; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; Frey JE, 2005, GENETICA, V123, P255, DOI 10.1007/s10709-004-3711-y; Frey JE, 1999, THEOR APPL GENET, V99, P578, DOI 10.1007/s001220051271; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Greiner S, 2011, MOL ECOL, V20, P671, DOI 10.1111/j.1365-294X.2010.04984.x; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; Lewontin RC, 1996, EVOLUTION, V20, P215; LI LH, 1993, THEOR APPL GENET, V87, P361, DOI 10.1007/BF01184924; Lindau G., 1895, NATIIRLICHEN PFLANZE, P274, DOI DOI 10.5962/BHL.TITLE.4635; M?dus J., 1975, POLLEN SPORES, V17, P545; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MAYR E, 1992, AM J BOT, V79, P222, DOI 10.2307/2445111; McDade LA, 2005, SYST BOT, V30, P834, DOI 10.1600/036364405775097734; McDade LA, 2008, AM J BOT, V95, P1136, DOI 10.3732/ajb.0800096; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; NEWMAN SM, 1992, GENETICS, V132, P413; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; PRAGER EM, 1975, P NATL ACAD SCI USA, V72, P200, DOI 10.1073/pnas.72.1.200; Reed SM, 2008, J AM SOC HORTIC SCI, V133, P84, DOI 10.21273/JASHS.133.1.84; Reid EM, 1926, BEMBRIDGE FLORA CATA; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Scotland R. W., 2000, Kew Bulletin, V55, P513, DOI 10.2307/4118776; SOLTIS DE, 1991, AM J BOT, V78, P1091, DOI 10.2307/2444898; Soltis DE, 2008, SYST BOT, V33, P7, DOI 10.1600/036364408783887401; Son JH, 2010, GENES GENOM, V32, P165, DOI 10.1007/s13258-009-0849-0; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tripp EA, 2007, SYST BOT, V32, P628, DOI 10.1600/036364407782250625; Tripp EA, 2010, SYST BOT, V35, P629, DOI 10.1600/036364410792495845; Weihe A, 2009, MOL GENET GENOMICS, V282, P587, DOI 10.1007/s00438-009-0488-9; Wolfe AD, 2004, SYST BOT, V29, P1011, DOI 10.1600/0363644042451008; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	55	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55677	10.1371/journal.pone.0055677	http://dx.doi.org/10.1371/journal.pone.0055677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383261	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800183
J	Ando, K; Tsushima, H; Matsuo, E; Horio, K; Tominaga-Sato, S; Imanishi, D; Imaizumi, Y; Iwanaga, M; Itonaga, H; Yoshida, S; Hata, T; Moriuchi, R; Kiyoi, H; Nimer, S; Mano, H; Naoe, T; Tomonaga, M; Miyazaki, Y				Ando, Koji; Tsushima, Hideki; Matsuo, Emi; Horio, Kensuke; Tominaga-Sato, Shinya; Imanishi, Daisuke; Imaizumi, Yoshitaka; Iwanaga, Masako; Itonaga, Hidehiro; Yoshida, Shinichiro; Hata, Tomoko; Moriuchi, Ryozo; Kiyoi, Hitoshi; Nimer, Stephen; Mano, Hiroyuki; Naoe, Tomoki; Tomonaga, Masao; Miyazaki, Yasushi			Mutations in the Nucleolar Phosphoprotein, Nucleophosmin, Promote the Expression of the Oncogenic Transcription Factor MEF/ELF4 in Leukemia Cells and Potentiates Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ETS PROTEIN MEF; HEMATOPOIETIC-CELLS; NUCLEAR EXPORT; CANCER-CELLS; P53; GENE; IDENTIFICATION; LOCALIZATION; QUIESCENCE	Myeloid ELF1-like factor (MEF/ELF4), a member of the ETS transcription factors, can function as an oncogene in murine cancer models and is overexpressed in various human cancers. Here, we report a mechanism by which MEF/ELF4 may be activated by a common leukemia-associated mutation in the nucleophosmin gene. By using a tandem affinity purification assay, we found that MEF/ELF4 interacts with multifactorial protein nucleophosmin (NPM1). Coimmunoprecipitation and GST pull-down experiments demonstrated that MEF/ELF4 directly forms a complex with NPM1 and also identified the region of NPM1 that is responsible for this interaction. Functional analyses showed that wild-type NPM1 inhibited the DNA binding and transcriptional activity of MEF/ELF4 on the HDM2 promoter, whereas NPM1 mutant protein (Mt-NPM1) enhanced these activities of MEF/ELF4. Induction of Mt-NPM1 into MEF/ELF4-overexpressing NIH3T3 cells facilitated malignant transformation. In addition, clinical leukemia samples with NPM1 mutations had higher human MDM2 (HDM2) mRNA expression. Our data suggest that enhanced HDM2 expression induced by mutant NPM1 may have a role in MEF/ELF4-dependent leukemogenesis.	[Ando, Koji; Imanishi, Daisuke; Iwanaga, Masako; Itonaga, Hidehiro; Miyazaki, Yasushi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, Nagasaki 8528523, Japan; [Tsushima, Hideki; Imaizumi, Yoshitaka; Hata, Tomoko] Nagasaki Univ Hosp, Dept Hematol, Nagasaki 8528523, Japan; [Matsuo, Emi; Yoshida, Shinichiro] Nagasaki Med Ctr, Dept Hematol, Omura, Nagasaki 8560835, Japan; [Horio, Kensuke; Tomonaga, Masao] Japanese Red Cross Nagasaki Atom Bomb Hosp, Dept Hematol, Nagasaki 8528104, Japan; [Tominaga-Sato, Shinya] Sasebo City Gen Hosp, Div Hematol, Sasebo, Nagasaki 8578511, Japan; [Moriuchi, Ryozo] Keijyu Hosp, Dept Internal Med, Isahaya, Nagasaki 8540121, Japan; [Kiyoi, Hitoshi; Naoe, Tomoki] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4668550, Japan; [Nimer, Stephen] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, New York, NY 10021 USA; [Mano, Hiroyuki] Jichi Med Univ, Div Funct Genom, Shimotsuke, Tochigi 3290498, Japan	Nagasaki University; Nagasaki University; Nagoya University; Memorial Sloan Kettering Cancer Center; Jichi Medical University	Miyazaki, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	y-miyaza@nagasaki-u.ac.jp	Naoe, Tomoki/I-1888-2012		Ministry of Health, Welfare, and Labor; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [24591387] Funding Source: KAKEN	Ministry of Health, Welfare, and Labor(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Ministry of Health, Welfare, and Labor and a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Bhat UG, 2011, J BIOL CHEM, V286, P41425, DOI 10.1074/jbc.M111.270843; Bolli N, 2010, BLOOD, V115, P3329, DOI 10.1182/blood-2009-02-207225; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Cheng K, 2010, BLOOD, V115, P3341, DOI 10.1182/blood-2009-03-208587; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; den Besten W, 2005, CELL CYCLE, V4, P1593; Du Y, 2005, BLOOD, V106, P2498, DOI 10.1182/blood-2004-12-4840; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; Fukushima T, 2003, LEUKEMIA RES, V27, P387, DOI 10.1016/S0145-2126(02)00214-X; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hedvat CV, 2004, J BIOL CHEM, V279, P6395, DOI 10.1074/jbc.M307524200; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Li J, 2005, LEUKEMIA RES, V29, P1415, DOI 10.1016/j.leukres.2005.05.005; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lu Z, 2004, FEBS LETT, V561, P117, DOI 10.1016/S0014-5793(04)00138-3; Mao SF, 1999, MOL CELL BIOL, V19, P3635; Mariano AR, 2006, ONCOGENE, V25, P4376, DOI 10.1038/sj.onc.1209453; Miyazaki Y, 2001, J BIOL CHEM, V276, P40528, DOI 10.1074/jbc.M103051200; Miyazaki Y, 1996, ONCOGENE, V13, P1721; Narayan V, 2011, J BIOL CHEM, V286, P14291, DOI 10.1074/jbc.M110.204602; Phelps M, 2003, CANCER RES, V63, P2616; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sashida G, 2009, MOL CELL BIOL, V29, P3687, DOI 10.1128/MCB.01551-08; Seki Y, 2002, CANCER RES, V62, P6579; Smith AM, 2012, MOL CELL BIOL, V32, P763, DOI 10.1128/MCB.05745-11; Suzuki T, 2005, BLOOD, V106, P2854, DOI 10.1182/blood-2005-04-1733; Taura M, 2011, NUCLEIC ACIDS RES, V39, P76, DOI 10.1093/nar/gkq762; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Yao JJ, 2007, ONCOGENE, V26, P4032, DOI 10.1038/sj.onc.1210170; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006	37	12	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9457	9467		10.1074/jbc.M112.415703	http://dx.doi.org/10.1074/jbc.M112.415703			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393136	Green Published, hybrid			2022-12-25	WOS:000316862200062
J	Bittner, MA; Aikman, RL; Holz, RW				Bittner, Mary A.; Aikman, Rachel L.; Holz, Ronald W.			A Nibbling Mechanism for Clathrin-mediated Retrieval of Secretory Granule Membrane after Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; DOPAMINE-BETA-HYDROXYLASE; RAPID ENDOCYTOSIS; PLASMA-MEMBRANE; MEDULLA; DYNAMIN; RECRUITMENT; CATECHOLAMINES; VISUALIZATION; RECAPTURE	Clathrin-mediated endocytosis is the major pathway for recycling of granule membrane components after strong stimulation and high exocytotic rates. It resembles "classical" receptor-mediated endocytosis but has a trigger that is unique to secretion, the sudden appearance of the secretory granule membrane in the plasma membrane. The spatial localization, the relationship to individual fusion events, the nature of the cargo, and the timing and nature of the nucleation events are unknown. Furthermore, a size mismatch between chromaffin granules (similar to 300-nm diameter) and typical clathrin-coated vesicles (similar to 90 nm) makes it unlikely that clathrin-mediated endocytosis internalizes as a unit the entire fused granule membrane. We have used a combination of total internal reflection fluorescence microscopy of transiently expressed proteins and time-resolved quantitative confocal imaging of endogenous proteins along with a fluid-phase marker to address these issues. We demonstrate that the fused granule membrane remains a distinct entity and serves as a nucleation site for clathrin- and dynamin-mediated endocytosis that internalizes granule membrane components in small increments.	[Bittner, Mary A.; Aikman, Rachel L.; Holz, Ronald W.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bittner, MA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 2220C MSRB 3, Ann Arbor, MI 48109 USA.	mbittner@umich.edu			National Institutes of Health [R01-NS38129, R56-NS38129, R21-NS073686, DK20572]; University of Michigan Comprehensive Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS038129, R21NS073686, R01NS038129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Comprehensive Cancer Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS38129, R56-NS38129, and R21-NS073686.; We thank Dr. Arun Anantharam (Wayne State University) for preparing the chromaffin cells for electron microscopy and Dorothy Sorenson (Microscope and Image Analysis Laboratory, Univ. of Michigan) for performing the electron microscopy. We thank Dr. Annita Ngatchou-Weiss for helpful suggestions about the manuscript. We are grateful to Dr. Bruno Gasnier (Institut de Biologie Physico-Chimique CNRS, Paris, France) for providing the VMAT2 antibody and to Dr. Phillip Robinson (University of Sidney, Sidney, Australia) for providing dyngo4a and dyngo8a. This research used the Sequencing Core of the Michigan Diabetes Research and Training Center, supported by National Institutes of Health Grant DK20572, and the Morphology Core, supported by the University of Michigan Comprehensive Cancer Center.	ABRAHAMS SJ, 1973, J CELL BIOL, V56, P540, DOI 10.1083/jcb.56.2.540; Allersma MW, 2004, MOL BIOL CELL, V15, P4658, DOI 10.1091/mbc.E04-02-0149; Anantharam A, 2011, MOL BIOL CELL, V22, P1907, DOI 10.1091/mbc.E11-02-0101; Anantharam A, 2010, J CELL BIOL, V188, P415, DOI 10.1083/jcb.200908010; Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; BUCKLEY JT, 1971, BIOCHIM BIOPHYS ACTA, V239, P517, DOI 10.1016/0005-2760(71)90047-6; Ceridono M, 2011, TRAFFIC, V12, P72, DOI 10.1111/j.1600-0854.2010.01125.x; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; COUPLAND RE, 1968, NATURE, V217, P384, DOI 10.1038/217384a0; CREUTZ CE, 1984, NATURE, V308, P208, DOI 10.1038/308208a0; DECAMILLI P, 1976, J CELL BIOL, V70, P59, DOI 10.1083/jcb.70.1.59; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; GRYNSZPA.O, 1971, PHILOS T ROY SOC B, V261, P291, DOI 10.1098/rstb.1971.0058; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; HERZOG V, 1977, P NATL ACAD SCI USA, V74, P5073, DOI 10.1073/pnas.74.11.5073; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; HUNTER A, 1989, EXP CELL RES, V182, P445, DOI 10.1016/0014-4827(89)90249-8; Kong MY, 2005, GEOL SOC AM BULL, V117, P244, DOI 10.1130/B25000.1; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; NAGASAWA J, 1972, BRAIN RES, V37, P141, DOI 10.1016/0006-8993(72)90356-3; Nunez D, 2011, TRAFFIC, V12, P1868, DOI 10.1111/j.1600-0854.2011.01273.x; PATZAK A, 1986, J CELL BIOL, V102, P510, DOI 10.1083/jcb.102.2.510; PATZAK A, 1984, J CELL BIOL, V98, P1817, DOI 10.1083/jcb.98.5.1817; PHILLIPS JH, 1983, J CELL BIOL, V97, P1906, DOI 10.1083/jcb.97.6.1906; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; THEODOSIS DT, 1976, J CELL BIOL, V70, P294, DOI 10.1083/jcb.70.2.294; TRIFARO JM, 1984, CELL TISSUE RES, V235, P365; VIVEROS OH, 1968, LIFE SCI PT 1 PHYSI, V7, P609, DOI 10.1016/0024-3205(68)90186-0; WICK PF, 1993, J BIOL CHEM, V268, P10983; Wick PF, 1997, NEUROSCIENCE, V80, P847, DOI 10.1016/S0306-4522(97)00062-6; WINKLER H, 1972, N-S ARCH PHARMAKOL, V273, P43, DOI 10.1007/BF00508079; WINKLER H, 1970, BIOCHEM J, V118, P303, DOI 10.1042/bj1180303; WINKLER H, 1980, NEUROSCIENCE, V5, P1803, DOI 10.1016/0306-4522(80)90031-7; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	42	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9177	9188		10.1074/jbc.M113.450361	http://dx.doi.org/10.1074/jbc.M113.450361			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386611	hybrid, Green Published			2022-12-25	WOS:000316862200037
J	Pascu, ML; Danko, B; Martins, A; Jedlinszki, N; Alexandru, T; Nastasa, V; Boni, M; Militaru, A; Andrei, IR; Staicu, A; Hunyadi, A; Fanning, S; Amaral, L				Pascu, Mihail Lucian; Danko, Balazs; Martins, Ana; Jedlinszki, Nikoletta; Alexandru, Tatiana; Nastasa, Viorel; Boni, Mihai; Militaru, Andra; Andrei, Ionut Relu; Staicu, Angela; Hunyadi, Attila; Fanning, Seamus; Amaral, Leonard			Exposure of Chlorpromazine to 266 nm Laser Beam Generates New Species with Antibacterial Properties: Contributions to Development of a New Process for Drug Discovery	PLOS ONE			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; BACTERIAL EFFLUX PUMPS; CLINICAL CONCENTRATIONS; STAPHYLOCOCCUS-AUREUS; FLASH-PHOTOLYSIS; SELF-ASSOCIATION; NON-ANTIBIOTICS; POTENTIAL USE; THIORIDAZINE; PHENOTHIAZINES	Introduction: Phenothiazines when exposed to white light or to UV radiation undergo a variety of reactions that result in degradation of parental compound and formation of new species. This process is slow and may be sped up with exposure to high energy light such as that produced by a laser. Methods: Varying concentrations of Chlorpromazine Hydrochloride (CPZ) (2-20 mg/mL in distilled water) were exposed to 266 nm laser beam (time intervals: 1-24 hrs). At distinct intervals the irradiation products were evaluated by spectrophotometry between 200-1500 nm, Thin Layer Chromatography, High Pressure Liquid Chromatography (HPLC) Diode Array Detection, HPLC tandem mass spectrometry, and for activity against the CPZ sensitive test organism Staphylococcus aureus ATCC 25923. Results: CPZ exposure to 266 nm laser beam of given energy levels yielded species, whose number increased with duration of exposure. Although the major species produced were Promazine (PZ), hydroxypromazine or PZ sulfoxide, and CPZ sulfoxide, over 200 compounds were generated with exposure of 20 mg/mL of CPZ for 24 hrs. Evaluation of the irradiation products indicated that the bioactivity against the test organism increased despite the total disappearance of CPZ, that is due, most probably, to one or more new species that remain yet unidentified. Conclusions: Exposure of CPZ to a high energy (6.5 mJ) 266 nm laser beam yields rapidly a large number of new and stable species. For biological grade phenothiazines (in other words knowing the impurities in the samples: solvent and solute) this process may be reproducible because one can control within reasonably low experimental errors: the concentration of the parent compound, the laser beam wavelength and average energy, as well as the duration of the exposure time. Because the process is "clean'' and rapid, it may offer advantages over the pyrogenically based methods for the production of derivatives.	[Pascu, Mihail Lucian; Alexandru, Tatiana; Nastasa, Viorel; Boni, Mihai; Militaru, Andra; Andrei, Ionut Relu; Staicu, Angela] Natl Inst Laser Plasma & Radiat Phys, Laser Dept, Magurele Ilfov, Romania; [Danko, Balazs; Martins, Ana; Jedlinszki, Nikoletta; Hunyadi, Attila] Univ Szeged, Fac Pharm, Inst Pharmacognosy, Szeged, Hungary; [Fanning, Seamus] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Ctr Food Safety, Dublin 2, Ireland; [Fanning, Seamus] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Ctr Food Borne Zoon, Dublin 2, Ireland; [Amaral, Leonard] Univ Nova Lisboa, Inst Hyg & Trop Med, Microbiol Unit, Grp Mycobacteria, P-1200 Lisbon, Portugal; [Pascu, Mihail Lucian; Alexandru, Tatiana; Nastasa, Viorel; Boni, Mihai; Militaru, Andra] Univ Bucharest, Fac Phys, Magurele Ilfov, Romania	National Institute for Laser, Plasma & Radiation Physics - Romania; Szeged University; University College Dublin; University College Dublin; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; University of Bucharest	Pascu, ML (corresponding author), Natl Inst Laser Plasma & Radiat Phys, Laser Dept, Magurele Ilfov, Romania.	mihai.pascu@inflpr.ro	Boni, Mihai/U-2458-2019; Tozar, Tatiana/P-3856-2019; Amaral, Leonard/I-2112-2012; Pascu, Mihail Lucian/U-3601-2019; Staicu, Angela/B-6741-2011; Nastasa, Viorel V/A-3881-2012; Pascu, Mihail Lucian M/C-4495-2011; Viveiros, Miguel/A-7326-2008; Andrei, Ionut Relu/GMW-7389-2022; Tozar (Alexandru), Tatiana/E-6369-2016; Dinache, Andra Cristina/A-2927-2017; Boni, Mihai/A-3915-2012	Boni, Mihai/0000-0003-3010-3003; Tozar, Tatiana/0000-0002-5953-9241; Amaral, Leonard/0000-0003-3127-1295; Pascu, Mihail Lucian/0000-0003-1151-9345; Staicu, Angela/0000-0003-0630-0314; Nastasa, Viorel V/0000-0002-9235-4492; Pascu, Mihail Lucian M/0000-0003-1151-9345; Viveiros, Miguel/0000-0001-9676-6251; Andrei, Ionut Relu/0000-0002-0952-8480; Tozar (Alexandru), Tatiana/0000-0002-5953-9241; Dinache, Andra Cristina/0000-0001-6107-7675; Boni, Mihai/0000-0003-3010-3003; Fanning, Seamus/0000-0002-1922-8836; Martins, Ana/0000-0002-8541-7440; Hunyadi, Attila/0000-0003-0074-3472	New Hungary Development Plan [TAMOP-4.2.1/B-09/1/KONV-2010-0005]; Baross Gabor Program [MFB-00339/2010]; Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal [EU-FSE / FEDERPOCI / SAU - MMO/59370/2004, EU-FSE / FEDER - PTDC/ BIAMIC / 71280/2006, SFRH/BCC/51099/2010]; ANCS (RO) project [LAPLAS 3-PN 09 33]; STSM (Short Term Scientific Mission) [CM0804, BM0701];  [PTDC/SAU-FCF/102807/2008];  [POSDRU 107/1.5/S/80765];  [POSDRU/88/1.5/S/56668]	New Hungary Development Plan; Baross Gabor Program; Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal(Portuguese Foundation for Science and Technology); ANCS (RO) project; STSM (Short Term Scientific Mission); ; ; 	This work was supported by the New Hungary Development Plan (TAMOP-4.2.1/B-09/1/KONV-2010-0005), the Baross Gabor Program (MFB-00339/2010) and partially supported by grants EU-FSE / FEDERPOCI / SAU - MMO/59370/2004 and EU-FSE / FEDER - PTDC/ BIAMIC / 71280/2006 provided by the Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal. Leonard Amaral was supported by BCC grant SFRH/BCC/51099/2010 provided by the Fundacao para a Ciencia e a Tecnologia (FCT) of Portugal and PTDC/SAU-FCF/102807/2008. It was also supported by the ANCS (RO) project LAPLAS 3-PN 09 33. Attila Hunyadi was supported by an STSM (Short Term Scientific Mission) within the COST Action CM0804 and Balazs Danko was supported by an STSM (Short Term Scientific Mission) within the COST Action BM0701. Andra Militaru and Viorel Nastasa were supported by projects POSDRU 107/1.5/S/80765 and POSDRU/88/1.5/S/56668, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral L, 2008, CURR DRUG TARGETS, V9, P816, DOI 10.2174/138945008785747798; Amaral L, 1996, J ANTIMICROB CHEMOTH, V38, P1049, DOI 10.1093/jac/38.6.1049; Amaral L, 2000, INT J ANTIMICROB AG, V14, P173, DOI 10.1016/S0924-8579(99)00153-3; Amaral L, 2001, TROP MED INT HEALTH, V6, P1016, DOI 10.1046/j.1365-3156.2001.00804.x; Amaral L, 2001, J ANTIMICROB CHEMOTH, V47, P505, DOI 10.1093/jac/47.5.505; Amaral L, 2011, RECENT PATENTS ANTII, V6, P284; Amaral L, 2006, CURR DRUG TARGETS, V7, P887, DOI 10.2174/138945006777709539; Amaral L, 2010, IN VIVO, V24, P409; Arakaki AK, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-315; Arce R, 2003, J PHOTOCH PHOTOBIO A, V154, P245, DOI 10.1016/S1010-6030(02)00353-2; Beijersbergen Van Henegouwen GMJ, 1997, ADV DRUG RES, V29, P119; BINFORD JS, 1994, BIOPHYS J, V66, P2024, DOI 10.1016/S0006-3495(94)80995-6; BUETTNER GR, 1986, PHOTOCHEM PHOTOBIOL, V44, P5, DOI 10.1111/j.1751-1097.1986.tb03556.x; BUETTNER GR, 1989, PHOTOCHEM PHOTOBIOL, V49, P249, DOI 10.1111/j.1751-1097.1989.tb04103.x; Caber-Ud-Din M, 2009, COLLOID J RUSS ACAD+, V71, P498, DOI [10.1134/S1061933X09040115, DOI 10.1134/S1061933X09040115]; CHIGNELL CF, 1985, ENVIRON HEALTH PERSP, V64, P103, DOI 10.2307/3430002; Ciamician G, 1908, CHEM BER, V41, P1928, DOI 10.1002/cber.19080410272; DAVIES AK, 1976, J CHEM SOC PERK T 2, P25, DOI 10.1039/p29760000025; Drucker AM, 2011, DRUG SAFETY, V34, P821, DOI 10.2165/11592780-000000000-00000; Ehrlich P, 1959, 1913 CHEMO THERAPY, VIII, P505; FELMEISTER A, 1964, J PHARM SCI, V53, P756, DOI 10.1002/jps.2600530712; Garcia C, 2005, J PHYS CHEM A, V109, P3360, DOI 10.1021/jp044530j; GARCIA C, 1995, J AM CHEM SOC, V117, P10871, DOI 10.1021/ja00149a010; Garcia C, 2002, J PHYS CHEM B, V106, P9794, DOI 10.1021/jp0257855; Garcia C, 2008, J PHYS CHEM B, V112, P168, DOI 10.1021/jp0710739; Garcia C, 2009, PHOTOCHEM PHOTOBIOL, V85, P160, DOI 10.1111/j.1751-1097.2008.00412.x; GRANT FW, 1972, TOXICOL APPL PHARM, V23, P71, DOI 10.1016/0041-008X(72)90205-0; HUANG C L, 1962, Psychopharmacol Serv Cent Bull, V2, P54; Itou H, 2005, J BIOL CHEM, V280, P38711, DOI 10.1074/jbc.M505999200; Kochevar IE, 1998, PHOTOCHEM PHOTOBIOL, V68, P692, DOI 10.1562/0031-8655(1998)068<0692:PTDBNC>2.3.CO;2; KOCHEVAR IE, 1979, PHOTOCHEM PHOTOBIOL, V29, P791, DOI 10.1111/j.1751-1097.1979.tb07768.x; KOCHEVAR IE, 1984, CHEM-BIOL INTERACT, V51, P273, DOI 10.1016/0009-2797(84)90153-4; KOCHEVAR IE, 1983, PHOTOCHEM PHOTOBIOL, V37, P163, DOI 10.1111/j.1751-1097.1983.tb04452.x; KOCHEVAR IE, 1980, TOXICOL APPL PHARM, V54, P258, DOI 10.1016/0041-008X(80)90195-7; Koenig J.L., 1999, SPECTROSCOPY POLYM; Kristiansen JE, 1997, J ANTIMICROB CHEMOTH, V40, P319, DOI 10.1093/jac/40.3.319; KYLE DE, 1993, AM J TROP MED HYG, V48, P126, DOI 10.4269/ajtmh.1993.48.126; Martins M, 2004, IN VIVO, V18, P787; Martins M, 2007, IN VIVO, V21, P771; McIntosh MP, 2010, J PHARM SCI-US, V99, P2999, DOI 10.1002/jps.22064; MINDER R, 1971, N-S ARCH PHARMAKOL, V268, P334, DOI 10.1007/BF00997266; Motten AG, 1983, PHOTOCHEM PHOTOBIOL, V42, P9; Nalecz-Jawecki G, 2008, ENVIRON TOXICOL, V23, P52, DOI 10.1002/tox.20310; Nalecz-Jawecki G, 2008, ECOTOXICOLOGY, V17, P13, DOI 10.1007/s10646-007-0171-z; NAVARATNAM S, 1978, J CHEM SOC FARAD T 1, V74, P1811, DOI 10.1039/f19787401811; Odian G., 2004, PRINCIPLES POLYM, P352; Ordway D, 2003, ANTIMICROB AGENTS CH, V47, P917, DOI 10.1128/AAC.47.3.917-922.2003; Pascu Mihail-Lucian, 2011, Recent Pat Antiinfect Drug Discov, V6, P147; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Pinero LE, 2009, PHOTOCHEM PHOTOBIOL, V85, P895, DOI 10.1111/j.1751-1097.2009.00584.x; PREMA K, 1974, BIOCHEM J, V137, P119, DOI 10.1042/bj1370119; Ray RS, 2008, TOXICOL IN VITRO, V22, P1775, DOI 10.1016/j.tiv.2008.06.015; Sala C, 2009, MOL MICROBIOL, V71, P1102, DOI 10.1111/j.1365-2958.2008.06583.x; Schreier S, 2000, BBA-BIOMEMBRANES, V1508, P210, DOI 10.1016/S0304-4157(00)00012-5; Spengler G, 2011, ANTICANCER RES, V31, P4201; Viveiros M, 2005, IN VIVO, V19, P733; Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307; Yde CW, 2009, ANTI-CANCER DRUG, V20, P723, DOI 10.1097/CAD.0b013e32832ec041	59	35	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55767	10.1371/journal.pone.0055767	http://dx.doi.org/10.1371/journal.pone.0055767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405212	Green Submitted, gold, Green Published			2022-12-25	WOS:000315153400157
J	Szabo, A; Gogolak, P; Pazmandi, K; Kis-Toth, K; Riedl, K; Wizel, B; Lingnau, K; Bacsi, A; Rethi, B; Rajnavolgyi, E				Szabo, Attila; Gogolak, Peter; Pazmandi, Kitti; Kis-Toth, Katalin; Riedl, Karin; Wizel, Benjamin; Lingnau, Karen; Bacsi, Attila; Rethi, Bence; Rajnavolgyi, Eva			The Two-Component Adjuvant IC31 (R) Boosts Type I Interferon Production of Human Monocyte-Derived Dendritic Cells via Ligation of Endosomal TLRs	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; ANTIMYCOBACTERIAL T-CELL; ADAPTIVE IMMUNITY; VACCINE ADJUVANTS; RESPONSES; VIVO; INDUCTION; AG85B-ESAT-6; ACTIVATION; SUBTYPES	The aim of this study was to characterize and identify the mode of action of IC31 (R), a two-component vaccine adjuvant. We found that IC31 (R) was accumulated in human peripheral blood monocytes, MHC class II positive cells and monocyte-derived DCs (moDCs) but not in plasmacytoid DCs (pDCs). In the presence of IC31 (R) the differentiation of inflammatory CD1a(+) moDCs and the secretion of chemokines, TNF-alpha and IL-6 cytokines was inhibited but the production of IFN beta was increased. Sustained addition of IC31 (R) to differentiating moDCs interfered with I kappa B alpha phosphorylation, while the level of phospho-IRF3 increased. We also showed that both IC31 (R) and its KLK component exhibited a booster effect on type I IFN responses induced by the specific ligands of TLR3 or TLR7/8, whereas TLR9 ligand induces type I IFN production only in the presence of IC31 (R) or ODN1. Furthermore, long term incubation of moDCs with IC31 (R) caused significantly higher expression of IRF and IFN genes than a single 24 hr treatment. The adjuvant activity of IC31 (R) on the IFN response was shown to be exerted through TLRs residing in the vesicular compartment of moDCs. Based on these results IC31 (R) was identified as a moDC modulatory adjuvant that sets the balance of the NF-kappa B and IRF3 mediated signaling pathways to the production of IFN beta. Thus IC31 (R) is emerging as a potent adjuvant to increase immune responses against intracellular pathogens and cancer in future vaccination strategies.	[Szabo, Attila; Gogolak, Peter; Pazmandi, Kitti; Kis-Toth, Katalin; Bacsi, Attila; Rajnavolgyi, Eva] Univ Debrecen, Med & Hlth Sci Ctr, Dept Immunol, H-4012 Debrecen, Hungary; [Kis-Toth, Katalin] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Rheumatol, Boston, MA 02215 USA; [Riedl, Karin; Wizel, Benjamin; Lingnau, Karen] Intercell AG, Vienna, Austria; [Rethi, Bence] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	University of Debrecen; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Intercell; Karolinska Institutet	Rajnavolgyi, E (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Dept Immunol, H-4012 Debrecen, Hungary.	evaraj@dote.hu	Rethi, Bence/C-5770-2013; Rajnavölgyi, Éva/D-4384-2013	Rethi, Bence/0000-0001-8220-5015; Bacsi, Attila/0000-0002-2311-2975; Gogolak, Peter/0000-0001-9411-9587; Pazmandi, Kitti Linda/0000-0001-7709-6707; Szabo, Attila/0000-0001-7833-8894	National Scientific Research grant OTKA [NK-10-15-38]; TAMOP [4.2.1./B-09/1/KONV-2010-0007]	National Scientific Research grant OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP	The experimental work was supported by the National Scientific Research grant OTKA NK-10-15-38 and TAMOP 4.2.1./B-09/1/KONV-2010-0007 both to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2006, VACCINE, V24, P5452, DOI 10.1016/j.vaccine.2006.03.072; Aichinger MC, 2008, CELL BIOL INT, V32, P1449, DOI 10.1016/j.cellbi.2008.08.024; Aichinger MC, 2011, VACCINE, V29, P426, DOI 10.1016/j.vaccine.2010.11.003; Beauvillain C, 2007, BLOOD, V110, P2965, DOI 10.1182/blood-2006-12-063826; Benko S, 2008, BIOL CHEM, V389, P469, DOI 10.1515/BC.2008.054; Berghofer B, 2007, J IMMUNOL, V178, P4072, DOI 10.4049/jimmunol.178.7.4072; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Butchi NB, 2010, GLIA, V58, P650, DOI 10.1002/glia.20952; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; Dustin ML, 2011, NAT REV IMMUNOL, V11, P672, DOI 10.1038/nri3066; Fritz JH, 2004, VACCINE, V22, P3274, DOI 10.1016/j.vaccine.2004.03.007; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Gogolak P, 2007, BLOOD, V109, P643, DOI 10.1182/blood-2006-04-016840; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kaisho T, 2010, VACCINE, V28, P8046, DOI 10.1016/j.vaccine.2010.09.025; Kamath AT, 2008, EUR J IMMUNOL, V38, P1247, DOI 10.1002/eji.200737889; Kamath AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003683; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kritsch CE, 2005, J CHROMATOGR B, V822, P263, DOI 10.1016/j.jchromb.2005.06.013; Lingnau K, 2007, EXPERT REV VACCINES, V6, P741, DOI 10.1586/14760584.6.5.741; Magyarics Z, 2008, CYTOM PART A, V73A, P254, DOI 10.1002/cyto.a.20529; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Pilz A, 2009, J IMMUNOL, V183, P2286, DOI 10.4049/jimmunol.0901383; Prchal M, 2009, VACCINE, V27, pG17, DOI 10.1016/j.vaccine.2009.10.016; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Szabo A, 2012, J LEUKOCYTE BIOL, V92, P159, DOI 10.1189/jlb.0711360; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Xiao HB, 2012, GENE THER, V19, P1030, DOI 10.1038/gt.2011.171	44	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55264	10.1371/journal.pone.0055264	http://dx.doi.org/10.1371/journal.pone.0055264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405128	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400073
J	Teh, MY; Morona, R				Teh, Min Yan; Morona, Renato			Identification of Shigella flexneri IcsA Residues Affecting Interaction with N-WASP, and Evidence for IcsA-IcsA Co-Operative Interaction	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; ALDRICH-SYNDROME PROTEIN; ANTIGEN CHAIN-LENGTH; FAMILY PROTEINS; ARP2/3 COMPLEX; VIRG PROTEIN; IN-VITRO; AUTOTRANSPORTER; SECRETION; VIRULENCE	The Shigella flexneri IcsA (VirG) protein is a polarly distributed outer membrane protein that is a fundamental virulence factor which interacts with neural Wiskott-Aldrich syndrome protein (N-WASP). The activated N-WASP then activates the Arp2/3 complex which initiates de novo actin nucleation and polymerisation to form F-actin comet tails and allows bacterial cell-to-cell spreading. In a previous study, IcsA was found to have three N-WASP interacting regions (IRs): IR I (aa 185-312), IR II (aa 330-382) and IR III (aa 508-730). The aim of this study was to more clearly define N-WASP interacting regions II and III by site-directed mutagenesis of specific amino acids. Mutant IcsA proteins were expressed in both smooth lipopolysaccharide (S-LPS) and rough LPS (R-LPS) S. flexneri strains and characterised for IcsA production level, N-WASP recruitment and F-actin comet tail formation. We have successfully identified new amino acids involved in N-WASP recruitment within different N-WASP interacting regions, and report for the first time using co-expression of mutant IcsA proteins, that N-WASP activation involves interactions with different regions on different IcsA molecules as shown by Arp3 recruitment. In addition, our findings suggest that autochaperone (AC) mutant protein production was not rescued by another AC region provided in trans, differing to that reported for two other autotransporters, PrtS and BrkA autotransporters.	[Teh, Min Yan; Morona, Renato] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Microbiol & Immunol, Adelaide, SA, Australia	University of Adelaide	Morona, R (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Discipline Microbiol & Immunol, Adelaide, SA, Australia.	renato.morona@adelaide.edu.au	Morona, Renato/B-7746-2013	Morona, Renato/0000-0001-7009-7440	National Health and Medical Research Council (NHMRC) of Australia [565526]; University of Adelaide	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide	This work is supported by a Program Grant (565526) from the National Health and Medical Research Council (NHMRC) of Australia. MYT was the recipient of a Faculty of Science Postgraduate Scholarship from the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SJ, 1999, MICROBIOL-SGM, V145, P367, DOI 10.1099/13500872-145-2-367; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200; BOLIVAR F, 1977, GENE, V2, P75, DOI 10.1016/0378-1119(77)90074-9; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; Cossart P, 2000, CELL MICROBIOL, V2, P195, DOI 10.1046/j.1462-5822.2000.00053.x; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Jain S, 2007, J BACTERIOL, V189, P5393, DOI 10.1128/JB.00228-07; Klemm P, 2006, INT J MED MICROBIOL, V296, P187, DOI 10.1016/j.ijmm.2005.10.002; Kuhnel K, 2011, J BACTERIOL, V193, P2042, DOI 10.1128/JB.00790-10; LETT MC, 1989, J BACTERIOL, V171, P353, DOI 10.1128/jb.171.1.353-359.1989; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; May KL, 2012, MICROBIOL-SGM, V158, P1874, DOI 10.1099/mic.0.056465-0; Meng GY, 2011, EMBO J, V30, P3864, DOI 10.1038/emboj.2011.279; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; OAKS EV, 1985, INFECT IMMUN, V48, P124, DOI 10.1128/IAI.48.1.124-129.1985; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; OHNISHI Y, 1994, J BIOL CHEM, V269, P32800; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Pallen MJ, 2003, CURR OPIN MICROBIOL, V6, P519, DOI 10.1016/j.mib.2003.09.005; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; Philpott DJ, 2000, PHILOS T R SOC B, V355, P575, DOI 10.1098/rstb.2000.0599; SANSONETTI PJ, 1991, VACCINE, V9, P416, DOI 10.1016/0264-410X(91)90128-S; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Suzuki T, 1995, J BIOL CHEM, V270, P30874, DOI 10.1074/jbc.270.52.30874; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Suzuki T, 2002, CELL MICROBIOL, V4, P223, DOI 10.1046/j.1462-5822.2002.00185.x; Suzuki T, 2001, INFECT IMMUN, V69, P5959, DOI 10.1128/IAI.69.10.5959-5966.2001; Teh MY, 2012, MICROBIOL-SGM, V158, P2835, DOI 10.1099/mic.0.062471-0; Van Den Bosch L, 2003, MICROB PATHOGENESIS, V35, P11, DOI 10.1016/S0882-4010(03)00064-0; VanDenBosch L, 1997, MOL MICROBIOL, V23, P765, DOI 10.1046/j.1365-2958.1997.2541625.x; Wells TJ, 2010, MICROBIOL-SGM, V156, P2459, DOI 10.1099/mic.0.039024-0; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7	45	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55152	10.1371/journal.pone.0055152	http://dx.doi.org/10.1371/journal.pone.0055152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405119	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400063
J	Kwiatek, JM; Owen, DM; Abu-Siniyeh, A; Yan, P; Loew, LM; Gaus, K				Kwiatek, Joanna M.; Owen, Dylan M.; Abu-Siniyeh, Ahmed; Yan, Ping; Loew, Leslie M.; Gaus, Katharina			Characterization of a New Series of Fluorescent Probes for Imaging Membrane Order	PLOS ONE			English	Article							LIPID RAFTS; GENERALIZED POLARIZATION; PLASMA-MEMBRANE; LAURDAN FLUORESCENCE; CELL-MEMBRANES; LIVING CELLS; DOMAINS; MICROSCOPY; DI-4-ANEPPDHQ; MODEL	Visualization and quantification of lipid order is an important tool in membrane biophysics and cell biology, but the availability of environmentally sensitive fluorescent membrane probes is limited. Here, we present the characterization of the novel fluorescent dyes PY3304, PY3174 and PY3184, whose fluorescence properties are sensitive to membrane lipid order. In artificial bilayers, the fluorescence emission spectra are red-shifted between the liquid-ordered and liquid-disordered phases. Using ratiometric imaging we demonstrate that the degree of membrane order can be quantitatively determined in artificial liposomes as well as live cells and intact, live zebrafish embryos. Finally, we show that the fluorescence lifetime of the dyes is also dependent on bilayer order. These probes expand the current palate of lipid excitation/emission wavelengths and possibly new opportunities in membrane biology.	[Kwiatek, Joanna M.; Owen, Dylan M.; Abu-Siniyeh, Ahmed; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Kwiatek, Joanna M.; Owen, Dylan M.; Abu-Siniyeh, Ahmed; Gaus, Katharina] Univ New S Wales, Australian Ctr Nanomed, Sydney, NSW, Australia; [Yan, Ping; Loew, Leslie M.] Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modelling, Farmington, CT USA	University of New South Wales Sydney; University of New South Wales Sydney; University of Connecticut	Owen, DM (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	dylan.owen@unsw.edu.au; les@volt.uchc.edu; k.gaus@unsw.edu.au	Zdilla, Michael J/B-4145-2011; Abu siniyeh, Ahmed/M-5591-2019; Wunder, Stephanie L/B-5066-2012	Abu siniyeh, Ahmed/0000-0002-1175-5017; Gaus, Katharina/0000-0002-8009-9658; Kwiatek, Joanna/0000-0001-8934-0922; Loew, Leslie/0000-0002-1851-4646; Yan, Ping/0000-0001-6472-150X	Australian Research Council (ARC) [DE130100251]; National Institutes of Health (NIH) [R01 EB001963]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001963] Funding Source: NIH RePORTER	Australian Research Council (ARC)(Australian Research Council); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	DMO and KG acknowledge funding from the Australian Research Council (ARC), grant DE130100251. LML and PY acknowledge support from the National Institutes of Health (NIH) grant R01 EB001963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; Demchenko AP, 2009, BIOPHYS J, V96, P3461, DOI 10.1016/j.bpj.2009.02.012; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Jin L, 2005, BIOPHYS J, V89, pL4, DOI 10.1529/biophysj.105.064816; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kim HM, 2007, CHEMBIOCHEM, V8, P553, DOI 10.1002/cbic.200700003; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Miguel L, 2011, J IMMUNOL, V186, P3505, DOI 10.4049/jimmunol.1002980; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Owen DM, 2007, SEMIN CELL DEV BIOL, V18, P591, DOI 10.1016/j.semcdb.2007.07.011; Owen DM, 2006, BIOPHYS J, V90, pL80, DOI 10.1529/biophysj.106.084673; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Owen DM, 2010, MOL MEMBR BIOL, V27, P178, DOI 10.3109/09687688.2010.495353; Owen DM, 2010, BIOPHYS J, V99, pL7, DOI 10.1016/j.bpj.2010.04.022; Owen DM, 2010, MICROSC RES TECHNIQ, V73, P618, DOI 10.1002/jemt.20801; Owen DM, 2009, TRAFFIC, V10, P962, DOI 10.1111/j.1600-0854.2009.00908.x; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Parasassi T, 1998, J FLUORESC, V8, P365, DOI 10.1023/A:1020528716621; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; VAN MEER G, 1987, J CELL BIOL, V105, P1623, DOI 10.1083/jcb.105.4.1623; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Weber P, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470446	34	51	52	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e52960	10.1371/journal.pone.0052960	http://dx.doi.org/10.1371/journal.pone.0052960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390489	Green Submitted, gold, Green Published			2022-12-25	WOS:000314691100005
J	Lin, WT; Hsieh, CH; Miki, T				Lin, Wei-Ting; Hsieh, Chih-hao; Miki, Takeshi			Difference Inadaptive Dispersal Ability Can Promote Species Coexistence in Fluctuating Environments	PLOS ONE			English	Article							IDEAL-FREE DISTRIBUTION; COLONIZATION TRADE-OFF; SPATIAL HETEROGENEITY; POPULATION-DYNAMICS; HABITAT SELECTION; COMPETITION; MOVEMENT; PREY; METACOMMUNITY; CONSEQUENCES	Theories and empirical evidence suggest that random dispersal of organisms promotes species coexistence in spatially structured environments. However, directed dispersal, where movement is adjusted with fitness-related cues, is less explored in studies of dispersal-mediated coexistence. Here, we present a metacommunity model of two consumers exhibiting directed dispersal and competing for a single resource. Our results indicated that directed dispersal promotes coexistence through two distinct mechanisms, depending on the adaptiveness of dispersal. Maladaptive directed dispersal may promote coexistence similar to random dispersal. More importantly, directed dispersal is adaptive when dispersers track patches of increased resources in fluctuating environments. Coexistence is promoted under increased adaptive dispersal ability of the inferior competitor relative to the superior competitor. This newly described dispersal-mediated coexistence mechanism is likely favored by natural selection under the trade-off between competitive and adaptive dispersal abilities.	[Lin, Wei-Ting; Hsieh, Chih-hao; Miki, Takeshi] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Miki, T (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan.	tksmiki@ntu.edu.tw	Hsieh, Chih-hao/B-3797-2008; Miki, Takeshi/F-8189-2010	Hsieh, Chih-hao/0000-0001-5935-7272; Miki, Takeshi/0000-0002-2452-8681	National Science Council, Taiwan [NSC 100-2611-M-002-010]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	TM was supported by National Science Council (NSC 100-2611-M-002-010), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, ECOLOGY, V81, P2902, DOI 10.2307/177350; Abrams PA, 2004, ECOL LETT, V7, P929, DOI 10.1111/j.1461-0248.2004.00644.x; Abrams PA, 2007, AM NAT, V169, P581, DOI 10.1086/512688; Abrams PA, 2012, ECOLOGY, V93, P281, DOI 10.1890/11-0011.1; Abrams PA, 2011, J THEOR BIOL, V277, P99, DOI 10.1016/j.jtbi.2011.02.019; Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Amarasekare P, 2010, J ANIM ECOL, V79, P282, DOI 10.1111/j.1365-2656.2009.01607.x; Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; Armsworth PR, 2005, AM NAT, V165, P449, DOI 10.1086/428595; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Byers JE, 2000, J EXP MAR BIOL ECOL, V248, P133, DOI 10.1016/S0022-0981(00)00163-5; Cadotte MW, 2006, OECOLOGIA, V149, P150, DOI 10.1007/s00442-006-0426-z; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; CAMPBELL CAM, 1993, J CHEM ECOL, V19, P1569, DOI 10.1007/BF00984897; Cantrell RS, 2008, J DIFFER EQUATIONS, V245, P3687, DOI 10.1016/j.jde.2008.07.024; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Cosner C, 2005, THEOR POPUL BIOL, V67, P101, DOI 10.1016/j.tpb.2004.09.002; Cote J, 2007, ECOL LETT, V10, P411, DOI 10.1111/j.1461-0248.2007.01032.x; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Flaxman SM, 2011, THEOR ECOL-NETH, V4, P255, DOI 10.1007/s12080-011-0120-6; France KE, 2006, NATURE, V441, P1139, DOI 10.1038/nature04729; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; GURNEY WSC, 1975, J THEOR BIOL, V52, P441, DOI 10.1016/0022-5193(75)90011-9; HANSKI I, 1983, ECOLOGY, V64, P493, DOI 10.2307/1939969; HOLT RD, 1985, THEOR POPUL BIOL, V28, P181, DOI 10.1016/0040-5809(85)90027-9; Holt RD, 1997, EVOL ECOL, V11, P723, DOI 10.1023/A:1018438403047; HSU SB, 1978, SIAM J APPL MATH, V35, P617, DOI 10.1137/0135051; HSU SB, 1978, ECOL MONOGR, V48, P337, DOI 10.2307/2937235; Jansen VAA, 1998, P NATL ACAD SCI USA, V95, P3696, DOI 10.1073/pnas.95.7.3696; Jansen VAA, 1999, ECOL LETT, V2, P379; KISHIMOTO K, 1990, THEOR POPUL BIOL, V38, P149, DOI 10.1016/0040-5809(90)90008-J; Kostal V, 1996, PHYSIOL ENTOMOL, V21, P123, DOI 10.1111/j.1365-3032.1996.tb00844.x; Krug PJ, 2000, J EXP BIOL, V203, P1741; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; Levine JM, 2002, AM NAT, V160, P452, DOI 10.1086/342073; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; Lin YTK, 2001, ECOL MONOGR, V71, P245, DOI 10.1890/0012-9615(2001)071[0245:TIOHQO]2.0.CO;2; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Mouquet N, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P237; Namba T, 2004, THEOR POPUL BIOL, V66, P53, DOI 10.1016/j.tpb.2004.03.003; NAMBA T, 1989, J MATH BIOL, V27, P1, DOI 10.1007/BF00276077; NAMBA T, 1980, J THEOR BIOL, V86, P351, DOI 10.1016/0022-5193(80)90011-9; Nieminen M, 1996, OECOLOGIA, V108, P643, DOI 10.1007/BF00329038; Ostman O, 2006, OIKOS, V114, P360, DOI 10.1111/j.2006.0030-1299.14521.x; Pillai P, 2012, AM NAT, V179, P204, DOI 10.1086/663674; Poethke HJ, 2010, AM NAT, V175, P577, DOI 10.1086/651595; Powers SP, 2000, LIMNOL OCEANOGR, V45, P727, DOI 10.4319/lo.2000.45.3.0727; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; RICHARDSON JS, 1991, ECOLOGY, V72, P873, DOI 10.2307/1940589; Ruokolainen L, 2011, J THEOR BIOL, V291, P76, DOI 10.1016/j.jtbi.2011.09.004; Saglam IK, 2008, J EVOLUTION BIOL, V21, P997, DOI 10.1111/j.1420-9101.2008.01548.x; Salomon Y, 2010, ECOL LETT, V13, P432, DOI 10.1111/j.1461-0248.2009.01436.x; Schaefer J, 2001, FRESHWATER BIOL, V46, P379, DOI 10.1046/j.1365-2427.2001.00685.x; SHIGESADA N, 1979, J THEOR BIOL, V79, P83, DOI 10.1016/0022-5193(79)90258-3; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Snider SB, 2008, ECOLOGY, V89, P1961, DOI 10.1890/07-0715.1; TAKEUCHI Y, 1989, MATH BIOSCI, V95, P65, DOI 10.1016/0025-5564(89)90052-7; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D., 1982, Monographs in Population Biology, pi; Wang WD, 2009, J THEOR BIOL, V258, P603, DOI 10.1016/j.jtbi.2009.02.014; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; Yu DW, 2001, AM NAT, V158, P49, DOI 10.1086/320865; Zhao LQ, 2010, ENTOMOL EXP APPL, V135, P288, DOI 10.1111/j.1570-7458.2010.00989.x	68	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55218	10.1371/journal.pone.0055218	http://dx.doi.org/10.1371/journal.pone.0055218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383314	Green Submitted, Green Published, gold			2022-12-25	WOS:000314597900021
J	Baez, MV; Oberholzer, MV; Cercato, MC; Snitcofsky, M; Aguirre, AI; Jerusalinsky, DA				Veronica Baez, Maria; Victoria Oberholzer, Maria; Cecilia Cercato, Magali; Snitcofsky, Marina; Ines Aguirre, Alejandra; Alicia Jerusalinsky, Diana			NMDA Receptor Subunits in the Adult Rat Hippocampus Undergo Similar Changes after 5 Minutes in an Open Field and after LTP Induction	PLOS ONE			English	Article							LONG-TERM DEPRESSION; ER RETENTION SIGNAL; SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; MEMORY FORMATION; CRITICAL PERIOD; WORKING-MEMORY; NR2B SUBUNIT; LATE-PHASE; EXPRESSION	NMDA receptor subunits change during development and their synaptic expression is modified rapidly after synaptic plasticity induction in hippocampal slices. However, there is scarce information on subunits expression after synaptic plasticity induction or memory acquisition, particularly in adults. GluN1, GluN2A and GluN2B NMDA receptor subunits were assessed by western blot in 1) adult rats that had explored an open field (OF) for 5 minutes, a time sufficient to induce habituation, 2) mature rat hippocampal neuron cultures depolarized by KCl and 3) hippocampal slices from adult rats where long term potentiation (LTP) was induced by theta-burst stimulation (TBS). GluN1 and GluN2A, though not GluN2B, were significantly higher 70 minutes -but not 30 minutes-after a 5 minutes session in an OF. GluN1 and GluN2A total immunofluorescence and puncta in neurites increased in cultures, as evaluated 70 minutes after KCl stimulation. Similar changes were found in hippocampal slices 70 minutes after LTP induction. To start to explore underlying mechanisms, hippocampal slices were treated either with cycloheximide (a translation inhibitor) or actinomycin D (a transcription inhibitor) during electrophysiological assays. It was corroborated that translation was necessary for LTP induction and expression. The rise in GluN1 depends on transcription and translation, while the increase in GluN2A appears to mainly depend on translation, though a contribution of some remaining transcriptional activity during actinomycin D treatment could not be rouled out. LTP effective induction was required for the subunits to increase. Although in the three models same subunits suffered modifications in the same direction, within an apparently similar temporal course, further investigation is required to reveal if they are related processes and to find out whether they are causally related with synaptic plasticity, learning and memory.	[Veronica Baez, Maria; Victoria Oberholzer, Maria; Cecilia Cercato, Magali; Snitcofsky, Marina; Ines Aguirre, Alejandra; Alicia Jerusalinsky, Diana] Univ Buenos Aires, Fac Med, CONICET, Inst Biol Celular & Neurociencia IBCN Prof Eduard, Buenos Aires, DF, Argentina; [Alicia Jerusalinsky, Diana] Univ Buenos Aires, CBC, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Jerusalinsky, DA (corresponding author), Univ Buenos Aires, Fac Med, CONICET, Inst Biol Celular & Neurociencia IBCN Prof Eduard, Buenos Aires, DF, Argentina.	djerusal@gmail.com	Baez, Veronica/ABF-9940-2021	Baez, Maria Veronica/0000-0001-5105-2888	Univesity of Buenos Aires (UBA); CONICET (LIA)	Univesity of Buenos Aires (UBA); CONICET (LIA)	This work has been supported by: Univesity of Buenos Aires (UBA) and CONICET (LIA). MVB has been awarded with a posdoctoral fellowship by Bunge&Born foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349, DOI 10.1152/jn.1995.74.6.2349; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Bannerman DM, 2008, J NEUROSCI, V28, P3623, DOI 10.1523/JNEUROSCI.3639-07.2008; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Chen WS, 2007, NEUROPHARMACOLOGY, V52, P200, DOI 10.1016/j.neuropharm.2006.07.003; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; DAVIS M, 1993, BRAZ J MED BIOL RES, V26, P235; Dravid SM, 2007, J PHYSIOL-LONDON, V581, P107, DOI 10.1113/jphysiol.2006.124958; Flint AC, 1997, J NEUROSCI, V17, P2469; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Gourley SL, 2009, NEUROPSYCHOPHARMACOL, V34, P707, DOI 10.1038/npp.2008.123; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Guscott MR, 2003, EUR J PHARMACOL, V476, P193, DOI 10.1016/S0014-2999(03)02182-4; Henderson AK, 2012, NEUROSCIENCE, V215, P98, DOI 10.1016/j.neuroscience.2012.04.040; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; IZQUIERDO I, 1992, BEHAV NEURAL BIOL, V58, P16, DOI 10.1016/0163-1047(92)90847-W; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kamphuis PJGH, 2003, FASEB J, V17, P911, DOI 10.1096/fj.02-0333fje; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Klann E, 2004, LEARN MEMORY, V11, P365, DOI 10.1101/lm.79004; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Klann E, 2008, NEUROBIOL LEARN MEM, V89, P247, DOI 10.1016/j.nlm.2007.08.009; KRUGERS HJ, 1993, NEUROSCI LETT, V154, P73, DOI 10.1016/0304-3940(93)90174-J; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Packard MG, 1997, NEUROBIOL LEARN MEM, V68, P42, DOI 10.1006/nlme.1996.3762; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Quevedo J, 1999, LEARN MEMORY, V6, P600, DOI 10.1101/lm.6.6.600; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Sobczyk A, 2007, NEURON, V53, P17, DOI 10.1016/j.neuron.2006.11.016; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; STEELE RJ, 1995, BRAIN RES, V674, P352, DOI 10.1016/0006-8993(95)00014-H; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tse YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027215; Baez MV, 2011, J CELL BIOL, V195, P1141, DOI 10.1083/jcb.201108159; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wang S, 2009, J NEUROSCI, V29, P15232, DOI 10.1523/JNEUROSCI.3809-09.2009; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049	64	22	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55244	10.1371/journal.pone.0055244	http://dx.doi.org/10.1371/journal.pone.0055244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383317	gold, Green Submitted, Green Published			2022-12-25	WOS:000314597900024
J	Chen, T; Zhu, J; Zhang, C; Huo, K; Fei, Z; Jiang, XF				Chen, Tao; Zhu, Jie; Zhang, Chi; Huo, Kai; Fei, Zhou; Jiang, Xiao-fan			Protective Effects of SKF-96365, a Non-Specific Inhibitor of SOCE, against MPP+-Induced Cytotoxicity in PC12 Cells: Potential Role of Homer1	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; ENDOPLASMIC-RETICULUM STRESS; PROTEIN-KINASE CASCADE; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; CALCIUM-CHANNELS; IP3 RECEPTORS; BINDS; ENTRY; BRAIN	Parkinson's disease (PD) is the most common neurodegenerative movement disorder, characterized by loss of dopominergic (DA) neurons in substantia nigra pars compacta (SNpc), and can be experimentally mimicked by the neurotoxin MPP+ in vitro models. In this study, we investigated the potential protective effect of SKF-96365, a non-specific inhibitor of SOCE (store-operated calcium entry), on MPP+ induced cytotoxicity in PC12 cells. We found that pretreatment with SKF-96365 (10 mu M and 50 mu M) 30 min before injury significantly increased cell viability, decreased LDH release, prevented nuclear damage, and inhibited apoptotic cell death in MPP+ stressed PC12 cells. The results of calcium image using the ratiometric calcium indicator Fura-2-AM also showed that SKF-96365 reduced the intracellular calcium overload induced by MPP+ in PC12 cells. In addition, SKF-96365 decreased the expression of Homer1, a more recently discovered postsynaptic scaffolding protein with calcium modulating function, following MPP+ administration in PC12 cells, while had no statistically significant effects on endoplasmic reticulum (ER) calcium concentration. Furthermore, overexpression of Homer1 by using recombinant lentivirus partly reversed protective effects of SKF-96365 against MPP+ injury. The ER Ca2+ release was further amplified and ER calcium recovery was delayed by Homer1 upregulation in PC12 cells following MPP+ insult. Taken together, these data suggest that SKF-96365 protects PC12 cells against MPP+ induced cytotoxicity, and this protection may be at least in part on the inhibition of intracellular calcium overload and suppression of Homer1-mediated ER Ca2+ release.	[Chen, Tao; Zhu, Jie; Zhang, Chi; Huo, Kai; Fei, Zhou; Jiang, Xiao-fan] Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Chen, Tao] PLA, Hosp 123, Dept Neurosurg, Bengbu, Anhui, Peoples R China	Air Force Military Medical University	Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Xijing Inst Clin Neurosci, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China.	fmmuzhoufei@163.com; fmmujiangxiaofan@163.com			National Natural Science Foundation of China [81071034, 30930093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (No. 81071034 and No. 30930093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ango F, 2002, MOL CELL NEUROSCI, V20, P323, DOI 10.1006/mcne.2002.1100; Becker C, 2008, NEUROLOGY, V70, P1438, DOI 10.1212/01.wnl.0000303818.38960.44; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brandt SK, 2011, NEUROSCIENCE, V172, P387, DOI 10.1016/j.neuroscience.2010.10.071; Cali T, 2011, BIOFACTORS, V37, P228, DOI 10.1002/biof.159; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Ding J, 2012, NEUROSCI BULL, V28, P173, DOI 10.1007/s12264-012-1213-y; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Fahn Stanley, 2004, NeuroRx, V1, P139, DOI 10.1007/BF03206574; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Harper JL, 2003, BIOCHEM PHARMACOL, V65, P329, DOI 10.1016/S0006-2952(02)01488-0; Ilijic E, 2011, NEUROBIOL DIS, V43, P364, DOI 10.1016/j.nbd.2011.04.007; Jellinger KA, 2001, ADV NEUROL, V86, P55; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Lo Bianco C, 2004, P NATL ACAD SCI USA, V101, P17510, DOI 10.1073/pnas.0405313101; Luo P, 2012, APOPTOSIS; Mekahli D, 2011, COLD SPRING HARB PER, V3; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Panariello F, 2012, J CELL PHYSIOL, V227, P1485, DOI 10.1002/jcp.22864; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peng L, 2011, INT J MOL MED, V28, P161, DOI 10.3892/ijmm.2011.684; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; ROSS WN, 1989, ANNU REV PHYSIOL, V51, P491, DOI 10.1146/annurev.physiol.51.1.491; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Schapira AHV, 2004, JAMA-J AM MED ASSOC, V291, P358, DOI 10.1001/jama.291.3.358; Sethi K, 2008, MOVEMENT DISORD, V23, pS521, DOI 10.1002/mds.22049; Shin DM, 2003, J CELL BIOL, V162, P293, DOI 10.1083/jcb.200210109; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Soldner F, 1999, EXP CELL RES, V250, P75, DOI 10.1006/excr.1999.4504; Surmeier DJ, 2011, NEUROSCIENCE, V198, P221, DOI 10.1016/j.neuroscience.2011.08.045; Szikra T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006723; TAKASHIMA A, 1985, BIOCHIM BIOPHYS ACTA, V847, P101, DOI 10.1016/0167-4889(85)90159-4; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang Y, 2012, NEUROSCI LETT, V515, P44, DOI 10.1016/j.neulet.2012.03.016; Weiner WJ, 2008, NEUROLOGY, V71, P470, DOI 10.1212/01.wnl.0000324860.70391.25; Wilhelmus MMM, 2011, FREE RADICAL BIO MED, V50, P469, DOI 10.1016/j.freeradbiomed.2010.11.033; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	44	56	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55601	10.1371/journal.pone.0055601	http://dx.doi.org/10.1371/journal.pone.0055601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383239	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600132
J	Mannaerts, I; Eysackers, N; Onyema, OO; Van Beneden, K; Valente, S; Mai, A; Odenthal, M; van Grunsven, LA				Mannaerts, Inge; Eysackers, Nathalie; Onyema, Oscar O.; Van Beneden, Katrien; Valente, Sergio; Mai, Antonello; Odenthal, Margarete; van Grunsven, Leo A.			Class II HDAC Inhibition Hampers Hepatic Stellate Cell Activation by Induction of MicroRNA-29	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; MATRIX METALLOPROTEINASES; TRICHOSTATIN-A; EXPRESSION; GENE; FIBROSIS; TARGET; TRANSDIFFERENTIATION; DIFFERENTIATION; TGF-BETA-1	Background: The conversion of a quiescent vitamin A storing hepatic stellate cell (HSC) to a matrix producing, contractile myofibroblast-like activated HSC is a key event in the onset of liver disease following injury of any aetiology. Previous studies have shown that class I histone deacetylases (HDACs) are involved in the phenotypical changes occurring during stellate cell activation in liver and pancreas. Aims: In the current study we investigate the role of class II HDACs during HSC activation. Methods: We characterized the expression of the class II HDACs freshly isolated mouse HSCs. We inhibited HDAC activity by selective pharmacological inhibition with MC1568, and by repressing class II HDAC gene expression using specific siRNAs. Results: Inhibition of HDAC activity leads to a strong reduction of HSC activation markers alpha-SMA, lysyl oxidase and collagens as well as an inhibition of cell proliferation. Knock down experiments showed that HDAC4 contributes to HSC activation by regulating lysyl oxidase expression. In addition, we observed a strong up regulation of miR-29, a well-known anti-fibrotic miR, upon treatment with MC1568. Our in vivo work suggests that a successful inhibition of class II HDACs could be promising for development of future anti-fibrotic compounds. Conclusions: In conclusion, the use of MC1568 has enabled us to identify a role for class II HDACs regulating miR-29 during HSC activation.	[Mannaerts, Inge; Eysackers, Nathalie; Onyema, Oscar O.; van Grunsven, Leo A.] Vrije Univ Brussel, Dept Cell Biol, Liver Cell Biol Lab, Brussels, Belgium; [Van Beneden, Katrien] Vrije Univ Brussel, Dept Human Anat, Liver Cell Biol Lab, Brussels, Belgium; [Valente, Sergio; Mai, Antonello] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, Rome, Italy; [Odenthal, Margarete] Univ Hosp Cologne, Inst Pathol, Cologne, Germany	Vrije Universiteit Brussel; Vrije Universiteit Brussel; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Cologne	van Grunsven, LA (corresponding author), Vrije Univ Brussel, Dept Cell Biol, Liver Cell Biol Lab, Brussels, Belgium.	leo.van.grunsven@vub.ac.be	Mannaerts, Inge/AAC-5487-2019; Mannaerts, Inge/F-2181-2015; van Grunsven, Leo/E-5839-2010; Mai, Antonello/AAC-2144-2019; Valente, Sergio/K-2198-2016	Mannaerts, Inge/0000-0002-2235-2555; Mannaerts, Inge/0000-0002-2235-2555; van Grunsven, Leo/0000-0002-0990-7034; Valente, Sergio/0000-0002-2241-607X; Mai, Antonello/0000-0001-9176-2382	Vrije Universiteit Brussel [GOA48, GOA78, OZR1930]; Fund for Scientific Research Flanders (FWO-V) [G.0260.09]; Vrije Universiteit Brussel through an Onderzoeksraad project [OZR1428, OZR1796]	Vrije Universiteit Brussel; Fund for Scientific Research Flanders (FWO-V)(FWO); Vrije Universiteit Brussel through an Onderzoeksraad project	I. Mannaerts and L. A. van Grunsven are supported by the Vrije Universiteit Brussel (GOA48, GOA78, OZR1930) and by the Fund for Scientific Research Flanders (FWO-V, http://www.fwo.be/) (G.0260.09). K. Van Beneden is supported by the Vrije Universiteit Brussel through an Onderzoeksraad project (OZR1428 and OZR1796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bechmann LP, 2009, HEPATOL RES, V39, P601, DOI 10.1111/j.1872-034X.2008.00485.x; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Borbone E, 2010, ONCOGENE, V29, P105, DOI 10.1038/onc.2009.306; Bulow R, 2007, BIOCHEM PHARMACOL, V74, P1747, DOI 10.1016/j.bcp.2007.08.023; Bush EW, 2010, CIRC RES, V106, P272, DOI 10.1161/CIRCRESAHA.109.209338; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Du SL, 2007, J PHARMACOL EXP THER, V322, P560, DOI 10.1124/jpet.107.122481; Fallowfield JA, 2011, AM J PHYSIOL-GASTR L, V300, pG709, DOI 10.1152/ajpgi.00451.2010; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Glenisson W, 2007, BBA-MOL CELL RES, V1773, P1572, DOI 10.1016/j.bbamcr.2007.05.016; Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; Haughton EL, 2006, GASTROENTEROLOGY, V131, P194, DOI 10.1053/j.gastro.2006.04.012; Horie S, 2000, PATHOL INT, V50, P937, DOI 10.1046/j.1440-1827.2000.01146.x; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Kee HJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/928326; Kordes C, 2008, BIOCHEM BIOPH RES CO, V367, P116, DOI 10.1016/j.bbrc.2007.12.085; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Lavelle D, 2001, AM J HEMATOL, V68, P170, DOI 10.1002/ajh.1174; Lenoir O, 2011, DIABETES, V60, P2861, DOI 10.2337/db11-0440; Li F, 2012, J CONTROL RELEASE, V159, P261, DOI 10.1016/j.jconrel.2011.12.023; Liu XJ, 2006, PHARM RES-DORDR, V23, P82, DOI 10.1007/s11095-005-9043-5; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Naldi M, 2009, PROTEOMICS, V9, P5437, DOI 10.1002/pmic.200800866; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; Ogawa T, 2010, BIOCHEM BIOPH RES CO, V391, P316, DOI 10.1016/j.bbrc.2009.11.056; Olsen AL, 2011, AM J PHYSL GASTROINT; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Poelstra K, 2011, J HEPATOL, V55, P726, DOI 10.1016/j.jhep.2011.04.008; Popov Y, 2006, J BIOL CHEM, V281, P15090, DOI 10.1074/jbc.M600030200; Qin L, 2010, AM J PATHOL, V177, P1915, DOI 10.2353/ajpath.2010.100011; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rombouts K, 2002, J HEPATOL, V37, P788, DOI 10.1016/S0168-8278(02)00275-1; Rombouts K, 2001, ACTA GASTRO-ENT BELG, V64, P239; Sampath D, 2012, BLOOD, V119, P1162, DOI 10.1182/blood-2011-05-351510; Scognamiglio A, 2008, BBA-MOL CELL RES, V1783, P2030, DOI 10.1016/j.bbamcr.2008.07.007; Shi YF, 2006, BBA-GEN SUBJECTS, V1760, P1587, DOI 10.1016/j.bbagen.2006.09.012; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Wendtner CM, 2012, BLOOD, V119, P1095, DOI 10.1182/blood-2011-12-394494; Xiao F, 2010, DIGEST DIS SCI, V55, P261, DOI 10.1007/s10620-009-0743-2; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	58	52	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55786	10.1371/journal.pone.0055786	http://dx.doi.org/10.1371/journal.pone.0055786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383282	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600159
J	Ruud, J; Wilhelms, DB; Nilsson, A; Eskilsson, A; Tang, YJ; Strohle, P; Caesar, R; Schwaninger, M; Wunderlich, T; Backhed, F; Engblom, D; Blomqvist, A				Ruud, Johan; Wilhelms, Daniel Bjork; Nilsson, Anna; Eskilsson, Anna; Tang, Yan-Juan; Stroehle, Peter; Caesar, Robert; Schwaninger, Markus; Wunderlich, Thomas; Backhed, Fredrik; Engblom, David; Blomqvist, Anders			Inflammation- and tumor-induced anorexia and weight loss require MyD88 in hematopoietic/myeloid cells but not in brain endothelial or neural cells	FASEB JOURNAL			English	Article						lipopolysaccharide; methylcholanthrene-induced sarcoma; food intake; chimeric mice; Cre-LoxP; inducible cell-specific deletion	LIPOPOLYSACCHARIDE-INDUCED ANOREXIA; NECROSIS-FACTOR; NERVOUS-SYSTEM; CYTOKINE; GENE; EXPRESSION; RECEPTOR; MICE; CNS; CYCLOOXYGENASE-2	Loss of appetite is a hallmark of inflammatory diseases. The underlying mechanisms remain undefined, but it is known that myeloid differentiation primary response gene 88 (MyD88), an adaptor protein critical for Toll-like and IL-1 receptor family signaling, is involved. Here we addressed the question of determining in which cells the MyD88 signaling that results in anorexia development occurs by using chimeric mice and animals with cell-specific deletions. We found that MyD88-knockout mice, which are resistant to bacterial lipopolysaccharide (LPS)-induced anorexia, displayed anorexia when transplanted with wild-type bone marrow cells. Furthermore, mice with a targeted deletion of MyD88 in hematopoietic or myeloid cells were largely protected against LPS-induced anorexia and displayed attenuated weight loss, whereas mice with MyD88 deletion in hepatocytes or in neural cells or the cerebrovascular endothelium developed anorexia and weight loss of similar magnitude as wild-type mice. Furthermore, in a model for cancer-induced anorexia-cachexia, deletion of MyD88 in hematopoietic cells attenuated the anorexia and protected against body weight loss. These findings demonstrate that MyD88-dependent signaling within the brain is not required for eliciting inflammation-induced anorexia. Instead, we identify MyD88 signaling in hematopoietic/myeloid cells as a critical component for acute inflammatory-driven anorexia, as well as for chronic anorexia and weight loss associated with malignant disease.	[Ruud, Johan; Wilhelms, Daniel Bjork; Nilsson, Anna; Eskilsson, Anna; Tang, Yan-Juan; Engblom, David; Blomqvist, Anders] Linkoping Univ, Fac Hlth Sci, Dept Cell Biol, Dept Clin & Expt Med, S-58185 Linkoping, Sweden; [Stroehle, Peter; Wunderlich, Thomas] Univ Cologne, Inst Genet, Ctr Mol Med, Dept Mouse Genet & Metab, Cologne, Germany; [Stroehle, Peter; Wunderlich, Thomas] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Caesar, Robert; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Schwaninger, Markus] Med Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, D-23538 Lubeck, Germany	Linkoping University; University of Cologne; Max Planck Society; University of Gothenburg; University of Lubeck	Blomqvist, A (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Cell Biol, Dept Clin & Expt Med, S-58185 Linkoping, Sweden.	anders.blomqvist@liu.se	Backhed, Fredrik/ABE-6613-2020; Caesar, Robert/AAX-3205-2020; Ruud, Johan/W-7407-2019; Blomqvist, Anders/K-3990-2019	Backhed, Fredrik/0000-0002-4871-8818; Blomqvist, Anders/0000-0002-6928-4473; Bjork Wilhelms, Daniel/0000-0001-6347-3970; Schwaninger, Markus/0000-0002-4510-9718; Eskilsson, Anna/0000-0002-6131-0403	Swedish Research Council [7879, 20725, 21677]; Swedish Cancer Foundation [100533]; Swedish Brain Foundation; Gustav V:s 80-ars fond; European Research Council [260820]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Swedish Brain Foundation; Gustav V:s 80-ars fond; European Research Council(European Research Council (ERC)European Commission)	The authors thank Maarit Jaarola for technical assistance. This work was supported by grants from the Swedish Research Council (7879), the Swedish Cancer Foundation (100533), the Swedish Brain Foundation, and the Gustav V:s 80-ars fond to A.B.; and the Swedish Research Council (20725 and 21677), the Swedish Brain Foundation, and the European Research Council (starting grant 260820) to D.E.	Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; BEUTLER B, 1988, ENDOCR REV, V9, P57, DOI 10.1210/edrv-9-1-57; BREDER CD, 1994, P NATL ACAD SCI USA, V91, P11393, DOI 10.1073/pnas.91.24.11393; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Ching S, 2007, J NEUROSCI, V27, P10476, DOI 10.1523/JNEUROSCI.3357-07.2007; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Ek M, 2001, NATURE, V410, P430, DOI 10.1038/35068632; Engstrom L, 2012, ENDOCRINOLOGY, V153, P4849, DOI 10.1210/en.2012-1375; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Gosselin D, 2008, MOL PSYCHIATR, V13, P480, DOI 10.1038/sj.mp.4002122; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Johnson PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE650, DOI 10.1152/ajpendo.00388.2001; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Kent S, 1996, NEUROSCI BIOBEHAV R, V20, P171, DOI 10.1016/0149-7634(95)00037-F; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lang MF, 2011, J NEUROENDOCRINOL, V23, P1194, DOI 10.1111/j.1365-2826.2011.02216.x; Langhans W, 2007, P NUTR SOC, V66, P321, DOI 10.1017/S0029665107005587; Laye S, 2000, AM J PHYSIOL-REG I, V279, pR93, DOI 10.1152/ajpregu.2000.279.1.R93; LAYE S, 1994, MOL BRAIN RES, V27, P157, DOI 10.1016/0169-328X(94)90197-X; Lugarini F, 2002, AM J PHYSIOL-REG I, V283, pR862, DOI 10.1152/ajpregu.00200.2002; LUNDHOLM K, 1978, CANCER-AM CANCER SOC, V42, P453, DOI 10.1002/1097-0142(197808)42:2<453::AID-CNCR2820420212>3.0.CO;2-T; Marks DL, 2001, CANCER RES, V61, P1432; Ogimoto K, 2006, ENDOCRINOLOGY, V147, P4445, DOI 10.1210/en.2006-0465; Quan N, 1998, NEUROSCIENCE, V83, P281, DOI 10.1016/S0306-4522(97)00350-3; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; Ruud J, 2013, BRAIN BEHAV IMMUN, V29, P124, DOI 10.1016/j.bbi.2012.12.020; Ruud J, 2010, BRAIN BEHAV IMMUN, V24, P554, DOI 10.1016/j.bbi.2010.01.006; Schilte MN, 2009, PERITON DIALYSIS INT, V29, P605; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; von Meyenburg C, 2004, AM J PHYSIOL-REG I, V287, pR298, DOI 10.1152/ajpregu.00659.2003; Wang WH, 2001, CANCER RES, V61, P4707; Wisse BE, 2007, ENDOCRINOLOGY, V148, P5230, DOI 10.1210/en.2007-0394; Yamawaki Y, 2010, AM J PHYSIOL-REG I, V298, pR403, DOI 10.1152/ajpregu.00395.2009	40	22	22	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1973	1980		10.1096/fj.12-225433	http://dx.doi.org/10.1096/fj.12-225433			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23395911				2022-12-25	WOS:000318226100017
J	Barone, A; Benktander, J; Angstrom, J; Aspegren, A; Bjorquist, P; Teneberg, S; Breimer, ME				Barone, Angela; Benktander, John; Angstrom, Jonas; Aspegren, Anders; Bjorquist, Petter; Teneberg, Susann; Breimer, Michael. E.			Structural Complexity of Non-acid Glycosphingolipids in Human Embryonic Stem Cells Grown under Feeder-free Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP; MASS-SPECTROMETRY; GLOBOSERIES GLYCOSPHINGOLIPIDS; CORRELATED SPECTROSCOPY; SMALL-INTESTINE; GANGLIO-SERIES; UDP-GALACTOSE; GLOBO-SERIES; O-GLYCANS; GROUP-A	Due to their pluripotency and growth capability, there are great expectations for human embryonic stem cells, both as a resource for functional studies of early human development and as a renewable source of cells for use in regenerative medicine and transplantation. However, to bring human embryonic stem cells into clinical applications, their cell surface antigen expression and its chemical structural complexity have to be defined. In the present study, total non-acid glycosphingolipid fractions were isolated from two human embryonic stem cell lines (SA121 and SA181) originating from leftover in vitro fertilized human embryos, using large amounts of starting material (1 x 10(9) cells/cell line). The total non-acid glycosphingolipid fractions were characterized by antibody and lectin binding, mass spectrometry, and proton NMR. In addition to the globo-series and type 1 core chain glycosphingolipids previously described in human embryonic stem cells, a number of type 2 core chain glycosphingolipids (neo-lactotetraosylceramide, the H type 2 pentaosylceramide, the Lex pentaosylceramide, and the Ley hexaosylceramide) were identified as well as the blood group A type 1 hexaosylceramide. Finally, the mono-, di-, and triglycosylceramides were characterized as galactosylceramide, glucosylceramide, lactosylceramide, galabiaosylceramide, globotriaosylceramide, and lactotriaosylceramide. Thus, the glycan diversity of human embryonic stem cells, including cell surface immune determinants, is more complex than previously appreciated.	[Barone, Angela; Breimer, Michael. E.] Sahlgrens Univ Hosp, Dept Surg, S-41345 Gothenburg, Sweden; [Benktander, John; Angstrom, Jonas; Teneberg, Susann] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, S-40530 Gothenburg, Sweden; [Aspegren, Anders; Bjorquist, Petter] Cellartis AB, Cellectis Stem Cells, S-41346 Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Takara Bio Inc.; Cellartis	Teneberg, S (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, POB 440, S-40530 Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se			Swedish Research Council [12628, 342-2004-4434]; Swedish Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This work was supported by Swedish Research Council Grant 12628, the Swedish Cancer Foundation, and governmental grants to the Sahlgrenska University Hospital.; The use of the LTQ linear quadrupole ion trap mass spectrometer (obtained by Swedish Research Council Grant 342-2004-4434 to Gunnar Hansson) and the Varian 600-MHz instrument at the Swedish NMR Centre, Hasselblad Laboratory, Goteborg University, is gratefully acknowledged.	Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Andrews PD, 2010, BIOCHEM J, V432, P21, DOI 10.1042/BJ20101022; Angstrom J, 2004, GLYCOBIOLOGY, V14, P1, DOI 10.1093/glycob/cwh003; Benktander J, 2012, J BIOL CHEM, V287, P31712, DOI 10.1074/jbc.M112.387654; BREIMER ME, 1982, J BIOL CHEM, V257, P906; Breimer ME, 2011, XENOTRANSPLANTATION, V18, P215, DOI 10.1111/j.1399-3089.2011.00644.x; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; CHEN C, 1989, BIOCHEMISTRY-US, V28, P2229, DOI 10.1021/bi00431a039; Chester MA, 1998, EUR J BIOCHEM, V257, P293; DABROWSKI J, 1988, CHEM PHYS LIPIDS, V49, P31, DOI 10.1016/0009-3084(88)90061-8; Diswall M, 2007, TRANSPLANTATION, V84, P1348, DOI 10.1097/01.tp.0000287599.46165.15; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FENDERSON BA, 1986, DEV BIOL, V114, P12, DOI 10.1016/0012-1606(86)90379-9; FENDERSON BA, 1987, DEV BIOL, V122, P21, DOI 10.1016/0012-1606(87)90328-9; GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369; HAKOMORI S, 1984, J BIOL CHEM, V259, P4672; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hallen U, 2008, GLYCOCONJUGATE J, V25, P561, DOI 10.1007/s10719-008-9113-0; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; HANSSON GC, 1983, J BIOL CHEM, V258, P4091; Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009; HOLGERSSON J, 1991, J BIOCHEM-TOKYO, V110, P120, DOI 10.1093/oxfordjournals.jbchem.a123530; HOLGERSSON J, 1990, J BIOCHEM-TOKYO, V108, P766, DOI 10.1093/oxfordjournals.jbchem.a123279; ITO M, 1989, J BIOL CHEM, V264, P9510; KANNAGI R, 1983, J BIOL CHEM, V258, P8934; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KOBATA A, 1992, EUR J BIOCHEM, V209, P483, DOI 10.1111/j.1432-1033.1992.tb17313.x; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; Li YT, 2009, GLYCOCONJUGATE J, V26, P929, DOI 10.1007/s10719-008-9125-9; Liang YJ, 2011, STEM CELLS, V29, P1995, DOI 10.1002/stem.750; Liang YJ, 2010, P NATL ACAD SCI USA, V107, P22564, DOI 10.1073/pnas.1007290108; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Robbe C, 2004, RAPID COMMUN MASS SP, V18, P412, DOI 10.1002/rcm.1352; SAMUELSSON BE, 1990, METHOD ENZYMOL, V193, P623, DOI 10.1016/0076-6879(90)93442-N; SCHNAAR RL, 2008, ESSENTIALS GLYCOBIOL, P129; Schwientek T, 1998, J BIOL CHEM, V273, P29331, DOI 10.1074/jbc.273.45.29331; Smith A, 1998, CURR BIOL, V8, pR802, DOI 10.1016/S0960-9822(07)00504-0; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Suila H, 2011, J MOL CELL BIOL, V3, P99, DOI 10.1093/jmcb/mjq041; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; TENEBERG S, 1994, J BIOL CHEM, V269, P8554; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Williams SA, 2009, GLYCOCONJUGATE J, V26, P335, DOI 10.1007/s10719-008-9181-1; Wright AJ, 2009, STEM CELL RES, V3, P3, DOI 10.1016/j.scr.2009.04.001; Yanagisawa M, 2011, NEUROCHEM RES, V36, P1623, DOI 10.1007/s11064-010-0358-1; ZHU ZM, 1995, BIOL REPROD, V52, P903, DOI 10.1095/biolreprod52.4.903	53	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10035	10050		10.1074/jbc.M112.436162	http://dx.doi.org/10.1074/jbc.M112.436162			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23404501	Green Published, hybrid			2022-12-25	WOS:000317114000042
J	Kosenko, T; Golder, M; Leblond, G; Weng, W; Lagace, TA				Kosenko, Tanja; Golder, Mia; Leblond, Geoffrey; Weng, Willy; Lagace, Thomas A.			Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LDL RECEPTOR; APOLIPOPROTEIN-B; SECRETED PCSK9; CHOLESTEROL; MUTATIONS; TARGET; IDENTIFICATION; DECREASES; CORRELATE; ANTIBODY	Proprotein convertase subtilisin/kexin type-9 (PCSK9) is a secreted protein that binds to the epidermal growth factor-like-A domain of the low density lipoprotein receptor (LDLR) and mediates LDLR degradation in liver. Gain-of-function mutations in PCSK9 are associated with autosomal dominant hypercholesterolemia in humans. Size-exclusion chromatography of human plasma has shown PCSK9 to be partly associated with undefined high molecular weight complexes within the LDL size range. We used density gradient centrifugation to isolate LDL in plasma pooled from 5 normolipidemic subjects and report that >40% of totalPCSK9was associated with LDL. Binding of fluorophore-labeled recombinant PCSK9 to isolated LDL in vitro was saturable with a K-D similar to 325 nM. This interaction was competed >95% by excess unlabeled PCSK9, and competition binding curves were consistent with a one-site binding model. An N-terminal region of the PCSK9 prodomain (amino acids 31-52) was required for binding to LDL in vitro. LDL dose-dependently inhibited binding and degradation of cell surface LDLRs by exogenous PCSK9 in HuH7 cells. LDL also inhibited PCSK9 binding to mutant LDLRs defective at binding LDL. These data suggest that association of PCSK9 with LDL particles in plasma lowers the ability of PCSK9 to bind to cell surface LDLRs, thereby blunting PCSK9-mediated LDLR degradation.	[Kosenko, Tanja; Golder, Mia; Leblond, Geoffrey; Weng, Willy; Lagace, Thomas A.] Univ Ottawa, Inst Heart, Dept Pathol & Lab Med, Ottawa, ON K1Y 4W7, Canada	University of Ottawa; University of Ottawa Heart Institute	Lagace, TA (corresponding author), Univ Ottawa, Inst Heart, Dept Pathol & Lab Med, 40 Ruskin St,Rm H-4213, Ottawa, ON K1Y 4W7, Canada.	tlagace@ottawaheart.ca		Weng, Willy/0000-0002-2848-5295	Heart and Stroke Foundation of Ontario [000120]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by Heart and Stroke Foundation of Ontario Grant-in-aid 000120 (to T.A.L.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2009, HUM MUTAT, V30, P520, DOI 10.1002/humu.20882; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Boren J, 1998, J CLIN INVEST, V101, P1084, DOI 10.1172/JCI1847; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Browning JD, 2010, J LIPID RES, V51, P3359, DOI 10.1194/jlr.P009860; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Davignon Jean, 2009, Trans Am Clin Climatol Assoc, V120, P163; Fan D, 2008, BIOCHEMISTRY-US, V47, P1631, DOI 10.1021/bi7016359; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Holla OL, 2011, BIOCHEM BIOPH RES CO, V406, P234, DOI 10.1016/j.bbrc.2011.02.023; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; INNERARITY TL, 1990, J LIPID RES, V31, P1337; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Karlsson H, 2005, PROTEOMICS, V5, P551, DOI 10.1002/pmic.200300938; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Lambert G, 2008, CLIN CHEM, V54, P1038, DOI 10.1373/clinchem.2007.099747; Luo Y, 2009, J LIPID RES, V50, P1581, DOI 10.1194/jlr.M800542-JLR200; MARCEL YL, 1988, ARTERIOSCLEROSIS, V8, P832, DOI 10.1161/01.ATV.8.6.832; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Mayne J, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-22; Mayne J, 2007, BIOCHEM BIOPH RES CO, V361, P451, DOI 10.1016/j.bbrc.2007.07.029; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Persson L, 2010, ARTERIOSCL THROM VAS, V30, P2666, DOI 10.1161/ATVBAHA.110.214130; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SCHNEIDER WJ, 1982, J BIOL CHEM, V257, P2664; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Sun H, 2012, ARTERIOSCL THROM VAS, V32, P1585, DOI 10.1161/ATVBAHA.112.250043; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144; Yee MS, 2008, J LIPID RES, V49, P1364, DOI 10.1194/jlr.D700044-JLR200; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	50	123	135	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8279	8288		10.1074/jbc.M112.421370	http://dx.doi.org/10.1074/jbc.M112.421370			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23400816	hybrid, Green Published			2022-12-25	WOS:000316564500028
J	Herkul, K; Kotta, J; Kutser, T; Vahtmae, E				Herkuel, Kristjan; Kotta, Jonne; Kutser, Tiit; Vahtmaee, Ele			Relating Remotely Sensed Optical Variability to Marine Benthic Biodiversity	PLOS ONE			English	Article							DIVERSITY; MACROALGAE; COMMUNITIES; PREFERENCES; REGRESSION; VEGETATION; ECOLOGY; BIOMASS; ISOPOD; ALPHA	Biodiversity is important in maintaining ecosystem viability, and the availability of adequate biodiversity data is a prerequisite for the sustainable management of natural resources. As such, there is a clear need to map biodiversity at high spatial resolutions across large areas. Airborne and spaceborne optical remote sensing is a potential tool to provide such biodiversity data. The spectral variation hypothesis (SVH) predicts a positive correlation between spectral variability (SV) of a remotely sensed image and biodiversity. The SVH has only been tested on a few terrestrial plant communities. Our study is the first attempt to apply the SVH in the marine environment using hyperspectral imagery recorded by Compact Airborne Spectrographic Imager (CASI). All coverage-based diversity measures of benthic macrophytes and invertebrates showed low but statistically significant positive correlations with SV whereas the relationship between biomass-based diversity measures and SV were weak or lacking. The observed relationships did not vary with spatial scale. SV had the highest independent effect among predictor variables in the statistical models of coverage-derived total benthic species richness and Shannon index. Thus, the relevance of SVH in marine benthic habitats was proved and this forms a prerequisite for the future use of SV in benthic biodiversity assessments.	[Herkuel, Kristjan; Kotta, Jonne; Kutser, Tiit; Vahtmaee, Ele] Univ Tartu, Estonian Marine Inst, Tallinn, Estonia	University of Tartu; Estonian Marine Institute	Herkul, K (corresponding author), Univ Tartu, Estonian Marine Inst, Tallinn, Estonia.	kristjan.herkyl@sea.ee	Kutser, Tiit/H-1304-2015; Herkül, Kristjan/G-5791-2016; Kotta, Jonne/B-5542-2009	Herkül, Kristjan/0000-0002-4356-8152; Kotta, Jonne/0000-0002-4970-6755; Kutser, Tiit/0000-0001-9679-1422	Central Baltic Interreg IVa Programme HISPARES; Estonian Research Council [IUT02-20]; Estonian Science Foundation [7813, 8254]; Environmental protection and technology programme of European Regional Fund [3.2.0802.11-0029]	Central Baltic Interreg IVa Programme HISPARES; Estonian Research Council(Estonian Research Council); Estonian Science Foundation; Environmental protection and technology programme of European Regional Fund	This work was funded by the Central Baltic Interreg IVa Programme HISPARES. The study was additionally supported by Institutional research funding IUT02-20 of the Estonian Research Council and by the Estonian Science Foundation grants 7813 and 8254. The study has been partly supported by the project "The status of marine biodiversity and its potential futures in the Estonian coastal sea" 3.2.0802.11-0029 of Environmental protection and technology programme of European Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrefouet S, 2004, MAR ECOL PROG SER, V283, P161, DOI 10.3354/meps283161; Asner GP, 2009, FRONT ECOL ENVIRON, V7, P269, DOI 10.1890/070152; Begin C, 2004, MAR ECOL PROG SER, V271, P121, DOI 10.3354/meps271121; Boero F, 2007, MAR ECOL-EVOL PERSP, V28, P134, DOI 10.1111/j.1439-0485.2007.00171.x; Carlson KM, 2007, ECOSYSTEMS, V10, P536, DOI 10.1007/s10021-007-9041-z; Ellis J, 2006, MAR ECOL PROG SER, V316, P69, DOI 10.3354/meps316069; Feilhauer H, 2009, APPL VEG SCI, V12, P429, DOI 10.1111/j.1654-109X.2009.01037.x; Foody GM, 2003, J BIOGEOGR, V30, P1053, DOI 10.1046/j.1365-2699.2003.00887.x; Gogina M, 2010, J MARINE SYST, V80, P57, DOI 10.1016/j.jmarsys.2009.10.001; Gustafsson C, 2011, OIKOS, V120, P1037, DOI 10.1111/j.1600-0706.2010.19008.x; Hansen JP, 2008, ESTUAR COAST SHELF S, V77, P535, DOI 10.1016/j.ecss.2007.10.013; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Helsinki Commission (HELCOM), 2008, MAN MAR MON COMBINE; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Innes JL, 1998, GLOBAL ECOL BIOGEOGR, V7, P397, DOI 10.2307/2997712; Isuus M., 2008, WAVE EXPOSURE CALCUL; Jormalainen V, 2001, MAR ECOL PROG SER, V220, P219, DOI 10.3354/meps220219; Knudby A, 2010, REMOTE SENS ENVIRON, V114, P1230, DOI 10.1016/j.rse.2010.01.007; Kotta J, 2000, INT REV HYDROBIOL, V85, P697; Kotta J, 2001, ANN ZOOL FENN, V38, P163; Kotta J., 2008, V197, P217, DOI 10.1007/978-3-540-73524-3_10; Kutser T, 2006, ESTUAR COAST SHELF S, V67, P521, DOI 10.1016/j.ecss.2005.12.004; Kutser Tiit, 2006, Proceedings of the Estonian Academy of Sciences Biology Ecology, V55, P329; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Mac Nally R, 1996, AUST J ECOL, V21, P224; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; McCullagh P., 1989, GEN LINEAR MODELS; Mumby PJ, 1999, J ENVIRON MANAGE, V55, P157, DOI 10.1006/jema.1998.0255; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Oldeland J, 2010, ECOL INDIC, V10, P390, DOI 10.1016/j.ecolind.2009.07.012; Orav-Kotta H, 2004, HYDROBIOLOGIA, V514, P79, DOI 10.1023/B:hydr.0000018208.72394.09; Palmer M.W., 2000, COOPERATION LONG TER, P123; Palmer MW, 2002, ENVIRONMETRICS, V13, P121, DOI 10.1002/env.516; Parker JD, 2001, MAR ECOL PROG SER, V224, P55, DOI 10.3354/meps224055; Purkis SJ, 2008, CORAL REEFS, V27, P167, DOI 10.1007/s00338-007-0306-y; R Foundation for Statistical Computing, 2010, R VERS 2 11 1; Ricotta C, 1999, INT J REMOTE SENS, V20, P3367, DOI 10.1080/014311699211381; Rocchini D, 2007, REMOTE SENS ENVIRON, V111, P423, DOI 10.1016/j.rse.2007.03.018; Sandman A, 2008, J MARINE SYST, V74, pS86, DOI 10.1016/j.jmarsys.2008.03.028; Silva TSF, 2008, ENVIRON MONIT ASSESS, V140, P131, DOI 10.1007/s10661-007-9855-3; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Vis C, 2003, AQUAT BOT, V77, P187, DOI 10.1016/S0304-3770(03)00105-0; White JC, 2010, REMOTE SENS ENVIRON, V114, P1576, DOI 10.1016/j.rse.2010.02.012; Willems W, 2008, ECOL MODEL, V212, P74, DOI 10.1016/j.ecolmodel.2007.10.017; Young MA, 2010, MAR ECOL PROG SER, V415, P247, DOI 10.3354/meps08760	46	20	21	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55624	10.1371/journal.pone.0055624	http://dx.doi.org/10.1371/journal.pone.0055624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405180	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400125
J	Li, L; Mori, S; Sakamoto, M; Takahashi, S; Kodama, T				Li, Li; Mori, Shiro; Sakamoto, Maya; Takahashi, Shoki; Kodama, Tetsuya			Mouse Model of Lymph Node Metastasis via Afferent Lymphatic Vessels for Development of Imaging Modalities	PLOS ONE			English	Article							HIGH-FREQUENCY ULTRASOUND; ISOLATED TUMOR-CELLS; BREAST-CANCER; IN-VIVO; PRECLINICAL MODELS; FAS LIGAND; MICE; MICROMETASTASES; CARCINOMA; ANGIOGENESIS	Animal studies of lymph node metastasis are constrained by limitations in the techniques available for noninvasive monitoring of the progression of lymph node metastasis, as well as difficulties in the establishment of appropriate animal models. To overcome these challenges, this study has developed a mouse model of inter-lymph-node metastasis via afferent lymphatic vessels for use in the development of imaging modalities. We used 14- to 18-week-old MRL/MpJ-/lpr/lpr (MRL/lpr) mice exhibiting remarkable systemic lymphadenopathy, with proper axillary lymph nodes (proper-ALNs) and subiliac lymph nodes (SiLNs) that are 6 to 12 mm in diameter (similar in size to human lymph nodes). When KM-Luc/GFP malignant fibrous histiocytoma-like cells stably expressing the firefly luciferase gene were injected into the SiLN, metastasis could be detected in the proper-ALN within 3 to 9 days, using in vivo bioluminescence imaging. The metastasis route was found to be via the efferent lymphatic vessels of the SiLN, and metastasis incidence depended on the number of cells injected, the injection duration and the SiLN volume. Three-dimensional contrast-enhanced high-frequency ultrasound imaging showed that the blood vessel volume and density in the metastasized proper-ALN significantly increased at 14 days after tumor cell inoculation into the SiLN. The present metastasis model, with lymph nodes similar in size to those of humans, has potential use in the development of ultrasound imaging with high-precision and high-sensitivity as well as other imaging modalities for the detection of blood vessels in lymph nodes during the progression of metastasis.	[Li, Li; Kodama, Tetsuya] Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Engn, Sendai, Miyagi 980, Japan; [Li, Li; Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 980, Japan; [Mori, Shiro] Tohoku Univ Hosp, Dept Oral & Maxillofacial Surg, Sendai, Miyagi, Japan; [Sakamoto, Maya] Tohoku Univ, Grad Sch Dent, Dept Oral Diag, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kodama, T (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Dept Biomed Engn, Sendai, Miyagi 980, Japan.	kodama@bme.tohoku.ac.jp	Kodama, Tetsuya/T-2246-2019	Kodama, Tetsuya/0000-0003-4727-9558	 [22390378];  [24659884];  [21390500];  [24659834];  [23300183];  [24650286]; Grants-in-Aid for Scientific Research [23300183] Funding Source: KAKEN	; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The following funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.jsps.go.jp/english/e-grants/grants01.html Grant-in-Aid for Scientific Research (B) (22390378) Grant-in-Aid for Challenging Exploratory Research (24659884) Grant-in-Aid for Scientific Research (B) (21390500) Grant-in-Aid for Challenging Exploratory Research (24659834) Grant-in-Aid for Scientific Research (B) (23300183) Grant-in-Aid for Challenging Exploratory Research (24650286)	Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Burton JB, 2008, NAT MED, V14, P882, DOI 10.1038/nm.1727; Castelijns JA, 2001, AM J NEURORADIOL, V22, P3; Chen SL, 2007, ANN SURG ONCOL, V14, P3378, DOI 10.1245/s10434-007-9513-6; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; de Boer M, 2009, NEW ENGL J MED, V361, P653, DOI 10.1056/NEJMoa0904832; Dickson PV, 2007, J PEDIATR SURG, V42, P1172, DOI 10.1016/j.jpedsurg.2007.02.027; Dieter M, 2003, LYMPHOLOGY, V36, P39; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; du Toit LC, 2011, PHARM RES-DORDR, V28, P494, DOI 10.1007/s11095-010-0247-y; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Furukawa H, 2009, AM J IMMUNOL, V5, P89; Graham KC, 2005, CANCER RES, V65, P5231, DOI 10.1158/0008-5472.CAN-05-0440; GYOTOKU Y, 1987, J IMMUNOL, V138, P3785; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hansen NM, 2009, J CLIN ONCOL, V27, P4679, DOI 10.1200/JCO.2008.19.0686; Hasegawa H, 2003, ARTHRITIS RHEUM, V48, P2555, DOI 10.1002/art.11231; Hayashi K, 2007, CANCER RES, V67, P8223, DOI 10.1158/0008-5472.CAN-07-1237; Huyn ST, 2009, CLIN CANCER RES, V15, P3126, DOI 10.1158/1078-0432.CCR-08-2666; Ito Y, 2010, CANCER SCI, V101, P1853, DOI 10.1111/j.1349-7006.2010.01607.x; Kasuya H, 2005, CANCER RES, V65, P3823, DOI 10.1158/0008-5472.CAN-04-2631; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Kiessling F, 2005, EUR RADIOL, V15, P1079, DOI 10.1007/s00330-005-2701-5; Kodama T, 2011, CANCER RES, V71, P6957, DOI 10.1158/0008-5472.CAN-11-2389; Kodama T, 2010, ULTRASOUND MED BIOL, V36, P1196, DOI 10.1016/j.ultrasmedbio.2010.04.016; Kodama T, 2010, J ELECTRON MICROSC, V59, P187, DOI 10.1093/jmicro/dfp056; Kozaki K, 2000, CANCER RES, V60, P2535; Loveless ME, 2008, J ULTRAS MED, V27, P1699, DOI 10.7863/jum.2008.27.12.1699; Lutman CV, 2006, GYNECOL ONCOL, V102, P92, DOI 10.1016/j.ygyno.2005.11.032; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Murphy ED, 1978, AUTOIMMUNIY LYMPHOPR, P207; NAGATA S, 1994, PHILOS T ROY SOC B, V345, P281, DOI 10.1098/rstb.1994.0107; Nathanson SD, 2007, CANCER TREAT RES, P129; Poon RTP, 2002, J CLIN ONCOL, V20, P1775, DOI 10.1200/JCO.2002.07.089; Ran S, 2010, PATHOPHYSIOLOGY, V17, P229, DOI DOI 10.1016/J.PATH0PHYS.2009.11.003; Rofstad EK, 2002, CANCER RES, V62, P661; Roitt I., 2001, IMMUNOLOGY, V6th; Servais EL, 2011, J MOL MED, V89, P753, DOI 10.1007/s00109-011-0764-0; Soltesz EG, 2005, ANN THORAC SURG, V79, P269, DOI 10.1016/j.athoracsur.2004.06.055; Swirski FK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001075; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; THOMPSON SC, 1974, BRIT J CANCER, V30, P332, DOI 10.1038/bjc.1974.201; TOKER C, 1963, CANCER, V16, P364, DOI 10.1002/1097-0142(196303)16:3<364::AID-CNCR2820160311>3.0.CO;2-K; Unno N, 2008, EUR J VASC ENDOVASC, V35, P205, DOI 10.1016/j.ejvs.2007.09.001; Uribarrena-Amezaga R, 2010, REV ESP ENFERM DIG, V102, P176, DOI 10.4321/s1130-01082010000300004; Vakoc BJ, 2012, NAT REV CANCER, V12, P363, DOI 10.1038/nrc3235; van den Brekel MWM, 1998, AM J NEURORADIOL, V19, P695; van Deurzen CHM, 2008, J NATL CANCER I, V100, P1574, DOI 10.1093/jnci/djn343; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Williams AD, 2001, AM J ROENTGENOL, V177, P343, DOI 10.2214/ajr.177.2.1770343; Williams Peter L, 1973, ANGIOLOGY, P588	52	60	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55797	10.1371/journal.pone.0055797	http://dx.doi.org/10.1371/journal.pone.0055797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405215	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400160
J	Pomschar, A; Koerte, I; Lee, S; Laubender, RP; Straube, A; Heinen, F; Ertl-Wagner, B; Alperin, N				Pomschar, Andreas; Koerte, Inga; Lee, Sang; Laubender, Ruediger P.; Straube, Andreas; Heinen, Florian; Ertl-Wagner, Birgit; Alperin, Noam			MRI Evidence for Altered Venous Drainage and Intracranial Compliance in Mild Traumatic Brain Injury	PLOS ONE			English	Article							PHASE-CONTRAST MRI; HEAD-INJURY; BLOOD-FLOW; PHYSIOLOGY; OUTFLOW; HUMANS; SYSTEM; ICP	Purpose: To compare venous drainage patterns and associated intracranial hydrodynamics between subjects who experienced mild traumatic brain injury (mTBI) and age-and gender-matched controls. Methods: Thirty adult subjects (15 with mTBI and 15 age- and gender-matched controls) were investigated using a 3T MR scanner. Time since trauma was 0.5 to 29 years (mean 11.4 years). A 2D-time-of-flight MR-venography of the upper neck was performed to visualize the cervical venous vasculature. Cerebral venous drainage through primary and secondary channels, and intracranial compliance index and pressure were derived using cine-phase contrast imaging of the cerebral arterial inflow, venous outflow, and the craniospinal CSF flow. The intracranial compliance index is the defined as the ratio of maximal intracranial volume and pressure changes during the cardiac cycle. MR estimated ICP was then obtained through the inverse relationship between compliance and ICP. Results: Compared to the controls, subjects with mTBI demonstrated a significantly smaller percentage of venous outflow through internal jugular veins (60.9+/-21% vs. controls: 76.8+/-10%; p=0.01) compensated by an increased drainage through secondary veins (12.3+/-10.9% vs. 5.5+/-3.3%; p<0.03). Mean intracranial compliance index was significantly lower in the mTBI cohort (5.8+/-1.4 vs. controls 8.4+/-1.9; p<0.0007). Consequently, MR estimate of intracranial pressure was significantly higher in the mTBI cohort (12.5+/-2.9 mmHg vs. 8.8+/-2.0 mmHg; p<0.0007). Conclusions: mTBI is associated with increased venous drainage through secondary pathways. This reflects higher outflow impedance, which may explain the finding of reduced intracranial compliance. These results suggest that hemodynamic and hydrodynamic changes following mTBI persist even in the absence of clinical symptoms and abnormal findings in conventional MR imaging.	[Pomschar, Andreas; Koerte, Inga; Ertl-Wagner, Birgit] Univ Munich, Inst Clin Radiol, Munich, Germany; [Lee, Sang; Alperin, Noam] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA; [Laubender, Ruediger P.] Univ Munich, Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Straube, Andreas] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Heinen, Florian] Univ Munich, Dept Pediat Neurol Dev Med, Dr von Hauners Childrens Hosp, Munich, Germany	University of Munich; University of Miami; University of Munich; University of Munich; University of Munich	Alperin, N (corresponding author), Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA.	nalperin@med.miami.edu	Heinen, Florian/B-6594-2015; Ertl-Wagner, Birgit/AAD-5708-2020; Koerte, Inga Katharina/AAW-3031-2021	Heinen, Florian/0000-0002-3872-6136; Ertl-Wagner, Birgit/0000-0002-7896-7049	National Institutes of Health [R01 NS05212]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health award R01 NS05212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperin N, 2005, ACTA NEUROCHIR SUPPL, V95, P191; Alperin N, 2005, ACT NEUR S, V95, P129; Alperin N, 2005, J MAGN RESON IMAGING, V22, P591, DOI 10.1002/jmri.20427; Alperin N, 2003, MAGNET RESON MED, V49, P934, DOI 10.1002/mrm.10455; Alperin N, 2002, P INT SOC MAG RESON, P2; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Bailey DM, 2012, CLIN SCI LOND; BATSON OV, 1957, AMER J ROENTGENOL RA, V78, P195; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Doepp F, 2004, NEURORADIOLOGY, V46, P565, DOI 10.1007/s00234-004-1213-3; Ertl-Wagner B, 2012, MULT SCLER J, V18, P1000, DOI 10.1177/1352458511432742; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Kivioja J, 2001, J CLIN IMMUNOL, V21, P272, DOI 10.1023/A:1010931309088; Koerte IK, 2011, INVEST RADIOL; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P289; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Miyati T, 2007, J MAGN RESON IMAGING, V26, P274, DOI 10.1002/jmri.20999; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Piccio L, 2005, J IMMUNOL, V174, P5805, DOI 10.4049/jimmunol.174.9.5805; Piechnik SK, 2001, NEUROSURGERY, V49, P1214, DOI 10.1097/00006123-200111000-00034; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Stoquart-ElSankari S, 2009, J CEREBR BLOOD F MET, V29, P1208, DOI [10.1038/jcbfm.2009.29, 10.1038/sj.jcbfm.jcbfm200929]; Tain RW, 2009, J MAGN RESON IMAGING, V30, P878, DOI 10.1002/jmri.21925; Tain RW, 2009, IEEE T BIO-MED ENG, V56, P544, DOI 10.1109/TBME.2008.2006010; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Zhang K, 2010, EXP BRAIN RES	37	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55447	10.1371/journal.pone.0055447	http://dx.doi.org/10.1371/journal.pone.0055447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405151	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400096
J	Tang, J; Agrawal, T; Cheng, Q; Qu, LK; Brewer, MD; Chen, JD; Yang, XL				Tang, Jun; Agrawal, Trisha; Cheng, Qian; Qu, Like; Brewer, Michael D.; Chen, Jiandong; Yang, Xiaolu			Phosphorylation of Daxx by ATM Contributes to DNA Damage-Induced p53 Activation	PLOS ONE			English	Article							REGULATING MDM2; PROTEIN; OLIGOMERIZATION; CHECKPOINT; PROMOTES; KINASES; COMPLEX; MICE	p53 plays a central role in tumor suppression. It does so by inducing anti-proliferative processes as a response to various tumor-promoting stresses. p53 is regulated by the ubiquitin ligase Mdm2. The optimal function of Mdm2 requires Daxx, which stabilizes Mdm2 through the deubiquitinase Hausp/USP7 and also directly promotes Mdm2's ubiquitin ligase activity towards p53. The Daxx-Mdm2 interaction is disrupted upon DNA damage. However, both the mechanisms and the consequence of the Daxx-Mdm2 dissociation are not understood. Here we show that upon DNA damage Daxx is phosphorylated in a manner that is dependent on ATM, a member of the PI 3-kinase family that orchestrates the DNA damage response. The main phosphorylation site of Daxx is identified to be Ser564, which is a direct target of ATM. Phosphorylation of endogenous Daxx at Ser564 occurs rapidly during the DNA damage response and precedes p53 activation. Blockage of this phosphorylation event prevents the separation of Daxx from Mdm2, stabilizes Mdm2, and inhibits DNA damage-induced p53 activation. These results suggest that phosphorylation of Daxx by ATM upon DNA damage disrupts the Daxx-Mdm2 interaction and facilitates p53 activation.	[Tang, Jun; Agrawal, Trisha; Qu, Like; Brewer, Michael D.; Yang, Xiaolu] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Tang, Jun; Agrawal, Trisha; Qu, Like; Brewer, Michael D.; Yang, Xiaolu] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Cheng, Qian; Chen, Jiandong] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Mol Oncol, Tampa, FL 33682 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Yang, XL (corresponding author), Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA.	xyang@mail.med.upenn.edu			National Institutes of Health [CA088868]; Department of Defense [W81XWH-07-1-0336]; NATIONAL CANCER INSTITUTE [T32CA009140, R01CA088868, P30CA016520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Institutes of Health (CA088868) and Department of Defense (W81XWH-07-1-0336) grants to XY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Chehab NH, 2000, GENE DEV, V14, P278; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Shieh SY, 2000, GENE DEV, V14, P289; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; Song JJ, 2003, J BIOL CHEM, V278, P47245, DOI 10.1074/jbc.M213201200; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037	27	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55813	10.1371/journal.pone.0055813	http://dx.doi.org/10.1371/journal.pone.0055813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405218	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400163
J	Mattsson, BJ; Zipkin, EF; Gardner, B; Blank, PJ; Sauer, JR; Royle, JA				Mattsson, Brady J.; Zipkin, Elise F.; Gardner, Beth; Blank, Peter J.; Sauer, John R.; Royle, J. Andrew			Explaining Local-Scale Species Distributions: Relative Contributions of Spatial Autocorrelation and Landscape Heterogeneity for an Avian Assemblage	PLOS ONE			English	Article							FOREST FRAGMENTATION; OCCUPANCY MODELS; BIRDS; INFERENCE; RICHNESS	Understanding interactions between mobile species distributions and landcover characteristics remains an outstanding challenge in ecology. Multiple factors could explain species distributions including endogenous evolutionary traits leading to conspecific clustering and endogenous habitat features that support life history requirements. Birds are a useful taxon for examining hypotheses about the relative importance of these factors among species in a community. We developed a hierarchical Bayes approach to model the relationships between bird species occupancy and local landcover variables accounting for spatial autocorrelation, species similarities, and partial observability. We fit alternative occupancy models to detections of 90 bird species observed during repeat visits to 316 point-counts forming a 400-m grid throughout the Patuxent Wildlife Research Refuge in Maryland, USA. Models with landcover variables performed significantly better than our autologistic and null models, supporting the hypothesis that local landcover heterogeneity is important as an exogenous driver for species distributions. Conspecific clustering alone was a comparatively poor descriptor of local community composition, but there was evidence for spatial autocorrelation in all species. Considerable uncertainty remains whether landcover combined with spatial autocorrelation is most parsimonious for describing bird species distributions at a local scale. Spatial structuring may be weaker at intermediate scales within which dispersal is less frequent, information flows are localized, and landcover types become spatially diversified and therefore exhibit little aggregation. Examining such hypotheses across species assemblages contributes to our understanding of community-level associations with conspecifics and landscape composition.	[Mattsson, Brady J.] US Geol Survey, Western Ecol Res Ctr, Sacramento, CA USA; [Zipkin, Elise F.; Blank, Peter J.; Sauer, John R.; Royle, J. Andrew] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Gardner, Beth] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of North Carolina; North Carolina State University	Mattsson, BJ (corresponding author), Univ Nat Resources & Life Sci, Dept Forest & Soil Sci, Vienna, Austria.	brady.mattsson@gmail.com	Mattsson, Brady/K-1688-2015	Mattsson, Brady/0000-0002-3182-9538; Royle, Jeffrey/0000-0003-3135-2167; Zipkin, Elise/0000-0003-4155-6139				Ando T, 2007, BIOMETRIKA, V94, P443, DOI 10.1093/biomet/asm017; Bahn V, 2006, ECOGRAPHY, V29, P835, DOI 10.1111/j.2006.0906-7590.04621.x; Betts MG, 2006, ECOL MODEL, V191, P197, DOI 10.1016/j.ecolmodel.2005.04.027; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Boulinier T, 2001, ECOLOGY, V82, P1159, DOI 10.1890/0012-9658(2001)082[1159:FFABCD]2.0.CO;2; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Bull EL, 1995, BIRDS N AM, V148, P1; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Campomizzi AJ, 2008, J WILDLIFE MANAGE, V72, P331, DOI 10.2193/2007-204; Carroll C, 2010, CONSERV BIOL, V24, P1538, DOI 10.1111/j.1523-1739.2010.01528.x; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; De Wan AA, 2009, BIOL CONSERV, V142, P982, DOI 10.1016/j.biocon.2008.12.032; Doherty PF, 2003, P NATL ACAD SCI USA, V100, P5858, DOI 10.1073/pnas.0836953100; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Dorazio RM, 2010, ECOLOGY, V91, P2466, DOI 10.1890/09-1033.1; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hahn BA, 2007, ANIM CONSERV, V10, P436, DOI 10.1111/j.1469-1795.2007.00128.x; Hartley S, 2004, P ROY SOC B-BIOL SCI, V271, P81, DOI 10.1098/rspb.2003.2531; Kearney R. F., 2003, PARTNERS FLIGHT LAND; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maryland Department of Natural Resources, 2007, NAT AGR IM PROGR NAI; Mattsson BJ, 2009, P 4 INT PARTN FLIGHT, P617; Mcgowan KJ, 2001, BIRDS N AM ONLINE; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Mordecai RS, 2011, J APPL ECOL, V48, P56, DOI 10.1111/j.1365-2664.2010.01921.x; O'Connell TJ, 2000, ECOL APPL, V10, P1706, DOI 10.2307/2641233; Proches S, 2010, ECOGRAPHY, V33, P128, DOI 10.1111/j.1600-0587.2009.06035.x; ROBBINS CS, 1989, WILDLIFE MONOGR, P1; Roberge JM, 2006, BIOL CONSERV, V130, P134, DOI 10.1016/j.biocon.2005.12.008; Rodewald AD, 2003, WILDLIFE SOC B, V31, P586; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2007, ECOL MONOGR, V77, P465, DOI 10.1890/06-0912.1; Sauer JR, 2012, J WILDLIFE IN PRESS; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thogmartin WE, 2007, LANDSCAPE ECOL, V22, P61, DOI 10.1007/s10980-006-9005-2; Verbeek N. A., 2002, BIRDS N AM ONLINE; Vogelmann JE, 2001, PHOTOGRAMM ENG REM S, V67, P650; Wagner HH, 2005, ECOLOGY, V86, P1975, DOI 10.1890/04-0914; Wiebe K. L., 2008, BIRDS N AM ONLINE; Zipkin EF, 2012, ECOL APPL, V22, P1962, DOI 10.1890/11-1936.1; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	53	22	24	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55097	10.1371/journal.pone.0055097	http://dx.doi.org/10.1371/journal.pone.0055097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393564	gold, Green Published, Green Submitted			2022-12-25	WOS:000314692800018
J	Nawijn, MC; Motta, AC; Gras, R; Shirinbak, S; Maazi, H; van Oosterhout, AJM				Nawijn, Martijn C.; Motta, Alexandre C.; Gras, Renee; Shirinbak, Soheila; Maazi, Hadi; van Oosterhout, Antoon J. M.			TLR-2 Activation Induces Regulatory T Cells and Long-Term Suppression of Asthma Manifestations in Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ALLERGIC AIRWAY INFLAMMATION; DENDRITIC CELLS; IMMUNE REGULATION; EPITHELIAL-CELLS; PROTEIN-KINASE; CUTTING EDGE; C-FOS; RESPONSES; TOLL-LIKE-RECEPTOR-2	Asthma is a chronic inflammatory disease of the airways characterized by variable airway obstruction and airway hyperresponsiveness (AHR). The T regulatory (Treg) cell subset is critically important for the regulation of immune responses. Adoptive transfer of Treg cells has been shown to be sufficient for the suppression of airway inflammation in experimental allergic asthma. Intervention strategies aimed at expanding the Treg cell population locally in the airways of sensitized individuals are therefore of high interest as a potential therapeutic treatment for allergic airway disease. Here, we aim to test whether long-term suppression of asthma manifestations can be achieved by locally expanding the Treg cell subset via intranasal administration of a TLR-2 agonist. To model therapeutic intervention aimed at expanding the endogenous Treg population in a sensitized host, we challenged OVA-sensitized mice by OVA inhalation with concomitant intranasal instillation of the TLR-2 agonist Pam3Cys, followed by an additional series of OVA challenges. Pam3Cys treatment induced an acute but transient aggravation of asthma manifestations, followed by a reduction or loss of AHR to methacholine, depending on the time between Pam3Cys treatment and OVA challenges. In addition, Pam3Cys-treatment induced significant reductions of eosinophils and increased numbers of Treg cells in the lung infiltrates. Our data show that, despite having adverse acute effects, TLR2 agonist treatment as a therapeutic intervention induces an expansion of the Treg cell population in the lungs and results in long-term protection against manifestation of allergic asthma upon subsequent allergen provocation. Our data indicate that local expansion of Tregs in allergic airway disease is an interesting therapeutic approach that warrants further investigation.	[Nawijn, Martijn C.; Motta, Alexandre C.; Gras, Renee; Shirinbak, Soheila; Maazi, Hadi; van Oosterhout, Antoon J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Lab Allergol & Pulm Dis,GRIAC Res Inst, Groningen, Netherlands	University of Groningen	Nawijn, MC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Lab Allergol & Pulm Dis,GRIAC Res Inst, Groningen, Netherlands.	m.c.nawijn@umcg.nl		Maazi, Hadi/0000-0002-8979-3769; Nawijn, Martijn/0000-0003-3372-6521	Netherlands Asthma Foundation [NAF 03.54]	Netherlands Asthma Foundation	This study was financially supported by the Netherlands Asthma Foundation (NAF 03.54). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Armstrong L, 2004, AM J RESP CELL MOL, V31, P241, DOI 10.1165/rcmb.2004-0078OC; Baru AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047102; Boudousquie C, 2009, CLIN EXP ALLERGY, V39, P1415, DOI 10.1111/j.1365-2222.2009.03314.x; Burchell JT, 2009, AM J PHYSIOL-LUNG C, V296, pL307, DOI 10.1152/ajplung.00521.2007; Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Fuchs Barbara, 2008, J Occup Med Toxicol, V3 Suppl 1, pS5, DOI 10.1186/1745-6673-3-S1-S5; Gomez MI, 2008, PEDIATR PULM, V43, P11, DOI 10.1002/ppul.20735; Inman MD, 2010, CLIN EXP ALLERGY, V40, P524, DOI 10.1111/j.1365-2222.2010.03485.x; Issa R, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-30; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jaffar Z, 2004, J IMMUNOL, V172, P3842, DOI 10.4049/jimmunol.172.6.3842; Kearley J, 2008, J ALLERGY CLIN IMMUN, V122, P617, DOI 10.1016/j.jaci.2008.05.048; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Liu GW, 2007, IMMUNOLOGY, V122, P149, DOI 10.1111/j.1365-2567.2007.02651.x; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Luhrmann A, 2005, VACCINE, V23, P4721, DOI 10.1016/j.vaccine.2005.05.009; Maazi H, 2012, CLIN EXP ALLERGY, V42, P1519, DOI 10.1111/j.1365-2222.2012.04064.x; Motta AC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-93; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Nawijn MC, 2011, AM J RESP CELL MOL, V45, P295, DOI 10.1165/rcmb.2009-0369OC; Ouabed A, 2008, J IMMUNOL, V180, P5862, DOI 10.4049/jimmunol.180.9.5862; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Ryanna K, 2009, ALLERGY, V64, P335, DOI 10.1111/j.1398-9995.2009.01972.x; Shirinbak S, 2010, J IMMUNOL, V185, P3857, DOI 10.4049/jimmunol.0903909; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Ueno K, 2008, AM J RESP CELL MOL, V38, P263, DOI 10.1165/rcmb.2007-0336RC; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Wong CK, 2007, AM J RESP CELL MOL, V37, P85, DOI 10.1165/rcmb.2006-0457OC; Xystrakis E, 2007, CURR OPIN ALLERGY CL, V7, P535, DOI 10.1097/ACI.0b013e3282f14d7c	40	39	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55307	10.1371/journal.pone.0055307	http://dx.doi.org/10.1371/journal.pone.0055307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393567	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800021
J	Merkx, MAG; Huberts, W; Bosboom, EMH; Bode, AS; Bescos, JO; Tordoir, JHM; Breeuwer, M; van de Vosse, FN				Merkx, Maarten A. G.; Huberts, Wouter; Bosboom, E. Marielle H.; Bode, Aron S.; Bescos, Javier Olivan; Tordoir, Jan H. M.; Breeuwer, Marcel; van de Vosse, Frans N.			The Benefit of Non Contrast-Enhanced Magnetic Resonance Angiography for Predicting Vascular Access Surgery Outcome: A Computer Model Perspective	PLOS ONE			English	Article							PULSE-WAVE PROPAGATION; STAGE RENAL-DISEASE; BLOOD-FLOW; EXPERIMENTAL VALIDATION; ARTERIOVENOUS-FISTULAS; HEMODYNAMICS; ACCURACY; VESSELS	Introduction: Vascular access (VA) surgery, a prerequisite for hemodialysis treatment of end-stage renal-disease (ESRD) patients, is hampered by complication rates, which are frequently related to flow enhancement. To assist in VA surgery planning, a patient-specific computer model for postoperative flow enhancement was developed. The purpose of this study is to assess the benefit of non contrast-enhanced magnetic resonance angiography (NCE-MRA) data as patient-specific geometrical input for the model-based prediction of surgery outcome. Methods: 25 ESRD patients were included in this study. All patients received a NCE-MRA examination of the upper extremity blood vessels in addition to routine ultrasound (US). Local arterial radii were assessed from NCE-MRA and converted to model input using a linear fit per artery. Venous radii were determined with US. The effect of radius measurement uncertainty on model predictions was accounted for by performing Monte-Carlo simulations. The resulting flow prediction interval of the computer model was compared with the postoperative flow obtained from US. Patients with no overlap between model-based prediction and postoperative measurement were further analyzed to determine whether an increase in geometrical detail improved computer model prediction. Results: Overlap between postoperative flows and model-based predictions was obtained for 71% of patients. Detailed inspection of non-overlapping cases revealed that the geometrical details that could be assessed from NCE-MRA explained most of the differences, and moreover, upon addition of these details in the computer model the flow predictions improved. Conclusions: The results demonstrate clearly that NCE-MRA does provide valuable geometrical information for VA surgery planning. Therefore, it is recommended to use this modality, at least for patients at risk for local or global narrowing of the blood vessels as well as for patients for whom an US-based model prediction would not overlap with surgical choice, as the geometrical details are crucial for obtaining accurate flow predictions.	[Merkx, Maarten A. G.; Bosboom, E. Marielle H.] Maastricht Univ, Med Ctr, Dept Biomed Engn, Maastricht, Netherlands; [Huberts, Wouter; Breeuwer, Marcel; van de Vosse, Frans N.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Bode, Aron S.; Tordoir, Jan H. M.] Maastricht Univ, Med Ctr, Dept Vasc Surg, Maastricht, Netherlands; [Bescos, Javier Olivan] Philips Healthcare, Dept Intervent Xray, Best, Netherlands; [Breeuwer, Marcel] Philips Healthcare, Dept MR Clin Sci, Best, Netherlands	Maastricht University; Eindhoven University of Technology; Maastricht University; Philips; Philips Healthcare; Philips; Philips Healthcare	Merkx, MAG (corresponding author), Maastricht Univ, Med Ctr, Dept Biomed Engn, Maastricht, Netherlands.	m.a.g.merkx@alumnus.tue.nl	van de Vosse, Frans N/I-4006-2013; Tordoir, Jan/AAE-4083-2020	van de Vosse, Frans N/0000-0002-4084-2064; Huberts, Wouter/0000-0002-0779-4785	ARCH project [ICT-224390]; European Commission	ARCH project; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was carried out in the context of the ARCH project (ICT-224390) funded by the 7th Framework programme of the European Commission (http://ec.europa.eu/information_society/activities/health/research/fp7vph/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; [Anonymous], 2006, AM J KIDNEY DIS, V48, pS4, DOI 10.1053/j.ajkd.2006.07.015; Bessems D., 2007, THESIS EINDHOVEN U T; Bessems D, 2007, J FLUID MECH, V580, P145, DOI 10.1017/S0022112007005344; Bode A, 2011, J VASC ACCESS, V12, P369, DOI 10.5301/JVA.2011.8382; Bode AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034491; Bode AS, 2011, EUR J VASC ENDOVASC, P88; Dammers R, 2005, ULTRASOUND MED BIOL, V31, P1327, DOI 10.1016/j.ultrasmedbio.2005.03.017; Deschamps T., 2001, THESIS U PARIS 9 DAU; Gjesdal KI, 2009, EUR RADIOL, V19, P110, DOI 10.1007/s00330-008-1113-8; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Grassmann A, 2006, ARTIF ORGANS, V30, P895, DOI 10.1111/j.1525-1594.2006.00321.x; HAACKE EM, 1990, RADIOLOGY, V175, P545, DOI 10.1148/radiology.175.2.2326480; Hoogeveen RM, 1998, JMRI-J MAGN RESON IM, V8, P1228, DOI 10.1002/jmri.1880080608; Huberts W, 2012, J BIOMECH, V45, P1684, DOI 10.1016/j.jbiomech.2012.03.028; Huberts W, 2012, MED ENG PHYS UNPUB; Huberts W, 2011, MED ENG PHYS; HUDSON DJ, 1966, J AM STAT ASSOC, V61, P1097, DOI 10.2307/2283203; Kroon JW, 2012, COMPUTATION IN PRESS; Kumar V, 2007, ROBBINS BASIC PATHOL; Lotz J, 2002, RADIOGRAPHICS, V22, P651, DOI 10.1148/radiographics.22.3.g02ma11651; Malovrh M, 1998, NEPHROL DIAL TRANSPL, V13, P125, DOI 10.1093/ndt/13.1.125; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Merkx M, 2012, ASSISTING VASC UNPUB; Merkx M, 2012, J VASCULAR IN PRESS; Merkx MAG, 2012, J MAGN RESON IMAGING, V36, P1186, DOI 10.1002/jmri.23752; Mulder G, 2011, MED ENG PHYS, V33, P195, DOI 10.1016/j.medengphy.2010.09.021; Olufsen MS, 2000, ANN BIOMED ENG, V28, P1281, DOI 10.1114/1.1326031; Planken RN, 2006, J VASC SURG, V44, P353, DOI 10.1016/j.jvs.2006.04.038; Planken RN, 2006, NEPHROL DIAL TRANSPL, V21, P802, DOI 10.1093/ndt/gfi340; Shemesh D, 2007, ULTRASOUND MED BIOL, V33, P727, DOI 10.1016/j.ultrasmedbio.2006.11.019; Tordoir J H, 1990, Eur J Vasc Surg, V4, P179, DOI 10.1016/S0950-821X(05)80434-7; Tordoir J, 2007, NEPHROL DIAL TRANSPL, V22, P88, DOI 10.1093/ndt/gfm021; Tordoir JHM, 2003, NEPHROL DIAL TRANSPL, V18, P378, DOI 10.1093/ndt/18.2.378; Tordoir JHM, 2004, EUR J VASC ENDOVASC, V27, P1, DOI 10.1016/j.ejvs.2003.10.007; van de Vosse FN, 2011, ANNU REV FLUID MECH, V43, P467, DOI 10.1146/annurev-fluid-122109-160730; WESTERHOF N, 1973, MED BIOL ENG, V11, P710, DOI 10.1007/BF02478659; Wijnen E, 2005, ARTIF ORGANS, V29, P960, DOI 10.1111/j.1525-1594.2005.00165.x; Wolters BJBM, 2007, MED ENG PHYS, V29, P1106, DOI 10.1016/j.medengphy.2006.11.008	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e53615	10.1371/journal.pone.0053615	http://dx.doi.org/10.1371/journal.pone.0053615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390490	Green Submitted, Green Published, gold			2022-12-25	WOS:000314691100006
J	Premanand, B; Prabakaran, M; Kiener, TK; Kwang, J				Premanand, Balraj; Prabakaran, Mookkan; Kiener, Tanja K.; Kwang, Jimmy			Recombinant Baculovirus Associated with Bilosomes as an Oral Vaccine Candidate against HEV71 Infection in Mice	PLOS ONE			English	Article							LETHAL ENTEROVIRUS-71 INFECTION; T-CELL RESPONSES; TOXIN B-SUBUNIT; INFLUENZA-VIRUS; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; GENE-DELIVERY; NEWBORN MICE; IMMUNIZATION; PROTECTION	Background: Human enterovirus 71 (HEV71) is one of the major pathogen responsible for hand, foot and mouth disease (HFMD). Currently no effective vaccine or antiviral drugs are available. Like poliovirus, EV71 is transmitted mainly by the feco-oral route. To date the majority of the studied EV71 vaccine candidates are administered parenterally. Injectable vaccines induce good systemic immunity but mucosal responses are often unsatisfactory, whereas mucosal vaccines provide both systemic and mucosal immunity. Therefore, oral immunization appears to be an attractive alternative to parenteral immunization. Methodology/Principal Findings: In this report, we studied the efficacy of an orally administered vaccine candidate developed using recombinant baculovirus displaying VP1 (Bac-VP1) in a murine model. Gastrointestinal delivery of Bac-VP1 significantly induced VP1-specific humoral (IgG) and mucosal (IgA) immune responses. Further, we studied the efficacy of the Bac-VP1 associated with bilosomes and observed that the Bac-VP1 associated with bilosomes elicited significantly higher immune responses compared to bilosomes non-associated with Bac-VP1. However, mice immunized subcutaneously with live Bac-VP1 had significantly enhanced VP1 specific serum IgG levels and higher neutralizing antibody titers compared with mice orally immunized with live Bac-VP1 alone or associated with bilosomes. Conclusion: Bilosomes have been shown to possess inherent adjuvant properties when associated with antigen. Therefore Bac-VP1 with bilosomes could be a promising oral vaccine candidate against EV71 infections. Thus, Bac-VP1 loaded bilosomes may provide a needle free, painless approach for immunization against EV71, thereby increasing patient compliance and consequently increasing vaccination coverage.	[Premanand, Balraj; Prabakaran, Mookkan; Kiener, Tanja K.; Kwang, Jimmy] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Kwang, Jimmy] Natl Univ Singapore, Fac Med, Dept Microbiol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Kwang, J (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	kwang@tll.org.sg		Prabakaran, Mookkan/0000-0002-9816-5908	Temasek Life Sciences Laboratory	Temasek Life Sciences Laboratory(National University of Singapore)	This project is funded by Temasek Life Sciences Laboratory (http://www.tll.org.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarthi D, 2004, BIOLOGICALS, V32, P153, DOI 10.1016/j.biologicals.2004.09.001; Allaoui-Attarki K, 1998, VACCINE, V16, P685, DOI 10.1016/S0264-410X(97)00261-2; Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; BREWER JM, 1995, VACCINE, V13, P1441, DOI 10.1016/0264-410X(95)00065-9; Chen SC, 1998, J VIROL, V72, P5757, DOI 10.1128/JVI.72.7.5757-5761.1998; Cheng XJ, 2001, PARASITOL RES, V87, P126, DOI 10.1007/s004360000323; Chiu CH, 2006, MICROBES INFECT, V8, P1671, DOI 10.1016/j.micinf.2006.01.021; Conacher M, 2001, VACCINE, V19, P2965, DOI 10.1016/S0264-410X(00)00537-5; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625; FRY DW, 1978, ANAL BIOCHEM, V90, P809, DOI 10.1016/0003-2697(78)90172-0; GHAZI HO, 1995, J MED MICROBIOL, V42, P53, DOI 10.1099/00222615-42-1-53; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Hu YC, 2003, ENZYME MICROB TECH, V33, P445, DOI 10.1016/S0141-0229(03)00143-1; Isaka M, 2001, VACCINE, V19, P1460, DOI 10.1016/S0264-410X(00)00348-0; Kinnunen K, 2009, J GENE MED, V11, P382, DOI 10.1002/jgm.1311; Kolpe AB, 2012, VIRUS RES, V168, P64, DOI 10.1016/j.virusres.2012.06.014; Kost TA, 2002, TRENDS BIOTECHNOL, V20, P173, DOI 10.1016/S0167-7799(01)01911-4; LaBarre DD, 2001, J VIROL METHODS, V96, P107, DOI 10.1016/S0166-0934(01)00316-0; Lavelle Ed C, 2006, Expert Opin Drug Deliv, V3, P747, DOI 10.1517/17425247.3.6.747; Li XL, 2009, BIOCHEM BIOPH RES CO, V390, P1126, DOI 10.1016/j.bbrc.2009.09.103; Liu JN, 2010, VACCINE, V28, P7444, DOI 10.1016/j.vaccine.2010.08.080; Lotter H, 2004, INFECT IMMUN, V72, P7318, DOI 10.1128/IAI.72.12.7318-7321.2004; Lotter H, 2008, INT J MED MICROBIOL, V298, P79, DOI 10.1016/j.ijmm.2007.07.001; MALOY KJ, 1995, EUR J IMMUNOL, V25, P2835, DOI 10.1002/eji.1830251019; Mann BJ, 1997, VACCINE, V15, P659, DOI 10.1016/S0264-410X(96)00236-8; Mann JFS, 2009, VACCINE, V27, P3643, DOI 10.1016/j.vaccine.2009.03.040; Mann JFS, 2006, METHODS, V38, P90, DOI 10.1016/j.ymeth.2005.11.002; Mann JFS, 2004, VACCINE, V22, P2425, DOI 10.1016/j.vaccine.2003.11.067; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Meng T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021757; MOLDOVEANU Z, 1993, J INFECT DIS, V167, P84, DOI 10.1093/infdis/167.1.84; Musthaq SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026428; O'Reilly DR, 1992, BACULOVIRUS EXPRESSI, P60; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Pauletti GM, 1996, J CONTROL RELEASE, V41, P3, DOI 10.1016/0168-3659(96)01352-1; PFAFF E, 1988, J VIROL, V62, P2033, DOI 10.1128/JVI.62.6.2033-2040.1988; Prabakaran M, 2010, J VIROL, V84, P3201, DOI 10.1128/JVI.02175-09; Premanand B, 2012, ANTIVIR RES, V95, P311, DOI 10.1016/j.antiviral.2012.05.017; RUECKERT R R, 1990, P507; Rueda P, 2000, VACCINE, V19, P726, DOI 10.1016/S0264-410X(00)00259-0; SHALABY WSW, 1995, CLIN IMMUNOL IMMUNOP, V74, P127, DOI 10.1006/clin.1995.1019; Shoji I, 1997, J GEN VIROL, V78, P2657, DOI 10.1099/0022-1317-78-10-2657; Singh P, 2004, INT J PHARMACEUT, V278, P379, DOI 10.1016/j.ijpharm.2004.03.014; Strauss R, 2007, MOL THER, V15, P193, DOI 10.1038/sj.mt.6300008; Tan CS, 2007, ARCH VIROL, V152, P1069, DOI 10.1007/s00705-007-0941-1; Tani H, 2003, J VIROL, V77, P9799, DOI 10.1128/JVI.77.18.9799-9808.2003; TJIA ST, 1983, VIROLOGY, V125, P107; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; Watarai S, 1998, J VET MED SCI, V60, P1047, DOI 10.1292/jvms.60.1047; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1	52	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55536	10.1371/journal.pone.0055536	http://dx.doi.org/10.1371/journal.pone.0055536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390538	gold, Green Published, Green Submitted			2022-12-25	WOS:000314691100054
J	Balgi, AD; Wang, J; Cheng, DYH; Ma, CL; Pfeifer, TA; Shimizu, Y; Anderson, HJ; Pinto, LH; Lamb, RA; DeGrado, WF; Roberge, M				Balgi, Aruna D.; Wang, Jun; Cheng, Daphne Y. H.; Ma, Chunlong; Pfeifer, Tom A.; Shimizu, Yoko; Anderson, Hilary J.; Pinto, Lawrence H.; Lamb, Robert A.; DeGrado, William F.; Roberge, Michel			Inhibitors of the Influenza A Virus M2 Proton Channel Discovered Using a High-Throughput Yeast Growth Restoration Assay	PLOS ONE			English	Article							ADAMANTANE RESISTANCE; PANDEMIC INFLUENZA; PROTEIN; TRANSPORT; DERIVATIVES; MECHANISM; AMILORIDE; IDENTIFICATION; OSELTAMIVIR; DYNAMICS	The M2 proton channel of the influenza A virus is the target of the anti-influenza drugs amantadine and rimantadine. The effectiveness of these drugs has been dramatically limited by the rapid spread of drug resistant mutations, mainly at sites S31N, V27A and L26F in the pore of the channel. Despite progress in designing inhibitors of V27A and L26F M2, there are currently no drugs targeting these mutated channels in clinical trials. Progress in developing new drugs has been hampered by the lack of a robust assay with sufficient throughput for discovery of new active chemotypes among chemical libraries and sufficient sensitivity to provide the SAR data essential for their improvement and development as drugs. In this study we adapted a yeast growth restoration assay, in which expression of the M2 channel inhibits yeast growth and exposure to an M2 channel inhibitor restores growth, into a robust and sensitive high-throughput screen for M2 channel inhibitors. A screen of over 250,000 pure chemicals and semi-purified fractions from natural extracts identified 21 active compounds comprising amantadine, rimantadine, 13 related adamantanes and 6 non-adamantanes. Of the non-adamantanes, hexamethylene amiloride and a triazine derivative represented new M2 inhibitory chemotypes that also showed antiviral activity in a plaque reduction assay. Of particular interest is the fact that the triazine derivative was not sufficiently potent for detection as an inhibitor in the traditional two electrode voltage clamp assay for M2 channel activity, but its discovery in the yeast assay led to testing of analogues of which one was as potent as amantadine.	[Balgi, Aruna D.; Cheng, Daphne Y. H.; Anderson, Hilary J.; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Wang, Jun; DeGrado, William F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Ma, Chunlong; Pinto, Lawrence H.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Lamb, Robert A.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA; [Lamb, Robert A.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA; [Pfeifer, Tom A.; Shimizu, Yoko; Roberge, Michel] Ctr Drug Res & Dev, Vancouver, BC, Canada	University of British Columbia; University of California System; University of California San Francisco; Northwestern University; Northwestern University; Howard Hughes Medical Institute; Northwestern University	Roberge, M (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	michelr@mail.ubc.ca	Ma, Chunlong/AAT-7097-2021; Wang, Jun/G-6504-2010	Wang, Jun/0000-0002-4845-4621	Centre for Drug Research and Development; National Institutes of Health [GM56423, AI74571]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020201, U01AI074571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056423] Funding Source: NIH RePORTER	Centre for Drug Research and Development; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Centre for Drug Research and Development and National Institutes of Health grants GM56423 and AI74571. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; [Anonymous], 2009, PAND H1N1 2009 UPD 7; Astrahan P, 2011, BBA-BIOMEMBRANES, V1808, P394, DOI 10.1016/j.bbamem.2010.08.021; Balannik V, 2010, PFLUG ARCH EUR J PHY, V459, P593, DOI 10.1007/s00424-009-0760-1; Balannik V, 2009, BIOCHEMISTRY-US, V48, P11872, DOI 10.1021/bi9014488; Balgi Aruna D., 2009, V486, P125, DOI 10.1007/978-1-60327-545-3_9; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Cady SD, 2011, J AM CHEM SOC, V133, P4274, DOI 10.1021/ja102581n; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Camp D, 2012, J NAT PROD, V75, P72, DOI 10.1021/np200687v; Curman D, 2001, J BIOL CHEM, V276, P17914, DOI 10.1074/jbc.M100728200; Das K, 2012, J MED CHEM ASAP; Duque M.D., 2011, RECENT ADV PHARM SCI, P35; Eleftheratos S, 2010, BIOORG MED CHEM LETT, V20, P4182, DOI 10.1016/j.bmcl.2010.05.049; Ewart GD, 2002, EUR BIOPHYS J BIOPHY, V31, P26, DOI 10.1007/s002490100177; Fiorin G, 2010, SCIENCE, V330, P456, DOI 10.1126/science.1197748; Furuse Y, 2009, ANTIMICROB AGENTS CH, V53, P4457, DOI 10.1128/AAC.00650-09; Furuse Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-67; GIFFIN K, 1995, FEBS LETT, V357, P269, DOI 10.1016/0014-5793(94)01369-C; Govorkova EA, 2012, CURR TOP MICROBIOL I; GRAMBAS S, 1992, VIROLOGY, V191, P541, DOI 10.1016/0042-6822(92)90229-I; GRAMBAS S, 1992, VIROLOGY, V190, P11, DOI 10.1016/0042-6822(92)91187-Y; Hayden FG, 2011, J INFECT DIS, V203, P6, DOI 10.1093/infdis/jiq012; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Hu WH, 2010, J MED CHEM, V53, P3831, DOI 10.1021/jm901664a; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Karpenko I, 2010, ANTIMICROB AGENTS CH, V54, P2017, DOI 10.1128/AAC.01186-09; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; KURTZ S, 1995, ANTIMICROB AGENTS CH, V39, P2204, DOI 10.1128/AAC.39.10.2204; Leiding T, 2010, P NATL ACAD SCI USA, V107, P15409, DOI 10.1073/pnas.1009997107; Lin TI, 1997, J GEN VIROL, V78, P767, DOI 10.1099/0022-1317-78-4-767; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; MARTINEZ AG, 1995, J MED CHEM, V38, P4474, DOI 10.1021/jm00022a012; Moore C, 2011, J INFECT DIS, V203, P18, DOI 10.1093/infdis/jiq007; Nicholls H, 2006, PLOS BIOL, V4, P156, DOI 10.1371/journal.pbio.0040050; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Pervushin K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000511; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; Quinn RJ, 2008, J NAT PROD, V71, P464, DOI 10.1021/np070526y; Sakaguchi T, 1996, J CELL BIOL, V133, P733, DOI 10.1083/jcb.133.4.733; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Sheu TG, 2011, J INFECT DIS, V203, P13, DOI 10.1093/infdis/jiq005; SIMCHOWITZ L, 1986, MOL PHARMACOL, V30, P112; Stouffer AL, 2008, NATURE, V452, P380, DOI 10.1038/nature06845; Viboud C, 2012, LANCET INFECT DIS, V12, P651, DOI 10.1016/S1473-3099(12)70152-4; Vottero Eduardo, 2006, Biotechnology Journal, V1, P282, DOI 10.1002/biot.200600001; Wang J, 2011, J AM CHEM SOC, V133, P12834, DOI 10.1021/ja204969m; Wang J, 2011, ACS MED CHEM LETT, V2, P307, DOI 10.1021/ml100297w; Wang J, 2011, CURR OPIN STRUC BIOL, V21, P68, DOI 10.1016/j.sbi.2010.12.002; Wang J, 2009, J AM CHEM SOC, V131, P8066, DOI 10.1021/ja900063s; WHO, 2009, INFL SEAS; Zhao X, 2011, EUR J MED CHEM, V46, P52, DOI 10.1016/j.ejmech.2010.10.010	55	45	46	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55271	10.1371/journal.pone.0055271	http://dx.doi.org/10.1371/journal.pone.0055271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383318	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900025
J	Lally, JSV; Herbst, EAF; Matravadia, S; Maher, AC; Perry, CGR; Ventura-Clapier, R; Holloway, GP				Lally, James S. V.; Herbst, Eric A. F.; Matravadia, Sarthak; Maher, Amy C.; Perry, Christopher G. R.; Ventura-Clapier, Renee; Holloway, Graham P.			Over-Expressing Mitofusin-2 in Healthy Mature Mammalian Skeletal Muscle Does Not Alter Mitochondrial Bioenergetics	PLOS ONE			English	Article							CARNITINE-PALMITOYLTRANSFERASE-I; FATTY-ACID OXIDATION; OUTER-MEMBRANE; PALMITATE OXIDATION; 2A GENE; PROTEIN; FUSION; MORPHOLOGY; RETICULUM; INCREASES	The role of mitofusin-2 (MFN-2) in regulating mitochondrial dynamics has been well-characterized in lower order eukaryotic cell lines through the complete ablation of MFN-2 protein. However, to support the contractile function of mature skeletal muscle, the subcellular architecture and constituent proteins of this tissue differ substantially from simpler cellular organisms. Such differences may also impact the role of MFN-2 in mature mammalian muscle, and it is unclear if minor fluctuations in MFN-2, as observed in response to physiological perturbations, has a functional consequence. Therefore, we have transiently transfected MFN-2 cDNA into rat tibialis anterior muscle to determine the effect of physiolgically relevant increases in MFN-2 protein on mitochondrial bioenergetics. Permeabilized muscle fibres generated from muscle following MFN-2-transfection were used for functional assessments of mitochondrial bioenergetics. In addition, we have further established a novel method for selecting fibre bundles that are positively transfected, and using this approach transient transfection increased MFN-2 protein similar to 2.3 fold in selected muscle fibres. However, this did not alter maximal rates of oxygen consumption or the sensitivity for ADP-stimulated respiration. In addition, MFN-2 over-expression did not alter rates of H2O2 emission. Altogether, and contrary to evidence from lower order cell lines, our results indicate that over-expressing MFN-2 in healthy muscle does not influence mitochondrial bioenergetics in mature mammalian skeletal muscle.	[Lally, James S. V.; Herbst, Eric A. F.; Matravadia, Sarthak; Maher, Amy C.; Perry, Christopher G. R.; Holloway, Graham P.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Ventura-Clapier, Renee] Univ Paris 11, INSERM, U769, Paris, France	University of Guelph; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Holloway, GP (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	ghollowa@uoguelph.ca		Ventura-Clapier, Renee/0000-0002-7488-4123	Federal funding through the Canadian government	Federal funding through the Canadian government	Federal funding through the Canadian government funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Bruce CR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1231, DOI 10.1152/ajpendo.00561.2006; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Holloway GP, 2006, J PHYSIOL-LONDON, V571, P201, DOI 10.1113/jphysiol.2005.102178; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Holloway GP, 2007, J PHYSIOL-LONDON, V582, P393, DOI 10.1113/jphysiol.2007.135301; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Murphy RM, 2011, J APPL PHYSIOL, V110, P820, DOI 10.1152/japplphysiol.01082.2010; Ogata T, 1997, ANAT REC, V248, P214; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Santel A, 2001, J CELL SCI, V114, P867; Schertzer JD, 2006, MOL THER, V13, P795, DOI 10.1016/j.ymthe.2005.09.019; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Zhang JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1099; Zorzano A, 2006, IUBMB LIFE, V58, P441, DOI 10.1080/15216540600644838	44	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55660	10.1371/journal.pone.0055660	http://dx.doi.org/10.1371/journal.pone.0055660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383258	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600142
J	Doganli, C; Beck, HC; Ribera, AB; Oxvig, C; Lykke-Hartmann, K				Doganli, Canan; Beck, Hans C.; Ribera, Angeles B.; Oxvig, Claus; Lykke-Hartmann, Karin			alpha Na-3(+)/K+-ATPase Deficiency Causes Brain Ventricle Dilation and Abrupt Embryonic Motility in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAPID-ONSET DYSTONIA; NA,K-ATPASE ALPHA-SUBUNIT; CALCIUM-BINDING PROTEINS; MOLECULAR-CLONING; PARKINSONISM RDP; BETA-SUBUNIT; SODIUM-PUMP; RAT; EXPRESSION; NA+,K+-ATPASE	Na+/K+-ATPases are transmembrane ion pumps that maintain ion gradients across the basolateral plasma membrane in all animal cells to facilitate essential biological functions. Mutations in the Na+/K+-ATPase alpha(3) subunit gene (ATP1A3) cause rapid-onset dystonia-parkinsonism, a rare movement disorder characterized by sudden onset of dystonic spasms and slow movements. In the brain, ATP1A3 is principally expressed in neurons. In zebrafish, the transcripts of the two ATP1A3 orthologs, Atp1a3a and Atp1a3b, show distinct expression in the brain. Surprisingly, targeted knockdown of either Atp1a3a or Atp1a3b leads to brain ventricle dilation, a likely consequence of ion imbalances across the plasma membrane that cause accumulation of cerebrospinal fluid in the ventricle. The brain ventricle dilation is accompanied by a depolarization of spinal Rohon-Beard neurons in Atp1a3a knockdown embryos, suggesting impaired neuronal excitability. This is further supported by Atp1a3a or Atp1a3b knockdown results where altered responses to tactile stimuli as well as abnormal motility were observed. Finally, proteomic analysis identified several protein candidates highlighting proteome changes associated with the knockdown of Atp1a3a or Atp1a3b. Our data thus strongly support the role of alpha Na-3(+)/K+-ATPase in zebrafish motility and brain development, associating for the first time the alpha Na-3(+)/K(+)ATPase deficiency with brain ventricle dilation.	[Doganli, Canan; Lykke-Hartmann, Karin] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-1057 Copenhagen, Denmark; [Doganli, Canan; Lykke-Hartmann, Karin] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Doganli, Canan; Oxvig, Claus] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Beck, Hans C.] Odense Univ Hosp, Ctr Clin Prote, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Ribera, Angeles B.] Univ Colorado Denver, Dept Physiol & Biophys, Aurora, CO 80045 USA	Danmarks Grundforskningsfond; Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Lykke-Hartmann, K (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 3, DK-8000 Aarhus C, Denmark.	kly@biokemi.au.dk	Beck, Hans Christian/AAK-9147-2021	Oxvig, Claus/0000-0002-4715-9719; Ribera, Angie/0000-0002-0966-5856; Beck, Hans Christian/0000-0002-7763-3637; Lykke-Hartmann, Karin/0000-0002-6702-183X	Aarhus University Forskningsfond (AUFF); Danish National Research Foundation (DNRF) (Centre for Membrane Pumps in Cells and Disease (PUMPKIN) [DNRF85]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025217] Funding Source: NIH RePORTER	Aarhus University Forskningsfond (AUFF); Danish National Research Foundation (DNRF) (Centre for Membrane Pumps in Cells and Disease (PUMPKIN); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from Aarhus University Forskningsfond (AUFF), and Danish National Research Foundation (DNRF) (Centre for Membrane Pumps in Cells and Disease (PUMPKIN)) (DNRF85).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Ballerini L, 1997, J NEUROPHYSIOL, V77, P17, DOI 10.1152/jn.1997.77.1.17; Barut BA, 2000, PHYSIOL GENOMICS, V2, P49, DOI 10.1152/physiolgenomics.2000.2.2.49; Beck HC, 2011, NEUROCHEM RES, V36, P2002, DOI 10.1007/s11064-011-0524-0; Benarroch EE, 2011, NEUROLOGY, V77, P281, DOI [10.1212/WNL.0b013e31822550e2, 10.1212/WNL.0b013e3182074c2f]; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Bottger P, 2012, NEUROSCI BIOBEHAV R, V36, P855, DOI 10.1016/j.neubiorev.2011.10.005; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; Brashear A, 1997, NEUROLOGY, V48, P1066, DOI 10.1212/WNL.48.4.1066; Brashear A, 1999, MOVEMENT DISORD, V14, P132, DOI 10.1002/1531-8257(199901)14:1<132::AID-MDS1022>3.0.CO;2-J; Brashear A, 2007, BRAIN, V130, P828, DOI 10.1093/brain/awl340; Caillard O, 2000, P NATL ACAD SCI USA, V97, P13372, DOI 10.1073/pnas.230362997; Chang JT, 2012, DEV BIOL, V368, P312, DOI 10.1016/j.ydbio.2012.05.034; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; CLARKE JDW, 1984, J PHYSIOL-LONDON, V348, P511, DOI 10.1113/jphysiol.1984.sp015122; DeAndrade MP, 2011, BEHAV BRAIN RES, V216, P659, DOI 10.1016/j.bbr.2010.09.009; Desfrere L, 2009, P NATL ACAD SCI USA, V106, P2212, DOI 10.1073/pnas.0809253106; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Dobretsov M, 2003, NEUROSCIENCE, V116, P1069, DOI 10.1016/S0306-4522(02)00922-3; Doganli C., 2012, J CELL SCI IN PRESS; Doganli C, 2010, DNA CELL BIOL, V29, P713, DOI 10.1089/dna.2010.1085; FETCHO JR, 1992, BRAIN BEHAV EVOLUT, V40, P82, DOI 10.1159/000113905; Fiorio M, 2007, BRAIN, V130, P134, DOI 10.1093/brain/awl283; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Friedrich RW, 2010, CURR BIOL, V20, pR371, DOI 10.1016/j.cub.2010.02.039; Gutzman J. H., 2009, J VIS EXP, V26, P1218; HALLETT M, 1995, ANN NEUROL, V38, P139, DOI 10.1002/ana.410380203; Illarionova NB, 2010, NEUROSCIENCE, V168, P915, DOI 10.1016/j.neuroscience.2009.11.062; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kim J, 2012, J NEUROSCI RES, V90, P1437, DOI 10.1002/jnr.23017; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirshenbaum GS, 2011, P NATL ACAD SCI USA, V108, P18144, DOI 10.1073/pnas.1108416108; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lingrel J, 2003, ANN NY ACAD SCI, V986, P354, DOI 10.1111/j.1749-6632.2003.tb07214.x; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Lowery LA, 2009, BIOESSAYS, V31, P446, DOI 10.1002/bies.200800207; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Moreno RL, 2009, J NEUROPHYSIOL, V102, P2477, DOI 10.1152/jn.00446.2009; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Nemeth A. H., 1993, GENEREVIEWS; Parker D, 1996, J NEUROPHYSIOL, V76, P540, DOI 10.1152/jn.1996.76.1.540; Pineda RH, 2005, J NEUROPHYSIOL, V93, P3582, DOI 10.1152/jn.01070.2004; Pulver SR, 2010, NAT NEUROSCI, V13, P53, DOI 10.1038/nn.2444; Rajarao SJR, 2001, GENOME RES, V11, P1211, DOI 10.1101/gr.186001; Ribera AB, 1998, J NEUROSCI, V18, P9181; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rozzo A, 2002, J NEUROPHYSIOL, V88, P676, DOI 10.1152/jn.2002.88.2.676; SCHNEIDER JW, 1985, P NATL ACAD SCI USA, V82, P6357, DOI 10.1073/pnas.82.18.6357; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; SETOOHSHIMA A, 1994, ACTA HISTOCHEM CYTOC, V27, P93, DOI 10.1267/ahc.27.93; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SHYJAN AW, 1989, BIOCHEMISTRY-US, V28, P4531, DOI 10.1021/bi00437a002; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Stockler S, 1996, AM J HUM GENET, V58, P914; Sun YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035645; SWEADNER KJ, 1987, P NATL ACAD SCI USA, V84, P8404, DOI 10.1073/pnas.84.23.8404; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield D., 1995, ZEBRAFISH BOOK GUIDE, P787; Zhang HY, 2012, CURR BIOL, V22, P526, DOI 10.1016/j.cub.2012.01.058; Zugno AI, 2003, INT J DEV NEUROSCI, V21, P183, DOI 10.1016/S0736-5748(03)00038-8	66	17	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8862	8874		10.1074/jbc.M112.421529	http://dx.doi.org/10.1074/jbc.M112.421529			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23400780	Green Published, hybrid			2022-12-25	WOS:000316862200008
J	Gonzalez-Sancho, JM; Greer, YE; Abrahams, CL; Takigawa, Y; Baljinnyam, B; Lee, KH; Lee, KS; Rubin, JS; Brown, AMC				Gonzalez-Sancho, Jose M.; Greer, Yoshimi Endo; Abrahams, Cristina L.; Takigawa, Yutaka; Baljinnyam, Bolormaa; Lee, Kyung Ho; Lee, Kyung S.; Rubin, Jeffrey S.; Brown, Anthony M. C.			Functional Consequences of Wnt-induced Dishevelled 2 Phosphorylation in Canonical and Noncanonical Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STABILIZE BETA-CATENIN; PROTEIN ASSEMBLIES; NEURITE OUTGROWTH; DIX DOMAIN; PATHWAY; MECHANISM; DROSOPHILA; WINGLESS; CELL; ACTIVATION	Dishevelled (Dvl) proteins are intracellular effectors of Wnt signaling that have essential roles in both canonical and noncanonical Wnt pathways. It has long been known that Wnts stimulate Dvl phosphorylation, but relatively little is known about its functional significance. We have previously reported that both Wnt3a and Wnt5a induce Dvl2 phosphorylation that is associated with an electrophoretic mobility shift and loss of recognition by monoclonal antibody 10B5. In the present study, we mapped the 10B5 epitope to a 16-amino acid segment of human Dvl2 (residues 594-609) that contains four Ser/Thr residues. Alanine substitution of these residues (P4m) eliminated the mobility shift induced by either Wnt3a or Wnt5a. The Dvl2 P4m mutant showed a modest increase in canonical Wnt/beta-catenin signaling activity relative to wild type. Consistent with this finding, Dvl2 4Pm preferentially localized to cytoplasmic puncta. In contrast to wild-type Dvl2, however, the P4m mutant was unable to rescue Wnt3a-dependent neurite outgrowth in TC-32 cells following suppression of endogenous Dvl2/3. Earlier work has implicated casein kinase 1 delta/epsilon as responsible for the Dvl mobility shift, and a CK1 delta in vitro kinase assay confirmed that Ser(594), Thr(595), and Ser(597) of Dvl2 are CK1 targets. Alanine substitution of these three residues was sufficient to abrogate the Wnt-dependent mobility shift. Thus, we have identified a cluster of Ser/Thr residues in the C-terminal domain of Dvl2 that are Wnt-induced phosphorylation (WIP) sites. Our results indicate that phosphorylation at the WIP sites reduces Dvl accumulation in puncta and attenuates beta-catenin signaling, whereas it enables noncanonical signaling that is required for neurite outgrowth.	[Gonzalez-Sancho, Jose M.; Abrahams, Cristina L.; Takigawa, Yutaka; Brown, Anthony M. C.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Greer, Yoshimi Endo; Baljinnyam, Bolormaa; Rubin, Jeffrey S.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lee, Kyung Ho; Lee, Kyung S.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brown, AMC (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, 1300 York Ave, New York, NY 10065 USA.	amcbrown@med.cornell.edu	Greer, Yoshimi/K-2155-2019; Gonzalez-Sancho, Jose/AAA-6010-2019; Takigawa, Yutaka/ABD-8063-2020	Gonzalez-Sancho, Jose/0000-0001-5875-1964; 	National Institutes of Health Grant [R01 CA123238]; Ministerio de Educacion, Cultura, y Deportes, of Spain; New York State Department of Health postdoctoral Fellowship [NYS C021339];  [F32 CA117662]; NATIONAL CANCER INSTITUTE [ZIABC011224, ZIABC011324] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Educacion, Cultura, y Deportes, of Spain; New York State Department of Health postdoctoral Fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA123238 (to A. M. C. B.) and Postdoctoral Fellowship F32 CA117662 (to C. L. A.). This work was also supported by a fellowship from the Ministerio de Educacion, Cultura, y Deportes, of Spain (to J. M. G.-S.), by New York State Department of Health postdoctoral Fellowship NYS C021339 (to Y. T.), and by charitable donations to Strang Cancer Prevention Center. This research also was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute.	Baljinnyam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029455; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brennan K, 2004, ONCOGENE, V23, P4873, DOI 10.1038/sj.onc.1207642; Brown A. M., 1995, DNA CLONING, P113; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bryja V, 2007, CELL SIGNAL, V19, P610, DOI 10.1016/j.cellsig.2006.08.011; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Endo Y, 2005, J BIOL CHEM, V280, P777, DOI 10.1074/jbc.M406391200; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Greer YE, 2013, J BIOL CHEM, V288, P9438, DOI 10.1074/jbc.M112.448282; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Howe LR, 2001, J BIOL CHEM, V276, P20108, DOI 10.1074/jbc.M010692200; James Richard G., 2008, V468, P131, DOI 10.1007/978-1-59745-249-6_10; Kikuchi A, 2008, CANCER SCI, V99, P202, DOI 10.1111/j.1349-7006.2007.00675.x; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kikuchi K, 2010, EMBO J, V29, P3470, DOI 10.1038/emboj.2010.221; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klimowski LK, 2006, FEBS J, V273, P4594, DOI 10.1111/j.1742-4658.2006.05462.x; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Schulte G, 2005, J NEUROCHEM, V92, P1550, DOI 10.1111/j.1471-4159.2004.03022.x; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Semenov MV, 1997, GENOMICS, V42, P302, DOI 10.1006/geno.1997.4713; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yanfeng WA, 2011, DEV BIOL, V360, P132, DOI 10.1016/j.ydbio.2011.09.017; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	54	47	48	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9428	9437		10.1074/jbc.M112.448480	http://dx.doi.org/10.1074/jbc.M112.448480			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396967	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000316862200059
J	Li, SJ; Qi, Y; Zhao, JJ; Li, Y; Liu, XY; Chen, XH; Xu, P				Li, Shu-Jing; Qi, Yao; Zhao, Jing-Jing; Li, Ya; Liu, Xiao-Yan; Chen, Xian-Hua; Xu, Ping			Characterization of Nuclear Localization Signals (NLSs) and Function of NLSs and Phosphorylation of Serine Residues in Subcellular and Subnuclear Localization of Transformer-2 beta (Tra2 beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; ALTERNATIVE SPLICING PATTERNS; SR PROTEINS; IN-VIVO; MOLECULAR-CLONING; CELL-CYCLE; RS DOMAIN; SEQUENCE; GENE; ENHANCER	The serine/arginine-rich (SR) proteins are one type of major actors in regulation of pre-mRNA splicing. Their functions are closely related to the intracellular spatial organization. The RS domain and phosphorylation status of SR proteins are two critical factors in determining the subcellular distribution. Mammalian Transformer-2 beta (Tra2 beta) protein, a member of SR proteins, is known to play multiple important roles in development and diseases. In the present study, we characterized the subcellular and subnuclear localization of Tra2 beta protein and its related mechanisms. The results demonstrated that in the brain the nuclear and cytoplasmic localization of Tra2 beta were correlated with its phosphorylation status. Using deletional mutation analysis, we showed that the nuclear localization of Tra2 beta was determined by multiple nuclear localization signals (NLSs) in the RS domains. The point-mutation analysis disclosed that phosphorylation of serine residues in the NLSs inhibited the function of NLS in directing Tra2 beta to the nucleus. In addition, we identified at least two nuclear speckle localization signals within the RS1 domain, but not in the RS2 domain. The nuclear speckle localization signals determined the localization of RS1 domain-contained proteins to the nuclear speckle. The function of the signals did not depend on the presence of serine residues. The results provide new insight into the mechanisms by which the subcellular and subnuclear localization of Tra2 beta proteins are regulated.	[Li, Shu-Jing; Qi, Yao; Zhao, Jing-Jing; Li, Ya; Liu, Xiao-Yan; Chen, Xian-Hua; Xu, Ping] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Lab Genom Physiol,Inst Brain Sci,Sch Basic Med Sc, Shanghai 200032, Peoples R China	Fudan University	Chen, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Lab Genom Physiol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.	xhchen@fudan.edu.cn; matibuck@yahoo.com		Li, Shujing/0000-0003-2793-3065	National Foundation of Natural Sciences of China [30770661, 30971464, 81030020]; Shanghai Leading Academic Discipline Project [B111]	National Foundation of Natural Sciences of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Foundation of Natural Sciences of China (No. 30770661, 30971464, 81030020), and the Shanghai Leading Academic Discipline Project (No. B111).	Beil B, 1997, DNA CELL BIOL, V16, P679, DOI 10.1089/dna.1997.16.679; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chen XH, 2003, CELL BIOL INT, V27, P491, DOI 10.1016/S1065-6995(03)00072-6; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; D'Souza I, 2006, J BIOL CHEM, V281, P2460, DOI 10.1074/jbc.M505809200; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; Daoud R, 2002, J NEUROSCI, V22, P5889; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; FU XD, 1995, RNA, V1, P663; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Grellscheid S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002390; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Han Y, 2007, J NEUROTRAUM, V24, P722, DOI 10.1089/neu.2006.0174; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Huang S, 1996, J CELL BIOL, V133, P719, DOI 10.1083/jcb.133.4.719; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; JIMENEZGARCIA LF, 1993, CELL, V73, P47, DOI 10.1016/0092-8674(93)90159-N; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MATTOX W, 1990, GENE DEV, V4, P789, DOI 10.1101/gad.4.5.789; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; Misteli T, 1997, TRENDS CELL BIOL, V7, P135, DOI 10.1016/S0962-8924(96)20043-1; Nayler O, 1998, GENOMICS, V53, P191, DOI 10.1006/geno.1998.5471; OKEEFE RT, 1994, J CELL BIOL, V124, P249, DOI 10.1083/jcb.124.3.249; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Segade F, 1996, FEBS LETT, V387, P152, DOI 10.1016/0014-5793(96)00496-6; Shukla S, 2008, CIRC RES, V103, P485, DOI 10.1161/CIRCRESAHA.108.178384; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cellbio.9.1.265; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wang B, 2008, ANAL CHEM, V80, P9526, DOI 10.1021/ac801708p; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Watermann DO, 2006, CANCER RES, V66, P4774, DOI 10.1158/0008-5472.CAN-04-3294; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	50	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8898	8909		10.1074/jbc.M113.456715	http://dx.doi.org/10.1074/jbc.M113.456715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396973	Green Published, hybrid			2022-12-25	WOS:000316862200011
J	Walkinshaw, DR; Weist, R; Kim, GW; You, LY; Xiao, L; Nie, JY; Li, CS; Zhao, SP; Xu, MH; Yang, XJ				Walkinshaw, Donald R.; Weist, Ryan; Kim, Go-Woon; You, Linya; Xiao, Lin; Nie, Jianyun; Li, Cathy S.; Zhao, Songping; Xu, Minghong; Yang, Xiang-Jiao			The Tumor Suppressor Kinase LKB1 Activates the Downstream Kinases SIK2 and SIK3 to Stimulate Nuclear Export of Class IIa Histone Deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-INDUCIBLE KINASE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CARDIAC-HYPERTROPHY; PROTEIN-KINASES; CELL-CYCLE; PHOSPHORYLATION; SKELETAL; DIFFERENTIATION; LOCALIZATION	Histone deacetylases 4 (HDAC4), -5, -7, and -9 form class IIa within the HDAC superfamily and regulate diverse physiological and pathological cellular programs. With conserved motifs for phosphorylation-dependent 14-3-3 binding, these deacetylases serve as novel signal transducers that are able to modulate histone acetylation and gene expression in response to extracellular cues. Here, we report that in a PKA-sensitive manner the tumor suppressor kinase LKB1 acts through salt-inducible kinase 2 (SIK2) and SIK3 to promote nucleocytoplasmic trafficking of class IIa HDACs. Both SIK2 and SIK3 phosphorylate the deacetylases at the conserved motifs and stimulate 14-3-3 binding. SIK2 activates MEF2-dependent transcription and relieves repression of myogenesis by the deacetylases. Distinct from SIK2, SIK3 induces nuclear export of the deacetylases independent of kinase activity and 14-3-3 binding. These findings highlight the difference among members of the SIK family and indicate that LKB1-dependent SIK activation constitutes an important signaling module upstream from class IIa deacetylases for regulating cellular programs controlled by MEF2 and other transcription factors.	[Walkinshaw, Donald R.; Weist, Ryan; Kim, Go-Woon; You, Linya; Xiao, Lin; Nie, Jianyun; Li, Cathy S.; Xu, Minghong; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Walkinshaw, Donald R.; Weist, Ryan; Kim, Go-Woon; You, Linya; Xiao, Lin; Nie, Jianyun; Li, Cathy S.; Zhao, Songping; Xu, Minghong; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A3, Canada; [Kim, Go-Woon; Yang, Xiang-Jiao] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Nie, Jianyun] Kunming Med Univ, Affiliated Hosp 3, Yunnan 650031, Peoples R China	McGill University; McGill University; McGill University; McGill University; Kunming Medical University	Yang, XJ (corresponding author), McGill Univ, Ctr Hlth, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca		You, Linya/0000-0002-2569-0269	Canadian Institutes of Health Research; Canadian Cancer Society; Ministere du Developpement Economique, l'Innovation et Exportation (MDEIE, Quebec), Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Ministere du Developpement Economique, l'Innovation et Exportation (MDEIE, Quebec), Canada	This work was supported in part by the Canadian Institutes of Health Research, Canadian Cancer Society, and Ministere du Developpement Economique, l'Innovation et Exportation (MDEIE, Quebec), Canada (to X. J. Y.).	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; AMACHER SL, 1993, MOL CELL BIOL, V13, P2753, DOI 10.1128/MCB.13.5.2753; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Chang SR, 2005, P NATL ACAD SCI USA, V102, P8120, DOI 10.1073/pnas.0503275102; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Dequiedt F, 2006, MOL CELL BIOL, V26, P7086, DOI 10.1128/MCB.00231-06; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Feldman JD, 2000, J NEUROCHEM, V74, P2227, DOI 10.1046/j.1471-4159.2000.0742227.x; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004317; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kao HY, 2000, GENE DEV, V14, P55; Kasler HG, 2012, EMBO J, V31, P4453, DOI 10.1038/emboj.2012.295; Katoh Y, 2004, MOL CELL ENDOCRINOL, V217, P109, DOI 10.1016/j.mce.2003.10.016; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Larochelle N, 1997, GENE THER, V4, P465, DOI 10.1038/sj.gt.3300414; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Makowski L, 2008, BRIT J CANCER, V99, P683, DOI 10.1038/sj.bjc.6604515; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Romito A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009029; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Siow NL, 2002, J BIOL CHEM, V277, P36129, DOI 10.1074/jbc.M206498200; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Walkinshaw DR, 2013, J BIOL CHEM, V288, P5591, DOI 10.1074/jbc.M112.445668; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5; Williams S, 2010, BRIT DENT J, V208, P4, DOI 10.1038/sj.bdj.2010.7; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoshida M, 1999, ANN NY ACAD SCI, V886, P23, DOI 10.1111/j.1749-6632.1999.tb09397.x; Yu X, 2000, BIOCHEM BIOPH RES CO, V276, P564, DOI 10.1006/bbrc.2000.3508; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	81	67	77	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9345	9362		10.1074/jbc.M113.456996	http://dx.doi.org/10.1074/jbc.M113.456996			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393134	hybrid, Green Published			2022-12-25	WOS:000316862200052
J	Ainley, V; Tsakiris, M				Ainley, Vivien; Tsakiris, Manos			Body Conscious? Interoceptive Awareness, Measured by Heartbeat Perception, Is Negatively Correlated with Self-Objectification	PLOS ONE			English	Article							FOCUSED ATTENTION; CARDIAC AWARENESS; ANOREXIA-NERVOSA; BEAT PERCEPTION; PRIVATE; ALEXITHYMIA; SENSITIVITY; VALIDATION; REACTIVITY; EXPERIENCE	Background: 'Self-objectification' is the tendency to experience one's body principally as an object, to be evaluated for its appearance rather than for its effectiveness. Within objectification theory, it has been proposed that self-objectification accounts for the poorer interoceptive awareness observed in women, as measured by heartbeat perception. Our study is, we believe, the first specifically to test this relationship. Methodology/Principal Findings: Using a well-validated and reliable heartbeat perception task, we measured interoceptive awareness in women and compared this with their scores on the Self-Objectification Questionnaire, the Self-Consciousness Scale and the Body Consciousness Questionnaire. Interoceptive awareness was negatively correlated with self-objectification. Interoceptive awareness, public body consciousness and private body consciousness together explained 31% of the variance in self-objectification. However, private body consciousness was not significantly correlated with interoceptive awareness, which may explain the many nonsignificant results in self-objectification studies that have used private body consciousness as a measure of body awareness. Conclusions/Significance: We propose interoceptive awareness, assessed by heartbeat perception, as a measure of body awareness in self-objectification studies. Our findings have implications for those clinical conditions, in women, which are characterised by self-objectification and low interoceptive awareness, such as eating disorders.	[Ainley, Vivien; Tsakiris, Manos] Royal Holloway Univ London, Dept Psychol, London, England	University of London; Royal Holloway University London	Ainley, V (corresponding author), Royal Holloway Univ London, Dept Psychol, London, England.	Vivien.Ainley.2008@live.rhul.ac.uk	TSAKIRIS, MANOS/C-1529-2008	TSAKIRIS, MANOS/0000-0001-7753-7576; Ainley, Vivien/0000-0003-0373-0079	European Platform for Life Sciences, Mind Sciences and Humanities, Volkswagen Foundation [II/85 064]	European Platform for Life Sciences, Mind Sciences and Humanities, Volkswagen Foundation	This study was funded by the European Platform for Life Sciences, Mind Sciences and Humanities, Volkswagen Foundation (II/85 064) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley V, 2012, PSYCHOPHYSIOLOGY, V49, P1672, DOI 10.1111/j.1469-8986.2012.01468.x; Anderson EM, 1996, J PERS ASSESS, V66, P144, DOI 10.1207/s15327752jpa6601_11; [Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; BLASCOVICH J, 1992, J PERS SOC PSYCHOL, V63, P164, DOI 10.1037/0022-3514.63.1.164; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Buss A. H., 1975, TEMPERAMENT THEORY P; Cameron O.G., 2002, VISCERAL SENSORY NEU; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; CARVER CS, 1978, J PERS SOC PSYCHOL, V36, P324, DOI 10.1037/0022-3514.36.3.324; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Damasio Antonio, 2010, SELF COMES MIND CONS; Dunn BD, 2007, J ABNORM PSYCHOL, V116, P1, DOI 10.1037/0021-843X.116.1.1; Duval S., 1972, THEORY OBJECTIVE SEL; EHLERS A, 1992, J ABNORM PSYCHOL, V101, P371, DOI 10.1037/0021-843X.101.3.371; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Fairclough SH, 2007, J PSYCHOSOM RES, V62, P289, DOI 10.1016/j.jpsychores.2006.10.017; Fejfar MC, 2000, PERS SOC PSYCHOL REV, V4, P132, DOI 10.1207/S15327957PSPR0402_02; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; Fredrickson BL, 1998, J PERS SOC PSYCHOL, V75, P269, DOI 10.1037/0022-3514.75.1.269; Fredrickson BL, 1997, PSYCHOL WOMEN QUART, V21, P173, DOI 10.1111/j.1471-6402.1997.tb00108.x; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; GARNER DM, 1976, PSYCHOSOM MED, V38, P327, DOI 10.1097/00006842-197609000-00005; HARVER A, 1993, PSYCHOPHYSIOLOGY, V30, P223, DOI 10.1111/j.1469-8986.1993.tb03347.x; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036646; Herbert BM, 2011, J PERS, V79, P1149, DOI 10.1111/j.1467-6494.2011.00717.x; Herbert BM, 2010, PSYCHOPHYSIOLOGY, V47, P342, DOI 10.1111/j.1469-8986.2009.00931.x; JENNINGS JR, 1981, PSYCHOPHYSIOLOGY, V18, P226, DOI 10.1111/j.1469-8986.1981.tb03023.x; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Khalsa SS, 2008, PSYCHOPHYSIOLOGY, V45, P671, DOI 10.1111/j.1469-8986.2008.00666.x; Knapp-Kline K, 2005, BIOL PSYCHOL, V69, P387, DOI 10.1016/j.biopsycho.2004.09.002; KNOLL JF, 1992, PSYCHOPHYSIOLOGY, V29, P218, DOI 10.1111/j.1469-8986.1992.tb01689.x; Matthias E, 2009, INT J PSYCHOPHYSIOL, V72, P154, DOI 10.1016/j.ijpsycho.2008.12.001; McKinley NM, 1996, PSYCHOL WOMEN QUART, V20, P181, DOI 10.1111/j.1471-6402.1996.tb00467.x; Mehling WE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005614; MILLER LC, 1981, J PERS SOC PSYCHOL, V41, P397, DOI 10.1037/0022-3514.41.2.397; Miner-Rubino K, 2002, J RES PERS, V36, P147, DOI 10.1006/jrpe.2001.2343; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; Moradi B, 2008, PSYCHOL WOMEN QUART, V32, P377, DOI 10.1111/j.1471-6402.2008.00452.x; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Muehlenkamp JJ, 2002, PSYCHOL WOMEN QUART, V26, P371, DOI 10.1111/1471-6402.t01-1-00076; Mussap AJ, 2006, J HEALTH PSYCHOL, V11, P627, DOI 10.1177/1359105306065022; Mussgay L, 1999, J PSYCHOPHYSIOL, V13, P27, DOI 10.1027//0269-8803.13.1.27; Myers TA, 2008, PSYCHOL WOMEN QUART, V32, P172, DOI 10.1111/j.1471-6402.2008.00421.x; Peat CM, 2011, PSYCHOL WOMEN QUART, V35, P441, DOI 10.1177/0361684311400389; PENNEBAKER JW, 1980, J PERS SOC PSYCHOL, V39, P165, DOI 10.1037/0022-3514.39.1.165; Pennebaker JW., 1982, PSYCHOL PHYS SYMPTOM; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos Olga, 2008, Eat Behav, V9, P381, DOI 10.1016/j.eatbeh.2008.02.001; Pollatos O, 2007, J ANXIETY DISORD, V21, P931, DOI 10.1016/j.janxdis.2006.12.004; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V63, P117, DOI 10.1016/j.ijpsycho.2006.09.003; Pollatos O, 2011, PAIN, V152, P2157, DOI 10.1016/j.pain.2011.05.024; RING C, 1992, PSYCHOPHYSIOLOGY, V29, P535, DOI 10.1111/j.1469-8986.1992.tb02027.x; Rochat P, 2011, CONSCIOUS COGN, V20, P204, DOI 10.1016/j.concog.2010.06.007; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Silvia PJ, 2004, BEHAV RES METH INS C, V36, P325, DOI 10.3758/BF03195578; Silvia PJ, 2001, PERS SOC PSYCHOL REV, V5, P230, DOI 10.1207/S15327957PSPR0503_4; Szymanski DM, 2007, SEX ROLES, V56, P45, DOI 10.1007/s11199-006-9147-3; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Tiggemann M, 2004, BRIT J CLIN PSYCHOL, V43, P299, DOI 10.1348/0144665031752925; Tiggemann M, 2001, PSYCHOL WOMEN QUART, V25, P57, DOI 10.1111/1471-6402.00007; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Vaitl D, 1996, BIOL PSYCHOL, V42, P1, DOI 10.1016/0301-0511(95)05144-9; WEISZ J, 1988, PSYCHOPHYSIOLOGY, V25, P193, DOI 10.1111/j.1469-8986.1988.tb00987.x; WHITEHEAD WE, 1980, PSYCHOPHYSIOLOGY, V17, P552, DOI 10.1111/j.1469-8986.1980.tb02296.x; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905	69	84	84	7	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55568	10.1371/journal.pone.0055568	http://dx.doi.org/10.1371/journal.pone.0055568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405173	Green Published, gold			2022-12-25	WOS:000315153400118
J	Bagchi, DP; Yu, LH; Perlmutter, JS; Xu, JB; Mach, RH; Tu, ZD; Kotzbauer, PT				Bagchi, Devika P.; Yu, Lihai; Perlmutter, Joel S.; Xu, Jinbin; Mach, Robert H.; Tu, Zhude; Kotzbauer, Paul T.			Binding of the Radioligand SIL23 to alpha-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; LEWY BODIES; IN-VITRO; CLINICAL-DIAGNOSIS; DEMENTIA; TAU; NEURODEGENERATION; PATHOLOGY	Accumulation of alpha-synuclein (alpha-syn) fibrils in Lewy bodies and Lewy neurites is the pathological hallmark of Parkinson disease (PD). Ligands that bind alpha-syn fibrils could be utilized as imaging agents to improve the diagnosis of PD and to monitor disease progression. However, ligands for alpha-syn fibrils in PD brain tissue have not been previously identified and the feasibility of quantifying alpha-syn fibrils in brain tissue is unknown. We report the identification of the I-125-labeled alpha-syn radioligand SIL23. [I-125]SIL23 binds alpha-syn fibrils in postmortem brain tissue from PD patients as well as an alpha-syn transgenic mouse model for PD. The density of SIL23 binding sites correlates with the level of fibrillar alpha-syn in PD brain tissue, and [I-125] SIL23 binding site densities in brain tissue are sufficiently high to enable in vivo imaging with high affinity ligands. These results identify a SIL23 binding site on alpha-syn fibrils that is a feasible target for development of an alpha-syn imaging agent. The affinity of SIL23 for alpha-syn and its selectivity for alpha-syn versus Ab and tau fibrils is not optimal for imaging fibrillar alpha-syn in vivo, but we show that SIL23 competitive binding assays can be used to screen additional ligands for suitable affinity and selectivity, which will accelerate the development of an alpha-syn imaging agent for PD.	[Bagchi, Devika P.; Perlmutter, Joel S.; Kotzbauer, Paul T.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Bagchi, Devika P.; Kotzbauer, Paul T.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Bagchi, Devika P.; Yu, Lihai; Perlmutter, Joel S.; Xu, Jinbin; Mach, Robert H.; Tu, Zhude; Kotzbauer, Paul T.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA; [Yu, Lihai; Perlmutter, Joel S.; Xu, Jinbin; Mach, Robert H.; Tu, Zhude] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Perlmutter, Joel S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Perlmutter, Joel S.] Program Occupat Therapy, St Louis, MO USA; [Perlmutter, Joel S.] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Perlmutter, Joel S.] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Kotzbauer, PT (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	kotzbauerp@neuro.wustl.edu	Xu, Jinbin/ABG-1280-2020	Xu, Jinbin/0000-0002-2120-8287; Mach, Robert/0000-0002-7645-2869; Tu, Zhude/0000-0003-0325-835X	Michael J. Fox Foundation; Washington University Institute of Clinical and Translational Sciences [CTSA406]; American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University; Greater St. Louis Chapter of the APDA; Barnes-Jewish Hospital Foundation (Elliot Stein Family Fund for PD Research & the Jack Buck Research Fund); NIH/NINDS [NS075321, NS058714, NS41509]; NIH [NS061025, NS075527, MH092797]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH092797, R21MH092797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041509, R01NS058714, R21NS061025, R01NS075527, R03NS090214, R01NS075321] Funding Source: NIH RePORTER	Michael J. Fox Foundation; Washington University Institute of Clinical and Translational Sciences; American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University; Greater St. Louis Chapter of the APDA; Barnes-Jewish Hospital Foundation (Elliot Stein Family Fund for PD Research & the Jack Buck Research Fund); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Michael J. Fox Foundation grant supporting a Consortium to Develop an Alpha-Synuclein Imaging Agent (RHM, ZT, PTK), Washington University Institute of Clinical and Translational Sciences Grant CTSA406 (PTK, ZT), American Parkinson Disease Association (APDA) Center for Advanced PD Research at Washington University; Greater St. Louis Chapter of the APDA (JSP); the Barnes-Jewish Hospital Foundation (Elliot Stein Family Fund for PD Research & the Jack Buck Research Fund) (JSP), NIH/NINDS grants NS075321, NS058714 and NS41509 (JSP), and NIH grants NS061025, NS075527, and MH092797 (ZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burack MA, 2010, NEUROLOGY, V74, P77, DOI 10.1212/WNL.0b013e3181c7da8e; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Engel LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012897; Fodero-Tavoletti MT, 2007, J NEUROSCI, V27, P10365, DOI 10.1523/JNEUROSCI.0630-07.2007; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Fodero-Tavoletti MT, 2009, EUR J PHARMACOL, V617, P54, DOI 10.1016/j.ejphar.2009.06.042; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Fujishiro H, 2008, ACTA NEUROPATHOL, V116, P269, DOI 10.1007/s00401-008-0398-7; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hou C, 2006, NUCL MED BIOL, V33, P203, DOI 10.1016/j.nucmedbio.2005.10.001; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Jankovic J, 2000, ARCH NEUROL-CHICAGO, V57, P369, DOI 10.1001/archneur.57.3.369; Jensen JR, 2011, J ALZHEIMERS DIS, V26, P147, DOI 10.3233/JAD-2011-0003; Josephs KA, 2011, ACTA NEUROPATHOL, V122, P137, DOI 10.1007/s00401-011-0839-6; Klunk WE, 2005, J NEUROSCI, V25, P10598, DOI 10.1523/JNEUROSCI.2990-05.2005; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; KUNG MP, 1990, J NUCL MED, V31, P648; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; MURPHY RA, 1990, J MED CHEM, V33, P171, DOI 10.1021/jm00163a029; Ozawa T, 2004, BRAIN, V127, P2657, DOI 10.1093/brain/awh303; Paisan-Ruiz C, 2010, NEUROBIOL AGING; Parkkinen L, 2007, CLIN NEUROPATHOL, V26, P276; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Villemagne VL, 2011, J NUCL MED, V52, P1210, DOI 10.2967/jnumed.111.089730; Wakabayashi K, 2005, ACTA NEUROPATHOL, V110, P185, DOI 10.1007/s00401-005-1029-1; Ye L, 2008, J NEUROCHEM, V105, P1428, DOI 10.1111/j.1471-4159.2008.05245.x; Yu L, 2012, BIOORG MED IN PRESS	44	80	83	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55031	10.1371/journal.pone.0055031	http://dx.doi.org/10.1371/journal.pone.0055031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405108	gold, Green Published			2022-12-25	WOS:000315153400052
J	Jittawuttipoka, T; Planchon, M; Spalla, O; Benzerara, K; Guyot, F; Cassier-Chauvat, C; Chauvat, F				Jittawuttipoka, Thichakorn; Planchon, Mariane; Spalla, Olivier; Benzerara, Karim; Guyot, Francois; Cassier-Chauvat, Corinne; Chauvat, Franck			Multidisciplinary Evidences that Synechocystis PCC6803 Exopolysaccharides Operate in Cell Sedimentation and Protection against Salt and Metal Stresses	PLOS ONE			English	Article							SP PCC 6803; BIOFILM FORMATION; ESCHERICHIA-COLI; GENES; CYANOBACTERIA; MUTAGENESIS; EXPRESSION; RESISTANCE; TOXICITY; GENOME	Little is known about the production of exopolysaccharides (EPS) in cyanobacteria, and there are no genetic and physiological evidences that EPS are involved in cell protection against the frequently encountered environmental stresses caused by salt and metals. We studied four presumptive EPS production genes, sll0923, sll1581, slr1875 and sll5052, in the model cyanobacterium Synechocystis PCC6803, which produces copious amounts of EPS attached to cells (CPS) and released in the culture medium (RPS) as shown here. We show that sll0923, sll1581, slr1875 and sll5052 are all dispensable to the growth of all corresponding single and double deletion mutants in absence of stress. Furthermore, we report that sll0923, sll1581 and slr1875 unambiguously operate in the production of both CPS and RPS. Both sll1581 and slr1875 are more important than sll0923 for CPS production, whereas the contrary is true for RPS production. We show that the most EPS-depleted mutant, doubly deleted for sll1581 and slr1875, lacks the EPS mantle that surrounds WT cells and sorbs iron in their vicinity. Using this mutant, we demonstrate for the first time that cyanobacterial EPS directly operate in cell protection against NaCl, CoCl2, CdSO4 and Fe-starvation. We believe that our EPS-depleted mutants will be useful tools to investigate the role of EPS in cell-to-cell aggregation, biofilm formation, biomineralization and tolerance to environmental stresses. We also suggest using the fast sedimenting mutants as biotechnological cell factories to facilitate the otherwise expensive harvest of the producer cell biomass and/or its separation from products excreted in the growth media.	[Jittawuttipoka, Thichakorn; Cassier-Chauvat, Corinne; Chauvat, Franck] Univ Paris 11, UMR8221, CEA, CNRS,iBiTec S,LBBC,CEA Saclay, F-91191 Gif Sur Yvette, France; [Planchon, Mariane; Spalla, Olivier] CEA, DSM IRAMIS LIONS SIS2M, UMR CEA CNRS 3299, F-91191 Gif Sur Yvette, France; [Benzerara, Karim; Guyot, Francois] Univ Paris 06, UMR 7590, CNRS, IPGP,Inst Mineral & Phys Milieux Condenses, F-75252 Paris 05, France; [Benzerara, Karim; Guyot, Francois] Univ Paris 07, UMR 7590, CNRS, IPGP,Inst Mineral & Phys Milieux Condenses, F-75252 Paris 05, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris Cite	Cassier-Chauvat, C (corresponding author), Univ Paris 11, UMR8221, CEA, CNRS,iBiTec S,LBBC,CEA Saclay, Bat 142, F-91191 Gif Sur Yvette, France.	corinne-cassier.chauvat@cea.fr; franck.chauvat@cea.fr	CASSIER-CHAUVAT, Corinne/E-7505-2010; GUYOT, François J/C-3824-2016; Chauvat, Franck/E-7394-2010; Cassier-Chauvat, Corinnne/ABB-4815-2021; Benzerara, Karim/J-1532-2016	CASSIER-CHAUVAT, Corinne/0000-0001-6901-5559; GUYOT, François J/0000-0003-4622-2218; Chauvat, Franck/0000-0002-9151-7667; Cassier-Chauvat, Corinnne/0000-0001-6901-5559; Benzerara, Karim/0000-0002-0553-0137	french C'Nano programme (Enseine project); Region Ile de France [SESAME 2006 NuI-07-593/R]	french C'Nano programme (Enseine project); Region Ile de France(Region Ile-de-France)	The french C'Nano programme (Enseine project) for the postdoc and PhD fellowships to T.J and M. P, respectively. The Scanning Electron Microscope (SEM) facility at the Institut de Mineralogie et de Physique des Milieux Condenses is supported by Region Ile de France grant SESAME 2006 NuI-07-593/R, INSU-CNRS, INP-CNRS, Universite Pierre et Marie Curie - Paris 6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barras F, 2011, METALLOMICS, V3, P1130, DOI 10.1039/c1mt00099c; Cerantola S, 2000, FEMS MICROBIOL LETT, V185, P243, DOI 10.1016/S0378-1097(00)00099-9; Conover MS, 2012, J BACTERIOL, V194, P233, DOI 10.1128/JB.06020-11; De Philippis R, 2011, APPL MICROBIOL BIOT, V92, P697, DOI 10.1007/s00253-011-3601-z; Domain F, 2004, MOL MICROBIOL, V53, P65, DOI 10.1111/j.1365-2958.2004.04100.x; Foster JS, 2009, FEMS MICROBIOL LETT, V293, P298, DOI 10.1111/j.1574-6968.2009.01548.x; Freitas F, 2011, TRENDS BIOTECHNOL, V29, P388, DOI 10.1016/j.tibtech.2011.03.008; Griese M, 2011, FEMS MICROBIOL LETT, V323, P124, DOI 10.1111/j.1574-6968.2011.02368.x; GRIGORIEVA G, 1982, FEMS MICROBIOL LETT, V13, P367, DOI 10.1111/j.1574-6968.1982.tb08289.x; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Houot L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-350; Jansson C, 2010, CURR OPIN BIOTECH, V21, P365, DOI 10.1016/j.copbio.2010.03.017; LABARRE J, 1989, J BACTERIOL, V171, P3449, DOI 10.1128/jb.171.6.3449-3457.1989; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Mazouni K, 2004, MOL MICROBIOL, V52, P1145, DOI 10.1111/j.1365-2958.2004.04042.x; Mazouni K, 1998, MOL MICROBIOL, V30, P1113, DOI 10.1046/j.1365-2958.1998.01145.x; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Nilsson M, 2011, ENVIRON MICROBIOL, V13, P1357, DOI 10.1111/j.1462-2920.2011.02447.x; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Poncelet M, 1998, MOL MICROBIOL, V28, P813, DOI 10.1046/j.1365-2958.1998.00844.x; REED JW, 1991, J BACTERIOL, V173, P664, DOI 10.1128/jb.173.2.664-677.1991; Rendueles O, 2013, ENVIRON MICROBIOL, V15, P334, DOI 10.1111/j.1462-2920.2012.02810.x; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Souza LCA, 2006, FEMS MICROBIOL LETT, V257, P236, DOI 10.1111/j.1574-6968.2006.00176.x; Tchounwou P.B., 2012, EXP S, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4, DOI 10.1007/978-3-7643-8340-4_6]; Yoshida T, 2003, MICROBIOL-SGM, V149, P431, DOI 10.1099/mic.0.25913-0; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004; Zeyons O, 2009, NANOTOXICOLOGY, V3, P284, DOI 10.3109/17435390903305260	31	97	100	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55564	10.1371/journal.pone.0055564	http://dx.doi.org/10.1371/journal.pone.0055564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405172	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400117
J	Kiriazis, A; Vahakoski, RL; Santio, NM; Arnaudova, R; Eerola, SK; Rainio, EM; Aumuller, IB; Yli-Kauhaluoma, J; Koskinen, PJ				Kiriazis, Alexandros; Vahakoski, Riitta L.; Santio, Niina M.; Arnaudova, Ralica; Eerola, Sini K.; Rainio, Eeva-Marja; Aumuller, Ingo B.; Yli-Kauhaluoma, Jari; Koskinen, Paivi J.			Tricyclic Benzo[cd]azulenes Selectively Inhibit Activities of Pim Kinases and Restrict Growth of Epstein-Barr Virus-Transformed Cells	PLOS ONE			English	Article							C-MYC; EXPRESSION; SURVIVAL; CANCER; BAD; TRICARBONYL(TROPONE)IRON; TRANSCRIPTION; CARCINOMA; PATHWAY; BINDING	Oncogenic Pim family kinases are often overexpressed in human hematopoietic malignancies as well as in solid tumours. These kinases contribute to tumorigenesis by promoting cell survival and by enhancing resistance against chemotherapy and radiation therapy. Furthermore, we have recently shown that they increase the metastatic potential of adherent cancer cells. Here we describe identification of tricyclic benzo[cd]azulenes and their derivatives as effective and selective inhibitors of Pim kinases. These compounds inhibit Pim autophosphorylation and abrogate the anti-apoptotic effects of Pim kinases. They also reduce cancer cell motility and suppress proliferation of lymphoblastoid cell lines infected and immortalized by the Epstein-Barr virus. Thus, these novel Pim-selective inhibitors provide promising compounds for both research and therapeutic purposes.	[Kiriazis, Alexandros; Arnaudova, Ralica; Aumuller, Ingo B.; Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, FIN-00014 Helsinki, Finland; [Vahakoski, Riitta L.; Santio, Niina M.; Arnaudova, Ralica; Eerola, Sini K.; Rainio, Eeva-Marja; Koskinen, Paivi J.] Univ Turku, Dept Biol, SF-20500 Turku, Finland	University of Helsinki; University of Turku	Yli-Kauhaluoma, J (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, FIN-00014 Helsinki, Finland.	jari.yli-kauhaluoma@helsinki.fi; paivi.koskinen@utu.fi	Koskinen, Päivi J/G-8939-2014	Arnaudova, Ralica Zhorova/0000-0002-4907-9229; Koskinen, Paivi/0000-0002-6864-4457; Rainio, Eeva/0000-0002-5632-0455; Yli-Kauhaluoma, Jari/0000-0003-0370-7653	Academy of Finland [108376, 111820, 121533]; Graduate School in Pharmaceutical Research; Walter och Lisi Wahls Stiftelse for Naturvetenskaplig Forskning; Drug Discovery Graduate School; Turku University Foundation; Orion-Farmos Research Foundation; Cancer Society of Finland; Maud Kuistila Foundation; CIMO exchange programme;  [LSHB-CT-2004-503467]	Academy of Finland(Academy of Finland); Graduate School in Pharmaceutical Research; Walter och Lisi Wahls Stiftelse for Naturvetenskaplig Forskning; Drug Discovery Graduate School; Turku University Foundation; Orion-Farmos Research Foundation; Cancer Society of Finland; Maud Kuistila Foundation; CIMO exchange programme; 	LSHB-CT-2004-503467 to J.Y.K.), the Academy of Finland (grant 108376 to J.Y.K), Graduate School in Pharmaceutical Research (A.K.) and Walter och Lisi Wahls Stiftelse for Naturvetenskaplig Forskning (J.Y.K.). The biological experiments were supported by the Academy of Finland (grants 111820 and 121533 to P.J.K.), the Drug Discovery Graduate School (R.L.V., N.M.S.), Turku University Foundation (N.M.S.), the Orion-Farmos Research Foundation (R.L.V.), the Cancer Society of Finland (R.L.V.), the Maud Kuistila Foundation (R.L.V.) and the CIMO exchange programme (R. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho TL, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-21; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Akue-Gedu R, 2009, J MED CHEM, V52, P6369, DOI 10.1021/jm901018f; AMSON R, 1989, P NATL ACAD SCI USA, V86, P8857, DOI 10.1073/pnas.86.22.8857; Anizon F, 2010, CURR MED CHEM, V17, P4114, DOI 10.2174/092986710793348554; Aumuller IB, 2011, ORG LETT, V13, P1670, DOI 10.1021/ol2001528; Aumuller IB, 2009, ORG LETT, V11, P5363, DOI 10.1021/ol902283q; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BERGMANN ED, 1968, CHEM REV, V68, P41, DOI 10.1021/cr60251a002; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Cheng F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000324; Coquerel Y, 2002, J ORGANOMET CHEM, V659, P176, DOI 10.1016/S0022-328X(02)01725-4; DAUTRY F, 1988, J BIOL CHEM, V263, P17615; Eichmann A, 2000, ONCOGENE, V19, P1215, DOI 10.1038/sj.onc.1203355; Heslop HE, 2009, BLOOD, V114, P4002, DOI 10.1182/blood-2009-07-143545; Kiriazis A, 2011, TETRAHEDRON LETT, V52, P1151, DOI 10.1016/j.tetlet.2011.01.016; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; LEVINE SG, 1958, J AM CHEM SOC, V80, P6150, DOI 10.1021/ja01555a068; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; LILLY M, 1992, ONCOGENE, V7, P727; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Matikainen S, 1999, BLOOD, V93, P1980, DOI 10.1182/blood.V93.6.1980.406k20_1980_1991; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Morwick T, 2010, EXPERT OPIN THER PAT, V20, P193, DOI 10.1517/13543770903496442; PAUSON PL, 1955, CHEM REV, V55, P9, DOI 10.1021/cr50001a002; Peltola K, 2009, NEOPLASIA, V11, P629, DOI 10.1593/neo.81038; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Rainio EM, 2005, VIROLOGY, V333, P201, DOI 10.1016/j.virol.2005.01.001; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; RIGBY JH, 1990, TETRAHEDRON LETT, V31, P3385, DOI 10.1016/S0040-4039(00)97403-3; Santio NM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-279; Schenone S, 2010, CURR PHARM DESIGN, V16, P3964, DOI 10.2174/138161210794454996; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang J, 2011, ONCOGENE, V12, P1; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Zemskova M, 2008, J BIOL CHEM, V283, P20635, DOI 10.1074/jbc.M709479200	38	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55409	10.1371/journal.pone.0055409	http://dx.doi.org/10.1371/journal.pone.0055409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405147	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400092
J	Scheer, S; Nakelsky, S; Bingham, T; Damesyn, M; Sun, D; Chin, CS; Buckman, A; Mark, KE				Scheer, Susan; Nakelsky, Shoshanna; Bingham, Trista; Damesyn, Mark; Sun, Dan; Chin, Chi-Sheng; Buckman, Anthony; Mark, Karen E.			Estimated HIV Incidence in California, 2006-2009	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; UNITED-STATES; TRANSMISSION; PREVENTION	Introduction: Accurate estimates of HIV incidence are crucial for prioritizing, targeting, and evaluating HIV prevention efforts. Using the methodology the CDC used to estimate national HIV incidence, we estimated HIV incidence in Los Angeles County (LAC), San Francisco (SF), and California's remaining counties. Methods: We estimated new HIV infections in 2006-2009 among adults and adolescents in LAC, SF and the remaining California counties using the Serologic Testing Algorithm for Recent Seroconversion (STARHS). STARHS methodology uses the BED HIV-1 capture enzyme immunoassay to determine recent HIV infections by testing remnant serum from persons newly diagnosed with HIV. A population-based incidence estimate is calculated using HIV testing data from newly diagnosed cases and imputing for persons unaware of their HIV infection. Results: For years 2007-2009, respectively, we estimated new infections in LAC to be 2426 (95% CI 1871-2982), 1669 (CI 1309-2029) and 1898 (CI 1452-2344) (p < 0.01); in SF for 2006-2009, 492 (CI 327-657), 490 (CI 335-646), 458 (CI 342-574) and 367 (CI 261-473) (p = 0.14); and in the remaining California counties in 2008-2009, 2526 (CI 1688-3364) and 2993 (CI 2141-3846) respectively. HIV infection rates among men who have sex with men (MSM) in LAC were 100 times higher than other risk populations; the SF MSM rate was 3 to 18 times higher than other demographic groups. In LAC, incidence rates among African-Americans were twice those of whites and Latinos; persons 40 years or older had lower rates of infection than younger persons. Discussion: We report the first HIV incidence estimates for California, highlighting geographic disparities in HIV incidence and confirming national findings that MSM and African-Americans are disproportionately impacted by HIV. HIV incidence estimates can and should be used to target prevention efforts towards populations at highest risk of acquiring new HIV infections, focusing on geographic, racial and risk group disparities.	[Scheer, Susan; Chin, Chi-Sheng; Buckman, Anthony] San Francisco Dept Publ Hlth, HIV Epidemiol Sect, San Francisco, CA 94102 USA; [Nakelsky, Shoshanna; Bingham, Trista] Los Angeles Cty Dept Publ Hlth, Div HIV & STD Programs, Los Angeles, CA USA; [Damesyn, Mark; Sun, Dan; Mark, Karen E.] Calif Dept Publ Hlth, Off AIDS, Sacramento, CA USA	San Francisco Department of Public Health; Los Angeles County Department of Public Health; California Department of Public Health	Scheer, S (corresponding author), San Francisco Dept Publ Hlth, HIV Epidemiol Sect, San Francisco, CA 94102 USA.	susan.scheer@sfdph.org			Centers for Disease Control and Prevention (CDC); CDC [3U62PS001000, U62PSD001045]; Office of AIDS in Sacramento the CDC [5U62PS001024]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of AIDS in Sacramento the CDC	This study was funded by the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In San Francisco, the CDC grant number was 3U62PS001000, in Los Angeles the CDC grant number was U62PSD001045, and at the Office of AIDS in Sacramento the CDC grant number was 5U62PS001024. The url for the CDC is www.cdc.gov.	California Department of Public Health. Office of AIDS, 2010, HIV AIDS SURV Q REP; Centers for Disease Control and Prevention, 1981, MMWR-MORBID MORTAL W, V21, P1; Centers for Disease Control and Prevention, 2009, HIV SURV REP, V21; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; HIV Epidemiology Program Los Angeles County Department of Public Health, 2010, HIV AIDS SURV SUMM; Huizenga HM, 2011, BRIT J MATH STAT PSY, V64, P1, DOI 10.1348/000711010X522687; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; Lieb S, 2011, PUBLIC HEALTH REP, V126, P60, DOI 10.1177/003335491112600110; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Office of National AIDS Policy, 2010, NATL HIV AIDS STRAT; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; San Francisco Department of Public Health HIV Epidemiology Section, 2010, HIV AIDS EP ANN REP; Scheer S, 2009, AIDS, V23, P533, DOI 10.1097/QAD.0b013e328322432b; State of California Department of Finance, 2007, RAC ETHN POP AG SEX	20	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55002	10.1371/journal.pone.0055002	http://dx.doi.org/10.1371/journal.pone.0055002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405106	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400050
J	Sejdic, E; Kalika, D; Czarnek, N				Sejdic, Ervin; Kalika, Dmitry; Czarnek, Nicholas			An Analysis of Resting-State Functional Transcranial Doppler Recordings from Middle Cerebral Arteries	PLOS ONE			English	Article							FLOW-VELOCITY; LANGUAGE LATERALIZATION; SONOGRAPHY; VARIABILITY; ULTRASOUND; COMPLEXITY; HEMODYNAMICS; HANDEDNESS	Functional transcrannial Doppler (fTCD) is used for monitoring the hemodynamics characteristics of major cerebral arteries. Its resting-state characteristics are known only when considering the maximal velocity corresponding to the highest Doppler shift (so called the envelope signals). Significantly more information about the resting-state fTCD can be gained when considering the raw cerebral blood flow velocity (CBFV) recordings. In this paper, we considered simultaneously acquired envelope and raw CBFV signals. Specifically, we collected bilateral CBFV recordings from left and right middle cerebral arteries using 20 healthy subjects (10 females). The data collection lasted for 15 minutes. The subjects were asked to remain awake, stay silent, and try to remain thought-free during the data collection. Time, frequency and time-frequency features were extracted from both the raw and the envelope CBFV signals. The effects of age, sex and body-mass index were examined on the extracted features. The results showed that the raw CBFV signals had a higher frequency content, and its temporal structures were almost uncorrelated. The information-theoretic features showed that the raw recordings from left and right middle cerebral arteries had higher content of mutual information than the envelope signals. Age and body-mass index did not have statistically significant effects on the extracted features. Sex-based differences were observed in all three domains and for both, the envelope signals and the raw CBFV signals. These findings indicate that the raw CBFV signals provide valuable information about the cerebral blood flow which can be utilized in further validation of fTCD as a clinical tool.	[Sejdic, Ervin; Kalika, Dmitry; Czarnek, Nicholas] Univ Pittsburgh, Dept Elect & Comp Engn, Swanson Sch Engn, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sejdic, E (corresponding author), Univ Pittsburgh, Dept Elect & Comp Engn, Swanson Sch Engn, Pittsburgh, PA 15260 USA.	esejdic@ieee.org		Sejdic, Ervin/0000-0003-4987-8298; Czarnek, Nicholas/0000-0002-7889-0184	University of Pittsburgh	University of Pittsburgh(University of Pittsburgh)	The authors would like to thank the University of Pittsburgh for funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aboy M, 2006, IEEE T BIO-MED ENG, V53, P2282, DOI 10.1109/TBME.2006.883696; Alexandrov AV, 2007, J NEUROIMAGING, V17, P11, DOI 10.1111/j.1552-6569.2006.00088.x; Deppe M, 2004, NEUROIMAGE, V21, P1124, DOI 10.1016/j.neuroimage.2003.10.016; Duschek S, 2003, PSYCHOPHYSIOLOGY, V40, P436, DOI 10.1111/1469-8986.00046; KELLEY RE, 1992, STROKE, V23, P9, DOI 10.1161/01.STR.23.1.9; Knake S, 2003, NEUROIMAGE, V19, P1228, DOI 10.1016/S1053-8119(03)00174-5; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Krejza J, 1999, AM J ROENTGENOL, V172, P213, DOI 10.2214/ajr.172.1.9888770; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lee J, 2010, BIOMEDICAL ENG ONLIN, V9; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Lohmann H, 2005, NEUROIMAGE, V24, P780, DOI 10.1016/j.neuroimage.2004.08.053; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marinoni M, 1998, ACTA NEUROL SCAND, V97, P324, DOI 10.1111/j.1600-0404.1998.tb05961.x; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MARTIN PJ, 1994, STROKE, V25, P390, DOI 10.1161/01.STR.25.2.390; Matteis M, 2001, J NEUROL, V248, P104, DOI 10.1007/s004150170243; Moody M, 2005, AM J PHYSIOL-REG I, V288, pR1581, DOI 10.1152/ajpregu.00837.2004; Myrden AJB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024170; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papoulis A., 1991, PROBABILITY RANDOM V; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Rey B, 2010, VIRTUAL REAL-LONDON, V14, P55, DOI 10.1007/s10055-009-0141-2; Rey B, 2010, ULTRASOUND MED BIOL, V36, P383, DOI 10.1016/j.ultrasmedbio.2009.11.001; Salinet ASM, 2012, ULTRASOUND MED BIOL, V38, P997, DOI 10.1016/j.ultrasmedbio.2012.02.016; Sejdic E., 2010, BMC RES NOTES, V3, P269; Sejdic E, 2009, DIGIT SIGNAL PROCESS, V19, P153, DOI 10.1016/j.dsp.2007.12.004; Stroobant N, 2000, NEUROPSYCHOL REV, V10, P213, DOI 10.1023/A:1026412811036; VRIENS EM, 1988, ULTRASOUND MED BIOL, V15, P1	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55405	10.1371/journal.pone.0055405	http://dx.doi.org/10.1371/journal.pone.0055405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405146	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000315153400091
J	Yin, Q; Fu, BB; Li, BY; Shi, XC; Inagaki, F; Zhang, XH				Yin, Qi; Fu, Bingbing; Li, Bingyu; Shi, Xiaochong; Inagaki, Fumio; Zhang, Xiao-Hua			Spatial Variations in Microbial Community Composition in Surface Seawater from the Ultra-Oligotrophic Center to Rim of the South Pacific Gyre	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; RIBOSOMAL-RNA GENES; IN-SITU; OLIGONUCLEOTIDE PROBES; MARINE-SEDIMENTS; CLONE LIBRARIES; SEA-ICE; BACTERIA; DIVERSITY; OCEAN	Surface seawater in the South Pacific Gyre (SPG) is one of the cleanest oceanic environments on earth, and the photosynthetic primary production is extremely low. Despite the ecological significance of the largest aquatic desert on our planet, microbial community composition in the ultra-oligotrophic seawater remain largely unknown. In this study, we collected surface seawater along a southern transect of the SPG during the Integrated Ocean Drilling Program (IODP) Expedition 329. Samples from four distinct sites (Sites U1368, U1369, U1370 and U1371) were examined, representing similar to 5400 kilometers of transect line from the gyre heart to the edge area. Real-time PCR analysis showed 16S rRNA gene abundance in the gyre seawater, ranging from 5.96x10(5) to 2.55x10(6) copies ml(-1) for Bacteria and 1.17x10(3) to 1.90x10(4) copies ml(-1) for Archaea. The results obtained by statistic analyses of 16S rRNA gene clone libraries revealed the community composition in the southern SPG area: diversity richness estimators in the gyre center (Sites U1368 & U1369) are generally lower than those at sites in the gyre edge (Sites U1370 & U1371) and their community structures are clearly distinguishable. Phylogenetic analysis showed the predominance of Proteobacteria (especially Alphaproteobacteria) and Cyanobacteria in bacterial 16S rRNA gene clone libraries, whereas phylotypes of Betaproteobacteria were only detected in the central gyre. Archaeal 16S rRNA genes in the clone libraries were predominated by the sequences of Marine Group II within the Euryarchaeota, and the Crenarchaeota sequences were rarely detected, which is consistent with the real-time PCR data (only 9.9 to 22.1 copies ml(-1)). We also performed cultivation of heterotrophic microbes onboard, resulting in 18.9% of phylogenetically distinct bacterial isolates at least at the species level. Our results suggest that the distribution and diversity of microbial communities in the SPG surface seawater are closely related to the ultra-oligotrophic oceanographic features in the Pacific Ocean.	[Yin, Qi; Fu, Bingbing; Li, Bingyu; Shi, Xiaochong; Zhang, Xiao-Hua] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China; [Inagaki, Fumio] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Nankoku, Kochi, Japan	Ocean University of China; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Zhang, XH (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.	xhzhang@ouc.edu.cn	Inagaki, Fumio/AAI-1156-2019	Inagaki, Fumio/0000-0003-2887-6525	National Natural Science Foundation of China [41276141]; National Natural Science Foundation for Creative Research Groups [41221004]; National High Technology Research & Development Program of China (863 Programs) [2012AA091605]; IODP China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Creative Research Groups(Science Fund for Creative Research Groups); National High Technology Research & Development Program of China (863 Programs)(National High Technology Research and Development Program of China); IODP China	This research used samples and data provided by the Integrated Ocean Drilling Program (IODP). We thank all of the crews and technical staffs on the JOIDES Resolution during the IODP Expedition 329 for their great efforts and help in sample collection. This work was supported by the National Natural Science Foundation of China (No. 41276141), the National Natural Science Foundation for Creative Research Groups (No. 41221004), the National High Technology Research & Development Program of China (863 Programs, No. 2012AA091605) and the IODP China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Busse HJ, 2005, BERGEYS MANUAL SYSTE, P658, DOI DOI 10.1007/0-387-29298-5_; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Claustre H, 2003, SCIENCE, V302, P1514, DOI 10.1126/science.1092704; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Collins RE, 2010, ENVIRON MICROBIOL, V12, P1828, DOI 10.1111/j.1462-2920.2010.02179.x; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S., 2011, P IODP; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Halm H, 2012, ISME J, V6, P1238, DOI 10.1038/ismej.2011.182; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirchman DL, 2005, LIMNOL OCEANOGR, V50, P1697, DOI 10.4319/lo.2005.50.5.1697; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kwon KK, 2005, INT J SYST EVOL MICR, V55, P2033, DOI 10.1099/ijs.0.63684-0; Labrenz M, 2004, APPL ENVIRON MICROB, V70, P4971, DOI 10.1128/AEM.70.8.4971-4979.2004; Lami R, 2007, APPL ENVIRON MICROB, V73, P4198, DOI 10.1128/AEM.02652-06; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Meier H, 1999, SYST APPL MICROBIOL, V22, P186, DOI 10.1016/S0723-2020(99)80065-4; Moissl C, 2003, ARCH MICROBIOL, V180, P211, DOI 10.1007/s00203-003-0580-1; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Morel A, 2007, LIMNOL OCEANOGR, V52, P217, DOI 10.4319/lo.2007.52.1.0217; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Overmann J, 1999, ARCH MICROBIOL, V172, P83, DOI 10.1007/s002030050744; Park M, 2005, MICROBIOL RES, V160, P127, DOI 10.1016/j.micres.2004.10.003; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; Ras J, 2008, BIOGEOSCIENCES, V5, P353, DOI 10.5194/bg-5-353-2008; Sahm K, 1998, MAR ECOL PROG SER, V165, P71, DOI 10.3354/meps165071; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Vetriani C, 2003, APPL ENVIRON MICROB, V69, P6481, DOI 10.1128/AEM.69.11.6481-6488.2003; Voss M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020127; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang W, 2008, ESTUAR COAST SHELF S, V76, P668, DOI 10.1016/j.ecss.2007.07.040; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	55	67	72	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55148	10.1371/journal.pone.0055148	http://dx.doi.org/10.1371/journal.pone.0055148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405118	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400062
J	Liu, L; Nie, J; Chen, L; Dong, GL; Du, XH; Wu, X; Tang, Y; Han, WD				Liu, Lin; Nie, Jing; Chen, Lin; Dong, Guanglong; Du, Xiaohui; Wu, Xin; Tang, Yun; Han, Weidong			The Oncogenic Role of microRNA-130a/301a/454 in Human Colorectal Cancer via Targeting Smad4 Expression	PLOS ONE			English	Article							CELL-PROLIFERATION; PROMOTES APOPTOSIS; MICRORNA; GENE; PLURIPOTENCY; METASTASIS; MIRNA-130A	Transforming growth factor (TGF)-beta/Smad signaling plays an important role in colon cancer development, progression and metastasis. In this study we demonstrated that the microRNA-130a/301a/454 family is up-regulated in colon cancer tissues compared to paired adjacent normal mucosa, which share the same 3'-untranslational region (3'-UTR) binding seed sequence and are predicated to target Smad4. In colorectal cancer HCT116 and SW480 cells, overexpression of miRNA-130a/301a/454 mimics enhances cell proliferation and migration, while inhibitors of these miRNAs affect cell survival. The biological function of miRNA-130a/301a/454 on colon cancer cells is likely mediated by suppression of Smad4, and the up-regulation of the miRNAs is correlated with Smad4 down-regulation in human colon cancers. Collectively, these results suggest that miRNA-130a/301a/454 are novel oncogenic miRNAs contributing to colon tumorigenesis by regulating TGF-beta/Smad signaling, which may have potential application in cancer therapy.	[Liu, Lin; Chen, Lin; Dong, Guanglong; Du, Xiaohui; Wu, Xin; Tang, Yun] Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China; [Nie, Jing; Han, Weidong] Peoples Liberat Army Gen Hosp, Dept Mol Biol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Tang, Y (corresponding author), Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing, Peoples R China.	tangyun_301@163.com; hanwdrsw@sina.com		Dong, Guanglong/0000-0002-5545-1912	National Basic Research Programs [2012CB518103]; National Natural Science Foundation of China [31100554, 31270820, 81230061, 81121004]; Nursery Foundation of PLA General Hospital [12KMM48]; Beijing Nova Program [Z12111000250000]	National Basic Research Programs(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nursery Foundation of PLA General Hospital; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This project is supported by grants from the National Basic Research Programs (2012CB518103), National Natural Science Foundation of China (31100554, 31270820, 81230061, and 81121004), Nursery Foundation of PLA General Hospital (12KMM48), and Beijing Nova Program (Z12111000250000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chen Z, 2012, J CELL BIOCHEM, V113, P3229, DOI 10.1002/jcb.24200; Genovese G, 2012, CANCER DISCOV, V2, P736, DOI 10.1158/2159-8290.CD-12-0111; Hahn SA, 1998, CANCER RES, V58, P1124; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kovaleva V, 2012, CANCER RES, V72, P1763, DOI 10.1158/0008-5472.CAN-11-3671; Lee YH, 2011, BIOCELL, V35, pB43; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Lu ZX, 2011, EMBO J, V30, P57, DOI 10.1038/emboj.2010.296; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Mycko MP, 2012, P NATL ACAD SCI USA, V109, pE1248, DOI 10.1073/pnas.1114325109; Nie J, 2012, CARCINOGENESIS, V33, P220, DOI 10.1093/carcin/bgr245; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585; Pfaff N, 2011, EMBO REP, V12, P1153, DOI 10.1038/embor.2011.176; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Shi W, 2011, CANCER RES, V71, P2926, DOI 10.1158/0008-5472.CAN-10-3369; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Suresh S, 2011, J CELL COMMUN SIGNAL, V5, P183, DOI 10.1007/s12079-011-0139-x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Wang XC, 2010, AM J MED SCI, V340, P385, DOI 10.1097/MAJ.0b013e3181e892a0; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Xiao B, 2012, ONCOL REP, V27, P559, DOI 10.3892/or.2011.1514; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang BX, 2010, GASTROENTEROLOGY, V138, P969, DOI 10.1053/j.gastro.2009.11.004; Zhang Y, 2012, NUCLEIC ACIDS RES, V40, P9286, DOI 10.1093/nar/gks667; Zhou P, 2012, DIGEST DIS SCI, V57, P1171, DOI 10.1007/s10620-012-2099-2	40	84	88	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55532	10.1371/journal.pone.0055532	http://dx.doi.org/10.1371/journal.pone.0055532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393589	gold, Green Submitted, Green Published			2022-12-25	WOS:000314692800043
J	Junk, DJ; Cipriano, R; Stampfer, M; Jackson, MW				Junk, Damian J.; Cipriano, Rocky; Stampfer, Martha; Jackson, Mark W.			Constitutive CCND1/CDK2 Activity Substitutes for p53 Loss, or MYC or Oncogenic RAS Expression in the Transformation of Human Mammary Epithelial Cells	PLOS ONE			English	Article							BREAST-CANCER; CYCLIN D1; INDUCED SENESCENCE; GROWTH; AMPLIFICATION; GENES; CDK2; PHOSPHORYLATION; OVEREXPRESSION; PROLIFERATION	Cancer develops following the accumulation of genetic and epigenetic alterations that inactivate tumor suppressor genes and activate proto-oncogenes. Dysregulated cyclin-dependent kinase (CDK) activity has oncogenic potential in breast cancer due to its ability to inactivate key tumor suppressor networks and drive aberrant proliferation. Accumulation or over-expression of cyclin D1 (CCND1) occurs in a majority of breast cancers and over-expression of CCND1 leads to accumulation of activated CCND1/CDK2 complexes in breast cancer cells. We describe here the role of constitutively active CCND1/CDK2 complexes in human mammary epithelial cell (HMEC) transformation. A genetically-defined, stepwise HMEC transformation model was generated by inhibiting p16 and p53 with shRNA, and expressing exogenous MYC and mutant RAS. By replacing components of this model, we demonstrate that constitutive CCND1/CDK2 activity effectively confers anchorage independent growth by inhibiting p53 or replacing MYC or oncogenic RAS expression. These findings are consistent with several clinical observations of luminal breast cancer sub-types that show elevated CCND1 typically occurs in specimens that retain wild-type p53, do not amplify MYC, and contain no RAS mutations. Taken together, these data suggest that targeted inhibition of constitutive CCND1/CDK2 activity may enhance the effectiveness of current treatments for luminal breast cancer.	[Junk, Damian J.; Cipriano, Rocky; Jackson, Mark W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Stampfer, Martha] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Jackson, Mark W.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Case Western Reserve University	Jackson, MW (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	mark.w.jackson@case.edu		Junk, Damian/0000-0002-9251-3799	U.S. Department of Energy [DE-AC02-05CH11231]; NIH [T32 CA059366]; NATIONAL CANCER INSTITUTE [T32CA059366] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Martha Stampfer was supported under the U.S. Department of Energy contract No. DE-AC02-05CH11231. Damian Junk was supported by NIH T32 CA059366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993; Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Chytil A, 2004, J BIOL CHEM, V279, P47688, DOI 10.1074/jbc.M405938200; Cipriano R, 2011, P NATL ACAD SCI USA, V108, P8668, DOI 10.1073/pnas.1015022108; Corsino P, 2007, CANCER RES, V67, P3135, DOI 10.1158/0008-5472.CAN-06-3815; Corsino P, 2009, J BIOL CHEM, V284, P29945, DOI 10.1074/jbc.M109.055251; Cuny M, 2000, CANCER RES, V60, P1077; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; FILMUS J, 1994, ONCOGENE, V9, P3627; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Garrett MD, 1999, CURR OPIN GENET DEV, V9, P104, DOI 10.1016/S0959-437X(99)80015-X; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; GILLETT C, 1994, CANCER RES, V54, P1812; Guedj M, 2011, ONCOGENE; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hydbring P, 2010, CANCER RES, V70, P6687, DOI 10.1158/0008-5472.CAN-10-1383; Hydbring P, 2010, P NATL ACAD SCI USA, V107, P58, DOI 10.1073/pnas.0900121106; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Kan CE, 2007, CANCER RES, V67, P9862, DOI 10.1158/0008-5472.CAN-07-0259; KATO J, 1993, GENE DEV, V7, P331; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Mani S, 2000, EXPERT OPIN INV DRUG, V9, P1849, DOI 10.1517/13543784.9.8.1849; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; STAMPFER M, 1980, IN VITRO CELL DEV B, V16, P415; Sweeney KJ, 1998, ONCOGENE, V16, P2865, DOI 10.1038/sj.onc.1201814	39	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e53776	10.1371/journal.pone.0053776	http://dx.doi.org/10.1371/journal.pone.0053776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390492	gold, Green Submitted, Green Published			2022-12-25	WOS:000314691100008
J	Rachow, S; Zorn-Kruppa, M; Ohnemus, U; Kirschner, N; Vidal-y-Sy, S; von den Driesch, P; Bornchen, C; Eberle, J; Mildner, M; Vettorazzi, E; Rosenthal, R; Moll, I; Brandner, JM				Rachow, Susanne; Zorn-Kruppa, Michaela; Ohnemus, Ulrich; Kirschner, Nina; Vidal-y-Sy, Sabine; von den Driesch, Peter; Boernchen, Christian; Eberle, Juergen; Mildner, Michael; Vettorazzi, Eik; Rosenthal, Rita; Moll, Ingrid; Brandner, Johanna M.			Occludin Is Involved in Adhesion, Apoptosis, Differentiation and Ca2+-Homeostasis of Human Keratinocytes: Implications for Tumorigenesis	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; CELL-CELL ADHESION; EPITHELIAL-MESENCHYMAL TRANSITION; INVOLUCRIN EXPRESSION; EPIDERMAL BARRIER; TUMOR INVASION; SKIN; CLAUDINS; PROGRESSION; COMPLEX	Tight junction (TJ) proteins are involved in a number of cellular functions, including paracellular barrier formation, cell polarization, differentiation, and proliferation. Altered expression of TJ proteins was reported in various epithelial tumors. Here, we used tissue samples of human cutaneous squamous cell carcinoma (SCC), its precursor tumors, as well as sun-exposed and non-sun-exposed skin as a model system to investigate TJ protein alteration at various stages of tumorigenesis. We identified that a broader localization of zonula occludens protein (ZO)-1 and claudin-4 (Cldn-4) as well as downregulation of Cldn-1 in deeper epidermal layers is a frequent event in all the tumor entities as well as in sun-exposed skin, suggesting that these changes result from chronic UV irradiation. In contrast, SCC could be distinguished from the precursor tumors and sun-exposed skin by a frequent complete loss of occludin (Ocln). To elucidate the impact of downregulation of Ocln, we performed Ocln siRNA experiments in human keratinocytes and uncovered that Ocln downregulation results in decreased epithelial cell-cell adhesion and reduced susceptibility to apoptosis induction by UVB or TNF-related apoptosis-inducing ligand (TRAIL), cellular characteristics for tumorigenesis. Furthermore, an influence on epidermal differentiation was observed, while there was no change of E-cadherin and vimentin, markers for epithelial-mesenchymal transition. Ocln knock-down altered Ca2+-homeostasis which may contribute to alterations of cell-cell adhesion and differentiation. As downregulation of Ocln is also seen in SCC derived from other tissues, as well as in other carcinomas, we suggest this as a common principle in tumor pathogenesis, which may be used as a target for therapeutic intervention.	[Rachow, Susanne; Zorn-Kruppa, Michaela; Ohnemus, Ulrich; Kirschner, Nina; Vidal-y-Sy, Sabine; Boernchen, Christian; Moll, Ingrid; Brandner, Johanna M.] Univ Hosp Hamburg Eppendorf, Dept Dermatol & Venerol, Hamburg, Germany; [Rachow, Susanne] Tabea Clin GmbH, Hamburg, Germany; [von den Driesch, Peter] Klinikum Stuttgart, Dermatol Ctr, Stuttgart, Germany; [Eberle, Juergen] Charite, Skin Canc Ctr, Dept Dermatol Venerol & Allergol, Berlin, Germany; [Mildner, Michael] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Vettorazzi, Eik] Univ Hosp Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Rosenthal, Rita] Charite, Inst Clin Physiol, D-13353 Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Klinikum Stuttgart; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Vienna; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brandner, JM (corresponding author), Univ Hosp Hamburg Eppendorf, Dept Dermatol & Venerol, Hamburg, Germany.	brandner@uke.de	Rosenthal, Rita/M-5652-2014; Vettorazzi, Eik/B-8130-2019	Vettorazzi, Eik/0000-0002-3737-6402; Eberle, Jurgen/0000-0001-8533-1519; Mildner, Michael/0000-0002-6892-925X	Deutsche Forschungsgemeinschaft [Forschergruppe 721/2, TP9]; Johann und Anny Thomas Stiftung; COST Action [BM 0903]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Johann und Anny Thomas Stiftung; COST Action(European Cooperation in Science and Technology (COST))	Deutsche Forschungsgemeinschaft, Forschergruppe 721/2, TP9, Johann und Anny Thomas Stiftung, COST Action BM 0903 SkinBAD STSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Arabzadeh A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-196; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Beeman N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.14; Beeman NE, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-85; Behne MJ, 2012, ADV EXP MED BIOL, V740, P945, DOI 10.1007/978-94-007-2888-2_43; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; BRUSSELBACH S, 1995, ONCOGENE, V10, P79; BRYNE M, 1989, J ORAL PATHOL MED, V18, P432, DOI 10.1111/j.1600-0714.1989.tb01339.x; Caldwell CJ, 1997, CLIN EXP DERMATOL, V22, P11, DOI 10.1046/j.1365-2230.1997.d01-232.x; Chaturvedi V, 1999, J BIOL CHEM, V274, P23358, DOI 10.1074/jbc.274.33.23358; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; DUVIC M, 1994, J INVEST DERMATOL, V102, P462, DOI 10.1111/1523-1747.ep12373021; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Fujita H, 2008, MOL BIOL CELL, V19, P1912, DOI 10.1091/mbc.E07-09-0973; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gao Y, 2008, INT J PHARM, V359, P70, DOI 10.1016/j.ijpharm.2008.03.016; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Iseri OD, 2011, BIOMED PHARMACOTHER, V65, P40, DOI 10.1016/j.biopha.2010.10.004; Jansen BJH, 2003, J INVEST DERMATOL, V121, P1433, DOI 10.1046/j.1523-1747.2003.12636.x; Kirschner N, 2013, J INVEST DERMATOL, V133, P1161, DOI 10.1038/jid.2012.507; Kirschner N, 2012, EXP DERMATOL, V21, P171, DOI 10.1111/j.1600-0625.2011.01431.x; Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390; Kirschner N, 2010, EUR J CELL BIOL, V89, P839, DOI 10.1016/j.ejcb.2010.07.010; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; KREUSEL KM, 1991, AM J PHYSIOL, V261, pC574, DOI 10.1152/ajpcell.1991.261.4.C574; Langbein L, 2003, EUR J CELL BIOL, V82, P385, DOI 10.1078/0171-9335-00330; Lanigan F, 2009, INT J CANCER, V124, P2088, DOI 10.1002/ijc.24159; Lemieux E, 2009, INT J CANCER, V125, P1575, DOI 10.1002/ijc.24485; Martin TA, 2011, FRONT BIOSCI-LANDMRK, V16, P898, DOI 10.2741/3726; Martin TA, 2010, INT J MOL MED, V26, P721, DOI 10.3892/ijmm_00000519; Martinet N, 2003, AM J RESP CELL MOL, V28, P428, DOI 10.1165/rcmb.2002-0114OC; Mildner M, 2006, BIOCHEM BIOPH RES CO, V348, P76, DOI 10.1016/j.bbrc.2006.07.035; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Morita K, 2004, BRIT J DERMATOL, V151, P328, DOI 10.1111/j.1365-2133.2004.06029.x; Murata M, 2005, EXP CELL RES, V310, P140, DOI 10.1016/j.yexcr.2005.07.017; Nemeth Z, 2009, PATHOL ONCOL RES, V15, P533, DOI 10.1007/s12253-009-9150-4; Oliveira SS, 2007, CELL MOL LIFE SCI, V64, P17, DOI 10.1007/s00018-006-6314-1; Orban E, 2008, PATHOL ONCOL RES, V14, P299, DOI 10.1007/s12253-008-9031-2; Osanai M, 2006, CANCER RES, V66, P9125, DOI 10.1158/0008-5472.CAN-06-1864; Ouban A, 2011, INT J SURG PATHOL; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Paschoud S, 2007, MODERN PATHOL, V20, P947, DOI 10.1038/modpathol.3800835; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Pummi K, 2001, J INVEST DERMATOL, V117, P1050, DOI 10.1046/j.0022-202x.2001.01493.x; Pustisek N, 2011, COLLEGIUM ANTROPOL, V35, P339; Rodust PM, 2009, BRIT J DERMATOL, V161, P107, DOI 10.1111/j.1365-2133.2009.09458.x; Sayers TJ, 2011, CANCER IMMUNOL IMMUN, V60, P1173, DOI 10.1007/s00262-011-1008-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Sehrawat A, 2011, CANCER PREV RES, V4, P1107, DOI 10.1158/1940-6207.CAPR-10-0306; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; SOBER AJ, 1995, CANCER, V75, P645, DOI 10.1002/1097-0142(19950115)75:2+<645::AID-CNCR2820751405>3.0.CO;2-1; SUMITOMO S, 1986, ORAL SURG ORAL MED O, V62, P155, DOI 10.1016/0030-4220(86)90038-1; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tobioka H, 2004, VIRCHOWS ARCH, V445, P472, DOI 10.1007/s00428-004-1054-9; Tobioka H, 2004, HUM PATHOL, V35, P159, DOI 10.1016/j.humpath.2003.09.013; Troyanovsky SM, 1999, CURR OPIN CELL BIOL, V11, P561, DOI 10.1016/S0955-0674(99)00021-6; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Turksen K, 2011, BBA-REV CANCER, V1816, P73, DOI 10.1016/j.bbcan.2011.04.001; VanItallie CM, 1997, J CELL SCI, V110, P1113; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Vicanova J, 1998, J INVEST DERMATOL, V111, P97, DOI 10.1046/j.1523-1747.1998.00251.x; Viloria-Petit AM, 2010, CELL CYCLE, V9, P623, DOI 10.4161/cc.9.4.10779; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; WATANABE S, 1995, BRIT J DERMATOL, V132, P730; Weedon D., 2006, WHO CLASSIFICATION T, P20; Yamamoto T, 2008, ARCH DERMATOL RES, V300, P61, DOI 10.1007/s00403-007-0817-y; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Yuki T, 2011, J INVEST DERMATOL, V131, P744, DOI 10.1038/jid.2010.385	78	55	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55116	10.1371/journal.pone.0055116	http://dx.doi.org/10.1371/journal.pone.0055116			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390516	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100032
J	Rispens, T; Derksen, NIL; Commins, SP; Platts-Mills, TA; Aalberse, RC				Rispens, Theo; Derksen, Ninotska I. L.; Commins, Scott P.; Platts-Mills, Thomas A.; Aalberse, Rob C.			IgE Production to alpha-Gal Is Accompanied by Elevated Levels of Specific IgG1 Antibodies and Low Amounts of IgE to Blood Group B	PLOS ONE			English	Article							NATURAL ANTI-GAL; ANTI-GALACTOSE-ALPHA-1,3-GALACTOSE IGE; INDUCED ANAPHYLAXIS; CROSS-REACTIVITY; CARBOHYDRATE; BACTERIAL; EPITOPE; ACTIVATION; CETUXIMAB	IgE antibodies to gal-alpha-1,3-gal-beta-1,4-GlcNAc(alpha-gal) can mediate a novel form of delayed anaphylaxis to red meat. Although IgG antibodies to alpha-gal ( anti-alpha-gal or anti-Gal) are widely expressed in humans, IgE anti-alpha-gal is not. We explored the relationship between the IgG and IgE responses to both alpha-gal and the related blood group B antigen. Contradicting previous reports, antibodies to alpha-gal were found to be significantly less abundant in individuals with blood group B or AB. Importantly, we established a connection between IgE and IgG responses to alpha-gal: elevated titers of IgG anti-alpha-gal were found in IgE-positive subjects. In particular, proportionally more IgG1 anti-alpha-gal was found in IgE-positive subjects against a background of IgG2 production specific for alpha-gal. Thus, two types of immune response to alpha-gal epitopes can be distinguished: a 'typical' IgG2 response, presumably in response to gut bacteria, and an 'atypical', Th2-like response leading to IgG1 and IgE in addition to IgG2. These results suggest that IgE to a carbohydrate antigen can be formed (probably as part of a glycoprotein or glycolipid) even against a background of bacterial immune stimulation with essentially the same antigen.	[Rispens, Theo; Derksen, Ninotska I. L.; Aalberse, Rob C.] Univ Amsterdam, Acad Med Ctr, Sanquin Res, NL-1012 WX Amsterdam, Netherlands; [Rispens, Theo; Derksen, Ninotska I. L.; Aalberse, Rob C.] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1012 WX Amsterdam, Netherlands; [Commins, Scott P.; Platts-Mills, Thomas A.] Univ Virginia, Div Allergy & Immunol, Charlottesville, VA USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Virginia	Rispens, T (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res, NL-1012 WX Amsterdam, Netherlands.	t.rispens@sanquin.nl		Platts-Mills, Thomas/0000-0002-1263-329X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020565, T32AI007496] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007496, R01 AI020565, R37 AI020565] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; AALBERSE RC, 1993, ALLERGY, V48, P559, DOI 10.1111/j.1398-9995.1993.tb00749.x; Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Arkestal K, 2011, J ALLERGY CLIN IMMUN, V127, P1024, DOI 10.1016/j.jaci.2011.01.033; AVILA JL, 1989, J IMMUNOL, V142, P2828; BARRETT DJ, 1986, CLIN EXP IMMUNOL, V63, P127; Bernth-Jensen JM, 2011, J IMMUNOL METHODS, V373, P26, DOI 10.1016/j.jim.2011.07.017; Buonomano R, 1999, XENOTRANSPLANTATION, V6, P173, DOI 10.1034/j.1399-3089.1999.00023.x; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; Cornmins SP, 2012, AM J RESP CRIT CARE, V185, P723, DOI 10.1164/rccm.201111-2017OC; FERRANTE A, 1990, PEDIATR INFECT DIS J, V9, pS16; GALILI U, 1993, BLOOD, V82, P2485, DOI 10.1182/blood.V82.8.2485.bloodjournal8282485; GALILI U, 1987, J EXP MED, V165, P693, DOI 10.1084/jem.165.3.693; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; HAMADEH RM, 1992, J CLIN INVEST, V89, P1223, DOI 10.1172/JCI115706; Jacquenet S, 2009, J ALLERGY CLIN IMMUN, V124, P603, DOI 10.1016/j.jaci.2009.06.014; Krop EJM, 2011, ALLERGY, V66, P517, DOI 10.1111/j.1398-9995.2010.02508.x; Landsteiner K, 1925, J EXP MED, V42, P863, DOI 10.1084/jem.42.6.863; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Malandain H, 2005, Eur Ann Allergy Clin Immunol, V37, P122; McMorrow IM, 1997, TRANSPLANTATION, V64, P546, DOI 10.1097/00007890-199708150-00032; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; Milland J, 2007, IMMUNOL CELL BIOL, V85, P623, DOI 10.1038/sj.icb.7100111; Nouri-Aria KT, 2004, J IMMUNOL, V172, P3252, DOI 10.4049/jimmunol.172.5.3252; Plum M, 2011, J BIOL CHEM, V286, P43103, DOI 10.1074/jbc.M111.291823; Qian J, 2007, ANAL BIOCHEM, V364, P8, DOI 10.1016/j.ab.2007.01.023; RAVINDRAN B, 1988, IMMUNOL LETT, V19, P137, DOI 10.1016/0165-2478(88)90133-2; Saleh Hana, 2012, Clin Mol Allergy, V10, P5, DOI 10.1186/1476-7961-10-5; SIBER GR, 1980, NEW ENGL J MED, V303, P178, DOI 10.1056/NEJM198007243030402; Tomlinson S, 1997, J IMMUNOL, V159, P5606; van Bueren JJL, 2011, NAT BIOTECHNOL, V29, P574, DOI 10.1038/nbt.1912; Yu PB, 1996, J IMMUNOL, V157, P5163	33	83	84	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55566	10.1371/journal.pone.0055566	http://dx.doi.org/10.1371/journal.pone.0055566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390540	Green Submitted, gold, Green Published			2022-12-25	WOS:000314691100056
J	Bangirana, P; Menk, J; John, CC; Boivin, MJ; Hodges, JS				Bangirana, Paul; Menk, Jeremiah; John, Chandy C.; Boivin, Michael J.; Hodges, James S.			The Association between Cognition and Academic Performance in Ugandan Children Surviving Malaria with Neurological Involvement	PLOS ONE			English	Article							WORKING-MEMORY; CEREBRAL MALARIA; SKILLS; REHABILITATION; ACHIEVEMENT; PREDICTORS; COMPONENTS; SENEGALESE; ABILITY	Background: The contribution of different cognitive abilities to academic performance in children surviving cerebral insult can guide the choice of interventions to improve cognitive and academic outcomes. This study's objective was to identify which cognitive abilities are associated with academic performance in children after malaria with neurological involvement. Methods: 62 Ugandan children with a history of malaria with neurological involvement were assessed for cognitive ability (working memory, reasoning, learning, visual spatial skills, attention) and academic performance (reading, spelling, arithmetic) three months after the illness. Linear regressions were fit for each academic score with the five cognitive outcomes entered as predictors. Adjusters in the analysis were age, sex, education, nutrition, and home environment. Exploratory factor analysis (EFA) and structural equation models (SEM) were used to determine the nature of the association between cognition and academic performance. Predictive residual sum of squares was used to determine which combination of cognitive scores was needed to predict academic performance. Results: In regressions of a single academic score on all five cognitive outcomes and adjusters, only Working Memory was associated with Reading (coefficient estimate=0.36, 95% confidence interval=0.10 to 0.63, p<0.01) and Spelling (0.46, 0.13 to 0.78, p<0.01), Visual Spatial Skills was associated with Arithmetic (0.15, 0.03 to 0.26, p<0.05), and Learning was associated with Reading (0.06, 0.00 to 0.11, p<0.05). One latent cognitive factor was identified using EFA. The SEM found a strong association between this latent cognitive ability and each academic performance measure (P<0.0001). Working memory, visual spatial ability and learning were the best predictors of academic performance. Conclusion: Academic performance is strongly associated with the latent variable labelled "cognitive ability'' which captures most of the variation in the individual specific cognitive outcome measures. Working memory, visual spatial skills, and learning together stood out as the best combination to predict academic performance.	[Bangirana, Paul] Makerere Univ, Dept Psychiat, Coll Hlth Sci, Kampala, Uganda; [Menk, Jeremiah; Hodges, James S.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [John, Chandy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Boivin, Michael J.] Michigan State Univ, Dept Psychiat & Neurol Ophthalmol, E Lansing, MI 48824 USA; [Boivin, Michael J.] Univ Michigan, Dept Psychiat, Neuropsychol Sect, Ann Arbor, MI 48109 USA	Makerere University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Michigan State University; University of Michigan System; University of Michigan	Bangirana, P (corresponding author), Makerere Univ, Dept Psychiat, Coll Hlth Sci, Kampala, Uganda.	pbangirana@yahoo.com	John, Chandy/GNP-8431-2022	John, Chandy/0000-0002-1634-1411; Bangirana, Paul/0000-0002-7136-0594	Swedish Institute; Michigan State University Department of Psychiatry; Neurology/Ophthalmology faculty start-up; National Institute of Neurological Disorders and Stroke award [5R01NS055349]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055349, D43NS078280] Funding Source: NIH RePORTER	Swedish Institute; Michigan State University Department of Psychiatry; Neurology/Ophthalmology faculty start-up; National Institute of Neurological Disorders and Stroke award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded in part by grants from The Swedish Institute to Paul Bangirana for the Joint Makerere University/Karolinska Institutet PhD Program; Michigan State University Department of Psychiatry and Neurology/Ophthalmology faculty start-up funding to Michael J Boivin and National Institute of Neurological Disorders and Stroke award (5R01NS055349) to Chandy C. John. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagenda D, 2006, PEDIATRICS, V117, P729, DOI 10.1542/peds.2004-2699; Bangirana P, 2009, AFR HEALTH SCI, V9, P186; Bangirana P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-334; Bangirana P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-96; Bangirana P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007898; Bangirana P, 2009, J DEV BEHAV PEDIATR, V30, P310, DOI 10.1097/DBP.0b013e3181b0f01b; Barrouillet P, 2005, J EXP CHILD PSYCHOL, V91, P183, DOI 10.1016/j.jecp.2005.03.002; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008914; Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010; Caldwell B. M., 2001, HOME INVENTORY ADM M; de Hevia MD, 2008, NEUROSCI BIOBEHAV R, V32, P1361, DOI 10.1016/j.neubiorev.2008.05.015; Dupuy TR, 2005, TOVA MANUAL IBM PERS; Fernando D, 2003, T ROY SOC TROP MED H, V97, P161, DOI 10.1016/S0035-9203(03)90107-6; Forrest LF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-895; Holding PA, 1999, T ROY SOC TROP MED H, V93, P529, DOI 10.1016/S0035-9203(99)90368-1; Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524; Iglesias-Sarmiento V, 2011, J LEARN DISABIL-US, V44, P570, DOI 10.1177/0022219411400749; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Kaufman AS., 1983, KAUFMAN ASSESSMENT B; Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x; Knoop A, 2004, REHABILITATION COUNS, V47, P184; Lin RT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-85; McLean JF, 1999, J EXP CHILD PSYCHOL, V74, P240, DOI 10.1006/jecp.1999.2516; Polderman TJC, 2010, ACTA PSYCHIAT SCAND, V122, P271, DOI 10.1111/j.1600-0447.2010.01568.x; Rasmussen C, 2005, J EXP CHILD PSYCHOL, V91, P137, DOI 10.1016/j.jecp.2005.01.004; Sesma HW, 2009, CHILD NEUROPSYCHOL, V15, P232, DOI 10.1080/09297040802220029; Silva-Pereyra J, 2010, NEUROREPORT, V21, P34, DOI 10.1097/WNR.0b013e328332c566; Simmons FR, 2012, J EXP CHILD PSYCHOL, V111, P139, DOI 10.1016/j.jecp.2011.08.011; Weisberg S., 1980, APPL LINEAR REGRESSI; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Zheng XH, 2011, J EXP CHILD PSYCHOL, V110, P481, DOI 10.1016/j.jecp.2011.06.001	32	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55653	10.1371/journal.pone.0055653	http://dx.doi.org/10.1371/journal.pone.0055653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085EU	23383342	Green Published, gold, Green Submitted			2022-12-25	WOS:000314597900049
J	Milekovic, T; Ball, T; Schulze-Bonhage, A; Aertsen, A; Mehring, C				Milekovic, Tomislav; Ball, Tonio; Schulze-Bonhage, Andreas; Aertsen, Ad; Mehring, Carsten			Detection of Error Related Neuronal Responses Recorded by Electrocorticography in Humans during Continuous Movements	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; HUMAN SENSORIMOTOR CORTEX; PRESURGICAL EVALUATION; SPECTRAL-ANALYSIS; CORTICAL CONTROL; NEURAL-CONTROL; GAMMA-ACTIVITY; EEG; PERFORMANCE; POTENTIALS	Background: Brain-machine interfaces (BMIs) can translate the neuronal activity underlying a user's movement intention into movements of an artificial effector. In spite of continuous improvements, errors in movement decoding are still a major problem of current BMI systems. If the difference between the decoded and intended movements becomes noticeable, it may lead to an execution error. Outcome errors, where subjects fail to reach a certain movement goal, are also present during online BMI operation. Detecting such errors can be beneficial for BMI operation: (i) errors can be corrected online after being detected and (ii) adaptive BMI decoding algorithm can be updated to make fewer errors in the future. Methodology/Principal Findings: Here, we show that error events can be detected from human electrocorticography (ECoG) during a continuous task with high precision, given a temporal tolerance of 300-400 milliseconds. We quantified the error detection accuracy and showed that, using only a small subset of 262 ECoG electrodes, 82% of detection information for outcome error and 74% of detection information for execution error available from all ECoG electrodes could be retained. Conclusions/Significance: The error detection method presented here could be used to correct errors made during BMI operation or to adapt a BMI algorithm to make fewer errors in the future. Furthermore, our results indicate that smaller ECoG implant could be used for error detection. Reducing the size of an ECoG electrode implant used for BMI decoding and error detection could significantly reduce the medical risk of implantation.	[Milekovic, Tomislav; Ball, Tonio; Schulze-Bonhage, Andreas; Aertsen, Ad; Mehring, Carsten] Univ Freiburg, Bernstein Ctr Freiburg, D-79106 Freiburg, Germany; [Milekovic, Tomislav; Mehring, Carsten] Univ Freiburg, Inst Biol 1, Fac Biol, Freiburg, Germany; [Milekovic, Tomislav; Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Milekovic, Tomislav; Mehring, Carsten] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England; [Ball, Tonio; Schulze-Bonhage, Andreas] Univ Med Ctr Freiburg, Epilepsy Ctr, Freiburg, Germany; [Aertsen, Ad] Univ Freiburg, Inst Biol 3, Fac Biol, Freiburg, Germany	University of Freiburg; University of Freiburg; Imperial College London; Imperial College London; University of Freiburg; University of Freiburg	Milekovic, T (corresponding author), Brown Univ, Inst Brain Sci, Dept Neurosci, Providence, RI 02912 USA.	Tomislav_Milekovic@brown.edu	Schulze-Bonhage, Andreas/AAJ-3107-2020; Mehring, Carsten/R-8986-2019; Milekovic, Tomislav/R-7972-2017	Mehring, Carsten/0000-0001-8125-5205; Milekovic, Tomislav/0000-0001-6769-6506	German Federal Ministry of Education and Research (BMBF) [01GQ0420, 01GQ0830]; BMBF GoBio [0313891]; Imperial College London	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF GoBio(Federal Ministry of Education & Research (BMBF)); Imperial College London(General Electric)	This work was supported by the German Federal Ministry of Education and Research (BMBF) grant 01GQ0420 to BCCN Freiburg, BMBF 01GQ0830 grant to BFNT Freiburg and Tubingen, BMBF GoBio grant 0313891 and the Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman N, 2007, J NEURAL ENG, V4, P336, DOI 10.1088/1741-2560/4/3/018; Ball T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016006; Bashashati Ali, 2007, Comput Intell Neurosci, P84386, DOI 10.1155/2007/84386; Bechtereva NP, 2005, INT J PSYCHOPHYSIOL, V58, P227, DOI 10.1016/j.ijpsycho.2005.06.005; Blankertz B, 2003, IEEE T NEUR SYS REH, V11, P127, DOI 10.1109/TNSRE.2003.814456; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Blumberg J, 2007, P ANN INT IEEE EMBS, P2536, DOI 10.1109/IEMBS.2007.4352845; Boatman-Reich D, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00004; Bohm G., 2010, INTRO STAT DATA ANAL; Buttfield A, 2006, IEEE T NEUR SYS REH, V14, P164, DOI 10.1109/TNSRE.2006.875555; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Coombs C. H., 1970, MATH PSYCHOL ELEMENT; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; DiGiovanna J, 2009, IEEE T BIO-MED ENG, V56, P54, DOI 10.1109/TBME.2008.926699; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Ferrez PW, 2008, IEEE T BIO-MED ENG, V55, P923, DOI 10.1109/TBME.2007.908083; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gurel T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00164; Hasan BAS, 2010, MED BIOL ENG COMPUT, V48, P245, DOI 10.1007/s11517-009-0550-0; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hwang EJ, 2009, J NEUROSCI, V29, P14363, DOI 10.1523/JNEUROSCI.2081-09.2009; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jerbi K, 2009, HUM BRAIN MAPP, V30, P1758, DOI 10.1002/hbm.20750; Jocham G, 2009, NEUROSCI BIOBEHAV R, V33, P48, DOI 10.1016/j.neubiorev.2008.08.011; Jung J, 2010, HUM BRAIN MAPP, V31, P1217, DOI 10.1002/hbm.20930; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Kirkeby BS, 2005, J RES PERS, V39, P263, DOI 10.1016/j.jrp.2004.04.001; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Kovalev D, 2005, AM J NEURORADIOL, V26, P1078; Koyama S, 2010, J COMPUT NEUROSCI, V29, P73, DOI 10.1007/s10827-009-0196-9; Krigolson OE, 2006, NEUROSCIENCE, V137, P13, DOI 10.1016/j.neuroscience.2005.10.064; Krigolson OE, 2007, BRAIN RES, V1155, P70, DOI 10.1016/j.brainres.2007.04.024; Krigolson OE, 2008, EXP BRAIN RES, V190, P401, DOI 10.1007/s00221-008-1482-x; Krigolson OE, 2007, PSYCHOPHYSIOLOGY, V44, P586, DOI 10.1111/j.1469-8986.2007.00523.x; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Lee HC, 2007, J CLIN NEUROPHYSIOL, V24, P137, DOI 10.1097/WNP.0b013e318033715b; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Levine SP, 2000, IEEE T REHABIL ENG, V8, P180, DOI 10.1109/86.847809; MacKay D. J. C., 2003, INFORM THEORY INFERE, pxii; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; McFarland DJ, 2005, IEEE T NEUR SYS REH, V13, P372, DOI 10.1109/TNSRE.2005.848627; Meier R, 2008, J CLIN NEUROPHYSIOL, V25, P119, DOI 10.1097/WNP.0b013e3181775993; Milekovic T, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046003; Milekovic T, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026007; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moore D. S., 2009, INTRO PRACTICE STAT; Moran D, 2010, CURR OPIN NEUROBIOL, V20, P741, DOI 10.1016/j.conb.2010.09.010; Ojemann GA, 2004, NEUROPSYCHOLOGIA, V42, P1383, DOI 10.1016/j.neuropsychologia.2004.01.008; Ojemann GA, 2003, INT J PSYCHOPHYSIOL, V48, P141, DOI 10.1016/S0167-8760(03)00051-5; Parra LC, 2003, IEEE T NEUR SYS REH, V11, P173, DOI 10.1109/TNSRE.2003.814446; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Rana P, 2012, BIOMEDICAL ENG IEEE, P1; Ray S, 2008, CLIN NEUROPHYSIOL, V119, P116, DOI 10.1016/j.clinph.2007.09.136; Riffenburgh RH, 2006, STATISTICS IN MEDICINE, 2ND EDITION, P1; Rotermund D, 2006, BIOL CYBERN, V95, P243, DOI 10.1007/s00422-006-0083-7; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; Schalk G, 2000, CLIN NEUROPHYSIOL, V111, P2138, DOI 10.1016/S1388-2457(00)00457-0; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk Gerwin, 2011, IEEE Rev Biomed Eng, V4, P140, DOI 10.1109/RBME.2011.2172408; Schalk G, 2010, PRACTICAL GUIDE TO BRAIN-COMPUTER INTERFACING WITH BCI2000, P3, DOI 10.1007/978-1-84996-092-2_1; Schmidt NM, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-19; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; Sokolova M, 2006, LECT NOTES COMPUT SC, V4304, P1015; Solis-Escalante T, 2008, J NEUROSCI METH, V175, P148, DOI 10.1016/j.jneumeth.2008.07.019; STEINIER J, 1972, ANAL CHEM, V44, P1906, DOI 10.1021/ac60319a045; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; van Veen V, 2006, CLIN EEG NEUROSCI, V37, P330, DOI 10.1177/155005940603700411; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Victor JD, 2000, NEURAL COMPUT, V12, P2797, DOI 10.1162/089976600300014728; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Wang W, 2009, IEEE ENG MED BIO, P586, DOI 10.1109/IEMBS.2009.5333704; Wilson J Adam, 2009, Front Neuroeng, V2, P11, DOI 10.3389/neuro.16.011.2009; Wisneski KJ, 2008, STROKE, V39, P3351, DOI 10.1161/STROKEAHA.108.518175; Wong C, 2009, ACTA NEUROCHIR, V151, P37, DOI 10.1007/s00701-008-0171-7; Zanolie K, 2008, NEUROPSYCHOLOGIA, V46, P117, DOI 10.1016/j.neuropsychologia.2007.08.009	88	37	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55235	10.1371/journal.pone.0055235	http://dx.doi.org/10.1371/journal.pone.0055235			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383315	gold, Green Submitted, Green Published			2022-12-25	WOS:000314597900022
J	Mitra, A; Palaniyandi, S; Herren, CD; Zhu, XP; Mukhopadhyay, S				Mitra, Arindam; Palaniyandi, Senthilkumar; Herren, Christopher D.; Zhu, Xiaoping; Mukhopadhyay, Suman			Pleiotropic Roles of uvrY on Biofilm Formation, Motility and Virulence in Uropathogenic Escherichia coli CFT073	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; RNA-BINDING PROTEIN; INTRACELLULAR BACTERIAL COMMUNITIES; TYPE-1 FIMBRIAE; PHASE VARIATION; 2-COMPONENT SYSTEM; GENETIC-REGULATION; EPITHELIAL-CELLS; CSRA; REGULATOR	Urinary tract infections primarily caused by uropathogenic strains of Escherichia coli (E. coli) remain a significant public health problem in both developed and developing countries. An important virulence determinant in uropathogenesis is biofilm formation which requires expression of fimbriae, flagella, and other surface components such as lipopolysaccharides. In this study, we explored the regulation of uvrY and csrA genes in biofilm formation, motility and virulence determinants in uropathogenic E. coli. We found that mutation in uvrY suppressed biofilm formation on abiotic surfaces such as polyvinyl chloride, polystyrene and glass, and complementation of uvrY in the mutant restored the biofilm phenotype. We further evaluated the role of uvrY gene in expression of type 1 fimbriae, an important adhesin that facilitates adhesion to various abiotic surfaces. We found that phase variation of type 1 fimbriae between fimbriated and afimbriated mode was modulated by uvrY at its transcriptional level. Deletion mutant of uvrY lowered expression of fimbrial recombinase genes, such as fimB, fimE, and fimA, a gene encoding major fimbrial subunit. Furthermore, transcription of virulence specific genes such as papA, hlyB and galU was also reduced in the deletion mutant. Swarming motility and expression of flhD and flhC was also diminished in the mutant. Taken together, our findings unravel a possible mechanism in which uvrY facilitates biofilm formation, persistence and virulence of uropathogenic E. coli.	[Mitra, Arindam; Palaniyandi, Senthilkumar; Herren, Christopher D.; Zhu, Xiaoping; Mukhopadhyay, Suman] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Palaniyandi, Senthilkumar; Zhu, Xiaoping] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Mukhopadhyay, S (corresponding author), NIAID, Div Microbiol & Infect Dis, NIH, HHS, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mukhopadhyays@mail.nih.gov	Mitra, Arindam/A-1379-2013; Palaniyandi, Senthilkumar/B-9575-2016	Mitra, Arindam/0000-0002-1591-6164; 	USDA-NRI-CSREES Competitive Grant [2004-35204-14749]; USDA-Animal Health [2002-1106-0195318]; Maryland Agriculture Experimental Station grant from the University of Maryland; National Institutes of Health [R01 AI65892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065892] Funding Source: NIH RePORTER	USDA-NRI-CSREES Competitive Grant; USDA-Animal Health; Maryland Agriculture Experimental Station grant from the University of Maryland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by USDA-NRI-CSREES Competitive Grant 2004-35204-14749, USDA-Animal Health 2002-1106-0195318 and Maryland Agriculture Experimental Station grant from the University of Maryland (to S. M.) and a National Institutes of Health Grant R01 AI65892 (to X.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JM, 1985, P NATL ACAD SCI USA, V82, P5724, DOI 10.1073/pnas.82.17.5724; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Anderson GG, 2010, INFECT IMMUN, V78, P963, DOI 10.1128/IAI.00925-09; Antao EM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-22; Bahrani-Mougeot FK, 2002, MOL MICROBIOL, V45, P1079, DOI 10.1046/j.1365-2958.2002.03078.x; Belanger L, 2011, FEMS IMMUNOL MED MIC, V62, P1, DOI 10.1111/j.1574-695X.2011.00797.x; Blumer C, 2005, MICROBIOL-SGM, V151, P3287, DOI 10.1099/mic.0.28098-0; Bower JM, 2005, TRAFFIC, V6, P18, DOI 10.1111/j.1600-0854.2004.00251.x; Bryan A, 2006, INFECT IMMUN, V74, P1072, DOI 10.1128/IAI.74.2.1072-1083.2006; Chatterjee A, 2010, MOL PLANT MICROBE IN, V23, P1316, DOI 10.1094/MPMI-01-10-0017; Chenoweth CE, 2011, INFECT DIS CLIN N AM, V25, P103, DOI 10.1016/j.idc.2010.11.005; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; EISENSTEIN BI, 1981, SCIENCE, V214, P337, DOI 10.1126/science.6116279; EISENSTEIN BI, 1988, REV INFECT DIS, V10, pS341; Ferrieres L, 2007, FEMS IMMUNOL MED MIC, V51, P212, DOI 10.1111/j.1574-695X.2007.00296.x; Foxman B, 2002, AM J MED, V113, p5S; GALLY DL, 1993, J BACTERIOL, V175, P6186, DOI 10.1128/JB.175.19.6186-6193.1993; Goller CC, 2010, VIRULENCE, V1, P333, DOI 10.4161/viru.1.4.12388; Gudapaty S, 2001, J BACTERIOL, V183, P6017, DOI 10.1128/JB.183.20.6017-6027.2001; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213; HARSHEY RM, 1994, MOL MICROBIOL, V13, P389, DOI 10.1111/j.1365-2958.1994.tb00433.x; Hatt JK, 2008, CURR TOP MICROBIOL, V322, P163; Herren CD, 2006, INFECT IMMUN, V74, P4900, DOI 10.1128/IAI.00412-06; Jonas K, 2010, ENVIRON MICROBIOL, V12, P524, DOI 10.1111/j.1462-2920.2009.02097.x; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kariyawasam S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-81; Katouli M, 2010, IRAN J MICROBIOL, V2, P59; KLEMM P, 1986, EMBO J, V5, P1389, DOI 10.1002/j.1460-2075.1986.tb04372.x; Lane MC, 2007, KIDNEY INT, V72, P19, DOI 10.1038/sj.ki.5002230; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lim JK, 1998, INFECT IMMUN, V66, P3303, DOI 10.1128/IAI.66.7.3303-3310.1998; Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; MCCLAIN MS, 1991, J BACTERIOL, V173, P5308, DOI 10.1128/jb.173.17.5308-5314.1991; Melican K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001298; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mitra A, 2008, TOXICOGENOMICS POWER, P199; Mizuno T, 1998, J BIOCHEM, V123, P555; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Palaniyandi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031348; Pernestig AK, 2003, J BACTERIOL, V185, P843, DOI 10.1128/JB.185.3.843-853.2003; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Schwan WR, 2008, INT J MED MICROBIOL, V298, P441, DOI 10.1016/j.ijmm.2007.05.009; Schwan WR, 2002, INFECT IMMUN, V70, P1391, DOI 10.1128/IAI.70.3.1391-1402.2002; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; STAMM WE, 1991, AM J MED, V91, pS65, DOI 10.1016/0002-9343(91)90345-X; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Teplitski M, 2006, MICROBIOL-SGM, V152, P3411, DOI 10.1099/mic.0.29118-0; Timmermans J, 2010, CELL MOL LIFE SCI, V67, P2897, DOI 10.1007/s00018-010-0381-z; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Wei BD, 2000, J BACTERIOL, V182, P1632, DOI 10.1128/JB.182.6.1632-1640.2000; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Wright KJ, 2006, FUTURE MICROBIOL, V1, P75, DOI 10.2217/17460913.1.1.75; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005; Yang HH, 1996, J BACTERIOL, V178, P1012, DOI 10.1128/jb.178.4.1012-1017.1996	64	37	39	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55492	10.1371/journal.pone.0055492	http://dx.doi.org/10.1371/journal.pone.0055492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383333	Green Published, gold, Green Submitted			2022-12-25	WOS:000314597900040
J	Stiegler, AL; Grant, TD; Luft, JR; Calderwood, DA; Snell, EH; Boggon, TJ				Stiegler, Amy L.; Grant, Thomas D.; Luft, Joseph R.; Calderwood, David A.; Snell, Edward H.; Boggon, Titus J.			Purification and SAXS Analysis of the Integrin Linked Kinase, PINCH, Parvin (IPP) Heterotrimeric Complex	PLOS ONE			English	Article							FOCAL ADHESION PROTEIN; BIOLOGICAL MACROMOLECULES; STRUCTURAL BASIS; CELL-ADHESION; DEPENDENT REGULATION; SOLUTION SCATTERING; ADAPTER PROTEIN; ALPHA-PARVIN; ILK; PREDICTION	The heterotrimeric protein complex containing the integrin linked kinase (ILK), parvin, and PINCH proteins, termed the IPP complex, is an essential component of focal adhesions, where it interacts with many proteins to mediate signaling from integrin adhesion receptors. Here we conduct a biochemical and structural analysis of the minimal IPP complex, comprising full-length human ILK, the LIM1 domain of PINCH1, and the CH2 domain of alpha-parvin. We provide a detailed purification protocol for IPP and show that the purified IPP complex is stable and monodisperse in solution. Using small-angle X-ray scattering (SAXS), we also conduct the first structural characterization of IPP, which reveals an elongated shape with dimensions 120x60x40 angstrom. Flexibility analysis using the ensemble optimization method (EOM) is consistent with an IPP complex structure with limited flexibility, raising the possibility that inter-domain interactions exist. However, our studies suggest that the inter-domain linker in ILK is accessible and we detect no inter-domain contacts by gel filtration analysis. This study provides a structural foundation to understand the conformational restraints that govern the IPP complex.	[Stiegler, Amy L.; Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Grant, Thomas D.; Luft, Joseph R.; Snell, Edward H.] Hauptman Woodward Med Res Inst, Buffalo, NY USA; [Luft, Joseph R.; Snell, Edward H.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA; [Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Calderwood, David A.; Boggon, Titus J.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA	Yale University; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	titus.boggon@yale.edu	Snell, Edward/G-2055-2018; Grant, Thomas/T-2921-2019; Calderwood, David A/AAC-6954-2019; Grant, Thomas/GXH-9990-2022	Snell, Edward/0000-0001-8714-3191; Grant, Thomas/0000-0002-8583-3700; Calderwood, David A/0000-0002-0791-4142; Grant, Thomas/0000-0002-8583-3700	U.S. National Institutes of Health [R01GM088240, R01GM088396]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088240, R01GM088396] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by U.S. National Institutes of Health grants R01GM088240 and R01GM088396. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2007, P NATL ACAD SCI USA, V104, P6782, DOI 10.1073/pnas.0701999104; Bernado P, 2008, J MOL BIOL, V376, P492, DOI 10.1016/j.jmb.2007.11.066; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Chiswell BP, 2010, J STRUCT BIOL, V170, P157, DOI 10.1016/j.jsb.2009.12.002; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fukuda K, 2011, J BIOL CHEM, V286, P21886, DOI 10.1074/jbc.M111.240093; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Liang XQ, 2005, MOL CELL BIOL, V25, P3056, DOI 10.1128/MCB.25.8.3056-3062.2005; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Olski TM, 2001, J CELL SCI, V114, P525; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Stanchi F, 2005, J CELL SCI, V118, P5899, DOI 10.1242/jcs.02686; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Stiegler AL, 2012, J BIOL CHEM, V287, P32566, DOI 10.1074/jbc.M112.367342; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Vakaloglou KM, 2012, J CELL SCI; Velyvis A, 2001, J BIOL CHEM, V276, P4932, DOI 10.1074/jbc.M007632200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Yang YW, 2009, J BIOL CHEM, V284, P5836, DOI 10.1074/jbc.M805319200; Yoshimi R, 2006, J IMMUNOL, V176, P3611, DOI 10.4049/jimmunol.176.6.3611; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200	51	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55591	10.1371/journal.pone.0055591	http://dx.doi.org/10.1371/journal.pone.0055591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383235	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600130
J	Yu, Y; Zhang, D; Huang, H; Li, J; Zhang, M; Wan, Y; Gao, J; Huang, C				Yu, Y.; Zhang, D.; Huang, H.; Li, J.; Zhang, M.; Wan, Y.; Gao, J.; Huang, C.			NF-kappa B1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1	ONCOGENE			English	Article						p50; p53 translation; miR-190; PHLPP1; Akt/S6 ribosomal protein	NF-KAPPA-B; TUMOR-SUPPRESSOR; CANCER CELLS; INDUCED APOPTOSIS; ARSENIC TRIOXIDE; AKT ACTIVATION; DNA-DAMAGE; GROWTH; DEGRADATION; INDUCTION	The biological function of NF-kappa B1 (p50) in the regulation of protein expression is far from well understood owing to the lack of a transcriptional domain. Here, we report a novel function of p50 in its regulation of p53 protein translation under stress conditions. We found that the deletion of p50 (p50-/-) impaired arsenite-induced p53 protein expression, which could be restored after reconstitutive expression of HA-p50 in p50-/- cells, p50-/- (Ad-HA-p50). Further studies indicated that the amounts of p53 mRNA, p53 promoter-driven transcription activity and p53 protein degradation were comparable between wild-type and p50-/- cells. Moreover, we found that p50 was crucial for Akt/S6 ribosomal protein activation via inhibition of the translation of the PH domain and leucine-rich repeat protein phosphatases 1 (PHLPP1), a phosphatase of Akt. Further studies showed that p50-mediated upregulation of miR-190 was responsible for the inhibition of PHLPP1 translation by targeting the 30-untranslated region of its mRNA. Collectively, we have identified a novel function of p50 in modulating p53 protein translation via regulation of the miR-190/PHLPP1/Akt-S6 ribosomal protein pathway.	[Yu, Y.; Zhang, D.; Huang, H.; Li, J.; Zhang, M.; Huang, C.] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Yu, Y.; Wan, Y.] Wuhan Univ, Med Res Ctr, Oversea Lab, Wuhan 430072, Hubei, Peoples R China; [Huang, H.; Zhang, M.; Gao, J.; Huang, C.] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Zhejiang, Peoples R China	New York University; Wuhan University; Wenzhou Medical University	Huang, C (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org	Yu, Yonghui/AAZ-3746-2021; Yu, Yonghui/AAZ-4093-2021	Huang, Chuanshu/0000-0003-4133-5096	NIH/NCI [CA112557, NBRPC2012CB525004]; NIH/NIEHS [ES000260];  [NSFC81229002]; NATIONAL CANCER INSTITUTE [R01CA112557, P30CA016087, R01CA177665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Ms Nedda Tichi and Mr Andy Hu for their critical reading of this manuscript. We thank Dr Ping-Yee Law (Department of Pharmacology, University of Minnesota) for providing us with constructs of miR-190 and its control. We also thank Dr Fei Chen (Department of Pharmaceutical Sciences, Wayne State University) for providing us with the PHLPP1 3'-UTR luciferase reporter. This work was partially supported by grants from NSFC81229002, NIH/NCI CA112557, NBRPC2012CB525004 and NIH/NIEHS ES000260.	Beezhold K, 2011, TOXICOL SCI, V123, P411, DOI 10.1093/toxsci/kfr188; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; BOSARI S, 1995, AM J PATHOL, V147, P790; Chen A, 2002, EUR J PHARMACOL, V448, P11, DOI 10.1016/S0014-2999(02)01901-5; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Choudhuri T, 2002, FEBS LETT, V512, P334, DOI 10.1016/S0014-5793(02)02292-5; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Fiaschi Tania, 2012, Int J Cell Biol, V2012, P762825, DOI 10.1155/2012/762825; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gebel TW, 1999, SCIENCE, V283, P1458; Guo W, 2011, CELL MOL LIFE SCI, V68, P475, DOI 10.1007/s00018-010-0459-7; Heinrichs S, 2003, ONCOGENE, V22, P555, DOI 10.1038/sj.onc.1206138; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hinata N, 2003, UROL RES, V31, P387, DOI 10.1007/s00240-003-0355-9; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Karawajew L, 2005, BLOOD, V105, P4767, DOI 10.1182/blood-2004-09-3428; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li JL, 2004, HYBRIDOMA HYBRIDOM, V23, P1, DOI 10.1089/153685904322771962; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Ljungman M, 2000, NEOPLASIA, V2, P208, DOI 10.1038/sj.neo.7900073; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Quinn JE, 2003, CANCER RES, V63, P6221; Rossman TG, 2011, METALLOMICS, V3, P1135, DOI 10.1039/c1mt00074h; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Schuler M, 2003, CELL DEATH DIFFER, V10, P451, DOI 10.1038/sj.cdd.4401180; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Stahnke K, 2001, BLOOD, V98, P3066, DOI 10.1182/blood.V98.10.3066; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wang YJ, 2007, CELL RES, V17, P933, DOI 10.1038/cr.2007.89; Xu DK, 2002, EMBO J, V21, P4081, DOI 10.1093/emboj/cdf413; Yan WS, 2011, J BIOL CHEM, V286, P17478, DOI 10.1074/jbc.M111.231639; Yang DQ, 2006, ONCOGENE, V25, P4613, DOI 10.1038/sj.onc.1209483; Yang X, 2003, CELL DEATH DIFFER, V10, P400, DOI 10.1038/cj.cdd.4401182; Yih LH, 2000, CANCER RES, V60, P6346; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; Ying SY, 2004, GENE, V342, P25, DOI 10.1016/j.gene.2004.07.025; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Yu YH, 2009, CURR CANCER DRUG TAR, V9, P566, DOI 10.2174/156800909788486759; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zheng H, 2010, J BIOL CHEM, V285, P21994, DOI 10.1074/jbc.M110.112607	53	36	37	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 20	2014	33	8					996	1005		10.1038/onc.2013.8	http://dx.doi.org/10.1038/onc.2013.8			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XO	23396362	Green Accepted			2022-12-25	WOS:000331933200007
J	Matusali, G; Tchidjou, HK; Pontrelli, G; Bernardi, S; D'Ettorre, G; Vullo, V; Buonomini, AR; Andreoni, M; Santoni, A; Cerboni, C; Doria, M				Matusali, Giulia; Tchidjou, Hyppolite Kuekou; Pontrelli, Giuseppe; Bernardi, Stefania; D'Ettorre, Gabriella; Vullo, Vincenzo; Buonomini, Anna Rita; Andreoni, Massimo; Santoni, Angela; Cerboni, Cristina; Doria, Margherita			Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells	FASEB JOURNAL			English	Article						immune evasion; MICA/B; ULBP; shedding	MHC CLASS-I; NATURAL-KILLER CYTOTOXICITY; BLOOD MONONUCLEAR-CELLS; DOWN-REGULATION; MATRIX METALLOPROTEINASES; ACTIVATING RECEPTORS; T-LYMPHOCYTES; MIC LIGANDS; MOLECULES; MECHANISM	In humans, the interaction of the natural killer group 2 member D (NKG2D)-activating receptor on natural killer (NK) and CD8(+) T cells with its major histocompatibility complex class I-related chain (MIC) and UL16 binding protein (ULBP) ligands (NKG2DLs) promotes recognition and elimination of stressed cells, such as tumor or infected cells. Here, we investigated the capacity of HIV-1 to modulate NKG2DL expression and escape NGK2D-mediated immunosurveillance. In CD4(+) T lymphocytes, both cell surface expression and release of MICA, MICB, and ULBP2 were up-regulated >2-fold by HIV-1 infection. In HIV-infected CD4(+) T lymphocytes or Jurkat T-cell lines, increased shedding of soluble NKG2DLs (sNKG2DLs) was impaired by a matrix metalloproteinase inhibitor (MMPI). Moreover, naive HIV+ patients displayed increased plasma sMICA and sULBP2 levels and reduced NKG2D expression on NK and CD8(+) T cells compared to patients receiving highly active antiretroviral therapy (HAART) or healthy donors. In individual patients, HAART uptake resulted in the drop of sNKG2DL and recovery of NKG2D expression. Finally, sNKG2DLs in patients' plasma down-regulated NKG2D on NK and CD8(+) T cells and impaired NKG2D-mediated cytotoxicity of NK cells. Thus, NKG2D detuning by sNKG2DLs may promote HIV-1 immune evasion and compromise host resistance to opportunistic infections, but HAART and MMPI have the potential to avoid such immune dysfunction.-Matusali, G., Tchidjou, H. K., Pontrelli, G., Bernardi, S., D'Ettorre, G., Vullo, V., Buonomini, A. R., Andreoni, M., Santoni, A., Cerboni, C., Doria, M. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.	[Matusali, Giulia; Doria, Margherita] Bambino Gesu Pediat Hosp, Lab Immunoinfectivol, IRCCS, I-00165 Rome, Italy; [Tchidjou, Hyppolite Kuekou; Pontrelli, Giuseppe; Bernardi, Stefania] Bambino Gesu Pediat Hosp, Lab Immunoinfectivol, Univ Dept Pediat DPUO, I-00165 Rome, Italy; [D'Ettorre, Gabriella; Vullo, Vincenzo] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dept Publ Hlth & Infect Dis, Rome, Italy; [Santoni, Angela; Cerboni, Cristina] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Dept Mol Med, Rome, Italy; [Buonomini, Anna Rita; Andreoni, Massimo] Univ Roma Tor Vergata, Dept Clin Infect Dis, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; Fondazione Cenci Bolognetti; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Rome Tor Vergata	Doria, M (corresponding author), Bambino Gesu Pediat Hosp, Lab Immunoinfectivol, Piazza S Onofrio 4, I-00165 Rome, Italy.	doria@uniroma2.it	Bernardi, stefania/AAA-2803-2020; matusali, giulia/N-7201-2015; Andreoni, Masimo/AAL-2214-2020; Buonomini, Anna Rita/AAC-7325-2022; d'Ettorre, Gabriella/K-4511-2016; Doria, Margherita/K-3157-2016; Pontrelli, Giuseppe/AAB-5268-2020; santoni, angela/K-8997-2016	matusali, giulia/0000-0002-2948-4243; Buonomini, Anna Rita/0000-0001-7503-2742; Doria, Margherita/0000-0001-5533-0304; Pontrelli, Giuseppe/0000-0001-7831-8383; santoni, angela/0000-0003-1206-7731; Andreoni, Massimo/0000-0002-3205-9758; d'Ettorre, Gabriella/0000-0002-3571-5677; tchidjou kuekou, hyppolite/0000-0001-9573-3845; Bernardi, Stefania/0000-0001-5672-0881	Italian Ministry of Health, Programma Nazionale di Ricerca sull'AIDS; Istituto Superiore di Sanita; Ricerca Corrente	Italian Ministry of Health, Programma Nazionale di Ricerca sull'AIDS; Istituto Superiore di Sanita; Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC))	The authors thank Marina Potesta for technical work. The authors are grateful to Gabriella Palmieri, Alessandra Zingoni, and Alessandra Soriani for helpful discussions; to Mark Harris for providing anti-Nef mAb; and to Maria Luisa Romiti for help with statistics. The work was supported by grants of the Italian Ministry of Health, Programma Nazionale di Ricerca sull'AIDS, in collaboration with Istituto Superiore di Sanita and Ricerca Corrente, cofunded by the Italian 5 x 1000 contribution to M.D. The authors declare no conflicts of interest.	Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Cerboni C, 2007, J GEN VIROL, V88, P242, DOI 10.1099/vir.0.82125-0; Cerboni C, 2009, BLOOD, V113, P2955, DOI 10.1182/blood-2008-06-165944; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Conry SJ, 2009, J VIROL, V83, P11175, DOI 10.1128/JVI.00753-09; Diermayr S, 2008, BLOOD, V111, P1428, DOI 10.1182/blood-2007-07-101311; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Duan XH, 2011, MED ONCOL, V28, P466, DOI 10.1007/s12032-010-9480-9; Epling-Burnette PK, 2007, BLOOD, V109, P4816, DOI 10.1182/blood-2006-07-035519; Fausther-Bovendo H, 2009, AIDS, V23, P1077, DOI 10.1097/QAD.0b013e32832cb26b; Fu GF, 2010, CELL IMMUNOL, V265, P37, DOI 10.1016/j.cellimm.2010.06.011; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Jinushi M, 2003, J IMMUNOL, V171, P5423, DOI 10.4049/jimmunol.171.10.5423; Landi A, 2011, CURR HIV RES, V9, P496, DOI 10.2174/157016211798842116; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Latronico T, 2007, AIDS, V21, P677, DOI 10.1097/QAD.0b013e328018751d; Lecoeur H, 2001, J IMMUNOL METHODS, V253, P177, DOI 10.1016/S0022-1759(01)00359-3; Liuzzi GM, 2004, BRAIN, V127, P398, DOI 10.1093/brain/awh049; Mastroianni CM, 2007, TRENDS MOL MED, V13, P449, DOI 10.1016/j.molmed.2007.09.001; Matusali G, 2012, J VIROL, V86, P4496, DOI 10.1128/JVI.05788-11; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Mincheva-Nilsson L, 2006, J IMMUNOL, V176, P3585, DOI 10.4049/jimmunol.176.6.3585; Nolting A, 2010, VIROLOGY, V406, P12, DOI 10.1016/j.virol.2010.05.014; Norman JM, 2011, NAT IMMUNOL, V12, P975, DOI 10.1038/ni.2087; Nowbakht P, 2005, BLOOD, V105, P3615, DOI 10.1182/blood-2004-07-2585; Raffaghello L, 2004, NEOPLASIA, V6, P558, DOI 10.1593/neo.04316; Richard J, 2010, BLOOD, V115, P1354, DOI 10.1182/blood-2009-08-237370; Rognvaldsson T, 2007, EXPERT REV MOL DIAGN, V7, P435, DOI 10.1586/14737159.7.4.435; Salih HR, 2008, FRONT BIOSCI, V13, P3448; Salih HR, 2006, HUM IMMUNOL, V67, P188, DOI 10.1016/j.humimm.2006.02.008; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Shafi S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002922; Shah AH, 2010, CELL HOST MICROBE, V8, P397, DOI 10.1016/j.chom.2010.10.008; Stephens HAF, 2001, TRENDS IMMUNOL, V22, P378, DOI 10.1016/S1471-4906(01)01960-3; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; VULCANO M, 1993, IMMUNOL LETT, V36, P153, DOI 10.1016/0165-2478(93)90047-6; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Ward J, 2007, BLOOD, V110, P1207, DOI 10.1182/blood-2006-06-028175; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb.0306152; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720	46	55	60	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2440	2450		10.1096/fj.12-223057	http://dx.doi.org/10.1096/fj.12-223057			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23395909				2022-12-25	WOS:000319667600031
J	Kanasaki, K; Yu, WQ; von Bodungen, M; Larigakis, JD; Kanasaki, M; de la Pena, FA; Kalluri, R; Hill, WG				Kanasaki, Keizo; Yu, Weiqun; von Bodungen, Maximilian; Larigakis, John D.; Kanasaki, Megumi; de la Pena, Francisco Ayala; Kalluri, Raghu; Hill, Warren G.			Loss of beta 1-integrin from urothelium results in overactive bladder and incontinence in mice: a mechanosensory rather than structural phenotype	FASEB JOURNAL			English	Article						micturition; voiding dysfunction; mechanotransduction; urinary tract	URINARY-BLADDER; CONDITIONAL DELETION; INTEGRIN; EXPRESSION; RECEPTORS; MATRIX; ABLATION; CHANNELS; BARRIER; REVEAL	Bladder urothelium senses and communicates information about bladder fullness. However, the mechanoreceptors that respond to tissue stretch are poorly defined. Integrins are mechanotransducers in other tissues. Therefore, we eliminated beta 1-integrin selectively in urothelium of mice using Cre-LoxP targeted gene deletion. beta 1-Integrin localized to basal/intermediate urothelial cells by confocal microscopy. beta 1-Integrin conditional-knockout (beta 1-cKO) mice lacking urothelial beta 1-integrin exhibited down-regulation and mislocalization of alpha 3- and alpha 5-integrins by immunohistochemistry but, surprisingly, had normal morphology, permeability, and transepithelial resistance when compared with Cre-negative littermate controls. beta 1-cKO mice were incontinent, as judged by random urine leakage on filter paper (4-fold higher spotting, P<0.01; 2.5-fold higher urine area percentage, P<0.05). Urodynamic function assessed by cystometry revealed bladder overfilling with 80% longer intercontractile intervals (P<0.05) and detrusor hyperactivity (3-fold more prevoid contractions, P<0.05), but smooth muscle contractility remained intact. ATP secretion into the lumen was elevated (49 vs. 22 nM, P<0.05), indicating abnormal filling-induced purinergic signaling, and short-circuit currents (measured in Ussing chambers) revealed 2-fold higher stretch-activated ion channel conductances in response to hydrostatic pressure of 1 cmH(2)O (P<0.05). We conclude that loss of integrin signaling from urothelium results in incontinence and overactive bladder due to abnormal mechanotransduction; more broadly, our findings indicate that urothelium itself directly modulates voiding.-Kanasaki, K., Yu, W., von Bodungen, M., Larigakis, J. D., Kanasaki, M., Ayala de la Pena, F., Kalluri, R., Hill, W.G. Loss of beta 1-integrin from urothelium results in overactive bladder and incontinence in mice: a mechanosensory rather than structural phenotype. FASEB J. 27, 1950-1961 (2013). www.fasebj.org	[Kanasaki, Keizo; Kanasaki, Megumi; de la Pena, Francisco Ayala; Kalluri, Raghu; Hill, Warren G.] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Yu, Weiqun; von Bodungen, Maximilian; Larigakis, John D.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Yu, Weiqun; von Bodungen, Maximilian; Larigakis, John D.; Hill, Warren G.] Beth Israel Deaconess Med Ctr, Dept Med, Lab Voiding Dysfunct, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hill, WG (corresponding author), Beth Israel Deaconess Med Ctr, RN349,99 Brookline Ave, Boston, MA 02215 USA.	whill@bidmc.harvard.edu	Hill, Warren/AAM-1917-2020; Ayala, Francisco/C-5280-2011; Kalluri, Raghu/E-2677-2015	Hill, Warren/0000-0002-2772-7264; Ayala, Francisco/0000-0001-6311-920X; Kalluri, Raghu/0000-0002-2190-547X	U.S. National Institute of Diabetes and Digestive and Kidney Diseases grant [DK083299]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083299] Funding Source: NIH RePORTER	U.S. National Institute of Diabetes and Digestive and Kidney Diseases grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by U.S. National Institute of Diabetes and Digestive and Kidney Diseases grant DK083299 to W.G.H. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the U.S. National Institutes of Health.	Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003; Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Apodaca G, 2007, KIDNEY INT, V72, P1057, DOI 10.1038/sj.ki.5002439; Apodaca G, 2003, AM J PHYSIOL-RENAL, V284, pF966, DOI 10.1152/ajprenal.00359.2002; Arcangeli A, 2006, TRENDS CELL BIOL, V16, P631, DOI 10.1016/j.tcb.2006.10.003; Becchetti A, 2010, INT REV CEL MOL BIO, V279, P135, DOI 10.1016/S1937-6448(10)79005-5; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Birder LA, 2010, AUTON NEUROSCI-BASIC, V153, P33, DOI 10.1016/j.autneu.2009.07.005; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; de Groat WC, 2004, UROLOGY, V64, P7, DOI 10.1016/j.urology.2004.08.063; de Groat William C, 2009, Handb Exp Pharmacol, P91, DOI 10.1007/978-3-540-79090-7_4; de la Pena FA, 2011, J BIOL CHEM, V286, P20778, DOI 10.1074/jbc.M110.198069; DEBOER WI, 1994, AM J PATHOL, V145, P1199; Elneil S, 2001, PHARMACOLOGY, V63, P120, DOI 10.1159/000056122; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Hill WG, 2008, AM J PHYSIOL-RENAL, V294, pF919, DOI 10.1152/ajprenal.00265.2007; Jones RG, 2006, J CELL BIOL, V175, P505, DOI 10.1083/jcb.200602160; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Khandelwal P, 2010, EMBO J, V29, P1961, DOI 10.1038/emboj.2010.91; Lavelle J, 2002, AM J PHYSIOL-RENAL, V283, pF242, DOI 10.1152/ajprenal.00307.2001; Lee HY, 2000, J UROLOGY, V163, P2002, DOI 10.1016/S0022-5347(05)67618-5; Lewis SA, 2006, AM J PHYSIOL-RENAL, V291, pF332, DOI 10.1152/ajprenal.00340.2005; LIEBERT M, 1994, AM J PATHOL, V144, P787; LIEBERT M, 1994, AM J PATHOL, V144, P1016; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886, DOI 10.1152/ajprenal.1996.271.4.F886; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Simirskii VN, 2007, DEV BIOL, V306, P658, DOI 10.1016/j.ydbio.2007.04.004; SOUTHGATE J, 1995, CELL ADHES COMMUN, V3, P231, DOI 10.3109/15419069509081289; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001; Wang ECY, 2003, AM J PHYSIOL-RENAL, V285, pF651, DOI 10.1152/ajprenal.00403.2002; Wilson CB, 1996, WORLD J UROL, V14, pS30; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018704; Yu WQ, 2011, AM J PHYSIOL-RENAL, V300, pF49, DOI 10.1152/ajprenal.00349.2010; Yu WQ, 2009, MOL BIOL CELL, V20, P282, DOI 10.1091/mbc.E08-04-0439	43	30	32	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1950	1961		10.1096/fj.12-223404	http://dx.doi.org/10.1096/fj.12-223404			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23395910	Green Published			2022-12-25	WOS:000318226100015
J	Liu, SJ; Qian, Y; Li, L; Wei, GG; Guan, YT; Pan, HJ; Guan, X; Zhang, L; Lu, XL; Zhao, YX; Liu, MY; Li, DL				Liu, Shijie; Qian, Yu; Li, Liang; Wei, Gaigai; Guan, Yuting; Pan, Hongjie; Guan, Xin; Zhang, Long; Lu, Xiaoling; Zhao, Yongxiang; Liu, Mingyao; Li, Dali			Lgr4 Gene Deficiency Increases Susceptibility and Severity of Dextran Sodium Sulfate-induced Inflammatory Bowel Disease in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL STEM-CELL; COUPLED RECEPTOR 48; MALE REPRODUCTIVE-TRACT; PANETH CELLS; WNT/BETA-CATENIN; EPITHELIAL STEM; DOWN-REGULATION; HOMEOSTASIS; EXPRESSION; CANCER	Lgr4/Gpr48 is one of the newly identified R-spondins receptors and potentiates Wnt signaling, which regulates intestinal homeostasis. We used a hypomorphic mouse strain to determine the role of Lgr4 in intestinal inflammation and recovery. Intestinal inflammation was induced with dextran sulfate sodium (DSS) followed by a recovery period. Intestinal inflammation symptoms and molecular mechanisms were examined. We found that Lgr4(-/-) mice exhibited dramatically higher susceptibility to and mortality from DSS-induced inflammatory bowel disease than WT mice. Lgr4 deficiency resulted in greatly reduced numbers of either Paneth cells or stem cells in the intestine. During the intestinal regeneration process, cell proliferation but not apoptosis of intestinal epithelial cells was significantly impaired in Lgr4(-/-) mice. When Wnt/beta-catenin signaling was reactivated by crossing with APC(min/+) mice or by treating with a GSK-3 beta inhibitor, the number of Paneth cells was partially restored and the mortality caused by DSS-induced inflammatory bowel disease was strikingly reduced in Lgr4-deficient animals. Thus, Lgr4 is critically involved in the maintenance of intestinal homeostasis and protection against inflammatory bowel disease through modulation of the Wnt/beta-catenin signaling pathway.	[Liu, Shijie; Qian, Yu; Li, Liang; Wei, Gaigai; Guan, Yuting; Pan, Hongjie; Guan, Xin; Zhang, Long; Liu, Mingyao; Li, Dali] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Liu, Shijie; Qian, Yu; Li, Liang; Wei, Gaigai; Guan, Yuting; Pan, Hongjie; Guan, Xin; Zhang, Long; Liu, Mingyao; Li, Dali] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Lu, Xiaoling; Zhao, Yongxiang] Guangxi Med Univ, Biol Targeting Diag & Therapy Res Ctr, Nanning 530021, Guangxi, Peoples R China; [Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	East China Normal University; East China Normal University; Guangxi Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Liu, MY (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China.	myliu@bio.ecnu.edu.cn; dlli@bio.ecnu.edu.cn	lu, xl/HDO-8340-2022	Liu, Mingyao/0000-0001-7339-5048; Li, Dali/0000-0002-0046-8493; Guan, Yuting/0000-0003-1866-270X	State Key Development Programs of China [2012CB910400, 2010CB945403]; National Natural Science Foundation of China [31171318, 30930055]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]	State Key Development Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was partially supported by grants from the State Key Development Programs of China (Grants 2012CB910400 and 2010CB945403), the National Natural Science Foundation of China (Grants 31171318 and 30930055), and the Science and Technology Commission of Shanghai Municipality (Grant 11DZ2260300).	Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Lee G, 2010, GASTROENTEROLOGY, V139, P869, DOI 10.1053/j.gastro.2010.05.037; Li XY, 2010, DEVELOPMENT, V137, P151, DOI 10.1242/dev.040659; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang DH, 2011, P NATL ACAD SCI USA, V108, P10272, DOI 10.1073/pnas.1017668108; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	43	37	39	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8794	8803		10.1074/jbc.M112.436204	http://dx.doi.org/10.1074/jbc.M112.436204			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393138	Green Published, hybrid			2022-12-25	WOS:000316862200002
J	Sanbe, A; Marunouchi, T; Abe, T; Tezuka, Y; Okada, M; Aoki, S; Tsumura, H; Yamauchi, J; Tanonaka, K; Nishigori, H; Tanoue, A				Sanbe, Atsushi; Marunouchi, Tetsuro; Abe, Tsutomu; Tezuka, Yu; Okada, Mizuki; Aoki, Sayuri; Tsumura, Hideki; Yamauchi, Junji; Tanonaka, Kouichi; Nishigori, Hideo; Tanoue, Akito			Phenotype of Cardiomyopathy in Cardiac-specific Heat Shock Protein B8 K141N Transgenic Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESMIN-RELATED CARDIOMYOPATHY; MARIE-TOOTH DISEASE; CRYSTALLIN; ASSOCIATION; MODEL; PRESERVATION; PATHOGENESIS; DYSFUNCTION; INHIBITORS; INTEGRITY	A K141N missense mutation in heat shock protein (HSP) B8, which belongs to the small HSP family, causes distal hereditary motor neuropathy, which is characterized by the formation of inclusion bodies in cells. Although the HSPB8 gene causes hereditary motor neuropathy, obvious expression of HSPB8 is also observed in other tissues, such as the heart. The effects of a single mutation in HSPB8 upon the heart were analyzed using rat neonatal cardiomyocytes. Expression of HSPB8 K141N by adenoviral infection resulted in increased HSPB8-positive aggregates around nuclei, whereas no aggregates were observed in myocytes expressing wild-type HSPB8. HSPB8-positive aggresomes contained amyloid oligomer intermediates that were detected by a specific anti-oligomer antibody (A11). Expression of HSPB8 K141N induced slight cellular toxicity. Recombinant HSPB8 K141N protein showed reactivity against the anti-oligomer antibody, and reactivity of the mutant HSPB8 protein was much higher than that of wild-type HSPB8 protein. To extend our in vitro study, cardiac-specific HSPB8 K141N transgenic (TG) mice were generated. Echocardiography revealed that the HSPB8 K141N TG mice exhibited mild hypertrophy and apical fibrosis as well as slightly reduced cardiac function, although no phenotype was detected in wild-type HSPB8 TG mice. A single point mutation of HSPB8, such as K141N, can cause cardiac disease.	[Sanbe, Atsushi; Tezuka, Yu; Okada, Mizuki; Aoki, Sayuri; Nishigori, Hideo] Iwate Med Univ, Dept Pharmacotherapeut, Sch Pharm, Yahaba, Iwate 0283694, Japan; [Sanbe, Atsushi; Yamauchi, Junji; Tanoue, Akito] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo 1578535, Japan; [Marunouchi, Tetsuro; Abe, Tsutomu; Tanonaka, Kouichi] Tokyo Univ Pharm & Life Sci, Dept Pharmacol, Tokyo 1920392, Japan; [Tsumura, Hideki] Natl Res Inst Child Hlth & Dev, Div Lab Anim Resources, Tokyo 1578535, Japan	Iwate Medical University; National Center for Child Health & Development - Japan; Tokyo University of Pharmacy & Life Sciences; National Center for Child Health & Development - Japan	Sanbe, A (corresponding author), Iwate Med Univ, Dept Pharmacotherapeut, Sch Pharm, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan.	asanbe@iwate-med.ac.jp			Scientific Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare; Japan Health Sciences Foundation; Astellas Foundation for Research on Metabolic Disorders; Mitsubishi Pharma Research Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation	Scientific Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Astellas Foundation for Research on Metabolic Disorders; Mitsubishi Pharma Research Foundation; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation	This work was supported in part by research grants from the Scientific Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Ministry of Health, Labour and Welfare, the Japan Health Sciences Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Mitsubishi Pharma Research Foundation, the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Suzuken Memorial Foundation.	BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; Depre C, 2002, CIRC RES, V91, P1007, DOI 10.1161/01.RES.0000044380.54893.4B; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Golenhofen N, 2002, J MOL CELL CARDIOL, V34, P309, DOI 10.1006/jmcc.2001.1513; Hsu CD, 2006, INVEST OPHTH VIS SCI, V47, P2036, DOI 10.1167/iovs.05-0524; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kappe G, 2001, BBA-GENE STRUCT EXPR, V1520, P1, DOI 10.1016/S0167-4781(01)00237-8; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lee JS, 1998, BIOCHEM BIOPH RES CO, V244, P379, DOI 10.1006/bbrc.1998.8272; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; Motegi K, 2007, BRIT J PHARMACOL, V151, P963, DOI 10.1038/sj.bjp.0707321; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Pinz I, 2008, FASEB J, V22, P84, DOI 10.1096/fj.07-8130com; Qiu HY, 2011, CIRCULATION, V124, P406, DOI 10.1161/CIRCULATIONAHA.110.013847; Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Sanbe A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018922; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Yamauchi J, 2006, EXP CELL RES, V312, P2954, DOI 10.1016/j.yexcr.2006.05.016	31	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8910	8921		10.1074/jbc.M112.368324	http://dx.doi.org/10.1074/jbc.M112.368324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23389032	Green Published, hybrid			2022-12-25	WOS:000316862200012
J	Corbett, GT; Roy, A; Pahan, K				Corbett, Grant T.; Roy, Avik; Pahan, Kalipada			Sodium Phenylbutyrate Enhances Astrocytic Neurotrophin Synthesis via Protein Kinase C (PKC)-mediated Activation of cAMP-response Element-binding Protein (CREB) IMPLICATIONS FOR ALZHEIMER DISEASE THERAPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-LOWERING DRUG; PHASE-I; BRAIN; BDNF; EXPRESSION; FAMILY; PHENYLACETATE; TRANSCRIPTION; GEMFIBROZIL; MULTIPLE	Neurotrophins, such as brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), are believed to be genuine molecular mediators of neuronal growth and homeostatic synapse activity. However, levels of these neurotrophic factors decrease in different brain regions of patients with Alzheimer disease (AD). Induction of astrocytic neurotrophin synthesis is a poorly understood phenomenon but represents a plausible therapeutic target because neuronal neurotrophin production is aberrant in AD and other neurodegenerative diseases. Here, we delineate that sodium phenylbutyrate (NaPB), a Food and Drug Administration-approved oral medication for hyperammonemia, induces astrocytic BDNF and NT-3 expression via the protein kinase C (PKC)-cAMP-response element-binding protein (CREB) pathway. NaPB treatment increased the direct association between PKC and CREB followed by phosphorylation of CREB (Ser(133)) and induction of DNA binding and transcriptional activation of CREB. Up-regulation of markers for synaptic function and plasticity in cultured hippocampal neurons by NaPB-treated astroglial supernatants and its abrogation by anti-TrkB blocking antibody suggest that NaPB-induced astroglial neurotrophins are functionally active. Moreover, oral administration of NaPB increased the levels of BDNF and NT-3 in the CNS and improved spatial learning and memory in a mouse model of AD. Our results highlight a novel neurotrophic property of NaPB that may be used to augment neurotrophins in the CNS and improve synaptic function in disease states such as AD.	[Corbett, Grant T.] Rush Univ, Med Ctr, Dept Neurol Sci, Grad Program Neurosci, Chicago, IL 60612 USA; [Corbett, Grant T.; Roy, Avik; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA	Rush University; Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 W Harrison St,Suite Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu		Corbett, Grant/0000-0003-3606-9686	National Institutes of Health [AT6681, NS64564, NS71479]; NIA, National Institutes of Health [T32 AG00269]; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064564, R21NS071479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000269, P01AG014449, R01AG043375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AT6681, NS64564, and NS71479.; Supported by NIA, National Institutes of Health, Grant T32 AG00269.	Balkowiec A, 2002, J NEUROSCI, V22, P10399; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Carducci MA, 2001, CLIN CANCER RES, V7, P3047; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Corbett GT, 2012, J IMMUNOL, V189, P1002, DOI 10.4049/jimmunol.1102624; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; El-Hussein AE, 2000, SCIENCE, V290, P1364; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; GALL CM, 1992, TRENDS PHARMACOL SCI, V13, P401, DOI 10.1016/0165-6147(92)90123-N; Ghosh A, 2012, J BIOL CHEM, V287, P27189, DOI 10.1074/jbc.M112.346932; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kemp S, 1998, NAT MED, V4, P1261, DOI 10.1038/3242; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lu B, 1997, REV NEUROSCIENCE, V8, P1; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; MATSUMOTO K, 1995, CANCER RES, V55, P1798; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pardridge WM, 2006, CURR OPIN PHARMACOL, V6, P494, DOI 10.1016/j.coph.2006.06.001; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THIBAULT A, 1994, CANCER RES, V54, P1690; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Weiner HL, 2006, NAT REV IMMUNOL, V6, P404, DOI 10.1038/nri1843; YAN Q, 1994, EXP NEUROL, V127, P23, DOI 10.1006/exnr.1994.1076; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; ZAFRA F, 1992, J NEUROSCI, V12, P4793	59	44	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8299	8312		10.1074/jbc.M112.426536	http://dx.doi.org/10.1074/jbc.M112.426536			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23404502	Green Published, hybrid			2022-12-25	WOS:000316564500030
J	Flegel, C; Manteniotis, S; Osthold, S; Hatt, H; Gisselmann, G				Flegel, Caroline; Manteniotis, Stavros; Osthold, Sandra; Hatt, Hanns; Gisselmann, Guenter			Expression Profile of Ectopic Olfactory Receptors Determined by Deep Sequencing	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; MAMMALIAN ODORANT RECEPTOR; BITTER TASTE RECEPTORS; LONG NONCODING RNAS; FUNCTIONAL EXPRESSION; PROSTATE-CANCER; GENE-EXPRESSION; ENTEROCHROMAFFIN CELLS; GENOMIC STRUCTURE; HUMAN SPERM	Olfactory receptors (ORs) provide the molecular basis for the detection of volatile odorant molecules by olfactory sensory neurons. The OR supergene family encodes G-protein coupled proteins that belong to the seven-transmembrane-domain receptor family. It was initially postulated that ORs are exclusively expressed in the olfactory epithelium. However, recent studies have demonstrated ectopic expression of some ORs in a variety of other tissues. In the present study, we conducted a comprehensive expression analysis of ORs using an extended panel of human tissues. This analysis made use of recent dramatic technical developments of the so-called Next Generation Sequencing (NGS) technique, which encouraged us to use open access data for the first comprehensive RNA-Seq expression analysis of ectopically expressed ORs in multiple human tissues. We analyzed mRNA-Seq data obtained by Illumina sequencing of 16 human tissues available from Illumina Body Map project 2.0 and from an additional study of OR expression in testis. At least some ORs were expressed in all the tissues analyzed. In several tissues, we could detect broadly expressed ORs such as OR2W3 and OR51E1. We also identified ORs that showed exclusive expression in one investigated tissue, such as OR4N4 in testis. For some ORs, the coding exon was found to be part of a transcript of upstream genes. In total, 111 of 400 OR genes were expressed with an FPKM (fragments per kilobase of exon per million fragments mapped) higher than 0.1 in at least one tissue. For several ORs, mRNA expression was verified by RT-PCR. Our results support the idea that ORs are broadly expressed in a variety of tissues and provide the basis for further functional studies.	[Flegel, Caroline; Manteniotis, Stavros; Osthold, Sandra; Hatt, Hanns; Gisselmann, Guenter] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany	Ruhr University Bochum	Gisselmann, G (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	Guenter.Gisselmann@rub.de			Heinrich und Alma Vogelsang Stiftung; DFG [Sonderforschungsbereich 642]	Heinrich und Alma Vogelsang Stiftung; DFG(German Research Foundation (DFG))	Caroline Flegel was funded by the Heinrich und Alma Vogelsang Stiftung. Hanns Hatt was funded by the DFG-Sonderforschungsbereich 642 "GTP- and ATP dependent membrane processes''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; Bonigk W, 1999, J NEUROSCI, V19, P5332; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Branscomb A, 2000, GENETICS, V156, P785; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chiu IM, 2001, PROG NUCLEIC ACID RE, V70, P155, DOI 10.1016/S0079-6603(01)70016-5; Conzelmann S, 2000, EUR J NEUROSCI, V12, P3926, DOI 10.1046/j.1460-9568.2000.00286.x; Cunha AC, 2006, CANCER LETT, V236, P229, DOI 10.1016/j.canlet.2005.05.021; De la Cruz O, 2009, MOL BIOL EVOL, V26, P491, DOI 10.1093/molbev/msn294; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Durzynski L, 2005, BIOCHEM BIOPH RES CO, V333, P264, DOI 10.1016/j.bbrc.2005.05.085; Feingold EA, 1999, GENOMICS, V61, P15, DOI 10.1006/geno.1999.5935; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Frazee AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-449; Frenkel-Morgenstern M, 2012, GENOME RES, V22, P1231, DOI 10.1101/gr.130062.111; Fujita Y, 2007, J RECEPT SIG TRANSD, V27, P323, DOI 10.1080/10799890701534180; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Gaudin JC, 2001, CHEM SENSES, V26, P1157, DOI 10.1093/chemse/26.9.1157; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Illumina, 2011, RNA SEQ DAT COMP GEN; Itakura S, 2006, PLACENTA, V27, P103, DOI 10.1016/j.placenta.2004.12.006; Iwatsuki K, 2010, BIOCHEM BIOPH RES CO, V402, P495, DOI 10.1016/j.bbrc.2010.10.057; Kohli Utkarsh, 2009, Arch Drug Inf, V2, P41; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; L'Esperance S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-99; Leja J, 2009, MODERN PATHOL, V22, P261, DOI 10.1038/modpathol.2008.174; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, CELL CYCLE, V8, P218, DOI 10.4161/cc.8.2.7358; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Markovets AA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S8; Meyer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032354; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Otaki JM, 2004, J NEUROBIOL, V58, P315, DOI 10.1002/neu.10272; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Raming K, 1998, RECEPTOR CHANNEL, V6, P141; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez-Martinez A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-80; Rozengurt E, 2007, CURR OPIN PHARMACOL, V7, P557, DOI 10.1016/j.coph.2007.10.002; Salzberg Steven L, 2010, F1000 Biol Rep, V2, P64, DOI 10.3410/B2-64; Shiao MS, 2012, GENOME BIOL EVOL, V4, P703, DOI 10.1093/gbe/evs039; Shirokova E, 2008, FASEB J, V22, P1416, DOI 10.1096/fj.07-9233com; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; Spehr J, 2011, J BIOL CHEM, V286, P13184, DOI 10.1074/jbc.M110.183525; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Steinert RE, 2011, CLIN NUTR, V30, P524, DOI 10.1016/j.clnu.2011.01.007; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Vanderhaeghen P, 1997, BIOCHEM BIOPH RES CO, V237, P283, DOI 10.1006/bbrc.1997.7043; Vanderhaeghen P, 1997, GENOMICS, V39, P239, DOI 10.1006/geno.1996.4490; Veitinger T, 2011, J BIOL CHEM, V286, P17311, DOI 10.1074/jbc.M110.211524; Volz A, 2003, J BIOL CHEM, V278, P19691, DOI 10.1074/jbc.M212424200; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Walensky LD, 1998, J BIOL CHEM, V273, P9378, DOI 10.1074/jbc.273.16.9378; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weber M, 2002, J NEUROSCI RES, V68, P176, DOI 10.1002/jnr.10164; Weng JS, 2006, INT J CANCER, V118, P1471, DOI 10.1002/ijc.21527; Xia CZ, 2001, ONCOGENE, V20, P5903, DOI 10.1038/sj.onc.1204803; Xie LL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S4; Xu LL, 2000, CANCER RES, V60, P6568; Younger RM, 2001, GENOME RES, V11, P519, DOI 10.1101/gr.GR-1603R; Yue Y, 2006, CYTOGENET GENOME RES, V112, P6, DOI 10.1159/000087507; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; Ziegler A, 2002, AM J REPROD IMMUNOL, V48, P34, DOI 10.1034/j.1600-0897.2002.01097.x	83	169	182	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55368	10.1371/journal.pone.0055368	http://dx.doi.org/10.1371/journal.pone.0055368			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405139	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400084
J	Konschake, M; Lentz, HHK; Conraths, FJ; Hovel, P; Selhorst, T				Konschake, Mario; Lentz, Hartmut H. K.; Conraths, Franz J.; Hoevel, Philipp; Selhorst, Thomas			On the Robustness of In- and Out-Components in a Temporal Network	PLOS ONE			English	Article							TRADE PATTERNS; MOUTH-DISEASE; MOVEMENTS; CATTLE	Background: Many networks exhibit time-dependent topologies, where an edge only exists during a certain period of time. The first measurements of such networks are very recent so that a profound theoretical understanding is still lacking. In this work, we focus on the propagation properties of infectious diseases in time-dependent networks. In particular, we analyze a dataset containing livestock trade movements. The corresponding networks are known to be a major route for the spread of animal diseases. In this context chronology is crucial. A disease can only spread if the temporal sequence of trade contacts forms a chain of causality. Therefore, the identification of relevant nodes under time-varying network topologies is of great interest for the implementation of counteractions. Methodology/Findings: We find that a time-aggregated approach might fail to identify epidemiologically relevant nodes. Hence, we explore the adaptability of the concept of centrality of nodes to temporal networks using a data-driven approach on the example of animal trade. We utilize the size of the in-and out-component of nodes as centrality measures. Both measures are refined to gain full awareness of the time-dependent topology and finite infectious periods. We show that the size of the components exhibit strong temporal heterogeneities. In particular, we find that the size of the components is overestimated in time-aggregated networks. For disease control, however, a risk assessment independent of time and specific disease properties is usually favored. We therefore explore the disease parameter range, in which a time-independent identification of central nodes remains possible. Conclusions: We find a ranking of nodes according to their component sizes reasonably stable for a wide range of infectious periods. Samples based on this ranking are robust enough against varying disease parameters and hence are promising tools for disease control.	[Konschake, Mario; Lentz, Hartmut H. K.; Conraths, Franz J.; Selhorst, Thomas] Friedrich Loeffler Inst, Inst Epidemiol, Wusterhausen, Germany; [Konschake, Mario; Hoevel, Philipp] Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany; [Lentz, Hartmut H. K.] Humboldt Univ, Inst Phys, D-10099 Berlin, Germany; [Hoevel, Philipp] Humboldt Univ, Bernstein Ctr Computat Neurosci, D-10099 Berlin, Germany; [Hoevel, Philipp] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA	Friedrich Loeffler Institute; Technical University of Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Northeastern University	Selhorst, T (corresponding author), Friedrich Loeffler Inst, Inst Epidemiol, Wusterhausen, Germany.	thomas.selhorst@fli.bund.de		Conraths, Franz/0000-0002-7400-9409; Selhorst, Thomas/0000-0003-0969-1533; Lentz, Hartmut/0000-0002-1713-9506; Hoevel, Philipp/0000-0002-1370-4272	Friedrich-Loeffler-Institut: Forschungs-Sofort-Programm [A/H1N1-1.3]; German Academic Exchange Service (DAAD); Federal Ministry for Food, Agriculture and Consumer Protection: Forschungs-Sofort-Programm [A/H1N1-1.3]	Friedrich-Loeffler-Institut: Forschungs-Sofort-Programm; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Federal Ministry for Food, Agriculture and Consumer Protection: Forschungs-Sofort-Programm	MK is funded by The Friedrich-Loeffler-Institut: Forschungs-Sofort-Programm A/H1N1-1.3. PH is funded by German Academic Exchange Service (DAAD) via a post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. R. Carmanns, Bavarian State Ministry for Nutrition, Agriculture and Forestry for providing data. This work was supported by the Federal Ministry for Food, Agriculture and Consumer Protection: Forschungs-Sofort-Programm A/H1N1-1.3. PH acknowledges support of the German Academic Exchange Service (DAAD) via a postdoctoral fellowship. We also thank two anonymous reviewers for helpful comments.	Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; Basu P, 2010, ARXIV1012026011, P11; Bigras-Poulin M, 2007, PREV VET MED, V80, P143, DOI 10.1016/j.prevetmed.2007.02.004; Casteigts A, 2012, INT J PARALLEL EMERG, V27, P387, DOI [10.1080/17445760.2012.668546, 10.1007/978-3-642-22450-8_27]; Christley R. M., 2005, Society for Veterinary Epidemiology and Preventive Medicine. Proceedings of a meeting held at Nairn, Inverness, Scotland, 30th March-1st April 2005, P234; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Danon L., 2011, Interdisciplinary Perspectives on Infectious Diseases, V2011, P284909, DOI 10.1155/2011/284909; Dorogovtsev SN, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025101; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Fritzemeier J, 2000, VET MICROBIOL, V77, P29, DOI 10.1016/S0378-1135(00)00254-6; Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648; Grindrod P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046120; Holme P, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046119; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Horst H, 1998, RISK EC CONSEQUENCES; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Kim H, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026107; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kivela M, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/03/P03005; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036439; Lentz HHK, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066111; Lentz HHK, 2012, ARXIV12102283; Liu S, 2012, ARXIV12102776; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Miritello G, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.045102; Natale F, 2011, PREV VET MED, V98, P111, DOI 10.1016/j.prevetmed.2010.11.013; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Nicosia V, 2012, CHAOS, V22, DOI 10.1063/1.3697996; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Riolo CS, 2001, J URBAN HEALTH, V78, P446, DOI 10.1093/jurban/78.3.446; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Rocha LEC, 2012, ARXIV12045421; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rushton J, 2011, EC ANIMAL HLTH PRODU; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Tang J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.055101; Tang JP, 2010, PROCEEDINGS OF INTERNATIONAL FORUM OF KNOWLEDGE AS A SERVICE, P1, DOI 10.1145/1852658.1852661; UK Department for Environment Food and Rural Affairs (DEFRA), OR UK FOOT MOUTH DIS; Vazquez A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158702; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009	44	37	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55223	10.1371/journal.pone.0055223	http://dx.doi.org/10.1371/journal.pone.0055223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405124	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400069
J	Perez-Huerta, A; Etayo-Cadavid, MF; Andrus, CFT; Jeffries, TE; Watkins, C; Street, SC; Sandweiss, DH				Perez-Huerta, Alberto; Etayo-Cadavid, Miguel F.; Andrus, C. Fred T.; Jeffries, Teresa E.; Watkins, Clifton; Street, Shane C.; Sandweiss, Daniel H.			El Nino Impact on Mollusk Biomineralization-Implications for Trace Element Proxy Reconstructions and the Paleo-Archeological Record	PLOS ONE			English	Article							AMORPHOUS CALCIUM-CARBONATE; ARAGONITIC BIVALVE SHELLS; SR/CA RATIOS; BIOLOGICAL-CONTROLS; RAMAN; OSCILLATION; VARIABILITY; VATERITE; PIGMENTS; CLIMATE	Marine macroinvertebrates are ideal sentinel organisms to monitor rapid environmental changes associated with climatic phenomena. These organisms build up protective exoskeletons incrementally by biologically-controlled mineralization, which is deeply rooted in long-term evolutionary processes. Recent studies relating potential rapid environmental fluctuations to climate change, such as ocean acidification, suggest modifications on carbonate biominerals of marine invertebrates. However, the influence of known, and recurrent, climatic events on these biological processes during active mineralization is still insufficiently understood. Analysis of Peruvian cockles from the 1982-83 large magnitude El Nino event shows significant alterations of the chemico-structure of carbonate biominerals. Here, we show that bivalves modify the main biomineralization mechanism during the event to continue shell secretion. As a result, magnesium content increases to stabilize amorphous calcium carbonate (ACC), inducing a rise in Mg/Ca unrelated to the associated increase in sea-surface temperature. Analysis of variations in Sr/Ca also suggests that this proxy should not be used in these bivalves to detect the temperature anomaly, while Ba/Ca peaks are recorded in shells in response to an increase in productivity, or dissolved barium in seawater, after the event. Presented data contribute to a better understanding of the effects of abrupt climate change on shell biomineralization, while also offering an alternative view of bivalve elemental proxy reconstructions. Furthermore, biomineralization changes in mollusk shells can be used as a novel potential proxy to provide a more nuanced historical record of El Nino and similar rapid environmental change events.	[Perez-Huerta, Alberto; Etayo-Cadavid, Miguel F.; Andrus, C. Fred T.] Univ Alabama, Dept Geol Sci, Tuscaloosa, AL 35401 USA; [Jeffries, Teresa E.] Nat Hist Museum, Dept Mineral, London SW7 5BD, England; [Watkins, Clifton; Street, Shane C.] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA; [Sandweiss, Daniel H.] Univ Maine, Dept Anthropol, Climate Change Inst, Orono, ME USA	University of Alabama System; University of Alabama Tuscaloosa; Natural History Museum London; University of Alabama System; University of Alabama Tuscaloosa; University of Maine System; University of Maine Orono	Perez-Huerta, A (corresponding author), Univ Alabama, Dept Geol Sci, Tuscaloosa, AL 35401 USA.	aphuerta@as.ua.edu	Perez-Huerta, Alberto/A-6925-2015; Jeffries, Teresa/F-4415-2014; Sandweiss, Daniel/K-5808-2019	Jeffries, Teresa/0000-0001-6417-1704; Andrus, Fred/0000-0002-4075-8380	National Science Foundation [ESH-OCE-0502533]	National Science Foundation(National Science Foundation (NSF))	Funding by National Science Foundation grant ESH-OCE-0502533 to CFTA is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NJ, 2009, QUATERNARY SCI REV, V28, P2794, DOI 10.1016/j.quascirev.2009.07.006; Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; Andrus CFT, 2005, GEOL SOC AM SPEC PAP, V395, P13, DOI 10.1130/2005.2395(02); Bandaranayake WM, 2006, NAT PROD REP, V23, P223, DOI 10.1039/b307612c; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Batenburg SJ, 2011, PALAEOGEOGR PALAEOCL, V306, P75, DOI 10.1016/j.palaeo.2011.03.031; Carre M, 2005, HOLOCENE, V15, P42, DOI 10.1191/0959683605h1782rp; Carre M, 2006, GEOCHIM COSMOCHIM AC, V70, P4906, DOI 10.1016/j.gca.2006.07.019; Carre M, 2012, QUATERN INT, V253, P55, DOI 10.1016/j.quaint.2011.02.004; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; CUSACK M, 1992, COMP BIOCHEM PHYS B, V102, P93, DOI 10.1016/0305-0491(92)90278-Y; Dauphin Y, 2000, COMP BIOCHEM PHYS A, V126, P367, DOI 10.1016/S1095-6433(00)00213-0; dePaula SM, 2010, MICRON, V41, P983, DOI 10.1016/j.micron.2010.06.014; Edwards HGM, 2005, SPECTROCHIM ACTA A, V61, P2273, DOI 10.1016/j.saa.2005.02.026; Etayo-Cadavid MF, 2010, THESIS U ALABAMA; Foster LC, 2008, CHEM GEOL, V254, P113, DOI 10.1016/j.chemgeo.2008.06.007; Freitas PS, 2006, GEOCHIM COSMOCHIM AC, V70, P5119, DOI 10.1016/j.gca.2006.07.029; Gillikin DP, 2008, GEO-MAR LETT, V28, P351, DOI 10.1007/s00367-008-0111-9; Gillikin DP, 2006, GEOCHIM COSMOCHIM AC, V70, P395, DOI 10.1016/j.gca.2005.09.015; Gillikin DP, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000874; GRIFFITH WP, 1970, J CHEM SOC A, P286, DOI 10.1039/j19700000286; GUZMA N, 1998, ESTUD OCEANOL, V17, P17; Guzman N, 2007, MICROSC MICROANAL, V13, P397, DOI 10.1017/S1431927607070705; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Lorrain A, 2005, GEOLOGY, V33, P965, DOI 10.1130/G22048.1; Menadakis M, 2009, J MATH CHEM, V46, P484, DOI 10.1007/s10910-008-9490-4; Nebel H, 2008, Z ANORG ALLG CHEM, V634, P1439, DOI 10.1002/zaac.200800134; Olsson AA, 1961, MOLLUSKS TROPICAL E; Pokroy B, 2004, NAT MATER, V3, P900, DOI 10.1038/nmat1263; Purton LMA, 1999, GEOLOGY, V27, P1083, DOI 10.1130/0091-7613(1999)027<1083:MCSCRI>2.3.CO;2; ROLLINS HB, 1986, NATL GEOGR RES, V2, P106; ROLLINS HB, 1987, GEOARCHAEOLOGY, V2, P181; Sadler J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003595; Sandweiss D.H., 2007, CLIMATE CHANGE CULTU, P25, DOI DOI 10.1016/B978-012088390-5.50007-8; Sandweiss DH, 2003, PALAEOGEOGR PALAEOCL, V194, P23, DOI 10.1016/S0031-0182(03)00270-0; Schone BR, 2011, PALAEOGEOGR PALAEOCL, V302, P52, DOI 10.1016/j.palaeo.2010.03.016; Soldati AL, 2008, MINERAL MAG, V72, P579, DOI 10.1180/minmag.2008.072.2.579; Soldati AL, 2008, J RAMAN SPECTROSC, V39, P525, DOI 10.1002/jrs.1873; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; URBAN HJ, 1994, MAR ECOL PROG SER, V107, P139, DOI 10.3354/meps107139	42	16	16	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54274	10.1371/journal.pone.0054274	http://dx.doi.org/10.1371/journal.pone.0054274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405078	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400022
J	Duan, JZ; Lee, Y; Jania, C; Gong, JC; Rojas, M; Burk, L; Willis, M; Homeister, J; Tilley, S; Rubin, J; Deb, A				Duan, JinZhu; Lee, Yueh; Jania, Corey; Gong, Jucheng; Rojas, Mauricio; Burk, Laurel; Willis, Monte; Homeister, Jonathon; Tilley, Stephen; Rubin, Janet; Deb, Arjun			Rib Fractures and Death from Deletion of Osteoblast beta catenin in Adult Mice Is Rescued by Corticosteroids	PLOS ONE			English	Article							KAPPA-B LIGAND; RECEPTOR ACTIVATOR; BONE-RESORPTION; RANKL; FIBROBLASTS; BISPHOSPHONATES; LYMPHOCYTES; INHIBITION; EXPRESSION; CELLS	Ribs are primarily made of cortical bone and are necessary for chest expansion and ventilation. Rib fractures represent the most common type of non-traumatic fractures in the elderly yet few studies have focused on the biology of rib fragility. Here, we show that deletion of beta catenin in Col1a2 expressing osteoblasts of adult mice leads to aggressive osteoclastogenesis with increased serum levels of the osteoclastogenic cytokine RANKL, extensive rib resorption, multiple spontaneous rib fractures and chest wall deformities. Within days of osteoblast specific bcatenin deletion, animals die from respiratory failure with a vanishing rib cage that is unable to sustain ventilation. Increased bone resorption is also observed in the vertebrae and femur. Treatment with the bisphosphonate pamidronate delayed but did not prevent death or associated rib fractures. In contrast, administration of the glucocorticoid dexamethasone decreased serum RANKL and slowed osteoclastogenesis. Dexamethasone preserved rib structure, prevented respiratory compromise and strikingly increased survival. Our findings provide a novel model of accelerated osteoclastogenesis, where deletion of osteoblast bcatenin in adults leads to rapid development of destructive rib fractures. We demonstrate the role of bcatenin dependent mechanisms in rib fractures and suggest that glucocorticoids, by suppressing RANKL, may have a role in treating bone loss due to aggressive osteoclastogenesis.	[Duan, JinZhu; Jania, Corey; Gong, Jucheng; Rojas, Mauricio; Tilley, Stephen; Rubin, Janet; Deb, Arjun] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Duan, JinZhu; Gong, Jucheng; Deb, Arjun] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Lee, Yueh; Burk, Laurel] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC USA; [Lee, Yueh] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Willis, Monte; Homeister, Jonathon] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Deb, Arjun] Univ N Carolina, Div Cardiol, Chapel Hill, NC USA; [Rubin, Janet] Univ N Carolina, Div Endocrinol, Chapel Hill, NC USA; [Jania, Corey; Tilley, Stephen] Univ N Carolina, Div Pulmonol, Chapel Hill, NC USA; [Deb, Arjun] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Duan, JinZhu; Gong, Jucheng; Rojas, Mauricio; Willis, Monte; Homeister, Jonathon; Rubin, Janet; Deb, Arjun] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC USA; [Duan, JinZhu; Gong, Jucheng; Deb, Arjun] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Deb, A (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	arjundeb@med.unc.edu	Willis, Monte S/J-9994-2015; Lee, Yueh/AAF-1430-2021; , BRIC Small Animal Imaging Facility/AEV-1023-2022	Willis, Monte S/0000-0002-0769-5816; Lee, Yueh/0000-0003-1846-7680; , BRIC Small Animal Imaging Facility/0000-0002-0535-3214	National Institutes of Health [HL104129, HL090823, AR56655, HL102190]; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104129, R01HL102190, R01HL090823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	MW (HL104129), JH (HL090823) and JR (AR56655) were supported by respective grants from the National Institutes of Health. This study was supported by grants from the National Institutes of Health (HL102190) and Ellison Medical Foundation to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett-Connor E, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1069; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brault V, 2001, DEVELOPMENT, V128, P1253; Cao G, 2009, PHYS MED BIOL, V54, P2323, DOI 10.1088/0031-9155/54/8/005; Case N, 2010, J CELL BIOCHEM, V110, P545, DOI 10.1002/jcb.22574; Colucci S, 2007, J PATHOL, V212, P47, DOI 10.1002/path.2153; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Humphrey EL, 2006, BONE, V38, P652, DOI 10.1016/j.bone.2005.10.004; Kapoor M, 2008, J CLIN INVEST, V118, P3279, DOI 10.1172/JCI35381; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kim YH, 2002, EXP MOL MED, V34, P145, DOI 10.1038/emm.2002.21; LoMauro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035965; Lovgren AK, 2006, AM J PHYSIOL-LUNG C, V291, pL144, DOI 10.1152/ajplung.00492.2005; Makrygiannakis D, 2006, ARTHRITIS RHEUM-US, V54, P1463, DOI 10.1002/art.21767; Matzelle MM, 2012, ARTHRITIS RHEUM-US, V64, P1540, DOI 10.1002/art.33504; Morony S, 2005, ENDOCRINOLOGY, V146, P3235, DOI 10.1210/en.2004-1583; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Gradaigh D, 2004, ANN RHEUM DIS, V63, P354, DOI 10.1136/ard.2003.008458; Onal M, 2012, J BIOL CHEM, V287, P29851, DOI 10.1074/jbc.M112.377945; Onishi T, 2010, NAT REV CLIN ONCOL, V7, P641, DOI 10.1038/nrclinonc.2010.134; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Rousseau D, 1998, EUR CYTOKINE NETW, V9, P655; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Spiro AS, 2010, J TRAUMA, V69, P1473, DOI 10.1097/TA.0b013e3181dc59e4; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619; Wuermser LA, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/457591; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yeo L, 2011, ANN RHEUM DIS, V70, P2022, DOI 10.1136/ard.2011.153312; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55757	10.1371/journal.pone.0055757	http://dx.doi.org/10.1371/journal.pone.0055757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393600	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800054
J	Morin, L; Paini, DR; Randall, RP				Morin, Louise; Paini, Dean R.; Randall, Roderick P.			Can Global Weed Assemblages Be Used to Predict Future Weeds?	PLOS ONE			English	Article							RISK-ASSESSMENT SYSTEM; INVASION SUCCESS; SPECIES TRAITS; ALIEN PLANTS; INVASIVENESS; COMMUNITIES; ECOSYSTEMS; PATTERNS; IMPACTS; PESTS	Predicting which plant taxa are more likely to become weeds in a region presents significant challenges to both researchers and government agencies. Often it is done in a qualitative or semi-quantitative way. In this study, we explored the potential of using the quantitative self-organising map (SOM) approach to analyse global weed assemblages and estimate likelihoods of plant taxa becoming weeds before and after they have been moved to a new region. The SOM approach examines plant taxa associations by analysing where a taxon is recorded as a weed and what other taxa are recorded as weeds in those regions. The dataset analysed was extracted from a pre-existing, extensive worldwide database of plant taxa recorded as weeds or other related status and, following reformatting, included 187 regions and 6690 plant taxa. To assess the value of the SOM approach we selected Australia as a case study. We found that the key and most important limitation in using such analytical approach lies with the dataset used. The classification of a taxon as a weed in the literature is not often based on actual data that document the economic, environmental and/or social impact of the taxon, but mostly based on human perceptions that the taxon is troublesome or simply not wanted in a particular situation. The adoption of consistent and objective criteria that incorporate a standardized approach for impact assessment of plant taxa will be necessary to develop a new global database suitable to make predictions regarding weediness using methods like SOM. It may however, be more realistic to opt for a classification system that focuses on the invasive characteristics of plant taxa without any inference to impacts, which to be defined would require some level of research to avoid bias from human perceptions and value systems.	[Morin, Louise; Paini, Dean R.] CSIRO, Ecosyst Sci, Biosecur Flagship, Canberra, ACT, Australia; [Randall, Roderick P.] Dept Agr & Food Western Australia, Perth, WA, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Morin, L (corresponding author), CSIRO, Ecosyst Sci, Biosecur Flagship, Canberra, ACT, Australia.	louise.morin@csiro.au	Paini, Dean R/C-2341-2009; Morin, Louise/B-4822-2009	Morin, Louise/0000-0002-9515-2255				Binns JA, 2001, LAND DEGRAD DEV, V12, P341, DOI 10.1002/ldr.455; Burgman M., 2005, RISKS DECISIONS CONS; Caley P, 2006, BIOL INVASIONS, V8, P1595, DOI 10.1007/s10530-004-0010-6; Caley P, 2006, AUSTRAL ECOL, V31, P647, DOI 10.1111/j.1442-9993.2006.01617.x; Categorisation Working Group, 2011, NAT CAT INV SPEC; Cereghino R, 2005, BIOL CONSERV, V125, P459, DOI 10.1016/j.biocon.2005.04.018; Cousens R, 2008, WEED SCI, V56, P873, DOI 10.1614/WS-08-047.1; Cunningham DC, 2004, WEED TECHNOL, V18, P1189, DOI 10.1614/0890-037X(2004)018[1189:AFFPSW]2.0.CO;2; DAEHLER CC, 2000, BIOL INVASIONS, V2, P93, DOI DOI 10.1023/A:1010002005024; Diez JM, 2009, ECOL LETT, V12, P1174, DOI 10.1111/j.1461-0248.2009.01376.x; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Gordon DR, 2008, DIVERS DISTRIB, V14, P234, DOI 10.1111/j.1472-4642.2007.00460.x; Groves RH, 2006, EUPHYTICA, V148, P111, DOI 10.1007/s10681-006-5945-5; Groves R.H., 2003, WEED CATEGORIES NATU; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Heikkila J, 2011, AGR FOOD SCI, V20, P15, DOI 10.2137/145960611795163088; HOCKING PJ, 1986, J AUST I AGR SCI, V52, P191; Hulme PE, 2012, J APPL ECOL, V49, P10, DOI 10.1111/j.1365-2664.2011.02069.x; Hulme PE, 2011, DIVERS DISTRIB, V17, P1152, DOI 10.1111/j.1472-4642.2011.00800.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kohonen T., 2001, SELF ORG MAPS, DOI [DOI 10.1007/978-3-642-56927-2, 10.1007/978-3-642-56927-2, DOI 10.1007/978-3-642-56927-2_1]; Lambdon PW, 2008, PRESLIA, V80, P101; Lonsdale WM, 2011, CURR OPIN ENV SUST, V3, P31, DOI 10.1016/j.cosust.2010.12.008; LOVE DORIS, 1959, CANADIAN JOUR BOT, V37, P173; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mack RN, 2001, BIOSCIENCE, V51, P95, DOI 10.1641/0006-3568(2001)051[0095:HAGPDG]2.0.CO;2; Mathworks, 2007, MATLAB VERS 7 4; McClay A, 2010, BIOL INVASIONS, V12, P4085, DOI 10.1007/s10530-010-9819-3; National Weed Risk Assessment System Review Group, 2006, REV NAT WEED RISK AS; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Paini DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025695; Paini DR, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1118; Paini DR, 2010, J APPL ECOL, V47, P290, DOI 10.1111/j.1365-2664.2010.01782.x; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Randall R.P., 2012, GLOBAL COMPENDIUM WE; Randall R. P., 2007, INTRO FLORA AUSTR IT; Randall RP, 2009, PLANTS DATABAS UNPUB; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Roberts W, 2011, CURR OPIN ENV SUST, V3, P60, DOI 10.1016/j.cosust.2010.11.007; Sinden Jack, 2005, Plant Protection Quarterly, V20, P25; Smith C.S., 1999, Biological Invasions, V1, P89, DOI 10.1023/A:1010091918466; Standards Australia Standards New Zealand CRC Australian Weed Management, 2006, HB 294 2006 NAT POST; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; United Nations Statistics Division, 2011, COMP MACR CONT REG G; Vesanto J., 2000, SOM TOOLBOX MATLAB, V5; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Virtue J. G., 2008, Plant Protection Quarterly, V23, P166; Weber J, 2009, J ENVIRON MANAGE, V90, P798, DOI 10.1016/j.jenvman.2008.01.012; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x	56	10	11	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55547	10.1371/journal.pone.0055547	http://dx.doi.org/10.1371/journal.pone.0055547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393591	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800045
J	Lin, M; Wen, YF; Wu, JR; Wang, Q; Zheng, L; Liu, GR; Huang, Y; Yang, H; Lin, F; Zhan, XF; Lin, CP; Yang, HT; Weng, QQ; Huang, FT; Wang, Y; Yao, MQ; Chen, HZ; Wu, DH; Zeng, JB; Zeng, RX; Yang, H; Li, GC; Lu, M; Zhu, JJ; Xie, LX; Wang, JL; Yang, LY				Lin, Min; Wen, Ying-Fang; Wu, Jiao-Ren; Wang, Qian; Zheng, Lei; Liu, Gui-Rong; Huang, Yue; Yang, Hui; Lin, Fen; Zhan, Xiao-Fen; Lin, Chun-Ping; Yang, Hui-Tian; Weng, Qiu-Qing; Huang, Fen-Ting; Wang, Yuan; Yao, Mei-Qiong; Chen, Hui-Zhou; Wu, Di-Hong; Zeng, Jing-Bo; Zeng, Ri-Xin; Yang, Hua; Li, Gui-Cai; Lu, Min; Zhu, Juan-Juan; Xie, Long-Xu; Wang, Jun-Li; Yang, Li-Ye			Hemoglobinopathy: Molecular Epidemiological Characteristics and Health Effects on Hakka People in the Meizhou Region, Southern China	PLOS ONE			English	Article							BETA-THALASSEMIA; GUANGDONG PROVINCE; PREVALENCE; DISORDERS; ALPHA; POPULATIONS; SPECTRUM; GUANGXI; DISEASE; BURDEN	Background: Hemoglobinopathies are the most common inherited diseases in southern China. However, there have been only a few epidemiological studies of hemoglobinopathies in Guangdong province. Materials and Methods: Peripheral blood samples were collected from 15299 "healthy'' unrelated subjects of dominantly ethnic Hakka in the Meizhou region, on which hemoglobin electrophoresis and routine blood tests were performed. Suspected cases with hemoglobin variants and hereditary persistence of fetal hemoglobin (HPFH) were further characterized by PCR, DNA sequencing, reverse dot blot (RDB) or multiplex ligation-dependent probe amplification (MLPA). In addition, 1743 samples were randomly selected from the 15299 subjects for thalassemia screening, and suspected thalassemia carriers were identified by PCR and RDB. Results: The gene frequency of hemoglobin variants was 0.477% (73/15299). The five main subgroups of the ten hemoglobin variants were Hb E, Hb G-Chinese, Hb Q-Tahiland, Hb New York and Hb J-Bangkok. 277 cases (15.89%, 277/1743) of suspected thalassemia carriers with microcytosis (MCV<82 fl) were found by thalassemia screening, and were tested by a RDB gene chip to reveal a total of 196 mutant chromosomes: including 124 alpha-thalassemia mutant chromosomes and 72 beta-thalassemia mutant chromosomes. These results give a heterozygote frequency of 11.24% for common alpha and beta thalassemia in the Hakka population in the Meizhou region. 3 cases of HPFH/delta beta-thalassemia were found, including 2 cases of Vietnamese HPFH (FPFH-7) and a rare Belgian (G)gamma((A)gamma delta beta)(0) -thalassemia identified in Chinese. Conclusions: Our results provide a detailed prevalence and molecular characterization of hemoglobinopathies in Hakka people of the Meizhou region. The estimated numbers of pregnancies each year in the Meizhou region, in which the fetus would be at risk for beta thalassemia major or intermedia, Bart's hydrops fetalis, and Hb H disease, are 25 (95% CI, 15 to 38), 40 (95% CI, 26 to 57), and 15 (95% CI, 8 to 23), respectively.	[Lin, Min; Wu, Jiao-Ren; Huang, Yue; Yang, Hui; Lin, Fen; Zhan, Xiao-Fen; Lin, Chun-Ping; Yang, Hui-Tian; Li, Gui-Cai; Yang, Li-Ye] So Med Univ, Chaozhou Cent Hosp, Lab Med Ctr, Chaozhou, Guangdong, Peoples R China; [Wen, Ying-Fang; Liu, Gui-Rong; Weng, Qiu-Qing; Huang, Fen-Ting] Meixian Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Wang, Qian; Zheng, Lei] So Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Yuan] Jiaoling Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Yao, Mei-Qiong] Pingyuan Women & Children Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Chen, Hui-Zhou] Fengshun Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Wu, Di-Hong] Dabu Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Zeng, Jing-Bo] Xingning Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Zeng, Ri-Xin] Wuhua Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China; [Yang, Hua] Meizhou Entry Exit Inspect & Quarantine Bur, Dept Hlth Examinat, Meizhou, Guangdong, Peoples R China; [Lu, Min; Zhu, Juan-Juan; Xie, Long-Xu] Chaozhou Hybribio Ltd Corp, Chaozhou, Guangdong, Peoples R China; [Wang, Jun-Li] Youjiang Med Coll Nationalities, Affiliated Hosp, Ctr Clin Lab, Baise, Guangxi, Peoples R China	Southern Medical University - China; Southern Medical University - China; Youjiang Medical University for Nationalities	Yang, LY (corresponding author), So Med Univ, Chaozhou Cent Hosp, Lab Med Ctr, Chaozhou, Guangdong, Peoples R China.	yangleeyee@sina.com			National Natural Science Foundation of China [81101329]; Social Development Program of Guangdong province [2011B031800329]; Science and Technology Program of Meizhou [2011B31]; Social Development Program of Chaozhou [2009S14]; Foundation the Health Department of Guangxi Province, China [2012713]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development Program of Guangdong province; Science and Technology Program of Meizhou; Social Development Program of Chaozhou; Foundation the Health Department of Guangxi Province, China	This work was partially supported by the National Natural Science Foundation of China (contract/grant number 81101329 to Min Lin), Social Development Program of Guangdong province (contract/grant number 2011B031800329 to Min Lin), Science and Technology Program of Meizhou (contract/grant number 2011B31 to Ying-Fang Wen), Social Development Program of Chaozhou contract/grant number 2009S14 to Gui-Cai Li) and Foundation the Health Department of Guangxi Province, China (contract/grant number 2012713 to Jun-Li Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WQ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-31; Colah R, 2010, EXPERT REV HEMATOL, V3, P103, DOI [10.1586/ehm.09.74, 10.1586/EHM.09.74]; Du RF, 2004, POPULATION GENETICS, P202; Du RF, 2004, POPULATION GENETICS, P220; FLATZ G, 1965, ANN HUM GENET, V29, P151, DOI 10.1111/j.1469-1809.1965.tb00511.x; FLATZ G, 1967, HUMANGENETIK, V3, P189, DOI 10.1007/BF00273124; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; Hu SP, 2007, AM J PHYS ANTHROPOL, V132, P140, DOI 10.1002/ajpa.20460; Lau YL, 1997, NEW ENGL J MED, V336, P1298, DOI 10.1056/NEJM199705013361805; Li ZS, 2006, HEMOGLOBIN, V30, P9, DOI 10.1080/03630260500453818; Lin M, 2012, CLIN GENET, V81, P165, DOI 10.1111/j.1399-0004.2011.01627.x; Lin M, 2008, BLOOD CELL MOL DIS, V41, P259, DOI 10.1016/j.bcmd.2008.06.001; Lin M, 2012, BLOOD CELL MOL DIS, V48, P86, DOI 10.1016/j.bcmd.2011.12.001; Liu Z, 1999, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V16, P41; Manca L, 2008, IUBMB LIFE, V60, P94, DOI 10.1002/iub.4; MOTUM PI, 1993, HUM MUTAT, V2, P179, DOI 10.1002/humu.1380020305; Pan HF, 2007, CLIN GENET, V71, P419, DOI 10.1111/j.1399-0004.2007.00791.x; Qin LY, 2003, B MED RES, V32, P12; Singsanan S, 2010, BLOOD CELL MOL DIS, V45, P210, DOI 10.1016/j.bcmd.2010.06.001; So CC, 2009, J CLIN PATHOL, V62, P1107, DOI 10.1136/jcp.2009.067538; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Thein SL, 2008, BRIT J HAEMATOL, V141, P357, DOI 10.1111/j.1365-2141.2008.07084.x; Wang WZ, 2010, AM J PHYS ANTHROPOL, V141, P124, DOI 10.1002/ajpa.21124; Wang YZ, 1983, MEIJIANG MED, V1, P40; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Xiong F, 2010, CLIN GENET, V78, P139, DOI 10.1111/j.1399-0004.2010.01430.x; Xu XM, 2000, AM J HEMATOL, V65, P183, DOI 10.1002/1096-8652(200011)65:3<183::AID-AJH1>3.0.CO;2-R; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456	29	26	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55024	10.1371/journal.pone.0055024	http://dx.doi.org/10.1371/journal.pone.0055024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383304	Green Published, gold			2022-12-25	WOS:000314597900011
J	Yu, ZL; Zhou, N; Zhao, CT; Qiu, JP				Yu, Zhiliang; Zhou, Ning; Zhao, Chuntian; Qiu, Juanping			In-Gel Determination of L-Amino Acid Oxidase Activity Based on the Visualization of Prussian Blue-Forming Reaction	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; EXPRESSION; VENOM	L-amino acid oxidase (LAAO) is attracting increasing attention due to its important functions. Diverse detection methods with their own properties have been developed for characterization of LAAO. In the present study, a simple, rapid, sensitive, cost-effective and reproducible method for quantitative in-gel determination of LAAO activity based on the visualization of Prussian blue-forming reaction is described. Coupled with SDS-PAGE, this Prussian blue agar assay can be directly used to determine the numbers and approximate molecular weights of LAAO in one step, allowing straightforward application for purification and sequence identification of LAAO from diverse samples.	[Yu, Zhiliang; Zhou, Ning; Zhao, Chuntian; Qiu, Juanping] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology	Yu, ZL (corresponding author), Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China.	zhiliangyu76@gmail.com; qiujping@zjut.edu.cn			Natural Science Foundation of Zhejiang Province, China [Y5100153]; Science and Technology Planning Project of Zhejiang Province, China (Welfare Technology Applied Research Project of Zhejiang Province) [2011C23007]	Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Science and Technology Planning Project of Zhejiang Province, China (Welfare Technology Applied Research Project of Zhejiang Province)	This work was supported by Natural Science Foundation of Zhejiang Province, China (Y5100153) (http://www.zjnsf.gov.cn/), and Science and Technology Planning Project of Zhejiang Province, China (Welfare Technology Applied Research Project of Zhejiang Province, Grant No.: 2011C23007) (http://www.zjkjt.gov.cn/), to ZY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WM, 2010, ENZYME MICROB TECH, V47, P52, DOI 10.1016/j.enzmictec.2010.03.008; Davis MA, 2005, APPL ENVIRON MICROB, V71, P3551, DOI 10.1128/AEM.71.7.3551-3555.2005; Ehara T, 2002, FEBS LETT, V531, P509, DOI 10.1016/S0014-5793(02)03608-6; Gomez D, 2008, APPL MICROBIOL BIOT, V79, P925, DOI 10.1007/s00253-008-1499-x; Huang YL, 2011, BIOFOULING, V27, P287, DOI 10.1080/08927014.2011.562978; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Karyakin AA, 2001, ELECTROANAL, V13, P813, DOI 10.1002/1521-4109(200106)13:10<813::AID-ELAN813>3.0.CO;2-Z; Kitani Y, 2007, FISH SHELLFISH IMMUN, V23, P1178, DOI 10.1016/j.fsi.2007.04.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lucas-Elio P, 2006, J BACTERIOL, V188, P2493, DOI 10.1128/JB.188.7.2493-2501.2006; Okubo BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033639; Ralph EC, 2006, BIOCHEMISTRY-US, V45, P15844, DOI 10.1021/bi061894o; Rau JE, 2011, J MICROBIOL METH, V85, P228, DOI 10.1016/j.mimet.2011.03.002; ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020; Saito M, 2007, MICROBIOL IMMUNOL, V51, P889, DOI 10.1111/j.1348-0421.2007.tb03971.x; Sakurai Y, 2001, TOXICON, V39, P1827, DOI 10.1016/S0041-0101(01)00133-7; Singh S, 2009, CAN J MICROBIOL, V55, P1096, DOI [10.1139/W09-068, 10.1139/w09-068]; Timmer B, 2005, SENSOR ACTUAT B-CHEM, V107, P666, DOI 10.1016/j.snb.2004.11.054; VALLON O, 1993, EUR J BIOCHEM, V215, P351, DOI 10.1111/j.1432-1033.1993.tb18041.x; Yang HC, 2005, J EXP BIOL, V208, P3609, DOI 10.1242/jeb.01795; Yu ZL, 2012, APPL BIOCHEM BIOTECH, V167, P1, DOI 10.1007/s12010-012-9611-1	21	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55548	10.1371/journal.pone.0055548	http://dx.doi.org/10.1371/journal.pone.0055548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383337	Green Submitted, Green Published, gold			2022-12-25	WOS:000314597900044
J	Christiansson, L; Soderlund, S; Svensson, E; Mustjoki, S; Bengtsson, M; Simonsson, B; Olsson-Stromberg, U; Loskog, ASI				Christiansson, Lisa; Soderlund, Stina; Svensson, Emma; Mustjoki, Satu; Bengtsson, Mats; Simonsson, Bengt; Olsson-Stromberg, Ulla; Loskog, Angelica S. I.			Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; TUMOR BURDEN; B7-H1 PD-L1; PHASE-I; IMATINIB; CANCER; SAFETY; INTERLEUKIN-2-RECEPTOR; ARGINASE; ANTIBODY	Immunotherapy (eg interferon alpha) in combination with tyrosine kinase inhibitors is currently in clinical trials for treatment of chronic myeloid leukemia (CML). Cancer patients commonly have problems with so called immune escape mechanisms that may hamper immunotherapy. Hence, to study the function of the immune system in CML is of interest. In the present paper we have identified immune escape mechanisms in CML with focus on those that directly hamper T cells since these cells are important to control tumor progression. CML patient samples were investigated for the presence of myeloid-derived suppressor cells (MDSCs), expression of programmed death receptor ligand 1/programmed death receptor 1 (PD-L1/PD-1), arginase 1 and soluble CD25. MDSC levels were increased in samples from Sokal high risk patients (p<0,05) and the cells were present on both CD34 negative and CD34 positive cell populations. Furthermore, expression of the MDSC-associated molecule arginase 1, known to inhibit T cells, was increased in the patients (p = 0,0079). Myeloid cells upregulated PD-L1 (p<0,05) and the receptor PD-1 was present on T cells. However, PD-L1 blockade did not increase T cell proliferation but upregulated IL-2 secretion. Finally, soluble CD25 was increased in high risk patients (p<0,0001). In conclusion T cells in CML patients may be under the control of different immune escape mechanisms that could hamper the use of immunotherapy in these patients. These escape mechanisms should be monitored in trials to understand their importance and how to overcome the immune suppression.	[Christiansson, Lisa; Svensson, Emma; Bengtsson, Mats; Loskog, Angelica S. I.] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Soderlund, Stina; Simonsson, Bengt; Olsson-Stromberg, Ulla] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Soderlund, Stina; Simonsson, Bengt; Olsson-Stromberg, Ulla] Univ Uppsala Hosp, Dept Hematol, Uppsala, Sweden; [Mustjoki, Satu] Univ Helsinki, Dept Med, Div Hematol, Hematol Res Unit Helsinki, Helsinki, Finland; [Mustjoki, Satu] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Bengtsson, Mats] Univ Uppsala Hosp, Sect Clin Immunol & Transfus Med, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Uppsala University; Uppsala University Hospital	Christiansson, L (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	lisa.christiansson@igp.uu.se	Mustjoki, Satu/AAD-9974-2020	Mustjoki, Satu/0000-0002-0816-8241; Loskog, Angelica/0000-0001-8583-6138	Nordic CML study group; EuropeanLeukemiaNet; Uppsala University Hospital; Medical Faculty at Uppsala University; Cancer Foundation Finland sr [100118, 110101] Funding Source: researchfish	Nordic CML study group; EuropeanLeukemiaNet; Uppsala University Hospital; Medical Faculty at Uppsala University; Cancer Foundation Finland sr	The study was supported by the Nordic CML study group (http://www.nordiccml.org/), EuropeanLeukemiaNet (http://www.leukemia-net.org/content/home/), Uppsala University Hospital and the Medical Faculty at Uppsala University (http://www.akademiska.se/, http://www.medfarm.uu.se/medicinska_fakulteten/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Butt NM, 2005, HAEMATOLOGICA, V90, P1315; Chen XL, 2008, CANCER BIOL THER, V7, P622, DOI 10.4161/cbt.7.5.5689; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; El-Hady SBM, 2012, ANN HEMATOL, V91, P1193, DOI 10.1007/s00277-012-1427-0; Eleftheriadis T, 2012, RENAL FAILURE, V34, P1118, DOI 10.3109/0886022X.2012.713297; Ennishi D, 2009, ANN ONCOL, V20, P526, DOI 10.1093/annonc/mdn677; Fife BT, 2011, ANN NY ACAD SCI, V1217, P45, DOI 10.1111/j.1749-6632.2010.05919.x; Gabitass RF, 2011, CANC IMMUNOL IMMUNOT; Gadiot J, 2011, CANCER-AM CANCER SOC, V117, P2192, DOI 10.1002/cncr.25747; GAUSE A, 1992, ANN ONCOL, V3, pS49, DOI 10.1093/annonc/3.suppl_4.S49; Gross S, 2008, IMMUNOL LETT, V116, P7, DOI 10.1016/j.imlet.2007.11.012; Hasford J, 2011, BLOOD, V118, P686, DOI 10.1182/blood-2010-12-319038; Hehlmann R, 2011, J CLIN ONCOL, V29, P1634, DOI 10.1200/JCO.2010.32.0598; Herrmann H, 2011, ASH ANN M, V118, P961; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; HOROWITZ MM, 1990, BLOOD, V75, P555; Jiao ZJ, 2012, WORLD J GASTROENTERO, V18, P5454, DOI 10.3748/wjg.v18.i38.5454; Kawatani T, 1997, INT J HEMATOL, V65, P123; Kitagawa JI, 2009, J CANCER RES CLIN, V135, P53, DOI 10.1007/s00432-008-0440-0; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; LEU SY, 1992, CANCER, V70, P733, DOI 10.1002/1097-0142(19920815)70:4<733::AID-CNCR2820700403>3.0.CO;2-6; Li ZH, 2005, CLIN CANCER RES, V11, P4460, DOI 10.1158/1078-0432.CCR-05-0250; Lindqvist CA, 2010, IMMUNOLOGY, V131, P371, DOI 10.1111/j.1365-2567.2010.03308.x; Loos M, 2011, ANN THORAC SURG, V91, P1025, DOI 10.1016/j.athoracsur.2010.12.041; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; MOTOI T, 1989, BLOOD, V74, P1052; Mumprecht S, 2009, BLOOD, V114, P1528, DOI 10.1182/blood-2008-09-179697; Mustjoki S, 2010, LEUKEMIA, V24, P219, DOI 10.1038/leu.2009.190; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Or R, 2003, BLOOD, V101, P441, DOI 10.1182/blood-2002-02-0535; Panteli KE, 2005, BRIT J HAEMATOL, V130, P709, DOI 10.1111/j.1365-2141.2005.05674.x; Perez-Encinas M, 1998, HAEMATOLOGICA, V83, P752; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Preudhomme C, 2010, NEW ENGL J MED, V363, P2511, DOI 10.1056/NEJMoa1004095; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Rowe JH, 2008, J IMMUNOL, V180, P7553, DOI 10.4049/jimmunol.180.11.7553; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; RUBIN LA, 1986, J IMMUNOL, V137, P3841; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Salih HR, 2006, EXP HEMATOL, V34, P888, DOI 10.1016/j.exphem.2006.03.006; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Simonsson B, 2011, BLOOD, V118, P3228, DOI 10.1182/blood-2011-02-336685; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690	54	91	93	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55818	10.1371/journal.pone.0055818	http://dx.doi.org/10.1371/journal.pone.0055818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383287	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600164
J	Eitan, R; Krissi, H; Levavi, H; Sabah, G; Peled, Y				Eitan, Ram; Krissi, Haim; Levavi, Hanoch; Sabah, Gad; Peled, Yoav			Clinical Course of Patients Treated for Advanced Ovarian Carcinoma without Surgical Intervention	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; CANCER; SURVIVAL; METAANALYSIS; CARBOPLATIN; PACLITAXEL; CISPLATIN	Objective: To describe the clinical course and outcome of patients with non-surgically-treated advanced ovarian cancer attending a single institute. Methodology/Principal Findings: We reviewed the medical charts of all patients with advanced epithelial ovarian cancer who underwent chemotherapy at a tertiary medical center between January 2005 and December 2010 but were never operated. Data on patient characteristics, disease course, and outcome were collected from patient files. Sixteen patients met the inclusion criteria. Eight (50%) were diagnosed with apparent FIGO stage IIIC disease, and 8 with stage IV. Five patients (31%) achieved a complete clinical response, and 11 (69%) achieved a partial response. Among the complete responders, the median disease-free interval was 8 months (range 7-11 months). In all of them, the disease recurred and second-line chemotherapy was administered. Of them, four (80%) achieved a second complete response. Partial responders had up to four lines of chemotherapy, with continued disease progression. The median overall survival of the whole group was 19.5 months, and of the complete responders, 28 months. Conclusions/Significance: Most patients with advanced ovarian carcinoma who will not undergo surgery respond only partially to first-line chemotherapy. Having no surgery is associated with a short disease-free interval.	[Eitan, Ram] Helen Schneider Hosp Women, Rabin Med Ctr, Div Gynecol Oncol, Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Eitan, R (corresponding author), Helen Schneider Hosp Women, Rabin Med Ctr, Div Gynecol Oncol, Petah Tiqwa, Israel.	eitanr@clalit.org.il						Aletti GD, 2006, OBSTET GYNECOL, V107, P77, DOI 10.1097/01.AOG.0000192407.04428.bb; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bookman MA, 2003, INT J GYNECOL CANCER, V13, P735, DOI 10.1111/j.1525-1438.2003.13602.x; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Bristow RE, 2006, GYNECOL ONCOL, V103, P1070, DOI 10.1016/j.ygyno.2006.06.025; CHAMBERS JT, 1990, GYNECOL ONCOL, V37, P327, DOI 10.1016/0090-8258(90)90361-N; DeVita VT, 2001, CANC PRINCIPLES PRAC, P1092; du Bois A, 2004, ANN ONCOL S8, pviii7; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; HOSKINS WJ, 1994, AM J OBSTET GYNECOL, V170, P974, DOI 10.1016/S0002-9378(94)70090-7; Ozols RF, 2005, SEMIN ONCOL, V32, pS4, DOI 10.1053/j.seminoncol.2005.06.023; Schwartz PE, 2002, BEST PRACT RES CL OB, V16, P585, DOI 10.1053/beog.2002.0304; Vergote I, 1998, GYNECOL ONCOL, V71, P431, DOI 10.1006/gyno.1998.5213; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806	14	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55645	10.1371/journal.pone.0055645	http://dx.doi.org/10.1371/journal.pone.0055645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383254	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800179
J	Alghamdi, TA; Ho, CY; Mrakovic, A; Taylor, D; Mao, D; Botelho, RJ				Alghamdi, Tamadher A.; Ho, Cheuk Y.; Mrakovic, Amra; Taylor, Danielle; Mao, Daniel; Botelho, Roberto J.			Vac14 Protein Multimerization Is a Prerequisite Step for Fab1 Protein Complex Assembly and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; MEMBRANE HOMEOSTASIS; MULTIVESICULAR BODY; 5-KINASE ACTIVITY; PIKFYVE; PHOSPHATASE; MORPHOLOGY; SIZE; NEURODEGENERATION	Phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P-2) helps control various endolysosome functions including organelle morphology, membrane recycling, and ion transport. Further highlighting its importance, PtdIns(3,5)P-2 misregulation leads to the development of neurodegenerative diseases like Charcot-Marie-Tooth disease. The Fab1/PIKfyve lipid kinase phosphorylates PtdIns(3)P into PtdIns(3,5)P-2 whereas the Fig4/Sac3 lipid phosphatase antagonizes this reaction. Interestingly, Fab1 and Fig4 form a common protein complex that coordinates synthesis and degradation of PtdIns(3,5)P-2 by a poorly understood process. Assembly of the Fab1 complex requires Vac14/ArPIKfyve, a multimeric scaffolding adaptor protein that coordinates synthesis and turnover of PtdIns(3,5)P-2. However, the properties and function of Vac14 multimerization remain mostly uncharacterized. Here we identify several conserved C-terminal motifs on Vac14 required for self-interaction and provide evidence that Vac14 likely forms a dimer. We also show that monomeric Vac14 mutants do not support interaction with Fab1 or Fig4, suggesting that Vac14 multimerization is likely the first molecular event in the assembly of the Fab1 complex. Finally, we show that cells expressing monomeric Vac14 mutants have enlarged vacuoles that do not fragment after hyperosmotic shock, which indicates that PtdIns(3,5)P-2 levels are greatly abated. Therefore, our observations support an essential role for the Vac14 homocomplex in controlling PtdIns(3,5)P-2 levels.	[Alghamdi, Tamadher A.; Ho, Cheuk Y.; Mrakovic, Amra; Botelho, Roberto J.] Ryerson Univ, Dept Biol & Chem, Toronto, ON M5B 2K3, Canada; [Alghamdi, Tamadher A.; Ho, Cheuk Y.; Mrakovic, Amra; Botelho, Roberto J.] Ryerson Univ, Mol Sci Program, Toronto, ON M5B 2K3, Canada; [Taylor, Danielle] Univ Toronto, Inst Med Sci, Neurogenet Sect, Ctr Addict & Mental Hlth, Toronto, ON M5B 2K3, Canada; [Mao, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Toronto Metropolitan University; Toronto Metropolitan University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Botelho, RJ (corresponding author), Ryerson Univ, Dept Biol & Chem, Toronto, ON M5B 2K3, Canada.	rbotelho@ryerson.ca	Botelho, Roberto J/B-9145-2013	Botelho, Roberto J/0000-0002-7820-0999; Ho, Shannon/0000-0001-9301-3430	King Abdullah scholarship from Saudi Arabia; Natural Sciences and Engineering Research Council of Canada discovery grant; Dean's Research Fund from Ryerson University; Health Research Fund from Ryerson University	King Abdullah scholarship from Saudi Arabia; Natural Sciences and Engineering Research Council of Canada discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dean's Research Fund from Ryerson University; Health Research Fund from Ryerson University	Supported by a King Abdullah scholarship from Saudi Arabia.; Supported by an Natural Sciences and Engineering Research Council of Canada discovery grant and the Dean's Research and the Health Research Funds from Ryerson University. To whom correspondence should be addressed. Tel.: 416-979-5000 (ext. 2059); Fax: 416-979-5044; E-mail: rbotelho@ryerson.ca.	Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Duex JE, 2006, EUKARYOT CELL, V5, P723, DOI 10.1128/EC.5.4.723-731.2006; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Ho CY, 2012, TRAFFIC, V13, P1, DOI 10.1111/j.1600-0854.2011.01246.x; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Romero-Suarez S, 2010, AGING-US, V2, P504, DOI 10.18632/aging.100190; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104; Zieger M, 2012, MOL BIOL CELL, V23, P3438, DOI 10.1091/mbc.E12-05-0347	35	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9363	9372		10.1074/jbc.M113.453712	http://dx.doi.org/10.1074/jbc.M113.453712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23389034	hybrid, Green Published			2022-12-25	WOS:000316862200053
J	Fujihashi, M; Mito, K; Pai, EF; Miki, K				Fujihashi, Masahiro; Mito, Kazuya; Pai, Emil F.; Miki, Kunio			Atomic Resolution Structure of the Orotidine 5 '-Monophosphate Decarboxylase Product Complex Combined with Surface Plasmon Resonance Analysis IMPLICATIONS FOR THE CATALYTIC MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROFICIENT ENZYME; TRANSITION-STATE; VINYL CARBANION; ACTIVE-SITE; X-RAY; SUBSTRATE; DERIVATIVES; CRYSTALLIZATION; FALCIPARUM; INHIBITORS	Orotidine 5'-monophosphate decarboxylase (ODCase) accelerates the decarboxylation of its substrate by 17 orders of magnitude. One argument brought forward against steric/electrostatic repulsion causing substrate distortion at the carboxylate substituent as part of the catalysis has been the weak binding affinity of the decarboxylated product (UMP). The crystal structure of the UMP complex of ODCase at atomic resolution (1.03 angstrom) shows steric competition between the product UMP and the side chain of a catalytic lysine residue. Surface plasmon resonance analysis indicates that UMP binds 5 orders of magnitude more tightly to a mutant in which the interfering side chain has been removed than to wild-type ODCase. These results explain the low affinity of UMP and counter a seemingly very strong argument against a contribution of substrate distortion to the catalytic reaction mechanism of ODCase.	[Fujihashi, Masahiro; Mito, Kazuya; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Pai, Emil F.] Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1L7, Canada; [Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada	Kyoto University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Pai, EF (corresponding author), Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada.	pai@hera.med.utoronto.ca; miki@kuchem.kyoto-u.ac.jp	Pai, Emil/R-8908-2019	Pai, Emil/0000-0002-1162-7242	Japan Society for the Promotion of Science (JSPS) [20770081, 2277012, 24570130]; Uehara Memorial Foundation; Canadian Institutes for Health Research; Canada Research Chairs Program; Ontario Ministry of Health and Long Term Care; United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Institutes of Health, National Institute of General Medical Sciences [P41GM103543, P41RR007707]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103543] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grants-in-aid for Young Scientists (B) (20770081 and 2277012) and Scientific Research (C) (24570130) from the Japan Society for the Promotion of Science (JSPS) and the Uehara Memorial Foundation (to M. F.) as well as the Canadian Institutes for Health Research, the Canada Research Chairs Program, and the Ontario Ministry of Health and Long Term Care (to E. F. P.).; We are grateful to the staff members at the beamlines of the Photon Factory, SPring-8, and the BioCARS sector of the Advanced Photon Source for the help with data collection, to Wanda Gillon for sample preparation, and to Marie-Louise Hjaersen for help with crystallization experiments. Use of beamlines at the Photon Factory and SPring-8 was approved by the Photon Factory Advisory Committee (Proposal 2006G164) and by the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal 2006B1212), respectively. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract DE-AC02-06CH11357. Use of the BioCARS Sector 14 was supported by the National Institutes of Health, National Institute of General Medical Sciences grant P41GM103543 (formerly National Center for Research Resources P41RR007707).	Amyes TL, 2008, J AM CHEM SOC, V130, P1574, DOI 10.1021/ja710384t; Amyes TL, 2012, BIOCHEMISTRY-US, V51, P4630, DOI 10.1021/bi300585e; Appleby TC, 2000, P NATL ACAD SCI USA, V97, P2005, DOI 10.1073/pnas.259441296; Bello AM, 2008, J MED CHEM, V51, P439, DOI 10.1021/jm7010673; Bello AM, 2009, J MED CHEM, V52, P1648, DOI 10.1021/jm801224t; Callahan BP, 2006, BIOORG CHEM, V34, P59, DOI 10.1016/j.bioorg.2005.12.001; Chan KK, 2009, BIOCHEMISTRY-US, V48, P5518, DOI 10.1021/bi900623r; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Desai BJ, 2012, BIOCHEMISTRY-US, V51, P8665, DOI 10.1021/bi301188k; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujihashi M, 2005, J AM CHEM SOC, V127, P15048, DOI 10.1021/ja054865u; Fujihashi M, 2009, J MOL BIOL, V387, P1199, DOI 10.1016/j.jmb.2009.02.037; Gao JL, 2003, CURR OPIN STRUC BIOL, V13, P184, DOI 10.1016/S0959-440X(03)00041-1; Harris P, 2000, BIOCHEMISTRY-US, V39, P4217, DOI 10.1021/bi992952r; Heinrich D, 2009, CHEM-EUR J, V15, P6619, DOI 10.1002/chem.200900397; Kamerlin SCL, 2010, J ORG CHEM, V75, P6391, DOI 10.1021/jo100651s; Krungkrai SR, 2005, BIOCHEMISTRY-US, V44, P1643, DOI 10.1021/bi048439h; Lewis CA, 2007, BIOCHEMISTRY-US, V46, P13331, DOI 10.1021/bi700796t; Lewis M, 2011, J MED CHEM, V54, P2891, DOI 10.1021/jm101642g; LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526; Meza-Avina ME, 2010, BIOORGAN MED CHEM, V18, P4032, DOI 10.1016/j.bmc.2010.04.017; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; Miller BG, 2001, BIOCHEMISTRY-US, V40, P6227, DOI 10.1021/bi0028993; Miller BG, 2000, ACTA CRYSTALLOGR D, V56, P472, DOI 10.1107/S0907444900000949; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poduch E, 2008, J MED CHEM, V51, P432, DOI 10.1021/jm700968x; Poduch E, 2006, J MED CHEM, V49, P4937, DOI 10.1021/jm060202r; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Thirumalairajan S, 2010, CHEM COMMUN, V46, P3158, DOI 10.1039/b926894d; Tokuoka K, 2008, J BIOCHEM, V143, P69, DOI 10.1093/jb/mvm193; Toth K, 2010, J AM CHEM SOC, V132, P7018, DOI 10.1021/ja102408k; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Wittmann JG, 2008, STRUCTURE, V16, P82, DOI 10.1016/j.str.2007.10.020; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797; Wu N, 2002, J BIOL CHEM, V277, P28080, DOI 10.1074/jbc.M202362200; Wu N, 2002, BIOCHEMISTRY-US, V41, P4002, DOI 10.1021/bi015758p; Wu N, 2000, ACTA CRYSTALLOGR D, V56, P912, DOI 10.1107/S090744490000576X	39	10	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9011	9016		10.1074/jbc.M112.427252	http://dx.doi.org/10.1074/jbc.M112.427252			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23395822	Green Published, hybrid			2022-12-25	WOS:000316862200020
J	Oh, Y; Chung, KC				Oh, Yohan; Chung, Kwang Chul			UHRF2, a Ubiquitin E3 Ligase, Acts as a Small Ubiquitin-like Modifier E3 Ligase for Zinc Finger Protein 131	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE NETWORK; SUMO E3; CONJUGATING ENZYME; TUMOR-SUPPRESSOR; IN-VITRO; SUMOYLATION; P53; NIRF; ACTIVATION; IDENTIFICATION	Small ubiquitin-like modifier (SUMO), a member of the ubiquitin-related protein family, is covalently conjugated to lysine residues of its substrates in a process referred to as SUMOylation. SUMOylation occurs through a series of enzymatic reactions analogous to that of the ubiquitination pathway, resulting in modification of the biochemical and functional properties of substrates. To date, four mammalian SUMO isoforms, a single heterodimeric SUMO-activating E1 enzyme SAE1/SAE2, a single SUMO-conjugating E2 enzyme ubiquitin-conjugating enzyme E2I (UBC9), and a few subgroups of SUMO E3 ligases have been identified. Several SUMO E3 ligases such as topoisomerase I binding, arginine/serine-rich (TOPORS), TNF receptor-associated factor 7 (TRAF7), and tripartite motif containing 27 (TRIM27) have dual functions as ubiquitin E3 ligases. Here, we demonstrate that the ubiquitin E3 ligase UHRF2 also acts as a SUMO E3 ligase. UHRF2 effectively enhances zinc finger protein 131 (ZNF131) SUMOylation but does not enhance ZNF131 ubiquitination. In addition, the SUMO E3 activity of UHRF2 on ZNF131 depends on the presence of SET and RING finger-associated and nuclear localization signal-containing region domains, whereas the critical ubiquitin E3 activity RING domain is dispensable. Our findings suggest that UHRF2 has independent functional domains and regulatory mechanisms for these two distinct enzymatic activities.	[Oh, Yohan; Chung, Kwang Chul] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University	Chung, KC (corresponding author), Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Yonsei Ro 50, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	Oh, Yohan/C-9107-2013; rchnds, rchnds/D-7595-2016	Oh, Yohan/0000-0002-9249-8664; 	National Research Foundation Grant [2012R1A1A2021749]; Ministry of Education, Science, and Technology (MEST); Basic Science Research Program through NRF (Korea) [2012-0000810]; Brain Research Center of the 21st Century Frontier Research Program Technology [2009K-001251]; MEST; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea [A092004, A111653]	National Research Foundation Grant(National Research Foundation of Korea); Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Science Research Program through NRF (Korea)(National Research Foundation of Korea); Brain Research Center of the 21st Century Frontier Research Program Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea	This work was supported by National Research Foundation Grant 2012R1A1A2021749 (to K. C. C.) funded by the Ministry of Education, Science, and Technology (MEST) and by the Basic Science Research Program through NRF (Korea) 2012-0000810 (to K. C. C.). This work was also supported by the Brain Research Center of the 21st Century Frontier Research Program Technology (2009K-001251 (to K. C. C.) funded by MEST. This work was also supported in part by Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea Grants A092004 and A111653 (to K. C. C.).	Bai L, 2012, BIOCHEM BIOPH RES CO, V425, P908, DOI 10.1016/j.bbrc.2012.08.009; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Donaldson NS, 2007, BBA-MOL CELL RES, V1773, P546, DOI 10.1016/j.bbamcr.2006.12.005; Donaldson NS, 2010, EXP CELL RES, V316, P1692, DOI 10.1016/j.yexcr.2010.03.011; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Ihara M, 2005, MOL CELL BIOL, V25, P3506, DOI 10.1128/MCB.25.9.3506-3518.2005; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Li YY, 2004, BIOCHEM BIOPH RES CO, V319, P464, DOI 10.1016/j.bbrc.2004.04.190; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Mori T, 2004, FEBS LETT, V557, P209, DOI 10.1016/S0014-5793(03)01495-9; Mori T, 2002, BIOCHEM BIOPH RES CO, V296, P530, DOI 10.1016/S0006-291X(02)00890-2; Mori T, 2012, FEBS LETT, V586, P1570, DOI 10.1016/j.febslet.2012.04.038; Mori T, 2011, CELL CYCLE, V10, P3284, DOI 10.4161/cc.10.19.17176; Morita Y, 2005, MOL BIOL CELL, V16, P5433, DOI 10.1091/mbc.E05-08-0731; Oh Y, 2013, BIOCHEM BIOPH RES CO, V430, P400, DOI 10.1016/j.bbrc.2012.11.031; Oh Y, 2012, J BIOL CHEM, V287, P17517, DOI 10.1074/jbc.M111.336354; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; TOMMERUP N, 1995, GENOMICS, V27, P259, DOI 10.1006/geno.1995.1040; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401; Wu J, 2012, ONCOGENE, V31, P333, DOI 10.1038/onc.2011.227; Zhang JQ, 2011, CELL RES, V21, P1723, DOI 10.1038/cr.2011.176; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	44	18	22	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9102	9111		10.1074/jbc.M112.438234	http://dx.doi.org/10.1074/jbc.M112.438234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404503	hybrid, Green Published			2022-12-25	WOS:000316862200030
J	Ritt, M; Guan, JL; Sivaramakrishnan, S				Ritt, Michael; Guan, Jun Lin; Sivaramakrishnan, Sivaraj			Visualizing and Manipulating Focal Adhesion Kinase Regulation in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-TYROSINE KINASE; STRUCTURAL BASIS; FERM DOMAIN; IN-VITRO; FAK; PHOSPHORYLATION; MIGRATION; PH; OVEREXPRESSION	Focal Adhesion Kinase (FAK) is essential for cell migration and plays an important role in tumor metastasis. However, the complex intermolecular and intramolecular interactions that regulate FAK activity at the focal adhesion remain unresolved. We have engineered a toolbox of FRET sensors that retain all of the individual FAK domains but modulate a key intramolecular regulatory interaction between the band 4.1/ezrin/radixin/moesin (FERM) and kinase domains of FAK. We demonstrate systematic control and quantitative measurement of the FERM-kinase interaction at focal adhesions, which in turn allows us to control cell migration. Using these sensors, we find that Tyr-397 phosphorylation, rather than kinase activity of FAK, is the key determinant of cell migration. Our sensors directly demonstrate, for the first time, a pH-dependent change in a protein-protein interaction at a macromolecular structure in live cells. The FERM-kinase interaction at focal adhesions is enhanced at acidic pH, with a concomitant decrease in Tyr-397 phosphorylation, providing a potential mechanism for enhanced migration of cancer cells.	[Ritt, Michael; Guan, Jun Lin; Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Guan, Jun Lin] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sivaramakrishnan, S (corresponding author), Dept Cell & Dev Biol, 3045 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	sivaraj@umich.edu			American Heart Association National Scientist Development Grant [13SDG14270009]; McKay Award; University of Michigan; National Institutes of Health [CA 163493]; NATIONAL CANCER INSTITUTE [R01CA163493] Funding Source: NIH RePORTER	American Heart Association National Scientist Development Grant(American Heart Association); McKay Award; University of Michigan(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by American Heart Association National Scientist Development Grant 13SDG14270009, the McKay Award, and University of Michigan startup funds (to S. S.). This work was also supported in part by National Institutes of Health Grant CA 163493 (to J. L. G.).	Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Baumann Kim, 2012, Nat Rev Mol Cell Biol, V13, P138, DOI 10.1038/nrm3297; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; BUCKLER KJ, 1990, PFLUG ARCH EUR J PHY, V417, P234, DOI 10.1007/BF00370705; Cabrita MA, 2011, MOL ONCOL, V5, P517, DOI 10.1016/j.molonc.2011.10.004; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Cary LA, 1996, J CELL SCI, V109, P1787; Chow S, 2001, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0903s14; Chu PY, 2009, J BIOL CHEM, V284, P20215, DOI 10.1074/jbc.M109.018259; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; De Milito Angelo, 2005, Future Oncol, V1, P779, DOI 10.2217/14796694.1.6.779; Ding LS, 2010, TRANSL RES, V156, P45, DOI 10.1016/j.trsl.2010.05.001; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Golubovskaya VM, 2012, CARCINOGENESIS, V33, P1004, DOI 10.1093/carcin/bgs120; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kiyokawa E, 2006, CANCER SCI, V97, P8, DOI 10.1111/j.1349-7006.2006.00141.x; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Leve F, 2011, EUR J PHARMACOL, V671, P7, DOI 10.1016/j.ejphar.2011.09.006; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; LYU PCC, 1992, J MOL BIOL, V223, P343, DOI 10.1016/0022-2836(92)90735-3; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Miyazaki T, 2003, BRIT J CANCER, V89, P140, DOI 10.1038/sj.bjc.6601050; Moglich A, 2006, P NATL ACAD SCI USA, V103, P12394, DOI 10.1073/pnas.0604748103; OWENS LV, 1995, CANCER RES, V55, P2752; Papusheva E, 2009, J CELL SCI, V122, P656, DOI 10.1242/jcs.028738; Recher C, 2004, CANCER RES, V64, P3191, DOI 10.1158/0008-5472.CAN-03-3005; Salonikidis PS, 2011, J BIOL CHEM, V286, P23419, DOI 10.1074/jbc.M111.236869; Sawai H, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-37; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; STUBBS M, 1994, CANCER RES, V54, P4011; Sun XG, 2009, MICROVASC RES, V77, P304, DOI 10.1016/j.mvr.2008.12.004; Taylor J. R., 1997, INTRO ERROR ANAL STU, P73; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Tse KWK, 2009, J BIOL CHEM, V284, P22865, DOI 10.1074/jbc.M109.013169; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Withers BE, 1996, PROTEIN EXPRES PURIF, V7, P12, DOI 10.1006/prep.1996.0002; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang J, 2007, MOL BIOSYST, V3, P759, DOI 10.1039/b706628g; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	55	29	29	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8875	8886		10.1074/jbc.M112.421164	http://dx.doi.org/10.1074/jbc.M112.421164			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393139	hybrid, Green Published			2022-12-25	WOS:000316862200009
J	Bolognesi, A; Chatgilialoglu, A; Polito, L; Ferreri, C				Bolognesi, Andrea; Chatgilialoglu, Alexandros; Polito, Letizia; Ferreri, Carla			Membrane Lipidome Reorganization Correlates with the Fate of Neuroblastoma Cells Supplemented with Fatty Acids	PLOS ONE			English	Article							ARACHIDONIC-ACID; INDUCE APOPTOSIS; UP-REGULATION; GROWTH; ACTIVATION; BRAIN; STRESS	Palmitic acid is known to be apoptotic for nervous cells but no data are available on membrane lipidome transformations occurring during its supplementation, although membrane lipids are clearly involved in the apoptotic signaling cascade. NB100 neuroblastoma cells were supplemented with palmitic acid and membrane fatty acids were isolated, derivatized and analysed by gas chromatography at defined time intervals. Parallely, cell viability, morphology, apoptosis, cPLA2 and caspase activations were checked. Interestingly, under 150 mu M supplementation the incorporation of palmitic acid was accompanied by the specific release of arachidonic acid. This event was timely correlated with cPLA2 and caspases activations, and the time window of 60 minutes was envisaged for crucial membrane lipidome changes. The simultaneous addition of 50 mu M oleic, 50 mu M arachidonic and 150 mu M palmitic acids to the cell cultures influenced membrane changes with suppression of caspase activation and maintenance of cell viability. These results highlight the role of the membrane asset with fatty acid remodeling and suggest the potential of lipid-based strategies for influencing cell response and fate in human diseases, such as neurodegenerative disorders or tumours.	[Bolognesi, Andrea; Chatgilialoglu, Alexandros; Polito, Letizia] Alma Mater Studiorum Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy; [Chatgilialoglu, Alexandros; Ferreri, Carla] CNR, Ist Sintesi Organ & Fotoreattivita, Bologna, Italy	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR)	Bolognesi, A (corresponding author), Alma Mater Studiorum Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy.	andrea.bolognesi@unibo.it; carla.ferreri@isof.cnr.it	Polito, Letizia/H-2877-2019; FERRERI, CARLA/G-6821-2013; Bolognesi, Andrea/Q-6526-2017	Polito, Letizia/0000-0001-8051-4981; FERRERI, CARLA/0000-0002-1359-0869; Bolognesi, Andrea/0000-0001-7497-4586	University of Bologna; Pallotti's Legacies for Cancer Research	University of Bologna; Pallotti's Legacies for Cancer Research	This study was supported by the University of Bologna and the Pallotti's Legacies for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1989, ANN NY ACAD SCI, V559, P259; Andoh A, 2000, J NUTR, V130, P2636, DOI 10.1093/jn/130.11.2636; [Anonymous], 2002, NEW COMPREHENSIVE BI, DOI [DOI 10.1016/S0167-7306(02)36009-5, 10.1016/S0167-7306(02)36009-5]; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Brand A, 2010, J NEUROCHEM, V113, P465, DOI 10.1111/j.1471-4159.2010.06611.x; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cevc G., 1993, PHOSPHOLIPIDS HDB, V2ZxaucDNWHcC; Chatgilialoglu C, 2005, ACCOUNTS CHEM RES, V38, P441, DOI 10.1021/ar0400847; Christie W. W., 2007, LIPID HDB, P426; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; Dowhan W., 2002, NEW COMPR BIOCH, P1, DOI DOI 10.1016/50167-7306(02)36003-4; du Bois TM, 2005, PROG NEURO-PSYCHOPH, V29, P878, DOI 10.1016/j.pnpbp.2005.04.034; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Ferreri C, 2005, LIPIDS, V40, P661, DOI 10.1007/s11745-005-1428-7; Ferreri C, 2005, FREE RADICAL BIO MED, V38, P1180, DOI 10.1016/j.freeradbiomed.2004.12.026; Girotti AW, 1998, J LIPID RES, V39, P1529; Golomb BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032175; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Hammond EW., 1993, CHROMATOGRAPHY ANAL; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Kondoh Y, 2007, BBA-MOL CELL BIOL L, V1771, P500, DOI 10.1016/j.bbalip.2007.01.012; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Landau Z, 2006, APOPTOSIS, V11, P717, DOI 10.1007/s10495-006-5425-3; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; MANGOLD HK, 1960, J AM OIL CHEM SOC, V37, P383, DOI 10.1007/BF02672641; Matsuyama M, 2005, ONCOL REP, V14, P73; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; MCKENZIE KE, 1994, PROSTAG LEUKOTR ESS, V51, P437, DOI 10.1016/0952-3278(94)90062-0; Moghaddami N, 2003, J IMMUNOL, V171, P2616, DOI 10.4049/jimmunol.171.5.2616; Mozaffarian D, 2006, ATHEROSCLEROSIS SUPP, V7, P29, DOI 10.1016/j.atherosclerosissup.2006.04.007; Mu YM, 2001, ENDOCRINOLOGY, V142, P3590, DOI 10.1210/en.142.8.3590; Nano JL, 2003, PROSTAG LEUKOTR ESS, V69, P207, DOI 10.1016/S0952-3278(03)00083-8; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Puca AA, 2008, REJUV RES, V11, P63, DOI 10.1089/rej.2007.0566; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Spener F, 2003, EUR J LIPID SCI TECH, V105, P481, DOI 10.1002/ejlt.200390101; SUGIMOTO T, 1984, J NATL CANCER I, V73, P51; Ulloth JE, 2003, J NEUROCHEM, V84, P655, DOI 10.1046/j.1471-4159.2003.01571.x; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Yang X, 2007, FASEB J, V21, P943; Zambonin L, 2006, FREE RADICAL BIO MED, V40, P1549, DOI 10.1016/j.freeradbiomed.2005.12.021; ZHANG JP, 1995, J NEUROCHEM, V64, P1688; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	49	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55537	10.1371/journal.pone.0055537	http://dx.doi.org/10.1371/journal.pone.0055537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405167	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400112
J	Delogu, F; Tiest, WMB; Nijboer, TCW; Kappers, AML; Postma, A				Delogu, Franco; Tiest, Wouter M. Bergmann; Nijboer, Tanja C. W.; Kappers, Astrid M. L.; Postma, Albert			Binding in Haptics: Integration of "What" and "Where" Information in Working Memory for Active Touch	PLOS ONE			English	Article							LOCATION; PATHWAYS; VISION; BRAIN; TASK; FMRI	Information about the identity and the location of perceptual objects can be automatically integrated in perception and working memory (WM). Contrasting results in visual and auditory WM studies indicate that the characteristics of feature-to-location binding can vary according to the sensory modality of the input. The present study provides first evidence of binding between "what" and "where" information in WM for haptic stimuli. In an old-new recognition task, blindfolded participants were presented in their peripersonal space with sequences of three haptic stimuli varying in texture and location. They were then required to judge if a single probe stimulus was previously included in the sequence. Recall was measured both in a condition in which both texture and location were relevant for the task (Experiment 1) and in two conditions where only one feature had to be recalled (Experiment 2). Results showed that when both features were task-relevant, even if the association of location and texture was neither necessary nor required to perform the task, participants exhibited a recall advantage in conditions in which the location and the texture of the target probe was kept unaltered between encoding and recall. By contrast, when only one feature was task-relevant, the concurrent feature did not influence the recall of the target feature. We conclude that attention to feature binding is not necessary for the emergence of feature integration in haptic WM. For binding to take place, however, it is necessary to encode and maintain in memory both the identity and the location of items.	[Delogu, Franco; Nijboer, Tanja C. W.; Postma, Albert] Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, Utrecht, Netherlands; [Delogu, Franco] Lawrence Technol Univ, Dept Humanities Social Sci & Commun, Southfield, MI USA; [Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr, Dept Neurol, Utrecht, Netherlands; [Nijboer, Tanja C. W.; Postma, Albert] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Nijboer, Tanja C. W.; Postma, Albert] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Nijboer, Tanja C. W.; Postma, Albert] Rehabil Ctr De Hoogstraat, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Delogu, F (corresponding author), Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, Utrecht, Netherlands.	fdelogu@ltu.edu	Tiest, Wouter M Bergmann/N-8535-2013	Nijboer, Tanja/0000-0001-6683-0267	Intra-European Fellowships for career development (IEF) Marie Curie Actions [254446]; Netherlands Organization for Scientific Research (NWO) [451-10-013]	Intra-European Fellowships for career development (IEF) Marie Curie Actions; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the grant 254446 from the Intra-European Fellowships for career development (IEF) Marie Curie Actions to Franco Delogu and by the grant 451-10-013 from the Netherlands Organization for Scientific Research (NWO) to Tanja C. W. Nijboer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan JS, 2008, PERCEPT PSYCHOPHYS, V70, P36, DOI 10.3758/PP.70.1.36; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Kaas AL, 2007, CEREB CORTEX, V17, P1637, DOI 10.1093/cercor/bhl074; Kohler S, 2001, MEM COGNITION, V29, P948, DOI 10.3758/BF03195757; KUBOVY M, 1988, J EXP PSYCHOL HUMAN, V14, P318, DOI 10.1037/0096-1523.14.2.318; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; Maybery MT, 2009, J MEM LANG, V61, P112, DOI 10.1016/j.jml.2009.03.001; Millar S, 2004, PERCEPT PSYCHOPHYS, V66, P51, DOI 10.3758/BF03194860; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Munk MHJ, 2002, CEREB CORTEX, V12, P866, DOI 10.1093/cercor/12.8.866; Olson IR, 2005, PERCEPT PSYCHOPHYS, V67, P185, DOI 10.3758/BF03206483; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Purdy KA, 2004, CAN J EXP PSYCHOL, V58, P32, DOI 10.1037/h0087438; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Reed CL, 2005, NEUROIMAGE, V25, P718, DOI 10.1016/j.neuroimage.2004.11.044; Ricciardi E, 2006, NEUROSCIENCE, V139, P339, DOI 10.1016/j.neuroscience.2005.08.045; Tiest WMB, 2006, ACTA PSYCHOL, V121, P1, DOI 10.1016/j.actpsy.2005.04.005; Treisman A., 1999, ATTENTION SPACE ACTI, P91; Van Boven RW, 2005, P NATL ACAD SCI USA, V102, P12601, DOI 10.1073/pnas.0505907102; Zuidhoek S, 2003, EXP BRAIN RES, V149, P320, DOI 10.1007/s00221-002-1365-5	21	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55606	10.1371/journal.pone.0055606	http://dx.doi.org/10.1371/journal.pone.0055606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405177	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400122
J	Donovan, C; Schauss, A; Kramer, R; Bramkamp, M				Donovan, Catriona; Schauss, Astrid; Kraemer, Reinhard; Bramkamp, Marc			Chromosome Segregation Impacts on Cell Growth and Division Site Selection in Corynebacterium glutamicum	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; POLE OSCILLATION; INHIBITOR MINC; WALL SYNTHESIS; PROTEIN; SYSTEM; CYCLE; LOCALIZATION; PLACEMENT	Spatial and temporal regulation of bacterial cell division is imperative for the production of viable offspring. In many rod-shaped bacteria, regulatory systems such as the Min system and nucleoid occlusion ensure the high fidelity of midcell divisome positioning. However, regulation of division site selection in bacteria lacking recognizable Min and nucleoid occlusion remains less well understood. Here, we describe one such rod-shaped organism, Corynebacterium glutamicum, which does not always place the division septum precisely at midcell. Here we now show at single cell level that cell growth and division site selection are spatially and temporally regulated by chromosome segregation. Mutants defective in chromosome segregation have more variable cell growth and aberrant placement of the division site. In these mutants, division septa constrict over and often guillotine the nucleoid, leading to nonviable, DNA-free cells. Our results suggest that chromosome segregation or some nucleoid associated factor influences growth and division site selection in C. glutamicum. Understanding growth and regulation of C. glutamicum cells will also be of importance to develop strains for industrial production of biomolecules, such as amino acids.	[Donovan, Catriona; Bramkamp, Marc] Univ Munich, Dept Biol 1, Planegg Martinsried, Germany; [Donovan, Catriona; Kraemer, Reinhard; Bramkamp, Marc] Univ Cologne, Inst Biochem, D-50931 Cologne, Germany; [Schauss, Astrid] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	University of Munich; University of Cologne; University of Cologne	Bramkamp, M (corresponding author), Univ Munich, Dept Biol 1, Planegg Martinsried, Germany.	marc.bramkamp@lmu.de		Bramkamp, Marc/0000-0002-7704-3266				Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bigot S, 2007, MOL MICROBIOL, V64, P1434, DOI 10.1111/j.1365-2958.2007.05755.x; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Chastanet Arnaud, 2012, Front Biosci (Schol Ed), V4, P1582; Collier J, 2012, PLASMID, V67, P76, DOI 10.1016/j.plasmid.2011.12.007; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Donovan C, 2012, MOL MICROBIOL, V84, P105, DOI 10.1111/j.1365-2958.2012.08011.x; Donovan C, 2010, J BACTERIOL, V192, P3441, DOI 10.1128/JB.00214-10; Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; FUNNELL BE, 1988, J BACTERIOL, V170, P954, DOI 10.1128/JB.170.2.954-960.1988; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Grover NB, 2001, MICROBIOL-SGM, V147, P171, DOI 10.1099/00221287-147-1-171; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kiekebusch D, 2012, MOL CELL, V46, P245, DOI 10.1016/j.molcel.2012.03.004; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Lesterlin C, 2004, MOL MICROBIOL, V54, P1151, DOI 10.1111/j.1365-2958.2004.04356.x; Letek M, 2008, ANTON LEEUW INT J G, V94, P99, DOI 10.1007/s10482-008-9224-4; Letek M, 2008, J BACTERIOL, V190, P3283, DOI 10.1128/JB.01934-07; Lutkenhaus J, 2002, CURR OPIN MICROBIOL, V5, P548, DOI 10.1016/S1369-5274(02)00376-4; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Migocki MD, 2002, EMBO REP, V3, P1163, DOI 10.1093/embo-reports/kvf233; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Moriya S, 2010, MOL MICROBIOL, V76, P634, DOI 10.1111/j.1365-2958.2010.07102.x; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Ramos A, 2005, MICROBIOL-SGM, V151, P2563, DOI 10.1099/mic.0.28036-0; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Rodrigues CDA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002561; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Siegal-Gaskins D, 2008, BIOPHYS J, V95, P2063, DOI 10.1529/biophysj.108.128785; Sveiczer A, 1996, J CELL SCI, V109, P2947; Tauch A, 2002, CURR MICROBIOL, V45, P362, DOI 10.1007/s00284-002-3728-3; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; van Baarle S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009850; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Wu LJ, 2009, EMBO J, V28, P1940, DOI 10.1038/emboj.2009.144; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002	54	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55078	10.1371/journal.pone.0055078	http://dx.doi.org/10.1371/journal.pone.0055078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405112	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400056
J	Goheen, JR; Palmer, TM; Charles, GK; Helgen, KM; Kinyua, SN; Maclean, JE; Turner, BL; Young, HS; Pringle, RM				Goheen, Jacob R.; Palmer, Todd M.; Charles, Grace K.; Helgen, Kristofer M.; Kinyua, Stephen N.; Maclean, Janet E.; Turner, Benjamin L.; Young, Hillary S.; Pringle, Robert M.			Piecewise Disassembly of a Large-Herbivore Community across a Rainfall Gradient: The UHURU Experiment	PLOS ONE			English	Article							SEMIARID SAVANNA; WOODY COVER; PRODUCTIVITY; POPULATION; EXTINCTION; ECOSYSTEM; PREFERENCES; DIVERSITY; DYNAMICS; RODENTS	Large mammalian herbivores (LMH) strongly influence plant communities, and these effects can propagate indirectly throughout food webs. Most existing large-scale manipulations of LMH presence/absence consist of a single exclusion treatment, and few are replicated across environmental gradients. Thus, important questions remain about the functional roles of different LMH, and how these roles depend on abiotic context. In September 2008, we constructed a series of 1-ha herbivore-exclusion plots across a 20-km rainfall gradient in central Kenya. Dubbed "UHURU" (Ungulate Herbivory Under Rainfall Uncertainty), this experiment aims to illuminate the ecological effects of three size classes of LMH, and how rainfall regimes shape the direction and magnitude of these effects. UHURU consists of four treatments: total-exclusion (all ungulate herbivores), mesoherbivore-exclusion (LMH >120-cm tall), megaherbivore-exclusion (elephants and giraffes), and unfenced open plots. Each treatment is replicated three times at three locations ("sites") along the rainfall gradient: low (440 mm/year), intermediate (580 mm/year), and high (640 mm/year). There was limited variation across sites in soil attributes and LMH activity levels. Understory-plant cover was greater in plots without mesoherbivores, but did not respond strongly to the exclusion of megaherbivores, or to the additional exclusion of dik-dik and warthog. Eleven of the thirteen understory plant species that responded significantly to exclusion treatment were more common in exclusion plots than open ones. Significant interactions between site and treatment on plant communities, although uncommon, suggested that differences between treatments may be greater at sites with lower rainfall. Browsers reduced densities of several common overstory species, along with growth rates of the three dominant Acacia species. Small-mammal densities were 2-3 times greater in total-exclusion than in open plots at all sites. Although we expect patterns to become clearer with time, results from 2008-2012 show that the effects of excluding successively smaller-bodied subsets of the LMH community are generally non-additive for a given response variable, and inconsistent across response variables, indicating that the different LMH size classes are not functionally redundant. Several response variables showed significant treatment-by-site interactions, suggesting that the nature of plant-herbivore interactions can vary across restricted spatial scales.	[Goheen, Jacob R.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Goheen, Jacob R.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Goheen, Jacob R.; Palmer, Todd M.; Charles, Grace K.; Kinyua, Stephen N.; Maclean, Janet E.; Young, Hillary S.; Pringle, Robert M.] Mpala Res Ctr, Nanyuki, Kenya; [Palmer, Todd M.] Univ Florida, Dept Biol, Gainesville, FL USA; [Helgen, Kristofer M.] Natl Museum Nat Hist, Div Mammals, Washington, DE USA; [Kinyua, Stephen N.] Moi Univ, Dept Wildlife Management, Eldoret, Kenya; [Maclean, Janet E.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Turner, Benjamin L.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Young, Hillary S.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Pringle, Robert M.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Wyoming; University of Wyoming; State University System of Florida; University of Florida; Moi University; University of British Columbia; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Princeton University	Pringle, RM (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	rpringle@princeton.edu	Palmer, Todd/GRS-0639-2022; Helgen, Kristofer M./AAB-8348-2019; Turner, Benjamin L/E-5940-2011; Young, Hillary/S-1514-2017	Helgen, Kristofer M./0000-0002-8776-4040; Turner, Benjamin L/0000-0002-6585-0722; Palmer, Todd/0000-0001-5710-9750; Charles, Grace/0000-0003-2080-878X	Sherwood Family Foundation; National Sciences and Engineering Research Council of Canada; University of Florida; University of British Columbia; US National Science Foundation [DEB-0709880, OISE-0852961, DEB-0444071]; National Geographic Society; Stanford University's Woods Institute for the Environment; University of Wyoming; Harvard University	Sherwood Family Foundation; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Florida(University of Florida); University of British Columbia; US National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Stanford University's Woods Institute for the Environment; University of Wyoming; Harvard University	The UHURU experiment was built with seed funding from the Sherwood Family Foundation, by grants from the National Sciences and Engineering Research Council of Canada (to JRG), and by the Universities of Florida, and British Columbia. Support for various portions of this study was contributed by the US National Science Foundation (DEB-0709880 and OISE-0852961 to RMP and DEB-0444071 to TMP), the National Geographic Society, Stanford University's Woods Institute for the Environment, the University of Wyoming, and the William F. Milton Fund of Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Ahn P. M., 1987, SOILS LAIKIPIA DISTR; Anderson TM, 2007, ECOLOGY, V88, P1191, DOI 10.1890/06-0399; [Anonymous], 1993, USDA HDB; Augustine David J., 2011, Smithsonian Contributions to Zoology, P55; Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Augustine DJ, 2003, PLANT ECOL, V167, P319, DOI 10.1023/A:1023927512590; Augustine DJ, 2002, THESIS SYRACUSE U NE; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Belyea LR, 1999, OIKOS, V86, P402, DOI 10.2307/3546646; Blundell M., 1982, WILD FLOWERS KENYA; Bogdan AV, 1976, REVISED LIST KENYA G; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Brady N.C., 1999, NATURE PROPERTIES SO; Brook BW, 2005, POPUL ECOL, V47, P137, DOI 10.1007/s10144-005-0213-4; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chase JM, 2000, ECOLOGY, V81, P2485, DOI 10.1890/0012-9658(2000)081[2485:TEOPHA]2.0.CO;2; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; COUGHENOUR MB, 1991, J RANGE MANAGE, V44, P530, DOI 10.2307/4003033; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Dharani N., 2006, FIELD GUIDE ACACIAS; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; DUTOIT JT, 1990, AFR J ECOL, V28, P55, DOI 10.1111/j.1365-2028.1990.tb01136.x; Ernest SKM, 2000, OIKOS, V88, P470, DOI 10.1034/j.1600-0706.2000.880302.x; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Frank DA, 2011, GLOBAL CHANGE BIOL, V17, P495, DOI 10.1111/j.1365-2486.2010.02219.x; Gagnon M, 2000, J MAMMAL, V81, P490, DOI 10.1644/1545-1542(2000)081&lt;0490:DPIEAB&gt;2.0.CO;2; Gee G.W., 2002, METHODS SOIL ANAL PA, V5, P255, DOI [DOI 10.2136/SSSABOOKSER5.4.C12, 10.2136/sssabookser5.4.c12]; Gillett JB, 1970, NUMBERED CHECK LIST; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; Goheen JR, 2010, J ANIM ECOL, V79, P372, DOI 10.1111/j.1365-2656.2009.01644.x; Grossman R.B., 2002, METHODS SOIL ANAL 4, P201, DOI DOI 10.2136/SSSABOOKSER5.4.C9; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Hagenah N, 2009, J TROP ECOL, V25, P483, DOI 10.1017/S0266467409990046; Haynes RJ, 2001, NUTR CYCL AGROECOSYS, V59, P47, DOI 10.1023/A:1009823600950; Heady H.F., 1960, RANGE MANAGEMENT E A; Hendershot W.H., 2008, SOIL SAMPLING METHOD, P173, DOI DOI 10.1111/1365-2745.12546; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Ims RA, 2007, ECOSYSTEMS, V10, P607, DOI 10.1007/s10021-007-9060-9; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Kareiva P., 1988, Lecture Notes in Biomathematics, V77, P35; Keesing F, 1998, OECOLOGIA, V116, P381, DOI 10.1007/s004420050601; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Lagendijk G, 2012, BIOTROPICA, V44, P63, DOI 10.1111/j.1744-7429.2011.00776.x; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Lortie CJ, 2006, J ECOL, V94, P7, DOI 10.1111/j.1365-2745.2005.01066.x; Maclean JE, 2011, ECOLOGY, V92, P1626, DOI 10.1890/10-2097.1; McCauley DJ, 2006, ECOLOGY, V87, P2657, DOI 10.1890/0012-9658(2006)87[2657:IEOLHO]2.0.CO;2; McLaren JR, 2010, J ECOL, V98, P459, DOI 10.1111/j.1365-2745.2009.01630.x; McNaughton SJ, 1996, ECOLOGY, V77, P974, DOI 10.2307/2265518; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MCNAUGHTON SJ, 1983, ECOL MONOGR, V53, P291, DOI 10.2307/1942533; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Osem Y, 2004, J ECOL, V92, P297, DOI 10.1111/j.0022-0477.2004.00859.x; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; Pringle R. M., 2011, CONSERVING WILDLIFE, P55; Pringle RM, 2008, ECOLOGY, V89, P26, DOI 10.1890/07-0776.1; Pringle RM, 2007, P NATL ACAD SCI USA, V104, P193, DOI 10.1073/pnas.0609840104; Pringle RM, 2012, AM SCI, V100, P30; Riginos C, PASTORALISM IN PRESS; RODGERS WA, 1976, E AFR WILDL J, V14, P331; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Schmitz OJ., 2010, RESOLVING ECOSYSTEM; Smit R, 2001, PLANT ECOL, V155, P119, DOI 10.1023/A:1013239805915; SOIL SURVEY STAFF, 1999, SOIL TAX BAS SYST SO, V2nd; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; STEWART DRM, 1971, J WILDLIFE MANAGE, V35, P86, DOI 10.2307/3799875; Stuart C., 2000, FIELD GUIDE TRACKS S; Vagen T.-G., 2010, LAND DEGRADATION SUR; Van Oudtshoorn F., 2009, GUIDE GRASSES SO AFR; Vaughn KJ, 2010, RESTOR ECOL, V18, P59, DOI 10.1111/j.1526-100X.2010.00714.x; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Young TP, 2005, BIOL CONSERV, V122, P351, DOI 10.1016/j.biocon.2004.08.007	88	72	72	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55192	10.1371/journal.pone.0055192	http://dx.doi.org/10.1371/journal.pone.0055192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405122	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400067
J	Simonelli, L; Pedotti, M; Beltramello, M; Livoti, E; Calzolai, L; Sallusto, F; Lanzavecchia, A; Varani, L				Simonelli, Luca; Pedotti, Mattia; Beltramello, Martina; Livoti, Elsa; Calzolai, Luigi; Sallusto, Federica; Lanzavecchia, Antonio; Varani, Luca			Rational Engineering of a Human Anti-Dengue Antibody through Experimentally Validated Computational Docking	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; VIRUS ENVELOPE PROTEIN; DOMAIN-III; NEUTRALIZING ANTIBODY; CROSS-REACTIVITY; E-GLYCOPROTEIN; BINDING; DESIGN; ASSIGNMENTS; REVEALS	Antibodies play an increasing pivotal role in both basic research and the biopharmaceutical sector, therefore technology for characterizing and improving their properties through rational engineering is desirable. This is a difficult task thought to require high-resolution x-ray structures, which are not always available. We, instead, use a combination of solution NMR epitope mapping and computational docking to investigate the structure of a human antibody in complex with the four Dengue virus serotypes. Analysis of the resulting models allows us to design several antibody mutants altering its properties in a predictable manner, changing its binding selectivity and ultimately improving its ability to neutralize the virus by up to 40 fold. The successful rational design of antibody mutants is a testament to the accuracy achievable by combining experimental NMR epitope mapping with computational docking and to the possibility of applying it to study antibody/pathogen interactions.	[Simonelli, Luca; Pedotti, Mattia; Beltramello, Martina; Livoti, Elsa; Sallusto, Federica; Lanzavecchia, Antonio; Varani, Luca] Biomed Res Inst, Bellinzona, Switzerland; [Calzolai, Luigi] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, Italy; [Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland	Universita della Svizzera Italiana; European Commission Joint Research Centre; EC JRC ISPRA Site; Swiss Federal Institutes of Technology Domain; ETH Zurich	Varani, L (corresponding author), Biomed Res Inst, Bellinzona, Switzerland.	luca.varani@irb.usi.ch		Simonelli, Luca/0000-0001-6331-7716; Varani, Luca/0000-0002-0963-0987	Canton Ticino; Swiss Vaccine Research Institute; European Union (EU-NMR) [RII3- 622 026145]	Canton Ticino; Swiss Vaccine Research Institute; European Union (EU-NMR)(European Commission)	Funding was provided by Canton Ticino, Swiss Vaccine Research Institute, and European Union (EU-NMR, Contract #RII3- 622 026145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Chaudhury S, 2008, J MOL BIOL, V381, P1068, DOI 10.1016/j.jmb.2008.05.042; Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Huang KC, 2008, PROTEINS, V70, P1116, DOI 10.1002/prot.21806; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Morea V, 2000, METHODS, V20, P267, DOI 10.1006/meth.1999.0921; Park M-S, 2011, PLOS ONE, V6; Pedotti M, 2011, INT J MOL SCI, V12, P226, DOI 10.3390/ijms12010226; Simonelli L, 2010, J MOL BIOL, V396, P1491, DOI 10.1016/j.jmb.2009.12.053; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; Varani L, 2000, NAT STRUCT BIOL, V7, P329; Varani L, 2007, P NATL ACAD SCI USA, V104, P13080, DOI 10.1073/pnas.0703702104; Volk DE, 2007, VIROLOGY, V364, P147, DOI 10.1016/j.virol.2007.02.023; Volk DE, 2006, J BIOMOL NMR, V36, P62, DOI 10.1007/s10858-006-9048-3; Volk DE, 2008, BIOMOL NMR ASSIGN, V2, P155, DOI 10.1007/s12104-008-9109-5; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; WHO, 2009, DENG DENG HAEM FEV; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019	33	29	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55561	10.1371/journal.pone.0055561	http://dx.doi.org/10.1371/journal.pone.0055561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405171	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400116
J	Sun, BY; Ma, L; Yan, XW; Lee, D; Alexander, V; Hohmann, LJ; Lorang, C; Chandrasena, L; Tian, Q; Hood, L				Sun, Bingyun; Ma, Li; Yan, Xiaowei; Lee, Denis; Alexander, Vinita; Hohmann, Laura J.; Lorang, Cynthia; Chandrasena, Lalangi; Tian, Qiang; Hood, Leroy			N-Glycoproteome of E14.Tg2a Mouse Embryonic Stem Cells	PLOS ONE			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; RECEPTOR TYROSINE KINASES; RED-BLOOD-CELLS; MASS-SPECTROMETRY; MEMBRANE-PROTEINS; LYSOSOMAL MEMBRANE; STATISTICAL-MODEL; SURFACE; PROTEOMICS; GLYCOSYLATION	E14.Tg2a mouse embryonic stem (mES) cells are a widely used host in gene trap and gene targeting techniques. Molecular characterization of host cells will provide background information for a better understanding of functions of the knockout genes. Using a highly selective glycopeptide-capture approach but ordinary liquid chromatography coupled mass spectrometry (LC-MS), we characterized the N-glycoproteins of E14.Tg2a cells and analyzed the close relationship between the obtained N-glycoproteome and cell-surface proteomes. Our results provide a global view of cell surface protein molecular properties, in which receptors seem to be much more diverse but lower in abundance than transporters on average. In addition, our results provide a systematic view of the E14.Tg2a N-glycosylation, from which we discovered some striking patterns, including an evolutionarily preserved and maybe functionally selected complementarity between Nglycosylation and the transmembrane structure in protein sequences. We also observed an environmentally influenced Nglycosylation pattern among glycoenzymes and extracellular matrix proteins. We hope that the acquired information enhances our molecular understanding of mES E14.Tg2a as well as the biological roles played by N-glycosylation in cell biology in general.	[Sun, Bingyun; Ma, Li; Yan, Xiaowei; Lee, Denis; Alexander, Vinita; Hohmann, Laura J.; Lorang, Cynthia; Tian, Qiang; Hood, Leroy] Inst Syst Biol, Seattle, WA 98109 USA; [Sun, Bingyun; Chandrasena, Lalangi] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Institute for Systems Biology (ISB); Simon Fraser University	Sun, BY (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	bingyun_sun@sfu.ca; lhood@systemsbiology.org		Alexander, Vinita/0000-0003-1843-5398	NIH (National Institutes of Health) [1U54DA021519, 1U54CA119347]; NIH/NIGMS (National Institute of General Medical Sciences) [1P50GM076547]; NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) [P01 DK53074]; Startup fund from Simon Fraser University; NATIONAL CANCER INSTITUTE [U54CA119347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS (National Institute of General Medical Sciences); NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases); Startup fund from Simon Fraser University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This publication was made possible by Grant Numbers 1U54DA021519 and 1U54CA119347 from NIH (National Institutes of Health), 1P50GM076547 from NIH/NIGMS (National Institute of General Medical Sciences), P01 DK53074 from NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases), and LC is supported by the Startup fund from Simon Fraser University. The contents here are solely the responsibility of the authors and do not necessarily represent the official views of the NIH and Simon Fraser University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 1998, JPN J PHARMACOL, V78, P113, DOI 10.1254/jjp.78.113; Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Araki R, 2006, STEM CELLS, V24, P2522, DOI 10.1634/stemcells.2006-0005; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bond MR, 2007, CURR OPIN CHEM BIOL, V11, P52, DOI 10.1016/j.cbpa.2006.11.032; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burnstock G, 2002, CLIN MED, V2, P45, DOI 10.7861/clinmedicine.2-1-45; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; CARR SA, 1986, ANAL BIOCHEM, V157, P396, DOI 10.1016/0003-2697(86)90643-3; Cheung JC, 2007, METHODS, V41, P451, DOI 10.1016/j.ymeth.2006.10.002; Christopherson KW, 2002, J IMMUNOL, V169, P7000, DOI 10.4049/jimmunol.169.12.7000; Chu VT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r118; CRIMAUDO C, 1987, EMBO J, V6, P75, DOI 10.1002/j.1460-2075.1987.tb04721.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Dodds ED, 2012, MASS SPECTROM REV; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dormeyer W, 2008, PROTEOMICS, V8, P4036, DOI 10.1002/pmic.200800143; Downing GJ, 2004, STEM CELLS, V22, P1168, DOI 10.1634/stemcells.2004-0101; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fisher CE, 2006, DEV BIOL, V296, P279, DOI 10.1016/j.ydbio.2006.06.007; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Gajera CR, 2010, J CELL SCI, V123, P1922, DOI 10.1242/jcs.065912; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Gundry RL, 2011, PROTEOMICS, V11, P3947, DOI 10.1002/pmic.201100100; Haffner C, 2004, EMBO J, V23, P3041, DOI 10.1038/sj.emboj.7600307; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; HILTON DJ, 1992, J BIOL CHEM, V267, P10238; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hsu VW, 2010, CURR OPIN CELL BIOL, V22, P528, DOI 10.1016/j.ceb.2010.05.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jank H, 2011, THESCIENTIFICWORLDJO, V11, P173, DOI 10.1100/tsw.2011.25; JENNINGS ML, 1989, ANNU REV BIOPHYS BIO, V18, P397, DOI 10.1146/annurev.bb.18.060189.002145; Jensen ON, 2000, MODIFICATION SPECIFI; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Lauc G, 2010, MOL BIOSYST, V6, P329, DOI 10.1039/b910377e; Lazar IM, 2011, ELECTROPHORESIS, V32, P3, DOI 10.1002/elps.201000393; Ledermann B, 2000, EXP PHYSIOL, V85, P603, DOI 10.1017/S0958067000021059; LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001; Li QR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001750; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma L, 2007, CLIN CHIM ACTA, V378, P24, DOI 10.1016/j.cca.2006.12.016; MacKenzie AB, 1999, ANN NY ACAD SCI, V868, P716, DOI 10.1111/j.1749-6632.1999.tb11351.x; Mann M, 2008, P NATL ACAD SCI USA, V105, P18132, DOI 10.1073/pnas.0800788105; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Mastrangelo L, 2012, P NATL ACAD SCI USA, V109, P3377, DOI 10.1073/pnas.1118067109; Mataftsi A, 2007, INVEST OPHTH VIS SCI, V48, P5160, DOI 10.1167/iovs.06-1013; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Nagano K, 2008, PROTEOMICS, V8, P4025, DOI 10.1002/pmic.200800073; NEISS WF, 1984, HISTOCHEMISTRY, V80, P603, DOI 10.1007/BF00553724; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; NILSSON I, 1993, J BIOL CHEM, V268, P5798; North SJ, 2009, CURR OPIN STRUC BIOL, V19, P498, DOI 10.1016/j.sbi.2009.05.005; Nunomura K, 2005, MOL CELL PROTEOMICS, V4, P1968, DOI 10.1074/mcp.M500216-MCP200; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Ponten F, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.93; Ramos H, 2008, BIOINFORMATICS, V24, P2110, DOI 10.1093/bioinformatics/btn363; Rugg-Gunn PJ, 2012, DEV CELL, V22, P887, DOI 10.1016/j.devcel.2012.01.005; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith KA, 2011, DEVELOPMENT, V138, P4193, DOI 10.1242/dev.065375; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Sun BY, 2007, MOL CELL PROTEOMICS, V6, P141, DOI 10.1074/mcp.T600046-MCP200; Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597; Tissot B, 2009, FEBS LETT, V583, P1728, DOI 10.1016/j.febslet.2009.03.049; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Willekens FLA, 2005, BLOOD, V105, P2141, DOI 10.1182/blood-2004-04-1578; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Yamamoto-Katayama S, 2001, BIOCHEM J, V357, P385, DOI 10.1042/0264-6021:3570385	89	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55722	10.1371/journal.pone.0055722	http://dx.doi.org/10.1371/journal.pone.0055722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405203	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400148
J	Xiao, SJ; Hu, PP; Chen, LQ; Zhen, SJ; Peng, L; Li, YF; Huang, CZ				Xiao, Sai Jin; Hu, Ping Ping; Chen, Li Qiang; Zhen, Shu Jun; Peng, Li; Li, Yuan Fang; Huang, Cheng Zhi			A Visual Dual-Aptamer Logic Gate for Sensitive Discrimination of Prion Diseases-Associated Isoform with Reusable Magnetic Microparticles and Fluorescence Quantum Dots	PLOS ONE			English	Article							PROTEIN; CONFORMATION; RECOGNITION	Molecular logic gates, which have attracted increasing research interest and are crucial for the development of molecular-scale computers, simplify the results of measurements and detections, leaving the diagnosis of disease either "yes'' or "no''. Prion diseases are a group of fatal neurodegenerative disorders that happen in human and animals. The main problem with a diagnosis of prion diseases is how to sensitively and selectively discriminate and detection of the minute amount of PrPRes in biological samples. Our previous work had demonstrated that dual-aptamer strategy could achieve highly sensitive and selective discrimination and detection of prion protein (cellular prion protein, PrPC, and the diseases associated isoform, PrPRes) in serum and brain. Inspired by the advantages of molecular logic gate, we further conceived a new concept for dual-aptamer logic gate that responds to two chemical input signals (PrPC or PrPRes and Gdn-HCl) and generates a change in fluorescence intensity as the output signal. It was found that PrPRes performs the "OR'' logic operation while PrPC performs "XOR'' logic operation when they get through the gate consisted of aptamer modified reusable magnetic microparticles (MMPs-Apt1) and quantum dots (QDs-Apt2). The dual-aptamer logic gate simplifies the discrimination results of PrPRes, leaving the detection of PrPRes either "yes'' or "no''. The development of OR logic gate based on dual-aptamer strategy and two chemical input signals (PrPRes and Gdn-HCl) is an important step toward the design of prion diseases diagnosis and therapy systems.	[Xiao, Sai Jin; Zhen, Shu Jun; Li, Yuan Fang; Huang, Cheng Zhi] Southwest Univ, Coll Chem & Chem Engn, Educ Minist, Key Lab Luminescence & Real Time Anal, Chongqing, Peoples R China; [Xiao, Sai Jin] E China Inst Technol, Dept Appl Chem, Jiangxi Key Lab Mass Spectrometry & Instrumentat, Nanchang, Jiangxi, Peoples R China; [Hu, Ping Ping; Chen, Li Qiang; Peng, Li] Southwest Univ, Coll Life Sci, Chongqing, Peoples R China; [Huang, Cheng Zhi] Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China	Southwest University - China; East China University of Technology; Southwest University - China; Southwest University - China	Huang, CZ (corresponding author), Southwest Univ, Coll Chem & Chem Engn, Educ Minist, Key Lab Luminescence & Real Time Anal, Chongqing, Peoples R China.	chengzhi@swu.edu.cn	Li, Yuan/GXV-1310-2022	Chen, Liqiang/0000-0001-5430-4585	Ministry of Science and Technology of the People's Republic of China [2011CB933600]; National Natural Science Foundation of China (NSFC) [21035005]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Ministry of Science and Technology of the People's Republic of China (No. 2011CB933600) and the National Natural Science Foundation of China (NSFC, 21035005). The funders had no role in study design, data, collection and analysis, decision to publish, or preparation of the manuscript.	Benenson Y, 2009, CURR OPIN BIOTECH, V20, P471, DOI 10.1016/j.copbio.2009.08.002; Bibby DF, 2010, J VIROL METHODS, V151, P107; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Chang BG, 2008, J NEUROIMMUNOL, V205, P94, DOI 10.1016/j.jneuroim.2008.09.013; Chen LQ, 2012, ANAL CHEM, V84, P3099, DOI 10.1021/ac202810b; Chen LQ, 2010, J PHYS CHEM B, V114, P3655, DOI 10.1021/jp9104618; Chen X, 2006, ANGEW CHEM INT EDIT, V45, P1759, DOI 10.1002/anie.200502511; Coleman BM, 2009, BIOCHEM BIOPH RES CO, V380, P564, DOI 10.1016/j.bbrc.2009.01.120; Deng Y, 2008, J AM CHEM SOC, V130, P28, DOI 10.1021/ja0777584; Deonarine AS, 2003, FUTURE GENER COMP SY, V19, P87, DOI 10.1016/S0167-739X(02)00110-3; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Fujii F, 2007, ANAL BIOCHEM, V370, P131, DOI 10.1016/j.ab.2007.07.018; Gilch S, 2009, CELL MOL LIFE SCI, V66, P2445, DOI 10.1007/s00018-009-0031-5; Goulko AA, 2009, TRAC-TREND ANAL CHEM, V28, P878, DOI 10.1016/j.trac.2009.03.014; Grassi J, 2008, VET RES, V39, DOI 10.1051/vetres:2008009; Heyduk E, 2005, ANAL CHEM, V77, P1147, DOI 10.1021/ac0487449; Hu P, 2008, ANAL CHEM, V80, P1819, DOI 10.1021/ac702187y; Huang CC, 2009, ANAL CHEM, V81, P875, DOI 10.1021/ac8010654; Koneracka M, 1999, J MAGN MAGN MATER, V201, P427, DOI 10.1016/S0304-8853(99)00005-0; Konry T, 2009, J AM CHEM SOC, V131, P13232, DOI 10.1021/ja905125b; Krafft C, 2009, J BIOPHOTONICS, V2, P13, DOI 10.1002/jbio.200810024; Leliveld SR, 2007, J NEUROSCI RES, V85, P2285, DOI 10.1002/jnr.21353; Li CX, 2011, CHEM COMMUN, V47, P4442, DOI 10.1039/c1cc10544b; Liu ZL, 2002, J MATER SYNTH PROCES, V10, P83, DOI 10.1023/A:1021231527095; Margulies D, 2005, NAT MATER, V4, P768, DOI 10.1038/nmat1469; Miyoshi D, 2006, ANGEW CHEM INT EDIT, V45, P7716, DOI 10.1002/anie.200602404; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; Qu DH, 2005, ANGEW CHEM INT EDIT, V44, P5296, DOI 10.1002/anie.200501215; Silva-Rocha R, 2008, FEBS LETT, V582, P1237, DOI 10.1016/j.febslet.2008.01.060; Soto C, 2004, NAT REV MICROBIOL, V2, P809, DOI 10.1038/nrmicro1003; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Takemura K, 2006, EXP BIOL MED, V231, P204; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; Xiao SJ, 2010, ANAL CHEM, V82, P9736, DOI 10.1021/ac101865s; Yu SL, 2004, EUR J HUM GENET, V12, P867, DOI 10.1038/sj.ejhg.5201245; Zhang YL, 2007, J AM CHEM SOC, V129, P15448, DOI 10.1021/ja0773047; Zichel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031948	39	14	14	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e53935	10.1371/journal.pone.0053935	http://dx.doi.org/10.1371/journal.pone.0053935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393552	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800006
J	Xu, CL; Iuliano, AD; Chen, M; Cheng, PY; Chen, T; Shi, JH; Yang, J; Wang, LJ; Yuan, F; Widdowson, MA; Shu, YL				Xu, Cuiling; Iuliano, A. Danielle; Chen, Min; Cheng, Po-Yung; Chen, Tao; Shi, Jinghong; Yang, Jing; Wang, Lijie; Yuan, Fan; Widdowson, Marc-Alain; Shu, Yuelong			Characteristics of Hospitalized Cases with Influenza A (H1N1) pdm09 Infection during First Winter Season of Post-Pandemic in China	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; RISK-FACTORS; A(H1N1); MORTALITY; OBESITY; DEATH	Background: Influenza A (H1N1)pdm09 (2009 H1N1) re-circulated as the predominant virus from January through February 2011 in China. National surveillance of 2009 H1N1 as a notifiable disease was maintained to monitor potential changes in disease severity from the previous season. Methodology/Principal Findings: To describe the characteristics of hospitalized cases with 2009 H1N1 infection and analyze risk factors for severe illness during the 2010-2011winter season in China, we obtained surveillance data from hospitalized cases with 2009 H1N1 infection from November 2010 through May 2011, and reviewed medical records from 701 hospitalized cases. Age-standardized risk ratios were used to compare the age distribution of patients that were hospitalized and died due to 2009 H1N1 between the 2010-2011winter season to those during the 2009-2010 pandemic period. During the 2010-2011 winter season, children less than 5 years of age had the highest relative risk of hospitalization and death, followed by adults aged 65 years or older. Additionally, the relative risk of hospitalized cases aged 5-14 and 15-24 years was lower compared to children less than 5 years of age. During the winter season of 2010-2011, the proportions of adults aged 25 years or older for hospitalization and death were significantly higher than those during the 2009-2010 pandemic period. Being male, having a chronic medical condition, delayed hospital admission (>= 3 days from onset) or delayed initiation of antiviral treatment (>= 5 days from onset) were associated with severe illness among non-pregnant patients >= 2 years of age. Conclusions/Significance: We observed a change in high risk groups for hospitalization for 2009 H1N1 during the winter months immediately following the pandemic period compared to the high risk groups identified during the pandemic period. Our nationally notifiable disease surveillance system enabled us to understand the evolving epidemiology of 2009 H1N1 infection after the pandemic period.	[Xu, Cuiling; Chen, Min; Chen, Tao; Shi, Jinghong; Yang, Jing; Wang, Lijie; Yuan, Fan; Shu, Yuelong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Infect Dis Control & Prevent, Beijing, Peoples R China; [Iuliano, A. Danielle; Cheng, Po-Yung; Widdowson, Marc-Alain] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA	Shu, YL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Infect Dis Control & Prevent, Beijing, Peoples R China.	yshu@cnic.org.cn		Widdowson, Marc-Alain/0000-0002-0682-6933	Ministry of Health, China	Ministry of Health, China	We thank the participating hospitals, local health departments and Centers for Disease Control and Prevention in China for assistance in coordinating data collection, and the Ministry of Health, China for supporting this study.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P222; Athanasiou M, 2011, EUROSURVEILLANCE, V16, P14; Bolotin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030279; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Chinese National Influenza Center, 2011, CHINESE INFLUENZA WE; Choi Won-Il, 2011, BMC Res Notes, V4, P351, DOI 10.1186/1756-0500-4-351; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; EuroFlu, 2011, EUROFLU WEEKLY ELECT, V2; Fuhrman C, 2010, EUROSURVEILLANCE, V15, P17; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hanslik T., 2010, PLOS CURR-TREE LIFE, V2, DOI [10.1371/currents.RRN1150, DOI 10.1371/CURRENTS.RRN1150]; Health Protection Agency, 2011, WEEKLY NATIONAL INFL; Hong Kong Center for Health Protection, 2011, FLU EXPRESS, V8; Jeon MH, 2011, DIAGN MICR INFEC DIS, V70, P230, DOI 10.1016/j.diagmicrobio.2011.01.005; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Li Hui, 2009, Zhonghua Er Ke Za Zhi, V47, P493; Liu B, 2002, CHINA PUBLIC HLTH, V18, P890; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; National Bureau of Statistics of China, 2009, CHINA STATISTICAL YE; National Institute of Infectious Diseases, 2011, INFECT AGENTS SURVEI; Pebody RG, 2010, EUROSURVEILLANCE, V15; Santa-Olalla Peralta P, 2010, EUROSURVEILLANCE, V15; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Wang LD, 2005, COMPREHENSIVE REPORT, P50; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; World Health Organization, 2010, EVOLUTION OF A PANDE; World Health Organization (WHO), 2010, WORLD NOW START 2009; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55016	10.1371/journal.pone.0055016	http://dx.doi.org/10.1371/journal.pone.0055016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393563	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800017
J	Stirbat, TV; Mgharbel, A; Bodennec, S; Ferri, K; Mertani, HC; Rieu, JP; Delanoe-Ayari, H				Stirbat, Tomita Vasilica; Mgharbel, Abbas; Bodennec, Selena; Ferri, Karine; Mertani, Hichem C.; Rieu, Jean-Paul; Delanoe-Ayari, Helene			Fine Tuning of Tissues' Viscosity and Surface Tension through Contractility Suggests a New Role for alpha-Catenin	PLOS ONE			English	Article							CELL-CELL; E-CADHERIN; EMBRYONIC-TISSUES; LOCAL CONCENTRATION; ADHERENS JUNCTIONS; BETA-CATENIN; ADHESION; ACTIN; MECHANISM; RHO	What governs tissue organization and movement? If molecular and genetic approaches are able to give some answers on these issues, more and more works are now giving a real importance to mechanics as a key component eventually triggering further signaling events. We chose embryonic cell aggregates as model systems for tissue organization and movement in order to investigate the origin of some mechanical constraints arising from cells organization. Steinberg et al. proposed a long time ago an analogy between liquids and tissues and showed that indeed tissues possess a measurable tissue surface tension and viscosity. We question here the molecular origin of these parameters and give a quantitative measurement of adhesion versus contractility in the framework of the differential interfacial tension hypothesis. Accompanying surface tension measurements by angle measurements (at vertexes of cell-cell contacts) at the cell/medium interface, we are able to extract the full parameters of this model: cortical tensions and adhesion energy. We show that a tunable surface tension and viscosity can be achieved easily through the control of cell-cell contractility compared to cell-medium one. Moreover we show that alpha-catenin is crucial for this regulation to occur: these molecules appear as a catalyser for the remodeling of the actin cytoskeleton underneath cell-cell contact, enabling a differential contractility between the cell-medium and cell-cell interface to take place.	[Stirbat, Tomita Vasilica; Mgharbel, Abbas; Bodennec, Selena; Ferri, Karine; Rieu, Jean-Paul; Delanoe-Ayari, Helene] Univ Lyon 1, CNRS, UMR5306, Inst Lumiere Mat, F-69365 Lyon, France; [Mertani, Hichem C.] Univ Lyon 1, CNRS, INSERM U1052,UMR 5286, Ctr Rech Cancerol Lyon,Ctr Leon Berard, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard	Delanoe-Ayari, H (corresponding author), Univ Lyon 1, CNRS, UMR5306, Inst Lumiere Mat, F-69365 Lyon, France.	helene.ayari@univ-lyon1.fr	Delanoe-ayari, Helene/A-2085-2013; MERTANI, Hichem-Claude/AAR-6415-2020	Delanoe-ayari, Helene/0000-0002-8658-3942; 	Agence Nationale de la Recherche [ANR JCJC 2005]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche (ANR JCJC 2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Brevier J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.268101; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Douezan S, 2011, P NATL ACAD SCI USA, V108, P7315, DOI 10.1073/pnas.1018057108; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Evans EA, 1995, HDB BIOL PHYS A&B, V1, P723; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Foty RA, 1996, DEVELOPMENT, V122, P1611; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Frenkel J., 1945, J PHYS, V9, P385; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; GORDON R, 1972, J THEOR BIOL, V37, P43, DOI 10.1016/0022-5193(72)90114-2; Guevorkian K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218101; HARRIS AK, 1976, J THEOR BIOL, V61, P267, DOI 10.1016/0022-5193(76)90019-9; Hegedus B, 2006, BIOPHYS J, V91, P2708, DOI 10.1529/biophysj.105.077834; Jakab K, 2008, DEV DYNAM, V237, P2438, DOI 10.1002/dvdy.21684; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Kafer J, 2008, THESIS; Kalantarian A, 2009, BIOPHYS J, V96, P1606, DOI 10.1016/j.bpj.2008.10.064; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Li ZX, 2010, J PHYS CHEM B, V114, P2894, DOI 10.1021/jp906737q; Loomis WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042033; Maeno Y, 1999, AM J PATHOL, V154, P1323, DOI 10.1016/S0002-9440(10)65385-0; Maitre JL, 2012, SCIENCE NEW YORK NY, V253; Marmottant P, 2009, P NATL ACAD SCI USA, V106, P17271, DOI 10.1073/pnas.0902085106; Mgharbel A, 2009, HFSP J, V3, P213, DOI 10.2976/1.3116822; Miyaguchi K, 2000, J STRUCT BIOL, V132, P169, DOI 10.1006/jsbi.2000.4244; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Papusheva E, 2010, EMBO J, V29, P2753, DOI 10.1038/emboj.2010.182; Pokluda O, 1997, AICHE J, V43, P3253, DOI 10.1002/aic.690431213; Prakasam AK, 2006, P NATL ACAD SCI USA, V103, P15434, DOI 10.1073/pnas.0606701103; Rauzi M, 2011, CURR TOP DEV BIOL, V95, P93, DOI 10.1016/B978-0-12-385065-2.00004-9; Shaler A, 1949, METALS T, V185, P796; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shi QM, 2008, J BIOL CHEM, V283, P28454, DOI 10.1074/jbc.M802563200; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yonemura S, 2011, CURRENT OPINION CELL; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhang JK, 2005, J CELL SCI, V118, P5549, DOI 10.1242/jcs.02639	51	53	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e52554	10.1371/journal.pone.0052554	http://dx.doi.org/10.1371/journal.pone.0052554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390488	Green Submitted, Green Published, gold			2022-12-25	WOS:000314691100004
J	Wood, NI; McAllister, CJ; Cuesta, M; Aungier, J; Fraenkel, E; Morton, AJ				Wood, Nigel I.; McAllister, Catherine J.; Cuesta, Marc; Aungier, Juliet; Fraenkel, Eloise; Morton, A. Jennifer			Adaptation to Experimental Jet-Lag in R6/2 Mice despite Circadian Dysrhythmia	PLOS ONE			English	Article							HUNTINGTONS-DISEASE MUTATION; TRANSGENIC MOUSE MODEL; SLEEP DISTURBANCES; GENE-EXPRESSION; CLOCK; DYSREGULATION; DISRUPTION; RESPONSES; DEFICITS; LIGHT	The R6/2 transgenic mouse model of Huntington's disease (HD) shows a disintegration of circadian rhythms that can be delayed by pharmacological and non-pharmacological means. Since the molecular machinery underlying the circadian clocks is intact, albeit progressively dysfunctional, we wondered if light phase shifts could modulate the deterioration in daily rhythms in R6/2 mice. Mice were subjected to four x 4 hour advances in light onset. R6/2 mice adapted to phase advances, although angles of entrainment increased with age. A second cohort was subjected to a jet-lag paradigm (6 hour delay or advance in light onset, then reversal after 2 weeks). R6/2 mice adapted to the original shift, but could not adjust accurately to the reversal. Interestingly, phase shifts ameliorated the circadian rhythm breakdown seen in R6/2 mice under normal LD conditions. Our previous finding that the circadian period (tau) of 16 week old R6/2 mice shortens to approximately 23 hours may explain how they adapt to phase advances and maintain regular circadian rhythms. We tested this using a 23 hour period light/dark cycle. R6/2 mice entrained to this cycle, but onsets of activity continued to advance, and circadian rhythms still disintegrated. Therefore, the beneficial effects of phase-shifting are not due solely to the light cycle being closer to the tau of the mice. Our data show that R6/2 mice can adapt to changes in the LD schedule, even beyond the age when their circadian rhythms would normally disintegrate. Nevertheless, they show abnormal responses to changes in light cycles. These might be caused by a shortened tau, impaired photic re-synchronization, impaired light detection and/or reduced masking by evening light. If similar abnormalities are present in HD patients, they may suffer exaggerated jet-lag. Since the underlying molecular clock mechanism remains intact, light may be a useful treatment for circadian dysfunction in HD.	[Wood, Nigel I.; McAllister, Catherine J.; Cuesta, Marc; Aungier, Juliet; Fraenkel, Eloise; Morton, A. Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge	Morton, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	ajm41@cam.ac.uk	Morton, Jenny/AAT-8642-2020	Morton, Jenny/0000-0003-0181-6346; McAllister, Catherine/0000-0001-6147-6449; Aungier, Juliet/0000-0002-9144-5026	CHDI Foundation, Inc.	CHDI Foundation, Inc.	This work was supported by a grant to AJM from CHDI Foundation, Inc. (http://www.highqfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHOFF J, 1984, ANN NY ACAD SCI, V423, P442, DOI 10.1111/j.1749-6632.1984.tb23452.x; Aziz NA, 2009, J NEUROL, V256, P1961, DOI 10.1007/s00415-009-5196-1; Carter RJ, 1999, J NEUROSCI, V19, P3248; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cho KW, 2001, NAT NEUROSCI, V4, P567, DOI 10.1038/88384; Christofides J, 2006, J NEUROCHEM, V97, P1078, DOI 10.1111/j.1471-4159.2006.03807.x; Ciarnei A, 2008, NEUROBIOL LEARN MEM, V89, P533, DOI 10.1016/j.nlm.2007.10.009; Cuesta M, 2012, NEUROBIOL DIS, V45, P145, DOI 10.1016/j.nbd.2011.07.016; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Dodson ER, 2010, SLEEP MED CLIN, V5, DOI 10.1016/j.jsmc.2010.08.001; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; Harrington M, 2010, J CLIN INVEST, V120, P2265, DOI 10.1172/JCI43632; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Kudo T, 2011, EXP NEUROL, V228, P80, DOI 10.1016/j.expneurol.2010.12.011; Lione LA, 1999, J NEUROSCI, V19, P10428; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Maywood ES, 2010, J NEUROSCI, V30, P10199, DOI 10.1523/JNEUROSCI.1694-10.2010; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Most EIS, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-19; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Pallier PN, 2007, J NEUROSCI, V27, P7869, DOI 10.1523/JNEUROSCI.0649-07.2007; Penev PD, 1998, AM J PHYSIOL-HEART C, V275, pH2334; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Reddy AB, 2002, J NEUROSCI, V22, P7326; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; SIEGEL PV, 1969, SCIENCE, V164, P1249, DOI 10.1126/science.164.3885.1249; Vitiello MV, 2001, CNS DRUGS, V15, P777, DOI 10.2165/00023210-200115100-00004	30	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55036	10.1371/journal.pone.0055036	http://dx.doi.org/10.1371/journal.pone.0055036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390510	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100026
J	Brzoska, T; Suzuki, Y; Mogami, H; Sano, H; Urano, T				Brzoska, Tomasz; Suzuki, Yuko; Mogami, Hideo; Sano, Hideto; Urano, Tetsumei			Binding of Thrombin-Activated Platelets to a Fibrin Scaffold through alpha(IIb)beta(3) Evokes Phosphatidylserine Exposure on Their Cell Surface	PLOS ONE			English	Article							GLYCOPROTEIN-IIB-IIIA; ANTICOAGULANT PROTEIN-I; AMINOPHOSPHOLIPID EXPOSURE; INTEGRIN ALPHA(IIB)BETA(3); CONFORMATIONAL-CHANGES; PROCOAGULANT ACTIVITY; BLOOD-COAGULATION; TERMINAL PORTION; SCOTT-SYNDROME; ANNEXIN-V	Recently, by employing intra-vital confocal microscopy, we demonstrated that platelets expose phosphatidylserine ( PS) and fibrin accumulate only in the center of the thrombus but not in its periphery. To address the question how exposure of platelet anionic phospholipids is regulated within the thrombus, an in-vitro experiment using diluted platelet-rich plasma was employed, in which the fibrin network was formed in the presence of platelets, and PS exposure on the platelet surface was analyzed using Confocal Laser Scanning Microscopy. Almost all platelets exposed PS after treatment with tissue factor, thrombin or ionomycin. Argatroban abrogated fibrin network formation in all samples, however, platelet PS exposure was inhibited only in tissue factor- and thrombin-treated samples but not in ionomycin-treated samples. FK633, an alpha(IIb)beta(3) antagonist, and cytochalasin B impaired platelet binding to the fibrin scaffold and significantly reduced PS exposure evoked by thrombin. Gly-Pro-Arg-Pro amide abrogated not only fibrin network formation, but also PS exposure on platelets without suppressing platelet binding to fibrin/fibrinogen. These results suggest that outside-in signals in platelets generated by their binding to the rigid fibrin network are essential for PS exposure after thrombin treatment.	[Brzoska, Tomasz; Suzuki, Yuko; Sano, Hideto; Urano, Tetsumei] Hamamatsu Univ Sch Med, Dept Med Physiol, Hamamatsu, Shizuoka 4313192, Japan; [Mogami, Hideo] Hamamatsu Univ, Dept Hlth & Nutr Sci, Fac Hlth Promot Sci, Hamamatsu, Shizuoka, Japan; [Mogami, Hideo] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Japan Science & Technology Agency (JST)	Urano, T (corresponding author), Hamamatsu Univ Sch Med, Dept Med Physiol, Hamamatsu, Shizuoka 4313192, Japan.	uranot@hama-med.ac.jp	Sano, Hideto/GZM-5074-2022	Sano, Hideto/0000-0002-4185-3224; Urano, Tetsumei/0000-0002-7398-9732	Japan Society for the Promotion of Science (JSPS) [C:22590826, C:21590230]; Smoking Research Foundation; Grants-in-Aid for Scientific Research [24590273] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (C:22590826[YS] and C:21590230[TU]) from the Japan Society for the Promotion of Science (JSPS), and by a grant from the Smoking Research Foundation (TU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1998, BIOCHEMISTRY-US, V37, P1640, DOI 10.1021/bi972350c; ADELMAN B, 1990, CIRC RES, V67, P941, DOI 10.1161/01.RES.67.4.941; Aoki T, 1999, CARDIOVASC DRUG REV, V17, P147, DOI 10.1111/j.1527-3466.1999.tb00010.x; Basani RB, 2001, J BIOL CHEM, V276, P13975, DOI 10.1074/jbc.M011511200; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Budel S, 2001, AM J PHYSIOL-HEART C, V281, pH1156, DOI 10.1152/ajpheart.2001.281.3.H1156; CHEN YP, 1994, BLOOD, V84, P1857; DACHARYPRIGENT J, 1993, BLOOD, V81, P2554; Diaz-Ricart M, 2002, AM J PATHOL, V160, P329, DOI 10.1016/S0002-9440(10)64376-3; Dicker IB, 2001, THROMB HAEMOSTASIS, V86, P1065; Fox JEB, 1996, J BIOL CHEM, V271, P7004, DOI 10.1074/jbc.271.12.7004; Hayashi T, 2008, PFLUG ARCH EUR J PHY, V456, P1239, DOI 10.1007/s00424-008-0466-9; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Honda S, 1998, BLOOD, V92, P3675, DOI 10.1182/blood.V92.10.3675.422k38_3675_3683; Kasatkina L, 2010, NEUROCHEM INT, V56, P711, DOI 10.1016/j.neuint.2010.02.008; KAWASAKI K, 1993, CHEM PHARM BULL, V41, P975; LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085; Leung R, 2007, J THROMB HAEMOST, V5, P560, DOI 10.1111/j.1538-7836.2007.02354.x; LIPP P, 1993, CELL CALCIUM, V14, P359, DOI 10.1016/0143-4160(93)90040-D; MASSINI P, 1980, BIOCHIM BIOPHYS ACTA, V598, P575, DOI 10.1016/0005-2736(80)90037-1; Matsumoto Y, 1999, THROMB RES, V95, P19, DOI 10.1016/S0049-3848(98)00189-3; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; PLOW EF, 1982, P NATL ACAD SCI-BIOL, V79, P3711, DOI 10.1073/pnas.79.12.3711; Razmara M, 2007, CELL MOL LIFE SCI, V64, P999, DOI 10.1007/s00018-007-6546-8; Reutelingsperger CPM, 2001, THROMB HAEMOSTASIS, V86, P413; Reverter JC, 1996, J CLIN INVEST, V98, P863, DOI 10.1172/JCI118859; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SMITH JW, 1990, J BIOL CHEM, V265, P12267; Suehiro K, 1997, J BIOL CHEM, V272, P5360, DOI 10.1074/jbc.272.8.5360; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; TAIT JF, 1989, J BIOL CHEM, V264, P7944; Tanaka KA, 2009, ANESTH ANALG, V108, P1433, DOI 10.1213/ane.0b013e31819bcc9c; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; van der Meijden PEJ, 2012, CELL MOL LIFE SCI, V69, P3481, DOI 10.1007/s00018-012-1033-2; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Weiss HJ, 1997, BLOOD, V89, P1599, DOI 10.1182/blood.V89.5.1599.1599_1599_1611; Yeh RW, 2006, AM HEART J, V151, P1131, DOI 10.1016/j.ahj.2005.09.002; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	41	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55466	10.1371/journal.pone.0055466	http://dx.doi.org/10.1371/journal.pone.0055466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383331	Green Published, gold, Green Submitted			2022-12-25	WOS:000314597900038
J	Murakami, KS				Murakami, Katsuhiko S.			X-ray Crystal Structure of Escherichia coli RNA Polymerase sigma(70) Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR-DEPENDENT TRANSCRIPTION; C-TERMINAL DOMAIN; ALPHA-SUBUNIT; OMEGA-SUBUNIT; ANGSTROM RESOLUTION; DNA-BINDING; SEQUENCE INSERTIONS; INITIATION; PROMOTER; PPGPP	Escherichia coli RNA polymerase (RNAP) is the most studied bacterial RNAP and has been used as the model RNAP for screening and evaluating potential RNAP-targeting antibiotics. However, the x-ray crystal structure of E. coli RNAP has been limited to individual domains. Here, I report the x-ray structure of the E. coli RNAP sigma(70) holoenzyme, which shows sigma region 1.1 (sigma(1.1)) and the alpha subunit C-terminal domain for the first time in the context of an intact RNAP. sigma(1.1) is positioned at the RNAP DNA-binding channel and completely blocks DNA entry to the RNAP active site. The structure reveals that sigma(1.1) contains a basic patch on its surface, which may play an important role in DNA interaction to facilitate open promoter complex formation. The alpha subunit C-terminal domain is positioned next to sigma domain 4 with a fully stretched linker between the N- and C-terminal domains. E. coli RNAP crystals can be prepared from a convenient overexpression system, allowing further structural studies of bacterial RNAP mutants, including functionally deficient and antibiotic-resistant RNAPs.	Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA.	kum14@psu.edu		Murakami, Katsuhiko/0000-0003-2244-0501	National Institutes of Health Grant [GM087350-A1]; Center of Excellence of the Japan Society for the Promotion of Science; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087350] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence of the Japan Society for the Promotion of Science; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087350-A1. This work was also supported by a research fellowship from the Center of Excellence of the Japan Society for the Promotion of Science and a long-term postdoctoral research fellowship from the Human Frontier Science Program.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Belogurov GA, 2009, NATURE, V457, P332, DOI 10.1038/nature07510; Blanco AG, 2011, EMBO J, V30, P3776, DOI 10.1038/emboj.2011.271; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; Brueckner F, 2009, CURR OPIN STRUC BIOL, V19, P294, DOI 10.1016/j.sbi.2009.04.005; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2005, EMBO J, V24, P674, DOI 10.1038/sj.emboj.7600499; CASHEL M, 1969, J BIOL CHEM, V244, P3133; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Chatterji D, 2007, FEMS MICROBIOL LETT, V267, P51, DOI 10.1111/j.1574-6968.2006.00532.x; Chen H, 2003, MOL CELL, V11, P1621, DOI 10.1016/S1097-2765(03)00201-6; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita N, 1996, METHOD ENZYMOL, V273, P121; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; Ho MX, 2009, CURR OPIN STRUC BIOL, V19, P715, DOI 10.1016/j.sbi.2009.10.010; Hudson BP, 2009, P NATL ACAD SCI USA, V106, P19830, DOI 10.1073/pnas.0908782106; Hurwitz J, 2005, J BIOL CHEM, V280, P42477, DOI 10.1074/jbc.X500006200; IGARASHI K, 1989, NUCLEIC ACIDS RES, V17, P8755, DOI 10.1093/nar/17.21.8755; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Larson MH, 2011, MOL CELL, V41, P249, DOI 10.1016/j.molcel.2011.01.008; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Mathew R, 2006, TRENDS MICROBIOL, V14, P450, DOI 10.1016/j.tim.2006.08.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mukherjee K, 1999, EUR J BIOCHEM, V266, P228, DOI 10.1046/j.1432-1327.1999.00848.x; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ross W, 2003, GENE DEV, V17, P1293, DOI 10.1101/gad.1079403; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwartz EC, 2008, CHEM BIOL, V15, P1091, DOI 10.1016/j.chembiol.2008.09.008; Svetlov V, 2009, CURR OPIN STRUC BIOL, V19, P701, DOI 10.1016/j.sbi.2009.10.002; Tang H, 1996, METHOD ENZYMOL, V273, P130; Tebbutt J, 2002, FEMS MICROBIOL LETT, V210, P55, DOI 10.1016/S0378-1097(02)00586-4; Terui Y, 2012, INT J BIOCHEM CELL B, V44, P412, DOI 10.1016/j.biocel.2011.11.017; Tupin A, 2010, EMBO J, V29, P2527, DOI 10.1038/emboj.2010.135; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vrentas CE, 2008, J MOL BIOL, V377, P551, DOI 10.1016/j.jmb.2008.01.042; Vrentas CE, 2005, GENE DEV, V19, P2378, DOI 10.1101/gad.344505; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262	59	131	136	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9126	9134		10.1074/jbc.M112.430900	http://dx.doi.org/10.1074/jbc.M112.430900			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23389035	Green Published, hybrid			2022-12-25	WOS:000316862200032
J	Goult, BT; Zacharchenko, T; Bate, N; Tsang, R; Hey, F; Gingras, AR; Elliott, PR; Roberts, GCK; Ballestrem, C; Critchley, DR; Barsukov, IL				Goult, Benjamin T.; Zacharchenko, Thomas; Bate, Neil; Tsang, Ricky; Hey, Fiona; Gingras, Alexandre R.; Elliott, Paul R.; Roberts, Gordon C. K.; Ballestrem, Christoph; Critchley, David R.; Barsukov, Igor L.			RIAM and Vinculin Binding to Talin Are Mutually Exclusive and Regulate Adhesion Assembly and Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN; ACTIVATION; REVEALS; COMPLEX; SITES; HEAD; ROD; IDENTIFICATION; RECRUITMENT; MECHANISMS	Talin activates integrins, couples them to F-actin, and recruits vinculin to focal adhesions (FAs). Here, we report the structural characterization of the talin rod: 13 helical bundles (R1-R13) organized into a compact cluster of four-helix bundles (R2-R4) within a linear chain of five-helix bundles. Nine of the bundles contain vinculin-binding sites (VBS); R2R3 are atypical, with each containing two VBS. Talin R2R3 also binds synergistically to RIAM, a Rap1 effector involved in integrin activation. Biochemical and structural data show that vinculin and RIAM binding to R2R3 is mutually exclusive. Moreover, vinculin binding requires domain unfolding, whereas RIAM binds the folded R2R3 double domain. In cells, RIAM is enriched in nascent adhesions at the leading edge whereas vinculin is enriched in FAs. We propose a model in which RIAM binding to R2R3 initially recruits talin to membranes where it activates integrins. As talin engages F-actin, force exerted on R2R3 disrupts RIAM binding and exposes the VBS, which recruit vinculin to stabilize the complex.	[Goult, Benjamin T.; Bate, Neil; Hey, Fiona; Gingras, Alexandre R.; Roberts, Gordon C. K.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Zacharchenko, Thomas; Elliott, Paul R.; Barsukov, Igor L.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Tsang, Ricky; Ballestrem, Christoph] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Leicester; University of Liverpool; University of Manchester	Critchley, DR (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	drc@le.ac.uk; barsukov@liverpool.ac.uk	Gingras, Alexandre R/E-1867-2011; Goult, Benjamin T/B-3127-2009	Gingras, Alexandre R/0000-0002-5373-0176; Goult, Benjamin T/0000-0002-3438-2807; Roberts, Gordon/0000-0001-6200-1373; Ballestrem, Christoph/0000-0002-5375-7985; Elliott, Paul/0000-0002-7641-2103	National Institutes of Health Cell Migration Consortium, NIGMS [U54 GM64346]; Wellcome Trust; BBSRC; Cancer Research UK; Biotechnology and Biological Sciences Research Council [BB/G003637/1, BB/G004552/1] Funding Source: researchfish; BBSRC [BB/G003637/1, BB/G004552/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health Cell Migration Consortium, NIGMS; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Cell Migration Consortium Grant U54 GM64346 from NIGMS, the Wellcome Trust, BBSRC, and Cancer Research UK.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Banno A, 2012, J BIOL CHEM, V287, P13799, DOI 10.1074/jbc.M112.341214; Bate N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034461; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2008, BIOMOL NMR ASSIGN, V2, P17, DOI 10.1007/s12104-007-9073-5; Goult BT, 2010, FEBS LETT, V584, P2237, DOI 10.1016/j.febslet.2010.04.028; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hemmings L, 1996, J CELL SCI, V109, P2715; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kopp PM, 2010, EUR J CELL BIOL, V89, P661, DOI 10.1016/j.ejcb.2010.05.003; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; MCLACHLAN AD, 1994, J MOL BIOL, V235, P1278, DOI 10.1006/jmbi.1994.1081; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Roberts Gordon C. K., 2009, Biophysical Reviews, V1, P61, DOI 10.1007/s12551-009-0009-4; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Sun N, 2008, EXP CELL RES, V314, P1839, DOI 10.1016/j.yexcr.2008.01.034; Wang PB, 2011, J CELL BIOL, V195, P499, DOI 10.1083/jcb.201104128; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wynne JP, 2012, J CELL BIOL, V199, P317, DOI 10.1083/jcb.201201157; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zamir E, 1999, J CELL SCI, V112, P1655; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	49	117	122	5	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8238	8249		10.1074/jbc.M112.438119	http://dx.doi.org/10.1074/jbc.M112.438119			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23389036	Green Published, hybrid			2022-12-25	WOS:000316564500024
J	Albergaria, A; Resende, C; Nobre, AR; Ribeiro, AS; Sousa, B; Machado, JC; Seruca, R; Paredes, J; Schmitt, F				Albergaria, Andre; Resende, Carlos; Nobre, Ana Rita; Ribeiro, Ana Sofia; Sousa, Barbara; Machado, Jose Carlos; Seruca, Raquel; Paredes, Joana; Schmitt, Fernando			CCAAT/Enhancer Binding Protein beta (C/EBP beta) Isoforms as Transcriptional Regulators of the Pro-Invasive CDH3/P-Cadherin Gene in Human Breast Cancer Cells	PLOS ONE			English	Article							P-CADHERIN EXPRESSION; CARCINOMA CELLS; MAMMARY-GLAND; OVEREXPRESSION; ACTIVATION; INDICATOR; ADHESION; BEHAVIOR; FAMILY; ALPHA	P-cadherin is a cell-cell adhesion molecule codified by the CDH3 gene, which expression is highly associated with undifferentiated cells in normal adult epithelial tissues, as well as with poorly differentiated carcinomas. In breast cancer, P-cadherin is frequently overexpressed in high-grade tumours and is a well-established indicator of aggressive tumour behaviour and poor patient prognosis. However, till now, the mechanisms controlling CDH3 gene activation have been poorly explored. Since we recently described the existence of several CCAAT/Enhancer Binding Protein beta (C/EBP beta) transcription factor binding sites at the CDH3 promoter, the aim of this study was to assess if the distinct C/EBP beta isoforms were directly involved in the transcriptional activation of the CDH3 gene in breast cancer cells. DNA-protein interactions, mutation analysis and luciferase reporter assay studies have been performed. We demonstrated that C/EBP beta is co-expressed with P-cadherin in breast cancer cells and all the three isoforms function as transcriptional regulators of the CDH3 gene, directly interacting with specific regions of its promoter. Interestingly, this transcriptional activation was only reflected at the P-cadherin protein level concerning the LIP isoform. Taken together, our data show that CDH3 is a newly defined transcriptional target gene of C/EBPb isoforms in breast cancer, and we also identified the binding sites that are relevant for this activation.	[Albergaria, Andre; Resende, Carlos; Nobre, Ana Rita; Ribeiro, Ana Sofia; Sousa, Barbara; Machado, Jose Carlos; Seruca, Raquel; Paredes, Joana; Schmitt, Fernando] Porto Univ IPATIMUP, Inst Mol Pathol & Immunol, Canc Genet Grp, Oporto, Portugal; [Albergaria, Andre; Machado, Jose Carlos; Seruca, Raquel; Paredes, Joana; Schmitt, Fernando] Univ Porto, Fac Med, Dept Pathol, P-4100 Oporto, Portugal; [Nobre, Ana Rita; Sousa, Barbara] Inst Biomed Sci Abel Salazar ICBAS, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Schmitt, F (corresponding author), Porto Univ IPATIMUP, Inst Mol Pathol & Immunol, Canc Genet Grp, Oporto, Portugal.	fschmitt@ipatimup.pt	Paredes, Joana/F-8224-2011; Ribeiro, Ana/J-7334-2013; Sousa, Bárbara/K-8854-2014; Albergaria, André/J-6162-2013; seruca, raquel/F-8187-2011; Schmitt, Fernando/A-5270-2008; Machado, Jose Carlos/C-5907-2009	Paredes, Joana/0000-0002-1076-1343; Ribeiro, Ana/0000-0002-9698-9233; Sousa, Bárbara/0000-0002-0990-022X; Albergaria, André/0000-0002-2315-2360; Schmitt, Fernando/0000-0002-3711-8681; Machado, Jose Carlos/0000-0003-4741-8415; Schmitt, Fernando/0000-0003-1006-6946; Seruca, Raquel/0000-0002-8851-4166; Nobre, Ana Rita/0000-0002-5509-904X; Resende, Carlos/0000-0001-7143-7099	Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/73247/2010, SFRH/BD/46504/2008, SFRH/BPD/75705/2011, SFRH/BD/69353/2010]; Programa Ciencia (POPH - QREN); FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Programa Ciencia (POPH - QREN); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by research grants (SFRH/BPD/73247/2010 to A. A., SFRH/BD/46504/2008 to C. R., SFRH/BPD/75705/2011 to A. S. R. and SFRH/BD/69353/2010 to B. S.), from the Portuguese Foundation for Science and Technology (FCT). J.P. is supported by Programa Ciencia 2007 (POPH - QREN - Tipology 4.2). Institute of Molecular Pathology and Immunology of Porto University (IPATIMUP) is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albergaria A, 2011, INT J DEV BIOL, V55, P811, DOI 10.1387/ijdb.113382aa; Albergaria A, 2010, HUM MOL GENET, V19, P2554, DOI 10.1093/hmg/ddq134; BRACKE ME, 1991, BRIT J CANCER, V63, P867, DOI 10.1038/bjc.1991.191; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cheung LWT, 2010, ONCOGENE, V29, P2427, DOI 10.1038/onc.2009.523; Faraldo MM, 2007, FEBS LETT, V581, P831, DOI 10.1016/j.febslet.2007.01.053; Gamallo C, 2001, MODERN PATHOL, V14, P650, DOI 10.1038/modpathol.3880367; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Mandeville JA, 2008, BJU INT, V102, P1707, DOI 10.1111/j.1464-410X.2008.08115.x; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; Paredes J, 2005, CLIN CANCER RES, V11, P5869, DOI 10.1158/1078-0432.CCR-05-0059; Paredes J, 2004, CANCER RES, V64, P8309, DOI 10.1158/0008-5472.CAN-04-0795; Paredes J, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1774; Paredes J, 2007, VIRCHOWS ARCH, V450, P73, DOI 10.1007/s00428-006-0334-y; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Ribeiro AS, 2010, ONCOGENE, V29, P392, DOI 10.1038/onc.2009.338; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Shimomura Y, 2008, DEVELOPMENT, V135, P743, DOI 10.1242/dev.006718; Soler AP, 1999, CANCER-AM CANCER SOC, V86, P1263, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1263::AID-CNCR23>3.3.CO;2-U; Sousa B, 2010, HISTOL HISTOPATHOL, V25, P963, DOI 10.14670/HH-25.963; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Taniuchi K, 2005, CANCER RES, V65, P3092, DOI 10.1158/0008.5472.CAN-04-3646; Turashvili G, 2011, MODERN PATHOL, V24, P64, DOI 10.1038/modpathol.2010.189; Van Marck V, 2005, CANCER RES, V65, P8774, DOI 10.1158/0008-5472.CAN-04-4414; Van Marck V, 2011, INT J CANCER, V128, P1031, DOI 10.1002/ijc.25427; Vieira AF, 2012, STEM CELLS; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Zahnow CA, 2002, BREAST CANCER RES, V4, P109, DOI 10.1186/bcr428; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zahnow CA, 2001, CANCER RES, V61, P261; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033	36	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55749	10.1371/journal.pone.0055749	http://dx.doi.org/10.1371/journal.pone.0055749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405208	Green Submitted, gold, Green Published			2022-12-25	WOS:000315153400153
J	Cronican, AA; Fitz, NF; Carter, A; Saleem, M; Shiva, S; Barchowsky, A; Koldamova, R; Schug, J; Lefterov, I				Cronican, Andrea A.; Fitz, Nicholas F.; Carter, Alexis; Saleem, Muzamil; Shiva, Sruti; Barchowsky, Aaron; Koldamova, Radosveta; Schug, Jonathan; Lefterov, Iliya			Genome-Wide Alteration of Histone H3K9 Acetylation Pattern in Mouse Offspring Prenatally Exposed to Arsenic	PLOS ONE			English	Article							CHILDRENS INTELLECTUAL FUNCTION; CENTRAL-NERVOUS-SYSTEM; REPRESSOR DOMAIN; DRINKING-WATER; NOX ENZYMES; PHOSPHOACETYLATION; METABOLISM; RESOLUTION; EXPRESSION; CHROMATIN	Chronic exposure to arsenic in drinking water, especially in utero or perinatal exposure, can initiate neurological and cognitive dysfunction, as well as memory impairment. Several epidemiological studies have demonstrated cognitive and learning deficits in children with early exposure to low to moderate levels of arsenic, but pathogenic mechanisms or etiology for these deficits are poorly understood. Since in vivo studies show a role for histone acetylation in cognitive performance and memory formation, we examined if prenatal exposure to arsenic causes changes in the epigenomic landscape. We exposed C57Bl6/J mice to 100 mu g/L arsenic in the drinking water starting 1 week before conception till birth and applied chromatin immunoprecipitation followed by high-throughput massive parallel sequencing (ChIP-seq) to evaluate H3K9 acetylation pattern in the offspring of exposed and control mice. Arsenic exposure during embryonic life caused global hypo-acetylation at H3K9 and changes in functional annotation with highly significant representation of Kruppel associated box (KRAB) transcription factors in brain samples from exposed pups. We also found that arsenic exposure of adult mice impaired spatial and episodic memory, as well as fear conditioning performance. This is the first study to demonstrate: a) genome wide changes in H3K9 acetylation pattern in an offspring prenatally exposed to arsenic, and b) a connection between moderate arsenic exposure and cognitive impairment in adult mice. The results also emphasize the applicability of Next Generation Sequencing methodology in studies aiming to reveal the role of environmental factors, other than dietary restriction, in developmental reprogramming through histone modifications during embryonic development.	[Cronican, Andrea A.; Fitz, Nicholas F.; Carter, Alexis; Saleem, Muzamil; Barchowsky, Aaron; Koldamova, Radosveta; Lefterov, Iliya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Schug, Jonathan] Univ Penn, Perelman Sch Med, Funct Genom & Next Generat Sequencing Core, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine	Schug, J (corresponding author), Univ Penn, Perelman Sch Med, Funct Genom & Next Generat Sequencing Core, Philadelphia, PA 19104 USA.	jschug@upenn.edu; iliyal@pitt.edu	Lefterov, Iliya/B-4767-2008; Saleem, Muzamil/AAC-9192-2019	Saleem, Muzamil/0000-0001-9910-136X; Fitz, Nicholas/0000-0001-6938-6536; Lefterov, Iliya/0000-0002-0249-0280; Koldamova, Radosveta/0000-0002-6761-0984	National Institute on Aging [AG027973, AG037919]; National Institute of Environmental Health Sciences [ES021243]; NIA [F32AG034031]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG034031, R01AG027973, R01AG037919] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the following awards: AG027973 (RK) and AG037919 (IL and JS) from the National Institute on Aging and ES021243 (IL and AB) from the National Institute of Environmental Health Sciences. NFF is supported by NIA F32AG034031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Arita A, 2012, J TRACE ELEM MED BIO, V26, P174, DOI 10.1016/j.jtemb.2012.03.012; ARRIGO AP, 1983, NUCLEIC ACIDS RES, V11, P1389, DOI 10.1093/nar/11.5.1389; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; Calderon J, 2001, ENVIRON RES, V85, P69, DOI 10.1006/enrs.2000.4106; Cheng T.F., 2012, J APPL TOXICOL; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Cui X, 2006, TOXICOL SCI, V91, P372, DOI 10.1093/toxsci/kfj159; Curtis E, 2012, ANTIOXID REDOX SIGN, V17, P951, DOI 10.1089/ars.2011.4242; Day JJ, 2012, NEUROPSYCHOPHARMACOL, V37, P247, DOI 10.1038/npp.2011.85; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Garelick H, 2008, REV ENVIRON CONTAM T, V197, P17, DOI 10.1007/978-0-387-79284-2_2; Gong G, 2010, ARSENIC EXPOSURE HYP; Hall M, 2007, ENVIRON HEALTH PERSP, V115, P1503, DOI 10.1289/ehp.9906; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Jensen TJ, 2008, CARCINOGENESIS, V29, P1500, DOI 10.1093/carcin/bgn102; Jin YP, 2004, TOXICOL APPL PHARM, V196, P396, DOI 10.1016/j.taap.2004.01.015; Jo WJ, 2009, TOXICOL APPL PHARM, V241, P294, DOI 10.1016/j.taap.2009.08.027; Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Koldamova R, 2010, BBA-MOL CELL BIOL L, V1801, P824, DOI 10.1016/j.bbalip.2010.02.010; Lee BM, 2009, J CELL BIOCHEM, V108, P22, DOI 10.1002/jcb.22250; Lefterov I, 2010, J BIOL CHEM, V285, P36945, DOI 10.1074/jbc.M110.127738; Lefterov I, 2009, ASN NEURO, V1, DOI 10.1042/AN20090015; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lester BM, 2011, ANN NY ACAD SCI, V1226, P14, DOI 10.1111/j.1749-6632.2011.06037.x; Li J, 2003, J BIOL CHEM, V278, P13183, DOI 10.1074/jbc.M300269200; Li J, 2002, J BIOL CHEM, V277, P49504, DOI 10.1074/jbc.M207836200; Luo JH, 2012, TOXICOL LETT, V211, P39, DOI 10.1016/j.toxlet.2012.02.021; Luo JH, 2009, TOXICOL LETT, V184, P121, DOI 10.1016/j.toxlet.2008.10.029; Martinez EJ, 2008, NEUROTOXICOLOGY, V29, P647, DOI 10.1016/j.neuro.2008.05.004; Martinez L, 2011, NEUROCHEM INT, V58, P574, DOI 10.1016/j.neuint.2011.01.020; Martinez-Finley EJ, 2009, PHARMACOL BIOCHEM BE, V94, P271, DOI 10.1016/j.pbb.2009.09.006; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; O'Bryant SE, 2011, INT J ENV RES PUB HE, V8, P861, DOI 10.3390/ijerph8030861; Padovani AMS, 2010, ARTERIOSCL THROM VAS, V30, P1228, DOI 10.1161/ATVBAHA.110.205500; Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Pilsner JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037147; Rahman M, 2006, J EPIDEMIOL COMMUN H, V60, P242, DOI 10.1136/jech.2005.040212; Rahman MM, 2009, ENVIRON GEOCHEM HLTH, V31, P9, DOI 10.1007/s10653-008-9233-2; Rai A, 2010, TOXICOL SCI, V118, P586, DOI 10.1093/toxsci/kfq266; Ramirez T, 2008, CHROMOSOMA, V117, P147, DOI 10.1007/s00412-007-0133-5; Ren XF, 2011, ENVIRON HEALTH PERSP, V119, P11, DOI 10.1289/ehp.1002114; Rodriguez VM, 2001, BRAIN RES BULL, V55, P301, DOI 10.1016/S0361-9230(01)00477-4; Rosado JL, 2007, ENVIRON HEALTH PERSP, V115, P1371, DOI 10.1289/ehp.9961; Schatz MC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-474; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Sorce S, 2012, CELL MOL LIFE SCI, V69, P2387, DOI 10.1007/s00018-012-1014-5; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Trapnell C, 2009, NAT BIOTECHNOL, V27, P455, DOI 10.1038/nbt0509-455; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; von Ehrenstein OS, 2007, EPIDEMIOLOGY, V18, P44, DOI 10.1097/01.ede.0000248900.65613.a9; Waalkes MP, 2004, JNCI-J NATL CANCER I, V96, P466, DOI 10.1093/jnci/djh070; Waalkes MP, 2003, TOXICOL APPL PHARM, V186, P7, DOI 10.1016/S0041-008X(02)00022-4; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Wehner Jeanne M, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805cs27; Xi SH, 2009, ARCH TOXICOL, V83, P549, DOI 10.1007/s00204-009-0403-5; Zhao FH, 2012, TOXICOL IN VITRO, V26, P24, DOI 10.1016/j.tiv.2011.10.003	66	60	64	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53478	10.1371/journal.pone.0053478	http://dx.doi.org/10.1371/journal.pone.0053478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405071	Green Published, gold			2022-12-25	WOS:000315153400014
J	Jalali, S; Bhartiya, D; Lalwani, MK; Sivasubbu, S; Scaria, V				Jalali, Saakshi; Bhartiya, Deeksha; Lalwani, Mukesh Kumar; Sivasubbu, Sridhar; Scaria, Vinod			Systematic Transcriptome Wide Analysis of lncRNA-miRNA Interactions	PLOS ONE			English	Article							LONG NONCODING RNA; MICRORNA TARGET SITES; BINDING PROTEIN; NETWORK; IDENTIFICATION; EXPRESSION; PROMOTE	Background: Long noncoding RNAs (lncRNAs) are a recently discovered class of non-protein coding RNAs, which have now increasingly been shown to be involved in a wide variety of biological processes as regulatory molecules. The functional role of many of the members of this class has been an enigma, except a few of them like Malat and HOTAIR. Little is known regarding the regulatory interactions between noncoding RNA classes. Recent reports have suggested that lncRNAs could potentially interact with other classes of non-coding RNAs including microRNAs (miRNAs) and modulate their regulatory role through interactions. We hypothesized that lncRNAs could participate as a layer of regulatory interactions with miRNAs. The availability of genome-scale datasets for Argonaute targets across human transcriptome has prompted us to reconstruct a genome-scale network of interactions between miRNAs and lncRNAs. Results: We used well characterized experimental Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation (PAR-CLIP) datasets and the recent genome-wide annotations for lncRNAs in public domain to construct a comprehensive transcriptome-wide map of miRNA regulatory elements. Comparative analysis revealed that in addition to targeting protein-coding transcripts, miRNAs could also potentially target lncRNAs, thus participating in a novel layer of regulatory interactions between noncoding RNA classes. Furthermore, we have modeled one example of miRNA-lncRNA interaction using a zebrafish model. We have also found that the miRNA regulatory elements have a positional preference, clustering towards the mid regions and 39 ends of the long noncoding transcripts. We also further reconstruct a genome-wide map of miRNA interactions with lncRNAs as well as messenger RNAs. Conclusions: This analysis suggests widespread regulatory interactions between noncoding RNAs classes and suggests a novel functional role for lncRNAs. We also present the first transcriptome scale study on miRNA-lncRNA interactions and the first report of a genome-scale reconstruction of a noncoding RNA regulatory interactome involving lncRNAs.	[Jalali, Saakshi; Bhartiya, Deeksha; Scaria, Vinod] IGIB, CSIR, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India; [Lalwani, Mukesh Kumar; Sivasubbu, Sridhar] IGIB, CSIR, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Sivasubbu, S (corresponding author), IGIB, CSIR, Delhi, India.	s.sivasubbu@igib.res.in; vinods@igib.res.in	Scaria, Vinod/B-2819-2008; Scaria, Vinod/AAS-3151-2021	Scaria, Vinod/0000-0001-7644-7181	Council of Scientific and Industrial Research (CSIR), India [NWP0036, FAC002]; CSIR, India	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge funding from the Council of Scientific and Industrial Research (CSIR), India through the NWP0036 and FAC002 Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank Dr. Chetana Sachidanandan for scientific inputs, which helped in formulating the study and preparation of the manuscript. DB and MKL acknowledge Senior Research Fellowship from CSIR, India.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Bhartiya D, 2012, EXPERT OPIN DRUG DIS, V7, P503, DOI 10.1517/17460441.2012.682055; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Collins LJ, 2011, ADV EXP MED BIOL, V722, P1, DOI 10.1007/978-1-4614-0332-6_1; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; de Planell-Saguer M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/j.aca.2011.05.025; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Fiore R, 2011, PROG MOL BIOL TRANSL, V102, P47, DOI 10.1016/B978-0-12-415795-8.00004-0; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014; Hollox EJ, 2012, METHODS MOL BIOL, V838, P187, DOI 10.1007/978-1-61779-507-7_9; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Iwasaki S, 2009, FLY, V3, P204; Jalali S, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-25; Janga SC, 2011, ADV EXP MED BIOL, V722, P59, DOI 10.1007/978-1-4614-0332-6_4; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jungkamp AC, 2011, MOL CELL, V44, P828, DOI 10.1016/j.molcel.2011.11.009; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lalwani MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052588; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nagele P, 2011, BEST PRACT RES-CLIN, V25, P549, DOI 10.1016/j.bpa.2011.09.001; Pase Luke, 2009, V546, P227, DOI 10.1007/978-1-60327-977-2_14; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pontier DB, 2011, HUM GENET, V130, P223, DOI 10.1007/s00439-011-1008-7; Rederstorff M, 2010, CURR OPIN MOL THER, V12, P684; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sati S, 2012, NUCL ACIDS RES; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Scaria V, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-82; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Severin AJ, 2010, PLANT PHYSIOL, V154, P3, DOI 10.1104/pp.110.158949; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Wan Y, 2010, CELL CYCLE, V9, P3391, DOI 10.4161/cc.9.17.13122; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang R, 2009, J GENET GENOMICS, V36, P1, DOI 10.1016/S1673-8527(09)60001-1; Zhao Y, 2008, TRENDS GENET, V24, P323, DOI 10.1016/j.tig.2008.04.004; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	66	339	356	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53823	10.1371/journal.pone.0053823	http://dx.doi.org/10.1371/journal.pone.0053823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405074	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400018
J	Rink, WJ; Mercier, N; Mihailovic, D; Morley, MW; Thompson, JW; Roksandic, M				Rink, William J.; Mercier, Norbert; Mihailovic, Dusan; Morley, Mike W.; Thompson, Jeroen W.; Roksandic, Mirjana			New Radiometric Ages for the BH-1 Hominin from Balanica (Serbia): Implications for Understanding the Role of the Balkans in Middle Pleistocene Human Evolution	PLOS ONE			English	Article							U-SERIES DATES; PHYLOGENETIC POSITION; HOMO-HEIDELBERGENSIS; HUMAN REMAINS; SITE; CEPRANO; SIMA; VISOGLIANO; ATAPUERCA; TRIESTE	Newly obtained ages, based on electron spin resonance combined with uranium series isotopic analysis, and infrared/post-infrared luminescence dating, provide a minimum age that lies between 397 and 525 ka for the hominin mandible BH-1 from Mala Balanica cave, Serbia. This confirms it as the easternmost hominin specimen in Europe dated to the Middle Pleistocene. Inferences drawn from the morphology of the mandible BH-1 place it outside currently observed variation of European Homo heidelbergensis. The lack of derived Neandertal traits in BH-1 and its contemporary specimens in Southeast Europe, such as Kocabas, Vasogliano and Ceprano, coupled with Middle Pleistocene synapomorphies, suggests different evolutionary forces acting in the east of the continent where isolation did not play such an important role during glaciations.	[Rink, William J.] McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON, Canada; [Mercier, Norbert] Ctr Rech Phys Appl Archeol, Inst Rech Archeomat, Pessac, France; [Mihailovic, Dusan] Univ Belgrade, Dept Archaeol, Fac Philosophy, Belgrade, Serbia; [Morley, Mike W.] Oxford Brookes Univ, Dept Social Sci, Human Origins & Palaeoenvironm HOPE Res Grp, Oxford OX3 0BP, England; [Thompson, Jeroen W.] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON, Canada; [Roksandic, Mirjana] Univ Winnipeg, Dept Anthropol, Winnipeg, MB R3B 2E9, Canada	McMaster University; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Universite de Orleans; Universite de Technologie de Belfort-Montbeliard (UTBM); University of Belgrade; Oxford Brookes University; McMaster University; University of Winnipeg	Rink, WJ (corresponding author), McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON, Canada.	rinkwj@mcmaster.ca; m.roksandic@uwinnipeg.ca	; Roksandic, Mirjana/B-1812-2019	Mihailovic, Dusan/0000-0002-8607-8196; Morley, Mike/0000-0001-7730-9637; Roksandic, Mirjana/0000-0003-0291-6357; Mercier, Norbert/0000-0002-6375-9108	Natural Sciences and Engineering Council of Canada	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Sciences and Engineering Council of Canada to WJR and MR (grant numbers not disclosed). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiec G., 1998, ANCIENT TL, V16, P37, DOI DOI 10.1016/S0277-3791(03)00021-0; Aitken MJ, 1985, THERMOLUMINESCENCE D; Arsuaga JL, 1997, J HUM EVOL, V33, P109, DOI 10.1006/jhev.1997.0132; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; Bischoff JL, 2007, J ARCHAEOL SCI, V34, P763, DOI 10.1016/j.jas.2006.08.003; Brennan BJ, 2000, RADIAT MEAS, V32, P759, DOI 10.1016/S1350-4487(00)00107-4; BRUMBY S, 1992, NUCL TRACKS RAD MEAS, V20, P595; Bruner E, 2007, AM J PHYS ANTHROPOL, V132, P355, DOI 10.1002/ajpa.20545; Buylaert JP, 2009, RADIAT MEAS, V44, P560, DOI 10.1016/j.radmeas.2009.02.007; CARTMILL M, 2009, HUMAN LINEAGE; CATTANI L, 1991, ANTHROPOLOGIE, V95, P9; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Engin B, 1999, APPL RADIAT ISOTOPES, V51, P689, DOI 10.1016/S0969-8043(99)00090-1; Falgueres C, 2004, J ARCHAEOL SCI, V31, P941, DOI 10.1016/j.jas.2003.12.008; Falgueres C, 2008, QUAT GEOCHRONOL, V3, P390, DOI 10.1016/j.quageo.2008.01.007; Gran R., 2000, ANCIENT TL, V18, P1; Grun R, 1996, J HUM EVOL, V30, P227, DOI 10.1006/jhev.1996.0020; GRUN R, 1988, NUCL TRACKS RAD MEAS, V14, P237; Grun R, 2009, QUAT GEOCHRONOL, V4, P231, DOI 10.1016/j.quageo.2008.12.005; Guerin G, 2011, ANCIENT TL, V29, P5; Harvati K, 2011, J HUM EVOL, V60, P246, DOI 10.1016/j.jhevol.2010.09.008; Howell F.C., 1996, CONT ISSUES HUMAN EV, P1; Lamothe M, 2003, RADIAT MEAS, V37, P493, DOI 10.1016/S1350-4487(03)00016-7; Lebel S, 2001, P NATL ACAD SCI USA, V98, P11097, DOI 10.1073/pnas.181353998; Lowick SE, 2012, QUAT GEOCHRONOL, V8, P33, DOI 10.1016/j.quageo.2011.12.003; Mallegni F, 2001, HOMO, V52, P233; Manzi G, 2001, P NATL ACAD SCI USA, V98, P10011, DOI 10.1073/pnas.151259998; de Castro JMB, 2013, QUATERN INT, V295, P102, DOI 10.1016/j.quaint.2012.02.036; MARSH R, 1999, THESIS MCMASTER U HA; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Mihailovic D, 2008, PALAEOLITHIC BALKANS, V1819, P93; Mounier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018821; Nomade S, 2011, QUAT GEOCHRONOL, V6, P453, DOI 10.1016/j.quageo.2011.03.008; Rightmire GP, 2008, EVOL ANTHROPOL, V6, P218; RINK WJ, 1995, NATURE, V378, P24, DOI 10.1038/378024a0; RINK WJ, 1994, J ARCHAEOL SCI, V21, P839, DOI 10.1006/jasc.1994.1081; Roksandic M, 2011, J HUM EVOL, V61, P186, DOI 10.1016/j.jhevol.2011.03.003; Schoetensack O., 1908, UNTERKIEFER HOMOHEID; Schwarcz HP, 1997, ADV ARC MUS, V2, P159; Schwartz JH, 2010, AM J PHYS ANTHROPOL, P94, DOI 10.1002/ajpa.21443; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Thomsen KJ, 2008, RADIAT MEAS, V24, P473; Vialet A, 2012, CR PALEVOL, V11, P89, DOI 10.1016/j.crpv.2011.06.005; Wagner GA, 2010, P NATL ACAD SCI USA, V107, P19726, DOI 10.1073/pnas.1012722107	45	34	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54608	10.1371/journal.pone.0054608	http://dx.doi.org/10.1371/journal.pone.0054608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405085	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400029
J	Uzsak, A; Schal, C				Uzsak, Adrienn; Schal, Coby			Sensory Cues Involved in Social Facilitation of Reproduction in Blattella germanica Females	PLOS ONE			English	Article							JUVENILE-HORMONE BIOSYNTHESIS; BEHAVIORAL PHASE STATE; OOCYTE DEVELOPMENT; DESERT LOCUST; SEX-PHEROMONE; CALLING BEHAVIOR; AMERICAN COCKROACH; CIRCADIAN-RHYTHM; SCHISTOCERCA; DICTYOPTERA	Cockroaches, like many other animal species, form aggregations in which social stimuli from conspecifics can alter the physiology, morphology, or behavior of individuals. In adult females of the German cockroach, Blattella germanica, social isolation slows oocyte development, sexual maturation, and sexual receptivity, whereas social interactions as minimal as between just two females accelerate reproduction; however, the sensory modalities and pathways that mediate these physiological and behavioral changes are poorly understood. We explored the roles of visual, olfactory, and tactile cues in the reproductive physiology of German cockroach females, and whether their effects are species-specific and related to circadian time. Our results show that tactile cues are the primary sensory input associated with social conditions-with no evidence for involvement of the visual and olfactory systems-and that the antennae play an important role in the reception of these tactile cues. This conclusion is supported by the observation that interactions with other insect species of similar or larger size and with similar antennal morphology also stimulate oocyte development in B. germanica. Social facilitation of reproduction is expected to be influenced by the circadian timing system, as females engage in more social contact during the day when they shelter in aggregations with conspecifics. Surprisingly, however, the female's reproductive rate was unresponsive to social interactions during the photophase, whereas social interactions as short as two hours during the scotophase were sufficient to induce faster reproduction. We discuss the adaptive significance of these sensory-neuroendocrine responses in the German cockroach.	[Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Schal, C (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	coby_schal@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358	North Carolina Pest Management Association; Structural Pest Management Training and Research Facility; Blanton J. Whitmire endowment at North Carolina State University	North Carolina Pest Management Association; Structural Pest Management Training and Research Facility; Blanton J. Whitmire endowment at North Carolina State University	This project was supported by the Blanton J. Whitmire endowment at North Carolina State University and scholarships from the North Carolina Pest Management Association and the Structural Pest Management Training and Research Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey ML, 2009, SCIENCE, V323, P627, DOI 10.1126/science.1165939; BELLES X, 1987, INSECT BIOCHEM, V17, P1007, DOI 10.1016/0020-1790(87)90111-9; Bloch G, 2012, J INSECT PH IN PRESS; Boroczky K, P NAT ACAD IN PRESS; BRADLEY JT, 1985, ENTOMOL EXP APPL, V38, P249, DOI 10.1007/BF00295258; BURNS EL, 1991, J INSECT PHYSIOL, V37, P401, DOI 10.1016/0022-1910(91)90049-6; CHAUVIN R, 1946, B SOC ZOOL FRANCE, V71, P39; CHON TS, 1990, ENVIRON ENTOMOL, V19, P1716, DOI 10.1093/ee/19.6.1716; CREWS D, 1975, SCIENCE, V189, P1059, DOI 10.1126/science.1172294; Cullen DA, 2010, J INSECT PHYSIOL, V56, P937, DOI 10.1016/j.jinsphys.2010.04.023; DAMBACH M, 1994, ENTOMOL GEN, V19, P129; Eliyahu D, 2008, J CHEM ECOL, V34, P229, DOI 10.1007/s10886-007-9409-8; GADOT M, 1989, J INSECT PHYSIOL, V35, P537, DOI 10.1016/0022-1910(89)90141-8; GADOT M, 1989, ARCH INSECT BIOCHEM, V11, P189, DOI 10.1002/arch.940110306; Gemeno C, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P179, DOI 10.1017/CBO9780511542664.007; Gervet J, 1968, NETH J ZOOL, V18, P205; GRASSE PP, 1946, EXPERIENTIA, V2, P77, DOI 10.1007/BF02172562; Hagele BF, 2000, J INSECT PHYSIOL, V46, P1295, DOI 10.1016/S0022-1910(00)00051-2; Heifetz Y, 1996, J CHEM ECOL, V22, P1717, DOI 10.1007/BF02272410; HIGHNAM KC, 1964, J INSECT PHYSIOL, V10, P849, DOI 10.1016/0022-1910(64)90077-0; Holbrook GL, 1998, PHYSIOL ENTOMOL, V23, P121, DOI 10.1046/j.1365-3032.1998.232077.x; Holbrook GL, 2000, J INSECT PHYSIOL, V46, P941, DOI 10.1016/S0022-1910(99)00201-2; ISHII S, 1967, Applied Entomology and Zoology, V2, P203; ISHII S, 1971, Applied Entomology and Zoology, V6, P192; IWANAGA K, 1986, J INSECT PHYSIOL, V32, P585, DOI 10.1016/0022-1910(86)90076-4; IZUTSU M, 1970, Applied Entomology and Zoology, V5, P159; JOHNSON BRUCE, 1965, ENTOMOL EXP APPL, V8, P49, DOI 10.1007/BF00304538; Knadler JJ, 2009, CHRONOBIOL INT, V26, P415, DOI 10.1080/07420520902876634; Krause J, 2002, LIVING GROUPS; KURTTI TJ, 1976, IN VITRO CELL DEV B, V12, P141; LEES AD, 1967, J INSECT PHYSIOL, V13, P289, DOI 10.1016/0022-1910(67)90155-2; Lester RL, 2005, J INSECT PHYSIOL, V51, P737, DOI 10.1016/j.jinsphys.2005.03.015; LIANG DS, 1994, J INSECT PHYSIOL, V40, P251, DOI 10.1016/0022-1910(94)90048-5; LIANG DS, 1993, J INSECT BEHAV, V6, P603, DOI 10.1007/BF01048126; LIANG DS, 1990, PHYSIOL ENTOMOL, V15, P355, DOI 10.1111/j.1365-3032.1990.tb00523.x; Lihoreau M, 2008, ANIM BEHAV, V75, P1965, DOI 10.1016/j.anbehav.2007.12.006; LONG D. B., 1953, TRANS ROY ENT SOC LONDON, V104, P543; Maeno K, 2011, J INSECT PHYSIOL, V57, P74, DOI 10.1016/j.jinsphys.2010.09.009; MCFARLANE JE, 1984, J INSECT PHYSIOL, V30, P103, DOI 10.1016/0022-1910(84)90112-4; NAKAI Y, 1986, JPN J APPL ENTOMOL Z, V30, P1, DOI 10.1303/jjaez.30.1; Nojima S, 1999, J INSECT BEHAV, V12, P627, DOI 10.1023/A:1020975619618; Nojima S, 2005, SCIENCE, V307, P1104, DOI 10.1126/science.1107163; Norris M.J., 1950, ANTILOCUST B, V6, P1; Norris M. J., 1952, ANTILOCUST B, V13, P1; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Roessingh P, 1998, J INSECT PHYSIOL, V44, P883, DOI 10.1016/S0022-1910(98)00070-5; Rogers SM, 2004, J EXP BIOL, V207, P3603, DOI 10.1242/jeb.01183; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Roth L. M., 1960, BIOTIC ASS COCKROACH; Rust MK, 1995, UNDERSTANDING CONTRO; Rymer J, 2007, J BIOL RHYTHM, V22, P43, DOI 10.1177/0748730406295462; Saunders D.S., 2002, INSECT CLOCKS, P7, DOI DOI 10.1016/B978-044450407-4/50003-3; SCHAL C, 1995, EXPERIENTIA, V51, P994, DOI 10.1007/BF01921755; Schal C, 1997, ARCH INSECT BIOCHEM, V35, P405, DOI 10.1002/(SICI)1520-6327(1997)35:4<405::AID-ARCH5>3.3.CO;2-3; SCHAL C, 1993, J INSECT PHYSIOL, V39, P303, DOI 10.1016/0022-1910(93)90061-U; Seelinger G., 1981, P217; Sevala V, 1999, J INSECT PHYSIOL, V45, P431, DOI 10.1016/S0022-1910(98)00142-5; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; SMITH AF, 1991, J INSECT BEHAV, V4, P1, DOI 10.1007/BF01092546; Stay B, 2010, J INSECT PHYSIOL, V56, P266, DOI 10.1016/j.jinsphys.2009.10.012; STEVENS EF, 1994, ZOO BIOL, V13, P501, DOI 10.1002/zoo.1430130512; SUTHERLAND OR, 1969, J INSECT PHYSIOL, V15, P1385, DOI 10.1016/0022-1910(69)90199-1; Treiblmayr K, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.4301; Uzsak A, 2012, J EXP BIOL, V215, P3037, DOI 10.1242/jeb.069997; WEAVER DK, 1990, J INSECT PHYSIOL, V36, P531, DOI 10.1016/0022-1910(90)90105-O; WHARTON DRA, 1968, J INSECT PHYSIOL, V14, P637, DOI 10.1016/0022-1910(68)90224-2; Wijenberg R, 2008, ENTOMOL EXP APPL, V129, P124, DOI 10.1111/j.1570-7458.2008.00758.x; WILEYTO EP, 1984, ENVIRON ENTOMOL, V13, P1557, DOI 10.1093/ee/13.6.1557; Wilson E.O., 1971, INSECT SOC; WOODHEAD AP, 1983, J INSECT PHYSIOL, V29, P665, DOI 10.1016/0022-1910(83)90040-9; ZERA AJ, 1988, J INSECT PHYSIOL, V34, P489, DOI 10.1016/0022-1910(88)90190-4; ZHUKOVSKAYA MI, 1995, J INSECT PHYSIOL, V41, P941, DOI 10.1016/0022-1910(95)00060-8	73	7	7	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55678	10.1371/journal.pone.0055678	http://dx.doi.org/10.1371/journal.pone.0055678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405195	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400140
J	Xing, H; Ruan, YH; Li, JY; Shang, H; Zhong, P; Wang, X; Liao, LJ; Li, HP; Zhang, M; Xue, YL; Wang, Z; Su, B; Liu, W; Dong, YH; Ma, YL; Li, HQ; Qin, GM; Chen, L; Pan, XH; Chen, X; Peng, G; Fu, JH; Chen, RY; Kang, LY; Shao, YM				Xing, Hui; Ruan, Yuhua; Li, Jingyun; Shang, Hong; Zhong, Ping; Wang, Xia; Liao, Lingjie; Li, Hanping; Zhang, Min; Xue, Yile; Wang, Zhe; Su, Bin; Liu, Wei; Dong, Yonghui; Ma, Yanling; Li, Huiqin; Qin, Guangming; Chen, Lin; Pan, Xiaohong; Chen, Xi; Peng, Guoping; Fu, Jihua; Chen, Ray Y.; Kang, Laiyi; Shao, Yiming		Chinese Natl HIVDR Surveillance Mo	HIV Drug Resistance and Its Impact on Antiretroviral Therapy in Chinese HIV-Infected Patients	PLOS ONE			English	Article							ZIDOVUDINE; OUTCOMES	Background: Highly active antiretroviral therapy (HAART) has significantly decreased mortality among Chinese HIV patients. However, emerging HIV drug resistance (HIVDR) poses a growing threat to the long-term success and durability of HAART. Methods: Three cross-sectional surveys were conducted across the country from 2004 to 2006, respectively. Patients completed a questionnaire and provided blood for CD4 cell count, HIV viral load (VL), and HIV resistance genotyping. Factors associated with HIVDR were identified by logistic regression. Results: 3667 unique patients were included across the three surveys. Among 2826 treatment-experienced patients, median duration of treatment was 17.4 (IQR 8.6-28.4) months and HIVDR was identified in 543 (19.2%). Factors significantly associated with HIVDR included ART drug distribution location, CD4 cell count, initial HAART regimen, self-reported medication adherence, and province. Conclusions: Virologic failure increased over time on therapy but a significant proportion of patients in failure had no resistance mutations identified, suggesting that treatment adherence is suboptimal and must be emphasized. Due to the significantly higher risk of HIVDR in certain provinces, additional steps to reduce HIVDR should be taken.	[Xing, Hui; Ruan, Yuhua; Wang, Xia; Liao, Lingjie; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xing, Hui; Ruan, Yuhua; Wang, Xia; Liao, Lingjie; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Li, Jingyun; Li, Hanping] Acad Mil Med Sci, Inst Microbiol & Epidemiol, AIDS Res Dept, Beijing, Peoples R China; [Shang, Hong; Zhang, Min] China Med Univ, Affiliated Hosp 1, Minist Hlth, Key Lab Immunol AIDS, Shenyang, Peoples R China; [Zhong, Ping; Xue, Yile; Kang, Laiyi] Shanghai Municipal Ctr Dis Control & Prevent, Dept AIDS & STD, Shanghai, Peoples R China; [Wang, Zhe] Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Su, Bin] Anhui Ctr Dis Control & Prevent, Hefei, Peoples R China; [Liu, Wei] Guangxi Ctr Dis Control & Prevent, Nanning, Peoples R China; [Dong, Yonghui] Xinjiang Ctr Dis Control & Prevent, Urumqi, Peoples R China; [Ma, Yanling] Yunnan Ctr Dis Control & Prevent, Kunming, Peoples R China; [Li, Huiqin] Yunnan Infect Dis Hosp, Kunming, Peoples R China; [Qin, Guangming] Sichuan Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Chen, Lin] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Pan, Xiaohong] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Chen, Xi] Hunan Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Peng, Guoping] Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Fu, Jihua] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [Chen, Ray Y.] US Embassy Beijing, Natl Inst Allergy & Infect Dis, US Natl Inst Hlth, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Academy of Military Medical Sciences - China; China Medical University; Shanghai Center for Disease Control & Prevention; Shenzhen Center for Disease Control & Prevention (SZCDC)	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao08@gmail.com	Wang, Xia/C-3298-2018; Chen, Ray/T-5102-2019; Chen, Ray/GRJ-6736-2022; MA, YAN/HHN-2912-2022	Wang, Xia/0000-0002-1684-7076; Chen, Ray/0000-0001-6344-1442	Ministry of Science and Technology of China [2012ZX10001-002, 2009DFB30420]; International Development Research Center of Canada [104519-010]; Chinese State Key Laboratory for Infectious Disease Develop Grant [2011SKLID102]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); International Development Research Center of Canada; Chinese State Key Laboratory for Infectious Disease Develop Grant	The Ministry of Science and Technology of China (2012ZX10001-002 and 2009DFB30420) and the International Development Research Center of Canada (#104519-010), and Chinese State Key Laboratory for Infectious Disease Develop Grant (2011SKLID102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; Casado JL, 2000, AIDS, V14, pF1, DOI 10.1097/00002030-200001280-00001; DAQUILA RT, 1995, ANN INTERN MED, V122, P401, DOI 10.7326/0003-4819-122-6-199503150-00001; DeGruttola V, 2000, ANTIVIR THER, V5, P41; Dou ZH, 2010, INT J EPIDEMIOL, V39, pII56, DOI 10.1093/ije/dyq215; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Garrido C, 2008, J ANTIMICROB CHEMOTH, V61, P694, DOI 10.1093/jac/dkm515; Joly V, 2000, ANTIMICROB AGENTS CH, V44, P3155, DOI 10.1128/AAC.44.11.3155-3157.2000; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Ma Y, 2010, INT J EPIDEMIOL, V39, P973, DOI 10.1093/ije/dyp233; Ruan YH, 2010, TROP MED INT HEALTH, V15, P1357, DOI 10.1111/j.1365-3156.2010.02621.x; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Zhang F, 2008, NATL FREE HIV ANTIRE; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196; Zolopa AR, 1999, ANN INTERN MED, V131, P813, DOI 10.7326/0003-4819-131-11-199912070-00003	19	32	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54917	10.1371/journal.pone.0054917	http://dx.doi.org/10.1371/journal.pone.0054917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405098	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400042
J	Herrera, VLM; Pasion, KA; Moran, AM; Ruiz-Opazo, N				Herrera, Victoria L. M.; Pasion, Khristine A.; Moran, Ann Marie; Ruiz-Opazo, Nelson			Worse Renal Disease in Postmenopausal F2[Dahl S x R]-Intercross Rats: Detection of Novel QTLs Affecting Hypertensive Kidney Disease	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; SALT; PROGRESSION; THERAPY; CREATININE; MYELOMA; WOMEN; MAP	The prevalence of hypertension increases after menopause with 75% of postmenopausal women developing hypertension in the United States, along with hypertensive end organ diseases. While human and animal model studies have indicated a protective role for estrogen against cardiovascular disease and glomerulosclerosis, clinical studies of hormone replacement therapy in postmenopausal women have shown polar results with some improvement in hypertension but worsening of hypertensive kidney disease, or no effect at all. These observations suggest that the pathogenesis of postmenopausal hypertension and its target organ complications is more complex than projected, and that loss of endogenous estrogens induces epigenetic changes that alter genetic susceptibility to end-organ complications per se resulting in pathogenetic mechanisms beyond correction by hormone replacement. We studied postmenopausal-induced changes in renal disease and performed a total genome scan for quantitative trait loci (QTLs) affecting kidney disease in postmenopausal 16m-old F2[Dahl S x R]-intercross female rats. We used glomerular injury score (GIS) as quantitative trait. We compared QTLs amongst premenopausal, ovariectomized and postmenopausal F2[Dahl S x R]-intercross rats using identical phenotype characterization. Postmenopausal F2[Dahl S x R]-intercross rats exhibited increased hypertensive glomerulosclerosis (P<0.01) and equivalent levels of kidney disease when compared to premenopausal and ovariectomized F2[Dahl S x R]-intercross rats respectively. We detected three significant to highly significant GIS-QTLs (GIS-pm1 on chromosome 4, LOD 3.54; GIS-pm2 on chromosome 3, LOD 2.72; GIS-pm3 on chromosome 5, LOD 2.37) and two suggestive GIS-QTLs (GIS-pm4 on chromosome 2, LOD 1.70; GIS-pm5 on chromosome 7, LOD 1.28), all of which were unique to this postmenopausal population. Detection of increased renal disease phenotype in postmenopausal and ovariectomized subjects suggests a protective role of ovarian hormones. Furthermore, the detection of distinct GIS-QTLs in postmenopausal intercross female rats suggests that distinct genetic mechanisms underlie hypertensive glomerulosclerosis in premenopausal and postmenopausal states.	[Herrera, Victoria L. M.; Pasion, Khristine A.; Moran, Ann Marie; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA	Boston University	Ruiz-Opazo, N (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA.	nruizo@bu.edu		Herrera, Victoria/0000-0001-8991-2134; Ruiz-Opazo, Nelson/0000-0001-8234-1332	NIH [HL086532]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086532] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the NIH: HL086532 to NR-O. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2005, AM J KIDNEY DIS, V45, P1019, DOI 10.1053/j.ajkd.2005.02.025; Ahmed SB, 2008, KIDNEY INT, V74, P370, DOI 10.1038/ki.2008.205; Arimura A, 2006, BLOOD, V107, P661, DOI 10.1182/blood-2005-03-1186; Bolignano D, 2010, CURR OPIN NEPHROL HY, V19, P499, DOI 10.1097/MNH.0b013e32833d35cf; Brubel R, 2011, TRANSPL P, V43, P1297, DOI 10.1016/j.transproceed.2011.03.081; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Fortepiani LA, 2003, HYPERTENSION, V41, P640, DOI 10.1161/01.HYP.0000046924.94886.EF; Fung MM, 2011, MENOPAUSE, V18, P629, DOI 10.1097/gme.0b013e3181fca9c4; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Herrera VL, 2012, J HYPERTENS, V30, P1572, DOI 10.1097/HJH.0b013e3283550eb8; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; Herrera VLM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043160; Herrera VLM, 1998, J CLIN INVEST, V102, P1102, DOI 10.1172/JCI3868; Hocher B, 1996, HYPERTENSION, V28, P196, DOI 10.1161/01.HYP.28.2.196; Hovind P, 2004, BRIT MED J, V328, P1105, DOI 10.1136/bmj.38070.450891.FE; Iseki K, 1997, KIDNEY INT, V51, P850, DOI 10.1038/ki.1997.119; Jafar TH, 2003, NEPHROL DIAL TRANSPL, V18, P2047, DOI 10.1093/ndt/gfg317; LEFEVRE J, 1988, BIOL REPROD, V38, P780, DOI 10.1095/biolreprod38.4.780; Li M, 2008, REGUL PEPTIDES, V145, P24, DOI 10.1016/j.regpep.2007.09.012; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Maric C, 2008, GENDER MED, V5, P147, DOI 10.1016/j.genm.2008.05.002; Monster TBM, 2001, ARCH INTERN MED, V161, P2000, DOI 10.1001/archinte.161.16.2000; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Pechere-Bertschi A, 2004, AM J HYPERTENS, V17, P994, DOI 10.1016/j.amjhyper.2004.08.009; Pimenta E, 2012, HYPERTENS RES, V35, P148, DOI 10.1038/hr.2011.190; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Schulman IH, 2006, HYPERTENSION, V47, P1168, DOI 10.1161/01.HYP.0000218857.67880.75; Szakaly P, 2008, J MOL NEUROSCI, V36, P89, DOI 10.1007/s12031-008-9064-8; Szekacs B, 2000, BRIT J OBSTET GYNAEC, V107, P1017, DOI 10.1111/j.1471-0528.2000.tb10406.x; Uchide T, 2006, EXP BIOL MED, V231, P997; Williams JM, 2008, AM J PHYSIOL-RENAL, V295, pF1764, DOI 10.1152/ajprenal.90525.2008	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e56096	10.1371/journal.pone.0056096	http://dx.doi.org/10.1371/journal.pone.0056096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393608	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800063
J	Jensen, RA; Sim, XL; Li, XH; Cotch, MF; Ikram, MK; Holliday, EG; Eiriksdottir, G; Harris, TB; Jonasson, F; Klein, BEK; Launer, LJ; Smith, AV; Boerwinkle, E; Cheung, N; Hewitt, AW; Liew, G; Mitchell, P; Wang, JJ; Attia, J; Scott, R; Glazer, NL; Lumley, T; McKnight, B; Psaty, BM; Taylor, K; Hofman, A; de Jong, PTVM; Rivadeneira, F; Uitterlinden, AG; Tay, WT; Teo, YY; Seielstad, M; Liu, JJ; Cheng, CY; Saw, SM; Aung, T; Ganesh, SK; O'Donnell, CJ; Nalls, MA; Wiggins, KL; Kuo, JZ; van Duijn, CM; Gudnason, V; Klein, R; Siscovick, DS; Rotter, JI; Tai, ES; Vingerling, J; Wong, TY				Jensen, Richard A.; Sim, Xueling; Li, Xiaohui; Cotch, Mary Frances; Ikram, M. Kamran; Holliday, Elizabeth G.; Eiriksdottir, Gudny; Harris, Tamara B.; Jonasson, Fridbert; Klein, Barbara E. K.; Launer, Lenore J.; Smith, Albert Vernon; Boerwinkle, Eric; Cheung, Ning; Hewitt, Alex W.; Liew, Gerald; Mitchell, Paul; Wang, Jie Jin; Attia, John; Scott, Rodney; Glazer, Nicole L.; Lumley, Thomas; McKnight, Barbara; Psaty, Bruce M.; Taylor, Kent; Hofman, Albert; de Jong, Paulus T. V. M.; Rivadeneira, Fernando; Uitterlinden, Andre G.; Tay, Wan-Ting; Teo, Yik Ying; Seielstad, Mark; Liu, Jianjun; Cheng, Ching-Yu; Saw, Seang-Mei; Aung, Tin; Ganesh, Santhi K.; O'Donnell, Christopher J.; Nalls, Mike A.; Wiggins, Kerri L.; Kuo, Jane Z.; van Duijn, Cornelia M.; Gudnason, Vilmundur; Klein, Ronald; Siscovick, David S.; Rotter, Jerome I.; Tai, E. Shong; Vingerling, Johannes; Wong, Tien Y.		Blue Mt Eye Study GWAS Team; CKDGen Consortium	Genome-Wide Association Study of Retinopathy in Individuals without Diabetes	PLOS ONE			English	Article							RETINAL MICROVASCULAR ABNORMALITIES; ANTIHYPERTENSIVE DRUG THERAPIES; ATHEROSCLEROSIS RISK; BLOOD-PRESSURE; CARDIOVASCULAR HEALTH; HYPERTENSION; COMMUNITIES; MORTALITY; DESIGN; STROKE	Background: Mild retinopathy (microaneurysms or dot-blot hemorrhages) is observed in persons without diabetes or hypertension and may reflect microvascular disease in other organs. We conducted a genome-wide association study (GWAS) of mild retinopathy in persons without diabetes. Methods: A working group agreed on phenotype harmonization, covariate selection and analytic plans for within-cohort GWAS. An inverse-variance weighted fixed effects meta-analysis was performed with GWAS results from six cohorts of 19,411 Caucasians. The primary analysis included individuals without diabetes and secondary analyses were stratified by hypertension status. We also singled out the results from single nucleotide polymorphisms (SNPs) previously shown to be associated with diabetes and hypertension, the two most common causes of retinopathy. Results: No SNPs reached genome-wide significance in the primary analysis or the secondary analysis of participants with hypertension. SNP, rs12155400, in the histone deacetylase 9 gene (HDAC9) on chromosome 7, was associated with retinopathy in analysis of participants without hypertension, -1.3 +/- 0.23 (beta +/- standard error), p=6.6x10(-9). Evidence suggests this was a false positive finding. The minor allele frequency was low (similar to 2%), the quality of the imputation was moderate (r(2) similar to 0.7), and no other common variants in the HDAC9 gene were associated with the outcome. SNPs found to be associated with diabetes and hypertension in other GWAS were not associated with retinopathy in persons without diabetes or in subgroups with or without hypertension. Conclusions: This GWAS of retinopathy in individuals without diabetes showed little evidence of genetic associations. Further studies are needed to identify genes associated with these signs in order to help unravel novel pathways and determinants of microvascular diseases.	[Jensen, Richard A.; Lumley, Thomas; McKnight, Barbara; Psaty, Bruce M.; Wiggins, Kerri L.; Siscovick, David S.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Jensen, Richard A.; Psaty, Bruce M.; Wiggins, Kerri L.; Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA USA; [Sim, Xueling; Teo, Yik Ying] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Li, Xiaohui; Taylor, Kent; Kuo, Jane Z.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Ikram, M. Kamran; Tay, Wan-Ting; Cheng, Ching-Yu; Saw, Seang-Mei; Aung, Tin; Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Ikram, M. Kamran; Vingerling, Johannes] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Holliday, Elizabeth G.; Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Eiriksdottir, Gudny; Smith, Albert Vernon; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Jonasson, Fridbert; Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, Dept Med, Reykjavik, Iceland; [Jonasson, Fridbert] Landspitalinn Univ Hosp, Dept Ophthalmol, Reykjavik, Iceland; [Klein, Barbara E. K.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX USA; [Cheung, Ning; Hewitt, Alex W.; Liew, Gerald; Wang, Jie Jin; Wong, Tien Y.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Liew, Gerald; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Liew, Gerald; Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Attia, John] John Hunter Hosp, Dept Med, Newcastle, NSW, Australia; [Attia, John] Hunter Med Res Inst, Newcastle, NSW, Australia; [Scott, Rodney] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2300, Australia; [Glazer, Nicole L.] Boston Univ, Sch Med, Sect Prevent Med & Epidemiol, Boston, MA 02118 USA; [Lumley, Thomas] Univ Auckland, Dept Stat, Auckland 1, New Zealand; [McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Psaty, Bruce M.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Vingerling, Johannes] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [de Jong, Paulus T. V. M.] Netherlands Inst Neurosci, Amsterdam, Netherlands; [de Jong, Paulus T. V. M.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Clin Chem, Rotterdam, Netherlands; [Teo, Yik Ying; Cheng, Ching-Yu; Saw, Seang-Mei; Tai, E. Shong] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik Ying; Liu, Jianjun] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Cheng, Ching-Yu; Saw, Seang-Mei; Aung, Tin; Wong, Tien Y.] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Ganesh, Santhi K.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [O'Donnell, Christopher J.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [O'Donnell, Christopher J.] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [O'Donnell, Christopher J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Nalls, Mike A.] NIA, Neurogenet Lab, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Tai, E. Shong] Natl Univ Singapore, Singapore 117548, Singapore; [Tai, E. Shong] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National University of Singapore; Cedars Sinai Medical Center; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National University of Singapore; Singapore National Eye Center; Erasmus University Rotterdam; Erasmus MC; University of Newcastle; Icelandic Heart Association; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Iceland; Landspitali National University Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Centre for Eye Research Australia; University of Melbourne; University of Sydney; University of Sydney; Westmead Institute for Medical Research; John Hunter Hospital; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Boston University; University of Auckland; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of California System; University of California San Francisco; National University of Singapore; University of Michigan System; University of Michigan; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National University of Singapore; National University of Singapore	Jensen, RA (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA.	richaj@uw.edu	Hewitt, Alex W/D-1936-2013; Attia, John R/F-5376-2013; Gudnason, Vilmundur/AAE-7126-2019; Rotter, Jerome/AAY-6598-2021; Mitchell, Paul/P-1498-2014; Sim, Xueling/AAZ-6652-2020; Cheng, Ching-Yu/K-7017-2013; Rivadeneira, Fernando/O-5385-2015; Wong, Tien Yin/AAC-9724-2020; Liew, Gerald/AAB-6870-2022; Jonasson, Fridbert/ABA-9889-2021; Cheng, Ching-Yu/Y-2229-2019; Tai, E Shyong/J-9831-2013; Wang, Jie Jin/P-1499-2014; Liu, Jianjun/AAK-4989-2020; wang, jie/GRS-0942-2022; Smith, Albert Vernon/K-5150-2015; Gudnason, Vilmundur/K-6885-2015; Cheung, Ning Danny/F-2043-2013; Seielstad, Mark/T-7841-2019; Scott, Rodney/B-2827-2013	Hewitt, Alex W/0000-0002-5123-5999; Attia, John R/0000-0001-9800-1308; Gudnason, Vilmundur/0000-0001-5696-0084; Sim, Xueling/0000-0002-1233-7642; Cheng, Ching-Yu/0000-0003-0655-885X; Rivadeneira, Fernando/0000-0001-9435-9441; Wong, Tien Yin/0000-0002-8448-1264; Cheng, Ching-Yu/0000-0003-0655-885X; Wang, Jie Jin/0000-0001-9491-4898; Liu, Jianjun/0000-0002-3255-3019; Smith, Albert Vernon/0000-0003-1942-5845; Gudnason, Vilmundur/0000-0001-5696-0084; Tai, E Shyong/0000-0003-2929-8966; Baird, Paul/0000-0002-1305-3502; Cotch, Mary Frances/0000-0002-2046-4350; Scott, Rodney/0000-0001-7724-3404; Klein, Ronald/0000-0002-4428-6237; Van Duijn, Cornelia/0000-0002-2374-9204; Ikram, Mohammad Kamran/0000-0003-0173-9571; Wiggins, Kerri L/0000-0003-2749-1279; Glazer, Nicole/0000-0002-6397-609X; Seielstad, Mark/0000-0001-5783-1401	National Institutes of Health (NIH) [N01-AG-12100]; National Institute on Aging Intramural Research Program at the NIH [ZIAAG007380, ZIAEY000401]; National Eye Institute Intramural Research Program at the NIH [ZIAAG007380, ZIAEY000401]; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C]; National Institutes of Health and NIH Roadmap for Medical Research [UL1RR025005]; Australian National Health & Medical Research Council (NHMRC) [974159, 991407, 211069, 457349]; NHMRC [512423, 475604, 529912, 590204]; Wellcome Trust, UK as part of Wellcome Trust Case Control Consortium; genotyping costs of the entire BMES population [085475/B/08/Z, 085475/08/Z]; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-85239, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133]; NHLBI [HL080295, HL075366, HL087652, HL105756, N02-HL-6-4278]; National Institute on Aging [AG-023629, AG-15928, AG-20098, AG-027058]; Clinical Translational Science Institute [UL1RR033176]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR); Netherlands Organization of Scientific Research NWO [175.010.2005.011]; Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organization for Scientific Research; Netherlands Organization for Health Research and Development; Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII) the Netherlands; Municipality of Rotterdam; Lijf en Leven, Krimpen a/d Lek the Netherlands; MD Fonds, Utrecht the Netherlands; Oogfonds Nederland, Utrecht the Netherlands; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam the Netherlands; Swart van Essen, Rotterdam the Netherlands; Netherlands Organisation for Scientific Research the Netherlands; Bevordering van Volkskracht, Rotterdam the Netherlands; Blindenhulp, The Hague the Netherlands; Rotterdamse Vereniging Blindenbelangen, Rotterdam the Netherlands; OOG, The Hague the Netherlands; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn the Netherlands; Blinden-Penning, Amsterdam the Netherlands; Blindenhulp, 's Gravenzande the Netherlands; Henkes Stichting, Rotterdam the Netherlands; Topcon Europe BV, Capelle aan de IJssel the Netherlands; Medical Workshop BV, Groningen the Netherlands;  [N01 HC-95159];  [N01-HC-95169];  [RR-024156]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085086, N01HC095159, N01HC095169, N01HC035129, N01HC085079, N01HC015103, N01HC075150, N01HC045133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176, UL1RR025005, UL1RR024156] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000403, ZIAEY000401, ZIAEY000426] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087652, R01HL105756, R01HL087641, R01HL080295, R01HL086694, U01HL080295, R01HL075366, R01HL059367, R01HL064278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000, R01AG023629, R56AG020098, N01AG012100, R01AG020098, R01AG027058, R01AG015928, ZIAAG007420, ZIAAG007270, R56AG023629, ZIAAG007380] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging Intramural Research Program at the NIH; National Eye Institute Intramural Research Program at the NIH; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health and NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, UK as part of Wellcome Trust Case Control Consortium; genotyping costs of the entire BMES population; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Clinical Translational Science Institute; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR); Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII) the Netherlands; Municipality of Rotterdam; Lijf en Leven, Krimpen a/d Lek the Netherlands; MD Fonds, Utrecht the Netherlands(Netherlands Government); Oogfonds Nederland, Utrecht the Netherlands; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam the Netherlands(Netherlands Government); Swart van Essen, Rotterdam the Netherlands; Netherlands Organisation for Scientific Research the Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Bevordering van Volkskracht, Rotterdam the Netherlands(Netherlands Government); Blindenhulp, The Hague the Netherlands(Netherlands Government); Rotterdamse Vereniging Blindenbelangen, Rotterdam the Netherlands(Netherlands Government); OOG, The Hague the Netherlands; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn the Netherlands(Netherlands Government); Blinden-Penning, Amsterdam the Netherlands(Netherlands Government); Blindenhulp, 's Gravenzande the Netherlands(Netherlands Government); Henkes Stichting, Rotterdam the Netherlands; Topcon Europe BV, Capelle aan de IJssel the Netherlands(Netherlands Government); Medical Workshop BV, Groningen the Netherlands; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors declare that they have no relevant financial interests. Age, Gene/Environment Susceptibility-Reykjavik Study has been funded by National Institutes of Health (NIH) contract N01-AG-12100, the National Institute on Aging and National Eye Institute Intramural Research Programs at the NIH (ZIAAG007380 and ZIAEY000401), Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The Blue Mountains Eye Study (BMES) was supported by the Australian National Health & Medical Research Council (NHMRC) grants (IDs 974159, 991407, 211069 and 457349). The genome-wide association study was supported by the following grants: NHMRC project grants IDs 512423, 475604, 529912 and 590204, and funding by the Wellcome Trust, UK as part of Wellcome Trust Case Control Consortium 2 (A Viswanathan, P McGuffin, P Mitchell, F Topouzis, P Foster), which supported the genotyping costs of the entire BMES population (Grant numbers 085475/B/08/Z and 085475/08/Z). The Cardiovascular Health Study research was supported by National Heart, Lung, and Blood Institute (NHLBI) contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086; N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133 and NHLBI grants HL080295, HL075366, HL087652, HL105756 with additional contribution from the National Institute of Neurological Disorders and Stroke. Additional support was provided through AG-023629, AG-15928, AG-20098, and AG-027058 from the National Institute on Aging. See also http://www.chs-nhlbi.org/pi.htm. DNA handling and genotyping was supported in part by the Clinical Translational Science Institute grant UL1RR033176 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. Additional funding was provided by the Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR). The Multi-Ethnic Study of Atherosclerosis (MESA) and MESA SNP Health Association Resource (SHARe) are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support is provided by grants and contracts N01 HC-95159 through N01-HC-95169 and RR-024156. Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-6-4278. The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. The GWA database of the Rotterdam Study was funded through the Netherlands Organization of Scientific Research NWO (nr. 175.010.2005.011).; The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for Scientific Research, the Netherlands Organization for Health Research and Development, the Research Institute for Diseases in the Elderly, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The ophthalmologic part of the Rotterdam Study was supported by Lijf en Leven, Krimpen a/d Lek; MD Fonds, Utrecht. Oogfonds Nederland, Utrecht; Stichting Nederlands Oogheelkundig Onderzoek, Nijmegen/Rotterdam; Swart van Essen, Rotterdam; Netherlands Organisation for Scientific Research; Bevordering van Volkskracht, Rotterdam; Blindenhulp, The Hague; Rotterdamse Vereniging Blindenbelangen, Rotterdam; OOG, The Hague; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Doorn; Blinden-Penning, Amsterdam; Blindenhulp, 's Gravenzande; Henkes Stichting, Rotterdam; Topcon Europe BV, Capelle aan de IJssel; Medical Workshop BV, Groningen; all in the Netherlands; Heidelberg Engineering, Dossenheim, Germany. The Singapore Indian Eye Study was funded by grants from the Biomedical Research Council of Singapore (BMRC 09/1/35/19/616 and BMRC 08/1/35/19/550) and the National Medical Research Council of Singapore (NMRC/STaR/0003/2008). The Singapore BioBank and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for tissue archival and genotyping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cooper LS, 2006, STROKE, V37, P82, DOI 10.1161/01.STR.0000195134.04355.e5; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edwards MS, 2005, AM J KIDNEY DIS, V46, P214, DOI 10.1053/j.ajkd.2005.05.005; Fossdal R, 2004, HUM MOL GENET, V13, P975, DOI 10.1093/hmg/ddh106; Franceschini N, 2011, AM J HYPERTENS, V24, P392, DOI 10.1038/ajh.2010.218; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grosso A, 2011, J HYPERTENS, V29, P1667, DOI 10.1097/HJH.0b013e3283496655; Gunnlaugsdottir E, 2011, RETINOPATHY OLD PERS; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Izzedine H, 2003, J AM SOC NEPHROL, V14, P516, DOI 10.1097/01.ASN.0000051705.97966.AD; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; Klein Ronald, 2006, Trans Am Ophthalmol Soc, V104, P98; Klein R, 2010, ARCH OPHTHALMOL-CHIC, V128, P1568, DOI 10.1001/archophthalmol.2010.298; Klungel OH, 2001, ARCH INTERN MED, V161, P37, DOI 10.1001/archinte.161.1.37; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Longstreth WT, 2007, AM J EPIDEMIOL, V165, P78, DOI 10.1093/aje/kwj350; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mitchell P, 2005, NEUROLOGY, V65, P1005, DOI 10.1212/01.wnl.0000179177.15900.ca; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Perronnet C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/849426; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Singleton JR, 2003, DIABETES, V52, P2867, DOI 10.2337/diabetes.52.12.2867; Sobrin L, 2011, INVEST OPHTH VIS SCI, V52, P7593, DOI 10.1167/iovs.11-7510; van Hecke MV, 2005, DIABETOLOGIA, V48, P1300, DOI 10.1007/s00125-005-1799-y; van Hecke MV, 2003, DIABETES CARE, V26, P2958, DOI 10.2337/diacare.26.10.2958; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; Vassy JL, 2012, BEST PRACT RES CL EN, V26, P189, DOI 10.1016/j.beem.2011.09.002; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Wong TY, 2002, JAMA-J AM MED ASSOC, V288, P67, DOI 10.1001/jama.288.1.67; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P301, DOI 10.1136/bjo.2005.084400; Wong TY, 2005, AM J OPHTHALMOL, V140, P1157, DOI 10.1016/j.ajo.2005.07.030; Wong TY, 2005, JAMA-J AM MED ASSOC, V293, P63, DOI 10.1001/jama.293.1.63; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; Wong TY, 2004, J AM SOC NEPHROL, V15, P2469, DOI 10.1097/01.ASN.0000136133.28194.E4; Wong TY, 2003, OPHTHALMOLOGY, V110, P933, DOI 10.1016/S0161-6420(03)00084-8; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5	52	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54232	10.1371/journal.pone.0054232	http://dx.doi.org/10.1371/journal.pone.0054232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393555	Green Submitted, Green Published, gold			2022-12-25	WOS:000314692800009
J	Morgan, KS; Donnelley, M; Paganin, DM; Fouras, A; Yagi, N; Suzuki, Y; Takeuchi, A; Uesugi, K; Boucher, RC; Parsons, DW; Siu, KKW				Morgan, Kaye S.; Donnelley, Martin; Paganin, David M.; Fouras, Andreas; Yagi, Naoto; Suzuki, Yoshio; Takeuchi, Akihisa; Uesugi, Kentaro; Boucher, Richard C.; Parsons, David W.; Siu, Karen K. W.			Measuring Airway Surface Liquid Depth in Ex Vivo Mouse Airways by X-Ray Imaging for the Assessment of Cystic Fibrosis Airway Therapies	PLOS ONE			English	Article							HYPERTONIC SALINE; PATHOGENESIS; CLEARANCE	In the airways of those with cystic fibrosis (CF), the leading pathophysiological hypothesis is that an ion channel defect results in a relative decrease in airway surface liquid (ASL) volume, producing thick and sticky mucus that facilitates the establishment and progression of early fatal lung disease. This hypothesis predicts that any successful CF airway treatment for this fundamental channel defect should increase the ASL volume, but up until now there has been no method of measuring this volume that would be compatible with in vivo monitoring. In order to accurately monitor the volume of the ASL, we have developed a new x-ray phase contrast imaging method that utilizes a highly attenuating reference grid. In this study we used this imaging method to examine the effect of a current clinical CF treatment, aerosolized hypertonic saline, on ASL depth in ex vivo normal mouse tracheas, as the first step towards non-invasive in vivo ASL imaging. The ex vivo tracheas were treated with hypertonic saline, isotonic saline or no treatment using a nebuliser integrated within a small animal ventilator circuit. Those tracheas exposed to hypertonic saline showed a transient increase in the ASL depth, which continued for nine minutes post-treatment, before returning to baseline by twelve minutes. These findings are consistent with existing measurements on epithelial cell cultures, and therefore suggest promise for the future development of in vivo testing of treatments. Our grid-based imaging technique measures the ASL depth with micron resolution, and can directly observe the effect of treatments expected to increase ASL depth, prior to any changes in overall lung health. The ability to non-invasively observe micron changes in the airway surface, particularly if achieved in an in vivo setting, may have potential in pre-clinical research designed to bring new treatments for CF and other airway diseases to clinical trials.	[Morgan, Kaye S.; Paganin, David M.; Siu, Karen K. W.] Monash Univ, Sch Phys, Melbourne, Vic 3004, Australia; [Donnelley, Martin; Parsons, David W.] Womens & Childrens Hosp, Adelaide, SA, Australia; [Donnelley, Martin; Parsons, David W.] Univ Adelaide, Dept Paediat & Reprod Hlth, Adelaide, SA, Australia; [Donnelley, Martin; Parsons, David W.] Univ Adelaide, Ctr Stem Cell Res, Adelaide, SA, Australia; [Fouras, Andreas] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia; [Yagi, Naoto; Suzuki, Yoshio; Takeuchi, Akihisa; Uesugi, Kentaro] SPring 8 Japan Synchrotron Radiat Res Inst, Kouto, Hyogo, Japan; [Boucher, Richard C.] Univ N Carolina, Cyst Fibrosis Res & Treatment Ctr, Chapel Hill, NC USA; [Siu, Karen K. W.] Monash Univ, Melbourne, Vic 3004, Australia; [Siu, Karen K. W.] Australian Synchrotron, Melbourne, Vic, Australia	Monash University; Womens & Childrens Hospital Australia; University of Adelaide; University of Adelaide; Monash University; University of North Carolina; University of North Carolina Chapel Hill; Monash University	Morgan, KS (corresponding author), Monash Univ, Sch Phys, Melbourne, Vic 3004, Australia.	kaye.morgan@monash.edu	Fouras, Andreas/A-9410-2008; Parsons, David Webb/A-5831-2011; Morgan, Kaye/A-3632-2011; Siu, Karen K W/C-1472-2008; Donnelley, Martin/A-1195-2019	Fouras, Andreas/0000-0002-8933-1759; Parsons, David Webb/0000-0003-1746-3290; Morgan, Kaye/0000-0001-6997-7977; Paganin, David/0000-0002-7758-7140; Uesugi, Kentaro/0000-0003-2579-513X; Donnelley, Martin/0000-0002-5320-7756	International Synchrotron Access Program (ISAP); Australian Government; Australian Research Council; National Health and Medical Research Council; Cure4CF Foundation Limited; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108808] Funding Source: NIH RePORTER	International Synchrotron Access Program (ISAP); Australian Government(Australian GovernmentCGIAR); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cure4CF Foundation Limited; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge travel funding provided by the International Synchrotron Access Program (ISAP) managed by the Australian Synchrotron and funded by the Australian Government. This work is supported by the Australian Research Council, the National Health and Medical Research Council and Cure4CF Foundation Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Brody AS, 2005, AM J RESP CRIT CARE, V172, P1246, DOI 10.1164/rccm.200503-401PP; Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Daviskas E, 1996, EUR RESPIR J, V9, P725, DOI 10.1183/09031936.96.09040725; Donaldson S, 2006, NEW ENGL J MED, V354, P250; Donnelley M, 2010, J SYNCHROTRON RADIAT, V17, P719, DOI 10.1107/S0909049510028451; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Griesenbach Uta, 2005, J Cyst Fibros, V4, P89, DOI 10.1016/j.jcf.2005.02.002; Hartmann J, 1900, ZT INSTRUMENTENKD, V29; Kitchen MJ, 2008, PHYS MED BIOL, V53, P6065, DOI 10.1088/0031-9155/53/21/012; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Mayo SC, 2004, OPT LETT, V29, P866, DOI 10.1364/OL.29.000866; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Morgan KS, 2012, AIP CONF PROC, V1466, P124, DOI 10.1063/1.4742280; Morgan KS, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694918; Morgan KS, 2011, OPT EXPRESS, V19, P19781, DOI 10.1364/OE.19.019781; Morgan KS, 2011, OPT LETT, V36, P55, DOI 10.1364/OL.36.000055; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ratjen F, 2012, CURR PHARM DESIGN, V18, P614, DOI 10.2174/138161212799315984; Shack RV, 1971, J OPTICAL SOC AM, V61; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; Song YL, 2009, AM J PHYSIOL-LUNG C, V297, pL1131, DOI 10.1152/ajplung.00085.2009; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6	28	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55822	10.1371/journal.pone.0055822	http://dx.doi.org/10.1371/journal.pone.0055822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383288	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800189
J	Bossenmeyer-Pourie, C; Pourie, G; Koziel, V; Helle, D; Jeannesson, E; Gueant, JL; Beck, B				Bossenmeyer-Pourie, Carine; Pourie, Gregory; Koziel, Violette; Helle, Deborah; Jeannesson, Elise; Gueant, Jean-Louis; Beck, Bernard			Early methyl donor deficiency produces severe gastritis in mothers and offspring through N-homocysteinylation of cytoskeleton proteins, cellular stress, and inflammation	FASEB JOURNAL			English	Article						E-cadherin; actin; oxidative stress; NF-kappa B pathway; apoptosis	FACTOR-KAPPA-B; SMOOTH-MUSCLE-CELLS; INSULIN-RESISTANCE; E-CADHERIN; IN-VITRO; ELDERLY POPULATION; ATROPHIC GASTRITIS; FOLATE-DEFICIENCY; TREFOIL FACTOR-1; OXIDATIVE STRESS	We examined the gastric mucosa structure and inflammatory status in control well-nourished Wistar dams and in Wistar dams deprived of choline, folate, and vitamin B-12 during gestation and suckling periods, and in their offspring just before birth and at weaning. In this model of methyl donor deficiency (MDD), structural protein (E-cadherin and actin) N-homocysteinylation was measured through immunoprecipitation and proximity ligation assays. Cellular stress, inflammation, and apoptosis were estimated by the analysis of the NF-kappa B pathway, and the expression of superoxide dismutase, cyclooxygenase-2, tumor necrosis factor alpha, caspases 3 and 9, and TUNEL assay. Aberrant gastric mucosa formation and signs of surface layer erosion were detected in MDD fetuses and weanlings. E-cadherin and actin were N-homocysteinylated (+215 and +249% vs. controls, respectively; P< 0.001). Expression of beta-catenin staining drastically decreased (-98%; P<0.01). NF-kappa B pathway was activated (+124%; P<0.01). Expressions of all inflammatory factors (+70%; P<0.01), superoxide dismutase (+55%; P<0.01), and caspases (+104%; P<0.01) were markedly increased. These changes were also observed in dams, to a lesser extent. Early MDD induced gastric mucosa injury similar to atrophic gastritis through structural protein N-homocysteinylation, marked inflammation, and apoptosis, despite activation of repair machinery.	[Bossenmeyer-Pourie, Carine; Pourie, Gregory; Koziel, Violette; Helle, Deborah; Jeannesson, Elise; Gueant, Jean-Louis; Beck, Bernard] INSERM, Nutr Genet & Exposit Risques Environm U954, Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Beck, B (corresponding author), Fac Med, INSERM, U954, BP 184, F-54505 Vandoeuvre Les Nancy, France.	bernard.beck@inserm.fr	Bossenmeyer-Pourié, Carine/F-7695-2019	Bossenmeyer-Pourié, Carine/0000-0003-3831-4809				AimoneGastin I, 1997, GUT, V41, P475, DOI 10.1136/gut.41.4.475; Akchiche N, 2012, FASEB J, V26, P3980, DOI 10.1096/fj.12-205757; Bai YP, 2007, BIOCHEM BIOPH RES CO, V360, P20, DOI 10.1016/j.bbrc.2007.05.222; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; BERGMANN S, 1994, J IMMUNOL, V153, P1736; Blaise S, 2005, PEDIATR RES, V57, P777, DOI 10.1203/01.PDR.0000161406.19231.98; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Bossenmeyer-Pourie C, 2002, J CELL BIOL, V157, P761, DOI 10.1083/jcb200108056; Bossenmeyer-Pourie C, 2010, AM J PATHOL, V176, P270, DOI 10.2353/ajpath.2010.090153; Cheung GTY, 2008, CAN J PHYSIOL PHARM, V86, P88, DOI [10.1139/Y08-002, 10.1139/y08-002]; Contasta I, 1999, CANCER BIOTHER RADIO, V14, P465, DOI 10.1089/cbr.1999.14.465; Dholakia KR, 2005, WORLD J GASTROENTERO, V11, P7078, DOI 10.3748/wjg.v11.i45.7078; Ducros V, 2006, CLIN CHEM LAB MED, V44, P987, DOI 10.1515/CCLM.2006.178; Durer U, 2007, CELL PHYSIOL BIOCHEM, V20, P329, DOI 10.1159/000107519; Eida M., 2002, GASTROINTEST ONCOL, V4, P203; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; Giraud AS, 2007, AM J PHYSIOL-GASTR L, V292, pG1, DOI 10.1152/ajpgi.00382.2006; Gori AM, 2007, CLIN CHEM LAB MED, V45, P1728, DOI 10.1515/CCLM.2007.347; Hanby AM, 1996, AM J PATHOL, V148, P723; Herrmann W, 2001, CLIN CHEM, V47, P1094; Howell JM, 2006, PROTEOMICS, V6, P2050, DOI 10.1002/pmic.200500517; Huerta JM, 2004, FREE RADICAL RES, V38, P1215, DOI 10.1080/10715760400017269; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H, 2009, FASEB J, V23, P1721, DOI 10.1096/fj.08-127548; Karam SM, 2004, GUT, V53, P1408, DOI 10.1136/gut.2003.031963; KRASINSKI SD, 1986, J AM GERIATR SOC, V34, P800, DOI 10.1111/j.1532-5415.1986.tb03985.x; Lee JE, 2010, AM J CLIN NUTR, V91, P1303, DOI 10.3945/ajcn.2009.28456; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; LINDENBAUM J, 1994, AM J CLIN NUTR, V60, P2, DOI 10.1093/ajcn/60.1.2; MAGNUSSON I, 1985, Scandinavian Journal of Gastroenterology, V20, P623, DOI 10.3109/00365528509089707; Maloney CA, 2007, BRIT J NUTR, V97, P1090, DOI 10.1017/S0007114507670834; Martos R, 2006, METABOLISM, V55, P72, DOI 10.1016/j.metabol.2005.07.008; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; Milman N, 2006, EUR J HAEMATOL, V76, P521, DOI 10.1111/j.0902-4441.2006.t01-1-EJH2550.x; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; MONGIN M, 1993, ANN GASTROENT HEPATO, V29, P42; Moriyama N, 2001, J LAB CLIN MED, V138, P236, DOI 10.1067/mlc.2001.118177; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; NEWBERNE PM, 1973, NATURE, V242, P263, DOI 10.1038/242263b0; Obeid R, 2005, CLIN CHEM LAB MED, V43, P1052, DOI 10.1515/CCLM.2005.184; Paoli P, 2010, J MOL BIOL, V400, P889, DOI 10.1016/j.jmb.2010.05.039; Perla-Kajan J, 2007, AMINO ACIDS, V32, P561, DOI 10.1007/s00726-006-0432-9; Perna AF, 2003, AMINO ACIDS, V25, P409, DOI 10.1007/s00726-003-0026-8; Peyrin-Biroulet L, 2007, AM J GASTROENTEROL, V102, P1108, DOI 10.1111/j.1572-0241.2007.01170.x; Roubenoff R, 1997, ARTHRITIS RHEUM, V40, P718, DOI 10.1002/art.1780400418; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Sibrian-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P551, DOI 10.1073/pnas.0909737107; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sipponen P, 2003, SCAND J GASTROENTERO, V38, P1209, DOI 10.1080/00365520310007224; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Stabler SP, 2004, ANNU REV NUTR, V24, P299, DOI 10.1146/annurev.nutr.24.012003.132440; Stroylova YY, 2011, BBA-PROTEINS PROTEOM, V1814, P1234, DOI 10.1016/j.bbapap.2011.05.017; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Takahashi S, 1998, AM J PHYSIOL-GASTR L, V275, pG1137, DOI 10.1152/ajpgi.1998.275.5.G1137; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; Testino G, 1993, Ann Ital Med Int, V8, P86; Tomasetto C, 2000, GASTROENTEROLOGY, V118, P70, DOI 10.1016/S0016-5085(00)70415-X; Undas A, 2004, STROKE, V35, P1299, DOI 10.1161/01.STR.0000128412.59768.6e; Wallace JL, 2005, BRIT J PHARMACOL, V145, P275, DOI 10.1038/sj.bjp.0706201; Wallace JL, 2001, EXP BIOL MED, V226, P1003, DOI 10.1177/153537020122601107; Wang GP, 2000, BIOCHEM J, V352, P817, DOI 10.1042/0264-6021:3520817; Weinberg JB, 2000, IMMUNOL RES, V22, P319, DOI 10.1385/IR:22:2-3:319; Wu N, 2009, AM J PHYSIOL-REG I, V297, pR1086, DOI 10.1152/ajpregu.00293.2009; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Zeisel SH, 2009, AM J CLIN NUTR, V89, p673S, DOI 10.3945/ajcn.2008.26811D; Zeng XK, 2005, ACTA PHARMACOL SIN, V26, P85, DOI 10.1111/j.1745-7254.2005.00005.x; Zhang L, 2006, CELL BIOL INT, V30, P592, DOI 10.1016/j.cellbi.2006.03.007	67	18	19	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2185	2197		10.1096/fj.12-224642	http://dx.doi.org/10.1096/fj.12-224642			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23401564				2022-12-25	WOS:000319667600010
J	Ahmedli, NB; Gribanova, Y; Njoku, CC; Naidu, A; Young, A; Mendoza, E; Yamashita, CK; Ozgul, RK; Johnson, JE; Fox, DA; Farber, DB				Ahmedli, Novruz B.; Gribanova, Yekaterina; Njoku, Collins C.; Naidu, Akash; Young, Alejandra; Mendoza, Emmanuel; Yamashita, Clyde K.; Ozgul, Riza Koksal; Johnson, Jerry E.; Fox, Donald A.; Farber, Debora B.			Dynamics of the Rhomboid-like Protein RHBDD2 Expression in Mouse Retina and Involvement of Its Human Ortholog in Retinitis Pigmentosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE PROTEOLYSIS; FINGER PROTEIN; SALT BRIDGES; DROSOPHILA; PHOTORECEPTOR; PROTEASES; GENES; CONES; ROD; SPECIFICITY	The novel rhomboid-like protein RHBDD2 is distantly related to rhomboid proteins, a group of highly specialized membrane-bound proteases that catalyze regulated intramembrane proteolysis. In retina, RHBDD2 is expressed from embryonic stages to adulthood, and its levels show age-dependent changes. RHBDD2 is distinctly abundant in the perinuclear region of cells, and it localizes to their Golgi. A glycine zipper motif present in one of the transmembrane domains of RHBDD2 is important for its packing into the Golgi membranes. Its deletion causes dislodgment of RHBDD2 from the Golgi. A specific antibody against RHBDD2 recognizes two forms of the protein, one with low (39 kDa; RHBDD2(L)) and the other with high (117 kDa; RHBDD2(H)) molecular masses in mouse retinal extracts. RHBDD2(L) seems to be ubiquitously expressed in all retinal cells. In contrast, RHBDD2(H) seems to be present only in the outer segments of cone photoreceptors and may correspond to a homotrimer of RHBDD2(L). This protein consistently co-localizes with S- and M-types of cone opsins. We identified a homozygous mutation in the human RHBDD2 gene, R85H, that co-segregates with disease in affected members of a family with autosomal recessive retinitis pigmentosa. Our findings suggest that the RHBDD2 protein plays important roles in the development and normal function of the retina.	[Ahmedli, Novruz B.; Gribanova, Yekaterina; Njoku, Collins C.; Naidu, Akash; Young, Alejandra; Mendoza, Emmanuel; Yamashita, Clyde K.; Farber, Debora B.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Farber, Debora B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Ozgul, Riza Koksal] Hacettepe Univ, Dept Mol Biol, TR-06230 Beytepe, Turkey; [Johnson, Jerry E.] Univ Houston Downtown, Dept Nat Sci, Houston, TX 77002 USA; [Fox, Donald A.] Univ Houston, Coll Optometry, Houston, TX 77004 USA; [Fox, Donald A.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Fox, Donald A.] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77004 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Hacettepe University; University of Houston System; University of Houston; University of Houston Downtown; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston	Ahmedli, NB (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, 100 Stein Plaza, Los Angeles, CA 90095 USA.	akhmedov@jsei.ucla.edu	OZGUL, RIZA KOKSAL/J-1569-2013	Ozgul, Riza Koksal/0000-0002-0283-635X; Farber, Debora/0000-0002-3207-697X; Young, Alejandra/0000-0002-1855-0559	National Institutes of Health [RO1 EY08285, RO1 ES012482, P30 EY000331, T32 EY07024, P30 EY07551]; Hope for Vision; Oppenheimer Foundation; NATIONAL EYE INSTITUTE [T32EY007024, P30EY007551, P30EY000331, R01EY008285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Vision; Oppenheimer Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY08285 (to D. B. F.), RO1 ES012482 (to D. A. F.), P30 EY000331 (to the Jules Stein Eye Institute), and T32 EY07024 and P30 EY07551 (to the University of Houston College of Optometry). This work was also supported by Hope for Vision and Oppenheimer Foundation grants (to N. B. A.).	Abba MC, 2009, BBA-MOL BASIS DIS, V1792, P988, DOI 10.1016/j.bbadis.2009.07.006; Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chiu CF, 2008, EMBO J, V27, P934, DOI 10.1038/emboj.2008.40; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Freeman M, 2009, SEMIN CELL DEV BIOL, V20, P231, DOI 10.1016/j.semcdb.2008.10.006; Frigyes D, 2001, J MOL STRUC-THEOCHEM, V574, P39, DOI 10.1016/S0166-1280(01)00368-2; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; Giddabasappa A, 2011, ENVIRON HEALTH PERSP, V119, P71, DOI 10.1289/ehp.1002524; Gough LL, 2003, MOL BIOL CELL, V14, P2410, DOI 10.1091/mbc.E02-07-0446; Ha Y, 2009, SEMIN CELL DEV BIOL, V20, P240, DOI 10.1016/j.semcdb.2008.11.006; Johnson JE, 2007, MOL VIS, V13, P887; Kerov VS, 2005, MOL CELL NEUROSCI, V28, P485, DOI 10.1016/j.mcn.2004.10.010; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Lacunza E, 2012, TUMOR BIOL, V33, P2393, DOI 10.1007/s13277-012-0503-3; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lerner LE, 2005, J BIOL CHEM, V280, P20642, DOI 10.1074/jbc.M500957200; LLEWELLYN DH, 1993, HUM MOL GENET, V2, P1315, DOI 10.1093/hmg/2.8.1315; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Morahan BJ, 2009, EXP PARASITOL, V122, P280, DOI 10.1016/j.exppara.2009.04.013; Perkins GA, 2003, MOL VIS, V9, P60; Saghizadeh M, 2011, MOL VIS, V17, P2011; Saghizadeh M, 2009, INVEST OPHTH VIS SCI, V50, P3580, DOI 10.1167/iovs.08-2751; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Srinivasan P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000262; SUNDARALINGAM M, 1985, P NATL ACAD SCI USA, V82, P7944, DOI 10.1073/pnas.82.23.7944; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Walder K, 2005, DIABETOLOGIA, V48, P459, DOI 10.1007/s00125-005-1675-9; Wasserman JD, 2000, GENE DEV, V14, P1651; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Wilson C, 2011, BIOCHEM J, V433, P1, DOI 10.1042/BJ20101058; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187	41	10	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9742	9754		10.1074/jbc.M112.419960	http://dx.doi.org/10.1074/jbc.M112.419960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23386608	Green Published, hybrid			2022-12-25	WOS:000317114000016
J	Fricker, M; Vilalta, A; Tolkovsky, AM; Brown, GC				Fricker, Michael; Vilalta, Anna; Tolkovsky, Aviva M.; Brown, Guy C.			Caspase Inhibitors Protect Neurons by Enabling Selective Necroptosis of Inflamed Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIC BRAIN-INJURY; PRIMARY PHAGOCYTOSIS; CELL-DEATH; CEREBRAL-ISCHEMIA; VIABLE NEURONS; RIP1 KINASE; TNF-ALPHA; NEURODEGENERATION; ACTIVATION; APOPTOSIS	Microglia are resident brain macrophages, which can cause neuronal loss when activated in infectious, ischemic, traumatic, and neurodegenerative diseases. Caspase-8 has both prodeath and prosurvival roles, mediating apoptosis and/or preventing RIPK1-mediated necroptosis depending on cell type and stimulus. We found that inflammatory stimuli (LPS, lipoteichoic acid, or TNF-alpha) caused an increase in caspase-8 IETDase activity in primary rat microglia without inducing apoptosis. Inhibition of caspase-8 with either Z-VAD-fmk or IETD-fmk resulted in necrosis of activated microglia. Inhibition of caspases with Z-VAD-fmk did not kill non-activated microglia, or astrocytes and neurons in any condition. Necrostatin-1, a specific inhibitor of RIPK1, prevented microglial caspase inhibition-induced death, indicating death was by necroptosis. In mixed cerebellar cultures of primary neurons, astrocytes, and microglia, LPS induced neuronal loss that was prevented by inhibition of caspase-8 (resulting in microglial necroptosis), and neuronal death was restored by rescue of microglia with necrostatin-1. We conclude that the activation of caspase-8 in inflamed microglia prevents their death by necroptosis, and thus, caspase-8 inhibitors may protect neurons in the inflamed brain by selectively killing activated microglia.	[Fricker, Michael; Vilalta, Anna; Brown, Guy C.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Tolkovsky, Aviva M.] Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB2 OPY, England	University of Cambridge; University of Cambridge	Fricker, M (corresponding author), Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2305, Australia.	michael.fricker@gmail.com	Brown, Guy C./HHC-1102-2022; FRICKER, MICHAEL/ABE-2316-2021	Vilalta, Anna/0000-0002-2183-072X; Brown, Guy/0000-0002-3610-1730; Fricker, Michael/0000-0002-8587-1774	Wellcome Trust Grant [RG50995]	Wellcome Trust Grant(Wellcome Trust)	This work was supported by Wellcome Trust Grant RG50995.	Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Ciechomska Iwona A., 2008, V445, P175, DOI 10.1007/978-1-59745-157-4_12; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2013, CELL DEATH DIFFER, V20, P366, DOI 10.1038/cdd.2012.133; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Feng YZ, 2003, EUR J PHARMACOL, V481, P169, DOI 10.1016/j.ejphar.2003.09.016; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196; Fricker M, 2012, J NEUROSCI, V32, P2657, DOI 10.1523/JNEUROSCI.4837-11.2012; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Inoue S, 2006, ANESTH ANALG, V102, P1548, DOI 10.1213/01.ane.0000202381.40516.8d; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kinsner A, 2005, J NEUROCHEM, V95, P1132, DOI 10.1111/j.1471-4159.2005.03422.x; Neher JJ, 2007, BIOCHEM SOC T, V35, P1166, DOI 10.1042/BST0351166; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Solorzano CC, 1997, SHOCK, V7, P427, DOI 10.1097/00024382-199706000-00007; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Venero JL, 2011, CELL DEATH DIFFER, V18, P1679, DOI 10.1038/cdd.2011.107; Venters HD, 2000, TRENDS NEUROSCI, V23, P175, DOI 10.1016/S0166-2236(99)01533-7; Wiessner C, 2000, CELL MOL BIOL, V46, P53	28	68	71	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9145	9152		10.1074/jbc.M112.427880	http://dx.doi.org/10.1074/jbc.M112.427880			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386613	Green Published, hybrid			2022-12-25	WOS:000316862200034
J	Antonioni, A; Cacault, MP; Lalive, R; Tomassini, M				Antonioni, Alberto; Cacault, Maria Paula; Lalive, Rafael; Tomassini, Marco			Coordination on Networks: Does Topology Matter?	PLOS ONE			English	Article							LOCAL INTERACTION; COOPERATION	Effective coordination is key to many situations that affect the well-being of two or more humans. Social coordination can be studied in coordination games between individuals located on networks of contacts. We study the behavior of humans in the laboratory when they play the Stag Hunt game - a game that has a risky but socially efficient equilibrium and an inefficient but safe equilibrium. We contrast behavior on a cliquish network to behavior on a random network. The cliquish network is highly clustered and resembles more closely to actual social networks than the random network. In contrast to simulations, we find that human players dynamics do not converge to the efficient outcome more often in the cliquish network than in the random network. Subjects do not use pure myopic best-reply as an individual update rule. Numerical simulations agree with laboratory results once we implement the actual individual updating rule that human subjects use in our laboratory experiments.	[Antonioni, Alberto; Cacault, Maria Paula; Lalive, Rafael; Tomassini, Marco] Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland	University of Lausanne	Antonioni, A (corresponding author), Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland.	alberto.antonioni@unil.ch	Antonioni, Alberto/B-9686-2014; Tomassini, Marco/D-6312-2013; Antonioni, Alberto/U-6497-2018	Antonioni, Alberto/0000-0002-5788-3348; Antonioni, Alberto/0000-0002-5788-3348; Cacault, Maria Paula/0000-0001-9241-2368; Lalive, Rafael/0000-0003-1938-692X	Swiss National Scientific Foundation [200021-132802/1]	Swiss National Scientific Foundation(Swiss National Science Foundation (SNSF))	For A. Antonioni the project is funded by the Swiss National Scientific Foundation under grant n. 200021-132802/1 (http://www.snf.ch/F/Pages/default.aspx). This support was also used to pay the experimental subjects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battalio R, 2001, ECONOMETRICA, V61, P989; Berninghaus SK, 2002, GAME ECON BEHAV, V39, P177, DOI 10.1006/game.2001.0897; Camerer C, 2003, BEHAV GAME THEORY; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; COOPER R, 1992, Q J ECON, V107, P739, DOI 10.2307/2118488; Easley D, 2010, NETWORKS CROWDS MARK; Efferson C, 2008, SCIENCE, V321, P1844, DOI 10.1126/science.1155805; ELLISON G, 1993, ECONOMETRICA, V61, P1047, DOI 10.2307/2951493; Ellison G, 2000, REV ECON STUD, V67, P17, DOI 10.1111/1467-937X.00119; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frey V, 2012, REV NETW ECON, V11, DOI 10.1515/1446-9022.1365; Goyal Sanjeev, 2007, CONNECTIONS INTRO EC; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; Keser C, 1998, ECON LETT, V58, P269, DOI 10.1016/S0165-1765(97)00289-9; Luthi L, 2008, PHYSICA A, V387, P955, DOI 10.1016/j.physa.2007.09.046; Morris S, 2000, REV ECON STUD, V67, P57, DOI 10.1111/1467-937X.00121; My KB, 1999, WORKING PAPERS BETA; Roca CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015210; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Samuelson L., 1997, EVOLUTIONARY GAMES E; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tomassini M, 2010, INT J MOD PHYS C, V21, P1277, DOI 10.1142/S012918311001583X; VANHUYCK JB, 1993, GAME ECON BEHAV, V5, P485, DOI 10.1006/game.1993.1026; VANHUYCK JB, 1990, AM ECON REV, V80, P234; Vega-Redondo F., 2003, EC THEORY GAMES, P1, DOI [10.1017/CBO9780511753954, DOI 10.1017/CBO9780511753954]; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weidenholzer S, 2010, GAMES-BASEL, V1, P551; Young H.P., 1998, INDIVIDUAL STRATEGY, DOI DOI 10.1515/9780691214252	33	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55033	10.1371/journal.pone.0055033	http://dx.doi.org/10.1371/journal.pone.0055033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405109	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400053
J	Arachiche, A; de la Fuente, M; Nieman, MT				Arachiche, Amal; de la Fuente, Maria; Nieman, Marvin T.			Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets	PLOS ONE			English	Article							THROMBIN; PATHWAYS; AGGREGATION; INHIBITION; GENERATION; EXPOSURE; G(12/13); RELEASE; ABSENCE; ADP	Thrombin activates platelets through protease activated receptors (PARs). Mouse platelets express PAR3 and PAR4. PAR3 does not signal in platelets. However, PAR4 is a relatively poor thrombin substrate and requires PAR3 as a cofactor at low thrombin concentrations. In this study we show that PAR3 also regulates PAR4 signaling. In response to thrombin (30-100 nM) or PAR4 activating peptide (AYPGKF), platelets from PAR3(-/-) mice had increased Gq signaling compared to wild type mice as demonstrated by a 1.6-fold increase in the maximum intracellular calcium (Ca2+) mobilization, an increase in phosphorylation level of protein kinase C (PKC) substrates, and a 2-fold increase of Ca2+ release from intracellular stores. Moreover, platelets from heterozygous mice (PAR3(+/-)) had an intermediate increase in maximum Ca2+ mobilization. Treatment of PAR3(-/-) mice platelets with P2Y(12) antagonist (2MeSAMP) did not affect Ca2+ mobilization from PAR4 in response to thrombin or AYPGKF. The activation of RhoA-GTP downstream G(12/13) signaling in response to thrombin was not significantly different between wild type and PAR3(-/-) mice. Since PAR3 influenced PAR4 signaling independent of agonist, we examined the direct interaction between PAR3 and PAR4 with bioluminescence resonance energy transfer (BRET). PAR3 and PAR4 form constitutive homodimers and heterodimers. In summary, our results demonstrate that in addition to enhancing PAR4 activation at low thrombin concentrations, PAR3 negatively regulates PAR4-mediated maximum Ca2+ mobilization and PKC activation in mouse platelets by physical interaction.	[Arachiche, Amal; de la Fuente, Maria; Nieman, Marvin T.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Nieman, MT (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	nieman@case.edu			American Society for Hematology (Scholar Award); National Institutes of Health [R01 HL098217]; Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland [P30 CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098217] Funding Source: NIH RePORTER	American Society for Hematology (Scholar Award); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the American Society for Hematology (Scholar Award) and the National Institutes of Health (R01 HL098217) to MN. This research was also supported by the Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arachiche A, 2009, ARTERIOSCL THROM VAS, V29, P1883, DOI 10.1161/ATVBAHA.109.190926; Bachelot-Loza C, 2006, BRIT J HAEMATOL, V133, P419, DOI 10.1111/j.1365-2141.2006.06031.x; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; de la Fuente M, 2012, J BIOL CHEM, V287, P10414, DOI 10.1074/jbc.M112.341438; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harper MT, 2011, J THROMB HAEMOST, V9, P1599, DOI 10.1111/j.1538-7836.2011.04393.x; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Ishihara H, 1998, BLOOD, V91, P4152, DOI 10.1182/blood.V91.11.4152.411k22_4152_4157; Jantzen HM, 2001, J CLIN INVEST, V108, P477; Jardin I, 2007, BIOCHEM J, V401, P167, DOI 10.1042/BJ20060888; Jin JG, 2009, BIOCHEM PHARMACOL, V77, P835, DOI 10.1016/j.bcp.2008.11.017; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Madhusudhan T, 2012, BLOOD, V119, P874, DOI 10.1182/blood-2011-07-365973; Mao YY, 2009, PLATELETS, V20, P191, DOI 10.1080/09537100902803635; McCoy KL, 2012, CELL SIGNAL, V24, P1351, DOI 10.1016/j.cellsig.2012.01.011; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; NANEVICZ T, 1995, J BIOL CHEM, V270, P21619, DOI 10.1074/jbc.270.37.21619; Nieman MT, 2008, BIOCHEMISTRY-US, V47, P13279, DOI 10.1021/bi801334s; O'Brien KA, 2011, BLOOD, V118, P4215, DOI 10.1182/blood-2010-12-323204; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; Rosado JA, 2011, CELL CALCIUM, V50, P168, DOI 10.1016/j.ceca.2010.11.011; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Weiss EJ, 2002, BLOOD, V100, P3240, DOI 10.1182/blood-2002-05-1470; Wolberg AS, 2008, TRANSFUS APHER SCI, V38, P15, DOI 10.1016/j.transci.2007.12.005	36	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55740	10.1371/journal.pone.0055740	http://dx.doi.org/10.1371/journal.pone.0055740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405206	Green Submitted, gold, Green Published			2022-12-25	WOS:000315153400151
J	Ballhorn, DJ; Kautz, S; Heil, M				Ballhorn, Daniel J.; Kautz, Stefanie; Heil, Martin			Distance and Sex Determine Host Plant Choice by Herbivorous Beetles	PLOS ONE			English	Article							BEAN PHASEOLUS-LUNATUS; COLORADO-POTATO-BEETLE; LEAF BEETLE; PHYTOPHAGOUS INSECTS; SPECIALIST HERBIVORE; INDIRECT DEFENSES; NATURAL ENEMIES; CYDIA-POMONELLA; MATE LOCATION; VOLATILES	Background: Plants respond to herbivore damage with the release of volatile organic compounds (VOCs). This indirect defense can cause ecological costs when herbivores themselves use VOCs as cues to localize suitable host plants. Can VOCs reliably indicate food plant quality to herbivores? Methodology: We determined the choice behavior of herbivorous beetles (Chrysomelidae: Gynandrobrotica guerreroensis and Cerotoma ruficornis) when facing lima bean plants (Fabaceae: Phaseolus lunatus) with different cyanogenic potential, which is an important constitutive direct defense. Expression of inducible indirect defenses was experimentally manipulated by jasmonic acid treatment at different concentrations. The long-distance responses of male and female beetles to the resulting induced plant volatiles were investigated in olfactometer and free-flight experiments and compared to the shortdistance decisions of the same beetles in feeding trials. Conclusion: Female beetles of both species were repelled by VOCs released from all induced plants independent of the level of induction. In contrast, male beetles were repelled by strongly induced plants, showed no significant differences in choice behavior towards moderately induced plants, but responded positively to VOCs released from little induced plants. Thus, beetle sex and plant VOCs had a significant effect on host searching behavior. By contrast, feeding behavior of both sexes was strongly determined by the cyanogenic potential of leaves, although females again responded more sensitively than males. Apparently, VOCs mainly provide information to these beetles that are not directly related to food quality. Being induced by herbivory and involved in indirect plant defense, such VOCs might indicate the presence of competitors and predators to herbivores. We conclude that plant quality as a food source and finding a potentially enemy-free space is more important for female than for male insect herbivores, whereas the presence of a slightly damaged plant can help males to localize putative mating partners.	[Ballhorn, Daniel J.; Kautz, Stefanie; Heil, Martin] Univ Duisburg Essen, Dept Bot Plant Ecol, Essen, Germany	University of Duisburg Essen	Ballhorn, DJ (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.	ballhorn@pdx.edu	Heil, Martin/I-1797-2012; Heil, Martin/T-3960-2019; Heil, Martin/AAC-2730-2022	Heil, Martin/0000-0001-8036-8697; 	German Science Foundation (DFG) [He 3169/4-2, Ba 3966/1-1]; Deutscher Akademischer Austauschdienst (DAAD); German Academy of Sciences Leopoldina [LPDS 2009-29]	German Science Foundation (DFG)(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Academy of Sciences Leopoldina	This work was supported by the German Science Foundation (DFG) (:http://www.dfg.de/foerderung/index.html), grant numbers He 3169/4-2 and Ba 3966/1-1. The DFG provided equipment and consumables (He 3169/4-2) and salary to DJB (Ba 3966/1-1). The Deutscher Akademischer Austauschdienst (DAAD) (http://www.daad.de/de/index.html) provided salary to SK (no specific project number). The German Academy of Sciences Leopoldina (http://www.leopoldinahalle.de) provided salary to SK (grant number LPDS 2009-29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2003, J CHEM ECOL, V29, P1403, DOI 10.1023/A:1024265420375; Agrawal AA, 2003, J ECOL, V91, P1049, DOI 10.1046/j.1365-2745.2003.00831.x; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Ballhorn DJ, 2007, J CHEM ECOL, V33, P2195, DOI 10.1007/s10886-007-9380-4; Ballhorn DJ, 2010, ENTOMOL EXP APPL, V134, P245, DOI 10.1111/j.1570-7458.2009.00961.x; Ballhorn DJ, 2008, J CHEM ECOL, V34, P1298, DOI 10.1007/s10886-008-9540-1; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; Ballhorn DJ, 2006, J CHEM ECOL, V32, P1861, DOI 10.1007/s10886-006-9114-z; Ballhorn DJ, 2013, OECOLOGIA, V172, P833, DOI 10.1007/s00442-012-2539-x; Ballhorn DJ, 2011, J APPL BOT FOOD QUAL, V84, P65; Ballhorn DJ, 2011, J CHEM ECOL, V37, P141, DOI 10.1007/s10886-010-9905-0; Ballhorn DJ, 2009, PLANT SIGNAL BEHAV, V4, P743, DOI 10.4161/psb.4.8.9088; Ballhorn DJ, 2010, J ECOL, V98, P226, DOI 10.1111/j.1365-2745.2009.01591.x; Ballhorn DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005450; Ballhorn DJ, 2006, J CHEM ECOL, V32, P261, DOI 10.1007/s10886-005-9001-z; Ballhorn DJ, 2005, J CHEM ECOL, V31, P1445, DOI 10.1007/s10886-005-5791-2; Bolter CJ, 1997, J CHEM ECOL, V23, P1003, DOI 10.1023/B:JOEC.0000006385.70652.5e; Bonte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011174; Brilli F, 2009, PLANT CELL ENVIRON, V32, P542, DOI 10.1111/j.1365-3040.2009.01948.x; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Carroll MJ, 2008, J CHEM ECOL, V34, P291, DOI 10.1007/s10886-007-9414-y; Clark KE, 2011, ECOL ENTOMOL, V36, P117, DOI 10.1111/j.1365-2311.2010.01248.x; Cornelius ML, 2001, J ENTOMOL SCI, V36, P259, DOI 10.18474/0749-8004-36.3.259; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; DONATH J, 1994, J PLANT PHYSIOL, V143, P473, DOI 10.1016/S0176-1617(11)81809-2; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Ehrlich PR, 1964, EVOLUTION, V76, P1483; Fernandez P, 2007, BASIC APPL ECOL, V8, P97, DOI 10.1016/j.baae.2006.05.001; Frati F, 2008, PHYSIOL ENTOMOL, V33, P129, DOI 10.1111/j.1365-3032.2008.00614.x; Frati F, 2009, J CHEM ECOL, V35, P505, DOI 10.1007/s10886-009-9625-5; Ginzel MD, 2005, J CHEM ECOL, V31, P213, DOI 10.1007/s10886-005-6735-6; Hanks LM, 1996, J INSECT BEHAV, V9, P383, DOI 10.1007/BF02214017; Heil M, 2004, J ECOL, V92, P527, DOI 10.1111/j.0022-0477.2004.00890.x; Heil M, 2004, J CHEM ECOL, V30, P1289, DOI 10.1023/B:JOEC.0000030299.59863.69; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Hern A, 1999, ENTOMOL EXP APPL, V92, P63, DOI 10.1023/A:1003756428631; Hern A, 2004, NATURWISSENSCHAFTEN, V91, P77, DOI 10.1007/s00114-003-0484-6; Ikonen A, 2002, CHEMOECOLOGY, V12, P23, DOI 10.1007/s00049-002-8323-3; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; JERMY T, 1988, ENTOMOL EXP APPL, V49, P83, DOI 10.1007/BF00188242; Johnson SN, 2006, ECOL ENTOMOL, V31, P395, DOI 10.1111/j.1365-2311.2006.00776.x; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kessler A, 2009, FUNCT ECOL, V23, P901, DOI 10.1111/j.1365-2435.2009.01639.x; Koch T, 1999, PLANT PHYSIOL, V121, P153, DOI 10.1104/pp.121.1.153; Kost C, 2005, BASIC APPL ECOL, V6, P237, DOI 10.1016/j.baae.2004.11.002; Lill JT, 2001, OECOLOGIA, V126, P418, DOI 10.1007/s004420000557; Meiners T, 2005, ENTOMOL EXP APPL, V115, P171, DOI 10.1111/j.1570-7458.2005.00280.x; MIGUEL AA, 2005, J CHEM ECOL, V31, P315; Miyamoto Y, 2004, ENTOMOL SCI, V7, P315, DOI 10.1111/j.1479-8298.2004.00079.x; Mumm R, 2010, CAN J ZOOL, V88, P628, DOI 10.1139/Z10-032; Nahrung HF, 2003, AGRIC FOR ENTOMOL, V5, P155, DOI 10.1046/j.1461-9563.2003.00172.x; Natale D, 2003, B ENTOMOL RES, V93, P335, DOI 10.1079/BER2003250; Nieminen M, 2003, J CHEM ECOL, V29, P823, DOI 10.1023/A:1022923514534; PALANISWAMY P, 1993, CAN ENTOMOL, V125, P903, DOI 10.4039/Ent125903-5; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; RANK NE, 1992, OECOLOGIA, V90, P95, DOI 10.1007/BF00317814; Rausher MD, 1996, TRENDS GENET, V12, P212, DOI 10.1016/0168-9525(96)10020-2; Rostas M, 2003, BASIC APPL ECOL, V4, P43, DOI 10.1078/1439-1791-00132; Rudgers JA, 2006, J ECOL, V94, P1249, DOI 10.1111/j.1365-2745.2006.01161.x; Schutz S, 1997, NATURWISSENSCHAFTEN, V84, P212, DOI 10.1007/s001140050381; Sokal R. R., 2012, BIOMETRY; Strong DR, 1984, INSECTS ON PLANTS; Sun XL, 2010, J CHEM ECOL, V36, P388, DOI 10.1007/s10886-010-9771-9; Szentesi A, 2002, ENTOMOL EXP APPL, V105, P141, DOI 10.1023/A:1022194408297; Tanaka M, 2002, POPUL ECOL, V44, P1, DOI 10.1007/s101440200000; Thaler JS, 1999, INDUCED PLANT DEFENSES AGAINST PATHOGENS AND HERBIVORES, P319; Wybouw N, 2012, INSECT BIOCHEM MOLEC, V42, P881, DOI 10.1016/j.ibmb.2012.08.002; Yi HS, 2009, PLANT PHYSIOL, V151, P2152, DOI 10.1104/pp.109.144782; ZEHNDER G, 1987, ENVIRON ENTOMOL, V16, P1199, DOI 10.1093/ee/16.5.1199	74	23	26	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55602	10.1371/journal.pone.0055602	http://dx.doi.org/10.1371/journal.pone.0055602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405176	Green Published, gold			2022-12-25	WOS:000315153400121
J	Rodriguez-Raecke, R; Niemeier, A; Ihle, K; Ruether, W; May, A				Rodriguez-Raecke, Rea; Niemeier, Andreas; Ihle, Kristin; Ruether, Wolfgang; May, Arne			Structural Brain Changes in Chronic Pain Reflect Probably Neither Damage Nor Atrophy	PLOS ONE			English	Article							GRAY-MATTER DECREASE; CHRONIC BACK-PAIN; MOTOR CORTEX; SOMATOSENSORY CORTEX; GREY-MATTER; REORGANIZATION; FIBROMYALGIA; PLASTICITY; STIMULATION; MORPHOMETRY	Chronic pain appears to be associated with brain gray matter reduction in areas ascribable to the transmission of pain. The morphological processes underlying these structural changes, probably following functional reorganisation and central plasticity in the brain, remain unclear. The pain in hip osteoarthritis is one of the few chronic pain syndromes which are principally curable. We investigated 20 patients with chronic pain due to unilateral coxarthrosis (mean age 63.25 +/- 9.46 (SD) years, 10 female) before hip joint endoprosthetic surgery (pain state) and monitored brain structural changes up to 1 year after surgery: 6-8 weeks, 12-18 weeks and 10-14 month when completely pain free. Patients with chronic pain due to unilateral coxarthrosis had significantly less gray matter compared to controls in the anterior cingulate cortex (ACC), insular cortex and operculum, dorsolateral prefrontal cortex (DLPFC) and orbitofrontal cortex. These regions function as multi-integrative structures during the experience and the anticipation of pain. When the patients were pain free after recovery from endoprosthetic surgery, a gray matter increase in nearly the same areas was found. We also found a progressive increase of brain gray matter in the premotor cortex and the supplementary motor area (SMA). We conclude that gray matter abnormalities in chronic pain are not the cause, but secondary to the disease and are at least in part due to changes in motor function and bodily integration.	[Rodriguez-Raecke, Rea; Ihle, Kristin; May, Arne] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Niemeier, Andreas; Ruether, Wolfgang] Univ Med Ctr Hamburg Eppendorf, Dept Orthopaed, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	May, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	a.may@uke.uni-hamburg.de	Rodriguez-Raecke, Rea/AAU-8948-2020		DFG (German Research Foundation) [MA 1862/2-3]; BMBF (The Federal Ministry of Education and Research) [371 57 01]	DFG (German Research Foundation)(German Research Foundation (DFG)); BMBF (The Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the DFG (German Research Foundation) (MA 1862/2-3) and BMBF (The Federal Ministry of Education and Research) (371 57 01 and NeuroImage Nord). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Antal A, 2008, CLIN J PAIN, V24, P56, DOI 10.1097/AJP.0b013e318157233b; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Draganski B, 2006, NEUROIMAGE, V31, P951, DOI 10.1016/j.neuroimage.2006.01.018; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Duerden EG, 2008, J NEUROSCI, V28, P8655, DOI 10.1523/JNEUROSCI.2650-08.2008; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Fontaine D, 2009, J NEUROSURG, V110, P251, DOI 10.3171/2008.6.17602; Franke G, 2002, SYMPTOM CHECKLISTE N; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Geissner E, 1995, Rehabilitation (Stuttg), V34, pXXXV; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gwilym SE, 2010, ARTHRITIS RHEUM; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Levy R, 2010, PAIN PHYSICIAN, V13, P157; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; May A, 2009, MORPHING VOXELS HYPE; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; May A, 2009, BRAIN, V132, P1419, DOI 10.1093/brain/awp116; Nikolajsen L, 2006, ACTA ANAESTH SCAND, V50, P495, DOI 10.1111/j.1399-6576.2006.00976.x; O'Connell NE, 2011, EUR J PHYS REHAB MED, V47, P309; Puri BK, 2010, J INT MED RES, V38, P1468, DOI 10.1177/147323001003800429; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Schmidt-Wilcke T, 2010, HEADACHE; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Swart CMA, 2009, EUR J PAIN, V13, P902, DOI 10.1016/j.ejpain.2008.11.010; Teepker M, 2010, CEPHALALGIA, V30, P137, DOI 10.1111/j.1468-2982.2009.01911.x; Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Tsao H, 2008, BRAIN, V131, P2161, DOI 10.1093/brain/awn154; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072	49	93	94	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54475	10.1371/journal.pone.0054475	http://dx.doi.org/10.1371/journal.pone.0054475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405082	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400026
J	Smid, JH; Gras, LM; de Boer, AG; French, NP; Havelaar, AH; Wagenaar, JA; van Pelt, W				Smid, Joost H.; Gras, Lapo Mughini; de Boer, Albert G.; French, Nigel P.; Havelaar, Arie H.; Wagenaar, Jaap A.; van Pelt, Wilfrid			Practicalities of Using Non-Local or Non-Recent Multilocus Sequence Typing Data for Source Attribution in Space and Time of Human Campylobacteriosis	PLOS ONE			English	Article							HOST ASSOCIATION; JEJUNI; GENOTYPES; RECOMBINATION; POPULATION; RESISTANCE; CLONES	In this study, 1208 Campylobacter jejuni and C. coli isolates from humans and 400 isolates from chicken, collected in two separate periods over 12 years in The Netherlands, were typed using multilocus sequence typing (MLST). Statistical evidence was found for a shift of ST frequencies in human isolates over time. The human MLST data were also compared to published data from other countries to determine geographical variation. Because only MLST typed data from chicken, taken from the same time point and spatial location, were available in addition to the human data, MLST datasets for other Campylobacter reservoirs from selected countries were used. The selection was based on the degree of similarity of the human isolates between countries. The main aim of this study was to better understand the consequences of using non-local or non-recent MLST data for attributing domestically acquired human Campylobacter infections to specific sources of origin when applying the asymmetric island model for source attribution. In addition, a power-analysis was done to find the minimum number of source isolates needed to perform source attribution using an asymmetric island model. This study showed that using source data from other countries can have a significant biasing effect on the attribution results so it is important to carefully select data if the available local data lack in quality and/or quantity. Methods aimed at reducing this bias were proposed.	[Smid, Joost H.; Havelaar, Arie H.; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands; [Smid, Joost H.; Havelaar, Arie H.] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Gras, Lapo Mughini] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Gras, Lapo Mughini] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [de Boer, Albert G.; Wagenaar, Jaap A.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [French, Nigel P.] Massey Univ, Palmerston North, New Zealand; [Wagenaar, Jaap A.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap A.] WHO, Collaborating Ctr Reference & Res Campylobacter, OIE Reference Lab Campylobacteriosis, Lelystad, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Istituto Superiore di Sanita (ISS); University of Bologna; Wageningen University & Research; Massey University; Utrecht University; World Health Organization	Gras, LM (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands.	lapo.mughinigras2@unibo.it	French, Nigel/F-5725-2011; Havelaar, Arie H./P-8495-2014	French, Nigel/0000-0002-6334-0657; Havelaar, Arie H./0000-0002-6456-5460	Dutch ministery of Health, Welfare and Sports	Dutch ministery of Health, Welfare and Sports	This study was funded by Dutch ministery of Health, Welfare and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, EFSA J, V8, P1437, DOI DOI 10.2903/J.EFSA.2010.1437; de Haan CPA, 2010, APPL ENVIRON MICROB, V76, P5228, DOI 10.1128/AEM.00581-10; de Haan CPA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-200; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Doorduyn Y., 2010, EPIDEMIOL INFECT, V12, P1; Duim B, 2003, J CLIN MICROBIOL, V41, P5593, DOI 10.1128/JCM.41.12.5593-5597.2003; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Ercsey-Ravasz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037810; FAOSTAT, FAOSTAT FOOD BAL SHE; Fearnbead P, 2005, J MOL EVOL, V61, P333, DOI 10.1007/s00239-004-0316-0; Fitch BR, 2005, J CLIN MICROBIOL, V43, P4221, DOI 10.1128/JCM.43.8.4221-4224.2005; Garrett N, 2007, J APPL MICROBIOL, V103, P2113, DOI 10.1111/j.1365-2672.2007.03437.x; Gormley FJ, 2008, APPL ENVIRON MICROB, V74, P383, DOI 10.1128/AEM.01455-07; Karenlampi R, 2007, APPL ENVIRON MICROB, V73, P148, DOI 10.1128/AEM.01488-06; Kittl S, 2011, J APPL MICROBIOL, V110, P513, DOI 10.1111/j.1365-2672.2010.04906.x; Korczak BM, 2009, J CLIN MICROBIOL, V47, P1996, DOI 10.1128/JCM.00237-09; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; McTavish SM, 2008, EPIDEMIOL INFECT, V136, P1244, DOI 10.1017/S0950268807009892; Mickan L, 2007, J APPL MICROBIOL, V102, P144, DOI 10.1111/j.1365-2672.2006.03049.x; Mughini-Gras L., 2012, PLOS ONE, V7; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; Niederer L, 2012, APPL ENVIRON MICROB, V78, P288, DOI 10.1128/AEM.06194-11; Olson KE, 2008, EPIDEMIOLOGY CAMPYLO, P163; Oporto B, 2011, ZOONOSES PUBLIC HLTH, V58, P365, DOI 10.1111/j.1863-2378.2010.01373.x; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Sproston EL, 2011, APPL ENVIRON MICROB, V77, P6579, DOI 10.1128/AEM.00428-11; Strachan NJC, 2009, J INFECT DIS, V199, P1205, DOI 10.1086/597417; Venegas S. A., 1997, MANUAL EOF SVD ANAL; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203	32	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55029	10.1371/journal.pone.0055029	http://dx.doi.org/10.1371/journal.pone.0055029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405107	Green Published, gold			2022-12-25	WOS:000315153400051
J	Wu, SJ; Luo, J; Li, QQ; Wang, YQ; Murphy, RW; Blair, C; Wu, SF; Yue, BS; Zhang, YP				Wu, Shan-Jin; Luo, Jing; Li, Qing-Qing; Wang, Yan-Qin; Murphy, Robert W.; Blair, Christopher; Wu, Shi-Fang; Yue, Bi-Song; Zhang, Ya-Ping			Ecological Genetics of Chinese Rhesus Macaque in Response to Mountain Building: All Things Are Not Equal	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISMS SNPS; MAXIMUM-LIKELIHOOD-ESTIMATION; MACACA-MULATTA; PHYLOGENETIC-RELATIONSHIPS; POPULATION-GENETICS; MIGRATION RATES; INDIAN-ORIGIN; SOFTWARE; INFERENCE; EVOLUTION	Background: Pliocene uplifting of the Qinghai-Tibetan Plateau (QTP) and Quaternary glaciation may have impacted the Asian biota more than any other events. Little is documented with respect to how the geological and climatological events influenced speciation as well as spatial and genetic structuring, especially in vertebrate endotherms. Macaca mulatta is the most widely distributed non-human primate. It may be the most suitable model to test hypotheses regarding the genetic consequences of orogenesis on an endotherm. Methodology and Principal Findings: Using a large dataset of maternally inherited mitochondrial DNA gene sequences and nuclear microsatellite DNA data, we discovered two maternal super-haplogroups exist, one in western China and the other in eastern China. M. mulatta formed around 2.31 Ma (1.51-3.15, 95%), and divergence of the two major matrilines was estimated at 1.15 Ma (0.78-1.55, 95%). The western super-haplogroup exhibits significant geographic structure. In contrast, the eastern super-haplogroup has far greater haplotypic variability with little structure based on analyses of six variable microsatellite loci using STRUCTURE and GENELAND. Analysis using MIGRATE detected greater gene flow from WEST to EAST than vice versa. We did not detect signals of bottlenecking in most populations. Conclusions: Analyses of the nuclear and mitochondrial datasets obtained large differences in genetic patterns for M. mulatta. The difference likely reflects inheritance mechanisms of the maternally inherited mtDNA genome versus nuclear biparentally inherited STRs and male-mediated gene flow. Dramatic environmental changes may be responsible for shaping the matrilineal history of macaques. The timing of events, the formation of M. mulatta, and the divergence of the super-haplogroups, corresponds to both the uplifting of the QTP and Quaternary climatic oscillations. Orogenesis likely drove divergence of western populations in China, and Pleistocene glaciations are likely responsible for genetic structuring in the eastern super-haplogroup via geographic isolation and secondary contact.	[Wu, Shan-Jin; Luo, Jing; Wang, Yan-Qin] Yunnan Univ, Sch Life Sci, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Wu, Shan-Jin; Yue, Bi-Song] Sichuan Univ, Sichuan Key Lab Conservat Biol Endangered Wildlif, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China; [Wu, Shan-Jin; Murphy, Robert W.; Wu, Shi-Fang; Zhang, Ya-Ping] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China; [Li, Qing-Qing] Yunnan Normal Univ, Sch Life Sci, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Blair, Christopher] Duke Univ, Dept Biol, Durham, NC USA	Yunnan University; Sichuan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan Normal University; Royal Ontario Museum; Duke University	Yue, BS (corresponding author), Sichuan Univ, Sichuan Key Lab Conservat Biol Endangered Wildlif, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China.	bsyue@yahoo.com; zhangyp@mail.kiz.ac.cn		Murphy, Robert/0000-0001-8555-2338	National Basic Research Program of China (973 Program) [2007CB411600, 2007CB109106]; National Natural Science Foundation of China; Bureau of Science and Technology of Yunnan Province; Chinese Academy of Sciences; Natural Sciences and Engineering Research Council [A3148]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province; Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the National Basic Research Program of China (973 Program, 2007CB411600 and 2007CB109106), National Natural Science Foundation of China, and Bureau of Science and Technology of Yunnan Province, and by a Visiting Professorship for Senior International Scientists from the Chinese Academy of Sciences and a Natural Sciences and Engineering Research Council Discovery Grant (A3148) to R.W. Murphy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg C, 2002, BIOL J LINN SOC, V75, P555, DOI 10.1046/j.1095-8312.2002.00045.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Blair C, 2013, J HERED, V104, P72, DOI 10.1093/jhered/ess079; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Chatterji S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r29; Chu JH, 2007, MOL PHYLOGENET EVOL, V43, P418, DOI 10.1016/j.ympev.2006.11.022; Cornuet JM, 1996, GENETICS, V144, P2001; DAUGHERTY CH, 1990, NATURE, V347, P177, DOI 10.1038/347177a0; Deinard A, 2001, J HUM EVOL, V41, P45, DOI 10.1006/jhev.2001.0480; Deinard AS, 2002, J MED PRIMATOL, V31, P8, DOI 10.1034/j.1600-0684.2002.1o022.x; Delson E., 1980, P10; Doxiadis GGM, 2003, IMMUNOGENETICS, V55, P540, DOI 10.1007/s00251-003-0590-9; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Fooden J, 1999, INT J PRIMATOL, V20, P431, DOI 10.1023/A:1020556922189; Fooden J, 2000, FIELDIANA ZOOL, V96, P1, DOI DOI 10.5962/BHL.TITLE.7192; FRENZEL B, 1968, SCIENCE, V161, P637, DOI 10.1126/science.161.3842.637; Fu YX, 1997, GENETICS, V147, P915; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Groves CP, 2001, PRIMATE TAXONOMY; GU YM, 1980, VERTEBRAT PALASIATIC, V18, P324; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P2222, DOI 10.1093/bioinformatics/btn419; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Harrison T, 2002, J HUM EVOL, V43, P207, DOI 10.1006/jhev.2002.0570; Hayaishi S, 2006, PRIMATES, V47, P158, DOI 10.1007/s10329-005-0169-1; Hayasaka K, 1996, MOL BIOL EVOL, V13, P1044, DOI 10.1093/oxfordjournals.molbev.a025655; Hernandez RD, 2007, SCIENCE, V316, P240, DOI 10.1126/science.1140462; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jijun L., 2001, QUAT SCI, V21, P381, DOI DOI 10.3321/J.ISSN:1001-7410.2001.05.001; Kanthaswamy S, 2004, COMPARATIVE MED, V54, P193; Kayser M, 1996, MOL ECOL, V5, P157, DOI 10.1111/j.1365-294X.1996.tb00302.x; Kyes RC, 2006, AM J PRIMATOL, V68, P445, DOI 10.1002/ajp.20240; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Li DY, 2011, AM J PRIMATOL, V73, P883, DOI 10.1002/ajp.20956; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Li Qing-qing, 2004, Zoological Research, V25, P385; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; Melnick D. J., 1996, P413; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Morales JC, 1998, J HUM EVOL, V34, P1, DOI 10.1006/jhev.1997.0171; Morin PA, 1997, AM J PRIMATOL, V42, P199, DOI 10.1002/(SICI)1098-2345(1997)42:3<199::AID-AJP3>3.0.CO;2-S; Nurnberg P, 1998, AM J PRIMATOL, V44, P1; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2006, FIGTREE TREE FIGURE; RAMBAUT A, 2005, TRACER V1 3 MCMC TRA; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rollins LA, 2009, MOL ECOL, V18, P1560, DOI 10.1111/j.1365-294X.2009.04132.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SADE DS, 1972, FUNCTION EVOLUTIONAR; Satkoski J, 2008, J MED PRIMATOL, V37, P67, DOI 10.1111/j.1600-0684.2007.00228.x; Satkoski JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-256; SLATKIN M, 1991, GENETICS, V129, P555; Smith DG, 2006, INT J PRIMATOL, V27, P881, DOI 10.1007/s10764-006-9026-3; Smith DG, 2005, COMPARATIVE MED, V55, P227; Smith DG, 2005, AM J PRIMATOL, V65, P1, DOI 10.1002/ajp.20094; Smith DG, 2000, AM J PRIMATOL, V50, P1; Street SL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-480; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tosi AJ, 2000, MOL PHYLOGENET EVOL, V17, P133, DOI 10.1006/mpev.2000.0834; Tosi AJ, 2003, EVOLUTION, V57, P1419; Vallet D, 2008, CONSERV GENET, V9, P677, DOI 10.1007/s10592-007-9361-8; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Wolfheim J, 1983, PRIMATES WORLD DISTR; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21; ZHANG R, 1991, Acta Theriologica Sinica, V11, P171; Zhang Ying-Qi, 2010, Vertebrata Palasiatica, V48, P275; ZHANG YP, 1993, INT J PRIMATOL, V14, P587, DOI 10.1007/BF02215449; [No title captured]	92	5	8	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55315	10.1371/journal.pone.0055315	http://dx.doi.org/10.1371/journal.pone.0055315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405134	Green Published, gold			2022-12-25	WOS:000315153400079
J	Kim, BW; Koppula, S; Hong, SS; Jeon, SB; Kwon, JH; Hwang, BY; Park, EJ; Choi, DK				Kim, Byung-Wook; Koppula, Sushruta; Hong, Seong-Su; Jeon, Sae-Bom; Kwon, Ji-Hye; Hwang, Bang-Yeon; Park, Eun-Jung; Choi, Dong-Kug			Regulation of Microglia Activity by Glaucocalyxin-A: Attenuation of Lipopolysaccharide-Stimulated Neuroinflammation through NF-kappa B and p38 MAPK Signaling Pathways	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; LIPOCALIN 2 REGULATION; TNF-ALPHA RELEASE; INFLAMMATORY RESPONSE; KAURANE DITERPENOIDS; PARKINSONS-DISEASE; INTERFERON-GAMMA; ISODON-JAPONICUS; GLIAL-CELLS	Microglial cells are the resident macrophages and intrinsic arm of the central nervous system innate immune defense. Microglial cells become activated in response to injury, infection, environmental toxins, and other stimuli that threaten neuronal survival. Therefore, regulating microglial activation may have therapeutic benefits that lead to alleviating the progression of inflammatory-mediated neurodegeneration. In the present study, we investigated the effect of glaucocalyxin A (GLA) isolated from Rabdosia japonica on the production of pro-inflammatory mediators in lipopolysaccharide (LPS)-stimulated primary microglia and BV-2 cells. GLA significantly inhibited LPS-induced production of nitric oxide and reversed the morphological changes in primary microglia. Further, GLA suppressed expression of inducible nitric oxide synthase and cyclooxygenase-2 dose-dependently at the mRNA and protein levels. The production of proinflammatory cytokines such as tumor necrosis factor-alpha, interleukin-1 beta (IL)-1 beta, and IL-6 were inhibited by suppressing their transcriptional activity. Furthermore, GLA suppressed nuclear factor-kappa B activation by blocking degradation of I kappa B-alpha and inhibited the induction of lipocalin-2 expression in LPS-stimulated BV-2 cells. Mechanistic study revealed that the inhibitory effects of GLA were accompanied by blocking the p38 mitogen activated protein kinase signaling pathway in activated microglia. In conclusion, given that microglial activation contributes to the pathogenesis of neurodegenerative diseases, GLA could be developed as a potential therapeutic agent for treating microglia-mediated neuroinflammatory diseases.	[Kim, Byung-Wook; Koppula, Sushruta; Kwon, Ji-Hye; Choi, Dong-Kug] Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, South Korea; [Hong, Seong-Su; Hwang, Bang-Yeon] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea; [Hong, Seong-Su; Hwang, Bang-Yeon] Chungbuk Natl Univ, Med Res Ctr CICT, Cheongju, South Korea; [Jeon, Sae-Bom; Park, Eun-Jung] Natl Canc Ctr, Branch Immune Therapy, Goyang, South Korea; [Jeon, Sae-Bom; Park, Eun-Jung] Natl Canc Ctr, Branch Cell Therapy, Goyang, South Korea	Konkuk University; Chungbuk National University; Chungbuk National University; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Choi, DK (corresponding author), Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, South Korea.	choidk@kku.ac.kr	Koppula, Sushruta/F-2817-2013; KIM, Byungwook/U-2187-2017	Koppula, Sushruta/0000-0002-8597-7763; KIM, Byungwook/0000-0001-8390-7713; Choi, Dong-Kug/0000-0001-7041-1524	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0014923]; Regional Innovation Center (RIC) Program of the Ministry of Knowledge Economy through the Bio-Food & Drug Research Center at Konkuk University, Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Regional Innovation Center (RIC) Program of the Ministry of Knowledge Economy through the Bio-Food & Drug Research Center at Konkuk University, Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0014923) and also supported by the Regional Innovation Center (RIC) Program of the Ministry of Knowledge Economy through the Bio-Food & Drug Research Center at Konkuk University, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner F, 2007, AM J TRANSPLANT, V7, P779, DOI 10.1111/j.1600-6143.2006.01723.x; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Block ML, 2006, FASEB J, V20, P251, DOI 10.1096/fj.05-4553com; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Boche D, 2003, J CEREBR BLOOD F MET, V23, P1174, DOI 10.1097/01.WCB.0000090080.64176.44; Boche D, 2006, NEUROBIOL DIS, V22, P638, DOI 10.1016/j.nbd.2006.01.004; Bonaiuto C, 1997, J NEUROIMMUNOL, V77, P51, DOI 10.1016/S0165-5728(97)00054-4; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Brenneman DE, 1996, J CLIN INVEST, V97, P2299, DOI 10.1172/JCI118672; Caivano M, 1998, FEBS LETT, V429, P249, DOI 10.1016/S0014-5793(98)00578-X; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Choi Y, 2008, INT IMMUNOPHARMACOL, V8, P548, DOI 10.1016/j.intimp.2007.12.010; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; Couch Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-166; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; DaSilva J, 1997, J BIOL CHEM, V272, P28373, DOI 10.1074/jbc.272.45.28373; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hong SS, 2008, J NAT PROD, V71, P1055, DOI 10.1021/np0705965; Hong SS, 2007, J NAT PROD, V70, P632, DOI 10.1021/np060638+; Ip JPK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-124; Jeohn GH, 2002, NEUROSCIENCE, V114, P689, DOI 10.1016/S0306-4522(02)00356-1; Jung WK, 2009, FOOD CHEM TOXICOL, V47, P410, DOI 10.1016/j.fct.2008.11.041; Kim BW, 2011, J PHARMACOL SCI, V116, P296, DOI 10.1254/jphs.10324FP; KIM DS, 1992, PHYTOCHEMISTRY, V31, P697, DOI 10.1016/0031-9422(92)90064-W; Le WD, 2001, J NEUROSCI, V21, P8447, DOI 10.1523/JNEUROSCI.21-21-08447.2001; LEE SC, 1993, J IMMUNOL, V150, P2659; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Li C, 2011, CYTOKINE, V56, P435, DOI 10.1016/j.cyto.2011.07.021; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Miharada K, 2008, J CELL PHYSIOL, V215, P526, DOI 10.1002/jcp.21334; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Oh YT, 2009, NEUROSCI LETT, V464, P93, DOI 10.1016/j.neulet.2009.08.040; Qin LY, 2005, ANN NY ACAD SCI, V1053, P107, DOI 10.1196/annals.1344.009; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Rivest S, 2006, NEURON, V49, P4, DOI 10.1016/j.neuron.2005.12.004; Roudkenar MH, 2009, EXP CELL RES, V315, P3140, DOI 10.1016/j.yexcr.2009.08.019; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; St-Onge M, 2007, BBA-MOL CELL BIOL L, V1771, P1235, DOI 10.1016/j.bbalip.2007.06.002; Sun HD, 2006, NAT PROD REP, V23, P673, DOI 10.1039/b604174d; Svensson CI, 2003, J NEUROCHEM, V86, P1534, DOI 10.1046/j.1471-4159.2003.01969.x; Teismann P, 2003, MOVEMENT DISORD, V18, P121, DOI 10.1002/mds.10332; Wang W, 2003, J NEUROCHEM, V84, P189, DOI 10.1046/j.1471-4159.2003.01544.x; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420	54	81	83	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55792	10.1371/journal.pone.0055792	http://dx.doi.org/10.1371/journal.pone.0055792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393601	Green Submitted, gold, Green Published			2022-12-25	WOS:000314692800056
J	Munro, KM; Dixon, KJ; Gresle, MM; Jonas, A; Kemper, D; Doherty, W; Fabri, LJ; Owczarek, CM; Pearse, M; Boyd, AW; Kilpatrick, TJ; Butzkueven, H; Turnley, AM				Munro, Kathryn M.; Dixon, Kirsty J.; Gresle, Melissa M.; Jonas, Anna; Kemper, Dennis; Doherty, William; Fabri, Louis J.; Owczarek, Catherine M.; Pearse, Martin; Boyd, Andrew W.; Kilpatrick, Trevor J.; Butzkueven, Helmut; Turnley, Ann M.			EphA4 Receptor Tyrosine Kinase Is a Modulator of Onset and Disease Severity of Experimental Autoimmune Encephalomyelitis (EAE)	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; EPHA4-DEFICIENT MICE; STIMULATES MIGRATION; AXONAL INJURY; PATHOGENESIS; DEMYELINATION; INFLAMMATION; MICROGLIA; LESIONS; IMMUNE	The EphA4 receptor tyrosine kinase is a major regulator of axonal growth and astrocyte reactivity and is a possible inflammatory mediator. Given that multiple sclerosis (MS) is primarily an inflammatory demyelinating disease and in mouse models of MS, such as experimental autoimmune encephalomyelitis (EAE), axonal degeneration and reactive gliosis are prominent clinical features, we hypothesised that endogenous EphA4 could play a role in modulating EAE. EAE was induced in EphA4 knockout and wildtype mice using MOG peptide immunisation and clinical severity and histological features of the disease were then compared in lumbar spinal cord sections. EphA4 knockout mice exhibited a markedly less severe clinical course than wildtype mice, with a lower maximum disease grade and a slightly later onset of clinical symptoms. Numbers of infiltrating T cells and macrophages, the number and size of the lesions, and the extent of astrocytic gliosis were similar in both genotypes; however, EphA4 knockout mice appeared to have decreased axonal pathology. Blocking of EphA4 in wildtype mice by administration of soluble EphA4 (EphA4-Fc) as a decoy receptor following induction of EAE produced a delay in onset of clinical symptoms; however, most mice had clinical symptoms of similar severity by 22 days, indicating that EphA4 blocking treatment slowed early EAE disease evolution. Again there were no apparent differences in histopathology. To determine whether the role of EphA4 in modulating EAE was CNS mediated or due to an altered immune response, MOG primed T cells from wildtype and EphA4 knockout mice were passively transferred into naive recipient mice and both were shown to induce disease of equivalent severity. These results are consistent with a non-inflammatory, CNS specific, deleterious effect of EphA4 during neuroinflammation that results in axonal pathology.	[Munro, Kathryn M.; Dixon, Kirsty J.; Kilpatrick, Trevor J.; Turnley, Ann M.] Univ Melbourne, Neurosci Res Ctr, Melbourne, Vic 3010, Australia; [Munro, Kathryn M.; Kilpatrick, Trevor J.; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic 3010, Australia; [Gresle, Melissa M.; Butzkueven, Helmut] Univ Melbourne, Dept Med, Melbourne Brain Ctr, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia; [Jonas, Anna; Kemper, Dennis; Doherty, William; Kilpatrick, Trevor J.] Florey Neurosci Inst, MS Div, Melbourne, Vic, Australia; [Fabri, Louis J.; Owczarek, Catherine M.; Pearse, Martin] CSL Ltd, Parkville, Vic, Australia; [Boyd, Andrew W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Melbourne; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; CSL; QIMR Berghofer Medical Research Institute	Turnley, AM (corresponding author), Univ Melbourne, Neurosci Res Ctr, Melbourne, Vic 3010, Australia.	turnley@unimelb.edu.au		Turnley, Ann/0000-0002-8442-127X; fabri, louis/0000-0003-4033-3304; gresle, melissa/0000-0003-0738-1136; Kilpatrick, Trevor/0000-0003-3999-085X; Butzkueven, Helmut/0000-0003-3940-8727	NHMRC [1045125]; Multiple Sclerosis Research Australia grant; CRE fellowship through the Melbourne Brain Centre	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia grant; CRE fellowship through the Melbourne Brain Centre	This work was supported by a NH&MRC Project Grant #1045125 and a Multiple Sclerosis Research Australia grant. AMT is supported by an NH&MRC Fellowship, HB by an NH&MRC career development fellowship, MG by a CRE fellowship through the Melbourne Brain Centre, and KMM was supported by an NH&MRC Australian Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Butovsky O, 2006, J CLIN INVEST, V116, P905, DOI 10.1172/JCI26836; Butzkueven H, 2006, GLIA, V53, P696, DOI 10.1002/glia.20321; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Coonan JR, 2001, J COMP NEUROL, V436, P248; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Gresle MM, 2008, J NEUROSCI RES, V86, P3548, DOI 10.1002/jnr.21803; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Herz J, 2010, EXP NEUROL, V225, P9, DOI 10.1016/j.expneurol.2009.11.019; Holen HL, 2010, J LEUKOCYTE BIOL, V87, P1059, DOI 10.1189/jlb.0709497; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Jones MV, 2008, J NEUROIMMUNOL, V199, P83, DOI 10.1016/j.jneuroim.2008.05.013; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Munoz JJ, 2006, J IMMUNOL, V177, P804, DOI 10.4049/jimmunol.177.2.804; Munro KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037635; Napoli I, 2010, EXP NEUROL, V225, P24, DOI 10.1016/j.expneurol.2009.04.024; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Parmentier-Batteur S, 2011, J NEUROCHEM, V118, P1016, DOI 10.1111/j.1471-4159.2011.07375.x; Puschmann TB, 2010, J NEUROCHEM, V113, P881, DOI 10.1111/j.1471-4159.2010.06655.x; Sobel RA, 2005, BRAIN PATHOL, V15, P35; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Williams A, 2007, GLIA, V55, P1300, DOI 10.1002/glia.20546; Xu LY, 2003, IMMUNOLOGY, V110, P141, DOI 10.1046/j.1365-2567.2003.01713.x	32	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55948	10.1371/journal.pone.0055948	http://dx.doi.org/10.1371/journal.pone.0055948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390555	gold, Green Published, Green Submitted			2022-12-25	WOS:000314691100071
J	Shelby, SJ; Colwill, K; Dhe-Paganon, S; Pawson, T; Thompson, DA				Shelby, Shameka J.; Colwill, Karen; Dhe-Paganon, Sirano; Pawson, Tony; Thompson, Debra A.			MERTK Interactions with SH2-Domain Proteins in the Retinal Pigment Epithelium	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; FOCAL ADHESION KINASE; ROD-CONE DYSTROPHY; NF-KAPPA-B; OUTER SEGMENTS; ALPHA-V-BETA-5 INTEGRIN; APOPTOTIC CELLS; C-MER; MEDIATED PHAGOCYTOSIS; RETINITIS-PIGMENTOSA	The receptor tyrosine kinase MERTK plays an essential role in the phagocytic uptake of shed photoreceptor membranes by the retinal pigment epithelium (RPE). A fundamental aspect of signal transduction by receptor tyrosine kinases involves autophosphorylation of tyrosine residues that recruit Src-homology 2 (SH2)-domain proteins to the receptor intracellular domain. The goal of the current study was to evaluate the interactions of human MERTK with SH2-domain proteins present in the RPE. The MERTK intracellular domain was expressed as a 6xHis-fusion protein (6xHis-rMERTK(571-999)), purified and phosphorylated. Ni2+-NTA pull downs were performed using 6xHis-rMERTK(571-999) in incubations with recombinant phosphotyrosine-recognition sequences expressed as GST-fusion proteins. In addition, pull downs of native SH2-domain proteins were performed using 6xHis-rMERTK(571-999) and protein homogenates from rat RPE/choroid. For both recombinant and native proteins, western analysis detected MERTK interactions with GRB2, PIK3R1 (P85 alpha), VAV3, and SRC. Immunohistochemical analysis localized each protein to mouse RPE. In cultured RPE-J cells incubated with rod outer segments (OS), siRNA knockdown of Grb2 had no effect on OS binding, but significantly reduced OS uptake. Pik3r1 localized to early phagosomes along with Rab5 and Eea1. Phosphorylation and activation of Src was detected downstream of phagocytosis and Mertk activation. These findings suggest that MERTK signaling in the RPE involves a cohort of SH2-domain proteins with the potential to regulate both cytoskeletal rearrangement and membrane movement. Identification of the SH2-domain signaling partners of MERTK is an important step toward further defining the mechanism of RPE phagocytosis that is central to the function and survival of the retina.	[Shelby, Shameka J.; Thompson, Debra A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Colwill, Karen; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Pawson, Tony] Univ Toronto, Dept Med Genet, Toronto, ON, Canada; [Thompson, Debra A.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University of Michigan System; University of Michigan	Thompson, DA (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	dathom@umich.edu	Colwill, Karen/K-5101-2012; Pawson, Tony J/E-4578-2013	Colwill, Karen/0000-0002-8979-1659; Thompson, Debra/0000-0003-3485-0794	National Institutes of Health [P30-EY007003, P60-DK-020572, T32-EY13934]; Midwest Eye Bank & Transplantation Center; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Research to Prevent Blindness; University of Michigan Rackham School of Graduate Studies Merit Fellowship; King-Chavez-Parks Future Faculty Program Fellowship; NATIONAL EYE INSTITUTE [T32EY013934, P30EY007003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Eye Bank & Transplantation Center; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); University of Michigan Rackham School of Graduate Studies Merit Fellowship; King-Chavez-Parks Future Faculty Program Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from National Institutes of Health (P30-EY007003, P60-DK-020572, T32-EY13934), The Midwest Eye Bank & Transplantation Center. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. DAT is a recipient of a Senior Scientific Investigator Award from Research to Prevent Blindness. SJS is a recipient of a University of Michigan Rackham School of Graduate Studies Merit Fellowship, and a King-Chavez-Parks Future Faculty Program Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brea-Fernandez AJ, 2008, BRIT J OPHTHALMOL, V92, P1419, DOI 10.1136/bjo.2008.139204; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Caberoy NB, 2010, EMBO J, V29, P3898, DOI 10.1038/emboj.2010.265; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Fujikawa K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009050; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Georgescu MM, 1999, MOL CELL BIOL, V19, P1171; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Hall MO, 2003, ADV EXP MED BIOL, V533, P331; Hed J, 1986, Methods Enzymol, V132, P198; Huang XD, 2009, J STRUCT BIOL, V165, P88, DOI 10.1016/j.jsb.2008.10.003; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jeong SJ, 2006, ACTA BIOCH BIOPH SIN, V38, P556, DOI 10.1111/j.1745-7270.2006.00193.x; LaVail M M, 2001, Prog Brain Res, V131, P617; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LAVAIL MM, 1981, INVEST OPHTH VIS SCI, V20, P671; LAVAIL MM, 1975, J HERED, V66, P242, DOI 10.1093/oxfordjournals.jhered.a108621; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Mackay DS, 2010, MOL VIS, V16, P369; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; Mao YY, 2012, MOL BIOL CELL, V23, P1104, DOI 10.1091/mbc.E11-10-0840; May RC, 2001, J CELL SCI, V114, P1061; McHenry CL, 2004, INVEST OPHTH VIS SCI, V45, P1456, DOI 10.1167/iovs.03-0909; Nandrot EF, 2012, BIOL CELL, V104, P326, DOI 10.1111/boc.201100076; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Qin SF, 2012, EXP EYE RES, V94, P63, DOI 10.1016/j.exer.2011.11.007; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strick DJ, 2009, INVEST OPHTH VIS SCI, V50, P2427, DOI 10.1167/iovs.08-3058; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; Tschernutter M, 2006, BRIT J OPHTHALMOL, V90, P718, DOI 10.1136/bjo.2005.084897; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Yi ZA, 2009, BLOOD, V114, P3191, DOI 10.1182/blood-2009-03-207522; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zhang YB, 2012, IMMUNOLOGY, V135, P268, DOI 10.1111/j.1365-2567.2011.03549.x; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	53	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e53964	10.1371/journal.pone.0053964	http://dx.doi.org/10.1371/journal.pone.0053964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390493	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100009
J	Suwannasai, N; Martin, MP; Phosri, C; Sihanonth, P; Whalley, AJS; Spouge, JL				Suwannasai, Nuttika; Martin, Maria P.; Phosri, Cherdchai; Sihanonth, Prakitsin; Whalley, Anthony J. S.; Spouge, John L.			Fungi in Thailand: A Case Study of the Efficacy of an ITS Barcode for Automatically Identifying Species within the Annulohypoxylon and Hypoxylon Genera	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; DNA BARCODES; PHYLOGENETIC-RELATIONSHIPS; LAND PLANTS; SEQUENCE; IDENTIFICATION; XYLARIACEAE; TAXONOMY; NUCLEAR; ALGORITHMS	Thailand, a part of the Indo-Burma biodiversity hotspot, has many endemic animals and plants. Some of its fungal species are difficult to recognize and separate, complicating assessments of biodiversity. We assessed species diversity within the fungal genera Annulohypoxylon and Hypoxylon, which produce biologically active and potentially therapeutic compounds, by applying classical taxonomic methods to 552 teleomorphs collected from across Thailand. Using probability of correct identification (PCI), we also assessed the efficacy of automated species identification with a fungal barcode marker, ITS, in the model system of Annulohypoxylon and Hypoxylon. The 552 teleomorphs yielded 137 ITS sequences; in addition, we examined 128 GenBank ITS sequences, to assess biases in evaluating a DNA barcode with GenBank data. The use of multiple sequence alignment in a barcode database like BOLD raises some concerns about non-protein barcode markers like ITS, so we also compared species identification using different alignment methods. Our results suggest the following. (1) Multiple sequence alignment of ITS sequences is competitive with pairwise alignment when identifying species, so BOLD should be able to preserve its present bioinformatics workflow for species identification for ITS, and possibly therefore with at least some other non-protein barcode markers. (2) Automated species identification is insensitive to a specific choice of evolutionary distance, contributing to resolution of a current debate in DNA barcoding. (3) Statistical methods are available to address, at least partially, the possibility of expert misidentification of species. Phylogenetic trees discovered a cryptic species and strongly supported monophyletic clades for many Annulohypoxylon and Hypoxylon species, suggesting that ITS can contribute usefully to a barcode for these fungi. The PCIs here, derived solely from ITS, suggest that a fungal barcode will require secondary markers in Annulohypoxylon and Hypoxylon, however. The URL http://tinyurl.com/spouge-barcode contains computer programs and other supplementary material relevant to this article.	[Suwannasai, Nuttika] Srinakharinwirot Univ, Fac Sci, Dept Biol, Bangkok, Thailand; [Martin, Maria P.] Real Jardin Botan CSIC, Dept Mycol, Madrid, Spain; [Phosri, Cherdchai] Pibulsongkram Rajabhat Univ, Fac Sci & Technol, Microbiol Programme, Phitsanulok, Thailand; [Sihanonth, Prakitsin] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Whalley, Anthony J. S.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 5UX, Merseyside, England; [Spouge, John L.] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	Srinakharinwirot University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Pibulsongkram Rajabhat University; Chulalongkorn University; Liverpool John Moores University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Spouge, JL (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.	spouge@ncbi.nlm.nih.gov	phosri, Cherdchai/H-2747-2014; Martín, María/HDL-9512-2022; Martín, María/H-8069-2012; Spouge, John/AAI-2769-2020	Martín, María/0000-0002-1235-4418; Phosri, Cherdchai/0000-0003-3963-752X	Royal Golden Jubilee Ph.D. Program (RGJ); National Research Council of Thailand; International Foundation for Science (IFS); British Council; Liverpool John Moores University; British Mycological Society; Plan Nacional I+D+I (Ministerio de Ciencia y Tecnologia, Spain) [REN2002-04068-CO2-01GLO]; Intramural Research Program of the National Institutes of Health (NIH) (National Library of Medicine, USA); NATIONAL LIBRARY OF MEDICINE [ZIALM200883] Funding Source: NIH RePORTER	Royal Golden Jubilee Ph.D. Program (RGJ)(Thailand Research Fund (TRF)); National Research Council of Thailand(National Research Council of Thailand (NRCT)); International Foundation for Science (IFS)(International Foundation for Science); British Council(The British Council in India); Liverpool John Moores University; British Mycological Society; Plan Nacional I+D+I (Ministerio de Ciencia y Tecnologia, Spain); Intramural Research Program of the National Institutes of Health (NIH) (National Library of Medicine, USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported in part by the Royal Golden Jubilee Ph.D. Program (RGJ), National Research Council of Thailand, International Foundation for Science (IFS), the British Council, Liverpool John Moores University, the British Mycological Society, the Plan Nacional I+D+I (REN2002-04068-CO2-01GLO, Ministerio de Ciencia y Tecnologia, Spain), and the Intramural Research Program of the National Institutes of Health (NIH) (National Library of Medicine, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul S, 1999, SCIENTIST, V13, P15; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARRATIA R, 1985, ANN PROBAB, V13, P1236, DOI 10.1214/aop/1176992808; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Brock PM, 2009, NEW PHYTOL, V181, P719, DOI 10.1111/j.1469-8137.2008.02703.x; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Collins RA, 2012, METHODS ECOLOGY EVOL; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Karkouri K, 2007, APPL ENVIRON MICROB, V73, P5320, DOI 10.1128/AEM.00530-07; Erickson DL, 2008, TAXON, V57, P1304, DOI 10.1002/tax.574020; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; Feau N, 2009, MYCOL RES, V113, P713, DOI 10.1016/j.mycres.2009.02.007; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Fournier J, 2010, FUNGAL DIVERS, V40, P23, DOI 10.1007/s13225-010-0026-4; Fregin S, 2012, MOL PHYLOGENET EVOL, V62, P319, DOI 10.1016/j.ympev.2011.10.003; GARDES M, 1991, CAN J BOT, V69, P180, DOI 10.1139/b91-026; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HOLM S, 1979, SCAND J STAT, V6, P65; Hsieh HM, 2005, MYCOLOGIA, V97, P844, DOI 10.3852/mycologia.97.4.844; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Ju YM, 2002, NOVA HEDWIGIA, V74, P75, DOI 10.1127/0029-5035/2002/0074-0075; Ju YM, 1996, MYCOL MEM, V20, P1; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kuksa P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S9; Kwong S, 2012, MOL PHYLOGENET EVOL, V62, P1009, DOI 10.1016/j.ympev.2011.11.034; LAESSOE T, 1989, MYCOL RES, V93, P121, DOI 10.1016/S0953-7562(89)80111-X; Laessoe T, 2010, FUNGAL BIOL-UK, V114, P481, DOI 10.1016/j.funbio.2010.03.010; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lee JS, 2000, FEMS MICROBIOL LETT, V187, P89; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Lumbsch T, 2010, FIELDIANA LIFE EARTH, P1; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nguyen HDT, 2008, PERSOONIA, V21, P57, DOI 10.3767/003158508X361334; Ogden TH, 2007, MOL PHYLOGENET EVOL, V42, P817, DOI 10.1016/j.ympev.2006.07.021; Okane I, 2008, MYCOSCIENCE, V49, P359, DOI 10.1007/s10267-008-0440-6; Pelaez F, 2008, FUNGAL DIVERS, V31, P111; Pinnoi A, 2010, MYCOSPHERE, V1, P1; ROGERS JD, 1994, NATO ADV SCI INST SE, V269, P321; ROGERS JD, 1977, CAN J BOT, V55, P2394, DOI 10.1139/b77-272; Rogers JD, 2000, MYCOL RES, V104, P1412, DOI 10.1017/S0953756200003464; Sanchez-Ballesteros J, 2000, MYCOLOGIA, V92, P964, DOI 10.2307/3761591; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stadler Marc, 2006, Revista Iberoamericana de Micologia, V23, P160; Stadler M, 2005, RRD PHYTOCHEM, V9, P41; Suwannasai N, 2005, MYCOTAXON, V94, P303; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tang AMC, 2009, FUNGAL DIVERS, V34, P127; Tantichareon M, 2004, THAI FUNGAL DIVERSIT, P1; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Thienhirun S, 1997, PRELIMINARY ACCOUNT; Thienhirun S, 2004, THAI FUNGAL DIVERSIT, P71; Triebel D, 2005, NOVA HEDWIGIA, V80, P25, DOI 10.1127/0029-5035/2005/0080-0025; Whalley AJS, 1996, MYCOL RES, V100, P897, DOI 10.1016/S0953-7562(96)80042-6; Whalley AJS, 2012, RAJABHAT J S HUMANIT, V13, P9; Whalley Margaret, 1996, Mycologist, V10, P149; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	67	21	21	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54529	10.1371/journal.pone.0054529	http://dx.doi.org/10.1371/journal.pone.0054529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390499	Green Submitted, gold, Green Published			2022-12-25	WOS:000314691100015
J	Stamatiou, G; Vidaurre, DP; Shim, I; Tang, XR; Moeder, W; Bonetta, D; McCourt, P				Stamatiou, George; Vidaurre, Danielle P.; Shim, Isaac; Tang, Xurong; Moeder, Wolfgang; Bonetta, Dario; McCourt, Peter			Forward Genetic Screening for the Improved Production of Fermentable Sugars from Plant Biomass	PLOS ONE			English	Article							CELL-WALL; INFLORESCENCE DEVELOPMENT; ARABIDOPSIS-THALIANA; STARCH DEGRADATION; BIOFUEL PRODUCTION; AUXIN TRANSPORT; MUTANTS; RECALCITRANCE; MANIPULATION; SWITCHGRASS	With their unique metabolism and the potential to produce large amounts of biomass, plants are an excellent bio-energy feedstock for a variety of industrial purposes. Here we developed a high-throughput strategy, using the model plant Arabidopsis thaliana, to identify mutants with improved sugar release from plant biomass. Molecular analysis indicates a variety of processes including starch degradation, cell wall composition and polar transport of the plant hormone auxin can contribute to this improved saccharification. To demonstrate translatability, polar auxin transport in maize was either genetically or chemical inhibited and this also resulted in increased sugar release from plant tissues. Our forward genetic approach using Arabidopsis not only uncovers new functions that contribute to cell wall integrity but also demonstrates that information gleaned from this genetic model can be directly translated to monocotyledonous crops such as maize to improve sugar extractability from biomass.	[Stamatiou, George; Vidaurre, Danielle P.; Moeder, Wolfgang; McCourt, Peter] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Shim, Isaac; Tang, Xurong; Bonetta, Dario] Univ Ontario Inst Technol, Fac Sci, Oshawa, ON, Canada	University of Toronto; Ontario Tech University	Bonetta, D (corresponding author), Univ Ontario Inst Technol, Fac Sci, Oshawa, ON, Canada.	dario.bonetta@uoit.ca		Moeder, Wolfgang/0000-0003-3889-6183	NSERC grants	NSERC grants	This work was funded by NSERC grants to P.M. and D.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; CASPAR T, 1991, PLANT PHYSIOL, V95, P1181, DOI 10.1104/pp.95.4.1181; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Chuck GS, 2011, P NATL ACAD SCI USA, V108, P17550, DOI 10.1073/pnas.1113971108; Dische Z., 1962, METHODS CARBOHYDRATE, P477; Feraru E, 2011, CURR BIOL, V21, P338, DOI 10.1016/j.cub.2011.01.036; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Pauly M, 2010, CURR OPIN PLANT BIOL, V13, P305, DOI 10.1016/j.pbi.2009.12.009; Pingali SV, 2010, BIOMACROMOLECULES, V11, P2329, DOI 10.1021/bm100455h; Przemeck GKH, 1996, PLANTA, V200, P229, DOI 10.1007/BF00208313; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; Sanchez-Rodriguez C, 2010, TRENDS PLANT SCI, V15, P291, DOI 10.1016/j.tplants.2010.03.002; Skirpan A, 2008, PLANT J, V55, P787, DOI 10.1111/j.1365-313X.2008.03546.x; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Vanholme R, 2010, TRENDS BIOTECHNOL, V28, P543, DOI 10.1016/j.tibtech.2010.07.008; Vidaurre D, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00119; Wattebled F, 2005, PLANT PHYSIOL, V138, P184, DOI 10.1104/pp.105.059295; Weise SE, 2012, PLANT BIOTECHNOL J, V10, P545, DOI 10.1111/j.1467-7652.2012.00684.x; Williams ME, 2005, PLANT PHYSIOL, V138, P686, DOI 10.1104/pp.105.061317; Wu XT, 2007, AM J BOT, V94, P1745, DOI 10.3732/ajb.94.11.1745; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319; Zhong RQ, 2003, PLANT PHYSIOL, V132, P544, DOI 10.1104/pp.103.021444	36	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55616	10.1371/journal.pone.0055616	http://dx.doi.org/10.1371/journal.pone.0055616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383246	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600136
J	Ma, L; Huang, DW; Cuomo, CA; Sykes, S; Fantoni, G; Das, B; Sherman, BT; Yang, J; Huber, C; Xia, Y; Davey, E; Kutty, G; Bishop, L; Sassi, M; Lempicki, RA; Kovacs, JA				Ma, Liang; Huang, Da-Wei; Cuomo, Christina A.; Sykes, Sean; Fantoni, Giovanna; Das, Biswajit; Sherman, Brad T.; Yang, Jun; Huber, Charles; Xia, Yun; Davey, Emma; Kutty, Geetha; Bishop, Lisa; Sassi, Monica; Lempicki, Richard A.; Kovacs, Joseph A.			Sequencing and characterization of the complete mitochondrial genomes of three Pneumocystis species provide new insights into divergence between human and rodent Pneumocystis	FASEB JOURNAL			English	Article						inverted repeats; DNA replication; pneumonia	F SP. HOMINIS; DNA-SEQUENCES; GENETIC-DIVERGENCE; TANDEM REPEATS; SP CARINII; EVOLUTION; MICE; FUNGI; CHAIN; IDENTIFICATION	Pneumocystis jirovecii is an important opportunistic pathogen associated with AIDS and other immunodeficient conditions. Currently, very little is known about its nuclear and mitochondrial genomes. In this study, we sequenced the complete mitochondrial genome (mtDNA) of this organism and its closely related species Pneumocystis carinii and Pneumocystis murina by a combination of sequencing technologies. Our study shows that P. carinii and P. murina mtDNA share a nearly identical number and order of genes in a linear configuration, whereas P. jirovecii has a circular mtDNA containing nearly the same set of genes but in a different order. Detailed studies of the mtDNA terminal structures of P. murina and P. carinii suggest a unique replication mechanism for linear mtDNA. Phylogenetic analysis supports a close association of Pneumocystis species with Taphrina, Saitoella, and Schizosaccharomyces, and divergence within Pneumocystis species, with P. murina and P. carinii being more closely related to each other than either is to P. jirovecii. Comparative analysis of four complete P. jirovecii mtDNA sequences in this study and previously reported mtDNA sequences for diagnosing and genotyping suggests that the current diagnostic and typing methods can be improved using the complete mtDNA data. The availability of the complete P. jirovecii mtDNA also opens the possibility of identifying new therapeutic targets.-Ma, L., Huang, D. W., Cuomo, C. A., Sykes, S., Fantoni, G., Das, B., Sherman, B. T., Yang, J., Huber, C., Xia, Y., Davey, E., Kutty, G., Bishop, L., Sassi, M., Lempicki, R. A., Kovacs, J. A. Sequencing and characterization of the complete mitochondrial genomes of three Pneumocystis species provide new insights into divergence between human and rodent Pneumocystis. FASEB J. 27, 1962-1972 (2013). www.fasebj.org	[Ma, Liang; Fantoni, Giovanna; Xia, Yun; Davey, Emma; Kutty, Geetha; Bishop, Lisa; Sassi, Monica; Kovacs, Joseph A.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Huber, Charles] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Huang, Da-Wei; Das, Biswajit; Sherman, Brad T.; Yang, Jun; Lempicki, Richard A.] Sci Applicat Int Corp Frederick, Lab Immunopathogenesis & Bioinformat, Clin Serv Program, Frederick, MD USA; [Cuomo, Christina A.; Sykes, Sean] MIT, Broad Inst, Cambridge, MA 02139 USA; [Cuomo, Christina A.; Sykes, Sean] Harvard Univ, Cambridge, MA 02138 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Science Applications International Corporation (SAIC); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Ma, L (corresponding author), NIH, Dept Crit Care Med, Ctr Clin, 10 Ctr Dr, Bethesda, MD 20892 USA.	mal3@mail.nih.gov	Lempicki, Richard A/E-1844-2012; Cuomo, Christina/L-2222-2019; Kovacs, Joseph/AAU-6105-2021	Lempicki, Richard A/0000-0002-7059-409X; Cuomo, Christina/0000-0002-5778-960X; Kovacs, Joseph/0000-0002-5191-9880; Sykes, Sean/0000-0001-8344-5176; Ma, Liang/0000-0002-6078-5730	Intramural Research Program of the U.S. National Institutes of Health Clinical Center; National Institute of Allergy and Infectious Diseases [NOI-CO-56000]; National Human Genome Research Institute [U54HG003067]; Chongqing Medical University (Chongqing, China); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL000192] Funding Source: NIH RePORTER	Intramural Research Program of the U.S. National Institutes of Health Clinical Center; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Chongqing Medical University (Chongqing, China); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CLINICAL CENTER	This work was supported by the Intramural Research Program of the U.S. National Institutes of Health Clinical Center; the National Institute of Allergy and Infectious Diseases (contract NOI-CO-56000); and the National Human Genome Research Institute (grant U54HG003067). Y.X. was supported by a scholarship from Chongqing Medical University (Chongqing, China). The authors declare no conflicts of interests. The authors thank Rene Costello and Howard Mostowski for their support of the animal studies.	BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; Ben Beard C, 2004, EMERG INFECT DIS, V10, P1729, DOI 10.3201/eid1010.030981; Bishop LR, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-39; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P759, DOI 10.1093/nar/gkg134; DINOUEL N, 1993, MOL CELL BIOL, V13, P2315, DOI 10.1128/MCB.13.4.2315; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDMAN JC, 1988, NATURE, V334, P519, DOI 10.1038/334519a0; Gianella S, 2010, TRANSPL INFECT DIS, V12, P1, DOI 10.1111/j.1399-3062.2009.00447.x; Helweg-Larsen J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-28; Hunter JAC, 1996, J EUKARYOT MICROBIOL, V43, pS24, DOI 10.1111/j.1550-7408.1996.tb04962.x; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Keely SP, 2004, MICROBIOL-SGM, V150, P1153, DOI 10.1099/mic.0.26921-0; Kessl JJ, 2004, J BIOL CHEM, V279, P2817, DOI 10.1074/jbc.M309984200; Kosa P, 2006, NUCLEIC ACIDS RES, V34, P2472, DOI 10.1093/nar/gkl327; KOVACS JA, 1988, J IMMUNOL, V140, P2023; Kovacs JA, 2009, JAMA-J AM MED ASSOC, V301, P2578, DOI 10.1001/jama.2009.880; Larsen HH, 2002, J CLIN MICROBIOL, V40, P2989, DOI 10.1128/JCM.40.8.2989-2993.2002; Lee CH, 1998, J CLIN MICROBIOL, V36, P734, DOI 10.1128/JCM.36.3.734-741.1998; Liu Y, 2009, MOL BIOL EVOL, V26, P27, DOI 10.1093/molbev/msn221; Ma L, 2003, J MED MICROBIOL, V52, P955, DOI 10.1099/jmm.0.05131-0; Ma L, 2002, J INFECT DIS, V186, P1647, DOI 10.1086/345721; Ma L, 2001, J INFECT DIS, V184, P1358, DOI 10.1086/324208; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Martins VD, 2011, J BIOENERG BIOMEMBR, V43, P81, DOI 10.1007/s10863-011-9331-1; Maskell NA, 2003, THORAX, V58, P594, DOI 10.1136/thorax.58.7.594; MORIN GB, 1986, CELL, V46, P873, DOI 10.1016/0092-8674(86)90069-3; Nosek J, 1998, TRENDS GENET, V14, P184, DOI 10.1016/S0168-9525(98)01443-7; Perez-Brocal V, 2010, GENOME BIOL EVOL, V2, P257, DOI 10.1093/gbe/evq015; Redhead S, 2006, J EUKARYOT MICROBIOL, V53, P2, DOI 10.1111/j.1550-7408.2005.00072.x; Rodova M, 2003, MOL BIOL EVOL, V20, P1669, DOI 10.1093/molbev/msg191; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Sesterhenn TM, 2010, MOL GENET GENOMICS, V283, P63, DOI 10.1007/s00438-009-0498-7; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiller JW, 1999, MOL BIOL EVOL, V16, P1270, DOI 10.1093/oxfordjournals.molbev.a026217; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tsolaki AG, 1998, J CLIN MICROBIOL, V36, P90, DOI 10.1128/JCM.36.1.90-93.1998; Valach M, 2011, NUCLEIC ACIDS RES, V39, P4202, DOI 10.1093/nar/gkq1345; Vestereng VH, 2004, J INFECT DIS, V189, P1540, DOI 10.1086/382486; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; Wakefield AE, 1996, J CLIN MICROBIOL, V34, P1754, DOI 10.1128/JCM.34.7.1754-1759.1996; Walker DJ, 1998, J INFECT DIS, V178, P1767, DOI 10.1086/314509; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Xu Z, 2003, GENETICS, V163, P1299	44	30	34	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1962	1972		10.1096/fj.12-224444	http://dx.doi.org/10.1096/fj.12-224444			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23392351	Green Published			2022-12-25	WOS:000318226100016
J	Sung, RJ; Zhang, M; Qi, Y; Verdine, GL				Sung, Rou-Jia; Zhang, Michael; Qi, Yan; Verdine, Gregory L.			Structural and Biochemical Analysis of DNA Helix Invasion by the Bacterial 8-Oxoguanine DNA Glycosylase MutM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN-STRUCTURE; FPG PROTEIN; REPAIR; LESION; SYSTEM; RECOGNITION; VALIDATION; CLONING; ACID	MutM is a bacterial DNA glycosylase that serves as the first line of defense against the highly mutagenic 8-oxoguanine (oxoG) lesion, catalyzing glycosidic bond cleavage of oxoG to initiate base excision DNA repair. Previous work has shown that MutM actively interrogates DNA for the presence of an intrahelical oxoG lesion. This interrogation process involves significant buckling and bending of the DNA to promote extrusion of oxoG from the duplex. Structural snapshots have revealed several different highly conserved residues that are prominently inserted into the duplex in the vicinity of the target oxoG before and after base extrusion has occurred. However, the roles of these helix-invading residues during the lesion recognition and base extrusion process remain unclear. In this study, we set out to probe the function of residues Phe(114) and Met(77) in oxoG recognition and repair. Here we report a detailed biochemical and structural characterization of MutM variants containing either a F114A or M77A mutation, both of which showed significant decreases in the efficiency of oxoG repair. These data reveal that Met77 plays an important role in stabilizing the lesion-extruded conformation of the DNA. Phe(114), on the other hand, appears to destabilize the intrahelical state of the oxoG lesion, primarily by buckling the target base pair. We report the observation of a completely unexpected interaction state, in which the target base pair is ruptured but remains fully intrahelical; this structure vividly illustrates the disruptive influence of MutM on the target base pair.	[Sung, Rou-Jia; Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Zhang, Michael; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Sung, Rou-Jia; Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Chem Biol Initiat, Boston, MA 02115 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Qi, Yan] Harvard Univ, Sch Med, Grad Program Biophys, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Verdine, GL (corresponding author), 12 Oxford St, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu		Zhang, Michael/0000-0002-7067-0689	National Institutes of Health [GM044853, CA100742]; Harvard College Research Program; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard College Research Program; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM044853 and CA100742.; Supported by a grant by the Harvard College Research Program.; Supported by a predoctoral fellowship from the National Science Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bowman BR, 2008, STRUCTURE, V16, P1166, DOI 10.1016/j.str.2008.04.012; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dunn AR, 2011, NUCLEIC ACIDS RES, V39, P7487, DOI 10.1093/nar/gkr459; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorova OS, 2002, BIOCHEMISTRY-US, V41, P1520, DOI 10.1021/bi011524u; Fromme JC, 2002, NAT STRUCT BIOL, V9, P544, DOI 10.1038/nsb809; Ishchenko AA, 2002, BIOCHEMISTRY-US, V41, P7540, DOI 10.1021/bi0121297; Koval VV, 2010, MUTAT RES-FUND MOL M, V685, P3, DOI 10.1016/j.mrfmmm.2009.08.018; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Nam K, 2009, J AM CHEM SOC, V131, P18208, DOI 10.1021/ja907544b; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Qi Y, 2012, P NATL ACAD SCI USA, V109, P1086, DOI 10.1073/pnas.1111237108; Qi Y, 2010, J BIOL CHEM, V285, P1468, DOI 10.1074/jbc.M109.069799; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Sung RJ, 2012, J BIOL CHEM, V287, P18044, DOI 10.1074/jbc.M111.313635; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197	33	21	21	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10012	10023		10.1074/jbc.M112.415612	http://dx.doi.org/10.1074/jbc.M112.415612			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23404556	Green Published, hybrid			2022-12-25	WOS:000317114000040
J	Kong, E; Peng, SY; Chandra, G; Sarkar, C; Zhang, ZJ; Bagh, MB; Mukherjee, AB				Kong, Eryan; Peng, Shiyong; Chandra, Goutam; Sarkar, Chinmoy; Zhang, Zhongjian; Bagh, Maria B.; Mukherjee, Anil B.			Dynamic Palmitoylation Links Cytosol-Membrane Shuttling of Acyl-protein Thioesterase-1 and Acyl-protein Thioesterase-2 with That of Proto-oncogene H-Ras Product and Growth-associated Protein-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL DEVELOPMENT; LYSOPHOSPHOLIPASE I; MOLECULAR-CLONING; EXPRESSION; IDENTIFICATION; LOCALIZATION; PURIFICATION; PALMITATE; ACYLATION	Acyl-protein thioesterase-1 (APT1) and APT2 are cytosolic enzymes that catalyze depalmitoylation of membrane-anchored, palmitoylated H-Ras and growth-associated protein-43 (GAP-43), respectively. However, the mechanism(s) of cytosol-membrane shuttling of APT1 and APT2, required for depalmitoylating their substrates H-Ras and GAP-43, respectively, remained largely unknown. Here, we report that both APT1 and APT2 undergo palmitoylation on Cys-2. Moreover, blocking palmitoylation adversely affects membrane localization of both APT1 and APT2 and that of their substrates. We also demonstrate that APT1 not only catalyzes its own depalmitoylation but also that of APT2 promoting dynamic palmitoylation (palmitoylation-depalmitoylation) of both thioesterases. Furthermore, shRNA suppression of APT1 expression or inhibition of its thioesterase activity by palmostatin B markedly increased membrane localization of APT2, and shRNA suppression of APT2 had virtually no effect on membrane localization of APT1. In addition, mutagenesis of the active site Ser residue to Ala (S119A), which renders catalytic inactivation of APT1, also increased its membrane localization. Taken together, our findings provide insight into a novel mechanism by which dynamic palmitoylation links cytosol-membrane trafficking of APT1 and APT2 with that of their substrates, facilitating steady- state membrane localization and function of both.	[Kong, Eryan; Peng, Shiyong; Chandra, Goutam; Sarkar, Chinmoy; Zhang, Zhongjian; Bagh, Maria B.; Mukherjee, Anil B.] Eunice Kennedy Shriver NICHD, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mukherjee, AB (corresponding author), NIH, Bldg 10,Room 9D42,10 Ctr Dr, Bethesda, MD 20892 USA.	mukherja@exchange.nih.gov	Kong, Eryan/GRS-2219-2022; Sarkar, Chinmoy/AAI-2461-2019; Peng, Shiyong/D-6391-2014	Kong, Eryan/0000-0002-4086-1441; Peng, Shiyong/0000-0003-0697-3674	National Institutes of Health Intramural Program of the Eunice Kennedy-Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000910] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program of the Eunice Kennedy-Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in whole by National Institutes of Health Intramural Program of the Eunice Kennedy-Shriver NICHD.	Adam RM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-30; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; CAMP LA, 1993, J BIOL CHEM, V268, P22566; CAMP LA, 1994, J BIOL CHEM, V269, P23212; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Hellsten E, 1996, EMBO J, V15, P5240, DOI 10.1002/j.1460-2075.1996.tb00909.x; Hirano T, 2009, BBA-MOL CELL BIOL L, V1791, P797, DOI 10.1016/j.bbalip.2009.05.001; Ladygina N, 2011, ADV IMMUNOL, V109, P1, DOI 10.1016/B978-0-12-387664-5.00001-7; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rusch M, 2011, ANGEW CHEM INT EDIT, V50, P9838, DOI 10.1002/anie.201102967; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; SCHMIDT MFG, 1989, BIOCHIM BIOPHYS ACTA, V988, P411, DOI 10.1016/0304-4157(89)90013-0; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Soyombo AA, 1997, J BIOL CHEM, V272, P27456, DOI 10.1074/jbc.272.43.27456; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang AJ, 1997, J BIOL CHEM, V272, P22030, DOI 10.1074/jbc.272.35.22030; Wang AJ, 1997, J BIOL CHEM, V272, P12723, DOI 10.1074/jbc.272.19.12723; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	33	86	86	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9112	9125		10.1074/jbc.M112.421073	http://dx.doi.org/10.1074/jbc.M112.421073			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396970	Green Published, hybrid			2022-12-25	WOS:000316862200031
J	Quan, Y; Jiang, JX; Dingledine, R				Quan, Yi; Jiang, Jianxiong; Dingledine, Ray			EP2 Receptor Signaling Pathways Regulate Classical Activation of Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN E-2 BIOSYNTHESIS; PROTEIN-KINASE INHIBITORS; TUMOR-NECROSIS-FACTOR; KAPPA-B PATHWAYS; CYCLIC-AMP; PROSTANOID RECEPTORS; RAT MICROGLIA; INTERFERON-GAMMA; MOUSE MICROGLIA; INNATE IMMUNITY	Activation of EP2 receptors by prostaglandin E2 (PGE(2)) promotes brain inflammation in neurodegenerative diseases, but the pathways responsible are unclear. EP2 receptors couple to G alpha(s) and increase cAMP, which associates with protein kinase A (PKA) and cAMP-regulated guanine nucleotide exchange factors (Epacs). Here, we studied EP2 function and its signaling pathways in rat microglia in their resting state or undergoing classical activation in vitro following treatment with low concentrations of lipopolysaccharide and interferon-gamma. Real time PCR showed that PGE(2) had no effect on expression of CXCL10, TGF-beta 1, and IL-11 and exacerbated the rapid up-regulation of mRNAs encoding cyclooxygenase-2, inducible NOS, IL-6, and IL-1 beta but blunted the production of mRNAs encoding TNF-alpha, IL-10, CCL3, and CCL4. These effects were mimicked fully by the EP2 agonist butaprost but only weakly by the EP1/EP3 agonist 17-phenyl trinor PGE(2) or the EP4 agonist CAY10598 and not at all by the EP3/EP1 agonist sulprostone and confirmed by protein measurements of cyclooxygenase-2, IL-6, IL-10, and TNF-alpha. In resting microglia, butaprost induced cAMP formation and altered the mRNA expression of inflammatory mediators, but protein expression was unchanged. The PKA inhibitor H89 had little or no effect on inflammatory mediators modulated by EP2, whereas the Epac activator 8-(4-chlorophenylthio)-2'-O-methyladenosine 3',5'-cyclic monophosphate acetoxymethyl ester mimicked all butaprost effects. These results indicate that EP2 activation plays a complex immune regulatory role during classical activation of microglia and that Epac pathways are prominent in this role.	[Quan, Yi; Jiang, Jianxiong; Dingledine, Ray] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Dingledine, R (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rdingledine@pharm.emory.edu	Jiang, Jianxiong/A-1987-2010	Jiang, Jianxiong/0000-0003-3955-8928; Dingledine, Ray/0000-0001-7128-4520	National Institutes of Health from the NINDS [U01NS058158, R21NS074169]; Countermeasures against Chemical Threats (CounterACT) Program, National Institutes of Health Office of the Director; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058158, R21NS074169] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; Countermeasures against Chemical Threats (CounterACT) Program, National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants U01NS058158 and R21NS074169 (both to R.D.) from the NINDS and the Countermeasures against Chemical Threats (CounterACT) Program, National Institutes of Health Office of the Director. This work was also supported by the Epilepsy Foundation (to J.J.).	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Aloisi F, 1999, J NEUROSCI RES, V56, P571; Aloisi F, 1997, J IMMUNOL, V159, P1604; Aronoff DM, 2006, J INTERF CYTOK RES, V26, P827, DOI 10.1089/jir.2006.26.827; Billot X, 2003, BIOORG MED CHEM LETT, V13, P1129, DOI 10.1016/S0960-894X(03)00042-8; Caggiano AO, 1999, J NEUROCHEM, V72, P565, DOI 10.1046/j.1471-4159.1999.0720565.x; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chavant F, 2010, J PHARMACOL EXP THER, V332, P505, DOI 10.1124/jpet.109.162164; Chen HJ, 2012, BIOORG MED CHEM LETT, V22, P4038, DOI 10.1016/j.bmcl.2012.04.082; Chen K, 2010, BRAIN STRUCT FUNCT, V214, P219, DOI 10.1007/s00429-009-0226-4; Chepurny OG, 2009, J BIOL CHEM, V284, P10728, DOI 10.1074/jbc.M900166200; Cimino PJ, 2008, CURR MED CHEM, V15, P1863, DOI 10.2174/092986708785132915; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Dargahi L, 2011, J MOL NEUROSCI, V45, P10, DOI 10.1007/s12031-010-9401-6; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Ezcurra ALD, 2010, NEUROBIOL DIS, V37, P630, DOI 10.1016/j.nbd.2009.11.018; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Foey AD, 1998, J IMMUNOL, V160, P920; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Iglesias BM, 1997, J NEUROIMMUNOL, V72, P83, DOI 10.1016/S0165-5728(96)00155-5; Jiang JX, 2013, P NATL ACAD SCI USA, V110, P3591, DOI 10.1073/pnas.1218498110; Jiang JX, 2013, J PHARMACOL EXP THER, V344, P360, DOI 10.1124/jpet.112.200444; Jiang JX, 2012, P NATL ACAD SCI USA, V109, P3149, DOI 10.1073/pnas.1120195109; Jiang JX, 2010, P NATL ACAD SCI USA, V107, P2307, DOI 10.1073/pnas.0909310107; Jin JJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-2; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar A, 2010, NEUROSCI RES, V66, P271, DOI 10.1016/j.neures.2009.11.009; Liang XB, 2008, ANN NEUROL, V64, P304, DOI 10.1002/ana.21437; Liu J, 2011, J MOL NEUROSCI, V45, P186, DOI 10.1007/s12031-010-9426-x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Melchior B, 2006, NEUROCHEM INT, V49, P145, DOI 10.1016/j.neuint.2006.04.002; Minghetti L, 1997, GLIA, V19, P152, DOI 10.1002/(SICI)1098-1136(199702)19:2<152::AID-GLIA6>3.0.CO;2-2; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Quan Y, 2007, J NEUROSCI RES, V85, P3150, DOI 10.1002/jnr.21421; Quan Y, 2011, ACTA PHARMACOL SIN, V32, P188, DOI 10.1038/aps.2010.174; Quan Y, 2009, NEUROSCI LETT, V464, P29, DOI 10.1016/j.neulet.2009.08.013; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Sanchez-Pernaute R, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-6; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Serrano GE, 2011, J NEUROSCI, V31, P14850, DOI 10.1523/JNEUROSCI.3922-11.2011; Shi J, 2010, J IMMUNOL, V184, P7207, DOI 10.4049/jimmunol.0903487; Shie FS, 2005, GLIA, V52, P70, DOI 10.1002/glia.20220; Shie FS, 2005, AM J PATHOL, V166, P1163, DOI 10.1016/S0002-9440(10)62336-X; Tanaka T, 2001, CYTOKINE, V13, P193, DOI 10.1006/cyto.2000.0828; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; von Zahn J, 1997, NEUROREPORT, V8, P3851, DOI 10.1097/00001756-199712220-00003; Weinstein JR, 2009, NEUROCHEM RES, V34, P445, DOI 10.1007/s11064-008-9803-9; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yamashita M, 2007, AM J PHYSIOL-CELL PH, V293, pC184, DOI 10.1152/ajpcell.00346.2006; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102	59	78	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9293	9302		10.1074/jbc.M113.455816	http://dx.doi.org/10.1074/jbc.M113.455816			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404506	Green Published, hybrid			2022-12-25	WOS:000316862200047
J	Buffen, K; Oosting, M; Mennens, S; Anand, PK; Plantinga, TS; Sturm, P; van de Veerdonk, FL; van der Meer, JWM; Xavier, RJ; Kanneganti, TD; Netea, MG; Joosten, LAB				Buffen, Kathrin; Oosting, Marije; Mennens, Svenja; Anand, Paras K.; Plantinga, Theo S.; Sturm, Patrick; van de Veerdonk, Frank L.; van der Meer, Jos W. M.; Xavier, Ramnik J.; Kanneganti, Thirumala-Devi; Netea, Mihai G.; Joosten, Leo A. B.			Autophagy Modulates Borrelia burgdorferi-induced Production of Interleukin-1 beta (IL-1 beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE ACTIVATION; TREPONEMA-PALLIDUM; INFLAMMASOME; DISEASE; CELLS; LIPOPROTEINS; RECOGNITION; LIPOPOLYSACCHARIDE; PHAGOCYTOSIS; INDUCTION	Borrelia burgdorferi sensu lato is the causative agent of Lyme disease. Recent studies have shown that recognition of the spirochete is mediated by TLR2 and NOD2. The latter receptor has been associated with the induction of the intracellular degradation process called autophagy. The present study demonstrated for the first time the induction of autophagy by exposure to B. burgdorferi and that autophagy modulates the B. burgdorferi-dependent cytokine production. Human peripheral blood mononuclear cells treated with autophagy inhibitors showed an increased IL-1 beta and IL-6 production in response to the exposure of the spirochete, whereas TNF alpha production was unchanged. Autophagy induction against B. burgdorferi was dependent on reactive oxygen species (ROS) because cells from patients with chronic granulomatous disease, which are defective in ROS production, also produced elevated IL-1 beta. Further, the enhanced production of the proinflammatory cytokines was because of the elevated mRNA expression in the absence of autophagy. Our results thus demonstrate the induction of autophagy, which, in turn, modulates cytokine production by B. burgdorferi for the first time.	[Buffen, Kathrin; Oosting, Marije; Mennens, Svenja; Plantinga, Theo S.; van de Veerdonk, Frank L.; van der Meer, Jos W. M.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 GA Nijmegen, Netherlands; [Buffen, Kathrin; Oosting, Marije; Plantinga, Theo S.; van de Veerdonk, Frank L.; van der Meer, Jos W. M.; Netea, Mihai G.; Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 GA Nijmegen, Netherlands; [Mennens, Svenja; Anand, Paras K.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Sturm, Patrick] Radboud Univ Nijmegen, Dept Microbiol, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA	Radboud University Nijmegen; Radboud University Nijmegen; St Jude Children's Research Hospital; Radboud University Nijmegen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Joosten, LAB (corresponding author), Radboud Univ Nijmegen, Dept Med 463, Med Ctr, Geert Grootepl Zuid 8, NL-6525 GA Nijmegen, Netherlands.	l.joosten@aig.umcn.nl	Mennens, Svenja/F-3106-2016; Plantinga, Theo S./A-6895-2015; Kanneganti, Thirumala-Devi/M-9435-2018; van der Meer, Jos W.M./C-8521-2013; Netea, Mihai/N-5155-2014; Kanneganti, Thirumala-Devi/Y-2503-2019; Oosting, Marije/H-7437-2015; Joosten, Leo AB/H-3138-2015; van de Veerdonk, Frank L/C-7256-2008	Mennens, Svenja/0000-0003-1099-2894; Plantinga, Theo S./0000-0003-4990-6084; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; van der Meer, Jos W.M./0000-0001-5120-3690; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Joosten, Leo AB/0000-0001-6166-9830; van de Veerdonk, Frank L/0000-0002-1121-4894; Anand, Paras/0000-0003-2503-3653	Dutch Arthritis Association [NR 10-1-303]; Veni Grant from the Netherlands Organization for Scientific Research; National Institute of Health [R01AR056296]; Vici grant from The Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Dutch Arthritis Association; Veni Grant from the Netherlands Organization for Scientific Research; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vici grant from The Netherlands Organization for Scientific Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Dutch Arthritis Association Grant NR 10-1-303.; Supported by a Veni Grant from the Netherlands Organization for Scientific Research.; Supported by National Institute of Health Grant R01AR056296.; Supported by a Vici grant from The Netherlands Organization for Scientific Research.	Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Campbell J, 2004, J IMMUNOL, V173, P6928, DOI 10.4049/jimmunol.173.11.6928; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Derdakova M, 2005, ANN AGR ENV MED, V12, P165; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hefty PS, 2001, INFECT IMMUN, V69, P3618, DOI 10.1128/IAI.69.6.3618-3627.2001; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Huang J, 2009, AUTOPHAGY, V5, P887, DOI 10.4161/auto.9125; Jha S, 2009, J IMMUNOL, V183, P7623, DOI 10.4049/jimmunol.0902425; Kleinnijenhuis J, 2011, IMMUNOLOGY, V134, P341, DOI 10.1111/j.1365-2567.2011.03494.x; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lee J, 2012, J BIOL CHEM, V287, P4033, DOI 10.1074/jbc.M111.280065; Liu N, 2009, INFECT IMMUN, V77, P3320, DOI 10.1128/IAI.00100-09; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Marquez A, 2009, INFLAMM BOWEL DIS, V15, P1697, DOI 10.1002/ibd.21001; Moore MW, 2007, INFECT IMMUN, V75, P2046, DOI 10.1128/IAI.01666-06; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Netea MG, 2010, NAT MED, V16, P28, DOI 10.1038/nm0110-28; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Norgard MV, 1996, INFECT IMMUN, V64, P3845, DOI 10.1128/IAI.64.9.3845-3852.1996; Oh JE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00044; Oosting M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025998; Oosting M, 2010, J INFECT DIS, V201, P1849, DOI 10.1086/652871; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Pietruczuk Adam, 2004, Pol Merkur Lekarski, V17, P446; Plantinga TS, 2012, CURR OPIN PHARMACOL, V12, P497, DOI 10.1016/j.coph.2012.01.017; Plantinga TS, 2011, AUTOPHAGY, V7, P1074, DOI 10.4161/auto.7.9.15867; Plantinga TS, 2011, GUT, V60, P1229, DOI 10.1136/gut.2010.228908; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Segovia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029695; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; TOSATO G, 1990, BLOOD, V75, P1305, DOI 10.1182/blood.V75.6.1305.1305; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vincent MS, 1998, J IMMUNOL, V161, P5762; Zhang HF, 2009, HUM GENET, V125, P627, DOI 10.1007/s00439-009-0660-7	46	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8658	8666		10.1074/jbc.M112.412841	http://dx.doi.org/10.1074/jbc.M112.412841			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386602	hybrid, Green Published			2022-12-25	WOS:000316564500066
J	Luo, Y; Zhang, YH; Liu, T; Rutherford, S; Xu, YJ; Xu, XJ; Wu, W; Xiao, JP; Zeng, WL; Chu, C; Ma, WJ				Luo, Yuan; Zhang, Yonghui; Liu, Tao; Rutherford, Shannon; Xu, Yanjun; Xu, Xiaojun; Wu, Wei; Xiao, Jianpeng; Zeng, Weilin; Chu, Cordia; Ma, Wenjun			Lagged Effect of Diurnal Temperature Range on Mortality in a Subtropical Megacity of China	PLOS ONE			English	Article							HIGH AMBIENT-TEMPERATURE; AIR-POLLUTION; DISTRIBUTED LAG; RISK-FACTOR; EUROPEAN CITIES; UNITED-STATES; HEAT WAVES; US CITIES; WEATHER; COLD	Background: Many studies have found extreme temperature can increase the risk of mortality. However, it is not clear whether extreme diurnal temperature range (DTR) is associated with daily disease-specific mortality, and how season might modify any association. Objectives: To better understand the acute effect of DTR on mortality and identify whether season is a modifier of the DTR effect. Methods: The distributed lag nonlinear model (DLNM) was applied to assess the non-linear and delayed effects of DTR on deaths (non-accidental mortality (NAD), cardiovascular disease (CVD), respiratory disease (RD) and cerebrovascular disease (CBD)) in the full year, the cold season and the warm season. Results: A non-linear relationship was consistently found between extreme DTR and mortality. Immediate effects of extreme low DTR on all types of mortality were stronger than those of extreme high DTR in the full year. The cumulative effects of extreme DTRs increased with the increment of lag days for all types of mortality in cold season, and they were greater for extreme high DTRs than those of extreme low DTRs. In hot season, the cumulative effects for extreme low DTRs increased with the increment of lag days, but for extreme high DTR they reached maxima at a lag of 13 days for all types of mortality except for CBD(at lag6 days), and then decreased. Conclusions: Our findings suggest that extreme DTR is an independent risk factor of daily mortality, and season is a modifier of the association of DTR with daily mortality.	[Luo, Yuan; Liu, Tao; Wu, Wei; Xiao, Jianpeng; Zeng, Weilin; Ma, Wenjun] Guangdong Prov Inst Publ Hlth, Dept Environm & Hlth, Guangzhou, Guangdong, Peoples R China; [Luo, Yuan; Zhang, Yonghui; Liu, Tao; Xu, Yanjun; Xu, Xiaojun; Wu, Wei; Xiao, Jianpeng; Zeng, Weilin; Ma, Wenjun] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Rutherford, Shannon; Chu, Cordia] Griffith Univ, Sch Environm, Ctr Environm & Populat Hlth, Brisbane, Qld 4111, Australia	Griffith University	Ma, WJ (corresponding author), Guangdong Prov Inst Publ Hlth, Dept Environm & Hlth, Guangzhou, Guangdong, Peoples R China.	mwj68@tom.com	Xiao, Jianpeng/GRY-5231-2022; 马, 文军/GQQ-7852-2022; Xiao, Jian/GYU-4351-2022	Chu, Cordia/0000-0002-3683-5638	 [ACCC/20100528]		Funding was provided by http://www.ccadaptation.org.cn/, grant number ACCC/20100528. The funders had no role in study design, data collection and analysis, desicion to publish, or preparation of the manuscript.	Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basu R, 2011, ENVIRON RES, V111, P1286, DOI 10.1016/j.envres.2011.09.006; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Brazdil R, 1996, INT J CLIMATOL, V16, P765, DOI 10.1002/(SICI)1097-0088(199607)16:7<765::AID-JOC46>3.0.CO;2-O; Cao JY, 2009, J EPIDEMIOL, V19, P328, DOI 10.2188/jea.JE20080074; Carder M, 2005, OCCUP ENVIRON MED, V62, P702, DOI 10.1136/oem.2004.016394; Chen GH, 2007, INT J CARDIOL, V116, P408, DOI 10.1016/j.ijcard.2006.03.067; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; D'Ippoliti Daniela MP, 2010, ENV HLTH, V9, P37; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Guo YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016511; Ha J, 2011, SCI TOTAL ENV; Hastie TJ., 1990, GEN ADDITIVE MODELS; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Kan HD, 2007, ENVIRON RES, V103, P424, DOI 10.1016/j.envres.2006.11.009; Karl TR, 1993, PAPERS NATURAL RESOU, P185; Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670; Leung M.K.H., 2004, FEASIBILITY STUDY RE; Li Q, 2008, P 16 IAHR APD C 3 S; Liang WM, 2009, INT J BIOMETEOROL, V53, P17, DOI 10.1007/s00484-008-0187-y; Lim YH, 2012, INT J BIOMETEOROL, V56, P33, DOI 10.1007/s00484-010-0395-0; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; McMicheal A, 2003, CLIMATE CHANGES HUMA; Medina-Ramon M, 2007, OCCUP ENV MED; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Roberts S, 2007, ENVIRON RES, V104, P193, DOI 10.1016/j.envres.2007.01.009; Rocklov J, 2008, SCAND J PUBLIC HEALT, V36, P516, DOI 10.1177/1403494807088458; Rocklov J, 2010, INT J ENV RES PUB HE, V7, P2607, DOI 10.3390/ijerph7062607; Schneider A, 2008, INT J BIOMETEOROL, V52, P535, DOI 10.1007/s00484-008-0144-9; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; Schwartz J, 2000, AM J EPIDEMIOL, V151, P440, DOI 10.1093/oxfordjournals.aje.a010228; Song GX, 2008, RESPIROLOGY, V13, P1066, DOI 10.1111/j.1440-1843.2008.01401.x; Tam WWS, 2009, ARCH ENVIRON OCCUP H, V64, P202, DOI 10.1080/19338240903241192; Tank AMGK, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006316; Tong SL, 2010, INT J BIOMETEOROL, V54, P393, DOI 10.1007/s00484-009-0290-8; Vose RS, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024379; WHO, 2008, PROT HLTH CLIM CHANG; WHO, 2010, INT STAT CLASS DIS R; Zanobetti A, 2008, EPIDEMIOLOGY, V19, P563, DOI 10.1097/EDE.0b013e31816d652d; Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015	44	68	70	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55280	10.1371/journal.pone.0055280	http://dx.doi.org/10.1371/journal.pone.0055280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405130	Green Published, gold			2022-12-25	WOS:000315153400075
J	Sousa, MML; Zub, KA; Aas, PA; Hanssen-Bauer, A; Demirovic, A; Sarno, A; Tian, EM; Liabakk, NB; Slupphaug, G				Sousa, Mirta M. L.; Zub, Kamila Anna; Aas, Per Arne; Hanssen-Bauer, Audun; Demirovic, Aida; Sarno, Antonio; Tian, Erming; Liabakk, Nina B.; Slupphaug, Geir			An Inverse Switch in DNA Base Excision and Strand Break Repair Contributes to Melphalan Resistance in Multiple Myeloma Cells	PLOS ONE			English	Article							INTERSTRAND CROSS-LINK; CYCLE REGULATION; DRUG-RESISTANCE; DAMAGE; PROTEIN; APOPTOSIS; PATHWAY; CANCER; URACIL; GLYCOSYLASE	Alterations in checkpoint and DNA repair pathways may provide adaptive mechanisms contributing to acquired drug resistance. Here, we investigated the levels of proteins mediating DNA damage signaling and -repair in RPMI8226 multiple myeloma cells and its Melphalan-resistant derivative 8226-LR5. We observed markedly reduced steady-state levels of DNA glycosylases UNG2, NEIL1 and MPG in the resistant cells and cross-resistance to agents inducing their respective DNA base lesions. Conversely, repair of alkali-labile sites was apparently enhanced in the resistant cells, as substantiated by alkaline comet assay, autoribosylation of PARP-1, and increased sensitivity to PARP-1 inhibition by 4-AN or KU58684. Reduced base-excision and enhanced single-strand break repair would both contribute to the observed reduction in genomic alkali-labile sites, which could jeopardize productive processing of the more cytotoxic Melphalan-induced interstrand DNA crosslinks (ICLs). Furthermore, we found a marked upregulation of proteins in the non-homologous end-joining (NHEJ) pathway of double-strand break (DSB) repair, likely contributing to the observed increase in DSB repair kinetics in the resistant cells. Finally, we observed apparent upregulation of ATR-signaling and downregulation of ATM-signaling in the resistant cells. This was accompanied by markedly increased sensitivity towards Melphalan in the presence of ATR-, DNA-PK, or CHK1/2 inhibitors whereas no sensitizing effect was observed subsequent to ATM inhibition, suggesting that replication blocking lesions are primary triggers of the DNA damage response in the Melphalan resistant cells. In conclusion, Melphalan resistance is apparently contributed by modulation of the DNA damage response at multiple levels, including downregulation of specific repair pathways to avoid repair intermediates that could impair efficient processing of cytotoxic ICLs and ICL-induced DSBs. This study has revealed several novel candidate biomarkers for Melphalan sensitivity that will be included in targeted quantitation studies in larger patient cohorts to validate their value in prognosis as well as targets for replacement-or adjuvant therapies.	[Sousa, Mirta M. L.; Zub, Kamila Anna; Aas, Per Arne; Hanssen-Bauer, Audun; Demirovic, Aida; Sarno, Antonio; Tian, Erming; Liabakk, Nina B.; Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Sousa, Mirta M. L.; Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, Prote & Metabol Core Facil PROMEC, Trondheim, Norway; [Zub, Kamila Anna; Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, KG Jebsen Ctr Myeloma Res, Trondheim, Norway; [Tian, Erming] Univ Arkansas Med Sci, Lab Myeloma Genet, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Arkansas System; University of Arkansas Medical Sciences	Slupphaug, G (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway.	geir.slupphaug@ntnu.no	Slupphaug, Geir/AAN-3794-2020	Slupphaug, Geir/0000-0002-7498-3500; Sarno, Antonio/0000-0002-9308-8018	Research Council of Norway [183423, 183432]; Norwegian Cancer Society [TS-02-2008-0185]; Cancer Fund at St. Olavs Hospital, Trondheim [47063403]; Central Norway Regional Health Authority (RHA) [81133200]; Norwegian University of Science and Technology (NTNU) [81133200]; Familien Blix fond til fremme av medisinsk forskning; NATIONAL CANCER INSTITUTE [P01CA055819] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Cancer Fund at St. Olavs Hospital, Trondheim; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); Familien Blix fond til fremme av medisinsk forskning; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906), grant no. 183423 and 183432; the Norwegian Cancer Society (https://kreftforeningen.no/en/), grant no. TS-02-2008-0185; the Cancer Fund at St. Olavs Hospital, Trondheim (http://www.stolav.no/en/), grant no. 47063403; the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) (http://www.ntnu.no/dmf/rad/samorg), grant no. 81133200; and Familien Blix fond til fremme av medisinsk forskning (http://www.legatsiden.no/innhold/visettlegat.php?id=1017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS DS, 1979, CLIN PHARMACOL THER, V26, P737; ALEXANIAN R, 1969, J AMER MED ASSOC, V208, P1680, DOI 10.1001/jama.208.9.1680; Audebert M, 2008, BIOCHEM BIOPH RES CO, V369, P982, DOI 10.1016/j.bbrc.2007.11.132; Balcome S, 2004, CHEM RES TOXICOL, V17, P950, DOI 10.1021/tx0499463; Bauer GB, 1997, NUCLEIC ACIDS RES, V25, P1211, DOI 10.1093/nar/25.6.1211; BELLAMY WT, 1991, CANCER RES, V51, P995; Bergoglio V, 2001, ONCOGENE, V20, P6181, DOI 10.1038/sj.onc.1204743; BERGSAGEL DE, 1962, CANCER CHEMOTH REP, P87; Boldogh I, 2003, TOXICOLOGY, V193, P137, DOI 10.1016/j.tox.2003.08.013; BOSANQUET AG, 1988, CANCER CHEMOTH PHARM, V21, P211; BOSANQUET AG, 1985, J PHARM SCI, V74, P348, DOI 10.1002/jps.2600740329; BRAVO R, 1980, J CELL BIOL, V84, P795, DOI 10.1083/jcb.84.3.795; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Clingen PH, 2008, BIOCHEM PHARMACOL, V76, P19, DOI 10.1016/j.bcp.2008.03.025; Coste F, 1999, NUCLEIC ACIDS RES, V27, P1837, DOI 10.1093/nar/27.8.1837; Couve S, 2009, J BIOL CHEM, V284, P11963, DOI 10.1074/jbc.M900746200; DALTON WS, 1989, J CLIN ONCOL, V7, P415, DOI 10.1200/JCO.1989.7.4.415; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Dannenberg JH, 2010, CELL, V141, P18, DOI 10.1016/j.cell.2010.03.020; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Dvorakova K, 2002, MOL CANCER THER, V1, P185; Edler M, 2006, J MASS SPECTROM, V41, P507, DOI 10.1002/jms.1009; EHRSSON H, 1990, CLIN PHARMACOL THER, V47, P86, DOI 10.1038/clpt.1990.13; FERNBERG JO, 1991, EUR J HAEMATOL, V47, P161; Fishel ML, 2003, CANCER RES, V63, P608; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Goncalves TL, 2009, PHARMACOL RES, V59, P279, DOI 10.1016/j.phrs.2008.12.005; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hazlehurst LA, 2003, CANCER RES, V63, P7900; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Kim DK, 2001, BIOCHEM BIOPH RES CO, V289, P34; Kothandapani A, 2011, J BIOL CHEM; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Kumar A, 2011, AM J HEMATOL, V86, P18, DOI 10.1002/ajh.21904; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Lukamowicz M, 2011, MUTAGENESIS, V26, P763, DOI 10.1093/mutage/ger044; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; Ma WJ, 2012, P NATL ACAD SCI USA, V109, P6590, DOI 10.1073/pnas.1118078109; Mace-Aime G, 2010, ENVIRON MOL MUTAGEN, V51, P508, DOI 10.1002/em.20548; Merchionne F, 2007, CLIN EXP MED, V7, P83, DOI 10.1007/s10238-007-0134-y; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Oancea M, 2004, INT J HEMATOL, V80, P224, DOI 10.1532/IJH97.04107; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Palumbo A, 2009, LEUKEMIA, V23, P449, DOI 10.1038/leu.2008.325; POVIRK LF, 1994, MUTAT RES-REV GENET, V318, P205, DOI 10.1016/0165-1110(94)90015-9; Pyndiah S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001556; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rothbarth J, 2002, CHEM-BIOL INTERACT, V140, P93, DOI 10.1016/S0009-2797(02)00014-5; Sabbioneda S, 2007, DNA REPAIR, V6, P121, DOI 10.1016/j.dnarep.2006.09.002; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SLUPPHAUG G, 1991, NUCLEIC ACIDS RES, V19, P5131, DOI 10.1093/nar/19.19.5131; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Sousa MML, 2007, MOL ASPECTS MED, V28, P276, DOI 10.1016/j.mam.2007.04.006; Spanswick VJ, 2002, BLOOD, V100, P224, DOI 10.1182/blood.V100.1.224; Stolz A, 2011, CLIN CANCER RES, V17, P401, DOI 10.1158/1078-0432.CCR-10-1215; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Tsvetkov LM, 2005, CELL CYCLE, V4, P609; Vasquez KM, 2010, ENVIRON MOL MUTAGEN, V51, P527, DOI 10.1002/em.20557; Wang D, 2009, LUNG CANCER, V66, P298, DOI 10.1016/j.lungcan.2009.02.019; Wang Dong, 2006, Zhonghua Bing Li Xue Za Zhi, V35, P352; Wang LC, 2010, CRIT REV BIOCHEM MOL, V45, P424, DOI 10.3109/10409238.2010.502166; WANG P, 1991, BIOCHEMISTRY-US, V30, P11515, DOI 10.1021/bi00113a005; WANG Z, 1989, J BIOL CHEM, V264, P1163; Wilson DM, 2010, TRENDS BIOCHEM SCI, V35, P247, DOI 10.1016/j.tibs.2010.01.003; Xiang Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005520; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Yarde DN, 2009, CANCER RES, V69, P9367, DOI 10.1158/0008-5472.CAN-09-2616; Zhang Y, 2009, INT J ONCOL, V35, P1069, DOI 10.3892/ijo_00000422; Zhu GY, 2010, BIOCHEMISTRY-US, V49, P6177, DOI 10.1021/bi100775t	79	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55493	10.1371/journal.pone.0055493	http://dx.doi.org/10.1371/journal.pone.0055493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405159	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400104
J	Szasz, T; Davis, RP; Garver, HS; Burnett, RJ; Fink, GD; Watts, SW				Szasz, Theodora; Davis, Robert Patrick; Garver, Hannah S.; Burnett, Robert J.; Fink, Gregory D.; Watts, Stephanie W.			Long-Term Inhibition of Xanthine Oxidase by Febuxostat Does Not Decrease Blood Pressure in Deoxycorticosterone Acetate (DOCA)-Salt Hypertensive Rats	PLOS ONE			English	Article							URIC-ACID; ALLOPURINOL; GOUT; HYPERURICEMIA; PREVENTS; URATE; OXIDOREDUCTASE; EFFICACY; INJURY; SAFETY	Xanthine oxidase and its products, uric acid and ROS, have been implicated in the pathogenesis of cardiovascular disease, such as hypertension. We have previously reported that allopurinol inhibition of XO does not alter the progression of deoxycorticosterone acetate (DOCA)-salt hypertension in rats. However other researchers have observed a reduction in blood pressure after allopurinol treatment in the same model. To resolve this controversy, in this study we used the newer and more effective XO inhibitor febuxostat, and hypothesized that a more complete XO blockade might impair hypertension development and its end-organ consequences. We used DOCA-salt hypertensive rats and administered vehicle (salt water) or febuxostat (orally, 5 mg/kg/day in salt water) in a short-term "reversal" experiment (2 weeks of treatment 3 weeks after DOCA-salt beginning) and a long-term "prevention" experiment (treatment throughout 4 weeks of DOCA-salt). We confirmed XO inhibition by febuxostat by measuring circulating and tissue levels of XO metabolites. We found an overall increase in hypoxanthine (XO substrate) and decrease in uric acid (XO product) levels following febuxostat treatment. However, despite a trend for reduced blood pressure in the last week of long-term febuxostat treatment, no statistically significant difference in hemodynamic parameters was observed in either study. Additionally, no change was observed in relative heart and kidney weight. Aortic media/lumen ratio was minimally improved by long-term febuxostat treatment. Additionally, febuxostat incubation in vitro did not modify contraction of aorta or vena cava to norepinephrine, angiotensin II or endothelin-1. We conclude that XO inhibition is insufficient to attenuate hypertension in the rat DOCA-salt model, although beneficial vascular effects are possible.	[Szasz, Theodora] Georgia Hlth Sci Univ, Dept Physiol, Augusta, GA USA; [Davis, Robert Patrick; Garver, Hannah S.; Burnett, Robert J.; Fink, Gregory D.; Watts, Stephanie W.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA	University System of Georgia; Augusta University; Michigan State University	Szasz, T (corresponding author), Georgia Hlth Sci Univ, Dept Physiol, Augusta, GA USA.	iszasz@georgiahealth.edu			Takeda Pharmaceuticals U.S.A., Inc. [MSA-FEB-134]; study drug (febuxostat)	Takeda Pharmaceuticals U.S.A., Inc.; study drug (febuxostat)	Financial support was provided by Takeda Pharmaceuticals U.S.A., Inc. in the form of a research grant (#MSA-FEB-134) and the study drug (febuxostat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was provided by Takeda Pharmaceuticals U.S.A., Inc. in the form of a research grant(#MSA-FEB-134) and the study drug (febuxostat). Febuxostat is a product of Takeda Pharmaceuticals U.S.A., Inc. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Briones AM, 2010, CURR HYPERTENS REP, V12, P135, DOI 10.1007/s11906-010-0100-z; Callera GE, 2006, CLIN SCI, V110, P243, DOI 10.1042/CS20050307; Chohan S, 2012, ARTHRIT CARE RES, V64, P256, DOI 10.1002/acr.20680; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Gersch C, 2008, NUCLEOS NUCLEOT NUCL, V27, P967, DOI 10.1080/15257770802257952; Hair PI, 2008, DRUGS, V68, P1865, DOI 10.2165/00003495-200868130-00006; Hamburger M, 2011, PHYSICIAN SPORTSMED, V39, P98, DOI 10.3810/psm.2011.11.1946; Ho WJ, 2010, RHEUMATOLOGY, V49, P1929, DOI 10.1093/rheumatology/keq184; Jackson RL, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-11; Jin L, 2006, J PHYSIOL PHARMACOL, V57, P343; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kasal DAB, 2008, HISTOL HISTOPATHOL, V23, P1241, DOI 10.14670/HH-23.1241; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Laakso JT, 2004, J HYPERTENS, V22, P1333, DOI 10.1097/01.hjh.0000125441.28861.9f; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Minami M, 2005, BLOOD PRESSURE, V14, P120, DOI 10.1080/08037050510008878; Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200; Ong SLH, 2007, CLIN EXP PHARMACOL P, V34, P517, DOI 10.1111/j.1440-1681.2007.04605.x; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Sahan-Firat S, 2010, AM J PHYSIOL-HEART C, V299, pH1891, DOI 10.1152/ajpheart.00655.2010; Sanchez-Lozada LG, 2008, NEPHRON PHYSIOL, V108, P69, DOI 10.1159/000127837; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V294, pF710, DOI 10.1152/ajprenal.00454.2007; Sanchez-Lozada LG, 2008, NEPHROL DIAL TRANSPL, V23, P1179, DOI 10.1093/ndt/gfm783; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Suzuki H, 1998, P NATL ACAD SCI USA, V95, P4754, DOI 10.1073/pnas.95.8.4754; Szasz T, 2010, J CARDIOVASC PHARM, V56, P627, DOI 10.1097/FJC.0b013e3181f80194; Takano Y, 2005, LIFE SCI, V76, P1835, DOI 10.1016/j.lfs.2004.10.031; Tian N, 2005, HYPERTENSION, V45, P934, DOI 10.1161/01.HYP.0000160404.08866.5a; Viel EC, 2008, AM J PHYSIOL-HEART C, V295, pH281, DOI 10.1152/ajpheart.00304.2008; Xu H, 2004, HYPERTENSION, V43, P329, DOI 10.1161/01.HYP.0000112304.26158.5c; Yamamoto Y, 2006, HYPERTENS RES, V29, P915, DOI 10.1291/hypres.29.915; Yang J, 2008, HYPERTENS RES, V31, P931, DOI 10.1291/hypres.31.931; Zhang Y, 2005, AM J HYPERTENS, V18, P910, DOI 10.1016/j.amjhyper.2005.02.017	35	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e56046	10.1371/journal.pone.0056046	http://dx.doi.org/10.1371/journal.pone.0056046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393607	Green Submitted, gold, Green Published			2022-12-25	WOS:000314692800062
J	Chaubey, S; Jones, GE; Shah, AM; Cave, AC; Wells, CM				Chaubey, Sanjay; Jones, Gareth E.; Shah, Ajay M.; Cave, Alison C.; Wells, Claire M.			Nox2 Is Required for Macrophage Chemotaxis towards CSF-1	PLOS ONE			English	Article							NADPH OXIDASE; NAD(P)H OXIDASE; ANGIOTENSIN-II; REVERSIBLE INACTIVATION; GENE-EXPRESSION; ACTIVATION; RAC; KINASE; CELLS; CDC42	Macrophage migration and infiltration is an important first step in many pathophysiological processes, in particular inflammatory diseases. Redox modulation of the migratory signalling processes has been reported in endothelial cells, vascular smooth muscle cells and fibroblasts. However the redox modulation of the migratory process in macrophages and in particular that from the NADPH oxidase-2 (Nox2) dependent ROS has not been established. To investigate the potential role of Nox2 in the migratory response of macrophages, bone marrow derived macrophages were obtained from WT and NOX2 knockout mice (Nox2KO) and subjected to CSF-1 stimulation. We report here that loss of Nox2 expression in BMM resulted in a significant reduction in the CSF-1 induced spreading response suggesting that Nox2 can modulate cytoskeletal events. Moreover, Nox2KO BMMs were deficient in cellular displacement in the presence of CSF-1. More significantly, when challenged with a gradient of CSF-1, Nox2KO BMMs showed a complete loss of chemotaxis accompanied by a reduction in cell migration speed and directional migration persistence. These results point to a specific role for Nox2KO downstream of CSF-1 during the BMM migratory response. Indeed, we have further found that Nox2KO BMMs display a significant reduction in the levels of ERK1/2 phosphorylation following stimulation with CSF-1. Thus Nox2 is important in BMM cellular motion to CSF-1 stimulation and necessary for their directed migration towards a CSF-1 gradient, highlighting Nox2 dependent signalling as a potential anti-inflammatory target.	[Chaubey, Sanjay; Shah, Ajay M.; Cave, Alison C.] Kings Coll London, BHF Ctr Excellence, James Black Ctr, Div Cardiovasc, London WC2R 2LS, England; [Jones, Gareth E.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Wells, Claire M.] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Wells, CM (corresponding author), Kings Coll London, Div Canc Studies, London WC2R 2LS, England.	claire.wells@kcl.ac.uk	Jones, Gareth E/H-2282-2012	Jones, Gareth E/0000-0001-5879-3048; Shah, Ajay/0000-0002-6547-0631	British Heart Foundation; Guy's and St. Thomas Charity; Department of Health via a National Institute for Health Research (NIHR) Biomedical Research Centre award; King's College London; King's College Hospital NHS Foundation Trust; MRC [G0100152] Funding Source: UKRI; British Heart Foundation [RG/08/011/25922] Funding Source: researchfish; Medical Research Council [G0100152] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Guy's and St. Thomas Charity; Department of Health via a National Institute for Health Research (NIHR) Biomedical Research Centre award; King's College London; King's College Hospital NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SC, AC and AMS were supported by the British Heart Foundation. CW is supported by the Guy's and St. Thomas Charity. The authors also acknowledge support from the Department of Health via a National Institute for Health Research (NIHR) Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Bengtsson T, 2006, CELL BIOL INT, V30, P154, DOI 10.1016/j.cellbi.2005.10.017; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Cui WH, 2011, HEPATOLOGY, V54, P949, DOI 10.1002/hep.24465; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Diebold BA, 2004, J BIOL CHEM, V279, P28136, DOI 10.1074/jbc.M313891200; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Johar S, 2006, FASEB J, V20, P1546, DOI 10.1096/fj.05-4642fje; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Kim JH, 2008, FREE RADICAL BIO MED, V45, P885, DOI 10.1016/j.freeradbiomed.2008.06.019; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Liu JH, 2003, ARTERIOSCL THROM VAS, V23, P776, DOI 10.1161/01.ATV.0000066684.37829.16; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549; Morimatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P206, DOI 10.1006/bbrc.1996.5881; Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Ridley AJ, 2004, CELL, V116, P357, DOI 10.1016/S0092-8674(04)00123-0; San Martin A, 2008, CIRC RES, V102, P432, DOI 10.1161/CIRCRESAHA.107.158923; Schroder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117; Sester DP, 2005, IMMUNOBIOLOGY, V210, P97, DOI 10.1016/j.imbio.2005.05.004; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stokes KY, 2001, CIRC RES, V88, P499, DOI 10.1161/01.RES.88.5.499; Thomas M, 2006, CIRCULATION, V114, P404, DOI 10.1161/CIRCULATIONAHA.105.607168; Touyz RM, 2005, ARTERIOSCL THROM VAS, V25, P512, DOI 10.1161/01.ATV.0000154141.66879.98; Umanskiy K, 2003, SURGERY, V134, P378, DOI 10.1067/msy.2003.253; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Vendrov AE, 2007, ARTERIOSCL THROM VAS, V27, P2714, DOI 10.1161/ATVBAHA.107.152629; Ward SG, 2004, TRENDS IMMUNOL, V25, P67, DOI 10.1016/j.it.2003.12.003; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244	53	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e54869	10.1371/journal.pone.0054869	http://dx.doi.org/10.1371/journal.pone.0054869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383302	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900009
J	Hinaut, X; Dominey, PF				Hinaut, Xavier; Dominey, Peter Ford			Real-Time Parallel Processing of Grammatical Structure in the Fronto-Striatal System: A Recurrent Network Simulation Study Using Reservoir Computing	PLOS ONE			English	Article							ECHO-STATE-NETWORKS; SENTENCE COMPREHENSION; BRAIN POTENTIALS; PARKINSONS-DISEASE; DECLARATIVE/PROCEDURAL MODEL; DISTRIBUTED REPRESENTATIONS; NEUROLINGUISTIC MODEL; NATURAL-LANGUAGE; RHESUS-MONKEY; BASAL GANGLIA	Sentence processing takes place in real-time. Previous words in the sentence can influence the processing of the current word in the timescale of hundreds of milliseconds. Recent neurophysiological studies in humans suggest that the fronto-striatal system (frontal cortex, and striatum - the major input locus of the basal ganglia) plays a crucial role in this process. The current research provides a possible explanation of how certain aspects of this real-time processing can occur, based on the dynamics of recurrent cortical networks, and plasticity in the cortico-striatal system. We simulate prefrontal area BA47 as a recurrent network that receives on-line input about word categories during sentence processing, with plastic connections between cortex and striatum. We exploit the homology between the cortico-striatal system and reservoir computing, where recurrent frontal cortical networks are the reservoir, and plastic cortico-striatal synapses are the readout. The system is trained on sentence-meaning pairs, where meaning is coded as activation in the striatum corresponding to the roles that different nouns and verbs play in the sentences. The model learns an extended set of grammatical constructions, and demonstrates the ability to generalize to novel constructions. It demonstrates how early in the sentence, a parallel set of predictions are made concerning the meaning, which are then confirmed or updated as the processing of the input sentence proceeds. It demonstrates how on-line responses to words are influenced by previous words in the sentence, and by previous sentences in the discourse, providing new insight into the neurophysiology of the P600 ERP scalp response to grammatical complexity. This demonstrates that a recurrent neural network can decode grammatical structure from sentences in real-time in order to generate a predictive representation of the meaning of the sentences. This can provide insight into the underlying mechanisms of human cortico-striatal function in sentence processing.	[Hinaut, Xavier; Dominey, Peter Ford] INSERM, U846, Stem Cell & Brain Res Inst, F-69500 Bron, France; [Hinaut, Xavier; Dominey, Peter Ford] Univ Lyon 1, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Dominey, PF (corresponding author), INSERM, U846, Stem Cell & Brain Res Inst, F-69500 Bron, France.	peter.dominey@inserm.fr	Dominey, Peter/H-3832-2012	Dominey, Peter/0000-0002-9318-179X; Hinaut, Xavier/0000-0002-1924-1184	EC [231267 Organic, 270490 EFAA]	EC(European CommissionEuropean Commission Joint Research Centre)	This work has been financed by the EC FP7-ICT Projects 231267 Organic, and 270490 EFAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnickel T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006393; BATES E, 1991, BRAIN LANG, V41, P123, DOI 10.1016/0093-934X(91)90149-U; BATES E, 1982, COGNITION, V11, P245, DOI 10.1016/0010-0277(82)90017-8; Busing L, 2010, NEURAL COMPUT, V22, P1272, DOI 10.1162/neco.2009.01-09-947; CAPLAN D, 1985, COGNITION, V21, P117, DOI 10.1016/0010-0277(85)90048-4; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Chang F, 2000, J PSYCHOLINGUIST RES, V29, P217, DOI 10.1023/A:1005101313330; Chang F., 2002, COGNITIVE SCI, V93, P1, DOI [10.1207/s15516709cog2605_3, DOI 10.1207/S15516709COG2605_3]; CHEVALIER G, 1990, TRENDS NEUROSCI, V13, P277, DOI 10.1016/0166-2236(90)90109-N; Collobert R., 2008, P 25 ICML, V25, P160, DOI [DOI 10.1145/1390156.1390177, 10.1145/1390156.1390177]; Di Filippo M, 2009, BEHAV BRAIN RES, V199, P108, DOI 10.1016/j.bbr.2008.09.025; DOMINEY P, 1995, J COGNITIVE NEUROSCI, V7, P311, DOI 10.1162/jocn.1995.7.3.311; Dominey PF, 2009, CORTEX, V45, P1012, DOI 10.1016/j.cortex.2009.03.007; Dominey PF, 2006, J COGNITIVE NEUROSCI, V18, P2088, DOI 10.1162/jocn.2006.18.12.2088; Dominey PF, 2006, CORTEX, V42, P476, DOI 10.1016/S0010-9452(08)70381-2; Dominey PF, 2009, BRAIN LANG, V109, P80, DOI 10.1016/j.bandl.2008.08.002; Dominey PF, 2000, LANG COGNITIVE PROC, V15, P87, DOI 10.1080/016909600386129; DOMINEY PF, 1995, BIOL CYBERN, V73, P265, DOI 10.1007/BF00201428; Dominey PF, 2005, ARTIF INTELL, V167, P31, DOI 10.1016/j.artint.2005.06.007; Dominey PF, 2003, BRAIN LANG, V86, P207, DOI 10.1016/S0093-934X(02)00529-1; Elman J., 1990, COGNITIVE, V15, P179, DOI DOI 10.1207/S15516709C0G1402_1; ELMAN JL, 1991, MACH LEARN, V7, P195, DOI 10.1007/BF00114844; Frank SL, 2011, PSYCHOL SCI, V22, P829, DOI 10.1177/0956797611409589; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2003, NEUROIMAGE, V20, pS8, DOI 10.1016/j.neuroimage.2003.09.003; Friederici AD, 2003, NEUROPSYCHOLOGY, V17, P133, DOI 10.1037/0894-4105.17.1.133; Friederici AD, 2001, COGNITIVE BRAIN RES, V11, P305, DOI 10.1016/S0926-6410(00)00065-3; Frisch S, 2003, CLIN NEUROPHYSIOL, V114, P336, DOI 10.1016/S1388-2457(02)00366-8; Frisch S, 2002, COGNITION, V85, pB83, DOI 10.1016/S0010-0277(02)00126-9; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gibson E, 2000, J PSYCHOLINGUIST RES, V29, P231, DOI 10.1023/A:1005153330168; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Goldberg AdeleE., 1995, CONSTRUCTIONS CONSTR; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; Graben PB, 2008, COGN NEURODYNAMICS, V2, P229, DOI 10.1007/s11571-008-9041-5; Hagoort P, 2003, J COGNITIVE NEUROSCI, V15, P883, DOI 10.1162/089892903322370807; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1531, DOI 10.1016/S0028-3932(00)00053-1; Hagoort P, 2008, PHILOS T R SOC B, V363, P1055, DOI 10.1098/rstb.2007.2159; Hagoort P, 2007, PHILOS T R SOC B, V362, P801, DOI 10.1098/rstb.2007.2089; Hinaut X, 2012, LECT NOTES COMPUTER, P596; Hinaut X, 2011, J PHYSIOL-PARIS, V105, P16, DOI 10.1016/j.jphysparis.2011.07.010; Hochstadt J, 2006, BRAIN LANG, V97, P243, DOI 10.1016/j.bandl.2005.10.011; Hochstadt J, 2009, CORTEX, V45, P991, DOI 10.1016/j.cortex.2009.03.010; Hopf JM, 2003, COGNITIVE BRAIN RES, V15, P165, DOI 10.1016/S0926-6410(02)00149-0; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Jaegera H, 2007, NEURAL NETWORKS, V20, P335, DOI 10.1016/j.neunet.2007.04.016; Kotz SA, 2003, J INT NEUROPSYCH SOC, V9, P1053, DOI 10.1017/S1355617703970093; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lewis RL, 2000, J PSYCHOLINGUIST RES, V29, P241, DOI 10.1023/A:1005105414238; Lieven E, 2003, J CHILD LANG, V30, P333, DOI 10.1017/S0305000903005592; Liu YY, 2008, IEEE T NEURAL NETWOR, V19, P983, DOI 10.1109/TNN.2007.915114; Lukosevicius M, 2009, COMPUT SCI REV, V3, P127, DOI 10.1016/j.cosrev.2009.03.005; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; McClelland J.L., 1989, LANG COGNITIVE PROC, V4, P287; Miikkulainen R, 1996, COGNITIVE SCI, V20, P47, DOI 10.1207/s15516709cog2001_2; Moro A, 2001, NEUROIMAGE, V13, P110, DOI 10.1006/nimg.2000.0668; Ogawa K, 2008, NEUROREPORT, V19, P811, DOI 10.1097/WNR.0b013e3282ffda89; Roland D, 2007, J MEM LANG, V57, P348, DOI 10.1016/j.jml.2007.03.002; Service E, 2007, J COGNITIVE NEUROSCI, V19, P1193, DOI 10.1162/jocn.2007.19.7.1193; Tomasello M., 2003, CONSTRUCTING LANGUAG; Tong MH, 2007, NEURAL NETWORKS, V20, P424, DOI 10.1016/j.neunet.2007.04.013; Toni I, 2002, CEREB CORTEX, V12, P1040, DOI 10.1093/cercor/12.10.1040; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; van der Velde F, 2006, BEHAV BRAIN SCI, V29, P37, DOI 10.1017/S0140525X06009022; VANHOESEN GW, 1981, J COMP NEUROL, V199, P205, DOI 10.1002/cne.901990205; Verstraeten D, 2007, NEURAL NETWORKS, V20, P391, DOI 10.1016/j.neunet.2007.04.003; Voegtlin T, 2005, NEURAL NETWORKS, V18, P878, DOI 10.1016/j.neunet.2005.01.005; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; YETERIAN EH, 1989, J COMP NEUROL, V282, P80, DOI 10.1002/cne.902820107; Yildiz IB, 2012, NEURAL NETWORKS, V35, P1, DOI 10.1016/j.neunet.2012.07.005	72	85	85	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e52946	10.1371/journal.pone.0052946	http://dx.doi.org/10.1371/journal.pone.0052946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383296	Green Published, gold			2022-12-25	WOS:000314597900003
J	Hilbers, FS; Meijers, CM; Laros, JFJ; van Galen, M; Hoogerbrugge, N; Vasen, HFA; Nederlof, PM; Wijnen, JT; van Asperen, CJ; Devilee, P				Hilbers, Florentine S.; Meijers, Caro M.; Laros, Jeroen F. J.; van Galen, Michiel; Hoogerbrugge, Nicoline; Vasen, Hans F. A.; Nederlof, Petra M.; Wijnen, Juul T.; van Asperen, Christi J.; Devilee, Peter			Exome Sequencing of Germline DNA from Non-BRCA1/2 Familial Breast Cancer Cases Selected on the Basis of aCGH Tumor Profiling	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; GENETIC PREDISPOSITION; LINKAGE ANALYSIS; BRCA1; CARCINOMAS; MUTATIONS; XRCC2	The bulk of familial breast cancer risk (similar to 70%) cannot be explained by mutations in the known predisposition genes, primarily BRCA1 and BRCA2. Underlying genetic heterogeneity in these cases is the probable explanation for the failure of all attempts to identify further high-risk alleles. While exome sequencing of non-BRCA1/2 breast cancer cases is a promising strategy to detect new high-risk genes, rational approaches to the rigorous pre-selection of cases are needed to reduce heterogeneity. We selected six families in which the tumours of multiple cases showed a specific genomic profile on array comparative genomic hybridization (aCGH). Linkage analysis in these families revealed a region on chromosome 4 with a LOD score of 2.49 under homogeneity. We then analysed the germline DNA of two patients from each family using exome sequencing. Initially focusing on the linkage region, no potentially pathogenic variants could be identified in more than one family. Variants outside the linkage region were then analysed, and we detected multiple possibly pathogenic variants in genes that encode DNA integrity maintenance proteins. However, further analysis led to the rejection of all variants due to poor co-segregation or a relatively high allele frequency in a control population. We concluded that using CGH results to focus on a sub-set of families for sequencing analysis did not enable us to identify a common genetic change responsible for the aggregation of breast cancer in these families. Our data also support the emerging view that non-BRCA1/2 hereditary breast cancer families have a very heterogeneous genetic basis.	[Hilbers, Florentine S.; Meijers, Caro M.; Laros, Jeroen F. J.; Wijnen, Juul T.; Devilee, Peter] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Laros, Jeroen F. J.; van Galen, Michiel] Leiden Univ, Med Ctr, Leiden Genome Technol Ctr, Leiden, Netherlands; [Hoogerbrugge, Nicoline] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Vasen, Hans F. A.] Netherlands Fdn Detect Hereditary Tumors, Leiden, Netherlands; [Nederlof, Petra M.] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; [Wijnen, Juul T.; van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hilbers, FS (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands.	f.s.m.hilbers@lumc.nl	Devilee, Peter/GXV-8005-2022; DEVILEE, PETER/ABR-2140-2022; Hoogerbrugge, Nicoline/O-1016-2013; van Asperen, Christi J/D-3970-2012; Hilbers, Florentine/AAB-8162-2019	Hoogerbrugge, Nicoline/0000-0003-2393-8141; van Asperen, Christi J/0000-0002-1436-7650; Hilbers, Florentine/0000-0002-6764-3102; Laros, Jeroen F.J./0000-0002-8715-7371; Devilee, Peter/0000-0002-8023-2009; Vasen, Hans/0000-0003-2682-2603	Dutch Cancer Society [UL 2009-4388]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was financially supported by the Dutch Cancer Society (grant UL 2009-4388). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed M, 2009, EXPERT REV ANTICANC, V9, P1103, DOI 10.1586/ERA.09.38; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alvarez S, 2005, CLIN CANCER RES, V11, P1146; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cui JS, 2001, AM J HUM GENET, V68, P420, DOI 10.1086/318187; Didraga MA, 2011, BREAST CANCER RES TR, V130, P425, DOI 10.1007/s10549-011-1357-x; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; EASTON DF, 1993, AM J HUM GENET, V52, P678; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gordon A.H., 2010, FASTX TOOLKIT; Gronwald J, 2005, INT J CANCER, V114, P230, DOI 10.1002/ijc.20723; Hilbers FS, 2012, J MED GENET, V49, P618, DOI 10.1136/jmedgenet-2012-101191; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Joosse SA, 2012, BREAST CANCER RES TR, V132, P379, DOI 10.1007/s10549-010-1016-7; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mangia A, 2008, CANCER GENET CYTOGEN, V182, P75, DOI 10.1016/j.cancergencyto.2008.01.002; Muranen TA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3015; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; NHLBI Exome Sequencing Project (ESP), 2012, EX VAR SERV; Oldenburg RA, 2008, GENE CHROMOSOME CANC, V47, P947, DOI 10.1002/gcc.20597; Park DJ, 2012, AM J HUM GENET, V90, P734, DOI 10.1016/j.ajhg.2012.02.027; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Tirkkonen M, 1997, CANCER RES, V57, P1222; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; University of Washington, 2011, SEATTLESEQ; van Beers EH, 2005, CANCER RES, V65, P822; Wessels LFA, 2002, CANCER RES, V62, P7110; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	38	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55734	10.1371/journal.pone.0055734	http://dx.doi.org/10.1371/journal.pone.0055734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383274	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600154
J	Miller, TC; Sun, GH; Hasebe, T; Fu, LZ; Heimeier, RA; Das, B; Ishizuya-Oka, A; Shi, YB				Miller, Thomas C.; Sun, Guihong; Hasebe, Takashi; Fu, Liezhen; Heimeier, Rachel A.; Das, Biswajit; Ishizuya-Oka, Atsuko; Shi, Yun-Bo			Tissue-Specific Upregulation of MDS/EVI Gene Transcripts in the Intestine by Thyroid Hormone during Xenopus Metamorphosis	PLOS ONE			English	Article							STEM-CELLS; SONIC HEDGEHOG; LAEVIS INTESTINE; SELF-RENEWAL; EXPRESSION; EVI1; PROLIFERATION; EMBRYOGENESIS; EPITHELIUM; INSIGHTS	Background: Intestinal remodeling during amphibian metamorphosis resembles the maturation of the adult intestine during mammalian postembryonic development when the adult epithelial self-renewing system is established under the influence of high concentrations of plasma thyroid hormone (T3). This process involves de novo formation and subsequent proliferation and differentiation of the adult stem cells. Methodology/Principal Findings: The T3-dependence of the formation of adult intestinal stem cell during Xenopus laevis metamorphosis offers a unique opportunity to identify genes likely important for adult organ-specific stem cell development. We have cloned and characterized the ectopic viral integration site 1 (EVI) and its variant myelodysplastic syndrome 1 (MDS)/EVI generated via transcription from the upstream MDS promoter and alternative splicing. EVI and MDS/EVI have been implicated in a number of cancers including breast, leukemia, ovarian, and intestinal cancers. We show that EVI and MDS/EVI transcripts are upregulated by T3 in the epithelium but not the rest of the intestine in Xenopus laevis when adult stem cells are forming in the epithelium. Conclusions/Significance: Our results suggest that EVI and MDS/EVI are likely involved in the development and/or proliferation of newly forming adult intestinal epithelial cells.	[Miller, Thomas C.; Fu, Liezhen; Heimeier, Rachel A.; Das, Biswajit; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, PCRM, NIH, Bethesda, MD USA; [Sun, Guihong] Wuhan Univ, Sch Med, Key Lab Allergy & Immune Related Dis, Wuhan 430072, Peoples R China; [Sun, Guihong] Wuhan Univ, Sch Med, Med Res Ctr, Wuhan 430072, Peoples R China; [Hasebe, Takashi; Ishizuya-Oka, Atsuko] Nippon Med Sch, Dept Biol, Kawasaki, Kanagawa, Japan	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wuhan University; Wuhan University; Nippon Medical School	Ishizuya-Oka, A (corresponding author), Nippon Med Sch, Dept Biol, Kosugi Cho, Kawasaki, Kanagawa, Japan.	a-oka@nms.ac.jp; Shi@helix.nih.gov		Shi, Yun-Bo/0000-0002-6330-0639; Hasebe, Takashi/0000-0001-7200-8173	Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health; National Natural Science Foundation of China [30870113]; Grants-in-Aid for Scientific Research [25440160] Funding Source: KAKEN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901, ZIAHD008858] Funding Source: NIH RePORTER	Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health and the National Natural Science Foundation of China No. 30870113. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 1998, DEV GROWTH DIFFER, V40, P177; Bard-Chapeau E, 2012, P NATL ACAD SCI USA, V109; Buchholz DR, 2007, DEV BIOL, V303, P576, DOI 10.1016/j.ydbio.2006.11.037; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Das B, 2009, J BIOL CHEM, V284, P34167, DOI 10.1074/jbc.M109.066084; Gao JS, 2011, FEBS LETT, V585, P693, DOI 10.1016/j.febslet.2011.01.033; Gilbert L.I., 1996, METAMORPHOSIS POSTEM; Harper J, 2011, P NATL ACAD SCI USA, V108, P10585, DOI 10.1073/pnas.1105852108; Hasebe T, 2012, DEV DYNAM, V241, P403, DOI 10.1002/dvdy.23723; Hasebe T, 2011, STEM CELLS, V29, P154, DOI 10.1002/stem.560; Heimeier RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r55; Ishizuya-Oka A, 1997, DEV BIOL, V192, P149, DOI 10.1006/dbio.1997.8749; Ishizuya-Oka A, 2001, DIFFERENTIATION, V69, P27, DOI 10.1046/j.1432-0436.2001.690103.x; Ishizuya-Oka A, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-37; Ishizuya-Oka A, 2009, FASEB J, V23, P2568, DOI 10.1096/fj.08-128124; IshizuyaOka A, 1996, CELL TISSUE RES, V286, P467, DOI 10.1007/s004410050716; Kataoka K, 2012, CANC SCI; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Kress E, 2009, MOL CELL ENDOCRINOL, V313, P36, DOI 10.1016/j.mce.2009.08.028; Kumano K, 2010, J CELL PHYSIOL, V222, P282, DOI 10.1002/jcp.21953; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; MACDONALD WC, 1964, GASTROENTEROLOGY, V46, P405; Matsuda H, 2010, STEM CELLS, V28, P2073, DOI 10.1002/stem.529; Matsuura K, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-25; MCAVOY JW, 1977, J EXP ZOOL, V202, P129, DOI 10.1002/jez.1402020115; Mead PE, 2005, GENE EXPR PATTERNS, V5, P601, DOI 10.1016/j.modgep.2005.03.007; Muncan V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1463; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Schreiber AM, 2005, P NATL ACAD SCI USA, V102, P3720, DOI 10.1073/pnas.0409868102; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; Shi YB, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-42; Shi YB, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-30; Shi YB, 2009, THYROID, V19, P987, DOI 10.1089/thy.2009.0041; Sterling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047407; STOLOW MA, 1995, NUCLEIC ACIDS RES, V23, P2555, DOI 10.1093/nar/23.13.2555; Sun GH, 2012, INT J BIOL SCI, V8, P1217, DOI 10.7150/ijbs.5109; Sun GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013605; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Toner P. G., 1971, DIGESTIVE SYSTEM ULT; Van Campenhout C, 2006, DEV BIOL, V294, P203, DOI 10.1016/j.ydbio.2006.02.040; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Yoshimi A, 2011, ONCOTARGET, V2, P575, DOI 10.18632/oncotarget.304; Zhang Y, 2011, BLOOD, V118, P3853, DOI 10.1182/blood-2011-02-334680	48	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55585	10.1371/journal.pone.0055585	http://dx.doi.org/10.1371/journal.pone.0055585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383234	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600129
J	Moiani, A; Miccio, A; Rizzi, E; Severgnini, M; Pellin, D; Suerth, JD; Baum, C; De Bellis, G; Mavilio, F				Moiani, Arianna; Miccio, Annarita; Rizzi, Ermanno; Severgnini, Marco; Pellin, Danilo; Suerth, Julia Debora; Baum, Christopher; De Bellis, Gianluca; Mavilio, Fulvio			Deletion of the LTR Enhancer/Promoter Has No Impact on the Integration Profile of MLV Vectors in Human Hematopoietic Progenitors	PLOS ONE			English	Article							CELL GENE-THERAPY; LENTIVIRAL VECTOR; RETROVIRAL INTEGRATION; SITE SELECTION; MOUSE MODEL; ACTIVATION; IMMUNODEFICIENCY; ELEMENTS; DESIGN; RISK	Moloney murine leukemia virus (MLV)-derived gamma-retroviral vectors integrate preferentially near transcriptional regulatory regions in the human genome, and are associated with a significant risk of insertional gene deregulation. Self-inactivating (SIN) vectors carry a deletion of the U3 enhancer and promoter in the long terminal repeat (LTR), and show reduced genotoxicity in pre-clinical assays. We report a high-definition analysis of the integration preferences of a SIN MLV vector compared to a wild-type-LTR MLV vector in the genome of CD34(+) human hematopoietic stem/progenitor cells (HSPCs). We sequenced 13,011 unique SIN-MLV integration sites and compared them to 32,574 previously generated MLV sites in human HSPCs. The SIN-MLV vector recapitulates the integration pattern observed for MLV, with the characteristic clustering of integrations around enhancer and promoter regions associated to H3K4me3 and H3K4me1 histone modifications, specialized chromatin configurations (presence of the H2A.Z histone variant) and binding of RNA Pol II. SIN-MLV and MLV integration clusters and hot spots overlap in most cases and are generated at a comparable frequency, indicating that the reduced genotoxicity of SIN-MLV vectors in hematopoietic cells is not due to a modified integration profile.	[Moiani, Arianna] Ist Sci H San Raffaele, Div Genet & Cell Biol, Milan, Italy; [Miccio, Annarita; Mavilio, Fulvio] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Rizzi, Ermanno; Severgnini, Marco; De Bellis, Gianluca] CNR, Inst Biomed Technol, I-20133 Milan, Italy; [Pellin, Danilo] Univ Vita Salute San Raffaele, CUSSB, Milan, Italy; [Suerth, Julia Debora; Baum, Christopher] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Mavilio, Fulvio] Genethon, Evry, France	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Vita-Salute San Raffaele University; Hannover Medical School	Mavilio, F (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy.	fmavilio@genethon.fr	Severgnini, Marco/F-5832-2013; rizzi, ermanno/Q-3399-2016; Miccio, Annarita/H-9585-2017; MAVILIO, Fulvio/J-6125-2013; De Bellis, Gianluca/H-9725-2013	Severgnini, Marco/0000-0001-8655-1206; rizzi, ermanno/0000-0002-9898-2326; Miccio, Annarita/0000-0002-3409-9665; De Bellis, Gianluca/0000-0002-1622-4477; Mavilio, Fulvio/0000-0003-0459-4320	European Commission (PERSIST); European Research Council (GT-SKIN); Italian National Research Council (CNR - EPIGEN)	European Commission (PERSIST); European Research Council (GT-SKIN); Italian National Research Council (CNR - EPIGEN)	This work was supported by grants from the European Commission (PERSIST), the European Research Council (GT-SKIN), and the Italian National Research Council (CNR - EPIGEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Almarza D, 2011, GENE THER, V18, P674, DOI 10.1038/gt.2011.12; Bosticardo M, 2009, MOL THER, V17, P1910, DOI 10.1038/mt.2009.172; Boztug K, 2010, NEW ENGL J MED, V363, P1918, DOI 10.1056/NEJMoa1003548; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cattoglio C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015688; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cesana D, 2012, J CLIN INVEST, V122, P1667, DOI 10.1172/JCI62189; Coffin J, 1997, RETROVIRUSES; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Felice B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004571; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Heckl D, 2012, MOL THER, V20, P1187, DOI 10.1038/mt.2012.59; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Kim SY, 2007, PLOS GENET, V3, P1572, DOI 10.1371/journal.pgen.0030147; Krause D, 2011, HEMATOLOGIST, V8, P10; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Kustikova O, 2010, SEMIN CANCER BIOL, V20, P269, DOI 10.1016/j.semcancer.2010.06.003; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Maruggi G, 2009, MOL THER, V17, P851, DOI 10.1038/mt.2009.51; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Modlich U, 2005, BLOOD, V105, P4235, DOI 10.1182/blood-2004-11-4535; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Modlich U, 2009, MOL THER, V17, P1919, DOI 10.1038/mt.2009.179; Moiani A, 2012, J CLIN INVEST, V122, P1653, DOI 10.1172/JCI61852; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Studamire B, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-48; Thornhill SI, 2008, MOL THER, V16, P590, DOI 10.1038/sj.mt.6300393; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wang GP, 2009, MOL THER, V17, P844, DOI 10.1038/mt.2009.16; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; ZYCHLINSKI D, 2008, MOL THER	41	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55721	10.1371/journal.pone.0055721	http://dx.doi.org/10.1371/journal.pone.0055721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383272	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600152
J	Ogawa, Y; Tanaka, M; Tanabe, M; Suzuki, T; Togawa, T; Fukushige, T; Kanekura, T; Sakuraba, H; Oishi, K				Ogawa, Yasuhiro; Tanaka, Makoto; Tanabe, Miho; Suzuki, Toshihiro; Togawa, Tadayasu; Fukushige, Tomoko; Kanekura, Takuro; Sakuraba, Hitoshi; Oishi, Kazuhiko			Impaired Neural Differentiation of Induced Pluripotent Stem Cells Generated from a Mouse Model of Sandhoff Disease	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; GROWTH-FACTOR RECEPTOR; EPSTEIN-BARR-VIRUS; LOOP-HELIX GENES; HUMAN TAY-SACHS; PRECURSOR CELLS; EPIGENETIC CONTROL; PLASMID REPLICON; NERVOUS-SYSTEM; IN-VITRO	Sandhoff disease (SD) is a glycosphingolipid storage disease that arises from mutations in the Hexb gene and the resultant deficiency in beta-hexosaminidase activity. This deficiency results in aberrant lysosomal accumulation of the ganglioside GM2 and related glycolipids, and progressive deterioration of the central nervous system. Dysfunctional glycolipid storage causes severe neurodegeneration through a poorly understood pathogenic mechanism. Induced pluripotent stem cell (iPSC) technology offers new opportunities for both elucidation of the pathogenesis of diseases and the development of stem cell-based therapies. Here, we report the generation of disease-specific iPSCs from a mouse model of SD. These mouse model-derived iPSCs (SD-iPSCs) exhibited pluripotent stem cell properties and significant accumulation of GM2 ganglioside. In lineage-directed differentiation studies using the stromal cell-derived inducing activity method, SD-iPSCs showed an impaired ability to differentiate into early stage neural precursors. Moreover, fewer neurons differentiated from neural precursors in SD-iPSCs than in the case of the wild type. Recovery of the Hexb gene in SD-iPSCs improved this impairment of neuronal differentiation. These results provide new insights as to understanding the complex pathogenic mechanisms of SD.	[Ogawa, Yasuhiro; Tanaka, Makoto; Tanabe, Miho; Oishi, Kazuhiko] Meiji Pharmaceut Univ, Dept Pharmacol, Tokyo, Japan; [Suzuki, Toshihiro; Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Analyt Biochem, Tokyo, Japan; [Togawa, Tadayasu] Meiji Pharmaceut Univ, Dept Funct Bioanal, Tokyo, Japan; [Fukushige, Tomoko; Kanekura, Takuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Dermatol, Kagoshima 890, Japan; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan	Meiji Pharmaceutical University; Meiji Pharmaceutical University; Meiji Pharmaceutical University; Kagoshima University; Meiji Pharmaceutical University	Oishi, K (corresponding author), Meiji Pharmaceut Univ, Dept Pharmacol, Tokyo, Japan.	oishikz@my-pharm.ac.jp		Ogawa, Yasuhiro/0000-0003-3306-277X	High-Tech Research Center Project, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S0801043]; Program for Research on Intractable Diseases of Health and Labor Science Research; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [09-15]; JSPS Asia/Africa Scientific Platform Program; Japan Society for the Promotion of Science (JSPS) [21390314]	High-Tech Research Center Project, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Research on Intractable Diseases of Health and Labor Science Research; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); JSPS Asia/Africa Scientific Platform Program; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the High-Tech Research Center Project, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (S0801043); the Program for Research on Intractable Diseases of Health and Labor Science Research; the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (ID: 09-15); and the JSPS Asia/Africa Scientific Platform Program; and the Japan Society for the Promotion of Science (JSPS ID: 21390314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Ahmed RPH, 2011, CIRC RES, V109, P60, DOI 10.1161/CIRCRESAHA.110.240010; Bieberich E, 2004, GLYCOCONJUGATE J, V21, P315, DOI 10.1023/B:GLYC.0000046274.35732.47; Bieberich E, 2012, NEUROCHEM RES, V37, P1208, DOI 10.1007/s11064-011-0698-5; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Castaneda JA, 2008, ACTA NEUROPATHOL, V115, P159, DOI 10.1007/s00401-007-0296-4; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huang JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/hmg/6.11.1879; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kwak DH, 2011, EXP MOL MED, V43, P379, DOI 10.3858/emm.2011.43.7.048; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Lindner SE, 2007, PLASMID, V58, P1, DOI 10.1016/j.plasmid.2007.01.003; Mathew R, 2010, FASEB J, V24, P2702, DOI 10.1096/fj.09-148973; Meuillet EJ, 2000, EXP CELL RES, V256, P74, DOI 10.1006/excr.1999.4509; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miljan EA, 2002, J BIOL CHEM, V277, P10108, DOI 10.1074/jbc.M111669200; Mohammad HP, 2010, NAT BIOTECHNOL, V28, P1033, DOI 10.1038/nbt1010-1033; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Oishi K, 2002, J PHYSIOL-LONDON, V540, P139, DOI 10.1113/jphysiol.2001.013278; Oishi K, 2006, BIOCHEM BIOPH RES CO, V349, P1065, DOI 10.1016/j.bbrc.2006.08.135; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pelled D, 2003, NEUROPATH APPL NEURO, V29, P341, DOI 10.1046/j.1365-2990.2003.00455.x; Phaneuf D, 1996, HUM MOL GENET, V5, P1, DOI 10.1093/hmg/5.1.1; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Sango K, 2002, NEUROPATH APPL NEURO, V28, P23, DOI 10.1046/j.1365-2990.2002.00366.x; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sargeant TJ, 2011, HUM MOL GENET, V20, P4371, DOI 10.1093/hmg/ddr364; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; TAI T, 1987, J BIOL CHEM, V262, P6803; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Volk BW, 1964, PATHOLOGIC ANATOMY; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; YAMANAKA S, 1994, GENOMICS, V21, P588, DOI 10.1006/geno.1994.1318; Yanagisawa M, 2005, J BIOCHEM, V138, P285, DOI 10.1093/jb/mvi129; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419	57	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55856	10.1371/journal.pone.0055856	http://dx.doi.org/10.1371/journal.pone.0055856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383290	gold, Green Submitted, Green Published			2022-12-25	WOS:000314610600165
J	Redshaw, N; Camps, C; Sharma, V; Motallebipour, M; Guzman-Ayala, M; Oikonomopoulos, S; Thymiakou, E; Ragoussis, J; Episkopou, V				Redshaw, Nicholas; Camps, Carme; Sharma, Vikas; Motallebipour, Mehdi; Guzman-Ayala, Marcela; Oikonomopoulos, Spyros; Thymiakou, Efstathia; Ragoussis, Jiannis; Episkopou, Vasso			TGF-beta/Smad2/3 Signaling Directly Regulates Several miRNAs in Mouse ES Cells and Early Embryos	PLOS ONE			English	Article							TGF-BETA; MICRORNA EXPRESSION; STEM-CELLS; PRIMITIVE STREAK; GENE-EXPRESSION; ENZYME DICER; GROWTH; DIFFERENTIATION; PROFILES; FOXH1	The Transforming Growth Factor-beta (TGF-beta) signaling pathway is one of the major pathways essential for normal embryonic development and tissue homeostasis, with anti-tumor but also pro-metastatic properties in cancer. This pathway directly regulates several target genes that mediate its downstream functions, however very few microRNAs (miRNAs) have been identified as targets. miRNAs are modulators of gene expression with essential roles in development and a clear association with diseases including cancer. Little is known about the transcriptional regulation of the primary transcripts (pri-miRNA, pri-miR) from which several mature miRNAs are often derived. Here we present the identification of miRNAs regulated by TGF-beta signaling in mouse embryonic stem (ES) cells and early embryos. We used an inducible ES cell system to maintain high levels of the TGF-beta activated/phosphorylated Smad2/3 effectors, which are the transcription factors of the pathway, and a specific inhibitor that blocks their activation. By performing short RNA deep-sequencing after 12 hours Smad2/3 activation and after 16 hours inhibition, we generated a database of responsive miRNAs. Promoter/enhancer analysis of a subset of these miRNAs revealed that the transcription of pri-miR-181c/d and the pri-miR-341 similar to 3072 cluster were found to depend on activated Smad2/3. Several of these miRNAs are expressed in early mouse embryos, when the pathway is known to play an essential role. Treatment of embryos with TGF-beta inhibitor caused a reduction of their levels confirming that they are targets of this pathway in vivo. Furthermore, we showed that pri-miR-341 similar to 3072 transcription also depends on FoxH1, a known Smad2/3 transcription partner during early development. Together, our data show that miRNAs are regulated directly by the TGF-beta/Smad2/3 pathway in ES cells and early embryos. As somatic abnormalities in functions known to be regulated by the TGF-beta/Smad2/3 pathway underlie tumor suppression and metastasis, this research also provides a resource for miRNAs involved in cancer.	[Redshaw, Nicholas; Sharma, Vikas; Motallebipour, Mehdi; Guzman-Ayala, Marcela; Thymiakou, Efstathia; Episkopou, Vasso] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, London, England; [Camps, Carme; Oikonomopoulos, Spyros; Ragoussis, Jiannis] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Imperial College London; University of Oxford; Wellcome Centre for Human Genetics	Episkopou, V (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, London, England.	vasso.episkopou@imperial.ac.uk	Ragoussis, Ioannis/AAD-9790-2022	Ragoussis, Ioannis/0000-0002-8515-0934; Thymiakou, Efstathia/0000-0003-0204-5141	Medical Research Council, UK; Cancer Research UK; BBSRC; FP7 ITN programme InteGer; The Wellcome Trust [090532/Z/09/Z, 075491/Z/04]; Biotechnology and Biological Sciences Research Council [BB/G00577X/1, BB/G00577X/2] Funding Source: researchfish; Medical Research Council [MC_U120074332, MR/J013331/1] Funding Source: researchfish; BBSRC [BB/G00577X/1, BB/G00577X/2] Funding Source: UKRI; MRC [MR/J013331/1, MC_U120074332] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FP7 ITN programme InteGer; The Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NR, MGA and VE were supported by the Medical Research Council, UK. VS and ET were supported by Cancer Research UK and the BBSRC respectively. MM was a Swedish Research Council postdoctoral fellow. SO is a fellow funded by the FP7 ITN programme InteGer. JR and CC are supported by The Wellcome Trust grants 090532/Z/09/Z and 075491/Z/04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attisano L, 2001, MOL CELL ENDOCRINOL, V180, P3, DOI 10.1016/S0303-7207(01)00524-X; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998b; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Cohen JE, 2011, P NATL ACAD SCI USA, V108, P11650, DOI 10.1073/pnas.1017576108; Costa FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025114; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Derynck R., 2008, TGF BETA FAMILY; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; Enright AJ, 2004, GENOME BIOL, V5; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fu SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027965; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Garmire LX, 2012, RNA, V18, P1279, DOI 10.1261/rna.030916.111; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guzman-Ayala M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004268; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iwatsuki M, 2010, ANN SURG ONCOL, V17, P2526, DOI 10.1245/s10434-010-1041-0; Ji JF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-4; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim TH, 2010, HISTOPATHOLOGY, V57, P734, DOI 10.1111/j.1365-2559.2010.03686.x; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kriegel AJ, 2010, NUCLEIC ACIDS RES, V38, P8338, DOI 10.1093/nar/gkq718; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson RA, 2010, CHEM-BIOL INTERACT, V184, P21, DOI 10.1016/j.cbi.2009.10.002; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Liu HQ, 2005, BIOINFORMATICS, V21, P671, DOI 10.1093/bioinformatics/bth437; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Meng FY, 2012, J CELL MOL MED, V16, P160, DOI 10.1111/j.1582-4934.2011.01282.x; Mian C, 2012, THYROID, V22, P890, DOI 10.1089/thy.2012.0045; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Norris DP, 2002, DEVELOPMENT, V129, P3455; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Qi YH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/915980; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roccaro AM, 2009, BLOOD, V113, P6669, DOI 10.1182/blood-2009-01-198408; Rodriguez TA, 2001, DEV BIOL, V234, P304, DOI 10.1006/dbio.2001.0265; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schanen BC, 2011, GENOMICS, V97, P1, DOI 10.1016/j.ygeno.2010.10.005; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Tombol Z, 2010, MODERN PATHOL, V23, P1583, DOI 10.1038/modpathol.2010.164; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang H, 2012, ONCOL LETT, V3, P229, DOI 10.3892/ol.2011.448; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Weisberg E, 1998, MECH DEVELOP, V79, P17, DOI 10.1016/S0925-4773(98)00160-9; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yabushita S, 2012, PANCREAS, V41, P1013, DOI 10.1097/MPA.0b013e31824ac3a5; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	94	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55186	10.1371/journal.pone.0055186	http://dx.doi.org/10.1371/journal.pone.0055186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23390484	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800126
J	Boitz, JM; Strasser, R; Yates, PA; Jardim, A; Ullman, B				Boitz, Jan M.; Strasser, Rona; Yates, Phillip A.; Jardim, Armando; Ullman, Buddy			Adenylosuccinate Synthetase and Adenylosuccinate Lyase Deficiencies Trigger Growth and Infectivity Deficits in Leishmania donovani	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; PURINE METABOLISM; ESCHERICHIA-COLI; ADENOSINE-DEAMINASE; IN-VITRO; ENZYMATIC AMPLIFICATION; ADENINE AMINOHYDROLASE; GENETIC-ANALYSIS; KINASE; RESISTANCE	Leishmania are auxotrophic for purines, and consequently purine acquisition from the host is a requisite nutritional function for the parasite. Both adenylosuccinate synthetase (ADSS) and adenylosuccinate lyase (ASL) have been identified as vital components of purine salvage in Leishmania donovani, and therefore Delta adss and Delta asl null mutants were constructed to test this hypothesis. Unlike wild type L. donovani, Delta adss and Delta asl parasites in culture exhibited a profoundly restricted growth phenotype in which the only permissive growth conditions were a 6-aminopurine source in the presence of 2'-deoxycoformycin, an inhibitor of adenine aminohydrolase activity. Although both knock-outs showed a diminished capacity to infect murine peritoneal macrophages, only the Delta asl null mutant was profoundly incapacitated in its ability to infect mice. The enormous discrepancy in parasite loads observed in livers and spleens from mice infected with either Delta adss or Delta asl parasites can be explained by selective accumulation of adenylosuccinate in the Delta asl knock-out and consequent starvation for guanylate nucleotides. Genetic complementation of a Delta asl lesion in Escherichia coli implied that the L. donovani ASL could also recognize 5-aminoimidazole-(N-succinylocarboxamide) ribotide as a substrate, and purified recombinant ASL displayed an apparent K-m of similar to 24 mu M for adenylosuccinate. Unlike many components of the purine salvage pathway of L. donovani, both ASL and ADSS are cytosolic enzymes. Overall, these data underscore the paramount importance of ASL to purine salvage by both life cycle stages of L. donovani and authenticate ASL as a potential drug target in Leishmania.	[Boitz, Jan M.; Yates, Phillip A.; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Strasser, Rona; Jardim, Armando] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Oregon Health & Science University; McGill University	Ullman, B (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	ullmanb@ohsu.edu			National Institutes of Health from the NIAID [AI023682]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023682, R01AI023682] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI023682 from the NIAID (to B. U.). This work was also supported by a grant from the Canadian Institutes of Health Research (to A. J.).	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6; Boitz JM, 2006, MOL BIOCHEM PARASIT, V148, P24, DOI 10.1016/j.molbiopara.2006.02.015; Boitz JM, 2006, J BIOL CHEM, V281, P16084, DOI 10.1074/jbc.M600188200; Boitz JM, 2012, J BIOL CHEM, V287, P7626, DOI 10.1074/jbc.M111.307884; Boitz JM, 2010, J BIOL CHEM, V285, P18555, DOI 10.1074/jbc.M110.125393; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; CASEY PJ, 1986, J BIOL CHEM, V261, P3637; CRAIG SP, 1991, P NATL ACAD SCI USA, V88, P2500, DOI 10.1073/pnas.88.6.2500; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Croft SL, 2002, CURR PHARM DESIGN, V8, P319, DOI 10.2174/1381612023396258; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; DATTA AK, 1987, J BIOL CHEM, V262, P5515; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Dobie F, 2007, MOL BIOCHEM PARASIT, V152, P11, DOI 10.1016/j.molbiopara.2006.11.007; DWYER DM, 1972, J PARASITOL, V58, P847, DOI 10.2307/3278338; Eaazhisai K, 2004, J MOL BIOL, V335, P1251, DOI 10.1016/j.jmb.2003.11.036; Galazka J, 2006, MOL BIOCHEM PARASIT, V149, P223, DOI 10.1016/j.molbiopara.2006.06.001; Garg R, 2006, INDIAN J MED RES, V123, P439; Goyard S, 2000, MOL BIOCHEM PARASIT, V108, P249, DOI 10.1016/S0166-6851(00)00210-3; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HOLBROOK TW, 1975, AM J TROP MED HYG, V24, P704, DOI 10.4269/ajtmh.1975.24.704; Hwang HY, 1997, J BIOL CHEM, V272, P19488, DOI 10.1074/jbc.272.31.19488; Hwang HY, 1996, J BIOL CHEM, V271, P30840, DOI 10.1074/jbc.271.48.30840; Ilgoutz SC, 1999, EMBO J, V18, P3643, DOI 10.1093/emboj/18.13.3643; Iovannisci D M, 1984, Adv Exp Med Biol, V165 Pt A, P239; IOVANNISCI DM, 1984, J BIOL CHEM, V259, P4617; IOVANNISCI DM, 1984, MOL BIOCHEM PARASIT, V12, P139, DOI 10.1016/0166-6851(84)90131-2; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; Jardim A, 2002, MOL BIOCHEM PARASIT, V124, P51, DOI 10.1016/S0166-6851(02)00164-0; Jayalakshmi R, 2002, PROTEIN EXPRES PURIF, V25, P65, DOI 10.1006/prep.2001.1610; JOCHIMSEN B, 1975, MOL GEN GENET, V143, P85, DOI 10.1007/BF00269424; KIDDER GW, 1979, P NATL ACAD SCI USA, V76, P3670, DOI 10.1073/pnas.76.8.3670; KIDDER GW, 1977, ARCH BIOCHEM BIOPHYS, V183, P7, DOI 10.1016/0003-9861(77)90412-X; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; Krenitsky T A, 1979, Adv Exp Med Biol, V122B, P51; LAFON SW, 1982, BIOCHEM PHARMACOL, V31, P231, DOI 10.1016/0006-2952(82)90216-7; LOOKER DL, 1983, MOL BIOCHEM PARASIT, V9, P15, DOI 10.1016/0166-6851(83)90053-1; MARR JJ, 1982, BIOCHEM PHARMACOL, V31, P143, DOI 10.1016/0006-2952(82)90203-9; MARR JJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P360, DOI 10.1016/0304-4165(78)90104-6; Michaelis L, 1913, BIOCHEM Z, V49, P333; Michels PAM, 2000, PARASITOL TODAY, V16, P482, DOI 10.1016/S0169-4758(00)01810-X; MILLER SI, 1986, NUCLEIC ACIDS RES, V14, P7341, DOI 10.1093/nar/14.18.7341; Mullen AB, 1998, ANTIMICROB AGENTS CH, V42, P2722, DOI 10.1128/AAC.42.10.2722; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; Parsons M, 2001, MOL BIOCHEM PARASIT, V115, P19, DOI 10.1016/S0166-6851(01)00261-4; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Pilar AVC, 2008, MOL BIOCHEM PARASIT, V158, P72, DOI 10.1016/j.molbiopara.2007.11.013; Poland BW, 1996, J MOL BIOL, V264, P1013, DOI 10.1006/jmbi.1996.0693; Russel D. W., 2001, MOL CLONING LAB MANU, P1633; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHAEFFER HJ, 1974, J MED CHEM, V17, P6, DOI 10.1021/jm00247a002; Shih S, 1998, J BIOL CHEM, V273, P1534, DOI 10.1074/jbc.273.3.1534; Sillero MAG, 2001, EUR J BIOCHEM, V268, P3605, DOI 10.1046/j.1432-1327.2001.02271.x; SPECTOR T, 1982, BIOCHEM PHARMACOL, V31, P3891, DOI 10.1016/0006-2952(82)90307-0; SPECTOR T, 1979, J BIOL CHEM, V254, P8422; SPECTOR T, 1984, BIOCHEM PHARMACOL, V33, P1611, DOI 10.1016/0006-2952(84)90282-X; TUTTLE JV, 1980, J BIOL CHEM, V255, P909; WIGINTON DA, 1982, J BIOL CHEM, V257, P3211; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; WOLFE SA, 1988, J BIOL CHEM, V263, P19147; Zarella-Boitz JM, 2004, MOL BIOCHEM PARASIT, V134, P43, DOI 10.1016/j.molbiopara.2003.08.016	67	26	27	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8977	8990		10.1074/jbc.M112.431486	http://dx.doi.org/10.1074/jbc.M112.431486			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404497	hybrid, Green Published			2022-12-25	WOS:000316862200017
J	Bartley, SN; Tzeng, YL; Heel, K; Lee, CW; Mowlaboccus, S; Seemann, T; Lu, W; Lin, YH; Ryan, CS; Peacock, C; Stephens, DS; Davies, JK; Kahler, CM				Bartley, Stephanie N.; Tzeng, Yih-Ling; Heel, Kathryn; Lee, Chiang W.; Mowlaboccus, Shakeel; Seemann, Torsten; Lu, Wei; Lin, Ya-Hsun; Ryan, Catherine S.; Peacock, Christopher; Stephens, David S.; Davies, John K.; Kahler, Charlene M.			Attachment and Invasion of Neisseria meningitidis to Host Cells Is Related to Surface Hydrophobicity, Bacterial Cell Size and Capsule	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; POLYSIALIC ACID CAPSULE; OUTER-MEMBRANE PROTEIN; INNER-CORE STRUCTURE; SEROGROUP-B; PILIN GLYCOSYLATION; ENDOTHELIAL-CELLS; PHASE VARIATION; SIALIC-ACID; LIPOOLIGOSACCHARIDE STRUCTURE	We compared exemplar strains from two hypervirulent clonal complexes, strain NMB-CDC from ST-8/11 cc and strain MC58 from ST-32/269 cc, in host cell attachment and invasion. Strain NMB-CDC attached to and invaded host cells at a significantly greater frequency than strain MC58. Type IV pili retained the primary role for initial attachment to host cells for both isolates regardless of pilin class and glycosylation pattern. In strain MC58, the serogroup B capsule was the major inhibitory determinant affecting both bacterial attachment to and invasion of host cells. Removal of terminal sialylation of lipooligosaccharide (LOS) in the presence of capsule did not influence rates of attachment or invasion for strain MC58. However, removal of either serogroup B capsule or LOS sialylation in strain NMB-CDC increased bacterial attachment to host cells to the same extent. Although the level of inhibition of attachment by capsule was different between these strains, the regulation of the capsule synthesis locus by the two-component response regulator MisR, and the level of surface capsule determined by flow cytometry were not significantly different. However, the diplococci of strain NMB-CDC were shown to have a 1.89-fold greater surface area than strain MC58 by flow cytometry. It was proposed that the increase in surface area without changing the amount of anchored glycolipid capsule in the outer membrane would result in a sparser capsule and increase surface hydrophobicity. Strain NMB-CDC was shown to be more hydrophobic than strain MC58 using hydrophobicity interaction chromatography and microbial adhesion-to-solvents assays. In conclusion, improved levels of adherence of strain NMB-CDC to cell lines was associated with increased bacterial cell surface and surface hydrophobicity. This study shows that there is diversity in bacterial cell surface area and surface hydrophobicity within N. meningitidis which influence steps in meningococcal pathogenesis.	[Bartley, Stephanie N.; Lee, Chiang W.; Mowlaboccus, Shakeel; Lu, Wei; Peacock, Christopher; Kahler, Charlene M.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Tzeng, Yih-Ling; Stephens, David S.] Vet Affairs Med Ctr, Atlanta, GA 30033 USA; [Tzeng, Yih-Ling; Stephens, David S.] Emory Univ, Sch Med, Atlanta, GA USA; [Heel, Kathryn] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [Heel, Kathryn] Univ Western Australia, Sch Pathol & Lab Med, Translat Canc Pathol Lab, Perth, WA 6009, Australia; [Seemann, Torsten] Monash Univ, Victorian Bioinformat Consortium, Melbourne, Vic 3004, Australia; [Lin, Ya-Hsun; Ryan, Catherine S.; Davies, John K.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia	University of Western Australia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; University of Western Australia; University of Western Australia; Monash University; Monash University	Kahler, CM (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia.	Charlene.Kahler@uwa.edu.au	Fuller, Kathy A/C-5454-2011; Fuller, Kathy A/GWZ-2885-2022; Seemann, Torsten/B-2318-2010; Kahler, Charlene M/H-5159-2014	Fuller, Kathy A/0000-0002-3462-7501; Fuller, Kathy A/0000-0002-3462-7501; Seemann, Torsten/0000-0001-6046-610X; Kahler, Charlene M/0000-0003-4322-3055; Mowlaboccus, Shakeel/0000-0001-9408-6068	Amanda Young Foundation; National Health and Medical Research Council [APP546003]; National Institutes of Health [R01-AI061031]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI061031, R01AI061031] Funding Source: NIH RePORTER	Amanda Young Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SB was supported by a PhD scholarship from the Amanda Young Foundation (http://www.amandayoungfoundation.org.au/). CMK and JKD are supported by the National Health and Medical Research Council (APP546003). YT and DSS are supported by the National Institutes of Health (R01-AI061031 to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APICELLA MA, 1981, INFECT IMMUN, V34, P751, DOI 10.1128/IAI.34.3.751-756.1981; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; BARRETT SJ, 1994, MICROBIOL-UK, V140, P2867, DOI 10.1099/00221287-140-10-2867; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Bille E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003885; Bogdan JA, 2002, J MICROBIOL METH, V49, P97, DOI 10.1016/S0167-7012(01)00364-5; Bonifait L, 2010, FEMS MICROBIOL LETT, V311, P160, DOI 10.1111/j.1574-6968.2010.02086.x; Borud B, 2011, P NATL ACAD SCI USA, V108, P9643, DOI 10.1073/pnas.1103321108; Boyer RR, 2007, J FOOD PROTECT, V70, P1339, DOI 10.4315/0362-028X-70.6.1339; Boyer RR, 2011, INT J FOOD MICROBIOL, V147, P228, DOI 10.1016/j.ijfoodmicro.2011.04.016; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Callaghan MJ, 2006, INFECT IMMUN, V74, P5085, DOI 10.1128/IAI.00293-06; Calvert MEK, 2008, CYTOM PART A, V73A, P825, DOI 10.1002/cyto.a.20609; Carbonnelle E, 2009, VACCINE, V27, pB78, DOI 10.1016/j.vaccine.2009.04.069; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Cehovin A, 2010, VACCINE, V28, P4817, DOI 10.1016/j.vaccine.2010.04.065; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Chen HT, 2009, MICROFLUID NANOFLUID, V6, P529, DOI 10.1007/s10404-008-0335-z; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Comanducci M, 2004, INFECT IMMUN, V72, P4217, DOI 10.1128/IAI.72.7.4217-4223.2004; Courtney HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004166; Dalia AB, 2011, CELL HOST MICROBE, V10, P486, DOI 10.1016/j.chom.2011.09.009; de Vries FP, 1998, MOL MICROBIOL, V27, P1203, DOI 10.1046/j.1365-2958.1998.00763.x; deVries FP, 1996, INFECT IMMUN, V64, P2998, DOI 10.1128/IAI.64.8.2998-3006.1996; Dolan-Livengood JM, 2003, J INFECT DIS, V187, P1616, DOI 10.1086/374740; FROSCH M, 1989, P NATL ACAD SCI USA, V86, P1669, DOI 10.1073/pnas.86.5.1669; GOTSCHLICH EC, 1981, J BIOL CHEM, V256, P8915; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x; Hassan AN, 2004, INT J FOOD MICROBIOL, V96, P103, DOI 10.1016/S0168-1605(03)00160-0; Helm RA, 2010, J BACTERIOL, V192, P3822, DOI 10.1128/JB.00280-10; Hill NS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002549; Hobb RI, 2010, MICROBES INFECT, V12, P476, DOI 10.1016/j.micinf.2010.02.009; JANIK A, 1976, J CLIN MICROBIOL, V4, P71; Jennings MP, 2011, CELL MICROBIOL, V13, P885, DOI 10.1111/j.1462-5822.2011.01586.x; Joseph B, 2012, PLOS ONE, V6; Kahler CM, 2006, J BIOL CHEM, V281, P19939, DOI 10.1074/jbc.M601308200; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Kahler CM, 1998, CRIT REV MICROBIOL, V24, P281, DOI 10.1080/10408419891294216; Kahler CM, 1996, J BACTERIOL, V178, P6677, DOI 10.1128/jb.178.23.6677-6684.1996; Kahler CM, 2005, GLYCOBIOLOGY, V15, P409, DOI 10.1093/glycob/cwi018; Kahler CM, 2001, INFECT IMMUN, V69, P3597, DOI 10.1128/IAI.69.6.3597-3604.2001; Kahler CM, 1996, J BACTERIOL, V178, P1265, DOI 10.1128/jb.178.5.1265-1273.1996; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Kempf M, 2012, CAN J MICROBIOL, V58, P311, DOI [10.1139/W11-131, 10.1139/w11-131]; Koch AL, 1994, GEN MOL BACTERIOLOGY; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P1466, DOI 10.1128/jb.168.3.1466-1467.1986; Kumar P, 2011, MOL MICROBIOL, V79, P1557, DOI 10.1111/j.1365-2958.2011.07546.x; Langsrud S, 1996, J APPL BACTERIOL, V81, P411; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li MS, 2009, MED MICROBIOL IMMUN, V198, P57, DOI 10.1007/s00430-008-0105-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LJUNGH A, 1985, INFECT IMMUN, V47, P522, DOI 10.1128/IAI.47.2.522-526.1985; Ly MH, 2006, COLLOID SURFACE B, V52, P149, DOI 10.1016/j.colsurfb.2006.04.015; Marceau M, 1998, MOL MICROBIOL, V27, P705, DOI 10.1046/j.1365-2958.1998.00706.x; MENARD R, 1993, J BACTERIOL, V175, P5899; Moore J, 2005, J BIOL CHEM, V280, P31489, DOI 10.1074/jbc.M506354200; Morand PC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006834; Nagele V, 2011, J BIOL CHEM, V286, P20536, DOI 10.1074/jbc.M110.188326; Naessan CL, 2008, J BACTERIOL, V190, P387, DOI 10.1128/JB.00765-07; Nassif X, 1999, Int Microbiol, V2, P133; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Nassif X, 1997, GENE, V192, P149, DOI 10.1016/S0378-1119(96)00802-5; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Neil RB, 2009, MICROBES INFECT, V11, P281, DOI 10.1016/j.micinf.2008.12.001; Plant L, 2006, INFECT IMMUN, V74, P1360, DOI 10.1128/IAI.74.2.1360-1367.2006; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Rahman MM, 1997, CARBOHYD RES, V301, P213; Rahman MM, 2001, GLYCOBIOLOGY, V11, P703, DOI 10.1093/glycob/11.8.703; Read RC, 1996, INFECT IMMUN, V64, P3210, DOI 10.1128/IAI.64.8.3210-3217.1996; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; Rosenberg M., 1990, MICROBIAL CELL SURFA, P1; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1; RUDEL T, 1992, MOL MICROBIOL, V6, P3439, DOI 10.1111/j.1365-2958.1992.tb02211.x; Schoen C, 2009, VACCINE, V27, pB103, DOI 10.1016/j.vaccine.2009.04.064; Serruto D, 2003, MOL MICROBIOL, V48, P323, DOI 10.1046/j.1365-2958.2003.03420.x; Sjolinder H, 2008, INFECT IMMUN, V76, P5412, DOI 10.1128/IAI.00478-08; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; STEPHENS DS, 1991, INFECT IMMUN, V59, P4097, DOI 10.1128/IAI.59.11.4097-4102.1991; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Swartley JS, 1996, J BACTERIOL, V178, P4052, DOI 10.1128/jb.178.14.4052-4059.1996; Takahashi H, 2008, FEMS IMMUNOL MED MIC, V52, P36, DOI 10.1111/j.1574-695X.2007.00342.x; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; TINSLEY CR, 1986, J GEN MICROBIOL, V132, P2483; TRUST TJ, 1983, INFECT IMMUN, V41, P106, DOI 10.1128/IAI.41.1.106-113.1983; Tunio SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-280; Turner DPJ, 2006, INFECT IMMUN, V74, P2957, DOI 10.1128/IAI.74.5.2957-2964.2006; Tzeng YL, 2008, INFECT IMMUN, V76, P704, DOI 10.1128/IAI.01007-07; Tzeng YL, 2005, INFECT IMMUN, V73, P1491, DOI 10.1128/IAI.73.3.1491-1505.2005; Tzeng YL, 2004, J BIOL CHEM, V279, P35053, DOI 10.1074/jbc.M401433200; Tzeng YL, 2002, J BIOL CHEM, V277, P24103, DOI 10.1074/jbc.M200931200; Tzeng YL, 2001, INFECT IMMUN, V69, P2502, DOI 10.1128/IAI.69.4.2502-2511.2001; Unkmeir A, 2002, INFECT IMMUN, V70, P2454, DOI 10.1128/IAI.70.5.2454-2462.2002; VIRJI M, 1983, J GEN MICROBIOL, V129, P2761; VIRJI M, 1993, MOL MICROBIOL, V10, P1013, DOI 10.1111/j.1365-2958.1993.tb00972.x; VIRJI M, 1992, MOL MICROBIOL, V6, P2785, DOI 10.1111/j.1365-2958.1992.tb01458.x; Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; VIRJI M, 1993, MOL MICROBIOL, V10, P499, DOI 10.1111/j.1365-2958.1993.tb00922.x; VIRJI M, 1992, MOL MICROBIOL, V6, P1271, DOI 10.1111/j.1365-2958.1992.tb00848.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Warren MJ, 2004, FEMS IMMUNOL MED MIC, V41, P43, DOI 10.1016/j.femsim.2004.01.002; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Zhou DG, 1996, GENE, V171, P133, DOI 10.1016/0378-1119(96)00103-5; ZOLLINGER WD, 1983, INFECT IMMUN, V40, P257, DOI 10.1128/IAI.40.1.257-264.1983	112	43	43	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55798	10.1371/journal.pone.0055798	http://dx.doi.org/10.1371/journal.pone.0055798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405216	Green Published, gold			2022-12-25	WOS:000315153400161
J	Peroval, MY; Boyd, AC; Young, JR; Smith, AL				Peroval, Marylene Y.; Boyd, Amy C.; Young, John R.; Smith, Adrian L.			A Critical Role for MAPK Signalling Pathways in the Transcriptional Regulation of Toll Like Receptors	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE PRODUCTION; FACTOR-KAPPA-B; DIFFERENT GENETIC BACKGROUNDS; MURINE ALVEOLAR MACROPHAGES; HUMAN DENDRITIC CELLS; NEGATIVE REGULATION; PHOSPHOINOSITIDE 3-KINASE; CPG-OLIGODEOXYNUCLEOTIDE; DIFFERENTIAL EXPRESSION	Toll-like Receptors (TLR) are phylogenetically conserved transmembrane proteins responsible for detection of pathogens and activation of immune responses in diverse animal species. The stimulation of TLR by pathogen-derived molecules leads to the production of pro-inflammatory mediators including cytokines and nitric oxide. Although TLR-induced events are critical for immune induction, uncontrolled inflammation can be life threatening and regulation is a critical feature of TLR biology. We used an avian macrophage cell line (HD11) to determine the relationship between TLR agonist-induced activation of inflammatory responses and the transcriptional regulation of TLR. Exposure of macrophages to specific TLR agonists induced upregulation of cytokine and nitric oxide pathways that were inhibited by blocking various components of the TLR signalling pathways. TLR activation also led to changes in the levels of mRNA encoding the TLR responsible for recognising the inducing agonist (cognate regulation) and cross-regulation of other TLR (non-cognate regulation). Interestingly, in most cases, regulation of TLR mRNA was independent of NFkB activity but dependent on one or more of the MAPK pathway components. Moreover, the relative importance of ERK, JNK and p38 was dependent upon both the stimulating agonist and the target TLR. These results provide a framework for understanding the complex pathways involved in transcriptional regulation of TLR, immune induction and inflammation. Manipulation of these pathways during vaccination or management of acute inflammatory disease may lead to improved clinical outcome or enhanced vaccine efficacy.	[Peroval, Marylene Y.; Young, John R.] Inst Anim Hlth, Compton, Berks, England; [Boyd, Amy C.] Univ Oxford, Nuffield Dept Clin Med, Jenner Inst, Oxford, England; [Smith, Adrian L.] Univ Oxford, Dept Zool, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford; Jenner Institute; University of Oxford	Smith, AL (corresponding author), Univ Oxford, Dept Zool, Tinbergen Bldg, Oxford, England.	adrian.smith@zoo.ox.ac.uk		Smith, Adrian/0000-0002-7657-6191	Department for Environment, Food and Rural Affairs [OD0547]; Institute for Animal Health doctoral training account; University of Oxford; BBSRC [BB/K004468/1] Funding Source: UKRI	Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Institute for Animal Health doctoral training account; University of Oxford; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Department for Environment, Food and Rural Affairs project number OD0547 with further funds from the Institute for Animal Health doctoral training account and the University of Oxford (John Fell Fund and the Jenner Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-69; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Baldassare JJ, 1999, J IMMUNOL, V162, P5367; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boyd A, 2007, BIOCHEM SOC T, V35, P1504, DOI 10.1042/BST0351504; Briscoe J, 1996, PHILOS T ROY SOC B, V351, P167, DOI 10.1098/rstb.1996.0013; Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675; Brownlie R, 2009, MOL IMMUNOL, V46, P3163, DOI 10.1016/j.molimm.2009.06.002; Bryn T, 2006, J IMMUNOL, V176, P7361, DOI 10.4049/jimmunol.176.12.7361; Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC; Cabral ES, 2006, J INFECT DIS, V193, P849, DOI 10.1086/500467; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Chen S, 2007, J ENDOTOXIN RES, V13, P281, DOI 10.1177/0968051907085096; Cormican P, 2009, DEV COMP IMMUNOL, V33, P967, DOI 10.1016/j.dci.2009.04.001; Crippen TL, 2006, VET IMMUNOL IMMUNOP, V109, P127, DOI 10.1016/j.vetimm.2005.08.024; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dalpke AH, 2005, IMMUNOLOGY, V116, P203, DOI 10.1111/j.1365-2567.2005.02211.x; De Nardo D, 2009, J IMMUNOL, V183, P8110, DOI 10.4049/jimmunol.0901031; de Zoete MR, 2011, P NATL ACAD SCI USA, V108, P4968, DOI 10.1073/pnas.1018135108; Dil N, 2002, VET IMMUNOL IMMUNOP, V84, P191, DOI 10.1016/S0165-2427(01)00402-0; Dil N, 2002, VET IMMUNOL IMMUNOP, V88, P149, DOI 10.1016/S0165-2427(02)00153-8; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fuku A, 2001, J BIOL CHEM, V276, P47143, DOI 10.1074/jbc.M103902200; Fukuzono S, 2010, ARCH BIOCH BIOPHYS; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Gillespie M, 2011, MAMM GENOME, V22, P130, DOI 10.1007/s00335-010-9296-0; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hayashi T, 2009, P NATL ACAD SCI USA, V106, P2764, DOI 10.1073/pnas.0813037106; Hazeki K, 2006, MOL PHARMACOL, V69, P1717, DOI 10.1124/mol.105.021162; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; He HQ, 2007, MOL IMMUNOL, V44, P3234, DOI 10.1016/j.molimm.2007.01.034; He HQ, 2005, DEV COMP IMMUNOL, V29, P255, DOI 10.1016/j.dci.2004.07.005; He HQ, 2003, CELL SIGNAL, V15, P911, DOI 10.1016/S0898-6568(03)00100-1; He HQ, 2003, DEV COMP IMMUNOL, V27, P621, DOI 10.1016/S0145-305X(03)00013-2; Higgs R, 2006, INFECT IMMUN, V74, P1692, DOI 10.1128/IAI.74.3.1692-1698.2006; Higuchi M, 2007, DEV COMP IMMUNOL; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Iwami K, 2000, J IMMUNOL, V165, P6682, DOI 10.4049/jimmunol.165.12.6682; Izadi H, 2007, INFECT IMMUN, V75, P5027, DOI 10.1128/IAI.00492-07; Jenkins KA, 2009, DEV COMP IMMUNOL, V33, P660, DOI 10.1016/j.dci.2008.11.009; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Juarez E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-2; Karpala AJ, 2008, DEV COMP IMMUNOL, V32, P435, DOI 10.1016/j.dci.2007.08.004; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Keestra AM, 2008, J IMMUNOL, V181, P4354, DOI 10.4049/jimmunol.181.6.4354; Keestra AM, 2008, MOL IMMUNOL, V45, P1298, DOI 10.1016/j.molimm.2007.09.013; Keestra AM, 2007, J IMMUNOL, V178, P7110, DOI 10.4049/jimmunol.178.11.7110; Kimura A, 2005, P NATL ACAD SCI USA, V102, P17089, DOI 10.1073/pnas.0508517102; Kogut MH, 2005, DEV COMP IMMUNOL, V29, P791, DOI 10.1016/j.dci.2005.02.002; Kogut MH, 2008, INNATE IMMUN-LONDON, V14, P213, DOI 10.1177/1753425908094416; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; LeBouder E, 2003, J IMMUNOL, V171, P6680, DOI 10.4049/jimmunol.171.12.6680; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lehner MD, 2001, J IMMUNOL, V166, P5161, DOI 10.4049/jimmunol.166.8.5161; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Lynn DJ, 2003, VET IMMUNOL IMMUNOP, V93, P177, DOI 10.1016/S0165-2427(03)00058-8; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Marshall JD, 2007, J LEUKOCYTE BIOL, V82, P497, DOI 10.1189/jlb.0906575; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; McCartney-Francis N, 2004, J IMMUNOL, V172, P3814, DOI 10.4049/jimmunol.172.6.3814; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Miyake Kensuke, 2004, Current Drug Targets - Inflammation and Allergy, V3, P291, DOI 10.2174/1568010043343633; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Nerren JR, 2009, IMMUNOGENETICS, V61, P71, DOI 10.1007/s00251-008-0340-0; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Okugawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC399, DOI 10.1152/ajpcell.00026.2003; Oshikawa K, 2003, EXP LUNG RES, V29, P401, DOI 10.1080/01902140303756; Palazzo M, 2008, INT IMMUNOL, V20, P709, DOI 10.1093/intimm/dxn027; Philbin VJ, 2005, IMMUNOLOGY, V114, P507, DOI 10.1111/j.1365-2567.2005.02125.x; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Re F, 2004, J IMMUNOL, V173, P7548, DOI 10.4049/jimmunol.173.12.7548; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Robinson-White A, 2002, ANN NY ACAD SCI, V968, P256, DOI 10.1111/j.1749-6632.2002.tb04340.x; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Schwarz H, 2007, J INTERF CYTOK RES, V27, P97, DOI 10.1089/jir.2006.0098; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Torgersen KM, 2002, CELL SIGNAL, V14, P1, DOI 10.1016/S0898-6568(01)00214-5; Tsukamoto K, 2008, J IMMUNOL, V180, P2054, DOI 10.4049/jimmunol.180.4.2054; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Uto T, 2005, BIOCHEM PHARMACOL, V70, P1211, DOI 10.1016/j.bcp.2005.07.011; Utsugi M, 2009, J IMMUNOL, V182, P5225, DOI 10.4049/jimmunol.0801352; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Woodgett JR, 2005, NAT IMMUNOL, V6, P751, DOI 10.1038/ni0805-751; Yang HT, 2011, J IMMUNOL, V186, P1989, DOI 10.4049/jimmunol.1001003	99	79	82	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e51243	10.1371/journal.pone.0051243	http://dx.doi.org/10.1371/journal.pone.0051243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405061	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400004
J	Scheler, G				Scheler, Gabriele			Transfer Functions for Protein Signal Transduction: Application to a Model of Striatal Neural Plasticity	PLOS ONE			English	Article							DYNAMICS; DARPP-32; SIMULATION; EQUATIONS	We present a novel formulation for biochemical reaction networks in the context of protein signal transduction. The model consists of input-output transfer functions, which are derived from differential equations, using stable equilibria. We select a set of "source'' species, which are interpreted as input signals. Signals are transmitted to all other species in the system (the "target'' species) with a specific delay and with a specific transmission strength. The delay is computed as the maximal reaction time until a stable equilibrium for the target species is reached, in the context of all other reactions in the system. The transmission strength is the concentration change of the target species. The computed input-output transfer functions can be stored in a matrix, fitted with parameters, and even recalled to build dynamical models on the basis of state changes. By separating the temporal and the magnitudinal domain we can greatly simplify the computational model, circumventing typical problems of complex dynamical systems. The transfer function transformation of biochemical reaction systems can be applied to mass-action kinetic models of signal transduction. The paper shows that this approach yields significant novel insights while remaining a fully testable and executable dynamical model for signal transduction. In particular we can deconstruct the complex system into local transfer functions between individual species. As an example, we examine modularity and signal integration using a published model of striatal neural plasticity. The modularizations that emerge correspond to a known biological distinction between calcium-dependent and cAMP-dependent pathways. Remarkably, we found that overall interconnectedness depends on the magnitude of inputs, with higher connectivity at low input concentrations and significant modularization at moderate to high input concentrations. This general result, which directly follows from the properties of individual transfer functions, contradicts notions of ubiquitous complexity by showing input-dependent signal transmission inactivation.			Scheler, G (corresponding author), Carl Correns Fdn Math Biol, Mountain View, CA 94040 USA.	gscheler@gmail.com	Scheler, Gabriele/N-2939-2017	Scheler, Gabriele/0000-0002-7425-4404				Bandara S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000558; Barbano PE, 2007, P NATL ACAD SCI USA, V104, P19169, DOI 10.1073/pnas.0709955104; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Cepeda Carlos, 2006, Sci STKE, V2006, ppe20, DOI 10.1126/stke.3332006pe20; Deng JM, 2011, APPL MECH MATER, V43, P1, DOI 10.4028/www.scientific.net/AMM.43.1; Erhard F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-356; Eriksson O, 2009, IET SYST BIOL, V3, P113, DOI 10.1049/iet-syb.2007.0028; Fernandez E, 2006, PLOS COMPUT BIOL, V2, P1619, DOI 10.1371/journal.pcbi.0020176; Gilbert D, 2006, BRIEF BIOINFORM, V7, P339, DOI 10.1093/bib/bbl043; Hughey JJ, 2010, WIRES SYST BIOL MED, V2, P194, DOI 10.1002/wsbm.52; Kim M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000691; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; Kraeutler MJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-157; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Le Novere N, 2008, CELL MOL LIFE SCI, V65, P2125, DOI 10.1007/s00018-008-8150-y; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Lindskog M, 2006, PLOS COMPUT BIOL, V2, P1045, DOI 10.1371/journal.pcbi.0020119; Manninen T, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00152; Maslov S, 2007, P NATL ACAD SCI USA, V104, P13655, DOI 10.1073/pnas.0702905104; Maslov S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/273; Nakano T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000670; Oliveira RF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002383; Pepke S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000675; Purvis JE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000298; Qi Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-26; Qi Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002444; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Srividhya J, 2007, BIOPHYS CHEM, V125, P286, DOI 10.1016/j.bpc.2006.09.001; Stefan MI, 2008, P NATL ACAD SCI USA, V105, P10768, DOI 10.1073/pnas.0804672105; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Theis F, 2011, B MATH BIOL, V73, P978, DOI 10.1007/s11538-010-9548-x; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Woo NH, 2003, HIPPOCAMPUS, V13, P293, DOI 10.1002/hipo.10086; Wu JL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-187; Yger M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00056; Yu RC, 2008, IET SYST BIOL, V2, P222, DOI 10.1049/iet-syb:20080127	36	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55762	10.1371/journal.pone.0055762	http://dx.doi.org/10.1371/journal.pone.0055762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405211	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400156
J	Ciaccioli, G; Martins, A; Rodrigues, C; Vieira, H; Calado, P				Ciaccioli, Gianmario; Martins, Ana; Rodrigues, Catia; Vieira, Helena; Calado, Patricia			A Powerful Yeast Model to Investigate the Synergistic Interaction of alpha-Synuclein and Tau in Neurodegeneration	PLOS ONE			English	Article							PROTEIN-TAU; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; NEURONAL LOSS; PHOSPHORYLATION; AGGREGATION; TOXICITY; MUTATION; HYPERPHOSPHORYLATION; ACCUMULATION	Several studies revealed consistent overlap between synucleinopathies and tauopathies, demonstrating that alpha-synuclein (ASYN) and tau co-localize in neurofibrillary tangles and in Lewy bodies from Alzheimer's and Parkinson's disease patients and corresponding animal models. Additionally, it has been shown that ASYN can act as an initiator of tau aggregation and phosphorylation and that these two proteins directly interact. Despite these evidences, the cellular pathway implicated in this synergistic interaction remains to be clarified. The aim of this study was to create a yeast model where the concomitant expression of ASYN and tau can be used to perform genome wide screenings for the identification of genes that modulate this interaction, in order to shed light into the pathological mechanism of cell dysfunction and to provide new targets for future therapeutic intervention. We started by validating the synergistic toxicity of tau and ASYN co-expression in yeast, by developing episomal and integrative strains expressing WT and mutant forms of both proteins, alone or in combination. The episomal strains showed no differences in growth delay upon expression of ASYN isoforms (WT or A53T) alone or in combination with tau 2N/4R isoforms (WT or P301L). However, in these strains, the presence of ASYN led to increased tau insolubility and correlated with increased tau phosphorylation in S396/404, which is mainly mediated by RIM11, the human homolog of GSK3 beta in yeast. On the other hand, the integrative strains showed a strong synergistic toxic effect upon co-expression of ASYN WT and tau WT, which was related to high levels of intracellular ASYN inclusions and increased tau phosphorylation and aggregation. Taken together, the strains described in the present study are able to mimic relevant pathogenic features involved in neurodegeneration and are powerful tools to identify potential target genes able to modulate the synergistic pathway driven by ASYN and tau interaction.	[Ciaccioli, Gianmario; Martins, Ana; Rodrigues, Catia; Vieira, Helena; Calado, Patricia] Biotecnologia SA, Serv Invest & Desenvolvimento, BIOALVO, Campo Grande, Edificio ICAT,Campus FCUL, Lisbon, Portugal; [Ciaccioli, Gianmario; Vieira, Helena] Univ Lisbon, Fac Sci, DEIO, P-1699 Lisbon, Portugal; [Ciaccioli, Gianmario; Vieira, Helena] Univ Lisbon, Fac Sci, BIOFig Ctr, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Calado, P (corresponding author), Biotecnologia SA, Serv Invest & Desenvolvimento, BIOALVO, Campo Grande, Edificio ICAT,Campus FCUL, Lisbon, Portugal.	patricia.calado@bioalvo.com	Vieira, Helena/GWC-5973-2022; Vieira, Helena/M-1623-2017	Vieira, Helena/0000-0002-3663-289X	European Community's Seventh Framework Programme FP7 [238316]; FCT (Fundacao para a Ciencia e a Tecnologia) [SFRH/BI/51091/2010]	European Community's Seventh Framework Programme FP7; FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology)	The work leading to this publication has received funding from the European Community's Seventh Framework Programme FP7/2009 under grant agreement no. 238316 and from the FCT (Fundacao para a Ciencia e a Tecnologia) under grant agreement no. SFRH/BI/51091/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2011, AM J PATHOL, V178, P803, DOI 10.1016/j.ajpath.2010.10.034; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Badiola N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026609; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P228, DOI 10.1177/0891988710383572; Benussi L, 2005, EXP CELL RES, V308, P78, DOI 10.1016/j.yexcr.2005.04.021; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BueeScherrer V, 1996, MOL BRAIN RES, V39, P79, DOI 10.1016/0169-328X(96)00003-4; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; De Vos Ann, 2011, Int J Alzheimers Dis, V2011, P428970, DOI 10.4061/2011/428970; Dixon C, 2005, GENETICS, V170, P47, DOI 10.1534/genetics.104.035493; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Elbaz A, 2011, ANN NEUROL, V69, P778, DOI 10.1002/ana.22321; Esposito A, 2007, NEUROBIOL DIS, V26, P521, DOI 10.1016/j.nbd.2007.01.014; Ferrer I, 2003, ACTA NEUROPATHOL, V106, P419, DOI 10.1007/s00401-003-0756-4; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Franssens V, 2010, CELL DEATH DIFFER, V17, P746, DOI 10.1038/cdd.2009.203; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Fujishiro H, 2009, ACTA NEUROPATHOL, V117, P151, DOI 10.1007/s00401-008-0463-2; Fushimi K, 2011, PROTEIN CELL, V2, P141, DOI 10.1007/s13238-011-1014-5; Giasson BI, 2003, NEUROMOL MED, V4, P49, DOI 10.1385/NMM:4:1-2:49; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Girish V, 2004, Indian J Cancer, V41, P47; Goedert M, 2000, BBA-MOL BASIS DIS, V1502, P110, DOI 10.1016/S0925-4439(00)00037-5; Griffioen G, 2006, BBA-MOL BASIS DIS, V1762, P312, DOI 10.1016/j.bbadis.2005.11.009; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Karakaya T, 2012, CURR TREAT OPTION NE, V14, P126, DOI 10.1007/s11940-012-0168-7; Kassir Y, 2006, CURR DRUG TARGETS, V7, P1455, DOI 10.2174/1389450110607011455; Kawakami F, 2011, FEBS J, V278, P4895, DOI 10.1111/j.1742-4658.2011.08389.x; Kiakos K, 2002, J BIOL CHEM, V277, P44576, DOI 10.1074/jbc.M208169200; Kimura T, 2010, J BIOL CHEM, V285, P38692, DOI 10.1074/jbc.M110.136630; Kimura Y, 2003, CELL STRUCT FUNCT, V28, P187; Klucken J, 2006, ACTA NEUROPATHOL, V111, P101, DOI 10.1007/s00401-005-0027-7; Ko LW, 2008, J NEUROPATH EXP NEUR, V67, P1084, DOI 10.1097/NEN.0b013e31818c3618; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Marti MJ, 2003, MOVEMENT DISORD, V18, pS21, DOI 10.1002/mds.10560; Morris M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029257; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Popescu A, 2004, ARCH NEUROL-CHICAGO, V61, P1915, DOI 10.1001/archneur.61.12.1915; Pritchard SM, 2011, J CELL MOL MED, V15, P1621, DOI 10.1111/j.1582-4934.2011.01273.x; Probst A, 2000, ACTA NEUROPATHOL, V99, P469, DOI 10.1007/s004010051148; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; Sellbach AN, 2006, PARKINSONISM RELAT D, V12, P399, DOI 10.1016/j.parkreldis.2006.03.002; Sharma N, 2006, J MOL NEUROSCI, V28, P161, DOI 10.1385/JMN:28:2:161; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Trotta L, 2012, PARKINSONISM RELAT D, V18, P257, DOI 10.1016/j.parkreldis.2011.10.014; Vandebroek T, 2006, J BIOL CHEM, V281, P25388, DOI 10.1074/jbc.M602792200; Vanhelmont T, 2010, FEMS YEAST RES, V10, P992, DOI 10.1111/j.1567-1364.2010.00662.x; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; WENNING GK, 1995, J NEUROL NEUROSUR PS, V58, P160, DOI 10.1136/jnnp.58.2.160; Wills J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017953; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Zabrocki P, 2005, FEBS J, V272, P1386, DOI 10.1111/j.1742-4658.2005.04571.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	74	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55848	10.1371/journal.pone.0055848	http://dx.doi.org/10.1371/journal.pone.0055848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393603	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800058
J	Wang, C; Zhang, J; Liu, X; Li, CC; Ye, ZC; Peng, H; Chen, ZJ; Lou, TQ				Wang, Cheng; Zhang, Jun; Liu, Xun; Li, Cuicui; Ye, Zengchun; Peng, Hui; Chen, Zhujiang; Lou, Tanqi			Reversed Dipper Blood-Pressure Pattern Is Closely Related to Severe Renal and Cardiovascular Damage in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; DECLINE	Background: A non-dipper blood pressure (BP) pattern is very common in chronic kidney disease (CKD) patients and affects the progression and development of cardiovascular disease. However, data on the reversed dipper BP pattern on target-organ damage in Chinese CKD patients are lacking. Methods: A total of 540 CKD patients were enrolled. Ambulatory blood pressure monitoring (ABPM), clinical BP, ultrasonographic assessment and other clinical data were collected. Univariate and multivariate analyses were used to ascertain the relationship between ABPM results and clinical parameters. Results: A total of 21.9% CKD patients had a reversed dipper BP pattern, 42% of patients had a non-dipper BP pattern and 36.1% of patients had a dipper BP pattern. Patients with reversed dipper BP pattern had the worst renal function and most severe cardiovascular damages among these CKD patients (p < 0.05). The estimated glomerular filtration rate (eGFR) and left ventricular mass index (LVMI) correlated significantly with the rate of decline of nocturnal BP. A reversed dipper BP pattern was an independent factor affecting kidney damage and left ventricular hypertrophy. Age, lower hemoglobin level, higher 24-h systolic BP from ABPM, and higher serum phosphate levels were independent associated with a reversed dipper BP pattern after multivariate logistic regression analyses. Conclusion: The reversed dipper BP pattern is closely related to severe renal damage and cardiovascular injuries in CKD patients, and special attention should be given to these CKD patients.	[Wang, Cheng; Zhang, Jun; Liu, Xun; Li, Cuicui; Ye, Zengchun; Peng, Hui; Chen, Zhujiang; Lou, Tanqi] Sun Yat Sen Univ, Affiliated Hosp 3, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lou, TQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China.	lou.tq@163.com	wang, cheng/A-4225-2017					Bakris GL, 2009, J CLIN HYPERTENS, V11, P144, DOI 10.1111/j.1751-7176.2009.00092.x; Black HR, 1997, ARCH INTERN MED, V157, P2413; Brotman DJ, 2008, AM J HYPERTENS, V21, P92, DOI 10.1038/ajh.2007.7; Crespo JJ, 2012, CHRONOBIOL INT; Davidson MB, 2006, ARCH INTERN MED, V166, P846, DOI 10.1001/archinte.166.8.846; Drawz PE, 2010, RENAL FAILURE, V32, P1036, DOI 10.3109/0886022X.2010.510615; Dudeja SK, 2009, NEW ENGL J MED, V360, P2034; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Fukuda M, 2008, HYPERTENSION, V52, P1155, DOI 10.1161/HYPERTENSIONAHA.108.115329; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Gonzalez Rodriguez E, 2012, Rev Med Suisse, V8, P1709; Hermida RC, 2011, J AM SOC NEPHROL, V22, P2313, DOI 10.1681/ASN.2011040361; Hermida RC, 2005, HYPERTENSION, V46, P960, DOI 10.1161/01.HYP.0000174616.36290.fa; Kanbay M, 2007, AM J NEPHROL, V27, P516, DOI 10.1159/000107489; Khattar R S, 2001, J Clin Hypertens (Greenwich), V3, P90, DOI 10.1111/j.1524-6175.2001.00445.x; Lurbe E, 2002, NEW ENGL J MED, V347, P797, DOI 10.1056/NEJMoa013410; OBRIEN E, 1988, LANCET, V2, P397; Ommen SR, 2003, HEART, V89, P18; Pogue V, 2009, HYPERTENSION, V53, P20, DOI 10.1161/HYPERTENSIONAHA.108.115154; Ptinopoulou AG, 2013, HYPERTENS RES, V36, P91, DOI 10.1038/hr.2012.157; Sarafidis PA, 2012, AM J NEPHROL, V35, P238, DOI 10.1159/000336111; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Wadei HM, 2011, J AM SOC HYPERTENS, V5, P39, DOI 10.1016/j.jash.2010.11.004; Wang C, 2012, J CLIN HYPE IN PRESS; Zoccali C, 2001, J AM SOC NEPHROL, V12, P2768, DOI 10.1681/ASN.V12122768	26	16	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55419	10.1371/journal.pone.0055419	http://dx.doi.org/10.1371/journal.pone.0055419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393577	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800031
J	Garcia-Rates, S; Lewis, M; Worrall, R; Greenfield, S				Garcia-Rates, Sara; Lewis, Matthew; Worrall, Rosemary; Greenfield, Susan			Additive Toxicity of beta-Amyloid by a Novel Bioactive Peptide In Vitro: Possible Implications for Alzheimer's Disease	PLOS ONE			English	Article							ACETYLCHOLINESTERASE PROMOTES; NEUROFIBRILLARY TANGLES; PHEOCHROMOCYTOMA CELLS; CHROMAFFIN CELLS; BRAIN; RECEPTORS; BUTYRYLCHOLINESTERASE; INVOLVEMENT; RELEASE; PLAQUES	Background: beta-amyloid is regarded as a significant factor in Alzheimer's disease: but inefficient therapies based on this rationale suggests that additional signalling molecules or intermediary mechanisms must be involved in the actual initiation of the characteristic degeneration of neurons. One clue could be that acetylcholinesterase, also present in amyloid plaques, is aberrant in peripheral tissues such as blood and adrenal medulla that can be implicated in Alzheimer's disease. The aim of this study was to assess the bioactivity of a fragment of acetylcholinesterase responsible for its non-enzymatic functions, a thirty amino acid peptide ("T30") which has homologies with beta-amyloid. Methods: Cell viability was measured by sulforhodamine B assay and also lactate dehydrogenase assay: meanwhile, changes in the status of living cells was monitored by measuring release of acetylcholinesterase in cell perfusates using the Ellman reagent. Findings: T30 peptide and beta-amyloid each have toxic effects on PC12 cells, comparable to hydrogen peroxide. However only the two peptides selectively then evoke a subsequent, enhanced release in acetylcholinesterase that could only be derived from the extant cells. Moreover, unlike hydrogen peroxide, the T30 peptide selectively shifted a sub-threshold dose of beta-amyloid to a toxic effect, which also resulted in a comparable enhanced release of acetylcholinesterase. Interpretation: This is the first study comparing directly the bioactivity of beta-amyloid with a peptide derived from acetylcholinesterase: the similarity in action suggests that the sequence homology between the two compounds might have a functional and/or pathological relevance. The subsequent enhanced release of acetylcholinesterase from the extant cells could reflect a primary 'compensatory' response of cells prone to degeneration, paradoxically providing further availability of the toxic C-terminal peptide to modulate the potency of beta-amyloid. Such a cycle of events may provide new insights into the mechanism of continuing selective cell loss in Alzheimer's disease and related degenerative disorders.	[Garcia-Rates, Sara; Lewis, Matthew; Worrall, Rosemary; Greenfield, Susan] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Garcia-Rates, S (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	sara.garciarates@pharm.ox.ac.uk			The Sharp Foundation (USA)	The Sharp Foundation (USA)	This work was supported by The Sharp Foundation (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez A, 1997, J MOL BIOL, V272, P348, DOI 10.1006/jmbi.1997.1245; APPLEYARD ME, 1991, LANCET, V338, P1085, DOI 10.1016/0140-6736(91)91947-S; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; ATACK JR, 1985, J NEUROL SCI, V70, P1, DOI 10.1016/0022-510X(85)90182-0; AVERBACK P, 1983, LANCET, V2, P1203; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Bond CE, 2007, GLIA, V55, P1348, DOI 10.1002/glia.20547; Bond CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004846; Bornstein SR, 2012, MOL PSYCHIATR, V17, P354, DOI 10.1038/mp.2011.176; Carvajal FJ, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00019; Day T, 2004, EXP BRAIN RES, V155, P500, DOI 10.1007/s00221-003-1757-1; DAYAN AD, 1970, ACTA NEUROPATHOL, V16, P85, DOI 10.1007/BF00687663; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emery VOB, 2011, J NEURAL TRANSM, V118, P1361, DOI 10.1007/s00702-011-0663-0; Emmett SR, 2004, NEUROSCI LETT, V358, P210, DOI 10.1016/j.neulet.2003.12.078; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Fodero LR, 2004, J NEUROCHEM, V88, P1186, DOI 10.1046/j.1471-4159.2003.02296.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greenfield S, 2002, NEUROSCIENCE, V113, P485, DOI 10.1016/S0306-4522(02)00194-X; Greenfield S, 1996, NEUROCHEM INT, V28, P485, DOI 10.1016/0197-0186(95)00100-X; Greenfield SA, 2004, J NEUROCHEM, V90, P325, DOI 10.1111/j.1471-4159.2004.02494.x; Greenfield SA, 2008, FEBS J, V275, P604, DOI 10.1111/j.1742-4658.2007.06235.x; IZUMIYAMA N, 1990, ACTA NEUROPATHOL, V81, P213, DOI 10.1007/BF00334510; MIZRACHI Y, 1990, P NATL ACAD SCI USA, V87, P6161, DOI 10.1073/pnas.87.16.6161; Nithianantharajah J, 2011, PROG NEURO-PSYCHOPH, V35, P331, DOI 10.1016/j.pnpbp.2010.10.026; Onganer PU, 2006, BBA-GEN SUBJECTS, V1760, P415, DOI 10.1016/j.bbagen.2005.12.016; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; SOMOGYI P, 1975, PROC R SOC SER B-BIO, V191, P271, DOI 10.1098/rspb.1975.0128; TAKEDA M, 1994, NEUROSCI LETT, V168, P57, DOI 10.1016/0304-3940(94)90415-4; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Zbarsky V, 2004, NEUROBIOL DIS, V16, P283, DOI 10.1016/j.nbd.2004.02.009; Zhang XJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00040; Zimmerman G, 2006, CELL TISSUE RES, V326, P655, DOI 10.1007/s00441-006-0239-8	37	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54864	10.1371/journal.pone.0054864	http://dx.doi.org/10.1371/journal.pone.0054864			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390503	gold, Green Published, Green Submitted			2022-12-25	WOS:000314691100019
J	Gay-Jordi, G; Guash, E; Benito, B; Brugada, J; Nattel, S; Mont, L; Serrano-Mollar, A				Gay-Jordi, Gemma; Guash, Eduard; Benito, Begona; Brugada, Josep; Nattel, Stanley; Mont, Lluis; Serrano-Mollar, Anna			Losartan Prevents Heart Fibrosis Induced by Long-Term Intensive Exercise in an Animal Model	PLOS ONE			English	Article							II TYPE-1 RECEPTOR; ANGIOTENSIN-CONVERTING ENZYME; LEFT-VENTRICULAR HYPERTROPHY; MYOCARDIAL FIBROSIS; CARDIAC FIBROBLASTS; ATRIAL-FIBRILLATION; ESSENTIAL-HYPERTENSION; ALDOSTERONE SYSTEM; COLLAGEN; BLOCKADE	Rationale: Recently it has been shown that long-term intensive exercise practice is able to induce myocardial fibrosis in an animal model. Angiotensin II is a profibrotic hormone that could be involved in the cardiac remodeling resulting from endurance exercise. Objective: This study examined the antifibrotic effect of losartan, an angiotensin II type 1 receptor antagonist, in an animal model of heart fibrosis induced by long-term intense exercise. Methods and Results: Male Wistar rats were randomly distributed into 4 experimental groups: Exercise, Exercise plus losartan, Sedentary and Sedentary plus losartan. Exercise groups were conditioned to run vigorously for 16 weeks. Losartan was orally administered daily before each training session (50 mg/kg/day). Time-matched sedentary rats served as controls. After euthanasia, heart hypertrophy was evaluated by histological studies; ventricular collagen deposition was quantified by histological and biochemical studies; and messenger RNA and protein expression of transforming growth factor-beta 1, fibronectin-1, matrix metalloproteinase-2, tissue inhibitor of metalloproteinase-1, procollagen-I and procollagen-III was evaluated in all 4 cardiac chambers. Daily intensive exercise caused hypertrophy in the left ventricular heart wall and originated collagen deposition in the right ventricle. Additionally long-term intensive exercise induced a significant increase in messenger RNA expression and protein synthesis of the major fibrotic markers in both atria and in the right ventricle. Losartan treatment was able to reduce all increases in messenger RNA expression and protein levels caused by exercise, although it could not completely reverse the heart hypertrophy. Conclusions: Losartan treatment prevents the heart fibrosis induced by endurance exercise in training animals.	[Gay-Jordi, Gemma; Serrano-Mollar, Anna] Inst Invest Biomed Barcelona IIBB CSIC, Dept Expt Pathol, Barcelona, Spain; [Gay-Jordi, Gemma; Guash, Eduard; Benito, Begona; Brugada, Josep; Mont, Lluis; Serrano-Mollar, Anna] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Catalonia, Spain; [Guash, Eduard; Benito, Begona; Brugada, Josep; Mont, Lluis] Univ Barcelona, Dept Cardiol, Thorax Inst, Hosp Clin, Barcelona, Catalonia, Spain; [Guash, Eduard; Benito, Begona; Nattel, Stanley] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Guash, Eduard; Benito, Begona; Nattel, Stanley] Univ Montreal, Montreal, PQ, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Universite de Montreal; Universite de Montreal	Serrano-Mollar, A (corresponding author), Inst Invest Biomed Barcelona IIBB CSIC, Dept Expt Pathol, Barcelona, Spain.	anna.serranomollar@iibb.csic.es	Benito, Begoña/D-7401-2014; Mont, Lluís/AAO-9518-2021; Guasch, Eduard/D-1243-2013; Serrano-Mollar, Anna/S-1583-2019	Mont, Lluís/0000-0002-8115-5906; Guasch, Eduard/0000-0003-4238-5319; Nattel, Stanley/0000-0002-5565-3311; BRUGADA, JOSEP/0000-0002-5662-8302; Serrano-Mollar, Anna/0000-0002-4990-8162	Sociedad Espanola de Cardiologia; Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III [PI050210, PS09/02362]; Rio Hortega from the Spanish Health Ministry [CM06/00189, CM08/00201]; Universitats i Recerca [2005SGR00497]	Sociedad Espanola de Cardiologia(Instituto de Salud Carlos III); Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III; Rio Hortega from the Spanish Health Ministry; Universitats i Recerca	This work was supported by grants from the Sociedad Espanola de Cardiologia, Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III (PI050210 and PS09/02362), and Rio Hortega (CM06/00189 and CM08/00201) from the Spanish Health Ministry, Universitats i Recerca (2005SGR00497). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanza AC, 2009, J HUM HYPERTENS, V23, P259, DOI 10.1038/jhh.2008.127; Baldesberger S, 2008, EUR HEART J, V29, P71, DOI 10.1093/eurheartj/ehm555; Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282; Bernstein KE, 2006, HYPERTENSION, V47, P509, DOI 10.1161/01.HYP.0000196266.23639.c6; Biffi A, 2002, J AM COLL CARDIOL, V40, P446, DOI 10.1016/S0735-1097(02)01977-0; CASALE PN, 1986, ANN INTERN MED, V105, P173, DOI 10.7326/0003-4819-105-2-173; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Chen YJ, 2000, J APPL PHYSIOL, V88, P1749, DOI 10.1152/jappl.2000.88.5.1749; D'Amore A, 2005, HYPERTENSION, V46, P1347, DOI 10.1161/01.HYP.0000193504.51489.cf; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; DAHLOF B, 1992, AM J HYPERTENS, V5, P900; Fagard R, 2003, HEART, V89, P1455, DOI 10.1136/heart.89.12.1455; Fleming I, 2006, CURR OPIN NEPHROL HY, V15, P8, DOI 10.1097/01.mnh.0000196146.65330.ea; GANAU A, 1992, J AM COLL CARDIOL, V19, P1550, DOI 10.1016/0735-1097(92)90617-V; Goette A, 2000, J AM COLL CARDIOL, V35, P1669, DOI 10.1016/S0735-1097(00)00611-2; Jiang YN, 2002, HYPERTENS RES, V25, P191, DOI 10.1291/hypres.25.191; Julius S, 2007, AM J CARDIOL, V100, p32J, DOI 10.1016/j.amjcard.2007.05.012; La Gerche Andre, 2007, Heart Lung Circ, V16 Suppl 3, pS102, DOI 10.1016/j.hlc.2007.03.014; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lindsay MM, 2007, BRIT J SPORT MED, V41, P447, DOI 10.1136/bjsm.2006.031534; Liu YH, 1997, J CLIN INVEST, V99, P1926, DOI 10.1172/JCI119360; Marshall RP, 2004, AM J PHYSIOL-LUNG C, V286, pL156, DOI 10.1152/ajplung.00313.2002; Molina-Molina M, 2006, THORAX, V61, P604, DOI 10.1136/thx.2005.051946; Mont L, 2002, EUR HEART J, V23, P477, DOI 10.1053/euhj.2001.2802; Mont L, 2008, EUROPACE, V10, P15, DOI 10.1093/europace/eum263; Norton GR, 1997, CIRCULATION, V96, P1991, DOI 10.1161/01.CIR.96.6.1991; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Querejeta R, 2000, CIRCULATION, V101, P1729; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; SCHIEFFER B, 1994, CIRCULATION, V89, P2273, DOI 10.1161/01.CIR.89.5.2273; Sun Y, 1998, ANN MED, V30, P3; Taniike M, 2008, CIRCULATION, V117, P545, DOI 10.1161/CIRCULATIONAHA.107.710434; Verzola RMM, 2006, BRAZ J MED BIOL RES, V39, P621, DOI 10.1590/S0100-879X2006000500009; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; Weber KT, 1997, CIRCULATION, V96, P4065; Whyte G, 2008, BRIT J SPORT MED, V42, P304, DOI 10.1136/bjsm.2007.038158; Wilson M, 2011, J APPL PHYSIOL, V110, P1622, DOI 10.1152/japplphysiol.01280.2010; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Wu L, 2002, ARTERIOSCL THROM VAS, V22, P49, DOI 10.1161/hq0102.102277; Yoshiji H, 2007, J GASTROEN HEPATOL, V22, pS93, DOI 10.1111/j.1440-1746.2006.04663.x; Zhou GP, 1996, MOL CELL BIOCHEM, V154, P171, DOI 10.1007/BF00226785	42	36	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55427	10.1371/journal.pone.0055427	http://dx.doi.org/10.1371/journal.pone.0055427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383330	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900037
J	Lee, SW; Devlin, JM; Markham, JF; Noormohammadi, AH; Browning, GF; Ficorilli, NP; Hartley, CA; Markham, PF				Lee, Sang-Won; Devlin, Joanne M.; Markham, John F.; Noormohammadi, Amir H.; Browning, Glenn F.; Ficorilli, Nino P.; Hartley, Carol A.; Markham, Philip F.			Phylogenetic and Molecular Epidemiological Studies Reveal Evidence of Multiple Past Recombination Events between Infectious Laryngotracheitis Viruses	PLOS ONE			English	Article							LIVE ATTENUATED VACCINES; GENOME SEQUENCE; HERPESVIRUS-INFECTION; GLYCOPROTEIN-G; DNA; INFERENCE; DYNAMICS; CHICKEN; ORIGIN; FAMILY	In contrast to the RNA viruses, the genome of large DNA viruses such as herpesviruses have been considered to be relatively stable. Intra-specific recombination has been proposed as an important, but underestimated, driving force in herpesvirus evolution. Recently, two distinct field strains of infectious laryngotracheitis virus (ILTV) have been shown to have arisen from independent recombination events between different commercial ILTV vaccines. In this study we sequenced the genomes of additional ILTV strains and also utilized other recently updated complete genome sequences of ILTV to confirm the existence of a number of ILTV recombinants in nature. Multiple recombination events were detected in the unique long and repeat regions of the genome, but not in the unique short region. Most recombinants contained a pair of crossover points between two distinct lineages of ILTV, corresponding to the European origin and the Australian origin vaccine strains of ILTV. These results suggest that there are two distinct genotypic lineages of ILTV and that these commonly recombine in the field.	[Lee, Sang-Won; Devlin, Joanne M.; Browning, Glenn F.; Ficorilli, Nino P.; Hartley, Carol A.; Markham, Philip F.] Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia; [Noormohammadi, Amir H.] Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Werribee, Vic, Australia; [Markham, John F.] Univ Melbourne, Natl ICT Australia NICTA Victoria Res Lab, Dept Elect & Elect Engn, Sch Engn, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; NICTA; University of Melbourne	Lee, SW (corresponding author), Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia.	leesw@unimelb.edu.au	Browning, Glenn Francis/P-4459-2014	Browning, Glenn Francis/0000-0002-0903-2469; Markham, John/0000-0002-5738-3861; NOORMOHAMMADI, AMIR/0000-0003-3459-2692; Devlin, Joanne/0000-0003-0400-9670; Hartley, Carol/0000-0001-6174-7341	Rural Industries Research and Development Corporation, Australia; National ICT, Australia (NICTA); Australian Government; Australian Research Council through the ICT Centre of Excellence program	Rural Industries Research and Development Corporation, Australia; National ICT, Australia (NICTA); Australian Government(Australian GovernmentCGIAR); Australian Research Council through the ICT Centre of Excellence program(Australian Research Council)	The Rural Industries Research and Development Corporation, Australia, funded this study. This work is supported by National ICT, Australia (NICTA). NICTA is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, APVMA GAZETTE, P12; BAGUST TJ, 1986, AVIAN DIS, V30, P179, DOI 10.2307/1590631; Bagust TJ, 2000, REV SCI TECH OIE, V19, P483, DOI 10.20506/rst.19.2.1229; Bagust TJ, 1991, EPO patent, Patent No. [1991,002,053, 1991002053]; BirdLife International, 2012, SPEC FACTSH GALL GAL; Blacker HP, 2011, AUST VET J, V89, P89, DOI 10.1111/j.1751-0813.2010.00665.x; Bowden R, 2004, INFECT GENET EVOL, V4, P115, DOI 10.1016/j.meegid.2004.01.009; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Chandra YG, 2012, VIRUS GENES, V44, P470, DOI 10.1007/s11262-012-0728-7; Cheng TP, 2010, J VIROL, V84, P2623, DOI 10.1128/JVI.02142-09; Devlin JM, 2006, J GEN VIROL, V87, P2839, DOI 10.1099/vir.0.82194-0; Devlin JM, 2011, VACCINE, V29, P5699, DOI 10.1016/j.vaccine.2011.06.002; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2010, GEN V5 0; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; FAHEY KJ, 1983, AVIAN PATHOL, V12, P505, DOI 10.1080/03079458308436195; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; JUKES T H, 1969, P21; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kirkpatrick NC, 2006, AVIAN DIS, V50, P28, DOI 10.1637/7414-072205R.1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lee SW, 2011, VACCINE, V29, P9583, DOI 10.1016/j.vaccine.2011.10.055; Lee SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-197; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; Norberg P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022527; Peters GA, 2006, J VIROL, V80, P9850, DOI 10.1128/JVI.00715-06; PULSFORD M. F., 1956, Australian Veterinary Journal, V32, P138, DOI 10.1111/j.1751-0813.1956.tb05637.x; PULSFORD M. L., 1953, AUSTRALIAN VET JOUR, V29, P8, DOI 10.1111/j.1751-0813.1953.tb05189.x; PURCELL DA, 1974, AUST VET J, V50, P419, DOI 10.1111/j.1751-0813.1974.tb05357.x; ROIZMANN B, 1992, ARCH VIROL, V123, P425, DOI 10.1007/BF01317276; RZHETSKY A, 1993, MOL BIOL EVOL, V10, P1073; Schynts F, 2003, J VIROL, V77, P12535, DOI 10.1128/JVI.77.23.12535-12542.2003; Spatz SJ, 2012, VIRUS GENES, V44, P273, DOI 10.1007/s11262-011-0696-3; Szpara ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002282; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thureen DR, 2006, J VIROL, V80, P7863, DOI 10.1128/JVI.00134-06; Trewin D, 2001, YB AUSTR 2001, P611; van Tuinen M, 2001, MOL BIOL EVOL, V18, P206, DOI 10.1093/oxfordjournals.molbev.a003794; Wilkinson DE, 2003, IUBMB LIFE, V55, P451, DOI 10.1080/15216540310001612237; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811	45	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55121	10.1371/journal.pone.0055121	http://dx.doi.org/10.1371/journal.pone.0055121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383306	Green Published, gold, Green Submitted			2022-12-25	WOS:000314597900013
J	Lombardi, G; Lanteri, P; Porcelli, S; Mauri, C; Colombini, A; Grasso, D; Zani, V; Bonomi, FG; Melegati, G; Banfi, G				Lombardi, Giovanni; Lanteri, Patrizia; Porcelli, Simone; Mauri, Clara; Colombini, Alessandra; Grasso, Dalila; Zani, Viviana; Bonomi, Felice Giulio; Melegati, Gianluca; Banfi, Giuseppe			Hematological Profile and Martial Status in Rugby Players during Whole Body Cryostimulation	PLOS ONE			English	Article							IRON-DEFICIENCY; BLOOD; CRYOTHERAPY; INFLAMMATION	Cold-based therapies are commonly applied to alleviate pain symptoms secondary to inflammatory diseases, but also to treat injuries or overuse, as done in sports rehabilitation. Whole body cryotherapy, a relatively new form of cold therapy, consists of short whole-body exposure to extremely cold air (-110 degrees C to -140 degrees C). Cryostimulation is gaining wider acceptance as an effective part of physical therapy to accelerate muscle recovery in rugby players. The aim of this study was to evaluate the effect of repeated cryostimulation sessions on the hematological profile and martial status markers in professional rugby players. Twenty-seven professional rugby players received 2 daily cryostimulation treatments for 7 consecutive days. Blood samples were collected before and after administration of the cryotherapic protocol and hematological profiles were obtained. No changes in the leukocyte count or composition were seen. There was a decrease in the values for erythrocytes, hematocrit, hemoglobin and mean corpuscular hemoglobin content, and an increase in mean corpuscular volume and red cell distribution width. Platelet count and mean volume remained unchanged. Serum transferrin and ferritin decreased, while soluble transferrin receptor increased. Serum iron and transferrin saturation were unchanged, as was reticulocyte count, whereas the immature reticulocyte fraction decreased substantially. In conclusion, in this sample of professional rugby players, cryostimulation modified the hematological profile, with a reduction in erythrocyte count and hemoglobinization paralleled by a change in martial status markers.	[Lombardi, Giovanni; Lanteri, Patrizia; Colombini, Alessandra; Grasso, Dalila; Banfi, Giuseppe] IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Milan, Italy; [Porcelli, Simone] CNR, Inst Bioimaging & Mol Physiol, Milan, Italy; [Mauri, Clara; Melegati, Gianluca] IRCCS Ist Ortoped Galeazzi, Dept Multifunct Rehabil, Milan, Italy; [Zani, Viviana; Bonomi, Felice Giulio] Poliambulatorio Bongi, Ctr Syst Cryotherapy, Orzinuovi, Italy; [Bonomi, Felice Giulio] Humanitas Gavazzeni, Cardiovasc Dept, OU Cardiol, Bergamo, Italy; [Banfi, Giuseppe] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; Consiglio Nazionale delle Ricerche (CNR); IRCCS Istituto Ortopedico Galeazzi; Istituto Clinico Humanitas Gavazzeni; University of Milan	Lombardi, G (corresponding author), IRCCS Ist Ortoped Galeazzi, Lab Expt Biochem & Mol Biol, Milan, Italy.	giovanni.lombardi@grupposandonato.it	Mauri, Chiara/GXN-0766-2022; Lombardi, Giovanni/I-2414-2012; Colombini, Alessandra/I-2441-2012; Banfi, Giuseppe/K-6585-2015; porcelli, simone/A-1977-2016	Lombardi, Giovanni/0000-0002-8365-985X; Colombini, Alessandra/0000-0002-1800-3424; Mauri, Claudia/0000-0001-9761-2625; Banfi, Giuseppe/0000-0001-9578-5338; porcelli, simone/0000-0002-9494-0858	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work has been funded by Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banffi G, 2008, BRIT J SPORT MED, V42, P858; Banfi G, 2006, CLIN LAB HAEMATOL, V28, P183, DOI 10.1111/j.1365-2257.2006.00771.x; Banfi G, 2003, J SPORT MED PHYS FIT, V43, P223; Banfi G, 2010, SPORTS MED, V40, P509, DOI 10.2165/11531940-000000000-00000; Banfi G, 2009, J SCI MED SPORT, V12, P609, DOI [10.1016/j.jsams.2008.06.004, 10.1016/j.jsams.2008.02.004]; Banfi G, 2009, J THERM BIOL, V34, P55, DOI 10.1016/j.jtherbio.2008.10.003; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Hallberg L, 2003, AM J CLIN NUTR, V78, P1225, DOI 10.1093/ajcn/78.6.1225; HARRISON MH, 1985, PHYSIOL REV, V65, P149, DOI 10.1152/physrev.1985.65.1.149; Hausswirth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027749; Lubkowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046352; Lubkowska A, 2010, INT J OCCUP MED ENV, V23, P367, DOI 10.2478/v10001-010-0037-0; Lubkowska A, 2010, CRYOBIOLOGY, V61, P22, DOI 10.1016/j.cryobiol.2010.03.010; Lubkowska A, 2010, EUR J APPL PHYSIOL, V109, P67, DOI 10.1007/s00421-009-1207-2; Munoz M, 2009, WORLD J GASTROENTERO, V15, P4617, DOI 10.3748/wjg.15.4617; Nachtigall D, 1996, INT J SPORTS MED, V17, P473, DOI 10.1055/s-2007-972881; Peeling P, 2008, EUR J APPL PHYSIOL, V103, P381, DOI 10.1007/s00421-008-0726-6; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Robinson N, 2011, INT J LAB HEMATOL, V33, P146, DOI 10.1111/j.1751-553X.2010.01256.x; Sottas Pierre-Edouard, 2010, Handb Exp Pharmacol, P305, DOI 10.1007/978-3-540-79088-4_14; Suedekum Natalie A, 2005, Curr Sports Med Rep, V4, P199, DOI 10.1097/01.CSMR.0000306207.79809.7f; Tomkins A, 2003, J NUTR, V133, p1649S, DOI 10.1093/jn/133.5.1649S; World Anti-doping Agency, 2011, REQ PASSP OP INT STA; Zoller H, 2004, NUTRITION, V20, P615, DOI 10.1016/j.nut.2004.04.006	24	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55803	10.1371/journal.pone.0055803	http://dx.doi.org/10.1371/journal.pone.0055803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383348	gold, Green Submitted, Green Published			2022-12-25	WOS:000314597900055
J	Dunn, KA; Jiang, WY; Field, C; Bielawski, JP				Dunn, Katherine A.; Jiang, Wenyi; Field, Christopher; Bielawski, Joseph P.			Improving Evolutionary Models for Mitochondrial Protein Data with Site-Class Specific Amino Acid Exchangeability Matrices	PLOS ONE			English	Article							MIXTURE MODEL; PHYLOGENETIC ANALYSES; DIVERGENCE TIMES; DNA-SEQUENCES; CODING GENES; LIKELIHOOD; SUBSTITUTION; REPLACEMENT; RATES	Adequate modeling of mitochondrial sequence evolution is an essential component of mitochondrial phylogenomics (comparative mitogenomics). There is wide recognition within the field that lineage-specific aspects of mitochondrial evolution should be accommodated through lineage-specific amino-acid exchangeability matrices (e.g., mtMam for mammalian data). However, such a matrix must be applied to all sites and this implies that all sites are subject to the same, or largely similar, evolutionary constraints. This assumption is unjustified. Indeed, substantial differences are expected to arise from three-dimensional structures that impose different physiochemical environments on individual amino acid residues. The objectives of this paper are (1) to investigate the extent to which amino acid evolution varies among sites of mitochondrial proteins, and (2) to assess the potential benefits of explicitly modeling such variability. To achieve this, we developed a novel method for partitioning sites based on amino acid physiochemical properties. We apply this method to two datasets derived from complete mitochondrial genomes of mammals and fish, and use maximum likelihood to estimate amino acid exchangeabilities for the different groups of sites. Using this approach we identified large groups of sites evolving under unique physiochemical constraints. Estimates of amino acid exchangeabilities differed significantly among such groups. Moreover, we found that joint estimates of amino acid exchangeabilities do not adequately represent the natural variability in evolutionary processes among sites of mitochondrial proteins. Significant improvements in likelihood are obtained when the new matrices are employed. We also find that maximum likelihood estimates of branch lengths can be strongly impacted. We provide sets of matrices suitable for groups of sites subject to similar physiochemical constraints, and discuss how they might be used to analyze real data. We also discuss how the general approach might be employed to improve a variety of mitogenomic-based research activities.	[Dunn, Katherine A.; Bielawski, Joseph P.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Jiang, Wenyi; Field, Christopher; Bielawski, Joseph P.] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Dunn, KA (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	kathy.dunn@dal.ca		Bielawski, Joseph/0000-0002-1621-1772; Dunn, Katherine/0000-0002-9516-589X	Natural Sciences and Engineering Research Council of Canada (NSERC); Tula Foundation; Centre for Comparative Genomics and Evolutionary Bioinformatics Dalhousie University	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tula Foundation; Centre for Comparative Genomics and Evolutionary Bioinformatics Dalhousie University	Sources of funding that supported this work include: Natural Sciences and Engineering Research Council of Canada (NSERC), Tula Foundation, and Centre for Comparative Genomics and Evolutionary Bioinformatics Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2007, MOL BIOL EVOL, V24, P1; Bay RA, J MOL EVOL UNPUB; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; Chan YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014419; Dang CC, 2012, MOL BIOL EVOL; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; Gardiner Brian G., 1996, P117, DOI 10.1016/B978-012670950-6/50007-2; Garvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024127; Gaston D, 2011, BIOINFORMATICS, V27, P2655, DOI 10.1093/bioinformatics/btr470; Goldman N, 1998, GENETICS, V149, P445; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hess J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022783; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; KIDERA A, 1985, J PROTEIN CHEM, V4, P23, DOI 10.1007/BF01025492; Koshi JM, 1998, PROTEINS, V32, P289, DOI 10.1002/(SICI)1097-0134(19980815)32:3<289::AID-PROT4>3.3.CO;2-3; KOSHI JM, 1995, PROTEIN ENG, V8, P641; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Mathura VS, 2005, BIOINFORMATION, V1, P2, DOI 10.6026/97320630001002; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Paijmans J. L. A., 2012, MOL PHYLOGENET EVOL; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; Patterson C., 1973, Zoological J Linn Soc, V53, P233; Pupko T, 2002, P ROY SOC B-BIOL SCI, V269, P1313, DOI 10.1098/rspb.2002.2025; Quang LS, 2008, BIOINFORMATICS, V24, P2317, DOI 10.1093/bioinformatics/btn445; R Development Core Team, 2007, R LANG ENV STAT COMP; Robinson DM, 2003, MOL BIOL EVOL, V20, P1692, DOI 10.1093/molbev/msg184; Rokas A, 2008, MOL BIOL EVOL, V25, P1943, DOI 10.1093/molbev/msn143; Rota-Stabelli O, 2009, MOL PHYLOGENET EVOL, V52, P268, DOI 10.1016/j.ympev.2009.01.011; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Wang HC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-331; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888	45	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55816	10.1371/journal.pone.0055816	http://dx.doi.org/10.1371/journal.pone.0055816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383286	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600163
J	Muanprasat, C; Wongborisuth, C; Pathomthongtaweechai, N; Satitsri, S; Hongeng, S				Muanprasat, Chatchai; Wongborisuth, Chokdee; Pathomthongtaweechai, Nutthapoom; Satitsri, Saravut; Hongeng, Suradej			Protection against Oxidative Stress in Beta Thalassemia/Hemoglobin E Erythrocytes by Inhibitors of Glutathione Efflux Transporters	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-1; BLOOD-CELLS; CFTR; DISULFIDE; MEMBRANE; EXPORT; PATHOPHYSIOLOGY; MODULATION; NUCLEOTIDE; PLASMA	In beta thalassemia/hemoglobin E (Hb E), abnormally high levels of oxidative stress account for accelerated senescence and increased destruction of erythrocytes. The present study aimed to investigate the role of glutathione efflux transporters, namely cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein 1 (MRP1), in the control of glutathione levels and protection against oxidative challenges in beta thalassemia/Hb E erythrocytes. We found that CFTR protein was expressed in the erythrocytes of beta thalassemia/Hb E patients. Treatments with GlyH-101 (50 mu M), a small molecule CFTR inhibitor, and MK571 (50 mu M), an MRP1 inhibitor, reduced H2O2-induced free radical generation in the erythrocytes by similar to 80% and 50%, respectively. Furthermore, combined treatment with GlyH-101 and MK571 completely abolished the induction of reactive oxygen radicals. Increased oxidative stress in the erythrocytes following H2O2 challenges was accompanied by a decrease in intracellular level of reduced glutathione (GSH), which was prevented by treatments with GlyH-101 and MK571. CMFDA-based assays revealed that GlyH-101 and MK571 reduced H2O2-induced glutathione efflux from the erythrocytes by 87% and 66%, respectively. Interestingly, H2O2-induced osmotic tolerance of erythrocytes, a sign of erythrocyte aging, was ameliorated by treatment with GlyH-101. Our study indicates that oxidative stress induces glutathione efflux via CFTR and MRP1 in beta thalassemia/Hb E erythrocytes. Pharmacological inhibition of glutathione efflux represents a potential therapy to delay aging and premature destruction of erythrocytes in beta thalassemia/Hb E.	[Muanprasat, Chatchai; Pathomthongtaweechai, Nutthapoom; Satitsri, Saravut] Mahidol Univ, Fac Sci, Dept Physiol, Res Ctr Transport Prot Med Innovat, Bangkok 10400, Thailand; [Wongborisuth, Chokdee] Mahidol Univ, Ramathibodi Hosp, Fac Med, Res Ctr, Bangkok 10400, Thailand; [Hongeng, Suradej] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand	Mahidol University; Mahidol University; Mahidol University	Muanprasat, C (corresponding author), Mahidol Univ, Fac Sci, Dept Physiol, Res Ctr Transport Prot Med Innovat, Bangkok 10400, Thailand.	chatchai.mua@mahidol.ac.th; suradej.hon@mahidol.ac.th	Satitsri, Saravut/I-6616-2013	Satitsri, Saravut/0000-0002-1555-4917; Hongeng, Suradej/0000-0002-7376-9393; Pathomthongtaweechai, Nutthapoom/0000-0003-4641-5829	Mahidol University research grant; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Thailand Research Fund [MRG5380125]; Mahidol University	Mahidol University research grant; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University	This work was supported by Mahidol University research grant (CM and SH), the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative (CM) and an MRG5380125 grant from the Thailand Research Fund, the Office of the Higher Education Commission and Mahidol University (CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer J, 2004, CYTOM PART A, V60A, P73, DOI 10.1002/cyto.a.20017; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Barrand MA, 2012, BIOCHEM J, V448, P389, DOI 10.1042/BJ20121050; Cakir Y, 2013, BLOOD CELL MOL DIS, V50, P1, DOI 10.1016/j.bcmd.2012.07.001; Day BJ, 2004, INFECT IMMUN, V72, P2045, DOI 10.1128/IAI.72.4.2045-2051.2004; Freikman I, 2011, J MEMBRANE BIOL, V240, P73, DOI 10.1007/s00232-011-9345-y; Fucharoen S, 2000, CURR OPIN HEMATOL, V7, P106, DOI 10.1097/00062752-200003000-00006; Fucharoen Suthat, 2011, Indian J Med Res, V134, P498; HARRIS RR, 1995, INT J IMMUNOPHARMACO, V17, P147, DOI 10.1016/0192-0561(94)00093-4; Hirrlinger J, 2001, J NEUROCHEM, V76, P627, DOI 10.1046/j.1471-4159.2001.00101.x; Kalpravidh RW, 2010, CLIN BIOCHEM, V43, P424, DOI 10.1016/j.clinbiochem.2009.10.057; Kariya C, 2007, AM J PHYSIOL-LUNG C, V292, pL1590, DOI 10.1152/ajplung.00365.2006; Kock K, 2007, CLIN PHARMACOKINET, V46, P449; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; l'Hoste S, 2010, AM J PHYSIOL-RENAL, V298, pF435, DOI 10.1152/ajprenal.00286.2009; L'hoste S, 2009, FREE RADICAL BIO MED, V46, P1017, DOI 10.1016/j.freeradbiomed.2008.12.009; Lange T, 2006, MOL MEMBR BIOL, V23, P317, DOI 10.1080/09687860600738304; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Mueller CFH, 2005, CIRC RES, V97, P637, DOI 10.1161/01.RES.0000183734.21112.b7; Origa Raffaella, 2011, Pediatr Endocrinol Rev, V8 Suppl 2, P263; Pulaski L, 1996, EUR J BIOCHEM, V241, P644, DOI 10.1111/j.1432-1033.1996.00644.x; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; RUND D, 1995, CRIT REV ONCOL HEMAT, V20, P237, DOI 10.1016/1040-8428(95)00162-Z; Rund D, 2001, SEMIN HEMATOL, V38, P343, DOI 10.1053/shem.2001.27579; SCOTT MD, 1993, J CLIN INVEST, V91, P1706, DOI 10.1172/JCI116380; SHINAR E, 1990, SEMIN HEMATOL, V27, P70; Tesoriere L, 2001, FREE RADICAL RES, V34, P529, DOI 10.1080/10715760100300461; Weiss J, 2007, DRUG METAB DISPOS, V35, P340, DOI 10.1124/dmd.106.012765; Yildiz D, 2012, BIOL TRACE ELEM RES, V150, P451, DOI 10.1007/s12011-012-9491-9	31	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55685	10.1371/journal.pone.0055685	http://dx.doi.org/10.1371/journal.pone.0055685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383265	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600146
J	Shaw, JA; Graham, TA; Stebbing, J				Shaw, J. A.; Graham, T. A.; Stebbing, J.			Genomic instability in pre-neoplastic colonic lesions	ONCOGENE			English	Editorial Material							NONPOLYPOSIS COLORECTAL-CANCER; GENETIC INSTABILITY; HMLH1 PROMOTER; HYPERMETHYLATION; PROGRESSION; HISTORY	Genomic instability is a characteristic of most cancers and it is argued that genomic instability is a driving force for tumorigenesis. Data herein demonstrate that genomic instability, as evidenced by microsatellite instability (MSI) and promoter methylation of DNA mismatch repair genes, is common in individual glands of pre-malignant colorectal lesions and raises interesting questions about the role of MSI in the development of colorectal carcinoma.	[Shaw, J. A.] Leicester Royal Infirm, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Graham, T. A.] Univ Calif San Francisco, Dept Surg, Helen Diller Family Comprehens Canc Ctr, Ctr Evolut & Canc, San Francisco, CA USA; [Stebbing, J.] Imperial Coll Sch Med, Div Canc, London W12 0NN, England	University of Leicester; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Imperial College London	Stebbing, J (corresponding author), Imperial Coll Sch Med, Div Canc, Hammersmith Hosp Campus, London W12 0NN, England.	j.stebbing@imperial.ac.uk		Stebbing, Justin/0000-0002-1117-6947; Shaw, Jacqui/0000-0003-4227-503X	Cancer Research UK [14549] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053] Funding Source: researchfish; Cancer Research UK [13462] Funding Source: Medline; Department of Health [NIHR-RP-011-053] Funding Source: Medline	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Department of Health		Beggs AD, 2013, ONCOGENE, V32, P5333, DOI 10.1038/onc.2012.584; Bodmer W, 2008, CANCER RES, V68, P3558, DOI 10.1158/0008-5472.CAN-07-6544; Cunningham JM, 1998, CANCER RES, V58, P3455; Datta RS, 2013, EVOL APPL, V6, P20, DOI 10.1111/eva.12024; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Kane MF, 1997, CANCER RES, V57, P808; KIM HG, 1994, AM J PATHOL, V145, P148; Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661; LOTHE RA, 1993, CANCER RES, V53, P5849; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; Lynch HT, 1999, J MED GENET, V36, P801; Maley CC, 2004, CANCER RES, V64, P7629, DOI 10.1158/0008-5472.CAN-04-1738; Nakagawa H, 2001, CANCER RES, V61, P6991; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193	14	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 14	2013	32	46					5331	5332		10.1038/onc.2013.21	http://dx.doi.org/10.1038/onc.2013.21			2	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	251IU	23396367	Green Published			2022-12-25	WOS:000326922400002
J	Copits, BA; Swanson, GT				Copits, Bryan A.; Swanson, Geoffrey T.			Kainate Receptor Post-translational Modifications Differentially Regulate Association with 4.1N to Control Activity-dependent Receptor Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE PROTEIN 4.1; AMPA RECEPTOR; GLUTAMATE RECEPTORS; FUNCTIONAL-CHARACTERIZATION; SURFACE EXPRESSION; TRAFFICKING; PHOSPHORYLATION; SUMOYLATION; DOMAIN; PALMITOYLATION	Kainate receptors exhibit a highly compartmentalized distribution within the brain; however, the molecular and cellular mechanisms that coordinate their expression at neuronal sites of action are poorly characterized. Here we report that the GluK1 and GluK2 kainate receptor subunits interact with the spectrin-actin binding scaffolding protein 4.1N through a membrane-proximal domain in the C-terminal tail. We found that this interaction is important for the forward trafficking of GluK2a receptors, their distribution in the neuronal plasma membrane, and regulation of receptor endocytosis. The association between GluK2a receptors and 4.1N was regulated by both palmitoylation and protein kinase C (PKC) phosphorylation of the receptor subunit. Palmitoylation of the GluK2a subunit promoted 4.1N association, and palmitoylation-deficient receptors exhibited reduced neuronal surface expression and compromised endocytosis. Conversely, PKC activation decreased 4.1N interaction with GluK2/3-containing kainate receptors in acute brain slices, an effect that was reversed after inhibition of PKC. Our data and previous studies therefore demonstrate that these two post-translational modifications have opposing effects on 4.1N association with GluK2 kainate and GluA1 AMPA receptors. The convergence of the signaling pathways regulating 4.1N protein association could thus result in the selective removal of AMPA receptors from the plasma membrane while simultaneously promoting the insertion and stabilization of kainate receptors, which may be important for tuning neuronal excitability and synaptic plasticity.	[Copits, Bryan A.; Swanson, Geoffrey T.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Swanson, GT (corresponding author), Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA.	gtswanson@northwestern.edu			National Institutes of Health, NINDS [R01 NS071952]; National Institutes of Health, NCI [CCSG P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071952] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01 NS071952 (to G. T. S.).; We thank Dr. William Marszalec (Northwestern University Feinberg School of Medicine, Chicago, IL) for preparation of the cultured hippocampal neurons used in these studies. Imaging was performed at the Northwestern University Cell Imaging Facility and was partially subsidized by National Institutes of Health, NCI, Grant CCSG P30 CA060553 (to the Robert H. Lurie Comprehensive Cancer Center).	An XL, 2006, BIOCHEMISTRY-US, V45, P5725, DOI 10.1021/bi060015v; An XL, 2001, J BIOL CHEM, V276, P35778, DOI 10.1074/jbc.M101364200; Baines AJ, 2009, BLOOD CELL MOL DIS, V42, P211, DOI 10.1016/j.bcmd.2009.01.016; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; Binda AV, 2002, MOL PHARMACOL, V62, P507, DOI 10.1124/mol.62.3.507; Buttermore ED, 2011, J NEUROSCI, V31, P8013, DOI 10.1523/JNEUROSCI.1015-11.2011; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Coleman SK, 2003, J NEUROSCI, V23, P798; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Copits BA, 2012, NAT REV NEUROSCI, V13, P675, DOI 10.1038/nrn3335; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Horresh I, 2010, J NEUROSCI, V30, P2480, DOI 10.1523/JNEUROSCI.5225-09.2010; Huyghe D, 2011, J NEUROSCI, V31, P11645, DOI 10.1523/JNEUROSCI.2206-11.2011; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Konopacki FA, 2011, P NATL ACAD SCI USA, V108, P19772, DOI 10.1073/pnas.1111575108; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Mondin M, 2010, J BIOL CHEM, V285, P40060, DOI 10.1074/jbc.M110.140442; Nasu-Nishimura Y, 2010, J BIOL CHEM, V285, P2847, DOI 10.1074/jbc.M109.081141; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Nunomura W, 2000, J BIOL CHEM, V275, P6360, DOI 10.1074/jbc.275.9.6360; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Parra M, 2000, J BIOL CHEM, V275, P3247, DOI 10.1074/jbc.275.5.3247; Parra M, 1998, GENOMICS, V49, P298, DOI 10.1006/geno.1998.5265; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Pinheiro PS, 2013, CEREB CORTEX, V23, P323, DOI 10.1093/cercor/bhs022; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rivera R, 2007, EMBO J, V26, P4359, DOI 10.1038/sj.emboj.7601865; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vivithanaporn P, 2007, J NEUROSCI, V27, P10423, DOI 10.1523/JNEUROSCI.2674-07.2007; Wozny C, 2009, J CELL SCI, V122, P735, DOI 10.1242/jcs.037382; Yan S, 2004, J NEUROSCI, V24, P679, DOI 10.1523/JNEUROSCI.4985-03.2004	55	26	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8952	8965		10.1074/jbc.M112.440719	http://dx.doi.org/10.1074/jbc.M112.440719			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23400781	Green Published, hybrid			2022-12-25	WOS:000316862200015
J	Megyeri, M; Harmat, V; Major, B; Vegh, A; Balczer, J; Heja, D; Szilagyi, K; Datz, D; Pal, G; Zavodszky, P; Gal, P; Dobo, J				Megyeri, Marton; Harmat, Veronika; Major, Balazs; Vegh, Adam; Balczer, Julia; Heja, David; Szilagyi, Katalin; Datz, Daniel; Pal, Gabor; Zavodszky, Peter; Gal, Peter; Dobo, Jozsef			Quantitative Characterization of the Activation Steps of Mannan-binding Lectin (MBL)-associated Serine Proteases (MASPs) Points to the Central Role of MASP-1 in the Initiation of the Complement Lectin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATTERN-RECOGNITION MOLECULES; C1 COMPLEX; CATALYTIC REGION; STRUCTURAL INSIGHT; FACTOR-XII; AUTOACTIVATION; ZYMOGEN; PROTEIN; MECHANISM; REVEALS	Mannan-binding lectin (MBL)-associated serine proteases, MASP-1 and MASP-2, have been thought to autoactivate when MBL/ficolin.MASP complexes bind to pathogens triggering the complement lectin pathway. Autoactivation of MASPs occurs in two steps: 1) zymogen autoactivation, when one proenzyme cleaves another proenzyme molecule of the same protease, and 2) autocatalytic activation, when the activated protease cleaves its own zymogen. Using recombinant catalytic fragments, we demonstrated that a stable proenzyme MASP-1 variant (R448Q) cleaved the inactive, catalytic site Ser-to-Ala variant (S646A). The autoactivation steps of MASP-1 were separately quantified using these mutants and the wild type enzyme. Analogous mutants were made for MASP-2, and rate constants of the autoactivation steps as well as the possible cross-activation steps between MASP-1 and MASP-2 were determined. Based on the rate constants, a kinetic model of lectin pathway activation was outlined. The zymogen autoactivation rate of MASP-1 is similar to 3000-fold higher, and the autocatalytic activation of MASP-1 is about 140-fold faster than those of MASP-2. Moreover, both activated and proenzyme MASP-1 can effectively cleave proenzyme MASP-2. MASP-3, which does not autoactivate, is also cleaved by MASP-1 quite efficiently. The structure of the catalytic region of proenzyme MASP-1 R448Q was solved at 2.5A. Proenzyme MASP-1 R448Q readily cleaves synthetic substrates, and it is inhibited by a specific canonical inhibitor developed against active MASP-1, indicating that zymogen MASP-1 fluctuates between an inactive and an active-like conformation. The determined structure provides a feasible explanation for this phenomenon. In summary, autoactivation of MASP-1 is crucial for the activation of MBL/ficolin.MASP complexes, and in the proenzymic phase zymogen MASP-1 controls the process.	[Megyeri, Marton; Major, Balazs; Balczer, Julia; Szilagyi, Katalin; Datz, Daniel; Zavodszky, Peter; Gal, Peter; Dobo, Jozsef] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1113 Budapest, Hungary; [Harmat, Veronika; Vegh, Adam] Eotvos Lorand Univ, Hungarian Acad Sci, Inst Chem, H-1117 Budapest, Hungary; [Harmat, Veronika; Vegh, Adam] Eotvos Lorand Univ, Hungarian Acad Sci, Prot Modeling Res Grp, H-1117 Budapest, Hungary; [Heja, David; Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Datz, Daniel] Pazmany Peter Catholic Univ, Fac Informat Technol, H-1083 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University	Dobo, J (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, 29 Karolina St, H-1113 Budapest, Hungary.	dobo@enzim.hu	Pal, Gabor/A-6244-2009; Gal, Peter/B-5886-2011; Harmat, Veronika/B-8033-2016; Dobo, Jozsef/C-7331-2014	Pal, Gabor/0000-0001-7868-7971; Harmat, Veronika/0000-0002-1866-9904; Dobo, Jozsef/0000-0001-9187-8502	Hungarian Scientific Research Fund [NK77978, NK100834, NK101072, NK100769, NK81950]; National Development Agency Grant [KMOP 4.2.1.B/10-2011]; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency Grant; Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by Hungarian Scientific Research Fund Grants NK77978, NK100834, NK101072, NK100769, and NK81950; National Development Agency Grant KMOP 4.2.1.B/10-2011; and the Janos Bolyai Research Fellowship of the Hungarian Academy of Sciences. A preliminary version of this work was presented at the 13th European Meeting on Complement in Human Disease, August 22, 2011, Leiden, Netherlands.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Degn SE, 2010, J IMMUNOL METHODS, V361, P37, DOI 10.1016/j.jim.2010.07.006; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dobo J, 1999, J IMMUNOL, V162, P1108; Dobo J, 2008, ACTA CRYSTALLOGR F, V64, P781, DOI 10.1107/S174430910802294X; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; Gal P, 2007, IMMUNOBIOLOGY, V212, P267, DOI 10.1016/j.imbio.2006.11.002; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; Hess K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035690; Iwaki D, 2011, J IMMUNOL, V187, P3751, DOI 10.4049/jimmunol.1100280; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kardos J, 2008, MOL IMMUNOL, V45, P1752, DOI 10.1016/j.molimm.2007.09.031; KAY J, 1971, J BIOL CHEM, V246, P6661; Kereszturi E, 2009, J BIOL CHEM, V284, P33392, DOI 10.1074/jbc.M109.056812; Khan AR, 1998, PROTEIN SCI, V7, P815; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Kuzmic P, 2000, ANAL BIOCHEM, V281, P62, DOI 10.1006/abio.2000.4501; LACROIX MB, 1989, BIOCHEM J, V257, P885, DOI 10.1042/bj2570885; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lorincz Z, 2000, J IMMUNOL, V165, P2048, DOI 10.4049/jimmunol.165.4.2048; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; NEUENSCHWANDER PF, 1993, J BIOL CHEM, V268, P21489; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6275, DOI 10.1021/bi0100992; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; SILVERBERG M, 1982, BLOOD, V60, P64; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; THIELENS NM, 1994, BIOCHEM J, V301, P509, DOI 10.1042/bj3010509; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001; Zundel S, 2004, J IMMUNOL, V172, P4342, DOI 10.4049/jimmunol.172.7.4342	64	49	54	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8922	8934		10.1074/jbc.M112.446500	http://dx.doi.org/10.1074/jbc.M112.446500			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386610	hybrid, Green Published			2022-12-25	WOS:000316862200013
J	Imbalzano, KM; Cohet, N; Wu, Q; Underwood, JM; Imbalzano, AN; Nickerson, JA				Imbalzano, Karen M.; Cohet, Nathalie; Wu, Qiong; Underwood, Jean M.; Imbalzano, Anthony N.; Nickerson, Jeffrey A.			Nuclear Shape Changes Are Induced by Knockdown of the SWI/SNF ATPase BRG1 and Are Independent of Cytoskeletal Connections	PLOS ONE			English	Article							DISRUPT MICROFILAMENT ORGANIZATION; CHROMATIN REMODELING COMPLEXES; INTERMEDIATE-FILAMENT NETWORKS; ACTIN-BINDING PROTEIN; SWI-SNF COMPLEX; BREAST-CARCINOMA; MEMBRANE PROTEIN; DYNAMIC ASPECTS; CULTURED-CELLS; CANCER-CELLS	Changes in nuclear morphology occur during normal development and have been observed during the progression of several diseases. The shape of a nucleus is governed by the balance of forces exerted by nuclear-cytoskeletal contacts and internal forces created by the structure of the chromatin and nuclear envelope. However, factors that regulate the balance of these forces and determine nuclear shape are poorly understood. The SWI/SNF chromatin remodeling enzyme ATPase, BRG1, has been shown to contribute to the regulation of overall cell size and shape. Here we document that immortalized mammary epithelial cells show BRG1-dependent nuclear shape changes. Specifically, knockdown of BRG1 induced grooves in the nuclear periphery that could be documented by cytological and ultrastructural methods. To test the hypothesis that the observed changes in nuclear morphology resulted from altered tension exerted by the cytoskeleton, we disrupted the major cytoskeletal networks and quantified the frequency of BRG1-dependent changes in nuclear morphology. The results demonstrated that disruption of cytoskeletal networks did not change the frequency of BRG1-induced nuclear shape changes. These findings suggest that BRG1 mediates control of nuclear shape by internal nuclear mechanisms that likely control chromatin dynamics.	[Imbalzano, Karen M.; Cohet, Nathalie; Wu, Qiong; Underwood, Jean M.; Imbalzano, Anthony N.; Nickerson, Jeffrey A.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Imbalzano, AN (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA.	Anthony.imbalzano@umassmed.edu; Jeffrey.nickerson@umassmed.edu			National Cancer Institute [P01 CA82834]; National Institute of Diabetes and Digestive and Kidney Diseases [5P30 DK32520]; National Institute of Biomedical Imaging and Bioengineering [R01 EB014869]; NATIONAL CANCER INSTITUTE [P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Cancer Institute grant P01 CA82834 (http://cancer.gov). A.N.I. is a member of the University of Massachusetts Diabetes Endocrinology Research Center, which is supported by the National Institute of Diabetes and Digestive and Kidney Diseases Grant 5P30 DK32520 (http://www.niddk.nih.gov). J.A.N. acknowledges additional support from the National Institute of Biomedical Imaging and Bioengineering grant R01 EB014869 (http://www.nibib.nih.gov). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asp P, 2002, J CELL SCI, V115, P2735; Bank EM, 2011, BIOCHEM SOC T, V39, P1705, DOI 10.1042/BST20110603; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Beale LS, 1860, ARCH MED LOND, V2, P44; Bourgo RJ, 2009, MOL BIOL CELL, V20, P3192, DOI 10.1091/mbc.E08-12-1224; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; CARMOFONSECA M, 1988, EUR J CELL BIOL, V45, P282; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cohet N, 2010, J CELL PHYSIOL, V223, P667, DOI 10.1002/jcp.22072; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; DJABALI K, 1991, CELL, V64, P109, DOI 10.1016/0092-8674(91)90213-I; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Feoli F, 2008, ACTA CYTOL, V52, P145, DOI 10.1159/000325472; FEY EG, 1984, J CELL BIOL, V99, pS203, DOI 10.1083/jcb.99.1.203s; FRANKE WW, 1971, PROTOPLASMA, V73, P263, DOI 10.1007/BF01275600; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Giardina C, 1996, ANAL QUANT CYTOL, V18, P374; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Goulbourne CN, 2011, J CELL SCI, V124, P4253, DOI 10.1242/jcs.091009; Haroske G, 1996, HISTOCHEM CELL BIOL, V105, P479, DOI 10.1007/BF01457662; Heeboll S, 2008, HISTOL HISTOPATHOL, V23, P1069, DOI 10.14670/HH-23.1069; Hill DA, 2004, J CELL SCI, V117, P5847, DOI 10.1242/jcs.01502; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Javed A, 2005, P NATL ACAD SCI USA, V102, P1454, DOI 10.1073/pnas.0409121102; JONES JCR, 1982, CELL MOTIL CYTOSKEL, V2, P197, DOI 10.1002/cm.970020302; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kim SI, 2009, P NATL ACAD SCI USA, V106, P2259, DOI 10.1073/pnas.0806420106; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Liu R, 2011, CHEMBIOCHEM, V12, P1813, DOI 10.1002/cbic.201100284; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; MARSHALL PN, 1983, MICROSC ACTA, V87, P233; Martin S, 2001, TELECONNECT, V19, P10; Mazumder A, 2010, METHOD CELL BIOL, V98, P221, DOI 10.1016/S0091-679X(10)98010-2; Mazumder A, 2010, J R SOC INTERFACE, V7, pS321, DOI 10.1098/rsif.2010.0039.focus; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Paesmans M, 2008, REV MAL RESPIR, V25, p3S99; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Saladi SV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-280; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Serber DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031346; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; Shimi T, 2010, COLD SH Q B, V75, P525, DOI 10.1101/sqb.2010.75.045; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Strnad P, 2002, J CELL SCI, V115, P4133, DOI 10.1242/jcs.00096; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; VIKSTROM KL, 1989, P NATL ACAD SCI USA, V86, P549, DOI 10.1073/pnas.86.2.549; Wagner S, 2003, P NATL ACAD SCI USA, V100, P3269, DOI 10.1073/pnas.0438055100; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Watanabe T, 2011, BRIT J CANCER, V104, P146, DOI 10.1038/sj.bjc.6606018; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Zhen YY, 2002, J CELL SCI, V115, P3207; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	78	36	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55628	10.1371/journal.pone.0055628	http://dx.doi.org/10.1371/journal.pone.0055628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405182	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400127
J	Su, CY; Lin, HC; Cheng, HC; Yen, AMF; Chen, YH; Kao, S				Su, Chen-Yi; Lin, Herng-Ching; Cheng, Hsin-Chung; Yen, Amy Ming-Fang; Chen, Yi-Hua; Kao, Senyeong			Pregnancy Outcomes of Anti-Hypertensives for Women with Chronic Hypertension: A Population-Based Study	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; ANTIHYPERTENSIVE DRUGS; FETAL-GROWTH; PRETERM DELIVERY; SOUTH-AUSTRALIA; BIRTH-WEIGHT; AGE; ATENOLOL; RISK; MALFORMATIONS	Background: The impact of anti-hypertensive treatment on fetus was unclear, and hence, remains controversial. We set out in this study to estimate the prevalence of adverse pregnancy outcomes, including low birth weight, preterm delivery and small for gestational age amongst women with chronic hypertension, and to determine whether the use of antihypertensive drugs increases the risk of such adverse pregnancy outcomes. Methodology/Principal Findings: A total of 2,727 hypertension mothers and 8,181 matched controls were identified from the population-based cohort. These hypertension women were divided into seven sub-groups according to different types of prescribed anti-hypertensive drugs. Multivariable logistic regressions were conducted to estimate the risk of low birth weight, preterm birth and small for gestational age. Increased risk of low birth weight (OR = 2.29, 95% CI = 1.95-2.68), preterm birth (OR = 2.18, 95% CI = 1.89-2.52) and small for gestational age (OR = 1.62, 95% CI = 1.45-1.81) were all discernible within the hypertension group after adjusting for potential confounding factors. The increased ORs were found to differ with different types of anti-hypertensive drugs. Women who received vasodilators were associated with the highest risk of low birth weight (OR = 2.96, 95% CI = 2.06-4.26), preterm birth (OR = 2.92 95% CI = 2.06-4.15) and small for gestational age (OR = 2.12, 95% CI = 1.60-2.82). Conclusions/Significance: This finding is important for practitioners, because it indicates the need for caution while considering the administration of anti-hypertensive drugs to pregnant women. These observations require confirmation in further studies that can better adjust for the severity of the underlying HTN.	[Su, Chen-Yi; Kao, Senyeong] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Cheng, Hsin-Chung] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan; [Cheng, Hsin-Chung] Taipei Med Univ Hosp, Dept Dent, Taipei, Taiwan; [Yen, Amy Ming-Fang] Taipei Med Univ, Sch Oral Hyg, Coll Oral Med, Taipei, Taiwan; [Chen, Yi-Hua] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Kao, Senyeong] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; National Defense Medical Center	Kao, S (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	kao@mail.ndmctsgh.edu.tw		Kao, Senyeong/0000-0002-0209-240X				Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; Afifi Y, 2003, CURR PHARM DESIGN, V9, P1745, DOI 10.2174/1381612033454487; Allen Victoria M, 2004, BMC Pregnancy Childbirth, V4, P17, DOI 10.1186/1471-2393-4-17; ANANTH CV, 1995, EPIDEMIOLOGY, V6, P391, DOI 10.1097/00001648-199507000-00011; [Anonymous], 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002863; Bell R, 2012, DIABETOLOGIA, V55, P936, DOI 10.1007/s00125-012-2455-y; BUTTERS L, 1990, BMJ-BRIT MED J, V301, P587, DOI 10.1136/bmj.301.6752.587; Catov JM, 2008, OBSTET GYNECOL, V112, P290, DOI 10.1097/AOG.0b013e31817f589b; Chang CJ, 2000, DIABETES RES CLIN PR, V50, pS49, DOI 10.1016/S0168-8227(00)00179-0; Chen YH, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.025; CONSTANTINE G, 1987, BRIT J OBSTET GYNAEC, V94, P1136, DOI 10.1111/j.1471-0528.1987.tb02312.x; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Easterling TR, 2001, OBSTET GYNECOL, V98, P427, DOI 10.1016/S0029-7844(01)01477-6; FENAKEL K, 1991, OBSTET GYNECOL, V77, P331; Haelterman E, 1997, AM J EPIDEMIOL, V145, P689, DOI 10.1093/aje/145.8.689; HANSSENS M, 1991, OBSTET GYNECOL, V78, P128; Heard AR, 2004, AUST NZ J OBSTET GYN, V44, P404, DOI 10.1111/j.1479-828X.2004.00267.x; Hsieh T T, 1991, J Formos Med Assoc, V90, P382; JANNET D, 1994, OBSTET GYNECOL, V84, P354; Lee HC, 2010, J AFFECT DISORDERS, V121, P100, DOI 10.1016/j.jad.2009.05.019; Lennestal R, 2009, EUR J CLIN PHARMACOL, V65, P615, DOI 10.1007/s00228-009-0620-0; Li DK, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5931; Lin HC, 2010, BJOG-INT J OBSTET GY, V117, P585, DOI 10.1111/j.1471-0528.2010.02504.x; Ludford I, 2012, AUST NZ J OBSTET GYN, V52, P235, DOI 10.1111/j.1479-828X.2012.01442.x; Lydakis C, 1999, AM J HYPERTENS, V12, P541, DOI 10.1016/S0895-7061(99)00031-X; Magee LA, 1999, BMJ-BRIT MED J, V318, P1332, DOI 10.1136/bmj.318.7194.1332; Olesen C, 2001, BRIT J CLIN PHARMACO, V51, P153, DOI 10.1111/j.1365-2125.2001.01310.x; Parazzini F, 1998, BRIT J OBSTET GYNAEC, V105, P718; PLOUIN PF, 1990, BRIT J OBSTET GYNAEC, V97, P134, DOI 10.1111/j.1471-0528.1990.tb01738.x; Podymow T, 2008, HYPERTENSION, V51, P960, DOI 10.1161/HYPERTENSIONAHA.106.075895; Ray Joel G, 2001, BMC Pregnancy Childbirth, V1, P6, DOI 10.1186/1471-2393-1-6; REDMAN CWG, 1976, LANCET, V2, P753; RUBIN PC, 1983, LANCET, V1, P431; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P960, DOI 10.1016/0002-9378(90)91297-P; Sibai BM, 2000, AM J OBSTET GYNECOL, V183, P1520, DOI 10.1067/mob.2000.107621; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; WEITZ C, 1987, INT J GYNECOL OBSTET, V25, P35, DOI 10.1016/0020-7292(87)90181-0	37	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53844	10.1371/journal.pone.0053844	http://dx.doi.org/10.1371/journal.pone.0053844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405075	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400019
J	Guidi, V; Lehner, A; Luthy, P; Tonolla, M				Guidi, Valeria; Lehner, Angelika; Luethy, Peter; Tonolla, Mauro			Dynamics of Bacillus thuringiensis var. israelensis and Lysinibacillus sphaericus Spores in Urban Catch Basins after Simultaneous Application against Mosquito Larvae	PLOS ONE			English	Article							IN-FIELD POPULATIONS; CULEX-QUINQUEFASCIATUS; SUBSP ISRAELENSIS; HIGH-LEVEL; POLLUTED WATER; SP NOV.; PERSISTENCE; RESISTANCE; STRAINS; TOXIN	Bacillus thuringiensis var. israelensis (Bti) and Lysinibacillus sphaericus (Lsph) are extensively used in mosquito control programs. These biocides are the active ingredients of a commercial larvicide. Quantitative data on the fate of both Bti and Lsph applied together for the control of mosquitoes in urban drainage structures such as catch basins are lacking. We evaluated the dynamics and persistence of Bti and Lsph spores released through their concomitant application in urban catch basins in southern Switzerland. Detection and quantification of spores over time in water and sludge samples from catch basins were carried out using quantitative real-time PCR targeting both cry4A and cry4B toxin genes for Bti and the binA gene for Lsph. After treatment, Bti and Lsph spores attained concentrations of 3.76 (+/- 0.08) and 4.13 (+/- 0.09) log ml(-1) in water, then decreased progressively over time, reaching baseline values. For both Bti and Lsph, spore levels in the order of 10(5) g(-1) were observed in the bottom sludge two days after the treatment and remained constant for the whole test period (275 days). Indigenous Lsph strains were isolated from previously untreated catch basins. A selection of those was genotyped using pulsed field gel electrophoresis of SmaI-digested chromosomal DNA, revealing that a subset of isolates were members of the clonal population of strain 2362. No safety issues related to the use of this biopesticide in the environment have been observed during this study, because no significant increase in the number of spores was seen during the long observation period. The isolation of native Lysinibacillus sphaericus strains belonging to the same clonal population as strain 2362 from catch basins never treated with Lsph-based products indicates that the use of a combination of Bti and Lsph for the control of mosquitoes does not introduce non-indigenous microorganisms in this area.	[Guidi, Valeria; Tonolla, Mauro] Univ Geneva, Microbiol Unit, Microbial Ecol Grp, Dept Plant Biol, Geneva, Switzerland; [Guidi, Valeria; Tonolla, Mauro] Inst Microbiol, Bellinzona, Switzerland; [Lehner, Angelika] Univ Zurich, Vetsuisse Fac, Inst Food Safety & Hyg, Zurich, Switzerland; [Luethy, Peter] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland	University of Geneva; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tonolla, M (corresponding author), Univ Geneva, Microbiol Unit, Microbial Ecol Grp, Dept Plant Biol, Geneva, Switzerland.	mauro.tonolla@ti.ch	Lehner, Angelika/B-2363-2018	Lehner, Angelika/0000-0003-1863-5090; Tonolla, Mauro/0000-0002-8861-7763; Guidi, Valeria/0000-0001-5553-3136				Ahmed I, 2007, INT J SYST EVOL MICR, V57, P1117, DOI 10.1099/ijs.0.63867-0; Ali Arshad, 2000, Medical Entomology and Zoology, V51, P257; Ammons D, 2002, J INVERTEBR PATHOL, V79, P203, DOI 10.1016/S0022-2011(02)00018-6; Anderson JF, 2011, J AM MOSQUITO CONTR, V27, P45, DOI 10.2987/10-6079.1; Benagli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016424; BenDov E, 1997, APPL ENVIRON MICROB, V63, P4883, DOI 10.1128/AEM.63.12.4883-4890.1997; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; DAVIDSON EW, 1984, APPL ENVIRON MICROB, V47, P125, DOI 10.1128/AEM.47.1.125-129.1984; De Barjac H., 1990, Bacterial control of mosquitoes & black flies: biochemistry, genetics & applications of Bacillus thuringiensis israelensis and Bacillus sphaericus., P228; De Respinis S, 2006, LETT APPL MICROBIOL, V43, P495, DOI 10.1111/j.1472-765x.2006.01999.x; Delecluse A, 1995, BACILLUS THURINGIENS, P125; Dritz DA, 2011, J AM MOSQUITO CONTR, V27, P398, DOI 10.2987/11-6161.1; Ge Y, 2011, APPL ENVIRON MICROB, V77, P5553, DOI 10.1128/AEM.00207-11; Georghiou GP, 1997, APPL ENVIRON MICROB, V63, P1095, DOI 10.1128/AEM.63.3.1095-1101.1997; Guidi V, 2010, J APPL MICROBIOL, V109, P1209, DOI 10.1111/j.1365-2672.2010.04741.x; Guidi V, 2011, APPL ENVIRON MICROB, V77, P3663, DOI 10.1128/AEM.00132-11; Hajaij M, 2005, MICROB ECOL, V50, P475, DOI 10.1007/s00248-005-0247-3; Jahnz U, 1996, FEMS MICROBIOL ECOL, V20, P91; Joly P, 2006, APPL ENVIRON MICROB, V72, P2801, DOI 10.1128/AEM.72.4.2801-2808.2006; Jones GW, 2008, ENVIRON MICROBIOL, V10, P2418, DOI 10.1111/j.1462-2920.2008.01667.x; Jones GW, 2007, FASEB J, V21, P4112, DOI 10.1096/fj.07-8913com; KRYCH VK, 1980, INT J SYST BACTERIOL, V30, P476, DOI 10.1099/00207713-30-2-476; Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Lee CS, 2010, INT J SYST EVOL MICR, V60, P281, DOI 10.1099/ijs.0.013367-0; Logan NA., 2009, BERGEYS MANUAL SYSTE, P21; Mulla MS, 2003, J AM MOSQUITO CONTR, V19, P39; Mulla MS, 1999, J VECTOR ECOL, V24, P99; NICOLAS L, 1987, APPL MICROBIOL BIOT, V25, P341, DOI 10.1007/BF00252544; PEDERSEN JC, 1995, CAN J MICROBIOL, V41, P118, DOI 10.1139/m95-016; Poopathi S, 2010, J PHYSL PATHOPHYSIOL, V1, P22, DOI DOI 10.5897/JPAP; Priest FG, 2000, APPLIED MICROBIAL SYSTEMATICS, P165; PRIEST FG, 1992, J APPL BACTERIOL, V72, P357, DOI 10.1111/j.1365-2672.1992.tb01847.x; RAO DR, 1995, J AM MOSQUITO CONTR, V11, P1; SILAPANUNTAKUL S, 1983, J INVERTEBR PATHOL, V42, P387, DOI 10.1016/0022-2011(83)90179-9; SILVAFILHA MH, 1995, J ECON ENTOMOL, V88, P525, DOI 10.1093/jee/88.3.525; Skovmand O, 2000, J INVERTEBR PATHOL, V75, P243, DOI 10.1006/jipa.2000.4935; Smith RA, 1998, J INVERTEBR PATHOL, V71, P263, DOI 10.1006/jipa.1997.4738; Su TY, 2004, J AM MOSQUITO CONTR, V20, P405; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Cuyk S, 2011, APPL ENVIRON MICROB, V77, P7954, DOI 10.1128/AEM.05207-11; Vettori C, 2003, SOIL BIOL BIOCHEM, V35, P1635, DOI 10.1016/j.soilbio.2003.08.009; Wirth MC, 2004, J MED ENTOMOL, V41, P935, DOI 10.1603/0022-2585-41.5.935; YOUSTEN AA, 1969, J BACTERIOL, V100, P1229, DOI 10.1128/JB.100.3.1229-1236.1969; Yuan ZM, 2000, BIOCONTROL SCI TECHN, V10, P41, DOI 10.1080/09583150029378; Zahner V, 1998, SYST APPL MICROBIOL, V21, P162, DOI 10.1016/S0723-2020(98)80020-9; ZAHNER V, 1995, MEM I OSWALDO CRUZ, V90, P65, DOI [10.1590/S0074-02761995000100015, 10.1590/S0074-02761995000600021]	51	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55658	10.1371/journal.pone.0055658	http://dx.doi.org/10.1371/journal.pone.0055658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390547	Green Published, gold, Green Accepted			2022-12-25	WOS:000314691100063
J	Lucchetti, C; Caligiuri, I; Toffoli, G; Giordano, A; Rizzolio, F				Lucchetti, Chiara; Caligiuri, Isabella; Toffoli, Giuseppe; Giordano, Antonio; Rizzolio, Flavio			The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor alpha in Breast Cancer	PLOS ONE			English	Article							PHOSPHORYLATION SITES; HINGE REGION; DISEASE-FREE; ER-ALPHA; ACTIVATION; TRANSFORMATION; ISOMERIZATION; INACTIVATION; SURVIVAL; OUTCOMES	In hormone receptor-positive breast cancers, most tumors in the early stages of development depend on the activity of the estrogen receptor and its ligand, estradiol. Anti-estrogens, such as tamoxifen, have been used as the first line of therapy for over three decades due to the fact that they elicit cell cycle arrest. Unfortunately, after an initial period, most cells become resistant to hormonal therapy. Peptidylprolyl isomerase 1 (Pin1), a protein overexpressed in many tumor types including breast, has been demonstrated to modulate ERalpha activity and is involved in resistance to hormonal therapy. Here we show a new mechanism through which CDK2 drives an ERalpha-Pin1 interaction under hormone- and growth factor-free conditions. The PI3K/AKT pathway is necessary to activate CDK2, which phosphorylates ERalphaSer294, and mediates the binding between Pin1 and ERalpha. Site-directed mutagenesis demonstrated that ERalphaSer294 is essential for Pin1-ERalpha interaction and modulates ERalpha phosphorylation on Ser118 and Ser167, dimerization and activity. These results open up new drug treatment opportunities for breast cancer patients who are resistant to anti-estrogen therapy.	[Lucchetti, Chiara; Caligiuri, Isabella; Giordano, Antonio; Rizzolio, Flavio] Temple Univ, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Caligiuri, Isabella; Giordano, Antonio] Human Hlth Fdn, Terni, PG, Italy; [Caligiuri, Isabella; Giordano, Antonio] Human Hlth Fdn, Spoleto, PG, Italy; [Caligiuri, Isabella; Giordano, Antonio] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, SI, Italy; [Toffoli, Giuseppe; Rizzolio, Flavio] Natl Canc Inst, Div Expt & Clin Pharmacol, Dept Mol Biol & Translat Res, Aviano, PN, Italy; [Toffoli, Giuseppe; Rizzolio, Flavio] Ctr Mol Biomed, Aviano, PN, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Siena	Giordano, A (corresponding author), Temple Univ, Sbarro Inst Canc Res & Mol Med, Ctr Biotechnol, Coll Sci & Technol, Philadelphia, PA 19122 USA.	giordano@temple.edu; rizzolio@temple.edu	Toffoli, Giuseppe/F-6642-2018; Giordano, Antonio/F-1927-2010; Giordano, Antonio/AAU-1201-2020; Rizzolio, Flavio/K-2690-2018; Caligiuri, Isabella/J-9956-2016	Toffoli, Giuseppe/0000-0002-5323-4762; Giordano, Antonio/0000-0002-5959-016X; Giordano, Antonio/0000-0002-5959-016X; Rizzolio, Flavio/0000-0002-3400-4363; Caligiuri, Isabella/0000-0002-4355-5597	Associazione Italiana per la Ricerca sul Cancro (AIRC); Special Program Molecular Clinical Oncology, 5x1000 [12214]; European Research Council, Programme "Ideas'' [269051]; Italian Ministry of Education MIUR (FIRB) [RBAP11ETKA]; Sbarro Health Research Organization; Istituto Tumori Toscano ITT; Human Health Foundation; Commonwealth of Pennsylvania	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Special Program Molecular Clinical Oncology, 5x1000; European Research Council, Programme "Ideas''; Italian Ministry of Education MIUR (FIRB)(Ministry of Education, Universities and Research (MIUR)); Sbarro Health Research Organization; Istituto Tumori Toscano ITT; Human Health Foundation; Commonwealth of Pennsylvania	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) (A.G.), Special Program Molecular Clinical Oncology, 5x1000, (number 12214) (G.T.), European Research Council, Programme "Ideas'', proposal number 269051 (F.R., G.T.), Italian Ministry of Education MIUR (FIRB prot. RBAP11ETKA (G.T.)), Sbarro Health Research Organization (A.G.), Istituto Tumori Toscano ITT (A.G.), Human Health Foundation (A.G.) and Commonwealth of Pennsylvania (A.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; ALLEGRA JC, 1979, CANCER TREAT REP, V63, P1271; Bao L, 2004, PREVALENT OVEREXPRES; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Burns KA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187773; Caligiuri I, 2012, J CELL PHYSIOL, V227, P2988, DOI 10.1002/jcp.24031; Chen D, 2002, PHOSPHORYLATION HUMA; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Dutertre M, 2003, MOL ENDOCRINOL, V17, P1296, DOI 10.1210/me.2001-0316; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Henry MK, 2004, EXP CELL RES, V299, P257, DOI 10.1016/j.yexcr.2004.06.003; Jiang J, 2007, CLIN CANCER RES, V13, P5769, DOI 10.1158/1078-0432.CCR-07-0822; Khanal P, 2010, MOL CANCER THER, V9, P606, DOI 10.1158/1535-7163.MCT-09-0560; Kumar Raj, 2011, J Amino Acids, V2011, P812540, DOI 10.4061/2011/812540; Kumar R, 2012, ENDOCR REV, V33, P271, DOI 10.1210/er.2011-1033; Kuntz MA, 1997, J BIOL CHEM, V272, P27949, DOI 10.1074/jbc.272.44.27949; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Lee KY, 2011, MOL CELLS, V32, P107, DOI 10.1007/s10059-011-0074-y; Liao Y, 2009, ONCOGENE, V28, P2436, DOI 10.1038/onc.2009.98; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Napoli M, 2011, ONCOTARGET, V2, P654; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; OSBORNE CK, 1980, CANCER-AM CANCER SOC, V46, P2884, DOI 10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Rizzolio F, 2012, CELL DEATH DIFFER, V19, P1152, DOI 10.1038/cdd.2011.202; Rizzolio F, 2009, J MED GENET, V46, P585, DOI 10.1136/jmg.2007.056093; Rizzolio F, 2012, J CELL PHYSL; Roberti A, 2011, CELL CYCLE, V10, P127, DOI 10.4161/cc.10.1.14446; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Skliris GP, 2010, ENDOCR-RELAT CANCER, V17, P589, DOI 10.1677/ERC-10-0030; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Takeda A, 2004, PANCREAS, V28, P353, DOI 10.1097/00006676-200404000-00026; Trowbridge JM, 1997, P NATL ACAD SCI USA, V94, P10132, DOI 10.1073/pnas.94.19.10132; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Vilgelm A, 2006, CANCER RES, V66, P3375, DOI 10.1158/0008-5472.CAN-05-4019; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Wierod L, 2007, CELL PROLIFERAT, V40, P475, DOI 10.1111/j.1365-2184.2007.00451.x; Williams CC, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-36; WILLIAMS MR, 1987, BRIT J CANCER, V55, P67, DOI 10.1038/bjc.1987.14; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yamashita H, 2008, ENDOCR-RELAT CANCER, V15, P755, DOI 10.1677/ERC-08-0078; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026	51	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55355	10.1371/journal.pone.0055355	http://dx.doi.org/10.1371/journal.pone.0055355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390529	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100045
J	Hentze, JL; Moeller, ME; Jorgensen, AF; Bengtsson, MS; Bordoy, AM; Warren, JT; Gilbert, LI; Andersen, O; Rewitz, KF				Hentze, Julie L.; Moeller, Morten E.; Jorgensen, Anne F.; Bengtsson, Meghan S.; Bordoy, Anna M.; Warren, James T.; Gilbert, Lawrence I.; Andersen, Ole; Rewitz, Kim F.			Accessory Gland as a Site for Prothoracicotropic Hormone Controlled Ecdysone Synthesis in Adult Male Insects	PLOS ONE			English	Article							MALE COURTSHIP BEHAVIOR; MOSQUITO AEDES-AEGYPTI; DROSOPHILA-MELANOGASTER; MOLTING HORMONE; MANDUCA-SEXTA; ECDYSTEROIDOGENIC PATHWAY; CYTOCHROME-P450 ENZYME; JUVENILE-HORMONE; P450 ENZYMES; BOMBYX-MORI	Insect steroid hormones (ecdysteroids) are important for female reproduction in many insect species and are required for the initiation and coordination of vital developmental processes. Ecdysteroids are also important for adult male physiology and behavior, but their exact function and site of synthesis remains unclear, although previous studies suggest that the reproductive system may be their source. We have examined expression profiles of the ecdysteroidogenic Halloween genes, during development and in adults of the flour beetle Tribolium castaneum. Genes required for the biosynthesis of ecdysone (E), the precursor of the molting hormone 20-hydroxyecdysone (20E), are expressed in the tubular accessory glands (TAGs) of adult males. In contrast, expression of the gene encoding the enzyme mediating 20E synthesis was detected in the ovaries of females. Further, Spookiest (Spot), an enzyme presumably required for endowing tissues with competence to produce ecdysteroids, is male specific and predominantly expressed in the TAGs. We also show that prothoracicotropic hormone (PTTH), a regulator of E synthesis during larval development, regulates ecdysteroid levels in the adult stage in Drosophila melanogaster and the gene for its receptor Torso seems to be expressed specifically in the accessory glands of males. The composite results suggest strongly that the accessory glands of adult male insects are the main source of E, but not 20E. The finding of a possible male-specific source of E raises the possibility that E and 20E have sex-specific roles analogous to the vertebrate sex steroids, where males produce primarily testosterone, the precursor of estradiol. Furthermore this study provides the first evidence that PTTH regulates ecdysteroid synthesis in the adult stage and could explain the original finding that some adult insects are a rich source of PTTH.	[Hentze, Julie L.; Jorgensen, Anne F.; Bengtsson, Meghan S.; Bordoy, Anna M.; Andersen, Ole] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Moeller, Morten E.; Rewitz, Kim F.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Warren, James T.; Gilbert, Lawrence I.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Roskilde University; University of Copenhagen; University of North Carolina; University of North Carolina Chapel Hill	Rewitz, KF (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	Kim.Rewitz@bio.ku.dk	Moeller, Morten E./P-4663-2018; Rewitz, Kim F/M-6012-2014; Møller, Morten/N-2269-2014	Moeller, Morten E./0000-0001-7411-7189; Rewitz, Kim F/0000-0002-4409-9941; Møller, Morten/0000-0001-7411-7189; Hentze, Julie Lilith/0000-0002-8572-2090; Jorgensen, Anne Faerch/0000-0001-9836-7393	Danish Council for Independent Research - Natural Sciences	Danish Council for Independent Research - Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by funding from the The Danish Council for Independent Research - Natural Sciences to OA and KFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Beckstead RB, 2007, INSECT BIOCHEM MOLEC, V37, P570, DOI 10.1016/j.ibmb.2007.03.001; Belles X, 2005, INVERTEBR REPROD DEV, V47, P23, DOI 10.1080/07924259.2005.9652144; BRIERS T, 1983, COMP BIOCHEM PHYS A, V74, P521, DOI 10.1016/0300-9629(83)90541-8; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Carney GE, 2000, GENETICS, V154, P1203; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; DAI JD, 1991, DEV BIOL, V144, P309, DOI 10.1016/0012-1606(91)90424-2; Dalton JE, 2009, CURR BIOL, V19, P1447, DOI 10.1016/j.cub.2009.06.063; De Loof Arnold, 2006, Insect Science, V13, P325, DOI 10.1111/j.1744-7917.2006.00101.x; De Loof A, 2010, J INSECT PHYSIOL, V56, P919, DOI 10.1016/j.jinsphys.2010.02.021; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Fletcher JC, 1997, P NATL ACAD SCI USA, V94, P4582, DOI 10.1073/pnas.94.9.4582; Ganter GK, 2011, J INSECT PHYSIOL, V57, P1179, DOI 10.1016/j.jinsphys.2011.05.007; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gilbert LI, 2009, ECDYSONE STRUCTURES, P229; GILLOTT C, 1995, INVERTEBR REPROD DEV, V27, P65, DOI 10.1080/07924259.1995.9672435; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Grillo M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00762; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; HAPP GM, 1992, ANNU REV ENTOMOL, V37, P303, DOI 10.1146/annurev.en.37.010192.001511; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Ishimoto H, 2010, GENETICS, V185, P269, DOI 10.1534/genetics.110.114587; Ishimoto H, 2009, P NATL ACAD SCI USA, V106, P6381, DOI 10.1073/pnas.0810213106; KATAOKA H, 1991, AGR BIOL CHEM TOKYO, V55, P73, DOI 10.1080/00021369.1991.10870535; KOOLMAN J, 1979, EXPERIENTIA, V35, P134, DOI 10.1007/BF01917923; Lafont R., 2012, INSECT ENDOCRINOLOGY, P106, DOI DOI 10.1016/13978-0-12-384749-2.10004.4; Luine VN, 2008, J NEUROENDOCRINOL, V20, P866, DOI 10.1111/j.1365-2826.2008.01710.x; Manolakou P, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-59; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; MEISTER MF, 1985, MOL CELL ENDOCRINOL, V41, P27, DOI 10.1016/0303-7207(85)90140-6; Minami R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032302; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Morris LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046109; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Ono H, 2012, BIOCHEM BIOPH RES CO, V421, P561, DOI 10.1016/j.bbrc.2012.04.045; Parthasarathy R, 2009, MECH DEVELOP, V126, P563, DOI 10.1016/j.mod.2009.03.005; Perriere C, 1992, CAMP BIOCH PHYSL A, V104A, P51; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pondeville E, 2008, P NATL ACAD SCI USA, V105, P19631, DOI 10.1073/pnas.0809264105; Rewitz KF, 2006, BIOCHEM SOC T, V34, P1256, DOI 10.1042/BST0341256; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Rewitz KF, 2009, INSECT BIOCHEM MOLEC, V39, P475, DOI 10.1016/j.ibmb.2009.04.005; Riddiford L., 1993, DEV DROSOPHILA MELAN, V2, P899; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Rosen O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015281; Rybczynski R, 2009, ARCH INSECT BIOCHEM, V70, P217, DOI 10.1002/arch.20295; Schonbauer C, 2011, NATURE, V479, P406, DOI 10.1038/nature10559; Schwedes C, 2011, J INSECT PHYSIOL, V57, P899, DOI 10.1016/j.jinsphys.2011.03.027; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Simonet G, 2004, J NEUROENDOCRINOL, V16, P649, DOI 10.1111/j.1365-2826.2004.01222.x; Smith WA, 2012, INSECT ENDOCRINOLOGY, P1, DOI [10.1016/B978-0-12-384749-2.10001-9, DOI 10.1016/B978-0-12-384749-2.10001-9]; Spindler KD, 2009, CELL MOL LIFE SCI, V66, P3837, DOI 10.1007/s00018-009-0112-5; Svechnikov K, 2008, BEST PRACT RES CL EN, V22, P95, DOI 10.1016/j.beem.2007.09.002; Terashima J, 2005, J ENDOCRINOL, V187, P69, DOI 10.1677/joe.1.06220; Tricoire H, 2009, MECH AGEING DEV, V130, P547, DOI 10.1016/j.mad.2009.05.004; Tu MP, 2002, AGING CELL, V1, P158, DOI 10.1046/j.1474-9728.2002.00016.x; Wang C, 2011, DEV BIOL, V351, P146, DOI 10.1016/j.ydbio.2010.12.042; Warren JT, 2009, INSECT BIOCHEM MOLEC, V39, P677, DOI 10.1016/j.ibmb.2009.08.004; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; WARREN JT, 1986, INSECT BIOCHEM, V16, P65, DOI 10.1016/0020-1790(86)90080-6; WEEVERS RDG, 1966, J EXP BIOL, V44, P163; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	74	53	57	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55131	10.1371/journal.pone.0055131	http://dx.doi.org/10.1371/journal.pone.0055131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383307	Green Published, gold, Green Submitted			2022-12-25	WOS:000314597900014
J	Gad, W; Nair, MG; Van Belle, K; Wahni, K; De Greve, H; Van Ginderachter, JA; Vandenbussche, G; Endo, Y; Artis, D; Messens, J				Gad, Wael; Nair, Meera G.; Van Belle, Karolien; Wahni, Khadija; De Greve, Henri; Van Ginderachter, Jo A.; Vandenbussche, Guy; Endo, Yaeta; Artis, David; Messens, Joris			The Quiescin Sulfhydryl Oxidase ( hQSOX1b) Tunes the Expression of Resistin-Like Molecule Alpha (RELM-alpha or mFIZZ1) in a Wheat Germ Cell-Free Extract	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; BOND FORMATION; ESCHERICHIA-COLI; PULMONARY INFLAMMATION; ENDOPLASMIC-RETICULUM; TYPE-2 INFLAMMATION; SECONDARY STRUCTURE; SINGLE CYSTEINE; GENE-EXPRESSION; FAMILY	Background: Although disulfide bond formation in proteins is one of the most common types of post-translational modifications, the production of recombinant disulfide-rich proteins remains a challenge. The most popular host for recombinant protein production is Escherichia coli, but disulfide-rich proteins are here often misfolded, degraded, or found in inclusion bodies. Methodology/Principal findings: We optimize an in vitro wheat germ translation system for the expression of an immunological important eukaryotic protein that has to form five disulfide bonds, resistin-like alpha (mFIZZ1). Expression in combination with human quiescin sulfhydryl oxidase (hQSOX1b), the disulfide bond-forming enzyme of the endoplasmic reticulum, results in soluble, intramolecular disulfide bonded, monomeric, and biological active protein. The mFIZZ1 protein clearly suppresses the production of the cytokines IL-5 and IL-13 in mouse splenocytes cultured under Th2 permissive conditions. Conclusion/Significance: The quiescin sulfhydryl oxidase hQSOX1b seems to function as a chaperone and oxidase during the oxidative folding. This example for mFIZZ1 should encourage the design of an appropriate thiol/disulfide oxidoreductase-tuned cell free expression system for other challenging disulfide rich proteins.	[Gad, Wael; Van Belle, Karolien; Wahni, Khadija; Messens, Joris] Brussels Ctr Redox Biol, Brussels, Belgium; [Gad, Wael; Van Belle, Karolien; Wahni, Khadija; De Greve, Henri; Messens, Joris] VIB, Dept Biol Struct, Brussels, Belgium; [Gad, Wael; Van Belle, Karolien; Wahni, Khadija; De Greve, Henri; Messens, Joris] Vrije Univ Brussel, Brussels, Belgium; [Van Ginderachter, Jo A.] Vrije Univ Brussel, Cellular & Mol Immunol Lab, Brussels, Belgium; [Van Ginderachter, Jo A.] VIB, Myeloid Cell Immunol Lab, Brussels, Belgium; [Endo, Yaeta] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan; [Nair, Meera G.; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nair, Meera G.; Artis, David] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Vandenbussche, Guy] Univ Libre Bruxelles, Ctr Biol Struct & Bioinformat Struct & Fonct Memb, Brussels, Belgium; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Nair, Meera G.] Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Ehime University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Universite Libre de Bruxelles; University of Pennsylvania; University of California System; University of California Riverside	Messens, J (corresponding author), Brussels Ctr Redox Biol, Brussels, Belgium.	joris.messens@vib-vub.be	Van Ginderachter, Jo A/H-5473-2013; Messens, Joris/AAH-3008-2020	Van Ginderachter, Jo A/0000-0002-4442-7474; Messens, Joris/0000-0002-2128-8264; Gad, Wael/0000-0003-3208-9110; Nair, Meera/0000-0002-1807-5161; Artis, David/0000-0002-1753-4100; Vandenbussche, Guy/0000-0001-9592-2304	Vlaams Instituut voor Biotechnologie (VIB); Flanders Hercules Foundation [HERC16]; European Student Exchange Program "Erasmus Mundus ECW II'' [141085-EM-1-2008-BE-ERA Mundus-ECW]; National Institutes of Health [AI091759, AI061570, AI074878]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074878, R01AI091759, R01AI061570] Funding Source: NIH RePORTER	Vlaams Instituut voor Biotechnologie (VIB); Flanders Hercules Foundation; European Student Exchange Program "Erasmus Mundus ECW II''; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was made possible thanks to financial support from Vlaams Instituut voor Biotechnologie (VIB) and the Hercules grant from the Flanders Hercules Foundation (HERC16). JM is group leader Redox Biology of the VIB. WG supported by the European Student Exchange Program "Erasmus Mundus ECW II'' reference (141085-EM-1-2008-BE-ERA Mundus-ECW). MGN and DA are supported by the National Institutes of Health (AI091759 to MGN; AI061570, AI074878 to DA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abskharon RNN, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-6; Alon A, 2010, FEBS LETT, V584, P1521, DOI 10.1016/j.febslet.2010.03.001; Banerjee RR, 2001, J BIOL CHEM, V276, P25970, DOI 10.1074/jbc.M103109200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAI H, 1994, J BIOL CHEM, V269, P24550; COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483; Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605; Depuydt M, 2011, ANTIOXID REDOX SIGN, V15, P49, DOI 10.1089/ars.2010.3575; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; GRYNBERG A, 1977, CR ACAD SCI D NAT, V284, P235; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Juan CC, 2003, J BIOTECHNOL, V103, P113, DOI 10.1016/S0168-1656(03)00099-3; Karala AR, 2010, J MOL BIOL, V396, P883, DOI 10.1016/j.jmb.2009.12.014; Kodali VK, 2010, ANTIOXID REDOX SIGN, V13, P1217, DOI 10.1089/ars.2010.3098; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Messens J, 2007, J BIOL CHEM, V282, P31302, DOI 10.1074/jbc.M705236200; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Munitz A, 2009, J IMMUNOL, V182, P2357, DOI 10.4049/jimmunol.0803130; Nair MG, 2006, J IMMUNOL, V177, P1393, DOI 10.4049/jimmunol.177.3.1393; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Nguyen VD, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-1; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Panchaud A, 2008, MOL CELL PROTEOMICS, V7, P800, DOI 10.1074/mcp.M700216-MCP200; Park S, 2011, BIOCHEMISTRY-US, V50, P2567, DOI 10.1021/bi2000214; Patel SD, 2004, SCIENCE, V304, P1154, DOI 10.1126/science.1093466; Plesa M, 2006, RES MICROBIOL, V157, P582, DOI 10.1016/j.resmic.2005.11.015; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Rancy PC, 2008, BIOCHEMISTRY-US, V47, P12047, DOI 10.1021/bi801604x; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Updegrove TB, 2011, RNA, V17, P489, DOI 10.1261/rna.2452111; Van Laer K, 2012, MOL MICROBIOL, V86, P787, DOI 10.1111/mmi.12030; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Wittke I, 2003, CANCER RES, V63, P7742; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019	49	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55621	10.1371/journal.pone.0055621	http://dx.doi.org/10.1371/journal.pone.0055621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383248	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600138
J	Li, SW; Lin, K; Ma, P; Zhang, ZL; Zhou, YD; Lu, SY; Zhou, X; Liu, SM				Li, Si-Wei; Lin, Kun; Ma, Pei; Zhang, Zhen-Lu; Zhou, Yi-Dan; Lu, Shuang-Yan; Zhou, Xin; Liu, Song-Mei			FADS Gene Polymorphisms Confer the Risk of Coronary Artery Disease in a Chinese Han Population through the Altered Desaturase Activities: Based on High-Resolution Melting Analysis	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; DIETARY SATURATED FAT; VARIANTS; OMEGA-6; CLUSTER; ATHEROSCLEROSIS; INFLAMMATION; ASSOCIATION; TISSUES	Objective: We explored the desaturase activities and the correlation of fatty acid desaturases (FADS) gene single nucleotide polymorphisms (SNPs) with plasma fatty acid in coronary artery disease (CAD) patients in a Chinese Han population. Methods: Plasma fatty acids were measured by gas chromatography in CAD patients (n=505) and a control group (n=510). Five SNPs in the FADS gene were genotyped with high-resolution melting (HRM) methods. Results: After adjustment, D6D activity, assessed as arachidonic acid (AA, C20:4n-6)/linoleic acid (LA, C18:2n-6), was higher in CAD patients (p<0.001). D9D activity, which was estimated as the ratio of palmitoleic acid (C16:1)/palmitic acid (C16: 0) or oleic acid (C18:1n-9) to stearic acid (C18:0), was also increased (p<0.001). The genotype distributions of rs174537 G>T and rs174460 C>T were different between the two groups. The rs174537 T allele was associated with a lower risk of CAD [ OR 0.743, 95% CI (0.624, 0.884), p=0.001]. Carriers of the rs174460 C allele were associated with a higher risk of CAD [ OR 1.357, 95% CI (1.106, 1.665), p=0.003]. Conclusions: We firstly report that the rs174460 C allele is associated with a higher risk of CAD, and confirm that the rs174537 T allele is associated with a lower risk of CAD. Our results indicate that FADS gene polymorphisms are likely to influence plasma fatty acid concentrations and desaturase activities.	[Li, Si-Wei; Lin, Kun; Ma, Pei; Zhang, Zhen-Lu; Lu, Shuang-Yan; Zhou, Xin; Liu, Song-Mei] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China; [Zhang, Zhen-Lu] Wuhan Asia Heart Hosp, Dept Cardiol, Wuhan, Hubei, Peoples R China; [Zhou, Yi-Dan] Jianghan Univ, Sch Life Sci, Wuhan, Hubei, Peoples R China	Wuhan University; Jianghan University	Zhou, X (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China.	zhouxjyk@163.com; smliu@whu.edu.cn			National Basic Research Program of China (973 Program) [2012CB720600, 2012CB720605]; National Natural Science Foundation of China [81271919]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (2012CB720600, 2012CB720605) and the National Natural Science Foundation of China (81271919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/315134; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Das UN, 2007, PROSTAG LEUKOTR ESS, V76, P251, DOI 10.1016/j.plefa.2007.03.001; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; FOLCH J, 1957, J BIOL CHEM, V226, P497; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kim OY, 2013, NUTR METAB CARDIOVAS, V23, P366, DOI 10.1016/j.numecd.2011.06.006; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lee TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042051; Lelliott C, 2004, INT J OBESITY, V28, pS22, DOI 10.1038/sj.ijo.0802854; Lu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041681; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Martinelli N, 2009, J NUTRIGENET NUTRIGE, V2, P129, DOI 10.1159/000238177; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; Mathias RA, 2010, J LIPID RES, V51, P2766, DOI 10.1194/jlr.M008359; Merino DM, 2011, MOL GENET METAB, V103, P171, DOI 10.1016/j.ymgme.2011.02.012; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Pedrono F, 2010, J LIPID RES, V51, P472, DOI 10.1194/jlr.M000588; Petersson H, 2008, BRIT J NUTR, V99, P1186, DOI 10.1017/S0007114507871674; RAPAPORT E, 1979, CIRCULATION, V59, P607; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Warensjo E, 2008, AM J CLIN NUTR, V88, P203, DOI 10.1093/ajcn/88.1.203	27	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55869	10.1371/journal.pone.0055869	http://dx.doi.org/10.1371/journal.pone.0055869			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383292	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600167
J	Wijesundara, DK; Tscharke, DC; Jackson, RJ; Ranasinghe, C				Wijesundara, Danushka K.; Tscharke, David C.; Jackson, Ronald J.; Ranasinghe, Charani			Reduced Interleukin-4 Receptor alpha Expression on CD8(+) T Cells Correlates with Higher Quality Anti-Viral Immunity	PLOS ONE			English	Article							HIGH-AVIDITY CTL; VACCINIA VIRUS; IN-VIVO; LYMPHOCYTE-RESPONSES; CYTOKINE EXPRESSION; VIRAL-INFECTION; PROTECTIVE ROLE; IL-4; GAMMA; IL-4R-ALPHA	With the hope of understanding how interleukin (IL)-4 and IL-13 modulated quality of anti-viral CD8(+) T cells, we evaluated the expression of receptors for these cytokines following a range of viral infections (e.g. pox viruses and influenza virus). Results clearly indicated that unlike other IL-4/IL-13 receptor subunits, IL-4 receptor alpha (IL-4R alpha) was significantly down-regulated on anti-viral CD8(+) T cells in a cognate antigen dependent manner. The infection of gene knockout mice and wild-type (WT) mice with vaccinia virus (VV) or VV expressing IL-4 confirmed that IL-4, IL-13 and signal transducer and activator of transcription 6 (STAT6) were required to increase IL-4R alpha expression on CD8(+) T cells, but not interferon (IFN)-gamma. STAT6 dependent elevation of IL-4R alpha expression on CD8(+) T cells was a feature of poor quality anti-viral CD8(+) T cell immunity as measured by the production of IFN-gamma and tumor necrosis factor alpha (TNF-alpha) in response to VV antigen stimulation in vitro. We propose that down-regulation of IL-4R alpha, but not the other IL-4/IL-13 receptor subunits, is a mechanism by which CD8(+) T cells reduce responsiveness to IL-4 and IL-13. This can improve the quality of anti-viral CD8(+) T cell immunity. Our findings have important implications in understanding anti-viral CD8(+) T cell immunity and designing effective vaccines against chronic viral infections.	[Wijesundara, Danushka K.; Jackson, Ronald J.; Ranasinghe, Charani] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Mol Mucosal Vaccine Immunol Grp, Canberra, ACT 2601, Australia; [Tscharke, David C.] Australian Natl Univ, Res Sch Biol, Viruses & Immun Lab, Div Biomed Sci & Biochem, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Wijesundara, DK (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol, Mol Mucosal Vaccine Immunol Grp, Canberra, ACT 2601, Australia.	danushka.wijesundara@anu.edu.au	Tscharke, David/C-9133-2009	Tscharke, David/0000-0001-6825-9172; Wijesundara, Danushka/0000-0002-0740-8362	Australian National Health and Medical Research Council [525431, APP1000703]; Australian Centre for Hepatitis and HIV Virology EOI grant	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for Hepatitis and HIV Virology EOI grant	This work was supported by the Australian National Health and Medical Research Council project grant award 525431 (CR) and development grant award APP1000703 (CR) and the Australian Centre for Hepatitis and HIV Virology EOI grant 2010 (CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pinheiro AAD, 2007, J LEUKOCYTE BIOL, V81, P1102, DOI 10.1189/jlb.0906583; Albanesi C, 2007, J IMMUNOL, V179, P984, DOI 10.4049/jimmunol.179.2.984; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Apte SH, 2010, J IMMUNOL, V185, P998, DOI 10.4049/jimmunol.0903372; Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8; Derby MA, 2001, J IMMUNOL, V166, P1690, DOI 10.4049/jimmunol.166.3.1690; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; ERARD F, 1993, SCIENCE, V260, P1802, DOI 10.1126/science.8511588; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452; Kawakami K, 2001, BLOOD, V97, P2673, DOI 10.1182/blood.V97.9.2673; Kienzle N, 2005, J IMMUNOL, V174, P2021, DOI 10.4049/jimmunol.174.4.2021; Kroger CJ, 2008, J IMMUNOL, V180, P5784, DOI 10.4049/jimmunol.180.9.5784; La Gruta NL, 2006, EUR J IMMUNOL, V36, P2951, DOI 10.1002/eji.200636390; MAGGI E, 1994, J EXP MED, V180, P489, DOI 10.1084/jem.180.2.489; Marsland BJ, 2005, EUR J IMMUNOL, V35, P1391, DOI 10.1002/eji.200425768; Mohrs M, 1999, J IMMUNOL, V162, P7302; Morrot A, 2005, J EXP MED, V202, P551, DOI 10.1084/jem.20042463; Perona-Wright G, 2010, J IMMUNOL, V184, P615, DOI 10.4049/jimmunol.0902408; Ranasinghe C, 2007, J IMMUNOL, V178, P2370, DOI 10.4049/jimmunol.178.4.2370; Ranasinghe C, 2006, VACCINE, V24, P5881, DOI 10.1016/j.vaccine.2006.04.023; Ranasinghe C, 2009, EUR J IMMUNOL, V39, P1819, DOI 10.1002/eji.200838995; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Serpier H, 1997, J INVEST DERMATOL, V109, P158, DOI 10.1111/1523-1747.ep12319207; Sharma DP, 1996, J VIROL, V70, P7103, DOI 10.1128/JVI.70.10.7103-7107.1996; Sivaprasad U, 2010, J IMMUNOL, V185, P6802, DOI 10.4049/jimmunol.1002118; Tabata Y, 2007, CURR ALLERGY ASTHM R, V7, P338, DOI 10.1007/s11882-007-0051-x; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Yuen TJ, 2010, J VIROL, V84, P10220, DOI 10.1128/JVI.01281-10; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	35	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55788	10.1371/journal.pone.0055788	http://dx.doi.org/10.1371/journal.pone.0055788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383283	Green Published, gold			2022-12-25	WOS:000314610600160
J	Knizhnik, AV; Roos, WP; Nikolova, T; Quiros, S; Tomaszowski, KH; Christmann, M; Kaina, B				Knizhnik, Anna V.; Roos, Wynand P.; Nikolova, Teodora; Quiros, Steve; Tomaszowski, Karl-Heinz; Christmann, Markus; Kaina, Bernd			Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage	PLOS ONE			English	Article							MISMATCH REPAIR; ALKYLATING-AGENTS; IN-VIVO; O-6-METHYLGUANINE; CANCER; MGMT; ATM; P53; O(6)-METHYLGUANINE; GENOTOXICITY	Apoptosis, autophagy, necrosis and cellular senescence are key responses of cells that were exposed to genotoxicants. The types of DNA damage triggering these responses and their interrelationship are largely unknown. Here we studied these responses in glioma cells treated with the methylating agent temozolomide (TMZ), which is a first-line chemotherapeutic for this malignancy. We show that upon TMZ treatment cells undergo autophagy, senescence and apoptosis in a specific time-dependent manner. Necrosis was only marginally induced. All these effects were completely abrogated in isogenic glioma cells expressing O-6-methylguanine-DNA methyltransferase (MGMT), indicating that a single type of DNA lesion, O-6-methylguanine (O(6)MeG), is able to trigger all these responses. Studies with mismatch repair mutants and MSH6, Rad51 and ATM knockdowns revealed that autophagy induced by O(6)MeG requires mismatch repair and ATM, and is counteracted by homologous recombination. We further show that autophagy, which precedes apoptosis, is a survival mechanism as its inhibition greatly ameliorated the level of apoptosis following TMZ at therapeutically relevant doses (<100 mu M). Cellular senescence increases with post-exposure time and, similar to autophagy, precedes apoptosis. If autophagy was abrogated, TMZ-induced senescence was reduced. Therefore, we propose that autophagy triggered by O(6)MeG adducts is a survival mechanism that stimulates cells to undergo senescence rather than apoptosis. Overall, the data revealed that a specific DNA adduct, O(6)MeG, has the capability of triggering autophagy, senescence and apoptosis and that the decision between survival and death is determined by the balance of players involved. The data also suggests that inhibition of autophagy may ameliorate the therapeutic outcome of TMZ-based cancer therapy.	[Knizhnik, Anna V.; Roos, Wynand P.; Nikolova, Teodora; Quiros, Steve; Tomaszowski, Karl-Heinz; Christmann, Markus; Kaina, Bernd] Med Univ Ctr, Dept Toxicol, Mainz, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Kaina, B (corresponding author), Med Univ Ctr, Dept Toxicol, Mainz, Germany.	kaina@uni-mainz.de	Roos, Wynand/B-4846-2008; Quiros, Steve/A-2969-2015; Kaina, Bernd/AAE-4692-2020	Roos, Wynand/0000-0002-0474-7414; Quiros, Steve/0000-0002-9377-0199; 	BMBF [02NUK016]; DFG [KA724]	BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	Work was supported by BMBF 02NUK016 and DFG KA724. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Baker SD, 1999, CLIN CANCER RES, V5, P309; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Caporali S, 2004, MOL PHARMACOL, V66, P478; Chen LH, 2011, BIOCHEM PHARMACOL, V81, P594, DOI 10.1016/j.bcp.2010.12.011; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; Hammond LA, 1999, J CLIN ONCOL, V17, P2604, DOI 10.1200/JCO.1999.17.8.2604; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Hickman MJ, 1999, P NATL ACAD SCI USA, V96, P10764, DOI 10.1073/pnas.96.19.10764; Hirose Y, 2001, CANCER RES, V61, P5843; Kaina B, 1997, MUTAT RES-FUND MOL M, V381, P227, DOI 10.1016/S0027-5107(97)00187-5; Kaina B, 2001, PROG NUCLEIC ACID RE, V68, P41; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Lin CJ, 2012, FREE RADICAL BIO MED, V52, P377, DOI 10.1016/j.freeradbiomed.2011.10.487; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Naumann SC, 2009, BRIT J CANCER, V100, P322, DOI 10.1038/sj.bjc.6604856; Ochs K, 2000, CANCER RES, V60, P5815; Palumbo S, 2012, J CELL BIOCH; Patschan S, 2008, AM J PHYSIOL-HEART C, V294, pH1119, DOI 10.1152/ajpheart.00713.2007; Quiros S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027183; Quiros S, 2010, CELL CYCLE, V9, P168, DOI 10.4161/cc.9.1.10363; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Roos WP, 2012, CANC LETT; Roos WP, 2009, DNA REPAIR, V8, P72, DOI 10.1016/j.dnarep.2008.09.003; Sage JM, 2010, J BIOL CHEM, V285, P18984, DOI 10.1074/jbc.M109.099846; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Singh K, 2012, AUTOPHAGY, V8, P236, DOI 10.4161/auto.8.2.18600; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vasilevskaya IA, 2004, MOL PHARMACOL, V65, P235, DOI 10.1124/mol.65.1.235; Villano JL, 2009, CANCER CHEMOTH PHARM, V64, P647, DOI 10.1007/s00280-009-1050-5; White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	40	181	185	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55665	10.1371/journal.pone.0055665	http://dx.doi.org/10.1371/journal.pone.0055665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383259	gold, Green Submitted, Green Published			2022-12-25	WOS:000315563800182
J	Sun, HT; Cheng, SX; Tu, Y; Li, XH; Zhang, S				Sun, Hong-Tao; Cheng, Shi-Xiang; Tu, Yue; Li, Xiao-Hong; Zhang, Sai			FoxQ1 Promotes Glioma Cells Proliferation and Migration by Regulating NRXN3 Expression	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; NEUREXIN GENES; FOXM1; IDENTIFICATION; PROTEINS; ALPHA; HAIR	Background: Forkhead box Q1 (FoxQ1) is a member of the forkhead transcription factor family, and it has recently been found to participate in cancer development. However, whether FoxQ1 expression contributes to glioma development and progression is not known. We investigate FoxQ1 expression in gliomas and the role of FoxQ1 during tumorgenesis. Methods: Reverse transcription quantitative real-time PCR (RT-qPCR) and Western blot were used to determine the FoxQ1 and Neurexins 3 (NRXN3) expression in gliomas. Chromatin immunoprecipitation (ChIP) and luciferase assays were used to determine the regulation between FoxQ1 and NRXN3. We established depleted FoxQ1 stable clones in U-87MG cells and overexpressed FoxQ1 stable clones in SW1088 cells. MTT and transwell were used to evaluate the ability of proliferation and migration, respectively. Results: FoxQ1 mRNA and protein were up-regulated in gliomas and negatively related to the NRXN3 expression (r = -0.373, P = 0.042). FoxQ1 directly binds to NRXN3 promoter region and suppresses the promoter activity. Furthermore, the ability of proliferation and migration is reduced in depleted FoxQ1 cells. Conclusion: FoxQ1 promotes glioma cell proliferation and migration by down-regulation of NRXN3 expression.	[Sun, Hong-Tao; Cheng, Shi-Xiang; Tu, Yue; Li, Xiao-Hong; Zhang, Sai] Chinese Peoples Armed Police Forces, Inst Traumat Brain Injury & Neurol, Tianjin, Peoples R China		Zhang, S (corresponding author), Chinese Peoples Armed Police Forces, Inst Traumat Brain Injury & Neurol, Tianjin, Peoples R China.	zhangsai718@yahoo.com			National Natural Science Foundation of China [30872668]; Logistics College of Chinese People's Armed Police Forces [WYM201015, WYM201109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Logistics College of Chinese People's Armed Police Forces	This work was supported by the National Natural Science Foundation of China (30872668) and intramural research programs from Logistics College of Chinese People's Armed Police Forces (WYM201015 and WYM201109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; Cao DF, 2004, CANCER BIOL THER, V3, P1081, DOI 10.4161/cbt.3.11.1175; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039937; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Hoggatt AM, 2000, J BIOL CHEM, V275, P31162, DOI 10.1074/jbc.M005595200; Hong HK, 2001, GENESIS, V29, P163, DOI 10.1002/gene.1020; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Katoh M, 2004, INT J ONCOL, V25, P1495; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kusinska R, 2012, MOL BIOL REP, V39, P2915, DOI 10.1007/s11033-011-1053-2; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Occhi G, 2002, BIOCHEM BIOPH RES CO, V298, P151, DOI 10.1016/S0006-291X(02)02403-8; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Potter CS, 2006, J BIOL CHEM, V281, P29245, DOI 10.1074/jbc.M603646200; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825	31	33	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55693	10.1371/journal.pone.0055693	http://dx.doi.org/10.1371/journal.pone.0055693			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383267	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800185
J	Madaro, L; Marrocco, V; Carnio, S; Sandri, M; Bouche, M				Madaro, Luca; Marrocco, Valeria; Carnio, Silvia; Sandri, Marco; Bouche, Marina			Intracellular signaling in ER stress-induced autophagy in skeletal muscle cells	FASEB JOURNAL			English	Article						protein kinase C theta; muscle atrophy autophagosome; CHOP	ENDOPLASMIC-RETICULUM STRESS; KINASE-C-THETA; PKC-THETA; ACTIVATION; EXPRESSION; FOXO3; PATHWAYS; SURVIVAL; DELTA; MODEL	Skeletal muscle remodeling in response to muscle disuse and unloading is known to be associated with so-called ER stress, which, in turn, activates autophagy and contributes to muscle atrophy. Different molecules are involved in ER stress-induced autophagy, among which PKC theta has recently been described. In this study, we dissected both in vitro and in vivo ER stress-induced autophagy pathways in muscle. Using C2C12 muscle cells in culture, we demonstrated that PKC activation induced autophagy in the absence of ER stress. We further demonstrated that PKC theta was strongly activated in cultured myoblasts and myotubes during ER stress induced by different stimuli, such as TG or TN treatment, and that it localized into Lc3-positive autophagic dots upon TG treatment. Neither Akt dephosphorylation nor Foxo or GSK3 beta activation was observed in these conditions. Moreover, PKC theta inhibition in myoblasts and myotubes prevented ER stress-induced Lc3 activation and autophagic dot formation, but not ER stress. In vivo, lack of PKC theta prevented both food deprivation- and immobilization-induced autophagy and muscle atrophy, irrespective of Akt pathway inhibition. Taken together, these results demonstrate that PKC theta functions as an ER stress sensor in skeletal muscle, required for ER-stress-dependent autophagy activation, and can be proposed as a novel molecular target to maintain muscle homeostasis in response to external stimuli, such as disuse and unloading, still allowing intracellular clearance.	[Madaro, Luca; Marrocco, Valeria; Bouche, Marina] Univ Roma La Sapienza, Unit Histol, Dept Anat Histol Forensis Med & Orthoped, I-00161 Rome, Italy; [Madaro, Luca; Marrocco, Valeria; Sandri, Marco; Bouche, Marina] Univ Roma La Sapienza, Interuniv Inst Myol, I-00161 Rome, Italy; [Carnio, Silvia] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Sandri, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy	Sapienza University Rome; Sapienza University Rome; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Padua	Bouche, M (corresponding author), Univ Roma La Sapienza, Unit Histol, DAHFMO, Via A Scarpa 14, I-00161 Rome, Italy.	marina.bouche@uniroma1.it	Madaro, Luca/ABE-4683-2021; Madaro, Luca/K-4629-2016	Madaro, Luca/0000-0003-0839-5724; Madaro, Luca/0000-0003-0839-5724; Bouche, Marina/0000-0002-0938-5360	Italian Ministry for University and Research; Sapienza University of Rome; French Association against Myopathies (AFM); Duchenne Parent Project (The Netherlands) Fellowship; Fondazione Telethon Funding Source: Custom	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Sapienza University of Rome; French Association against Myopathies (AFM)(Association Francaise contre les Myopathies); Duchenne Parent Project (The Netherlands) Fellowship(Netherlands Government); Fondazione Telethon(Fondazione Telethon)	The authors thank Prof. D. A. Littman (New York University, New York, NY, USA) for providing the PKC theta mutant mice and Dr. M. Brown (Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA) for providing the C20 inhibitor. The authors also thank Dr. F. Padula and Dr. P. Fiore for support in cytofluorimetric analysis. This work was supported by the Italian Ministry for University and Research, by the Sapienza University of Rome, and by the French Association against Myopathies (AFM). L.M. is the recipient of a Duchenne Parent Project (The Netherlands) Fellowship.	Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; D'Andrea M, 2006, J CELL PHYSIOL, V207, P379, DOI 10.1002/jcp.20585; Fouillet A, 2012, AUTOPHAGY, V8, P915, DOI 10.4161/auto.19716; Greene MW, 2010, J BIOL CHEM, V285, P42115, DOI 10.1074/jbc.M110.168575; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Madaro L, 2008, BASIC APPL MYOL, V18, P149; Madaro L, 2011, MOL BIOL CELL, V22, P1409, DOI 10.1091/mbc.E10-10-0821; Madaro L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031515; Maioli E, 2012, SCI WORLD J, DOI 10.1100/2012/350826; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Messina G, 2010, CELL, V140, P554, DOI 10.1016/j.cell.2010.01.027; Nascimbeni AC, 2012, CELL DEATH DIFFER, V19, P1698, DOI 10.1038/cdd.2012.52; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Paoletti R, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.24; Paul PK, 2011, AUTOPHAGY, V7, P555, DOI 10.4161/auto.7.5.15102; Qi X, 2007, J MOL CELL CARDIOL, V43, P420, DOI 10.1016/j.yjmcc.2007.07.061; Rayavarapu S, 2012, CURR RHEUMATOL REP, V14, P238, DOI 10.1007/s11926-012-0247-5; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Serra C, 2003, J CELL PHYSIOL, V196, P89, DOI 10.1002/jcp.10278; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tokugawa S, 2009, NEUROPATHOLOGY, V29, P211, DOI 10.1111/j.1440-1789.2008.00967.x; Zappelli F, 1996, DEV BIOL, V180, P156, DOI 10.1006/dbio.1996.0292; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	33	44	45	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1990	2000		10.1096/fj.12-215475	http://dx.doi.org/10.1096/fj.12-215475			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23388382				2022-12-25	WOS:000318226100019
J	Chen, CC; Wang, KY; Shen, CKJ				Chen, Chun-Chang; Wang, Keh-Yang; Shen, Che-Kun James			DNA 5-Methylcytosine Demethylation Activities of the Mammalian DNA Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; DE-NOVO; PATERNAL GENOME; GENE-EXPRESSION; CALCIUM; METHYLATION; CANCER; 5-HYDROXYMETHYLCYTOSINE; OSCILLATIONS; DNMT3B	Methylation at the 5-position of DNA cytosine on the vertebrate genomes is accomplished by the combined catalytic actions of three DNA methyltransferases (DNMTs), the de novo enzymes DNMT3A and DNMT3B and the maintenance enzyme DNMT1. Although several metabolic routes have been suggested for demethylation of the vertebrate DNA, whether active DNA demethylase(s) exist has remained elusive. Surprisingly, we have found that the mammalian DNMTs, and likely the vertebrates DNMTs in general, can also act as Ca2+ ion- and redox state-dependent active DNA demethylases. This finding suggests new directions for reinvestigation of the structures and functions of these DNMTs, in particular their roles in Ca2+ ion-dependent biological processes, including the genome-wide/local DNA demethylation during early embryogenesis, cell differentiation, neuronal activity-regulated gene expression, and carcinogenesis.	[Chen, Chun-Chang] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chen, Chun-Chang] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Chen, Chun-Chang; Wang, Keh-Yang; Shen, Che-Kun James] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Shen, CKJ (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	ckshen@imb.sinica.edu.tw	shen, Che-Kun James/L-1343-2015		Frontier of Science Award from the National Science Council; Academia Sinica (Taipei, Taiwan)	Frontier of Science Award from the National Science Council; Academia Sinica (Taipei, Taiwan)(Academia Sinica - Taiwan)	This work was supported in part by the Frontier of Science Award from the National Science Council and Academia Sinica (Taipei, Taiwan).	Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; BONDY SC, 1993, FREE RADICAL BIO MED, V14, P633, DOI 10.1016/0891-5849(93)90144-J; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Girault I, 2003, CLIN CANCER RES, V9, P4415; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Har-Vardi I, 2007, HUM REPROD, V22, P2183, DOI 10.1093/humrep/dem170; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hermann A, 2003, J BIOL CHEM, V278, P31717, DOI 10.1074/jbc.M305448200; Hernandez-Fonseca K, 2008, J NEUROSCI RES, V86, P1768, DOI 10.1002/jnr.21634; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; HOMA ST, 1993, HUM REPROD, V8, P1274, DOI 10.1093/oxfordjournals.humrep.a138240; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ko YG, 2005, J BIOL CHEM, V280, P9627, DOI 10.1074/jbc.M413822200; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Santella L, 2004, TRENDS BIOCHEM SCI, V29, P400, DOI 10.1016/j.tibs.2004.06.009; Sardet C, 1998, BIOPHYS CHEM, V72, P131, DOI 10.1016/S0301-4622(98)00129-X; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tang LY, 2003, J BIOL CHEM, V278, P33613, DOI 10.1074/jbc.C300255200; TAYLOR CT, 1993, HUM REPROD, V8, P2174, DOI 10.1093/oxfordjournals.humrep.a137999; Ulrey CL, 2005, HUM MOL GENET, V14, pR139, DOI 10.1093/hmg/ddi100; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	58	65	68	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9084	9091		10.1074/jbc.M112.445585	http://dx.doi.org/10.1074/jbc.M112.445585			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393137	Green Published, hybrid			2022-12-25	WOS:000316862200028
J	Corpe, CP; Eck, P; Wang, J; Al-Hasani, H; Levine, M				Corpe, Christopher P.; Eck, Peter; Wang, Jin; Al-Hasani, Hadi; Levine, Mark			Intestinal Dehydroascorbic Acid (DHA) Transport Mediated by the Facilitative Sugar Transporters, GLUT2 and GLUT8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ASCORBIC-ACID; ISOLATED RAT ADIPOCYTES; VITAMIN-C; GLUCOSE TRANSPORTERS; HEXOSE TRANSPORTERS; XENOPUS OOCYTES; IRON-METABOLISM; MOUSE; CELLS; INHIBITION	Intestinal vitamin C (Asc) absorption was believed to be mediated by the Na+-dependent ascorbic acid transporter SVCT1. However, Asc transport across the intestines of SVCT1 knockout mice is normal indicating that alternative ascorbic acid transport mechanisms exist. To investigate these mechanisms, rodents were gavaged with Asc or its oxidized form dehydroascorbic acid (DHA), and plasma Asc concentrations were measured. Asc concentrations doubled following DHA but not Asc gavage. We hypothesized that the transporters responsible were facilitated glucose transporters (GLUTs). Using Xenopus oocyte expression, we investigated whether facilitative glucose transporters GLUT2 and GLUT5-12 transported DHA. Only GLUT2 and GLUT8, known to be expressed in intestines, transported DHA with apparent transport affinities (K-m) of 2.33 and 3.23 mM and maximal transport rates (V-max) of 25.9 and 10.1 pmol/min/oocyte, respectively. Maximal rates for DHA transport mediated by GLUT2 and GLUT8 in oocytes were lower than maximal rates for 2-deoxy-D-glucose (V-max of 224 and 32 pmol/min/oocyte for GLUT2 and GLUT8, respectively) and fructose (V-max of 406 and 116 pmol/min/oocyte for GLUT2 and GLUT8, respectively). These findings may be explained by differences in the exofacial binding of substrates, as shown by inhibition studies with ethylidine glucose. DHA transport activity in GLUT2- and GLUT8-expressing oocytes was inhibited by glucose, fructose, and by the flavonoids phloretin and quercetin. These studies indicate intestinal DHA transport may be mediated by the facilitative sugar transporters GLUT2 and GLUT8. Furthermore, dietary sugars and flavonoids in fruits and vegetables may modulate Asc bioavailability via inhibition of small intestinal GLUT2 and GLUT8.	[Corpe, Christopher P.; Eck, Peter; Wang, Jin; Al-Hasani, Hadi; Levine, Mark] NIDDK, Mol & Clin Nutr Sect, Digest Dis Branch, Intramural Res Program,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Corpe, CP (corresponding author), Kings Coll London, Diabet & Nutr Sci Div, Sch Med, Room 3-114,Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.		WANG, Jin/A-8327-2012	WANG, Jin/0000-0002-0062-2489; Eck, Peter/0000-0003-2371-9774; corpe, christopher/0000-0003-1994-8312	National Institutes of Health Intramural Research Program Grant from NIDDK [DK054506-15]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK053211, ZIADK053218, ZIADK054506] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program Grant from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant DK054506-15 from NIDDK.	Anderson Gregory J, 2005, Curr Gastroenterol Rep, V7, P365, DOI 10.1007/s11894-005-0005-1; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; COLVILLE CA, 1993, BIOCHEM J, V290, P701, DOI 10.1042/bj2900701; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; Corpe CP, 2005, J BIOL CHEM, V280, P5211, DOI 10.1074/jbc.M412925200; DEOLIVEIRA JED, 1959, AM J CLIN NUTR, V7, P630, DOI 10.1093/ajcn/7.6.630; GOLDMAN HM, 1981, AM J CLIN NUTR, V34, P24, DOI 10.1093/ajcn/34.1.24; Ibberson M, 2000, J BIOL CHEM, V275, P4607, DOI 10.1074/jbc.275.7.4607; Koshiishi I, 1998, BBA-GEN SUBJECTS, V1425, P209, DOI 10.1016/S0304-4165(98)00073-7; Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com; Latunde-Dada GO, 2002, BLOOD CELL MOL DIS, V29, P356, DOI 10.1006/bcmd.2002.0574; Li HY, 2012, ANAL BIOCHEM, V426, P109, DOI 10.1016/j.ab.2012.04.014; Li Q, 2004, AM J PHYSIOL-GASTR L, V287, pG236, DOI 10.1152/ajpgi.00396.2003; Lisinski I, 2001, BIOCHEM J, V358, P517, DOI 10.1042/0264-6021:3580517; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; May JM, 2002, METHOD ENZYMOL, V347, P327; Mckie AT, 2008, BIOCHEM SOC T, V36, P1239, DOI 10.1042/BST0361239; Ogiri Y, 2002, J AGR FOOD CHEM, V50, P227, DOI 10.1021/jf010910f; OTSUKA M, 1986, J NUTR SCI VITAMINOL, V32, P183, DOI 10.3177/jnsv.32.183; Park JB, 1999, BIOCHEM BIOPH RES CO, V260, P568, DOI 10.1006/bbrc.1999.0890; Romero A, 2009, J CELL BIOCHEM, V106, P1068, DOI 10.1002/jcb.22090; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Rumsey SC, 2000, J BIOL CHEM, V275, P28246; SMITH RM, 1993, ARCH BIOCHEM BIOPHYS, V300, P238, DOI 10.1006/abbi.1993.1033; Song J, 2002, J BIOL CHEM, V277, P15252, DOI 10.1074/jbc.M110496200; SOREQ H, 1992, METHOD ENZYMOL, V207, P225; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Su D, 2006, J BIOL CHEM, V281, P39852, DOI 10.1074/jbc.M606543200; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; WASHKO PW, 1989, ANAL BIOCHEM, V181, P276, DOI 10.1016/0003-2697(89)90243-1	33	85	86	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9092	9101		10.1074/jbc.M112.436790	http://dx.doi.org/10.1074/jbc.M112.436790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396969	hybrid, Green Published			2022-12-25	WOS:000316862200029
J	Harris, NC; Davydova, N; Roufail, S; Paquet-Fifield, S; Paavonen, K; Karnezis, T; Zhang, YF; Sato, T; Rothacker, J; Nice, EC; Stacker, SA; Achen, MG				Harris, Nicole C.; Davydova, Natalia; Roufail, Sally; Paquet-Fifield, Sophie; Paavonen, Karri; Karnezis, Tara; Zhang, You-Fang; Sato, Teruhiko; Rothacker, Julie; Nice, Edouard C.; Stacker, Steven A.; Achen, Marc G.			The Propeptides of VEGF-D Determine Heparin Binding, Receptor Heterodimerization, and Effects on Tumor Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-GROWTH-FACTOR; FACTOR-D EXPRESSION; LYMPHATIC METASTASIS; MOLECULAR CONTROL; D PROMOTES; LYMPHANGIOGENESIS; CANCER; ANGIOGENESIS; NEUROPILIN-1; CELLS	VEGF-D is an angiogenic and lymphangiogenic glycoprotein that can be proteolytically processed generating various forms differing in subunit composition due to the presence or absence of N- and C-terminal propeptides. These propeptides flank the central VEGF homology domain, that contains the binding sites for VEGF receptors (VEGFRs), but their biological functions were unclear. Characterization of propeptide function will be important to clarify which forms of VEGF-D are biologically active and therefore clinically relevant. Here we use VEGF-D mutants deficient in either propeptide, and in the capacity to process the remaining propeptide, to monitor the functions of these domains. We report for the first time that VEGF-D binds heparin, and that the C-terminal propeptide significantly enhances this interaction (removal of this propeptide from fulllength VEGF-D completely prevents heparin binding). We also show that removal of either the N- or C-terminal propeptide is required for VEGF-D to drive formation of VEGFR-2/VEGFR-3 heterodimers which have recently been shown to positively regulate angiogenic sprouting. The mature form of VEGF-D, lacking both propeptides, can also promote formation of these receptor heterodimers. In a mouse tumor model, removal of only the C-terminal propeptide from full-length VEGF-D was sufficient to enhance angiogenesis and tumor growth. In contrast, removal of both propeptides is required for high rates of lymph node metastasis. The findings reported here show that the propeptides profoundly influence molecular interactions of VEGF-D with VEGF receptors, co-receptors, and heparin, and its effects on tumor biology.	[Harris, Nicole C.; Davydova, Natalia; Roufail, Sally; Paquet-Fifield, Sophie; Karnezis, Tara; Zhang, You-Fang; Sato, Teruhiko; Stacker, Steven A.; Achen, Marc G.] Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, East Melbourne, Vic 3002, Australia; [Harris, Nicole C.; Paavonen, Karri; Rothacker, Julie; Nice, Edouard C.; Stacker, Steven A.; Achen, Marc G.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; [Stacker, Steven A.; Achen, Marc G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3050, Australia	Peter Maccallum Cancer Center; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; Peter Maccallum Cancer Center; University of Melbourne	Achen, MG (corresponding author), Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, East Melbourne, Vic 3002, Australia.	Marc.achen@petermac.org	Paquet-Fifield, Sophie/AAL-6410-2021	Achen, Marc/0000-0002-3791-803X; Rothacker, Julie/0000-0001-7560-4982; Stacker, Steven/0000-0003-4096-9273	National Health and Medical Research Council of Australia; Melbourne Research Scholarship; Victorian Government, Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Research Scholarship; Victorian Government, Australia	This work was supported by a Program Grant and Research Fellowships (to S.A.S. and M.G.A.) from the National Health and Medical Research Council of Australia, a Melbourne Research Scholarship (to N.C.H.) and funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. S.A.S. and M.G.A. are consultants to Vegenics Ltd., a company developing anti-cancer therapeutics.	Achen MG, 2006, BRIT J CANCER, V94, P1355, DOI 10.1038/sj.bjc.6603120; Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Achen MG, 2012, GROWTH FACTORS, V30, P283, DOI 10.3109/08977194.2012.704917; Achen MG, 2001, J PATHOL, V193, P147, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO;2-G; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Baldwin ME, 2001, J BIOL CHEM, V276, P19166, DOI 10.1074/jbc.M100097200; Baldwin ME, 2005, MOL CELL BIOL, V25, P2441, DOI 10.1128/MCB.25.6.2441-2449.2005; Baldwin ME, 2002, BIOESSAYS, V24, P1030, DOI 10.1002/bies.10173; Baldwin ME, 2001, J BIOL CHEM, V276, P44307, DOI 10.1074/jbc.M106188200; Bhardwaj S, 2003, HUM GENE THER, V14, P1451, DOI 10.1089/104303403769211664; Debinski W, 2001, MOL MED, V7, P598, DOI 10.1007/BF03401866; Dixelius J, 2003, J BIOL CHEM, V278, P40973, DOI 10.1074/jbc.M304499200; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Grau S, 2011, J NEURO-ONCOL, V104, P103, DOI 10.1007/s11060-010-0480-6; Haiko P, 2008, MOL CELL BIOL, V28, P4843, DOI 10.1128/MCB.02214-07; Harris NC, 2011, FASEB J, V25, P2615, DOI 10.1096/fj.10-179788; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Juttner S, 2006, J CLIN ONCOL, V24, P228, DOI 10.1200/JCO.2004.00.3467; Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026; Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Keck RG, 1997, ARCH BIOCHEM BIOPHYS, V344, P103, DOI 10.1006/abbi.1997.0145; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kopfstein L, 2007, AM J PATHOL, V170, P1348, DOI 10.2353/ajpath.2007.060835; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; McColl BK, 2003, J EXP MED, V198, P863, DOI 10.1084/jem.20030361; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Moffat BA, 2006, CLIN CANCER RES, V12, P1525, DOI 10.1158/1078-0432.CCR-05-1408; Nakamura Y, 2003, CLIN CANCER RES, V9, P716; Nice EC, 1999, BIOESSAYS, V21, P339, DOI 10.1002/(SICI)1521-1878(199904)21:4<339::AID-BIES11>3.0.CO;2-C; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Oh H, 2002, P NATL ACAD SCI USA, V99, P383, DOI 10.1073/pnas.012074399; PAJUSOLA K, 1994, ONCOGENE, V9, P3545; Partanen TA, 2000, FASEB J, V14, P2087, DOI 10.1096/fj.99-1049com; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rutanen J, 2003, CARDIOVASC RES, V59, P971, DOI 10.1016/S0008-6363(03)00518-2; Rutanen J, 2004, CIRCULATION, V109, P1029, DOI 10.1161/01.CIR.0000115519.03688.A2; Seyama K, 2010, LYMPHAT RES BIOL, V8, P21, DOI 10.1089/lrb.2009.0018; Shayan R, 2006, CARCINOGENESIS, V27, P1729, DOI 10.1093/carcin/bgl031; Shraga-Heled N, 2007, FASEB J, V21, P915, DOI 10.1096/fj.06-6277com; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stacker SA, 2004, APMIS, V112, P539, DOI 10.1111/j.1600-0463.2004.apm11207-0812.x; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; van Iterson V, 2007, AM J CLIN PATHOL, V128, P759, DOI 10.1309/7FXVRMXF58PVRJUH; Von Marschall Z, 2005, INT J ONCOL, V27, P669; White JD, 2002, CANCER RES, V62, P1669; Wise LM, 2003, J BIOL CHEM, V278, P38004, DOI 10.1074/jbc.M301194200; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137; Yin X, 2011, J BIOL CHEM, V286, P14952, DOI 10.1074/jbc.M110.206664; Yuan L, 2002, DEVELOPMENT, V129, P4797	55	23	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8176	8186		10.1074/jbc.M112.439299	http://dx.doi.org/10.1074/jbc.M112.439299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23404505	hybrid, Green Published			2022-12-25	WOS:000316564500018
J	Nallar, SC; Kalakonda, S; Lindner, DJ; Lorenz, RR; Lamarre, E; Xiao, WH; Kalvakolanu, DV				Nallar, Shreeram C.; Kalakonda, Sudhakar; Lindner, Daniel J.; Lorenz, Robert R.; Lamarre, Eric; Xiao Weihua; Kalvakolanu, Dhananjaya V.			Tumor-derived Mutations in the Gene Associated with Retinoid Interferon-induced Mortality (GRIM-19) Disrupt Its Anti-signal Transducer and Activator of Transcription 3 (STAT3) Activity and Promote Oncogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; DOWN-REGULATION; UNPHOSPHORYLATED STAT3; MITOCHONDRIAL STAT3; PROTEIN INHIBITOR; BONE METASTASIS; CORTACTIN; CANCER; INVASION; RECEPTOR	The signal transducer and activator of transcription 3 (STAT3) protein is critical for multiple cytokine and growth factor-induced biological responses in vivo. Its transcriptional activity is controlled by a transient phosphorylation of a critical tyrosine. Constitutive activation of STAT3 imparts resistance to apoptosis, promotes cell proliferation, and induces de novo micro-angiogenesis, three of the six cardinal hallmarks of a typical cancer cell. Earlier we reported the isolation of GRIM-19 as a growth suppressor using a genome-wide expression knockdown strategy. GRIM-19 binds to STAT3 and suppresses its transcriptional activity. To understand the pathological relevance of GRIM-19, we screened a set of primary head and neck tumors and identified three somatic mutations in GRIM-19. Wild-type GRIM-19 suppressed cellular transformation by a constitutively active form of STAT3, whereas tumor-derived mutants L71P, L91P and A95T significantly lost their ability to associate with STAT3, block gene expression, and suppress cellular transformation and tumor growth in vivo. Additionally, these mutants lost their capacity to prevent metastasis. These mutations define a mechanism by which STAT3 activity is deregulated in certain human head and neck tumors.	[Nallar, Shreeram C.; Kalakonda, Sudhakar; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Program Oncol,Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Lindner, Daniel J.] Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Lorenz, Robert R.; Lamarre, Eric] Cleveland Clin Fdn, Head & Neck Inst, Cleveland, OH 44195 USA; [Xiao Weihua] Univ Sci Technol, Hefei 230027, Peoples R China	University System of Maryland; University of Maryland Baltimore; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Kalvakolanu, DV (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Program Oncol,Greenebaum Canc Ctr, Baltimore, MD 21201 USA.	dkalvako@umaryland.edu	Lindner, Daniel/ABB-5440-2020; Xiao, Weihua/N-2775-2013	Xiao, Weihua/0000-0001-9102-6326	National Institutes of Health [R01 CA105005]; Cigarette Restitution Funds of the University of Maryland Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE [R01CA105005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cigarette Restitution Funds of the University of Maryland Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA105005 (to D. V. K.). This work was also supported by an intramural award from the Cigarette Restitution Funds of the University of Maryland Greenebaum Cancer Center (to D. V. K.).	Alchanati I, 2006, ONCOGENE, V25, P7138, DOI 10.1038/sj.onc.1209708; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Anolik Robert, 2009, Dermatol Online J, V15, P16; Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; Couto JP, 2012, P NATL ACAD SCI USA, V109, pE2361, DOI 10.1073/pnas.1201232109; Du XL, 2009, ONCOGENE, V28, P3714, DOI 10.1038/onc.2009.237; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Fan XY, 2012, MED ONCOL, V29, P3183, DOI 10.1007/s12032-012-0249-1; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Gong Long-Bo, 2007, Ai Zheng, V26, P683; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Gresser I, 2002, CYTOKINE GROWTH F R, V13, P111, DOI 10.1016/S1359-6101(01)00035-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao HB, 2012, J CELL PHYSIOL, V227, P1212, DOI 10.1002/jcp.24025; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Jimenez-Lara AM, 2002, FEBS LETT, V526, P142, DOI 10.1016/S0014-5793(02)03154-X; Junicho A, 2000, BIOCHEM BIOPH RES CO, V278, P9, DOI 10.1006/bbrc.2000.3753; Kalakonda S, 2007, CANCER RES, V67, P6212, DOI 10.1158/0008-5472.CAN-07-0031; Kalvakolanu DV, 2004, CYTOKINE GROWTH F R, V15, P169, DOI 10.1016/j.cytogfr.2004.01.002; Kim DW, 2007, MOL ENDOCRINOL, V21, P3039, DOI 10.1210/me.2007-0269; KIMURA G, 1975, INT J CANCER, V15, P694, DOI 10.1002/ijc.2910150419; Kumanovics A, 2010, J CLIN IMMUNOL, V30, P886, DOI 10.1007/s10875-010-9452-z; Levy C, 2003, MOL CELL BIOL, V23, P9073, DOI 10.1128/MCB.23.24.9073-9080.2003; Li FF, 2012, MED ONCOL, V29, P3046, DOI 10.1007/s12032-012-0234-8; Li XH, 2008, INT J ONCOL, V33, P69; Li YS, 2001, CANCER RES, V61, P6906; Lindner DJ, 1997, CLIN CANCER RES, V3, P931; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Masuda M, 2010, CURR CANCER DRUG TAR, V10, P117, DOI 10.2174/156800910790980197; Maximo V, 2005, BRIT J CANCER, V92, P1892, DOI 10.1038/sj.bjc.6602547; Nallar SC, 2010, AM J PATHOL, V177, P896, DOI 10.2353/ajpath.2010.091280; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Okamoto T, 2010, MOL CANCER THER, V9, P2333, DOI 10.1158/1535-7163.MCT-09-1147; Papanastasiou AD, 2010, MOL IMMUNOL, V47, P1629, DOI 10.1016/j.molimm.2010.01.010; Patel AS, 1998, ONCOGENE, V16, P3227, DOI 10.1038/sj.onc.1201850; Renner ED, 2007, NEW ENGL J MED, V357, P1667, DOI 10.1056/NEJMc076367; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Sato N, 2001, AM J PATHOL, V159, P2017, DOI 10.1016/S0002-9440(10)63053-2; Seo T, 2002, J VIROL, V76, P8797, DOI 10.1128/JVI.76.17.8797-8807.2002; Shulga N, 2012, J CELL SCI, V125, P2995, DOI 10.1242/jcs.103093; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Taniguchi T, 1997, BBA-REV CANCER, V1333, pM9, DOI 10.1016/S0304-419X(97)00014-0; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; USHIJIMA T, 1994, JPN J CANCER RES, V85, P455, DOI 10.1111/j.1349-7006.1994.tb02379.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang XL, 2003, BLOOD, V102, P3478, DOI 10.1182/blood-2003-05-1432; Wang ZJ, 1999, BRIT J CANCER, V80, P70, DOI 10.1038/sj.bjc.6690323; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Xie LX, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/289873; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang L, 2008, CLIN CANCER RES, V14, P559, DOI 10.1158/1078-0432.CCR-07-1176; Zhang YM, 2011, CANCER SCI, V102, P1991, DOI 10.1111/j.1349-7006.2011.02059.x; Zhou Ai-Min, 2009, Ai Zheng, V28, P431; Zhou Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022065; Zhou Y, 2009, J INTERF CYTOK RES, V29, P695, DOI 10.1089/jir.2009.0003	70	25	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7930	7941		10.1074/jbc.M112.440610	http://dx.doi.org/10.1074/jbc.M112.440610			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23386605	Green Published, hybrid			2022-12-25	WOS:000316455300046
J	Overcash, RF; Chappell, VA; Green, T; Geyer, CB; Asch, AS; Ruiz-Echevarria, MJ				Overcash, Ryan F.; Chappell, Vesna A.; Green, Thomas; Geyer, Christopher B.; Asch, Adam S.; Ruiz-Echevarria, Maria J.			Androgen Signaling Promotes Translation of TMEFF2 in Prostate Cancer Cells via Phosphorylation of the alpha Subunit of the Translation Initiation Factor 2	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; PROTEIN-SYNTHESIS; GENE-EXPRESSION; BLOOD-PRESSURE; RECEPTOR; GROWTH; DIHYDROTESTOSTERONE; EIF2-ALPHA; IDENTIFICATION; PROLIFERATION	The type I transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2), is expressed mainly in brain and prostate. Expression of TMEFF2 is deregulated in prostate cancer, suggesting a role in this disease, but the molecular mechanism(s) involved in this effect are not clear. Although androgens promote tmeff2 transcription, androgen delivery to castrated animals carrying CWR22 xenografts increases TMEFF2 protein levels in the absence of mRNA changes, suggesting that TMEFF2 may also be post-transcriptionally regulated. Here we show that translation of TMEFF2 is regulated by androgens. Addition of physiological concentrations of dihydrotestosterone (DHT) to prostate cancer cell lines increases translation of endogenous TMEFF2 or transfected TMEFF2-Luciferase fusions, and this effect requires the presence of upstream open reading frames (uORFs) in the 59-untranslated region (59-UTR) of TMEFF2. Using chemical and siRNA inhibition of the androgen receptor (AR), we show that the androgen effect on TMEFF2 translation is mediated by the AR. Importantly, DHT also promotes phosphorylation of the alpha subunit of the translation initiation factor 2 (eIF2 alpha) in an AR-dependent manner, paralleling the effect on TMEFF2 translation. Moreover, endoplasmic reticulum (ER) stress conditions, which promote eIF2 alpha phosphorylation, also stimulate TMEFF2 translation. These results indicate that androgen signaling promotes eIF2 alpha phosphorylation and subsequent translation of TMEFF2 via a mechanism that requires uORFs in the 59-UTR of TMEFF2.	[Overcash, Ryan F.] E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC USA; [Chappell, Vesna A.; Geyer, Christopher B.; Ruiz-Echevarria, Maria J.] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27858 USA; [Green, Thomas; Asch, Adam S.; Ruiz-Echevarria, Maria J.] E Carolina Univ, Brody Sch Med, Div Hematol Oncol, Dept Internal Med, Greenville, NC USA; [Asch, Adam S.; Ruiz-Echevarria, Maria J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill	Ruiz-Echevarria, MJ (corresponding author), E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27858 USA.	ruizechevarriam@ecu.edu		Ruiz Echevarria, Maria Jesus/0000-0001-7133-9982	National Cancer Institute [1R15CA155873]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD072552] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R15CA155873] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant from the National Cancer Institute (1R15CA155873). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afar DEH, 2004, MOL CANCER THER, V3, P921; Aktas H, 1998, P NATL ACAD SCI USA, V95, P8280, DOI 10.1073/pnas.95.14.8280; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bennett NC, 2010, INT J BIOCHEM CELL B, V42, P813, DOI 10.1016/j.biocel.2009.11.013; Chen TR, 2012, BIOCHEM BIOPH RES CO, V425, P189, DOI 10.1016/j.bbrc.2012.07.064; Chen XF, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193805; Clemens MJ, 2001, PROG MOLEC, V27, P57; Cuesta R, 2009, PROG MOL BIOL TRANSL, V90, P255, DOI 10.1016/S1877-1173(09)90007-2; Dai RY, 2012, J CELL BIOCHEM, V113, P1800, DOI 10.1002/jcb.24051; El-Awady MK, 2004, ENDOCR J, V51, P37, DOI 10.1507/endocrj.51.37; Esfahani A, 2010, IN VITRO CELL DEV-AN, V46, P856, DOI 10.1007/s11626-010-9351-x; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Floryk D, 2011, MOL CELL ENDOCRINOL, V345, P58, DOI 10.1016/j.mce.2011.07.011; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Gaughan L, 2011, NUCLEIC ACIDS RES, V39, P1266, DOI 10.1093/nar/gkq861; Gery S, 2002, ONCOGENE, V21, P4739, DOI 10.1038/sj.onc.1205142; Glynne-Jones E, 2001, INT J CANCER, V94, P178, DOI 10.1002/ijc.1450; Gregory CW, 2001, CANCER RES, V61, P4315; Hamdi MM, 2011, J PHYSIOL-LONDON, V589, P3623, DOI 10.1113/jphysiol.2011.207175; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haren MT, 2011, INT J ANDROL, V34, P55, DOI 10.1111/j.1365-2605.2010.01061.x; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Ikeda Y, 2012, J ENDOCRINOL, V214, P1, DOI 10.1530/JOE-12-0126; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Kim HJ, 2006, TOXICOL IN VITRO, V20, P1159, DOI 10.1016/j.tiv.2006.03.003; Kinoshita H, 2000, CANCER RES, V60, P3623; Ko S, 2011, MOL ENDOCRINOL, V25, P433, DOI 10.1210/me.2010-0482; Kumarasamy S, 2011, HYPERTENS RES, V34, P1263, DOI 10.1038/hr.2011.116; LIANG T, 1975, P NATL ACAD SCI USA, V72, P706, DOI 10.1073/pnas.72.2.706; LIANG T, 1975, J STEROID BIOCHEM, V6, P549, DOI 10.1016/0022-4731(75)90033-3; Lin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018608; Liu SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011302; Lizotte E, 2009, CELL PHYSIOL BIOCHEM, V23, P75, DOI 10.1159/000204096; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lozon TI, 2011, AM J PHYSIOL-LUNG C, V300, pL422, DOI 10.1152/ajplung.00166.2010; Masek T, 2011, METHODS MOL BIOL, V703, P293, DOI 10.1007/978-1-59745-248-9_20; Mehraein-Ghomi F, 2008, PROSTATE, V68, P924, DOI 10.1002/pros.20737; Mohler JL, 2002, PROSTATE, V51, P247, DOI 10.1002/pros.10086; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Mounir Z, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000389; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pan CL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S17; Pascall JC, 1997, J MOL ENDOCRINOL, V18, P177, DOI 10.1677/jme.0.0180177; Pausova Z, 2010, HYPERTENSION, V55, P706, DOI 10.1161/HYPERTENSIONAHA.109.146720; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Putluri N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021417; Quinkler M, 2005, HYPERTENSION, V46, P787, DOI 10.1161/01.HYP.0000184362.61744.c1; Rajabi H, 2011, PROSTATE, V71, P1299, DOI 10.1002/pros.21344; Ramberg H, 2008, PROSTATE, V68, P1133, DOI 10.1002/pros.20778; Ripple MO, 1999, ANTIOXID REDOX SIGN, V1, P71, DOI 10.1089/ars.1999.1.1-71; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; SRIVASTAVA SP, 1995, J BIOL CHEM, V270, P16619, DOI 10.1074/jbc.270.28.16619; Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682; Sun XY, 2001, CARCINOGENESIS, V22, P1775, DOI 10.1093/carcin/22.11.1775; Uchida T, 1999, BIOCHEM BIOPH RES CO, V266, P593, DOI 10.1006/bbrc.1999.1873; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yoshioka M, 2006, J MOL ENDOCRINOL, V36, P247, DOI 10.1677/jme.1.01964; Zhao JC, 2012, GENOME RES, V22, P322, DOI 10.1101/gr.131508.111	65	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55257	10.1371/journal.pone.0055257	http://dx.doi.org/10.1371/journal.pone.0055257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405127	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400072
J	Ward, A; Quinn, KP; Bellas, E; Georgakoudi, I; Kaplan, DL				Ward, Andrew; Quinn, Kyle P.; Bellas, Evangelia; Georgakoudi, Irene; Kaplan, David L.			Noninvasive Metabolic Imaging of Engineered 3D Human Adipose Tissue in a Perfusion Bioreactor	PLOS ONE			English	Article							IN-VITRO; SILK FIBROIN; STEM-CELLS; MODEL	The efficacy and economy of most in vitro human models used in research is limited by the lack of a physiologically-relevant three-dimensional perfused environment and the inability to noninvasively quantify the structural and biochemical characteristics of the tissue. The goal of this project was to develop a perfusion bioreactor system compatible with two-photon imaging to noninvasively assess tissue engineered human adipose tissue structure and function in vitro. Three-dimensional (3D) vascularized human adipose tissues were engineered in vitro, before being introduced to a perfusion environment and tracked over time by automated quantification of endogenous markers of metabolism using two-photon excited fluorescence (TPEF). Depth-resolved image stacks were analyzed for redox ratio metabolic profiling and compared to prior analyses performed on 3D engineered adipose tissue in static culture. Traditional assessments with H&E staining were used to qualitatively measure extracellular matrix generation and cell density with respect to location within the tissue. The distribution of cells within the tissue and average cellular redox ratios were different between static and perfusion cultures, while the trends of decreased redox ratio and increased cellular proliferation with time in both static and perfusion cultures were similar. These results establish a basis for noninvasive optical tracking of tissue structure and function in vitro, which can be applied to future studies to assess tissue development or drug toxicity screening and disease progression.	[Ward, Andrew; Quinn, Kyle P.; Bellas, Evangelia; Georgakoudi, Irene; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Tufts University	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	David.Kaplan@tufts.edu		Quinn, Kyle/0000-0002-6876-3608	National Institutes of Health (NIH) [P41 EB002520-05]; National Institute of Biomedical Imaging and Bioengineering/NIH [R01EB007542]; National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH [F32AR061933]; Armed Forces Institute of Regenerative Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR061933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520, R01EB007542] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Armed Forces Institute of Regenerative Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	All funding for this project was from the National Institutes of Health (NIH) (grant P41 EB002520-05 (Tissue Engineering Resource Center), R01EB007542 from National Institute of Biomedical Imaging and Bioengineering/NIH and F32AR061933 from National Institute of Arthritis and Musculoskeletal and Skin Diseases/NIH). The authors also thank Armed Forces Institute of Regenerative Medicine for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUCHER RC, 1980, J APPL PHYSIOL, V48, P169, DOI 10.1152/jappl.1980.48.1.169; Choi JH, 2010, TISSUE ENG PART B-RE, V16, P413, DOI [10.1089/ten.teb.2009.0544, 10.1089/ten.TEB.2009.0544]; Fournier R. L., 1999, BASIC TRANSPORT PHEN; Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]; Georgakoudi I, 2012, ANN REV BIOMED ENG; Georgakoudi I, 2007, OPT EXPRESS, V15, P1043, DOI 10.1364/OE.15.001043; Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248; Grayson WL, 2011, BIOTECHNOL BIOENG, V108, P1159, DOI 10.1002/bit.23024; Hillel AT, 2009, TISSUE ENG PT A, V15, P479, DOI 10.1089/ten.tea.2007.0352; Job Charles K, 2003, Indian J Pathol Microbiol, V46, P541; Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017; Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051; Provenzano PP, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940365; Quinn KP, 2012, BIOMATERIALS, V33, P5341, DOI 10.1016/j.biomaterials.2012.04.024; Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003; Ren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012520; Rice WL, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2823019; Rice WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010075; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Soini E, 2000, BIOCHEM SOC T, V28, P70, DOI 10.1042/bst0280070; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013	26	27	28	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55696	10.1371/journal.pone.0055696	http://dx.doi.org/10.1371/journal.pone.0055696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405199	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400144
J	Geurts, L; Muccioli, GG; Delzenne, NM; Cani, PD				Geurts, Lucie; Muccioli, Giulio G.; Delzenne, Nathalie M.; Cani, Patrice D.			Chronic Endocannabinoid System Stimulation Induces Muscle Macrophage and Lipid Accumulation in Type 2 Diabetic Mice Independently of Metabolic Endotoxaemia	PLOS ONE			English	Article							HIGH-FAT DIET; HEPATIC CB1 RECEPTORS; GUT MICROBIOTA; CANNABINOID RECEPTORS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; ENERGY-METABOLISM; INDUCED OBESITY; RISK-FACTORS; ACTIVATION	Aims: Obesity and type 2 diabetes are characterised by low-grade inflammation, metabolic endotoxaemia (i.e., increased plasma lipopolysaccharides [LPS] levels) and altered endocannabinoid (eCB)-system tone. The aim of this study was to decipher the specific role of eCB-system stimulation or metabolic endotoxaemia in the onset of glucose intolerance, metabolic inflammation and altered lipid metabolism. Methods: Mice were treated with either a cannabinoid (CB) receptor agonist (HU210) or low-dose LPS using subcutaneous mini-pumps for 6 weeks. After 3 weeks of the treatment under control (CT) diet, one-half of each group of mice were challenged with a high fat (HF) diet for the following 3-week period. Results: Under basal conditions (control diet), chronic CB receptor agonist treatment (i.e., 6 weeks) induced glucose intolerance, stimulated metabolic endotoxaemia, and increased macrophage infiltration (CD11c and F4/80 expression) in the muscles; this phenomenon was associated with an altered lipid metabolism (increased PGC-1 alpha expression and decreased CPT-1b expression) in this tissue. Chronic LPS treatment tended to increase the body weight and fat mass, with minor effects on the other metabolic parameters. Challenging mice with an HF diet following pre-treatment with the CB agonist exacerbated the HF diet-induced glucose intolerance, the muscle macrophage infiltration and the muscle's lipid content without affecting the body weight or the fat mass. Conclusion: Chronic CB receptor stimulation under basal conditions induces glucose intolerance, stimulates metabolic inflammation and alters lipid metabolism in the muscles. These effects worsen following the concomitant ingestion of an HF diet. Here, we highlight the central roles played by the eCB system and LPS in the pathophysiology of several hallmarks of obesity and type 2 diabetes.	[Geurts, Lucie; Delzenne, Nathalie M.; Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Lab, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Cani, PD (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium.	patrice.cani@uclouvain.be	Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016	Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Muccioli, Giulio/0000-0002-1600-9259	SFD (Societe Francophone du Diabete); FSR (Fonds Speciaux de Recherche, UCL (Universite catholique de Louvain); FRSM (Fonds de la Recherche Scientifique Medicale)	SFD (Societe Francophone du Diabete); FSR (Fonds Speciaux de Recherche, UCL (Universite catholique de Louvain); FRSM (Fonds de la Recherche Scientifique Medicale)(Fonds de la Recherche Scientifique - FNRS)	Sources of funding: SFD (Societe Francophone du Diabete); FSR (Fonds Speciaux de Recherche, UCL (Universite catholique de Louvain); FRSM (Fonds de la Recherche Scientifique Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamoruni A, 2012, BRIT J PHARMACOL, V165, P2598, DOI 10.1111/j.1476-5381.2011.01589.x; Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; Andre A, 2010, INT J BIOCHEM CELL B, V42, P1788, DOI 10.1016/j.biocel.2010.06.002; Bartelt A, 2011, DIABETOLOGIA, V54, P2900, DOI 10.1007/s00125-011-2274-6; Bermudez-Siva FJ, 2006, EUR J PHARMACOL, V531, P282, DOI 10.1016/j.ejphar.2005.12.016; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Bosier B, 2012, NEUROPHARMACOLOGY, V62, P2328, DOI 10.1016/j.neuropharm.2012.02.003; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Di Marzo V, 2009, DIABETOLOGIA, V52, P213, DOI 10.1007/s00125-008-1178-6; Di Marzo V, 2008, BRIT J PHARMACOL, V154, P915, DOI 10.1038/bjp.2008.170; Di Marzo V, 2008, BRIT J PHARMACOL, V153, P1272, DOI 10.1038/sj.bjp.0707682; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; Di Marzo V, 2009, EUR J ENDOCRINOL, V161, P715, DOI 10.1530/EJE-09-0643; Di Marzo V, 2009, BEST PRACT RES CL EN, V23, pVII, DOI 10.1016/j.beem.2008.12.005; Di Marzo V, 2008, DRUG DISCOV TODAY, V13, P1026, DOI 10.1016/j.drudis.2008.09.001; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Doyle ME, 2011, CURR OPIN ENDOCRINOL, V18, P153, DOI 10.1097/MED.0b013e32834455a8; Eckardt K, 2009, DIABETOLOGIA, V52, P664, DOI 10.1007/s00125-008-1240-4; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; Kunos G, 2011, BRIT J PHARMACOL, V163, P1423, DOI 10.1111/j.1476-5381.2011.01352.x; Lambert DM, 2007, CURR OPIN CLIN NUTR, V10, P735, DOI 10.1097/MCO.0b013e3282f00061; Li C, 2010, ISLETS, V2, P293, DOI 10.4161/isl.2.5.12729; Li C, 2011, PHARMACOL THERAPEUT, V129, P307, DOI 10.1016/j.pharmthera.2010.10.006; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Liu J, 2012, GASTROENTEROLOGY; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Muccio GG, 2008, ANAL BIOCHEM, V373, P220, DOI 10.1016/j.ab.2007.09.030; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Nakata M, 2008, REGUL PEPTIDES, V145, P49, DOI 10.1016/j.regpep.2007.08.009; Nogueiras R, 2008, DIABETES, V57, P2977, DOI 10.2337/db08-0161; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Ottani A, 2001, CNS DRUG REV, V7, P131; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Song D, 2011, DIABETOLOGIA, V54, P1181, DOI 10.1007/s00125-011-2082-z; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X	53	23	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55963	10.1371/journal.pone.0055963	http://dx.doi.org/10.1371/journal.pone.0055963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393605	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800060
J	Biraro, S; Ruzagira, E; Kamali, A; Whitworth, J; Grosskurth, H; Weiss, HA				Biraro, Samuel; Ruzagira, Eugene; Kamali, Anatoli; Whitworth, James; Grosskurth, Heiner; Weiss, Helen A.			HIV-1 Transmission within Marriage in Rural Uganda: A Longitudinal Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MALE-TO-FEMALE; DISCORDANT COUPLES; HIV-1-DISCORDANT COUPLES; SEXUAL TRANSMISSION; MALE CIRCUMCISION; DOUBLE-BLIND; VIRAL LOAD; INFECTION; RISK	Background: Early initiation of antiretroviral therapy reduces risk of transmission to the uninfected partner in HIV discordant couples, but there are relatively little observational data on HIV transmission within couples from non-trial settings. The aims of this paper are to estimate HIV incidence among HIV discordant couples using longstanding observational data from a rural Ugandan population and to identify factors associated with HIV transmission within couples, including the role of HSV-2 infection. Methods: Using existing data collected at population-wide annual serological and behavioural surveys in a rural district in southwest Uganda between 1989 and 2007, HIV discordant partners were identified. Stored serum samples were tested for HSV-2 serostatus using the Kalon ELISA test. HIV seroconversion rates and factors association with HIV seroconversion were analysed using Poisson regression. Results: HIV status of both partners was known in 2465 couples and of these 259 (10.5%) were HIV serodiscordant. At enrolment, HSV-2 prevalence was 87.3% in HIV positive partners and 71.5% in HIV negative partners. Of the 259 discordant couples, 62 converted to HIV (seroconversion rate 7.11/100 PYAR, 95% CI; 5.54, 9.11) with the rate decreasing from 10.89 in 1990-1994 to 4.32 in 2005-2007. Factors independently associated with HIV seroconversion were female sex, non-Muslim religion, greater age difference (man older than woman by more than 15 years), higher viral load in the positive partner and earlier calendar period. HSV-2 was not independently associated with HIV acquisition (HR 1.62, 95% CI; 0.57, 4.55) or transmission (HR 0.61, 95% CI; 0.24, 1.57). No transmissions occurred in the 29 couples where the index partner was on ART during follow up (872 person-years on ART). Discussion: HIV negative partners in serodiscordant couples have a high incidence of HIV if the index partner is not on antiretroviral therapy and should be provided with interventions such as couple counselling, condoms and antiretroviral treatment.	[Biraro, Samuel; Ruzagira, Eugene; Kamali, Anatoli; Grosskurth, Heiner] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Biraro, Samuel; Grosskurth, Heiner; Weiss, Helen A.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Dept Infect Dis Epidemiol, London WC1, England; [Whitworth, James] Wellcome Trust Res Labs, London, England	Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine	Biraro, S (corresponding author), Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda.	samuel.biraro@mrcuganda.org	weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Ruzagira, Eugene/0000-0002-7291-1693; Grosskurth, Heiner/0000-0001-9960-7280	United Kingdom Medical Research Council; Medical Research Council [MR/K012126/1] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the United Kingdom Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baeten JM, 2010, AIDS, V24, P737, DOI 10.1097/QAD.0b013e32833616e0; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chemaitelly H, 2012, AIDS; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Eyawo O, 2010, LANCET INFECT DIS, V10, P770, DOI 10.1016/S1473-3099(10)70189-4; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2008, LANCET, V371, P2064, DOI 10.1016/S0140-6736(08)60896-X; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Kairania RM, 2010, AIDS CARE, V22, P1041, DOI 10.1080/09540121003602226; Kalon Biologicals Ltd, 2008, KIT INS HSV TYP 2 IG; Kamali A, 1999, SEX TRANSM INFECT, V75, P98, DOI 10.1136/sti.75.2.98; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; Kumarasamy N, 2010, HIV MED, V11, P178, DOI 10.1111/j.1468-1293.2009.00760.x; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; [Ministry of Health Uganda ORC Macro], 2006, UG HIV AIDS SER SURV; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024037; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Seeley J, 2008, SOC SCI MED, V67, P1434, DOI 10.1016/j.socscimed.2008.07.001; SERWADDA D, 1995, AIDS, V9, P745, DOI 10.1097/00002030-199507000-00012; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Van der Paal L, 2007, TROP MED INT HEALTH, V12, P920, DOI [10.1111/j.1365-3156.2007.01873.x, 10.1111/j.1365-3156.2007.001873.x]; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wabwire-Mangen F, 2009, UGANDA HIV MODES TRA; Wald Anna, 2004, Herpes, V11, P70; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X	44	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55060	10.1371/journal.pone.0055060	http://dx.doi.org/10.1371/journal.pone.0055060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390512	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000314691100028
J	Couto, E; Sandin, S; Lof, M; Ursin, G; Adami, HO; Weiderpass, E				Couto, Elisabeth; Sandin, Sven; Lof, Marie; Ursin, Giske; Adami, Hans-Olov; Weiderpass, Elisabete			Mediterranean Dietary Pattern and Risk of Breast Cancer	PLOS ONE			English	Article							MENOPAUSAL HORMONE-THERAPY; HEALTH; MORTALITY; SURVIVAL; ALCOHOL; COHORT; WOMEN	Background: A Mediterranean diet has a recognized beneficial effect on health and longevity, with a protective influence on several cancers. However, its association with breast cancer risk remains unclear. Objective: We aimed to investigate whether adherence to a Mediterranean dietary pattern influences breast cancer risk. Design: The Swedish Women's Lifestyle and Health cohort study includes 49,258 women aged 30 to 49 years at recruitment in 1991-1992. Consumption of foods and beverages was measured at enrollment using a food frequency questionnaire. A Mediterranean diet score was constructed based on the consumption of alcohol, vegetables, fruits, legumes, cereals, fish, the ratio of unsaturated to saturated fat, and dairy and meat products. Relative risks (RR) for breast cancer and specific tumor characteristics (invasiveness, histological type, estrogen/progesterone receptor status, malignancy grade and stage) associated with this score were estimated using Cox regression controlling for potential confounders. Results: 1,278 incident breast cancers were diagnosed. Adherence to a Mediterranean dietary pattern was not statistically significantly associated with reduced risk of breast cancer overall, or with specific breast tumor characteristics. A RR (95% confidence interval) for breast cancer associated with a two-point increment in the Mediterranean diet score was 1.08 (1.00-1.15) in all women, and 1.10 (1.01-1.21) and 1.02 (0.91-1.15) in premenopausal and postmenopausal women, respectively. When alcohol was excluded from the Mediterranean diet score, results became not statistically significant. Conclusions: Adherence to a Mediterranean dietary pattern did not decrease breast cancer risk in this cohort of relatively young women.	[Couto, Elisabeth; Sandin, Sven; Adami, Hans-Olov; Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Couto, Elisabeth; Ursin, Giske; Weiderpass, Elisabete] Canc Registry Norway, Oslo, Norway; [Couto, Elisabeth] Norwegian Knowledge Ctr Hlth Serv, Hlth Econ & Drug Unit, Oslo, Norway; [Lof, Marie] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Lof, Marie] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Ursin, Giske] Univ Oslo, Dept Nutr, Oslo, Norway; [Ursin, Giske] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Dept Genet Epidemiol, Helsinki, Finland; [Weiderpass, Elisabete] Univ Tromso, Dept Community Med, Tromso, Norway	Karolinska Institutet; University of Oslo; Norwegian Knowledge Centre for Health Services; Linkoping University; Karolinska Institutet; University of Oslo; University of Southern California; Harvard University; Harvard T.H. Chan School of Public Health; Folkhalsan Research Center; UiT The Arctic University of Tromso	Weiderpass, E (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Elisabete.Weiderpass@ki.se	Löf, Marie/ABB-2697-2020; Weiderpass, Elisabete/AAP-2747-2021; Sandin, Sven/L-5357-2015; Weiderpass, Elisabete/M-4029-2016; Sandin, Sven/ABE-2959-2021; Löf, Marie/AAW-3323-2020; Ursin, Giske/U-6637-2017	Löf, Marie/0000-0002-2273-4430; Weiderpass, Elisabete/0000-0003-2237-0128; Sandin, Sven/0000-0001-6994-4884; Weiderpass, Elisabete/0000-0003-2237-0128; Sandin, Sven/0000-0001-6994-4884; Ursin, Giske/0000-0002-0835-9507	Swedish Research Council (Vetenskapsradet) [K2012-69X-22062-01-3]; Swedish Cancer Society	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society)	Supported by the Swedish Research Council (Vetenskapsradet) grant K2012-69X-22062-01-3 and by the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Benitez-Arciniega AA, 2011, PUBLIC HEALTH NUTR, V14, P2015, DOI 10.1017/S1368980011001212; Bergstrom L., 1991, Var Foda, V43, P439; Brinton LA, 2008, CANCER EPIDEM BIOMAR, V17, P3150, DOI 10.1158/1055-9965.EPI-08-0435; Cade JE, 2011, EUR J CLIN NUTR, V65, P920, DOI 10.1038/ejcn.2011.69; COLDITZ GA, 1992, CANCER CAUSE CONTROL, V3, P433, DOI 10.1007/BF00051356; Cottet V, 2009, AM J EPIDEMIOL, V170, P1257, DOI 10.1093/aje/kwp257; Couto E, 2011, BRIT J CANCER, V104, P1493, DOI 10.1038/bjc.2011.106; Edefonti V, 2009, NUTR REV, V67, P297, DOI 10.1111/j.1753-4887.2009.00203.x; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Fung TT, 2006, J NUTR, V136, P466, DOI 10.1093/jn/136.2.466; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Jacques PF, 2001, AM J CLIN NUTR, V73, P1, DOI 10.1093/ajcn/73.1.1; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kumle M, 2002, CANCER EPIDEM BIOMAR, V11, P1375; Lagiou P, 2006, BRIT J NUTR, V96, P384, DOI 10.1079/BJN20061824; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ma HY, 2006, BREAST CANCER RES, V8, DOI [10.1186/bcr1525, 10.1186/bcr1512]; Murtaugh MA, 2008, AM J CLIN NUTR, V87, P978, DOI 10.1093/ajcn/87.4.978; Saxena T, 2010, CANCER EPIDEM BIOMAR, V19, P2366, DOI 10.1158/1055-9965.EPI-10-0162; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Therneau TM, 2001, MODELING SURVIVAL DA; Thiebaut ACM, 2007, ANN INTERN MED, V146, P65, DOI 10.7326/0003-4819-146-1-200701020-00012; Trichopoulou A, 2004, PUBLIC HEALTH NUTR, V7, P943, DOI 10.1079/PHN2004558; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Trichopoulou A, 2010, AM J CLIN NUTR, V92, P620, DOI 10.3945/ajcn.2010.29619; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; United Nations Educational Scientific and Cultural Organization, 2011, INT HER LISTS MED DI; Wolk A, 1998, ARCH INTERN MED, V158, P41, DOI 10.1001/archinte.158.1.41; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu AH, 2009, AM J CLIN NUTR, V89, P1145, DOI 10.3945/ajcn.2008.26915	33	65	68	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55374	10.1371/journal.pone.0055374	http://dx.doi.org/10.1371/journal.pone.0055374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390532	gold, Green Published			2022-12-25	WOS:000314691100048
J	Lanyon, LJ; Barton, JJS				Lanyon, Linda J.; Barton, Jason J. S.			Visual Search and Line Bisection in Hemianopia: Computational Modelling of Cortical Compensatory Mechanisms and Comparison with Hemineglect	PLOS ONE			English	Article							OBJECT-BASED ATTENTION; VISION RESTORATION THERAPY; UNILATERAL SPATIAL NEGLECT; SHREW STRIATE CORTEX; HOMONYMOUS HEMIANOPIA; RESIDUAL VISION; CALLOSAL CONNECTIONS; EYE-MOVEMENT; FIELD DEFECTS; FUNCTIONAL SPECIFICITY	Hemianopia patients have lost vision from the contralateral hemifield, but make behavioural adjustments to compensate for this field loss. As a result, their visual performance and behaviour contrast with those of hemineglect patients who fail to attend to objects contralateral to their lesion. These conditions differ in their ocular fixations and perceptual judgments. During visual search, hemianopic patients make more fixations in contralesional space while hemineglect patients make fewer. During line bisection, hemianopic patients fixate the contralesional line segment more and make a small contralesional bisection error, while hemineglect patients make few contralesional fixations and a larger ipsilesional bisection error. Hence, there is an attentional failure for contralesional space in hemineglect but a compensatory adaptation to attend more to the blind side in hemianopia. A challenge for models of visual attentional processes is to show how compensation is achieved in hemianopia, and why such processes are hindered or inaccessible in hemineglect. We used a neurophysiology-derived computational model to examine possible cortical compensatory processes in simulated hemianopia from a V1 lesion and compared results with those obtained with the same processes under conditions of simulated hemineglect from a parietal lesion. A spatial compensatory bias to increase attention contralesionally replicated hemianopic scanning patterns during visual search but not during line bisection. To reproduce the latter required a second process, an extrastriate lateral connectivity facilitating form completion into the blind field: this allowed accurate placement of fixations on contralesional stimuli and reproduced fixation patterns and the contralesional bisection error of hemianopia. Neither of these two cortical compensatory processes was effective in ameliorating the ipsilesional bias in the hemineglect model. Our results replicate normal and pathological patterns of visual scanning, line bisection, and differences between hemianopia and hemineglect, and may explain why compensatory processes that counter the effects of hemianopia are ineffective in hemineglect.	[Lanyon, Linda J.; Barton, Jason J. S.] Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada; [Lanyon, Linda J.; Barton, Jason J. S.] Univ British Columbia, Dept Ophthalmol, Vancouver, BC, Canada; [Lanyon, Linda J.; Barton, Jason J. S.] Univ British Columbia, Dept Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Lanyon, Linda J.] Karolinska Inst, Int Neuroinformat Coordinating Facil Secretariat, Stockholm, Sweden	University of British Columbia; University of British Columbia; University of British Columbia; Karolinska Institutet	Lanyon, LJ (corresponding author), Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada.	linda.lanyon@incf.org	Lanyon, Linda/L-9238-2019; Barton, Jason JS/A-6362-2012	Lanyon, Linda/0000-0002-0885-1825; 	Michael Smith Foundation for Health Research; Canadian Institute of Health Research; Canada Research Chair program	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program(Canada Research Chairs)	LL was supported by a Post Doctoral Fellowship from the Michael Smith Foundation for Health Research and by the Canadian Institute of Health Research. JB was supported by the Canada Research Chair program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Anderson EJ, 2012, CEREB CORTEX, V22, P765, DOI 10.1093/cercor/bhr110; Axenfeld D, 1894, NEUROLOGISCHES CENTR, V13, P437; Barrett AM, 2006, J COGNITIVE NEUROSCI, V18, P1223, DOI 10.1162/jocn.2006.18.7.1223; Bartolomeo P, 2012, FRONTIERS HUMAN NEUR, V6; Barton JJS, 1998, BRAIN, V121, P1117, DOI 10.1093/brain/121.6.1117; Barton JJS, 1997, BRAIN, V120, P681, DOI 10.1093/brain/120.4.681; Barton JJS, 1998, J NEUROL NEUROSUR PS, V64, P660, DOI 10.1136/jnnp.64.5.660; Behrmann M, 2004, CORTEX, V40, P247, DOI 10.1016/S0010-9452(08)70120-5; Behrmann M, 1997, NEUROPSYCHOLOGIA, V35, P1445, DOI 10.1016/S0028-3932(97)00058-4; Berman R, 2009, VISION RES, V49, P1233, DOI 10.1016/j.visres.2008.06.017; BLYTHE IM, 1986, NATURE, V320, P619, DOI 10.1038/320619a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bosking WH, 2000, J NEUROSCI, V20, P2346; BRADDICK O, 1992, NATURE, V360, P461, DOI 10.1038/360461a0; Chavane F, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00004; CHOUDHURY BP, 1965, Q J EXP PHYSIOL CMS, V50, P214, DOI 10.1113/expphysiol.1965.sp001783; DAMASIO AR, 1980, NEUROPSYCHOLOGIA, V18, P123, DOI 10.1016/0028-3932(80)90058-5; Danckert J, 2005, NEUROSCI BIOBEHAV R, V29, P1035, DOI 10.1016/j.neubiorev.2005.02.001; Danziger S, 1998, J EXP PSYCHOL HUMAN, V24, P1467, DOI 10.1037/0096-1523.24.5.1467; Deco G, 2001, LECT NOTES ARTIF INT, V2036, P114; Farivar R, 2009, J NEUROSCI, V29, P5336, DOI 10.1523/JNEUROSCI.4978-08.2009; Faubert J, 2001, PROG BRAIN RES, V134, P399; Faubert J, 1999, VISION RES, V39, P149, DOI 10.1016/S0042-6989(98)00107-2; GASSEL MM, 1963, BRAIN, V86, P1, DOI 10.1093/brain/86.1.1; GASSEL MM, 1963, BRAIN, V86, P229, DOI 10.1093/brain/86.2.229; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GROSSBERG S, 1989, IEEE T BIO-MED ENG, V36, P65, DOI 10.1109/10.16450; Grossberg S, 2000, VISION RES, V40, P1413, DOI 10.1016/S0042-6989(99)00229-1; Heilman K M, 1977, Adv Neurol, V18, P93; Heilman K.M., 1985, INT J CLIN NEUROPSYC, V2nd, P243; Heilman K. M., 1987, NEUROPHYSIOLOGICAL N, V45, P115, DOI [DOI 10.1016/S0166-4115(08)61711-2, 10.1016/S0166-4115(08)61711-2]; HEILMAN KM, 1972, NEUROLOGY, V22, P660, DOI 10.1212/WNL.22.6.660; HEILMAN KM, 1979, ANN NEUROL, V5, P166, DOI 10.1002/ana.410050210; HEILMAN KM, 1979, CLIN NEUROPSYCHOLOGY, P268, DOI DOI 10.1055/S-2008-1041551; HUBEL DH, 1967, J NEUROPHYSIOL, V30, P1561, DOI 10.1152/jn.1967.30.6.1561; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Husain M, 2001, BRAIN, V124, P941, DOI 10.1093/brain/124.5.941; ISHIAI S, 1987, NEUROPSYCHOLOGIA, V25, P675, DOI 10.1016/0028-3932(87)90058-3; ISHIAI S, 1989, BRAIN, V112, P1485, DOI 10.1093/brain/112.6.1485; Kasten E, 2006, NEUROCASE, V12, P98, DOI 10.1080/13554790600582562; Kasten E, 1998, J CLIN EXP NEUROPSYC, V20, P581, DOI 10.1076/jcen.20.5.581.1129; KENNEDY H, 1986, J COMP NEUROL, V247, P398, DOI 10.1002/cne.902470309; Kerkhoff G, 2008, CORTEX, V44, P200, DOI 10.1016/j.cortex.2006.07.002; King SM, 1996, VISUAL NEUROSCI, V13, P1, DOI 10.1017/S0952523800007082; Kinsbourne M, 1970, Trans Am Neurol Assoc, V95, P143; Kinsbourne M., 1987, NEUROPHYSIOLOGICAL N, P69, DOI DOI 10.1016/S0166-4115(08)61709-4; Kinsbourne M, 1993, UNILATERAL NEGLECT C, V6386; Klein RM, 1999, PSYCHOL SCI, V10, P346, DOI 10.1111/1467-9280.00166; Lanyon LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011128; Lanyon LJ, 2009, COGN NEURODYNAMICS, V3, P223, DOI 10.1007/s11571-008-9073-x; Lanyon LJ, 2004, NEURAL NETWORKS, V17, P873, DOI 10.1016/j.neunet.2004.03.012; LEPORE F, 1982, EXP BRAIN RES, V46, P413; Luaute J, 2006, NEUROSCI BIOBEHAV R, V30, P961, DOI 10.1016/j.neubiorev.2006.03.001; Machner B, 2009, J NEUROL, V256, P289, DOI 10.1007/s00415-009-0148-3; Mannan SK, 2010, J NEUROL, V257, P1812, DOI 10.1007/s00415-010-5615-3; Mazer JA, 2011, BIOL PSYCHIAT, V69, P1147, DOI 10.1016/j.biopsych.2011.03.014; McCarthy RA, 2006, NEUROPSYCHOLOGIA, V44, P1269, DOI 10.1016/j.neuropsychologia.2006.01.036; MEIENBERG O, 1981, ANN NEUROL, V9, P537, DOI 10.1002/ana.410090605; Milner A. D., 1995, VISUAL BRAIN ACTION; Mitra AR, 2010, NEUROPSYCHOLOGIA, V48, P1742, DOI 10.1016/j.neuropsychologia.2010.02.023; Motter BC, 1998, VISION RES, V38, P1805, DOI 10.1016/S0042-6989(97)00349-0; Nelles G, 2010, J NEUROL, V257, P1832, DOI 10.1007/s00415-010-5617-1; Nelles G, 2009, J NEUROL, V256, P726, DOI 10.1007/s00415-009-5005-x; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; PERENIN MT, 1975, NEUROPSYCHOLOGIA, V13, P1, DOI 10.1016/0028-3932(75)90041-X; Poggel DA, 2004, NEUROLOGY, V63, P2069, DOI 10.1212/01.WNL.0000145773.26378.E5; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; POPPELREUTER W, 1917, PSYCHISCHEN SCHADIGU, V1; POSNER MI, 1984, J NEUROSCI, V4, P1863; RIDDOCH MJ, 1983, NEUROPSYCHOLOGIA, V21, P589, DOI 10.1016/0028-3932(83)90056-8; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Romano JG, 2008, J NEUROL SCI, V273, P70, DOI 10.1016/j.jns.2008.06.026; Rushmore RJ, 2006, BRAIN, V129, P1803, DOI 10.1093/brain/awl140; SANDERS MD, 1974, LANCET, V1, P707; Schall JD, 2002, PHILOS T ROY SOC B, V357, P1073, DOI 10.1098/rstb.2002.1098; Scharli H, 1999, J COGNITIVE NEUROSCI, V11, P52, DOI 10.1162/089892999563247; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Schmidt KE, 1997, J NEUROSCI, V17, P5480; Scialfa CT, 1998, PERCEPT PSYCHOPHYS, V60, P1067, DOI 10.3758/BF03211940; Simpson SA, 2011, RAPID ADAPTATION VIS; Stoerig P, 1996, NEUROREPORT, V7, P1990, DOI 10.1097/00001756-199608120-00027; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; Stoerig P, 2007, CURR BIOL, V17, pR822, DOI 10.1016/j.cub.2007.07.016; Umilta C, 1988, HDB NEUROPSYCHOLOGY, P175; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Van der Stigchel S, 2010, BRAIN COGNITION, V74, P66, DOI 10.1016/j.bandc.2010.06.006; Van der Stigchel S, 2008, J COGNITIVE NEUROSCI, V20, P2025, DOI 10.1162/jocn.2008.20145; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; Verlohr D, 2007, STRABISMUS, V15, P63, DOI 10.1080/09273970601180305; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WARRINGTON EK, 1962, J NEUROL NEUROSUR PS, V25, P208, DOI 10.1136/jnnp.25.3.208; WATSON RT, 1979, NEUROLOGY, V29, P690, DOI 10.1212/WNL.29.5.690; Weil RS, 2009, NEUROPSYCHOLOGIA, V47, P457, DOI 10.1016/j.neuropsychologia.2008.09.020; Weiskrantz L, 1996, CURR OPIN NEUROBIOL, V6, P215, DOI 10.1016/S0959-4388(96)80075-4; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; WEISKRANTZ L, 1987, BRAIN, V110, P77, DOI 10.1093/brain/110.1.77; Wessinger CM, 1996, PROG BRAIN RES, V112, P405; Wessinger CM, 1996, NEUROPSYCHOLOGIA, V34, P1129, DOI 10.1016/0028-3932(96)00023-1; Williams DE, 2001, PSYCHON B REV, V8, P476, DOI 10.3758/BF03196182; Zihl J, 2009, NEUROPSYCHOLOGIA, V47, P2417, DOI 10.1016/j.neuropsychologia.2009.04.009	102	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54919	10.1371/journal.pone.0054919	http://dx.doi.org/10.1371/journal.pone.0054919			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390506	Green Submitted, gold, Green Published			2022-12-25	WOS:000314691100022
J	Peter, JG; Theron, G; Dheda, K				Peter, Jonathan G.; Theron, Grant; Dheda, Keertan			Can Point-of-Care Urine LAM Strip Testing for Tuberculosis Add Value to Clinical Decision Making in Hospitalised HIV-Infected Persons?	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; DIAGNOSTIC-ACCURACY; LOW-COST; LIPOARABINOMANNAN; ASSAY; ALGORITHM	Background: The urine lipoarabinomannan (LAM) strip-test (Determine (R)-TB) can rapidly rule-in TB in HIV-infected persons with advanced immunosuppression. However, given high rates of empiric treatment amongst hospitalised patients in high-burden settings (similar to 50%) it is unclear whether LAM can add any value to clinical decision making, or identify a subset of patients with unfavourable outcomes that would otherwise have been missed by empiric treatment. Methods: 281 HIV-infected hospitalised patients with suspected TB received urine LAM strip testing, and were categorised as definite (culture-positive), probable-, or non-TB. Both the proportion and morbidity of TB cases identified by LAM testing, early empiric treatment (initiated prior to test result availability) and a set of clinical predictors were compared across groups. Results: 187/281 patients had either definite- (n = 116) or probable-TB (n = 71). As a rule-in test for definite and probable-TB, LAM identified a similar proportion of TB cases compared to early empiric treatment (85/187 vs. 93/187, p = 0.4), but a greater proportion than classified by a set of clinical predictors alone (19/187; p<0.001). Thirty-nine of the 187 (21%) LAM-positive patients who had either definite- or probable-TB were missed by early empiric treatment, and of these 25/39 (64%) would also have been missed by smear microscopy. Thus, 25/187 (8%) of definite- or probable-TB patients with otherwise delayed initiation of TB treatment could be detected by the LAM strip test. LAM-positive patients missed by early empiric treatment had a lower median CD4 count (p = 0.008), a higher median illness severity score (p = 0.001) and increased urea levels (p = 0.002) compared to LAM-negative patients given early empiric treatment. Conclusions: LAM strip testing outperformed TB diagnosis based on clinical criteria but in day-to-day practice identified a similar proportion of patients compared to early empiric treatment. However, compared to empiric treatment, LAM identified a different subset of patients with more advanced immunosuppression and greater disease severity.	[Peter, Jonathan G.; Theron, Grant; Dheda, Keertan] Univ Cape Town, Dept Med, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Peter, Jonathan G.; Theron, Grant; Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] UCL, Sch Med, Dept Infect, London W1N 8AA, England	University of Cape Town; University of Cape Town; University of Cape Town; University of London; University College London; UCL Medical School	Dheda, K (corresponding author), Univ Cape Town, Dept Med, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	Keertan.Dheda@uct.ac.za	Theron, Grant/ABB-1167-2020	Theron, Grant/0000-0002-9216-2415; Peter, Jonathan/0000-0002-2658-0723	Carnegie Academic Fellowship; SAMA fellowship; EDCTP (TB-NEAT); South African National Research Foundation; Claude Leon Foundation; EDCTP (TB-NEAT, TESA); SA DST; SA NRF (SARChI)	Carnegie Academic Fellowship; SAMA fellowship; EDCTP (TB-NEAT); South African National Research Foundation(National Research Foundation - South Africa); Claude Leon Foundation; EDCTP (TB-NEAT, TESA); SA DST; SA NRF (SARChI)	JP is supported by a Carnegie Academic Fellowship, a SAMA fellowship and the EDCTP (TB-NEAT). GT is supported by the EDCTP (TB-NEAT), the South African National Research Foundation, and the Claude Leon Foundation. KD is supported by the EDCTP (TB-NEAT, TESA), the SA DST and the SA NRF (SARChI). Alere provided in kind co-funding in the form of ELISA and LAM strip tests free of charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakari M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-32; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Edginton ME, 2005, INT J TUBERC LUNG D, V9, P398; Gill CJ, 2005, BRIT MED J, V330, P1080, DOI 10.1136/bmj.330.7499.1080; Holtz TH, 2011, LANCET INFECT DIS, V11, P533, DOI 10.1016/S1473-3099(11)70057-3; Koole O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018502; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Pai NP, 2012, DISCOV MED, V13, P35; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Peter JG, 2012, EUR RESPIR MONOGR, P124, DOI 10.1183/1025448x.10023211; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Peter JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039966; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Talbot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032876; Theron G, 2011, LANCET, V378, P481, DOI 10.1016/S0140-6736(11)61242-7; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Wilson D, 2011, INT J TUBERC LUNG D, V15, P919, DOI 10.5588/ijtld.10.0440	24	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54875	10.1371/journal.pone.0054875	http://dx.doi.org/10.1371/journal.pone.0054875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390504	gold, Green Submitted, Green Published			2022-12-25	WOS:000314691100020
J	Allen, M; Bird, C; Feng, W; Liu, GL; Li, WQ; Perrone-Bizzozero, NI; Feng, Y				Allen, Megan; Bird, Clark; Feng, Wei; Liu, Guanglu; Li, Wenqi; Perrone-Bizzozero, Nora I.; Feng, Yue			HuD Promotes BDNF Expression in Brain Neurons via Selective Stabilization of the BDNF Long 3 ' UTR mRNA	PLOS ONE			English	Article							BINDING PROTEIN HUD; NEUROTROPHIC FACTOR; POSTTRANSCRIPTIONAL REGULATION; DEPENDENT TRANSLATION; NEURITE OUTGROWTH; UP-REGULATION; GAP-43 GENE; LOCALIZATION; CELLS; OVEREXPRESSION	Complex regulation of brain-derived neurotrophic factor (BDNF) governs its intricate functions in brain development and neuronal plasticity. Besides tight transcriptional control from multiple distinct promoters, alternative 3'end processing of the BDNF transcripts generates either a long or a short 3'untranslated region (3'UTR). Previous reports indicate that distinct RNA sequence in the BDNF 3'UTRs differentially regulates BDNF production in the brain to accommodate neuronal activity changes, conceivably through differential interactions with undefined trans-acting factors that regulate stability and translation of these BDNF mRNA isoforms. In this study, we report that the neuronal RNA-binding protein (RBP) HuD interacts with a highly conserved AU-rich element (ARE) specifically located in the BDNF long 3'UTR. Such interaction is necessary and sufficient for selective stabilization of mRNAs that contain the BDNF long 3'UTR in vitro and in vivo. Moreover, in a HuD transgenic mouse model, the BDNF long 3'UTR mRNA is increased in the hippocampal dentate granule cells (DGCs), leading to elevated expression of BDNF protein that is transported and stored in the mossy fiber (MF) terminals. Our results identify HuD as the first trans-acting factor that enhances BDNF expression specifically through the long 3'UTR and a novel mechanism that regulates BDNF protein production in selected neuronal populations by HuD abundance.	[Allen, Megan; Feng, Wei; Liu, Guanglu; Li, Wenqi; Feng, Yue] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Bird, Clark; Perrone-Bizzozero, Nora I.] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA	Emory University; University of New Mexico	Perrone-Bizzozero, NI (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	nbizzozero@salud.unm.edu; yfeng@emory.edu	FENG, WEI/B-8713-2018	FENG, WEI/0000-0002-9106-4258; Feng, Yue/0000-0002-7905-2182; Bird, Clark/0000-0001-7712-6531	National Institutes of Health [5R01NS070526]; March of Dimes [6-FY2012-378, 5R01NS030255, 1R01DA034097]; Fraxa postdoctoral fellowship;  [5T32GM008602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602, T32GM008367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030255, R01NS070526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034097, R21DA034452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Fraxa postdoctoral fellowship; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health 5R01NS070526 and March of Dimes 6-FY2012-378 to YF, 5R01NS030255 and 1R01DA034097 to NPB. WF is partly supported by the Fraxa postdoctoral fellowship. MA is a trainee supported by 5T32GM008602. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Anderson KD, 2003, EXP NEUROL, V183, P100, DOI 10.1016/S0014-4886(03)00103-1; Anderson KD, 2000, J NEUROCHEM, V75, P1103, DOI 10.1046/j.1471-4159.2000.0751103.x; Anderson KD, 2001, EXP NEUROL, V168, P250, DOI 10.1006/exnr.2000.7599; Beckel-Mitchener AC, 2002, J BIOL CHEM, V277, P27996, DOI 10.1074/jbc.M201982200; Bolognani F, 2006, J NEUROCHEM, V96, P790, DOI 10.1111/j.1471-4159.2005.03607.x; Bolognani F, 2004, NEUROSCI LETT, V371, P152, DOI 10.1016/j.neulet.2004.08.074; Bolognani F, 2007, NEUROCHEM RES, V32, P2142, DOI 10.1007/s11064-007-9388-8; Bolognani F, 2007, NEUROBIOL LEARN MEM, V87, P635, DOI 10.1016/j.nlm.2006.11.004; Bolognani F, 2010, NUCLEIC ACIDS RES, V38, P117, DOI 10.1093/nar/gkp863; Castren E, 1998, PROG BRAIN RES, V117, P57; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chung SM, 1997, J BIOL CHEM, V272, P6593, DOI 10.1074/jbc.272.10.6593; Danzer SC, 2004, J NEUROSCI, V24, P11346, DOI 10.1523/JNEUROSCI.3846-04.2004; Danzer SC, 2004, HIPPOCAMPUS, V14, P345, DOI 10.1002/hipo.10190; Deschenes-Furry J, 2006, BIOESSAYS, V28, P822, DOI 10.1002/bies.20449; Fukao A, 2009, MOL CELL, V36, P1007, DOI 10.1016/j.molcel.2009.11.013; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Li Y, 2004, J BIOCHEM BIOPH METH, V60, P85, DOI 10.1016/j.jbbm.2004.03.008; Lim CS, 2012, HIPPOCAMPUS, V22, P2303, DOI 10.1002/hipo.22048; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Miura P, 2012, J NEUROCHEM, V120, P230, DOI 10.1111/j.1471-4159.2011.07583.x; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Obata N, 2011, BIOCHEM BIOPH RES CO, V408, P139, DOI 10.1016/j.bbrc.2011.03.137; Okano HJ, 1997, J NEUROSCI, V17, P3024; Pascale A, 2004, P NATL ACAD SCI USA, V101, P1217, DOI 10.1073/pnas.0307674100; Pattabiraman PP, 2005, MOL CELL NEUROSCI, V28, P556, DOI 10.1016/j.mcn.2004.11.010; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Perrone-Bizzozero N, 2012, FRONTIERS BIOSCIENCE; Perrone-Bizzozero NI, 2011, ASN NEURO, V3, DOI 10.1042/AN20110015; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; Tiruchinapalli DM, 2008, J NEUROCHEM, V107, P1529, DOI 10.1111/j.1471-4159.2008.05718.x; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Zhao LX, 2006, J NEUROSCI, V26, P11278, DOI 10.1523/JNEUROSCI.2677-06.2006; Zhao LX, 2010, P NATL ACAD SCI USA, V107, P19061, DOI 10.1073/pnas.1007487107	44	39	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55718	10.1371/journal.pone.0055718	http://dx.doi.org/10.1371/journal.pone.0055718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383270	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600150
J	Miller, MF; Cohen, ED; Baggs, JE; Hogenesch, JB; Morrisey, EE				Miller, Mayumi F.; Cohen, Ethan David; Baggs, Julie E.; Hogenesch, John B.; Morrisey, Edward E.			High Throughput Genomic Screen Identifies Multiple Factors That Promote Cooperative Wnt Signaling	PLOS ONE			English	Article							BETA-CATENIN; EMBRYONIC-DEVELOPMENT; DEPENDENT ACTIVATION; HOMEOBOX GENE; EXPRESSION; INTERACT; MOUSE; CELLS; MSX2; COACTIVATORS	Previous studies have demonstrated that certain Wnt ligands can promote high levels of cooperative signaling in a cell type specific manner. To explore the underlying mechanism of this cooperative Wnt signaling, we performed a high-throughput screen of more than 14,000 cDNAs to identify genes that promote cooperative Wnt signaling in the context of a single Wnt ligand, Wnt2. This screen identified several homeobox factors including Msx2, Nkx5.2, and Esx1, in addition to other factors known to promote Wnt signaling including Pias4. Generation of dominant-active or dominant-negative forms of Msx2 indicate that the mechanism by which homeobox factors cooperatively promote Wnt signaling is through their ability to repress gene transcription. These data identify a broad homeobox code, which acts to increase Wnt signaling through transcriptional repression.	[Miller, Mayumi F.; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Baggs, Julie E.; Hogenesch, John B.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Cohen, Ethan David] Univ Rochester, Sch Med & Dent, Dept Med, Div Endocrinol & Metab, Rochester, NY 14642 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Rochester	Morrisey, EE (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu			National Institutes for Health [HL087825, HL100405, HL110942]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL110942, R01HL087825, U01HL100405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by funding from the National Institutes for Health (HL087825, HL100405, HL110942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; BOBER E, 1994, DEV BIOL, V162, P288, DOI 10.1006/dbio.1994.1086; Boras K, 2002, J BIOL CHEM, V277, P1120, DOI 10.1074/jbc.M109912200; Boras-Granic K, 2006, INT J DEV BIOL, V50, P601, DOI 10.1387/ijdb.062153kb; Cajanek L, 2010, J CELL BIOCHEM, V111, P1077, DOI 10.1002/jcb.22771; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Cheng SL, 2008, J BIOL CHEM, V283, P20505, DOI 10.1074/jbc.M800851200; Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Gitler AD, 2003, DEV DYNAM, V228, P643, DOI 10.1002/dvdy.10418; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; HOLLAND PWH, 1991, GENE, V98, P253, DOI 10.1016/0378-1119(91)90182-B; Hussein SM, 2003, J BIOL CHEM, V278, P48805, DOI 10.1074/jbc.M305472200; Ihara M, 2005, MOL CELL BIOL, V25, P3506, DOI 10.1128/MCB.25.9.3506-3518.2005; Li YH, 1997, DEV BIOL, V188, P85, DOI 10.1006/dbio.1997.8640; Marfil V, 2010, J BIOL CHEM, V285, P5726, DOI 10.1074/jbc.M109.046649; Miller KA, 2007, DEV BIOL, V311, P665, DOI 10.1016/j.ydbio.2007.07.022; Miller MF, 2012, PNAS; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rossol-Allisone J, 2009, CELL SIGNAL, V21, P1559, DOI 10.1016/j.cellsig.2009.05.010; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Song LY, 2009, DEVELOPMENT, V136, P3161, DOI 10.1242/dev.037440; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204	28	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55782	10.1371/journal.pone.0055782	http://dx.doi.org/10.1371/journal.pone.0055782			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383281	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600158
J	Padilla, FM; Mommer, L; de Caluwe, H; Smit-Tiekstra, AE; Wagemaker, CAM; Ouborg, NJ; de Kroon, H				Padilla, Francisco M.; Mommer, Liesje; de Caluwe, Hannie; Smit-Tiekstra, Annemiek E.; Wagemaker, Cornelis A. M.; Ouborg, N. Joop; de Kroon, Hans			Early Root Overproduction Not Triggered by Nutrients Decisive for Competitive Success Belowground	PLOS ONE			English	Article							INTERSPECIFIC COMPETITION; PLANT DIVERSITY; NICHE DIFFERENTIATION; SEED YIELD; PRODUCTIVITY; COMMUNITIES; MAINTENANCE; MECHANISMS; ABUNDANCE; FEEDBACK	Background: Theory predicts that plant species win competition for a shared resource by more quickly preempting the resource in hotspots and by depleting resource levels to lower concentrations than its competitors. Competition in natural grasslands largely occurs belowground, but information regarding root interactions is limited, as molecular methods quantifying species abundance belowground have only recently become available. Principal Findings: In monoculture, the grass Festuca rubra had higher root densities and a faster rate of soil nitrate depletion than Plantago lanceolata, projecting the first as a better competitor for nutrients. However, Festuca lost in competition with Plantago. Plantago not only replaced the lower root mass of its competitor, but strongly overproduced roots: with only half of the plants in mixture than in monoculture, Plantago root densities in mixture were similar or higher than those in its monocultures. These responses occurred equally in a nutrient-rich and nutrient-poor soil layer, and commenced immediately at the start of the experiment when root densities were still low and soil nutrient concentrations high. Conclusions/Significance: Our results suggest that species may achieve competitive superiority for nutrients by root growth stimulation prior to nutrient depletion, induced by the presence of a competitor species, rather than by a better ability to compete for nutrients per se. The root overproduction by which interspecific neighbors are suppressed independent of nutrient acquisition is consistent with predictions from game theory. Our results emphasize that root competition may be driven by other mechanisms than is currently assumed. The long-term consequences of these mechanisms for community dynamics are discussed.	[Padilla, Francisco M.; Mommer, Liesje; de Caluwe, Hannie; Smit-Tiekstra, Annemiek E.; Wagemaker, Cornelis A. M.; Ouborg, N. Joop; de Kroon, Hans] Radboud Univ Nijmegen, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands; [Mommer, Liesje] Wageningen Univ, NL-6700 AP Wageningen, Netherlands	Radboud University Nijmegen; Wageningen University & Research	Padilla, FM (corresponding author), Univ Almeria, Dept Agron, La Canada De San Urbano, Almeria, Spain.	f.padilla@ual.es	de Kroon, Hans/B-3359-2009; Mommer, Liesje/ABF-7005-2020; Wagemaker, C.A.M./N-6570-2018; Ouborg, Joop/C-1028-2011; Padilla, Francisco/C-5204-2009	de Kroon, Hans/0000-0001-6151-3561; Mommer, Liesje/0000-0002-3775-0716; Padilla, Francisco/0000-0003-1021-0258	Spanish Ministry of Education; Stipendium Bottelier (KNBV); Veni grant [016091116]	Spanish Ministry of Education(Spanish Government); Stipendium Bottelier (KNBV); Veni grant	F.M.P. was supported by a postdoc grant (Spanish Ministry of Education) and Stipendium Bottelier (KNBV), and L.M. by a Veni grant (016091116, NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bartelheimer M, 2006, PLANT SOIL, V280, P101, DOI 10.1007/s11104-005-2612-x; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; BERENDSE F, 1979, OECOLOGIA, V43, P19, DOI 10.1007/BF00346669; BERENDSE F, 1981, OECOLOGIA, V48, P334, DOI 10.1007/BF00346491; BERENDSE F, 1983, J ECOL, V71, P379, DOI 10.2307/2259721; Bertin C, 2007, P NATL ACAD SCI USA, V104, P16964, DOI 10.1073/pnas.0707198104; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Brassard BW, 2011, FUNCT ECOL, V25, P238, DOI 10.1111/j.1365-2435.2010.01769.x; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Chen BJW, 2012, PLANT SCI, V195, P157, DOI 10.1016/j.plantsci.2012.07.006; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Craine JM, 2005, J ECOL, V93, P1041, DOI 10.1111/j.1365-2745.2005.01043.x; Craine JM, 2005, NEW PHYTOL, V166, P933, DOI 10.1111/j.1469-8137.2005.01386.x; Craine JM, 2006, PLANT SOIL, V285, P171, DOI 10.1007/s11104-006-9002-x; de Kroon H, 2007, SCIENCE, V318, P1562, DOI 10.1126/science.1150726; de Kroon H, 2012, J ECOL, V100, P6, DOI 10.1111/j.1365-2745.2011.01906.x; DE WIT C. T., 1960, Versl. landbouwkund. Onderzoek; Fargione J, 2006, FUNCT ECOL, V20, P533, DOI 10.1111/j.1365-2435.2006.01116.x; Fargione J, 2005, OECOLOGIA, V143, P598, DOI 10.1007/s00442-005-0010-y; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; Goldberg D. E., 1990, Perspectives on plant competition., P27; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Grime J. P., 1994, EXPLOITATION ENV HET, P1; Hendriks M, 2013, J ECOLOGY IN PRESS; Inderjit, 2011, TRENDS ECOL EVOL, V26, P655, DOI 10.1016/j.tree.2011.08.003; Kulmatiski A, 2012, P ROY SOC B-BIOL SCI, V279, P3020, DOI 10.1098/rspb.2012.0285; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Li L, 2006, OECOLOGIA, V147, P280, DOI 10.1007/s00442-005-0256-4; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; MAHALL BE, 1992, ECOLOGY, V73, P2145, DOI 10.2307/1941462; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Mills KE, 1998, ECOLOGY, V79, P1595, DOI 10.1890/0012-9658(1998)079[1595:MODWPC]2.0.CO;2; Mitchell CE, 2010, ECOL LETT, V13, P1525, DOI 10.1111/j.1461-0248.2010.01543.x; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Mommer L, 2008, MOL ECOL RESOUR, V8, P947, DOI 10.1111/j.1755-0998.2008.02130.x; Mommer L, 2011, PLANT SOIL, V348, P115, DOI 10.1007/s11104-011-0962-0; Mommer L, 2010, J ECOL, V98, P1117, DOI 10.1111/j.1365-2745.2010.01702.x; O'Brien EE, 2005, NEW PHYTOL, V168, P401, DOI 10.1111/j.1469-8137.2005.01520.x; O'Brien EE, 2007, P ROY SOC B-BIOL SCI, V274, P929, DOI 10.1098/rspb.2006.0113; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Piper JK, 1998, AGR ECOSYST ENVIRON, V68, P1, DOI 10.1016/S0167-8809(97)00097-2; Polley HW, 2007, BASIC APPL ECOL, V8, P209, DOI 10.1016/j.baae.2006.02.006; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Robinson D, 1999, P ROY SOC B-BIOL SCI, V266, P431, DOI 10.1098/rspb.1999.0656; Roscher C, 2007, OECOLOGIA, V154, P535, DOI 10.1007/s00442-007-0846-4; Schenk HJ, 2006, J ECOL, V94, P725, DOI 10.1111/j.1365-2745.2006.01124.x; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Semchenko M, 2007, NEW PHYTOL, V176, P644, DOI 10.1111/j.1469-8137.2007.02211.x; Semchenko M, 2010, EVOL ECOL, V24, P1433, DOI 10.1007/s10682-010-9401-6; Tilman D., 1982, Monographs in Population Biology, pi; van Ruijven J, 2009, OIKOS, V118, P101, DOI 10.1111/j.1600-0706.2008.17119.x; VANDENBERGH JP, 1970, J APPL ECOL, V7, P311, DOI 10.2307/2401382; Venterink HO, 2010, FUNCT ECOL, V24, P877, DOI 10.1111/j.1365-2435.2010.01692.x; von Felten S, 2012, ECOLOGY, V93, P2386, DOI 10.1890/11-1439.1; WEDIN D, 1993, ECOL MONOGR, V63, P199, DOI 10.2307/2937180	62	57	61	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55805	10.1371/journal.pone.0055805	http://dx.doi.org/10.1371/journal.pone.0055805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383284	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600161
J	Zheng, LD; Qi, T; Yang, DH; Qi, M; Li, D; Xiang, X; Huang, K; Tong, QS				Zheng, Liduan; Qi, Teng; Yang, Dehua; Qi, Meng; Li, Dan; Xiang, Xuan; Huang, Kai; Tong, Qiangsong			microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1	PLOS ONE			English	Article							REGULATES E-CADHERIN; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; OVARIAN-CANCER; BREAST-CANCER; EXPRESSION; CARCINOMA; MIR-9; ADENOCARCINOMA; PROTOONCOGENE	Recent evidence shows that altered microRNA-9 (miR-9) expression is implicated in the progression of gastric cancer. However, the exact roles and underlying mechanisms of miR-9 in the proliferation, invasion and metastasis of gastric cancer still remain unknown. In this study, miR-9 was found to be down-regulated and inversely correlated with the expression of cyclin D1 and v-ets erythroblastosis virus E26 oncogene homolog 1 (Ets1) in gastric cancer tissues and cell lines. Bioinformatics analysis revealed the putative miR-9 binding sites in the 3'-untranslated regions (3'-UTR) of cyclin D1 and Ets1 mRNA. Ectopic expression or knockdown of miR-9 resulted in responsively altered expression of cyclin D1, Ets1 and their downstream targets phosphorylated retinoblastoma and matrix metalloproteinase 9 in cultured gastric cancer cell lines SGC-7901 and AGS. In the luciferase reporter system, miR-9 directly targeted the 3'-UTR of cyclin D1 and Ets1, and these effects were abolished by mutating the miR-9 binding sites. Over-expression of miR-9 suppressed the proliferation, invasion, and metastasis of SGC-7901 and AGS cells in vitro and in vivo. Restoration of miR-9-mediated down-regulation of cyclin D1 and Ets1 by transient transfection, rescued the cancer cells from decrease in proliferation, migration and invasion. Furthermore, anti-miR-9 inhibitor promoted the proliferation, migration and invasion of gastric cancer cells, while knocking down of cyclin D1 or Ets1 partially phenocopied the effects of miR-9 over-expression. These data indicate that miR-9 suppresses the expression of cyclin D1 and Ets1 via the binding sites in their 3'-UTR, thus inhibiting the proliferation, invasion and metastasis of gastric cancer.	[Zheng, Liduan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pathol, Wuhan 430074, Hubei Province, Peoples R China; [Zheng, Liduan; Huang, Kai; Tong, Qiangsong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Clin Ctr Human Genom Res, Wuhan 430074, Hubei Province, Peoples R China; [Qi, Teng; Yang, Dehua; Qi, Meng; Li, Dan; Xiang, Xuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Surg, Wuhan 430074, Hubei Province, Peoples R China; [Huang, Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tong, QS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Clin Ctr Human Genom Res, Wuhan 430074, Hubei Province, Peoples R China.	qs_tong@hotmail.com	Tong, Qiangsong/B-4500-2014	Tong, Qiangsong/0000-0002-2615-6404; Zheng, Liduan/0000-0001-5566-673X	National Natural Science Foundation of China [30600278, 30772359, 81071997, 81072073, 81272779]; Program for New Century Excellent Talents in University [NCET-06-0641]; Scientific Research Foundation for the Returned Overseas Chinese Scholars [2008-889]; Fundamental Research Funds for the Central Universities [2012QN224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Supported by the National Natural Science Foundation of China (No. 30600278, No. 30772359, No. 81071997, No. 81072073, No. 81272779), Program for New Century Excellent Talents in University (NCET-06-0641), Scientific Research Foundation for the Returned Overseas Chinese Scholars (2008-889), and Fundamental Research Funds for the Central Universities (2012QN224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Endo K, 2006, HUM PATHOL, V37, P1111, DOI 10.1016/j.humpath.2006.03.020; Guo LM, 2009, FEBS J, V276, P5537, DOI 10.1111/j.1742-4658.2009.07237.x; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Hsu PY, 2009, CANCER RES, V69, P5936, DOI 10.1158/0008-5472.CAN-08-4914; Inoue T, 2012, ONCOL REP, V27, P1759, DOI 10.3892/or.2012.1709; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Jiang GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031379; KATO J, 1993, GENE DEV, V7, P331; Ke Yang, 1994, Zhonghua Zhongliu Zazhi, V16, P7; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Liu SJ, 2012, J PATHOL, V226, P61, DOI 10.1002/path.2964; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Nakayama T, 2001, MODERN PATHOL, V14, P415, DOI 10.1038/modpathol.3880328; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Noguchi T, 2001, AM J CLIN PATHOL, V115, P828; Omura N, 2008, CANCER BIOL THER, V7, P1146, DOI 10.4161/cbt.7.7.6208; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Rotkrua P, 2011, INT J CANCER, V129, P2611, DOI 10.1002/ijc.25923; Sahin A, 2005, INT J MOL MED, V15, P771; Saito Y, 2012, BIOCHEM BIOPH RES CO, V426, P33, DOI 10.1016/j.bbrc.2012.08.012; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Terry MB, 2002, SEMIN RADIAT ONCOL, V12, P111, DOI 10.1053/srao.30814; Tong OS, 2008, ANTI-CANCER DRUG, V19, P573, DOI 10.1097/CAD.0b013e3282fc46b0; Tsai KW, 2011, EPIGENETICS-US, V6, P1189, DOI 10.4161/epi.6.10.16535; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Wan HY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-16; Wang HJ, 2010, EUR J CANCER, V46, P2295, DOI 10.1016/j.ejca.2010.05.012; Wang XT, 2012, WORLD J GASTROENTERO, V18, P1903, DOI 10.3748/wjg.v18.i16.1903; Wilting SM, 2013, ONCOGENE, V32, P106, DOI 10.1038/onc.2012.20; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Younger ST, 2011, NUCLEIC ACIDS RES, V39, P5682, DOI 10.1093/nar/gkr155; Yu Y, 2003, WORLD J GASTROENTERO, V9, P2154; Zhang HY, 2012, MOL CANCER THER, V11, P1454, DOI 10.1158/1535-7163.MCT-12-0001; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714; Zheng LD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-33	50	144	152	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55719	10.1371/journal.pone.0055719	http://dx.doi.org/10.1371/journal.pone.0055719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383271	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600151
J	Hu, LYR; Kontrogianni-Konstantopoulos, A				Hu, Li-Yen R.; Kontrogianni-Konstantopoulos, Aikaterini			The kinase domains of obscurin interact with intercellular adhesion proteins	FASEB JOURNAL			English	Article						myosin light chain; N-cadherin; sodium-potassium ATPase	UNC-89 OBSCURIN; GENE; ISOFORM; FAMILY; MLCK; PHOSPHORYLATION; IDENTIFICATION; LOCALIZATION; INVOLVEMENT; EXPRESSION	Obscurins comprise a family of giant (similar to 870- to 600-kDa) and small (similar to 250- to 55-kDa) proteins that play important roles in myofibrillogenesis, cytoskeletal organization, and cell adhesion and are implicated in hypertrophic cardiomyopathy and tumorigenesis. Giant obscurins are composed of tandem structural and signaling motifs, including 2 serine/threonine kinase domains, SK1 and SK2, present at the COOH terminus of giant obscurin-B. Using biochemical and cellular approaches, we show for the first time that both SK1 and SK2 possess enzymatic activities and undergo autophosphorylation. SK2 can phosphorylate the cytoplasmic domain of N-cadherin, a major component of adherens junctions, and SK1 can interact with the extracellular domain of the beta(1)-subunit of the Na+/K+-ATPase, which also resides in adherens junctions. Immunostaining of nonpermeabilized myofibers and cardiocytes revealed that some obscurin kinase isoforms localize extracellularly. Quantification of the exofacial expression of obscurin kinase proteins indicated that they occupy similar to 16 and similar to 5% of the sarcolemmal surface in myofibers and cardiocytes, respectively. Treatment of heart lysates with peptide-N-glycosidase F revealed that while giant obscurin-B localizes intracellularly, possessing dual kinase activity, a small obscurin kinase isoform that contains SK1 localizes extracellularly, where it undergoes N-glycosylation. Collectively, our studies demonstrate that the obscurin kinase domains are enzymatically active and may be involved in the regulation of cell adhesion.	[Hu, Li-Yen R.; Kontrogianni-Konstantopoulos, Aikaterini] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Kontrogianni-Konstantopoulos, A (corresponding author), Univ Maryland, Sch Med, 108 N Greene St, Baltimore, MD 21201 USA.	akons001@umaryland.edu			U.S. National Institutes of Health [5T32GM08181-23, 2T32AR7592-16]; American Heart Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. J. W. Lederer, B. Prosser, and M. Bamgboye (University of Maryland) for providing the primary cultures of adult mouse cardiocytes. This work was supported by U.S. National Institutes of Health training grants 5T32GM08181-23 and 2T32AR7592-16 (L.-Y.R.H.) and the American Heart Association (A.K.K.).	Ackermann MA, 2009, MOL BIOL CELL, V20, P2963, DOI 10.1091/mbc.E08-12-1251; Borisov AB, 2003, BIOCHEM BIOPH RES CO, V310, P910, DOI 10.1016/j.bbrc.2003.09.035; Borisov AB, 2008, J CELL BIOCHEM, V103, P1621, DOI 10.1002/jcb.21551; Bowman AL, 2007, FEBS LETT, V581, P1549, DOI 10.1016/j.febslet.2007.03.011; Carlsson L, 2008, HISTOCHEM CELL BIOL, V130, P91, DOI 10.1007/s00418-008-0413-z; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; Fukuzawa A, 2005, J MUSCLE RES CELL M, V26, P427, DOI 10.1007/s10974-005-9025-6; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hsieh CM, 2000, J BIOL CHEM, V275, P36966, DOI 10.1074/jbc.M006028200; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Liu XL, 2009, CIRCULATION, V119, P261, DOI 10.1161/CIRCULATIONAHA.108.799536; McDonough AA, 1996, AM J PHYSIOL-CELL PH, V270, pC1221, DOI 10.1152/ajpcell.1996.270.4.C1221; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Perry NA, 2012, FASEB J, V26, P2764, DOI 10.1096/fj.12-205419; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Qadota H, 2008, MOL BIOL CELL, V19, P2424, DOI 10.1091/mbc.E08-01-0053; Qadota H, 2007, MOL BIOL CELL, V18, P4317, DOI 10.1091/mbc.E07-03-0278; Qi JF, 2006, MOL BIOL CELL, V17, P1261, DOI 10.1091/mbc.E05-10-0927; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Russell MW, 2002, GENE, V282, P237, DOI 10.1016/S0378-1119(01)00795-8; Small TM, 2004, J MOL BIOL, V342, P91, DOI 10.1016/j.jmb.2004.07.006; Spooner PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040182; Sutter SB, 2004, DEV GENES EVOL, V214, P352, DOI 10.1007/s00427-004-0413-5; Tokhtaeva E, 2012, J CELL SCI, V125, P1605, DOI 10.1242/jcs.100149; Vagin O, 2012, AM J PHYSIOL-CELL PH, V302, pC1271, DOI 10.1152/ajpcell.00456.2011; Weinert S, 2006, J CELL BIOL, V173, P559, DOI 10.1083/jcb.200601014; Xiong G, 2009, J MOL BIOL, V386, P976, DOI 10.1016/j.jmb.2009.01.016	32	30	34	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					2001	2012		10.1096/fj.12-221317	http://dx.doi.org/10.1096/fj.12-221317			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23392350	Green Published			2022-12-25	WOS:000318226100020
J	Arman, M; Adams, Y; Lindergard, G; Rowe, JA				Arman, Monica; Adams, Yvonne; Lindergard, Gabriella; Rowe, J. Alexandra			A Method for Positive and Negative Selection of Plasmodium falciparum Platelet-Mediated Clumping Parasites and Investigation of the Role of CD36	PLOS ONE			English	Article							RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; CEREBRAL MALARIA; PROTEIN-1; ADHESION; INHIBITION; MECHANISMS; ANTIBODIES; SECRETION; BINDING	Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes (IEs) is a frequently observed parasite adhesion phenotype. The importance of clumping in severe malaria and the molecular mechanisms behind this phenomenon are incompletely understood. Three platelet surface molecules have previously been identified as clumping receptors: CD36, globular C1q receptor (gC1qR/HABP1/p32), and P-selectin (CD62P), but the parasite ligands mediating this phenotype are unknown. The aim of this work was to develop a selection method to facilitate investigations of the molecular mechanisms of clumping in selected P. falciparum lines. Magnetic beads coated with anti-platelet antibodies were used to positively and negatively select clumping IEs from P. falciparum strains IT, HB3, 3D7 and Dd2. Clumping in all four positively selected parasite lines was abolished by antibodies to CD36, but was not affected by antibodies to gC1qR or P-selectin. Clumping positive lines showed significantly higher binding to CD36 than clumping negative lines in flow adhesion assays (strains IT, HB3 and 3D7, p<0.05 for all strains, paired t test) and static assays (strain Dd2, p<0.0001 paired t test). However, clumping negative lines IT, HB3 and 3D7 did show some binding to CD36 under flow conditions, indicating that CD36-binding is not sufficient for clumping. These data show that CD36-dependent clumping positive and negative lines can easily be selected from P. falciparum laboratory strains. CD36-binding is necessary but not sufficient for clumping, and the molecular differences between clumping positive and negative parasite lines responsible for the phenotype require further investigation.	[Arman, Monica; Adams, Yvonne; Lindergard, Gabriella; Rowe, J. Alexandra] Univ Edinburgh, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Rowe, JA (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	Alex.Rowe@ed.ac.uk	Adams, Yvonne/GRX-3572-2022; Adams, Yvonne/AAX-8901-2021	Adams, Yvonne/0000-0001-8041-6580; Rowe, Alexandra/0000-0002-7702-1892	Wellcome Trust [084226]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust Senior Fellowship in Basic Biomedical Science to JAR, grant number 084226. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arman M, 2007, AM J TROP MED HYG, V77, P943, DOI 10.4269/ajtmh.2007.77.943; Arman M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-243; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Biswas AK, 2007, PLOS PATHOG, V3, P1271, DOI 10.1371/journal.ppat.0030130; CARLSON J, 1990, P NATL ACAD SCI USA, V87, P2511, DOI 10.1073/pnas.87.7.2511; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; Cox D, 2011, J THROMB HAEMOST, V9, P1097, DOI 10.1111/j.1538-7836.2011.04264.x; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Dawood BB, 2007, PLATELETS, V18, P329, DOI 10.1080/09537100601024111; Dorovini-Zis K, 2011, AM J PATHOL, V178, P2146, DOI 10.1016/j.ajpath.2011.01.016; Frankland S, 2007, EUKARYOT CELL, V6, P1584, DOI 10.1128/EC.00063-07; Herricks T, 2009, CELL MICROBIOL, V11, P1340, DOI 10.1111/j.1462-5822.2009.01334.x; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANGRETH SG, 1979, EXP PARASITOL, V48, P213, DOI 10.1016/0014-4894(79)90101-2; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MARSH K, 1988, EXP PARASITOL, V65, P202, DOI 10.1016/0014-4894(88)90123-3; Mayor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019422; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Perrotta PL, 2007, PLATELETS, 2ND EDITION, P1265, DOI 10.1016/B978-012369367-9/50831-4; PEYRON F, 1989, PARASITOLOGY, V99, P317, DOI 10.1017/S0031182000059011; POLOGE LG, 1986, NATURE, V322, P474, DOI 10.1038/322474a0; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rowe JA, 2002, AM J TROP MED HYG, V66, P458, DOI 10.4269/ajtmh.2002.66.458; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; TAYLOR DW, 1987, MOL BIOCHEM PARASIT, V25, P165, DOI 10.1016/0166-6851(87)90005-3; Wahlgren M, 1995, SCAND J IMMUNOL, V42, P626, DOI 10.1111/j.1365-3083.1995.tb03705.x; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Wassmer SC, 2008, J INFECT DIS, V197, P72, DOI 10.1086/523761; Winograd E, 2004, MOL BIOCHEM PARASIT, V136, P243, DOI 10.1016/j.molbiopara.2004.04.005	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55453	10.1371/journal.pone.0055453	http://dx.doi.org/10.1371/journal.pone.0055453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405153	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400098
J	Ismaeil, I; Doury, G; Desouhant, E; Dubois, F; Prevost, G; Couty, A				Ismaeil, Ibrahim; Doury, Geraldine; Desouhant, Emmanuel; Dubois, Francoise; Prevost, Genevieve; Couty, Aude			Trans-Generational Effects of Mild Heat Stress on the Life History Traits of an Aphid Parasitoid	PLOS ONE			English	Article							TRICHOGRAMMA-BRASSICAE HYM; DROSOPHILA-MELANOGASTER; CLIMATE-CHANGE; TEMPERATURE; HYMENOPTERA; HOST; RESISTANCE; WASP; SURVIVORSHIP; REPRODUCTION	Temperature changes are common in nature and insects are particularly exposed and sensitive to such variations which can be potential stresses, ultimately affecting life history traits and overall fitness. Braconids have been widely used to study the effects of temperature on host-parasitoid interactions and the present work focused on the solitary endoparasitoid Aphidius ervi Haliday (Hymenoptera: Braconidae Aphidiidae), an efficient biological control agent commercially used against aphids such as the potato aphid Macrosiphum euphorbiae Thomas (Sternorrhyncha: Aphididae). Contrary to previous studies using heat shocks at extreme temperatures, we evaluated the effects of mild heat stresses by transferring young parasitoid adults from the constant temperature of 20 degrees C to either a warm (25 degrees C) or hot (28 degrees C) temperature, for either 1 h or 48 h. Such treatments are consistent with situations commonly experienced by parasitoids when moved from their rearing conditions to greenhouses or field conditions. The effects were evaluated both on the heat stressed A. ervi adults (G0) (immediate effects) and on their first generation (G1) progeny (trans-generational effects). G0 wasps' mortality was significantly affected by the temperature in interaction with the duration of the stress. Longevity of G0 wasps surviving the heat stress was negatively affected by the temperature and females lived longer than males. Heat stress applied to A. ervi parents also had consequences on their G1 progeny whose developmental time, rates of mummification and percentage of parasitoid completing total development were negatively affected. Surprisingly, the egg load at emergence of the G1 female progeny was increased when their mothers had been submitted to a mild heat stress of 25 degrees C or 28 degrees C. These results clearly demonstrate trans-generational phenotypic plasticity, showing that adaptation to thermal stresses may be achieved via maternal effects. This study also sheds light on the complexity of insect responses and underlying mechanisms to fluctuating conditions in their natural environment.	[Ismaeil, Ibrahim; Doury, Geraldine; Dubois, Francoise; Prevost, Genevieve; Couty, Aude] Univ Picardie Jules Verne, EA Ecol & Dynam Syst Anthropises 4698, Equipe Bioecol Insectes Phytophages & Entomophage, Amiens, France; [Desouhant, Emmanuel] Univ Lyon 1, CNRS, UMR Biometrie & Biol Evolut 5558, F-69622 Villeurbanne, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Couty, A (corresponding author), Univ Picardie Jules Verne, EA Ecol & Dynam Syst Anthropises 4698, Equipe Bioecol Insectes Phytophages & Entomophage, Amiens, France.	aude.couty@u-picardie.fr		DESOUHANT, Emmanuel/0000-0003-0317-4463	Atomic Energy Commission of Syria	Atomic Energy Commission of Syria	This work was made possible by the financial support of the Atomic Energy Commission of Syria through a PhD scholarship for Ibrahim Ismaeil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat I, 2006, OECOLOGIA, V148, P153, DOI 10.1007/s00442-005-0332-9; Amice G, 2008, ECOL ENTOMOL, V33, P701, DOI 10.1111/j.1365-2311.2008.01019.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2010, R LANG ENV STAT COMP; Bell HA, 2003, J APPL ENTOMOL, V127, P332, DOI 10.1046/j.1439-0418.2003.00760.x; Bensadia F, 2006, J INSECT PHYSIOL, V52, P146, DOI 10.1016/j.jinsphys.2005.09.011; BERNAL J, 1993, ENTOMOL EXP APPL, V69, P173, DOI 10.1007/BF02380643; Bezemer TM, 1998, OECOLOGIA, V116, P128, DOI 10.1007/s004420050571; Boivin G, 2010, NEOTROP ENTOMOL, V39, P457, DOI 10.1590/S1519-566X2010000400001; Candolfi MP, 1999, CHEMOSPHERE, V39, P1357, DOI 10.1016/S0045-6535(98)00489-5; Chihrane J, 1996, BIOL CONTROL, V7, P95, DOI 10.1006/bcon.1996.0070; CHIHRANE J, 1993, ENTOMOPHAGA, V38, P185, DOI 10.1007/BF02372552; Colinet H, 2006, ENVIRON ENTOMOL, V35, P228, DOI 10.1603/0046-225X-35.2.228; Denlinger DL, 1998, TEMPERATURES SENSITIVITY IN INSECTS AND APPLICATION IN INTEGRATED PEST MANAGEMENT, P7; Desneux N, 2006, ENVIRON TOXICOL CHEM, V25, P2675, DOI 10.1897/05-562R.1; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; DIGILIO M C, 1989, Bollettino del Laboratorio di Entomologia Agraria Filippo Silvestri, V46, P59; Djawdan M, 1997, ECOLOGY, V78, P828, DOI 10.1890/0012-9658(1997)078[0828:DSFSRL]2.0.CO;2; Feder ME, 2000, OECOLOGIA, V123, P460, DOI 10.1007/s004420000334; Fox CW, 1999, EVOLUTION, V53, P552, DOI [10.2307/2640791, 10.1111/j.1558-5646.1999.tb03790.x]; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Hagvar E.B., 1991, Biocontrol News and Information, V12, P13; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hoffmann AA, 2000, FUNCT ECOL, V14, P55, DOI 10.1046/j.1365-2435.2000.00388.x; Hoffmann AA, 1997, EXTREME ENV CHANGE E; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; Joseph JR, 2011, PHYTOPARASITICA, V39, P35, DOI 10.1007/s12600-010-0134-4; KIRKPATRICK M, 1989, EVOLUTION, V43, P485, DOI 10.1111/j.1558-5646.1989.tb04247.x; KOEHN RK, 1989, BIOL J LINN SOC, V37, P157, DOI 10.1111/j.1095-8312.1989.tb02100.x; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; Levie A, 2005, J ECON ENTOMOL, V98, P704, DOI 10.1603/0022-0493-98.3.704; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu YH, 2002, ENVIRON ENTOMOL, V31, P418, DOI 10.1603/0046-225X-31.2.418; Lopez SN, 2005, BIOL CONTROL, V33, P123, DOI 10.1016/j.biocontrol.2004.11.003; MACKAUER M, 1986, J INSECT PHYSIOL, V32, P275, DOI 10.1016/0022-1910(86)90039-9; March PM, 1977, ENTOMOPHAGA, V22, P365; McCullagh P, 1989, GEN LINEAR MODELS; Mironidis GK, 2008, ENVIRON ENTOMOL, V37, P16, DOI 10.1603/0046-225X(2008)37[16:DSAROH]2.0.CO;2; Mironidis GK, 2010, J THERM BIOL, V35, P59, DOI 10.1016/j.jtherbio.2009.11.001; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pennacchio F, 1999, ARCH INSECT BIOCHEM, V40, P53, DOI 10.1002/(SICI)1520-6327(1999)40:1&lt;53::AID-ARCH6&gt;3.0.CO;2-J; Roux O, 2010, B ENTOMOL RES, V100, P543, DOI 10.1017/S0007485309990575; SEQUEIRA R, 1992, EVOL ECOL, V6, P34, DOI 10.1007/BF02285332; SIBLY RM, 1989, BIOL J LINN SOC, V37, P101, DOI 10.1111/j.1095-8312.1989.tb02007.x; Speight MR, 1999, ECOLOGY INSECTS CONC; Stary P, 1962, ZOOL LISTY, V11, P285; THIREAU JC, 1995, ENTOMOL EXP APPL, V76, P67, DOI 10.1007/BF02382312; Thomson LJ, 2010, BIOL CONTROL, V52, P296, DOI 10.1016/j.biocontrol.2009.01.022	51	17	18	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54306	10.1371/journal.pone.0054306	http://dx.doi.org/10.1371/journal.pone.0054306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405079	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400023
J	Lenders, M; Duning, T; Schelleckes, M; Schmitz, B; Stander, S; Rolfs, A; Brand, SM; Brand, E				Lenders, Malte; Duning, Thomas; Schelleckes, Michael; Schmitz, Boris; Stander, Sonja; Rolfs, Arndt; Brand, Stefan-Martin; Brand, Eva			s Multifocal White Matter Lesions Associated with the D313Y Mutation of the alpha-Galactosidase A Gene	PLOS ONE			English	Article							FABRY-DISEASE; VARIANT; PREVALENCE; FREQUENCY; DIAGNOSIS; PLASMA; STROKE	White matter lesions (WML) are clinically relevant since they are associated with strokes, cognitive decline, depression, or epilepsy, but the underlying etiology in young adults without classical risk factors still remains elusive. Our aim was to elucidate the possible clinical diagnosis and mechanisms leading to WML in patients carrying the D313Y mutation in the alpha-galactosidase A (GLA) gene, a mutation that was formerly described as nonpathogenic. Pathogenic GLA mutations cause Fabry disease, a vascular endothelial glycosphingolipid storage disease typically presenting with a symptom complex of renal, cardiac, and cerebrovascular manifestations. We performed in-depths clinical, biochemical and genetic examinations as well as advanced magnetic resonance imaging analyses in a pedigree with the genetically determined GLA mutation D313Y. We detected exclusive neurologic manifestations of the central nervous system of the "pseudo''-deficient D313Y mutation leading to manifest WML in 7 affected adult family members. Furthermore, two family members that do not carry the mutation showed no WML. The D313Y mutation resulted in a normal GLA enzyme activity in leukocytes and severely decreased activities in plasma. In conclusion, our results provide evidence that GLA D313Y is potentially involved in neural damage with significant WML, demonstrating the necessity of evaluating patients carrying D313Y more thoroughly. D313Y might broaden the spectrum of hereditary small artery diseases of the brain, which preferably occur in young adults without classical risk factors. In view of the existing causal therapy regime, D313Y should be more specifically taken into account in these patients.	[Lenders, Malte; Schelleckes, Michael; Schmitz, Boris; Brand, Eva] Univ Hosp Muenster, Dept Nephrol Hypertens & Rheumatol, Munster, Germany; [Duning, Thomas] Univ Hosp Muenster, Dept Neurol, Munster, Germany; [Schmitz, Boris; Brand, Stefan-Martin] Univ Hosp Muenster, Inst Sports Med Mol Genet & Cardiovasc Dis, Munster, Germany; [Stander, Sonja] Univ Hosp Muenster, Dept Dermatol, Munster, Germany; [Rolfs, Arndt] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Rostock	Brand, E (corresponding author), Univ Hosp Muenster, Dept Nephrol Hypertens & Rheumatol, Munster, Germany.	Eva.Brand@ukmuenster.de	Schmitz, Boris/M-3205-2019	Schmitz, Boris/0000-0001-7041-7424; Stander, Sonja/0000-0003-3612-7786	Shire HGT; Genzyme Corporation	Shire HGT; Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	AR, EB and TD have received speaker fees and research support from both Shire HGT and Genzyme Corporation. This also does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Assareh A, 2011, CNS NEUROSCI THER, V17, P525, DOI 10.1111/j.1755-5949.2010.00181.x; Baptista MV, 2010, STROKE, V41, P431, DOI 10.1161/STROKEAHA.109.570499; Basile AM, 2006, CEREBROVASC DIS, V21, P315, DOI 10.1159/000091536; Buechner S, 2008, J NEUROL NEUROSUR PS, V79, P1249, DOI 10.1136/jnnp.2008.143693; de Groot JC, 2000, ARCH GEN PSYCHIAT, V57, P1071, DOI 10.1001/archpsyc.57.11.1071; de Groot JC, 2000, ANN NEUROL, V47, P145; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; ENG CM, 1993, AM J HUM GENET, V53, P1186; Enzinger C, 2007, J NEUROL SCI, V257, P5, DOI 10.1016/j.jns.2007.01.018; Froissart R, 2010, REV MED INTERNE, V31, pS275, DOI 10.1016/S0248-8663(10)70027-8; Froissart R, 2003, MOL GENET METAB, V80, P307, DOI 10.1016/S1096-7192(03)00136-7; Gaspar P, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-19; Hoffmann B, 2006, FABRY DIS PERSPECTIV; Hoffmann B, 2007, CLIN J PAIN, V23, P535, DOI 10.1097/AJP.0b013e318074c986; Lin HY, 2009, CIRC-CARDIOVASC GENE, V2, P450, DOI 10.1161/CIRCGENETICS.109.862920; Matsuzawa F, 2005, HUM GENET, V117, P317, DOI 10.1007/s00439-005-1300-5; Maxwell H, 2012, CLIN NEUROL IN PRESS; Mehta A, 2009, LANCET, V374, P1986, DOI 10.1016/S0140-6736(09)61493-8; Monserrat L, 2007, J AM COLL CARDIOL, V50, P2399, DOI 10.1016/j.jacc.2007.06.062; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Poggesi A, 2011, CEREBROVASC DIS, V32, P577, DOI 10.1159/000334498; Ringelstein EB, 2010, J NEUROL SCI, V299, P81, DOI 10.1016/j.jns.2010.08.037; Sachdev P, 2008, CURR OPIN PSYCHIATR, V21, P268, DOI 10.1097/YCO.0b013e3282f945d5; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Sims K, 2009, STROKE, V40, P788, DOI 10.1161/STROKEAHA.108.526293; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Sugawara K, 2008, J HUM GENET, V53, P812, DOI 10.1007/s10038-008-0316-9; Tetaud C, 2003, J BIOL CHEM, V278, P45200, DOI 10.1074/jbc.M303868200; Tolouian R, 2010, CLIN KIDNEY J, V3, P81, DOI 10.1093/ndtplus/sfp156; Wozniak MA, 2010, STROKE, V41, P78, DOI 10.1161/STROKEAHA.109.558320; Yasuda M, 2003, HUM MUTAT, V22, P486, DOI 10.1002/humu.10275; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5	32	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55565	10.1371/journal.pone.0055565	http://dx.doi.org/10.1371/journal.pone.0055565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393592	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800046
J	Ma, XC; Dang, YH; Jia, M; Ma, R; Wang, F; Wu, J; Gao, CG; Hashimoto, K				Ma, Xian-Cang; Dang, Yong-Hui; Jia, Min; Ma, Rui; Wang, Fen; Wu, Jin; Gao, Cheng-Ge; Hashimoto, Kenji			Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; D-ASPARTATE ANTAGONIST; INDUCED HYPERACTIVITY; DEPRESSION; GLUTAMATE; SENSITIZATION; INVOLVEMENT; EFFICACY; SYNAPSE; SYSTEM	Background: Clinical studies demonstrate that the N-methyl-D-aspartate (NMDA) receptor antagonist, ketamine, induces rapid antidepressant effects in patients with refractive major depressive disorder and bipolar depression. This rapid onset of action makes ketamine a highly attractive drug for patients, particularly those who do not typically respond to therapy. A recent study suggested that glycogen synthase kinase (GSK)-3 may underlie the rapid antidepressant action of ketamine, although the precise mechanisms are unclear. In this study, we examined the effects of ketamine and GSK-3 inhibitor SB216763 in the unpredictable, chronic mild stress (CMS) mouse model of mice. Methodology/Principal Findings: Adult C57/B6 male mice were divided into 2 groups, a non-stressed control group and the unpredictable CMS (35 days) group. Then, either vehicle, ketamine (10 mg/kg), or the established GSK-3 inhibitor, SB216763 (10 mg/kg), were administered into mice in the CMS group, while vehicle was administered to controls. In the open field test, there was no difference between the four groups (control+vehicle, CMS+vehicle, CMS+ketamine, CMS+SB216763). In the sucrose intake test, a 1% sucrose intake drop, seen in CMS mice, was significantly attenuated after a single dose of ketamine, but not SB216763. In the tail suspension test (TST) and forced swimming test (FST), the increased immobility time seen in CMS mice was significantly attenuated by a single dose of ketamine, but not SB216763. Interestingly, the ketamine-induced increase in the sucrose intake test persisted for 8 days after a single dose of ketamine. Furthermore, a single administration of ketamine, but not SB216763, significantly attenuated the immobility time of the TST and FST in the control (non-stressed) mice. Conclusions/Significance: These findings suggest that a single administration of ketamine, but not GSK-3 inhibitor SB216763, produces a long-lasting antidepressant action in CMS model mice.	[Ma, Xian-Cang; Jia, Min; Ma, Rui; Wang, Fen; Gao, Cheng-Ge] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Psychiat, Xian 710049, Peoples R China; [Dang, Yong-Hui] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis,Educ Minist, Key Lab,Hlth Minist Forens Med, Dept Forens Med,Sch Med, Xian 710049, Peoples R China; [Wu, Jin; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Xi'an Jiaotong University; Xi'an Jiaotong University; Chiba University	Gao, CG (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Psychiat, Xian 710049, Peoples R China.	yaogaow@163.com; hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	National Natural Science Foundation of China [81171256, 81171262]; Minister of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [24116006] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Minister of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the National Natural Science Foundation of China (# 81171256 and # 81171262) and a grant from the Minister of Education, Culture, Sports, Science, and Technology of Japan (to K. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAMURA CA, 1993, AM J PSYCHIAT, V150, P1731; Amar S, 2011, CURR PHARM DESIGN, V17, P2264; Auer DP, 2000, BIOL PSYCHIAT, V47, P305, DOI 10.1016/S0006-3223(99)00159-6; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Beurel E, 2011, MOL PSYCHIATR, V16, P1068, DOI 10.1038/mp.2011.47; Block W, 2009, INT J NEUROPSYCHOPH, V12, P415, DOI 10.1017/S1461145708009516; Chan MH, 2012, SCHIZOPHR RES, V136, P96, DOI 10.1016/j.schres.2012.01.024; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Duman RS, 2012, NEUROPHARMACOLOGY, V62, P35, DOI 10.1016/j.neuropharm.2011.08.044; Elyaman W, 2002, EUR J NEUROSCI, V15, P651, DOI 10.1046/j.1460-9568.2002.01899.x; Enman NM, 2012, BEHAV BRAIN RES, V231, P217, DOI 10.1016/j.bbr.2012.03.027; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Hashimoto K, 2007, BIOL PSYCHIAT, V62, P1310, DOI 10.1016/j.biopsych.2007.03.017; Hashimoto K, 2011, PROG NEURO-PSYCHOPH, V35, P1558, DOI 10.1016/j.pnpbp.2010.06.013; Hashimoto K, 2011, EXPERT REV NEUROTHER, V11, P33, DOI 10.1586/ERN.10.176; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; Jope RS, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00016; Kaidanovich-Beilin O, 2004, BIOL PSYCHIAT, V55, P781, DOI 10.1016/j.biopsych.2004.01.008; KIM JS, 1982, ARCH PSYCHIAT NERVEN, V232, P299, DOI 10.1007/BF00345492; Krystal JH, 2010, ARCH GEN PSYCHIAT, V67, P1110, DOI 10.1001/archgenpsychiatry.2010.138; Lei G, 2008, NEUROPSYCHOPHARMACOL, V33, P1343, DOI 10.1038/sj.npp.1301511; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Luykx JJ, 2010, EUR NEUROPSYCHOPHARM, V20, P357, DOI 10.1016/j.euroneuro.2010.02.008; Ma XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020955; Machado-Vieira R, 2009, BIPOLAR DISORD, V11, P92, DOI 10.1111/j.1399-5618.2009.00714.x; Machado-Vieira R, 2009, PHARMACOL THERAPEUT, V123, P143, DOI 10.1016/j.pharmthera.2009.02.010; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Mathew SJ, 2012, CNS DRUGS, V26, P189, DOI 10.2165/11599770-000000000-00000; Mayorga AJ, 2001, PSYCHOPHARMACOLOGY, V155, P110, DOI 10.1007/s002130100687; Miller JS, 2010, BRAIN RES BULL, V82, P184, DOI 10.1016/j.brainresbull.2010.03.005; Miller JS, 2009, NEUROPHARMACOLOGY, V56, P1116, DOI 10.1016/j.neuropharm.2009.03.006; Mitani H, 2006, PROG NEURO-PSYCHOPH, V30, P1155, DOI 10.1016/j.pnpbp.2006.03.036; Murrough JW, 2012, CLIN PHARMACOL THER, V91, P303, DOI 10.1038/clpt.2011.244; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Rosa AO, 2008, PROG NEURO-PSYCHOPH, V32, P1549, DOI 10.1016/j.pnpbp.2008.05.020; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Tokita K, 2012, PHARMACOL BIOCHEM BE, V100, P688, DOI 10.1016/j.pbb.2011.04.016; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zarate CA, 2012, BIOL PSYCHIAT, V71, P939, DOI 10.1016/j.biopsych.2011.12.010; Zarate C, 2010, HARVARD REV PSYCHIAT, V18, P293, DOI 10.3109/10673229.2010.511059	51	71	73	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e56053	10.1371/journal.pone.0056053	http://dx.doi.org/10.1371/journal.pone.0056053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390559	gold, Green Submitted, Green Published			2022-12-25	WOS:000314691100075
J	Nevalainen, N; Lundblad, M; Gerhardt, GA; Stromberg, I				Nevalainen, Nina; Lundblad, Martin; Gerhardt, Greg A.; Stromberg, Ingrid			Striatal Glutamate Release in L-DOPA-Induced Dyskinetic Animals	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIA; INDUCED MOTOR COMPLICATIONS; AMINO-ACID DECARBOXYLASE; RAT MODEL; SEROTONERGIC FIBERS; BASAL GANGLIA; MULTISITE MICROELECTRODES; NIGROSTRIATAL DOPAMINE; RECEPTOR ANTAGONISM; AMANTADINE	L-DOPA-induced dyskinesia is a common side effect developed after chronic treatment with 3,4-dihydroxyphenyl-L-alanine (L-DOPA) in Parkinson's disease. The biological mechanisms behind this side effect are not fully comprehended although involvement of dopaminergic, serotonergic, and glutamatergic systems has been suggested. The present study utilizes in vivo amperometry to investigate the impact from unilateral 6-hydroxydopamine lesions and L-DOPA (4 mg/kg, including benserazide 15 mg/kg) -induced dyskinetic behavior on striatal basal extracellular glutamate concentration and potassium-evoked glutamate release in urethane-anesthetized rats. Recordings were performed before and after local L-DOPA application in the striatum. In addition, effects from the 5-HT1A receptor agonist (2R)-(+)-8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide (8-OHDPAT; 1 mg/kg) was assessed on glutamate release and on dyskinetic behavior. The results revealed a bilateral similar to 30% reduction of basal extracellular glutamate concentration and attenuated potassium-evoked glutamate release after a unilateral dopamine-depletion in L-DOPA naive animals. In dyskinetic subjects, basal glutamate concentration was comparable to normal controls, although potassium-evoked glutamate release was reduced to similar levels as in drug naive dopamine-lesioned animals. Furthermore, acute striatal L-DOPA administration attenuated glutamate release in all groups, except in the dopamine-lesioned striatum of dyskinetic animals. Co-administration of 8-OHDPAT and L-DOPA decreased dyskinesia in dopamine-lesioned animals, but did not affect potassium-evoked glutamate release, which was seen in normal animals. These findings indicate altered glutamate transmission upon dopamine-depletion and dyskinesia.	[Nevalainen, Nina; Stromberg, Ingrid] Umea Univ, Umea, Sweden; [Lundblad, Martin] Lund Univ, Dept Expt Med Sci, Basal Ganglia Pathophysiol Unit, Neurosci Sect, Lund, Sweden; [Gerhardt, Greg A.] Univ Kentucky, Med Ctr, Lexington, KY USA	Umea University; Lund University; University of Kentucky	Stromberg, I (corresponding author), Umea Univ, Umea, Sweden.	ingrid.stromberg@histocel.umu.se	Lundblad, Martin/AIA-7458-2022	Lundblad, Martin/0000-0001-8623-3152	Swedish Research Council Grant [09917]; Umea University Medical Faculty Funds; Konung Gustav V and Drottning Victorias Fond, Sweden	Swedish Research Council Grant(Swedish Research Council); Umea University Medical Faculty Funds; Konung Gustav V and Drottning Victorias Fond, Sweden	This study was funded by the Swedish Research Council Grant #09917, The Umea University Medical Faculty Funds, and Konung Gustav V and Drottning Victorias Fond, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Ahmed I, 2011, BRAIN, V134, P979, DOI 10.1093/brain/awr028; Antonelli T, 2005, SYNAPSE, V58, P193, DOI 10.1002/syn.20195; Arai A, 2003, BRAIN RES, V972, P229, DOI 10.1016/S0006-8993(03)02531-9; Arai R, 1996, BRAIN RES, V706, P177, DOI 10.1016/0006-8993(95)01281-8; ARAI R, 1995, NEUROSCI LETT, V195, P195, DOI 10.1016/0304-3940(95)11817-G; Aubert I, 2005, ANN NEUROL, V57, P17, DOI 10.1002/ana.20296; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Bianchi L, 2003, EUR J NEUROSCI, V18, P856, DOI 10.1046/j.1460-9568.2003.02795.x; Bibbiani F, 2005, EXP NEUROL, V196, P422, DOI 10.1016/j.expneurol.2005.08.017; Bido S, 2011, J NEUROCHEM, V118, P1043, DOI 10.1111/j.1471-4159.2011.07376.x; Blanchet PJ, 1998, MOVEMENT DISORD, V13, P798, DOI 10.1002/mds.870130507; Breit S, 2008, J NEUROSCI RES, V86, P1388, DOI 10.1002/jnr.21588; Brotchie JA, 2005, MOVEMENT DISORD, V20, P919, DOI 10.1002/mds.20612; Burmeister JJ, 2002, J NEUROSCI METH, V119, P163, DOI 10.1016/S0165-0270(02)00172-3; Burmeister JJ, 2001, ANAL CHEM, V73, P1037, DOI 10.1021/ac0010429; Burmeister JJ, 2000, ANAL CHEM, V72, P187, DOI 10.1021/ac9907991; Calon F, 2003, NEUROBIOL DIS, V14, P404, DOI 10.1016/j.nbd.2003.07.003; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Cenci MA, 2007, CURR PROTOC NEUROSCI; Chase TN, 2000, TRENDS NEUROSCI, V23, pS86, DOI 10.1016/S1471-1931(00)00018-5; Corsi C, 2003, EUR J PHARMACOL, V464, P33, DOI 10.1016/S0014-2999(03)01352-9; Darmopil S, 2009, BIOL PSYCHIAT, V66, P603, DOI 10.1016/j.biopsych.2009.04.025; Day BK, 2006, J NEUROCHEM, V96, P1626, DOI 10.1111/j.1471-4159.2006.03673.x; DeFelipe J, 2001, J COMP NEUROL, V433, P148, DOI 10.1002/cne.1132; Del Dotto P, 2001, MOVEMENT DISORD, V16, P515, DOI 10.1002/mds.1112; Dupre KB, 2008, PSYCHOPHARMACOLOGY, V199, P99, DOI 10.1007/s00213-008-1135-6; Dupre KB, 2011, EXP NEUROL, V229, P288, DOI 10.1016/j.expneurol.2011.02.012; Fiorentini C, 2006, MOL PHARMACOL, V69, P805, DOI 10.1124/mol.105.016667; FISHER RS, 1984, NEUROSCI LETT, V48, P369, DOI 10.1016/0304-3940(84)90066-1; GOODWIN GM, 1987, PSYCHOPHARMACOLOGY, V91, P506, DOI 10.1007/BF00216019; Hascup KN, 2007, FRONT NEUROENG, V1, P407; HOLLISTER AS, 1979, J PHARMACOL EXP THER, V208, P37; Holmer HK, 2005, NEUROSCIENCE, V136, P333, DOI 10.1016/j.neuroscience.2005.08.003; HORNYKIEWICZ O, 1975, Psychopharmacology Bulletin, V11, P34; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; Iravani MM, 2006, J PHARMACOL EXP THER, V319, P1225, DOI 10.1124/jpet.106.110429; JENNER P, 1983, BRIT J CLIN PHARMACO, V15, pS277, DOI 10.1111/j.1365-2125.1983.tb05876.x; JONES EG, 1977, J COMP NEUROL, V173, P53, DOI 10.1002/cne.901730105; Jonkers N, 2002, BRAIN RES, V926, P149, DOI 10.1016/S0006-8993(01)03147-X; King JM, 2011, LIFE SCI, V89, P638, DOI 10.1016/j.lfs.2011.08.008; Kish SJ, 2008, BRAIN, V131, P120, DOI 10.1093/brain/awm239; Kobylecki C, 2010, J NEUROCHEM, V114, P499, DOI 10.1111/j.1471-4159.2010.06776.x; Konitsiotis S, 2000, NEUROLOGY, V54, P1589, DOI 10.1212/WNL.54.8.1589; LINDEFORS N, 1990, NEUROSCI LETT, V115, P248, DOI 10.1016/0304-3940(90)90463-J; Luginger E, 2000, MOVEMENT DISORD, V15, P873, DOI 10.1002/1531-8257(200009)15:5<873::AID-MDS1017>3.0.CO;2-I; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; Lundblad M, 2009, J NEUROCHEM, V108, P998, DOI 10.1111/j.1471-4159.2008.05848.x; Maeda T, 2005, BRAIN RES, V1046, P230, DOI 10.1016/j.brainres.2005.04.019; MCGEORGE AJ, 1987, BRAIN RES, V423, P318, DOI 10.1016/0006-8993(87)90855-9; Mela F, 2007, J NEUROCHEM, V101, P483, DOI 10.1111/j.1471-4159.2007.04456.x; Mela F, 2012, NEUROBIOL DIS, V45, P573, DOI 10.1016/j.nbd.2011.09.015; Meshul CK, 1999, NEUROSCIENCE, V88, P1, DOI 10.1016/S0306-4522(98)00189-4; Metman LV, 1998, NEUROLOGY, V50, P1323, DOI 10.1212/WNL.50.5.1323; Mignon LJ, 2005, NEUROREPORT, V16, P699, DOI 10.1097/00001756-200505120-00009; Morin N, 2010, NEUROPHARMACOLOGY, V58, P981, DOI 10.1016/j.neuropharm.2009.12.024; Munoz A, 2008, BRAIN, V131, P3380, DOI 10.1093/brain/awn235; Nahimi A, 2012, J NEUROCHEM, V120, P806, DOI 10.1111/j.1471-4159.2011.07598.x; Navailles S, 2011, NEUROBIOL DIS, V41, P585, DOI 10.1016/j.nbd.2010.11.007; Nevalainen N, 2011, J NEUROCHEM, V118, P12, DOI 10.1111/j.1471-4159.2011.07292.x; NG KY, 1970, SCIENCE, V170, P76, DOI 10.1126/science.170.3953.76; Oh JD, 1998, BRAIN RES, V813, P150, DOI 10.1016/S0006-8993(98)01049-X; Ostock CY, 2011, NEUROPHARMACOLOGY, V61, P753, DOI 10.1016/j.neuropharm.2011.05.021; Papa SM, 1996, ANN NEUROL, V39, P574, DOI 10.1002/ana.410390505; Paquette MA, 2010, NEUROPHARMACOLOGY, V58, P1002, DOI 10.1016/j.neuropharm.2010.01.003; PETER D, 1995, J NEUROSCI, V15, P6179; Robelet S, 2004, EUR J NEUROSCI, V20, P1255, DOI 10.1111/j.1460-9568.2004.03591.x; Rylander D, 2010, NEUROBIOL DIS, V39, P352, DOI 10.1016/j.nbd.2010.05.001; Santini E, 2007, J NEUROSCI, V27, P6995, DOI 10.1523/JNEUROSCI.0852-07.2007; Silverdale MA, 2010, SYNAPSE, V64, P177, DOI 10.1002/syn.20739; SPROUSE JS, 1987, SYNAPSE, V1, P3, DOI 10.1002/syn.890010103; Tahar AH, 2004, NEUROBIOL DIS, V15, P171, DOI 10.1016/j.nbd.2003.10.007; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Westin JE, 2007, BIOL PSYCHIAT, V62, P800, DOI 10.1016/j.biopsych.2006.11.032; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Yamada H, 2007, NEUROSCI RES, V59, P1, DOI 10.1016/j.neures.2007.05.002; YAMADA J, 1988, EUR J PHARMACOL, V154, P299, DOI 10.1016/0014-2999(88)90205-1	77	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55706	10.1371/journal.pone.0055706	http://dx.doi.org/10.1371/journal.pone.0055706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390548	Green Submitted, Green Published, gold			2022-12-25	WOS:000314691100064
J	Panchapakesan, U; Pegg, K; Gross, S; Komala, MG; Mudaliar, H; Forbes, J; Pollock, C; Mather, A				Panchapakesan, Usha; Pegg, Kate; Gross, Simon; Komala, Muralikrishna Gangadharan; Mudaliar, Harshini; Forbes, Josephine; Pollock, Carol; Mather, Amanda			Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells-Renoprotection in Diabetic Nephropathy?	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA(1); PPAR-GAMMA AGONISTS; HIGH GLUCOSE; GENE-EXPRESSION; STIMULATION; DISEASE; MATRIX	Sodium/glucose cotransporter 2 (SGLT2) inhibitors are oral hypoglycemic agents used to treat patients with diabetes mellitus. SGLT2 inhibitors block reabsorption of filtered glucose by inhibiting SGLT2, the primary glucose transporter in the proximal tubular cell (PTC), leading to glycosuria and lowering of serum glucose. We examined the renoprotective effects of the SGLT2 inhibitor empagliflozin to determine whether blocking glucose entry into the kidney PTCs reduced the inflammatory and fibrotic responses of the cell to high glucose. We used an in vitro model of human PTCs. HK2 cells (human kidney PTC line) were exposed to control 5 mM, high glucose (HG) 30 mM or the profibrotic cytokine transforming growth factor beta (TGF beta 1; 0.5 ng/ml) in the presence and absence of empagliflozin for up to 72 h. SGLT1 and 2 expression and various inflammatory/fibrotic markers were assessed. A chromatin immunoprecipitation assay was used to determine the binding of phosphorylated smad3 to the promoter region of the SGLT2 gene. Our data showed that TGF beta 1 but not HG increased SGLT2 expression and this occurred via phosphorylated smad3. HG induced expression of Toll-like receptor-4, increased nuclear deoxyribonucleic acid binding for nuclear factor kappa B (NF-kappa B) and activator protein 1, induced collagen IV expression as well as interleukin-6 secretion all of which were attenuated with empagliflozin. Empagliflozin did not reduce high mobility group box protein 1 induced NF-kappa B suggesting that its effect is specifically related to a reduction in glycotoxicity. SGLT1 and GLUT2 expression was not significantly altered with HG or empagliflozin. In conclusion, empagliflozin reduces HG induced inflammatory and fibrotic markers by blocking glucose transport and did not induce a compensatory increase in SGLT1/GLUT2 expression. Although HG itself does not regulate SGLT2 expression in our model, TGF beta increases SGLT2 expression through phosphorylated smad3.	[Panchapakesan, Usha; Pegg, Kate; Gross, Simon; Komala, Muralikrishna Gangadharan; Mudaliar, Harshini; Pollock, Carol; Mather, Amanda] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Dept Med,Renal Res Grp, St Leonards, NSW 2065, Australia; [Forbes, Josephine] Mater Med Res Inst, Glycat & Diabet Res Grp, Brisbane, Qld, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Mater Research	Panchapakesan, U (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Dept Med,Renal Res Grp, St Leonards, NSW 2065, Australia.	usha.panchapakesan@sydney.edu.au	Forbes, Josephine M/A-4569-2012; Gangadharan Komala, Muralikrishna/ABA-5078-2021; Gangadharan Komala, Muralikrishna/ABH-3183-2021	Forbes, Josephine M/0000-0002-5595-8174; Gangadharan Komala, Muralikrishna/0000-0003-0534-0584; 	National Health and Medical Council of Australia [1004926]	National Health and Medical Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors are grateful to the National Health and Medical Council of Australia for funding this study (1004926). The authors would like to thank Boehringer Ingelheim for providing the empagliflozin and funding for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires I, 2010, CURR OPIN INVEST DR, V11, P1182; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Ghosh RK, 2011, J CLIN PHARM; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Holian J, 2008, AM J PHYSIOL-RENAL, V295, pF1388, DOI 10.1152/ajprenal.00055.2008; Isono M, 2000, J AM SOC NEPHROL, V11, P2222, DOI 10.1681/ASN.V11122222; Johnson DW, 1998, KIDNEY INT, V53, P1601, DOI 10.1046/j.1523-1755.1998.00916.x; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; Mather A, 2010, NAT REV NEPHROL, V6, P307, DOI 10.1038/nrneph.2010.38; Mudaliar H, 2011, NEPHROLOGY, V16, P31; Musso G, 2011, ANN MED; NAKAMURA T, 1995, DIABETES, V44, P895, DOI 10.2337/diabetes.44.8.895; Nicolle LE, 2012, CURR MED RES OPIN, V28, P1167, DOI 10.1185/03007995.2012.689956; Panchapakesan U, 2005, AM J PHYSIOL-RENAL, V289, pF1153, DOI 10.1152/ajprenal.00097.2005; Panchapakesan U, 2004, AM J PHYSIOL-RENAL, V287, pF528, DOI 10.1152/ajprenal.00445.2003; POLLOCK CA, 1991, AM J PHYSIOL, V260, pF946, DOI 10.1152/ajprenal.1991.260.6.F946; POLLOCK CA, 1991, PFLUG ARCH EUR J PHY, V418, P14, DOI 10.1007/BF00370446; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Qi W, 2006, AM J PHYSIOL-RENAL, V291, pF1070, DOI 10.1152/ajprenal.00013.2006; Sharma K, 1997, DIABETES, V46, P854, DOI 10.2337/diabetes.46.5.854; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Thomson SC, 2011, AM J PHYSL REGUL INT; Vallon V, 2010, CURR OPIN NEPHROL HY, V19, P425, DOI 10.1097/MNH.0b013e32833bec06; Wolf G, 1997, AM J KIDNEY DIS, V29, P153, DOI 10.1016/S0272-6386(97)90023-8; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; YANG CW, 1994, P NATL ACAD SCI USA, V91, P9436, DOI 10.1073/pnas.91.20.9436; ZIYADEH FN, 1994, J CLIN INVEST, V93, P536, DOI 10.1172/JCI117004	30	201	220	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54442	10.1371/journal.pone.0054442	http://dx.doi.org/10.1371/journal.pone.0054442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390498	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100014
J	Rizzetti, DA; Torres, JGD; Escobar, AG; Pecanha, FM; Santos, FW; Puntel, RL; Alonso, MJ; Briones, AM; Salaices, M; Vassallo, DV; Wiggers, GA				Rizzetti, Danize A.; Torres, Joao Guilherme D.; Escobar, Alyne G.; Pecanha, Franck M.; Santos, Francielli W.; Puntel, Robson L.; Alonso, Maria J.; Briones, Ana M.; Salaices, Mercedes; Vassallo, Dalton V.; Wiggers, Giulia A.			Apocynin Prevents Vascular Effects Caused by Chronic Exposure to Low Concentrations of Mercury	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; OXIDATIVE STRESS; LIPID-PEROXIDATION; ENDOTHELIAL DYSFUNCTION; NAD(P)H OXIDASE; GLUTATHIONE-PEROXIDASE; INORGANIC MERCURY; IN-VITRO; RAT; METHYLMERCURY	Mercury increases the risk of cardiovascular disease and oxidative stress and alters vascular reactivity. This metal elicits endothelial dysfunction causing decreased NO bioavailability via increased oxidative stress and contractile prostanoid production. NADPH oxidase is the major source of reactive oxygen species (ROS) in the vasculature. Our aim was to investigate whether treatment with apocynin, an NADPH oxidase inhibitor, prevents the vascular effects caused by chronic intoxication with low concentrations of mercury. Three-month-old male Wistar rats were treated for 30 days with a) intramuscular injections (i.m.) of saline; b) HgCl2 (i.m. 1(st) dose: 4.6 mu g/kg, subsequent doses: 0.07 mu g/kg/day); c) Apocynin (1.5 mM in drinking water plus saline i.m.); and d) Apocynin plus HgCl2. The mercury treatment resulted in 1) an increased aortic vasoconstrictor response to phenylephrine and reduced endothelium-dependent responses to acetylcholine; 2) the increased involvement of ROS and vasoconstrictor prostanoids in response to phenylephrine, whereas the endothelial NO modulation of such responses was reduced; and 3) the reduced activity of aortic superoxide dismutase (SOD) and glutathione peroxidase (GPx) and increased plasma malondialdehyde (MDA) levels. Treatment with apocynin partially prevented the increased phenylephrine responses and reduced the endothelial dysfunction elicited by mercury treatment. In addition, apocynin treatment increased the NO modulation of vasoconstrictor responses and aortic SOD activity and reduced plasma MDA levels without affecting the increased participation of vasoconstrictor prostanoids observed in aortic segments from mercury-treated rats. Conclusions: Mercury increases the vasoconstrictor response to phenylephrine by reducing NO bioavailability and increasing the involvement of ROS and constrictor prostanoids. Apocynin protects the vessel from the deleterious effects caused by NADPH oxidase, but not from those caused by prostanoids, thus demonstrating a two-way action.	[Rizzetti, Danize A.; Torres, Joao Guilherme D.; Escobar, Alyne G.; Pecanha, Franck M.; Santos, Francielli W.; Puntel, Robson L.; Wiggers, Giulia A.] Univ Fed Pampa, Postgrad Program Biochem, Uruguaiana, RS, Brazil; [Vassallo, Dalton V.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Alonso, Maria J.] Univ Rey Juan Carlos, Dept Biochem Physiol & Mol Genet, Alcorcon, Spain; [Briones, Ana M.; Salaices, Mercedes] Univ Autonoma Madrid, Dept Pharmacol, Sch Med, Madrid, Spain	Universidade Federal do Pampa; Universidade Federal do Espirito Santo; Universidad Rey Juan Carlos; Autonomous University of Madrid	Wiggers, GA (corresponding author), Univ Fed Pampa, Postgrad Program Biochem, Uruguaiana, RS, Brazil.	giuliawp@yahoo.com	Wiggers, Giulia/AAG-2039-2019; Rizzetti, Danize Aparecida/D-9792-2014; Alonso, María/AAB-4309-2019; Cibin, Francielli/AAW-3973-2020; Vassallo, Dalton/K-8289-2016	Wiggers, Giulia/0000-0001-5401-828X; Alonso, María/0000-0003-4912-1121; Cibin, Francielli/0000-0003-2178-1857; Puntel, Robson/0000-0001-9047-2906; Salaices Sanchez, Mercedes/0000-0003-3323-1692; Vassallo, Dalton/0000-0002-4463-4174; Briones, Ana/0000-0001-8218-5579	CAPES; CNPq/FAPES/FUNCITEC, Brazil [39767531/07]; MICIIN [SAF 2009-07201, PHB2011-0001-PC]; Pro-reitoria de Pesquisa - Federal University of Pampa [20120307165228-111]; ISCIII, Spain [Red RECAVA RD06/0014/0011]; Ramon y Cajal program [RYC-2010-06473]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/FAPES/FUNCITEC, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MICIIN; Pro-reitoria de Pesquisa - Federal University of Pampa; ISCIII, Spain(Instituto de Salud Carlos III); Ramon y Cajal program(Spanish Government)	This study was supported by and by grants from CAPES and CNPq/FAPES/FUNCITEC (39767531/07), Brazil, MICIIN (SAF 2009-07201, PHB2011-0001-PC), Pro-reitoria de Pesquisa (N degrees 20120307165228-111) - Federal University of Pampa and ISCIII (Red RECAVA RD06/0014/0011), Spain. Ana M. Briones is supported through the Ramon y Cajal program (RYC-2010-06473). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, J PHARMACOL EXP THER, V321, P381, DOI 10.1124/jpet.106.115287; BENOV LC, 1990, CHEM-BIOL INTERACT, V76, P321, DOI 10.1016/0009-2797(90)90099-9; Beswick RA, 2001, HYPERTENSION, V37, P781, DOI 10.1161/01.HYP.37.2.781; Beswick RA, 2001, HYPERTENSION, V38, P1107, DOI 10.1161/hy1101.093423; Bulat P, 1998, INT ARCH OCC ENV HEA, V71, pS37; CARMIGNANI M, 1992, BRIT J IND MED, V49, P226; Chan EC, 2007, CARDIOVASC RES, V75, P710, DOI 10.1016/j.cardiores.2007.06.005; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; da Cunha V, 2000, ARCH ENVIRON CON TOX, V39, P124; Durak D, 2009, ENVIRON TOXICOL, V24, P235, DOI 10.1002/tox.20423; El-Demerdash FM, 2001, J ENVIRON SCI HEAL B, V36, P489, DOI 10.1081/PFC-100104191; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Furieri LB, 2011, BRIT J PHARMACOL, V162, P1819, DOI 10.1111/j.1476-5381.2011.01203.x; GSTRAUNTHALER G, 1983, BIOCHEM PHARMACOL, V32, P2969, DOI 10.1016/0006-2952(83)90404-5; Hamilton CA, 2002, HYPERTENSION, V40, P755, DOI 10.1161/01.HYP.0000037063.90643.0B; Houston MC, 2007, ALTERN THER HEALTH M, V13, P128; Huang YL, 1996, BIOL TRACE ELEM RES, V52, P193, DOI 10.1007/BF02789461; Hussain S, 1999, J ENVIRON SCI HEAL B, V34, P645, DOI 10.1080/03601239909373219; Jin L, 2006, J PHYSIOL PHARMACOL, V57, P343; Kobal Alfred B., 2004, Journal of Trace Elements in Medicine and Biology, V17, P261, DOI 10.1016/S0946-672X(04)80028-2; Kobal AB, 2008, ENVIRON RES, V107, P115, DOI 10.1016/j.envres.2007.07.001; LUND BO, 1993, BIOCHEM PHARMACOL, V45, P2017, DOI 10.1016/0006-2952(93)90012-L; Martinez-Revelles S, 2012, ANTIOXID REDOX SIGNA; Massaroni L, 1995, PHARMACOL RES, V32, P27, DOI 10.1016/S1043-6618(95)80005-0; McKelvey W, 2007, ENVIRON HEALTH PERSP, V115, P1435, DOI 10.1289/ehp.10056; MISRA HP, 1972, J BIOL CHEM, V247, P3170; National Academy of Sciences, 2000, TOX EFF METH; Nyland JF, 2012, TOXICOL SCI, V125, P134, DOI 10.1093/toxsci/kfr264; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pecanha FM, 2010, J PHYSIOL PHARMACOL, V61, P29; PRABHU SD, 1990, ARCH BIOCHEM BIOPHYS, V277, P47, DOI 10.1016/0003-9861(90)90548-D; RHEE HM, 1989, EXP MOL PATHOL, V50, P281, DOI 10.1016/0014-4800(89)90038-5; Rice DC, 2004, ENVIRON RES, V95, P406, DOI 10.1016/j.envres.2003.08.013; Sancho P, 2011, FREE RADICAL BIO MED, V51, P1789, DOI 10.1016/j.freeradbiomed.2011.08.011; Tian XY, 2012, ANTIOXID REDOX SIGN, V16, P363, DOI 10.1089/ars.2010.3874; Virdis A, 2004, J HYPERTENS, V22, P535, DOI 10.1097/00004872-200403000-00016; Virtanen JK, 2005, ARTERIOSCL THROM VAS, V25, P228, DOI 10.1161/01.ATV.0000150040.20950.61; Wakisaka Y, 2008, J CEREBR BLOOD F MET, V28, P1175, DOI 10.1038/jcbfm.2008.7; WAKITA Y, 1987, TOXICOL APPL PHARM, V89, P144, DOI 10.1016/0041-008X(87)90185-2; Wendel A, 1981, Methods Enzymol, V77, P325; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Wiggers GA, 2008, COMP BIOCHEM PHYS C, V147, P252, DOI 10.1016/j.cbpc.2007.10.003; Yin ZB, 2007, BRAIN RES, V1131, P1, DOI 10.1016/j.brainres.2006.10.070; Zalups RK, 2000, PHARMACOL REV, V52, P113; Zemolin APP, 2012, TOXICOLOGY, V302, P60, DOI 10.1016/j.tox.2012.07.013; Zhang YB, 2011, TOXICOL SCI, V119, P270, DOI 10.1093/toxsci/kfq334	46	38	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55806	10.1371/journal.pone.0055806	http://dx.doi.org/10.1371/journal.pone.0055806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390552	Green Submitted, Green Published, gold			2022-12-25	WOS:000314691100068
J	Yuki, KE; Eva, MM; Richer, E; Chung, D; Paquet, M; Cellier, M; Canonne-Hergaux, F; Vaulont, S; Vidal, SM; Malo, D				Yuki, Kyoko E.; Eva, Megan M.; Richer, Etienne; Chung, Dudley; Paquet, Marilene; Cellier, Mathieu; Canonne-Hergaux, Francois; Vaulont, Sophie; Vidal, Silvia M.; Malo, Danielle			Suppression of Hepcidin Expression and Iron Overload Mediate Salmonella Susceptibility in Ankyrin 1 ENU-Induced Mutant	PLOS ONE			English	Article							CELLULAR-LOCALIZATION; MUTATIONS; MICE; FERROPORTIN; INFECTIONS; DEFICIENCY; METABOLISM; RESISTANCE; TRANSPORT; DISEASES	Salmonella, a ubiquitous Gram-negative intracellular bacterium, is a food borne pathogen that infects a broad range of hosts. Infection with Salmonella Typhimurium in mice is a broadly recognized experimental model resembling typhoid fever in humans. Using a N-ethyl-N-nitrosurea (ENU) mutagenesis recessive screen, we report the identification of lty16 (Immunity to Typhimurium locus 16), a locus responsible for increased susceptibility to infection. The position of lty16 was refined on chromosome 8 and a nonsense mutation was identified in the ankyrin 1 (Ank1) gene. ANK1 plays an important role in the formation and stabilization of the red cell cytoskeleton. The Ank1(lty16/lty16) mutation causes severe hemolytic anemia in uninfected mice resulting in splenomegaly, hyperbilirubinemia, jaundice, extramedullary erythropoiesis and iron overload in liver and kidneys. Ank1(lty16/lty16) mutant mice demonstrated low levels of hepcidin (Hamp) expression and significant increases in the expression of the growth differentiation factor 15 (Gdf15), erythropoietin (Epo) and heme oxygenase 1 (Hmox1) exacerbating extramedullary erythropoiesis, tissue iron deposition and splenomegaly. As the infection progresses in Ank1(lty16/lty16), the anemia worsens and bacterial load were high in liver and kidneys compared to wild type mice. Heterozygous Ank1(+/lty16) mice were also more susceptible to Salmonella infection although to a lesser extent than Ank1(lty16/lty16) and they did not inherently present anemia and splenomegaly. During infection, iron accumulated in the kidneys of Ank1(+/lty16) mice where bacterial loads were high compared to littermate controls. The critical role of HAMP in the host response to Salmonella infection was validated by showing increased susceptibility to infection in Hamp-deficient mice and significant survival benefits in Ank1(+/lty16) heterozygous mice treated with HAMP peptide. This study illustrates that the regulation of Hamp and iron balance are crucial in the host response to Salmonella infection in Ank1 mutants.	[Yuki, Kyoko E.; Eva, Megan M.; Richer, Etienne; Vidal, Silvia M.; Malo, Danielle] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Malo, Danielle] McGill Univ, Dept Med, Montreal, PQ, Canada; [Yuki, Kyoko E.; Eva, Megan M.; Richer, Etienne; Vidal, Silvia M.; Malo, Danielle] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada; [Paquet, Marilene] McGill Univ, Comparat Med & Anim Resources Ctr, Montreal, PQ, Canada; [Chung, Dudley] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Cellier, Mathieu] Univ Quebec, Inst Armand Frappier, Ctr INRS, Laval, PQ, Canada; [Canonne-Hergaux, Francois] Fac Med Toulouse, INSERM, U1043, CPTP, F-31073 Toulouse, France; [Vaulont, Sophie] Inst Cochin, INSERM, U1016, Paris, France; [Canonne-Hergaux, Francois] CNRS, U5282, Toulouse, France; [Canonne-Hergaux, Francois] Univ Toulouse, UPS, CPTP, Toulouse, France	McGill University; McGill University; McGill University; McGill University; University of Victoria; University of Quebec; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Malo, D (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	danielle.malo@mcgill.ca	CANONNE-HERGAUX, François/AAC-2073-2020; Paquet, Marilene/L-3414-2019; Canonne-Hergaux, Francois/L-5363-2016; Vaulont, Sophie/O-6732-2017	CANONNE-HERGAUX, François/0000-0002-0621-2157; Paquet, Marilene/0000-0002-3562-4636; Canonne-Hergaux, Francois/0000-0002-0621-2157; Malo, Danielle/0000-0003-3980-6610	Team Program of the Canadian Institutes of Health Research [CTP-87520]; Faculty of Medicine Internal Studentship Award; Research Institute of the MUHC Studentship	Team Program of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Faculty of Medicine Internal Studentship Award; Research Institute of the MUHC Studentship	This work was supported by the Team Program of the Canadian Institutes of Health Research (CTP-87520) to DM and SMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KEY was a recipient of a Faculty of Medicine Internal Studentship Award and MME was a recipient of a Research Institute of the MUHC Studentship. SMV holds a Canada Research Chair and DM is a McGill Dawson Scholar.	BENNETT V, 1992, J BIOL CHEM, V267, P8703; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Birkenmeier Connie S, 2003, Hematol J, V4, P445, DOI 10.1038/sj.thj.6200307; Boguslawska DM, 2004, ANN HEMATOL, V83, P28, DOI 10.1007/s00277-003-0739-5; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Bustamante J, 2008, IMMUNOL ALLERGY CLIN, V28, P235, DOI 10.1016/j.iac.2008.01.009; Casanova JL, 2008, J INTERN MED, V264, P115, DOI 10.1111/j.1365-2796.2008.01971.x; Collins HL, 2002, J IMMUNOL, V168, P3458, DOI 10.4049/jimmunol.168.7.3458; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Delaunay J, 2002, ACTA HAEMATOL-BASEL, V108, P210, DOI 10.1159/000065657; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; Ferguson CJ, 2001, AM J PHYSIOL-RENAL, V280, pF803, DOI 10.1152/ajprenal.2001.280.5.F803; Gallagher PG, 2005, BLOOD CELL MOL DIS, V35, P345, DOI 10.1016/j.bcmd.2005.08.008; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Gardenghi S, 2010, HEMATOL ONCOL CLIN N, V24, P1089, DOI 10.1016/j.hoc.2010.08.003; Gordeuk VR, 2011, BLOOD, V118, P5278, DOI 10.1182/blood-2011-03-345512; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Greth A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038999; Harris BS, 2009, NEW PALE LETHAL MOUS; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hughes MR, 2011, EXP HEMATOL, V39, P305, DOI 10.1016/j.exphem.2010.12.009; JONES RL, 1977, NATURE, V267, P63, DOI 10.1038/267063a0; Kattamis A, 2006, HAEMATOLOGICA, V91, P809; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kulaksiz H, 2005, J ENDOCRINOL, V184, P361, DOI 10.1677/joe.1.05729; Lakhal S, 2009, BLOOD, V113, P1555, DOI 10.1182/blood-2008-07-170431; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Mastroeni P., 2006, SALMONELLA INFECT CL; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193; Perrotta S, 2008, LANCET, V372, P1411, DOI 10.1016/S0140-6736(08)61588-3; PETERS LL, 1993, SEMIN HEMATOL, V30, P85; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Rank G, 2009, BLOOD, V113, P3352, DOI 10.1182/blood-2008-08-172841; Richer E, 2010, J IMMUNOL, V185, P3593, DOI 10.4049/jimmunol.1000890; Roy MF, 2007, J EXP MED, V204, P2949, DOI 10.1084/jem.20062606; Rubtsov AM, 2000, FEBS LETT, V482, P1, DOI 10.1016/S0014-5793(00)01924-4; Sanchez-Lopez JY, 2003, BLOOD CELL MOL DIS, V31, P357, DOI 10.1016/S1079-9796(03)00207-9; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; Team R. D. C, 2011, R LANG ENV STAT COMP; Vento S, 2006, LANCET INFECT DIS, V6, P226, DOI 10.1016/S1473-3099(06)70437-6; Veuthey T, 2008, AM J PHYSIOL-RENAL, V295, pF1213, DOI 10.1152/ajprenal.90216.2008; Viatte L, 2006, BLOOD, V107, P2952, DOI 10.1182/blood-2005-10-4071; VIDAL S, 1995, J LEUKOCYTE BIOL, V58, P382, DOI 10.1002/jlb.58.4.382; Walker EM, 2000, ANN CLIN LAB SCI, V30, P354; Wareing M, 2000, J PHYSIOL-LONDON, V524, P581, DOI 10.1111/j.1469-7793.2000.00581.x; Zhou XJ, 2000, LAB INVEST, V80, P1905, DOI 10.1038/labinvest.3780200	57	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55331	10.1371/journal.pone.0055331	http://dx.doi.org/10.1371/journal.pone.0055331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390527	Green Submitted, Green Published, gold			2022-12-25	WOS:000314691100043
J	Calzone, FJ; Cajulis, E; Chung, YA; Tsai, MM; Mitchell, P; Lu, J; Chen, C; Sun, JL; Radinsky, R; Kendall, R; Beltran, PJ				Calzone, Frank J.; Cajulis, Elaina; Chung, Young-Ah; Tsai, Mei-Mei; Mitchell, Petia; Lu, John; Chen, Ching; Sun, Jilin; Radinsky, Robert; Kendall, Richard; Beltran, Pedro J.			Epitope-Specific Mechanisms of IGF1R Inhibition by Ganitumab	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODIES; I RECEPTOR; INSULIN-RECEPTOR; DEGRADATION; BINDING; CANCER; SIGNAL; CELLS	Background: Therapeutic antibodies targeting the IGF1R have shown diverse efficacy and safety signals in oncology clinical trials. The success of these agents as future human therapeutics depends on understanding the specific mechanisms by which these antibodies target IGF1R signaling. Methodology/Principal Findings: A panel of well-characterized assays was used to investigate the mechanisms by which ganitumab, a fully human anti-IGF1R antibody undergoing clinical testing, inhibits IGF1R activity. Epitope mapping using IGF1R subdomains localized the ganitumab binding site to the L2 domain. Binding of ganitumab inhibited the high-affinity interaction of IGF-1 and IGF-2 required to activate IGF1R in cells engineered for IGF1R hypersensitivity and in human cancer cell lines, resulting in complete blockade of ligand-induced cellular proliferation. Inhibition of IGF1R activity by ganitumab did not depend on endosomal sequestration, since efficient ligand blockade was obtained without evidence of receptor internalization and degradation. Clinically relevant concentrations of ganitumab also inhibited the activation of hybrid receptors by IGF-1 and IGF-2. Ganitumab was not an agonist of homodimeric IGF1R or hybrid receptors in MCF-7 and COLO 205 cells, but low-level IGF1R activation was detected in cells engineered for IGF1R hypersensitivity. This activation seems biologically irrelevant since ganitumab completely inhibited ligand-driven proliferation. The in vivo efficacy profile of ganitumab was equivalent or better than CR and FnIII-1 domain-specific antibodies, alone or in combination with irinotecan. CR domain-specific antibodies only blocked IGF-1 binding to IGF1R but were more potent than ganitumab at inducing homodimer and hybrid receptor downregulation in vitro, however this difference was less obvious in vivo. No inhibition of hybrid receptors was observed with the FnIII-1 domain antibodies, which were relatively strong homodimer and hybrid agonists. Conclusions/Significance: The safety and efficacy profile of ganitumab and other anti-IGF1R antibodies may be explained by the distinct molecular mechanisms by which they inhibit receptor signaling.	[Calzone, Frank J.; Cajulis, Elaina; Chung, Young-Ah; Mitchell, Petia; Radinsky, Robert; Kendall, Richard; Beltran, Pedro J.] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA; [Tsai, Mei-Mei] Amgen Inc, Biol Discovery, Thousand Oaks, CA 91320 USA; [Lu, John] Amgen Inc, Metab Disorders, Thousand Oaks, CA 91320 USA; [Chen, Ching] Amgen Inc, Biol Optimizat, Thousand Oaks, CA 91320 USA; [Sun, Jilin] Amgen Inc, Clin Immunol, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen; Amgen	Beltran, PJ (corresponding author), Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA.	pbeltran@amgen.com						Ackerman ME, 2008, MOL CANCER THER, V7, P2233, DOI 10.1158/1535-7163.MCT-08-0067; Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Baserga Renato, 1998, P269; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Belleudi F, 2012, CELL CYCLE, V11, P1455, DOI 10.4161/cc.19861; Beltran PJ, 2011, J PHARMACOL EXP THER, V337, P644, DOI 10.1124/jpet.110.178400; Beltran PJ, 2007, P 19 INT EORTC NCI A, pA67; Beltran PJ, 2009, MOL CANC THERAPEUTIC; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Doern A, 2009, J BIOL CHEM, V284, P10254, DOI 10.1074/jbc.M809709200; Dupont J, 2001, HORM RES, V55, P22, DOI 10.1159/000063469; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Hailey J, 2002, MOL CANCER THER, V1, P1349; Hewish M, 2009, RECENT PAT ANTI-CANC, V4, P54, DOI 10.2174/157489209787002515; Kaneda A, 2005, CANCER RES, V65, P11236, DOI 10.1158/0008-5472.CAN-05-2959; KULL FC, 1983, J BIOL CHEM, V258, P6561; Mazot P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033581; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Rosen LS, 2012, CLIN CANC RES; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Martins AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019846; SOOS MA, 1992, J BIOL CHEM, V267, P12955; STEELEPERKINS G, 1990, BIOCHEM BIOPH RES CO, V171, P1244, DOI 10.1016/0006-291X(90)90819-9; Tolcher AW, 2009, J CLIN ONCOL, V27, P5800, DOI 10.1200/JCO.2009.23.6745; XIONG LM, 1992, P NATL ACAD SCI USA, V89, P5356, DOI 10.1073/pnas.89.12.5356; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258	32	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55135	10.1371/journal.pone.0055135	http://dx.doi.org/10.1371/journal.pone.0055135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383308	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900015
J	Freudenburg, W; Gautam, M; Chakraborty, P; James, J; Richards, J; Salvatori, AS; Baldwin, A; Schriewer, J; Buller, RML; Corbett, JA; Skowyra, D				Freudenburg, Wieke; Gautam, Madhav; Chakraborty, Pradipta; James, Jared; Richards, Jennifer; Salvatori, Alison S.; Baldwin, Aaron; Schriewer, Jill; Buller, R. Mark L.; Corbett, John A.; Skowyra, Dorota			Reduction in ATP Levels Triggers Immunoproteasome Activation by the 11S (PA28) Regulator during Early Antiviral Response Mediated by IFN beta in Mouse Pancreatic beta-Cells (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							DOUBLE-STRANDED RNA; INTERFERON-GAMMA; PROTEASOME SYSTEM; 26S PROTEASOMES; POTENTIAL ROLE; T-CELLS; EXPRESSION; GENES; INDUCTION; ALPHA	Autoimmune destruction of insulin producing pancreatic beta-cells is the hallmark of type I diabetes. One of the key molecules implicated in the disease onset is the immunoproteasome, a protease with multiple proteolytic sites that collaborates with the constitutive 19S and the inducible 11S (PA28) activators to produce immunogenic peptides for presentation by MHC class I molecules. Despite its importance, little is known about the function and regulation of the immunoproteasome in pancreatic beta-cells. Of special interest to immunoproteasome activation in beta-cells are the effects of IFN beta, a type I IFN secreted by virus-infected cells and implicated in type I diabetes onset, compared to IFN gamma, the classic immunoproteasome inducer secreted by cells of the immune system. By qPCR analysis, we show that mouse insulinoma MIN6 cells and mouse islets accumulate the immune proteolytic beta 1(i), beta 2(i) and beta 5(i), and 11S mRNAs upon exposure to IFN beta or IFN gamma. Higher concentrations of IFN beta than IFN gamma are needed for similar expression, but in each case the expression is transient, with maximal mRNA accumulation in 12 hours, and depends primarily on Interferon Regulatory Factor 1. IFNs do not alter expression of regular proteasome genes, and in the time frame of IFN beta-mediated response, the immune and regular proteolytic subunits co-exist in the 20S particles. In cell extracts with ATP, these particles have normal peptidase activities and degrade polyubiquitinated proteins with rates typical of the regular proteasome, implicating normal regulation by the 19S activator. However, ATP depletion rapidly stimulates the catalytic rates in a manner consistent with levels of the 11S activator. These findings suggest that stochastic combination of regular and immune proteolytic subunits may increase the probability with which unique immunogenic peptides are produced in pancreatic beta-cells exposed to IFN beta, but primarily in cells with reduced ATP levels that stimulate the 11S participation in immunoproteasome function.	[Freudenburg, Wieke; Gautam, Madhav; Chakraborty, Pradipta; James, Jared; Richards, Jennifer; Salvatori, Alison S.; Skowyra, Dorota] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Freudenburg, Wieke; Schriewer, Jill; Buller, R. Mark L.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA; [Baldwin, Aaron; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Saint Louis University; Saint Louis University; Medical College of Wisconsin	Skowyra, D (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	skowyra@slu.edu			American Diabetes Foundation [ADA 7-11-BS138, ADA 7-06-PST-03]; United States National Institutes of Health [DK52194, AI-44458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194] Funding Source: NIH RePORTER	American Diabetes Foundation(American Diabetes Association); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by Basic Science Award ADA 7-11-BS138 (DS) and Physician Scientist Training award ADA 7-06-PST-03 (WF) from American Diabetes Foundation (http://www.diabetes.org/); and DK52194 (JC) and AI-44458 (JC) from the United States National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Alba A, 2004, J IMMUNOL, V173, P6667, DOI 10.4049/jimmunol.173.11.6667; Arnush M, 1998, J IMMUNOL, V160, P2684; Baldeon ME, 1997, DIABETES, V46, P770, DOI 10.2337/diabetes.46.5.770; Baldeon ME, 1998, AM J PHYSIOL, V275, P25; Brucet M, 2004, GENES IMMUN, V5, P26, DOI 10.1038/sj.gene.6364035; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chakrabarti D, 1996, J IMMUNOL, V157, P522; Chatterjee-Kishore M, 1998, J BIOL CHEM, V273, P16177, DOI 10.1074/jbc.273.26.16177; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Fairweather D, 2002, NAT IMMUNOL, V3, P338, DOI 10.1038/ni0402-338; Foss GS, 1999, J BIOL CHEM, V274, P35196, DOI 10.1074/jbc.274.49.35196; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Geng Q, 2009, BIOCHEM BIOPH RES CO, V390, P1136, DOI 10.1016/j.bbrc.2009.10.067; Goettrup M, 1995, J BIOL CHEM, V270, P23808; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hendil KB, 1998, BIOCHEM J, V332, P749, DOI 10.1042/bj3320749; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HUANG XJ, 1994, IMMUNITY, V1, P469, DOI 10.1016/1074-7613(94)90089-2; HUANG XJ, 1995, DIABETES, V44, P658, DOI 10.2337/diabetes.44.6.658; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jun HS, 2003, DIABETES-METAB RES, V19, P8, DOI 10.1002/dmrr.337; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Khan S, 2001, J IMMUNOL, V167, P6859, DOI 10.4049/jimmunol.167.12.6859; Kiefer SM, 2002, J BIOL CHEM, V277, P14869, DOI 10.1074/jbc.M200052200; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kopp F, 2001, J MOL BIOL, V313, P465, DOI 10.1006/jmbi.2001.5063; Lehner PJ, 2003, IMMUNITY, V18, P315, DOI 10.1016/S1074-7613(03)00061-X; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; MA CP, 1992, J BIOL CHEM, V267, P10515; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Namiki S, 2005, FEBS LETT, V579, P2781, DOI 10.1016/j.febslet.2005.04.012; Pavlovic D, 1999, EUR CYTOKINE NETW, V10, P403; Pelegrin M, 1998, J BIOL CHEM, V273, P12332, DOI 10.1074/jbc.273.20.12332; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Rasschaert J, 2003, DIABETOLOGIA, V46, P1641, DOI 10.1007/s00125-003-1245-y; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Schwarz K, 2000, J IMMUNOL, V165, P768, DOI 10.4049/jimmunol.165.2.768; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shin EC, 2007, J INTERF CYTOK RES, V27, P985, DOI 10.1089/jir.2007.0039; Shin EC, 2006, J CLIN INVEST, V116, P3006, DOI 10.1172/JCI29832; Sijts AJAM, 2000, J EXP MED, V191, P503, DOI 10.1084/jem.191.3.503; SOMOZA N, 1994, J IMMUNOL, V153, P1360; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; White LC, 1996, IMMUNITY, V5, P365, DOI 10.1016/S1074-7613(00)80262-9; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250	59	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e52408	10.1371/journal.pone.0052408	http://dx.doi.org/10.1371/journal.pone.0052408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383295	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900002
J	Kim, EJ; Cho, SW; Shin, JO; Lee, MJ; Kim, KS; Jung, HS				Kim, Eun-Jung; Cho, Sung-Won; Shin, Jeong-Oh; Lee, Min-Jung; Kim, Kye-Seong; Jung, Han-Sung			Ihh and Runx2/Runx3 Signaling Interact to Coordinate Early Chondrogenesis: A Mouse Model	PLOS ONE			English	Article							INDIAN-HEDGEHOG; CHONDROCYTE DIFFERENTIATION; GENE-EXPRESSION; GROWTH; ROLES; BMP; PROLIFERATION; DISRUPTION; MATURATION; INDUCTION	Endochondral bone formation begins with the development of a cartilage intermediate that is subsequently replaced by calcified bone. The mechanisms occurring during early chondrogenesis that control both mesenchymal cell differentiation into chondrocytes and cell proliferation are not clearly understood in vertebrates. Indian hedgehog (Ihh), one of the hedgehog signaling molecules, is known to control both the hypertrophy of chondrocytes and bone replacement; these processes are particularly important in postnatal endochondral bone formation rather than in early chondrogenesis. In this study, we utilized the maternal transfer of 5E1 to E12.5 in mouse embryos, a process that leads to an attenuation of Ihh activity. As a result, mouse limb bud chondrogenesis was inhibited, and an exogenous recombinant IHH protein enhanced the proliferation and differentiation of mesenchymal cells. Analysis of the genetic relationships in the limb buds suggested a more extensive role for Ihh and Runx genes in early chondrogenesis. The transfer of 5E1 decreased the expression of Runx2 and Runx3, whereas an exogenous recombinant IHH protein increased Runx2 and Runx3 expression. Moreover, a transcription factor Gli1 in hedgehog pathway enhances the direct induction of both Runx2 and Runx3 transcription. These findings suggested that Ihh signaling plays an important role in chondrocyte proliferation and differentiation via interactions with Runx2 and Runx3.	[Kim, Eun-Jung; Cho, Sung-Won; Shin, Jeong-Oh; Lee, Min-Jung; Jung, Han-Sung] Yonsei Univ, Coll Dent, Oral Sci Res Ctr,Res Ctr Orofacial Hard Tissue Re, Brain Korea 21 Project,Div Anat & Dev Biol,Dept O, Seoul 120749, South Korea; [Kim, Kye-Seong] Hanyang Univ, Grad Sch Biomed Sci & Engn, Coll Anat & Cell Biol, Seoul 133791, South Korea	Yonsei University; Yonsei University Health System; Hanyang University	Kim, EJ (corresponding author), Yonsei Univ, Coll Dent, Oral Sci Res Ctr,Res Ctr Orofacial Hard Tissue Re, Brain Korea 21 Project,Div Anat & Dev Biol,Dept O, Seoul 120749, South Korea.	blueleah@yuhs.ac; hsjung@yuhs.ac	Jung, Han-Sung/I-3848-2012; CHO, Sung-Won/HDO-3680-2022	Kim, Eun-Jung/0000-0002-9515-7590; Cho, Sung-Won/0000-0001-7505-9769; Jung, Han-Sung/0000-0003-2795-531X	Bio and Medical Technology Development Program [2012M3A9B4028738]; National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea	Bio and Medical Technology Development Program; National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by the grant for the Bio and Medical Technology Development Program (2012M3A9B4028738) funded by the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bruce SJ, 2010, J BIOL CHEM, V285, P27967, DOI 10.1074/jbc.M109.091785; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Cho SW, 2011, DEVELOPMENT, V138, P1807, DOI 10.1242/dev.056051; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449; Colnot C, 2005, DEVELOPMENT, V132, P1057, DOI 10.1242/dev.01649; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Daluiski A, 2001, NAT GENET, V27, P84, DOI 10.1038/83810; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Haaijman A, 2000, GROWTH FACTORS, V17, P177, DOI 10.3109/08977190009001067; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lai LP, 2005, J CELL BIOCHEM, V96, P1163, DOI 10.1002/jcb.20635; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Minina E, 2001, DEVELOPMENT, V128, P4523; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; Shimizu H, 2007, DEV GROWTH DIFFER, V49, P449, DOI 10.1111/j.1440-169x.2007.00945.x; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Takamoto M, 2003, J ENDOCRINOL, V177, P413, DOI 10.1677/joe.0.1770413; Tickle C, 2002, AM J MED GENET, V112, P250, DOI 10.1002/ajmg.10774; Towers M, 2008, NATURE, V452, P882, DOI 10.1038/nature06718; Towers M, 2012, CURR OPIN CELL BIOL, V24, P181, DOI 10.1016/j.ceb.2011.11.005; Towers M, 2009, DEVELOPMENT, V136, P179, DOI 10.1242/dev.024158; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	35	39	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55296	10.1371/journal.pone.0055296	http://dx.doi.org/10.1371/journal.pone.0055296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383321	Green Submitted, gold, Green Published			2022-12-25	WOS:000314597900028
J	Kim, JW; Glasgow, JN; Nakayama, M; Ak, F; Ugai, H; Curiel, DT				Kim, Julius W.; Glasgow, Joel N.; Nakayama, Masaharu; Ak, Ferhat; Ugai, Hideyo; Curiel, David T.			An Adenovirus Vector Incorporating Carbohydrate Binding Domains Utilizes Glycans for Gene Transfer	PLOS ONE			English	Article							POLY-N-ACETYLLACTOSAMINE; IN-VIVO; FIBER PROTEIN; CANCER-CELLS; CELLULAR RECEPTORS; UDP-GALACTOSE; BREAST-CANCER; EX-VIVO; GLYCOSYLATION; THERAPY	Background: Vectors based on human adenovirus serotype 5 (HAdV-5) continue to show promise as delivery vehicles for cancer gene therapy. Nevertheless, it has become clear that therapeutic benefit is directly linked to tumor-specific vector localization, highlighting the need for tumor-targeted gene delivery. Aberrant glycosylation of cell surface glycoproteins and glycolipids is a central feature of malignant transformation, and tumor-associated glycoforms are recognized as cancer biomarkers. On this basis, we hypothesized that cancer-specific cell-surface glycans could be the basis of a novel paradigm in HAdV-5-based vector targeting. Methodology/Principal Findings: As a first step toward this goal, we constructed a novel HAdV-5 vector encoding a unique chimeric fiber protein that contains the tandem carbohydrate binding domains of the fiber protein of the NADC-1 strain of porcine adenovirus type 4 (PAdV-4). This glycan-targeted vector displays augmented CAR-independent gene transfer in cells with low CAR expression. Further, we show that gene transfer is markedly decreased in cells with genetic glycosylation defects and by inhibitors of glycosylation in normal cells. Conclusions/Significance: These data provide the initial proof-of-concept for HAdV-5 vector-mediated gene delivery based on the presence of cell-surface carbohydrates. Further development of this new targeting paradigm could provide targeted gene delivery based on vector recognition of disease-specific glycan biomarkers.	[Kim, Julius W.; Ugai, Hideyo; Curiel, David T.] Washington Univ, Sch Med, Div Canc Biol, St Louis, MO 63130 USA; [Curiel, David T.] Washington Univ, Sch Med, Biol Therapeut Ctr, Dept Radiat Oncol, St Louis, MO USA; [Ak, Ferhat] Univ Groningen, Dept Pharm, Fac Math & Nat Sci, Groningen, Netherlands; [Nakayama, Masaharu] Kyushu Univ, Med Inst Bioregulat, Div Mol & Clin Genet, Fukuoka 812, Japan; [Glasgow, Joel N.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Washington University (WUSTL); Washington University (WUSTL); University of Groningen; Kyushu University; University of Alabama System; University of Alabama Birmingham	Curiel, DT (corresponding author), Washington Univ, Sch Med, Div Canc Biol, St Louis, MO 63130 USA.	dcuriel@radonc.wustl.edu	Ugai, Hideyo/K-4920-2017	Ugai, Hideyo/0000-0002-9121-8480; Glasgow, Joel/0000-0002-2842-7917	National Institutes of Health [SP50 10 CA101955]; NATIONAL CANCER INSTITUTE [P50CA101955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant SP50 10 CA101955 from the National Institutes of Health (DTC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; [Anonymous], 2012, J GENE MED; Barrow H, 2011, INT J CANCER, V129, P1, DOI 10.1002/ijc.25945; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Battacharya M, 1968, HDB CANCER IMMUNOLOG, V4, P277; Belousova N, 2002, J VIROL, V76, P8621, DOI 10.1128/JVI.76.17.8621-8631.2002; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Connelly S, 1999, CURR OPIN MOL THER, V1, P565; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Davison E, 1997, J VIROL, V71, P6204, DOI 10.1128/JVI.71.8.6204-6207.1997; Dempsey E, 2012, ANN NY ACAD SCI, V1253, P122, DOI 10.1111/j.1749-6632.2011.06420.x; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DO KY, 1993, J BIOL CHEM, V268, P22028; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; ELBEIN AD, 1981, P NATL ACAD SCI-BIOL, V78, P7393, DOI 10.1073/pnas.78.12.7393; Fujishiro J, 2005, NEPHROL DIAL TRANSPL, V20, P1385, DOI 10.1093/ndt/gfh783; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Glasgow JN, 2004, VIROLOGY, V324, P103, DOI 10.1016/j.virol.2004.03.028; Guardado-Calvo P, 2010, J VIROL, V84, P10558, DOI 10.1128/JVI.00997-10; Guardado-Calvo P, 2009, ACTA CRYSTALLOGR F, V65, P1149, DOI 10.1107/S1744309109038287; Hakomori S, 1996, CANCER RES, V56, P5309; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Haviv YS, 2002, CANCER RES, V62, P4273; Heikkila P, 1996, GENE THER, V3, P21; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; HUARD J, 1995, GENE THER, V2, P107; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kanerva A, 2005, ANN MED, V37, P33, DOI 10.1080/07853890410018934; Kasono K, 1999, CLIN CANCER RES, V5, P2571; Kleiboeker SB, 1995, VIRUS RES, V39, P299, DOI 10.1016/0168-1702(95)00079-8; Krasnykh V, 1998, J VIROL, V72, P1844, DOI 10.1128/JVI.72.3.1844-1852.1998; Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Li E, 2001, J VIROL, V75, P5405, DOI 10.1128/JVI.75.11.5405-5409.2001; Li HJ, 2009, CURR OPIN BIOTECH, V20, P678, DOI 10.1016/j.copbio.2009.10.009; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2012, ANN NY ACAD SCI, V1253, P80, DOI 10.1111/j.1749-6632.2011.06386.x; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Miller CR, 1998, CANCER RES, V58, P5738; MOULLIER P, 1994, KIDNEY INT, V45, P1220, DOI 10.1038/ki.1994.162; Murakami M, 2009, PROSTATE; Murakami M, 2010, VIROLOGY, V407, P196, DOI 10.1016/j.virol.2010.08.010; Nagae M, 2009, GLYCOBIOLOGY, V19, P112, DOI 10.1093/glycob/cwn121; Nakayama M, 2006, VIROLOGY, V350, P103, DOI 10.1016/j.virol.2006.01.037; Nicklin SA, 2005, MOL THER, V12, P384, DOI 10.1016/j.ymthe.2005.05.008; Noureddini SC, 2006, VIRUS RES, V116, P185, DOI 10.1016/j.virusres.2005.10.002; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Okegawa T, 2000, CANCER RES, V60, P5031; Okegawa T, 2001, CANCER RES, V61, P6592; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Paul CPL, 2008, CANCER BIOL THER, V7, P786, DOI 10.4161/cbt.7.5.5421; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Renaut L, 2004, VIROLOGY, V321, P189, DOI 10.1016/j.virol.2003.12.023; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Scott Ken, 2004, Glycoconjugate Journal, V19, P467; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Short JJ, 2009, MOL CANCER THER, V8, P2096, DOI 10.1158/1535-7163.MCT-09-0367; Smith TAG, 2003, HUM GENE THER, V14, P777, DOI 10.1089/104303403765255165; STANLEY P, 1985, MOL CELL BIOL, V5, P923, DOI 10.1128/MCB.5.5.923; Takeda S, 2004, NEPHRON EXP NEPHROL, V96, pE119, DOI 10.1159/000077378; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Ugai H, 2007, J MOL BIOL, V366, P1142, DOI 10.1016/j.jmb.2006.11.090; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; van Raaij MJ, 1999, VIROLOGY, V262, P333, DOI 10.1006/viro.1999.9849; Wesseling JG, 2001, CANCER GENE THER, V8, P990, DOI 10.1038/sj.cgt.7700403; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200; YU DH, 1993, CANCER RES, V53, P891	76	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55533	10.1371/journal.pone.0055533	http://dx.doi.org/10.1371/journal.pone.0055533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383334	Green Published, gold, Green Submitted			2022-12-25	WOS:000314597900041
J	Parameshwaran, D; Bhalla, US				Parameshwaran, Dhanya; Bhalla, Upinder S.			Theta Frequency Background Tunes Transmission but Not Summation of Spiking Responses	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; IN-VIVO; GAMMA-OSCILLATIONS; RAT HIPPOCAMPUS; POTENTIAL OSCILLATIONS; CORTICAL-NEURONS; PHASE-PRECESSION; NETWORK ACTIVITY; MEMORY TASK; SYNCHRONIZATION	Hippocampal neurons are known to fire as a function of frequency and phase of spontaneous network rhythms, associated with the animal's behaviour. This dependence is believed to give rise to precise rate and temporal codes. However, it is not well understood how these periodic membrane potential fluctuations affect the integration of synaptic inputs. Here we used sinusoidal current injection to the soma of CA1 pyramidal neurons in the rat brain slice to simulate background oscillations in the physiologically relevant theta and gamma frequency range. We used a detailed compartmental model to show that somatic current injection gave comparable results to more physiological synaptically driven theta rhythms incorporating excitatory input in the dendrites, and inhibitory input near the soma. We systematically varied the phase of synaptic inputs with respect to this background, and recorded changes in response and summation properties of CA1 neurons using whole-cell patch recordings. The response of the cell was dependent on both the phase of synaptic inputs and frequency of the background input. The probability of the cell spiking for a given synaptic input was up to 40% greater during the depolarized phases between 30-135 degrees of theta frequency current injection. Summation gain on the other hand, was not affected either by the background frequency or the phasic afferent inputs. This flat summation gain, coupled with the enhanced spiking probability during depolarized phases of the theta cycle, resulted in enhanced transmission of summed inputs during the same phase window of 30-135 degrees. Overall, our study suggests that although oscillations provide windows of opportunity to selectively boost transmission and EPSP size, summation of synaptic inputs remains unaffected during membrane oscillations.	[Parameshwaran, Dhanya; Bhalla, Upinder S.] TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Bhalla, US (corresponding author), TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	bhalla@ncbs.res.in		Bhalla, Upinder/0000-0003-1722-5188	Department of Biotechnology, India,; National Centre for Biological Sciences (NCBS)/Tata Institute of Fundamental Research (TIFR) funds	Department of Biotechnology, India,(Department of Biotechnology (DBT) India); National Centre for Biological Sciences (NCBS)/Tata Institute of Fundamental Research (TIFR) funds	Supported by a grant from the Department of Biotechnology, India, to USB, and National Centre for Biological Sciences (NCBS)/Tata Institute of Fundamental Research (TIFR) funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akam T, 2012, NAT NEUROSCI; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bower JM, 1998, BOOK GENESIS EXPLORI; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Burchell TR, 1998, NEUROSCI LETT, V255, P151, DOI 10.1016/S0304-3940(98)00676-4; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deshmukh SS, 2003, J NEUROSCI, V23, P1903; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Fellous JM, 2001, J NEUROPHYSIOL, V85, P1782, DOI 10.1152/jn.2001.85.4.1782; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Holscher C, 1997, J NEUROSCI, V17, P6470; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kwag J, 2009, NAT NEUROSCI, V12, P1219, DOI 10.1038/nn.2388; LANTHORN T, 1984, EXP BRAIN RES, V53, P431; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Leung LS, 1998, J NEUROPHYSIOL, V79, P1592, DOI 10.1152/jn.1998.79.3.1592; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; McLelland D, 2009, J PHYSIOL-LONDON, V587, P769, DOI 10.1113/jphysiol.2008.164111; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Narayanan R, 2008, J NEUROSCI, V28, P5846, DOI 10.1523/JNEUROSCI.0835-08.2008; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Parameshwaran D, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00071; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Shu YS, 2003, J NEUROSCI, V23, P10388; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wyble BP, 2000, J NEUROPHYSIOL, V83, P2138, DOI 10.1152/jn.2000.83.4.2138	57	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55607	10.1371/journal.pone.0055607	http://dx.doi.org/10.1371/journal.pone.0055607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383242	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600134
J	Yu, CC; Yang, JC; Chang, YC; Chuang, JG; Lin, CW; Wu, MS; Chow, LP				Yu, Cheng-Chou; Yang, Jyh-Chin; Chang, Yen-Ching; Chuang, Jiing-Guang; Lin, Chung-Wu; Wu, Ming-Shiang; Chow, Lu-Ping			VCP Phosphorylation-Dependent Interaction Partners Prevent Apoptosis in Helicobacter pylori-Infected Gastric Epithelial Cells	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; PROTEASOME-MEDIATED DEGRADATION; GROWTH-FACTOR RECEPTOR; ELEVATED EXPRESSION; TUMOR-SUPPRESSOR; CANCER; P97; UBIQUITIN; CYCLE; AKT	Previous studies have demonstrated that valosin-containing protein (VCP) is associated with H. pylori-induced gastric carcinogenesis. By identifying the interactome of VCP overexpressed in AGS cells using a subtractive proteomics approach, we aimed to characterize the cellular responses mediated by VCP and its functional roles in H. pylori-associated gastric cancer. VCP immunoprecipitations followed by proteomic analysis identified 288 putative interacting proteins, 18 VCP-binding proteins belonged to the PI3K/Akt signaling pathway. H. pylori infection increased the interaction between Akt and VCP, Akt-dependent phosphorylation of VCP, levels of ubiquitinated proteins, and aggresome formation in AGS cells. Furthermore, phosphorylated VCP co-localized with the aggresome, bound ubiquitinated proteins, and increased the degradation of cellular regulators to protect H. pylori-infected AGS cells from apoptosis. Our study demonstrates that VCP phosphorylation following H. pylori infection promotes both gastric epithelial cell survival, mediated by the PI3K/Akt pathway, and the degradation of cellular regulators. These findings provide novel insights into the mechanisms of H. pylori infection induced gastric carcinogenesis.	[Yu, Cheng-Chou; Chang, Yen-Ching; Chuang, Jiing-Guang; Chow, Lu-Ping] Natl Taiwan Univ Hosp, Coll Med, Grad Inst Biochem & Mol Biol, Taipei, Taiwan; [Yang, Jyh-Chin; Wu, Ming-Shiang] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lin, Chung-Wu] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chow, LP (corresponding author), Natl Taiwan Univ Hosp, Coll Med, Grad Inst Biochem & Mol Biol, Taipei, Taiwan.	chowip@ntu.edu.tw			Program for Excellence Research Teams of the Ministry of Education; National Science Council [98-2320-B-002-030-MY3]; Liver Disease Prevention & Treatment Research Foundation, Taiwan	Program for Excellence Research Teams of the Ministry of Education; National Science Council(Ministry of Science and Technology, Taiwan); Liver Disease Prevention & Treatment Research Foundation, Taiwan	This work was supported in part by the Program for Excellence Research Teams of the Ministry of Education, Grant 98-2320-B-002-030-MY3 from the National Science Council, and Liver Disease Prevention & Treatment Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Carloni S, 2012, NEUROSCIENCE, V203, P160, DOI 10.1016/j.neuroscience.2011.12.021; Chan CH, 2006, MOL CELL PROTEOMICS, V5, P702, DOI 10.1074/mcp.M500029-MCP200; CORREA P, 1985, SEMIN ONCOL, V12, P2; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Graaf AO, 2004, LEUKEMIA, V18, P1751, DOI 10.1038/sj.leu.2403493; Deans DAC, 2006, BRIT J CANCER, V95, P1568, DOI 10.1038/sj.bjc.6603446; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Eguchi H, 2003, CANCER RES, V63, P4739; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; GONDA MA, 1976, J NATL CANCER I, V56, P245, DOI 10.1093/jnci/56.2.245; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Katoh M, 2007, CANCER BIOL THER, V6, P832, DOI 10.4161/cbt.6.6.4196; Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Li SP, 2010, BIOMED ENVIRON SCI, V23, P273, DOI 10.1016/S0895-3988(10)60063-3; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Moss SF, 1998, ALIMENT PHARM THER, V12, P91, DOI 10.1111/j.1365-2036.1998.00002.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Peek RM, 1999, CANCER RES, V59, P6124; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; Philip M, 2004, SEMIN CANCER BIOL, V14, P433, DOI 10.1016/j.semcancer.2004.06.006; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sheu BS, 1999, DIGEST DIS SCI, V44, P868, DOI 10.1023/A:1026627707103; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Sonenberg N, 2006, SCIENCE, V314, P428, DOI 10.1126/science.1134031; Tabassam FH, 2009, CELL MICROBIOL, V11, P70, DOI 10.1111/j.1462-5822.2008.01237.x; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Vandermoere F, 2007, MOL CELL PROTEOMICS, V6, P114, DOI 10.1074/mcp.M600335-MCP200; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; WANG JT, 1993, EUR J CLIN MICROBIOL, V12, P367, DOI 10.1007/BF01964436; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Wei JX, 2010, GASTROENTEROLOGY, V139, P1333, DOI 10.1053/j.gastro.2010.06.018; Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70; Wigley WC, 1999, J CELL BIOL, V145, P481; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Yamamoto S, 2004, ONCOLOGY-BASEL, V66, P468, DOI 10.1159/000079501; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Yamamoto S, 2003, J CLIN ONCOL, V21, P2537, DOI 10.1200/JCO.2003.12.102; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Yang LC, 2008, J NUTR, V138, P2084, DOI 10.3945/jn.108.090985; Zucchini C, 2008, INT J ONCOL, V32, P17	60	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55724	10.1371/journal.pone.0055724	http://dx.doi.org/10.1371/journal.pone.0055724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383273	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600153
J	Zhang, YG; Wang, XZ; Yang, Z; Zhang, H; Liu, M; Qiu, YS; Guo, X				Zhang, Yin-gang; Wang, Xuezhi; Yang, Zhi; Zhang, Hong; Liu, Miao; Qiu, Yushen; Guo, Xiong			The Therapeutic Effect of Negative Pressure in Treating Femoral Head Necrosis in Rabbits	PLOS ONE			English	Article							CELLS; OSTEONECROSIS; OSTEOGENESIS	Because negative pressure can stimulate vascular proliferation, improve blood circulation and promote osteogenic differentiation of bone marrow stromal cells, we investigated the therapeutic effect of negative pressure on femoral head necrosis (FHN) in a rabbit model. Animals were divided into four groups (n = 60/group): [1] model control, [2] core decompression, [3] negative pressure and [4] normal control groups. Histological investigation revealed that at 4 and 8 weeks postoperatively, improvements were observed in trabecular bone shape, empty lacunae and numbers of bone marrow hematopoietic cells and fat cells in the negative pressure group compared to the core decompression group. At week 8, there were no significant differences between the negative pressure and normal control groups. Immunohistochemistry staining revealed higher expression of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2 (BMP-2) in the femoral heads in the negative pressure group compared with the core decompression group. Transmission electron microscopy revealed that cell organelles were further developed in the negative pressure group compared with the core decompression group. Microvascular ink staining revealed an increased number of bone marrow ink-stained blood vessels, a thicker vascular lumen and increased microvascular density in the negative pressure group relative to the core decompression group. Real-time polymerase chain reaction revealed that expression levels of both VEGF and BMP-2 were higher in the negative pressure group compared with the core decompression group. In summary, negative pressure has a therapeutic effect on FHN. This effect is superior to core decompression, indicating that negative pressure is a potentially valuable method for treating early FHN.	[Zhang, Yin-gang; Yang, Zhi; Zhang, Hong; Liu, Miao; Qiu, Yushen] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Orthoped, Xian 710049, Peoples R China; [Wang, Xuezhi] Zhenghe Hosp, Dept Gen Surg, Xian, Peoples R China; [Guo, Xiong] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zhang, YG (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Orthoped, Xian 710049, Peoples R China.	zyingang@mail.xjtu.edu.cn	Yang, Zhi/X-6447-2019		National Natural Science Foundation of China [81171761, 30973063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by a grant from the National Natural Science Foundation of China (No. 81171761, 30973063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JM, 2007, ORTHOP CLIN N AM, V38, P13, DOI 10.1016/j.ocl.2006.10.012; Castro F P Jr, 2000, Am J Orthop (Belle Mead NJ), V29, P187; Fan M, 2011, RHEUMATOL INT, V31, P983, DOI 10.1007/s00296-011-1819-9; Guan XY, 2010, J ORTHOP SCI, V15, P365, DOI 10.1007/s00776-010-1452-6; Hunter Judith E, 2007, Int Wound J, V4, P256, DOI 10.1111/j.1742-481X.2007.00361.x; Lausten GS, 1999, INT ORTHOP, V23, P193, DOI 10.1007/s002640050348; Rajpura A, 2011, HIP INT, V21, P385, DOI 10.5301/HIP.2011.8538; Rombouts J J, 1999, Acta Orthop Belg, V65 Suppl 1, P3; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Specchiulli F, 2000, Chir Organi Mov, V85, P395; Van Laere C, 1998, Acta Orthop Belg, V64, P269; Venturi ML, 2005, AM J CLIN DERMATOL, V6, P185, DOI 10.2165/00128071-200506030-00005; YAMAMOTO T, 1995, CLIN ORTHOP RELAT R, P235; Yang Z, 2009, J ZHEJIANG UNIV-SC B, V10, P188, DOI 10.1631/jzus.B0820240; Zhang YG, 2010, CONNECT TISSUE RES, V51, P14, DOI 10.3109/03008200902855891; Zhang YG, 2009, MED HYPOTHESES, V73, P906, DOI 10.1016/j.mehy.2009.06.052	17	7	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55745	10.1371/journal.pone.0055745	http://dx.doi.org/10.1371/journal.pone.0055745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383276	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600156
J	Sabirov, RZ; Kurbannazarova, RS; Melanova, NR; Okada, Y				Sabirov, Ravshan Z.; Kurbannazarova, Ranokon S.; Melanova, Nazira R.; Okada, Yasunobu			Volume-Sensitive Anion Channels Mediate Osmosensitive Glutathione Release from Rat Thymocytes	PLOS ONE			English	Article							ATP RELEASE; INDUCED APOPTOSIS; CL-CHANNEL; GLUTAMATE RELEASE; MOUSE ASTROCYTES; GSH TRANSPORT; CELL-VOLUME; EFFLUX; BRAIN; ACTIVATION	Glutathione (GSH) is a negatively charged tripeptide, which is a major determinant of the cellular redox state and defense against oxidative stress. It is assembled inside and degraded outside the cells and is released under various physiological and pathophysiological conditions. The GSH release mechanism is poorly understood at present. In our experiments, freshly isolated rat thymocytes were found to release GSH under normal isotonic conditions at a low rate of 0.82 +/- 0.07 attomol/cell/min and that was greatly enhanced under hypoosomotic stimulation to reach a level of 6.1 +/- 0.4 attomol/cell/min. The swelling-induced GSH release was proportional to the cell density in the suspension and was temperature-dependent with relatively low activation energy of 5.4 +/- 0.6 kcal/mol indicating a predominant diffusion mechanism of GSH translocation. The osmosensitive release of GSH was significantly inhibited by blockers of volume-sensitive outwardly rectifying (VSOR) anion channel, DCPIB and phloretin. In patch-clamp experiments, osmotic swelling activated large anionic conductance with the VSOR channel phenotype. Anion replacement studies suggested that the thymic VSOR anion channel is permeable to GSH(-) with the permeability ratio P-GSH/P-Cl of 0.32 for influx and 0.10 for efflux of GSH. The osmosensitive GSH release was trans-stimulated by SLCO/OATP substrates, probenecid, taurocholic acid and estrone sulfate, and inhibited by an SLC22A/OAT blocker, p-aminohippuric acid (PAH). The inhibition by PAH was additive to the effect of DCPIB or phloretin implying that PAH and DCPIB/phloretin affected separate pathways. We suggest that the VSOR anion channel constitutes a major part of the gamma-glutamyl cycle in thymocytes and, in cooperation with OATP-like and OAT-like transporters, provides a pathway for the GSH efflux from osmotically swollen cells.	[Sabirov, Ravshan Z.; Kurbannazarova, Ranokon S.; Okada, Yasunobu] Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan; [Sabirov, Ravshan Z.; Kurbannazarova, Ranokon S.; Melanova, Nazira R.] RUz, Acad Sci, Lab Mol Physiol, Inst Bioorgan Chem, Tashkent, Uzbekistan; [Sabirov, Ravshan Z.; Kurbannazarova, Ranokon S.] Natl Univ, Dept Biophys, Tashkent, Uzbekistan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Academy of Sciences of Uzbekistan; Sadykov Institute of Bioorganic Chemistry	Okada, Y (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 444, Japan.	okada@nips.ac.jp	Kurbannazarova, Ranokhon/ABE-1836-2021; Sabirov, Ravshan/ABD-4896-2021	Sabirov, Ravshan/0000-0003-3512-0873; Ranokhon, Kurbannazarova/0000-0003-3819-910X; Tashmukhamedov, Bekjan/0000-0001-7383-1735	Ministry of Education, Culture, Sports, Science and Technology of Japan; Center for Science and Technology; Academy of Sciences of Uzbekistan; Japanese Government; Grants-in-Aid for Scientific Research [23659118] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Science and Technology; Academy of Sciences of Uzbekistan; Japanese Government; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to YO and RZS) as well as by Grants-in-Aid from the Center for Science and Technology and Academy of Sciences of Uzbekistan to RZS and RSK. The authors acknowledge visiting scientist fellowships from the Japanese Government to RZS and RSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2003, J PHYSIOL-LONDON, V549, P749, DOI 10.1113/jphysiol.2003.039784; Akita T, 2011, CELL PHYSIOL BIOCHEM, V28, P1181, DOI 10.1159/000335867; Akita T, 2011, J PHYSIOL-LONDON, V589, P3909, DOI 10.1113/jphysiol.2011.208173; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; ANDINE P, 1991, J NEUROCHEM, V57, P230, DOI 10.1111/j.1471-4159.1991.tb02120.x; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Ballatori N, 2009, MOL ASPECTS MED, V30, P13, DOI 10.1016/j.mam.2008.08.004; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bell PD, 2003, P NATL ACAD SCI USA, V100, P4322, DOI 10.1073/pnas.0736323100; Briz O, 2006, J BIOL CHEM, V281, P30326, DOI 10.1074/jbc.M602048200; Burnstock G, 2012, BIOESSAYS, V34, P218, DOI 10.1002/bies.201100130; Circu ML, 2012, BBA-MOL CELL RES, V1823, P1767, DOI 10.1016/j.bbamcr.2012.06.019; Circu ML, 2009, BIOCHEM PHARMACOL, V77, P76, DOI 10.1016/j.bcp.2008.09.011; Cowley EA, 2002, J PHYSIOL-LONDON, V543, P201, DOI 10.1113/jphysiol.2002.022400; Cullen KV, 2001, BIOCHEM PHARMACOL, V62, P417, DOI 10.1016/S0006-2952(01)00681-5; Decher T, 2001, BRIT J PHARMACOL, V134, P1467; Dutta AK, 2004, J PHYSIOL-LONDON, V559, P799, DOI 10.1113/jphysiol.2004.069245; Dutta AK, 2008, BIOPHYS J, V94, P1646, DOI 10.1529/biophysj.107.117820; Fan HT, 2001, BRIT J PHARMACOL, V133, P1096, DOI 10.1038/sj.bjp.0704159; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Franco R, 2006, J BIOL CHEM, V281, P29542, DOI 10.1074/jbc.M602500200; Franco R, 2008, J BIOL CHEM, V283, P36071, DOI 10.1074/jbc.M807061200; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Gao L, 2001, AM J PHYSIOL-LUNG C, V281, pL24, DOI 10.1152/ajplung.2001.281.1.L24; Garcia TB, 2011, NEUROCHEM RES, V36, P412, DOI 10.1007/s11064-010-0356-3; Haddoub Rose, 2009, Handb Exp Pharmacol, P385, DOI 10.1007/978-3-540-79885-9_19; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; HAUSSINGER D, 1990, EUR J BIOCHEM, V193, P891, DOI 10.1111/j.1432-1033.1990.tb19414.x; Hilgier W, 2010, TOXICOL SCI, V117, P163, DOI 10.1093/toxsci/kfq171; Hirrlinger J, 2002, J NEUROSCI RES, V69, P318, DOI 10.1002/jnr.10308; Hirrlinger J, 2010, BRAIN RES REV, V63, P177, DOI 10.1016/j.brainresrev.2009.10.003; Inoue H, 2005, EUR J NEUROSCI, V21, P1648, DOI 10.1111/j.1460-9568.2005.04006.x; Jungas T, 2002, J BIOL CHEM, V277, P27912, DOI 10.1074/jbc.M110288200; Kannan R, 2000, BRAIN RES, V852, P374, DOI 10.1016/S0006-8993(99)02184-8; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Krasilnikov OV, 2011, J PHYSIOL SCI, V61, P267, DOI 10.1007/s12576-011-0144-0; Kurbannazarova RS, 2008, B EXP BIOL MED+, V145, P606, DOI 10.1007/s10517-008-0152-0; Kurbannazarova RS, 2011, INT J MOL SCI, V12, P9125, DOI 10.3390/ijms12129125; Kurbannazarova RS, 2003, GEN PHYSIOL BIOPHYS, V22, P221; l'Hoste S, 2010, AM J PHYSIOL-RENAL, V298, pF435, DOI 10.1152/ajprenal.00286.2009; L'hoste S, 2009, FREE RADICAL BIO MED, V46, P1017, DOI 10.1016/j.freeradbiomed.2008.12.009; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; Linsdell P, 1998, AM J PHYSIOL-CELL PH, V275, pC323, DOI 10.1152/ajpcell.1998.275.1.C323; Liu HT, 2008, PURINERG SIGNAL, V4, P147, DOI 10.1007/s11302-007-9077-8; Liu HT, 2008, CELL RES, V18, P558, DOI 10.1038/cr.2008.49; Liu HT, 2006, GLIA, V54, P343, DOI 10.1002/glia.20400; Liu HT, 2009, J PHYSIOL-LONDON, V587, P2197, DOI 10.1113/jphysiol.2008.165084; Liu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC343; Marchan R, 2008, BBA-BIOMEMBRANES, V1778, P2413, DOI 10.1016/j.bbamem.2008.06.011; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; OKADA Y, 1994, JPN J PHYSIOL, V44, P403, DOI 10.2170/jjphysiol.44.403; Okada Y, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P283; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; ORWAR O, 1994, J NEUROCHEM, V63, P1371; Ranat S, 2007, NEUROSCI LETT, V415, P45, DOI 10.1016/j.neulet.2006.12.043; Rebbeor JF, 2002, BBA-BIOMEMBRANES, V1559, P171, DOI 10.1016/S0005-2736(01)00454-0; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Sabirov R, 2009, J PHYSIOL SCI, V59, P3, DOI 10.1007/s12576-008-0008-4; Sabirov RZ, 2004, BIOPHYS J, V87, P1672, DOI 10.1529/biophysj.104.043174; Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251; Sabirov RZ, 2000, J MEMBRANE BIOL, V177, P13, DOI 10.1007/s002320001090; Song Z, 2000, POULTRY SCI, V79, P1632, DOI 10.1093/ps/79.11.1632; Stridh MH, 2010, NEUROCHEM RES, V35, P1231, DOI 10.1007/s11064-010-0179-2; Ternovsky VI, 2004, FEBS LETT, V576, P433, DOI 10.1016/j.febslet.2004.09.051; Tetaud E, 1997, BIOCHEM J, V325, P569, DOI 10.1042/bj3250569; Trompier D, 2004, CANCER RES, V64, P4950, DOI 10.1158/0008-5472.CAN-04-0143; Wallin C, 1999, J NEUROCHEM, V73, P1566, DOI 10.1046/j.1471-4159.1999.0731566.x; Wang J, 2005, JPN J PHYSIOL, V55, P379, DOI 10.2170/jjphysiol.S655; YANG CS, 1994, J CHROMATOGR B, V661, P231, DOI 10.1016/S0378-4347(94)80050-2; ZANGERLE L, 1992, J NEUROCHEM, V59, P181, DOI 10.1111/j.1471-4159.1992.tb08889.x; Zhang H, 2012, SEMIN CELL IN PRESS	74	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55646	10.1371/journal.pone.0055646	http://dx.doi.org/10.1371/journal.pone.0055646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383255	gold, Green Published, Green Submitted			2022-12-25	WOS:000315563800180
J	Ye, Q; Kantonen, S; Henkels, KM; Gomez-Cambronero, J				Ye, Qing; Kantonen, Samuel; Henkels, Karen M.; Gomez-Cambronero, Julian			A New Signaling Pathway (JAK-Fes-phospholipase D) That Is Enhanced in Highly Proliferative Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; GROWTH-FACTOR RECEPTOR; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; EGF RECEPTOR; MIGRATION; ACTIVATION; PLD2; STIMULATION; CHEMOTAXIS	The products of the oncogene Fes and JAK3 are tyrosine kinases, whose expressions are elevated in tumor growth, angiogenesis, and metastasis. Phosphatidic acid, as synthesized by phospholipase D (PLD), enhances cancer cell survival. We report a new signaling pathway that integrates the two kinases with the lipase. Anew JAK3-Fes-PLD2 axis is responsible for the highly proliferative phenotype of MDA-MB-231 breast cancer cells. Conversely, this pathway is maintained at a low rate of expression and activity levels in untransformed cells such as MCF10A. We also deciphered the inter-regulation that exists between the two kinases (JAK3 and the oncogene Fes) and between these two kinases and the lipase (PLD2). Whereas JAK3 and Fes marginally activate PLD2 in non-transformed cells, these kinases greatly enhance (>200%) PLD activity following protein-protein interaction through the SH2 domain and the Tyr-415 residue of PLD2. We also found that phosphatidic acid enhances Fes activity in MDA-MB-231 cells providing a positive activation loop between Fes and PLD2. In summary, the JAK3, Fes and PLD2 interactions in transformed cells maintain PLD2 at an enhanced level that leads to abnormal cell growth. Modulating this new JAK3-Fes-PLD2 pathway could be important to control the highly invasive phenotype of breast cancer cells.	[Ye, Qing; Kantonen, Samuel; Henkels, Karen M.; Gomez-Cambronero, Julian] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653]; Boonshoft School of Medicine [229102]; State of Ohio Research Incentive Grant [668372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boonshoft School of Medicine; State of Ohio Research Incentive Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL056653, Boonshoft School of Medicine Grant 229102, and the State of Ohio Research Incentive Grant 668372 (to J. G. C.).	Andrews B, 2000, BIOCHEM BIOPH RES CO, V273, P302, DOI 10.1006/bbrc.2000.2938; Block ER, 2008, MOL BIOL CELL, V19, P4909, DOI 10.1091/mbc.E08-01-0097; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Di Fulvio M, 2006, ONCOGENE, V25, P3032, DOI 10.1038/sj.onc.1209340; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Frondorf K, 2010, J BIOL CHEM, V285, P15837, DOI 10.1074/jbc.M109.070524; Gomez-Cambronero J, 2007, J LEUKOCYTE BIOL, V82, P272, DOI 10.1189/jlb.0107033; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Henkels KM, 2011, J MOL BIOL, V408, P850, DOI 10.1016/j.jmb.2011.03.017; Henkels KM, 2010, MOL CELL BIOL, V30, P2251, DOI 10.1128/MCB.01239-09; Hui L, 2006, ONCOGENE, V25, P7305, DOI 10.1038/sj.onc.1209735; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; Kim YR, 2003, EXP MOL MED, V35, P118, DOI 10.1038/emm.2003.17; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Lee CS, 2009, BBA-MOL CELL BIOL L, V1791, P862, DOI 10.1016/j.bbalip.2009.04.007; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Mazie AR, 2006, J CELL SCI, V119, P1645, DOI 10.1242/jcs.02858; Nagasaki A, 2008, CELL STRUCT FUNCT, V33, P27, DOI 10.1247/csf.07042; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Natarajan V, 1996, CHEM PHYS LIPIDS, V80, P103, DOI 10.1016/0009-3084(96)02548-0; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Pilquil C, 2006, J BIOL CHEM, V281, P38418, DOI 10.1074/jbc.M601670200; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Singer WD, 1996, J BIOL CHEM, V271, P4504; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; WALKERNASIR E, 1982, JNCI-J NATL CANCER I, V69, P371; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	39	18	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9881	9891		10.1074/jbc.M113.450593	http://dx.doi.org/10.1074/jbc.M113.450593			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23404507	hybrid, Green Published			2022-12-25	WOS:000317114000028
J	Chen, WS; Chen, CC; Chen, LL; Lee, CC; Huang, TS				Chen, Wei-Shone; Chen, Chia-Chi; Chen, Li-Li; Lee, Chun-Chung; Huang, Tze-Sing			Secreted Heat Shock Protein 90 alpha (HSP90 alpha) Induces Nuclear Factor-kappa B-mediated TCF12 Protein Expression to Down-regulate E-cadherin and to Enhance Colorectal Cancer Cell Migration and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-ALPHA; HSP90; HSP70; BETA; PHOSPHORYLATION; CHAPERONE; COMPLEX	Secreted levels of HSP90 alpha and overexpression of TCF12 have been associated with the enhancement of colorectal cancer (CRC) cell migration and invasion. In this study, we observed that CRC patients with tumor TCF12 overexpression exhibited both a higher rate of metastatic occurrence and a higher average serum HSP90 alpha level compared with patients without TCF12 overexpression. Therefore, we studied the relationship between the actions of secreted HSP90 alpha and TCF12. Like overexpressed TCF12, secreted HSP90 alpha or recombinant HSP90 alpha (rHSP90 alpha) induced fibronectin expression and repressed E-cadherin, connexin-26, connexin-43, and gap junction levels in CRC cells. Consistently, rHSP90 alpha stimulated invasive outgrowths of CRC cells from spherical structures during three-dimensional culture. rHSP90 alpha also induced TCF12 expression in CRC cells. Its effects on CRC cell epithelial-mesenchymal transition, migration, and invasion were drastically prevented when TCF12 was knocked down. This suggests that TCF12 expression is required for secreted HSP90 alpha to enhance CRC cell spreading. Through the cellular receptor CD91, rHSP90 alpha facilitated the complex formation of CD91 with I kappa B kinases (IKKs) alpha and beta and increased the levels of phosphorylated (active) IKK alpha/beta and NF-kappa B. Use of an IKK alpha/beta inhibitor or ectopic overexpression of dominant-negative I kappa B alpha efficiently repressed rHSP90 alpha-induced TCF12 expression. Moreover, kappa B motifs were recognized in the gene sequence of the TCF12 promoter, and a physical association between NF-kappa B and the TCF12 promoter was detected in rHSP90 alpha-treated CRC cells. Together, these results suggest that the CD91/IKK/NF-kappa B signaling cascade is involved in secreted HSP90 alpha-induced TCF12 expression, leading to E-cadherin down-regulation and enhanced CRC cell migration/invasion.	[Chen, Wei-Shone] Taipei Vet Gen Hosp, Div Expt Surg, Taipei 112, Taiwan; [Chen, Wei-Shone] Taipei Vet Gen Hosp, Div Colorectal Surg, Taipei 112, Taiwan; [Chen, Wei-Shone] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Chen, Chia-Chi; Chen, Li-Li; Lee, Chun-Chung; Huang, Tze-Sing] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town 350, Miaoli, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan	Huang, TS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, 35 Keyan Rd, Zhunan Town 350, Miaoli, Taiwan.	tshuang@nhri.org.tw	Huang, Tze-Sing/C-9361-2013; Huang, Tze-Sing/E-3667-2010	Huang, Tze-Sing/0000-0001-8736-4330; 	National Science Council Grant, Taiwan, Republic of China [NSC101-2314-B-400-006]; National Health Research Institutes Grant, Taiwan, Republic of China [CA-101-PP-10]; Department of Health Grant, Taiwan, Republic of China [DOH102-TD-C-111-004]	National Science Council Grant, Taiwan, Republic of China; National Health Research Institutes Grant, Taiwan, Republic of China; Department of Health Grant, Taiwan, Republic of China	This work was supported by National Science Council Grant NSC101-2314-B-400-006, National Health Research Institutes Grant CA-101-PP-10, and Department of Health Grant DOH102-TD-C-111-004, Taiwan, Republic of China.	Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Cappello F, 2006, J CANC MOL, V2, P73; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Chen WS, 2011, INT J COLORECTAL DIS, V26, P1009, DOI 10.1007/s00384-011-1200-1; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goetz MP, 2003, ANN ONCOL, V14, P1169, DOI 10.1093/annonc/mdg316; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Huang TS, 1997, CANCER RES, V57, P2974; Lebret T, 2003, CANCER, V98, P970, DOI 10.1002/cncr.11594; Lee CC, 2012, J BIOL CHEM, V287, P2798, DOI 10.1074/jbc.M111.258947; Neckers Len, 2002, Breast Dis, V15, P53; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Xu A, 2007, J CANC MOL, V3, P107; Yamamoto Y, 2000, MOL CELL BIOL, V20, P3655, DOI 10.1128/MCB.20.10.3655-3666.2000; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhong L, 2003, CANCER DETECT PREV, V27, P285, DOI 10.1016/S0361-090X(03)00097-7	27	71	75	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9001	9010		10.1074/jbc.M112.437897	http://dx.doi.org/10.1074/jbc.M112.437897			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386606	hybrid, Green Published			2022-12-25	WOS:000316862200019
J	Malecka, KA; Szentpetery, Z; Peterson, JR				Malecka, Kimberly A.; Szentpetery, Zsofia; Peterson, Jeffrey R.			Synergistic Activation of p21-activated Kinase 1 by Phosphatidylinositol 4,5-Bisphosphate and Rho GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR SIGNALING COMPLEXES; PROTEIN-KINASE; N-WASP; PTDINS(4,5)P-2 SYNTHESIS; PLASMA-MEMBRANE; ARP2/3 COMPLEX; CELL POLARITY; LIVING CELLS; CDC42; ACTIN	Autoinhibited p21-activated kinase 1 (Pak1) can be activated in vitro by the plasma membrane-bound Rho GTPases Rac1 and Cdc42 as well as by the lipid phosphatidylinositol (4,5)-bisphosphate (PIP2). Activator binding is mediated by a GTPase-binding motif and an adjacent phosphoinositide-binding motif. Whether these two classes of activators play alternative, additive, or synergistic roles in Pak1 activation is unknown, as is their contributions to Pak1 activation in vivo. To address these questions, we developed a system to mimic the membrane anchoring of Rho GTPases by creating liposomes containing both PIP2 and a Ni2+-NTA modified lipid capable of binding hexahistidine-tagged Cdc42. We find that among all biologically relevant phosphoinositides, only PIP2 is able to synergistically activate Pak1 in concert with Cdc42. Membrane binding of the kinase was highly sensitive to the spatial density of PIP2 and Pak1 demonstrated dramatically enhanced affinity for Cdc42 anchored in a PIP2 environment. To validate these findings in vivo, we utilized an inducible recruitment system to drive the ectopic synthesis of PIP2 on Golgi membranes, which normally have active Cdc42 but lack significant concentrations of PIP2. Pak1 was recruited to PIP2-containing membranes in a manner dependent on the ability of Pak1 to bind to both PIP2 and Cdc42. These findings provide a mechanistic explanation for the essential role of both phosphoinositides and GTPases in Pak1 recruitment and activation. In contrast, Ack, another Cdc42 effector kinase that lacks an analogous phosphoinositide-binding motif, fails to show the same enhancement of membrane binding and activation by PIP2, thus indicating that regulation by PIP2 and Cdc42 could provide a combinatorial code for activation of different GTPase effectors in different subcellular locations.	[Malecka, Kimberly A.; Peterson, Jeffrey R.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Szentpetery, Zsofia] Eunice Kennedy Shriver NICHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	Fox Chase Cancer Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Peterson, JR (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	Jeffrey.peterson@fccc.edu		Peterson, Jeffrey/0000-0002-0604-718X	National Institutes of Health [GM083025, T32 CA009035, P30 CA006927]; FCCC Keystone Program in Head Neck Cancer; NATIONAL CANCER INSTITUTE [T32CA009035, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCCC Keystone Program in Head Neck Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083025 (to J. R. P.), T32 CA009035 (to K. Malecka), and P30 CA006927 to the Fox Chase Cancer Center. Additional support was provided by the FCCC Keystone Program in Head & Neck Cancer.	ADAMSON P, 1992, J BIOL CHEM, V267, P20033; Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Arias-Romero Luis E, 2010, Small GTPases, V1, P124, DOI 10.4161/sgtp.1.2.14109; ARMSTRONG SA, 1995, J BIOL CHEM, V270, P7864, DOI 10.1074/jbc.270.14.7864; Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Banting G, 1997, BBA-MOL CELL RES, V1355, P209, DOI 10.1016/S0167-4889(96)00146-2; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Braun V, 2010, CELL MICROBIOL, V12, P1352, DOI 10.1111/j.1462-5822.2010.01476.x; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Estrada L, 2001, HUM MOL GENET, V10, P485, DOI 10.1093/hmg/10.5.485; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Halstead JR, 2010, J CELL SCI, V123, P3535, DOI 10.1242/jcs.062679; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Jung ID, 2004, EUR J BIOCHEM, V271, P1557, DOI 10.1111/j.1432-1033.2004.04066.x; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Kodani A, 2009, MOL BIOL CELL, V20, P1192, DOI 10.1091/mbc.E08-08-0834; Koronakis V, 2011, P NATL ACAD SCI USA, V108, P14449, DOI 10.1073/pnas.1107666108; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Matas OB, 2004, TRAFFIC, V5, P838, DOI 10.1111/j.1600-0854.2004.00225.x; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Montefusco DJ, 2007, METHOD ENZYMOL, V423, P267, DOI 10.1016/S0076-6879(07)23012-5; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pavey S, 2006, MELANOMA RES, V16, P285, DOI 10.1097/01.cmr.0000222589.30117.f2; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Prehoda KE, 2002, CURR OPIN CELL BIOL, V14, P149, DOI 10.1016/S0955-0674(02)00307-1; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1998, J BIOL CHEM, V273, P18490, DOI 10.1074/jbc.273.29.18490; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Shrout AL, 2003, BIOCHEMISTRY-US, V42, P13379, DOI 10.1021/bi0352769; Strochlic TI, 2010, MOL CELL, V40, P493, DOI 10.1016/j.molcel.2010.10.015; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Takahashi S, 2007, MOL BIOL CELL, V18, P4945, DOI 10.1091/mbc.E07-07-0676; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Wild AC, 2004, J BIOL CHEM, V279, P17101, DOI 10.1074/jbc.M314035200; Yi CL, 2010, BIOCHEM PHARMACOL, V80, P683, DOI 10.1016/j.bcp.2010.03.012; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Zhang H., 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcpM110.005678, DOI 10.1074/MCPM110.005678]; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; ZIMAN M, 1991, MOL CELL BIOL, V11, P3537, DOI 10.1128/MCB.11.7.3537	61	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8887	8897		10.1074/jbc.M112.428904	http://dx.doi.org/10.1074/jbc.M112.428904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393142	Green Published, hybrid			2022-12-25	WOS:000316862200010
J	Liu, Y; Zhang, ZC; Qian, SW; Zhang, YY; Huang, HY; Tang, Y; Guo, L; Li, X; Tang, QQ				Liu, Yuan; Zhang, Zhi-chun; Qian, Shu-wen; Zhang, You-you; Huang, Hai-yan; Tang, Yan; Guo, Liang; Li, Xi; Tang, Qi-Qun			MicroRNA-140 Promotes Adipocyte Lineage Commitment of C3H10T1/2 Pluripotent Stem Cells via Targeting Osteopetrosis-associated Transmembrane Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION; OBESITY; OSTM1; BETA	BMP4 has been shown to induce C3H10T1/2 pluripotent stem cells to commit to adipocyte lineage. In addition to several proteins identified, microRNAs also play a critical role in the process. In this study, we identified microRNA-140 (miR-140) as a direct downstream component of the BMP4 signaling pathway during the commitment of C3H10T1/2 cells to adipocyte lineage. Overexpression of miR-140 in C3H10T1/2 cells promoted commitment, whereas knockdown of its expression led to impairment. Additional studies indicated that Ostm1 is a bona fide target of miR-140, which is significantly decreased during commitment, and Ostm1 was also demonstrated to function as an anti-adipogenic factor.	[Liu, Yuan; Zhang, Zhi-chun; Qian, Shu-wen; Huang, Hai-yan; Tang, Yan; Guo, Liang; Li, Xi; Tang, Qi-Qun] Fudan Univ, Shanghai Med Coll, Key Lab Mol Med, Minist Educ, Shanghai 200032, Peoples R China; [Liu, Yuan; Zhang, Zhi-chun; Qian, Shu-wen; Huang, Hai-yan; Tang, Yan; Guo, Liang; Li, Xi; Tang, Qi-Qun] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China; [Liu, Yuan; Qian, Shu-wen; Zhang, You-you; Huang, Hai-yan; Li, Xi; Tang, Qi-Qun] Fudan Univ, Inst Biomed Sci, Inst Stem Cell Res & Regenerat Med, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Li, X (corresponding author), Fudan Univ, Shanghai Med Coll, Key Lab Mol Med, Minist Educ, Shanghai 200032, Peoples R China.	lixi@shmu.edu.cn; qqtang@shmu.edu.cn	Zhang, Youyou/H-9677-2017; Li, Xi/W-4034-2019		National Key Basic Research Project [2011CB910201, 2011CBA01103]; National Natural Science Foundation [31030048, 81270954, 30870510]; Shanghai Key Science and Technology Research Project [10JC1401000]; Shanghai Rising Star Program [08QA14012]; Shanghai Leading Academic Discipline Project [B110, 985III-YFX0302]	National Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Key Science and Technology Research Project; Shanghai Rising Star Program; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work supported in part by National Key Basic Research Project Grants 2011CB910201 and 2011CBA01103, State Key Program of National Natural Science Foundation Grant 31030048, and Shanghai Key Science and Technology Research Project Grant 10JC1401000 (to Q.-q.T.); National Natural Science Foundation Grants 81270954 and 30870510 and Shanghai Rising Star Program Grant 08QA14012 (to X.L.); and Shanghai Leading Academic Discipline Project Grants B110 and 985III-YFX0302 (to the Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College).	Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Araldi E, 2010, GENE DEV, V24, P1075, DOI 10.1101/gad.1939310; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bilkovski R, 2010, J BIOL CHEM, V285, P6170, DOI 10.1074/jbc.M109.054338; Cho SW, 2009, BONE, V44, P1069, DOI 10.1016/j.bone.2009.02.012; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Feigin ME, 2008, CELL SIGNAL, V20, P949, DOI 10.1016/j.cellsig.2008.01.009; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Ling HY, 2011, CLIN EXP PHARMACOL P, V38, P239, DOI 10.1111/j.1440-1681.2011.05493.x; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Nakamura Y., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P321; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Yi C, 2011, FEBS LETT, V585, P3303, DOI 10.1016/j.febslet.2011.09.015; Yu ZK, 1997, OBES RES, V5, P9, DOI 10.1002/j.1550-8528.1997.tb00277.x; Zhao L, 2009, CALCIFIED TISSUE INT, V84, P56, DOI 10.1007/s00223-008-9189-3	36	24	26	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8222	8230		10.1074/jbc.M112.426163	http://dx.doi.org/10.1074/jbc.M112.426163			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23389033	Green Published, hybrid			2022-12-25	WOS:000316564500022
J	Xie, J; Yoon, J; Yang, SS; Lin, SH; Huang, CL				Xie, Jian; Yoon, Joonho; Yang, Sung-Sen; Lin, Shih-Hua; Huang, Chou-Long			WNK1 Protein Kinase Regulates Embryonic Cardiovascular Development through the OSR1 Signaling Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE; SPAK; MICE; COTRANSPORTER; CELLS; PHOSPHORYLATION; SUBFAMILY; LACKING; MODEL; NA+	WNK1 is a widely expressed serine/threonine protein kinase that regulates multiple cellular and organ functions via diverse mechanisms. We previously reported that endothelial-specific deletion of Wnk1 in mice results in embryonic lethality, with angiogenesis and cardiac defects beginning at embryonic day similar to 10.5. Here, we further investigated the signaling mechanism by which WNK1 regulates embryonic cardiovascular development. We found that mice with a global deletion of Osr1, which encodes oxidative stress-responsive kinase-1, a protein kinase activated by WNK1, died in utero beginning at embryonic day similar to 11. The defects in Osr1-null yolk sacs and embryos were virtually identical to those observed in Wnk1-knock-out mice: no mature large vessels in yolk sacs, defective angiogenesis in the brain and intersomitic vessels, and smaller chambers and reduced myocardial trabeculation in mutant hearts. Endothelial-specific deletion of Osr1 generated by crossing Osr1(flox/flox) mice with Tie2-Cre mice phenocopied defects caused by global Osr1 deletion. To investigate whether OSR1 acts downstream of WNK1 in embryonic angiogenesis, we generated a mouse line that carries a catalytically and constitutively active human OSR1 transgene in the ROSA26 locus under the control of a cassette of floxed transcription stop codons. We found that endothelial-specific expression of the constitutively active mutant OSR1, generated by Tie2-Cre-mediated excision of floxed stop codons in the mutated ROSA26 locus, rescued angiogenesis and cardiac defects in global Wnk1-null embryos. These results indicate that WNK1 activation of the OSR1 signaling cascade is an essential pathway that regulates angiogenesis and cardiac formation during mouse embryo development.	[Xie, Jian; Yoon, Joonho; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Yang, Sung-Sen; Lin, Shih-Hua] Natl Def Med Ctr, Dept Med, Tri Serv Gen Hosp, Taipei 114, Taiwan	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Defense Medical Center; Tri-Service General Hospital	Huang, CL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	chou-long.huang@utsouthwestern.edu		Xie, Jian/0000-0001-9454-1358	National Institutes of Health [DK59530, DK85726, DK79328]; Taiwan National Science Council [NSC-100-2314-B016-018-MY3]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328, R01DK085726, R01DK059530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59530, DK85726, and DK79328. This work was also supported Taiwan National Science Council Grant NSC-100-2314-B016-018-MY3.	An SW, 2011, CURR BIOL, V21, P1979, DOI 10.1016/j.cub.2011.11.002; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Gagnon KB, 2010, AM J PHYSIOL-CELL PH, V299, pC614, DOI 10.1152/ajpcell.00074.2010; Moya EMG, 2009, CELL SIGNAL, V21, P1727, DOI 10.1016/j.cellsig.2009.08.006; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Marlin JW, 2011, MAMM GENOME, V22, P306, DOI 10.1007/s00335-011-9326-6; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Tian YM, 2009, MECH DEVELOP, V126, P710, DOI 10.1016/j.mod.2009.05.002; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2009, AM J PATHOL, V175, P1315, DOI 10.2353/ajpath.2009.090094; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100	34	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8566	8574		10.1074/jbc.M113.451575	http://dx.doi.org/10.1074/jbc.M113.451575			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386621	Green Published, hybrid			2022-12-25	WOS:000316564500057
J	Zomot, E; Bahar, I				Zomot, Elia; Bahar, Ivet			Intracellular Gating in an Inward-facing State of Aspartate Transporter Glt(Ph) Is Regulated by the Movements of the Helical Hairpin HP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE TRANSPORTER; EXTRACELLULAR GATE; SUBSTRATE-BINDING; REENTRANT LOOP; STOICHIOMETRY; HOMOLOG; ACCESSIBILITY; MECHANISM; DYNAMICS; RESIDUE	Sodium-coupled neurotransmitter transporters play a key role in neuronal signaling by clearing excess transmitter from the synapse. Structural data on a trimeric archaeal aspartate transporter, Glt(Ph), have provided valuable insights into structural features of human excitatory amino acid transporters. However, the time-resolved mechanisms of substrate binding and release, as well as that of coupling to sodium co-transport, remain largely unknown for this important family. We present here the results of the most extensive simulations performed to date for Glt(Ph) in both outward-facing and inward-facing states by taking advantage of significant advances made in recent years in molecular simulation technology. The generated multiple microsecond trajectories consistently show that the helical hairpin HP2, not HP1, serves as an intracellular gate (in addition to its extracellular gating role). In contrast to previous proposals, HP1 can neither initiate nor accommodate neurotransmitter release without prior opening of HP2 by at least 4.0 angstrom. Aspartate release invariably follows that of a sodium ion located near the HP2 gate entrance. Asp-394 on TM8 and Arg-276 on HP1 emerge as key residues that promote the reorientation and diffusion of substrate toward the cell interior. These findings underscore the significance of examining structural dynamics, as opposed to static structure(s), to make inferences on the mechanisms of transport and key interactions.	[Zomot, Elia; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bahar, I (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, 3064 BST3,3501 5th Ave, Pittsburgh, PA 15213 USA.	bahar@pitt.edu	Bahar, Ivet/AAH-2921-2020		Pittsburgh Supercomputing Center [RC2GM09337]; National Institutes of Health, NIGMS [R01GM086238]; National Institutes of Health [P41 GM103712];  [R01 LM007994-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086238, P41GM103712] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007994] Funding Source: NIH RePORTER	Pittsburgh Supercomputing Center; National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The Anton machine has been provided generously by David E. Shaw Research (19). Anton computer time was provided by the Pittsburgh Supercomputing Center through Grant RC2GM09337. We thank M. Dittrich, N. Simakov, and other staff at the Pittsburgh Supercomputing Center for their support.; This work was supported, in whole or in part, by National Institutes of Health Grants R01GM086238 from the NIGMS (to I.B.) and R01 LM007994-08 (to I.B.) and the National Institutes of Health-funded Biomedical Technology Research Center (Grant P41 GM103712) (to I.B.).	Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Guvench Olgun, 2008, V443, P63, DOI 10.1007/978-1-59745-177-2_4; Huang ZJ, 2008, BIOPHYS J, V95, P2292, DOI 10.1529/biophysj.108.133421; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Owe SG, 2006, J PHYSIOL-LONDON, V577, P591, DOI 10.1113/jphysiol.2006.116830; Pastor RW, 2011, J PHYS CHEM LETT, V2, P1526, DOI 10.1021/jz200167q; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; STORMMATHISEN J, 1992, PROG BRAIN RES, V94, P225; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104	32	34	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8231	8237		10.1074/jbc.M112.438432	http://dx.doi.org/10.1074/jbc.M112.438432			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386619	Green Published, hybrid			2022-12-25	WOS:000316564500023
J	Altman, J; Hedl, R; Szabo, P; Mazurek, P; Riedl, V; Mullerova, J; Kopecky, M; Dolezal, J				Altman, Jan; Hedl, Radim; Szabo, Peter; Mazurek, Petr; Riedl, Vladan; Muellerova, Jana; Kopecky, Martin; Dolezal, Jiri			Tree-Rings Mirror Management Legacy: Dramatic Response of Standard Oaks to Past Coppicing in Central Europe	PLOS ONE			English	Article							FAGUS-SYLVATICA; RADIAL-GROWTH; QUERCUS-ROBUR; CANOPY DISTURBANCE; FOREST; REGENERATION; SEEDLINGS; DENDROCHRONOLOGY; COMPETITION; SUCCESSION	Background: Coppicing was one of the most important forest management systems in Europe documented in prehistory as well as in the Middle Ages. However, coppicing was gradually abandoned by the mid-20th century, which has altered the ecosystem structure, diversity and function of coppice woods. Methodology/Principal Findings: Our aim was to disentangle factors shaping the historical growth dynamics of oak standards (i.e. mature trees growing through several coppice cycles) in a former coppice-with-standards in Central Europe. Specifically, we tried to detect historical coppicing events from tree-rings of oak standards, to link coppicing events with the recruitment of mature oaks, and to determine the effects of neighbouring trees on the stem increment of oak standards. Large peaks in radial growth found for the periods 1895-1899 and 1935-1939 matched with historical records of coppice harvests. After coppicing, the number of newly recruited oak standards markedly grew in comparison with the preceding or following periods. The last significant recruitment of oak standards was after the 1930s following the last regular coppicing event. The diameter increment of oak standards from 1953 to 2003 was negatively correlated with competition indices, suggesting that neighbouring trees (mainly resprouting coppiced Tilia platyphyllos) partly suppressed the growth of oak standards. Our results showed that improved light conditions following historical coppicing events caused significant increase in pulses of radial growth and most probably maintained oak recruitment. Conclusions/Significance: Our historical perspective carries important implications for oak management in Central Europe and elsewhere. Relatively intense cutting creating open canopy woodlands, either as in the coppicing system or in the form of selective cutting, is needed to achieve significant radial growth in mature oaks. It is also critical for the successful regeneration and long-term maintenance of oak populations.	[Altman, Jan; Hedl, Radim; Szabo, Peter; Mazurek, Petr; Riedl, Vladan; Muellerova, Jana; Kopecky, Martin; Dolezal, Jiri] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Altman, Jan; Mazurek, Petr; Dolezal, Jiri] Univ S Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Riedl, Vladan] Adm Palava Protected Landscape Area, Mikulov, Czech Republic; [Kopecky, Martin] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Charles University Prague	Altman, J (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	altman.jan@gmail.com	Hédl, Radim/A-5631-2011; Mullerova, Jana/A-7915-2012; Doležal, Jiří/H-1583-2014; Kopecký, Martin/A-1466-2009; Altman, Jan/B-4305-2015; Szabó, Péter/B-1736-2010	Mullerova, Jana/0000-0001-7331-3479; Kopecký, Martin/0000-0002-1018-9316; Szabó, Péter/0000-0002-2985-0717; Dolezal, Jiri/0000-0002-5829-4051	Grant Agency of the Academy of Sciences of the Czech Republic [AV0 IAA600050812]; Grant Agency of the Czech Republic [P504/12/1952]; EC; state budget of the Czech Republic;  [RVO 67985939];  [CZ.1.07/2.3.00/20.0267];  [GAJU 138/2010/P]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); EC(European CommissionEuropean Commission Joint Research Centre); state budget of the Czech Republic; ; ; 	This study was funded by long-term research development project no. RVO 67985939, research grants AV0 IAA600050812 of the Grant Agency of the Academy of Sciences of the Czech Republic, P504/12/1952 of the Grant Agency of the Czech Republic, CZ.1.07/2.3.00/20.0267 with the financial contribution of EC and the state budget of the Czech Republic, and GAJU 138/2010/P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakala T, 2011, J VEG SCI, V22, P322, DOI 10.1111/j.1654-1103.2010.01253.x; Altman J, 2013, GLOBAL CHANGE BIOL, V19, P498, DOI 10.1111/gcb.12067; Baeten L, 2009, APPL VEG SCI, V12, P187, DOI 10.1111/j.1654-109X.2009.01013.x; Bartet E, 1890, REV EAUX FORESTS, V29, P310; Bergmeier E, 2010, BIODIVERS CONSERV, V19, P2995, DOI 10.1007/s10531-010-9872-3; Billamboz A, 2003, TREE RINGS WETLAND O; Birks HJB, 2005, TRENDS ECOL EVOL, V20, P154, DOI 10.1016/j.tree.2005.02.001; Black BA, 2003, ECOL APPL, V13, P1733, DOI 10.1890/02-5122; BRIDGE MC, 1986, J ECOL, V74, P1095, DOI 10.2307/2260236; Bridge MC, 2000, BOT J LINN SOC, V134, P61, DOI [10.1006/bojl.2000.0364, 10.1111/j.1095-8339.2000.tb02345.x]; Broome A, 2011, BIODIVERS CONSERV, V20, P729, DOI 10.1007/s10531-010-9974-y; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Busby PE, 2009, J VEG SCI, V20, P487, DOI 10.1111/j.1654-1103.2009.01056.x; Caquet B, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009086; CARTANSON M, 1992, VEGETATIO, V100, P61; Collet C, 2008, FORESTRY, V81, P135, DOI 10.1093/forestry/cpn004; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Dobrowolska D, 2008, FORESTRY, V81, P511, DOI 10.1093/forestry/cpn025; Dolezal J, 2004, ANN BOT-LONDON, V94, P333, DOI 10.1093/aob/mch149; Dolezal J, 2010, PRESLIA, V82, P289; Dolezal J, 2009, ECOL RES, V24, P281, DOI 10.1007/s11284-008-0505-1; Emborg J, 1998, FOREST ECOL MANAG, V106, P83, DOI 10.1016/S0378-1127(97)00299-5; Erdmann GG, 1973, RP100 SUDA NC FOR SE, P100; Fraver S, 2005, CAN J FOREST RES, V35, P1648, DOI 10.1139/X05-092; Fraver S, 2009, J ECOL, V97, P289, DOI 10.1111/j.1365-2745.2008.01474.x; Frelich L.E., 2002, FOREST DYNAMICS DIST, Vfirst; Fuller Robert J., 1995, P327; Gomez-Aparicio L, 2008, OIKOS, V117, P1683, DOI 10.1111/j.1600-0706.2008.16814.x; Haneca K, 2006, VEG HIST ARCHAEOBOT, V15, P137, DOI 10.1007/s00334-005-0022-x; Harmer R, 2007, FORESTRY, V80, P137, DOI 10.1093/forestry/cpm006; Hedl R., 2007, Acta Agronomica Hungarica, V55, P453, DOI 10.1556/AAgr.55.2007.4.6; Hedl R, 2005, SROVNANI STAVU LESNI; Hedl R, 2010, DIVERS DISTRIB, V16, P267, DOI 10.1111/j.1472-4642.2010.00637.x; Helama S, 2009, PLANT SOIL, V319, P163, DOI 10.1007/s11104-008-9858-z; Hilt DE, 1979, RES437 USDA NE FOR S, P437; Holscher D, 2002, FORSTWISS CENTRALBL, V121, P229, DOI 10.1046/j.1439-0337.2002.02031.x; Holscher D, 2002, FLORA, V197, P118, DOI 10.1078/0367-2530-00021; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Ito H, 2012, FOREST ECOL MANAG, V269, P99, DOI 10.1016/j.foreco.2011.12.017; Iverson LR, 2008, FOREST ECOL MANAG, V255, P3035, DOI 10.1016/j.foreco.2007.09.088; JONES EW, 1959, J ECOL, V47, P169, DOI 10.2307/2257253; Jung T, 2000, PLANT PATHOL, V49, P706, DOI 10.1046/j.1365-3059.2000.00521.x; Kelly DL, 2002, FOREST ECOL MANAG, V166, P207, DOI 10.1016/S0378-1127(01)00670-3; Konvicka M, 2005, BIOLOGIA, V60, P551; Kopecky M, 2013, J APPL ECOL, V50, P79, DOI 10.1111/1365-2664.12010; LORIMER CG, 1994, J ECOL, V82, P227, DOI 10.2307/2261291; LORIMER CG, 1989, CAN J FOREST RES, V19, P651, DOI 10.1139/x89-102; Luisi N., 1992, P INT C, P1; MITCHELL PL, 1987, J APPL ECOL, V24, P239, DOI 10.2307/2403801; NOAA, 2012, CONTR INT TREE RING; Nowacki GJ, 1997, ECOL MONOGR, V67, P225, DOI 10.1890/0012-9615(1997)067[0225:RGACFR]2.0.CO;2; Nunez V, 2012, J NAT CONSERV, V20, P1, DOI 10.1016/j.jnc.2011.07.001; Olano JM, 2009, ANN FOREST SCI, V66, P8; Oliver WW, 1986, R180 USDA PSW FOR SE, P180; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rackham O, 2003, ANCIENT WOODLAND ITS; Rackham O., 1975, HAYLEY WOOD ITS HIST; Rentch JS, 2002, CAN J FOREST RES, V32, P915, DOI [10.1139/x02-016, 10.1139/X02-016]; Rubino Darrin L., 2004, Dendrochronologia, V21, P97, DOI 10.1078/1125.7865.00047; Spiecker H., 2002, Dendrochronologia, V20, P191, DOI 10.1078/1125-7865-00016; Splechtna BE, 2005, J VEG SCI, V16, P511, DOI 10.1658/1100-9233(2005)16[511:DHOAEO]2.0.CO;2; Svoboda M, 2012, J VEG SCI, V23, P86, DOI 10.1111/j.1654-1103.2011.01329.x; Swaine MD, 2008, BIOTROPICA, V40, P370, DOI 10.1111/j.1744-7429.2007.00386.x; Szabo P, 2011, CONSERV BIOL, V25, P680, DOI 10.1111/j.1523-1739.2011.01710.x; Szabo P, 2010, FOREST ECOL MANAG, V259, P650, DOI 10.1016/j.foreco.2009.11.026; Valladares F, 2002, TREES-STRUCT FUNCT, V16, P395, DOI 10.1007/s00468.002.0184.4; von Lupke B, 1998, FOREST ECOL MANAG, V106, P19, DOI 10.1016/S0378-1127(97)00235-1; Webster CR, 2007, CAN J FOREST RES, V37, P682, DOI 10.1139/X06-267; Welander NT, 1998, FOREST ECOL MANAG, V107, P117, DOI 10.1016/S0378-1127(97)00326-5; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P1365, DOI 10.1007/s10531-012-0244-z; Zhang J, 2010, ACTA OECOL, V36, P29, DOI 10.1016/j.actao.2009.09.005; Zhang JW, 2006, FOREST ECOL MANAG, V223, P275, DOI 10.1016/j.foreco.2005.11.007	73	58	60	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55770	10.1371/journal.pone.0055770	http://dx.doi.org/10.1371/journal.pone.0055770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405213	Green Submitted, gold, Green Published			2022-12-25	WOS:000315153400158
J	Baker, DM; Weigt, L; Fogel, M; Knowlton, N				Baker, David M.; Weigt, Lee; Fogel, Marilyn; Knowlton, Nancy			Ancient DNA from Coral-Hosted Symbiodinium Reveal a Static Mutualism over the Last 172 Years	PLOS ONE			English	Article							ALGAL SYMBIONTS; REEF CORALS; MONTASTRAEA-ANNULARIS; SCLERACTINIAN CORALS; GORGONIA-VENTALINA; CARIBBEAN CORALS; SPECIFICITY; ZOOXANTHELLAE; DIVERSITY; ENDOSYMBIONTS	Ancient DNA (aDNA) provides powerful evidence for detecting the genetic basis for adaptation to environmental change in many taxa. Among the greatest of changes in our biosphere within the last century is rapid anthropogenic ocean warming. This phenomenon threatens corals with extinction, evidenced by the increasing observation of widespread mortality following mass bleaching events. There is some evidence and conjecture that coral-dinoflagellate symbioses change partnerships in response to changing external conditions over ecological and evolutionary timescales. Until now, we have been unable to ascertain the genetic identity of Symbiodinium hosted by corals prior to the rapid global change of the last century. Here, we show that Symbiodinium cells recovered from dry, century old specimens of 6 host species of octocorals contain sufficient DNA for amplification of the ITS2 subregion of the nuclear ribosomal DNA, commonly used for genotyping within this genus. Through comparisons with modern specimens sampled from similar locales we show that symbiotic associations among several species have been static over the last century, thereby suggesting that adaptive shifts to novel symbiont types is not common among these gorgonians, and perhaps, symbiotic corals in general.	[Baker, David M.] Smithsonian Inst, Marine Sci Network, Washington, DC 20560 USA; [Baker, David M.; Fogel, Marilyn] Carnegie Inst Sci, Geophys Lab, Washington, DC USA; [Weigt, Lee] Smithsonian Inst, Museum Support Ctr, Labs Analyt Biol, Suitland, MD USA; [Knowlton, Nancy] Smithsonian Inst, Dept Invertebrate Zool, Washington, DC 20560 USA	Smithsonian Institution; Carnegie Institution for Science; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Baker, DM (corresponding author), Smithsonian Inst, Marine Sci Network, Washington, DC 20560 USA.	dmbaker@hku.hk	Baker, David/B-2512-2010	Baker, David/0000-0002-0308-4954	Smithsonian's Marine Science Network Fellowship; Laboratories of Analytical Biology	Smithsonian's Marine Science Network Fellowship; Laboratories of Analytical Biology	This work was funded by the Smithsonian's Marine Science Network Fellowship and the Laboratories of Analytical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras JP, 2011, MOL ECOL, V20, P2525, DOI 10.1111/j.1365-294X.2011.05115.x; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2007, MAR ECOL PROG SER, V335, P237, DOI 10.3354/meps335237; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Drohan AF, 2005, B MAR SCI, V77, P257; Drummond AJ, 2010, GENEIOUS V5 3; Finney JC, 2010, MICROB ECOL, V60, P250, DOI 10.1007/s00248-010-9681-y; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Frenz-Ross JL, 2008, MAR BIOTECHNOL, V10, P572, DOI 10.1007/s10126-008-9095-8; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Goulet TL, 2008, MAR BIOL, V154, P795, DOI 10.1007/s00227-008-0972-5; Goulet TL, 2008, MAR ECOL PROG SER, V355, P45, DOI 10.3354/meps07214; Goulet TL, 2007, MAR ECOL PROG SER, V335, P243, DOI 10.3354/meps335243; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Goulet TL, 2004, CORAL REEFS, V23, P465, DOI 10.1007/s00338-004-0408-8; Goulet TL, 2003, MAR ECOL PROG SER, V250, P117, DOI 10.3354/meps250117; Hannes AR, 2009, MAR ECOL PROG SER, V391, P65, DOI 10.3354/meps07990; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; Kirk NL, 2005, BIOL BULL-US, V209, P227, DOI 10.2307/3593112; LaJeunesse TC, 2005, CORAL REEFS, V24, P157, DOI 10.1007/s00338-004-0436-4; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; Lajeunesse TC, 2012, J PHYCOL, V48, P1380, DOI 10.1111/j.1529-8817.2012.01217.x; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Lasker HR, 2003, CORAL REEFS, V22, P23, DOI 10.1007/s00338-003-0276-7; Leverette CL, 2008, SPECTROCHIM ACTA A, V69, P1058, DOI 10.1016/j.saa.2007.07.018; Lewis CL, 2004, SCIENCE, V304, P1490, DOI 10.1126/science.1097323; Oliver TA, 2011, CORAL REEFS, V30, P241, DOI 10.1007/s00338-010-0696-0; Pettay DT, 2007, MOL ECOL NOTES, V7, P1271, DOI 10.1111/j.1471-8286.2007.01852.x; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; PORTER JW, 1976, AM NAT, V110, P731, DOI 10.1086/283100; Prada C, 2010, CORAL REEFS, V29, P41, DOI 10.1007/s00338-009-0547-z; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Santos SR, 2004, MOL ECOL, V13, P459, DOI 10.1046/j.1365-294X.2003.02058.x; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Van Oppen MJH, 2005, MOL ECOL, V14, P2403, DOI 10.1111/j.1365-294X.2005.02545.x; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	47	6	6	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55057	10.1371/journal.pone.0055057	http://dx.doi.org/10.1371/journal.pone.0055057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405111	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400055
J	Milhomem, SSR; Scacchetti, PC; Pieczarka, JC; Ferguson-Smith, MA; Pansonato-Alves, JC; O'Brien, PCM; Foresti, F; Nagamachi, CY				Milhomem, Susana S. R.; Scacchetti, Priscilla C.; Pieczarka, Julio C.; Ferguson-Smith, Malcolm A.; Pansonato-Alves, Jose C.; O'Brien, Patricia C. M.; Foresti, Fausto; Nagamachi, Cleusa Y.			Are NORs Always Located on Homeologous Chromosomes? A FISH Investigation with rDNA and Whole Chromosome Probes in Gymnotus Fishes (Gymnotiformes)	PLOS ONE			English	Article							NUCLEOLUS ORGANIZER REGIONS; RIBOSOMAL-RNA GENES; ELECTRIC KNIFEFISH; SEX-CHROMOSOMES; TELEOSTEI; AMAZON; REARRANGEMENTS; STERNOPYGIDAE; POLYMORPHISM; GYMNOTOIDEI	Gymnotus (Gymnotiformes, Gymnotidae) is the most diverse known Neotropical electric knife fish genus. Cytogenetic studies in Gymnotus demonstrate a huge karyotypic diversity for this genus, with diploid numbers ranging from 34 to 54. The NOR are also variable in this genus, with both single and multiple NORs described. A common interpretation is that the single NOR pair is a primitive trait while multiple NORs are derivative. However this hypothesis has never been fully tested. In this report we checked if the NOR-bearing chromosome and the rDNA site are homeologous in different species of the genus Gymnotus: G. carapo (2n = 40, 42, 54), G. mamiraua (2n = 54), G. arapaima (2n = 44), G. sylvius (2n = 40), G. inaequilabiatus (2n = 54) and G. capanema (2n = 34), from the monophyletic group G. carapo (Gymnotidae-Gymnotiformes), as well as G. jonasi (2n = 52), belonging to the G1 group. They were analyzed with Fluorescence in situ hybridization (FISH) using 18S rDNA and whole chromosome probes of the NOR-bearing chromosome 20 (GCA20) of G. carapo (cytotype 2n = 42), obtained by Fluorescence Activated Cell Sorting. All species of the monophyletic G. carapo group show the NOR in the same single pair, confirmed by hybridization with CGA20 whole chromosome probe. In G. jonasi the NORs are multiple, and located on pairs 9, 10 and 11. In G. jonasi the GCA20 chromosome probe paints the distal half of the long arm of pair 7, which is not a NOR-bearing chromosome. Thus these rDNA sequences are not always in the homeologous chromosomes in different species thus giving no support to the hypothesis that single NOR pairs are primitive traits while multiple NORs are derived. The separation of groups of species in the genus Gymnotus proposed by phylogenies with morphologic and molecular data is supported by our cytogenetic data.	[Milhomem, Susana S. R.; Pieczarka, Julio C.; Nagamachi, Cleusa Y.] Fed Univ Para, Lab Citogenet, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Scacchetti, Priscilla C.; Pansonato-Alves, Jose C.; Foresti, Fausto] Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Morfol, Botucatu, SP, Brazil; [Ferguson-Smith, Malcolm A.; O'Brien, Patricia C. M.] Univ Cambridge, Cambridge Resource Ctr Comparat Genom, Dept Vet Med, Cambridge, England	Universidade Federal do Para; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; University of Cambridge	Nagamachi, CY (corresponding author), Fed Univ Para, Lab Citogenet, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	cleusa@ufpa.br	Nagamachi, Cleusa/AAV-8985-2021; Pieczarka, Julio C/E-7585-2016; Pansonato Alves, Jose Carlos/C-3062-2014	Pieczarka, Julio C/0000-0003-2951-8877; Pansonato Alves, Jose Carlos/0000-0003-3580-7384; Nagamachi, Cleusa Yoshiko/0000-0003-1516-2734	FAPESPA (Para Foundation for Supporting Science) through the National Excellence on Research Program (PRONEX) [TO 011/2008]; CNPq; CAPES; UFPA; FAPESPA; FAPESP; Wellcome Trust; CNPq-Brazil	FAPESPA (Para Foundation for Supporting Science) through the National Excellence on Research Program (PRONEX)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UFPA; FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Wellcome Trust(Wellcome TrustEuropean Commission); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Most of this research was supported by FAPESPA (Para Foundation for Supporting Science) through the National Excellence on Research Program (PRONEX, TO 011/2008) on a project coordinated by J. C. Pieczarka. Funding to the Brazilian authors was provided by CNPq, CAPES, UFPA, FAPESPA and FAPESP. Wellcome Trust provided a grant to M. A. Ferguson-Smith, the CNPq-Brazil provided Post-Doctoral scholarships to C. Y. Nagamachi and J. C. Pieczarka and a Doctoral scholarship to S. S. R. Milhomem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J. S., 2005, SYST BIODIVERS, V2, P375, DOI DOI 10.1017/S1477200004001574; Albert JS, 1995, P BIOL SOC WASH, V108, P662; Almeida-Toledo LF, 1985, CIENC CULT, V3, P448; Artoni RF, 2002, HEREDITY, V89, P15, DOI 10.1038/sj.hdy.6800081; BERTOLLO L A C, 1978, Revista Brasileira de Genetica, V1, P103; Cardoso AL, 2011, REV FISH BIOL FISHER, V21, P613, DOI 10.1007/s11160-010-9196-0; Deiana AM, 2006, ITAL J ZOOL, V73, P1, DOI 10.1080/11250000500502038; DERGAM JA, 1990, REV BRAS GENET, V13, P755; Dumas F, 2005, CHROMOSOME RES, V13, P85, DOI 10.1007/s10577-005-7063-y; Ferguson-Smith Malcolm A., 1998, ILAR J, V39, P68; Fernandes FMC, 2005, ZOOTAXA, P1; Fernandes-Matioli FMC, 1998, CARYOLOGIA, V51, P221, DOI 10.1080/00087114.1998.10797414; Fernandes-Matioli FMC, 1997, CYTOGENET CELL GENET, V78, P236, DOI 10.1159/000134665; Ferro DAD, 2000, GENETICA, V110, P55; Fonteles SBA, 2008, GENET MOL BIOL, V31, P227, DOI 10.1590/S1415-47572008000200010; FORESTI F, 1981, CYTOGENET CELL GENET, V31, P137, DOI 10.1159/000131639; Geoffrey MC, 2002, CELULA ABORDAGEM MOL; GOLD JR, 1984, COPEIA, P133, DOI 10.2307/1445043; Hatanaka T, 2004, GENETICA, V122, P239, DOI 10.1007/s10709-004-2039-y; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; HSU TC, 1975, CHROMOSOMA, V53, P25, DOI 10.1007/BF00329388; Lovejoy NR, 2010, MOL PHYLOGENET EVOL, V54, P278, DOI 10.1016/j.ympev.2009.09.017; Machado MA, 2011, 14 S CIT GEN PEIX; Machado TC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-65; Margarido VP, 2007, J FISH BIOL, V70, P155, DOI 10.1111/j.1095-8649.2007.01365.x; Marques DK, 2006, NEOTROP ICHTHYOL, V4, P215, DOI 10.1590/S1679-62252006000200007; MartinsSantos IC, 1996, BRAZ J GENET, V19, P271; Milhomem SSR, 2012, J FISH BIOL, V80, P802, DOI 10.1111/j.1095-8649.2012.03219.x; Milhomem SSR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-75; Nagamachi CY, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-28; PENDAS AM, 1993, CYTOGENET CELL GENET, V63, P128, DOI 10.1159/000133517; Pieczarka JC, 2005, CHROMOSOME RES, V13, P339, DOI 10.1007/s10577-005-2886-0; Porto Jorge Ivan Rebelo, 1992, Revue d'Hydrobiologie Tropicale, V25, P287; Reed KM, 1997, CHROMOSOME RES, V5, P221, DOI 10.1023/A:1018411417816; Milhomem SSR, 2007, ZOOTAXA, P55; Milhomem SSR, 2012, REV FISH BIOL FISHER, V22, P485, DOI 10.1007/s11160-011-9239-1; Sanchez Sebastian, 2004, Cytologia (Tokyo), V69, P155, DOI 10.1508/cytologia.69.155; Scacchetti PC, 2011, COMP CYTOGENET, V5, P223, DOI 10.3897/CompCytogen.v5i3.1375; Sharma OP, 2002, SOME ASPECTS CHROMOS, P109; Silva DD, 2008, MICRON, V39, P1251, DOI 10.1016/j.micron.2008.04.001; Silva DS, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-74; Yang F, 1997, CHROMOSOMA, V106, P37, DOI 10.1007/s004120050222; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691	43	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55608	10.1371/journal.pone.0055608	http://dx.doi.org/10.1371/journal.pone.0055608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405178	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400123
J	Plominsky, AM; Larsson, J; Bergman, B; Delherbe, N; Osses, I; Vasquez, M				Plominsky, Alvaro M.; Larsson, John; Bergman, Birgitta; Delherbe, Nathalie; Osses, Igor; Vasquez, Monica			Dinitrogen Fixation Is Restricted to the Terminal Heterocysts in the Invasive Cyanobacterium Cylindrospermopsis raciborskii CS-505	PLOS ONE			English	Article							BLUE-GREEN-ALGA; NITROGEN-FIXATION; PATTERN-FORMATION; VEGETATIVE CELLS; ANABAENA; GENE; DIFFERENTIATION; GROWTH; PATA; IDENTIFICATION	The toxin producing nitrogen-fixing heterocystous freshwater cyanobacterium Cylindrospermopsis raciborskii recently radiated from its endemic tropical environment into sub-tropical and temperate regions, a radiation likely to be favored by its ability to fix dinitrogen (diazotrophy). Although most heterocystous cyanobacteria differentiate regularly spaced intercalary heterocysts along their trichomes when combined nitrogen sources are depleted, C. raciborskii differentiates only two terminal heterocysts (one at each trichome end) that can reach >100 vegetative cells each. Here we investigated whether these terminal heterocysts are the exclusive sites for dinitrogen fixation in C. raciborskii. The highest nitrogenase activity and NifH biosynthesis (western-blot) were restricted to the light phase of a 12/12 light/dark cycle. Separation of heterocysts and vegetative cells (sonication and two-phase aqueous polymer partitioning) demonstrated that the terminal heterocysts are the sole sites for nifH expression (RT-PCR) and NifH biosynthesis. The latter finding was verified by the exclusive localization of nitrogenase in the terminal heterocysts of intact trichomes (immunogold-transmission electron microscopy and in situ immunofluorescence-light microscopy). These results suggest that the terminal heterocysts provide the combined nitrogen required by the often long trichomes (>100 vegetative cells). Our data also suggests that the terminal-heterocyst phenotype in C. raciborskii may be explained by the lack of a patL ortholog. These data help identify mechanisms by which C. raciborskii and other terminal heterocyst-forming cyanobacteria successfully inhabit environments depleted in combined nitrogen.	[Plominsky, Alvaro M.; Delherbe, Nathalie; Osses, Igor; Vasquez, Monica] Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Santiago, Chile; [Larsson, John; Bergman, Birgitta] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden	Pontificia Universidad Catolica de Chile; Stockholm University	Vasquez, M (corresponding author), Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Alameda 340, Santiago, Chile.	mvasquez@bio.puc.cl		M. Plominsky, Alvaro/0000-0003-0816-8580	FONDECYT [1050433, 1080075]; Proyecto Puente [10/2011, 13/2012 VRI-PUC]; Swedish Research Council Formas; K. and A. Wallenberg Foundation	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Puente; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); K. and A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This study was financially supported by FONDECYT 1050433 and 1080075, Proyecto Puente no. 10/2011 and no. 13/2012 VRI-PUC, the Swedish Research Council Formas and the K. and A. Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bar-Yosef Y, 2010, CURR BIOL, V20, P1557, DOI 10.1016/j.cub.2010.07.032; Bergman B, 1997, FEMS MICROBIOL REV, V19, P139, DOI 10.1016/S0168-6445(96)00028-9; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; Castro D, 2004, TOXICON, V44, P483, DOI 10.1016/j.toxicon.2004.06.005; Coute A, 1997, CRYPTOGAMIE ALGOL, V18, P57; Dokulil MT, 1996, ALGOLOGICAL STUDIES, V83, P179, DOI DOI 10.1127/ALG0L_STUD/83/1996/179; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELHAI J, 1990, EMBO J, V9, P3379, DOI 10.1002/j.1460-2075.1990.tb07539.x; Fan Q, 2005, MOL MICROBIOL, V58, P227, DOI 10.1111/j.1365-2958.2005.04818.x; Fiedler G, 1998, MOL MICROBIOL, V27, P1193, DOI 10.1046/j.1365-2958.1998.00762.x; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; FREDRIKSSON C, 1995, MICROBIOL-UK, V141, P2471, DOI 10.1099/13500872-141-10-2471; Hamilton PB, 2005, PHYCOLOGIA, V44, P17, DOI 10.2216/0031-8884(2005)44[17:TOOTCC]2.0.CO;2; Hess WR, 2011, CURR OPIN MICROBIOL, V14, P608, DOI 10.1016/j.mib.2011.07.024; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Klint J, 2007, J PLANT PHYSIOL, V164, P11, DOI 10.1016/j.jplph.2005.08.021; KRIENITZ L, 1996, LAUTERBORNIA, V26, P55; Lagos N, 1999, TOXICON, V37, P1359, DOI 10.1016/S0041-0101(99)00080-X; Larsson J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-187; Lawton L, 1999, TOXIC CYANOBACTERIA, P354; Liaimer A, 2011, ENV MICROBIOL REP, V3, P550, DOI 10.1111/j.1758-2229.2011.00258.x; LIANG J, 1992, P NATL ACAD SCI USA, V89, P5655, DOI 10.1073/pnas.89.12.5655; Liu JJ, 2011, J BACTERIOL, V193, P6070, DOI 10.1128/JB.05523-11; Lundgren P, 2003, J PHYCOL, V39, P310, DOI 10.1046/j.1529-8817.2003.02080.x; Makarova KS, 2006, BIOINFORMATICS, V22, P1297, DOI 10.1093/bioinformatics/btl096; Moisander PH, 2012, FEMS MICROBIOL ECOL, V79, P800, DOI 10.1111/j.1574-6941.2011.01264.x; Neilan BA, 2003, MOL ECOL, V12, P133, DOI 10.1046/j.1365-294X.2003.01709.x; Neunuebel MR, 2008, J BACTERIOL, V190, P6829, DOI 10.1128/JB.00701-08; Olmedo-Verd E, 2006, J BACTERIOL, V188, P6694, DOI 10.1128/JB.00509-06; Padisak J., 1997, ARCH HYDROBIOL, V107, P563; Plominsky AM, 2009, LETT APPL MICROBIOL, V49, P332, DOI 10.1111/j.1472-765X.2009.02665.x; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Popa R, 2007, ISME J, V1, P354, DOI 10.1038/ismej.2007.44; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ran LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011486; REDDY PM, 1974, NATURE, V249, P493, DOI 10.1038/249493a0; Risser DD, 2008, J BACTERIOL, V190, P7645, DOI 10.1128/JB.01110-08; Rucker J, 1997, HYDROBIOLOGIA, V342, P107, DOI 10.1023/A:1017013208039; Saker ML, 1999, J PHYCOL, V35, P599, DOI 10.1046/j.1529-8817.1999.3530599.x; Saker ML, 2003, ECOTOX ENVIRON SAFE, V55, P243, DOI 10.1016/S0147-6513(02)00043-X; Sambrook J, 2001, MOL CLONING LAB MANU; Sandh G, 2012, MICROBIOL-SGM, V158, P345, DOI 10.1099/mic.0.051268-0; Sandh G, 2011, PROTEOMICS, V11, P406, DOI 10.1002/pmic.201000382; SINGH PK, 1976, Z ALLG MIKROBIOL, V16, P453, DOI 10.1002/jobm.3630160606; SKUJA H., 1938, BOT REV, V4, P665, DOI 10.1007/BF02869845; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; THIEL T, 1995, P NATL ACAD SCI USA, V92, P9358, DOI 10.1073/pnas.92.20.9358; Thiel T, 2001, J BACTERIOL, V183, P280, DOI 10.1128/JB.183.1.280-286.2001; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Van Alstine JM, 2000, METH BIOTEC, V11, P119; VANDEWATER S, 1984, J GEN MICROBIOL, V130, P789; WEI TF, 1994, J BACTERIOL, V176, P4473, DOI 10.1128/JB.176.15.4473-4482.1994; Wiedner C, 2007, OECOLOGIA, V152, P473, DOI 10.1007/s00442-007-0683-5; WILCOX M, 1973, J CELL SCI, V12, P707; Wilson K, 1990, CURRENT PROTOCOLS MO; Wood SA, 2003, NEW ZEAL J MAR FRESH, V37, P821, DOI 10.1080/00288330.2003.9517211	58	24	24	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e51682	10.1371/journal.pone.0051682	http://dx.doi.org/10.1371/journal.pone.0051682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405062	Green Published, gold			2022-12-25	WOS:000315153400005
J	Zhong, DB; Chang, XL; Zhou, GF; He, ZB; Fu, FY; Yan, ZT; Zhu, GD; Xu, TL; Bonizzoni, M; Wang, MH; Cui, LW; Zheng, B; Chen, B; Yan, GY				Zhong, Daibin; Chang, Xuelian; Zhou, Guofa; He, Zhengbo; Fu, Fengyang; Yan, Zhentian; Zhu, Guoding; Xu, Tielong; Bonizzoni, Mariangela; Wang, Mei-Hui; Cui, Liwang; Zheng, Bin; Chen, Bin; Yan, Guiyun			Relationship between Knockdown Resistance, Metabolic Detoxification and Organismal Resistance to Pyrethroids in Anopheles sinensis	PLOS ONE			English	Article							MALARIA VECTOR MOSQUITO; GATED SODIUM-CHANNEL; TRIATOMA-INFESTANS HEMIPTERA; IMPREGNATED BED NETS; INSECTICIDE RESISTANCE; AEDES-AEGYPTI; MOLECULAR CHARACTERIZATION; HAEMATOBIA-IRRITANS; CENTRAL-AFRICA; KDR MUTATION	Anopheles sinensis is the most important vector of malaria in Southeast Asia, including China. Currently, the most effective measure to prevent malaria transmission relies on vector control through the use of insecticides, primarily pyrethroids. Extensive use of insecticides poses strong selection pressure on mosquito populations for resistance. Resistance to insecticides can arise due to mutations in the insecticide target site (target site resistance), which in the case of pyrethroids is the para-type sodium channel gene, and/or the catabolism of the insecticide by detoxification enzymes before it reaches its target (metabolic detoxification resistance). In this study, we examined deltamethrin resistance in An. sinensis from China and investigated the relative importance of target site versus metabolic detoxification mechanisms in resistance. A high frequency (>85%) of nonsynonymous mutations in the para gene was found in populations from central China, but not in populations from southern China. Metabolic detoxification as measured by the activity of monooxygenases and glutathione S-transferases (GSTs) was detected in populations from both central and southern China. Monooxygenase activity levels were significantly higher in the resistant than the susceptible mosquitoes, independently of their geographic origin. Stepwise multiple regression analyses in mosquito populations from central China found that both knockdown resistance (kdr) mutations and monooxygenase activity were significantly associated with deltamethrin resistance, with monooxygenase activity playing a stronger role. These results demonstrate the importance of metabolic detoxification in pyrethroid resistance in An. sinensis, and suggest that different mechanisms of resistance could evolve in geographically different populations.	[Zhong, Daibin; Chang, Xuelian; Zhou, Guofa; Zhu, Guoding; Bonizzoni, Mariangela; Wang, Mei-Hui; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Coll Hlth Sci, Irvine, CA USA; [Chang, Xuelian] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Chang, Xuelian] Bengbu Med Coll, Dept Pathogen Biol, Bengbu, Anhui, Peoples R China; [He, Zhengbo; Fu, Fengyang; Yan, Zhentian; Chen, Bin] Chongqing Normal Univ, Inst Entomol & Mol Biol, Coll Life Sci, Chongqing, Peoples R China; [Zhu, Guoding] Jiangsu Inst Parasit Dis, Div Malaria Control, Wuxi, Peoples R China; [Xu, Tielong; Zheng, Bin] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	University of California System; University of California Irvine; Nanjing Medical University; Bengbu Medical College; Chongqing Normal University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zheng, B (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China.	chuner1997@yahoo.com; c_bin@hotmail.com; guiyuny@uci.edu	bonizzoni, mariangela/AAM-9035-2021; Zhong, Daibin/GRF-0564-2022	bonizzoni, mariangela/0000-0003-0568-8564; Tie-Long, Xu/0000-0001-9432-9584	National Institutes of Health [R01 AI050243, R03 TW008237, R01 AI095184, U19 AI089672]; FOGARTY INTERNATIONAL CENTER [R03TW008237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095184, R01AI050243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants from the National Institutes of Health (R01 AI050243, R03 TW008237, R01 AI095184 and U19 AI089672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audino PG, 2004, MEM I OSWALDO CRUZ, V99, P335, DOI 10.1590/S0074-02762004000300018; Bouvier JC, 1998, ARCH INSECT BIOCHEM, V39, P55, DOI 10.1002/(SICI)1520-6327(1998)39:2&lt;55::AID-ARCH2&gt;3.0.CO;2-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Chandre F, 1999, B WHO, V77; Chareonviriyaphap Theeraphap, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P225; Chen H, 2008, J MED ENTOMOL, V45, P242, DOI 10.1603/0022-2585(2008)45[242:MLAKRK]2.0.CO;2; Corbel V, 2006, NEUROTOXICOLOGY, V27, P508, DOI 10.1016/j.neuro.2006.01.011; Cui F, 2007, PEST MANAG SCI, V63, P453, DOI 10.1002/ps.1356; Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Enayati AA, 2003, MED VET ENTOMOL, V17, P138, DOI 10.1046/j.1365-2915.2003.00418.x; Fanello C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P323; Farenhorst M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012081; Guerrero FD, 1997, INSECT BIOCHEM MOLEC, V27, P745, DOI 10.1016/S0965-1748(97)00057-X; [何大明 He Daming], 2005, [地球科学进展, Advance in Earth Sciences], V20, P338; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Jamroz RC, 1998, INSECT BIOCHEM MOLEC, V28, P1031, DOI 10.1016/S0965-1748(98)00094-0; Joshi D, 2010, MOL ECOL RESOUR, V10, P748, DOI 10.1111/j.1755-0998.2010.02835.x; Jung J, 2006, MOL ECOL NOTES, V6, P1272, DOI 10.1111/j.1471-8286.2006.01512.x; Jung J, 2007, AM J TROP MED HYG, V77, P310, DOI 10.4269/ajtmh.2007.77.310; Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79; Kang S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-151; Kang W, 1995, ANN TROP MED PARASIT, V89, P677, DOI 10.1080/00034983.1995.11813001; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Khambay BPS., 2010, INSECT CONTROL BIOL, P1; Kim H, 2007, PESTIC BIOCHEM PHYS, V87, P54, DOI 10.1016/j.pestbp.2006.06.009; LI ZZ, 1989, AM J TROP MED HYG, V40, P356; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Liu Nannan, 2006, Insect Science, V13, P159, DOI 10.1111/j.1744-7917.2006.00078.x; Liu XB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-221; Ma YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022219; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mathenge EM, 2001, J MED ENTOMOL, V38, P531, DOI 10.1603/0022-2585-38.4.531; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Munhenga G, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-247; Overgaard Hans J, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P152; Penilla RP, 1998, MED VET ENTOMOL, V12, P217, DOI 10.1046/j.1365-2915.1998.00123.x; Picollo MI, 2005, J MED ENTOMOL, V42, P637, DOI 10.1603/0022-2585(2005)042[0637:HRTPIA]2.0.CO;2; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SEXTON JD, 1994, AM J TROP MED HYG, V50, P72, DOI 10.4269/ajtmh.1994.50.72; Singh OP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-59; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Syafruddin D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-315; Tan W-L, 2011, PLOS ONE, V7; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Verhaeghen K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-59; WHO, 2006, GLOB MAL PROGR US IN; WHO, 1998, WHOCDSCPCMAL9812; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; World Health Organization, 2005, MAL CONTR TOD CURR W	56	54	72	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55475	10.1371/journal.pone.0055475	http://dx.doi.org/10.1371/journal.pone.0055475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405157	Green Published, gold			2022-12-25	WOS:000315153400102
J	Bisconti, R; Canestrelli, D; Nascetti, G				Bisconti, Roberta; Canestrelli, Daniele; Nascetti, Giuseppe			Has Living on Islands Been So Simple? Insights from the Insular Endemic Frog Discoglossus montalentii	PLOS ONE			English	Article							LIZARD PODARCIS-TILIGUERTA; GENETIC DIVERSITY; SOFTWARE PACKAGE; POPULATION-SIZE; PHYLOGEOGRAPHY; EVOLUTIONARY; NEUTRALITY; AMPHIBIA; CORSICA; TESTS	Island populations have been extensively used as model systems in ecology, biogeography, conservation and evolutionary biology, owing to the several simplifying assumptions that they allow. Nevertheless, recent findings from intra-island phylogeographic studies are casting doubts on the generality of some of these underlying assumptions. We investigated the phylogeography, historical demography, and population genetic structure of the Corsican endemic frog, Discoglossus montalentii. In contrast with expectations based on its insular, restricted and continuous distribution, we found evidence of 3 phylogroups, whose rather ancient divergence (Early-Middle Pleistocene) was likely primed by climatic changes that occurred during the 'middle Pleistocene revolution'. Furthermore, their differentiation explained most (68%) of the overall genetic diversity that was observed. These results and the growing evidence from intra-island phylogeographies, suggest that island populations frequently may not conform to some long-standing assumptions, including long-term stability, range-wide panmixia and the correlation of effective population size to the island size. As a consequence, both for theoretical and for applied purposes, the extensive use of these assumptions in the study of island populations warrants a careful re-examination.	[Bisconti, Roberta; Canestrelli, Daniele; Nascetti, Giuseppe] Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy	Tuscia University	Canestrelli, D (corresponding author), Univ Tuscia, Dipartimento Sci Ecol & Biol, Viterbo, Italy.	canestrelli@unitus.it	Canestrelli, Daniele/N-1724-2015; bisconti, roberta/AAA-8795-2020; Nascetti, Giuseppe/AAA-6396-2020	Canestrelli, Daniele/0000-0001-9351-4972; Nascetti, Giuseppe/0000-0002-1159-8103; Bisconti, Roberta/0000-0002-0600-7436	Tuscia University	Tuscia University	This work was supported by Tuscia University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barton N. H., 1998, P102; Bisconti R, 2012, MOL ECOL IN PRESS; Bisconti R, 2011, BIOL J LINN SOC, V103, P159, DOI 10.1111/j.1095-8312.2011.01643.x; Canestrelli D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041754; Canestrelli D, 2012, BIOL J LINN SOC, V105, P42, DOI 10.1111/j.1095-8312.2011.01767.x; Capula M, 1996, HEREDITY, V77, P518, DOI 10.1038/hdy.1996.179; Darwin C., 1877, DIFFERENT FORMS FLOW; Delaugerre M., 1992, ATLAS REPARTITION BA; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Emerson BC, 2006, MOL ECOL, V15, P449, DOI 10.1111/j.1365-294X.2005.02786.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falchi A, 2009, MOL PHYLOGENET EVOL, V52, P538, DOI 10.1016/j.ympev.2009.04.002; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Fu YX, 1997, GENETICS, V147, P915; Gasc J. P., 1997, COLLECTION PATRIMOIN; Gentile G, 2010, MOL PHYLOGENET EVOL, V54, P640, DOI 10.1016/j.ympev.2009.10.005; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Grant P.R., 2007, WHY SPECIES MULTIPLY; Grant P.R., 1998, EVOLUTION ISLANDS; Harris DJ, 2005, AMPHIBIA-REPTILIA, V26, P401, DOI 10.1163/156853805774408676; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Head MJ, 2005, GEOL SOC SPEC PUBL, V247, P1, DOI 10.1144/GSL.SP.2005.247.01.01; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Holland BS, 2002, MOL ECOL, V11, P365, DOI 10.1046/j.1365-294X.2002.01464.x; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Ketmaier V, 2010, MALACOLOGIA, V52, P81, DOI 10.4002/040.052.0106; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kuhlemann J, 2008, SCIENCE, V321, P1338, DOI 10.1126/science.1157638; LANZA B, 1984, MONIT ZOOL ITAL, V18, P133; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MAC ARTHUR ROBERT H., 1967; Mannion, 2008, MEDITERRANEAN ISLAND; Miaud C, 2009, IUCN 2012 IUCN RED L; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Mouillot F., 2008, V9, P220; Nei M., 1987, MOL EVOLUTIONARY GEN; Nevo E., 1984, Lecture Notes in Biomathematics, V53, P13; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Salvi D, 2010, MOL PHYLOGENET EVOL, V56, P690, DOI 10.1016/j.ympev.2010.03.017; Salvi D, 2009, BIOL J LINN SOC, V98, P661, DOI 10.1111/j.1095-8312.2009.01313.x; Stebbins G. Ledyard, 1942, MADRONO, V6, P241; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thompson J., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorpe Roger S., 1998, P67; Villacorta C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-7; Wallace AR, 1880, ISLAND LIFE PHENOMEN; Wallis GP, 2009, MOL ECOL, V18, P3548, DOI 10.1111/j.1365-294X.2009.04294.x; Waters JM, 2012, TRENDS ECOL IN PRESS; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Woolfit M, 2005, P ROY SOC B-BIOL SCI, V272, P2277, DOI 10.1098/rspb.2005.3217; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2011, MOL PHYLOGENET EVOL, V59, P342, DOI 10.1016/j.ympev.2011.01.017; Young AG, 2000, CONSERV BIOL SER, V4, P335; Zangari F, 2006, BIOL J LINN SOC, V87, P515	63	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55735	10.1371/journal.pone.0055735	http://dx.doi.org/10.1371/journal.pone.0055735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393599	Green Submitted, Green Published, gold			2022-12-25	WOS:000314692800053
J	Jiang, JS; Magilnick, N; Tsirulnikov, K; Abuladze, N; Atanasov, I; Ge, P; Narla, M; Pushkin, A; Zhou, ZH; Kurtz, I				Jiang, Jiansen; Magilnick, Nathaniel; Tsirulnikov, Kirill; Abuladze, Natalia; Atanasov, Ivo; Ge, Peng; Narla, Mohandas; Pushkin, Alexander; Zhou, Z. Hong; Kurtz, Ira			Single Particle Electron Microscopy Analysis of the Bovine Anion Exchanger 1 Reveals a Flexible Linker Connecting the Cytoplasmic and Membrane Domains	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE; TRANSPORT PROTEIN; BAND-3 PROTEIN; TILT; VISUALIZATION; PLASMODIUM; MECHANISM	Anion exchanger 1 (AE1) is the major erythrocyte membrane protein that mediates chloride/bicarbonate exchange across the erythrocyte membrane facilitating CO2 transport by the blood, and anchors the plasma membrane to the spectrin-based cytoskeleton. This multi-protein cytoskeletal complex plays an important role in erythrocyte elasticity and membrane stability. An in-frame AE1 deletion of nine amino acids in the cytoplasmic domain in a proximity to the membrane domain results in a marked increase in membrane rigidity and ovalocytic red cells in the disease Southeast Asian Ovalocytosis (SAO). We hypothesized that AE1 has a flexible region connecting the cytoplasmic and membrane domains, which is partially deleted in SAO, thus causing the loss of erythrocyte elasticity. To explore this hypothesis, we developed a new non-denaturing method of AE1 purification from bovine erythrocyte membranes. A three-dimensional (3D) structure of bovine AE1 at 2.4 nm resolution was obtained by negative staining electron microscopy, orthogonal tilt reconstruction and single particle analysis. The cytoplasmic and membrane domains are connected by two parallel linkers. Image classification demonstrated substantial flexibility in the linker region. We propose a mechanism whereby flexibility of the linker region plays a critical role in regulating red cell elasticity.	[Jiang, Jiansen; Atanasov, Ivo; Ge, Peng; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Jiang, Jiansen; Atanasov, Ivo; Ge, Peng; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Jiang, Jiansen; Zhou, Z. Hong] Baylor Coll Med, Struct Computat Biol & Mol Biophys Program, Houston, TX 77030 USA; [Magilnick, Nathaniel; Tsirulnikov, Kirill; Abuladze, Natalia; Pushkin, Alexander; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Narla, Mohandas] New York Blood Ctr, New York, NY 10021 USA; [Kurtz, Ira] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York Blood Center; University of California System; University of California Los Angeles	Pushkin, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	apushkin@mednet.ucla.edu; Hong.Zhou@ucla.edu; ikurtz@mednet.ucla.edu	Jiang, Jiansen/J-2057-2015; Zhou, Z Hong/HDN-0747-2022	Jiang, Jiansen/0000-0002-1692-7906; Magilnick, Nathaniel/0000-0002-8515-4919	National Institutes of Health [DK077162, DK058563, GM071940]; American Heart Association Western State Affiliate grant [10GRNT4140074]; National Kidney Foundation Serving Southern California and Southern Nevada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162, R37DK026263, R01DK058563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Western State Affiliate grant; National Kidney Foundation Serving Southern California and Southern Nevada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the National Institutes of Health grants DK077162 and DK058563 (I.K.), and GM071940 (Z.H.Z.), and the American Heart Association Western State Affiliate grant 10GRNT4140074 (A.P.). Jiansen Jiang is a recipient of a postdoctoral fellowship from the National Kidney Foundation Serving Southern California and Southern Nevada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 2005, J PHYSIOL-LONDON, V565, P717, DOI 10.1113/jphysiol.2005.084988; Alberts B., 2008, MOL BIOL CELL, VFifth; Alper SL, 2009, J EXP BIOL, V212, P1672, DOI 10.1242/jeb.029454; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; BENNETT V, 1979, NATURE, V280, P468, DOI 10.1038/280468a0; Butler J, 2008, BIOPHYS J, V95, P1826, DOI 10.1529/biophysj.108.129163; CASEY JR, 1991, J BIOL CHEM, V266, P15726; Colfen H, 1996, BIOPHYS J, V71, P1611, DOI 10.1016/S0006-3495(96)79364-5; Crandall IE, 2007, BIOCHEM PHARMACOL, V73, P632, DOI 10.1016/j.bcp.2006.10.030; DOLDER M, 1993, J MOL BIOL, V231, P119, DOI 10.1006/jmbi.1993.1261; Drew C, 2004, BIOELECTROCHEMISTRY, V62, P153, DOI 10.1016/j.bioelechem.2003.07.003; Ficarra S, 2009, J MEMBRANE BIOL, V228, P43, DOI 10.1007/s00232-009-9157-5; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GarciaRomeu F, 1996, CELL MOL BIOL, V42, P985; Ito D, 2006, J CELL SCI, V119, P3602, DOI 10.1242/jcs.03101; KANG D, 1992, J BIOL CHEM, V267, P19211; Kodippili GC, 2012, J BIOL CHEM, V287, P4129, DOI 10.1074/jbc.M111.294439; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lemieux MJ, 2002, J STRUCT BIOL, V137, P322; Leschziner AE, 2006, J STRUCT BIOL, V153, P284, DOI 10.1016/j.jsb.2005.10.012; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mgone CS, 1996, T ROY SOC TROP MED H, V90, P228, DOI 10.1016/S0035-9203(96)90223-0; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MOHANDAS N, 1992, J CLIN INVEST, V89, P686, DOI 10.1172/JCI115636; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Nakao M, 2002, CURR OPIN HEMATOL, V9, P127, DOI 10.1097/00062752-200203000-00008; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Peters LL, 1996, CELL, V86, P917, DOI 10.1016/S0092-8674(00)80167-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; SHEETZ MP, 1983, SEMIN HEMATOL, V20, P175; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; von Kalckreuth V, 2006, J INFECT DIS, V194, P949, DOI 10.1086/507430; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; WANG DN, 1993, EMBO J, V12, P2233, DOI 10.1002/j.1460-2075.1993.tb05876.x; WANG DN, 1994, EMBO J, V13, P3230, DOI 10.1002/j.1460-2075.1994.tb06624.x; Winograd E, 2004, MOL BIOCHEM PARASIT, V136, P243, DOI 10.1016/j.molbiopara.2004.04.005; WONG P, 1994, J THEOR BIOL, V171, P197, DOI 10.1006/jtbi.1994.1223; Yamaguchi T, 2010, J MOL BIOL, V397, P179, DOI 10.1016/j.jmb.2010.01.027; Zhang DC, 2000, BLOOD, V96, P2925; Zhou Z, 2005, BIOCHEMISTRY-US, V44, P15115, DOI 10.1021/bi050931t	43	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55408	10.1371/journal.pone.0055408	http://dx.doi.org/10.1371/journal.pone.0055408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393575	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800029
J	Schottner, S; Hoffmann, F; Cardenas, P; Rapp, HT; Boetius, A; Ramette, A				Schoettner, Sandra; Hoffmann, Friederike; Cardenas, Paco; Rapp, Hans Tore; Boetius, Antje; Ramette, Alban			Relationships between Host Phylogeny, Host Type and Bacterial Community Diversity in Cold-Water Coral Reef Sponges	PLOS ONE			English	Article							CHONDRILLA-NUCULA DEMOSPONGIAE; INTERGENIC SPACER ANALYSIS; VERTICAL TRANSMISSION; MICROBIAL DIVERSITY; LOPHELIA-PERTUSA; MARINE SPONGES; ORGANIC-CARBON; SYMBIOTIC BACTERIA; DEEP; PORIFERA	Cold-water coral reefs are known to locally enhance the diversity of deep-sea fauna as well as of microbes. Sponges are among the most diverse faunal groups in these ecosystems, and many of them host large abundances of microbes in their tissues. In this study, twelve sponge species from three cold-water coral reefs off Norway were investigated for the relationship between sponge phylogenetic classification (species and family level), as well as sponge type (high versus low microbial abundance), and the diversity of sponge-associated bacterial communities, taking also geographic location and water depth into account. Community analysis by Automated Ribosomal Intergenic Spacer Analysis (ARISA) showed that as many as 345 (79%) of the 437 different bacterial operational taxonomic units (OTUs) detected in the dataset were shared between sponges and sediments, while only 70 (16%) appeared purely sponge-associated. Furthermore, changes in bacterial community structure were significantly related to sponge species (63% of explained community variation), sponge family (52%) or sponge type (30%), whereas mesoscale geographic distances and water depth showed comparatively small effects (< 5% each). In addition, a highly significant, positive relationship between bacterial community dissimilarity and sponge phylogenetic distance was observed within the ancient family of the Geodiidae. Overall, the high diversity of sponges in cold-water coral reefs, combined with the observed sponge-related variation in bacterial community structure, support the idea that sponges represent heterogeneous, yet structured microbial habitats that contribute significantly to enhancing bacterial diversity in deep-sea ecosystems.	[Schoettner, Sandra; Hoffmann, Friederike; Boetius, Antje; Ramette, Alban] Max Planck Inst Marine Microbiol, HGF MPG Grp Deep Sea Ecol & Technol, Bremen, Germany; [Schoettner, Sandra] Univ Bergen, Marine Microbiol Grp, Dept Biol, Bergen, Norway; [Hoffmann, Friederike; Rapp, Hans Tore] Univ Bergen, Dept Biol, Ctr Geobiol, Bergen, Norway; [Cardenas, Paco] Univ Bergen, Dept Biol, Bergen High Technol Ctr, Bergen, Norway	Max Planck Society; University of Bergen; University of Bergen; University of Bergen	Ramette, A (corresponding author), Max Planck Inst Marine Microbiol, HGF MPG Grp Deep Sea Ecol & Technol, Bremen, Germany.	aramette@mpi-bremen.de	Boetius, Antje/D-5459-2013; Ramette, Alban/E-9197-2016	Boetius, Antje/0000-0003-2117-4176; Ramette, Alban/0000-0002-3437-4639	EU [GOCE-CT-2005-511234-1, 226354]; SPONGES [017800]; Deutsche Forschungsgemeinschaft (DFG) [HO 3293/1-1]; Norwegian Research Council [28630]; Max Planck Society	EU(European Commission); SPONGES; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was funded by the EU FP6 project HERMES (GOCE-CT-2005-511234-1), the EU FP7 project HERMIONE (contract no. 226354) and SPONGES (project 017800). FH was funded by the Deutsche Forschungsgemeinschaft (DFG project HO 3293/1-1). HTR was funded by the Norwegian Research Council through contract number 28630. This study was also supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Bruck WM, 2010, ISME J, V4, P686, DOI 10.1038/ismej.2009.149; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Cardebas Paco, 2012, Zootaxa, V3253, P1; Cardenas P, 2012, ADV MAR BIOL, V61, P79, DOI 10.1016/B978-0-12-387787-1.00010-6; Cardenas P, 2007, J MAR BIOL ASSOC UK, V87, P1511, DOI 10.1017/S0025315407058286; Cardenas P, 2010, ZOOL SCR, V39, P89, DOI 10.1111/j.1463-6409.2009.00402.x; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; de Goeij JM, 2008, LIMNOL OCEANOGR, V53, P1376, DOI 10.4319/lo.2008.53.4.1376; de Goeij JM, 2007, LIMNOL OCEANOGR, V52, P2608, DOI 10.4319/lo.2007.52.6.2608; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Ereskovsky AV, 2005, MAR BIOL, V146, P869, DOI 10.1007/s00227-004-1489-1; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Freiwald Andre, 2004, P1; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Hansson L, 2009, MAR ECOL PROG SER, V397, P89, DOI 10.3354/meps08429; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Hill M, 2006, MAR BIOL, V148, P1221, DOI 10.1007/s00227-005-0164-5; Hoffmann F, 2005, GEOMICROBIOL J, V22, P1, DOI 10.1080/01490450590922505; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Holmes B, 2007, MAR BIOL, V150, P759, DOI 10.1007/s00227-006-0361-x; Hooper JNA, 2002, SYSTEMA PORIFERA GUI; JENSEN A, 1992, SARSIA, V77, P53, DOI 10.1080/00364827.1992.10413492; Jensen S, 2008, DEEP-SEA RES PT I, V55, P1554, DOI 10.1016/j.dsr.2008.06.008; Kamke J, 2010, ISME J, V4, P498, DOI 10.1038/ismej.2009.143; Kellogg CA, 2009, APPL ENVIRON MICROB, V75, P2294, DOI 10.1128/AEM.02357-08; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Lee OO, 2009, APPL ENVIRON MICROB, V75, P3513, DOI 10.1128/AEM.00002-09; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0021326, 10.1371/journal.pone.0018318]; Morrow CC, 2012, MOL PHYLOGENET EVOL, V62, P174, DOI 10.1016/j.ympev.2011.09.016; Neulinger SC, 2008, APPL ENVIRON MICROB, V74, P7272, DOI 10.1128/AEM.01777-08; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Pisera A, 2006, CAN J ZOOL, V84, P242, DOI 10.1139/Z05-169; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Reitner Joachim, 1995, Geologisch-Palaeontologische Mitteilungen, V20, P335; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schmitt S, 2007, APPL ENVIRON MICROB, V73, P2067, DOI 10.1128/AEM.01944-06; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Schmitt S, 2008, APPL ENVIRON MICROB, V74, P7694, DOI 10.1128/AEM.00878-08; Schottner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032093; Schottner S, 2011, ENVIRON MICROBIOL, V13, P1815, DOI 10.1111/j.1462-2920.2011.02494.x; Schottner S, 2009, ISME J, V3, P756, DOI 10.1038/ismej.2009.15; SCISCIOLI M, 1991, MOL REPROD DEV, V28, P346, DOI 10.1002/mrd.1080280406; SCISCIOLI M, 1994, CAH BIOL MAR, V35, P471; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Thacker RW, 2003, MAR BIOL, V142, P643, DOI 10.1007/s00227-002-0971-x; Thiel V, 2007, MICROB ECOL, V54, P101, DOI 10.1007/s00248-006-9177-y; Thoms C, 2003, MAR BIOL, V142, P685, DOI 10.1007/s00227-002-1000-9; Van Soest RWM, 2005, MAR BIOL RES, V1, P338, DOI 10.1080/17451000500380322; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; Weisz JB, 2007, MAR BIOL, V152, P475, DOI 10.1007/s00227-007-0708-y; Wichels A, 2006, FEMS MICROBIOL ECOL, V56, P102, DOI 10.1111/j.1574-6941.2006.00067.x; Wild C, 2008, MAR ECOL PROG SER, V372, P67, DOI 10.3354/meps07724; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141; Yakimov MM, 2006, DEEP-SEA RES PT I, V53, P62, DOI 10.1016/j.dsr.2005.07.005; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	76	62	64	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55505	10.1371/journal.pone.0055505	http://dx.doi.org/10.1371/journal.pone.0055505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393586	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800040
J	Wang, LF; Taneja, R; Wang, W; Yao, LJ; Veldhuizen, RAW; Gill, SE; Fortin, D; Inculet, R; Malthaner, R; Mehta, S				Wang, Lefeng; Taneja, Ravi; Wang, Wei; Yao, Li-Juan; Veldhuizen, Ruud A. W.; Gill, Sean E.; Fortin, Dalilah; Inculet, Richard; Malthaner, Richard; Mehta, Sanjay			Human Alveolar Epithelial Cells Attenuate Pulmonary Microvascular Endothelial Cell Permeability under Septic Conditions	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; NITRIC-OXIDE SYNTHASE; MURINE SEPSIS; PROTEIN LEAK; IN-VITRO; MIGRATION; KINASE; MODEL; PATHOGENESIS	Acute lung injury (ALI) and its most severe form, acute respiratory distress syndrome (ARDS), are characterised by high-protein pulmonary edema and severe hypoxaemic respiratory failure due to increased permeability of pulmonary microvascular endothelial cells (PMVEC). Alveolar epithelial cells (AEC) contribute importantly to normal alveolar function, and AEC dysfunction in ALI/ARDS is associated with worse outcomes. We hypothesized that AEC can modulate human PMVEC barrier function, and investigated the effects of AEC presence on human PMVEC barrier under septic conditions in vitro. PMVEC isolated from human lung were treated in vitro with septic stimulation (lipopolysaccharide [LPS], a mixture of clinically-relevant cytokines [cytomix], or plasma from patients with severe sepsis), and the trans-PMVEC leak of Evans Blue dye-labeled albumin assessed. PMVEC septic responses were compared in the presence/absence of co-cultured A549 epithelial cell line or primary human AEC. Septic stimulation with LPS, cytomix, or septic plasma induced marked PMVEC hyper-permeability (10.2 +/- 1.8, 8.9 +/- 2.2, and 3.7 +/- 0.2 fold-increase vs. control, respectively, p<0.01 for all). The presence of A549 cells or primary human AEC in a non-contact co-culture model attenuated septic PMVEC hyper-permeability by 39 +/- 4% to 100 +/- 3%, depending on the septic stimulation (p<0.05). Septic PMVEC hyper-permeability was also attenuated following treatment with culture medium conditioned by previous incubation with either naive or cytomix-treated A549 cells (p<0.05), and this protective effect of A549 cell-conditioned medium was both heat-stable and transferable following lipid extraction. Cytomix-stimulated PMN-dependent PMVEC hyper-permeability and trans-PMVEC PMN migration were also inhibited in the presence of A549 cells or A549 cell-conditioned medium (p<0.05). Human AEC appear to protect human PMVEC barrier function under septic conditions in vitro, through release of a soluble mediator(s), which are at least partly lipid in nature. This study suggests a scientific and potential clinical therapeutic importance of epithelial-endothelial cross talk in maintaining alveolar integrity in ALI/ARDS.	[Wang, Lefeng; Taneja, Ravi; Wang, Wei; Yao, Li-Juan; Veldhuizen, Ruud A. W.; Gill, Sean E.; Mehta, Sanjay] London Hlth Sci Ctr, Lawson Hlth Res Inst, Ctr Crit Illness Res, Div Respirol, London, ON, Canada; [Wang, Lefeng; Wang, Wei; Veldhuizen, Ruud A. W.; Gill, Sean E.; Mehta, Sanjay] Univ Western Ontario, Schulich Fac Med & Dent, Dept Med, London, ON, Canada; [Taneja, Ravi] Univ Western Ontario, Schulich Fac Med & Dent, Dept Anesthesia, London, ON, Canada; [Taneja, Ravi; Fortin, Dalilah] Univ Western Ontario, Schulich Fac Med & Dent, Dept Crit Care Med, London, ON, Canada; [Fortin, Dalilah; Inculet, Richard; Malthaner, Richard] Univ Western Ontario, Schulich Fac Med & Dent, Dept Thorac Surg, London, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Mehta, S (corresponding author), London Hlth Sci Ctr, Lawson Hlth Res Inst, Ctr Crit Illness Res, Div Respirol, London, ON, Canada.	Sanjay.Mehta@lhsc.on.ca	Veldhuizen, Ruud/G-3352-2011; Gill, Sean E/G-4057-2012; Mehta, Sanjay/G-3332-2011	Veldhuizen, Ruud/0000-0002-8802-1580; Mehta, Sanjay/0000-0002-7707-1056	Heart & Stroke Foundation of Ontario/Canada [T6461]; Ontario Thoracic Society; Lawson Health Research Institute; LHSC Department of Medicine Program of Experimental Medicine	Heart & Stroke Foundation of Ontario/Canada; Ontario Thoracic Society; Lawson Health Research Institute; LHSC Department of Medicine Program of Experimental Medicine	Funding support by Heart & Stroke Foundation of Ontario/Canada grant #T6461, Ontario Thoracic Society, Lawson Health Research Institute, LHSC Department of Medicine Program of Experimental Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastarache JA, 2009, AM J PHYSIOL-LUNG C, V297, pL1035, DOI 10.1152/ajplung.00214.2009; Berthiaume Y, 2007, RESP PHYSIOL NEUROBI, V159, P350, DOI 10.1016/j.resp.2007.05.010; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Breslin JW, 2004, AM J PHYSIOL-HEART C, V286, pH1057, DOI 10.1152/ajpheart.00841.2003; Burns AR, 2003, PHYSIOL REV, V83, P309, DOI 10.1152/physrev.00023.2002; Clerici C, 2011, AM J PHYSIOL-LUNG C, V301, pL20, DOI 10.1152/ajplung.00126.2011; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Ehrhardt Carsten, 2005, Methods Mol Med, V107, P207; Farley KS, 2006, AM J PHYSIOL-LUNG C, V290, pL1164, DOI 10.1152/ajplung.00248.2005; GORIN AB, 1979, J APPL PHYSIOL, V47, P1315, DOI 10.1152/jappl.1979.47.6.1315; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hermanns MI, 2009, CELL TISSUE RES, V336, P91, DOI 10.1007/s00441-008-0750-1; Jacobs ER, 2001, AM J PHYSIOL-HEART C, V280, pH1, DOI 10.1152/ajpheart.2001.280.1.H1; Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Moss M, 1996, CRIT CARE MED, V24, P1782, DOI 10.1097/00003246-199611000-00004; Ochoa CD, 2012, AM J PHYSIOL-LUNG C, V302, pL275, DOI [10.1152/ajplung.00215.2011., 10.1152/ajplung.00215.2011]; Orgeig S, 2010, RESP PHYSIOL NEUROBI, V173, pS43, DOI 10.1016/j.resp.2010.04.023; Perl M, 2011, EXPERT REV RESP MED, V5, P115, DOI 10.1586/ERS.10.92; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Razavi HM, 2005, CRIT CARE MED, V33, P1333, DOI 10.1097/01.CCM.0000165445.48350.4F; Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; Shelton JL, 2008, MICROVASC RES, V76, P80, DOI 10.1016/j.mvr.2008.06.001; Shelton JL, 2007, MICROVASC RES, V74, P23, DOI 10.1016/j.mvr.2007.02.008; Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003; Singh LS, 2007, JNCI-J NATL CANCER I, V99, P1313, DOI 10.1093/jnci/djm107; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Tomashefski JF, 2000, CLIN CHEST MED, V21, P435, DOI 10.1016/S0272-5231(05)70158-1; Wang LF, 2012, SHOCK, V37, P539, DOI 10.1097/SHK.0b013e31824dcb5a; Wang LF, 2002, AM J RESP CRIT CARE, V165, P1634, DOI 10.1164/rccm.2110017; Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC; Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weppler A, 2006, EXP LUNG RES, V32, P455, DOI 10.1080/01902140601059463; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	42	30	36	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55311	10.1371/journal.pone.0055311	http://dx.doi.org/10.1371/journal.pone.0055311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393568	gold, Green Published, Green Submitted			2022-12-25	WOS:000314692800022
J	Wood, MP; Cole, AL; Ruchala, P; Waring, AJ; Rohan, LC; Marx, P; Tarwater, PM; Gupta, P; Cole, AM				Wood, Matthew P.; Cole, Amy L.; Ruchala, Piotr; Waring, Alan J.; Rohan, Lisa C.; Marx, Preston; Tarwater, Patrick M.; Gupta, Phalguni; Cole, Alexander M.			A Compensatory Mutation Provides Resistance to Disparate HIV Fusion Inhibitor Peptides and Enhances Membrane Fusion	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RETROCYCLIN ANALOG RC-101; ENVELOPE GLYCOPROTEIN; TYPE-1 VARIANT; 6-HELIX BUNDLE; GP41; INFECTION; BINDING; MODEL; ENFUVIRTIDE	Fusion inhibitors are a class of antiretroviral drugs used to prevent entry of HIV into host cells. Many of the fusion inhibitors being developed, including the drug enfuvirtide, are peptides designed to competitively inhibit the viral fusion protein gp41. With the emergence of drug resistance, there is an increased need for effective and unique alternatives within this class of antivirals. One such alternative is a class of cyclic, cationic, antimicrobial peptides known as theta-defensins, which are produced by many non-human primates and exhibit broad-spectrum antiviral and antibacterial activity. Currently, the theta-defensin analog RC-101 is being developed as a microbicide due to its specific antiviral activity, lack of toxicity to cells and tissues, and safety in animals. Understanding potential RC-101 resistance, and how resistance to other fusion inhibitors affects RC-101 susceptibility, is critical for future development. In previous studies, we identified a mutant, R5-tropic virus that had evolved partial resistance to RC-101 during in vitro selection. Here, we report that a secondary mutation in gp41 was found to restore replicative fitness, membrane fusion, and the rate of viral entry, which were compromised by an initial mutation providing partial RC-101 resistance. Interestingly, we show that RC-101 is effective against two enfuvirtide-resistant mutants, demonstrating the clinical importance of RC-101 as a unique fusion inhibitor. These findings both expand our understanding of HIV drug-resistance to diverse peptide fusion inhibitors and emphasize the significance of compensatory gp41 mutations.	[Wood, Matthew P.; Cole, Amy L.; Cole, Alexander M.] Univ Cent Florida, Dept Mol Biol & Microbiol, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Ruchala, Piotr; Waring, Alan J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Rohan, Lisa C.; Gupta, Phalguni] Univ Pittsburgh, Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Rohan, Lisa C.] Univ Pittsburgh, Sch Pharm, Magee Womens Res Inst, Pittsburgh, PA USA; [Rohan, Lisa C.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Marx, Preston] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA; [Tarwater, Patrick M.] Texas Tech Univ, Dept Biostat, Hlth Sci Ctr, El Paso, TX USA	State University System of Florida; University of Central Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tulane University; Texas Tech University System; Texas Tech University	Cole, AM (corresponding author), Univ Cent Florida, Dept Mol Biol & Microbiol, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	acole@ucf.edu		RUCHALA, PIOTR/0000-0002-5574-2779; Wood, Matthew/0000-0001-6741-0088	National Institutes of Health [AI052017, AI082623, AI082693]; National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [P51 RR00164-50]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052017, R33AI082693, U19AI082623, R21AI082693, R56AI052017] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grants AI052017 (to A.M.C.), AI082623 (to A.M.C., P.G., L.C.R., P.A.M., and P.M.T.), and AI082693 (to A.M.C.) from the National Institutes of Health (to A.M.C.). This project was supported by the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through Grant Number P51 RR00164-50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Baldwin C, 2008, J VIROL, V82, P7735, DOI 10.1128/JVI.02524-07; Barrio AM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S18; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Cole AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015111; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AL, 2007, IMMUNOLOGY, V121, P140, DOI 10.1111/j.1365-2567.2006.02553.x; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Eade CR, 2012, CURR HIV RES, V10, P61, DOI 10.2174/157016212799304580; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fuhrman CA, 2007, FEBS J, V274, P6477, DOI 10.1111/j.1742-4658.2007.06165.x; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Lamers RP, 2011, ANTIMICROB AGENTS CH, V55, P5338, DOI 10.1128/AAC.00619-11; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Micewicz ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014360; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Owen SM, 2004, AIDS RES HUM RETROV, V20, P1157, DOI 10.1089/aid.2004.20.1157; Poveda E, 2004, J MED VIROL, V74, P21, DOI 10.1002/jmv.20141; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Trivedi VD, 2003, PROTEIN ENG, V16, P311, DOI 10.1093/proeng/gzg036; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770	32	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55478	10.1371/journal.pone.0055478	http://dx.doi.org/10.1371/journal.pone.0055478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393582	Green Accepted, gold, Green Published			2022-12-25	WOS:000314692800036
J	Siozios, S; Ioannidis, P; Klasson, L; Andersson, SGE; Braig, HR; Bourtzis, K				Siozios, Stefanos; Ioannidis, Panagiotis; Klasson, Lisa; Andersson, Siv G. E.; Braig, Henk R.; Bourtzis, Kostas			The Diversity and Evolution of Wolbachia Ankyrin Repeat Domain Genes	PLOS ONE			English	Article							ANAPLASMA-PHAGOCYTOPHILUM ANKA; SEQUENCE TYPING SYSTEM; CYTOPLASMIC INCOMPATIBILITY; GENOME SEQUENCE; LEGIONELLA-PNEUMOPHILA; DNA-SEQUENCES; CULEX-PIPIENS; BRUGIA-MALAYI; RECOMBINATION; PROTEIN	Ankyrin repeat domain-encoding genes are common in the eukaryotic and viral domains of life, but they are rare in bacteria, the exception being a few obligate or facultative intracellular Proteobacteria species. Despite having a reduced genome, the arthropod strains of the alphaproteobacterium Wolbachia contain an unusually high number of ankyrin repeat domain-encoding genes ranging from 23 in wMel to 60 in wPip strain. This group of genes has attracted considerable attention for their astonishing large number as well as for the fact that ankyrin proteins are known to participate in protein-protein interactions, suggesting that they play a critical role in the molecular mechanism that determines host-Wolbachia symbiotic interactions. We present a comparative evolutionary analysis of the wMel-related ankyrin repeat domain-encoding genes present in different Drosophila-Wolbachia associations. Our results show that the ankyrin repeat domain-encoding genes change in size by expansion and contraction mediated by short directly repeated sequences. We provide examples of intragenic recombination events and show that these genes are likely to be horizontally transferred between strains with the aid of bacteriophages. These results confirm previous findings that the Wolbachia genomes are evolutionary mosaics and illustrate the potential that these bacteria have to generate diversity in proteins potentially involved in the symbiotic interactions.	[Siozios, Stefanos; Ioannidis, Panagiotis; Bourtzis, Kostas] Univ Western Greece, Dept Environm & Nat Resources Management, Agrinion, Greece; [Klasson, Lisa; Andersson, Siv G. E.] Uppsala Univ, Dept Mol Evolut, Uppsala, Sweden; [Braig, Henk R.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Bourtzis, Kostas] Biomed Sci Res Ctr Al Fleming, Vari, Greece; [Bourtzis, Kostas] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria	Uppsala University; Bangor University; Alexander Fleming Biomedical Sciences Research Center; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency	Bourtzis, K (corresponding author), Univ Western Greece, Dept Environm & Nat Resources Management, Agrinion, Greece.	K.Bourtzis@iaea.org	Ioannidis, Panagiotis/I-4281-2014; Braig, Henk/I-5477-2013	Ioannidis, Panagiotis/0000-0003-0939-6745; Braig, Henk/0000-0001-9592-1141; Klasson, Lisa/0000-0002-5874-7153; Siozios, Stefanos/0000-0002-1104-7061	European Community [203590]; EU COST Action [FA0701]	European Community(European Commission); EU COST Action(European Cooperation in Science and Technology (COST)European Commission)	This research was supported in part by the European Community's Seventh Framework Programme CSA-SA_REGPROT-2007-1 (under grant agreement no 203590 (KB). LK, SA, HRB and KB benefitted by travel grants in the frame of the EU COST Action FA0701 "Arthropod Symbiosis: from fundamental studies to pest and disease management". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Amiri H, 2003, MOL BIOL EVOL, V20, P1575, DOI 10.1093/molbev/msg175; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Baldo L, 2005, J BACTERIOL, V187, P5406, DOI 10.1128/JB.187.15.5406-5418.2005; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; Bordenstein SR, 2004, MOL BIOL EVOL, V21, P1981, DOI 10.1093/molbev/msh211; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017; Bourtzis K., 1994, Insect Molecular Biology, V3, P131, DOI 10.1111/j.1365-2583.1994.tb00160.x; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Cai XJ, 2006, MOL BIOL EVOL, V23, P550, DOI 10.1093/molbev/msj056; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Caturegli P, 2000, INFECT IMMUN, V68, P5277, DOI 10.1128/IAI.68.9.5277-5283.2000; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chafee ME, 2010, MOL BIOL EVOL, V27, P501, DOI 10.1093/molbev/msp275; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Cordaux R, 2008, MOL BIOL EVOL, V25, P1889, DOI 10.1093/molbev/msn134; Cordaux R, 2012, ZOOKEYS, P123, DOI 10.3897/zookeys.176.2284; Cordaux R, 2011, TRENDS GENET, V27, P332, DOI 10.1016/j.tig.2011.05.002; Doudoumis V, 2012, J INVERTEBR PATHOL; DRUMMOND AJ, 2008, GENEIOUS V4 0; Duron O, 2005, MOL ECOL, V14, P1561, DOI 10.1111/j.1365-294X.2005.02495.x; Duron O, 2007, J BACTERIOL, V189, P4442, DOI 10.1128/JB.00142-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felix C, 2008, RES MICROBIOL, V159, P481, DOI 10.1016/j.resmic.2008.05.007; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Garcia-Garcia JC, 2009, INFECT IMMUN, V77, P2385, DOI 10.1128/IAI.00023-09; Gavotte L, 2007, MOL BIOL EVOL, V24, P427, DOI 10.1093/molbev/msl171; GIORDANO R, 1995, GENETICS, V140, P1307; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Habyarimana F, 2008, ENVIRON MICROBIOL, V10, P1460, DOI 10.1111/j.1462-2920.2007.01560.x; Hadfield SJ, 1999, NATURE, V402, P482, DOI 10.1038/45002; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; HOLDEN PR, 1993, MOL GEN GENET, V240, P213, DOI 10.1007/BF00277059; HOLMES DS, 1973, BIOCHEMISTRY-US, V12, P2330, DOI 10.1021/bi00736a023; Ijdo JW, 2007, CELL MICROBIOL, V9, P1284, DOI 10.1111/j.1462-5822.2006.00871.x; Ioannidis P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-182; Ishmael N, 2009, MICROBIOLOGY, V106, P5725; Iturbe-Ormaetxe I, 2005, J BACTERIOL, V187, P5136, DOI 10.1128/JB.187.15.5136-5145.2005; Jiggins FM, 2002, MOL BIOL EVOL, V19, P1640, DOI 10.1093/oxfordjournals.molbev.a004228; Kent BN, 2010, TRENDS MICROBIOL, V18, P173, DOI 10.1016/j.tim.2009.12.011; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Leclercq S, 2011, MOL BIOL EVOL, V28, P685, DOI 10.1093/molbev/msq238; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; McGraw EA, 2001, P ROY SOC B-BIOL SCI, V268, P2565, DOI 10.1098/rspb.2001.1839; MERCOT H, 1995, GENETICS, V141, P1015; Metcalf JA, 2012, CURR OPIN MICROBIOL, V15, P546, DOI 10.1016/j.mib.2012.04.010; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nakayama K, 2008, DNA RES, V15, P185, DOI 10.1093/dnares/dsn011; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Papafotiou G, 2011, RES MICROBIOL, V162, P764, DOI 10.1016/j.resmic.2011.06.012; Paraskevopoulos C, 2006, CURR MICROBIOL, V53, P388, DOI 10.1007/s00284-006-0054-1; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Riegler M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S12; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Rocha EPC, 2003, GENOME RES, V13, P1123, DOI 10.1101/gr.966203; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P1886, DOI 10.1093/nar/30.9.1886; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Salzberg S. L., 2005, GENOME BIOL, V6; Salzberg SL, 2009, J BACTERIOL, V191, P1725, DOI 10.1128/JB.01731-08; Sambrook S, 1989, MOL CLONING LAB MANU; Saridaki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019708; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sinkins SP, 2005, NATURE, V436, P257, DOI 10.1038/nature03629; SMITH JM, 1992, J MOL EVOL, V34, P126; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Tripp KW, 2004, J MOL BIOL, V344, P169, DOI 10.1016/j.jmb.2004.09.038; Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Walker T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-39; Werden SJ, 2008, BBA-PROTEINS PROTEOM, V1784, P228, DOI 10.1016/j.bbapap.2007.08.001; Werren JH, 2001, CURR BIOL, V11, P431, DOI 10.1016/S0960-9822(01)00101-4; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yamada R, 2011, INSECT MOL BIOL, V20, P75, DOI 10.1111/j.1365-2583.2010.01042.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zabalou S, 2004, GENETICS, V167, P827, DOI 10.1534/genetics.103.015990; Zabalou S, 2008, GENETICS, V178, P2145, DOI 10.1534/genetics.107.086488; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	106	55	55	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55390	10.1371/journal.pone.0055390	http://dx.doi.org/10.1371/journal.pone.0055390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390535	gold, Green Published, Green Submitted			2022-12-25	WOS:000314691100051
J	Wang, C; Wang, JY; Borer, JG; Li, X				Wang, Chen; Wang, JingYing; Borer, Joseph G.; Li, Xue			Embryonic Origin and Remodeling of the Urinary and Digestive Outlets	PLOS ONE			English	Article							EXTERNAL GENITALIA DEVELOPMENT; MAMMALIAN KIDNEY; SONIC-HEDGEHOG; HEAD INDUCTION; APOPTOSIS; MOUSE; SEPTATION; TUBERCLE; CATENIN; GROWTH	Separating digestive and urinary outlets is a critical step during mammalian embryogenesis. However, the natural history of these structures is poorly studied, and little is known about their embryonic origin. Here, we show that peri-cloacal mesenchymal (PCM) progenitors are the major source of these structures. Surprisingly, PCM progenitors also contribute to perineum, a structural barrier separating the urinary and digestive tracts, suggesting a potential role of PCM progenitors in establishing independent urinary and digestive outlets. We demonstrate that Six1 and Six2 are complementarily but asymmetrically expressed in the PCM progenitors. Deletion of these genes results in decreased cell survival and proliferation, and consequently in agenesis of the perineum and severe hypoplasia of the genital tubercle. Together, these findings suggest that PCM progenitors are the unexpected source of perineum and genital tubercle, and establish a basic framework for investigating normal and abnormal development of anorectal and genitourinary structures.	[Wang, Chen; Wang, JingYing; Borer, Joseph G.; Li, Xue] Boston Childrens Hosp, Dept Urol, Boston, MA USA; [Wang, JingYing; Li, Xue] Harvard Univ, Sch Med, Dept Surg & Pathol, Boston, MA USA; [Wang, JingYing; Li, Xue] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Li, X (corresponding author), Boston Childrens Hosp, Dept Urol, Boston, MA USA.	sean.li@childrens.harvard.edu	Wang, Jingying/G-5568-2012	Wang, Jingying/0000-0001-8692-6928	Harvard Stem Cell Institute; National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR) [1R01DE019823]; NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) [1R01DK091645-01A1]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091645] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the Harvard Stem Cell Institute, National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR) (1R01DE019823, XL) and NIH/NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) (1R01DK091645-01A1, XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J ANAT; [Anonymous], J ANAT PHYSL; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; Blaschko SD, 2012, DIFFERENTIATION; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Haraguchi R, 2000, DEVELOPMENT, V127, P2471; Hynes PJ, 2004, BRIT J PLAST SURG, V57, P27, DOI 10.1016/j.bjps.2003.08.019; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; KLUTH D, 1995, J PEDIATR SURG, V30, P1143, DOI 10.1016/0022-3468(95)90007-1; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Li X, 2002, SCIENCE, V297, P1180; Lin CX, 2008, DEVELOPMENT, V135, P2815, DOI 10.1242/dev.020586; Lin CX, 2009, DEVELOPMENT, V136, P3959, DOI 10.1242/dev.039768; Miyagawa S, 2009, DEVELOPMENT, V136, P3969, DOI 10.1242/dev.039438; Miyagawa S, 2009, MOL ENDOCRINOL, V23, P871, DOI 10.1210/me.2008-0478; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Paidas CN, 1999, J PEDIATR SURG, V34, P877, DOI 10.1016/S0022-3468(99)90391-3; Penington EC, 2003, J PEDIATR SURG, V38, P1287, DOI 10.1016/S0022-3468(03)00384-1; Qi BQ, 2000, J PEDIATR SURG, V35, P1556, DOI 10.1053/jpsu.2000.18309; Rathke H, 1832, ABHANDLUNGEN BILDUNG; Rodriguez E, 2011, BIOL REPROD, V85, P1216, DOI 10.1095/biolreprod.111.091504; Sasaki C, 2004, ANAT REC PART A, V279A, P761, DOI 10.1002/ar.a.20062; Seifert AW, 2008, DEV BIOL, V318, P143, DOI 10.1016/j.ydbio.2008.03.017; Seifert AW, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1020; Seifert AW, 2009, DEVELOPMENT, V136, P3949, DOI 10.1242/dev.042291; Seifert AW, 2009, DEVELOPMENT, V136, P2643, DOI 10.1242/dev.036830; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suzuki K, 2003, DEVELOPMENT, V130, P6209, DOI 10.1242/dev.00846; van der Putte SCJ, 2005, ADV ANAT EMBRYOL CEL, V177, P1; VANDERPUTTE SCJ, 1986, J PEDIATR SURG, V21, P434, DOI 10.1016/S0022-3468(86)80515-2; Wang C, 2011, DEV BIOL, V360, P186, DOI 10.1016/j.ydbio.2011.09.020; Weiss DA, 2012, MOL CELL ENDOCRINOL, V354, P94, DOI 10.1016/j.mce.2011.08.009; Wu XY, 2009, GENE EXPR PATTERNS, V9, P224, DOI 10.1016/j.gep.2008.12.005; Xu PX, 2003, DEVELOPMENT, V130, P3085, DOI 10.1242/dev.00536; Yucel S, 2004, ADV EXP MED BIOL, V545, P123	43	120	121	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55587	10.1371/journal.pone.0055587	http://dx.doi.org/10.1371/journal.pone.0055587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390542	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100058
J	Hamilton, CM; Martinuzzi, S; Plantinga, AJ; Radeloff, VC; Lewis, DJ; Thogmartin, WE; Heglund, PJ; Pidgeon, AM				Hamilton, Christopher M.; Martinuzzi, Sebastian; Plantinga, Andrew J.; Radeloff, Volker C.; Lewis, David J.; Thogmartin, Wayne E.; Heglund, Patricia J.; Pidgeon, Anna M.			Current and Future Land Use around a Nationwide Protected Area Network	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; CLIMATE-CHANGE; MINIMIZING IMPACTS; SPECIES RICHNESS; HOUSING DENSITY; FOREST-COVER; TRADE-OFF; LANDSCAPE; CONSERVATION; HABITAT	Land-use change around protected areas can reduce their effective size and limit their ability to conserve biodiversity because land-use change alters ecological processes and the ability of organisms to move freely among protected areas. The goal of our analysis was to inform conservation planning efforts for a nationwide network of protected lands by predicting future land use change. We evaluated the relative effect of three economic policy scenarios on land use surrounding the U.S. Fish and Wildlife Service's National Wildlife Refuges. We predicted changes for three land-use classes (forest/range, crop/pasture, and urban) by 2051. Our results showed an increase in forest/range lands (by 1.9% to 4.7% depending on the scenario), a decrease in crop/pasture between 15.2% and 23.1%, and a substantial increase in urban land use between 28.5% and 57.0%. The magnitude of land-use change differed strongly among different USFWS administrative regions, with the most change in the Upper Midwestern US (approximately 30%), and the Southeastern and Northeastern US (25%), and the rest of the U.S. between 15 and 20%. Among our scenarios, changes in land use were similar, with the exception of our "restricted-urban-growth'' scenario, which resulted in noticeably different rates of change. This demonstrates that it will likely be difficult to influence land-use change patterns with national policies and that understanding regional land-use dynamics is critical for effective management and planning of protected lands throughout the U.S.	[Hamilton, Christopher M.; Martinuzzi, Sebastian; Radeloff, Volker C.; Pidgeon, Anna M.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Plantinga, Andrew J.] Oregon State Univ, Dept Agr & Resource Econ, Corvallis, OR 97331 USA; [Lewis, David J.] Univ Puget Sound, Dept Econ, Tacoma, WA 98416 USA; [Thogmartin, Wayne E.] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA; [Heglund, Patricia J.] US Fish & Wildlife Serv, Upper Midwest Environm Sci Ctr, La Crosse, WI USA	University of Wisconsin System; University of Wisconsin Madison; Oregon State University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Hamilton, CM (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	cmhamilton2@wisc.edu	Thogmartin, Wayne/A-4461-2008; Lewis, David J/I-5700-2013; Lewis, David/AFQ-9010-2022; Radeloff, Volker C/B-6124-2016; Lewis, David/AAH-4137-2022	Thogmartin, Wayne/0000-0002-2384-4279; Lewis, David J/0000-0002-2161-4189; Lewis, David/0000-0002-2161-4189; Radeloff, Volker C/0000-0001-9004-221X; Lewis, David/0000-0002-2161-4189	USGS-USFWS Science Support Partnership program [G10AC00352]	USGS-USFWS Science Support Partnership program	This work is supported by the USGS-USFWS Science Support Partnership program, grant #G10AC00352. More information about the funding organization can be found on the world wide web at http://www.usgs.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attum O, 2008, J ZOOL, V275, P245, DOI 10.1111/j.1469-7998.2008.00435.x; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Bowen ME, 2009, BIOL CONSERV, V142, P3051, DOI 10.1016/j.biocon.2009.08.005; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; Burgman MA, 2005, ECOLOGY, V86, P2007, DOI 10.1890/04-0906; Comber A, 2012, REMOTE SENS ENVIRON, V127, P237, DOI 10.1016/j.rse.2012.09.005; Coreau A, 2009, ECOL LETT, V12, P1277, DOI 10.1111/j.1461-0248.2009.01392.x; Cox RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014508; D'Eon R, 2002, CONSERV ECOL, V6; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Davis BE, 2010, WATERBIRDS, V33, P349, DOI 10.1675/063.033.0311; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; Eigenbrod F, 2008, BIOL CONSERV, V141, P35, DOI 10.1016/j.biocon.2007.08.025; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fleishman E, 2011, BIOSCIENCE, V61, P290, DOI 10.1525/bio.2011.61.4.9; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; Gagne SA, 2010, ECOL SOC, V15; Gagne SA, 2010, BASIC APPL ECOL, V11, P723, DOI 10.1016/j.baae.2010.09.001; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gavier-Pizarro GI, 2010, LANDSCAPE ECOL, V25, P1505, DOI 10.1007/s10980-010-9516-8; Griffith B, 2009, ENVIRON MANAGE, V44, P1043, DOI 10.1007/s00267-009-9323-7; Gude PH, 2007, ECOL APPL, V17, P1004, DOI 10.1890/05-1108; Haim D, 2011, CLIMATE CHANGE EC, V2; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hansen AJ, 2007, ECOL APPL, V17, P972, DOI 10.1890/05-1112; Huston MA, 2005, ECOL APPL, V15, P1864, DOI 10.1890/03-5281; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Leinwand IIF, 2010, LANDSCAPE URBAN PLAN, V97, P182, DOI 10.1016/j.landurbplan.2010.05.009; Lubowski RN, 2006, J ENVIRON ECON MANAG, V51, P135, DOI 10.1016/j.jeem.2005.08.001; MAUSER DM, 1994, J WILDLIFE MANAGE, V58, P88, DOI 10.2307/3809553; Merenlender AM, 2009, CONSERV LETT, V2, P240, DOI 10.1111/j.1755-263X.2009.00073.x; Meretsky VJ, 2006, BIOSCIENCE, V56, P135, DOI 10.1641/0006-3568(2006)056[0135:NDICFT]2.0.CO;2; Nelson AC, 1996, LAND USE POLICY, V13, P241, DOI 10.1016/0264-8377(96)84555-8; Nelson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014327; Nusser SM, 1997, ENVIRON ECOL STAT, V4, P181, DOI 10.1023/A:1018574412308; Olden JD, 2004, J ANIM ECOL, V73, P1190, DOI 10.1111/j.0021-8790.2004.00889.x; Pidgeon AM, 2007, ECOL APPL, V17, P1989, DOI 10.1890/06-1489.1; Pijanowski BC, 2011, LANDSCAPE URBAN PLAN, V102, P102, DOI 10.1016/j.landurbplan.2011.03.014; Predick KI, 2008, J ECOL, V96, P91, DOI 10.1111/j.1365-2745.2007.01329.x; Radeloff VC, 2012, ECOL APPL, V22, P1036, DOI 10.1890/11-0306.1; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Radeloff VC, 2010, P NATL ACAD SCI USA, V107, P940, DOI 10.1073/pnas.0911131107; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schulte LA, 2005, CONSERV BIOL, V19, P1944, DOI 10.1111/j.1523-1739.2005.00254.x; Scott JM, 2004, NAT RESOUR J, V44, P1041; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Smith B, 2000, CLIMATIC CHANGE, V45, P223, DOI 10.1023/A:1005661622966; Sohl TL, 2012, AGR ECOSYST ENVIRON, V153, P1, DOI 10.1016/j.agee.2012.02.019; Sohl TL, 2010, LANDSCAPE ECOL, V25, P233, DOI 10.1007/s10980-009-9391-3; Sohngen B, 1998, AM ECON REV, V88, P686; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Theobald DM, 2009, J HYDROL ENG, V14, P362, DOI 10.1061/(ASCE)1084-0699(2009)14:4(362); Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; van Vuuren DP, 2006, ECOL SOC, V11; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wade AA, 2010, CONSERV BIOL, V24, P151, DOI 10.1111/j.1523-1739.2009.01296.x; White D, 1997, CONSERV BIOL, V11, P349, DOI 10.1046/j.1523-1739.1997.95458.x; Wiens JA, 2009, LANDSCAPE ECOL, V24, P1053, DOI 10.1007/s10980-008-9284-x; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Woo M, 2011, URBAN STUD, V48, P3511, DOI 10.1177/0042098011399594	66	65	68	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55737	10.1371/journal.pone.0055737	http://dx.doi.org/10.1371/journal.pone.0055737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23383275	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600155
J	Paaijmans, KP; Cator, LJ; Thomas, MB				Paaijmans, Krijn P.; Cator, Lauren J.; Thomas, Matthew B.			Temperature-Dependent Pre-Bloodmeal Period and Temperature-Driven Asynchrony between Parasite Development and Mosquito Biting Rate Reduce Malaria Transmission Intensity	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; VECTORIAL CAPACITY; GONOTROPHIC CYCLES; MODEL; CULICIDAE; DURATION; DIPTERA; RISK	A mosquito needs to bite at least twice for malaria transmission to occur: once to acquire parasites and, after these parasites complete their development in their mosquito host, once to transmit the parasites to the next vertebrate host. Here we investigate the relationship between temperature, parasite development, and biting frequency in a mosquito-rodent malaria model system. We show that the pre-bloodmeal period (the time lag between mosquito emergence and first bloodmeal) increases at lower temperatures. In addition, parasite development time and feeding exhibit different thermal sensitivities such that mosquitoes might not be ready to feed at the point at which the parasite is ready to be transmitted. Exploring these effects using a simple theoretical model of human malaria shows that delays in infection and transmission can reduce the vectorial capacity of malaria mosquitoes by 20 to over 60%, depending on temperature. These delays have important implications for disease epidemiology and control, and should be considered in future transmission models.	Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Paaijmans, KP (corresponding author), Barcelona Ctr Int Hlth Res, Barcelona, Spain.	krijn@paaijmans.nl	Paaijmans, Krijn/ABC-9928-2020		NSF-EID program [EF-0914384]; NIH-NIAID ICEMR award [U19AI089676-01]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089676] Funding Source: NIH RePORTER	NSF-EID program(National Science Foundation (NSF)); NIH-NIAID ICEMR award; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a NSF-EID program grant (#EF-0914384) and NIH-NIAID ICEMR award (#U19AI089676-01). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, and the National Institutes of Health. This project was also assisted by a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; Afrane YA, 2008, EMERG INFECT DIS, V14, P1533, DOI 10.3201/eid1410.070781; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], 1949, MALARIOLOGY; Bell AS, 2009, J INVERTEBR PATHOL, V100, P160, DOI 10.1016/j.jip.2009.01.006; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; Blanford S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023591; Cator LJ, 2012, TRENDS PARASITOL, V28, P466, DOI 10.1016/j.pt.2012.08.004; Dawes EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-228; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-35; Fernandes L, 2005, J VECTOR ECOL, V30, P11; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hancock PA, 2009, P ROY SOC B-BIOL SCI, V276, P71, DOI 10.1098/rspb.2008.0689; Harris C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030849; Joy DA, 2008, MOL BIOL EVOL, V25, P1245, DOI 10.1093/molbev/msn073; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kiware SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037661; Lardeux FJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-141; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Napp S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-4; Norris LC, 2010, AM J TROP MED HYG, V83, P33, DOI 10.4269/ajtmh.2010.09-0296; Paaijmans KP, 2012, BIOL LETTERS, V8, P465, DOI 10.1098/rsbl.2011.1075; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256; Scott TW, 2006, AM J TROP MED HYG, V75, P231, DOI 10.4269/ajtmh.2006.75.231; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Stone CM, 2011, ANIM BEHAV, V81, P765, DOI 10.1016/j.anbehav.2011.01.008; Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639; [No title captured]	35	39	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55777	10.1371/journal.pone.0055777	http://dx.doi.org/10.1371/journal.pone.0055777			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383280	gold, Green Submitted, Green Published			2022-12-25	WOS:000314610600157
J	Wang, YC; Liu, F; Mao, F; Hang, QL; Huang, XD; He, S; Wang, YY; Cheng, C; Wang, HJ; Xu, GF; Zhang, TY; Shen, AG				Wang, Yuchan; Liu, Fang; Mao, Feng; Hang, Qinlei; Huang, Xiaodong; He, Song; Wang, Yingying; Cheng, Chun; Wang, Huijie; Xu, Guangfei; Zhang, Tianyi; Shen, Aiguo			Interaction with Cyclin H/Cyclin-dependent Kinase 7 (CCNH/CDK7) Stabilizes C-terminal Binding Protein 2 (CtBP2) and Promotes Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COREPRESSOR CTBP; MESENCHYMAL TRANSITIONS; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; FAMILY PROTEINS; PROSTATE-CANCER; ACETYLATION; ASSOCIATION; METASTASIS; MECHANISMS	CtBP2 has been demonstrated to possess tumor-promoting capacities by virtue of up-regulating epithelial-mesenchymal transition (EMT) and down-regulating apoptosis in cancer cells. As a result, cellular CtBP2 levels are considered a key factor determining the outcome of oncogenic transformation. How pro-tumorigenic and anti-tumorigenic factors compete for fine-tuning CtBP2 levels is incompletely understood. Here we report that the cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) complex interacted with CtBP2 in vivo and in vitro. Depletion of either CCNH or CDK7 decreased CtBP2 protein levels by accelerating proteasome-dependent CtBP2 clearance. Further analysis revealed that CCNH/CDK7 competed with the tumor repressor HIPK2 for CtBP2 binding and consequently inhibited phosphorylation and dimerization of CtBP2. Phosphorylation-defective CtBP2 interacted more strongly with CCNH/CDK7 and was more resistant to degradation. Finally, overexpression of CtBP2 increased whereas depletion of CtBP2 dampened the invasive and migratory potential of breast cancer cells. CtBP2 promoted the invasion and migration of breast cancer cells in a CCNH-dependent manner. Taken together, our data have delineated a novel pathway that regulates CtBP2 stability, suggesting that targeting the CCNH/CDK7-CtBP2 axis may yield a viable anti-tumor strategy.	[Wang, Yuchan; Liu, Fang; Mao, Feng; Hang, Qinlei; Wang, Yingying; Cheng, Chun; Xu, Guangfei; Zhang, Tianyi; Shen, Aiguo] Nantong Univ, Coll Med, Dept Pathogen & Immunol, Nantong 226001, Peoples R China; [Shen, Aiguo] Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [Huang, Xiaodong; He, Song] Nantong Univ, Affiliated Hosp, Nantong 226001, Peoples R China; [Wang, Huijie] Fudan Univ, Shanghai Med Coll, Dept Oncol, Yangpu Shanghai 200082, Peoples R China	Nantong University; Nantong University; Nantong University; Fudan University	Shen, AG (corresponding author), Nantong Univ, Coll Med, Dept Pathogen & Immunol, Nantong 226001, Peoples R China.	shen_aiguo@yahoo.com	Mao, Feng/B-8280-2019; wang, yingying/GRS-3058-2022		National Basic Research Program 973 of China [2012CB822104, 2011CB910604]; National Natural Science Foundation of China [31070723, 81172879, 31270802, 81201858]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu province [BK2012231]	National Basic Research Program 973 of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Basic Research Program 973 of China Grants No. 2012CB822104 and No. 2011CB910604; the National Natural Science Foundation of China Grants 31070723, 81172879, 31270802, and 81201858; a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions; and by the Natural Science Foundation of Jiangsu province Grant BK2012231.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Barroilhet L, 2013, ONCOGENE, V32, P3896, DOI 10.1038/onc.2012.380; Bergman LM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-35; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; Birts CN, 2011, BIOL CELL, V103, P1, DOI 10.1042/BC20100067; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Collins CS, 2006, P NATL ACAD SCI USA, V103, P3775, DOI 10.1073/pnas.0600040103; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Kayaselcuk F, 2006, INT J GYNECOL CANCER, V16, P402, DOI 10.1111/j.1525-1438.2006.00407.x; Liang HZ, 2011, MOL CELL BIOL, V31, P955, DOI 10.1128/MCB.01062-10; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Poser I, 2004, HISTOL HISTOPATHOL, V19, P173, DOI 10.14670/HH-19.173; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Straza MW, 2010, CELL CYCLE, V9, P3740, DOI 10.4161/cc.9.18.12936; Tang LD, 2010, EUR J CANCER, V46, P170, DOI 10.1016/j.ejca.2009.10.003; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Tsilidis KK, 2012, AM J EPIDEMIOL, V175, P926, DOI 10.1093/aje/kwr423; Verger A, 2006, MOL CELL BIOL, V26, P4882, DOI 10.1128/MCB.02402-05; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	29	58	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9028	9034		10.1074/jbc.M112.432005	http://dx.doi.org/10.1074/jbc.M112.432005			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393140	Green Published, hybrid			2022-12-25	WOS:000316862200022
J	Kulkarni, MM; Karafova, A; Kamysz, W; Schenkman, S; Pelle, R; McGwire, BS				Kulkarni, Manjusha M.; Karafova, Anna; Kamysz, Wojciech; Schenkman, Sergio; Pelle, Roger; McGwire, Bradford S.			Secreted Trypanosome Cyclophilin Inactivates Lytic Insect Defense Peptides and Induces Parasite Calcineurin Activation and Infectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-METALLOPROTEASE; CYCLOSPORINE-BINDING; RHODNIUS-PROLIXUS; ENCODING GENES; A HOMOLOG; CRUZI; LEISHMANIA; EXPRESSION; PROTEIN; PATHWAY	The mechanisms by which Trypanosoma cruzi survives antimicrobial peptides and differentiates during its transit through the gastrointestinal tract of the reduviid vector are unknown. We show that cyclophilin, a peptidyl-prolyl isomerase secreted from T. cruzi epimastigotes, binds to and neutralizes the reduviid antimicrobial peptide trialysin promoting parasite survival. This is dependent on a singular proline residue in trialysin and is inhibited by the cyclophilin inhibitor cyclosporine A. In addition, cyclophilin-trialysin complexes enhance the production of ATP and reductase responses of parasites, which are inhibited by both calcineurin-specific inhibitors cyclosporine A and FK506. Calcineurin phosphatase activity of cyclophilin-trialysin-treated parasites was higher than in controls and was inhibited by preincubation by either inhibitor. Parasites exposed to cyclophilin-trialysin have enhanced binding and invasion of host cells leading to higher infectivity. Leishmanial cyclophilin also mediates trialysin protection and metabolic stimulation by T. cruzi, indicating that extracellular cyclophilin may be critical to adaptation in other insect-borne protozoa. This work demonstrates that cyclophilin serves as molecular sensor leading to the evasion and adaptive metabolic response to insect defense peptides.	[McGwire, Bradford S.] Ohio State Univ, Med Ctr, Div Infect Dis, Columbus, OH 43210 USA; [Kulkarni, Manjusha M.; McGwire, Bradford S.] Ohio State Univ, Med Ctr, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Karafova, Anna; Kamysz, Wojciech] Med Univ Gdansk, Fac Pharm, PL-80120 Gdansk, Poland; [Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; [Pelle, Roger] Int Livestock Res Inst, Nairobi 00100, Kenya	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Fahrenheit Universities; Medical University Gdansk; Universidade Federal de Sao Paulo (UNIFESP); CGIAR; International Livestock Research Institute (ILRI)	McGwire, BS (corresponding author), Doan N-1145,410 W 10th Ave, Columbus, OH 43210 USA.	brad.mcgwire@osumc.edu	Schenkman, Sergio/A-9227-2013; McGwire, Bradford/E-3637-2011	Schenkman, Sergio/0000-0001-9353-8480; McGwire, Bradford/0000-0002-9646-5931; Karafova, Anna/0000-0003-1346-7438; Kamysz, Wojciech/0000-0001-5335-3043	American Heart Association; Ohio State University	American Heart Association(American Heart Association); Ohio State University(Ohio State University)	This work was supported by the American Heart Association (to B. S. M) and The Ohio State University.	Akuffo H, 1998, INT J MOL MED, V1, P77; Amino R, 2002, J BIOL CHEM, V277, P6207, DOI 10.1074/jbc.M109874200; Araujo CAC, 2006, INSECT BIOCHEM MOLEC, V36, P547, DOI 10.1016/j.ibmb.2006.04.003; Araya JE, 2008, MICROBES INFECT, V10, P892, DOI 10.1016/j.micinf.2008.05.003; Arias DG, 2011, FREE RADICAL BIO MED, V50, P37, DOI 10.1016/j.freeradbiomed.2010.10.695; ASIN S, 1995, J PARASITOL, V81, P1, DOI 10.2307/3283997; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bua J, 2008, PARASITOLOGY, V135, P217, DOI 10.1017/S003118200700371X; Bua J, 2004, BIOORG MED CHEM LETT, V14, P4633, DOI 10.1016/j.bmcl.2004.07.003; Bua J, 2001, FEMS MICROBIOL LETT, V200, P43, DOI 10.1016/S0378-1097(01)00193-8; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; Burleigh Barbara A, 2005, Sci STKE, V2005, ppe36, DOI 10.1126/stke.2932005pe36; Dao-Thi MH, 1998, ACTA CRYSTALLOGR D, V54, P1046, DOI 10.1107/S0907444998001607; Diaz-Achirica P, 1998, BIOCHEM J, V330, P453, DOI 10.1042/bj3300453; Fearon P, 2011, J INVEST DERMATOL, V131, P1085, DOI 10.1038/jid.2010.415; Feng B, 1999, BIOCHEMISTRY-US, V38, P12481, DOI 10.1021/bi990492w; Florencio-Martinez L, 2010, EXP PARASITOL, V126, P332, DOI 10.1016/j.exppara.2010.04.015; FRAIDENRAICH D, 1993, P NATL ACAD SCI USA, V90, P10140, DOI 10.1073/pnas.90.21.10140; Fraidenraich Diego, 1993, Biological Research, V26, P279; Garcia ES, 1995, EXP PARASITOL, V81, P255, DOI 10.1006/expr.1995.1116; Gluenz E, 2007, INT J PARASITOL, V37, P617, DOI 10.1016/j.ijpara.2006.11.016; KRASSNER SM, 1990, J PROTOZOOL, V37, P128, DOI 10.1111/j.1550-7408.1990.tb05882.x; Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x; Kulkarni MM, 2011, CELL MICROBIOL, V13, P913, DOI 10.1111/j.1462-5822.2011.01589.x; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lis M, 2010, FEMS YEAST RES, V10, P579, DOI 10.1111/j.1567-1364.2010.00638.x; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Lopez L, 2003, INSECT BIOCHEM MOLEC, V33, P439, DOI 10.1016/S0965-1748(03)00008-0; Lorenzen S, 2005, PROTEINS, V58, P589, DOI 10.1002/prot.20342; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Malaga S, 2001, INFECT IMMUN, V69, P353, DOI 10.1128/IAI.69.1.353-359.2001; Manque PM, 2000, INFECT IMMUN, V68, P478, DOI 10.1128/IAI.68.2.478-484.2000; Marin-Menendez A, 2011, PROTEIN EXPRES PURIF, V78, P225, DOI 10.1016/j.pep.2011.04.012; Martins RM, 2009, INFECT IMMUN, V77, P3023, DOI 10.1128/IAI.00138-09; Martins RM, 2006, BIOCHEMISTRY-US, V45, P1765, DOI 10.1021/bi0514515; McGwire BS, 2010, EXP PARASITOL, V126, P397, DOI 10.1016/j.exppara.2010.02.006; McGwire BS, 2003, J INFECT DIS, V188, P146, DOI 10.1086/375747; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; Miele R, 2003, PEPTIDES, V24, P1713, DOI 10.1016/j.peptides.2003.07.024; Moreno VR, 2007, ACTA TROP, V101, P80, DOI 10.1016/j.actatropica.2006.11.008; Naderer T, 2011, MOL MICROBIOL, V80, P471, DOI 10.1111/j.1365-2958.2011.07584.x; NOGUEIRA N, 1977, AM J TROP MED HYG, V26, P194, DOI 10.4269/ajtmh.1977.26.194; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; PALLEN CJ, 1984, J BIOL CHEM, V259, P6134; PALLEN CJ, 1983, J BIOL CHEM, V258, P8550; Pelle R, 2002, GENE, V290, P181, DOI 10.1016/S0378-1119(02)00559-0; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PERRINO BA, 1995, J BIOL CHEM, V270, P7012; Potenza M, 2006, PARASITOLOGY, V132, P867, DOI 10.1017/S0031182005009558; Rascher C, 1998, BIOCHEM J, V334, P659, DOI 10.1042/bj3340659; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; SCHUMACHER A, 1994, EUR J CELL BIOL, V63, P182; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; UEKI K, 1993, J BIOL CHEM, V268, P6554; Waniek PJ, 2009, J INSECT PHYSIOL, V55, P840, DOI 10.1016/j.jinsphys.2009.05.015; Watanabe Y, 1996, BIOCHEMISTRY-US, V35, P562, DOI 10.1021/bi951703+; Woolsey AM, 2004, CELL MICROBIOL, V6, P829, DOI 10.1111/j.1462-5822.2004.00405.x; Yamada-Ogatta SF, 2004, ACTA TROP, V90, P171, DOI 10.1016/j.actatropica.2003.10.018; Yau WL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000729	63	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8772	8784		10.1074/jbc.M112.421057	http://dx.doi.org/10.1074/jbc.M112.421057			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386612	Green Published, hybrid			2022-12-25	WOS:000316564500076
J	Hsiao, NY; Stinson, K; Myer, L				Hsiao, Nei-Yuan; Stinson, Kathryn; Myer, Landon			Linkage of HIV-Infected Infants from Diagnosis to Antiretroviral Therapy Services across the Western Cape, South Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RESOURCE-LIMITED SETTINGS; HEALTH-CARE FACILITIES; TO-CHILD TRANSMISSION; BLOOD; MORTALITY; PROGRAM; TANZANIA; OUTCOMES; MALAWI	Introduction: Early infant diagnosis (EID) of HIV infection is an important service to reduce paediatric morbidity and mortality related to HIV/AIDS. Although South Africa has a national EID programme based on PCR testing, there are no population-wide data on the linkage of infants testing HIV PCR-positive to HIV care and treatment services. Methods: We conducted a retrospective analysis of all public sector laboratory data from across the Western Cape province between 2005 and 2011. We linked positive HIV PCR results to subsequent HIV viral load testing to determine the proportion of infants who were successfully linked to HIV care. Results: A total of 83 698 unique infant HIV PCR tests were documented, of which 6322 (8%) were PCR positive. The proportion of PCR-positive children declined from 12% in 2005 to 3% in 2011. Of the children testing PCR-positive, 4105 (65%) had subsequent viral load testing indicating successful linkage to care. The proportion of successfully linked infants increased from 54% in 2005 to 71% in 2010, while the median delay in days to successful linkage decreased from 146 days in 2005 to 33 days in 2010. Discussion: From 2005 to 2011 there has been a reduction in the proportion of children testing HIV PCR-positive, and an increase in the proportion of infected infants successfully linked to HIV care and treatment, in this setting. However a large proportion of infected infants remain unlinked to antiretroviral therapy services and there is a clear need for interventions to further strengthen EID programmes.	[Hsiao, Nei-Yuan] Univ Cape Town, Div Virol, ZA-7925 Cape Town, South Africa; [Hsiao, Nei-Yuan] Natl Hlth Lab Serv, Cape Town, South Africa; [Stinson, Kathryn; Myer, Landon] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Hsiao, NY (corresponding author), Univ Cape Town, Div Virol, ZA-7925 Cape Town, South Africa.	marvin.hsiao@nhls.ac.za			Elizabeth Glaser Pediatric AIDS Foundation	Elizabeth Glaser Pediatric AIDS Foundation	Landon Myer is funded by the Elizabeth Glaser Pediatric AIDS Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Bourne DE, 2009, AIDS, V23, P101, DOI 10.1097/QAD.0b013e32831c54bd; Braun M, 2011, JAIDS-J ACQ IMM DEF, V56, pE122, DOI 10.1097/QAI.0b013e31820a7f2f; Chatterjee A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-553; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Creek T, 2008, PEDIATR INFECT DIS J, V27, P22, DOI 10.1097/INF.0b013e3181469050; Creek TL, 2007, AM J OBSTET GYNECOL, V197, pS64, DOI 10.1016/j.ajog.2007.03.002; Dramowski A, 2012, S AFR J HIV MED, V12, P16; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Goga A, 2012, EVALUATION EFFECTIVE; Grimwood A, 2012, SAMJ S AFR MED J, V102, P81, DOI 10.7196/SAMJ.5294; Hassan AS, 2012, AIDS BEHAV, V16, P5, DOI 10.1007/s10461-010-9877-7; Jangam SR, 2009, J CLIN MICROBIOL, V47, P2363, DOI 10.1128/JCM.r00092-09; Lofgren SM, 2009, AIDS, V23, P2459, DOI 10.1097/QAD.0b013e328331f702; McCollum ED, 2012, JAIDS-J ACQ IMM DEF, V60, pE107, DOI 10.1097/QAI.0b013e31825aa721; Nuwagaba-Biribonwoha H, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-44; Parpia ZA, 2010, JAIDS-J ACQ IMM DEF, V55, P413, DOI 10.1097/QAI.0b013e3181f1afbc; Rollins N, 2009, AIDS, V23, P1851, DOI 10.1097/QAD.0b013e32832d84fd; Seidenberg P, 2012, B WORLD HEALTH ORGAN, V90, P348, DOI 10.2471/BLT.11.100032; Silal SP, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-120; Tejiokem MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021840; Vearey J, 2012, GLOB PUBLIC HEALTH, V7, P58, DOI [10.1080/17441692.2010.549494, 10.3402/gha.v4i0.5898]; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organisation The Joint United Nations Programme on HIV/AIDS and The United Nations Children's Fund, 2012, GLOB HIV AIDS RESP E; World Health Organisation The Joint United Nations Programme on HIV/AIDS and The United Nations Children's Fund, 2010, UN ACC SCAL PRIOR HI; World Health Organization, 2010, WHO REC DIAGN HIV IN	27	50	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55308	10.1371/journal.pone.0055308	http://dx.doi.org/10.1371/journal.pone.0055308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405133	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400078
J	Ou, YY; Chen, SA; Wu, SC				Ou, Yu-Yen; Chen, Shu-An; Wu, Sheng-Cheng			ETMB-RBF: Discrimination of Metal-Binding Sites in Electron Transporters Based on RBF Networks with PSSM Profiles and Significant Amino Acid Pairs	PLOS ONE			English	Article							BARREL MEMBRANE-PROTEINS; FUNCTION NEURAL-NETWORK; SUBCELLULAR-LOCALIZATION; CLEAVAGE SITES; WEB SERVER; PREDICTION; SEQUENCE; CLASSIFIER; MATRICES; SVM	Background: Cellular respiration is the process by which cells obtain energy from glucose and is a very important biological process in living cell. As cells do cellular respiration, they need a pathway to store and transport electrons, the electron transport chain. The function of the electron transport chain is to produce a trans-membrane proton electrochemical gradient as a result of oxidation-reduction reactions. In these oxidation-reduction reactions in electron transport chains, metal ions play very important role as electron donor and acceptor. For example, Fe ions are in complex I and complex II, and Cu ions are in complex IV. Therefore, to identify metal-binding sites in electron transporters is an important issue in helping biologists better understand the workings of the electron transport chain. Methods: We propose a method based on Position Specific Scoring Matrix (PSSM) profiles and significant amino acid pairs to identify metal-binding residues in electron transport proteins. Results: We have selected a non-redundant set of 55 metal-binding electron transport proteins as our dataset. The proposed method can predict metal-binding sites in electron transport proteins with an average 10-fold cross-validation accuracy of 93.2% and 93.1% for metal-binding cysteine and histidine, respectively. Compared with the general metal-binding predictor from A. Passerini et al., the proposed method can improve over 9% of sensitivity, and 14% specificity on the independent dataset in identifying metal-binding cysteines. The proposed method can also improve almost 76% sensitivity with same specificity in metal-binding histidine, and MCC is also improved from 0.28 to 0.88. Conclusions: We have developed a novel approach based on PSSM profiles and significant amino acid pairs for identifying metal-binding sites from electron transport proteins. The proposed approach achieved a significant improvement with independent test set of metal-binding electron transport proteins.	[Ou, Yu-Yen; Chen, Shu-An; Wu, Sheng-Cheng] Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan	Yuan Ze University	Ou, YY (corresponding author), Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan.	yien@csie.org	Ou, Yu-Yen/AAA-1716-2022	Ou, Yu-Yen/0000-0002-9894-926X	National Science Council (NSC) of Taiwan [NSC 101-2221-E-155-068]	National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was partially supported by National Science Council (NSC) of Taiwan, NSC 101-2221-E-155-068 to Yu-Yen Ou. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Chen SA, 2011, BIOINFORMATICS, V27, P2062, DOI 10.1093/bioinformatics/btr340; Chen SA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-536; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Hayat M, 2012, J THEOR BIOL, V292, P93, DOI 10.1016/j.jtbi.2011.09.026; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lee TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017331; Li DD, 2010, PROTEIN PEPTIDE LETT, V17, P1566, DOI 10.2174/0929866511009011566; Lin CT, 2005, INT J NEURAL SYST, V15, P71, DOI 10.1142/S0129065705000116; Lippi M, 2008, BIOINFORMATICS, V24, P2094, DOI 10.1093/bioinformatics/btn371; Menchetti S, 2006, LECT NOTES COMPUT SC, V3909, P309, DOI 10.1007/11732990_26; Ou, 2005, QUICKRBF PACKAGE EFF; Ou YY, 2008, COMPUT BIOL CHEM, V32, P227, DOI 10.1016/j.compbiolchem.2008.03.002; Ou YY, 2010, PROTEINS, V78, P1789, DOI 10.1002/prot.22694; Ou YY, 2010, J COMPUT CHEM, V31, P217, DOI 10.1002/jcc.21281; Ou YY, 2005, IEEE IJCNN, P1383; Passerini A, 2006, PROTEINS, V65, P305, DOI 10.1002/prot.21135; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwartz RM, 1978, ATLAS PROTEIN SEQ S3, P353; Su CT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-319; Wu ZC, 2012, PROTEIN PEPTIDE LETT, V19, P4, DOI 10.2174/092986612798472839; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Yang ZR, 2005, IEEE T NEURAL NETWOR, V16, P263, DOI 10.1109/TNN.2004.836196; Zhang GZ, 2004, J COMPUT AID MOL DES, V18, P797, DOI 10.1007/s10822-005-0578-7	32	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e46572	10.1371/journal.pone.0046572	http://dx.doi.org/10.1371/journal.pone.0046572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405059	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400002
J	Unick, GJ; Rosenblum, D; Mars, S; Ciccarone, D				Unick, George Jay; Rosenblum, Daniel; Mars, Sarah; Ciccarone, Daniel			Intertwined Epidemics: National Demographic Trends in Hospitalizations for Heroin- and Opioid-Related Overdoses, 1993-2009	PLOS ONE			English	Article							INJECTION-DRUG USERS; NALOXONE DISTRIBUTION; UNITED-STATES; MORTALITY; PREVENTION; DEATHS; ABUSE; HIV	The historical patterns of opiate use show that sources and methods of access greatly influence who is at risk. Today, there is evidence that an enormous increase in the availability of prescription opiates is fuelling a rise in addiction nationally, drawing in new initiates to these drugs and changing the geography of opiate overdoses. Recent efforts at supply-based reductions in prescription opiates may reduce harm, but addicted individuals may switch to other opiates such as heroin. In this analysis, we test the hypothesis that changes in the rates of Prescription Opiate Overdoses (POD) are correlated with changes in the rate of heroin overdoses (HOD). ICD9 codes from the Nationwide Inpatient Sample and population data from the Census were used to estimate overall and demographic specific rates of POD and HOD hospital admissions between 1993 and 2009. Regression models were used to test for linear trends and lagged negative binomial regression models were used to model the interrelationship between POD and HOD hospital admissions. Findings show that whites, women, and middle-aged individuals had the largest increase in POD and HOD rates over the study period and that HOD rates have increased in since 2007. The lagged models show that increases in a hospitals POD predict an increase in the subsequent years HOD admissions by a factor of 1.26 (p < 0.001) and that each increase in HOD admissions increase the subsequent years POD by a factor of 1.57 (p < 0.001). Our hypothesis of fungibility between prescription opiates and heroin was supported by these analyses. These findings suggest that focusing on supply-based interventions may simply lead to a shift in use to heroin rather minimizing the reduction in harm. The alternative approach of using drug abuse prevention resources on treatment and demand-side reduction is likely to be more productive at reducing opiate abuse related harm.	[Unick, George Jay] Univ Maryland, Sch Social Work, Baltimore, MD 21201 USA; [Rosenblum, Daniel] Dalhousie Univ, Dept Econ, Halifax, NS, Canada; [Mars, Sarah; Ciccarone, Daniel] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	University System of Maryland; University of Maryland Baltimore; Dalhousie University; University of California System; University of California San Francisco	Unick, GJ (corresponding author), Univ Maryland, Sch Social Work, 525 W Redwood St, Baltimore, MD 21201 USA.	junick@ssw.umaryland.edu	Ciccarone, Daniel/I-5404-2013	Ciccarone, Daniel/0000-0002-2355-5477; Rosenblum, Daniel/0000-0003-0056-9734	National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA) [RO1DA2759]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027599, R01DA010164] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was support by The National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA), grant number RO1DA2759 to Daniel Ciccarone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; Barrett M, 2012, POPULATION DENOMINAT; Broz D, 2008, DRUG ALCOHOL DEPEN, V94, P221, DOI 10.1016/j.drugalcdep.2007.11.020; Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Centers for Disease Control, 2010, UN DRUG POIS US; Ciccarone D, 2009, INT J DRUG POLICY, V20, P392, DOI 10.1016/j.drugpo.2008.12.001; Cicero TJ, 2012, NEW ENGL J MED, V367, P187, DOI 10.1056/NEJMc1204141; Coben JH, 2010, AM J PREV MED, V38, P517, DOI 10.1016/j.amepre.2010.01.022; Colson J, 2012, PAIN PHYSICIAN, V15, pES231; Courtwright DT., 2001, DARK PARADISE HIST O, VEnl. ed., pxiii, 326; Daly EM, 2012, RISE YOUNG PAINKILLE; Darke S., 2007, MORTALITY ILLICIT DR; Denton JS, 2008, J FORENSIC SCI, V53, P452, DOI 10.1111/j.1556-4029.2008.00669.x; Doe-Simkins M, 2009, AM J PUBLIC HEALTH, V99, P788, DOI 10.2105/AJPH.2008.146647; Evans JL, 2012, AM J EPIDEMIOL, V175, P302, DOI 10.1093/aje/kwr318; FDA, 2009, JOINT M AN LIF SUPP; Frosch Dan, 2012, NY TIMES, P22; Galea S, 2006, ADDICT BEHAV, V31, P907, DOI 10.1016/j.addbeh.2005.07.020; Green TC, 2008, ADDICTION, V103, P979, DOI 10.1111/j.1360-0443.2008.02182.x; Hansen RN, 2011, CLIN J PAIN, V27, P194, DOI 10.1097/AJP.0b013e3181ff04ca; Havens JR, 2009, AM J DRUG ALCOHOL AB, V35, P18, DOI 10.1080/00952990802326298; HCUP, 1993, NAT INP SAMPL NIS; HCUP, 1993, NAT INP SAMPL TRENDS; Hickman T. A., 2004, ALTERING AM CONSCIOU, P182; IMS Institute for Healthcare Informatics, 2011, US MED US REV 2010; Kerlikowske R., 2012, COMMUNICATION; Khosla N, 2011, ADDICT BEHAV, V36, P1282, DOI 10.1016/j.addbeh.2011.07.046; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; Manchikanti Laxmaiah, 2007, Pain Physician, V10, P399; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P287; Manchikanti Laxmaiah, 2006, Pain Physician, V9, P215; Mars S, 2012, HARM RED C PORTL OR; Masson CL, 2002, DRUG ALCOHOL DEPEN, V66, P45, DOI 10.1016/S0376-8716(01)00182-X; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Paulozzi LJ, 2008, PHARMACOEPIDEM DR S, V17, P997, DOI 10.1002/pds.1626; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Peavy KM, 2012, J PSYCHOACTIVE DRUGS, V44, P259, DOI 10.1080/02791072.2012.704591; Piper Tinka Markham, 2007, Harm Reduct J, V4, P3, DOI 10.1186/1477-7517-4-3; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; Roy E, 2011, SUBST USE MISUSE, V46, P1142, DOI 10.3109/10826084.2011.552932; Schneider EC, 2008, POLIT CULT MOD AM, P1; Scott G, 2007, J URBAN HEALTH, V84, P292, DOI 10.1007/s11524-007-9157-7; Seal KH, 2005, J URBAN HEALTH, V82, P303, DOI 10.1093/jurban/jti053; Semaan S, 2011, DRUG ALCOHOL DEPEN, V118, P100, DOI 10.1016/j.drugalcdep.2011.03.006; Shah NG, 2008, ADDICTION, V103, P126, DOI 10.1111/j.1360-0443.2007.02054.x; Tobin KE, 2009, INT J DRUG POLICY, V20, P131, DOI 10.1016/j.drugpo.2008.03.002; U.S. General Accounting Office, 2003, PRESCR DRUGS OXYCONT; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1346, DOI 10.1001/jama.2011.369; Walley A, 2012, FDA PUBL WORKSH SEP; Walley AY, 2013, J SUBST ABUSE TREAT, V44, P241, DOI 10.1016/j.jsat.2012.07.004; Wang CL, 2005, AIDS, V19, P935, DOI 10.1097/01.aids.0000171407.30866.22; Warner M, 2009, INCREASE FATAL POISO; Webster PC, 2012, CAN MED ASSOC J, V184, pE345, DOI 10.1503/cmaj.109-4158; Wheeler Eliza, 2012, Morbidity and Mortality Weekly Report, V61, P101	55	208	208	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54496	10.1371/journal.pone.0054496	http://dx.doi.org/10.1371/journal.pone.0054496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405084	Green Published, gold			2022-12-25	WOS:000315153400028
J	Bellieny-Rabelo, D; Oliveira, AEA; Venancio, TM				Bellieny-Rabelo, Daniel; Amancio Oliveira, Antonia Elenir; Venancio, Thiago Motta			Impact of Whole-Genome and Tandem Duplications in the Expansion and Functional Diversification of the F-Box Family in Legumes (Fabaceae)	PLOS ONE			English	Article							NATURAL-HISTORY; GLYCINE-MAX; UBIQUITIN; EVOLUTION; SEQUENCE; ATLAS; PROTEINS; GENES	F-box proteins constitute a large gene family that regulates processes from hormone signaling to stress response. F-box proteins are the substrate recognition modules of SCF E3 ubiquitin ligases. Here we report very distinct trends in family size, duplication, synteny and transcription of F-box genes in two nitrogen-fixing legumes, Glycine max (soybean) and Medicago truncatula (alfafa). While the soybean FBX genes emerged mainly through segmental duplications (including whole-genome duplications), M. truncatula genome is dominated by locally-duplicated (tandem) F-box genes. Many of these young FBX genes evolved complex transcriptional patterns, including preferential transcription in different tissues, suggesting that they have probably been recruited to important biochemical pathways (e.g. nodulation and seed development).	[Bellieny-Rabelo, Daniel; Amancio Oliveira, Antonia Elenir; Venancio, Thiago Motta] Univ Estadual N Fluminense Darcy Ribeiro, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil		Venancio, TM (corresponding author), Univ Estadual N Fluminense Darcy Ribeiro, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil.	thiago.venancio@gmail.com	Bellieny-Rabelo, Daniel/B-3871-2017; Oliveira, Antonia Elenir Amancio/AAS-3885-2021; Venancio, Thiago M/B-5003-2011	Bellieny-Rabelo, Daniel/0000-0003-2544-7899; Oliveira, Antonia Elenir Amancio/0000-0002-2618-8916; Venancio, Thiago M/0000-0002-2215-8082	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.236/2011, E-26/111.314/2011]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471929/201-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Universidade Estadual do Norte Fluminense Darcy Ribeiro	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidade Estadual do Norte Fluminense Darcy Ribeiro	The authors acknowledge Universidade Estadual do Norte Fluminense Darcy Ribeiro and the following Brazilian funding agencies for supporting their research: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (Grants E-26/110.236/2011 and E-26/111.314/2011), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant 471929/201-5) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2009, BIRTH DEFECTS RES C, V87, P143, DOI 10.1002/bdrc.20153; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Burroughs AM, 2011, MOL BIOSYST, V7, P2261, DOI 10.1039/c1mb05061c; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Burroughs AM, 2012, FRONT BIOSCI-LANDMRK, V17, P1433, DOI 10.2741/3996; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hua ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016219; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Venancio TM, 2010, MOL BIOSYST, V6, P1475, DOI 10.1039/c002567b; Venancio TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r33; Venancio Thiago Motta, 2012, Frontiers in Genetics, V3, P47, DOI 10.3389/fgene.2012.00047; Vierstra RD, 2012, PLANT PHYSL; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Young ND, 2012, ANNU REV PLANT BIOL, V63, P283, DOI 10.1146/annurev-arplant-042110-103754; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	40	23	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55127	10.1371/journal.pone.0055127	http://dx.doi.org/10.1371/journal.pone.0055127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390519	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100035
J	Ivarsson, Y; Wawrzyniak, AM; Kashyap, R; Polanowska, J; Betzi, S; Lembo, F; Vermeiren, E; Chiheb, D; Lenfant, N; Morelli, X; Borg, JP; Reboul, J; Zimmermann, P				Ivarsson, Ylva; Wawrzyniak, Anna Maria; Kashyap, Rudra; Polanowska, Jolanta; Betzi, Stephane; Lembo, Frederique; Vermeiren, Elke; Chiheb, Driss; Lenfant, Nicolas; Morelli, Xavier; Borg, Jean-Paul; Reboul, Jerome; Zimmermann, Pascale			Prevalence, Specificity and Determinants of Lipid-Interacting PDZ Domains from an In-Cell Screen and In Vitro Binding Experiments	PLOS ONE			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; NMDA RECEPTOR SUBUNITS; GENOME-WIDE; PROTEIN INTERACTIONS; GUANYLATE KINASES; MEMBRANE; PHOSPHOINOSITIDE; SYNTENIN; LOCALIZATION; INHIBITOR	Background: PDZ domains are highly abundant protein-protein interaction modules involved in the wiring of protein networks. Emerging evidence indicates that some PDZ domains also interact with phosphoinositides (PtdInsPs), important regulators of cell polarization and signaling. Yet our knowledge on the prevalence, specificity, affinity, and molecular determinants of PDZ-PtdInsPs interactions and on their impact on PDZ-protein interactions is very limited. Methodology/Principal Findings: We screened the human proteome for PtdInsPs interacting PDZ domains by a combination of in vivo cell-localization studies and in vitro dot blot and Surface Plasmon Resonance (SPR) experiments using synthetic lipids and recombinant proteins. We found that PtdInsPs interactions contribute to the cellular distribution of some PDZ domains, intriguingly also in nuclear organelles, and that a significant subgroup of PDZ domains interacts with PtdInsPs with affinities in the low-to-mid micromolar range. In vitro specificity for the head group is low, but with a trend of higher affinities for more phosphorylated PtdInsPs species. Other membrane lipids can assist PtdInsPs-interactions. PtdInsPs-interacting PDZ domains have generally high pI values and contain characteristic clusters of basic residues, hallmarks that may be used to predict additional PtdInsPs interacting PDZ domains. In tripartite binding experiments we established that peptide binding can either compete or cooperate with PtdInsPs binding depending on the combination of ligands. Conclusions/Significance: Our screen substantially expands the set of PtdInsPs interacting PDZ domains, and shows that a full understanding of the biology of PDZ proteins will require a comprehensive insight into the intricate relationships between PDZ domains and their peptide and lipid ligands.	[Ivarsson, Ylva; Wawrzyniak, Anna Maria; Kashyap, Rudra; Vermeiren, Elke; Chiheb, Driss; Zimmermann, Pascale] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium; [Kashyap, Rudra; Polanowska, Jolanta; Betzi, Stephane; Lembo, Frederique; Lenfant, Nicolas; Morelli, Xavier; Borg, Jean-Paul; Reboul, Jerome; Zimmermann, Pascale] INSERM, CRCM, U1068, F-13258 Marseille, France; [Kashyap, Rudra; Polanowska, Jolanta; Betzi, Stephane; Lembo, Frederique; Lenfant, Nicolas; Morelli, Xavier; Borg, Jean-Paul; Reboul, Jerome; Zimmermann, Pascale] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Kashyap, Rudra; Polanowska, Jolanta; Betzi, Stephane; Lembo, Frederique; Lenfant, Nicolas; Morelli, Xavier; Borg, Jean-Paul; Reboul, Jerome; Zimmermann, Pascale] Univ Aix Marseille, Marseille, France; [Kashyap, Rudra; Polanowska, Jolanta; Betzi, Stephane; Lembo, Frederique; Lenfant, Nicolas; Morelli, Xavier; Borg, Jean-Paul; Reboul, Jerome; Zimmermann, Pascale] CNRS, CRCM, UMR7258, Marseille, France	KU Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Zimmermann, P (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium.	Pascale.Zimmermann@med.kuleuven.be	Zimmermann, Pascale/P-4190-2017; Polanowska, Jolanta/P-9117-2016; Betzi, Stephane/AAC-6103-2022; morelli, xavier/A-9218-2016; Reboul, Jerome/P-9103-2016; Ivarsson, Ylva/HGE-0283-2022; Borg, Jean-Paul/AAX-8096-2020; Kashyap, Rudra/ABD-3316-2020	Polanowska, Jolanta/0000-0001-7666-7010; Betzi, Stephane/0000-0001-5935-5058; morelli, xavier/0000-0001-8101-7901; Reboul, Jerome/0000-0002-5513-4546; Ivarsson, Ylva/0000-0002-7081-3846; Borg, Jean-Paul/0000-0001-8418-3382; Lenfant, Nicolas/0000-0002-0519-1120	Fund for Scientific Research - Flanders (FWO); Cell Imaging Core; Concerted Actions Program of K. U. Leuven; Hercules Foundation [AKUL005 HER/08/061]; Belgian Foundation against cancer; Ph.D. fellowship from FWO; La Ligue contre le Cancer	Fund for Scientific Research - Flanders (FWO)(FWO); Cell Imaging Core; Concerted Actions Program of K. U. Leuven; Hercules Foundation; Belgian Foundation against cancer; Ph.D. fellowship from FWO(FWO); La Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the Fund for Scientific Research - Flanders (FWO), the Cell Imaging Core and the Concerted Actions Program of K. U. Leuven, the Hercules Foundation (AKUL005 HER/08/061) and the Belgian Foundation against cancer. AMW was supported by a Ph.D. fellowship from FWO, YI was an EMBO long-term fellow and PZ was an EMBO young investigator. JPB is supported by La Ligue contre le Cancer (Label 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Chang BH, 2011, CHEM BIOL, V18, P1143, DOI 10.1016/j.chembiol.2011.06.013; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen Y, 2012, MOL CELL, V46, P226, DOI 10.1016/j.molcel.2012.02.012; Chi CN, 2006, J BIOL CHEM, V281, P36811, DOI 10.1074/jbc.M607883200; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Ivarsson Y, 2011, J BIOL CHEM, V286, P44669, DOI 10.1074/jbc.M111.285734; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jeynov B, 2006, FEBS LETT, V580, P5917, DOI 10.1016/j.febslet.2006.09.058; KELLER GA, 1991, J CELL BIOL, V114, P893, DOI 10.1083/jcb.114.5.893; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lambaerts K, 2012, J CELL SCI, V125, P1129, DOI 10.1242/jcs.089987; Lemmon MA, 1997, TRENDS CELL BIOL, V7, P237, DOI 10.1016/S0962-8924(97)01065-9; Lenfant N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-671; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Meerschaert K, 2007, EXP CELL RES, V313, P1790, DOI 10.1016/j.yexcr.2007.03.014; Meerschaert K, 2009, CELL MOL LIFE SCI, V66, P3951, DOI 10.1007/s00018-009-0156-6; MICHALIK J, 1981, LIFE SCI, V28, P1371, DOI 10.1016/0024-3205(81)90411-2; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Narayan K, 2006, METHODS, V39, P122, DOI 10.1016/j.ymeth.2006.05.006; Niethammer M, 1996, J NEUROSCI, V16, P2157; Osborne SL, 2001, J CELL SCI, V114, P2501; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Velthuis AJWT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016047; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; Wawrzyniak AM, 2012, FEBS LETT, V586, P1445, DOI 10.1016/j.febslet.2012.04.024; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	60	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54581	10.1371/journal.pone.0054581	http://dx.doi.org/10.1371/journal.pone.0054581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390500	gold, Green Submitted, Green Published			2022-12-25	WOS:000314691100016
J	Verrier, ER; Dorson, M; Mauger, S; Torhy, C; Ciobotaru, C; Hervet, C; Dechamp, N; Genet, C; Boudinot, P; Quillet, E				Verrier, Eloi R.; Dorson, Michel; Mauger, Stephane; Torhy, Corinne; Ciobotaru, Celine; Hervet, Caroline; Dechamp, Nicolas; Genet, Carine; Boudinot, Pierre; Quillet, Edwige			Resistance to a Rhabdovirus (VHSV) in Rainbow Trout: Identification of a Major QTL Related to Innate Mechanisms	PLOS ONE			English	Article							INFECTIOUS PANCREATIC NECROSIS; QUANTITATIVE TRAIT LOCI; SALMON SALMO-SALAR; SEPTICEMIA VIRUS-REPLICATION; MICROSATELLITE LINKAGE MAP; ONCORHYNCHUS-MYKISS; DISEASE RESISTANCE; HIV-1 INFECTION; FISH; SELECTION	Health control is a major issue in animal breeding and a better knowledge of the genetic bases of resistance to diseases is needed in farm animals including fish. The detection of quantitative trait loci (QTL) will help uncovering the genetic architecture of important traits and understanding the mechanisms involved in resistance to pathogens. We report here the detection of QTL for resistance to Viral Haemorrhagic Septicaemia Virus (VHSV), a major threat for European aquaculture industry. Two induced mitogynogenetic doubled haploid F2 rainbow trout (Oncorhynchus mykiss) families were used. These families combined the genome of susceptible and resistant F0 breeders and contained only fully homozygous individuals. For phenotyping, fish survival after an immersion challenge with the virus was recorded, as well as in vitro virus replication on fin explants. A bidirectional selective genotyping strategy identified seven QTL associated to survival. One of those QTL was significant at the genome-wide level and largely explained both survival and viral replication in fin explants in the different families of the design (up to 65% and 49% of phenotypic variance explained respectively). These results evidence the key role of innate defence in resistance to the virus and pave the way for the identification of the gene(s) responsible for resistance. The identification of a major QTL also opens appealing perspectives for selective breeding of fish with improved resistance.	[Verrier, Eloi R.; Mauger, Stephane; Ciobotaru, Celine; Hervet, Caroline; Dechamp, Nicolas; Genet, Carine; Quillet, Edwige] INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Verrier, Eloi R.; Dorson, Michel; Torhy, Corinne; Boudinot, Pierre] INRA, Virol & Immunol Mol UR892, Jouy En Josas, France; [Verrier, Eloi R.] AgroParisTech, Paris, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech	Quillet, E (corresponding author), INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France.	edwige.quillet@jouy.inra.fr	Verrier, Eloi/AAH-3249-2021; boudinot, pierre/L-4246-2016	boudinot, pierre/0000-0002-7490-9677; Verrier, Eloi/0000-0002-9022-5611; Mauger, Stephane/0000-0002-8779-1516; Dechamp, Nicolas/0000-0003-3248-2182	European Community (IFOP); French Ministry of Research [2004/190]; European Community's Seventh Framework Programme (FP7), Research Infrastructures action [FP7-228394]; Animal Genetics and Animal Health Divisions of INRA	European Community (IFOP)(European Commission); French Ministry of Research(Ministry of Research, FranceEuropean Commission); European Community's Seventh Framework Programme (FP7), Research Infrastructures action; Animal Genetics and Animal Health Divisions of INRA	The research leading to these results has received co-funding from European Community (IFOP) and French Ministry of Research (grant agreement DPMA/CIPA/INRA No. 2004/190, AGENOP project) and funding from the European Community's Seventh Framework Programme (FP7, 2007-2013), Research Infrastructures action, under the grant agreement No. FP7-228394 (NADIR). E.R. VERRIER is a recipient of a PhD fellowship co-funded by Animal Genetics and Animal Health Divisions of INRA. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Hussinee L, 2011, DIS AQUAT ORGAN, V93, P117, DOI 10.3354/dao02285; [Anonymous], 1997, GENETICS ANAL QUANTI; Ayoub M, 2002, GENOME, V45, P1116, DOI [10.1139/g02-089, 10.1139/G02-089]; Baerwald MR, 2011, HEREDITY, V106, P920, DOI 10.1038/hdy.2010.137; Bain MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010156; Bearzotti M, 1999, J VIROL, V73, P7703, DOI 10.1128/JVI.73.9.7703-7709.1999; Bishop SC, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P1, DOI 10.1079/9781845935559.0000; Bisset SA, 1996, INT J PARASITOL, V26, P857, DOI 10.1016/S0020-7519(96)80056-7; Boudinot P, 1999, J VIROL, V73, P1846, DOI 10.1128/JVI.73.3.1846-1852.1999; Boudinot P, 2001, J IMMUNOL, V167, P6202, DOI 10.4049/jimmunol.167.11.6202; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Boussaha M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-238; de Givry S, 2005, BIOINFORMATICS, V21, P1703, DOI 10.1093/bioinformatics/bti222; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DITER A, 1993, J FISH BIOL, V42, P777, DOI 10.1111/j.1095-8649.1993.tb00383.x; DORSON M, 1993, J FISH DIS, V16, P403, DOI 10.1111/j.1365-2761.1993.tb00874.x; DORSON M, 1975, ANN INST PASTEUR MIC, VB126, P485; Elsen JM, 1999, GENET SEL EVOL, V31, P213, DOI 10.1051/gse:19990302; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Filangi O, 2010, P 9 WORLD C GEN APPL; Gilbey J, 2006, DIS AQUAT ORGAN, V71, P119, DOI 10.3354/dao071119; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; Guyomard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-302; Guyomard R, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-15; HARRELL FE, 1982, BIOMETRIKA, V69, P635; Heringstad B, 2000, LIVEST PROD SCI, V64, P95, DOI 10.1016/S0301-6226(99)00128-1; Houston RD, 2008, GENETICS, V178, P1109, DOI 10.1534/genetics.107.082974; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Jorgensen HBH, 2011, MOL IMMUNOL, V48, P1046, DOI 10.1016/j.molimm.2011.01.014; LANDER ES, 1989, GENETICS, V121, P185; le Berre M, 1977, Bulletin Off int Epizoot, V87, P391; Le Roy P, 1998, 6 WORLD C GEN APPL L, V26, P257; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Massault C, 2011, ANIM GENET, V42, P191, DOI 10.1111/j.1365-2052.2010.02110.x; Miller MR, 2012, MOL ECOL, V21, P237, DOI 10.1111/j.1365-294X.2011.05305.x; Moen T, 2010, BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION, P166, DOI 10.1079/9781845935559.0166; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Moreno CR, 2005, GENET RES, V85, P139, DOI 10.1017/S0016672305007366; Navabi A, 2009, THEOR APPL GENET, V118, P347, DOI 10.1007/s00122-008-0904-2; O'Farrell C, 2002, J VIROL, V76, P8040, DOI 10.1128/JVI.76.16.8040-8049.2002; Odegard J, 2011, AQUAC RES, V42, P103, DOI 10.1111/j.1365-2109.2010.02669.x; Overturf K, 2010, J FISH DIS, V33, P321, DOI 10.1111/j.1365-2761.2009.01124.x; Ozaki A, 2001, MOL GENET GENOMICS, V265, P23, DOI 10.1007/s004380000392; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Palti Y, 2011, DEV COMP IMMUNOL, V35, P1263, DOI 10.1016/j.dci.2011.03.006; Palti Y, 2010, DEV COMP IMMUNOL, V34, P219, DOI 10.1016/j.dci.2009.10.002; Penaranda MMD, 2009, J GEN VIROL, V90, P2172, DOI 10.1099/vir.0.012286-0; Pierce LR, 2012, MOL PHYLOGENET EVOL, V63, P327, DOI 10.1016/j.ympev.2011.12.024; PINCUS T, 1971, J EXP MED, V133, P1219, DOI 10.1084/jem.133.6.1219; Purcell MK, 2012, VIRUSES-BASEL, V4, P140, DOI 10.3390/v4010140; Purcell MK, 2010, FISH SHELLFISH IMMUN, V28, P98, DOI 10.1016/j.fsi.2009.10.005; Quillet E, 2007, PROD ANIM, V20, P239; QUILLET E, 1994, AQUACULTURE, V123, P223, DOI 10.1016/0044-8486(94)90061-2; Quillet E, 2001, DIS AQUAT ORGAN, V45, P171, DOI 10.3354/dao045171; Quillet E, 2007, DIS AQUAT ORGAN, V76, P7, DOI 10.3354/dao076007; Quillet E, 2007, FISH SHELLFISH IMMUN, V22, P510, DOI 10.1016/j.fsi.2006.07.002; Rodriguez-Ramilo ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-541; Sakamoto T, 2000, GENETICS, V155, P1331; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Seymour DK, 2012, P NATL ACAD SCI USA, V109, P4227, DOI 10.1073/pnas.1117277109; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Sun YP, 2010, MOL BREEDING, V26, P493, DOI 10.1007/s11032-010-9390-8; Tomar D, 2012, BBA-MOL CELL RES, V1823, P316, DOI 10.1016/j.bbamcr.2011.11.015; Trobridge GD, 2000, DIS AQUAT ORGAN, V40, P1, DOI 10.3354/dao040001; Verrier ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033935; Verrier ER, 2011, DEV COMP IMMUNOL, V35, P1204, DOI 10.1016/j.dci.2011.03.012; Villanueva B, 2011, J ANIM SCI, V89, P3433, DOI 10.2527/jas.2010-3814; Wahli T., 2011, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V6, P1, DOI 10.1079/PAVSNNR20116002; Wargo AR, 2012, VIRUS RES, V165, P71, DOI 10.1016/j.virusres.2012.01.010; Wilkie B, 1999, VET IMMUNOL IMMUNOP, V72, P231, DOI 10.1016/S0165-2427(99)00136-1; Winton JR, 1997, DEV BIOLOGICALS, V90, P211; WOOLASTON RR, 1992, INT J PARASITOL, V22, P947, DOI 10.1016/0020-7519(92)90052-M	73	36	36	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55302	10.1371/journal.pone.0055302	http://dx.doi.org/10.1371/journal.pone.0055302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390526	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100042
J	Overbeek, SA; Braber, S; Koelink, PJ; Henricks, PAJ; Mortaz, E; Loi, ATL; Jackson, PL; Garssen, J; Wagenaar, GTM; Timens, W; Koenderman, L; Blalock, JE; Kraneveld, AD; Folkerts, G				Overbeek, Saskia A.; Braber, Saskia; Koelink, Pim J.; Henricks, Paul A. J.; Mortaz, Esmaeil; Loi, Adele T. LoTam; Jackson, Patricia L.; Garssen, Johan; Wagenaar, Gerry T. M.; Timens, Wim; Koenderman, Leo; Blalock, J. Edwin; Kraneveld, Aletta D.; Folkerts, Gert			Cigarette Smoke-Induced Collagen Destruction; Key to Chronic Neutrophilic Airway Inflammation?	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INDUCED SPUTUM; COPD; LUNG; CHEMOATTRACTANT; EXACERBATION; BURDEN; ROLES; MICE; PGP	Background: Cigarette smoking induces inflammatory responses in all smokers and is the major risk factor for lung disease such as chronic obstructive pulmonary disease (COPD). In this progressive disease, chronic inflammation in the lung contributes to lung tissue destruction leading to the formation of chemotactic collagen fragments such as N-acetylated Proline-Glycine-Proline (N-ac-PGP). The generation of this tripeptide is mediated by a multistep pathway involving matrix metalloproteases (MMPs) 8 and 9 and prolyl endopeptidase (PE). Here we investigated whether cigarette smoke extract (CSE) stimulates human PMNs to breakdown whole matrix collagen leading to the generation of the chemotactic collagen fragment N-ac-PGP. Methodology/Principal Findings: Incubating PMNs with CSE led to the release of chemo-attractant CXCL8 and proteases MMP8 and MMP9. PMNs constitutively expressed PE activity as well as PE protein. Incubating CSE-primed PMNs with collagen resulted in collagen breakdown and in N-ac-PGP generation. Incubation of PMNs with the tripeptide N-ac-PGP resulted in the release of CXCL8, MMP8 and MMP9. Moreover, we tested whether PMNs from COPD patients are different from PMNs from healthy donors. Here we show that the intracellular basal PE activity of PMNs from COPD patients increased 25-fold compared to PMNs from healthy donors. Immunohistological staining of human lung tissue for PE showed that besides neutrophils, macrophages and epithelial cells express PE. Conclusions: This study indicates that neutrophils activated by cigarette smoke extract can breakdown collagen into N-ac-PGP and that this collagen fragment itself can activate neutrophils, which may lead in vivo to a self-propagating cycle of neutrophil infiltration, chronic inflammation and lung emphysema. MMP-, PE-or PGP-inhibitors can serve as an attractive therapeutic target and may open new avenues towards effective treatment of COPD.	[Overbeek, Saskia A.; Braber, Saskia; Koelink, Pim J.; Henricks, Paul A. J.; Mortaz, Esmaeil; Garssen, Johan; Kraneveld, Aletta D.; Folkerts, Gert] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [Mortaz, Esmaeil; Koenderman, Leo] Shahid Beheshti Univ Med Sci, Chron Resp Dis Res Ctr, NRITLD, Masih Daneshvari Hosp, Tehran, Iran; [Loi, Adele T. LoTam; Blalock, J. Edwin] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Jackson, Patricia L.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA; [Jackson, Patricia L.] Univ Alabama Birmingham, Dept Med, UAB Lung Hlth Ctr, Birmingham, AL 35294 USA; [Garssen, Johan] Danone Res Ctr Specialised Nutr, Wageningen, Netherlands; [Wagenaar, Gerry T. M.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands; [Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands	Utrecht University; Shahid Beheshti University Medical Sciences; Utrecht University; Utrecht University Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Danone Nutricia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen	Folkerts, G (corresponding author), Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands.	G.Folkerts@uu.nl	Henricks, Paul/I-8255-2016; Kraneveld, Aletta D/J-3351-2016; Timens, Wim/K-5570-2013; Koenderman, Leo/AAE-7870-2020; Wagenaar, Gerry/GRS-3567-2022; garssen, johan/I-7159-2016; mortaz, esmael/G-7647-2017	Kraneveld, Aletta D/0000-0001-9819-383X; Timens, Wim/0000-0002-4146-6363; Koenderman, Leo/0000-0002-5636-6453; mortaz, esmael/0000-0002-6689-3556; Mortaz, Esmaeil/0000-0003-0250-087X; Blalock, J. Edwin/0000-0001-5303-8123; Wagenaar, Gerry/0000-0001-5716-6018	Dutch Top Institute Pharma [T1.103]; National Heart, Lung and Blood Institute [HL07783, HL090999, HL087824]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090999, R01HL087824, R01HL114439, F33HL007783, R01HL077783, R01HL110950] Funding Source: NIH RePORTER	Dutch Top Institute Pharma; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was performed within the framework of Dutch Top Institute Pharma (project number T1.103). This study was supported in part by National Heart, Lung and Blood Institute grants HL07783, HL090999, and HL087824 to J.E.B. The content is solely the responsibility of the authors and does not necessarily represent views of the National Heart, Lung and Blood Institute or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2010, MED PRIN PRACT, V19, P330, DOI 10.1159/000316368; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; BAZZONI F, 1991, J EXP MED, V173, P771, DOI 10.1084/jem.173.3.771; Beeh KM, 2003, CHEST, V123, P1240, DOI 10.1378/chest.123.4.1240; Braber S, 2011, PATHOGENESIS LUNG EM; Braber S, 2011, EUR J PHARMACOL, V668, P443, DOI 10.1016/j.ejphar.2011.03.025; Braber S, 2011, AM J PHYSIOL-LUNG C, V300, pL255, DOI 10.1152/ajplung.00304.2010; BRUNNEMANN KD, 1991, CRIT REV TOXICOL, V21, P235, DOI 10.3109/10408449109017910; Domagala-Kulawik J, 2008, J PHYSIOL PHARMACOL, V59, P19; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Hardison MT, 2009, J IMMUNOL, V182, P4423, DOI 10.4049/jimmunol.0802457; Henson PM, 2006, NAT MED, V12, P280, DOI 10.1038/nm0306-280; Ilumets H, 2008, SCAND J CLIN LAB INV, V68, P618, DOI 10.1080/00365510801983773; Ilumets Helen, 2007, Int J Chron Obstruct Pulmon Dis, V2, P369; Karimi K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-66; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Louhelainen Noora, 2009, BMC Pulm Med, V9, P25, DOI 10.1186/1471-2466-9-25; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mercer PF, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-151; Miller M, 2010, CHEST; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; O'Reilly P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-38; O'Reilly PJ, 2009, J NEUROIMMUNOL, V217, P51, DOI 10.1016/j.jneuroim.2009.09.020; Overbeek SA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-75; Pfister RR, 1998, INVEST OPHTH VIS SCI, V39, P1744; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Stockley Robert A, 2009, Proc Am Thorac Soc, V6, P524, DOI 10.1513/pats.200904-016DS; Suki B, 2005, J APPL PHYSIOL, V98, P1892, DOI 10.1152/japplphysiol.01087.2004; Vernooy JHJ, 2004, CHEST, V126, P1802, DOI 10.1378/chest.126.6.1802; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781	33	46	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55612	10.1371/journal.pone.0055612	http://dx.doi.org/10.1371/journal.pone.0055612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383243	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600135
J	Schoffelen, T; Illnait-Zaragozi, MT; Joosten, LAB; Netea, MG; Boekhout, T; Meis, JF; Sprong, T				Schoffelen, Teske; Illnait-Zaragozi, Maria-Teresa; Joosten, Leo A. B.; Netea, Mihai G.; Boekhout, Teun; Meis, Jacques F.; Sprong, Tom			Cryptococcus gattii Induces a Cytokine Pattern That Is Distinct from Other Cryptococcal Species	PLOS ONE			English	Article							POLYSACCHARIDE CAPSULE; VANCOUVER-ISLAND; HOST RESPONSE; NEOFORMANS; TOLL-LIKE-RECEPTOR-4; RECOGNITION; PATHOGEN; OUTBREAK; DEFENSE; MYD88	Understanding more about the host's immune response to different Cryptococcus spp. will provide additional insight into the pathogenesis of cryptocococcis. We hypothesized that the ability of C. gattii to cause disease in immunocompetent humans depends on a distinct innate cytokine response of the host to this emerging pathogen. In the current study we assessed the cytokine profile of human peripheral blood mononuclear cells (PBMCs) of healthy individuals, after in vitro stimulation with 40 different well-defined heat-killed isolates of C. gattii, C. neoformans and several hybrid strains. In addition, we investigated the involvement of TLR2, TLR4 and TLR9 in the pro-inflammatory cytokine response to C. gattii. Isolates of C. gattii induced higher concentrations of the pro-inflammatory cytokines IL-1 beta, TNF-alpha and IL-6 and the Th17/22 cytokine IL-17 and IL-22 compared to C. neoformans var neoformans and C. neoformans var grubii. In addition, clinical C. gattii isolates induced higher amounts of cytokines than environmental isolates. This difference was not observed in C. neoformans var. grubii isolates. Furthermore, we demonstrated a likely contribution of TLR4 and TLR9, but no role for TLR2, in the host's cytokine response to C. gattii. In conclusion, clinical heat-killed C. gattii isolates induced a more pronounced inflammatory response compared to other Cryptococcus species and non-clinical C. gattii. This is dependent on TLR4 and TLR9 as cellular receptors.	[Schoffelen, Teske; Joosten, Leo A. B.; Netea, Mihai G.; Sprong, Tom] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Schoffelen, Teske; Joosten, Leo A. B.; Netea, Mihai G.; Sprong, Tom] Radboud Univ Nijmegen, Med Ctr, N4i, NL-6525 ED Nijmegen, Netherlands; [Illnait-Zaragozi, Maria-Teresa] Inst Pedro Kouri, Dept Bacteriol & Mycol, Havana, Cuba; [Boekhout, Teun] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Boekhout, Teun] Second Mil Med Univ, Changzheng Hosp, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Meis, Jacques F.; Sprong, Tom] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Sprong, Tom] Canisius Wilhelmina Hosp, Dept Med, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Naval Medical University; Canisius-Wilhelmina Hospital; Canisius-Wilhelmina Hospital	Sprong, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	T.Sprong@cwz.nl	Boekhout, Teunis/ABF-2538-2020; Netea, Mihai/N-5155-2014; Meis, Jacques F/A-9241-2010; Joosten, Leo AB/H-3138-2015	Boekhout, Teunis/0000-0002-0476-3609; Meis, Jacques F/0000-0003-3253-6080; Joosten, Leo AB/0000-0001-6166-9830	Vici Grant of the Netherlands Organization for Scientific Research	Vici Grant of the Netherlands Organization for Scientific Research	M.G.N. was supported by a Vici Grant of the Netherlands Organization for Scientific Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biondo C, 2005, EUR J IMMUNOL, V35, P870, DOI 10.1002/eji.200425799; Brown Gordon D., 2007, pVII; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Chaturvedi V, 2011, TRENDS MICROBIOL, V19, P564, DOI 10.1016/j.tim.2011.07.010; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Illnait-Zaragozi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009124; Kasperkovitz PV, 2011, INFECT IMMUN, V79, P4858, DOI 10.1128/IAI.05626-11; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; LEVITZ SM, 1991, J INFECT DIS, V163, P1108, DOI 10.1093/infdis/163.5.1108; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; MODY CH, 1993, INFECT IMMUN, V61, P464, DOI 10.1128/IAI.61.2.464-469.1993; Nakamura K, 2008, J IMMUNOL, V180, P4067, DOI 10.4049/jimmunol.180.6.4067; Nakamura K, 2006, FEMS IMMUNOL MED MIC, V47, P148, DOI 10.1111/j.1574-695X.2006.00078.x; Ngamskulrungroj P, 2012, MBIO, V3; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Popa C, 2007, INFECT IMMUN, V75, P4831, DOI 10.1128/IAI.00237-07; Shoham S, 2001, J IMMUNOL, V166, P4620, DOI 10.4049/jimmunol.166.7.4620; Siddiqui AA, 2006, INFECT IMMUN, V74, P5302, DOI 10.1128/IAI.00661-06; SPEED B, 1995, CLIN INFECT DIS, V21, P28, DOI 10.1093/clinids/21.1.28; Stunz LL, 2002, EUR J IMMUNOL, V32, P1212, DOI 10.1002/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO;2-D; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; van de Veerdonk FL, 2010, CURR OPIN CRIT CARE, V16, P453, DOI 10.1097/MCC.0b013e32833e046e; van de Veerdonk FL, 2009, BMB REP, V42, P776, DOI 10.5483/BMBRep.2009.42.12.776; Yauch LE, 2004, INFECT IMMUN, V72, P5373, DOI 10.1128/IAI.72.9.5373-5382.2004	29	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55579	10.1371/journal.pone.0055579	http://dx.doi.org/10.1371/journal.pone.0055579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383232	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600128
J	Lee, A; Hakuno, F; Northcott, P; Pessin, JE; Adcock, MR				Lee, Andrew; Hakuno, Fumihiko; Northcott, Paul; Pessin, Jeffrey E.; Adcock, Maria Rozakis			Nexilin, a Cardiomyopathy-Associated F-Actin Binding Protein, Binds and Regulates IRS1 Signaling in Skeletal Muscle Cells	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; GLUCOSE-TRANSPORT; 3T3L1 ADIPOCYTES; L6 MYOTUBES; Z-DISC; MEMBRANE; 3-KINASE; PHOSPHORYLATION	Insulin stimulates glucose uptake through a highly organized and complex process that involves movement of the glucose transporter 4 (GLUT4) from intracellular storage sites to the plasma membrane. Previous studies in L6 skeletal muscle cells have shown that insulin-induced activation and assembly of insulin receptor substrate 1 (IRS1) and p85 alpha the regulatory subunit of the Type 1A phosphatidylinositol-3-kinase (PI3K), within remodeled actin-rich membrane structures is critical for downstream signalling mediating the translocation of GLUT4. The mechanism for localization within actin cytoskeletal scaffolds is not known, as direct interaction of IRS1 or p85 alpha with F-actin has not been demonstrated. Here we show that nexilin, a F-actin binding protein implicated in the pathogenesis of familial dilated cardiomyopathies, preferentially binds to IRS1 over IRS2 to influence glucose transport in skeletal muscle cells. Nexilin stably associates with IRS1 under basal conditions in L6 myotubes and this complex is disassembled by insulin. Exposure of L6 myotubes to Latrunculin B disrupts the spatial patterning of nexilin and its transient association with IRS1. Functional silencing of nexilin has no effect on insulin-stimulated IRS1 tyrosine phosphorylation, however it enhances recruitment of p85 alpha to IRS1 resulting in increased PI-3, 4, 5-P-3 formation, coincident with enhanced AKT activation and glucose uptake. By contrast, overexpression of nexilin inhibits transmission of IRS1 signals to AKT. Based on these findings we propose that nexilin may tether IRS1 to actin-rich structures under basal conditions, confining IRS1 signaling to specific subcellular locations in the cell. Insulin-elicited release of this constraint may enhance the efficiency of IRS1/PI3K interaction and PI-3, 4, 5-P-3 production at localized sites. Moreover, the selective binding of nexilin to IRS1 and not IRS2 may contribute to the differential specificity of IRS isoforms in the modulation of GLUT4 trafficking in skeletal muscle cells.	[Lee, Andrew; Northcott, Paul; Adcock, Maria Rozakis] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hakuno, Fumihiko] Univ Tokyo, Dept Anim Sci & Appl Biol Chem, Tokyo, Japan; [Pessin, Jeffrey E.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	University of Toronto; University of Tokyo; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Adcock, MR (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	maria.rozakis@utoronto.ca	Northcott, Paul A/N-4022-2018	Northcott, Paul A/0000-0002-1220-5252; Hakuno, Fumihiko/0000-0002-4447-6225	Canadian Diabetes Association; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541] Funding Source: NIH RePORTER	Canadian Diabetes Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Canadian Diabetes Association and the Canadian Institutes of Health Research to MRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anai O, 1998, J BIOL CHEM, V273, P29686, DOI 10.1074/jbc.273.45.29686; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Clark SF, 2000, J BIOL CHEM, V275, P3819, DOI 10.1074/jbc.275.6.3819; Emoto M, 2001, J BIOL CHEM, V276, P10677, DOI 10.1074/jbc.M010785200; Eyster CA, 2005, J BIOL CHEM, V280, P17978, DOI 10.1074/jbc.M409806200; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Higaki Y, 1999, J BIOL CHEM, V274, P20791, DOI 10.1074/jbc.274.30.20791; Hoffman NJ, 2011, TRENDS ENDOCRIN MET, V22, P110, DOI 10.1016/j.tem.2010.12.001; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; Kanzaki M, 2002, MOL BIOL CELL, V13, P2334, DOI 10.1091/mbc.01-10-0490; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kanzaki M, 2001, J BIOL CHEM, V276, P49331, DOI 10.1074/jbc.M109657200; Khayat ZA, 2000, J CELL SCI, V113, P279; KNIGHT JB, 1995, J BIOL CHEM, V270, P10199, DOI 10.1074/jbc.270.17.10199; Kriauciunas KM, 2000, MOL CELL BIOL, V20, P6849, DOI 10.1128/MCB.20.18.6849-6859.2000; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Patel N, 2003, MOL CELL BIOL, V23, P4611, DOI 10.1128/MCB.23.13.4611-4626.2003; Samuelsson AM, 2006, AM J PHYSIOL-HEART C, V291, pH787, DOI 10.1152/ajpheart.00974.2005; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Shimizu I, 2010, J CLIN INVEST, V120, P1506, DOI 10.1172/JCI40096; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; TSAKIRIDIS T, 1994, J BIOL CHEM, V269, P29934; Waardenberg AJ, 2011, J BIOL CHEM, V286, P30837, DOI 10.1074/jbc.M111.271684; Wang H, 2010, AM J HUM GENET, V87, P687, DOI 10.1016/j.ajhg.2010.10.002; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074	33	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55634	10.1371/journal.pone.0055634	http://dx.doi.org/10.1371/journal.pone.0055634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383252	Green Published, Green Submitted, gold			2022-12-25	WOS:000315563800178
J	Nakamura, K; Sakurai, M; Miura, K; Morikawa, Y; Nagasawa, S; Ishizaki, M; Kido, T; Naruse, Y; Suwazono, Y; Nakagawa, H				Nakamura, Koshi; Sakurai, Masaru; Miura, Katsuyuki; Morikawa, Yuko; Nagasawa, Shin-ya; Ishizaki, Masao; Kido, Teruhiko; Naruse, Yuchi; Suwazono, Yasushi; Nakagawa, Hideaki			Nicotine Dependence and Cost-Effectiveness of Individualized Support for Smoking Cessation: Evidence from Practice at a Worksite in Japan	PLOS ONE			English	Article							NATIONAL-HEALTH INSURANCE; REPLACEMENT THERAPY; FAGERSTROM TEST; FOLLOW-UP; INTERVENTION; POPULATION; PROGRAM; QUESTIONNAIRE; COMPETITION; INCENTIVES	Given the lack of economic studies evaluating the outcomes of smoking cessation programs from the viewpoint of program sponsors, we conducted a case study to provide relevant information for worksites. The present study was carried out between 2006 and 2008 at a manufacturing factory in the Toyama Prefecture of Japan and included subjects who voluntarily entered a smoking cessation program. The program included face-to-face counselling followed by weekly contact to provide encouragement over six months using e-mail or inter-office mail. Nicotine patches were available if required. All 151 participants stopped smoking immediately. Over the 24-month study period, self-report showed 49.7% abstained continuously from smoking. The rate of 24-month consecutive abstinence was higher in participants with lower Fagerstrom Test scores for Nicotine Dependence at baseline than in those with higher scores (63.6% for 0-2 points vs. 46.5% for 3-6 points vs. 43.8% for 7-10 points; chi-square test p = 0.19). A logistic regression model showed a significant linear trend for the association between the score and abstinence status after adjustment for possible confounding factors (p = 0.03). The crude incremental cost for one individual to successfully quit smoking due to the support program was 46,379 (i.e., (sic)100 = $1.28, 0.83 pound, or (sic)1.03 at foreign exchange rates). The corresponding costs for the three categories of the Fagerstrom Test score for Nicotine Dependence were (sic)31,953, (sic)47,450 and 64,956, respectively. When a sensitivity analysis was conducted based on the 95% confidence interval of the success rate, the variance in the corresponding costs was (sic)25,514-45,034 for 0-2 points, (sic)38,344-61,824 for 3-6 points, and (sic)45,698-108,260 for 7-10 points. The degree of nicotine dependence may therefore be an important determinant of the cost-effectiveness of smoking cessation programs.	[Nakamura, Koshi; Sakurai, Masaru; Morikawa, Yuko; Nagasawa, Shin-ya; Nakagawa, Hideaki] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa 92002, Japan; [Miura, Katsuyuki] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 52021, Japan; [Ishizaki, Masao] Kanazawa Med Univ, Dept Social & Environm Med, Uchinada, Ishikawa 92002, Japan; [Kido, Teruhiko] Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Sch Hlth Sci, Kanazawa, Ishikawa, Japan; [Naruse, Yuchi] Toyama Univ, Sch Nursing, Dept Human Sci & Fundamental Nursing, Toyama 930, Japan; [Suwazono, Yasushi] Chiba Univ, Grad Sch Med, Dept Occupat & Environm Med, Chiba, Japan	Kanazawa Medical University; Shiga University of Medical Science; Kanazawa Medical University; Kanazawa University; University of Toyama; Chiba University	Nakamura, K (corresponding author), Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa 92002, Japan.	knaka@kanazawa-med.ac.jp	Sakurai, Masaru/AAC-6551-2021	Sakurai, Masaru/0000-0002-4929-3225	Ministry of Health, Labour and Welfare of Japan [H22-Junkankitou [Seishuu]-Ippan-012]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was funded by a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan (Comprehensive Research on Cardiovascular and Life-Style Related Disease: H22-Junkankitou [Seishuu]-Ippan-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1987, AM J PUBLIC HEALTH, V77, P162, DOI 10.2105/AJPH.77.2.162; Bertera R L, 1990, Am J Health Promot, V4, P187, DOI 10.4278/0890-1171-4.3.187; BLYTH CR, 1986, J AM STAT ASSOC, V81, P843, DOI 10.2307/2289018; Central Social Insurance Medical Council, 2007, EV REV MED SERV FEE; Chan M, 2008, WHO REPORT GLOBAL TO; DiFranza JR, 2012, ADDICT BEHAV, V37, P856, DOI 10.1016/j.addbeh.2012.03.013; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Erfurt J C, 1991, Am J Health Promot, V5, P438; Hawkins J, 2010, NICOTINE TOB RES, V12, P1228, DOI 10.1093/ntr/ntq175; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Indurkhya A, 2001, STAT MED, V20, P1469, DOI 10.1002/sim.683; Izumi Y, 2001, INT J EPIDEMIOL, V30, P616, DOI 10.1093/ije/30.3.616; JASON LA, 1995, BEHAV THER, V26, P393, DOI 10.1016/S0005-7894(05)80090-5; Kadowaki T, 2000, IND HEALTH, V38, P396, DOI 10.2486/indhealth.38.396; Kadowaki T, 2006, J OCCUP HEALTH, V48, P402, DOI 10.1539/joh.48.402; Katanoda K, 2008, J EPIDEMIOL, V18, P251, DOI 10.2188/jea.JE2007429; Kawakami N, 1999, ADDICT BEHAV, V24, P155, DOI 10.1016/S0306-4603(98)00127-0; Koffman DM, 1998, AM J HEALTH PROMOT, V13, P105, DOI 10.4278/0890-1171-13.2.105; Lancaster T, 2000, BRIT MED J, V321, P355, DOI 10.1136/bmj.321.7257.355; MAHEU MM, 1989, PREV MED, V18, P867, DOI 10.1016/0091-7435(89)90022-4; Ministry of Health Labor and Welfare of Japan, 2010, 2009 NAT HLTH NUTR S; Ministry of Health Labour and Welfare, BAS SURV WAG STRUCT; Nakamura K, 2009, TOB CONTROL, V18, P345, DOI 10.1136/tc.2008.028795; Nakamura K, 2012, AM J HYPERTENS, V25, P979, DOI 10.1038/ajh.2012.37; Nakamura K, 2010, HYPERTENS RES, V33, P802, DOI 10.1038/hr.2010.81; Nakamura Masakazu, 2004, Environ Health Prev Med, V9, P152, DOI 10.1007/BF02898094; Ong MK, 2005, AM J PUBLIC HEALTH, V95, P969, DOI 10.2105/AJPH.2004.040667; Razavi D, 1999, EUR J CANCER, V35, P1238, DOI 10.1016/S0959-8049(99)00110-0; Ringen K, 2002, AM J IND MED, V42, P367, DOI 10.1002/ajim.10129; Sakurai M, 2012, METABOLISM, V61, P47, DOI 10.1016/j.metabol.2011.05.015; SALINA D, 1994, AM J COMMUN PSYCHOL, V22, P257, DOI 10.1007/BF02506865; Sawayama T, 2011, TEISHIN IGAKU, V63, P48; Shiffman S, 2005, TOB CONTROL, V14, P346, DOI 10.1136/tc.2004.009183; Shimizu J, 1999, JPN J PUBLIC HLTH, V46, P3; Takayama S, 2005, MANUAL SMOKING CESSA, P86; Tanaka H, 2006, J OCCUP HEALTH, V48, P175, DOI 10.1539/joh.48.175; Taniguchi C, 2011, JPN J TOB CONTROL, V6, P34; Terazawa T, 2001, Sangyo Eiseigaku Zasshi, V43, P207; Terry PE, 2011, POPUL HEALTH MANAG, V14, P117, DOI 10.1089/pop.2010.0026; The Japanese Circulation Society The Japan Lung Cancer Society The Japanese Cancer Association and The Japanese Respiratory Society, MAN SMOK CESS SUPP; Wu P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-300	41	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55836	10.1371/journal.pone.0055836	http://dx.doi.org/10.1371/journal.pone.0055836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098QM	23383289	Green Published, gold, Green Submitted			2022-12-25	WOS:000315563800190
J	Byrne, FL; Yang, L; Phillips, PA; Hansford, LM; Fletcher, JI; Ormandy, CJ; McCarroll, JA; Kavallaris, M				Byrne, F. L.; Yang, L.; Phillips, P. A.; Hansford, L. M.; Fletcher, J. I.; Ormandy, C. J.; McCarroll, J. A.; Kavallaris, M.			RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model	ONCOGENE			English	Article						orthotopic xenograft; cytoskeleton; cofilin; tubulin	CELL-MIGRATION; POOR-PROGNOSIS; EARLY RECURRENCE; ACTIN DYNAMICS; CANCER CELLS; LIM KINASES; RHO-KINASE; TUMOR; INVASION; MOTILITY	Metastatic neuroblastoma is an aggressive childhood cancer of neural crest origin. Stathmin, a microtubule destabilizing protein, is highly expressed in neuroblastoma although its functional role in this malignancy has not been addressed. Herein, we investigate stathmin's contribution to neuroblastoma tumor growth and metastasis. Small interfering RNA (siRNA)-mediated stathmin suppression in two independent neuroblastoma cell lines, BE(2)-C and SH-SY5Y, did not markedly influence cell proliferation, viability or anchorage-independent growth. In contrast, stathmin suppression significantly reduced cell migration and invasion in both the neuroblastoma cell lines. Stathmin suppression altered neuroblastoma cell morphology and this was associated with changes in the cytoskeleton, including increased tubulin polymer levels. Stathmin suppression also modulated phosphorylation of the actin-regulatory proteins, cofilin and myosin light chain (MLC). Treatment of stathmin-suppressed neuroblastoma cells with the ROCKI and ROCKII inhibitor, Y-27632, ablated MLC phosphorylation and returned the level of cofilin phosphorylation and cell invasion back to that of untreated control cells. ROCKII inhibition (H-1152) and siRNA suppression also reduced cofilin phosphorylation in stathmin-suppressed cells, indicating that ROCKII mediates stathmin's regulation of cofilin phosphorylation. This data demonstrates a link between stathmin and the regulation of cofilin and MLC phosphorylation via ROCK. To examine stathmin's role in neuroblastoma metastasis, stathmin short hairpin RNA (shRNA)\luciferase-expressing neuroblastoma cells were injected orthotopically into severe combined immunodeficiency-Beige mice, and tumor growth monitored by bioluminescent imaging. Stathmin suppression did not influence neuroblastoma cell engraftment or tumor growth. In contrast, stathmin suppression significantly reduced neuroblastoma lung metastases by 71% (P<0.008) compared with control. This is the first study to confirm a role for stathmin in hematogenous spread using a clinically relevant orthotopic cancer model, and has identified stathmin as an important contributor of cell invasion and metastasis in neuroblastoma.	[Byrne, F. L.; Yang, L.; McCarroll, J. A.; Kavallaris, M.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Tumour Biol & Targeting Program, Randwick, NSW 2031, Australia; [Phillips, P. A.] Univ New S Wales, Sch Med Sci, Pancreat Canc Translat Res Grp, Randwick, NSW 2031, Australia; [Hansford, L. M.] Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Fletcher, J. I.] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Expt Therapeut Program, Randwick, NSW 2031, Australia; [Ormandy, C. J.] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [McCarroll, J. A.; Kavallaris, M.] Univ New S Wales, Australian Ctr Nanomed, Randwick, NSW 2031, Australia	Children's Cancer Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's Cancer Institute; University of New South Wales Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Kavallaris, M (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Tumour Biol & Targeting Program, POB 81, Randwick, NSW 2031, Australia.	jmccarroll@ccia.unsw.edu.au; mkavallaris@ccia.unsw.edu.au	Kavallaris, Maria/J-5240-2014; Phillips, Phoebe A/E-6006-2010; McCarroll, Joshua/E-8481-2010; Ormandy, Chris/G-4165-2014; Fletcher, Jamie/V-4667-2019; Byrne, Frances/AAW-7748-2020	Phillips, Phoebe A/0000-0002-4481-8782; McCarroll, Joshua/0000-0001-8807-3623; Byrne, Frances/0000-0002-8897-8438; Ormandy, Christopher/0000-0002-2504-7919; Fletcher, Jamie/0000-0003-2949-9469	Children's Cancer Institute Australia for Medical Research; Anthony Rothe Memorial Trust; National Health and Medical Research Council (NHMRC); Cancer Council New South Wales Program Grant; Cure Cancer Australia Foundation Grant; Cancer Institute New South Wales Early Career Development Fellowship; NHMRC	Children's Cancer Institute Australia for Medical Research; Anthony Rothe Memorial Trust; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales Program Grant(Cancer Council New South Wales); Cure Cancer Australia Foundation Grant; Cancer Institute New South Wales Early Career Development Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank Dr Vladimir Ponomarev (Memorial Sloan Kettering Cancer Center) for kindly providing the TGL reporter vector, Dr Michael Shum and Dr Toby Trahair for helpful discussions and Zillan Neiron for technical assistance. Biological Resources Imaging Laboratory and the Biomedical Imaging Facility, Mark Wainwright Analytical Center, University of New South Wales. This study was financially supported by: Children's Cancer Institute Australia for Medical Research, which is affiliated with the University of New South Wales and the Sydney Children's Hospital. Funding from the Anthony Rothe Memorial Trust (F Byrne, The Anthony Rothe Scholarship) and grants from the National Health and Medical Research Council (NHMRC) (M Kavallaris and J McCarroll), Cancer Council New South Wales Program Grant (M Kavallaris), Cure Cancer Australia Foundation Grant (J McCarroll), Cancer Institute New South Wales Early Career Development Fellowship (J McCarroll, J Fletcher), NHMRC Career Development Fellowship (P Phillips) and an NHMRC Senior Research Fellowship (M Kavallaris).	Ara T, 2006, CANCER METAST REV, V25, P645, DOI 10.1007/s10555-006-9028-9; Balasubramani M, 2011, MUTAT RES-GEN TOX EN, V722, P154, DOI 10.1016/j.mrgentox.2010.08.019; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Campostrini N, 2004, J CHROMATOGR B, V808, P279, DOI 10.1016/j.jchromb.2004.05.013; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Don S, 2004, MOL CANCER THER, V3, P1137; DuBois SG, 1999, J PEDIAT HEMATOL ONC, V21, P181, DOI 10.1097/00043426-199905000-00005; DuBois SG, 2008, PEDIATR BLOOD CANCER, V51, P589, DOI 10.1002/pbc.21684; Gutierrez JC, 2007, PEDIATR SURG INT, V23, P637, DOI 10.1007/s00383-007-1933-7; Gutjahr MC, 2005, EXP CELL RES, V308, P422, DOI 10.1016/j.yexcr.2005.05.001; HAILAT N, 1990, ONCOGENE, V5, P1615; Henriksson KC, 2004, CLIN EXP METASTAS, V21, P563, DOI 10.1007/s10585-004-4091-5; Hsieh SY, 2010, MOL CARCINOGEN, V49, P476, DOI 10.1002/mc.20627; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jeon TY, 2010, BRIT J CANCER, V102, P710, DOI 10.1038/sj.bjc.6605537; Kadir S, 2011, J CELL SCI, V124, P2642, DOI 10.1242/jcs.087965; Khanna C, 2002, IN VIVO, V16, P77; McCarroll JA, 2010, CANCER RES, V70, P4995, DOI 10.1158/0008-5472.CAN-09-4487; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nevo I, 2008, NEOPLASIA, V10, P817, DOI 10.1593/neo.08402; Phillips PA, 2003, GUT, V52, P677, DOI 10.1136/gut.52.5.677; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Sadow PM, 2008, ENDOCR PATHOL, V19, P97, DOI 10.1007/s12022-008-9028-0; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Singer S, 2009, CANCER RES, V69, P2234, DOI 10.1158/0008-5472.CAN-08-3338; Takahashi K, 2010, CELL SIGNAL, V22, P510, DOI 10.1016/j.cellsig.2009.11.005; Takahashi K, 2009, CELL SIGNAL, V21, P695, DOI 10.1016/j.cellsig.2009.01.007; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; Torka R, 2006, EXP CELL RES, V312, P3857, DOI 10.1016/j.yexcr.2006.08.025; Trovik J, 2011, CLIN CANCER RES, V17, P3368, DOI 10.1158/1078-0432.CCR-10-2412; Wittmann T, 2001, J CELL SCI, V114, P3795; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011	40	52	53	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					882	890		10.1038/onc.2013.11	http://dx.doi.org/10.1038/onc.2013.11			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23396365				2022-12-25	WOS:000331626900009
J	Lowery, J; Szul, T; Styers, M; Holloway, Z; Oorschot, V; Klumperman, J; Sztul, E				Lowery, Jason; Szul, Tomasz; Styers, Melanie; Holloway, Zoe; Oorschot, Viola; Klumperman, Judith; Sztul, Elizabeth			The Sec7 Guanine Nucleotide Exchange Factor GBF1 Regulates Membrane Recruitment of BIG1 and BIG2 Guanine Nucleotide Exchange Factors to the Trans-Golgi Network (TGN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTORS; CLASS-II ARFS; BREFELDIN-A; ENDOPLASMIC-RETICULUM; RECYCLING ENDOSOMES; VESICULAR TRANSPORT; DISTINCT FUNCTIONS; PROTEIN-1 BIG1; LIVING CELLS; GGA PROTEINS	Three Sec7 guanine nucleotide exchange factors (GEFs) activate ADP-ribosylation factors (ARFs) to facilitate coating of transport vesicles within the secretory and endosomal pathways. GBF1 recruits COPI to pre-Golgi and Golgi compartments, whereas BIG1 and BIG2 recruit AP1 and GGA clathrin adaptors to the trans-Golgi network (TGN) and endosomes. Here, we report a functional cascade between these GEFs by showing that GBF1-activated ARFs (ARF4 and ARF5, but not ARF3) facilitate BIG1 and BIG2 recruitment to the TGN. We localize GBF1 ultrastructurally to the pre-Golgi, the Golgi, and also the TGN. Our findings suggest a model in which GBF1 localized within pre-Golgi and Golgi compartments mediates ARF activation to facilitate recruitment of COPI to membranes, whereas GBF1 localized at the TGN mediates ARF activation that leads to the recruitment of BIG1 and BIG2 to the TGN. Membrane-associated BIG1/2 then activates ARFs that recruit clathrin adaptors. In this cascade, an early acting GEF (GBF1) activates ARFs that mediate recruitment of late acting GEFs (BIG1/2) to coordinate coating events within the pre-Golgi/Golgi/TGN continuum. Such coordination may optimize the efficiency and/or selectivity of cargo trafficking through the compartments of the secretory pathway.	[Lowery, Jason; Szul, Tomasz; Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Styers, Melanie] Birmingham Southern Coll, Dept Biol, Birmingham, AL 35254 USA; [Holloway, Zoe; Oorschot, Viola] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Klumperman, Judith] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	University of Alabama System; University of Alabama Birmingham; University of Oxford; Wellcome Centre for Human Genetics; Utrecht University; Utrecht University Medical Center	Sztul, E (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, 1918 Univ Blvd,MCLM 668, Birmingham, AL 35233 USA.	esztul@uab.edu			National Science Foundation [NSF0744471]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Science Foundation Grant NSF0744471 (to E. S.).	Alvarez C, 2003, SYNTHESE, V134, P1; Barlowe C, 2000, TRAFFIC, V1, P371, DOI 10.1034/j.1600-0854.2000.010501.x; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Boal F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009898; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Cherfils J, 2005, BIOCHEM SOC T, V33, P635, DOI 10.1042/BST0330635; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Citterio C, 2006, P NATL ACAD SCI USA, V103, P2683, DOI 10.1073/pnas.0510571103; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Cobbold C, 2004, MOL MEMBR BIOL, V21, P59, DOI 10.1080/096870310001607350; Deng Y, 2009, EMBO REP, V10, P58, DOI 10.1038/embor.2008.221; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Duijsings D, 2009, TRAFFIC, V10, P316, DOI 10.1111/j.1600-0854.2008.00868.x; Francis MJ, 1999, J CELL SCI, V112, P1721; Gao YS, 1998, J BIOL CHEM, V273, P33825, DOI 10.1074/jbc.273.50.33825; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Ghosh P, 2004, EUR J CELL BIOL, V83, P257, DOI 10.1078/0171-9335-00374; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; Grzmil P, 2010, INT J DEV BIOL, V54, P1259, DOI 10.1387/ijdb.092959pg; Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922; Holloway ZG, 2007, AM J PHYSIOL-CELL PH, V293, pC1753, DOI 10.1152/ajpcell.00253.2007; Houghton FJ, 2009, CELL, V138, P787, DOI 10.1016/j.cell.2009.05.048; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Ishizaki R, 2006, GENES CELLS, V11, P949, DOI 10.1111/j.1365-2443.2006.00991.x; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kondo Y, 2012, CELL STRUCT FUNCT, V37, P141, DOI 10.1247/csf.12015; Kuroda F, 2007, P NATL ACAD SCI USA, V104, P3201, DOI 10.1073/pnas.0611696104; Lefrancois P, 2007, TRAFFIC, V8, P1440, DOI 10.1111/j.1600-0854.2007.00623.x; Li CP, 2011, EUR PHYS J-SPEC TOP, V193, P1, DOI 10.1140/epjst/e2011-01377-3; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lowery J, 2011, J BIOL CHEM, V286, P36898, DOI 10.1074/jbc.M111.230631; Lu L, 2005, METHOD ENZYMOL, V404, P432, DOI 10.1016/S0076-6879(05)04038-3; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Manolea F, 2010, MOL BIOL CELL, V21, P1836, DOI 10.1091/mbc.E10-01-0016; Mansour SJ, 1999, P NATL ACAD SCI USA, V96, P7968, DOI 10.1073/pnas.96.14.7968; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Nakayama K, 2003, CELL STRUCT FUNCT, V28, P431, DOI 10.1247/csf.28.431; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Padilla PI, 2004, P NATL ACAD SCI USA, V101, P2752, DOI 10.1073/pnas.0307345101; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Reaves BJ, 1998, MOL MEMBR BIOL, V15, P133, DOI 10.3109/09687689809074524; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Richardson BC, 2012, DEV CELL, V22, P799, DOI 10.1016/j.devcel.2012.02.006; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; SARASTE J, 1991, J CELL SCI, V100, P415; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shen XY, 2006, P NATL ACAD SCI USA, V103, P2635, DOI 10.1073/pnas.0510599103; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Storrie B, 2012, TRAFFIC, V13, P727, DOI 10.1111/j.1600-0854.2012.01343.x; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714; Yamaji R, 2000, P NATL ACAD SCI USA, V97, P2567, DOI 10.1073/pnas.97.6.2567; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	71	53	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11532	11545		10.1074/jbc.M112.438481	http://dx.doi.org/10.1074/jbc.M112.438481			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23386609	Green Published, hybrid			2022-12-25	WOS:000317915500059
J	Sigfridsson, KGV; Chernev, P; Leidel, N; Popovic-Bijelic, A; Graslund, A; Haumann, M				Sigfridsson, Kajsa G. V.; Chernev, Petko; Leidel, Nils; Popovic-Bijelic, Ana; Graslund, Astrid; Haumann, Michael			Rapid X-ray Photoreduction of Dimetal-Oxygen Cofactors in Ribonucleotide Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-FUNCTIONAL THEORY; PROTEIN-STRUCTURE DETERMINATION; BIOLOGICAL METAL CENTERS; TYROSYL RADICAL COFACTOR; FREE-ELECTRON LASERS; SITE H-CLUSTER; PHOTOSYSTEM-II; CHLAMYDIA-TRACHOMATIS; ACTIVE-SITE; CRYSTAL-STRUCTURE	Prototypic dinuclear metal cofactors with varying metallation constitute a class of O-2-activating catalysts in numerous enzymes such as ribonucleotide reductase. Reliable structures are required to unravel the reaction mechanisms. However, protein crystallography data may be compromised by x-ray photoreduction (XRP). We studied XPR of Fe(III) Fe(III) and Mn(III)-Fe(III) sites in the R2 subunit of Chlamydia trachomatis ribonucleotide reductase using x-ray absorption spectroscopy. Rapid and biphasic x-ray photoreduction kinetics at 20 and 80 K for both cofactor types suggested sequential formation of (III, II) and (II, II) species and similar redox potentials of iron and manganese sites. Comparing with typical x-ray doses in crystallography implies that (II, II) states are reached in < 1 s in such studies. First-sphere metal coordination and metal-metal distances differed after chemical reduction at room temperature and after XPR at cryogenic temperatures, as corroborated by model structures from density functional theory calculations. The inter-metal distances in the XPR-induced (II, II) states, however, are similar to R2 crystal structures. Therefore, crystal data of initially oxidized R2-type proteins mostly contain photoreduced (II, II) cofactors, which deviate from the native structures functional in O-2 activation, explaining observed variable metal ligation motifs. This situation may be remedied by novel femtosecond free electron-laser protein crystallography techniques.	[Popovic-Bijelic, Ana; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Sigfridsson, Kajsa G. V.; Chernev, Petko; Leidel, Nils; Haumann, Michael] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany	Stockholm University; Free University of Berlin	Haumann, M (corresponding author), Free Univ Berlin, FB Phys, Arnimallee 14, D-14195 Berlin, Germany.	michael.haumann@fu-berlin.de	MIchael, Haumann/A-7087-2013; Chernev, Petko/F-9964-2018; Popovic Bijelic, Ana/C-6314-2017; MS-Powder+MS-Surfdiff+Micro-XAS+Super-XAS, SLS/M-1551-2019	Chernev, Petko/0000-0002-2836-838X; Popovic Bijelic, Ana/0000-0003-3121-2391; Sigfridsson Clauss, Kajsa/0000-0002-7604-251X	Stiftelsen Bengt Lundqvist minne; Wenner-Gren foundation; Swedish Research Council; Heisenberg fellowship; Deutsche Forschungsgemeinschaft [Ha3265/3-1, Ha3265/6-1]	Stiftelsen Bengt Lundqvist minne; Wenner-Gren foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Heisenberg fellowship(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by fellowships from the "Stiftelsen Bengt Lundqvist minne" and the Wenner-Gren foundation. Present address: MAX IV Laboratory, Lund University, 22100 Lund, Sweden.; Supported by the Swedish Research Council.; Supported by a Heisenberg fellowship and Grants Ha3265/3-1 and Ha3265/6-1 from the Deutsche Forschungsgemeinschaft. To whom correspondence should be addressed: Freie Universitat Berlin, FB Physik, Arnimallee 14, 14195 Berlin, Germany. Fax: 49-30-8385-6299; E-mail: michael. haumann@fu-berlin.de.	Adam V, 2004, STRUCTURE, V12, P1729, DOI 10.1016/j.str.2004.07.013; Adrait A, 2002, BIOCHEMISTRY-US, V41, P6510, DOI 10.1021/bi012043d; Andersson CS, 2012, J AM CHEM SOC, V134, P123, DOI 10.1021/ja209678x; Andersson CS, 2009, P NATL ACAD SCI USA, V106, P5633, DOI 10.1073/pnas.0812971106; Baldwin J, 2003, BIOCHEMISTRY-US, V42, P13269, DOI 10.1021/bi035198p; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Boal AK, 2012, BIOCHEMISTRY-US, V51, P3861, DOI 10.1021/bi201925t; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Bollinger JM, 2008, CURR OPIN STRUC BIOL, V18, P650, DOI 10.1016/j.sbi.2008.11.007; Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Brignole EJ, 2012, BIOCHEM SOC T, V40, P523, DOI 10.1042/BST20120081; Burdi D, 1998, J AM CHEM SOC, V120, P12910, DOI 10.1021/ja9824270; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; CHEN S.-H., 2006, Nuclear Engineering and Technology, V38, P201; Chernev P, 2011, J BIOL CHEM, V286, P5368, DOI 10.1074/jbc.M110.202879; Cotelesage JJH, 2012, J INORG BIOCHEM, V115, P127, DOI 10.1016/j.jinorgbio.2012.06.019; Cotruvo JA, 2012, METALLOMICS, V4, P1020, DOI 10.1039/c2mt20142a; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Danford JJ, 2009, INORG CHEM, V48, P11352, DOI 10.1021/ic901890d; Dassama LMK, 2012, J AM CHEM SOC, V134, P2520, DOI 10.1021/ja211314p; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y; de Serrano VS, 2010, ACTA CRYSTALLOGR D, V66, P770, DOI 10.1107/S0907444910014605; Dubois L, 2006, CHEM COMMUN, P4521, DOI 10.1039/b609072a; Fromme P, 2011, CURR OPIN STRUC BIOL, V21, P509, DOI 10.1016/j.sbi.2011.06.001; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; GONZALEZ A, 1994, ACTA CRYSTALLOGR D, V50, P874, DOI 10.1107/S0907444994006311; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Griese JJ, 2012, METALLOMICS, V4, P894, DOI 10.1039/c2mt20080e; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Han WG, 2006, J INORG BIOCHEM, V100, P771, DOI 10.1016/j.jinorgbio.2006.01.032; Han WG, 2010, INORG CHEM, V49, P7266, DOI 10.1021/ic902051t; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Hermes S, 2006, BIOCHEMISTRY-US, V45, P353, DOI 10.1021/bi0515725; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3209, DOI 10.1073/pnas.0536684100; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Hogbom M, 2011, METALLOMICS, V3, P110, DOI 10.1039/c0mt00095g; Hogbom M, 2010, J BIOL INORG CHEM, V15, P339, DOI 10.1007/s00775-009-0606-5; Holton JM, 2009, J SYNCHROTRON RADIAT, V16, P133, DOI 10.1107/S0909049509004361; Hough MA, 2008, J MOL BIOL, V378, P353, DOI 10.1016/j.jmb.2008.01.097; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Kern J, 2012, P NATL ACAD SCI USA, V109, P9721, DOI 10.1073/pnas.1204598109; Kim JH, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3187544; Klockenkamper R., 1996, TOTAL REFLECTION XRA; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Krebs C, 2007, BIOCHEMISTRY-US, V46, P10413, DOI 10.1021/bi701060g; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Lambertz C, 2011, J BIOL CHEM, V286, P40614, DOI 10.1074/jbc.M111.283648; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; Leidel N, 2012, J AM CHEM SOC, V134, P14142, DOI 10.1021/ja304970p; Leidel N, 2012, BBA-BIOENERGETICS, V1817, P430, DOI 10.1016/j.bbabio.2011.12.008; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; LIU WT, 1993, INORG CHEM, V32, P4102, DOI 10.1021/ic00071a023; Logan DT, 1996, STRUCTURE, V4, P1053, DOI 10.1016/S0969-2126(96)00112-8; Lomoth R, 2002, EUR J INORG CHEM, P2965; Macedo S, 2009, J SYNCHROTRON RADIAT, V16, P191, DOI 10.1107/S0909049509003331; Magnuson A, 2006, J INORG BIOCHEM, V100, P1234, DOI 10.1016/j.jinorgbio.2006.02.001; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Mitic N, 2007, J AM CHEM SOC, V129, P9049, DOI 10.1021/ja070909i; Neese F., 2008, ORCA AB INITIO DFT S; Neutze R, 2012, CURR OPIN STRUC BIOL, V22, P651, DOI 10.1016/j.sbi.2012.08.006; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Petrie S, 2012, PHYS CHEM CHEM PHYS, V14, P11333, DOI 10.1039/c2cp41020f; Popovic-Bijelic A, 2009, BIOCHEMISTRY-US, V48, P6532, DOI 10.1021/bi900693s; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Purwar N, 2011, BIOCHEMISTRY-US, V50, P4491, DOI 10.1021/bi200130r; Que L, 2004, J BIOL INORG CHEM, V9, P684, DOI 10.1007/s00775-004-0574-8; Que L, 2002, ANGEW CHEM INT EDIT, V41, P1114; QUE L, 1991, SCIENCE, V253, P273, DOI 10.1126/science.1857963; Rasaiah JC, 2008, ANNU REV PHYS CHEM, V59, P713, DOI 10.1146/annurev.physchem.59.032607.093815; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Rehr JJ, 2006, RADIAT PHYS CHEM, V75, P1547, DOI 10.1016/j.radphyschem.2005.11.014; Riggs-Gelasco PJ, 1998, J AM CHEM SOC, V120, P849, DOI 10.1021/ja9718230; Roos K, 2011, J BIOL INORG CHEM, V16, P553, DOI 10.1007/s00775-011-0755-1; Roos K, 2009, BIOCHEMISTRY-US, V48, P1878, DOI 10.1021/bi801695d; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Schenk G, 2001, J BIOL CHEM, V276, P19084, DOI 10.1074/jbc.M009778200; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schlichting I, 2012, CURR OPIN STRUC BIOL, V22, P613, DOI 10.1016/j.sbi.2012.07.015; Seal P, 2008, J PHYS CHEM A, V112, P3409, DOI 10.1021/jp076654c; Shi WX, 2011, CURR OPIN CHEM BIOL, V15, P144, DOI 10.1016/j.cbpa.2010.11.004; Sinnecker S, 2004, J AM CHEM SOC, V126, P2613, DOI 10.1021/ja0390202; Sinnecker S, 2006, J PHYS CHEM A, V110, P2235, DOI 10.1021/jp056016z; SJOBERG BM, 1983, ADV INORG BIOCHEM, V5, P87; Sommerhalter M, 2005, INORG CHEM, V44, P770, DOI 10.1021/ic0485256; Stripp S, 2009, BIOCHEMISTRY-US, V48, P5042, DOI 10.1021/bi900010b; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; Tinberg CE, 2011, ACCOUNTS CHEM RES, V44, P280, DOI 10.1021/ar1001473; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VASS I, 1991, BIOCHEMISTRY-US, V30, P830, DOI 10.1021/bi00217a037; Visser H, 2001, J AM CHEM SOC, V123, P7031, DOI 10.1021/ja004306h; Voegtli WC, 2003, J AM CHEM SOC, V125, P15822, DOI 10.1021/ja0370387; Voevodskaya N, 2005, BIOCHEM BIOPH RES CO, V330, P1213, DOI 10.1016/j.bbrc.2005.03.104; Voevodskaya N, 2007, BBA-PROTEINS PROTEOM, V1774, P1254, DOI 10.1016/j.bbapap.2007.07.001; Voevodskaya N, 2007, FEBS LETT, V581, P3351, DOI 10.1016/j.febslet.2007.06.023; Voevodskaya N, 2009, J BIOL CHEM, V284, P4555, DOI 10.1074/jbc.M807190200; Weigend F, 2006, PHYS CHEM CHEM PHYS, V8, P1057, DOI 10.1039/b515623h; Westerheide L, 2000, CURR OPIN CHEM BIOL, V4, P235, DOI 10.1016/S1367-5931(99)00081-2; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; Wuerges J, 2004, P NATL ACAD SCI USA, V101, P8569, DOI 10.1073/pnas.0308514101; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yi J, 2010, BIOCHEMISTRY-US, V49, P5969, DOI 10.1021/bi100801g; Younker JM, 2008, J AM CHEM SOC, V130, P15022, DOI 10.1021/ja804365e; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zwart PH, 2003, ACTA CRYSTALLOGR D, V59, P2104, DOI 10.1107/S0907444903018596	115	28	28	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9648	9661		10.1074/jbc.M112.438796	http://dx.doi.org/10.1074/jbc.M112.438796			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23400774	hybrid, Green Published			2022-12-25	WOS:000317114000008
J	Desai, S; Liu, ZX; Yao, J; Patel, N; Chen, JQ; Wu, Y; Ahn, EEY; Fodstad, O; Tan, M				Desai, Shruti; Liu, Zixing; Yao, Jun; Patel, Nishant; Chen, Jieqing; Wu, Yun; Ahn, Erin Eun-Young; Fodstad, Oystein; Tan, Ming			Heat Shock Factor 1 (HSF1) Controls Chemoresistance and Autophagy through Transcriptional Regulation of Autophagy-related Protein 7 (ATG7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; PROMOTES; ACTIVATION; INDUCTION; INHIBITION; RESISTANCE; SURVIVAL; STRESS; PHOSPHORYLATION; OLIGOMERIZATION	Heat shock factor 1 (HSF1), a master regulator of heat shock responses, plays an important role in tumorigenesis. In this study we demonstrated that HSF1 is required for chemotherapeutic agent-induced cytoprotective autophagy through transcriptional up-regulation of autophagy-related gene ATG7. Interestingly, this is independent of the HSF1 heat shock response function. Treatment of cancer cells with the FDA-approved chemotherapeutic agent carboplatin induced autophagy and growth inhibition, which were significantly increased upon knockdown of HSF1. Mechanistic studies revealed that HSF1 regulates autophagy by directly binding to ATG7 promoter and transcriptionally up-regulating its expression. Significantly, breast cancer patient sample study revealed that a higher ATG7 expression level is associated with poor patient survival. This novel finding was further confirmed by analysis of two independent patient databases, demonstrating a prognostic value of ATG7. Furthermore, a strong positive correlation was observed between levels of HSF1 and ATG7 in triple-negative breast cancer patient samples, thus validating our in vitro findings. This is the first study identifying a critical role for HSF1 in controlling cytoprotective autophagy through regulation of ATG7, which is distinct from the HSF1 function in the heat shock response. This is also the first study demonstrating a prognostic value of ATG7 in breast cancer patients. These findings strongly argue that combining chemotherapeutic agents with autophagy inhibition by repressing HSF1/ATG7 axis represents a promising strategy for future cancer treatment.	[Desai, Shruti; Liu, Zixing; Ahn, Erin Eun-Young; Tan, Ming] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Yao, Jun] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Patel, Nishant] Northwest Florida State Coll, Dept Math, Niceville, FL 32578 USA; [Chen, Jieqing; Wu, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Fodstad, Oystein] Univ Oslo, Norwegian Radium Hosp, Dept Tumor Biol, N-0310 Oslo, Norway; [Tan, Ming] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36604 USA	University of South Alabama; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Oslo; University of South Alabama	Tan, M (corresponding author), Univ S Alabama, Mitchell Canc Inst, 1660 Spring Hill Ave, Mobile, AL 36604 USA.	mtan@usouthal.edu	Tan, Ming/ABD-5847-2021	Tan, Ming/0000-0003-2007-9898; Desai, Shruti/0000-0002-5234-5890; Ahn, Eun-Young Erin/0000-0001-8795-7734	National Institutes of Health Grant [R01CA149646]; Radium-hospitalets Legater Award [334003]; Vincent F. Kilborn, Jr. Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA149646] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radium-hospitalets Legater Award; Vincent F. Kilborn, Jr. Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA149646 (to M. T.). This work was also supported by Radium-hospitalets Legater Award Project 334003 (to M. T. and O. F.) and by The Vincent F. Kilborn, Jr. Cancer Research Foundation (to M. T.).	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Cen H, 2004, WORLD J GASTROENTERO, V10, P3122; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Desai S, 2010, MOL CANCER RES, V8, P907, DOI 10.1158/1541-7786.MCR-10-0131; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Hoang AT, 2000, AM J PATHOL, V156, P857, DOI 10.1016/S0002-9440(10)64954-1; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Lee YJ, 2008, CANCER RES, V68, P7550, DOI 10.1158/0008-5472.CAN-08-0129; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Lopez G, 2011, CANCER RES, V71, P185, DOI 10.1158/0008-5472.CAN-10-2799; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; Paglin S, 2001, CANCER RES, V61, P439; Perez EA, 2004, ONCOLOGIST, V9, P518, DOI 10.1634/theoncologist.9-5-518; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shousha S, 2008, HISTOPATHOLOGY, V53, P346, DOI 10.1111/j.1365-2559.2008.03075.x; Tan M, 2002, MOL CELL, V9, P993, DOI 10.1016/S1097-2765(02)00510-5; Uebersax J. S., 2006, TETMAT USER GUIDE V; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Zhao YH, 2011, CANCER RES, V71, P4585, DOI 10.1158/0008-5472.CAN-11-0127; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	46	93	101	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9165	9176		10.1074/jbc.M112.422071	http://dx.doi.org/10.1074/jbc.M112.422071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386620	Green Published, hybrid			2022-12-25	WOS:000316862200036
J	Greer, YE; Fields, AP; Brown, AMC; Rubin, JS				Greer, Yoshimi Endo; Fields, Alan P.; Brown, Anthony M. C.; Rubin, Jeffrey S.			Atypical Protein Kinase C iota Is Required for Wnt3a-dependent Neurite Outgrowth and Binds to Phosphorylated Dishevelled 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON GUIDANCE; NEURONAL POLARITY; EWINGS-SARCOMA; PKC-ZETA; WNT; CELLS; RYK; CENTROSOME; PATHWAY; GROWTH	Previously we reported that Wnt3a-dependent neurite outgrowth in Ewing sarcoma family tumor cell lines was mediated by Frizzled3, Dishevelled (Dvl), and c-Jun N-terminal kinase (Endo, Y., Beauchamp, E., Woods, D., Taylor, W. G., Toretsky, J. A., Uren, A., and Rubin, J. S. (2008) Mol. Cell. Biol. 28, 2368-2379). Subsequently, we observed that Dvl2/3 phosphorylation correlated with neurite outgrowth and that casein kinase 1 delta, one of the enzymes that mediate Wnt3a-dependent Dvl phosphorylation, was required for neurite extension (Greer, Y. E., and Rubin, J. S. (2011) J. Cell Biol. 192, 993-1004). However, the functional relevance of Dvl phosphorylation in neurite outgrowth was not established. Dvl1 has been shown by others to be important for axon specification in hippocampal neurons via an interaction with atypical PKC zeta, but the role of Dvl phosphorylation was not evaluated. Here we report that Ewing sarcoma family tumor cells express PKC iota but not PKC zeta. Wnt3a stimulated PKC iota activation and caused a punctate distribution of pPKC iota in the neurites and cytoplasm, with a particularly intense signal at the centrosome. Knockdown of PKC iota expression with siRNA reagents blocked neurite formation in response to Wnt3a. Aurothiomalate, a specific inhibitor of PKC iota/Par6 binding, also suppressed neurite extension. Wnt3a enhanced the co-immunoprecipitation of endogenous PKC iota and Dvl2. Although FLAG-tagged wild-type Dvl2 immunoprecipitated with PKC iota, a phosphorylation-deficient Dvl2 derivative did not. This derivative also was unable to rescue neurite outgrowth when endogenous Dvl2/3 was suppressed by siRNA (Gonzalez-Sancho, J. M., Greer, Y. E., Abrahams, C. L., Takigawa, Y., Baljinnyam, B., Lee, K. H., Lee, K. S., Rubin, J. S., and Brown, A. M. (2013) J. Biol. Chem. 288, 9428-9437). Taken together, these results suggest that site-specific Dvl2 phosphorylation is required for Dvl2 association with PKC iota. This interaction is likely to be one of the mechanisms essential for Wnt3a-dependent neurite outgrowth.	[Greer, Yoshimi Endo; Rubin, Jeffrey S.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Fields, Alan P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA; [Brown, Anthony M. C.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Cornell University	Rubin, JS (corresponding author), NCI, Bldg 37,Rm 2042,37 Convent Dr,MSC 4256, Bethesda, MD 20892 USA.	rubinj@mail.nih.gov	Greer, Yoshimi/K-2155-2019		National Institutes of Health [R01 CA123238, R01 CA081436-15]; Intramural Research Program of the National Institutes of Health; National Cancer Institute; Florida Biomedical Research Program [KG05-339710-03]; NATIONAL CANCER INSTITUTE [ZIABC011224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA123238 (to A. M. C. B.) and R01 CA081436-15 (to A. P. F.). This work was also supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and Florida Biomedical Research Program Grant KG05-339710-03 (to A. P. F.).	Bovolenta P, 2006, DEVELOPMENT, V133, P4399, DOI 10.1242/dev.02592; Bryan B, 2005, FEBS LETT, V579, P1015, DOI 10.1016/j.febslet.2004.12.074; CAVAZZANA AO, 1987, AM J PATHOL, V127, P507; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Endo Y, 2008, MOL CELL BIOL, V28, P2368, DOI 10.1128/MCB.01780-07; Endo Y, 2007, CANCER SCI, V98, P1311, DOI 10.1111/j.1349-7006.2007.00536.x; Frederick MJ, 2011, AM J PATHOL, V178, P548, DOI 10.1016/j.ajpath.2010.10.044; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Gonzalez-Sancho JM, 2013, J BIOL CHEM, V288, P9428, DOI 10.1074/jbc.M112.448480; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Higginbotham H, 2006, MOL CELL NEUROSCI, V32, P118, DOI 10.1016/j.mcn.2006.03.003; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kikuchi K, 2010, EMBO J, V29, P3470, DOI 10.1038/emboj.2010.221; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; LIPINSKI M, 1987, CANCER RES, V47, P183; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Malaterre J, 2007, FRONT BIOSCI-LANDMRK, V12, P492, DOI 10.2741/2077; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; NOGUERA R, 1992, LAB INVEST, V66, P143; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; Tanabe K, 2010, J NEUROSCI, V30, P16983, DOI 10.1523/JNEUROSCI.3352-10.2010; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Wang YS, 2002, J NEUROSCI, V22, P8563; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Yanfeng WA, 2011, DEV BIOL, V360, P132, DOI 10.1016/j.ydbio.2011.09.017; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603	43	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9438	9446		10.1074/jbc.M112.448282	http://dx.doi.org/10.1074/jbc.M112.448282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23396968	Green Published, hybrid			2022-12-25	WOS:000316862200060
J	Lobo, GP; Amengual, J; Baus, D; Shivdasani, RA; Taylor, D; von Lintig, J				Lobo, Glenn P.; Amengual, Jaume; Baus, Diane; Shivdasani, Ramesh A.; Taylor, Derek; von Lintig, Johannes			Genetics and Diet Regulate Vitamin A Production via the Homeobox Transcription Factor ISX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CAROTENE 15,15'-MONOOXYGENASE; RETINOIC ACID; CELLULAR UPTAKE; DOUBLE-TRACER; SR-BI; METABOLISM; CONVERSION; EXPRESSION; TRANSPORT; LOCALIZATION	Low dietary intake of beta-carotene is associated with chronic disease and vitamin A deficiency. beta-Carotene is converted to vitamin A in the intestine by the enzyme beta-carotene-15,15'-monoxygenase (BCMO1) to support vision, reproduction, immune function, and cell differentiation. Considerable variability for this key step in vitamin A metabolism, as reported in the human population, could be related to genetics and individual vitamin A status, but it is unclear how these factors influence beta-carotene metabolism and vitamin A homeostasis. Here we show that the intestine-specific transcription factor ISX binds to the Bcmo1 promoter. Moreover, upon induction by the beta-carotene derivative retinoic acid, this ISX binding decreased expression of a luciferase reporter gene in human colonic CaCo-2 cells indicating that ISX acts as a transcriptional repressor of BCMO1 expression. Mice deficient for this transcription factor displayed increased intestinal BCMO1 expression and produced significantly higher amounts of vitamin A from supplemental beta-carotene. The ISX binding site in the human BCMO1 promoter contains a common single nucleotide polymorphism that is associated with decreased conversion rates and increased fasting blood levels of beta-carotene. Thus, our study establishes ISX as a critical regulator of vitamin A production and provides a mechanistic explanation for how both genetics and diet can affect this process.	[Lobo, Glenn P.; Amengual, Jaume; Baus, Diane; Taylor, Derek; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Shivdasani, Ramesh A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Case Western Reserve University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol W341, 10900 Euclid Ave, Cleveland, OH 44106 USA.	johannes.vonlintig@case.edu	Lobo, Glenn P./AAI-9736-2020	von Lintig, Johannes/0000-0002-2079-2143	National Institutes of Health [EY019641, EY020551]; NATIONAL EYE INSTITUTE [R01EY019641, R01EY020551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019641 and EY020551.	Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Bachmann H, 2002, J NUTR, V132, P3616, DOI 10.1093/jn/132.12.3616; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Borel P, 1998, J LIPID RES, V39, P2250; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Castenmiller JJM, 1998, ANNU REV NUTR, V18, P19, DOI 10.1146/annurev.nutr.18.1.19; Choi MY, 2006, DEVELOPMENT, V133, P4119, DOI 10.1242/dev.02537; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; During A, 2005, J NUTR, V135, P2305, DOI 10.1093/jn/135.10.2305; Ferrucci L, 2009, AM J HUM GENET, V84, P123, DOI 10.1016/j.ajhg.2008.12.019; Grune T, 2010, J NUTR, V140, p2268S, DOI 10.3945/jn.109.119024; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hickenbottom SJ, 2002, AM J CLIN NUTR, V75, P900, DOI 10.1093/ajcn/75.5.900; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; Lietz G, 2012, J NUTR, V142, p161S, DOI 10.3945/jn.111.140756; Lietz G, 2010, ARCH BIOCHEM BIOPHYS, V502, P8, DOI 10.1016/j.abb.2010.06.032; Lin YM, 2000, AM J CLIN NUTR, V71, P1545; Lindqvist A, 2007, J NUTR, V137, P2346, DOI 10.1093/jn/137.11.2346; Lobo GP, 2008, HUM MOL GENET, V17, P2877, DOI 10.1093/hmg/ddn185; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Nassif NT, 2004, ONCOGENE, V23, P617, DOI 10.1038/sj.onc.1207059; Reboul E, 2006, J BIOL CHEM, V281, P4739, DOI 10.1074/jbc.M509042200; Reboul E, 2011, PROG LIPID RES, V50, P388, DOI 10.1016/j.plipres.2011.07.001; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Seino Y, 2008, J BIOL CHEM, V283, P4905, DOI 10.1074/jbc.M707928200; Sommer A, 2008, J NUTR, V138, P1835, DOI 10.1093/jn/138.10.1835; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; von Lintig J, 2012, J BIOL CHEM, V287, P1627, DOI 10.1074/jbc.R111.303990; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; VONLINTIG J, 1994, J BACTERIOL, V176, P495, DOI 10.1128/JB.176.2.495-503.1994; Wyss A, 2001, BIOCHEM J, V354, P521, DOI 10.1042/0264-6021:3540521	34	81	83	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9017	9027		10.1074/jbc.M112.444240	http://dx.doi.org/10.1074/jbc.M112.444240			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23393141	Green Published, hybrid			2022-12-25	WOS:000316862200021
J	Fillion, D; Cabana, J; Guillemette, G; Leduc, R; Lavigne, P; Escher, E				Fillion, Dany; Cabana, Jerome; Guillemette, Gaetan; Leduc, Richard; Lavigne, Pierre; Escher, Emanuel			Structure of the Human Angiotensin II Type 1 (AT1) Receptor Bound to Angiotensin II from Multiple Chemoselective Photoprobe Contacts Reveals a Unique Peptide Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; 3RD TRANSMEMBRANE DOMAIN; CONTAINING AMINO-ACIDS; AT(1) RECEPTOR; CRYSTAL-STRUCTURE; LIGAND-BINDING; 4-CARBOXYBENZOPHENONE-SENSITIZED PHOTOOXIDATION; EXTRACELLULAR DOMAINS; COVALENT ATTACHMENT; OPIOID RECEPTOR	Breakthroughs in G protein-coupled receptor structure determination based on crystallography have been mainly obtained from receptors occupied in their transmembrane domain core by low molecular weight ligands, and we have only recently begun to elucidate how the extracellular surface of G protein-coupled receptors (GPCRs) allows for the binding of larger peptide molecules. In the present study, we used a unique chemoselective photoaffinity labeling strategy, the methionine proximity assay, to directly identify at physiological conditions a total of 38 discrete ligand/receptor contact residues that form the extracellular peptide-binding site of an activated GPCR, the angiotensin II type 1 receptor. This experimental data set was used in homology modeling to guide the positioning of the angiotensin II (AngII) peptide within several GPCR crystal structure templates. We found that the CXC chemokine receptor type 4 accommodated the results better than the other templates evaluated; ligand/receptor contact residues were spatially grouped into defined interaction clusters with AngII. In the resulting receptor structure, a beta-hairpin fold in extracellular loop 2 in conjunction with two extracellular disulfide bridges appeared to open and shape the entrance of the ligand-binding site. The bound AngII adopted a somewhat vertical binding mode, allowing concomitant contacts across the extracellular surface and deep within the transmembrane domain core of the receptor. We propose that such a dualistic nature of GPCR interaction could be well suited for diffusible linear peptide ligands and a common feature of other peptidergic class A GPCRs.	[Fillion, Dany; Cabana, Jerome; Guillemette, Gaetan; Leduc, Richard; Lavigne, Pierre; Escher, Emanuel] Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Escher, E (corresponding author), Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Emanuel.Escher@USherbrooke.ca		Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research [MOP-69019, MOP-13193]; Quebec Chapter of the Heart and Stroke Foundation of Canada [G-09-ES-3595]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Quebec Chapter of the Heart and Stroke Foundation of Canada	This work was supported in part by Canadian Institutes of Health Research Grants MOP-69019 and MOP-13193 as well as Quebec Chapter of the Heart and Stroke Foundation of Canada Grant G-09-ES-3595 (to E.E.).	Arsenault J, 2010, BIOCHEM PHARMACOL, V80, P990, DOI 10.1016/j.bcp.2010.06.004; Baker M, 2010, NAT METHODS, V7, P429, DOI 10.1038/nmeth0610-429; BOBROWSKI K, 1992, J AM CHEM SOC, V114, P10279, DOI 10.1021/ja00052a025; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Clement M, 2005, J BIOL CHEM, V280, P27121, DOI 10.1074/jbc.M413653200; Clement M, 2006, J RECEPT SIG TRANSD, V26, P417, DOI 10.1080/10799890600923195; Clement M, 2009, J BIOL CHEM, V284, P26603, DOI 10.1074/jbc.M109.012922; Correa SAA, 2002, CAN J PHYSIOL PHARM, V80, P426, DOI 10.1139/y02-046; Correa SAA, 2002, REGUL PEPTIDES, V106, P33, DOI 10.1016/S0167-0115(02)00033-2; Costa-Neto CM, 2000, BRIT J PHARMACOL, V130, P1263, DOI 10.1038/sj.bjp.0703430; Costa-Neto CM, 2002, CAN J PHYSIOL PHARM, V80, P413, DOI 10.1139/y02-058; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Deseke E, 1998, EUR J ORG CHEM, V1998, P243, DOI 10.1002/(SICI)1099-0690(199802)1998:2<243::AID-EJOC243>3.0.CO;2-I; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Fillion D, 2010, J MED CHEM, V53, P2063, DOI 10.1021/jm9015747; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; GROBLEWSKI T, 1995, BIOCHEM BIOPH RES CO, V209, P153, DOI 10.1006/bbrc.1995.1483; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kage R, 1996, J BIOL CHEM, V271, P25797, DOI 10.1074/jbc.271.42.25797; Kaiser R, 1999, ANAL BIOCHEM, V266, P1, DOI 10.1006/abio.1998.2945; Karnik SS, 2003, TRENDS ENDOCRIN MET, V14, P431, DOI 10.1016/j.tem.2003.09.007; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Lanctot PM, 1999, BIOCHEMISTRY-US, V38, P8621, DOI 10.1021/bi9830516; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MARCINIAK B, 1993, J PHYS CHEM-US, V97, P11937, DOI 10.1021/j100148a015; MARCINIAK B, 1995, J PHYS CHEM-US, V99, P13560, DOI 10.1021/j100036a037; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Miura SI, 2008, MOL ENDOCRINOL, V22, P139, DOI 10.1210/me.2007-0312; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; NODA K, 1995, J BIOL CHEM, V270, P28511, DOI 10.1074/jbc.270.48.28511; NODA K, 1995, J BIOL CHEM, V270, P2284, DOI 10.1074/jbc.270.5.2284; OHYAMA K, 1995, REGUL PEPTIDES, V57, P141, DOI 10.1016/0167-0115(95)00030-F; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perlman S, 1997, MOL PHARMACOL, V51, P301, DOI 10.1124/mol.51.2.301; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rihakova L, 2002, J RECEPT SIGNAL TR R, V22, P297, DOI 10.1081/RRS-120014603; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Sachon E, 2002, J BIOL CHEM, V277, P50409, DOI 10.1074/jbc.M207242200; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Takezako T, 2004, J BIOL CHEM, V279, P15248, DOI 10.1074/jbc.M312728200; Tate JJ, 1998, NUCLEIC ACIDS RES, V26, P1421, DOI 10.1093/nar/26.6.1421; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Tzakos AG, 2003, EUR J BIOCHEM, V270, P849, DOI 10.1046/j.1432-1033.2003.03441.x; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weber PJA, 1997, J PEPT RES, V49, P375; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; YAMANO Y, 1995, J BIOL CHEM, V270, P14024, DOI 10.1074/jbc.270.23.14024; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S; Yan LP, 2010, J BIOL CHEM, V285, P2227, DOI 10.1074/jbc.M109.077180; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zuscik MJ, 1998, J BIOL CHEM, V273, P3401, DOI 10.1074/jbc.273.6.3401	69	35	35	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8187	8197		10.1074/jbc.M112.442053	http://dx.doi.org/10.1074/jbc.M112.442053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386604	Green Published, hybrid			2022-12-25	WOS:000316564500019
J	Lim, H; Kim, D; Lee, SJ				Lim, Hyoungsub; Kim, Donghoon; Lee, Sung Joong			Toll-like Receptor 2 Mediates Peripheral Nerve Injury-induced NADPH Oxidase 2 Expression in Spinal Cord Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROPATHIC PAIN; MECHANICAL ALLODYNIA; PROTEIN-KINASE; RAT MODEL; HYPERSENSITIVITY; ACTIVATION; PATHWAYS; P38; PHOSPHORYLATION; INTERLEUKIN-6	We have previously reported that NADPH oxidase 2 (Nox2) is up-regulated in spinal cord microglia after spinal nerve injury, demonstrating that it is critical for microglia activation and subsequent pain hypersensitivity. However, the mechanisms and molecules involved in Nox2 induction have not been elucidated. Previous studies have shown that Toll-like receptors (TLRs) are involved in nerve injury-induced spinal cord microglia activation. In this study, we investigated the role of TLR in Nox2 expression in spinal cord microglia after peripheral nerve injury. Studies using TLR knock-out mice have shown that nerve injury-induced microglial Nox2 up-regulation is abrogated in TLR2 but not in TLR3 or -4 knock-out mice. Intrathecal injection of lipoteichoic acid, a TLR2 agonist, induced Nox2 expression in spinal cord microglia both at them RNA and protein levels. Similarly, lipoteichoic acid stimulation induced Nox2 expression and reactive oxygen species production in primary spinal cord glial cells in vitro. Studies on intracellular signaling pathways indicate that NF-kappa B and p38 MAP kinase activation is required for TLR2-induced Nox2 expression in glial cells. Conclusively, our data show that TLR2 mediates nerve injury-induced Nox2 gene expression in spinal cord microglia via NF-kappa B and p38 activation and thereby may contribute to spinal cord microglia activation.	[Lim, Hyoungsub; Kim, Donghoon; Lee, Sung Joong] Seoul Natl Univ, Dent Res Inst, Dept Neurosci & Physiol, Seoul 110799, South Korea; [Lim, Hyoungsub; Kim, Donghoon; Lee, Sung Joong] Seoul Natl Univ, Sch Dent, Seoul 110799, South Korea; [Lim, Hyoungsub; Lee, Sung Joong] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Neurosci, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, SJ (corresponding author), Seoul Natl Univ, Sch Dent, Dept Neurosci & Physiol, 28 Yeongeon Dong, Seoul 110799, South Korea.	sjlee87@snu.ac.kr			National Research Foundation of Korea; Ministry of Education, Science, and Technology [2010-0002149, 2010-C00078, 2011-0000934, 2011-0027667]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (Grants 2010-0002149, 2010-C00078, 2011-0000934, and 2011-0027667).	Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kim D, 2010, P NATL ACAD SCI USA, V107, P14851, DOI 10.1073/pnas.1009926107; Koistinaho M, 2002, GLIA, V40, P175, DOI 10.1002/glia.10151; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Lin HY, 2011, J CELL PHYSIOL, V226, P1573, DOI 10.1002/jcp.22489; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzi P, 2004, J IMMUNOL, V172, P4941, DOI 10.4049/jimmunol.172.8.4941; Mei XP, 2011, NEUROSIGNALS, V19, P44, DOI 10.1159/000324293; Milligan ED, 2000, BRAIN RES, V861, P105, DOI 10.1016/S0006-8993(00)02050-3; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Schachtele SJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-35; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251	27	57	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7572	7579		10.1074/jbc.M112.414904	http://dx.doi.org/10.1074/jbc.M112.414904			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23386616	Green Published, hybrid			2022-12-25	WOS:000316455300014
J	Chang, KC; Hsu, CC; Liu, SH; Su, CC; Yen, CC; Lee, MJ; Chen, KL; Ho, TJ; Hung, DZ; Wu, CC; Lu, TH; Su, YC; Chen, YW; Huang, CF				Chang, Kai-Chih; Hsu, Ching-Cheng; Liu, Shing-Hwa; Su, Chin-Chuan; Yen, Cheng-Chieh; Lee, Ming-Jye; Chen, Kuo-Liang; Ho, Tsung-Jung; Hung, Dong-Zong; Wu, Chin-Ching; Lu, Tien-Hui; Su, Yi-Chang; Chen, Ya-Wen; Huang, Chun-Fa			Cadmium Induces Apoptosis in Pancreatic beta-Cells through a Mitochondria-Dependent Pathway: The Role of Oxidative Stress-Mediated c-Jun N-Terminal Kinase Activation	PLOS ONE			English	Article							BIOLOGICAL SAMPLES; INSULIN-SECRETION; URINARY CADMIUM; TOXIC METALS; EXPRESSION; GLUCOSE; DEATH; DYSFUNCTION; METABOLISM; P38	Cadmium (Cd), one of well-known highly toxic environmental and industrial pollutants, causes a number of adverse health effects and diseases in humans. The growing epidemiological studies have suggested a possible link between Cd exposure and diabetes mellitus (DM). However, the toxicological effects and underlying mechanisms of Cd-induced pancreatic beta-cell injury are still unknown. In this study, we found that Cd significantly decreased cell viability, and increased sub-G1 hypodiploid cells and annexin V-Cy3 binding in pancreatic beta-cell-derived RIN-m5F cells. Cd also increased intracellular reactive oxygen species (ROS) generation and malondialdehyde (MDA) production and induced mitochondrial dysfunction (the loss of mitochondrial membrane potential (MMP) and the increase of cytosolic cytochrome c release), the decreased Bcl-2 expression, increased p53 expression, poly (ADP-ribose) polymerase (PARP) cleavage, and caspase cascades, which accompanied with intracellular Cd accumulation. Pretreatment with the antioxidant N-acetylcysteine (NAC) effectively reversed these Cd-induced events. Furthermore, exposure to Cd induced the phosphorylations of c-jun N-terminal kinases (JNK), extracellular signal-regulated kinases (ERK) 1/2, and p38-mitogen-activated protein kinase (MAPK), which was prevented by NAC. Additionally, the specific JNK inhibitor SP600125 or JNK-specific small interference RNA (si-RNA) transfection suppressed Cd-induced beta-cell apoptosis and related signals, but not ERK1/2 and p38-MAPK inhibitors (PD98059 and SB203580) did not. However, the JNK inhibitor or JNK-specific si-RNA did not suppress ROS generation in Cd-treated cells. These results indicate that Cd induces pancreatic beta-cell death via an oxidative stress downstream-mediated JNK activation-triggered mitochondria-regulated apoptotic pathway.	[Chang, Kai-Chih; Hsu, Ching-Cheng; Lu, Tien-Hui; Chen, Ya-Wen] China Med Univ, Coll Med, Sch Med, Dept Physiol, Taichung, Taiwan; [Chang, Kai-Chih; Hsu, Ching-Cheng; Lu, Tien-Hui; Chen, Ya-Wen] China Med Univ, Coll Med, Sch Med, Grad Inst Basic Med Sci, Taichung, Taiwan; [Liu, Shing-Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Su, Chin-Chuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Changhua County, Taiwan; [Yen, Cheng-Chieh] Chung Shan Med Univ, Coll Hlth Care & Management, Dept Occupat Safety & Hlth, Taichung, Taiwan; [Yen, Cheng-Chieh] Chung Shan Med Univ Hosp, Dept Occupat Med, Taichung, Taiwan; [Lee, Ming-Jye] Peng Hu Hosp, Dept Surg, Makung City, Taiwan; [Lee, Ming-Jye] Execut Yuan, Dept Hlth, Taipei, Taiwan; [Chen, Kuo-Liang] China Med Univ Hosp, Dept Urol, Taichung, Taiwan; [Ho, Tsung-Jung; Su, Yi-Chang; Huang, Chun-Fa] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Hung, Dong-Zong] China Med Univ Hosp, Div Toxicol, Trauma & Emergency Ctr, Taichung, Taiwan; [Wu, Chin-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; National Taiwan University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chen, YW (corresponding author), China Med Univ, Coll Med, Sch Med, Dept Physiol, Taichung, Taiwan.	ywc@mail.cmu.edu.tw; cfhuang@mail.cmu.edu.tw		HSU, CHING-CHENG/0000-0002-8804-6171	National Science Council of Taiwan [NSC 98-2314-B-039-015, NSC 98-2815-C-039-031-B, NSC 100-2314-B-039-023-]; China Medical University, Taichung, Taiwan [CMU100-TC-01]; Central Region Hospital Alliance, Department of Health, Executive Yuan [9919]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taichung, Taiwan(China Medical University); Central Region Hospital Alliance, Department of Health, Executive Yuan; Taiwan Department of Health Clinical Trial and Research Center of Excellence	This study was supported by research grants form the National Science Council of Taiwan (NSC 98-2314-B-039-015, NSC 98-2815-C-039-031-B, and NSC 100-2314-B-039-023-), the China Medical University, Taichung, Taiwan (CMU100-TC-01), the Central Region Hospital Alliance, Department of Health, Executive Yuan (9919), and also supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi HI, 2008, DIABETES RES CLIN PR, V80, P280, DOI 10.1016/j.diabres.2007.12.021; Azevedo-Martins AK, 2006, TOXICOL IN VITRO, V20, P1106, DOI 10.1016/j.tiv.2006.02.007; Bagchi D, 2000, J BIOCHEM MOL TOXIC, V14, P33, DOI 10.1002/(SICI)1099-0461(2000)14:1<33::AID-JBT5>3.3.CO;2-P; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bernard A, 2008, INDIAN J MED RES, V128, P557; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHAPATWALA KD, 1982, DRUG CHEM TOXICOL, V5, P305, DOI 10.3109/01480548209041060; Chen YW, 2006, DIABETES, V55, P1614, DOI 10.2337/db06-0029; Chen YW, 2009, ISLETS, V1, P169, DOI 10.4161/isl.1.3.9262; Dorrell C, 2008, STEM CELL RES, V1, P183, DOI 10.1016/j.scr.2008.04.001; Edwards JR, 2009, TOXICOL APPL PHARM, V238, P289, DOI 10.1016/j.taap.2009.03.007; Galluzzi L, 2008, CELL CYCLE, V7, P1949, DOI 10.4161/cc.7.13.6222; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Gobe G, 2010, TOXICOL LETT, V198, P49, DOI 10.1016/j.toxlet.2010.04.013; Han JC, 2003, ARCH BIOCHEM BIOPHYS, V413, P213, DOI 10.1016/S0003-9861(03)00120-6; Haswell-Elkins M, 2008, ENVIRON RES, V106, P379, DOI 10.1016/j.envres.2007.10.004; Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988; Inaba T, 2005, TOXICOL LETT, V159, P192, DOI 10.1016/j.toxlet.2005.05.011; IPCS, 1992, ENV HLTH CRIT 134; ITHAKISSIOS DS, 1975, TOXICOL APPL PHARM, V31, P143, DOI 10.1016/0041-008X(75)90062-9; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kaneto Hideaki, 2005, Am J Ther, V12, P529, DOI 10.1097/01.mjt.0000178773.31525.c2; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; Kolachi NF, 2011, BIOL TRACE ELEM RES, V143, P196, DOI 10.1007/s12011-010-8879-7; Lei LJ, 2007, BIOMED ENVIRON SCI, V20, P295; Lei Li-jian, 2005, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V23, P45; Lei Li-jian, 2006, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V24, P3; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Lemarie A, 2004, FREE RADICAL BIO MED, V36, P1517, DOI 10.1016/j.freeradbiomed.2004.03.020; Liu Y, 2008, J CELL PHYSIOL, V217, P307, DOI 10.1002/jcp.21499; MERALI Z, 1980, BRIT J PHARMACOL, V69, P151, DOI 10.1111/j.1476-5381.1980.tb10895.x; Mokhtari D, 2008, ENDOCRINOLOGY, V149, P3046, DOI 10.1210/en.2007-0438; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pitocco Dario, 2010, Rev Diabet Stud, V7, P15, DOI 10.1900/RDS.2010.7.15; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2; Schwartz GG, 2003, DIABETES CARE, V26, P468, DOI 10.2337/diacare.26.2.468; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Son YO, 2010, TOXICOL SCI, V113, P127, DOI 10.1093/toxsci/kfp259; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; World Health Organization, 1993, WHO TECHN REP SER, V837; Xu BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019052; Yen CC, 2011, ARCH TOXICOL, V85, P565, DOI 10.1007/s00204-011-0709-y	49	117	123	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54374	10.1371/journal.pone.0054374	http://dx.doi.org/10.1371/journal.pone.0054374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405080	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400024
J	Isolani, ME; Abril, JF; Salo, E; Deri, P; Bianucci, AM; Batistoni, R				Isolani, Maria Emilia; Abril, Josep F.; Salo, Emili; Deri, Paolo; Bianucci, Anna Maria; Batistoni, Renata			Planarians as a Model to Assess In Vivo the Role of Matrix Metalloproteinase Genes during Homeostasis and Regeneration	PLOS ONE			English	Article							EXTRINSIC APOPTOTIC PATHWAY; EXTRACELLULAR-MATRIX; STEM-CELLS; SCHMIDTEA-MEDITERRANEA; TISSUE INHIBITORS; PROTECTIVE ROLES; BASAL LAMINA; EXPRESSION; TRANSCRIPTOME; MEMBRANE	Matrix metalloproteinases (MMPs) are major executors of extracellular matrix remodeling and, consequently, play key roles in the response of cells to their microenvironment. The experimentally accessible stem cell population and the robust regenerative capabilities of planarians offer an ideal model to study how modulation of the proteolytic system in the extracellular environment affects cell behavior in vivo. Genome-wide identification of Schmidtea mediterranea MMPs reveals that planarians possess four mmp-like genes. Two of them (mmp1 and mmp2) are strongly expressed in a subset of secretory cells and encode putative matrilysins. The other genes (mt-mmpA and mt-mmpB) are widely expressed in postmitotic cells and appear structurally related to membrane-type MMPs. These genes are conserved in the planarian Dugesia japonica. Here we explore the role of the planarian mmp genes by RNA interference (RNAi) during tissue homeostasis and regeneration. Our analyses identify essential functions for two of them. Following inhibition of mmp1 planarians display dramatic disruption of tissues architecture and significant decrease in cell death. These results suggest that mmp1 controls tissue turnover, modulating survival of postmitotic cells. Unexpectedly, the ability to regenerate is unaffected by mmp1(RNAi). Silencing of mt-mmpA alters tissue integrity and delays blastema growth, without affecting proliferation of stem cells. Our data support the possibility that the activity of this protease modulates cell migration and regulates anoikis, with a consequent pivotal role in tissue homeostasis and regeneration. Our data provide evidence of the involvement of specific MMPs in tissue homeostasis and regeneration and demonstrate that the behavior of planarian stem cells is critically dependent on the microenvironment surrounding these cells. Studying MMPs function in the planarian model provides evidence on how individual proteases work in vivo in adult tissues. These results have high potential to generate significant information for development of regenerative and anti cancer therapies.	[Isolani, Maria Emilia; Deri, Paolo; Batistoni, Renata] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Isolani, Maria Emilia; Bianucci, Anna Maria] Univ Pisa, Dipartimento Sci Farmaceut, Pisa, Italy; [Abril, Josep F.; Salo, Emili] Univ Barcelona, Dept Genet, Barcelona, Catalonia, Spain; [Abril, Josep F.; Salo, Emili] Univ Barcelona, Inst Biomed, Barcelona, Catalonia, Spain	University of Pisa; University of Pisa; University of Barcelona; University of Barcelona	Batistoni, R (corresponding author), Univ Pisa, Dipartimento Biol, Pisa, Italy.	rbatistoni@biologia.unipi.it	Salo, Emili/M-3928-2014; Ferrando, Josep F Abril/B-3877-2014	Salo, Emili/0000-0001-5460-9223; Ferrando, Josep F Abril/0000-0001-7793-589X	Fondazione Cassa di Risparmio di Volterra; Ministerio de Educacion y Ciencia (MEC) [BFU2011-22786, BFU2009-09102]	Fondazione Cassa di Risparmio di Volterra; Ministerio de Educacion y Ciencia (MEC)(Spanish Government)	This work was supported by Fondazione Cassa di Risparmio di Volterra to RB. This work was also funded by grants BFU2011-22786 from the Ministerio de Educacion y Ciencia (MEC) to ES and BFU2009-09102 from the MEC to JFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2011, TRENDS CELL BIOL, V21, P304, DOI 10.1016/j.tcb.2011.01.005; Abril JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-731; Adamidi C, 2011, GENOME RES, V21, P1193, DOI 10.1101/gr.113779.110; Adell T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000505; Agata K, 2007, DEV GROWTH DIFFER, V49, P73, DOI 10.1111/j.1440-169x.2007.00919.x; Altincicek B, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-6; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Banchetti R, 1973, REND ACCAD NAZ LINCE, V55, P107; Beaucher M, 2007, DEV BIOL, V303, P625, DOI 10.1016/j.ydbio.2006.12.001; Biljana E, 2000, J CELL ANIM BIOL, V5, P113; Blythe MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015617; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Das A, 2003, NEUROPATHOLOGY, V23, P275, DOI 10.1046/j.1440-1789.2003.00512.x; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Fata JE, 2000, CELL MOL LIFE SCI, V57, P77, DOI 10.1007/s000180050500; Fernandez-Taboada E, 2010, DEVELOPMENT, V137, P1055, DOI 10.1242/dev.042564; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Fu LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036707; Fu XY, 2008, SEMIN CELL DEV BIOL, V19, P2, DOI 10.1016/j.semcdb.2007.06.005; Fukushima K, 2007, BMC MUSCULOSKEL DIS, V28, P8; Gilles C, 2001, J CELL SCI, V114, P2967; Gondi CS, 2009, INT J ONCOL, V35, P851, DOI 10.3892/ijo_00000399; Gonzalez-Estevez C, 2007, P NATL ACAD SCI USA, V104, P13373, DOI 10.1073/pnas.0703588104; Gourevitch D, 2003, DEV DYNAM, V226, P377, DOI 10.1002/dvdy.10243; Guedelhoefer OC, 2012, DEVELOPMENT, V139, P3510, DOI 10.1242/dev.082099; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Hayashi T, 2010, DEV GROWTH DIFFER, V52, P131, DOI 10.1111/j.1440-169X.2009.01157.x; Higuchi S, 2007, DEV GROWTH DIFFER, V49, P571, DOI 10.1111/j.1440-169X.2007.00947.x; HORI I, 1991, International Journal of Developmental Biology, V35, P101; HORI I, 1979, TISSUE CELL, V11, P611, DOI 10.1016/0040-8166(79)90018-1; HORI I, 1979, RADIAT RES, V77, P521, DOI 10.2307/3575163; HORI I, 1980, TISSUE CELL, V12, P513, DOI 10.1016/0040-8166(80)90040-3; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Huxley-Jones J, 2008, DRUG DISCOV TODAY, V13, P685, DOI 10.1016/j.drudis.2008.05.005; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isolani ME, 2012, EUR J PHARMACOL, V686, P1, DOI 10.1016/j.ejphar.2012.03.036; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim YN, 2012, INT J CELL BIOL, V2012, P3068; King RS, 2012, J CELL BIOL, V196, P553, DOI 10.1083/jcb.201105099; Knapinska A, 2012, CHEMBIOCHEM, V13, P2002, DOI 10.1002/cbic.201200298; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Leontovich AA, 2000, DEVELOPMENT, V127, P907; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Liu H, 2008, MED ONCOL, V25, P419, DOI 10.1007/s12032-008-9057-z; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956; Mancini A, 2006, FRONT BIOSCI-LANDMRK, V11, P423, DOI 10.2741/1809; Mannello F, 2005, APOPTOSIS, V10, P19, DOI 10.1007/s10495-005-6058-7; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Menze MA, 2010, APOPTOSIS, V15, P293, DOI 10.1007/s10495-009-0443-6; Miller CM, 2008, DEVELOPMENT, V135, P95, DOI 10.1242/dev.011072; Mineta K, 2003, P NATL ACAD SCI USA, V100, P7666, DOI 10.1073/pnas.1332513100; Mitsiades N, 2001, CANCER RES, V61, P577; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Nogi T, 2005, DEV BIOL, V287, P314, DOI 10.1016/j.ydbio.2005.09.002; Oviedo NJ, 2008, DIS MODEL MECH, V1, P131, DOI 10.1242/dmm.000117; Page-McCaw A, 2008, SEMIN CELL DEV BIOL, V19, P14, DOI 10.1016/j.semcdb.2007.06.004; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park IS, 1999, MOL CELLS, V9, P119; Peiris TH, 2012, BIOCH BIOPHYS ACTA; Pellettieri J, 2010, DEV BIOL, V338, P76, DOI 10.1016/j.ydbio.2009.09.015; Pontius J., 2003, NCBI HDB, P1; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Reddien PW, 2008, DEV DYNAM, V237, P3099, DOI 10.1002/dvdy.21623; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rieger MR, 1991, PLATYHELMINTHES NEME, V3, P7; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rossi L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r62; Salo E, 2006, BIOESSAYS, V28, P546, DOI 10.1002/bies.20416; Salvetti A, 2000, DEV DYNAM, V218, P603, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1016>3.0.CO;2-C; Sandmann T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r76; Sarras MP, 2002, CELL RES, V12, P163, DOI 10.1038/sj.cr.7290123; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Sawada T, 1999, WOUND REPAIR REGEN, V7, P458, DOI 10.1046/j.1524-475X.1999.00458.x; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Sivakumar P, 1999, COMP BIOCHEM PHYS B, V123, P273, DOI 10.1016/S0305-0491(99)00067-X; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tessmar-Raible K, 2003, CURR OPIN GENET DEV, V13, P331, DOI 10.1016/S0959-437X(03)00086-8; Tu KC, 2012, DEV BIOL, V365, P458, DOI 10.1016/j.ydbio.2012.03.010; Umesono Y, 1997, DEV GROWTH DIFFER, V39, P723; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Vargo-Gogola T, 2002, CANCER RES, V62, P5559; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007; Wada K, 1998, GENE, V211, P57, DOI 10.1016/S0378-1119(98)00076-6; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yan L, 2000, DEV BIOL, V219, P115, DOI 10.1006/dbio.1999.9568; Yuan SC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000906; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	119	31	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55649	10.1371/journal.pone.0055649	http://dx.doi.org/10.1371/journal.pone.0055649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405188	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400133
J	Wei, XL; Shi, X; Zhong, W; Zhao, YT; Tang, YA; Sun, WL; Yin, XM; Bogdanov, B; Kim, S; McClain, C; Zhou, ZX; Zhang, X				Wei, Xiaoli; Shi, Xue; Zhong, Wei; Zhao, Yantao; Tang, Yunan; Sun, Wenlong; Yin, Xinmin; Bogdanov, Bogdan; Kim, Seongho; McClain, Craig; Zhou, Zhanxiang; Zhang, Xiang			Chronic Alcohol Exposure Disturbs Lipid Homeostasis at the Adipose Tissue-Liver Axis in Mice: Analysis of Triacylglycerols Using High-Resolution Mass Spectrometry in Combination with In Vivo Metabolite Deuterium Labeling	PLOS ONE			English	Article							SERUM LEPTIN LEVELS; FATTY LIVER; PROTECTIVE ACTION; CHRONIC ETHANOL; PATHOGENESIS; ROSIGLITAZONE; NORMALIZATION; ADIPONECTIN; CONTRIBUTES; EXPRESSION	A method of employing high-resolution mass spectrometry in combination with in vivo metabolite deuterium labeling was developed in this study to investigate the effects of alcohol exposure on lipid homeostasis at the white adipose tissue (WAT)-liver axis in a mouse model of alcoholic fatty liver. In order to differentiate the liver lipids synthesized from the fatty acids that were transported back from adipose tissue and the lipids synthesized from other sources of fatty acids, a two-stage mouse feeding experiment was performed to incorporate deuterium into metabolites. Hepatic lipids extracted from mouse liver, epididymal white adipose tissue (eWAT) and subcutaneous white adipose tissue (sWAT) were analyzed. It was found that 13 and 10 triacylglycerols (TGs) incorporated with a certain number of deuterium were significantly increased in alcohol induced fatty liver at two and four weeks of alcohol feeding periods, respectively. The concentration changes of these TGs ranged from 1.7 to 6.3-fold increase. A total of 14 deuterated TGs were significantly decreased in both eWAT and sWAT at the two and four weeks and the fold-change ranged from 0.19 to 0.77. The increase of deuterium incorporated TGs in alcohol-induced fatty liver and their decrease in both eWAT and sWAT indicate that alcohol exposure induces hepatic influx of fatty acids which are released from WATs. The results of time course analysis further indicate a mechanistic link between adipose fat loss and hepatic fat gain in alcoholic fatty liver.	[Wei, Xiaoli; Shi, Xue; Sun, Wenlong; Yin, Xinmin; Bogdanov, Bogdan; Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40292 USA; [Zhao, Yantao; Tang, Yunan; McClain, Craig] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Kim, Seongho] Univ Louisville, Bioinformat & Biostat Dept, Louisville, KY 40292 USA; [McClain, Craig] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [McClain, Craig] Univ Louisville, Alcohol Res Ctr, Louisville, KY 40292 USA; [McClain, Craig] Robley Rex Louisville VAMC, Louisville, KY USA; [Zhong, Wei; Zhou, Zhanxiang] Univ North Carolina Greensboro, Ctr Translat Biomed Res, Kannapolis, NC USA; [Zhong, Wei; Zhou, Zhanxiang] Univ North Carolina Greensboro, Dept Nutr, Kannapolis, NC USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro	Zhou, ZX (corresponding author), Univ North Carolina Greensboro, Ctr Translat Biomed Res, North Carolina Res Campus, Kannapolis, NC USA.	z_zhou@uncg.edu; xiang.zhang@louisville.edu	sun, wenlong/AAW-7486-2020; Shi, Xue/N-6907-2015; sun, wenlong/HCH-0574-2022	Shi, Xue/0000-0003-2040-7425; sun, wenlong/0000-0003-0164-8733	National Institutes of Health [1R01GM087735, R01AA018844, 1RC2AA019385, P01AA017103, P30AA019360, R01AA015970, R37AA010762, R01AA018016, R01AA018869, R01DK7071765]; Veteran's Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020212, R01AA018869, U01AA021901, R01AA018844, R01AA018016, RC2AA019385, P30AA019360, R37AA010762, R01AA015970, P01AA017103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants 1R01GM087735, R01AA018844, 1RC2AA019385, P01AA017103, P30AA019360, R01AA015970, R37AA010762, R01AA018016, R01AA018869, R01DK7071765, and Veteran's Affairs. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addolorato G, 1997, ALCOHOL CLIN EXP RES, V21, P962, DOI 10.1097/00000374-199709000-00003; Addolorato G, 1998, J INTERN MED, V244, P387; [Anonymous], 1932, STAT METHODS RES WOR; Astrand M, 2003, J COMPUT BIOL, V10, P95, DOI 10.1089/106652703763255697; Berk Paul D, 2005, Trans Am Clin Climatol Assoc, V116, P335; BERK PD, 2005, T AM CLIN CLIMAT ASS, V116, P345; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bradbury Michael W, 2004, Clin Liver Dis, V8, P639, DOI 10.1016/j.cld.2004.04.005; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Greco AV, 2000, J HEPATOL, V33, P38, DOI 10.1016/S0168-8278(00)80157-9; JANERO DR, 1984, J CELL BIOCHEM, V24, P131, DOI 10.1002/jcb.240240205; Kang L, 2007, J BIOL CHEM, V282, P28465, DOI 10.1074/jbc.M705503200; Kang L, 2006, ENDOCRINOLOGY, V147, P4330, DOI 10.1210/en.2006-0120; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Kharbanda KK, 2009, MOL CELL BIOCHEM, V327, P75, DOI 10.1007/s11010-009-0044-2; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Pouteau E, 2009, METHODS MOL BIOL, V579, P337, DOI 10.1007/978-1-60761-322-0_17; Santolaria F, 2003, ALCOHOL ALCOHOLISM, V38, P60, DOI 10.1093/alcalc/agg015; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Sozio MS, 2010, SEMIN LIVER DIS, V30, P378, DOI 10.1055/s-0030-1267538; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Sun XH, 2012, AM J PHYSIOL-GASTR L, V302, pG548, DOI 10.1152/ajpgi.00342.2011; Tahara M, 1999, J CLIN INVEST, V103, P313, DOI 10.1172/JCI4433; Tan XB, 2012, AM J PATHOL, V181, P1279, DOI 10.1016/j.ajpath.2012.06.013; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; Wei XL, 2011, ANAL CHEM, V83, P7668, DOI 10.1021/ac2017025; Xiao CT, 2011, AM J PHYSIOL-ENDOC M, V301, pE429, DOI 10.1152/ajpendo.00178.2011; Yao Z, 2012, CURR OPIN LIPIDOL; You M, 2005, HEPATOLOGY, V42, P568, DOI 10.1002/hep.20821; You M, 2009, EXP BIOL MED, V234, P850, DOI 10.3181/0902-MR-61; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017; Zhou SL, 1998, HEPATOLOGY, V27, P1064, DOI 10.1002/hep.510270423	36	51	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55382	10.1371/journal.pone.0055382	http://dx.doi.org/10.1371/journal.pone.0055382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405143	gold, Green Published			2022-12-25	WOS:000315153400088
J	Colucci, R; Gambaccini, D; Ghisu, N; Rossi, G; Costa, F; Tuccori, M; De Bortoli, N; Fornai, M; Antonioli, L; Ricchiuti, A; Mumolo, MG; Marchi, S; Blandizzi, C; Bellini, M				Colucci, Rocchina; Gambaccini, Dario; Ghisu, Narcisa; Rossi, Giuseppe; Costa, Francesco; Tuccori, Marco; De Bortoli, Nicola; Fornai, Matteo; Antonioli, Luca; Ricchiuti, Angelo; Mumolo, Maria Gloria; Marchi, Santino; Blandizzi, Corrado; Bellini, Massimo			Influence of the Serotonin Transporter 5HTTLPR Polymorphism on Symptom Severity in Irritable Bowel Syndrome	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; GENE-EXPRESSION; ASSOCIATION; DISTENSION; DEPRESSION; PROMOTER; PATHOPHYSIOLOGY; PATHOGENESIS; METAANALYSIS; ACTIVATION	5HTTLPR polymorphism of serotonin transporter yields short (S) and long (L) alleles. SS and LS genotypes are associated with reduced expression of serotonin transporter. This cross-sectional study investigated the association of 5HTTLPR with symptom severity of irritable bowel syndrome (IBS). Patients with IBS (Rome III) and healthy controls were included. Genomic DNA was extracted from saliva, and 5HTTLPR alleles were assessed by polymerase chain reaction. IBS symptom severity was evaluated by means of IBS-SSS questionnaire. Two hundreds and four IBS patients (159 females; mean age: 39.6 +/- 12.3 years; 106 with constipation: C-IBS; 98 with diarrhea: D-IBS) and 200 healthy controls (154 females; mean age: 40.4 +/- 15.8 years) were enrolled. The overall IBS-SSS value was higher in LS/SS than LL patients (319.0 +/- 71.5 versus 283.8 +/- 62.3; P = 0.0006). LS/SS patients had also higher values of abdominal pain (59.7 +/- 21.0 versus 51.0 +/- 18.8; P = 0.020) and bowel dissatisfaction (80.1 +/- 23.9 versus 70.5 +/- 22.8; P = 0.035). The overall IBS-SSS values in C-IBS and D-IBS patients were 317.2 +/- 68.3 and 296.1 +/- 71.4, respectively (P = 0.192), with significantly higher values for abdominal distension (65.0 +/- 24.4 versus 51.4 +/- 24.8; P = 0.0006), but not for bowel dissatisfaction (80.5 +/- 21.7 versus 72.9 +/- 25.7; P = 0.138). Frequencies of 5HTTLPR genotypes did not differ significantly when comparing IBS patients (overall or upon stratification in C-IBS and D-IBS) with healthy controls. In conclusion, the LS and SS genotypes are significantly correlated with IBS symptom severity, although their possible direct causal role remains to be proven. In addition, the present findings do not support an association of 5HTTLPR with IBS or its clinical presentation in terms of bowel habit predominance.	[Colucci, Rocchina; Ghisu, Narcisa; Tuccori, Marco; Fornai, Matteo; Antonioli, Luca; Blandizzi, Corrado] Univ Pisa, Dept Clin & Expt Med, Div Pharmacol & Chemotherapy, Pisa, Italy; [Gambaccini, Dario; Costa, Francesco; De Bortoli, Nicola; Ricchiuti, Angelo; Mumolo, Maria Gloria; Marchi, Santino; Bellini, Massimo] Univ Pisa, Gastroenterol Unit, Dept Translat Med, Pisa, Italy; [Rossi, Giuseppe] CNR, Inst Clin Physiol, Unit Epidemiol & Biostat, Pisa, Italy	University of Pisa; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Blandizzi, C (corresponding author), Univ Pisa, Dept Clin & Expt Med, Div Pharmacol & Chemotherapy, Pisa, Italy.	c.blandizzi@virgilio.it	Gambaccini, Dario/AAC-6716-2022; Blandizzi, Corrado/AAB-8736-2019; Rossi, Giuseppe/G-7838-2012; Tuccori, Marco/B-2113-2012	Gambaccini, Dario/0000-0002-6506-0253; DE BORTOLI, NICOLA/0000-0003-1995-1060; Costa, Francesco/0000-0002-9150-3345; COLUCCI, ROCCHINA LUCIA/0000-0002-2593-5457; bellini, massimo/0000-0002-6387-6443; FORNAI, MATTEO/0000-0002-0812-3959; BLANDIZZI, CORRADO/0000-0001-9927-5386	Italian Ministry of Education, University and Research (PRIN) [2007Z292XF_002]	Italian Ministry of Education, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The present work was supported by a grant from the Italian Ministry of Education, University and Research (PRIN 2007, Project number 2007Z292XF_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam B, 2007, NAT CLIN PRACT GASTR, V4, P102, DOI 10.1038/ncpgasthep0717; Brandt LJ, 2009, AM J GASTROENTEROL, V104, pS1, DOI 10.1038/ajg.2008.122; Camilleri M, 2008, AM J PHYSIOL-GASTR L, V295, pG219, DOI 10.1152/ajpgi.90202.2008; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V302, pG1075, DOI 10.1152/ajpgi.00537.2011; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen JX, 1998, AM J PHYSIOL-GASTR L, V275, pG433, DOI 10.1152/ajpgi.1998.275.3.G433; Colucci R, 2008, TRENDS MOL MED, V14, P295, DOI 10.1016/j.molmed.2008.05.001; Ford AC, 2009, GUT, V58, P367, DOI 10.1136/gut.2008.163162; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Fukudo S, 2009, NEUROIMAGE, V47, P946, DOI 10.1016/j.neuroimage.2009.04.083; Garrigues V, 2007, ALIMENT PHARM THER, V25, P323, DOI 10.1111/j.1365-2036.2006.03197.x; Gershon MD, 2005, J CLIN GASTROENTEROL, V39, pS184, DOI 10.1097/01.mcg.0000156403.37240.30; Gerson CD, 2008, EUR J GASTROEN HEPAT, V20, P659, DOI 10.1097/MEG.0b013e3282f53a24; Hamaguchi T, 2004, NEUROGASTROENT MOTIL, V16, P299, DOI 10.1111/j.1365-2982.2004.00498.x; Hasler WL, 2011, GASTROENTEROL CLIN N, V40, P21, DOI 10.1016/j.gtc.2010.12.004; Heils A, 1996, J NEUROCHEM, V66, P2621; Hranilovic D, 2004, BIOL PSYCHIAT, V55, P1090, DOI 10.1016/j.biopsych.2004.01.029; Kim DY, 2000, AM J GASTROENTEROL, V95, P2698, DOI 10.1016/S0002-9270(00)01970-5; Kim HJ, 2004, GUT, V53, P829, DOI 10.1136/gut.2003.030882; Kohen R, 2009, DIGEST DIS SCI, V54, P2663, DOI 10.1007/s10620-008-0666-3; Lee Dok Yong, 2004, Korean J Gastroenterol, V43, P18; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2001, EUR NEUROPSYCHOPHARM, V11, P457, DOI 10.1016/S0924-977X(01)00123-7; Li YY, 2007, DIGEST DIS SCI, V52, P2942, DOI 10.1007/s10620-006-9679-y; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Mawe GM, 2006, ALIMENT PHARM THER, V23, P1067, DOI 10.1111/j.1365-2036.2006.02858.x; MAYER EA, 1994, GASTROENTEROLOGY, V107, P271, DOI 10.1016/0016-5085(94)90086-8; Mertz H, 2000, GASTROENTEROLOGY, V118, P842, DOI 10.1016/S0016-5085(00)70170-3; Niesler B, 2010, EUR J GASTROEN HEPAT, V22, P856, DOI 10.1097/MEG.0b013e32832e9d6b; Noskova T, 2008, PROG NEURO-PSYCHOPH, V32, P1735, DOI 10.1016/j.pnpbp.2008.07.012; Ohman L, 2007, DIGEST LIVER DIS, V39, P201, DOI 10.1016/j.dld.2006.10.014; Park JM, 2006, NEUROGASTROENT MOTIL, V18, P995, DOI 10.1111/j.1365-2982.2006.00829.x; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Saito YA, 2007, NEUROGASTROENT MOTIL, V19, P465, DOI 10.1111/j.1365-2982.2007.00905.x; Saito YA, 2011, GASTROENTEROL CLIN N, V40, P45, DOI 10.1016/j.gtc.2010.12.011; Serretti A, 2006, CURR DRUG TARGETS, V7, P1659, DOI 10.2174/138945006779025419; Sikander A, 2009, J CLIN GASTROENTEROL, V43, P957, DOI 10.1097/MCG.0b013e3181b37e8c; Smits KM, 2004, MOL PSYCHIATR, V9, P433, DOI 10.1038/sj.mp.4001488; Spiller R, 2007, LANCET, V369, P1586, DOI 10.1016/S0140-6736(07)60726-0; Van Kerkhoven LAS, 2007, ALIMENT PHARM THER, V26, P979, DOI 10.1111/j.1365-2036.2007.03453.x; Wang YM, 2012, NEUROGASTROENT MOTIL, V24, P560, DOI 10.1111/j.1365-2982.2012.01902.x; Yeo A, 2004, GUT, V53, P1452, DOI 10.1136/gut.2003.035451	43	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54831	10.1371/journal.pone.0054831	http://dx.doi.org/10.1371/journal.pone.0054831			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393559	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800013
J	Gaikwad, SM; Gunjal, L; Junutula, AR; Astanehe, A; Gambhir, SS; Ray, P				Gaikwad, Snehal M.; Gunjal, Lata; Junutula, Anitha R.; Astanehe, Arezoo; Gambhir, Sanjiv Sam; Ray, Pritha			Non-Invasive Imaging of Phosphoinositide-3-Kinase-Catalytic-Subunit-Alpha (PIK3CA) Promoter Modulation in Small Animal Models	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FUSION REPORTER GENE; LIVING SUBJECTS; OVARIAN-CANCER; FLUORESCENT PROTEINS; BREAST-CANCER; RESISTANCE; CELLS; PI3K; P53	Activation of the PI3K/Akt pathway, a critical step for survival in cancer cells is often associated with decreased sensitivity to several chemotherapeutic drugs. PIK3CA gene amplification is observed in 16-24% of epithelial ovarian cancer (EOC) patients in conjunction with p53 mutations. A 900 bp long PIK3CA promoter is shown to be negatively regulated by p53 in ovarian surface epithelial cells but the consequence of chemotherapeutic drug treatments on this promoter in ovarian cancer cells is largely unknown. We aim to study the modulation of this promoter by cisplatin using an improved fusion reporter in ovarian cancer cells and tumor xenografts by non-invasive imaging approach. A PIK3CA sensor was developed using a bi-fusion reporter from a newly constructed library of bi- and tri-fusion vectors comprising of two mutant far red fluorescent proteins (mcherry/mch and tdTomato/tdt), a mutant firefly luciferase (fluc2), and a PET reporter protein (ttk). In vivo imaging of mice implanted with 293T cells transiently expressing these bi- and tri-fusion reporters along with respective controls revealed comparable activity of each reporter in the fusion background and fluc2-tdt as the most sensitive one. Repression of the PIK3CA sensor by drugs was inversely proportional to cellular p53 level in a germline (PA1) and in an EOC (A2780) cell line but not in a p53 deficient EOC (SKOV3) cell line. Bioluminescence imaging of tumor xenografts stably expressing the PIK3CA sensor in PA1 and A2780 cells exhibited attenuating activity without any change in SKOV3 tumors expressing the PIK3CA sensor after cisplatin treatment. Sequential mutation at p53 binding sites showed gradual increase in promoter activity and decreased effects of the drugs. These newly developed PIK3CA-fluc2-tdt and the mutant reporter sensors thus would be extremely useful for screening new drugs and for functional assessment of PIK3CA expression from intact cells to living subjects.	[Gaikwad, Snehal M.; Gunjal, Lata; Ray, Pritha] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India; [Junutula, Anitha R.; Gambhir, Sanjiv Sam] Stanford Univ, Sch Med, Bio X Program,Mol Imaging Program Stanford, Dept Radiol,Dept Mat Sci & Engn, Palo Alto, CA 94304 USA; [Junutula, Anitha R.; Gambhir, Sanjiv Sam] Stanford Univ, Sch Med, Bio X Program, Dept Bioengn,Dept Mat Sci & Engn, Palo Alto, CA 94304 USA; [Astanehe, Arezoo] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Stanford University; Stanford University; University of British Columbia	Ray, P (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India.	pray@actrec.gov.in	Gaikwad, Snehal/K-2858-2019; Gaikwad, Snehal/AAJ-7984-2020	Gaikwad, Snehal/0000-0002-3366-4116	ACTREC [IRG-2698]; CSIR [27(232)/10]; NIH In Vivo Cellular and Molecular Imaging Centre grant (ICMIC) [P50CA114747]; Council of Scientific and Industrial Research (India); NATIONAL CANCER INSTITUTE [P50CA114747] Funding Source: NIH RePORTER	ACTREC; CSIR(Council of Scientific & Industrial Research (CSIR) - India); NIH In Vivo Cellular and Molecular Imaging Centre grant (ICMIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by ACTREC start up fund, IRG-2698 and CSIR 27(232)/10 (PR), NIH In Vivo Cellular and Molecular Imaging Centre grant (ICMIC grant P50CA114747) (SSG). SMG acknowledges fellowship funding from Council of Scientific and Industrial Research (India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini MR, 2009, ONCOGENE, P11; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Astanehe A, 2008, J CELL SCI, V121, P664, DOI 10.1242/jcs.013029; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; DeBlasio SL, 2010, BRIEF FUNCT GENOMICS, V9, P129, DOI 10.1093/bfgp/elp060; Doubrovin M, 2004, BIOCONJUGATE CHEM, V15, P1376, DOI 10.1021/bc0498572; Fraser Michael, 2003, Reprod Biol Endocrinol, V1, P66, DOI 10.1186/1477-7827-1-66; Gaikwad SM, 2012, AM J NUCL MED MOLEC, V2, P418; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; Kolasa IK, 2009, CANCER BIOL THER, V8, P21, DOI 10.4161/cbt.8.1.7209; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Massoud TF, 2007, CURR OPIN BIOTECH, V18, P31, DOI 10.1016/j.copbio.2007.01.007; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Mayer-Kuckuk P, 2004, BIOL CHEM, V385, P353, DOI 10.1515/BC.2004.039; Min JJ, 2006, ANN NUCL MED, V20, P165, DOI 10.1007/BF03027425; Prasad SB, 2006, ASIAN J EXP SCI, V20, P55; Rakovitch E, 1999, INT J RADIAT ONCOL, V44, P1119, DOI 10.1016/S0360-3016(99)00109-1; Ray P, 2003, CANCER RES, V63, P1160; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; Ray P, 2001, SEMIN NUCL MED, V31, P312, DOI 10.1053/snuc.2001.26209; Ray P, 2008, CLIN CANCER RES, V14, P5801, DOI 10.1158/1078-0432.CCR-07-5244; Ray P, 2007, CANCER RES, V67, P3085, DOI 10.1158/0008-5472.CAN-06-2402; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shu CYJ, 2005, P NATL ACAD SCI USA, V102, P17412, DOI 10.1073/pnas.0508698102; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Winnard PT, 2006, NEOPLASIA, V8, P796, DOI 10.1593/neo.06304; Yaghoubi SS, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2821415; Yang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001758; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	36	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55971	10.1371/journal.pone.0055971	http://dx.doi.org/10.1371/journal.pone.0055971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393606	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800061
J	Orman, MA; Ierapetritou, MG; Androulakis, IP; Berthiaume, F				Orman, Mehmet A.; Ierapetritou, Marianthi G.; Androulakis, Ioannis P.; Berthiaume, Francois			Effect of Fasting on the Metabolic Response of Liver to Experimental Burn Injury	PLOS ONE			English	Article							RAT-LIVER; GENE-EXPRESSION; AMINO-ACID; BALANCE ANALYSIS; PERFUSED LIVERS; FLUX ANALYSIS; HYPERMETABOLIC LIVERS; THERMAL-INJURY; GLUCOSE; MODEL	Liver metabolism is altered after systemic injuries such as burns and trauma. These changes have been elucidated in rat models of experimental burn injury where the liver was isolated and perfused ex vivo. Because these studies were performed in fasted animals to deplete glycogen stores, thus simplifying quantification of gluconeogenesis, these observations reflect the combined impact of fasting and injury on liver metabolism. Herein we asked whether the metabolic response to experimental burn injury is different in fed vs. fasted animals. Rats were subjected to a cutaneous burn covering 20% of the total body surface area, or to similar procedures without administering the burn, hence a sham-burn. Half of the animals in the burn and sham-burn groups were fasted starting on postburn day 3, and the others allowed to continue ad libitum. On postburn day 4, livers were isolated and perfused for 1 hour in physiological medium supplemented with 10% hematocrit red blood cells. The uptake/release rates of major carbon and nitrogen sources, oxygen, and carbon dioxide were measured during the perfusion and the data fed into a mass balance model to estimate intracellular fluxes. The data show that in fed animals, injury increased glucose output mainly from glycogen breakdown and minimally impacted amino acid metabolism. In fasted animals, injury did not increase glucose output but increased urea production and the uptake of several amino acids, namely glutamine, arginine, glycine, and methionine. Furthermore, sham-burn animals responded to fasting by triggering gluconeogenesis from lactate; however, in burned animals the preferred gluconeogenic substrate was amino acids. Taken together, these results suggest that the fed state prevents the burn-induced increase in hepatic amino acid utilization for gluconeogenesis. The role of glycogen stores and means to increase and/or maintain internal sources of glucose to prevent increased hepatic amino acid utilization warrant further studies.	[Orman, Mehmet A.; Ierapetritou, Marianthi G.; Androulakis, Ioannis P.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ USA; [Androulakis, Ioannis P.; Berthiaume, Francois] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Berthiaume, F (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA.	fberthia@rci.rutgers.edu	Ierapetritou, Marianthi/GVT-1369-2022; Berthiaume, Francois/ABD-2139-2020		National Institutes of Health [GM082974]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge the financial support from National Institutes of Health grant GM082974. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon RR, 2008, J PHARMACOL EXP THER, V326, P700, DOI 10.1124/jpet.108.140186; Arai K, 2001, HEPATOLOGY, V34, P360, DOI 10.1053/jhep.2001.26515; Banta S, 2005, J SURG RES, V127, P93, DOI 10.1016/j.jss.2005.01.001; Banta S, 2007, BIOTECHNOL BIOENG, V97, P118, DOI 10.1002/bit.21200; BESSEY PQ, 1989, WORLD J SURG, V13, P465, DOI 10.1007/BF01660758; BIOLO G, 1997, NUTRITION S, V13, P52; Chan C, 2003, BIOTECHNOL BIOENG, V81, P33, DOI 10.1002/bit.10453; Chan C, 2003, METAB ENG, V5, P1, DOI 10.1016/S1096-7176(02)00011-3; Chen CY, 2003, FORTUNE, V148, P52; HERNDON DN, 1978, J SURG RES, V25, P394, DOI 10.1016/S0022-4804(78)80003-1; Herndon DN, 2004, LANCET, V363, P1895, DOI 10.1016/S0140-6736(04)16360-5; Hu RH, 1998, J SURG RES, V75, P153, DOI 10.1006/jsre.1998.5274; Izamis ML, 2011, BIOTECHNOL BIOENG, V108, P839, DOI 10.1002/bit.22998; Jeschke MG, 2001, ARCH SURG-CHICAGO, V136, P1301, DOI 10.1001/archsurg.136.11.1301; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Lee K, 2003, BIOTECHNOL BIOENG, V83, P400, DOI 10.1002/bit.10682; Lee K, 2000, METAB ENG, V2, P312, DOI 10.1006/mben.2000.0160; Lohmann R, 1999, AM J PHYSIOL-GASTR L, V276, pG743, DOI 10.1152/ajpgi.1999.276.3.G743; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; MORTIMORE GE, 1984, P NUTR SOC, V43, P161, DOI 10.1079/PNS19840039; Nguyen TT, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-279; Nolan RP, 2006, METAB ENG, V8, P30, DOI 10.1016/j.ymben.2005.08.004; Orman MA, 2012, J THEOR BIOL, V293, P101, DOI 10.1016/j.jtbi.2011.10.019; Orman MA, 2011, BIOTECHNOL BIOENG, V108, P2947, DOI 10.1002/bit.23261; Orman MA, 2011, J THEOR BIOL, V272, P131, DOI 10.1016/j.jtbi.2010.11.042; Orman MA, 2010, BIOTECHNOL BIOENG, V107, P825, DOI 10.1002/bit.22878; Ovacik MA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-540; Rutter MT, 2004, J MOL EVOL, V58, P218, DOI 10.1007/s00239-003-2546-y; Schwarz R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-135; Soares AF, 2010, METAB ENG, V12, P552, DOI 10.1016/j.ymben.2010.08.002; Soares AF, 2009, MAGN RESON MED, V61, P1, DOI 10.1002/mrm.21830; Vemula M, 2004, PHYSIOL GENOMICS, V18, P87, DOI 10.1152/physiolgenomics.00189.2003; WALKER HL, 1968, J TRAUM, V8, P1049, DOI 10.1097/00005373-196811000-00006; Wilmore DW, 2001, J NUTR, V131, p2543S, DOI 10.1093/jn/131.9.2543S; WOLFE RR, 1987, NEW ENGL J MED, V317, P403, DOI 10.1056/NEJM198708133170702; Yamaguchi Y, 1997, SURGERY, V121, P295, DOI 10.1016/S0039-6060(97)90358-5; Yang H, 2011, OMICS, V15, P449, DOI 10.1089/omi.2010.0070; Yang Q, 2011, J SURG RES; Yarmush DM, 1999, J BURN CARE REHABIL, V20, P292, DOI 10.1097/00004630-199907000-00004; Yu YM, 2001, AM J PHYSIOL-ENDOC M, V280, pE509, DOI 10.1152/ajpendo.2001.280.3.E509	40	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54825	10.1371/journal.pone.0054825	http://dx.doi.org/10.1371/journal.pone.0054825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393558	gold, Green Published			2022-12-25	WOS:000314692800012
J	Foster, PG; Bergo, ES; Bourke, BP; Oliveira, TMP; Nagaki, SS; Sant'Ana, DC; Sallum, MAM				Foster, Peter G.; Bergo, Eduardo S.; Bourke, Brian P.; Oliveira, Tatiane M. P.; Nagaki, Sandra S.; Sant'Ana, Denise C.; Sallum, Maria Anice M.			Phylogenetic Analysis and DNA-based Species Confirmation in Anopheles (Nyssorhynchus)	PLOS ONE			English	Article							MITOCHONDRIAL GENOME PHYLOGENY; INTERNAL TRANSCRIBED SPACER; DIPTERA-CULICIDAE; COMPLEX DIPTERA; MALARIA VECTOR; MYZORHYNCHELLA SECTION; PLASMODIUM-FALCIPARUM; ALBITARSIS COMPLEX; RIBOSOMAL DNA; NUCLEAR	Specimens of neotropical Anopheles (Nyssorhynchus) were collected and identified morphologically. We amplified three genes for phylogenetic analysis-the single copy nuclear white and CAD genes, and the COI barcode region. Since we had multiple specimens for most species we were able to test how well the single or combined genes were able to corroborate morphologically defined species by placing the species into exclusive groups. We found that single genes, including the COI barcode region, were poor at confirming species, but that the three genes combined were able to do so much better. This has implications for species identification, species delimitation, and species discovery, and we caution that single genes are not enough. Higher level groupings were partially resolved with some well-supported groupings, whereas others were found to be either polyphyletic or paraphyletic. There were examples of known groups, such as the Myzorhynchella Section, which were poorly supported with single genes but were well supported with combined genes. From this we can infer that more sequence data will be needed in order to show more higher-level groupings with good support. We got unambiguously good support (0.94-1.0 Bayesian posterior probability) from all DNA-based analyses for a grouping of An. dunhami with An. nuneztovari and An. goeldii, and because of this and because of morphological similarities we propose that An. dunhami be included in the Nuneztovari Complex. We obtained phylogenetic corroboration for new species which had been recognised by morphological differences; these will need to be formally described and named.	[Foster, Peter G.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Bergo, Eduardo S.] Secretaria Estado Saude Sao Paulo, Sao Paulo, Brazil; [Bourke, Brian P.; Oliveira, Tatiane M. P.; Nagaki, Sandra S.; Sant'Ana, Denise C.; Sallum, Maria Anice M.] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil	Natural History Museum London; Universidade de Sao Paulo	Foster, PG (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	p.foster@nhm.ac.uk	Oliveira, Tatiane/O-6518-2014; Bourke, Brian/A-9985-2012; Bergo, Eduardo/F-5374-2014; Sallum, Maria Anice Mureb/B-8537-2012; Nagaki, Sandra Sayuri/G-7069-2016	Bourke, Brian/0000-0002-2638-0967; Bergo, Eduardo/0000-0003-4928-0368; Sallum, Maria Anice Mureb/0000-0002-7051-2891; Foster, Peter/0000-0003-0194-9237; Nagaki, Sandra/0000-0001-5019-442X; Sant'Ana, Denise Cristina/0000-0001-6883-6611	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/20397-7, 2005/53973-0]; Conselho Nacional de Desenvolvimento Tecnico e Cientifico (CNPq) [301666/2011-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Tecnico e Cientifico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This investigation was financially supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Grants no. 2011/20397-7; 2005/53973-0; http://www.fapesp.br/), and Conselho Nacional de Desenvolvimento Tecnico e Cientifico (CNPq BPP no. 301666/2011-3 to MAMS; http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besansky NJ, 1997, MOL BIOL EVOL, V14, P442, DOI 10.1093/oxfordjournals.molbev.a025780; Birney E, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P56; Birney E, 2012, WISE2; Bourke BP, 2010, ACTA TROP, V114, P88, DOI 10.1016/j.actatropica.2010.01.009; Bourke BP, 2011, MEM I OSWALDO CRUZ, V106, P705, DOI 10.1590/S0074-02762011000600010; Brochero HHL, 2007, AM J TROP MED HYG, V76, P1113, DOI 10.4269/ajtmh.2007.76.1113; Calado DC, 2008, MEM I OSWALDO CRUZ, V103, P791, DOI 10.1590/S0074-02762008000800009; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Causey O. R., 1945, JOUR NATION MALARIA SOC, V4, P231; Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; CONN J, 1993, J AM MOSQUITO CONTR, V9, P294; CONN J, 1990, J AM MOSQUITO CONTR, V6, P400; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; da Rocha JAM, 2008, AM J TROP MED HYG, V78, P872, DOI 10.4269/ajtmh.2008.78.872; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DEARRUDA M, 1986, AM J TROP MED HYG, V35, P873, DOI 10.4269/ajtmh.1986.35.873; DEOLIVEIRAFERREIRA J, 1990, AM J TROP MED HYG, V43, P6, DOI 10.4269/ajtmh.1990.43.1.TM0430010006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faran M, 1980, CONTRIB AM ENTOMOL I, V15; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Flores-Mendoza C, 2004, J MED ENTOMOL, V41, P489, DOI 10.1603/0022-2585-41.3.489; Flores-Mendoza C, 2004, P ENTOMOL SOC WASH, V106, P118; Forattini OP, 1998, J AM MOSQUITO CONTR, V14, P256; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; GALVAO A. L. AYROZA, 1941, ARCH ZOOL SAO PAULO, V2, P505; Harbach RE, SUBGENUS NYSSORHYNCH; Harbach RE, 1902, SUBGENUS NYSSORHYNCH; Harbach RE, 1818, GENUS ANOPHELES MEIG; HAYES J, 1987, J AM MOSQUITO CONTR, V3, P418; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KITZMILLER JB, 1973, B WORLD HEALTH ORGAN, V48, P435; Krzywinski J, 2011, MOL PHYLOGENET EVOL, V58, P469, DOI 10.1016/j.ympev.2011.01.003; Linthicum K, 1988, TECHNICAL REPORT; Marrelli MT, 2006, MEM I OSWALDO CRUZ, V101, P817, DOI 10.1590/S0074-02762006000800002; Marrelli MT, 1999, J MED ENTOMOL, V36, P679, DOI 10.1093/jmedent/36.6.679; Motoki MT, 2011, J AM MOSQUITO CONTR, V27, P191, DOI 10.2987/10-6094.1; Motoki MT, 2009, MEM I OSWALDO CRUZ, V104, P823, DOI 10.1590/S0074-02762009000600004; Sallum MAM, 2010, J MED ENTOMOL, V47, P504, DOI 10.1603/ME09229; Nagaki SS, 2011, ANN ENTOMOL SOC AM, V104, P374, DOI 10.1603/AN10126; Nagaki SS, 2010, MEM I OSWALDO CRUZ, V105, P278, DOI 10.1590/S0074-02762010000300006; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quinones ML, 2006, MEM I OSWALDO CRUZ, V101, P617, DOI 10.1590/S0074-02762006000600007; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Reidenbach Kyanne R., 2009, BMC Evolutionary Biology, V9, DOI 10.1186/1471-2148-9-298; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Lopez F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-44; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sallum MAM, 2008, J MED ENTOMOL, V45, P970, DOI 10.1603/0022-2585(2008)45[970:IIANDC]2.0.CO;2; Sallum MAM, 2002, SYST ENTOMOL, V27, P361, DOI 10.1046/j.1365-3113.2002.00182.x; Sallum MAM, 2000, ANN ENTOMOL SOC AM, V93, P745, DOI 10.1603/0013-8746(2000)093[0745:POADCB]2.0.CO;2; Sierra DM, 2004, J MED ENTOMOL, V41, P302, DOI 10.1603/0022-2585-41.3.302; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silva-Do-Nascimento TF, 2007, MEM I OSWALDO CRUZ, V102, P975, DOI 10.1590/S0074-02762007000800013; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Talavera G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-315; Unti O, 1940, Ann; paulist Med Cirurg Sao Paulo, V40, P489; Unti O, 1941, SAO PAULO SERV PROFI, V33, P3; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; White BJ, 2011, ANNU REV ECOL EVOL S, V42, P111, DOI 10.1146/annurev-ecolsys-102710-145028; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Zapata MA, 2007, AM J TROP MED HYG, V77, P67, DOI 10.4269/ajtmh.2007.77.67	67	62	65	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54063	10.1371/journal.pone.0054063	http://dx.doi.org/10.1371/journal.pone.0054063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390494	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100010
J	Li, T; Gao, CQ; Cui, Y; Xie, Q; Bu, WJ				Li, Teng; Gao, Cuiqing; Cui, Ying; Xie, Qiang; Bu, Wenjun			The Complete Mitochondrial Genome of the Stalk-Eyed Bug Chauliops fallax Scott, and the Monophyly of Malcidae (Hemiptera: Heteroptera)	PLOS ONE			English	Article							A+T-RICH REGION; RIBOSOMAL-RNA; SECONDARY STRUCTURE; PHYLOGENETIC ANALYSIS; INSECTA; SEQUENCE; DNA; EVOLUTION; LEPIDOPTERA; MODEL	Chauliops fallax Scott, 1874 (Hemiptera: Heteroptera: Malcidae: Chauliopinae) is one of the most destructive insect pests of soybean and rice fields in Asia. Here we sequenced the complete mitochondrial genome of this pest. This genome is 15,739 bp long, with an A+T content of 73.7%, containing 37 typical animal mitochondrial genes and a control region. All genes were arranged in the same order as most of other Heteroptera. A remarkable strand bias was found for all nine protein coding genes (PCGs) encoded by the majority strand were positive AT-skew and negative GC-skew, whereas the reverse were found in the remaining four PCGs encoded by the minority strand and two rRNA genes. The models of secondary structures for the two rRNA genes of sequenced true bugs and Lygaeoidea were predicted. 16S rRNA consisted of six domains (domain III is absent as in other known arthropod mitochondrial genomes) and 45 helices, while three domains and 27 helices for 12S rRNA. The control region consists of five subregions: a microsatellite-like region, a tandem repeats region and other three motifs. The unusual intergenic spacer between tRNA-H and ND4 only found in the species of Lygaeoidea, not in other heteropteran species, may be the synapomorphy of this superfamily. Phylogenetic analyses were carried out based on all the 13 PCGs showed that Chauliopinae was the sister group of Malcinae and the monophyly of Lygaeoidea.	[Li, Teng; Gao, Cuiqing; Cui, Ying; Xie, Qiang; Bu, Wenjun] Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China	Nankai University	Bu, WJ (corresponding author), Nankai Univ, Coll Life Sci, Inst Entomol, Tianjin 300071, Peoples R China.	wenjunbu@nankai.edu.cn		Li, Teng/0000-0002-3224-0477	National Science Foundation of China [31071959, 30970350]; National Education Project in Basic Science for Special Subjects (Insect Systematics) [J0930005]; Doctoral Fund of Ministry of Education of China [20100031110026]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Education Project in Basic Science for Special Subjects (Insect Systematics); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This project was supported by the National Science Foundation of China [No. 31071959, 30970350], the National Education Project in Basic Science for Special Subjects (Insect Systematics) [No. J0930005] and the Doctoral Fund of Ministry of Education of China 20100031110026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, ACTA ENT MUS NAT PRA; BARRETTE RJ, 1994, GENOME, V37, P858, DOI 10.1139/g94-121; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Breddin G, 1907, DTSCH ENTOMOLOGISCHE, V6, P34, DOI DOI 10.1002/MMND.48019070609; Buckley TR, 2000, INSECT MOL BIOL, V9, P565, DOI 10.1046/j.1365-2583.2000.00220.x; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; CLARY DO, 1987, J MOL EVOL, V25, P116, DOI 10.1007/BF02101753; Comandi S, 2009, GENE, V439, P25, DOI 10.1016/j.gene.2009.02.020; Distant W. L., 1904, Entomologist, P278; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Henry TJ, 1997, ANN ENTOMOL SOC AM, V90, P275, DOI 10.1093/aesa/90.3.275; Hickson RE, 1996, MOL BIOL EVOL, V13, P150, DOI 10.1093/oxfordjournals.molbev.a025552; Hua JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-134; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Niehuis O, 2006, ORG DIVERS EVOL, V6, P17, DOI 10.1016/j.ode.2005.03.001; Niehuis O, 2006, MOL PHYLOGENET EVOL, V39, P812, DOI 10.1016/j.ympev.2006.01.007; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Page RDM, 2000, NUCLEIC ACIDS RES, V28, P3839, DOI 10.1093/nar/28.20.3839; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reineke A, 1998, INSECT MOL BIOL, V7, P95, DOI 10.1046/j.1365-2583.1998.71048.x; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schuh R.T., 1995, TRUE BUGS WORLD HEMI; Schuh RT, 2008, ANN ENTOMOL SOC AM, V101, P20, DOI 10.1603/0013-8746(2008)101[20:CANFOH]2.0.CO;2; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song N, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.7601; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; Stys P, 1963, ACTA U CAROLINAE BIO, V1963, P209; Suzaki Y, 2011, APPL ENTOMOL ZOOL, V46, P429, DOI 10.1007/s13355-011-0057-7; SWEET MH, 1985, ANN ENTOMOL SOC AM, V78, P526, DOI 10.1093/aesa/78.4.526; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xie Q, 2005, MOL PHYLOGENET EVOL, V34, P448, DOI 10.1016/j.ympev.2004.10.015; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhao XY, 2000, J MOUNT AGR BIOL, V19, P321; Zhou JF, 2011, BIOINFORMATICS, V27, P1255, DOI 10.1093/bioinformatics/btr140; Zhou ZJ, 2007, GENOME, V50, P855, DOI 10.1139/G07-057; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	31	35	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55381	10.1371/journal.pone.0055381	http://dx.doi.org/10.1371/journal.pone.0055381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390534	gold, Green Published, Green Submitted			2022-12-25	WOS:000314691100050
J	Zhao, MF; Xiang, WH; Tian, DL; Deng, XW; Huang, ZH; Zhou, XL; Peng, CH				Zhao, Meifang; Xiang, Wenhua; Tian, Dalun; Deng, Xiangwen; Huang, Zhihong; Zhou, Xiaolu; Peng, Changhui			Effects of Increased Nitrogen Deposition and Rotation Length on Long-Term Productivity of Cunninghamia lanceolata Plantation in Southern China	PLOS ONE			English	Article							CLIMATE-CHANGE; FOREST ECOSYSTEMS; ATMOSPHERIC DEPOSITION; SUCCESSIVE ROTATIONS; CARBON SEQUESTRATION; SUBTROPICAL CHINA; FIR PLANTATIONS; N DEPOSITION; MODEL; STORAGE	Cunninghamia lanceolata (Lamb.) Hook. has been widely planted in subtropical China to meet increasing timber demands, leading to short-rotation practices that deplete soil nutrients. However, increased nitrogen (N) deposition offsets soil N depletion. While long-term experimental data investigating the coupled effects related to short rotation practices and increasing N deposition are scarce, applying model simulations may yield insights. In this study, the CenW3.1 model was validated and parameterized using data from pure C. lanceolata plantations. The model was then used to simulate various changes in long-term productivity. Results indicated that responses of productivity of C. lanceolata plantation to increased N deposition were more related to stand age than N addition, depending on the proportion and age of growing forests. Our results have also shown a rapid peak in growth and N dynamics. The peak is reached sooner and is higher under higher level of N deposition. Short rotation lengths had a greater effect on productivity and N dynamics than high N deposition levels. Productivity and N dynamics decreased as the rotation length decreased. Total productivity levels suggest that a 30-year rotation length maximizes productivity at the 4.9 kg N ha(-1) year(-1) deposition level. For a specific rotation length, higher N deposition levels resulted in greater overall ecosystem C and N storage, but this positive correlation tendency gradually slowed down with increasing N deposition levels. More pronounced differences in N deposition levels occurred as rotation length decreased. To sustain C. lanceolata plantation productivity without offsite detrimental N effects, the appropriate rotation length is about 20-30 years for N deposition levels below 50 kg N ha(-1) year(-1) and about 15-20 years for N deposition levels above 50 kg N ha(-1) year(-1). These results highlight the importance of assessing N effects on carbon management and the long-term productivity of forest ecosystems.	[Zhao, Meifang; Xiang, Wenhua; Tian, Dalun; Deng, Xiangwen; Huang, Zhihong; Peng, Changhui] Cent S Univ Forestry & Technol, Fac Life Sci & Technol, Changsha, Hunan, Peoples R China; [Zhou, Xiaolu; Peng, Changhui] Univ Quebec, Dept Biol Sci, Inst Environm Sci, Montreal, PQ H3C 3P8, Canada	Central South University of Forestry & Technology; University of Quebec; University of Quebec Montreal	Xiang, WH (corresponding author), Cent S Univ Forestry & Technol, Fac Life Sci & Technol, Changsha, Hunan, Peoples R China.	xiangwh2005@163.com		deng, xiang wen/0000-0002-9399-1231	Key Program of State Forestry Special Fund for Public Welfare Industry of China [2011432009]; Program of Introducing Advanced Technology (948 program) from the China State Forestry Administration [2010-4-03]; Furong Scholar Program	Key Program of State Forestry Special Fund for Public Welfare Industry of China; Program of Introducing Advanced Technology (948 program) from the China State Forestry Administration; Furong Scholar Program	This study was financially supported by the Key Program of State Forestry Special Fund for Public Welfare Industry of China (number 2011432009), the Program of Introducing Advanced Technology (948 program) from the China State Forestry Administration (number 2010-4-03), and the Furong Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; [Anonymous], [No title captured]; [Anonymous], 2001, ACTA ECOL SIN, DOI DOI 10.3321/J.ISSN:1000-0933.2001.12.006; Bi J, 2007, CAN J FOREST RES, V37, P1615, DOI 10.1139/X07-018; Chen R., 2010, HUNAN AGR SCI, V5, P125; Chen XY, 2007, SCI TOTAL ENVIRON, V378, P317, DOI 10.1016/j.scitotenv.2007.02.028; Chen XY, 2004, ENVIRON GEOCHEM HLTH, V26, P179, DOI 10.1023/B:EGAH.0000039580.79321.1a; Chen XY, 1989, J CENTRAL S FORESTRY, V9, P66; Clein JS, 2002, PLANT SOIL, V242, P15, DOI 10.1023/A:1019673420225; Davidson EA, 2007, NATURE, V447, P995, DOI 10.1038/nature05900; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Ding Y. X., 1995, Pedosphere, V5, P57; Fang JY., 1996, ACTA ECOL SIN, V16, P497, DOI DOI 10.1016/j.chnaes.2015.03.001; Fang X, 2002, J CENTRAL S FORESTRY, V22, P1; Fang YT, 2006, J ENVIRON SCI, V18, P756; FAO, 2006, PLANTED FORESTS TREE; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gu Feng-Xue, 2008, Zhiwu Shengtai Xuebao, V32, P1041, DOI 10.3773/j.issn.1005-264x.2008.05.009; Guo Jian-fen, 2009, Journal of Forestry Research (Harbin), V20, P49, DOI 10.1007/s11676-009-0009-z; Hakkila P, 2002, BIOENERGY SUSTAINABL; Heilman P, 1998, BIOMASS BIOENERG, V14, P361, DOI 10.1016/S0961-9534(97)10072-1; Helms JA, 1998, DICT FORESTRY; Hu ZY, 2007, PEDOSPHERE, V17, P360, DOI 10.1016/S1002-0160(07)60043-5; Hynynen J, 2005, FOREST ECOL MANAG, V207, P5, DOI 10.1016/j.foreco.2004.10.015; Kaipainen T, 2004, ENVIRON SCI POLICY, V7, P205, DOI 10.1016/j.envsci.2004.03.001; [康文星 KANG Wenxing], 2007, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V27, P1; Kirschbaum MUF, 1999, TELLUS B, V51, P871, DOI 10.1034/j.1600-0889.1999.t01-4-00002.x; Kirschbaum MUF, 2002, SOIL BIOL BIOCHEM, V34, P341, DOI 10.1016/S0038-0717(01)00189-4; Lei J F, 2005, FOREST RESOURCES CHI; Liu X.Z., 1993, LONG TERM LOCATED RE, P221; Lu XK, 2009, PEDOSPHERE, V19, P189, DOI 10.1016/S1002-0160(09)60108-9; Ma X. H., 1989, Acta Ecologica Sinica, V9, P15; Ma XQ, 2007, FOREST ECOL MANAG, V243, P61, DOI 10.1016/j.foreco.2007.02.018; Maskell LC, 2010, GLOBAL CHANGE BIOL, V16, P671, DOI 10.1111/j.1365-2486.2009.02022.x; Miller R.E., 2004, NCASI TECHNICAL B 88; Moffat AS, 1998, SCIENCE, V279, P988, DOI 10.1126/science.279.5353.988; Morford SL, 2011, NATURE, V477, P78, DOI 10.1038/nature10415; Murty D, 2000, ECOL MODEL, V134, P185, DOI 10.1016/S0304-3800(00)00345-8; Nash J.E., 1970, J HYDROL, V10, P282, DOI [DOI 10.1016/0022-1694(70)90255-6, 10.1016/0022-1694(70)90255-6]; OVERPECK JT, 1990, NATURE, V343, P51, DOI 10.1038/343051a0; Pan W., 1989, J CENTRAL S FOR U, V9, P1; PASTOR J, 1988, NATURE, V334, P55, DOI 10.1038/334055a0; Peng CH, 2002, ECOL MODEL, V155, P177, DOI 10.1016/S0304-3800(02)00134-5; Pussinen A, 2002, FOREST ECOL MANAG, V158, P103, DOI 10.1016/S0378-1127(00)00675-7; Qian N, 1989, J NANJING FORESTRY U, V13, P75; Ren W, 2011, GLOBAL ECOL BIOGEOGR, V20, P391, DOI 10.1111/j.1466-8238.2010.00606.x; RUNNING SW, 1987, CAN J FOREST RES, V17, P472, DOI 10.1139/x87-081; RYAN MG, 1991, ECOL APPL, V1, P157, DOI 10.2307/1941808; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Tian DL, 2011, FORESTRY, V84, P411, DOI 10.1093/forestry/cpr029; Tian DL, 1993, LONG TERM LOCATED RE; Tian DL, 1989, J CENTRAL S FORESTRY, V9, P29; Wang SQ, 2011, J ENVIRON MANAGE, V92, P1651, DOI 10.1016/j.jenvman.2011.01.024; Weetman GF, 1992, U WASHINGTON CONTRIB, V73; Wei X, 2003, ECOL MODEL, V164, P239, DOI 10.1016/S0304-3800(03)00062-0; Wei XH, 2012, SCI TOTAL ENVIRON, V416, P351, DOI 10.1016/j.scitotenv.2011.11.087; Wen D., 1999, CHIN J PLANT ECOL, V23, P361; Wen SZ, 1993, LONG TERM LOCATED RE; Wu Z., 1984, CHINESE FIR; Xin ZanHong, 2011, Journal of Zhejiang A&F University, V28, P855; Xue L, 2005, CHINESE J PLANT ECOL, V29, P415; Yang YS, 2003, PEDOSPHERE, V13, P87; Yang YS, 2002, CHINESE J APPL ENV B, V8, P2230; Yin H, 2009, IMPROVEMENT CROWN IN; Zaehle S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041345; Zhang J, 2009, J ENVIRON SCI-CHINA, V21, P352, DOI 10.1016/S1001-0742(08)62276-7; Zhang XQ, 2004, FOREST ECOL MANAG, V202, P131, DOI 10.1016/j.foreco.2004.07.032; Zhao MF, 2009, FOREST ECOL MANAG, V257, P1520, DOI 10.1016/j.foreco.2008.12.025	70	15	17	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55376	10.1371/journal.pone.0055376	http://dx.doi.org/10.1371/journal.pone.0055376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390533	Green Submitted, Green Published, gold			2022-12-25	WOS:000314691100049
J	Cheng, DY; Liang, H; Li, YH				Cheng, Daye; Liang, Bin; Li, Yunhui			Serum Vascular Endothelial Growth Factor (VEGF-C) as a Diagnostic and Prognostic Marker in Patients with Ovarian Cancer	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; CELL LUNG-CANCER; BREAST-CANCER; EXPRESSION; LYMPHANGIOGENESIS; MACROPHAGES; CARCINOMA; DENSITY; COX-2	VEGF-C is regarded as one of the most efficient factors in regulating lymphangiogenesis. The aim of this study was to better understand the role of VEGF-C in the progression of ovarian cancer and to assess its diagnostic and prognostic significance. A total of 109 patients with ovarian cancer, 76 patients with benign ovarian diseases, and 50 healthy controls were recruited in this study. Serum levels of VEGF-C were determined by ELISA method. The results showed that serum levels of VEGF-C were significantly higher in the patients with ovarian cancer than those with benign ovarian diseases and healthy controls (P<0.01). Serum level of VEGF-C was correlated with FIGO stage, lymph node metastasis, tumor resectability, and survival of the patients (P<0.05). The areas of receiver operating curves of VEGF-C were higher than those of CA125 in different screening groups. Analysis using the Kaplan-meier method indicated that patients with high VEGF-C had significantly shorter overall survival time than those with low VEGF-C (P<0.0001). In a multivariate analysis along with clinical prognostic parameters, serum VEGF-C was identified as an independent adverse prognostic variable for overall survival. These results indicated that serum VEGF-C may be a clinically useful indicator for diagnostic and prognostic evaluation in ovarian cancer patients.	[Cheng, Daye] China Med Univ, Hosp 1, Dept Transfus, Shenyang, Peoples R China; [Liang, Bin] China Med Univ, High Vocat Technol Coll, Shenyang, Peoples R China; [Li, Yunhui] 202 Hosp, Dept Clin Lab, Shenyang, Peoples R China	China Medical University; China Medical University	Cheng, DY (corresponding author), China Med Univ, Hosp 1, Dept Transfus, Shenyang, Peoples R China.	dayecheng_cmu@yahoo.cn			Liaoning Nature Science Fund [201102257]	Liaoning Nature Science Fund	This work was supported by a grant from the Liaoning Nature Science Fund (201102257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aishima S, 2008, MODERN PATHOL, V21, P256, DOI 10.1038/modpathol.3800985; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Coticchia Christine M, 2008, J Natl Compr Canc Netw, V6, P795; Feng LZ, 2011, J INT MED RES, V39, P1333, DOI 10.1177/147323001103900420; Gou HF, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-14; Guo XF, 2009, ACTA BIOCH BIOPH SIN, V41, P217, DOI 10.1093/abbs/gmp004; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huang KJ, 2012, MED ONCOL, V29, P318, DOI 10.1007/s12032-010-9817-4; Jeon BH, 2008, CANCER RES, V68, P1100, DOI 10.1158/0008-5472.CAN-07-2572; Joukov V, 1996, EMBO J, V15, P1751; Kim HS, 2008, ACTA OBSTET GYN SCAN, V87, P1136, DOI 10.1080/00016340802478158; Li XM, 2011, J GASTROINTEST SURG, V15, P2001, DOI 10.1007/s11605-011-1627-2; Nakamura Y, 2005, BREAST CANCER RES TR, V91, P125, DOI 10.1007/s10549-004-5783-x; Nakazato T, 2006, ONCOL REP, V15, P825; Ogawa E, 2004, BRIT J CANCER, V91, P498, DOI 10.1038/sj.bjc.6601992; Ozols RF, 2006, ANN ONCOL, V17, pV181, DOI 10.1093/annonc/mdj978; Sangoi AR, 2008, AM J SURG PATHOL, V32, P261, DOI 10.1097/PAS.0b013e318141fc7a; Schietroma C, 2003, CANCER, V98, P789, DOI 10.1002/cncr.11583; Schoppmann SF, 2006, SURGERY, V139, P839, DOI 10.1016/j.surg.2005.12.008; Shayan R, 2006, CARCINOGENESIS, V27, P1729, DOI 10.1093/carcin/bgl031; Sinn BV, 2009, VIRCHOWS ARCH, V455, P461, DOI 10.1007/s00428-009-0851-6; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2004, APMIS, V112, P539, DOI 10.1111/j.1600-0463.2004.apm11207-0812.x; Ueda M, 2005, CLIN CANCER RES, V11, P3225, DOI 10.1158/1078-0432.CCR-04-1148; Yang J, 2006, ASIAN J ANDROL, V8, P169, DOI 10.1111/j.1745-7262.2006.00120.x; Zhao YC, 2012, MED ONCOL	26	31	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55309	10.1371/journal.pone.0055309	http://dx.doi.org/10.1371/journal.pone.0055309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383322	Green Submitted, Green Published, gold			2022-12-25	WOS:000314597900029
J	Riedel, A; Mofolo, B; Avota, E; Schneider-Schaulies, S; Meintjes, A; Mulder, N; Kneitz, S				Riedel, Alice; Mofolo, Boitumelo; Avota, Elita; Schneider-Schaulies, Sibylle; Meintjes, Ayton; Mulder, Nicola; Kneitz, Susanne			Accumulation of Splice Variants and Transcripts in Response to PI3K Inhibition in T Cells	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MEASLES-VIRUS; IMMUNE-RESPONSE; GENE-EXPRESSION; SR PROTEINS; ACTIVATION; IMMUNOSUPPRESSION; RNA; PROLIFERATION; SUPPRESSION	Background: Measles virus (MV) causes T cell suppression by interference with phosphatidylinositol-3-kinase (PI3K) activation. We previously found that this interference affected the activity of splice regulatory proteins and a T cell inhibitory protein isoform was produced from an alternatively spliced pre-mRNA. Hypothesis: Differentially regulated and alternatively splice variant transcripts accumulating in response to PI3K abrogation in T cells potentially encode proteins involved in T cell silencing. Methods: To test this hypothesis at the cellular level, we performed a Human Exon 1.0 ST Array on RNAs isolated from T cells stimulated only or stimulated after PI3K inhibition. We developed a simple algorithm based on a splicing index to detect genes that undergo alternative splicing (AS) or are differentially regulated (RG) upon T cell suppression. Results: Applying our algorithm to the data, 9% of the genes were assigned as AS, while only 3% were attributed to RG. Though there are overlaps, AS and RG genes differed with regard to functional regulation, and were found to be enriched in different functional groups. AS genes targeted extracellular matrix (ECM)-receptor interaction and focal adhesion pathways, while RG genes were mainly enriched in cytokine-receptor interaction and Jak-STAT. When combined, AS/RG dependent alterations targeted pathways essential for T cell receptor signaling, cytoskeletal dynamics and cell cycle entry. Conclusions: PI3K abrogation interferes with key T cell activation processes through both differential expression and alternative splicing, which together actively contribute to T cell suppression.	[Riedel, Alice; Avota, Elita; Schneider-Schaulies, Sibylle] Univ Wurzburg, Inst Virol & Immunobiol, Versbacher, Wuerzburg, Germany; [Kneitz, Susanne] Univ Wurzburg, Dept Physiol Chem 1, Bioctr, Wurzburg, Germany; [Mofolo, Boitumelo; Meintjes, Ayton; Mulder, Nicola] Univ Cape Town, Fac Hlth Sci, Computat Biol Grp, Dept Clin Lab Sci,Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Wurzburg; University of Wurzburg; University of Cape Town	Kneitz, S (corresponding author), Univ Wurzburg, Dept Physiol Chem 1, Bioctr, Wurzburg, Germany.	susanne.kneitz@uni-wuerzburg.de		Mulder, Nicola J/0000-0003-4905-0941	National Research Fund; Deutsche Forschungsgemeinschaft; German Cancer Research Foundation	National Research Fund(Luxembourg National Research Fund); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Research Foundation	This study was supported by the National Research Fund, the Deutsche Forschungsgemeinschaft and the German Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2007, CIRCULATION, V116, P1707, DOI 10.1161/CIRCULATIONAHA.107.699470; Anupam R, 2011, J BIOL CHEM, V286, P7661, DOI 10.1074/jbc.M110.176354; Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Avota E, 2004, J VIROL, V78, P9552, DOI 10.1128/JVI.78.17.9552-9559.2004; Avota E, 2001, NAT MED, V7, P725, DOI 10.1038/89106; Avota E, 2006, CELL MICROBIOL, V8, P1826, DOI 10.1111/j.1462-5822.2006.00752.x; Avota E, 2010, MED MICROBIOL IMMUN, V199, P227, DOI 10.1007/s00430-010-0152-3; Blaustein M, 2007, INT J BIOCHEM CELL B, V39, P2031, DOI 10.1016/j.biocel.2007.04.004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; Burke KP, 2010, IMMUNOL RES, V47, P216, DOI 10.1007/s12026-009-8152-3; Carrette F, 2009, ADV EXP MED BIOL, V665, P3; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Cheung WMW, 2001, J BIOL CHEM, V276, P17083, DOI 10.1074/jbc.M010802200; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Cowper AE, 2001, J BIOL CHEM, V276, P48908, DOI 10.1074/jbc.M103967200; Fahey LM, 2010, CURR OPIN IMMUNOL, V22, P348, DOI 10.1016/j.coi.2010.03.004; Farnebo M, 2009, CELL CYCLE, V8, P2343, DOI 10.4161/cc.8.15.9223; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Fruman DA, 2009, IMMUNOL REV, V228, P253, DOI 10.1111/j.1600-065X.2008.00750.x; Gaidatzis D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp508; Gassert E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000623; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Griffin DE, 2010, IMMUNOL REV, V236, P176, DOI 10.1111/j.1600-065X.2010.00925.x; Grigoryev YA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007906; Ha KCH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-519; HALL C, 1990, J MOL BIOL, V211, P11, DOI 10.1016/0022-2836(90)90006-8; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; HAYASHI K, 1992, P NATL ACAD SCI USA, V89, P12122, DOI 10.1073/pnas.89.24.12122; Horst D, 2011, CURR OPIN IMMUNOL, V23, P96, DOI 10.1016/j.coi.2010.11.005; Hu W, 2010, J BIOL CHEM, V285, P7964, DOI 10.1074/jbc.M109.063586; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; Kerdiles YM, 2006, REV MED VIROL, V16, P49, DOI 10.1002/rmv.486; Krummrei U, 2003, P NATL ACAD SCI USA, V100, P2444, DOI 10.1073/pnas.0438007100; Liu XF, 2003, J VIROL, V77, P2105, DOI 10.1128/JVI.77.3.2105-2115.2003; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Mahmoudi S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.90; Mahmoudi S, 2009, MOL CELL, V33, P462, DOI 10.1016/j.molcel.2009.01.028; Martinez NM, 2012, RNA, V18, P1029, DOI 10.1261/rna.032243.112; Mayanagi T, 2011, CELL ADHES MIGR, V5, P150, DOI 10.4161/cam.5.2.14398; Niewiesk S, 1997, J VIROL, V71, P7214, DOI 10.1128/JVI.71.10.7214-7219.1997; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Okkenhaug K, 2010, CURR TOP MICROBIOL, V346, P57, DOI 10.1007/82_2010_45; Robinson MD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-449; Rohrschneider LR, 2000, GENE DEV, V14, P505; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schlender J, 1996, P NATL ACAD SCI USA, V93, P13194, DOI 10.1073/pnas.93.23.13194; Schneider-Schaulies S, 2006, J GEN VIROL, V87, P1423, DOI 10.1099/vir.0.81713-0; Schreiber-Agus N, 1998, NATURE, V393, P483, DOI 10.1038/31008; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Tran-Van H, 2011, EUR J IMMUNOL, V41, P151, DOI 10.1002/eji.201040847; Tsuzaka K, 2006, J IMMUNOL, V176, P949, DOI 10.4049/jimmunol.176.2.949; Tsuzaka K, 2006, SPRINGER SEMIN IMMUN, V28, P185, DOI 10.1007/s00281-006-0035-2; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-225; Ward SG, 2011, IMMUNOL LETT, V138, P15, DOI 10.1016/j.imlet.2011.02.007; Wernimont SA, 2011, J IMMUNOL, V187, P6256, DOI 10.4049/jimmunol.1102028; Whistler T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-496; Wolf I, 2000, GENOMICS, V69, P104, DOI 10.1006/geno.2000.6324; Yoshimoto K, 2006, INT IMMUNOL, V18, P1189, DOI 10.1093/intimm/dxl053	66	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e50695	10.1371/journal.pone.0050695	http://dx.doi.org/10.1371/journal.pone.0050695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383294	Green Submitted, gold, Green Published			2022-12-25	WOS:000314597900001
J	van Overveld, T; Matthysen, E				van Overveld, Thijs; Matthysen, Erik			Personality and Information Gathering in Free-Ranging Great Tits	PLOS ONE			English	Article							PARUS-MAJOR; INDIVIDUAL-DIFFERENCES; EXPLORATORY-BEHAVIOR; COPING STYLES; SPACE USE; FITNESS CONSEQUENCES; SOCIAL INFORMATION; SURVIVAL; POPULATIONS; DISPERSAL	One aspect of animal personality that has been well described in captivity, but received only little attention in studies in the wild, is that personality types may vary in their behavioural flexibility towards environmental changes. A fundamental factor underlying such differences is believed to be the degree to which individual behavior is guided by environmental stimuli. We tested this hypothesis in the wild using free-ranging great tits. Personality variation was quantified using exploratory behaviour in a novel environment, which has previously been shown to be repeatable and correlated with other behaviours in this and other populations of the same species. By temporarily removing food at feeding stations we examined whether birds with different personality differed in returning to visit empty feeders as this may provide information on how birds continue to sample their environment after a sudden change in conditions. In two summer experiments, we found that fast-exploring juveniles visited empty feeders less often compared to slow-exploring juveniles. In winter, sampling behaviour was sex dependent but not related to personality. In both seasons, we found that birds who sampled empty feeders more often were more likely to rediscover food after we again re-baited the feeding stations, but there was no effect of personality. Our results show that personality types may indeed differ in ways of collecting environmental information, which is consistent with the view of personalities as different styles of coping with environmental changes. The adaptive value of these alternative behavioural tactics, however, needs to be further explored.	[van Overveld, Thijs; Matthysen, Erik] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium	University of Antwerp	van Overveld, T (corresponding author), Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium.	thijs.vanoverveld@ua.ac.be	Overveld, Thijs/J-6501-2014	Matthysen, Erik/0000-0002-7521-9248; van Overveld, Mathijs/0000-0001-5472-0255	FWO-Flanders doctoral fellowship; BOF-NOI grant from the University of Antwerp	FWO-Flanders doctoral fellowship; BOF-NOI grant from the University of Antwerp	Financial support was received by a FWO-Flanders doctoral fellowship to TvO and a BOF-NOI grant from the University of Antwerp to EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauchau V, 1995, J APPL STAT, V22, P1031, DOI 10.1080/02664769524775; Bello N, 2001, J VET DIAGN INVEST, V13, P162, DOI 10.1177/104063870101300212; BENUS RF, 1987, BEHAVIOUR, V100, P105, DOI 10.1163/156853987X00099; Boon AK, 2008, OIKOS, V117, P1321, DOI 10.1111/j.0030-1299.2008.16567.x; Boyer N, 2010, J ANIM ECOL, V79, P538, DOI 10.1111/j.1365-2656.2010.01659.x; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; COX DR, 1972, J R STAT SOC B, V34, P187; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; DELAET J, 1984, ORNIS SCAND, V15, P73, DOI 10.2307/3675940; Dingemanse NJ, 2012, J ANIM ECOL, V81, P116, DOI 10.1111/j.1365-2656.2011.01877.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2004, BEHAV ECOL, V15, P1023, DOI 10.1093/beheco/arh115; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Dingemanse NJ, 2011, ANIMAL PERSONALITIES; Drent P.J., 1999, P 22 INT ORNITHOLOGI, P896; DRENT PJ, 1987, ARDEA, V75, P59; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Herborn KA, 2010, ANIM BEHAV, V79, P835, DOI 10.1016/j.anbehav.2009.12.026; Hollander FA, 2008, ETHOLOGY, V114, P405, DOI 10.1111/j.1439-0310.2008.01488.x; Jenni L., 1994, BIOL MOULT BIRDS; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korsten P, 2010, MOL ECOL, V19, P832, DOI 10.1111/j.1365-294X.2009.04518.x; Kurvers RHJM, 2010, ECOL LETT, V13, P829, DOI 10.1111/j.1461-0248.2010.01473.x; Kurvers RHJM, 2010, P ROY SOC B-BIOL SCI, V277, P601, DOI 10.1098/rspb.2009.1474; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; Mathot KJ, 2012, OIKOS, V121, P1009, DOI 10.1111/j.1600-0706.2012.20339.x; Matthysen E., 1990, Current Ornithology, V7, P209; Nicolaus M, 2008, ARDEA, V96, P286, DOI 10.5253/078.096.0215; Quinn JL, 2011, J ANIM ECOL, V80, P918, DOI 10.1111/j.1365-2656.2011.01835.x; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; SANDELL M, 1991, BEHAV ECOL SOCIOBIOL, V29, P147, DOI 10.1007/BF00166490; Schielzeth H, 2011, BEHAV ECOL, V22, P126, DOI 10.1093/beheco/arq184; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; van Overveld T, 2011, BEHAV ECOL, V22, P899, DOI 10.1093/beheco/arr063; van Overveld T, 2010, BIOL LETTERS, V6, P187, DOI 10.1098/rsbl.2009.0764; VANBALEN JH, 1967, ARDEA, V55, P1; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Wilson ADM, 2007, ANIM BEHAV, V74, P689, DOI 10.1016/j.anbehav.2007.01.009	44	17	17	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e54199	10.1371/journal.pone.0054199	http://dx.doi.org/10.1371/journal.pone.0054199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383299	Green Submitted, Green Published, gold			2022-12-25	WOS:000314597900006
J	Garcia-Perez, B; Hobson, KA; Powell, RL; Still, CJ; Huber, GH				Garcia-Perez, Belen; Hobson, Keith A.; Powell, Rebecca L.; Still, Christopher J.; Huber, Gernot H.			Switching Hemispheres: A New Migration Strategy for the Disjunct Argentinean Breeding Population of Barn Swallow (Hirundo rustica)	PLOS ONE			English	Article							STABLE-ISOTOPES; SOUTHERN-HEMISPHERE; GENETICS; HYDROGEN; AMERICA; CARBON; MOLT; C-13	Background: Barn Swallows (Hirundo rustica) breed almost exclusively in the Northern Hemisphere. However, since the early 1980's, a small disjunct breeding population has become established in eastern Argentina, presumably by birds previously derived from those breeding in North America. Currently, it is unknown where these individuals go following breeding and how they have adjusted to a reversal in phenology. Their austral wintering period corresponds to the breeding period of the northern ancestral population and so they can potentially return to these more traditional breeding sites or they may occupy other South American wintering regions left vacant by conspecifics returning to the Northern Hemisphere. Principal Findings: We used a three-isotope (delta C-13, delta N-15, delta H-2) approach to investigate potential wintering areas in Central and South America of individuals breeding in Argentina. Feather isotope values differed from those expected and measured at local breeding sites in Argentina indicating molt after the austral breeding period and away from the breeding grounds. Potential molting origins were identified applying likelihood-based assignment methods to a delta H-2 isoscape for South America and dichotomous prior information on the distribution of C3 and C4 vegetation types based on modeled vegetation-delta C-13 values. Barn Swallows now breeding in Argentina have changed their migratory behavior but presumably use the same cues as those used by the ancestral population, molting their feathers during the austral winter, likely in northeastern South America.	[Garcia-Perez, Belen; Hobson, Keith A.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Hobson, Keith A.] Environm Canada, Saskatoon, SK, Canada; [Powell, Rebecca L.] Wake Forest Univ, Ctr Energy Environm & Sustainabil, Winston Salem, NC 27109 USA; [Still, Christopher J.] Oregon State Univ, Corvallis, OR 97331 USA; [Still, Christopher J.] Oregon State Univ, Soc Geog, Corvallis, OR 97331 USA; [Huber, Gernot H.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	University of Saskatchewan; Environment & Climate Change Canada; Wake Forest University; Oregon State University; Oregon State University; Cornell University	Garcia-Perez, B (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada.	belen.garcia@usask.ca	Hobson, Keith/Q-9306-2019	Still, Christopher/0000-0002-8295-4494	Environment Canada; Isabel Maria Lopez Martinez Memorial Scholarship; University of Saskatchewan Department of Biology Graduate Scholarship	Environment Canada(CGIAR); Isabel Maria Lopez Martinez Memorial Scholarship; University of Saskatchewan Department of Biology Graduate Scholarship	This study was supported by Environment Canada. BGP received financial support from Isabel Maria Lopez Martinez Memorial Scholarship and University of Saskatchewan Department of Biology Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; BERTHOLD P, 1984, BIRD STUDY, V31, P19, DOI 10.1080/00063658409476810; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Billerman SM, 2011, AUK, V128, P506, DOI 10.1525/auk.2011.10252; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Brown C.R., 1999, BIRDS N AM ONLINE; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; ESRI, 2011, ARCGIS 9 3; France RL, 1997, CAN J FISH AQUAT SCI, V54, P1255, DOI 10.1139/f97-044; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; GWINNER E, 1987, ORNIS SCAND, V18, P251, DOI 10.2307/3676892; HOBSON KA, 2012, PLOS ONE, V7; Hobson KA, 2007, TERR ECOL SER, V1, P129; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Jenni-Eiermann S, 2002, J ORNITHOL, V143, P331; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; MARTINEZ M M, 1983, Neotropica (La Plata), V29, P83; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Paynter RA, 1995, NEARCTIC PASSERINE M; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Powell RL, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00162.1; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; Pyle P., 1997, IDENTIFICATION GUI 1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rohwer S, 2011, AUK, V128, P522, DOI 10.1525/auk.2011.10273; Royle JA, 2004, ECOL APPL, V14, P1780; SNOW DW, 1978, BIRD STUDY, V25, P134, DOI 10.1080/00063657809476588; Still CJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P179, DOI 10.1007/978-90-481-3354-3_9; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Whittington PA, 1999, IBIS, V141, P327, DOI 10.1111/j.1474-919X.1999.tb07555.x; Wolfaardt AC, 2001, T ROY SOC S AFR, V56, P45, DOI 10.1080/00359190109520455	34	17	18	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55654	10.1371/journal.pone.0055654	http://dx.doi.org/10.1371/journal.pone.0055654			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383257	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600141
J	Zhang, SD; Li, WY; Wang, WQ; Zhang, SS; Huang, P; Zhang, C				Zhang, Shaodan; Li, Weiyi; Wang, Wenqian; Zhang, Samuel S.; Huang, Ping; Zhang, Chun			Expression and Activation of STAT3 in the Astrocytes of Optic Nerve in a Rat Model of Transient Intraocular Hypertension	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; FIBRILLARY ACIDIC PROTEIN; REACTIVE ASTROCYTES; PROMOTES SURVIVAL; JAK/STAT PATHWAY; GENE-EXPRESSION; UP-REGULATION; NEURONS; ASTROGLIOSIS; INDUCTION	Lamina cribosa, an astrocyte-rich region, is the origin of axonal degeneration in glaucomatous neuropathy. Astrocytes are particularly activated during optic nerve (ON) degeneration and are likely to contribute to the pathogenesis of glaucomatous optic neuropathy. Signalling mechanisms that regulate different aspects of astrocyte reactiviation in response to intraocular hypertensive injury are not well defined. Signal transducer and activator of transcription protein-3 (STAT3) is a transcription factor that participates in many biological processes and has been implicated as activator of reactive astrogliosis. In this study, we investigated the role of STAT3 in regulating the activation of astrocytes to transient intraocular hypertension in vivo by using a rat ocular hypertension model. ON astrocytes hypertrophy was observed early after intraocular hypertensive stress. Morphological changes in glial fibrillary acidic protein (GFAP) positive cells coupled with axon loss in the optic nerve was detected at day 7 after the injury. Nestin was significantly upregulated in ON astrocytes as early as day 2 post injury and kept elevated through post injury day 7. Phosphorylated STAT3 (pSTAT3) was markedly upregulated in ON astrocytes at post injury day 1, prior to the reactivation of ON astrocytes. These findings indicate that STAT3 signalling is involved in the initiation of astrocyte reactivation in optic nerve injury.	[Zhang, Shaodan; Li, Weiyi; Wang, Wenqian; Huang, Ping; Zhang, Chun] Peking Univ, Ctr Eye, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China; [Zhang, Shaodan] 4th Peoples Hosp Shenyang, Dept Ophthalmol, Shenyang Inst Ophthalmol, Liaoning, Peoples R China; [Zhang, Samuel S.] Penn State Univ, Dept Neural & Behav Sci, Hershey, PA USA; [Zhang, Samuel S.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore	Peking University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National University of Singapore; Singapore National Eye Center	Huang, P (corresponding author), Peking Univ, Ctr Eye, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China.	huangping512@hotmail.com			Chinese State Natural and Science [30772376, 81041008]	Chinese State Natural and Science	This work was supported by grants from Chinese State Natural and Science 30772376 and 81041008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Albrecht PJ, 2002, EXP NEUROL, V173, P46, DOI 10.1006/exnr.2001.7834; Avraham BCR, 2008, CURR EYE RES, V33, P395, DOI 10.1080/02713680801932891; BALASINGAM V, 1994, J NEUROSCI, V14, P846; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; Cho KJ, 2011, BRAIN RES, V1403, P67, DOI 10.1016/j.brainres.2011.06.005; Choi JS, 2003, GLIA, V41, P237, DOI 10.1002/glia.10186; CONNOR JR, 1985, NEUROSCIENCE, V16, P33, DOI 10.1016/0306-4522(85)90044-2; Correa-Cerro LS, 2007, J NEUROPATH EXP NEUR, V66, P169, DOI 10.1097/01.jnen.0000248555.53079.d5; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Guerette D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-164; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Ji JZ, 2004, EUR J NEUROSCI, V19, P265, DOI 10.1111/j.0953-816X.2003.03107.x; Johnson EC, 2011, INVEST OPHTH VIS SCI, V52, P504, DOI 10.1167/iovs.10-5317; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Klein MA, 1997, GLIA, V19, P227, DOI 10.1002/(SICI)1098-1136(199703)19:3<227::AID-GLIA5>3.0.CO;2-W; Levison SW, 2000, GLIA, V32, P328, DOI 10.1002/1098-1136(200012)32:3<328::AID-GLIA110>3.0.CO;2-7; Lin JHC, 2008, J NEUROSCI, V28, P681, DOI 10.1523/JNEUROSCI.3827-07.2008; Liu B, 2006, J NEUROSCI, V26, P7532, DOI 10.1523/JNEUROSCI.1004-06.2006; Luna G, 2010, MOL VIS, V16, P2511; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Planas AM, 1996, EUR J NEUROSCI, V8, P2612, DOI 10.1111/j.1460-9568.1996.tb01556.x; Quigley HA, 2005, INVEST OPHTH VIS SCI, V46, P2663, DOI 10.1167/iovs.04-1070; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Roth S, 2003, INVEST OPHTH VIS SCI, V44, P5383, DOI 10.1167/iovs.03-0451; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Safavi-Abbasi S, 2001, GLIA, V36, P102, DOI 10.1002/glia.1099; Sakamoto K, 2006, EXP EYE RES, V82, P512, DOI 10.1016/j.exer.2005.08.011; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Son JL, 2010, GLIA, V58, P780, DOI 10.1002/glia.20962; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Sun D, 2009, J COMP NEUROL, V516, P1, DOI 10.1002/cne.22058; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Ueki Y, 2009, P NATL ACAD SCI USA, V106, P21389, DOI 10.1073/pnas.0906156106; Washburn KB, 2006, NEUROSCIENCE, V142, P411, DOI 10.1016/j.neuroscience.2006.06.034; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x; Zhang C, 2008, EXP EYE RES, V86, P991, DOI 10.1016/j.exer.2008.03.020; Zhang SSM, 2005, EXP EYE RES, V81, P103, DOI 10.1016/j.exer.2005.01.016; Zhang SSM, 2003, EXP EYE RES, V76, P421, DOI 10.1016/S0014-4835(03)00002-2	60	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55683	10.1371/journal.pone.0055683	http://dx.doi.org/10.1371/journal.pone.0055683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383263	Green Submitted, gold, Green Published			2022-12-25	WOS:000314610600145
J	Tani, H; Torimura, M; Akimitsu, N				Tani, Hidenori; Torimura, Masaki; Akimitsu, Nobuyoshi			The RNA Degradation Pathway Regulates the Function of GAS5 a Non-Coding RNA in Mammalian Cells	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; NECROSIS-FACTOR-ALPHA; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; GROWTH-ARREST; P-TEFB; 7SK SNRNA; GLUCOCORTICOID-RECEPTOR; CELLULAR INHIBITOR; MESSENGER-RNAS	Studies of various mRNAs have revealed that changes in the abundance of transcripts, through mRNA degradation, act as a critical step in the control of various biological pathways. Similarly, the regulation of non-coding RNA (ncRNA) levels is also considered to be important for their biological functions; however, far less is known about the mechanisms and biological importance of ncRNA turnover for the regulation of ncRNA functions. The growth arrest-specific 5 (GAS5) ncRNA accumulates during growth arrest induced by serum starvation and its transcript is degraded by the well characterized nonsense-mediated RNA decay (NMD) pathway. Historically, NMD was discovered as a RNA quality control system to eliminate aberrant transcripts; however, accumulating evidence shows that NMD also regulates the abundance of physiological transcripts. Interestingly, the GAS5 transcript has the ability to bind the glucocorticoid receptor (GR), resulting in the inhibition of its ligand-dependent association with DNA. The GR binds the promoters of various glucocorticoid-responsive genes, including apoptosis-related genes. In this study, we examined whether the RNA degradation pathway can regulate this function of GAS5. We measured the steady-state abundance and the decay rate of GAS5 in UPF1-depleted human cells using the 5'-bromo-uridine immunoprecipitation chase (BRIC) method, an inhibitor-free method for directly measuring RNA stability. We found that levels of the GAS5 transcript were elevated owing to prolonged decay rates in response to UPF1 depletion, and consequently the apoptosis-related genes, cIAP2 and SGK1, were down-regulated. In addition, serum starvation also increased the transcript levels of GAS5 because of prolonged decay rates, and conversely decreased levels of cIAP2 and SGK1 mRNA. Taken together, we found that the RNA degradation pathway can regulate the function of the GAS5 ncRNA in mammalian cells.	[Tani, Hidenori; Torimura, Masaki] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki, Japan; [Akimitsu, Nobuyoshi] Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Tani, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki, Japan.	h.tani@aist.go.jp; akimitsu@ric.u-tokyo.ac.jp	Tani, Hidenori/A-7175-2017; Torimura, Masaki/M-8401-2018; Tani, Hidenori/F-2042-2010	Tani, Hidenori/0000-0001-6390-4136; Tani, Hidenori/0000-0001-6390-4136	Takeda Science Foundation; Naito Foundation; Japan Society for the Promotion of Science; Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was financially supported by the Takeda Science Foundation, the Naito Foundation, Grants-in-Aid for Scientific Research, Research Fellowship of the Japan Society for the Promotion of Science, the Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science, and Grant-in-Aid for Scientific Research on Innovative Areas 'Functional machinery for non-coding RNAs' from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2012, BIOCHEM BIOPH RES CO, V428, P44, DOI 10.1016/j.bbrc.2012.09.144; Alonso CR, 2012, TRENDS GENET, V28, P78, DOI 10.1016/j.tig.2011.10.005; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Blattner C, 2000, MOL CELL BIOL, V20, P3616, DOI 10.1128/MCB.20.10.3616-3625.2000; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; Colley SM, 2011, BIOCHIMIE, V93, P1966, DOI 10.1016/j.biochi.2011.07.004; Cooper C, 2011, BIOCHIMIE, V93, P1973, DOI 10.1016/j.biochi.2011.07.002; Deblois G, 2003, J STEROID BIOCHEM, V85, P123, DOI 10.1016/S0960-0760(03)00225-5; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; Egloff S, 2006, MOL CELL BIOL, V26, P630, DOI 10.1128/MCB.26.2.630-642.2006; Elkon R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-259; Emberley E, 2003, BIOCHEM BIOPH RES CO, V301, P509, DOI 10.1016/S0006-291X(02)03070-X; Erwin JA, 2008, CURR OPIN CELL BIOL, V20, P349, DOI 10.1016/j.ceb.2008.04.007; Fleming JV, 1998, BIOCHEM J, V330, P573; Fontanier-Razzaq N, 2002, J NUTR, V132, P2137, DOI 10.1093/jn/132.8.2137; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Gardner LB, 2008, CELL CYCLE, V7, P1916, DOI 10.4161/cc.7.13.6203; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hatchell EC, 2006, MOL CELL, V22, P657, DOI 10.1016/j.molcel.2006.05.024; Hong SY, 2000, J BIOL CHEM, V275, P18022, DOI 10.1074/jbc.M001202200; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Ideue T, 2007, GENE DEV, V21, P1993, DOI 10.1101/gad.1557907; Ideue T, 2012, P NATL ACAD SCI USA, V109, P5693, DOI 10.1073/pnas.1200523109; Imamachi N, 2012, DRUG DISCOV THER, V6, P55, DOI 10.5582/ddt.2012.v6.2.55; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kawashima H, 2003, BIOCHEM J, V369, P163, DOI 10.1042/BJ20020743; Keene JD, 2010, ENDOCRINOLOGY, V151, P1391, DOI 10.1210/en.2009-1250; Kelly VR, 2010, MOL ENDOCRINOL, V24, P2281, DOI 10.1210/me.2010-0133; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kulkarni PA, 2004, RECENT PROG HORM RES, V59, P125, DOI 10.1210/rp.59.1.125; Lanz RB, 2002, P NATL ACAD SCI USA, V99, P16081, DOI 10.1073/pnas.192571399; Marz M, 2009, MOL BIOL EVOL, V26, P2821, DOI 10.1093/molbev/msp198; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Raghavan Arvind, 2004, Briefings in Functional Genomics & Proteomics, V3, P112, DOI 10.1093/bfgp/3.2.112; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ruegger S, 2012, TRENDS BIOCHEM SCI, V37, P436, DOI 10.1016/j.tibs.2012.07.002; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Sharifi Neda. A., 2006, P97; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Tani H, 2012, RNA BIOL, V9, P1370, DOI 10.4161/rna.22360; Tani H, 2012, RNA BIOL, V9, P1233, DOI 10.4161/rna.22036; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tani H, 2010, DRUG DISCOV THER, V4, P235; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Webster JC, 2002, ENDOCRINOLOGY, V143, P3866, DOI 10.1210/en.2002-220188; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Zhang Z, 2012, WIRES RNA, V3, P593, DOI 10.1002/wrna.1114; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	84	129	131	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55684	10.1371/journal.pone.0055684	http://dx.doi.org/10.1371/journal.pone.0055684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383264	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800184
J	Singh, D; Qi, RS; Jordan, JL; Mateo, LS; Kao, CC				Singh, Divyendu; Qi, Rongsu; Jordan, Jarrat L.; Mateo, Lani San; Kao, C. Cheng			The Human Antimicrobial Peptide LL-37, but Not the Mouse Ortholog, mCRAMP, Can Stimulate Signaling by Poly(I:C) through a FPRL1-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC PATHWAYS; DENDRITIC CELLS; SELF-DNA; INNATE; RECEPTOR; ACTIVATION; EXPRESSION; CLATHRIN; SURFACE; IL-8	LL-37 is an antimicrobial peptide produced by human cells that can down-regulate the lipopolysaccharide-induced innate immune responses and up-regulate double-stranded (ds) RNA-induced innate responses through Toll-like receptor 3 (TLR3). The murine LL-37 ortholog, mCRAMP, also inhibited lipopolysaccharide- induced responses, but unlike LL-37, it inhibited viral-induced responses in mouse cells. A fluorescence polarization assay showed that LL-37 was able to bind dsRNA better than mCRAMP. In the human lung epithelial cell line BEAS-2B, LL-37, but not mCRAMP, colocalized with TLR3, and the colocalization was increased in the presence of dsRNA. The presence of poly (I:C) increased the accumulation of LL-37 in Rab5 endosomes. Signaling by cells induced with both LL-37 and poly (I:C) was sensitive to inhibitors that affect clathrin-independent trafficking, whereas signaling by poly (I:C) alone was not, suggesting that the LL-37-poly (I:C) complex trafficked to signaling endosomes by a different mechanism than poly (I:C) alone. siRNA knockdown of known LL-37 receptors identified that FPRL1 was responsible for TLR3 signaling induced by LL-37-poly (I:C). These results show that LL-37 and mCRAMP have different activities in TLR3 signaling and that LL-37 can redirect trafficking of poly(I:C) to effect signaling by TLR3 in early endosomes in a mechanism that involves FPRL1.	[Singh, Divyendu; Qi, Rongsu; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Jordan, Jarrat L.; Mateo, Lani San] Janssen Pharmaceut Co Johnson & Johnson, Radnor, PA 19087 USA	Indiana University System; Indiana University Bloomington; Johnson & Johnson; Janssen Pharmaceuticals	Kao, CC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ckao@indiana.edu		Jordan, Jarrat/0000-0002-0699-3774	Indiana Economic Development Corporation; Indiana METACyt Initiative through Lilly Endowment, Inc.	Indiana Economic Development Corporation; Indiana METACyt Initiative through Lilly Endowment, Inc.	This work was supported in part by a grant from the Indiana Economic Development Corporation (to C.K.).; We are grateful to Y. Lai and members of the Kao laboratory at Indiana University for numerous helpful discussions. We thank L. Kao for editing the manuscript and Jim Powers and the Indiana University Light Microscopy center for use of the confocal microscopy facility, which is supported by an Indiana METACyt Initiative funded in part through a grant from the Lilly Endowment, Inc.	Agerberth B., 2012, ANN RHEUM D IN PRESS; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Filewod NCJ, 2009, FEMS IMMUNOL MED MIC, V56, P233, DOI 10.1111/j.1574-695X.2009.00571.x; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GAO JL, 1993, J BIOL CHEM, V268, P25395; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Girnita A, 2012, ONCOGENE, V31, P352, DOI 10.1038/onc.2011.239; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Hasan M, 2011, J IMMUNOL, V187, P5653, DOI 10.4049/jimmunol.1102144; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Into T, 2010, CELL IMMUNOL, V264, P104, DOI 10.1016/j.cellimm.2010.05.005; Itoh K, 2008, J IMMUNOL, V181, P5522, DOI 10.4049/jimmunol.181.8.5522; Kandler K, 2006, INT IMMUNOL, V18, P1729, DOI 10.1093/intimm/dxl107; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026632; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025837; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Limmongkon A, 2004, BIOCHEM BIOPH RES CO, V324, P382, DOI 10.1016/j.bbrc.2004.09.071; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; Qi RS, 2012, J BIOL CHEM, V287, P32617, DOI 10.1074/jbc.M112.387803; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Zhang XA, 2010, BBA-BIOMEMBRANES, V1798, P2201, DOI 10.1016/j.bbamem.2009.12.011	34	48	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2013	288	12					8258	8268		10.1074/jbc.M112.440883	http://dx.doi.org/10.1074/jbc.M112.440883			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112AS	23386607	hybrid, Green Published			2022-12-25	WOS:000316564500026
J	Chen, YH; Pizzolato, F; Cesari, P				Chen, Yin-Hua; Pizzolato, Fabio; Cesari, Paola			Observing Expertise-Related Actions Leads to Perfect Time Flow Estimations	PLOS ONE			English	Article							IMPLICIT-MOTION; STATIC IMAGES; MOTOR-SKILLS; PERCEPTION	The estimation of the time of exposure of a picture portraying an action increases as a function of the amount of movement implied in the action represented. This effect suggests that the perceiver creates an internal embodiment of the action observed as if internally simulating the entire movement sequence. Little is known however about the timing accuracy of these internal action simulations, specifically whether they are affected by the level of familiarity and experience that the observer has of the action. In this study we asked professional pianists to reproduce different durations of exposure (shorter or longer than one second) of visual displays both specific (a hand in piano-playing action) and non-specific to their domain of expertise (a hand in finger-thumb opposition and scrambled-pixels) and compared their performance with non-pianists. Pianists outperformed non-pianists independently of the time of exposure of the stimuli; remarkably the group difference was particularly magnified by the pianists' enhanced accuracy and stability only when observing the hand in the act of playing the piano. These results for the first time provide evidence that through musical training, pianists create a selective and self-determined dynamic internal representation of an observed movement that allows them to estimate precisely its temporal duration.	[Chen, Yin-Hua; Pizzolato, Fabio; Cesari, Paola] Univ Verona, Dept Neurol Neurophysiol Morphol & Movement Sci, I-37100 Verona, Italy	University of Verona	Cesari, P (corresponding author), Univ Verona, Dept Neurol Neurophysiol Morphol & Movement Sci, I-37100 Verona, Italy.	paola.cesari@univr.it		Chen, Yin-Hua/0000-0003-2481-1054; Cesari, Paola/0000-0002-1705-6065				Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; BOOTSMA RJ, 1990, J EXP PSYCHOL HUMAN, V16, P21, DOI 10.1037/0096-1523.16.1.21; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; David AS, 2000, TRENDS COGN SCI, V4, P293, DOI 10.1016/S1364-6613(00)01511-4; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; KILLEEN PR, 1987, PSYCHOL REV, V94, P455, DOI 10.1037/0033-295X.94.4.455; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Lorteije JAM, 2006, J COGNITIVE NEUROSCI, V18, P158, DOI 10.1162/089892906775783732; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Moscatelli A, 2011, EXP BRAIN RES, V210, P25, DOI 10.1007/s00221-011-2598-y; Nather FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019818; Nather FC, 2011, PERCEPT MOTOR SKILL, V113, P157, DOI 10.2466/24.25.27.PMS.113.4.157-170; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Senior C, 2000, CURR BIOL, V10, P16, DOI 10.1016/S0960-9822(99)00259-6; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; Wearden JH, 2008, Q J EXP PSYCHOL, V61, P569, DOI 10.1080/17470210701282576; Wearden JH, 2003, TIME AND MIND II: INFORMATION PROCESSING PERSPECTIVES, P21; WEARDEN JH, 1991, Q J EXP PSYCHOL-B, V43, P59; Wollner C, 2010, PSYCHOL RES-PSYCH FO, V74, P579, DOI 10.1007/s00426-010-0280-9; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	35	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55294	10.1371/journal.pone.0055294	http://dx.doi.org/10.1371/journal.pone.0055294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405131	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400076
J	Donini, LM; Neri, B; De Chiara, S; Poggiogalle, E; Muscaritoli, M				Donini, Lorenzo Maria; Neri, Barbara; De Chiara, Stefania; Poggiogalle, Eleonora; Muscaritoli, Maurizio			Nutritional Care in a Nursing Home in Italy	PLOS ONE			English	Article							MALNUTRITION; UNDERNUTRITION; REHABILITATION; ANOREXIA; COMPLICATIONS; SATISFACTION; REPLACEMENT; COMORBIDITY; PREVALENCE; MORTALITY	Introduction: Malnutrition is a clinical condition due to the imbalance among needs, intake and use of nutrients, leading to the increase of morbidity and mortality, and to the impairment of quality of life. Even in industrialized countries undernutrition is becoming an alarming phenomenon, especially involving elderly institutionalized subjects. A multicentric study called PIMAI (Project Iatrogenic MAlnutrition in Italy), was carried out in Italy over 2005. The aims of this study were to determine the prevalence of malnutrition in hospitals and in nursing care homes (NH), to assess the level of nutritional attention and to measure the perceived quality in food and nutritional care. This paper represents a preliminary analysis of data collected in a NH included in the PIMAI project. Materials and methods: A total of 100 subjects (29 males and 71 females, aged 80.2 +/- 10 years), were recruited from January to June 2005 at the Clinical Rehabilitation Institute "Villa delle Querce'' in Nemi (Rome), among patients in the NH facility. All the participants underwent a multidimensional geriatric evaluation (considering nutritional, clinical, functional and cognitive parameters), and a survey on "perceived quality'' of nutritional care. Results and discussion: According to nutritional status defined by the Mini Nutritional Assessment (R), data analysis showed a high prevalence of malnutrition (36%) especially related to advanced age, chewing, cognitive and functional impairments. Patients seemed to consider nutrition to be important for their health; on the other hand, they were not thoroughly satisfied with the quality of food. Particularly, it was observed scarce attention to nutritional status from medical and nursing staff. Conclusions: Our study confirms the need to pay greater attention to nutritional status in elderly institutionalized subjects. Medical and nursing teams need to be aware of the importance to perform an evaluation of nutritional status in these subset of subjects.	[Donini, Lorenzo Maria; Neri, Barbara; De Chiara, Stefania; Poggiogalle, Eleonora] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Muscaritoli, Maurizio] Univ Roma La Sapienza, Dept Clin Med, Rome, Italy; [Donini, Lorenzo Maria] Rehabil Clin Inst Villa Querce, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Donini, LM (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	Lorenzomaria.donini@uniroma1.it	Donini, Lorenzo/AAS-3873-2020; Poggiogalle, Eleonora/AAB-9338-2019	Donini, Lorenzo/0000-0003-4692-4754; Poggiogalle, Eleonora/0000-0003-0862-5892	Nutricia (Milan, Italy); Nutricia	Nutricia (Milan, Italy)(Danone Nutricia); Nutricia(Danone Nutricia)	The PIMAI (Project: Iatrogenic MAlnutrition in Italy) study was partially supported by unrestricted grants by Nutricia (Milan, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This study was funded by Nutricia. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amaral TF, 2007, CLIN NUTR, V26, P778, DOI 10.1016/j.clnu.2007.08.002; Andreyev HJN, 1998, EUR J CANCER, V34, P503, DOI 10.1016/S0959-8049(97)10090-9; Beck AM, 2003, CLIN NUTR, V20, P455; Bostrom AM, 2012, J AM MED DIR ASSOC, V13, P210, DOI 10.1016/j.jamda.2010.12.004; Bourdel-Marchasson I, 2009, NUTRITION, V25, P155, DOI 10.1016/j.nut.2008.07.016; Carrier N, 2009, J NUTR HEALTH AGING, V13, P565, DOI 10.1007/s12603-009-0108-8; Cereda E, 2010, EUR J CLIN NUTR, V64, P894, DOI 10.1038/ejcn.2010.85; Cereda E, 2011, J AM MED DIR ASSOC, V12, P174, DOI 10.1016/j.jamda.2010.11.013; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; Crogan N L, 2000, J Nurses Staff Dev, V16, P216, DOI 10.1097/00124645-200009000-00004; Crogan NL, 2004, J GERONTOL A-BIOL, V59, P370; de Luis DA, 2011, EUR REV MED PHARMACO, V15, P259; Donini LM, 2008, CLIN NUTR, V27, P105, DOI 10.1016/j.clnu.2007.10.004; Donini L M, 2000, J Nutr Health Aging, V4, P72; Donini LM, 2011, J NUTR HEALTH AGING, V15, P586, DOI 10.1007/s12603-011-0030-8; Donini LM, 2005, MED SCI MONITOR, V11, pCR326; Donini LM, 2004, AGING CLIN EXP RES, V16, P132, DOI 10.1007/BF03324542; Donini LM, 2003, INT PSYCHOGERIATR, V15, P73, DOI 10.1017/S1041610203008779; Edington J, 2000, CLIN NUTR, V19, P191, DOI 10.1054/clnu.1999.0121; Fairbank J C, 1980, Physiotherapy, V66, P271; Ferry M, 2005, J NUTR HEALTH AGING, V9, P261; FRIED LP, 1992, AGING-CLIN EXP RES, V4, P251, DOI 10.1007/BF03324099; Friedmann JM, 1997, AM J CLIN NUTR, V65, P1714, DOI 10.1093/ajcn/65.6.1714; Garry PJ, 1994, GERIATRIC CLIN CHEM, P84; GREENFIELD S, 1993, MED CARE, V31, P141, DOI 10.1097/00005650-199302000-00005; Grieger Jessica A., 2009, Journal of Nutrition for the Elderly, V28, P47, DOI 10.1080/01639360802633979; Gunther CM, 2008, J HAND SURG-AM, V33A, P558, DOI 10.1016/j.jhsa.2008.01.008; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; Harris Connie L, 2004, Ostomy Wound Manage, V50, P54; Hassan Abdelmonem, 2009, Journal of Nutrition for the Elderly, V28, P313, DOI 10.1080/01639360903140353; Hassen TA, 2007, EUR J VASC ENDOVASC, V33, P696, DOI 10.1016/j.ejvs.2006.12.006; Hiesmayr M, 2009, CLIN NUTR, V28, P484, DOI 10.1016/j.clnu.2009.05.013; Hutton Brian, 2002, J Can Dent Assoc, V68, P182; INRAN-Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione, 2000, TABELLE COMPOSIZIONE; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kelly IE, 2000, QJM-MON J ASSOC PHYS, V93, P93, DOI 10.1093/qjmed/93.2.93; Kruizenga HM, 2005, AM J CLIN NUTR, V82, P1082, DOI 10.1093/ajcn/82.5.1082; Kubrak C, 2007, INT J NURS STUD, V44, P1036, DOI 10.1016/j.ijnurstu.2006.07.015; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lengyel Christina O., 2004, Journal of Nutrition for the Elderly, V24, P5, DOI 10.1300/J052v24n02_02; Lin LC, 2005, J ADV NURS, V51, P30, DOI 10.1111/j.1365-2648.2005.03457.x; Linee Guida SINPE per la Nutrizione artificiale ospedaliera, 2002, RIV IT NUT PARENT S, pS5; Lohman T. G., 1992, MANUALE RIFERIMENTO; Morley JE, 1996, DRUG AGING, V8, P134, DOI 10.2165/00002512-199608020-00007; Morley JE, 2001, NUTRITION, V17, P660, DOI 10.1016/S0899-9007(01)00574-3; Morrone A, 2011, Ann Ig, V23, P161; Oliveira MRM, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-54; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; PIKUL J, 1994, TRANSPLANTATION, V57, P469, DOI 10.1097/00007890-199402150-00030; Pirlich M, 2006, CLIN NUTR, V25, P563, DOI 10.1016/j.clnu.2006.03.005; Rai J, 2002, ORTHOPEDICS, V25, P417; Ramic Enisa, 2011, Med Arh, V65, P92; Rockwood K, 2000, DRUG AGING, V17, P295, DOI 10.2165/00002512-200017040-00005; Rozzini R, 2002, AGE AGEING, V31, P277, DOI 10.1093/ageing/31.4.277; Sanchez-Ayala A, 2010, IMPLANT DENT, V19, P196, DOI 10.1097/ID.0b013e3181d46903; Schiffman SS, 1997, JAMA-J AM MED ASSOC, V278, P1357, DOI 10.1001/jama.278.16.1357; Schneider SM, 2004, BRIT J NUTR, V92, P105, DOI 10.1079/BJN20041152; Soto ME, 2005, J NUTR HEALTH AGING, V9, P158; Stratton RJ, 2006, BRIT J NUTR, V96, P870, DOI 10.1017/BJN20061852; Stratton RJ, 2003, DIS RELATED MALNUTRI; Sullivan DH, 2002, J GEN INTERN MED, V17, P923, DOI 10.1046/j.1525-1497.2002.10930.x; Szczygiel B, 2006, POL J FOOD NUTR SCI, V15-56, P43; Wojszel Z B, 2006, Adv Med Sci, V51, P168; Wright ORL, 2010, J NUTR HEALTH AGING, V14, P775, DOI 10.1007/s12603-010-0123-9; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	66	24	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55804	10.1371/journal.pone.0055804	http://dx.doi.org/10.1371/journal.pone.0055804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405217	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400162
J	Sammarco, PW; Strychar, KB				Sammarco, Paul W.; Strychar, Kevin B.			Responses to High Seawater Temperatures in Zooxanthellate Octocorals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SYMBIODINIUM-MICROADRIATICUM FREUDENTHAL; PROGRAMMED CELL-DEATH; CORAL-REEFS; SCLERACTINIAN CORALS; PHOTOSYNTHETIC PIGMENTS; ALGAL ENDOSYMBIONTS; BLEACHING RESPONSE; OXIDATIVE STRESS; SYMBIOTIC ALGAE	Increases in Sea Surface Temperatures (SSTs) as a result of global warming have caused reef-building scleractinian corals to bleach worldwide, a result of the loss of obligate endosymbiotic zooxanthellae. Since the 1980's, bleaching severity and frequency has increased, in some cases causing mass mortality of corals. Earlier experiments have demonstrated that zooxanthellae in scleractinian corals from three families from the Great Barrier Reef, Australia (Faviidae, Poritidae, and Acroporidae) are more sensitive to heat stress than their hosts, exhibiting differential symptoms of programmed cell death - apoptosis and necrosis. Most zooxanthellar phylotypes are dying during expulsion upon release from the host. The host corals appear to be adapted or exapted to the heat increases. We attempt to determine whether this adaptation/exaptation occurs in octocorals by examining the heat-sensitivities of zooxanthellae and their host octocoral alcyonacean soft corals - Sarcophyton ehrenbergi (Alcyoniidae), Sinularia lochmodes (Alcyoniidae), and Xenia elongata (Xeniidae), species from two different families. The soft coral holobionts were subjected to experimental seawater temperatures of 28, 30, 32, 34, and 36 degrees C for 48 hrs. Host and zooxanthellar cells were examined for viability, apoptosis, and necrosis (in hospite and expelled) using transmission electron microscopy (TEM), fluorescent microscopy (FM), and flow cytometry (FC). As experimental temperatures increased, zooxanthellae generally exhibited apoptotic and necrotic symptoms at lower temperatures than host cells and were expelled. Responses varied species-specifically. Soft coral hosts were adapted/exapted to higher seawater temperatures than their zooxanthellae. As with the scleractinians, the zooxanthellae appear to be the limiting factor for survival of the holobiont in the groups tested, in this region. These limits have now been shown to operate in six species within five families and two orders of the Cnidaria in the western Pacific. We hypothesize that this relationship may have taxonomic implications for other obligate zooxanthellate cnidarians subject to bleaching.	[Sammarco, Paul W.] Louisiana Univ Marine Consortium, Chauvin, LA 70344 USA; [Strychar, Kevin B.] Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI USA	Grand Valley State University	Sammarco, PW (corresponding author), Louisiana Univ Marine Consortium, Chauvin, LA 70344 USA.	psammarco@lumcon.edu						Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; ACHITUV Y, 1990, ECOSYSTEMS WORLD, V25, P1; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Ambariyanto, 1997, MAR BIOL, V129, P635; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Asada K., 1987, PHOTOINHIBITION, P228; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Banin E, 2000, APPL ENVIRON MICROB, V66, P3031, DOI 10.1128/AEM.66.7.3031-3036.2000; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BERNER T, 1987, SYMBIOSIS, V3, P23; Bras M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P231, DOI 10.1007/s10541-005-0105-4; BROWN BE, 1985, ADV MAR BIOL, V22, P1, DOI 10.1016/S0065-2881(08)60049-8; Buck BH, 2002, AQUAT LIVING RESOUR, V15, P107, DOI 10.1016/S0990-7440(02)01159-2; Cervino JM, 2004, SYMBIOSIS, V37, P63; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; Davy SK, 2003, BIOL BULL-US, V205, P66, DOI 10.2307/1543446; DREW E A, 1972, Journal of Experimental Marine Biology and Ecology, V9, P71, DOI 10.1016/0022-0981(72)90008-1; Droop M. R, 1963, SYMBIOTIC ASSOCIATIO, V13, P171; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; FABRICIUS KE, 1995, MAR ECOL PROG SER, V126, P145, DOI 10.3354/meps126145; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fang LS, 1997, CORAL REEFS, V16, P127, DOI 10.1007/s003380050066; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; FITT WK, 1983, J CELL SCI, V64, P195; FITT WK, 1983, NEW PHYTOL, V94, P421, DOI 10.1111/j.1469-8137.1983.tb03456.x; FITT WK, 1981, BIOL BULL, V161, P213, DOI 10.2307/1540800; FREUDENTHAL HD, 1962, J PROTOZOOL, V9, P45, DOI 10.1111/j.1550-7408.1962.tb02579.x; Freudenthal T., 1969, Utrecht Micropaleontological Bulletins, V1, P1; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Geddes P., 1882, NATURE, V25, P303; Ginsburg RN, 2006, CORAL REEF BACKGROUN; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Gomez E, 1998, REEF ENCOUNTER, V24, P19; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; GOREAU TF, 1979, SCI AM, V241, P124, DOI 10.1038/scientificamerican0879-124; GOREAU TF, 1971, BIOL BULL, V141, P247, DOI 10.2307/1540115; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Goulet TL, 2008, MAR ECOL PROG SER, V355, P45, DOI 10.3354/meps07214; Harithsa S, 2005, CORAL REEFS, V24, P463, DOI 10.1007/s00338-005-0008-2; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Haslun Joshua A., 2011, Journal of Marine Biology, V2011, P1; Hill M, 2012, BIOL REV IN PRESS; Hill R, 2009, B MAR SCI, V85, P223; Hochberg EJ, 2006, CORAL REEFS, V25, P99, DOI 10.1007/s00338-005-0071-8; Hoegh Guldberg O, 1994, CLIMATE IMPACTS SERI, V1; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoogenboom MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030167; Huang ZB, 2010, J EXP ZOOL PART A, V313A, P660, DOI 10.1002/jez.637; JEFFREY SW, 1968, BIOL BULL, V135, P149, DOI 10.2307/1539622; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Karako S, 2002, CELL OR EX, V4, P539; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KERVIN MJ, 1969, J PHYCOL, V5, P341, DOI 10.1111/j.1529-8817.1969.tb02624.x; Krueger T, 2012, J EXP MAR BIOL ECOL, V413, P169, DOI 10.1016/j.jembe.2011.12.002; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lupinkova L, 2004, PHOTOCHEM PHOTOBIOL, V79, P152, DOI 10.1562/0031-8655(2004)079<0152:OMOTPI>2.0.CO;2; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; MCLAUGHLIN JJA, 1957, P SOC EXP BIOL MED, V95, P115; McLennan Deborah A., 2008, Evolution Education and Outreach, V1, P247, DOI 10.1007/s12052-008-0053-8; Miao W, 2005, J EUKARYOT MICROBIOL, V52, P11, DOI 10.1111/j.1550-7408.2005.3311r.x; Michalek-Wagner K, 2001, CORAL REEFS, V19, P231, DOI 10.1007/s003380170003; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Muscatine L, 1997, CORAL REEFS, V16, P205, DOI 10.1007/s003380050075; MUSCATINE L, 1989, PROC R SOC SER B-BIO, V236, P311, DOI 10.1098/rspb.1989.0025; MUSCATINE L, 1989, AM ZOOL, V29, P371; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Nishiyama Y, 2001, EMBO J, V20, P5587, DOI 10.1093/emboj/20.20.5587; Obura David, 2000, P65; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; PARDY RL, 1974, BIOL BULL, V147, P105, DOI 10.2307/1540572; Perez SF, 2001, J EXP MAR BIOL ECOL, V256, P1, DOI 10.1016/S0022-0981(00)00282-3; Podesta GP, 1997, J GEOPHYS RES-OCEANS, V102, P15749, DOI 10.1029/96JC03557; Rajasuriya Arjan, 2000, P95; Ralph PJ, 2005, J EXP MAR BIOL ECOL, V316, P17, DOI 10.1016/j.jembe.2004.10.003; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; RICHTER M, 1990, PHOTOSYNTH RES, V24, P237, DOI 10.1007/BF00032311; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P133, DOI 10.3354/meps001133; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Roth MS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00240; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sabourin Daryl T., 2013, International Journal of Biology, V5, P1; Salm RV, 2001, P WORKSH MIT COR BLE; Sammarco Paul W., 2009, Environmental Bioindicators, V4, P9, DOI 10.1080/15555270902905377; SAMMARCO PW, 1987, OECOLOGIA, V74, P93, DOI 10.1007/BF00377351; Sandeman I. M, 2006, Rev. biol. trop, V54, P79; Schleyer MH, 2008, MAR POLLUT BULL, V56, P493, DOI 10.1016/j.marpolbul.2007.11.011; Seipp S, 2001, DEVELOPMENT, V128, P4891; Smith Allan H., 2000, P315; Sokal R. R., 1981, BIOMETRY; Sotka EE, 2005, TRENDS ECOL EVOL, V20, P59, DOI 10.1016/j.tree.2004.11.015; Stambler N, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P87, DOI 10.1007/978-94-007-0114-4_7; Stambler N, 2010, CELL ORIG LIFE EXTRE, V17, P199, DOI 10.1007/978-90-481-9449-0_10; Stanley G. D. Jr., 2009, V205, P7; STANLEY GD, 1995, PALEOBIOLOGY, V21, P179, DOI 10.1017/S0094837300013191; STEELE RD, 1977, J ZOOL, V181, P421; Strychar KB, 2005, J EXP MAR BIOL ECOL, V320, P159, DOI 10.1016/j.jembe.2004.12.039; Strychar KB, 2004, PHYCOLOGIA, V43, P768, DOI 10.2216/i0031-8884-43-6-768.1; Strychar KB, 2004, J EXP MAR BIOL ECOL, V304, P99, DOI 10.1016/j.jembe.2003.11.023; Strychar KB, 2004, MAR FRESHWATER RES, V55, P135, DOI 10.1071/MF03080; Strychar KB, 2010, C INT SOC ENV IND; Strychar KB, 2002, THESIS CENTRAL QUEEN; Strychar KB, 2009, J EXP MAR BIOL ECOL, V369, P31, DOI 10.1016/j.jembe.2008.10.021; SUHARSONO, 1992, J EXP MAR BIOL ECOL, V158, P179, DOI 10.1016/0022-0981(92)90225-Y; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; TAYLOR CE, 1989, PROC R SOC SER B-BIO, V238, P277, DOI 10.1098/rspb.1989.0081; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Tchernov D, 2011, P NATL ACAD SCI USA, V108, P9905, DOI 10.1073/pnas.1106924108; Terahara K, 2008, CURR PHARM DESIGN, V14, P131, DOI 10.2174/138161208783378725; Thornhill DJ, 2006, J EXP MAR BIOL ECOL, V338, P50, DOI 10.1016/j.jembe.2006.06.032; Thurber RV, 2007, DEV BIOL, V303, P336, DOI 10.1016/j.ydbio.2006.11.018; Titlyanov EA, 1996, MAR ECOL PROG SER, V139, P167, DOI 10.3354/meps139167; Trench RK., 1987, BIOL DINOFLAGELLATES, P530; Tsubokawa R, 1999, DEV GENES EVOL, V209, P515, DOI 10.1007/s004270050284; van Oppen MJH, 2005, CORAL REEFS, V24, P482, DOI 10.1007/s00338-005-0487-1; Vivekanandan E, 2008, INDIAN COUNCIL AGR R, V1, P117; Vogt CI, 1842, UNTERSUCHUNGEN ENTWI; Wakefield TS, 2000, BIOL BULL-US, V199, P76, DOI 10.2307/1542709; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Wells S., 1992, GREENPEACE BOOK CORA; Welsh MF, 1936, BIOL BULL-US, V70, P282, DOI 10.2307/1537473; Wiens M, 2006, CAN J ZOOL, V84, P307, DOI 10.1139/Z05-165; Wijgerde T, 2012, CORAL REEFS GROW; Wilkinson Clive, 2000, P21; Wooldridge SA, 2010, BIOESSAYS, V32, P615, DOI 10.1002/bies.200900182; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Yonge C. M., 1930, Scientific Reports Great Barrier Reef Expedition, V1, P59; Yonge C. M., 1930, Scientific Reports Great Barrier Reef Expedition, V1, P13; Yonge CM, 1930, SCI REP GREAT BARRIE, V1, P83; Yonge CM, 1931, SCI REP GREAT BARRIE, V1928-29, P135; Zhang LL, 2011, DEV COMP IMMUNOL, V35, P603, DOI 10.1016/j.dci.2011.01.005	141	40	42	0	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54989	10.1371/journal.pone.0054989	http://dx.doi.org/10.1371/journal.pone.0054989			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405104	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400048
J	Sarikonda, G; Sachithanantham, S; Manenkova, Y; Kupfer, T; Posgai, A; Wasserfall, C; Bernstein, P; Straub, L; Pagni, PP; Schneider, D; Calvo, TR; Coulombe, M; Herold, K; Gill, RG; Atkinson, M; Nepom, G; Ehlers, M; Staeva, T; Garren, H; Steinman, L; Chan, AC; von Herrath, M				Sarikonda, Ghanashyam; Sachithanantham, Sowbarnika; Manenkova, Yulia; Kupfer, Tinalyn; Posgai, Amanda; Wasserfall, Clive; Bernstein, Philip; Straub, Laura; Pagni, Philippe P.; Schneider, Darius; Calvo, Teresa Rodriguez; Coulombe, Marilyne; Herold, Kevan; Gill, Ronald G.; Atkinson, Mark; Nepom, Gerald; Ehlers, Mario; Staeva, Teodora; Garren, Hideki; Steinman, Lawrence; Chan, Andrew C.; von Herrath, Matthias			Transient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD Mice	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; RECENT-ONSET; BETA-CELLS; LYMPHOCYTE DEPLETION; TYPE-1; ANTIGEN; EXPRESSION; PREVENTS; IMMUNOTHERAPY; DESTRUCTION	A recent type 1 diabetes (T1D) clinical trial of rituximab (a B cell-depleting anti-CD20 antibody) achieved some therapeutic benefit in preserving C-peptide for a period of approximately nine months in patients with recently diagnosed diabetes. Our previous data in the NOD mouse demonstrated that co-administration of antigen (insulin) with anti-CD3 antibody (a T cell-directed immunomodulator) offers better protection than either entity alone, indicating that novel combination therapies that include a T1D-related autoantigen are possible. To accelerate the identification and development of novel combination therapies that can be advanced into the clinic, we have evaluated the combination of a mouse anti-CD20 antibody with either oral insulin or a proinsulin-expressing DNA vaccine. Anti-CD20 alone, given once or on 4 consecutive days, produced transient B cell depletion but did not prevent or reverse T1D in the NOD mouse. Oral insulin alone (twice weekly for 6 weeks) was also ineffective, while proinsulin DNA (weekly for up to 12 weeks) showed a trend toward modest efficacy. Combination of anti-CD20 with oral insulin was ineffective in reversing diabetes in NOD mice whose glycemia was controlled with SC insulin pellets; these experiments were performed in three independent labs. Combination of anti-CD20 with proinsulin DNA was also ineffective in diabetes reversal, but did show modest efficacy in diabetes prevention (p = 0.04). In the prevention studies, anti-CD20 plus proinsulin resulted in modest increases in Tregs in pancreatic lymph nodes and elevated levels of proinsulin-specific CD4+ T-cells that produced IL-4. Thus, combination therapy with anti-CD20 and either oral insulin or proinsulin does not protect hyperglycemic NOD mice, but the combination with proinsulin offers limited efficacy in T1D prevention, potentially by augmentation of proinsulin-specific IL-4 production.	[Sarikonda, Ghanashyam; Sachithanantham, Sowbarnika; Manenkova, Yulia; Pagni, Philippe P.; Schneider, Darius; Calvo, Teresa Rodriguez; von Herrath, Matthias] La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA 92037 USA; [Kupfer, Tinalyn; Coulombe, Marilyne; Gill, Ronald G.] Univ Colorado Denver, Aurora, CO USA; [Posgai, Amanda; Wasserfall, Clive; Atkinson, Mark] Univ Florida, Gainesville, FL USA; [Bernstein, Philip; Straub, Laura; Ehlers, Mario] Immune Tolerance Network, San Francisco, CA USA; [Staeva, Teodora] JDRF Int, New York, NY USA; [Garren, Hideki; Steinman, Lawrence] Bayhill Therapeut, San Mateo, CA USA; [Steinman, Lawrence] Stanford Univ, Stanford, CA 94305 USA; [Chan, Andrew C.] Genentech Inc, San Francisco, CA 94080 USA; [Herold, Kevan] Yale Univ, New Haven, CT USA; [Nepom, Gerald] Benaroya Res Inst, Seattle, WA USA	La Jolla Institute for Immunology; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of Florida; Immune Tolerance Network; Stanford University; Roche Holding; Genentech; Yale University; Benaroya Research Institute	von Herrath, M (corresponding author), La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA 92037 USA.	matthias@liai.org	Gill, Ronald/GWM-5338-2022; Kupfer, Tinalyn M/P-1326-2018; Wasserfall, Clive/ABF-9385-2020; wasserfall, clive/J-9078-2012	Kupfer, Tinalyn M/0000-0001-8182-0235; Wasserfall, Clive/0000-0002-3522-8932; wasserfall, clive/0000-0002-3522-8932; Nepom, Gerald/0000-0002-8063-1464; Gill, Ronald/0000-0001-7520-4401; Steinman, Lawrence/0000-0002-2437-2250; Posgai, Amanda/0000-0002-9491-0958	University of Colorado, Denver (UCD) under NIH [5U19AI050864-08]; T1D center of San Diego Postdoctoral fellowship; ITN-JDRF (Immune Tolerence Network) Partnership; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864] Funding Source: NIH RePORTER	University of Colorado, Denver (UCD) under NIH; T1D center of San Diego Postdoctoral fellowship; ITN-JDRF (Immune Tolerence Network) Partnership; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a subaward from the University of Colorado, Denver (UCD) to MvH, issued under NIH award number 5U19AI050864-08 to UCD under the direction of Dr. George S. Eisenbarth, P. I. GS was a recipient of a T1D center of San Diego Postdoctoral fellowship; the ITN-JDRF (Immune Tolerence Network) Partnership supported members of the ITN-JDRF preclinical consortium, including TK, AP, CW, RG, MA, ME and MvH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bot A, 2001, J IMMUNOL, V167, P2950, DOI 10.4049/jimmunol.167.5.2950; Bour-Jordan H, 2007, J IMMUNOL, V179, P1004, DOI 10.4049/jimmunol.179.2.1004; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Coon B, 1999, J CLIN INVEST, V104, P189, DOI 10.1172/JCI7209; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Diabetes Prevention Trial Type Stu, 2005, DIABETES CARE, V28, P1068; Falcone M, 1998, J IMMUNOL, V161, P1163; Fourlanos S, 2011, DIABETES, V60, P1237, DOI 10.2337/db10-1360; Fousteri G, 2010, DIABETOLOGIA, V53, P1958, DOI 10.1007/s00125-010-1777-x; Gallagher MP, 2011, ANN NY ACAD SCI, V1243, P119, DOI 10.1111/j.1749-6632.2011.06321.x; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Homann D, 1999, J IMMUNOL, V163, P1833; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Huang HC, 2010, P NATL ACAD SCI USA, V107, P4658, DOI 10.1073/pnas.1001074107; Hulbert C, 2001, J IMMUNOL, V167, P5535, DOI 10.4049/jimmunol.167.10.5535; Martinez NR, 2003, J CLIN INVEST, V111, P1365, DOI 10.1172/JCI200317166; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nanto-Salonen K, 2008, LANCET; Noorchashm H, 1999, J IMMUNOL, V163, P743; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Orban T, 2010, J AUTOIMMUN, V34, P408, DOI 10.1016/j.jaut.2009.10.005; Peakman M, 2010, DIABETES, V59, P2087, DOI 10.2337/db10-0630; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Serreze DV, 2011, DIABETES, V60, P2914, DOI 10.2337/db11-0705; Silveira PA, 2002, EUR J IMMUNOL, V32, P3657, DOI 10.1002/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E; Solvason N, 2008, J IMMUNOL, V181, P8298, DOI 10.4049/jimmunol.181.12.8298; Thrower SL, 2009, CLIN EXP IMMUNOL, V155, P156, DOI 10.1111/j.1365-2249.2008.03814.x; von Herrath M, 2004, PEDIATR DIABETES, V5, P23, DOI 10.1111/j.1399-543X.2004.00076.x; vonHerrath MG, 1996, J CLIN INVEST, V98, P1324, DOI 10.1172/JCI118919; Waldron-Lynch F, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003401; Wong F Susan, 2005, Rev Diabet Stud, V2, P121, DOI 10.1900/RDS.2005.2.121; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Yu S, 2012, INT IMMUNOL	36	29	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54712	10.1371/journal.pone.0054712	http://dx.doi.org/10.1371/journal.pone.0054712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405091	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400035
J	Ma, HY; Hong, M; Duan, JN; Liu, P; Fan, XS; Shang, EX; Su, SL; Guo, JM; Qian, DW; Tang, YP				Ma, Hongyue; Hong, Min; Duan, Jinao; Liu, Pei; Fan, Xinsheng; Shang, Erxin; Su, Shulan; Guo, Jianming; Qian, Dawei; Tang, Yuping			Altered Cytokine Gene Expression in Peripheral Blood Monocytes across the Menstrual Cycle in Primary Dysmenorrhea: A Case-Control Study	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; EPIDERMAL-GROWTH-FACTOR; BETA SUPERFAMILY; TGF-BETA; OXYTOCIN RECEPTOR; HUMAN ENDOMETRIUM; MESSENGER-RNA; STROMAL CELLS; INFLAMMATION; INTERLEUKIN-1-BETA	Primary dysmenorrhea is one of the most common gynecological complaints in young women, but potential peripheral immunologic features underlying this condition remain undefined. In this paper, we compared 84 common cytokine gene expression profiles of peripheral blood mononuclear cells (PBMCs) from six primary dysmenorrheic young women and three unaffected controls on the seventh day before (secretory phase), and the first (menstrual phase) and the fifth (regenerative phase) days of menstruation, using a real-time PCR array assay combined with pattern recognition and gene function annotation methods. Comparisons between dysmenorrhea and normal control groups identified 11 (nine increased and two decreased), 14 (five increased and nine decreased), and 15 (seven increased and eight decreased) genes with >= 2-fold difference in expression (P<0.05) in the three phases of menstruation, respectively. In the menstrual phase, genes encoding pro-inflammatory cytokines (IL1B, TNF, IL6, and IL8) were up-regulated, and genes encoding TGF-beta superfamily members (BMP4, BMP6, GDF5, GDF11, LEFTY2, NODAL, and MSTN) were down-regulated. Functional annotation revealed an excessive inflammatory response and insufficient TGF-beta superfamily member signals with anti-inflammatory consequences, which may directly contribute to menstrual pain. In the secretory and regenerative phases, increased expression of pro-inflammatory cytokines and decreased expression of growth factors were also observed. These factors may be involved in the regulation of decidualization, endometrium breakdown and repair, and indirectly exacerbate primary dysmenorrhea. This first study of cytokine gene expression profiles in PBMCs from young primary dysmenorrheic women demonstrates a shift in the balance between expression patterns of pro-inflammatory cytokines and TGF-beta superfamily members across the whole menstrual cycle, underlying the peripheral immunologic features of primary dysmenorrhea.	[Ma, Hongyue; Hong, Min; Duan, Jinao; Liu, Pei; Fan, Xinsheng; Shang, Erxin; Su, Shulan; Guo, Jianming; Qian, Dawei; Tang, Yuping] Nanjing Univ Chinese Med, Jiangsu Key Lab TCM Formulae Res, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Duan, JN (corresponding author), Nanjing Univ Chinese Med, Jiangsu Key Lab TCM Formulae Res, Nanjing, Jiangsu, Peoples R China.	dja@njutcm.edu.cn			Open Project Program of Traditional Chinese Medicine Department of Nanjing University of Chinese Medicine [YS2012ZYX311]; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); National Natural Science Fund of China [81274199, 81073121]; National Science Fund for Distinguished Young Scholars [81102762]; National Basic Research Program of China (973 Program) [2011CB505300, 2011CB505303]	Open Project Program of Traditional Chinese Medicine Department of Nanjing University of Chinese Medicine; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the Open Project Program of Traditional Chinese Medicine Department of Nanjing University of Chinese Medicine (YS2012ZYX311), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD), the National Natural Science Fund of China (81274199, 81073121) and the National Science Fund for Distinguished Young Scholars (81102762), and National Basic Research Program of China (973 Program) (2011CB505300, 2011CB505303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Ahnstedt H, 2012, ACTA PHYSIOL, V205, P266, DOI 10.1111/j.1748-1716.2011.02392.x; Akerlund M, 2002, PROG BRAIN RES, V139, P359; Aksu K, 2012, CURR PHARM DESIGN, V18, P1478; Arcuri F, 2009, REPROD SCI, V16, P453, DOI 10.1177/1933719108328609; Bany BM, 1998, BIOL REPROD, V59, P131, DOI 10.1095/biolreprod59.1.131; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Braundmeier AG, 2006, J CLIN ENDOCR METAB, V91, P2358, DOI 10.1210/jc.2005-0601; Catalano RD, 2007, MOL HUM REPROD, V13, P641, DOI 10.1093/molehr/gam021; Clark RI, 2011, CURR BIOL, V21, P1672, DOI 10.1016/j.cub.2011.08.048; Coco AS, 1999, AM FAM PHYSICIAN, V60, P489; Cornet PB, 2002, J BIOL CHEM, V277, P42496, DOI 10.1074/jbc.M201793200; Dams-Kozlowska H, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-8; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85; Deepak P, 2010, INT IMMUNOL, V22, P53, DOI 10.1093/intimm/dxp114; Duncan WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023595; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Friebe-Hoffmann U, 2007, REGUL PEPTIDES, V142, P78, DOI 10.1016/j.regpep.2007.01.012; Friebe-Hoffmann U, 2001, AM J REPROD IMMUNOL, V46, P226, DOI 10.1034/j.1600-0897.2001.d01-6.x; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Giacomini D, 2009, MOL ENDOCRINOL, V23, P1102, DOI 10.1210/me.2008-0425; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Guo D, 2012, MOL CELL BIOCHEM, V363, P179, DOI 10.1007/s11010-011-1170-1; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016840; Gurantz D, 2005, J MOL CELL CARDIOL, V38, P505, DOI 10.1016/j.yjmcc.2004.12.015; Han S, 2011, BMB REP, V44, P129, DOI 10.5483/BMBRep.2011.44.2.129; Harel Z, 2008, ANN NY ACAD SCI, V1135, P185, DOI 10.1196/annals.1429.007; Hatakeyama Y, 2010, BONE TISSUE REGENERA, V3, P1; Henriet P, 2012, MOL CELL ENDOCRINOL, V358, P197, DOI 10.1016/j.mce.2011.07.042; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JC, 1998, J CLIN ENDOCR METAB, V83, P538, DOI 10.1210/jc.83.2.538; Hur J, 2009, BIOINFORMATICS, V25, P838, DOI 10.1093/bioinformatics/btp049; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; JEZIORSKA M, 1995, BIOL REPROD, V53, P312, DOI 10.1095/biolreprod53.2.312; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Kokabu S, 2012, MOL ENDOCRINOL, V26, P87, DOI 10.1210/me.2011-1168; LeBlanc MM, 2012, EQUINE VET J, V44, P8, DOI 10.1111/j.2042-3306.2011.00502.x; Lee CC, 2010, ONCOGENE, V29, P3110, DOI 10.1038/onc.2010.55; Lee HT, 2012, AM J PHYSIOL-RENAL, V303, pF1216, DOI 10.1152/ajprenal.00220.2012; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; Liedman R, 2008, GYNECOL ENDOCRINOL, V24, P508, DOI 10.1080/09513590802306218; Lundvig DMS, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00081; MacDonald TT, 2011, BIOCHEM SOC T, V39, P1061, DOI 10.1042/BST0391061; Madhyastha H, 2012, CLIN EXP PHARMACOL P, V39, P13, DOI 10.1111/j.1440-1681.2011.05627.x; Maybin JA, 2011, MOL CELL ENDOCRINOL, V335, P42, DOI 10.1016/j.mce.2010.08.006; Oliveira MR, 2001, LEUKEMIA RES, V25, P711, DOI 10.1016/S0145-2126(01)00011-X; Plake C, 2006, BIOINFORMATICS, V22, P2444, DOI 10.1093/bioinformatics/btl408; Ponnampalam AP, 2004, MOL HUM REPROD, V10, P879, DOI 10.1093/molehr/gah121; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Rauk PN, 2001, AM J REPROD IMMUNOL, V45, P148, DOI 10.1111/j.8755-8920.2001.450305.x; Saiga K, 2010, BIOCHEM BIOPH RES CO, V402, P329, DOI 10.1016/j.bbrc.2010.10.026; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; SCAMBIA G, 1994, INT J CANCER, V58, P769, DOI 10.1002/ijc.2910580603; Sheares KKK, 2004, AM J PHYSIOL-LUNG C, V287, pL919, DOI 10.1152/ajplung.00012.2004; Sheridan BC, 1999, AM J PHYSIOL-LUNG C, V277, pL861, DOI 10.1152/ajplung.1999.277.5.L861; Shimizu T, 2010, PHYSIOL GENOMICS, V42A, P290, DOI 10.1152/physiolgenomics.00107.2010; Skarzynski DJ, 2000, BIOL REPROD, V62, P1116, DOI 10.1095/biolreprod62.5.1116; Strakova Z, 2002, J REPROD IMMUNOL, V55, P35, DOI 10.1016/S0165-0378(01)00141-3; STROMBERG P, 1984, ACTA OBSTET GYN SCAN, V63, P533, DOI 10.3109/00016348409156715; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Suresh PS, 2011, ENDOCR J, V58, P223, DOI 10.1507/endocrj.K11E-098; Szostek AZ, 2011, DOMEST ANIM ENDOCRIN, V41, P14, DOI 10.1016/j.domaniend.2011.01.007; Takano M, 2012, MOL CELL ENDOCRINOL, V348, P224, DOI 10.1016/j.mce.2011.08.027; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3263, DOI 10.1210/jc.87.7.3263; Tang MY, 2010, ENDOCRINOLOGY, V151, P1320, DOI 10.1210/en.2009-1081; Terness P, 2001, INT IMMUNOPHARMACOL, V1, P119, DOI 10.1016/S0162-3109(00)00264-2; Terzidou V, 2011, BIOL REPROD, V84, P546, DOI 10.1095/biolreprod.110.086785; Thompson M, 2004, AM J PHYSIOL-ENDOC M, V287, pE1142, DOI 10.1152/ajpendo.00122.2004; Xu GX, 2004, J CLIN ENDOCR METAB, V89, P5523, DOI 10.1210/jc.2004-0893; Yan JD, 2009, FREE RADICAL BIO MED, V46, P1275, DOI 10.1016/j.freeradbiomed.2009.02.007; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC; Yeh ML, 2004, LIFE SCI, V75, P669, DOI 10.1016/j.lfs.2003.11.034; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200	75	39	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55200	10.1371/journal.pone.0055200	http://dx.doi.org/10.1371/journal.pone.0055200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390521	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100037
J	Muller, N; Lorenz, I; Langguth, B; Weisz, N				Mueller, Nadia; Lorenz, Isabel; Langguth, Berthold; Weisz, Nathan			rTMS Induced Tinnitus Relief Is Related to an Increase in Auditory Cortical Alpha Activity	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; DORSAL COCHLEAR NUCLEUS; REPETITIVE TMS; GAMMA-OSCILLATIONS; CORTEX; EXCITABILITY; RESPONSES; ATTENTION; SCHIZOPHRENIA	Chronic tinnitus, the continuous perception of a phantom sound, is a highly prevalent audiological symptom. A promising approach for the treatment of tinnitus is repetitive transcranial magnetic stimulation (rTMS) as this directly affects tinnitus-related brain activity. Several studies indeed show tinnitus relief after rTMS, however effects are moderate and vary strongly across patients. This may be due to a lack of knowledge regarding how rTMS affects oscillatory activity in tinnitus sufferers and which modulations are associated with tinnitus relief. In the present study we examined the effects of five different stimulation protocols (including sham) by measuring tinnitus loudness and tinnitus-related brain activity with Magnetoencephalography before and after rTMS. Changes in oscillatory activity were analysed for the stimulated auditory cortex as well as for the entire brain regarding certain frequency bands of interest (delta, theta, alpha, gamma). In line with the literature the effects of rTMS on tinnitus loudness varied strongly across patients. This variability was also reflected in the rTMS effects on oscillatory activity. Importantly, strong reductions in tinnitus loudness were associated with increases in alpha power in the stimulated auditory cortex, while an unspecific decrease in gamma and alpha power, particularly in left frontal regions, was linked to an increase in tinnitus loudness. The identification of alpha power increase as main correlate for tinnitus reduction sheds further light on the pathophysiology of tinnitus. This will hopefully stimulate the development of more effective therapy approaches.	[Mueller, Nadia; Weisz, Nathan] Univ Trento, Ctr Mind Brain Sci, Mattarello, Italy; [Lorenz, Isabel] Univ Konstanz, Dept Psychol, Constance, Germany; [Langguth, Berthold] Univ Hosp Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Weisz, Nathan] Univ Konstanz, Constance, Germany	University of Trento; University of Konstanz; University of Regensburg; University of Konstanz	Muller, N (corresponding author), Univ Trento, Ctr Mind Brain Sci, Mattarello, Italy.	nadia.muller@unitn.it	Müller-Voggel, Nadia/ABB-6603-2020; Langguth, Berthold/AAP-2638-2021; Weisz, Nathan/K-3325-2015	Müller-Voggel, Nadia/0000-0002-6414-5669; Weisz, Nathan/0000-0001-7816-0037	Deutsche Forschungsgemeinschaft [4156/2-1]; Tinnitus Research Initiative	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tinnitus Research Initiative	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (grant number: 4156/2-1) and the Tinnitus Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton H, 2007, NEUROSCI LETT, V426, P23, DOI 10.1016/j.neulet.2007.08.034; Baguley DM, 2002, CLIN OTOLARYNGOL, V27, P219, DOI 10.1046/j.1365-2273.2002.00566.x; Benali A, 2011, J NEUROSCI, V31, P1193, DOI 10.1523/JNEUROSCI.1379-10.2011; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; De Ridder D, 2005, OTOL NEUROTOL, V26, P616, DOI 10.1097/01.mao.0000178146.91139.3c; Di Lazzaro V, 2011, J NEUROPHYSIOL, V105, P2150, DOI 10.1152/jn.00781.2010; Dietrich V, 2001, HEARING RES, V158, P95, DOI 10.1016/S0378-5955(01)00282-9; Dohrmann K, 2007, PROG BRAIN RES, V166, P473, DOI 10.1016/S0079-6123(07)66046-4; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Ferrarelli F, 2008, AM J PSYCHIAT, V165, P996, DOI 10.1176/appi.ajp.2008.07111733; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Folmer RL, 2006, ACTA OTO-LARYNGOL, V126, P96, DOI 10.1080/03655230600895465; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Fregni F, 2006, EUR J NEUROL, V13, P996, DOI 10.1111/j.1468-1331.2006.01414.x; Fuggetta G, 2012, EXPT NEUROLOGY; Gamboa OL, 2010, EXP BRAIN RES, V204, P181, DOI 10.1007/s00221-010-2293-4; GOEBEL G, 1994, HNO, V42, P166; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kaltenbach JA, 2006, ACTA OTO-LARYNGOL, V126, P20, DOI 10.1080/03655230600895309; Khedr EM, 2009, EUR J NEUROL, V16, P404, DOI 10.1111/j.1468-1331.2008.02522.x; Kleinjung T, 2007, PROG BRAIN RES, V166, P359, DOI 10.1016/S0079-6123(07)66034-8; Kleinjung T, 2008, OTOLARYNG HEAD NECK, V138, P497, DOI 10.1016/j.otohns.2007.12.022; Kleinjung Tobias, 2009, Int Tinnitus J, V15, P154; Kleinjung Tobias, 2008, Int Tinnitus J, V14, P112; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Langguth B, 2006, BRAIN TOPOGR, V18, P241, DOI 10.1007/s10548-006-0002-1; Langguth B, 2008, BRAIN STIMUL, V1, P192, DOI 10.1016/j.brs.2008.06.003; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Londero A, 2006, NEUROPHYSIOL CLIN, V36, P145, DOI 10.1016/j.neucli.2006.08.001; Lorenz I, 2010, J NEUROPHYSIOL, V104, P1497, DOI 10.1152/jn.00370.2010; Marcondes RA, 2010, EUR J NEUROL, V17, P38, DOI 10.1111/j.1468-1331.2009.02730.x; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Moazami-Goudarzi M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-40; Moont R, 2011, PAIN, V60, P709; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ortmann M, 2011, EUR J NEUROSCI, V33, P568, DOI 10.1111/j.1460-9568.2010.07542.x; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Plewnia C, 2007, J NEUROL NEUROSUR PS, V78, P152, DOI 10.1136/jnnp.2006.095612; Plewnia C, 2003, ANN NEUROL, V53, P263, DOI 10.1002/ana.10468; Plewnia C, 2011, CNS NEUROSCI THER, V17, P449, DOI 10.1111/j.1755-5949.2010.00169.x; Poreisz C, 2008, EXP BRAIN RES, V185, P611, DOI 10.1007/s00221-007-1188-5; Poreisz C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-54; Pridmore S, 1998, J ECT, V14, P25; Quartarone A, 2005, EXP BRAIN RES, V161, P114, DOI 10.1007/s00221-004-2052-5; Rajan R, 1998, AUDIOL NEURO-OTOL, V3, P123, DOI 10.1159/000013786; Ramirez RR, 2009, IEEE ENG MED BIO, P1940, DOI 10.1109/IEMBS.2009.5333457; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Romei V, 2008, NEUROREPORT, V19, P203, DOI 10.1097/WNR.0b013e3282f454c4; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Sedley W, 2012, BRAIN, V135, P3089, DOI 10.1093/brain/aws220; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Soekadar SR, 2009, CNS SPECTRUMS, V14, P208, DOI 10.1017/S1092852900020228; Takano B, 2004, NEUROIMAGE, V23, P849, DOI 10.1016/j.neuroimage.2004.06.032; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Trippe J, 2009, EXPT BRAIN RES, V31, P1193; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; Vanneste S, 2010, EXP BRAIN RES, V202, P779, DOI 10.1007/s00221-010-2183-9; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Weiler Elmar W, 2002, Int Tinnitus J, V8, P87; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3; Westerhausen R, 2010, NEUROPSYCHOLOGIA, V48, P2075, DOI 10.1016/j.neuropsychologia.2010.03.028; Worden MS, 2000, J NEUROSCI, V20; Wunderlich AP, 2010, AUDIOL NEURO-OTOL, V15, P137, DOI 10.1159/000241094; Zacharek MA, 2002, HEARING RES, V172, P137, DOI 10.1016/S0378-5955(02)00575-0	87	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55557	10.1371/journal.pone.0055557	http://dx.doi.org/10.1371/journal.pone.0055557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390539	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100055
J	Stegmaier, J; Skanda, D; Lebiedz, D				Stegmaier, Johannes; Skanda, Dominik; Lebiedz, Dirk			Robust Optimal Design of Experiments for Model Discrimination Using an Interactive Software Tool	PLOS ONE			English	Article							CRITERION; KINETICS; SYSTEMS	Mathematical modeling of biochemical processes significantly contributes to a better understanding of biological functionality and underlying dynamic mechanisms. To support time consuming and costly lab experiments, kinetic reaction equations can be formulated as a set of ordinary differential equations, which in turn allows to simulate and compare hypothetical models in silico. To identify new experimental designs that are able to discriminate between investigated models, the approach used in this work solves a semi-infinite constrained nonlinear optimization problem using derivative based numerical algorithms. The method takes into account parameter variabilities such that new experimental designs are robust against parameter changes while maintaining the optimal potential to discriminate between hypothetical models. In this contribution we present a newly developed software tool that offers a convenient graphical user interface for model discrimination. We demonstrate the beneficial operation of the discrimination approach and the usefulness of the software tool by analyzing a realistic benchmark experiment from literature. New robust optimal designs that allow to discriminate between the investigated model hypotheses of the benchmark experiment are successfully calculated and yield promising results. The involved robustification approach provides maximally discriminating experiments for the worst parameter configurations, which can be used to estimate the meaningfulness of upcoming experiments. A major benefit of the graphical user interface is the ability to interactively investigate the model behavior and the clear arrangement of numerous variables. In addition to a brief theoretical overview of the discrimination method and the functionality of the software tool, the importance of robustness of experimental designs against parameter variability is demonstrated on a biochemical benchmark problem. The software is licensed under the GNU General Public License and freely available at http://sourceforge.net/projects/mdtgui/.	[Stegmaier, Johannes; Skanda, Dominik] Univ Freiburg, Ctr Anal Biol Syst ZBSA, D-79106 Freiburg, Germany; [Stegmaier, Johannes] Karlsruhe Inst Technol, Inst Appl Comp Sci IAI, D-76021 Karlsruhe, Germany; [Lebiedz, Dirk] Univ Ulm, Inst Numer Math, D-89069 Ulm, Germany; [Lebiedz, Dirk] Univ Ulm, Ulm Ctr Sci Comp UZWR, D-89069 Ulm, Germany	University of Freiburg; Helmholtz Association; Karlsruhe Institute of Technology; Ulm University; Ulm University	Lebiedz, D (corresponding author), Univ Ulm, Inst Numer Math, D-89069 Ulm, Germany.	dirk.lebiedz@uni-ulm.de	Stegmaier, Johannes/ABA-4230-2021	Stegmaier, Johannes/0000-0003-4072-3759	Freiburg Initiative for Systems Biology (FRISYS), part of the BMBF FORSYS Systems Biology Initiative; Freiburg Excellence Cluster Centre for Biological Signalling Studies (BIOSS); Helmholtz Alliance Systems Biology of Cancer; Nephage Initiative (BMBF Gerontosys II - NephAge) [031 5896A]; German Research Foundation (DFG); Albert-Ludwigs-University Freiburg	Freiburg Initiative for Systems Biology (FRISYS), part of the BMBF FORSYS Systems Biology Initiative; Freiburg Excellence Cluster Centre for Biological Signalling Studies (BIOSS); Helmholtz Alliance Systems Biology of Cancer; Nephage Initiative (BMBF Gerontosys II - NephAge); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert-Ludwigs-University Freiburg	The authors gratefully acknowledge the Freiburg Initiative for Systems Biology (FRISYS), part of the BMBF FORSYS Systems Biology Initiative, the Freiburg Excellence Cluster Centre for Biological Signalling Studies (BIOSS), the Helmholtz Alliance Systems Biology of Cancer and the Nephage Initiative (BMBF Gerontosys II - NephAge (031 5896A)) for various support and funding. The article processing charge was funded by the German Research Foundation (DFG) and the Albert-Ludwigs-University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Bisswanger H., 2008, ENZYME KINETICS; Bock H.G., 1984, P 9 IFAC WORLD C BUD; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; COIN-OR, AUT DIFF SOFTW CPPAD; COONEY MJ, 1995, APPL MICROBIOL BIOT, V43, P826; Digia, QT CROSS PLATF APPL; Flassig RJ, 2012, BIOINFORMATICS; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; Hart J.D., 1997, NONPARAMETRIC SMOOTH; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; HSL, COLL FORTR COD LARG; Koudriavtsev A B, 2001, LAW MASS ACTION; Kremling A, 2004, GENOME RES, V14, P1773, DOI 10.1101/gr.1226004; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Lopez-Fidalgo J, 2007, J R STAT SOC B, V69, P231, DOI 10.1111/j.1467-9868.2007.00586.x; Lorenz S, 2007, J COMPUT CHEM, V28, P1384, DOI 10.1002/jcc.20674; Myung JI, 2009, PSYCHOL REV, V116, P499, DOI 10.1037/a0016104; Polak E., 1997, OPTIMIZATION ALGORIT; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rawlings JO, 1998, APPL REGRESSION ANAL, DOI 10.1007/b98890; RUBSAMEN H, 1974, H-S Z PHYSIOL CHEM, V355, P687, DOI 10.1515/bchm2.1974.355.1.687; Skanda D, 2012, THESIS A LUDWIGS U F; Skanda D, 2013, MATH PROGRAM, V141, P405, DOI 10.1007/s10107-012-0532-0; Skanda D, 2010, BIOINFORMATICS, V26, P939, DOI 10.1093/bioinformatics/btq074; Takors R, 1997, BIOTECHNOL BIOENG, V56, P564, DOI 10.1002/(SICI)1097-0290(19971205)56:5<564::AID-BIT10>3.0.CO;2-C; Timmer J, 2004, INT J BIFURCAT CHAOS, V14, P2069, DOI 10.1142/S0218127404010461; Torres N., 2005, PATHWAY ANAL OPTIMIZ; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Wachter A, 2002, THESIS CARNEGIE MELL; Wagenmakers EJ, 2003, J MATH PSYCHOL, V47, P580, DOI 10.1016/S0022-2496(03)00064-6	32	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55723	10.1371/journal.pone.0055723	http://dx.doi.org/10.1371/journal.pone.0055723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390549	Green Published, gold			2022-12-25	WOS:000314691100065
J	Hong, SJ; Jia, SX; Xie, P; Xu, W; Leung, KP; Mustoe, TA; Galiano, RD				Hong, Seok Jong; Jia, Sheng-Xian; Xie, Ping; Xu, Wei; Leung, Kai P.; Mustoe, Thomas A.; Galiano, Robert D.			Topically Delivered Adipose Derived Stem Cells Show an Activated-Fibroblast Phenotype and Enhance Granulation Tissue Formation in Skin Wounds	PLOS ONE			English	Article							STROMAL CELLS; REGENERATIVE MEDICINE; BONE-MARROW; THERAPEUTIC ANGIOGENESIS; DERMAL FIBROBLASTS; GROWTH-FACTORS; IN-VITRO; REPAIR; DIFFERENTIATION; MICE	Multipotent mesenchymal stem cells (MSCs) are found in various tissues and can proliferate extensively in vitro. MSCs have been used in preclinical animal studies and clinical trials in many fields. Adipose derived stem cells (ASCs) have several advantages compared to other MSCs for use in cell-based treatments because they are easy to isolate with relative abundance. However, quantitative approaches for wound repair using ASCs have been limited because of lack of animal models which allow for quantification. Here, we addressed the effect of topically delivered ASCs in wound repair by quantitative analysis using the rabbit ear model. We characterized rabbit ASCs, and analyzed their multipotency in comparison to bone marrow derived-MSCs (BM-MSCs) and dermal fibroblasts (DFs) in vitro. Topically delivered ASCs increased granulation tissue formation in wounds when compared to saline controls, whereas BM-MSCs or DFs did not. These studies suggest that ASCs and BM-MSCs are not identical, though they have similar surface markers. We found that topically delivered ASCs are engrafted and proliferate in the wounds. We showed that transplanted ASCs exhibited activated fibroblast phenotype, increased endothelial cell recruitment, and enhanced macrophage recruitment in vivo.	[Hong, Seok Jong; Jia, Sheng-Xian; Xie, Ping; Xu, Wei; Mustoe, Thomas A.; Galiano, Robert D.] Northwestern Univ, Dept Surg, Div Plast & Reconstruct Surg, Lab Wound Repair & Regenerat Med,Feinberg Sch Med, Chicago, IL 60611 USA; [Leung, Kai P.] US Army Dent & Trauma Res Detachment, Inst Surg Res, Microbiol Branch, Ft Sam Houston, TX USA	Northwestern University; Feinberg School of Medicine	Hong, SJ (corresponding author), Northwestern Univ, Dept Surg, Div Plast & Reconstruct Surg, Lab Wound Repair & Regenerat Med,Feinberg Sch Med, Chicago, IL 60611 USA.	seok-hong@northwestern.edu; rgaliano@nmh.org	Xu, Wei/AAE-6526-2020	Xu, Wei/0000-0003-0023-4045	United States Army Medical Research and Material Command [W81XWH-10-2-0054]; Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant [NCI CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the United States Army Medical Research and Material Command (W81XWH-10-2-0054). Flow cytometry was supported by the Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant (NCI CA060553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178; Blasi A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-5; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Brown SA, 2010, PLAST RECONSTR SURG, V126, P1936, DOI 10.1097/PRS.0b013e3181f44790; Bunnell Bruce A., 2008, V456, P155, DOI 10.1007/978-1-59745-245-8_12; Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Cherubino M, 2011, ANN PLAS SURG, V66, P210, DOI 10.1097/SAP.0b013e3181e6d06c; DANON D, 1989, P NATL ACAD SCI USA, V86, P2018, DOI 10.1073/pnas.86.6.2018; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Di Rocco G, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/304562; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dubois Severine G., 2008, V449, P69, DOI 10.1007/978-1-60327-169-1_5; Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Gurtner GC, 2007, ANNU REV MED, V58, P299, DOI 10.1146/annurev.med.58.082405.095329; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Hasebe Y, 2011, J DERMATOL SCI, V62, P98, DOI 10.1016/j.jdermsci.2011.01.012; Hausman Dorothy B., 2008, V456, P201, DOI 10.1007/978-1-59745-245-8_15; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Hsiao ST, 2012, STEM CELLS DEV, DOI 22188562; Ii M, 2011, LAB INVEST, V91, P539, DOI 10.1038/labinvest.2010.191; Ikegame Y, 2011, CYTOTHERAPY, V13, P675, DOI 10.3109/14653249.2010.549122; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Kroeze KL, 2009, J INVEST DERMATOL, V129, P1569, DOI 10.1038/jid.2008.405; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Lee SH, 2011, ANN DERMATOL, V23, P150, DOI 10.5021/ad.2011.23.2.150; Li B, 2011, J TISSUE VIABILITY, V20, P108, DOI 10.1016/j.jtv.2009.11.004; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7; Locke M, 2011, STEM CELLS, V29, P404, DOI 10.1002/stem.593; Lu L, 2005, J AM COLL SURGEONS, V201, P391, DOI 10.1016/j.jamcollsurg.2005.03.032; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Meliga E, 2007, CELL TRANSPLANT, V16, P963, DOI 10.3727/096368907783338190; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Mogford JE, 2009, WOUND REPAIR REGEN, V17, P405, DOI 10.1111/j.1524-475X.2009.00481.x; Monaco E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032481; Morishita R, 2002, CIRCULATION, V105, P1491, DOI 10.1161/01.CIR.0000012146.07240.FD; Murohara T, 2009, CURR PHARM DESIGN, V15, P2784, DOI 10.2174/138161209788923796; Mustoe TA, 2004, BRIT MED J, V328, P1329, DOI 10.1136/bmj.328.7452.1329; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.091042; Nambu M, 2007, WOUND REPAIR REGEN, V15, P505, DOI 10.1111/j.1524-475X.2007.00258.x; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Saleh FA, 2011, CYTOTHERAPY, V13, P903, DOI 10.3109/14653249.2011.586998; Sarrazy V, 2011, WOUND REPAIR REGEN, V19, pS10, DOI 10.1111/j.1524-475X.2011.00708.x; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sisco M, 2003, METH MOLEC MED, V78, P55; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Steinberg JP, 2012, AESTHET SURG J, V32, P504, DOI 10.1177/1090820X12442679; Strioga M.M., 2012, STEM CELLS DEV; Tholpady SS, 2009, CURR OPIN ORGAN TRAN, V14, P51, DOI 10.1097/MOT.0b013e328320d2cf; van der Bogt KEA, 2009, TRANSPLANTATION, V87, P642, DOI 10.1097/TP.0b013e31819609d9; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	68	76	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55640	10.1371/journal.pone.0055640	http://dx.doi.org/10.1371/journal.pone.0055640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383253	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600140
J	Romao, LF; Mendes, FA; Feitosa, NM; Faria, JCO; Coelho-Aguiar, JM; de Souza, JM; Neto, VM; Abreu, JG				Romao, Luciana F.; Mendes, Fabio A.; Feitosa, Natalia M.; Faria, Jane Cristina O.; Coelho-Aguiar, Juliana M.; de Souza, Jorge Marcondes; Moura Neto, Vivaldo; Abreu, Jose Garcia			Connective Tissue Growth Factor (CTGF/CCN2) Is Negatively Regulated during Neuron-Glioblastoma Interaction	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEIN; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; FACTOR CTGF; IN-VITRO; THYROID-HORMONE; FACTOR-BETA; CCN FAMILY; IMMUNOHISTOCHEMICAL LOCALIZATION; CELL-PROLIFERATION	Connective-tissue growth factor (CTGF/CCN2) is a matricellular-secreted protein involved in complex processes such as wound healing, angiogenesis, fibrosis and metastasis, in the regulation of cell proliferation, migration and extracellular matrix remodeling. Glioblastoma (GBM) is the major malignant primary brain tumor and its adaptation to the central nervous system microenvironment requires the production and remodeling of the extracellular matrix. Previously, we published an in vitro approach to test if neurons can influence the expression of the GBM extracellular matrix. We demonstrated that neurons remodeled glioma cell laminin. The present study shows that neurons are also able to modulate CTGF expression in GBM. CTGF immnoreactivity and mRNA levels in GBM cells are dramatically decreased when these cells are co-cultured with neonatal neurons. As proof of particular neuron effects, neonatal neurons co-cultured onto GBM cells also inhibit the reporter luciferase activity under control of the CTGF promoter, suggesting inhibition at the transcription level. This inhibition seems to be contact-mediated, since conditioned media from embryonic or neonatal neurons do not affect CTGF expression in GBM cells. Furthermore, the inhibition of CTGF expression in GBM/neuronal co-cultures seems to affect the two main signaling pathways related to CTGF. We observed inhibition of TGF beta luciferase reporter assay; however phopho-SMAD2 levels did not change in these co-cultures. In addition levels of phospho-p44/42 MAPK were decreased in co-cultured GBM cells. Finally, in transwell migration assay, CTGF siRNA transfected GBM cells or GBM cells co-cultured with neurons showed a decrease in the migration rate compared to controls. Previous data regarding laminin and these results demonstrating that CTGF is down-regulated in GBM cells co-cultured with neonatal neurons points out an interesting view in the understanding of the tumor and cerebral microenvironment interactions and could open up new strategies as well as suggest a new target in GBM control.	[Romao, Luciana F.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Mendes, Fabio A.; Feitosa, Natalia M.; Faria, Jane Cristina O.; Coelho-Aguiar, Juliana M.; Moura Neto, Vivaldo; Abreu, Jose Garcia] Univ Fed Rio de Janeiro, Programa Anat, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [de Souza, Jorge Marcondes] Univ Fed Rio de Janeiro, Serv Neurocirurgia, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Abreu, JG (corresponding author), Univ Fed Rio de Janeiro, Programa Anat, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	garciajr@icb.ufrj.br	Mendes, Fabio/J-6911-2015; Romao, Luciana/I-4291-2015; Feitosa, Natalia M/B-6991-2013; Abreu, Jose G/ABB-1199-2021; Abreu, Jose G/G-6159-2010	Abreu, Jose G/0000-0002-1363-1755; Abreu, Jose G/0000-0002-9875-7786; /0000-0001-9425-8018	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Ary Frauzino para Pesquisa e Controle do Cancer (FAF); Programa de Nucleos de Excelencia (PRONEX); Programa de Ciencias Biomedicas (PCM); Instituto Nacional de Neurociencia Translacional (INNT)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Ary Frauzino para Pesquisa e Controle do Cancer (FAF); Programa de Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Ciencias Biomedicas (PCM); Instituto Nacional de Neurociencia Translacional (INNT)	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Ary Frauzino para Pesquisa e Controle do Cancer (FAF); Programa de Nucleos de Excelencia (PRONEX); Programa de Ciencias Biomedicas (PCM); Instituto Nacional de Neurociencia Translacional (INNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Alves TR, 2011, LIFE SCI, V89, P532, DOI 10.1016/j.lfs.2011.04.022; Amado NG, 2011, LIFE SCI, V89, P545, DOI 10.1016/j.lfs.2011.05.003; Amado NG, 2009, ANTI-CANCER DRUG, V20, P543, DOI 10.1097/CAD.0b013e32832d1149; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Crean JK, 2006, FASEB J, V20, P1712, DOI 10.1096/fj.05-5010fje; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; de Groot J, 2011, GLIA, V59, P1181, DOI 10.1002/glia.21113; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; Dhar A., 2010, Experimental Oncology, V32, P2; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Ernst A, 2010, ONCOGENE, V29, P3411, DOI 10.1038/onc.2010.83; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Faria J, 2006, DIFFERENTIATION, V74, P562, DOI 10.1111/j.1432-0436.2006.00090.x; Garcia-Abreu J, 2000, GLIA, V29, P260, DOI 10.1002/(SICI)1098-1136(20000201)29:3<260::AID-GLIA7>3.0.CO;2-I; GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406; Gomes FCA, 1999, GLIA, V26, P97; Gomes FCA, 1999, GLIA, V25, P247, DOI 10.1002/(SICI)1098-1136(19990201)25:3<247::AID-GLIA5>3.0.CO;2-2; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1987, J CELL BIOL, V104, P1353, DOI 10.1083/jcb.104.5.1353; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hertel M, 2000, EUR J NEUROSCI, V12, P376, DOI 10.1046/j.1460-9568.2000.00930.x; Higgins SC, 2010, ANTICANCER RES, V30, P391; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kennedy L, 2007, EXP CELL RES, V313, P952, DOI 10.1016/j.yexcr.2006.12.006; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kleihues P, 2000, PATHOLOGY GENETICS T; Kondo Y, 1999, BRAIN RES, V834, P146, DOI 10.1016/S0006-8993(99)01517-6; Kothapalli D, 1997, CELL GROWTH DIFFER, V8, P61; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Spohr TCLDE, 2011, J NEUROCHEM, V119, P113, DOI 10.1111/j.1471-4159.2011.07421.x; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Lima FRS, 1997, J ENDOCRINOL, V154, P167, DOI 10.1677/joe.0.1540167; Lin CS, 2002, BIOCHEM BIOPH RES CO, V295, P1014, DOI 10.1016/S0006-291X(02)00765-9; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Martinerie C, 1997, J CLIN PATHOL-MOL PA, V50, P310, DOI 10.1136/mp.50.6.310; Mason WP, 2008, EXPERT OPIN EMERG DR, V13, P81, DOI 10.1517/14728214.13.1.81 ; Mendes FA, 2003, DEV BRAIN RES, V142, P111, DOI 10.1016/S0165-3806(03)00036-1; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nagai N, 2009, INVEST OPHTH VIS SCI, V50, P1903, DOI 10.1167/iovs.08-2383; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; Pan LH, 2002, NEUROL RES, V24, P677, DOI 10.1179/016164102101200573; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; PINDZOLA RR, 1993, DEV BIOL, V156, P34, DOI 10.1006/dbio.1993.1057; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shimo T, 2005, J BONE MINER RES, V20, P867, DOI 10.1359/JBMR.041235; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Soletti RC, 2010, ANTICANCER RES, V30, P1209; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sontheimer H, 2008, J NEUROCHEM, V105, P287, DOI 10.1111/j.1471-4159.2008.05301.x; Sousa VD, 2004, EUR J NEUROSCI, V19, P1721, DOI 10.1111/j.1460.9568.2004.03249.x; Spohr TCLDE, 2002, EUR J NEUROSCI, V16, P2059, DOI 10.1046/j.1460-9568.2002.02283.x; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Stipursky J, 2011, LIFE SCI, V89, P524, DOI 10.1016/j.lfs.2011.04.005; Surveyor GA, 1999, GROWTH FACTORS, V17, P115, DOI 10.3109/08977199909103520; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Teymoortash A, 2003, ARCH ORAL BIOL, V48, P111, DOI 10.1016/S0003-9969(02)00168-1; TRENTIN AG, 1995, J NEUROSCI RES, V41, P409, DOI 10.1002/jnr.490410314; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wakimoto N, 2008, CANCER RES, V68, P6978, DOI 10.1158/0008-5472.CAN-07-5675; Wang SL, 2000, NEURON, V27, P197, DOI 10.1016/S0896-6273(00)00028-3; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Yin D, 2010, INT J CANCER, V127, P2257, DOI 10.1002/ijc.25257; Yosimichi G, 2001, EUR J BIOCHEM, V268, P6058, DOI 10.1046/j.0014-2956.2001.02553.x; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; Ziu M, 2006, J NEURO-ONCOL, V79, P125, DOI 10.1007/s11060-006-9121-5	77	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55605	10.1371/journal.pone.0055605	http://dx.doi.org/10.1371/journal.pone.0055605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383241	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600133
J	Satija, NK; Sharma, D; Afrin, F; Tripathi, RP; Gangenahalli, G				Satija, Neeraj Kumar; Sharma, Deepa; Afrin, Farhat; Tripathi, Rajendra P.; Gangenahalli, Gurudutta			High Throughput Transcriptome Profiling of Lithium Stimulated Human Mesenchymal Stem Cells Reveals Priming towards Osteoblastic Lineage	PLOS ONE			English	Article							MARROW STROMAL CELLS; INHIBITS OSTEOGENIC DIFFERENTIATION; BINDING PROTEIN-ALPHA; IN-VITRO EXPANSION; BONE-MARROW; GENE-EXPRESSION; GROWTH-FACTOR; KINASE ACTIVATION; MICROARRAY DATA; WNT	Human mesenchymal stem cells (hMSCs) present in the bone marrow are the precursors of osteoblasts, chondrocytes and adipocytes, and hold tremendous potential for osteoregenerative therapy. However, achieving directed differentiation into osteoblasts has been a major concern. The use of lithium for enhancing osteogenic differentiation has been documented in animal models but its effect in humans is not clear. We, therefore, performed high throughput transcriptome analysis of lithium-treated hMSCs to identify altered gene expression and its relevance to osteogenic differentiation. Our results show suppression of proliferation and enhancement of alkaline phosphatase (ALP) activity upon lithium treatment of hMSCs under non-osteogenic conditions. Microarray profiling of lithium-stimulated hMSC revealed decreased expression of adipogenic genes (CEBPA, CMKLR1, HSD11B1) and genes involved in lipid biosynthesis. Interestingly, osteoclastogenic factors and immune responsive genes (IL7, IL8, CXCL1, CXCL12, CCL20) were also downregulated. Negative transcriptional regulators of the osteogenic program (TWIST1 and PBX1) were suppressed while genes involved in mineralization like CLEC3B and ATF4 were induced. Gene ontology analysis revealed enrichment of upregulated genes related to mesenchymal cell differentiation and signal transduction. Lithium priming led to enhanced collagen 1 synthesis and osteogenic induction of lithium pretreated MSCs resulted in enhanced expression of Runx2, ALP and bone sialoprotein. However, siRNA-mediated knockdown of RRAD, CLEC3B and ATF4 attenuated lithium-induced osteogenic priming, identifying a role for RRAD, a member of small GTP binding protein family, in osteoblast differentiation. In conclusion, our data highlight the transcriptome reprogramming potential of lithium resulting in higher propensity of lithium "primed" MSCs for osteoblastic differentiation.	[Satija, Neeraj Kumar; Sharma, Deepa; Tripathi, Rajendra P.; Gangenahalli, Gurudutta] Inst Nucl Med & Allied Sci, Stem Cell & Gene Therapy Res Grp, Delhi, India; [Afrin, Farhat] Hamdard Univ, Dept Biotechnol, New Delhi, India	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); Jamia Hamdard University	Gangenahalli, G (corresponding author), Inst Nucl Med & Allied Sci, Stem Cell & Gene Therapy Res Grp, Brig SK Mazumdar Marg, Delhi, India.	gugdutta@rediffmail.com	Afrin, Farhat/F-2346-2018	Afrin, Farhat/0000-0003-4443-4284; Satija, Neeraj/0000-0002-4571-327X	Defence Research and Development Organisation, Ministry of Defence, Government of India	Defence Research and Development Organisation, Ministry of Defence, Government of India(Defence Research & Development Organisation (DRDO))	This work was supported by funding from Defence Research and Development Organisation, Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghaban Eslaminejad M., 2008, IRAN J BASIC MED SCI, V11, P143; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Berridge M.V., 1996, BIOCHEMICA, V4, P14, DOI DOI 10.1155/2013/420601; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bolton JM, 2008, J CLIN PSYCHOPHARM, V28, P384, DOI 10.1097/JCP.0b013e31817d5943; Bujalska IJ, 2008, J ENDOCRINOL, V197, P297, DOI 10.1677/JOE-08-0050; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Choi YA, 2010, J PROTEOME RES, V9, P2946, DOI 10.1021/pr901110q; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Elabd C, 2008, STEM CELLS, V26, P2399, DOI 10.1634/stemcells.2008-0127; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Gordon JAR, 2010, MOL CELL BIOL, V30, P3531, DOI 10.1128/MCB.00889-09; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Gregory CA, 2005, J BIOL CHEM, V280, P2309, DOI 10.1074/jbc.M406275200; Harmey D, 2004, J BONE MINER RES, V19, P661, DOI 10.1359/JBMR.040105; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Hipskind Robert A., 1998, Frontiers in Bioscience, V3, pD804; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Johnston J, 2010, TRANSGENIC RES, V19, P1017, DOI 10.1007/s11248-010-9376-7; Justesen J, 2004, ENDOCRINOLOGY, V145, P1916, DOI 10.1210/en.2003-1427; Kanazawa I, 2009, AM J PHYSIOL-ENDOC M, V296, pE139, DOI 10.1152/ajpendo.90677.2008; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Klapholz-Brown Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000945; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Krause U, 2010, P NATL ACAD SCI USA, V107, P4147, DOI 10.1073/pnas.0914360107; Kubo H, 2009, GENES CELLS, V14, P407, DOI 10.1111/j.1365-2443.2009.01281.x; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lai WT, 2011, STEM CELLS, V29, P1102, DOI 10.1002/stem.661; Larsen KH, 2010, J BONE MINER RES, V25, P796, DOI 10.1359/jbmr.091018; Larson BL, 2008, STEM CELLS, V26, P193, DOI 10.1634/stemcells.2007-0524; Li JJ, 2011, BONE, V48, P321, DOI 10.1016/j.bone.2010.09.033; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; LUKERT BP, 1990, ANN INTERN MED, V112, P352, DOI 10.7326/0003-4819-112-5-352; McEachin RC, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-158; Motomura H, 2007, BIOCHEM BIOPH RES CO, V357, P997, DOI 10.1016/j.bbrc.2007.04.035; Murie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-45; Muruganandan S, 2010, J BONE MINER RES, V25, P222, DOI 10.1359/jbmr.091106; Neth P, 2006, STEM CELLS, V24, P1892, DOI 10.1634/stemcells.2005-0503; Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019; Oh YT, 2010, J BIOL CHEM, V285, P41310, DOI 10.1074/jbc.M110.153775; Ohnaka K, 2001, BIOCHEM BIOPH RES CO, V287, P337, DOI 10.1006/bbrc.2001.5597; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Pandey R, 2004, BIOINFORMATICS, V20, P2156, DOI 10.1093/bioinformatics/bth215; Qu GW, 2006, BONE, V38, P21, DOI 10.1016/j.bone.2005.07.013; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9; Rintala J, 1999, NEUROREPORT, V10, P3887, DOI 10.1097/00001756-199912160-00030; Rosario M, 1999, EMBO J, V18, P1270, DOI 10.1093/emboj/18.5.1270; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson EM, 2001, EMBO J, V20, P4500, DOI 10.1093/emboj/20.16.4500; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Satija NK, 2009, J CELL MOL MED, V13, P4385, DOI 10.1111/j.1582-4934.2009.00857.x; Seelan RS, 2008, NEUROSCIENCE, V151, P1184, DOI 10.1016/j.neuroscience.2007.10.045; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; Shim M, 2003, J BIOL CHEM, V278, P19674, DOI 10.1074/jbc.M301356200; Sinha D, 2005, AM J PHYSIOL-RENAL, V288, pF703, DOI 10.1152/ajprenal.00189.2004; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106; Tamura M, 2011, INT J BIOCHEM CELL B, V43, P760, DOI 10.1016/j.biocel.2011.01.021; Tang GH, 2011, J DENT RES, V90, P336, DOI 10.1177/0022034510389180; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P1, DOI 10.1007/s00223-004-0258-y; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Warden SJ, 2010, BONE, V46, P985, DOI 10.1016/j.bone.2009.12.031; WEWER UM, 1994, J CELL BIOL, V127, P1767, DOI 10.1083/jcb.127.6.1767; Wilting I, 2007, BONE, V40, P1252, DOI 10.1016/j.bone.2006.12.055; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yoshida K, 2007, ORAL DIS, V13, P32, DOI 10.1111/j.1601-0825.2006.01239.x; Yoshiko Y, 2003, ENDOCRINOLOGY, V144, P4134, DOI 10.1210/en.2003-0130; Zamani A, 2009, BONE, V44, P331, DOI 10.1016/j.bone.2008.10.001; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhang WV, 2005, APOPTOSIS, V10, P75, DOI 10.1007/s10495-005-6063-x; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zhao YX, 2007, P NATL ACAD SCI USA, V104, P9673, DOI 10.1073/pnas.0703407104	92	48	56	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55769	10.1371/journal.pone.0055769	http://dx.doi.org/10.1371/journal.pone.0055769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383279	Green Submitted, gold, Green Published			2022-12-25	WOS:000315563800188
J	Liu, Y; Esser, L; Interlandi, G; Kisiela, DI; Tchesnokova, V; Thomas, WE; Sokurenko, E; Xia, D; Savarino, SJ				Liu, Yang; Esser, Lothar; Interlandi, Gianluca; Kisiela, Dagmara I.; Tchesnokova, Veronika; Thomas, Wendy E.; Sokurenko, Evgeni; Xia, Di; Savarino, Stephen J.			Tight Conformational Coupling between the Domains of the Enterotoxigenic Escherichia coli Fimbrial Adhesin CfaE Regulates Binding State Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR ANTIGEN-I; STRUCTURAL BASIS; STRUCTURE VALIDATION; BACTERIAL ADHESION; CRYSTAL-STRUCTURE; FIMH; MOLPROBITY; DYNAMICS; PROTEIN	CfaE, the tip adhesin of enterotoxigenic Escherichia coli colonization factor antigen I fimbriae, initiates binding of this enteropathogen to the small intestine. It comprises stacked beta-sandwich adhesin (AD) and pilin (PD) domains, with the putative receptor-binding pocket at one pole and an equatorial interdomain interface. CfaE binding to erythrocytes is enhanced by application of moderate shear stress. A G168D replacement along the AD facing the CfaE interdomain region was previously shown to decrease the dependence on shear by increasing binding at lower shear forces. To elucidate the structural basis for this functional change, we studied the properties of CfaE G168D (with a self-complemented donor strand) and solved its crystal structure at 2.6 angstrom resolution. Compared with native CfaE, CfaE G168D showed a downward shift in peak erythrocyte binding under shear stress and greater binding under static conditions. The thermal melting transition of CfaE G168D occurred 10 C below that of CfaE. Compared with CfaE, the atomic structure of CfaE G168D revealed a 36% reduction in the buried surface area at the interdomain interface. Despite the location of this single modification in the AD, CfaE G168D exhibited structural derangements only in the adjoining PD compared with CfaE. In molecular dynamics simulations, the G168D mutation was associated with weakened interdomain interactions under tensile force. Taken together, these findings indicate that the AD and PD of CfaE are conformationally tightly coupled and support the hypothesis that opening of the interface plays a critical modulatory role in the allosteric activation of CfaE.	[Liu, Yang; Savarino, Stephen J.] USN, Enter Dis Dept, Infect Dis Directorate, Med Res Ctr, Silver Spring, MD 20910 USA; [Esser, Lothar; Xia, Di] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Esser, Lothar; Thomas, Wendy E.] Univ Washington, Dept Engn, Seattle, WA 98195 USA; [Kisiela, Dagmara I.; Tchesnokova, Veronika; Sokurenko, Evgeni] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Savarino, Stephen J.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA	United States Department of Defense; United States Navy; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Uniformed Services University of the Health Sciences - USA	Sokurenko, E (corresponding author), Univ Washington, Dept Microbiol, Hlth Sci Bldg,Rm E309, Seattle, WA 98195 USA.	evs@u.washington.edu; dixia@helix.nih.gov; stephen.savarino@med.navy.mil		Thomas, Wendy/0000-0001-8602-0819	National Institutes of Health [R01 AI050940]; National Cancer Institute Intramural Research Program; Trans-National Institutes of Health/Food and Drug Administration Intramural Biodefense Program; United States Army Military Infectious Diseases Research Program Work Unit [A1207]; Henry M. Jackson Foundation for the Advancement of Military Medicine; TeraGrid Grant [TG-MCB060069N]; National Science Foundation; NATIONAL CANCER INSTITUTE [ZIABC010735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Trans-National Institutes of Health/Food and Drug Administration Intramural Biodefense Program; United States Army Military Infectious Diseases Research Program Work Unit; Henry M. Jackson Foundation for the Advancement of Military Medicine; TeraGrid Grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI050940 (to E. S.) and by the National Cancer Institute Intramural Research Program and the Trans-National Institutes of Health/Food and Drug Administration Intramural Biodefense Program (to D. X.). This work was also supported by United States Army Military Infectious Diseases Research Program Work Unit A1207 and the Henry M. Jackson Foundation for the Advancement of Military Medicine (to S. J. S.). This work was prepared as part of the official duty of S. J. S.; We thank the staff of the Southeast Regional Collaborative Access Team for assistance for data collection. The molecular dynamics simulations were run on the Trestles supercomputer at the San Diego Supercomputer Center supported by TeraGrid Grant TG-MCB060069N with funding from the National Science Foundation. We are grateful to Daniel Isaac for critical reading of the manuscript.	ABRAHAM SN, 1988, NATURE, V336, P682, DOI 10.1038/336682a0; Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; Andersson M, 2012, J MOL BIOL, V415, P918, DOI 10.1016/j.jmb.2011.12.006; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker KK, 2009, CELL MICROBIOL, V11, P742, DOI 10.1111/j.1462-5822.2009.01287.x; BARTUS H, 1985, J CLIN MICROBIOL, V21, P951, DOI 10.1128/JCM.21.6.951-954.1985; Bjornham O, 2010, BIOPHYS J, V99, P1331, DOI 10.1016/j.bpj.2010.06.003; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Interlandi G, 2010, PROTEINS, V78, P2506, DOI 10.1002/prot.22759; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Li YF, 2007, J BIOL CHEM, V282, P23970, DOI 10.1074/jbc.M700921200; Li YF, 2009, P NATL ACAD SCI USA, V106, P10793, DOI 10.1073/pnas.0812843106; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poole ST, 2007, MOL MICROBIOL, V63, P1372, DOI 10.1111/j.1365-2958.2007.05612.x; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804	31	8	8	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9993	10001		10.1074/jbc.M112.413534	http://dx.doi.org/10.1074/jbc.M112.413534			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23393133	hybrid, Green Published			2022-12-25	WOS:000317114000038
J	Rushworth, JV; Griffiths, HH; Watt, NT; Hooper, NM				Rushworth, Jo V.; Griffiths, Heledd H.; Watt, Nicole T.; Hooper, Nigel M.			Prion Protein-mediated Toxicity of Amyloid-beta Oligomers Requires Lipid Rafts and the Transmembrane LRP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE BRAIN; A-BETA; IN-VIVO; COGNITIVE IMPAIRMENTS; SYNAPTIC PLASTICITY; NEURONAL CELLS; N-TERMINUS; RECEPTOR; MEMORY; ENDOCYTOSIS	Soluble oligomers of the amyloid-beta (A beta) peptide cause neurotoxicity, synaptic dysfunction, and memory impairments that underlie Alzheimer disease (AD). The cellular prion protein (PrPC) was recently identified as a high affinity neuronal receptor for A beta oligomers. We report that fibrillar A beta oligomers recognized by the OC antibody, which have been shown to correlate with the onset and severity of AD, bind preferentially to cells and neurons expressing PrPC. The binding of A beta oligomers to cell surface PrPC, as well as their downstream activation of Fyn kinase, was dependent on the integrity of cholesterol-rich lipid rafts. In SH-SY5Y cells, fluorescence microscopy and co-localization with subcellular markers revealed that the A beta oligomers co-internalized with PrPC, accumulated in endosomes, and subsequently trafficked to lysosomes. The cell surface binding, internalization, and downstream toxicity of A beta oligomers was dependent on the transmembrane low density lipoprotein receptor-related protein-1 (LRP1). The binding of A beta oligomers to cell surface PrPC impaired its ability to inhibit the activity of the beta-secretase BACE1, which cleaves the amyloid precursor protein to produce A beta. The green tea polyphenol (-)-epigallo-catechin gallate and the red wine extract resveratrol both remodeled the fibrillar conformation of A beta oligomers. The resulting nonfibrillar oligomers displayed significantly reduced binding to PrPC-expressing cells and were no longer cytotoxic. These data indicate that soluble, fibrillar A beta oligomers bind to PrPC in a conformation-dependent manner and require the integrity of lipid rafts and the transmembrane LRP1 for their cytotoxicity, thus revealing potential targets to alleviate the neurotoxic properties of A beta oligomers in AD.	[Rushworth, Jo V.; Griffiths, Heledd H.; Watt, Nicole T.; Hooper, Nigel M.] Univ Leeds, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Hooper, NM (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	N.M.Hooper@leeds.ac.uk	Rushworth, Jo/AAL-2555-2021	Rushworth, Jo/0000-0002-7134-2011; Hooper, Nigel/0000-0002-5811-3484; Jarosz-Griffiths, Heledd/0000-0001-5154-4815	Wellcome Trust; Alzheimer's Research UK; Medical Research Council; Alzheimers Research UK [ART-PG2010-2] Funding Source: researchfish; Medical Research Council [G0802189] Funding Source: researchfish; MRC [G0802189] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust, Alzheimer's Research UK, and the Medical Research Council.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2009, NATURE, V457, P1090, DOI 10.1038/4571090a; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Dupiereux I, 2008, J NEUROSCI RES, V86, P653, DOI 10.1002/jnr.21506; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kanekiyo T, 2009, J BIOL CHEM, V284, P33352, DOI 10.1074/jbc.M109.015032; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis V, 2011, FRONT BIOSCI-LANDMRK, V16, P151, DOI 10.2741/3681; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Liu T, 2001, BRAIN RES, V896, P118, DOI 10.1016/S0006-8993(01)02050-9; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mount C, 2006, NAT MED, V12, P780, DOI 10.1038/nm0706-780; Nykjaer A, 2002, TRENDS CELL BIOL, V12, P273, DOI 10.1016/S0962-8924(02)02282-1; Paitel E, 2002, J NEUROCHEM, V83, P1208, DOI 10.1046/j.1471-4159.2002.01234.x; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Pflanzner T, 2012, J CEREBR BLOOD F MET, V32, P628, DOI 10.1038/jcbfm.2012.7; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rambold AS, 2008, J NEUROCHEM, V107, P218, DOI 10.1111/j.1471-4159.2008.05611.x; Rees S, 1996, BIOTECHNIQUES, V20, P102; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang XH, 2009, BBA-MOL BASIS DIS, V1792, P555, DOI 10.1016/j.bbadis.2009.02.014; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Williamson R, 2008, FASEB J, V22, P1552, DOI 10.1096/fj.07-9766com; Wimo A, 2010, WORLD ALZHEIMER REPO; Wu LH, 2005, J CELL BIOCHEM, V96, P1021, DOI 10.1002/jcb.20596; Zeng FN, 2003, J NEUROCHEM, V84, P480, DOI 10.1046/j.1471-4159.2003.01529.x	71	112	113	0	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					8935	8951		10.1074/jbc.M112.400358	http://dx.doi.org/10.1074/jbc.M112.400358			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23386614	hybrid, Green Published			2022-12-25	WOS:000316862200014
J	Yang, XF; Mei, S; Wang, XL; Li, X; Liu, R; Ma, Y; Hao, LP; Yao, P; Liu, LG; Sun, XF; Gu, HH; Liu, ZQ; Cao, WH				Yang, Xuefeng; Mei, Shuang; Wang, Xiaolei; Li, Xiang; Liu, Rui; Ma, Yan; Hao, Liping; Yao, Ping; Liu, Liegang; Sun, Xiufa; Gu, Haihua; Liu, Zhenqi; Cao, Wenhong			Leucine Facilitates Insulin Signaling through a G alpha(i) Protein-dependent Signaling Pathway in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; LOWERING AMINO-ACID; SKELETAL-MUSCLE; GLUCOSE DISPOSAL; KINASE PLAYS; RESISTANCE; MTOR; HYPERINSULINEMIA; GLUCONEOGENESIS; METABOLISM	In this study, we addressed the direct effect of leucine on insulin signaling. In investigating the associated mechanisms, we found that leucine itself does not activate the classical Akt- or ERK1/2 MAP kinase-dependent signaling pathways but can facilitate the insulin-induced phosphorylations of Akt(473) and ERK1/2 in a time- and dose-dependent manner in cultured hepatocytes. The leucine-facilitated insulin-induced phosphorylation of Akt at residue 473 was not affected by knocking down the key component of mTORC1 or -2 complexes but was blocked by inhibition of c-Src (PP2), PI3K (LY294002), G alpha(i) protein (pertussis toxin or siRNA against G alpha(i1) gene, or beta-arrestin 2 (siRNA)). Similarly, the leucine-facilitated insulin activation of ERK1/2 was also blunted by pertussis toxin. We further show that leucine facilitated the insulin-mediated suppression of glucose production and expression of key gluconeogenic genes in a G alpha(i1) protein-dependent manner in cultured primary hepatocytes. Together, these results show that leucine can directly facilitate insulin signaling through a G alpha(i) protein-dependent intracellular signaling pathway. This is the first evidence showing that macronutrients like amino acid leucine can facilitate insulin signaling through G proteins directly.	[Yang, Xuefeng; Wang, Xiaolei; Li, Xiang; Liu, Rui; Ma, Yan; Hao, Liping; Yao, Ping; Liu, Liegang; Sun, Xiufa] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Wuhan 430030, Hubei, Peoples R China; [Yang, Xuefeng; Wang, Xiaolei; Li, Xiang; Liu, Rui; Ma, Yan; Hao, Liping; Yao, Ping; Liu, Liegang; Sun, Xiufa] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430030, Hubei, Peoples R China; [Yang, Xuefeng; Mei, Shuang; Gu, Haihua; Cao, Wenhong] Univ N Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Nutr, Inst Nutr Res, Kannapolis, NC 28081 USA; [Yang, Xuefeng; Mei, Shuang; Gu, Haihua; Cao, Wenhong] Univ N Carolina Chapel Hill, Sch Med, Kannapolis, NC 28081 USA; [Liu, Zhenqi] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22908 USA; [Cao, Wenhong] Duke Univ, Sch Med, Dept Med Endocrinol & Metab, Durham, NC 27705 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; Duke University	Yang, XF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Wuhan 430030, Hubei, Peoples R China.	xuefengyang@gmail.com; caow@unc.edu	Yang, Xuefeng/AAB-7163-2019		National Natural Science Foundation of China [30800907]; Fundamental Research Funds for Central Universities Huazhong University of Science and Technology Grant [2011TS055]; American Diabetes Association Grant [7-09-BS-27]; National Institutes of Health Grant [R01DK076039]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities Huazhong University of Science and Technology Grant; American Diabetes Association Grant(American Diabetes Association); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China Grant 30800907 (to X. Y.), the Fundamental Research Funds for Central Universities Huazhong University of Science and Technology Grant 2011TS055 (to X. Y.), The American Diabetes Association Grant 7-09-BS-27 (to W. C.), and National Institutes of Health Grant R01DK076039 (to W. C.).	ABUMRAD NN, 1982, J SURG RES, V32, P453, DOI 10.1016/0022-4804(82)90126-3; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Cao Wenhong, 2011, Curr Mol Pharmacol, V4, P154; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Doi M, 2005, J NUTR, V135, P2103, DOI 10.1093/jn/135.9.2103; Doi M, 2003, BIOCHEM BIOPH RES CO, V312, P1111, DOI 10.1016/j.bbrc.2003.11.039; FELIG P, 1970, NEW ENGL J MED, V282, P166; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Feng XT, 2011, MOL BIOL REP, V38, P2517, DOI 10.1007/s11033-010-0389-3; Filiputti E, 2010, METABOLISM, V59, P635, DOI 10.1016/j.metabol.2009.09.007; FLAKOLL PJ, 1992, DIABETOLOGIA, V35, P357, DOI 10.1007/BF00401203; Guo KY, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-57; Hinault C, 2006, DIABETOLOGIA, V49, P1017, DOI 10.1007/s00125-006-0201-z; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Liu HY, 2009, J BIOL CHEM, V284, P27090, DOI 10.1074/jbc.M109.016675; Liu HY, 2009, J BIOL CHEM, V284, P14087, DOI 10.1074/jbc.M807992200; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; MORTIMORE GE, 1994, BIOCHEM BIOPH RES CO, V203, P200, DOI 10.1006/bbrc.1994.2168; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nishitani S, 2005, AM J PHYSIOL-GASTR L, V288, pG1292, DOI 10.1152/ajpgi.00510.2003; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; PISTERS PWT, 1991, METABOLISM, V40, P59, DOI 10.1016/0026-0495(91)90193-Z; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHWENK WF, 1987, DIABETES, V36, P199, DOI 10.2337/diabetes.36.2.199; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; TESSARI P, 1985, DIABETOLOGIA, V28, P870, DOI 10.1007/BF00291080; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yang JC, 2010, NUTR REV, V68, P270, DOI 10.1111/j.1753-4887.2010.00282.x; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	44	9	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9313	9320		10.1074/jbc.M112.409409	http://dx.doi.org/10.1074/jbc.M112.409409			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23404499	Green Published, hybrid			2022-12-25	WOS:000316862200049
J	Haggar, FA; Pereira, G; Preen, DD; Holman, CDJ; Einarsdottir, K				Haggar, Fatima A.; Pereira, Gavin; Preen, David D.; Holman, C. D'Arcy J.; Einarsdottir, Kristjana			Cancer Survival and Excess Mortality Estimates among Adolescents and Young Adults in Western Australia, 1982-2004: A Population-Based Study	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GERM-CELL TUMORS; CHILDHOOD; END; SEX	Background: Data are limited on cancer outcomes in adolescents and young adults. Methods: Based on data from the Western Australian Data Linkage System, this study modelled survival and excess mortality in all adolescents and young adults aged 15-39 years in Western Australia who had a diagnosis of cancer in the period 1982-2004. Relative survival and excess all-cause mortality for all cancers combined and for principal tumour subgroups were estimated, using the Ederer II method and generalised linear Poisson modelling, respectively. Results: A cancer diagnosis in adolescents and young adults conferred substantial survival decrement. However, overall outcomes improved over calendar period (excess mortality hazard ratio [HR], latest versus earliest diagnostic period: 0.52, trend p<0.0001). Case fatality varied according to age group (HR, oldest versus youngest: 1.38, trend p<0.0001), sex (HR, female versus male: 0.66, 95% confidence interval [CI] 0.62-0.71), ethnicity (HR, Aboriginal versus others: 1.47, CI 1.23-1.76), geographical area (HR, rural/remote versus urban: 1.13, CI 1.04-1.23) and residential socioeconomic status (HR, lowest versus highest quartile: 1.14, trend p<0.05). Tumour subgroups differed substantially in frequency according to age group and sex, and were critical outcome determinants. Conclusions: Marked progressive calendar-time improvement in overall outcomes was evident. Further research is required to disentangle the contributions of tumour biology and health service factors to outcome disparities between ethnodemographic, geographic and socioeconomic subgroups of adolescents and young adults with cancer.	[Haggar, Fatima A.; Preen, David D.; Holman, C. D'Arcy J.] Univ Western Australia, Ctr Hlth Serv Res, Sch Populat Hlth, Crawley, Australia; [Haggar, Fatima A.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Pereira, Gavin; Einarsdottir, Kristjana] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Pereira, Gavin] Yale Univ, Sch Publ Hlth, Yale Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT USA	University of Western Australia; University of Ottawa; Ottawa Hospital Research Institute; Telethon Kids Institute; University of Western Australia; Yale University	Haggar, FA (corresponding author), Univ Western Australia, Ctr Hlth Serv Res, Sch Populat Hlth, Crawley, Australia.	fhaggar@toh.on.ca	Pereira, Gavin/D-7136-2014; Preen, David B/H-5663-2014; Einarsdóttir, Kristjana/E-8337-2011; Holman, Cashel DJ/B-6173-2009	Pereira, Gavin/0000-0003-3740-8117; Preen, David B/0000-0002-2982-2169; Einarsdóttir, Kristjana/0000-0003-4931-7650; 	Cancer Council Western Australia; University of Western Australia; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	Cancer Council Western Australia(Cancer Council Western Australia); University of Western Australia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Cancer Council Western Australia and The University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adolescent and Young Adult Oncology Progress Review Group Department of Health and Human Services National Institutes of Health National Cancer Institute, 2006, CLOSING THE GAP RESE; Australian Bureau of Statistics, 2008, AUSTRALIAN HISTORICA; Australian Bureau of Statistics, 2001, AUSTRALIAN STANDARD; Australian Bureau of Statistics ABS, 2006, INFORMATION PAPER CE; Australian Institute of Health Welfare, 2011, YOUNG AUSTRALIANS TH; Barr RD, 2006, CANCER, V106, P1425, DOI 10.1002/cncr.21773; Barry E, 2007, J CLIN ONCOL, V25, P813, DOI 10.1200/JCO.2006.08.6397; Bleyer A, 2005, CANCER-AM CANCER SOC, V103, P1891, DOI 10.1002/cncr.20995; BLEYER A, 2002, P AN M AM SOC CLIN, V21, pA389; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Clark A, 2010, AUST HEALTH REVIEW, V34; Cole CH, 2004, MED J AUSTRALIA, V180, P52, DOI 10.5694/j.1326-5377.2004.tb05795.x; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; de Giorgi V, 2011, J CLIN ONCOL, V29, pE94, DOI 10.1200/JCO.2010.33.1876; De P, 2011, CAN MED ASSOC J, V183, pE187, DOI 10.1503/CMAJ.100800; Department of Health WA, 2011, WESTERN AUSTRALIAN C; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Ederer F, 1961, THE RELATIVE SURVIVA; Fritz A, 2000, INT CLASSIFICATION D; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Hall Sonja, 2004, J Health Serv Res Policy, V9 Suppl 2, P10, DOI 10.1258/1355819042248116; Hopkins S, 1996, APPL EC, V28; Kent EE, 2009, CANCER CAUSE CONTROL, V20, P1409, DOI 10.1007/s10552-009-9367-2; Lasithiotakis K, 2008, CANCER, V112, P1795, DOI 10.1002/cncr.23359; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Morris M, 2007, MED J AUSTRALIA, V186, P296, DOI 10.5694/j.1326-5377.2007.tb00904.x; Nachman J, 2005, BRIT J HAEMATOL, V130, P166, DOI 10.1111/j.1365-2141.2005.05544.x; National Centre in HIV Epidemiology and Clinical Research, 2007, AUSTR HIV SURV REP O, P23; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Pui CH, 1999, J CLIN ONCOL, V17, P818, DOI 10.1200/JCO.1999.17.3.818; Ribera JM, 2008, J CLIN ONCOL, V26, P1843, DOI 10.1200/JCO.2007.13.7265; Ries LAG, 2003, ONCOLOGIST, V8, P541; Ries LAG, 2007, SEER SURVIVAL MONOGR; Sarfati D, 2010, INT J EPIDEMIOL, V39, P598, DOI 10.1093/ije/dyp392; SAS Inc, 2009, SAS SOFTWARE VERSION; SATHER H, 1981, LANCET, V1, P739; SEER, 2008, SEER ADOLESCENT YOUN; SHUGG D, 1994, INT J CANCER, V59, P765, DOI 10.1002/ijc.2910590610; Shuster JJ, 1998, J CLIN ONCOL, V16, P2854, DOI 10.1200/JCO.1998.16.8.2854; St. Jude Children's Research Hospital, 2011, THE CHILDHOOD CANCER; Threlfall T, 2010, CANCER INCIDENCE AND; van de Schans SAM, 2011, J CLIN ONCOL, V29, P192, DOI 10.1200/JCO.2010.28.6377; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302	45	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55630	10.1371/journal.pone.0055630	http://dx.doi.org/10.1371/journal.pone.0055630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405184	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400129
J	Hayashi, H; Tamura, A; Krishnan, D; Tsukita, S; Suzuki, Y; Kocinsky, HS; Aronson, PS; Orlowski, J; Grinstein, S; Alexander, RT				Hayashi, Hisayoshi; Tamura, Atsushi; Krishnan, Devishree; Tsukita, Sachiko; Suzuki, Yuichi; Kocinsky, Hetal S.; Aronson, Peter S.; Orlowski, John; Grinstein, Sergio; Alexander, R. Todd			Ezrin Is Required for the Functional Regulation of the Epithelial Sodium Proton Exchanger, NHE3	PLOS ONE			English	Article							PROTEIN-KINASE-A; RENAL PROXIMAL TUBULE; NA+/H+-EXCHANGER; ERM PROTEINS; APICAL MEMBRANE; CAMP; INHIBITION; PHOSPHORYLATION; ISOFORMS; CELLS	The sodium hydrogen exchanger isoform 3 (NHE3) mediates absorption of sodium, bicarbonate and water from renal and intestinal lumina. This activity is fundamental to the maintenance of a physiological plasma pH and blood pressure. To perform this function NHE3 must be present in the apical membrane of renal tubular and intestinal epithelia. The molecular determinants of this localization have not been conclusively determined, although linkage to the apical actin cytoskeleton through ezrin has been proposed. We set out to evaluate this hypothesis. Functional studies of NHE3 activity were performed on ezrin knockdown mice (Vil2(kd/kd)) and NHE3 activity similar to wild-type animals detected. Interpretation of this finding was difficult as other ERM (ezrin/radixin/moesin) proteins were present. We therefore generated an epithelial cell culture model where ezrin was the only detectable ERM. After knockdown of ezrin expression with siRNA, radixin and moesin expression remained undetectable. Consistent with the animal ultrastructural data, cells lacking ezrin retained an epithelial phenotype but had shortened and thicker microvilli. NHE3 localization was identical to cells transfected with non-targeting siRNA. The attachment of NHE3 to the apical cytoskeleton was unaltered as assessed by fluorescent recovery after photobleaching (FRAP) and the solubility of NHE3 in Triton X-100. Baseline NHE3 activity was unaltered, however, cAMP-dependent inhibition of NHE3 was largely lost even though NHE3 was phosphorylated at serines 552 and 605. Thus, ezrin is not necessary for the apical localization, attachment to the cytoskeleton, baseline activity or cAMP induced phosphrylation of NHE3, but instead is required for cAMP mediated inhibition.	[Hayashi, Hisayoshi; Suzuki, Yuichi] Univ Shizuoka, Sch Food & Nutr Sci, Physiol Lab, Shizuoka 4228526, Japan; [Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Biol Sci Lab, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Tamura, Atsushi; Tsukita, Sachiko] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Krishnan, Devishree; Alexander, R. Todd] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Kocinsky, Hetal S.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Aronson, Peter S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Aronson, Peter S.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Grinstein, Sergio] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Alexander, R. Todd] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Shizuoka; Osaka University; Osaka University; University of Alberta; Yale University; Yale University; Yale University; McGill University; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta	Alexander, RT (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	todd2@ualberta.ca	Hayashi, Hisayoshi/K-5883-2013; Alexander, R. Todd/G-1373-2012	Orlowski, John/0000-0001-7371-175X	Canadian Institute of Health Research; Clinician Scientist Award from CIHR; Alberta Heritage Foundation for Medical Research (AHFMR); Grants-in-Aid for Scientific Research [23590334] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Clinician Scientist Award from CIHR; Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by The Canadian Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; R.T. Alexander is supported by a Clinician Scientist Award from CIHR and an Alberta Heritage Foundation for Medical Research (AHFMR) funded Clinical Investigator Award.	Alexander RT, 2007, J BIOL CHEM, V282, P7376, DOI 10.1074/jbc.M608557200; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; BIEMESDERFER D, 1993, AM J PHYSIOL, V265, pF736, DOI 10.1152/ajprenal.1993.265.5.F736; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 1997, J CELL SCI, V110, P3011; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Chalumeau C, 2001, AM J PHYSIOL-RENAL, V280, pF283, DOI 10.1152/ajprenal.2001.280.2.F283; Chiolero A, 2000, HYPERTENSION, V36, P631, DOI 10.1161/01.HYP.36.4.631; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Di Sole F, 2009, J AM SOC NEPHROL, V20, P1776, DOI 10.1681/ASN.2008121255; Dimke H, 2010, J AM SOC NEPHROL, V21, P1309, DOI 10.1681/ASN.2009111153; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; Hayashi H, 2003, AM J PHYSIOL-GASTR L, V284, pG617, DOI 10.1152/ajpgi.00201.2002; Honegger KJ, 2006, P NATL ACAD SCI USA, V103, P803, DOI 10.1073/pnas.0503562103; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Hryciw DH, 2004, CLIN EXP PHARMACOL P, V31, P372, DOI 10.1111/j.1440-1681.2004.04001.x; Jaumouille V, 2011, CHANNELS, V5, P308, DOI 10.4161/chan.5.4.16548; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Kocinsky HS, 2007, AM J PHYSIOL-RENAL, V293, pF212, DOI 10.1152/ajprenal.00042.2007; Kocinsky HS, 2005, AM J PHYSIOL-RENAL, V289, pF249, DOI 10.1152/ajprenal.00082.2004; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Kurashima K, 1997, J BIOL CHEM, V272, P28672, DOI 10.1074/jbc.272.45.28672; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Minkoff C, 1999, CURR OPIN NEPHROL HY, V8, P603, DOI 10.1097/00041552-199909000-00012; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Szaszi K, 2000, CELL PHYSIOL BIOCHEM, V10, P265, DOI 10.1159/000016358; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Watts BA, 1999, J CLIN INVEST, V104, P1593, DOI 10.1172/JCI7332; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Weinman EJ, 2001, KIDNEY INT, V60, P450, DOI 10.1046/j.1523-1755.2001.060002450.x; Weinman EJ, 2000, AM J PHYSIOL-RENAL, V279, pF393, DOI 10.1152/ajprenal.2000.279.3.F393; Woodward AM, 2001, CELL BIOL INT, V25, P205, DOI 10.1006/cbir.2000.0635; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978; Zhao HR, 2004, P NATL ACAD SCI USA, V101, P9485, DOI 10.1073/pnas.0308400101; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753	57	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55623	10.1371/journal.pone.0055623	http://dx.doi.org/10.1371/journal.pone.0055623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405179	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400124
J	Langer, MR; Weinmann, AE; Lotters, S; Bernhard, JM; Rodder, D				Langer, Martin R.; Weinmann, Anna E.; Loetters, Stefan; Bernhard, Joan M.; Roedder, Dennis			Climate-Driven Range Extension of Amphistegina (Protista, Foraminiferida): Models of Current and Predicted Future Ranges	PLOS ONE			English	Article							GLOBAL OCEAN CARBONATE; BENTHIC FORAMINIFERA; LARGER FORAMINIFERA; SEDIMENT PRODUCTION; COASTAL ECOSYSTEMS; INHACA ISLAND; AEGEAN SEA; ASSEMBLAGES; ORGANISMS; EXPANSION	Species-range expansions are a predicted and realized consequence of global climate change. Climate warming and the poleward widening of the tropical belt have induced range shifts in a variety of marine and terrestrial species. Range expansions may have broad implications on native biota and ecosystem functioning as shifting species may perturb recipient communities. Larger symbiont-bearing foraminifera constitute ubiquitous and prominent components of shallow water ecosystems, and range shifts of these important protists are likely to trigger changes in ecosystem functioning. We have used historical and newly acquired occurrence records to compute current range shifts of Amphistegina spp., a larger symbiont-bearing foraminifera, along the eastern coastline of Africa and compare them to analogous range shifts currently observed in the Mediterranean Sea. The study provides new evidence that amphisteginid foraminifera are rapidly progressing southwestward, closely approaching Port Edward (South Africa) at 31 degrees S. To project future species distributions, we applied a species distribution model (SDM) based on ecological niche constraints of current distribution ranges. Our model indicates that further warming is likely to cause a continued range extension, and predicts dispersal along nearly the entire southeastern coast of Africa. The average rates of amphisteginid range shift were computed between 8 and 2.7 km year 21, and are projected to lead to a total southward range expansion of 267 km, or 2.4 degrees latitude, in the year 2100. Our results corroborate findings from the fossil record that some larger symbiont-bearing foraminifera cope well with rising water temperatures and are beneficiaries of global climate change.	[Langer, Martin R.; Weinmann, Anna E.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Loetters, Stefan] Univ Trier, Biogeog Dept, Trier, Germany; [Bernhard, Joan M.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Roedder, Dennis] Museum Koenig, Zool Forsch Musem Alexander Koenig, Bonn, Germany	University of Bonn; Universitat Trier; Woods Hole Oceanographic Institution; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Langer, MR (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany.	martin.langer@uni-bonn.de	Weinmann, Anna E./AAS-7145-2021; Rödder, Dennis/AAT-8644-2021; Bernhard, Joan/M-3260-2013	Weinmann, Anna E./0000-0002-7999-0486; Rödder, Dennis/0000-0002-6108-1639; Bernhard, Joan/0000-0003-2121-625X	German Science Foundation (DFG) [LA 884/10-1, LA 884/5-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Science Foundation (DFG; www.dfg.de) to ML and SL (LA 884/10-1, LA 884/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABU TAIR N. K., 2011, THESIS RHEINISCHE FR; ALBANI A. D., 1965, CONTRIB CUSHMAN FOUND FORAMINIFERAL RES, V16, P60; Alory G, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028044; [Anonymous], 1999, BEACH FIELD GUIDE LA; Banner F.T., 1981, P350; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Battistini R., 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Geologie, V8, P147; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; Belderson RH, 1961, THESIS U NATAL DURBA; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Brady, 1884, ZOOLOGY, V9, P1; Braga J. M., 1961, Publicacoes do Instituto de Zoologia Dr Augusto Nobre, V77, P1; Cai WJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030380; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Chaproniere G.C.H., 1984, BUR MINERAL RESOUR G; CHAPRONIERE GCH, 1980, PALAEOGEOGR PALAEOCL, V31, P299, DOI 10.1016/0031-0182(80)90023-1; CHASENS S A, 1981, Journal of Foraminiferal Research, V11, P191; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clark RM, 2010, INT J CLIMATOL, V30, P1599, DOI 10.1002/joc.2004; Cooper J.A.G., 1987, South African Journal of Geology, V90, P489; Cudmore TJ, 2010, J APPL ECOL, V47, P1036, DOI 10.1111/j.1365-2664.2010.01848.x; Dale DC, 1998, S AFR J SCI, V94, P319; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Dambach J, 2011, AQUAT CONSERV, V21, P92, DOI 10.1002/aqc.1160; dOrbigny A., 1826, ANN SCI NATURELLES, V7, P245; Egger JG, 1893, KONIGLICHE BAYERISCH, V18, P139; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fu Q, 2006, SCIENCE, V312, P1179, DOI 10.1126/science.1125566; Funk C, 2008, P NATL ACAD SCI USA, V105, P11081, DOI 10.1073/pnas.0708196105; Goldbeck EJ, 2009, SOC SEDIMENT GEOL SP, V93, P187; Goldstein ST, 1999, MODERN FORAMINIFERA, P37; Grosholz ED, 1996, ECOLOGY, V77, P1680, DOI 10.2307/2265773; Guarino L, 2001, DIVA GIS GEOGRAPHIC; HALLOCK P, 1981, Journal of Foraminiferal Research, V11, P40; HALLOCK P, 1981, J SEDIMENT PETROL, V51, P467; HALLOCK P, 1986, J FORAMIN RES, V16, P1, DOI 10.2113/gsjfr.16.1.1; Hallock P, 1999, MODERN FORAMINIFERA, P123; Hallock P., 2011, GSA ABSTRACTS PROGRA, P556; Hannah L, 2002, GLOBAL ECOL BIOGEOGR, V11, P485, DOI 10.1046/j.1466-822X.2002.00306.x; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Heron-Allen E., 1915, Transactions of the Zoological Society of London, V20; Hiddink JG, 2012, GLOBAL CHANGE BIOL, V18, P2161, DOI 10.1111/j.1365-2486.2012.02698.x; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hottinger L., 1977, Memoires Mus natn Hist nat Paris (Sci Terre), V40, P1; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kinlan BP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P381; Kintisch E, 2008, SCIENCE, V322, P182, DOI 10.1126/science.322.5899.182; Langer M.R., 2008, AQABA EILAT IMPROBAB, P399; LANGER M.R., 2006, ANUARIO I GEOCIENCIA, V29, P686; Langer MR, 2008, J EUKARYOT MICROBIOL, V55, P163, DOI 10.1111/j.1550-7408.2008.00321.x; Langer MR, 2012, J FORAMIN RES, V42, P234, DOI 10.2113/gsjfr.42.3.234; Langer MR, 2000, MICROPALEONTOLOGY, V46, P105; Langer MR, 1997, J FORAMIN RES, V27, P271, DOI 10.2113/gsjfr.27.4.271; LARSEN AR, 1976, ISRAEL J EARTH SCI, V25, P1; Le Calvez Y, 1965, CAHIERS OFFICE RECHE, V11, P181; le Roux PC, 2008, GLOBAL CHANGE BIOL, V14, P2950, DOI 10.1111/j.1365-2486.2008.01687.x; LEE JJ, 1995, BIOSCIENCE, V45, P252, DOI 10.2307/1312418; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Levy A., 1982, Cahiers de Micropaleontologie Nouvelle Serie, V1982, P135; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Luning K, 1990, SEAWEEDS THEIR ENV B, P527; McIntyre-Wressnig A, MAR ECOL PR IN PRESS; McMillan I.K., 1974, THESIS U COLL WALES; MCMILLAN IK, 1986, S AFR J SCI, V82, P66; Mobius K., 1880, BEITRAGE MEERESFAUNA, P65, DOI [10.1007/978-94-017-6608-1, DOI 10.1007/978-94-017-6608-1]; MONIER C, 1973, Tethys, V5, P241; MONTAGGIONI LF, 1981, ANN I OCEANOGR PARIS, V57, P41; Moura AR, 1965, REV ESTUDOS GERAIS 2, V2, P1; Murray JW, 1973, DISTRIBUTION ECOLOGY, P244; NEAGU T, 1982, Revista Espanola de Micropaleontologia, V14, P99; Oviatt CA, 2004, ESTUARIES, V27, P895, DOI 10.1007/BF02803416; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parry M. L., 2007, CLIMATE CHANGE 2007; Pearce J, 2000, ECOL MODEL, V128, P127, DOI 10.1016/S0304-3800(99)00227-6; Pearson PN, 2010, SCIENCE, V330, P763, DOI 10.1126/science.1197894; Pereira CPG, 1979, THESIS U WALES ABERY; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Perry CT, 2005, SEDIMENT GEOL, V174, P161, DOI 10.1016/j.sedgeo.2004.12.003; Perry CT, 2003, CORAL REEFS, V22, P485, DOI 10.1007/s00338-003-0339-9; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Phleger F.B., 1976, Maritime Sediments Spec Publ, VNo. 1,A, P195; Phleger FB, 1976, ST LUC SCI ADV COUNC, P1; Pignatti J, 2012, ITAL J GEOSCI, V131, P47, DOI 10.3301/IJG.2011.22; Pujalte V, 2009, GEOL ACTA, V7, P161, DOI 10.1344/105.000000276; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Rogl Fred, 1993, Acta Geologica Polonica, V43, P121; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saikkonen K, 2012, NAT CLIM CHANGE, V2, P239, DOI [10.1038/NCLIMATE1430, 10.1038/nclimate1430]; Scheibner C., 2008, eEarth, V3, P19; Scheibner C, 2008, EARTH-SCI REV, V90, P71, DOI 10.1016/j.earscirev.2008.07.002; Schmidt-Nielson K, 1990, ANIMAL PHYSL ADAPTAT, P217; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; SIMBERLOFF D, 2000, INTRO SPECIES THREAT; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Todd R., 1976, P382; Toefy R., 2005, African Invertebrates, V46, P1; Triantaphyllou MV, 2009, MEDITERR MAR SCI, V10, P73, DOI 10.12681/mms.111; Triantaphyllou MV, 2012, J FORAMIN RES, V42, P143, DOI 10.2113/gsjfr.42.2.143; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Vogel N, 2012, J EXP MAR BIOL ECOL, V424, P15, DOI 10.1016/j.jembe.2012.05.008; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Wright C.I., 1990, South African Journal of Geology, V93, P592; Wright E. P., 1876, Proceedings of the Royal Irish Academy, V(2), P586; Wright EP, 1877, J NAT HIST 4, V4, P40; Yamano H, 2000, CORAL REEFS, V19, P51, DOI 10.1007/s003380050226; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZMIRI A, 1974, J PROTOZOOL, V21, P133, DOI 10.1111/j.1550-7408.1974.tb03626.x	119	50	51	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54443	10.1371/journal.pone.0054443	http://dx.doi.org/10.1371/journal.pone.0054443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405081	Green Published, gold			2022-12-25	WOS:000315153400025
J	Lima, FD; Stamm, DN; Della-Pace, ID; Dobrachinski, F; de Carvalho, NR; Royes, LFF; Soares, FA; Rocha, JB; Gonzalez-Gallego, J; Bresciani, G				Lima, Frederico D.; Stamm, Daniel N.; Della-Pace, Iuri D.; Dobrachinski, Fernando; de Carvalho, Nelson R.; Royes, Luiz Fernando F.; Soares, Felix A.; Rocha, Joao B.; Gonzalez-Gallego, Javier; Bresciani, Guilherme			Swimming Training Induces Liver Mitochondrial Adaptations to Oxidative Stress in Rats Submitted to Repeated Exhaustive Swimming Bouts	PLOS ONE			English	Article							SKELETAL-MUSCLE; SUPEROXIDE-DISMUTASE; PHYSICAL-EXERCISE; INTENSITY EXERCISE; ELECTRON-TRANSPORT; LIPID-PEROXIDATION; INSULIN-RESISTANCE; REGULAR EXERCISE; GENE-EXPRESSION; FREE-RADICALS	Background and Aims: Although acute exhaustive exercise is known to increase liver reactive oxygen species (ROS) production and aerobic training has shown to improve the antioxidant status in the liver, little is known about mitochondria adaptations to aerobic training. The main objective of this study was to investigate the effects of the aerobic training on oxidative stress markers and antioxidant defense in liver mitochondria both after training and in response to three repeated exhaustive swimming bouts. Methods: Wistar rats were divided into training (n = 14) and control (n = 14) groups. Training group performed a 6-week swimming training protocol. Subsets of training (n = 7) and control (n = 7) rats performed 3 repeated exhaustive swimming bouts with 72 h rest in between. Oxidative stress biomarkers, antioxidant activity, and mitochondria functionality were assessed. Results: Trained group showed increased reduced glutathione (GSH) content and reduced/oxidized (GSH/GSSG) ratio, higher superoxide dismutase (MnSOD) activity, and decreased lipid peroxidation in liver mitochondria. Aerobic training protected against exhaustive swimming ROS production herein characterized by decreased oxidative stress markers, higher antioxidant defenses, and increases in methyl-tetrazolium reduction and membrane potential. Trained group also presented higher time to exhaustion compared to control group. Conclusions: Swimming training induced positive adaptations in liver mitochondria of rats. Increased antioxidant defense after training coped well with exercise-produced ROS and liver mitochondria were less affected by exhaustive exercise. Therefore, liver mitochondria also adapt to exercise-induced ROS and may play an important role in exercise performance.	[Lima, Frederico D.; Stamm, Daniel N.; Della-Pace, Iuri D.; Royes, Luiz Fernando F.; Bresciani, Guilherme] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, BR-97119900 Santa Maria, RS, Brazil; [Dobrachinski, Fernando; de Carvalho, Nelson R.; Soares, Felix A.; Rocha, Joao B.] Univ Fed Santa Maria, CCNE, Dept Quim, BR-97119900 Santa Maria, RS, Brazil; [Gonzalez-Gallego, Javier] Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain; [Gonzalez-Gallego, Javier] Univ Leon, Ctr Invest Biomed Red Enfermedades Hepat & Digest, E-24071 Leon, Spain	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidad de Leon; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universidad de Leon	Bresciani, G (corresponding author), Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, BR-97119900 Santa Maria, RS, Brazil.	guilhermebresciani@gmail.com	Lima, Frederico Diniz/P-8479-2015; Dobrachinski, Fernando/C-4316-2014; Soares, Félix/AAE-6251-2020; royes, luiz/T-3581-2019; da Rocha, Joao Batista Teixeira/S-6813-2016; Soares, Félix AA/K-7611-2012; Rocha, João Batista Teixeira/AAI-5377-2021; Gonzalez-Gallego, Javier/D-8219-2012	Lima, Frederico Diniz/0000-0002-3298-2833; Dobrachinski, Fernando/0000-0002-3948-1273; Soares, Félix/0000-0002-6453-7902; da Rocha, Joao Batista Teixeira/0000-0003-3829-0595; Soares, Félix AA/0000-0002-6453-7902; Rocha, João Batista Teixeira/0000-0003-3829-0595; Gonzalez-Gallego, Javier/0000-0002-4386-9342; Stamm, Daniel Neis/0000-0003-2967-3391; Bresciani, Guilherme/0000-0003-1526-5573; Carvalho, Nelson/0000-0001-9882-2050; royes, luiz/0000-0003-4045-4827	Instituto de Salud Carlos III, Spain	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	CIBERehd is funded by the Instituto de Salud Carlos III, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Alessio HM, 2000, MED SCI SPORT EXER, V32, P1576; ALI SF, 1992, NEUROTOXICOLOGY, V13, P637; Arida RM, 1999, EPILEPSY RES, V37, P45, DOI 10.1016/S0920-1211(99)00032-7; Belardinelli P, 2007, NEUROIMAGE, V37, P1301, DOI 10.1016/j.neuroimage.2007.05.053; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; BHATTACHARYA SK, 1991, ANAL BIOCHEM, V192, P344, DOI 10.1016/0003-2697(91)90546-6; Botezelli JD, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-35; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cakir B, 2010, CELL BIOCHEM FUNCT, V28, P469, DOI 10.1002/cbf.1679; Clavel S, 2002, EUR J APPL PHYSIOL, V87, P193, DOI 10.1007/s00421-002-0612-6; Cobley JN, 2011, INT J SPORT NUTR EXE, V21, P451, DOI 10.1123/ijsnem.21.6.451; Cohen G, 1997, P NATL ACAD SCI USA, V94, P4890, DOI 10.1073/pnas.94.10.4890; da Luz G, 2011, EUR J APPL PHYSIOL, V111, P2015, DOI 10.1007/s00421-010-1802-2; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; de Araujo GG, 2007, COMP BIOCHEM PHYS A, V148, P888, DOI 10.1016/j.cbpa.2007.09.002; De Minicis S, 2006, GASTROENTEROLOGY, V131, P272, DOI 10.1053/j.gastro.2006.05.048; Dionisio N, 2009, J HEPATOL, V50, P872, DOI 10.1016/j.jhep.2008.12.026; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Fogarty MC, 2011, ENVIRON MOL MUTAGEN, V52, P35, DOI 10.1002/em.20572; Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2; Gomez-Cabrera MC, 2009, PHYSICIAN SPORTSMED, V37, P116, DOI 10.3810/psm.2009.12.1749; Grassi B, 2011, EUR J APPL PHYSIOL, V111, P345, DOI 10.1007/s00421-010-1609-1; Gul M, 2002, SCAND J MED SCI SPOR, V12, P163, DOI 10.1034/j.1600-0838.2002.120307.x; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hoene M, 2010, DIABETOLOGIA, V53, P1131, DOI 10.1007/s00125-010-1666-3; Hoene M, 2010, EXERC IMMUNOL REV, V16, P163; Hollander J, 1999, AM J PHYSIOL-REG I, V277, pR856, DOI 10.1152/ajpregu.1999.277.3.R856; Huang CC, 2008, EXP GERONTOL, V43, P571, DOI 10.1016/j.exger.2008.03.002; Kakarla P, 2005, J EXP ZOOL PART A, V303A, P203, DOI 10.1002/jez.a.149; Kiens B, 1998, AM J PHYSIOL-ENDOC M, V275, pE332, DOI 10.1152/ajpendo.1998.275.2.E332; Kiraly MA, 2005, INT J PSYCHIAT MED, V35, P75, DOI 10.2190/HX7L-4B40-PQNY-2A4P; Kiran TR, 2006, J COMP PHYSIOL B, V176, P749, DOI 10.1007/s00360-006-0096-5; Korivi M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/932165; Lazarevic G, 2006, DIABETES METAB, V32, P583, DOI 10.1016/S1262-3636(07)70312-9; Lee FT, 2009, AM J CHINESE MED, V37, P557, DOI 10.1142/S0192415X09007053; LEEUWENBURGH C, 1995, ARCH BIOCHEM BIOPHYS, V316, P941, DOI 10.1006/abbi.1995.1125; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; LEW H, 1985, FEBS LETT, V185, P262, DOI 10.1016/0014-5793(85)80919-4; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Linton S, 2001, EXP GERONTOL, V36, P1503, DOI 10.1016/S0531-5565(01)00136-X; Liu JK, 2000, J APPL PHYSIOL, V89, P21; Malaguti M, 2009, J APPL PHYSIOL, V107, P1028, DOI 10.1152/japplphysiol.00293.2009; Marquezi ML, 2003, INT J SPORT NUTR EXE, V13, P65, DOI 10.1123/ijsnem.13.1.65; Mastorakos G, 2005, HORM METAB RES, V37, P577, DOI 10.1055/s-2005-870426; MISRA HP, 1972, J BIOL CHEM, V247, P3170; MRTENSSON J, 1991, P NATL ACAD SCI USA, V88, P4656, DOI 10.1073/pnas.88.11.4656; Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003; Nikolaidis MG, 2008, SPORTS MED, V38, P579, DOI 10.2165/00007256-200838070-00005; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Packer L, 2007, FREE RADICAL RES, V41, P951, DOI 10.1080/10715760701490975; Pastor A, 1996, J HEPATOL, V24, P353, DOI 10.1016/S0168-8278(96)80016-X; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Radak Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje; Radak Z, 2000, ARCH BIOCHEM BIOPHYS, V383, P114, DOI 10.1006/abbi.2000.2042; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Rasmussen UF, 2001, PFLUG ARCH EUR J PHY, V443, P180, DOI 10.1007/s004240100689; Remedio RN, 2011, MICRON, V42, P484, DOI 10.1016/j.micron.2011.01.008; Sachdev S, 2008, FREE RADICAL BIO MED, V44, P215, DOI 10.1016/j.freeradbiomed.2007.07.019; Sies H., 1985, OXIDATIVE STRESS, V501, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3; Souza MA, 2009, EPILEPSIA, V50, P811, DOI 10.1111/j.1528-1167.2008.01908.x; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sun LJ, 2010, LIFE SCI, V86, P39, DOI 10.1016/j.lfs.2009.11.003; Veneroso C, 2009, J PINEAL RES, V47, P184, DOI 10.1111/j.1600-079X.2009.00699.x; VILLA JG, 1993, INT J SPORTS MED, V14, P179, DOI 10.1055/s-2007-1021160; WILLIS WT, 1994, MED SCI SPORT EXER, V26, P1347; Wilson DO, 2000, J APPL PHYSIOL, V88, P1791, DOI 10.1152/jappl.2000.88.5.1791; Yoshioka M, 2001, INT J OBESITY, V25, P332, DOI 10.1038/sj.ijo.0801554	71	56	57	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55668	10.1371/journal.pone.0055668	http://dx.doi.org/10.1371/journal.pone.0055668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405192	gold, Green Submitted, Green Published			2022-12-25	WOS:000315153400137
J	Merga, JY; Williams, NJ; Miller, WG; Leatherbarrow, AJH; Bennett, M; Hall, N; Ashelford, KE; Winstanley, C				Merga, J. Yvette; Williams, Nicola J.; Miller, William G.; Leatherbarrow, Andrew J. H.; Bennett, Malcolm; Hall, Neil; Ashelford, Kevin E.; Winstanley, Craig			Exploring the Diversity of Arcobacter butzleri from Cattle in the UK Using MLST and Whole Genome Sequencing	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; CAMPYLOBACTER SPP.; GENETIC DIVERSITY; HEALTHY CATTLE; RETAIL MEATS; PREVALENCE; IDENTIFICATION; ARTEMIS; SAMPLES	Arcobacter butzleri is considered to be an emerging human foodborne pathogen. The completion of an A. butzleri genome sequence along with microarray analysis of 13 isolates in 2007 revealed a surprising amount of diversity amongst A. butzleri isolates from humans, animals and food. In order to further investigate Arcobacter diversity, 792 faecal samples were collected from cattle on beef and dairy farms in the North West of England. Arcobacter was isolated from 42.5% of the samples and the diversity of the isolates was investigated using multilocus sequence typing. An A. butzleri whole genome sequence, obtained by 454 shotgun sequencing of an isolate from a clinically-healthy dairy cow, showed a number of differences when compared to the genome of a human-derived A. butzleri isolate. PCR-based prevalence assays for variable genes suggested some tentative evidence for source-related distributions. We also found evidence for phenotypic differences relating to growth capabilities between our representative human and cattle isolates. Our genotypic and phenotypic observations suggest that some level of niche adaptation may have occurred in A. butzleri.	[Merga, J. Yvette; Williams, Nicola J.; Leatherbarrow, Andrew J. H.; Bennett, Malcolm; Winstanley, Craig] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Miller, William G.] USDA, Produce Safety & Microbiol Res Unit, Albany, CA USA; [Hall, Neil; Ashelford, Kevin E.] Univ Liverpool, Inst Integrat Biol, Adv Genom Facil, Liverpool L69 3BX, Merseyside, England	University of Liverpool; United States Department of Agriculture (USDA); University of Liverpool	Merga, JY (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.	ysloane@liv.ac.uk	; Bennett, Malcolm/G-4004-2010	Merga, Yvette/0000-0002-0692-1455; Bennett, Malcolm/0000-0003-0475-390X; Hall, Neil/0000-0003-2808-0009; Williams, Nicola/0000-0003-4709-4190; Ashelford, Kevin/0000-0003-3217-2811; Bennett, Malcolm/0000-0002-5490-2910; Winstanley, Craig/0000-0002-2662-8053	Higher Education Funding Council for England (HEFCE); Department for Environment, Food and Rural Affairs; MRC [MR/K002279/1] Funding Source: UKRI; Medical Research Council [MR/K002279/1] Funding Source: researchfish	Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Higher Education Funding Council for England (HEFCE) and the Department for Environment, Food and Rural Affairs, as part of the Veterinary Training and Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Aydin F, 2007, J APPL MICROBIOL, V103, P27, DOI 10.1111/j.1365-2672.2006.03240.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Collado L, 2009, INT J SYST EVOL MICR, V59, P1391, DOI 10.1099/ijs.0.003749-0; De Smet S, 2011, INT J SYST EVOL MICR, V61, P356, DOI 10.1099/ijs.0.022665-0; Gonzalez A, 2007, CUADERNOS HISPANOAM, P85; Gonzalez I, 2000, LETT APPL MICROBIOL, V30, P207, DOI [10.1046/j.1472-765x.2000.00696.x, 10.1046/j.1472-765X.2000.00696.x]; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hamill S, 2008, J FOOD PROTECT, V71, P850, DOI 10.4315/0362-028X-71.4.850; Houf K, 2002, APPL ENVIRON MICROB, V68, P2172, DOI 10.1128/AEM.68.5.2172-2178.2002; Houf K, 2001, INT J FOOD MICROBIOL, V71, P189, DOI 10.1016/S0168-1605(01)00605-5; Houf K, 2000, FEMS MICROBIOL LETT, V193, P89, DOI 10.1111/j.1574-6968.2000.tb09407.x; Hume ME, 2001, J FOOD PROTECT, V64, P645, DOI 10.4315/0362-028X-64.5.645; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Kabeya H, 2004, INT J FOOD MICROBIOL, V90, P303, DOI 10.1016/S0168-1605(03)00322-2; Kemp R, 2005, APPL ENVIRON MICROB, V71, P1876, DOI 10.1128/AEM.71.4.1876-1882.2005; Merga Y, 2011, APPL ENVIRON MICROB, V75, P1646; Miller WG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001358; Miller WG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-196; Ongor H, 2004, LETT APPL MICROBIOL, V38, P339, DOI 10.1111/j.1472-765X.2004.01494.x; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307; Rivas L, 2004, INT J FOOD MICROBIOL, V91, P31, DOI 10.1016/S0168-1605(03)00328-3; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Scullion R, 2006, J FOOD PROTECT, V69, P1986, DOI 10.4315/0362-028X-69.8.1986; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toh H, 2011, J BACTERIOL, V193, P6411, DOI 10.1128/JB.06084-11; Van Driessche E, 2005, VET MICROBIOL, V105, P149, DOI 10.1016/j.vetmic.2004.11.002; Van Driessche E, 2004, RES MICROBIOL, V155, P662, DOI 10.1016/j.resmic.2004.04.011; Van Driessche E, 2003, FEMS MICROBIOL LETT, V229, P243, DOI 10.1016/S0378-1097(03)00840-1; VANDAMME P, 1992, J CLIN MICROBIOL, V30, P2335, DOI 10.1128/JCM.30.9.2335-2337.1992; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Vilar MJ, 2010, BERL MUNCH TIERARZTL, V123, P58, DOI 10.2376/0005-9366-123-58; Villarruel-Lopez A, 2003, J FOOD PROTECT, V66, P1374, DOI 10.4315/0362-028X-66.8.1374; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang GH, 2002, J CLIN MICROBIOL, V40, P4744, DOI 10.1128/JCM.40.12.4744-4747.2002; Wesley IV, 2000, APPL ENVIRON MICROB, V66, P1994, DOI 10.1128/AEM.66.5.1994-2000.2000	38	35	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55240	10.1371/journal.pone.0055240	http://dx.doi.org/10.1371/journal.pone.0055240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405126	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400071
J	Nyari, AS; Reddy, S				Nyari, Arpad S.; Reddy, Sushma			Comparative Phyloclimatic Analysis and Evolution of Ecological Niches in the Scimitar Babblers (Aves: Timaliidae: Pomatorhinus)	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTIONS; PLEISTOCENE REFUGIA; ALCIPPE-MORRISONIA; SPECIES-LIMITS; CONSERVATISM; DIVERSIFICATION; BIOGEOGRAPHY; PATTERNS; PHYLOGEOGRAPHY	We present the first extensive and integrative analysis of niche evolution based on climatic variables and a dated molecular phylogeny of a heterogeneous avian group of Southeast Asian scimitar babblers of the genus Pomatorhinus. The four main clades of scimitar babblers have species that co-occur in similar areas across southern Asia but some have diverged at different timeframes, with the most recently evolved clade harboring the highest number of species. Ecological niche models and analysis of contributing variables within a phylogenetic framework indicate instances of convergent evolution of members of different clades onto similar ecological parameter space, as well as divergent evolution of members from within clades. Pomatorhinus species from different clades occupying Himalayan foothills show convergence towards similar climatic tolerances, whereas within a clade, allopatric sister-species occurring in the Himalayas have diverged to occupy different climatic parameter spaces. Comparisons of climatic tolerances of Himalayan foothills taxa with species distributed further south in Assam/Burma and Burma/Thailand indicate convergence towards similar parameter spaces in several climatic variables. Niche overlap was observed to be lower among species of the youngest clade (ruficollis) and higher among species of older clades (ferruginosus). Analysis of accumulation of ecological disparity through time indicates rapid divergence within recent time frames. As a result, Himalayan taxa originating at different temporal scales within the four main scimitar babbler clades have differentiated ecologically only in recently diverged taxa. Our study suggests that the repeated orogenic and climatic fluctuations of the Pliocene and Pleistocene within mainland Southeast Asia served as an important ecological speciation driver within scimitar babblers, by providing opportunities for rapid geographic expansion and filling of novel environmental niches.	[Nyari, Arpad S.; Reddy, Sushma] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Nyari, Arpad S.] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA	Loyola University Chicago; Oklahoma State University System; Oklahoma State University - Stillwater	Nyari, AS (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	arpinyari@gmail.com		Reddy, Sushma/0000-0001-7263-0763	NSF [DEB-0962078]; Loyola University Chicago's Provost's Office	NSF(National Science Foundation (NSF)); Loyola University Chicago's Provost's Office	Funding for this research was provided by NSF DEB-0962078 and Loyola University Chicago's Provost's Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anciaes M, 2009, J AVIAN BIOL, V40, P591, DOI 10.1111/j.1600-048X.2009.04597.x; Brookfield ME, 1998, GEOMORPHOLOGY, V22, P285, DOI 10.1016/S0169-555X(97)00082-2; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Chen Y, 2007, CURRENT SCI, V92; Cibois A, 2003, AUK, V120, P35, DOI 10.1642/0004-8038(2003)120[0035:MDPOBT]2.0.CO;2; Collar NJ, 2007, HDB BIRDS WORLD, V12, P165; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eaton MD, 2008, BIOL J LINN SOC, V94, P869, DOI 10.1111/j.1095-8312.2008.01040.x; Evans MEK, 2009, AM NAT, V173, P225, DOI 10.1086/595757; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Gelang M, 2009, ZOOL SCR, V38, P225, DOI 10.1111/j.1463-6409.2008.00374.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jakob SS, 2010, MOL ECOL, V19, P1423, DOI 10.1111/j.1365-294X.2010.04582.x; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; Moyle RG, 2005, J AVIAN BIOL, V36, P96, DOI 10.1111/j.0908-8857.2005.03510.x; Moyle RG, 2012, SYST BIOL, V61, P631, DOI 10.1093/sysbio/sys027; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Nyari AS, 2009, MOL PHYLOGENET EVOL, V53, P613, DOI 10.1016/j.ympev.2009.06.014; Nyari AS, 2009, ZOOL SCR, V38, P553, DOI 10.1111/j.1463-6409.2009.00397.x; Ollier C., 2000, ORIGIN MOUNTAINS; Olsson U, 2005, MOL PHYLOGENET EVOL, V36, P261, DOI 10.1016/j.ympev.2005.01.012; Olsson U, 2006, MOL PHYLOGENET EVOL, V41, P556, DOI 10.1016/j.ympev.2006.05.009; Packert M, 2012, J BIOGEOGR, V39, P556, DOI 10.1111/j.1365-2699.2011.02606.x; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson A. T., 2006, BIODIVERSITY INFORM, V3, P59, DOI DOI 10.17161/BI.V3I0.29; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Peterson AT, 2007, ECOL MODEL, V203, P527, DOI 10.1016/j.ecolmodel.2006.12.023; Peterson A. Townsend, 2003, Bulletin of the British Ornithologists' Club, V123A, P186; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Peterson AT, 2009, FRONTIERS BIOGEOGRAP, V1, P19, DOI DOI 10.21425/F5FBG12232; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price TD, 2011, AM NAT, V178, pS97, DOI 10.1086/661926; Rambaut A, 2014, TRACER V1 6; Rangin C, 1995, TECTONOPHYSICS, V251, P179, DOI 10.1016/0040-1951(95)00006-2; Reddy S, 2008, MOL PHYLOGENET EVOL, V47, P54, DOI 10.1016/j.ympev.2008.01.014; Reddy S, 2011, BIOL J LINN SOC, V102, P846, DOI 10.1111/j.1095-8312.2010.01611.x; Rice NH, 2003, BIOL J LINN SOC, V80, P369, DOI 10.1046/j.1095-8312.2003.00242.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schidelko K, 2011, BIOL J LINN SOC, V102, P455, DOI 10.1111/j.1095-8312.2010.01570.x; Schnitzler J, 2012, J BIOGEOGR, V39, P2201, DOI 10.1111/jbi.12028; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Yesson C, 2006, SYST BIOL, V55, P785, DOI 10.1080/1063515060081570; Yesson C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-72; Zou FH, 2007, MOL PHYLOGENET EVOL, V44, P165, DOI 10.1016/j.ympev.2006.12.004	63	34	34	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55629	10.1371/journal.pone.0055629	http://dx.doi.org/10.1371/journal.pone.0055629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405183	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400128
J	Wang, JY; Zhang, Z; Wang, YL; Li, L; Chai, RY; Mao, XQ; Jiang, H; Qiu, HP; Du, XF; Lin, FC; Sun, GC				Wang, Jiaoyu; Zhang, Zhen; Wang, Yanli; Li, Ling; Chai, Rongyao; Mao, Xueqin; Jiang, Hua; Qiu, Haiping; Du, Xinfa; Lin, Fucheng; Sun, Guochang			PTS1 Peroxisomal Import Pathway Plays Shared and Distinct Roles to PTS2 Pathway in Development and Pathogenicity of Magnaporthe oryzae	PLOS ONE			English	Article							MEDIATED PLANT INFECTION; RICE BLAST FUNGUS; TARGETING SIGNAL TYPE-2; SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; PENICILLIUM-CHRYSOGENUM; COLLETOTRICHUM-LAGENARIUM; HANSENULA-POLYMORPHA; APPRESSORIUM TURGOR; YARROWIA-LIPOLYTICA	Peroxisomes participate in various important metabolisms and are required in pathogenicity of fungal plant pathogens. Peroxisomal matrix proteins are imported from cytoplasm into peroxisomes through peroxisomal targeting signal 1 (PTS1) or peroxisomal targeting signal 2 (PTS2) import pathway. PEX5 and PEX7 genes participate in the two pathways respectively. The involvement of PEX7 mediated PTS2 import pathway in fungal pathogenicity has been documented, while that of PTS1 remains unclear. Through null mutant analysis of MoPEX5, the PEX5 homolog in Magnaporthe oryzae, we report the crucial roles of PTS1 pathway in the development and host infection in the rice blast fungus, and compared with those of PTS2. We found that MoPEX5 disruption specifically blocked the PTS1 pathway. Delta mopex5 was unable to use lipids as sole carbon source and lost pathogenicity completely. Similar as Delta mopex7, Delta mopex5 exhibited significant reduction in lipid utilization and mobilization, appressorial turgor genesis and H2O2 resistance. Additionally, Delta mopex5 presented some distinct defects which were undetected in Delta mopex7 in vegetative growth, conidial morphogenesis, appressorial morphogenesis and melanization. The results indicated that the PTS1 peroxisomal import pathway, in addition to PTS2, is required for fungal development and pathogenicity of the rice blast fungus, and also, as a main peroxisomal import pathway, played a more predominant role than PTS2.	[Wang, Jiaoyu; Zhang, Zhen; Wang, Yanli; Li, Ling; Chai, Rongyao; Mao, Xueqin; Jiang, Hua; Qiu, Haiping; Du, Xinfa; Sun, Guochang] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect Microbiol, Hangzhou, Zhejiang, Peoples R China; [Lin, Fucheng] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang University	Sun, GC (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Inst Plant Protect Microbiol, Hangzhou, Zhejiang, Peoples R China.	sungc01@sina.com	Lin, Fucheng/ABE-7591-2021	Lin, Fucheng/0000-0002-4127-8143	Natural Science Foundation of China [30900933, 30970082, 31170136]; National Basic Research Program of China [2012CB722504]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the Natural Science Foundation of China (No: 30900933 to JW, 30970082 to GS and 31170136 to JW) and the National Basic Research Program of China (No: 2012CB722504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amano T, 2003, ANAL BIOCHEM, V314, P1, DOI 10.1016/S0003-2697(02)00653-X; Asakura M, 2006, APPL ENVIRON MICROB, V72, P6345, DOI 10.1128/AEM.00988-06; Asiegbu FO, 2004, FEMS MICROBIOL LETT, V230, P85, DOI 10.1016/S0378-1097(03)00858-9; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; COE JGS, 1994, MOL GEN GENET, V244, P661, DOI 10.1007/BF00282757; CRAWFORD MS, 1986, GENETICS, V114, P1111; Deng YZ, 2009, AUTOPHAGY, V5, P33, DOI 10.4161/auto.5.1.7175; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; Elgersma Y, 1996, BBA-REV BIOMEMBRANES, V1286, P269, DOI 10.1016/S0304-4157(96)00012-3; Fujihara N, 2010, MOL PLANT MICROBE IN, V23, P436, DOI 10.1094/MPMI-23-4-0436; Goh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028220; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Hayashi M, 2005, J BIOL CHEM, V280, P14829, DOI 10.1074/jbc.M411005200; Hettema EH, 1999, BBA-MOL CELL RES, V1451, P17, DOI 10.1016/S0167-4889(99)00087-7; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kiel JAKW, 2004, FUNGAL GENET BIOL, V41, P708, DOI 10.1016/j.fgb.2004.02.006; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Koch J, 2010, J CELL SCI, V123, P3389, DOI 10.1242/jcs.064907; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lee JR, 2006, PLANT J, V47, P457, DOI 10.1111/j.1365-313X.2006.02797.x; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Lu JP, 2005, FEMS MICROBIOL LETT, V245, P131, DOI 10.1016/j.femsle.2005.02.032; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; Meijer WH, 2010, APPL ENVIRON MICROB, V76, P5702, DOI 10.1128/AEM.02327-09; Min K, 2012, MOL PLANT MICROBE IN, V25, P1617, DOI 10.1094/MPMI-06-12-0149-R; MIURA S, 1992, J BIOL CHEM, V267, P14405; Moser HW, 2000, FRONT BIOSCI, V5, pD298, DOI 10.2741/Moser; MULLER WH, 1991, EMBO J, V10, P489, DOI 10.1002/j.1460-2075.1991.tb07971.x; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; NOTTEGHEM JL, 1992, PHYTOPATHOLOGY, V82, P421, DOI 10.1094/Phyto-82-421; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Peraza-Reyes L, 2011, MOL MICROBIOL, V82, P365, DOI 10.1111/j.1365-2958.2011.07816.x; Purdue PE, 1998, J CELL BIOL, V143, P1859; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Rho HS, 2001, MOL CELLS, V12, P407; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Sichting M, 2003, MOL BIOL CELL, V14, P810, DOI 10.1091/mbc.E02-08-0539; Soundararajan S, 2004, PLANT CELL, V16, P1564, DOI 10.1105/tpc.020677; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SZILARD RK, 1995, J CELL BIOL, V131, P1453, DOI 10.1083/jcb.131.6.1453; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Thoms S, 2006, BBA-MOL CELL RES, V1763, P1620, DOI 10.1016/j.bbamcr.2006.08.046; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Urban M, 1999, EMBO J, V18, P512, DOI 10.1093/emboj/18.3.512; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VANDERKLEI IJ, 1995, J BIOL CHEM, V270, P17229, DOI 10.1074/jbc.270.29.17229; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; Wang JY, 2008, J ZHEJIANG UNIV-SC B, V9, P802, DOI 10.1631/jzus.B0860001; Wang Jiaoyu, 2009, Sheng Wu Gong Cheng Xue Bao, V25, P129; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wang ZY, 2005, BIOCHEM SOC T, V33, P384, DOI 10.1042/BST0330384; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; WOLOSHUK CP, 1983, PHYSIOL PLANT PATHOL, V22, P245; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65	67	14	22	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55554	10.1371/journal.pone.0055554	http://dx.doi.org/10.1371/journal.pone.0055554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405169	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400114
J	Xu, Q; Zhao, WM; Chen, Y; Tong, YY; Rong, GH; Huang, ZY; Zhang, Y; Chang, GB; Wu, XS; Chen, GH				Xu, Qi; Zhao, WenMing; Chen, Yang; Tong, YiYu; Rong, GuangHui; Huang, ZhengYang; Zhang, Yang; Chang, GuoBing; Wu, XinSheng; Chen, GuoHong			Transcriptome Profiling of the Goose (Anser cygnoides) Ovaries Identify Laying and Broodiness Phenotypes	PLOS ONE			English	Article							DIGITAL GENE-EXPRESSION; PROGESTERONE PRODUCTION; STAR	Background: The geese have strong broodiness and poor egg performance. These characteristics are the key issues that hinder the goose industry development. Yet little is known about the mechanisms responsible for follicle development due to lack of genomic resources. Hence, studies based on high-throughput sequencing technologies are needed to produce a comprehensive and integrated genomic resource and to better understand the biological mechanisms of goose follicle development. Methodology/Principal Findings: In this study, we performed de novo transcriptome assembly and gene expression analysis using short-read sequencing technology (Illumina). We obtained 67,315,996 short reads of 100 bp, which were assembled into 130,514 unique sequences by Trinity strategy (mean size = 753bp). Based on BLAST results with known proteins, these analyses identified 52,642 sequences with a cut-off E-value above 10(-5). Assembled sequences were annotated with gene descriptions, gene ontology and clusters of orthologous group terms. In addition, we investigated the transcription changes during the goose laying/broodiness period using a tag-based digital gene expression (DGE) system. We obtained a sequencing depth of over 4.2 million tags per sample and identified a large number of genes associated with follicle development and reproductive biology including cholesterol side-chain cleavage enzyme gene and dopamine beta-hydroxylas gene. We confirm the altered expression levels of the two genes using quantitative real-time PCR (qRT-PCR). Conclusions/Significance: The obtained goose transcriptome and DGE profiling data provide comprehensive gene expression information at the transcriptional level that could promote better understanding of the molecular mechanisms underlying follicle development and productivity.	[Xu, Qi; Zhao, WenMing; Chen, Yang; Tong, YiYu; Rong, GuangHui; Huang, ZhengYang; Zhang, Yang; Chang, GuoBing; Wu, XinSheng; Chen, GuoHong] Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Peoples R China	Yangzhou University	Chen, GH (corresponding author), Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Peoples R China.	ghchen@yzu.edu.cn	Huang, Zhengyang/J-6297-2013; XU, Qi/AID-2262-2022	Huang, Zhengyang/0000-0001-9197-6700; 	earmarked fund for Modern Agro-industry Technology Research System [CARS-43-3]; Priority Academic Program Development of Jiangsu Higher Education Institutions [[2011]137]	earmarked fund for Modern Agro-industry Technology Research System; Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-43-3) and Priority Academic Program Development of Jiangsu Higher Education Institutions [2011]137. Jiangsu Lihua Animal Husbandry CO. LTD provided the animal sample. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barbara R, 2007, STATE WORLDS ANIMAL, P252; Chen GH, 2004, CHINAS POULTRY GENET, P25; Cheng JH, 2009, COMPUTATIONAL SCI DI, P31; Cheng JinHua, 2011, Jiangsu Journal of Agricultural Sciences, V27, P818; Ciraci C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-545; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Du XD, 2009, MRNA EXPRESSION PROF, P6; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; [郭军 Guo Jun], 2011, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V42, P1477; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang B, 2009, POULTRY SCI, V88, P1975, DOI 10.3382/ps.2008-00519; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozsolak F, 2010, GENOME RES, V20, P519, DOI 10.1101/gr.102129.109; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qin YF, 2011, GENOMICS, V97, P364, DOI 10.1016/j.ygeno.2011.02.002; Rangel PL, 2009, REPRODUCTION, V138, P961, DOI 10.1530/REP-09-0071; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Sechman A, 2011, DOMEST ANIM ENDOCRIN, V41, P137, DOI 10.1016/j.domaniend.2011.05.007; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Toma SA, 2006, ANIMAL GENETICS, V8, P279; Wang BW, 2009, CHINA GOOSE IND, P25; Wei RH, 2009, MRNA EXPRESSION PROF, P9; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Zhang B, 2012, CHINESE POULTRY BREE, P25; Zhu P, 2009, MRNA EXPRESSION PROF, P10	34	48	56	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55496	10.1371/journal.pone.0055496	http://dx.doi.org/10.1371/journal.pone.0055496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405160	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400105
J	Okroglic, S; Widmann, CN; Urbach, H; Scheltens, P; Heneka, MT				Okroglic, Sandra; Widmann, Catherine N.; Urbach, Horst; Scheltens, Philip; Heneka, Michael T.			Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; WHITE-MATTER CHANGES; TYPE-2 DIABETES-MELLITUS; ISCHEMIC-STROKE; ROTTERDAM SCAN; COGNITIVE IMPAIRMENT; BRAIN; LEUKOARAIOSIS; LESIONS; LADIS	Objective: Although the clinical manifestation and risk factors of cerebral microangiopathy (CM) remain unclear, the number of diagnoses is increasing. Hence, patterns of association among lesion topography and severity, clinical symptoms and demographic and disease risk factors were investigated retrospectively in a cohort of CM patients. Methods: Patients treated at the Department of Neurology, University of Bonn for CM (n = 223; 98m, 125f; aged 77.32 +/- 9.09) from 2005 to 2010 were retrospectively enrolled. Clinical symptoms, blood chemistry, potential risk factors, demographic data and ratings of vascular pathology in the brain based on the Wahlund scale were analyzed using Pearson's chi square test and one-way ANOVA. Results: Progressive cognitive decline (38.1%), gait apraxia (27.8%), stroke-related symptoms and seizures (24.2%), TIA-symptoms (22%) and vertigo (17%) were frequent symptoms within the study population. Frontal lobe WMLs/lacunar infarcts led to more frequent presentation of progressive cognitive decline, seizures, gait apraxia, stroke-related symptoms, TIA, vertigo and incontinence. Parietooccipital WMLs/lacunar infarcts were related to higher frequencies of TIA, seizures and incontinence. Basal ganglia WMLs/lacunar infarcts were seen in patients with more complaints of gait apraxia, vertigo and incontinence. Age (p = .012), arterial hypertension (p<.000), obesity (p<.000) and cerebral macroangiopathy (p = .018) were positively related to cerebral lesion load. For increased glucose level, homocysteine, CRP and D-Dimers there was no association. Conclusion: This underlines the association of CM with neurological symptoms upon admission in a topographical manner. Seizures and vertigo are symptoms of CM which may have been missed in previous studies. In addition to confirming known risk factors such as aging and arterial hypertension, obesity appears to increase the risk as well. Since the incidence of CM is increasing, future studies should focus on the importance of prevention of vascular risk factors on its pathogenesis.	[Okroglic, Sandra; Widmann, Catherine N.; Heneka, Michael T.] Univ Bonn, Dept Neurol, Clin Neurosci Unit, Bonn, Germany; [Urbach, Horst] Univ Bonn, Dept Radiol, Neuroradiol Unit, Bonn, Germany; [Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands; [Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands	University of Bonn; University of Bonn; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Heneka, MT (corresponding author), Univ Bonn, Dept Neurol, Clin Neurosci Unit, Bonn, Germany.	michael.heneka@ukb.uni-bonn.de	Heneka, Michael/AAE-8011-2019; Scheltens, Philip/AAL-9631-2020; Heneka, Michael/E-8072-2015	Scheltens, Philip/0000-0002-1046-6408; Heneka, Michael/0000-0003-4996-1630	Clinical Neuroscience Unit at the Department of Neurology, University of Bonn, Germany	Clinical Neuroscience Unit at the Department of Neurology, University of Bonn, Germany	Funding for this study was provided by the Clinical Neuroscience Unit at the Department of Neurology, University of Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Blahak C, 2009, J NEUROL NEUROSUR PS, V80, P608, DOI 10.1136/jnnp.2008.154633; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Brouns R, 2009, J NEUROL SCI, V285, P185, DOI 10.1016/j.jns.2009.06.032; de Lau LML, 2010, NEUROBIOL AGING, V31, P2020, DOI 10.1016/j.neurobiolaging.2008.10.004; De Reuck J, 2007, J NEUROL SCI, V263, P75, DOI 10.1016/j.jns.2007.06.004; Dufouil C, 2005, CIRCULATION, V112, P1644, DOI 10.1161/CIRCULATIONAHA.104.501163; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; INZITARI D, 1987, ARCH NEUROL-CHICAGO, V44, P42, DOI 10.1001/archneur.1987.00520130034014; Inzitari M, 2007, J NEUROL SCI, V257, P166, DOI 10.1016/j.jns.2007.01.026; Isenegger J, 2010, CEREBROVASC DIS, V29, P82, DOI 10.1159/000256652; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Jimenez-Conde J, 2010, STROKE, V41, P437, DOI 10.1161/STROKEAHA.109.563502; Karatas M, 2008, NEUROLOGIST, V14, P355, DOI 10.1097/NRL.0b013e31817533a3; Kuo HK, 2004, J GERONTOL A-BIOL, V59, P818; Laloux P, 2004, ACTA NEUROL BELG, V104, P13; Lin HJ, 2007, J CLIN NEUROSCI, V14, P17, DOI 10.1016/j.jocn.2005.07.026; Marchesi VT, 2011, FASEB J, V25, P5, DOI 10.1096/fj.11-0102ufm; Miki Y, 1998, NEUROLOGY, V50, P1301, DOI 10.1212/WNL.50.5.1301; Mok VCT, 2009, J NEUROL, V256, P750, DOI 10.1007/s00415-009-5008-7; Oh SH, 2010, J NEUROL SCI, V293, P97, DOI 10.1016/j.jns.2010.02.025; Pantoni L, 1997, ANN NY ACAD SCI, V826, P92, DOI 10.1111/j.1749-6632.1997.tb48463.x; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Patel B, 2011, INT J STROKE, V6, P47, DOI 10.1111/j.1747-4949.2010.00552.x; Poggesi A, 2008, J AM GERIATR SOC, V56, P1638, DOI 10.1111/j.1532-5415.2008.01832.x; Reitz C, 2007, STROKE, V38, P2356, DOI 10.1161/STROKEAHA.107.482661; SCHREINER A, 1995, J NEUROL SCI, V130, P171, DOI 10.1016/0022-510X(95)00020-3; SPSS Statistics, 2008, SPSS STAT; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Teodorczuk A, 2010, PSYCHOL MED, V40, P603, DOI 10.1017/S0033291709990857; van Dijk EJ, 2005, CIRCULATION, V112, P900, DOI 10.1161/CIRCULATIONAHA.104.506337; van Harten B, 2007, EUR NEUROL, V57, P70, DOI 10.1159/000098054; Vermeer SE, 2002, ANN NEUROL, V51, P285, DOI 10.1002/ana.10111; Viana-Baptista M, 2008, J NEUROL, V255, P360, DOI 10.1007/s00415-008-0661-9; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318	35	33	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e53455	10.1371/journal.pone.0053455	http://dx.doi.org/10.1371/journal.pone.0053455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393549	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800003
J	Sun, YL; Chen, JJ; Kumar, P; Chen, K; Sodani, K; Patel, A; Chen, YL; Chen, SD; Jiang, WQ; Chen, ZS				Sun, Yue-Li; Chen, Jun-Jiang; Kumar, Priyank; Chen, Kang; Sodani, Kamlesh; Patel, Atish; Chen, Yang-Lu; Chen, Si-Dong; Jiang, Wen-Qi; Chen, Zhe-Sheng			Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar	PLOS ONE			English	Article							P-GLYCOPROTEIN INHIBITOR; ABC TRANSPORTERS; PROTEIN-7 ABCC10; IN-VITRO; PHASE-I; XR9576; PACLITAXEL; MECHANISMS; EXPRESSION; SUBSTRATE	Multidrug resistance protein 7 (MRP7, ABCC10) is a recently discovered member of the ATP-binding cassette (ABC) family which are capable of conferring resistance to a variety of anticancer drugs, including taxanes and nucleoside analogs, in vivo. MRP7 is highly expressed in non-small cell lung cancer cells, and Mrp7-KO mice are highly sensitive to paclitaxel, making MRP7 an attractive chemotherapeutic target of non-small cell lung cancer. However, only a few inhibitors of MRP7 are currently identified, with none of them having progressed to clinical trials. We used MRP7-expressing cells to investigate whether tariquidar, a third generation inhibitor of P-glycoprotein, could inhibit MRP7-mediated multidrug resistance (MDR). We found that tariquidar, at 0.1 and 0.3 mu M, significantly potentiated the sensitivity of MRP7-transfected HEK293 cells to MRP7 substrates and increased the intracellular accumulation of paclitaxel. We further demonstrated that tariquidar directly impaired paclitaxel efflux and could downregulate MRP7 protein expression in a concentration-and time-dependent manner after prolonged treatment. Our findings suggest that tariquidar, at pharmacologically achievable concentrations, reverses MRP7-mediated MDR through inhibition of MRP7 protein expression and function, and thus represents a promising therapeutic agent in the clinical treatment of chemoresistant cancer patients.	[Sun, Yue-Li; Jiang, Wen-Qi] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Sun, Yue-Li; Jiang, Wen-Qi] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Yue-Li; Chen, Jun-Jiang; Kumar, Priyank; Sodani, Kamlesh; Patel, Atish; Chen, Yang-Lu; Chen, Zhe-Sheng] St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Queens, NY USA; [Chen, Jun-Jiang; Chen, Si-Dong] Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Chen, Kang] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Chen, Kang] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Bethesda, MD USA; [Chen, Yang-Lu] Montgomery High Sch, Skillman, NJ USA	Sun Yat Sen University; Saint John's University; Guangdong Pharmaceutical University; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Jiang, WQ (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	wqjiang@yahoo.com; chenz@stjohns.edu	jiang, wen/GYI-9662-2022; Patel, Atish/J-4699-2014	Chen, Yanglu/0000-0002-6520-0412; Chen, Zhe-Sheng/0000-0002-8289-097X; Patel, Atish/0000-0002-5549-9166; Sodani, Kamlesh/0000-0003-4488-2984; Kumar, Priyank/0000-0002-4772-2073	National Institutes of Health [1R15CA143701]; St. John's University Research Seed Grant [579-1110-7002]; NATIONAL CANCER INSTITUTE [R15CA143701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. John's University Research Seed Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from National Institutes of Health (number 1R15CA143701) and St. John's University Research Seed Grant (number 579-1110-7002) to Z.S. Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2009, CLIN CANCER RES, V15, P3574, DOI 10.1158/1078-0432.CCR-08-0938; Ahmed-Belkacem A, 2006, ANTI-CANCER DRUG, V17, P239, DOI 10.1097/00001813-200603000-00001; Bauer F, 2010, BIOORGAN MED CHEM, V18, P5489, DOI 10.1016/j.bmc.2010.06.057; Borel F, 2012, HEPATOLOGY, V55, P821, DOI 10.1002/hep.24682; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chen ZS, 2003, MOL PHARMACOL, V63, P351, DOI 10.1124/mol.63.2.351; Choi CH, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-30; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; Ferry DR, 1996, EUR J CANCER, V32A, P1070, DOI 10.1016/0959-8049(96)00091-3; Fox E, 2007, EXPERT REV ANTICANC, V7, P447, DOI 10.1586/14737140.7.4.447; Goler-Baron V, 2012, BIOCHEM PHARMACOL, V83, P1340, DOI 10.1016/j.bcp.2012.01.033; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Hopper-Borge E, 2004, CANCER RES, V64, P4927, DOI 10.1158/0008-5472.CAN-03-3111; Hopper-Borge E, 2009, CANCER RES, V69, P178, DOI 10.1158/0008-5472.CAN-08-1420; Hopper-Borge EA, 2011, CANCER RES, V71, P3649, DOI 10.1158/0008-5472.CAN-10-3623; Hubensack M, 2008, J CANCER RES CLIN, V134, P597, DOI 10.1007/s00432-007-0323-9; Kannan P, 2011, ACS CHEM NEUROSCI, V2, P82, DOI 10.1021/cn100078a; Kawamura K, 2010, ANN NUCL MED, V24, P403, DOI 10.1007/s12149-010-0373-y; Kelly RJ, 2011, CLIN CANCER RES, V17, P569, DOI 10.1158/1078-0432.CCR-10-1725; Kimura Y, 2007, CANCER SCI, V98, P1303, DOI 10.1111/j.1349-7006.2007.00538.x; Klinkhammer W, 2009, BIOORGAN MED CHEM, V17, P2524, DOI 10.1016/j.bmc.2009.01.072; Kuhnle M, 2009, J MED CHEM, V52, P1190, DOI 10.1021/jm8013822; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Malofeeva EV, 2012, CANC RES; Martin C, 1999, BRIT J PHARMACOL, V128, P403, DOI 10.1038/sj.bjp.0702807; Menefee ME, 2005, J CLIN ONCOL S, V23, P3093; Min W, 2010, APPL RADIAT ISOTOPES, V68, P1098, DOI 10.1016/j.apradiso.2010.02.008; Mistry P, 2001, CANCER RES, V61, P749; Muller H, 2008, BIOORGAN MED CHEM, V16, P2448, DOI 10.1016/j.bmc.2007.11.057; Oguri T, 2008, MOL CANCER THER, V7, P1150, DOI 10.1158/1535-7163.MCT-07-2088; Pajeva IK, 2009, AAPS J, V11, P435, DOI 10.1208/s12248-009-9118-z; Pick A, 2012, CHEMMEDCHEM, V7, P650, DOI 10.1002/cmdc.201100543; Pusztai L, 2005, CANCER-AM CANCER SOC, V104, P682, DOI 10.1002/cncr.21227; Robert J, 2003, J MED CHEM, V46, P4805, DOI 10.1021/jm030183a; Roe M, 1999, BIOORG MED CHEM LETT, V9, P595, DOI 10.1016/S0960-894X(99)00030-X; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Shi Z, 2006, CANCER BIOL THER, V5, P39, DOI 10.4161/cbt.5.1.2236; Smith AJ, 1998, J NATL CANCER I, V90, P1161, DOI 10.1093/jnci/90.15.1161; Stewart A, 2000, CLIN CANCER RES, V6, P4186; Takayanagi Shin-Ichiro, 2004, J Exp Ther Oncol, V4, P239; Tiwari AK, 2013, CANCER LETT, V328, P307, DOI 10.1016/j.canlet.2012.10.001; Tiwari AK, 2011, CURR PHARM BIOTECHNO, V12, P570; TWENTYMAN PR, 1990, BRIT J CANCER, V62, P89, DOI 10.1038/bjc.1990.235; Wagner CC, 2009, J NUCL MED, V50, P1954, DOI 10.2967/jnumed.109.063289; Walker J, 2004, EUR J CANCER, V40, P594, DOI 10.1016/j.ejca.2003.09.036; Wang Peng, 2009, Zhongguo Fei Ai Za Zhi, V12, P875, DOI 10.3779/j.issn.1009-3419.2009.08.08; Yu XH, 2012, CIRC J, V76, P1780, DOI 10.1253/circj.CJ-11-1338	50	30	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55576	10.1371/journal.pone.0055576	http://dx.doi.org/10.1371/journal.pone.0055576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393594	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800048
J	Honnuraiah, S; Narayanan, R				Honnuraiah, Suraj; Narayanan, Rishikesh			A Calcium-Dependent Plasticity Rule for HCN Channels Maintains Activity Homeostasis and Stable Synaptic Learning	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; INDEPENDENT COMPONENT ANALYSIS; RAT HIPPOCAMPAL-NEURONS; ACTIVATED CATION CHANNELS; LONG-TERM POTENTIATION; I-H; VISUAL-CORTEX; INFORMATION-TRANSMISSION; BIOPHYSICAL MODEL; NETWORK FUNCTION	Theoretical and computational frameworks for synaptic plasticity and learning have a long and cherished history, with few parallels within the well-established literature for plasticity of voltage-gated ion channels. In this study, we derive rules for plasticity in the hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, and assess the synergy between synaptic and HCN channel plasticity in establishing stability during synaptic learning. To do this, we employ a conductance-based model for the hippocampal pyramidal neuron, and incorporate synaptic plasticity through the well-established Bienenstock-Cooper-Munro (BCM)-like rule for synaptic plasticity, wherein the direction and strength of the plasticity is dependent on the concentration of calcium influx. Under this framework, we derive a rule for HCN channel plasticity to establish homeostasis in synaptically-driven firing rate, and incorporate such plasticity into our model. In demonstrating that this rule for HCN channel plasticity helps maintain firing rate homeostasis after bidirectional synaptic plasticity, we observe a linear relationship between synaptic plasticity and HCN channel plasticity for maintaining firing rate homeostasis. Motivated by this linear relationship, we derive a calcium-dependent rule for HCN-channel plasticity, and demonstrate that firing rate homeostasis is maintained in the face of synaptic plasticity when moderate and high levels of cytosolic calcium influx induced depression and potentiation of the HCN-channel conductance, respectively. Additionally, we show that such synergy between synaptic and HCN-channel plasticity enhances the stability of synaptic learning through metaplasticity in the BCM-like synaptic plasticity profile. Finally, we demonstrate that the synergistic interaction between synaptic and HCN-channel plasticity preserves robustness of information transfer across the neuron under a rate-coding schema. Our results establish specific physiological roles for experimentally observed plasticity in HCN channels accompanying synaptic plasticity in hippocampal neurons, and uncover potential links between HCN-channel plasticity and calcium influx, dynamic gain control and stable synaptic learning.	[Honnuraiah, Suraj; Narayanan, Rishikesh] Indian Inst Sci, Mol Biophys Unit, Cellular Neurophysiol Lab, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Narayanan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Cellular Neurophysiol Lab, Bangalore 560012, Karnataka, India.	rishi@mbu.iisc.ernet.in	Narayanan, Rishikesh/C-3191-2009	Honnuraiah, Suraj/0000-0002-6465-464X; Honnuraiah, Suraj/0000-0002-4949-676X; Narayanan, Rishikesh/0000-0002-1362-4635	International Human Frontier Science Program Organization	International Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by a career development award to RN by the International Human Frontier Science Program Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2003, ZOOLOGY, V106, P365, DOI 10.1078/0944-2006-00133; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Ascoli GA, 2010, J NEUROSCI, V30, P6434, DOI 10.1523/JNEUROSCI.4066-09.2010; Banakar A, 2011, ISRN APPL MATH, V2011, P12; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Brunel N, 1998, NEURAL COMPUT, V10, P1731, DOI 10.1162/089976698300017115; Campanac E, 2008, J NEUROSCI, V28, P8635, DOI 10.1523/JNEUROSCI.1411-08.2008; Canavier CC, 1999, J COMPUT NEUROSCI, V6, P49, DOI 10.1023/A:1008809000182; Carnevale NT, 2006, NEURON BOOK; Castellani GC, 2001, P NATL ACAD SCI USA, V98, P12772, DOI 10.1073/pnas.201404598; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Dayan P., 2001, THEORETICAL NEUROSCI; Dingledine R, 1999, PHARMACOL REV, V51, P7; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dyhrfjeld-Johnsen J, 2009, FRONT NEUROSCI-SWITZ, V3, P25, DOI 10.3389/neuro.01.005.2009; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Haykin S. O., 2008, NEURAL NETWORKS LEAR; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hyvarinen A, 1998, SIGNAL PROCESS, V64, P301, DOI 10.1016/S0165-1684(97)00197-7; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; JAHR CE, 1990, J NEUROSCI, V10, P3178; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Joshi P, 2009, RULES INFORM MAXIMIZ, P1456; Kim CS, 2012, NEURON, V75, P503, DOI 10.1016/j.neuron.2012.05.027; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Legenstein R, 2011, J NEUROSCI, V31, P10787, DOI 10.1523/JNEUROSCI.5684-10.2011; Lerche H, 2012, J PHYSL; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman JE, 2001, J PHYSIOL-LONDON, V532, P285, DOI 10.1111/j.1469-7793.2001.0285f.x; Lujan R, 2009, NAT REV NEUROSCI, V10, P475, DOI 10.1038/nrn2668; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1998, J NEUROSCI, V18, P7613; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Narayanan R, 2008, J NEUROSCI, V28, P5846, DOI 10.1523/JNEUROSCI.0835-08.2008; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Narayanan R, 2012, J NEUROPHYSIOL, V108, P2343, DOI 10.1152/jn.00530.2012; Narayanan R, 2010, J NEUROPHYSIOL, V104, P1020, DOI 10.1152/jn.01129.2009; Pavlov I, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1202; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Rabinowitch I, 2008, TRENDS NEUROSCI, V31, P377, DOI 10.1016/j.tins.2008.05.005; Rathour RK, 2012, J PHYSIOL-LONDON, V590, P5629, DOI 10.1113/jphysiol.2012.239418; Rieke F., 1999, SPIKES EXPLORING NEU; Savin C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000757; Seng KP, 2002, IEEE T CIRCUITS SYST, V49, P6; Shah MM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003593; Shah MM, 2010, TRENDS NEUROSCI, V33, P307, DOI 10.1016/j.tins.2010.03.002; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; Toyoizumi T, 2005, P NATL ACAD SCI USA, V102, P5239, DOI 10.1073/pnas.0500495102; Triesch J, 2007, NEURAL COMPUT, V19, P885, DOI 10.1162/neco.2007.19.4.885; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Yeung LC, 2004, P NATL ACAD SCI USA, V101, P14943, DOI 10.1073/pnas.0405555101; ZADOR A, 1990, P NATL ACAD SCI USA, V87, P6718, DOI 10.1073/pnas.87.17.6718	85	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55590	10.1371/journal.pone.0055590	http://dx.doi.org/10.1371/journal.pone.0055590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390543	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000314691100059
J	Huang, JY; Chiang, MT; Chau, LY				Huang, Jun-Yuan; Chiang, Ming-Tsai; Chau, Lee-Young			Adipose Overexpression of Heme Oxygenase-1 Does Not Protect against High Fat Diet-Induced Insulin Resistance in Mice	PLOS ONE			English	Article							MACROPHAGE POLARIZATION; APOLIPOPROTEIN-E; CARBON-MONOXIDE; SENSITIVITY; TISSUE; INFLAMMATION; OBESITY; ATHEROSCLEROSIS; DYSFUNCTION; MECHANISMS	Heme oxygenase-1 (HO-1) is a stress-responsive enzyme with potent anti-oxidant and anti-inflammatory activities. Previous studies have shown that systemic induction of HO-1 by chemical inducers reduces adiposity and improves insulin sensitivity. To dissect the specific function of HO-1 in adipose tissue, we generated transgenic mice with adipose HO-1 overexpression using the adipocyte-specific aP2 promoter. The transgenic (Tg) mice exhibit similar metabolic phenotype as wild type (WT) control under chow-fed condition. High fat diet (HFD) challenge significantly increased the body weights of WT and Tg mice to a similar extent. Likewise, HFD-induced glucose intolerance and insulin resistance were not much different between WT and Tg mice. Analysis of the adipose tissue gene expression revealed that the mRNA levels of adiponectin and interleukin-10 were significantly higher in chow diet-fed Tg mice as compared to WT counterparts, whereas HFD induced downregulation of adiponectin gene expression in both Tg and WT mice to a similar level. HFD-induced proinflammatory cytokine expression in adipose tissues were comparable between WT and transgenic mice. Nevertheless, immunohistochemistry and gene expression analysis showed that the number of infiltrating macrophages with preferential expression of M2 markers was significantly higher in the adipose tissue of obese Tg mice than WT mice. Further experiment demonstrated that myeloid cells from Tg mice expressed higher level of HO-1 and exhibited greater migration response toward chemoattractant in vitro. Collectively, these data indicate that HO-1 overexpression in adipocytes does not protect against HFD-induced obesity and the development of insulin resistance in mice.	[Huang, Jun-Yuan; Chau, Lee-Young] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Huang, Jun-Yuan; Chiang, Ming-Tsai; Chau, Lee-Young] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center	Chau, LY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	lyc@ibms.sinica.edu.tw	Chau, Lee-Young/N-7659-2018	Chau, Lee-Young/0000-0002-6316-2328	National Science Council of Taiwan [NSC-97-2320-B-001-010-MY3]; National Research Program for Genomic Medicine at the National Science Council of Taiwan [NSC97-3112-B001-025]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine at the National Science Council of Taiwan	This work was supported by a grant (NSC-97-2320-B-001-010-MY3) from the National Science Council of Taiwan (http://web1.nsc.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Taiwan Mouse Clinic Core (NSC97-3112-B001-025) funded by the National Research Program for Genomic Medicine at the National Science Council of Taiwan for technical support.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Bach FH, 2005, FASEB J, V19, P1216, DOI 10.1096/fj.04-3485cmt; Cao J, 2012, HYPERTENSION, V60, P467, DOI 10.1161/HYPERTENSIONAHA.112.193805; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038626; Johnson FK, 2006, AM J PHYSIOL-REG I, V290, pR601, DOI 10.1152/ajpregu.00308.2005; Juan SH, 2001, CIRCULATION, V104, P1519, DOI 10.1161/hc3801.095663; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Ndisang JF, 2009, ENDOCRINOLOGY, V150, P2098, DOI 10.1210/en.2008-0239; Nicolai A, 2009, HYPERTENSION, V53, P508, DOI 10.1161/HYPERTENSIONAHA.108.124701; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Soukas A, 2000, GENE DEV, V14, P963; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9	26	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55369	10.1371/journal.pone.0055369	http://dx.doi.org/10.1371/journal.pone.0055369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390531	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100047
J	Elliott, KL; Houston, DW; Fritzsch, B				Elliott, Karen L.; Houston, Douglas W.; Fritzsch, Bernd			Transplantation of Xenopus laevis Tissues to Determine the Ability of Motor Neurons to Acquire a Novel Target	PLOS ONE			English	Article							HAIR-CELLS; NICOTINIC RECEPTOR; TRAPEZIUS MUSCLE; EFFERENT SYSTEM; SPINAL-CORD; MOTONEURONS; EXPRESSION; EVOLUTION; INNERVATION; MICE	The evolutionary origin of novelties is a central problem in biology. At a cellular level this requires, for example, molecularly resolving how brainstem motor neurons change their innervation target from muscle fibers (branchial motor neurons) to neural crest-derived ganglia (visceral motor neurons) or ear-derived hair cells (inner ear and lateral line efferent neurons). Transplantation of various tissues into the path of motor neuron axons could determine the ability of any motor neuron to innervate a novel target. Several tissues that receive direct, indirect, or no motor innervation were transplanted into the path of different motor neuron populations in Xenopus laevis embryos. Ears, somites, hearts, and lungs were transplanted to the orbit, replacing the eye. Jaw and eye muscle were transplanted to the trunk, replacing a somite. Applications of lipophilic dyes and immunohistochemistry to reveal motor neuron axon terminals were used. The ear, but not somite-derived muscle, heart, or liver, received motor neuron axons via the oculomotor or trochlear nerves. Somite-derived muscle tissue was innervated, likely by the hypoglossal nerve, when replacing the ear. In contrast to our previous report on ear innervation by spinal motor neurons, none of the tissues (eye or jaw muscle) was innervated when transplanted to the trunk. Taken together, these results suggest that there is some plasticity inherent to motor innervation, but not every motor neuron can become an efferent to any target that normally receives motor input. The only tissue among our samples that can be innervated by all motor neurons tested is the ear. We suggest some possible, testable molecular suggestions for this apparent uniqueness.	[Elliott, Karen L.; Houston, Douglas W.; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Fritzsch, B (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bernd-fritzsch@uiowa.edu		Fritzsch, Bernd/0000-0002-4882-8398	NASA [NNX10AK63H];  [R01 DC055095590];  [P30 DC010362];  [R01 GM083999]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC010362] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was in part supported by R01 DC055095590 and P30 DC010362 (Bernd Fritzsch) and R01 GM083999 (Douglas W. Houston). This material is based upon work supported by NASA under Grant No. NNX10AK63H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2008, NEUROIMAG CLIN N AM, V18, P261, DOI 10.1016/j.nic.2007.11.001; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; BOORD RL, 1991, J MORPHOL, V207, P165, DOI 10.1002/jmor.1052070207; Borges A, 2010, EUR J RADIOL, V74, P323, DOI 10.1016/j.ejrad.2010.02.006; CANNATELLA DC, 1993, SYST BIOL, V42, P476, DOI 10.2307/2992485; Crook AC, 2006, AM MIDL NAT, V155, P417, DOI 10.1674/0003-0031(2006)155[417:AEOMAB]2.0.CO;2; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; Demer JL, 2007, INVEST OPHTH VIS SCI, V48, P194, DOI 10.1167/iovs.06-0632; Dudek A, 2011, POL J VET SCI, V14, P199, DOI 10.2478/v10181-011-0030-y; Dufour HD, 2006, P NATL ACAD SCI USA, V103, P8727, DOI 10.1073/pnas.0600805103; Eisen JS, 1999, TRENDS NEUROSCI, V22, P321, DOI 10.1016/S0166-2236(98)01370-8; Elliott KL, 2010, INT J DEV BIOL, V54, P1443, DOI 10.1387/ijdb.103061ke; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Franchini LF, 2006, MOL PHYLOGENET EVOL, V41, P622, DOI 10.1016/j.ympev.2006.05.042; FRITZSCH B, 1993, J NEUROSCI METH, V50, P95, DOI 10.1016/0165-0270(93)90060-5; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; FRITZSCH B, 1993, ACTA ANAT, V148, P96; Fritzsch B., 2007, P1; FRITZSCH B, 1990, NEUROSCI LETT, V114, P129, DOI 10.1016/0304-3940(90)90060-M; Fritzsch B, 1999, SING AUDIOL TEXTBK, P31; FRITZSCH B, 1995, J NEUROBIOL, V27, P457, DOI 10.1002/neu.480270403; FRITZSCH B, 1993, HEARING RES, V65, P51, DOI 10.1016/0378-5955(93)90200-K; Fritzsch B, 2007, INT J DEV BIOL, V51, P663, DOI 10.1387/ijdb.072367bf; Hellmann B, 1996, BRAIN BEHAV EVOLUT, V47, P185, DOI 10.1159/000113238; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Jones AK, 2004, BIOESSAYS, V26, P39, DOI 10.1002/bies.10377; Katz E, 2011, SPRINGER HANDB AUDIT, V38, P103, DOI 10.1007/978-1-4419-7070-1_5; Koppl C, 2011, SPRINGER HANDB AUDIT, V38, P217, DOI 10.1007/978-1-4419-7070-1_8; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANDMESSER LT, 1980, ANNU REV NEUROSCI, V3, P279, DOI 10.1146/annurev.ne.03.030180.001431; LEPERCHEY F, 1979, REV STOMATOL CHIR, V80, P45; Lipovsek M, 2012, P NATL ACAD SCI USA, V109, P4308, DOI 10.1073/pnas.1115488109; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Murakami Y, 2004, DEVELOPMENT, V131, P983, DOI 10.1242/dev.00986; NIKUNDIWE AM, 1983, J COMP NEUROL, V213, P199, DOI 10.1002/cne.902130207; Rossert C, 2011, J NEUROSCI, V31, P8359, DOI 10.1523/JNEUROSCI.6161-10.2011; Seipel K, 2004, DEV BIOL, V269, P331, DOI 10.1016/j.ydbio.2004.01.035; Sgard F, 2002, MOL PHARMACOL, V61, P150, DOI 10.1124/mol.61.1.150; Sienkiewicz W, 2010, VET MED-CZECH, V55, P242, DOI 10.17221/2994-VETMED; Simmons D, 2011, SPRINGER HANDB AUDIT, V38, P187, DOI 10.1007/978-1-4419-7070-1_7; Straka H, 2009, ANN NY ACAD SCI, V1164, P37, DOI 10.1111/j.1749-6632.2008.03740.x; Takano-Maruyama M, 2010, DEV DYNAM, V239, P1155, DOI 10.1002/dvdy.22273; Tonniges J, 2010, J MICROSCOPY, P9999; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Tsunoyama K, 1998, MOL BIOL EVOL, V15, P518, DOI 10.1093/oxfordjournals.molbev.a025951; Vernino S, 2009, AUTON NEUROSCI-BASIC, V146, P3, DOI 10.1016/j.autneu.2008.09.005; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Vetter DE, 2007, P NATL ACAD SCI USA, V104, P20594, DOI 10.1073/pnas.0708545105; Zuo J, 1999, P NATL ACAD SCI USA, V96, P14100, DOI 10.1073/pnas.96.24.14100	51	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55541	10.1371/journal.pone.0055541	http://dx.doi.org/10.1371/journal.pone.0055541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383335	gold, Green Published, Green Submitted			2022-12-25	WOS:000314597900042
J	Fasan, A; Alpermann, T; Haferlach, C; Grossmann, V; Roller, A; Kohlmann, A; Eder, C; Kern, W; Haferlach, T; Schnittger, S				Fasan, Annette; Alpermann, Tamara; Haferlach, Claudia; Grossmann, Vera; Roller, Andreas; Kohlmann, Alexander; Eder, Christiane; Kern, Wolfgang; Haferlach, Torsten; Schnittger, Susanne			Frequency and Prognostic Impact of CEBPA Proximal, Distal and Core Promoter Methylation in Normal Karyotype AML: A Study on 623 Cases	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; BINDING-PROTEIN-ALPHA; MINIMAL RESIDUAL DISEASE; C/EBP-ALPHA; DNA METHYLATION; MUTATIONS; GENE; EXPRESSION; HYPERMETHYLATION; CANCER	The clinical impact of aberrant CEBPA promoter methylation (PM) in AML is controversially discussed. The aim of this study was to clarify the significance of aberrant CEBPA PM with regard to clinical features in a cohort of 623 cytogenetically normal (CN) de novo AML. 555 cases had wild-type CEBPA, 68 cases harbored CEBPA mutations. The distal promoter was methylated in 238/623 cases (38.2%), the core promoter in 8 of 326 cases (2.5%), whereas proximal PM was never detected. CEBPA PM and CEBPA mutations were mutually exclusive. CEBPA distal PM positive cases were characterized by reduced CEBPA mRNA expression levels and elevated white blood cell counts. CEBPA distal PM was less frequent in patients with mutations in FLT3, NPM1 and TET2 and more frequent in cases with RUNX1 and IDH2R140 mutations. Overall, no association of methylation to prognosis was seen. However CEBPA distal PM was associated with inferior outcome in cases with low FLT3-ITD ratio or TET2 mutations. A distinct gene expression profile of CEBPA distal PM positive cases compared to CEBPA mutated and CEBPA distal PM negative cases was observed. In conclusion, the presence of aberrant CEBPA PM is associated with distinct biological features but impact on outcome is weak.	[Fasan, Annette; Alpermann, Tamara; Haferlach, Claudia; Grossmann, Vera; Roller, Andreas; Kohlmann, Alexander; Eder, Christiane; Kern, Wolfgang; Haferlach, Torsten; Schnittger, Susanne] MLL Munich Leukemia Lab, Munich, Germany	MLL Munich Leukemia Laboratory	Schnittger, S (corresponding author), MLL Munich Leukemia Lab, Munich, Germany.	susanne.schnittger@mll.com						Arber DA, 2008, WHO CLASSIFICATION T, P110; Barjesteh van Waalwijk van Doorn-Khosrovani Sahar, 2003, Hematol J, V4, P31; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Chim CS, 2002, BRIT J HAEMATOL, V119, P988, DOI 10.1046/j.1365-2141.2002.03952.x; Figueroa ME, 2009, BLOOD, V113, P2795, DOI 10.1182/blood-2008-08-172387; Grimwade David, 2009, Hematology Am Soc Hematol Educ Program, P385, DOI 10.1182/asheducation-2009.1.385; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Haferlach T, 2003, J CLIN ONCOL, V21, P3004, DOI 10.1200/JCO.2003.99.091; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hollink IHIM, 2011, HAEMATOL-HEMATOL J, V96, P384, DOI 10.3324/haematol.2010.031336; Jost E, 2009, LEUKEMIA RES, V33, P443, DOI 10.1016/j.leukres.2008.07.027; Kern W, 2004, BLOOD, V104, P3078, DOI 10.1182/blood-2004-03-1036; Kohlmann A, 2010, LEUKEMIA, V24, P1216, DOI 10.1038/leu.2010.73; Kohlmann A, 2008, CLIN CHEM, V54, P1705, DOI 10.1373/clinchem.2008.108506; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Kumagai T, 2009, INT J CANCER, V124, P827, DOI 10.1002/ijc.23994; Lin TC, 2011, LEUKEMIA, V25, P32, DOI 10.1038/leu.2010.222; MITELMAN F, 1995, GUIDELINES CANC CY S; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Schnittger S, 2011, LEUKEMIA, V25, P1297, DOI 10.1038/leu.2011.97; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Snaddon J, 2003, GENE CHROMOSOME CANC, V37, P72, DOI 10.1002/gcc.10185; Swerdlow E., 2008, WHO CLASSIFICATION T; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; TIMCHENKO N, 1995, MOL CELL BIOL, V15, P1192; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486	30	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e54365	10.1371/journal.pone.0054365	http://dx.doi.org/10.1371/journal.pone.0054365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383300	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900007
J	Michaillat, L; Mayer, A				Michaillat, Lydie; Mayer, Andreas			Identification of Genes Affecting Vacuole Membrane Fragmentation in Saccharomyces cerevisiae	PLOS ONE			English	Article							YEAST VACUOLE; PROTEIN COMPLEX; PHOSPHATIDATE PHOSPHATASE; MITOCHONDRIAL FISSION; ENDOPLASMIC-RETICULUM; TETHERING COMPLEX; LIPID-SYNTHESIS; CLATHRIN COATS; FUSION; PATHWAY	The equilibrium of membrane fusion and fission influences the volume and copy number of organelles. Fusion of yeast vacuoles has been well characterized but their fission and the mechanisms determining vacuole size and abundance remain poorly understood. We therefore attempted to systematically characterize factors necessary for vacuole fission. Here, we present results of an in vivo screening for deficiencies in vacuolar fragmentation activity of an ordered collection deletion mutants, representing 4881 non-essential genes of the yeast Saccharomyces cerevisiae. The screen identified 133 mutants with strong defects in vacuole fragmentation. These comprise numerous known fragmentation factors, such as the Fab1p complex, Tor1p, Sit4p and the V-ATPase, thus validating the approach. The screen identified many novel factors promoting vacuole fragmentation. Among those are 22 open reading frames of unknown function and three conspicuous clusters of proteins with known function. The clusters concern the ESCRT machinery, adaptins, and lipases, which influence the production of diacylglycerol and phosphatidic acid. A common feature of these factors of known function is their capacity to change membrane curvature, suggesting that they might promote vacuole fragmentation via this property.	[Michaillat, Lydie; Mayer, Andreas] Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland	University of Lausanne	Mayer, A (corresponding author), Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland.	Andreas.Mayer@unil.ch	Mayer, Andreas/AAE-4315-2020	Mayer, Andreas/0000-0001-6131-313X	European Research Council [233458]; Swiss National Science Foundation [3100A0-128661/1]	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the European Research Council (grant 233458) and the Swiss National Science Foundation (grant 3100A0-128661/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaguer C, 2003, EUKARYOT CELL, V2, P729, DOI 10.1128/EC.2.4.729-736.2003; Athenstaedt K, 2006, CELL MOL LIFE SCI, V63, P1355, DOI 10.1007/s00018-006-6016-8; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Brachmann CB, 1998, YEAST, V14, P115; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Catlett NL, 2000, CURR OPIN CELL BIOL, V12, P509, DOI 10.1016/S0955-0674(00)00124-1; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Duex JE, 2006, EUKARYOT CELL, V5, P723, DOI 10.1128/EC.5.4.723-731.2006; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Eitzen G, 2000, EMBO J, V19, P6713, DOI 10.1093/emboj/19.24.6713; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Heymann JAW, 2009, J CELL SCI, V122, P3427, DOI 10.1242/jcs.051714; Hodge CA, 2010, J CELL SCI, V123, P141, DOI 10.1242/jcs.055046; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Krick R, 2006, FEBS LETT, V580, P4632, DOI 10.1016/j.febslet.2006.07.041; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Lachmann Jens, 2011, Small GTPases, V2, P182; LaGrassa TJ, 2005, J CELL BIOL, V168, P401, DOI 10.1083/jcb.200407141; LARKIN JM, 1986, J CELL BIOL, V103, P2619, DOI 10.1083/jcb.103.6.2619; LEE KS, 1994, J BIOL CHEM, V269, P19725; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2001, BIOCHEM SOC T, V29, P476, DOI 10.1042/BST0290476; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Merkel O, 1999, J BIOL CHEM, V274, P28121, DOI 10.1074/jbc.274.40.28121; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Michaillat L, 2012, MOL BIOL CELL, V23, P881, DOI 10.1091/mbc.E11-08-0703; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Osteryoung KW, 2001, ANNU REV PLANT PHYS, V52, P315, DOI 10.1146/annurev.arplant.52.1.315; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Phelan JP, 2006, J CELL SCI, V119, P4225, DOI 10.1242/jcs.03188; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Prunuske AJ, 2006, CURR OPIN CELL BIOL, V18, P108, DOI 10.1016/j.ceb.2005.12.004; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reinke CA, 2004, P NATL ACAD SCI USA, V101, P18018, DOI 10.1073/pnas.0408256102; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Schmid S.L., 2011, ANN REV CELL DEV BIO; Schrader M, 2006, INT REV CYTOL, V255, P237, DOI 10.1016/S0074-7696(06)55005-3; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; Weisman LS, 2003, ANNU REV GENET, V37, P435, DOI 10.1146/annurev.genet.37.050203.103207; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200	99	53	55	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e54160	10.1371/journal.pone.0054160	http://dx.doi.org/10.1371/journal.pone.0054160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383298	gold, Green Submitted, Green Published			2022-12-25	WOS:000314597900005
J	Sultana, R; Vemula, MH; Banerjee, S; Guruprasad, L				Sultana, Rafiya; Vemula, Mani Harika; Banerjee, Sharmishta; Guruprasad, Lalitha			The PE16 (Rv1430) of Mycobacterium tuberculosis Is an Esterase Belonging to Serine Hydrolase Superfamily of Proteins	PLOS ONE			English	Article							CUTINASE-LIKE PROTEINS; LIPASE ACTIVITY; PGRS PROTEINS; CELL-SURFACE; PPE; GENE; TRIACYLGLYCEROL; VIRULENCE; RV2430C; IMMUNOGENICITY	The PE and PPE multigene families, first discovered during the sequencing of M. tuberculosis H37Rv genome are responsible for antigenic variation and have been shown to induce increased humoral and cell mediated immune response in the host. Using the bioinformatics tools, we had earlier reported that the 225 amino acid residue PE-PPE domain (Pfam: PF08237) common to some PE and PPE proteins has a "serine alpha/beta hydrolase" fold and conserved Ser, Asp and His catalytic triad characteristic of lipase, esterase and cutinase activities. In order to prove experimentally that PE-PPE domain is indeed a serine hydrolase, we have cloned the full-length Rv1430 and its PE-PPE domain into pET-28a vector, expressed the proteins in E. coli and purified to homogeneity. The activity assays of both purified proteins were carried out using p-nitrophenyl esters of aliphatic carboxylic acids with varying chain length (C2-C16) to study the substrate specificity. To characterize the active site of the PE-PPE domain, we mutated the Ser199 to Ala. The activity of the protein in the presence of serine protease inhibitor- PMSF and the mutant protein were measured. Our results reveal that Rv1430 and its PE-PPE domain possess esterase activity and hydrolyse short to medium chain fatty acid esters with the highest specific activity for pNPC6 at 37 degrees C, 38 degrees C and pH 7.0, 8.0. The details of this work and the observed results are reported in this manuscript.	[Sultana, Rafiya; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India; [Vemula, Mani Harika; Banerjee, Sharmishta] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Guruprasad, L (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	lgpsc@uohyd.ernet.in			CSIR, India for Research fellowship; UPE2, University of Hyderabad	CSIR, India for Research fellowship; UPE2, University of Hyderabad	RS and MHV thank CSIR, India for Research fellowship. LGP and SB thank UPE2, University of Hyderabad for support.	Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Barry CE, 2001, TRENDS MICROBIOL, V9, P237, DOI 10.1016/S0966-842X(01)02018-2; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Chaitra MG, 2008, J MED MICROBIOL, V57, P1079, DOI 10.1099/jmm.0.47565-0; Chen S, 2008, J BIOL CHEM, V283, P25854, DOI 10.1074/jbc.M800848200; Choudhary RK, 2004, PROTEIN EXPRES PURIF, V36, P249, DOI 10.1016/j.pep.2004.03.016; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Delogu G, 2001, INFECT IMMUN, V69, P5606, DOI 10.1128/IAI.69.9.5606-5611.2001; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Guo JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013143; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Kusner DJ, 2005, CLIN IMMUNOL, V114, P239, DOI 10.1016/j.clim.2004.07.016; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Lopez-Lopez S, 2003, COMP BIOCHEM PHYS B, V135, P337, DOI 10.1016/S1096-4959(03)00087-3; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Okkels LM, 2003, INFECT IMMUN, V71, P6116, DOI 10.1128/IAI.71.11.6116-6123.2003; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Pencreach G, 1996, ENZYME MICROB TECH, V18, P417, DOI 10.1016/0141-0229(95)00120-4; Pratt J, 2000, CURR MICROBIOL, V40, P306, DOI 10.1007/s002849910061; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sultana R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016745; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; WALTON TJ, 1972, BIOCHEMISTRY-US, V11, P1885, DOI 10.1021/bi00760a025; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; World Health Organization (WHO), 2006, GLOB REG INC	49	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55320	10.1371/journal.pone.0055320	http://dx.doi.org/10.1371/journal.pone.0055320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383323	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900030
J	Svenson, U; Gronlund, E; Soderstrom, I; Sitaram, RT; Ljungberg, B; Roos, G				Svenson, Ulrika; Gronlund, Elisabeth; Soderstrom, Ingegerd; Sitaram, Raviprakash T.; Ljungberg, Borje; Roos, Goran			Telomere Length in Relation to Immunological Parameters in Patients with Renal Cell Carcinoma	PLOS ONE			English	Article							REGULATORY T-CELLS; PERIPHERAL-BLOOD; HEPATOCELLULAR-CARCINOMA; IMMUNE SUPPRESSION; MULTIPLE-MYELOMA; BREAST-CANCER; B-LYMPHOCYTES; UP-REGULATION; SURVIVAL; INTERLEUKIN-7	Over the last decade, telomere length (TL) has gained attention as a potential biomarker in cancer disease. We previously reported that long blood TL was associated with a poorer outcome in patients with breast cancer and renal cell carcinoma. Based on these findings, we hypothesized that certain immunological components may have an impact on TL dynamics in cancer patients. One aim of the present study was to investigate a possible association between serum cytokines and TL of peripheral blood cells, tumors and corresponding kidney cortex, in patients with clear cell renal cell carcinoma. For this purpose, a multiplex cytokine assay was used. Correlation analysis revealed significant positive correlations between tumor TL and peripheral levels of three cytokines (IL-7, IL-8 and IL-10). In a parallel patient group with various kidney tumors, TL was investigated in whole blood and in immune cell subsets in relation to peripheral levels of regulatory T cells (Tregs). A significant positive association was found between whole blood TL and Treg levels. However, the strongest correlation was found between Tregs and TL of the T lymphocyte fraction. Thus, patients with higher Treg levels displayed longer T cell telomeres, which might reflect a suppressed immune system with fewer cell divisions and hence less telomere shortening. These results are in line with our earlier observation that long blood TL is an unfavorable prognostic factor for cancer-specific survival. In summary, we here show that immunological components are associated with TL in patients with renal cell carcinoma, providing further insight into the field of telomere biology in cancer.	[Svenson, Ulrika; Roos, Goran] Umea Univ, Dept Med Biosci, Umea, Sweden; [Gronlund, Elisabeth] Univ Hosp, Hematopathol Lab, Umea, Sweden; [Soderstrom, Ingegerd] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Sitaram, Raviprakash T.; Ljungberg, Borje] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Roos, G (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	goran.roos@medbio.umu.se		Ljungberg, Borje/0000-0002-4121-3753	Swedish Cancer Society; Swedish Research Council; Lions Cancer Research Foundation in Umea; Umea University; European Community [200950]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Research Foundation in Umea; Umea University; European Community(European Commission)	This work was supported by grants from The Swedish Cancer Society (G. Roos and B. Ljungberg), The Swedish Research Council (G. Roos), Lions Cancer Research Foundation in Umea and Umea University (G. Roos and B. Ljungberg). The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2011 under grant agreement no. 200950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2002, CANCER RES, V62, P3876; Al-Rawi MAA, 2004, EUR J CANCER, V40, P494, DOI 10.1016/j.ejca.2003.10.016; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Ben-Baruch A, 2006, SEMIN CANCER BIOL, V16, P38, DOI 10.1016/j.semcancer.2005.07.006; Bisoffi M, 2006, INT J CANCER, V119, P2255, DOI 10.1002/ijc.22120; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Eichelberg C, 2009, EUR UROL, V55, P851, DOI 10.1016/j.eururo.2009.01.003; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Frankenberger B, 2007, SEMIN CANCER BIOL, V17, P330, DOI 10.1016/j.semcancer.2007.06.004; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffiths RW, 2007, CANCER IMMUNOL IMMUN, V56, P1743, DOI 10.1007/s00262-007-0318-z; Heaphy CM, 2011, J CELL MOL MED, V15, P1227, DOI 10.1111/j.1582-4934.2011.01284.x; Hirokawa K, 2009, MECH AGEING DEV, V130, P86, DOI 10.1016/j.mad.2008.05.001; Hoffmann J, 2009, EXP GERONTOL, V44, P363, DOI 10.1016/j.exger.2009.02.006; Hu BT, 1999, EUR J IMMUNOL, V29, P3745, DOI 10.1002/(SICI)1521-4141(199911)29:11<3745::AID-IMMU3745>3.0.CO;2-1; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Igarashi H, 1997, BLOOD, V89, P1299, DOI 10.1182/blood.V89.4.1299; Kaszubowska L, 2008, J PHYSIOL PHARMACOL, V59, P169; Kawauchi K, 2005, J IMMUNOL, V174, P5261, DOI 10.4049/jimmunol.174.9.5261; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Lambeck AJA, 2007, CLIN CANCER RES, V13, P2385, DOI 10.1158/1078-0432.CCR-06-1828; Liu HQ, 2012, CARCINOGENESIS, V33, P1040, DOI 10.1093/carcin/bgs098; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Menetrier-Caux C, 1999, BRIT J CANCER, V79, P119, DOI 10.1038/sj.bjc.6690021; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Nordfjall K, 2007, BIOCHEM BIOPH RES CO, V358, P215, DOI 10.1016/j.bbrc.2007.04.099; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Sellmann L, 2011, INT J HEMATOL, V93, P74, DOI 10.1007/s12185-010-0750-2; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Svenson U, 2009, CANCER RES, V69, P2896, DOI 10.1158/0008-5472.CAN-08-3513; Viguier M, 2004, J IMMUNOL, V173, P1444, DOI 10.4049/jimmunol.173.2.1444; Wallace DL, 2006, IMMUNOLOGY, V119, P243, DOI 10.1111/j.1365-2567.2006.02429.x; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; Wittke F, 1999, BRIT J CANCER, V79, P1182, DOI 10.1038/sj.bjc.6690189; Wu KD, 2003, BLOOD, V101, P4982, DOI 10.1182/blood-2002-11-3451; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8	43	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55543	10.1371/journal.pone.0055543	http://dx.doi.org/10.1371/journal.pone.0055543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383336	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900043
J	Uribe, PM; Mueller, MA; Gleichman, JS; Kramer, MD; Wang, Q; Sibrian-Vazquez, M; Strongin, RM; Steyger, PS; Cotanche, DA; Matsui, JI				Uribe, Phillip M.; Mueller, Melissa A.; Gleichman, Julia S.; Kramer, Matthew D.; Wang, Qi; Sibrian-Vazquez, Martha; Strongin, Robert M.; Steyger, Peter S.; Cotanche, Douglas A.; Matsui, Jonathan I.			Dimethyl Sulfoxide (DMSO) Exacerbates Cisplatin-induced Sensory Hair Cell Death in Zebrafish (Danio rerio)	PLOS ONE			English	Article							LATERAL-LINE; DIMETHYLSULFOXIDE; SUSCEPTIBILITY; IDENTIFICATION; REGENERATION; OTOTOXICITY; NEUROMASTS; REVEALS; SCREEN; AGENTS	Inner ear sensory hair cells die following exposure to aminoglycoside antibiotics or chemotherapeutics like cisplatin, leading to permanent auditory and/or balance deficits in humans. Zebrafish (Danio rerio) are used to study drug-induced sensory hair cell death since their hair cells are similar in structure and function to those found in humans. We developed a cisplatin dose-response curve using a transgenic line of zebrafish that expresses membrane-targeted green fluorescent protein under the control of the Brn3c promoter/enhancer. Recently, several small molecule screens have been conducted using zebrafish to identify potential pharmacological agents that could be used to protect sensory hair cells in the presence of ototoxic drugs. Dimethyl sulfoxide (DMSO) is typically used as a solvent for many pharmacological agents in sensory hair cell cytotoxicity assays. Serendipitously, we found that DMSO potentiated the effects of cisplatin and killed more sensory hair cells than treatment with cisplatin alone. Yet, DMSO alone did not kill hair cells. We did not observe the synergistic effects of DMSO with the ototoxic aminoglycoside antibiotic neomycin. Cisplatin treatment with other commonly used organic solvents (i.e. ethanol, methanol, and polyethylene glycol 400) also did not result in increased cell death compared to cisplatin treatment alone. Thus, caution should be exercised when interpreting data generated from small molecule screens since many compounds are dissolved in DMSO.	[Uribe, Phillip M.; Gleichman, Julia S.; Matsui, Jonathan I.] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA; [Mueller, Melissa A.; Kramer, Matthew D.; Matsui, Jonathan I.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Wang, Qi; Steyger, Peter S.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol, Portland, OR 97201 USA; [Sibrian-Vazquez, Martha; Strongin, Robert M.] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [Cotanche, Douglas A.] Harvard MIT Hlth Sci & Technol, Cambridge, MA USA; [Cotanche, Douglas A.] Harvard Univ, Sch Publ Hlth, Harvard Noise Induced Hearing Loss Res Grp, Boston, MA 02115 USA; [Cotanche, Douglas A.; Matsui, Jonathan I.] Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, Boston, MA USA	Claremont Colleges; Pomona College; Harvard University; Oregon Health & Science University; Portland State University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Matsui, JI (corresponding author), Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA.	Jonathan.Matsui@pomona.edu	Strongin, Robert M./F-1026-2010; Steyger, Peter S./B-9147-2011	Steyger, Peter S./0000-0002-6103-5237; Cotanche, Douglas/0000-0001-7972-0446; Uribe, Phillip/0000-0002-7396-8907	Pomona College, National Institutes of Health (NIH) [DC010998, DC010231]; Harvard College; Sarah Fuller Funder; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010231, R15DC010998] Funding Source: NIH RePORTER	Pomona College, National Institutes of Health (NIH); Harvard College; Sarah Fuller Funder; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Pomona College, National Institutes of Health (NIH) DC010998 (JIM), NIH DC010231 (PSS, MSV, RMS), Harvard College (MAM, MDK), and Sarah Fuller Funder (DAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bever MM, 2002, DEV DYNAM, V223, P536, DOI 10.1002/dvdy.10062; Cheng Alan G, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P343, DOI 10.1097/01.moo.0000186799.45377.63; Chiu LL, 2008, JARO-J ASSOC RES OTO, V9, P178, DOI 10.1007/s10162-008-0118-y; Coffin AB, 2010, ZEBRAFISH, V7, P3, DOI 10.1089/zeb.2009.0639; Fischer SJ, 2008, NEUROTOXICOLOGY, V29, P444, DOI 10.1016/j.neuro.2008.02.010; Giari L, 2011, J APPL TOXICOL; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Hirose Y, 2011, JARO-J ASSOC RES OTO, V12, P719, DOI 10.1007/s10162-011-0278-z; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Li HZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019130; Matsui JI, 2006, INVEST OPHTH VIS SCI, V47, P4589, DOI 10.1167/iovs.05-0971; Miller M, 2011, MIDWINTER M ASS RES; Murakami SL, 2003, HEARING RES, V186, P47, DOI 10.1016/S0378-5955(03)00259-4; Musial-Bright L, 2011, CHILD NERV SYST, V27, P407, DOI 10.1007/s00381-010-1300-1; Namdaran P, 2012, J NEUROSCI, V32, P3516, DOI 10.1523/JNEUROSCI.3905-11.2012; Ou H, 2012, HEARING RES, V288, P58, DOI 10.1016/j.heares.2012.01.009; Ou HC, 2007, HEARING RES, V233, P46, DOI 10.1016/j.heares.2007.07.003; Ou HC, 2010, DRUG DISCOV TODAY, V15, P265, DOI 10.1016/j.drudis.2010.01.001; Ou HC, 2009, JARO-J ASSOC RES OTO, V10, P191, DOI 10.1007/s10162-009-0158-y; Owens KN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000020; Owens KN, 2007, J COMP NEUROL, V502, P522, DOI 10.1002/cne.21345; POMMIER RF, 1988, AM J OBSTET GYNECOL, V159, P848, DOI 10.1016/S0002-9378(88)80151-0; Qi WD, 2008, HEARING RES, V236, P52, DOI 10.1016/j.heares.2007.12.002; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Ryback L, 2007, PHARM OTOTOXICITY AU; Rybak Leonard P, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P364, DOI 10.1097/MOO.0b013e3282eee452; Safaei R, 2005, CLIN CANCER RES, V11, P756; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; SCHOENFELD RH, 1983, J AM OSTEOPATH ASSOC, V82, P570; SUNDQUIST WI, 1987, INORG CHEM, V26, P1524, DOI 10.1021/ic00257a013; Ton C, 2005, HEARING RES, V208, P79, DOI 10.1016/j.heares.2005.05.005; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861	35	25	26	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55359	10.1371/journal.pone.0055359	http://dx.doi.org/10.1371/journal.pone.0055359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383324	gold, Green Published			2022-12-25	WOS:000314597900031
J	Gurven, M; Jaeggi, AV; Kaplan, H; Cummings, D				Gurven, Michael; Jaeggi, Adrian V.; Kaplan, Hillard; Cummings, Daniel			Physical Activity and Modernization among Bolivian Amerindians	PLOS ONE			English	Article							DOUBLY-LABELED WATER; ACTIVITY ENERGY-EXPENDITURE; DISEASE RISK-FACTORS; TSIMANE AMERINDIANS; METABOLIC-RATE; HEART-RATE; INFECTION; HUMANS; ADULTS	Background: Physical inactivity is a growing public health problem, and the fourth leading risk factor for global mortality. Conversely, indigenous populations living traditional lifestyles reportedly engage in vigorous daily activity that is protective against non-communicable diseases. Here we analyze physical activity patterns among the Tsimane, forager-horticulturalists of Amazonian Bolivia with minimal heart disease and diabetes. We assess age patterns of adult activity among men and women, test whether modernization affects activity levels, and examine whether nascent obesity is associated with reduced activity. Methods and Findings: A factorial method based on a large sample of behavioral observations was employed to estimate effects of age, sex, body mass index, and modernization variables on physical activity ratio (PAR), the ratio of total energy expenditure to basal metabolic rate. Accelerometry combined with heart rate monitoring was compared to the factorial method and used for nighttime sampling. Tsimane men and women display 24 hr physical activity level (PAL) of 2.02-2.15 and 1.73-1.85, respectively. Little time was spent "sedentary'', whereas most activity was light to moderate, rather than vigorous. Activity peaks by the late twenties in men, and declines thereafter, but remains constant among women after the early teens. Neither BMI, fat free mass or body fat percentage are associated with PAR. There was no negative effect of modernization on physical activity. Conclusions: Tsimane display relatively high PALs typical of other subsistence populations, but of moderate intensity, and not outside the range of developed populations. Despite rapidly increasing socioeconomic change, there is little evidence that total activity has yet been affected. Overweight and obesity are more prevalent among women than men, and Spanish fluency is associated with greater obesity in women. The lack of cardiovascular disease among Tsimane is unlikely caused by activity alone; further study of diet, food intake and infectious disease is needed.	[Gurven, Michael; Jaeggi, Adrian V.] Univ Calif Santa Barbara, Dept Anthropol, Integrat Anthropol Sci Unit, Santa Barbara, CA 93106 USA; [Jaeggi, Adrian V.] Univ Calif Santa Barbara, Sage Ctr Study Mind, Santa Barbara, CA 93106 USA; [Kaplan, Hillard; Cummings, Daniel] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of New Mexico	Gurven, M (corresponding author), Univ Calif Santa Barbara, Dept Anthropol, Integrat Anthropol Sci Unit, Santa Barbara, CA 93106 USA.	gurven@anth.ucsb.edu	Jaeggi, Adrian V/L-1245-2019	Jaeggi, Adrian V/0000-0003-1695-0388; Gurven, Michael/0000-0002-5661-527X; Kaplan, Hillard/0000-0002-7398-7358	National Science Foundation [BCS-0422690, BCS0136274]; National Institute on Aging [R01AG024119-01, R56AG024119, P01AG022500]; Swiss National Science Foundation [PBZHP3-133443]; NATIONAL INSTITUTE ON AGING [R56AG024119, R01AG024119, P01AG022500] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research was supported by the National Science Foundation (BCS-0422690, BCS0136274), the National Institute on Aging (R01AG024119-01, R56AG024119, P01AG022500) and the Swiss National Science Foundation (PBZHP3-133443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Assah FK, 2011, INT J EPIDEMIOL, V40, P112, DOI 10.1093/ije/dyq098; Barreira T, 2009, INT J EXER SCI, V2, P60; BENTLEY GR, 1993, CURR ANTHROPOL, V34, P778, DOI 10.1086/204223; Black AE, 1996, EUR J CLIN NUTR, V50, P72; BLACK FL, 1975, SCIENCE, V187, P515, DOI 10.1126/science.163483; Bogin B, 1999, ANN HUM BIOL, V26, P333; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; CDC, 2006, HEALTH BEHAVIORS OF; Christensen DL, 2012, AM J HUM BIOL, V24, P723, DOI 10.1002/ajhb.22303; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Dufour DL, 2008, AM J HUM BIOL, V20, P249, DOI 10.1002/ajhb.20764; Dugas LR, 2011, AM J CLIN NUTR, V93, P427, DOI 10.3945/ajcn.110.007278; EATON SB, 1988, AM J MED, V84, P739, DOI 10.1016/0002-9343(88)90113-1; Ekelund U, 2002, AM J CLIN NUTR, V76, P935, DOI 10.1093/ajcn/76.5.935; [FAO WHO UNU], 1985, PROTEIN AND ENERGY R; FAO/ WHO/ UNU (Food and Agriculture Organization of the United Nations/ World Health Organization/ United Nations University), 2004, FAO FOOD NUTR TECHN; Filozof C, 2001, Obes Rev, V2, P99, DOI 10.1046/j.1467-789x.2001.00029.x; Finch C, 2007, THE BIOLOGY OF HUMAN; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Godoy R, 2005, J ANTHROPOL RES, V61, P157, DOI 10.3998/jar.0521004.0061.202; Godoy RA, 2004, HUM ECOL, V32, P339, DOI 10.1023/B:HUEC.0000028085.47707.08; Godoy R, 2005, ECON HUM BIOL, V3, P136, DOI 10.1016/j.ehb.2005.01.001; Godoy RA, 2006, ECON HUM BIOL, V4, P184, DOI 10.1016/j.ehb.2005.11.001; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Gurven M, 2012, EXP GERONTOL, V47, P807, DOI 10.1016/j.exger.2012.05.006; Gurven M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006590; Gurven M, 2009, HUM NATURE-INT BIOS, V20, P151, DOI 10.1007/s12110-009-9062-8; Hardman A., 2009, PHYSICAL ACTIVITY AN; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Hayes M, 2005, INT J OBESITY, V29, P151, DOI 10.1038/sj.ijo.0802842; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; HEWLETT BS, 1991, J ANTHROPOL RES, V47, P1; KASHIWAZAKI H, 1995, AM J CLIN NUTR, V62, P901, DOI 10.1093/ajcn/62.5.901; Kashiwazaki H, 2009, AM J HUM BIOL, V21, P337, DOI 10.1002/ajhb.20864; KATZMARZYK PT, 1994, AM J HUM BIOL, V6, P719, DOI 10.1002/ajhb.1310060606; Krishnaveni GV, 2009, EUR J CLIN NUTR, V63, P1313, DOI 10.1038/ejcn.2009.95; Lavie CJ, 2009, AM J MED, V122, P1106, DOI 10.1016/j.amjmed.2009.06.006; LAWRENCE M, 1988, EUR J CLIN NUTR, V42, P145; Leonard WR, 2010, J PHYS ACT HEALTH, V7, pS284, DOI 10.1123/jpah.7.s3.s284; Leonard WR, 1997, AM J PHYS ANTHROPOL, V103, P443, DOI 10.1002/(SICI)1096-8644(199708)103:4<443::AID-AJPA2>3.3.CO;2-5; Lindeberg S, 2010, FOOD AND WESTERN DIS; Lyden K, 2011, EUR J APPL PHYSIOL, V111, P187, DOI 10.1007/s00421-010-1639-8; Madimenos FC, 2011, AM J HUM BIOL, V23, P488, DOI 10.1002/ajhb.21163; Martin MA, 2012, MATERN CHILD NUTR, V8, P404, DOI 10.1111/j.1740-8709.2012.00412.x; Matsuzawa Y, 1997, DIABETES METAB REV, V13, P3, DOI 10.1002/(SICI)1099-0895(199703)13:1&lt;3::AID-DMR178&gt;3.0.CO;2-N; Nagata JM, 2009, ECON HUM BIOL, V7, P96, DOI 10.1016/j.ehb.2009.02.002; O'Donovan G, 2005, INT J OBESITY, V29, P1063, DOI 10.1038/sj.ijo.0803004; O'Keefe JH, 2010, AM J MED, V123, P1082, DOI 10.1016/j.amjmed.2010.04.026; Pennington R, 2001, BIOSOCIAL S, V13, P170; Pinheiro JC, 2012, NLME LINEAR AND NON; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Speakman JR, 2010, AM J CLIN NUTR, V92, P826, DOI 10.3945/ajcn.2009.28540; Steffen PR, 2006, PSYCHOSOM MED, V68, P386, DOI 10.1097/01.psy.0000221255.48190.32; Strasser B, 2013, ANN NY ACAD SCI, V1281, P141, DOI 10.1111/j.1749-6632.2012.06785.x; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tataranni PA, 2003, INT J OBESITY, V27, P1578, DOI 10.1038/sj.ijo.0802469; Team RDC, 2012, R LANG ENV STAT COMP; Thomas DM, 2012, OBES REV, V13, P835, DOI 10.1111/j.1467-789X.2012.01012.x; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074; Vuori I., 2004, KINESIOLOGY, V36, P123; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; Wyatt J, 2012, ACTILIFE 6 USERS MAN; Yngve A, 2003, MED SCI SPORT EXER, V35, P320, DOI 10.1249/01.MSS.0000048829.75758.A0	67	64	66	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55679	10.1371/journal.pone.0055679	http://dx.doi.org/10.1371/journal.pone.0055679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383262	gold, Green Published, Green Submitted			2022-12-25	WOS:000314610600144
J	Giardina, BJ; Dunton, D; Chiang, HL				Giardina, Bennett J.; Dunton, Danielle; Chiang, Hui-Ling			Vid28 Protein Is Required for the Association of Vacuole Import and Degradation (Vid) Vesicles with Actin Patches and the Retention of Vid Vesicle Proteins in the Intracellular Fraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CATABOLITE INACTIVATION; MALATE-DEHYDROGENASE; YEAST VACUOLE; GLUCONEOGENIC ENZYMES; MDH2 ISOZYME; FRUCTOSE-1,6-BISPHOSPHATASE; PATHWAY; AUTOPHAGY; MEMBRANE	Gluconeogenic enzymes are induced when Saccharomyces cerevisiae are starved of glucose. However, when glucose is added to prolonged starved cells, these enzymes are degraded in the vacuole via the vacuole import and degradation (Vid) pathway. The Vid pathway is linked to the nonclassical secretory and internalizing pathways. In prolonged starved cells, substantial amounts of the key gluconeogenic enzyme fructose-1,6-bisphosphatase (FBPase) are in the extracellular fraction (periplasm). However, when glucose is added to glucose-starved cells, levels of extracellular FBPase decrease rapidly. Ultrastructural studies indicate that FBPase is in Vid/endosomes following glucose addition, suggesting that FBPase is internalized in response to glucose refeeding. Under the same conditions, the majority of Vid vesicle proteins are in the intracellular fraction. In yeast, actin polymerization is involved in endocytosis. Vid vesicles associate with actin patches initially, and they dissociate later. Here, we show that VID28 plays a critical role in the association of Vid vesicles with actin patches and the retention of Vid vesicle proteins in the intracellular fraction. Vid28p was distributed to Vid vesicles and interacted with other Vid vesicle proteins. Vid28p contains an Armadillo (ARM) domain required for FBPase degradation. When VID28 was deleted or when the ARM domain was mutated, Vid vesicles failed to co-localize with actin patches, and Vid vesicle proteins appeared in the extracellular fraction. We suggest that the ARM domain is required for the association of Vid vesicles with actin patches and the retention of Vid vesicle proteins in the intracellular fraction.	[Giardina, Bennett J.; Dunton, Danielle; Chiang, Hui-Ling] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chiang, HL (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	hxc32@psu.edu			National Institutes of Health [R01 GM59480]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM59480 (to H. L. C.).	Alibhoy AA, 2012, J BIOL CHEM, V287, P33080, DOI 10.1074/jbc.M112.360412; Alibhoy AA, 2012, AUTOPHAGY, V8, P29, DOI 10.4161/auto.8.1.18104; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Brown CR, 2008, J BIOL CHEM, V283, P26116, DOI 10.1074/jbc.M709922200; Brown CR, 2010, J BIOL CHEM, V285, P23357, DOI 10.1074/jbc.M109.075143; Brown C Randell, 2009, Commun Integr Biol, V2, P177; Brown CR, 2010, J BIOL CHEM, V285, P1516, DOI 10.1074/jbc.M109.028241; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; Brown CR, 2003, J BIOL CHEM, V278, P25688, DOI 10.1074/jbc.M210549200; Brown CR, 2002, J CELL SCI, V115, P655; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Bryant NJ, 1998, J CELL BIOL, V142, P651, DOI 10.1083/jcb.142.3.651; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; GAMO FJ, 1994, EUR J BIOCHEM, V222, P879, DOI 10.1111/j.1432-1033.1994.tb18935.x; GANCEDO C, 1971, J BACTERIOL, V107, P401, DOI 10.1128/JB.107.2.401-405.1971; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Hammerle M, 1998, J BIOL CHEM, V273, P25000, DOI 10.1074/jbc.273.39.25000; Hoffman M, 1996, GENETICS, V143, P1555; HOLZER H, 1989, RBC-CELL BIOL REV, V21, P305; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Lee HS, 2009, J PROTEOME RES, V8, P2851, DOI 10.1021/pr900009y; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Mijaljica D, 2007, AUTOPHAGY, V3, P417, DOI 10.4161/auto.4441; MINARD KI, 1994, ARCH BIOCHEM BIOPHYS, V315, P302, DOI 10.1006/abbi.1994.1504; MINARD KI, 1992, J BIOL CHEM, V267, P17458; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; SCHORK SM, 1994, FEBS LETT, V349, P270, DOI 10.1016/0014-5793(94)00668-7; Schule T, 2000, EMBO J, V19, P2161, DOI 10.1093/emboj/19.10.2161; Sekiya-Kawasaki M, 2003, J CELL BIOL, V162, P765, DOI 10.1083/jcb.200305077; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; TOYODA Y, 1987, BIOCHEM BIOPH RES CO, V143, P212, DOI 10.1016/0006-291X(87)90652-8; TUTTLE DL, 1993, EUR J CELL BIOL, V60, P283; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1	53	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11636	11648		10.1074/jbc.M112.419895	http://dx.doi.org/10.1074/jbc.M112.419895			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23393132	hybrid, Green Published			2022-12-25	WOS:000318157600003
J	Aggarwal, C; Labuz, J; Gabrys, H				Aggarwal, Chhavi; Labuz, Justyna; Gabrys, Halina			Phosphoinositides Play Differential Roles in Regulating Phototropin1-and Phototropin2-Mediated Chloroplast Movements in Arabidopsis	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-AND 4-PHOSPHATE; BLUE; LIGHT; CALCIUM; CA2+; 4,5-BISPHOSPHATE; CELLS; OSCILLATIONS; INCREASES; MECHANISM	Phototropins are UVA/blue-light receptors involved in controlling the light-dependent physiological responses which serve to optimize the photosynthetic activity of plants and promote growth. The phototropin-induced phosphoinositide (PI) metabolism has been shown to be essential for stomatal opening and phototropism. However, the role of PIs in phototropin-induced chloroplast movements remains poorly understood. The aim of this work is to determine which PI species are involved in the control of chloroplast movements in Arabidopsis and the nature of their involvement. We present the effects of the inactivation of phospholipase C (PLC), PI3-kinase (PI3K) and PI4-kinase (PI4K) on chloroplast relocations in Arabidopsis. The inhibition of the phosphatidylinositol 4,5-bisphospahte [PI(4,5)P2]-PLC pathway, using neomycin and U73122, suppressed the phot2-mediated chloroplast accumulation and avoidance responses, without affecting movement responses controlled by phot1. On the other hand, PI3K and PI4K activities are more restricted to phot1- and phot2-induced weak-light responses. The inactivation of PI3K and PI4K by wortmannin and LY294002 severely affected the weak blue-light-activated accumulation response but had little effect on the strong blue-light-activated avoidance response. The inhibitory effect observed with PI metabolism inhibitors is, at least partly, due to a disturbance in Ca-(c)(2+) signaling. Using the transgenic aequorin system, we show that the application of these inhibitors suppresses the blue-light-induced transient Ca-(c)(2+) rise. These results demonstrate the importance of PIs in chloroplast movements, with the PI(4,5)P2-PLC pathway involved in phot2 signaling while PI3K and PI4K are required for the phot1- and phot2-induced accumulation response. Our results suggest that these PIs modulate cytosolic Ca2+ signaling during movements.	[Aggarwal, Chhavi; Labuz, Justyna; Gabrys, Halina] Jagiellonian Univ, Dept Plant Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland	Jagiellonian University	Gabrys, H (corresponding author), Jagiellonian Univ, Dept Plant Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	halina.gabrys@uj.edu.pl		Labuz, Justyna/0000-0002-2612-1658	European Union (EU) [215174]; Polish National Science Center [211/03/N/NZ3/00224, 2011/01/N/NZ3/00280]; Jagiellonian University within the SET project; European Union [POIG.02.01.00-12-064/08]	European Union (EU)(CGIAREuropean Commission); Polish National Science Center; Jagiellonian University within the SET project; European Union(European Commission)	Chhavi Aggarwal was supported from European Union (EU) funds within the framework of FP7, Marie Curie ITN, grant no. 215174 "Chloroplast Signals'' (COSI) and from Polish National Science Center, grant no. 211/03/N/NZ3/00224. Justyna Labuz was supported by the grant of the Polish National Science Center, no. 2011/01/N/NZ3/00280 and funding from the Jagiellonian University within the SET project (co-financed by the European Union). The Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is the beneficiary of structural funds from the European Union - grant No. POIG.02.01.00-12-064/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva Z, 2010, PLANTA, V232, P1263, DOI 10.1007/s00425-010-1256-0; Anielska-Mazur A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-64; Babourina O, 2002, P NATL ACAD SCI USA, V99, P2433, DOI 10.1073/pnas.042294599; Banas AK, 2012, J EXP BOT, V63, P1559, DOI 10.1093/jxb/err429; Baum G, 1999, P NATL ACAD SCI USA, V96, P13554, DOI 10.1073/pnas.96.23.13554; Bovet L, 2001, BIOCHEM BIOPH RES CO, V289, P269, DOI 10.1006/bbrc.2001.5969; Chen X, 2008, PLANT CELL, V20, P353, DOI 10.1105/tpc.107.052670; Choi Y, 2008, PLANT CELL ENVIRON, V31, P366, DOI 10.1111/j.1365-3040.2007.01769.x; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DeWald DB, 2001, PLANT PHYSIOL, V126, P759, DOI 10.1104/pp.126.2.759; Dowd PE, 2006, PLANT CELL, V18, P1438, DOI 10.1105/tpc.106.041582; Erneux C, 1998, BBA-MOL CELL BIOL L, V1436, P185, DOI 10.1016/S0005-2760(98)00132-5; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gonorazky G, 2010, J PLANT PHYSIOL, V167, P411, DOI 10.1016/j.jplph.2009.10.003; Grabalska M, 2004, PHOTOCHEM PHOTOBIOL, V79, P343, DOI 10.1562/LE-03-16.1; Harada A, 2003, P NATL ACAD SCI USA, V100, P8583, DOI 10.1073/pnas.1336802100; Harada A, 2009, PLANT CELL PHYSIOL, V50, P360, DOI 10.1093/pcp/pcn203; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Jung JY, 2002, PLANT CELL, V14, P2399, DOI 10.1105/tpc.004143; Kadota A, 2009, P NATL ACAD SCI USA, V106, P13106, DOI 10.1073/pnas.0906250106; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Kong SG, 2006, PLANT J, V45, P994, DOI 10.1111/j.1365-313X.2006.02667.x; Krzeszowiec W, 2007, BIOL CELL, V99, P251, DOI 10.1042/BC20060077; Lee Y, 2007, PLANT J, V52, P803, DOI 10.1111/j.1365-313X.2007.03277.x; Lemtiri-Chlieh F, 2003, P NATL ACAD SCI USA, V100, P10091, DOI 10.1073/pnas.1133289100; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Marten H, 2007, PLANT J, V50, P29, DOI 10.1111/j.1365-313X.2006.03026.x; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Munnik T, 2011, CURR OPIN PLANT BIOL, V14, P1; Rentel MC, 2004, PLANT PHYSIOL, V135, P1471, DOI 10.1104/pp.104.042663; Salinas-Mondragon RE, 2010, PLANT CELL ENVIRON, V33, P2041, DOI 10.1111/j.1365-3040.2010.02204.x; Silswal N, 2011, AM J PHYSIOL-HEART C, V300, pH2016, DOI 10.1152/ajpheart.01011.2010; Sousa E, 2008, PLANT CELL, V20, P3050, DOI 10.1105/tpc.108.058826; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Stoelzle S, 2003, P NATL ACAD SCI USA, V100, P1456, DOI 10.1073/pnas.0333408100; Sztatelman O, 2010, J PLANT PHYSIOL, V167, P709, DOI 10.1016/j.jplph.2009.12.015; Takac T, 2012, J PROTEOME RES, V11, P3127, DOI 10.1021/pr201111n; Tlalka M, 1999, PLANT J, V20, P461, DOI 10.1046/j.1365-313x.1999.00621.x; TLALKA M, 1993, PLANTA, V189, P491, DOI 10.1007/BF00198211; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vossen JH, 2010, PLANT J, V62, P224, DOI 10.1111/j.1365-313X.2010.04136.x; WALCZAK T, 1980, PHOTOSYNTHETICA, V14, P65; Wan YL, 2008, MOL PLANT, V1, P103, DOI 10.1093/mp/ssm011; YULE DI, 1992, J BIOL CHEM, V267, P13830; ZURZYCKI J., 1955, ACTA SOC BOT POLON, V24, P27	47	29	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55393	10.1371/journal.pone.0055393	http://dx.doi.org/10.1371/journal.pone.0055393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405144	Green Published, gold			2022-12-25	WOS:000315153400089
J	Cahoon, EK; Wheeler, DC; Kimlin, MG; Kwok, RK; Alexander, BH; Little, MP; Linet, MS; Freedman, DM				Cahoon, Elizabeth Khaykin; Wheeler, David C.; Kimlin, Michael G.; Kwok, Richard K.; Alexander, Bruce H.; Little, Mark P.; Linet, Martha S.; Freedman, Daryl Michal			Individual, Environmental, and Meteorological Predictors of Daily Personal Ultraviolet Radiation Exposure Measurements in a United States Cohort Study	PLOS ONE			English	Article							SUN EXPOSURE; VITAMIN-D; MEASUREMENT ERROR; CANCER INCIDENCE; MORTALITY-RATES; SKIN; RISK; REPRODUCIBILITY; LATITUDE; AUSTRALIA	Background: Individual exposure to ultraviolet radiation (UVR) is challenging to measure, particularly for diseases with substantial latency periods between first exposure and diagnosis of outcome, such as cancer. To guide the choice of surrogates for long-term UVR exposure in epidemiologic studies, we assessed how well stable sun-related individual characteristics and environmental/meteorological factors predicted daily personal UVR exposure measurements. Methods: We evaluated 123 United States Radiologic Technologists subjects who wore personal UVR dosimeters for 8 hours daily for up to 7 days (N = 837 days). Potential predictors of personal UVR derived from a self-administered questionnaire, and public databases that provided daily estimates of ambient UVR and weather conditions. Factors potentially related to personal UVR exposure were tested individually and in a model including all significant variables. Results: The strongest predictors of daily personal UVR exposure in the full model were ambient UVR, latitude, daily rainfall, and skin reaction to prolonged sunlight (R-2 = 0.30). In a model containing only environmental and meteorological variables, ambient UVR, latitude, and daily rainfall were the strongest predictors of daily personal UVR exposure (R-2 = 0.25). Conclusions: In the absence of feasible measures of individual longitudinal sun exposure history, stable personal characteristics, ambient UVR, and weather parameters may help estimate long-term personal UVR exposure.	[Cahoon, Elizabeth Khaykin; Little, Mark P.; Linet, Martha S.; Freedman, Daryl Michal] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Wheeler, David C.] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA USA; [Kimlin, Michael G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, AusSun Res Lab, Brisbane, Qld 4001, Australia; [Kwok, Richard K.] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Alexander, Bruce H.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Virginia Commonwealth University; Queensland University of Technology (QUT); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Minnesota System; University of Minnesota Twin Cities	Cahoon, EK (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	khaykine@mail.nih.gov	Kwok, Richard/B-6907-2017	Kwok, Richard/0000-0002-6794-8360; Kimlin, Michael/0000-0002-9536-8646; Little, Mark/0000-0003-0980-7567	Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services	Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LN, 2011, AM J EPIDEMIOL, V174, P293, DOI 10.1093/aje/kwr091; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Armstrong BK, 2006, INT J EPIDEMIOL, V35, P231, DOI 10.1093/ije/dyi292; BOICE JD, 1992, CANCER, V69, P586, DOI 10.1002/1097-0142(19920115)69:2<586::AID-CNCR2820690251>3.0.CO;2-3; Boscoe FP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-264; Chen ACH, 2008, J GEN VIROL, V89, P2891, DOI 10.1099/vir.0.2008/003665-0; Chodick G, 2008, PHOTOCHEM PHOTOBIOL, V84, P713, DOI 10.1111/j.1751-1097.2007.00236.x; Colli JL, 2010, INT UROL NEPHROL, V42, P659, DOI 10.1007/s11255-009-9655-5; Dadvand P, 2011, PHOTOCH PHOTOBIO SCI, V10, P1161, DOI 10.1039/c0pp00333f; Diffey B, 2008, PHOTOCHEM PHOTOBIOL, V84, P371, DOI 10.1111/j.1751-1097.2007.00271.x; Doody MM, 1998, CANCER CAUSE CONTROL, V9, P67, DOI 10.1023/A:1008801404245; English DR, 1998, CANCER EPIDEM BIOMAR, V7, P857; Freedman DM, 2010, J PHOTOCH PHOTOBIO B, V101, P321, DOI 10.1016/j.jphotobiol.2010.08.001; Grant WB, 2003, RECENT RESULTS CANC, V164, P371; Grant WB, 2002, CANCER-AM CANCER SOC, V94, P272, DOI 10.1002/cncr.10196; Grant WB, 2007, ASIAN PAC J CANCER P, V8, P236; Hall LM, 2010, J NUTR, V140, P542, DOI 10.3945/jn.109.115253; Handel AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014606; Hu S, 2004, CANCER EPIDEM BIOMAR, V13, P59, DOI 10.1158/1055-9965.EPI-03-0187; Hughes AM, 2011, PEDIAT ALLERG IMM-UK, V22, P327, DOI 10.1111/j.1399-3038.2010.01099.x; Karagas MR, 2007, AM J EPIDEMIOL, V165, P719, DOI 10.1093/aje/kwk055; KRICKER A, 1994, CANCER CAUSE CONTROL, V5, P367, DOI 10.1007/BF01804988; Lin SW, 2012, INT J CANC; MacKie RM, 2006, PROG BIOPHYS MOL BIO, V92, P92, DOI 10.1016/j.pbiomolbio.2006.02.008; McCurdy T, 2003, J EXPO ANAL ENV EPID, V13, P294, DOI 10.1038/sj.jea.7500281; Musselman JRB, 2011, BRIT J CANCER, V104, P214, DOI 10.1038/sj.bjc.6606015; National Aeronautics and Space Administration, 2004, TOT OZ MAPP SPECTR D; National Oceanic and Atmospheric Administration, 2004, 3505 DSI NAT OC ATM; O'Riordan DL, 2000, PHOTOCHEM PHOTOBIOL, V71, P60, DOI 10.1562/0031-8655(2000)071<0060:CBRAMU>2.0.CO;2; Orton SM, 2011, NEUROLOGY, V76, P425, DOI 10.1212/WNL.0b013e31820a0a9f; PARISI AV, 1994, PHOTOCHEM PHOTOBIOL, V60, P470, DOI 10.1111/j.1751-1097.1994.tb05136.x; Rosso S, 2002, INT J EPIDEMIOL, V31, P439, DOI 10.1093/ije/31.2.439; Sayers A, 2009, INT J EPIDEMIOL, V38, P1681, DOI 10.1093/ije/dyp237; Snijders TAB, 1999, MULTILEVEL ANAL INTR, Vviii; Stanton WR, 2003, INT J BEHAV MED, V10, P285, DOI 10.1207/S15327558IJBM1004_1; Staples JA, 2003, ENVIRON HEALTH PERSP, V111, P518, DOI 10.1289/ehp.5941; Thieden E, 2001, PHOTODERMATOL PHOTO, V17, P249, DOI 10.1034/j.1600-0781.2001.170601.x; Thieden E, 2008, DAN MED BULL, V55, P47; THOMAS D, 1993, ANNU REV PUBL HEALTH, V14, P69, DOI 10.1146/annurev.pu.14.050193.000441; Vajdic CM, 2003, INT J CANCER, V105, P117, DOI 10.1002/ijc.11057; Veierod MB, 2008, MELANOMA RES, V18, P1, DOI 10.1097/CMR.0b013e3282f120d2; Yaroch AL, 2006, HEALTH EDUC BEHAV, V33, P340, DOI 10.1177/1090198105285329; Yu GP, 2006, PHOTOCHEM PHOTOBIOL, V82, P1621, DOI 10.1562/2006-07-17-RA-970; Zhou XH, 2001, J ROY STAT SOC C-APP, V50, P303, DOI 10.1111/1467-9876.00235	44	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54983	10.1371/journal.pone.0054983	http://dx.doi.org/10.1371/journal.pone.0054983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405102	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400046
J	Heatherly, RD; Loukides, G; Denny, JC; Haines, JL; Roden, DM; Malin, BA				Heatherly, Raymond D.; Loukides, Grigorios; Denny, Joshua C.; Haines, Jonathan L.; Roden, Dan M.; Malin, Bradley A.			Enabling Genomic-Phenomic Association Discovery without Sacrificing Anonymity	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; PROTECTING PRIVACY; HEALTH DATA; REIDENTIFICATION; ANONYMIZATION; FRAMEWORK; BENEFITS; NETWORK; SUPPORT; SYSTEMS	Health information technologies facilitate the collection of massive quantities of patient-level data. A growing body of research demonstrates that such information can support novel, large-scale biomedical investigations at a fraction of the cost of traditional prospective studies. While healthcare organizations are being encouraged to share these data in a de-identified form, there is hesitation over concerns that it will allow corresponding patients to be re-identified. Currently proposed technologies to anonymize clinical data may make unrealistic assumptions with respect to the capabilities of a recipient to ascertain a patients identity. We show that more pragmatic assumptions enable the design of anonymization algorithms that permit the dissemination of detailed clinical profiles with provable guarantees of protection. We demonstrate this strategy with a dataset of over one million medical records and show that 192 genotype-phenotype associations can be discovered with fidelity equivalent to non-anonymized clinical data.	[Heatherly, Raymond D.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Loukides, Grigorios] Cardiff Univ, Sch Comp Sci & Informat, Cardiff CF10 3AX, S Glam, Wales; [Denny, Joshua C.] Vanderbilt Univ, Sch Med, Dept Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Haines, Jonathan L.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Dept Med, Nashville, TN 37212 USA; [Malin, Bradley A.] Vanderbilt Univ, Sch Med, Dept Elect Engn & Comp Sci, Dept Biomed Informat,Sch Engn, Nashville, TN 37212 USA	Vanderbilt University; Cardiff University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Heatherly, RD (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	r.heatherly@vanderbilt.edu	Denny, Josh/AAL-3359-2021; Haines, Jonathan/C-3374-2012; Roden, Dan/ABD-5412-2021	Denny, Josh/0000-0002-3049-7332; Haines, Jonathan/0000-0002-4351-4728; 	National Human Genome Research Institute [U01HG006385, U01HG006378]; National Library of Medicine [R01LM009989, R01LM010685]; Royal Academy of Engineering Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006385, R01HG006844, U01HG006378] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685, R01LM009989] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Royal Academy of Engineering Research Fellowship(Royal Academy of Engineering - UK); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was sponsored, in part, by grants U01HG006385 and U01HG006378 from the National Human Genome Research Institute and grants R01LM009989 and R01LM010685 from the National Library of Medicine. Dr. Loukides' research is supported by a Royal Academy of Engineering Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Nick, 2010, P 2010 WORKSH GOV TE, DOI [DOI 10.1145/1920320.1920323, 10.1145/1920320.1920323]; Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; Benitez K, 2010, J AM MED INFORM ASSN, V17, P169, DOI 10.1136/jamia.2009.000026; Blumenthal D, 2009, NEW ENGL J MED, V360, P1477, DOI 10.1056/NEJMp0901592; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Crosslin D, 2011, HUM GENET, P1; Delaney J, 2011, CLIN PHARM THERAPEUT; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, CIRCULATION, V122, P2016, DOI 10.1161/CIRCULATIONAHA.110.948828; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Department of Health and Human Services, 2011, FED REGISTER, V76, P44512; El Emam K, 2006, J MED INTERNET RES, V8; El Emam K, 2008, J AM MED INFORM ASSN, V15, P627, DOI 10.1197/jamia.M2716; El Emam K, 2009, J AM MED INFORM ASSN, V16, P670, DOI 10.1197/jamia.M3144; Elkin PL, 2012, ANN INTERN MED, V156, P11, DOI 10.7326/0003-4819-156-1-201201030-00003; Emam Khaled El, 2009, Can J Hosp Pharm, V62, P307; Fadly A, 2011, J BIOMEDICAL INFORM; Gionis A, 2008, PROC INT CONF DATA, P744, DOI 10.1109/ICDE.2008.4497483; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Jensen Peter, 2012, NATURE REV GENETICS; Kalra D, 2006, BRIT MED J, V333, P196, DOI 10.1136/bmj.333.7560.196; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Lazarus R, 2009, J AM MED INFORM ASSN, V16, P18, DOI 10.1197/jamia.M2848; Li FJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S12-S7; Loukides G, 2011, KNOWL INF SYST, V28, P251, DOI 10.1007/s10115-010-0354-4; Loukides G, 2010, J AM MED INFORM ASSN, V17, P322, DOI 10.1136/jamia.2009.002725; Loukides G, 2010, P NATL ACAD SCI USA, V107, P7898, DOI 10.1073/pnas.0911686107; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Malin B, 2004, J BIOMED INFORM, V37, P179, DOI 10.1016/j.jbi.2004.04.005; Malin B, 2011, HUM GENET, P1; Malin B, 2010, J INVEST MED, V58, P11, DOI 10.2310/JIM.0b013e3181c9b2ea; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Ohno-Machado L, 2012, J AM MED INFORM ASSN, V19, P196, DOI 10.1136/amiajnl-2011-000538; Pendergrass S, 2011, GENETIC EPIDEMIOLOGY; Piwowar HA, 2008, PLOS MED, V5, P1315, DOI 10.1371/journal.pmed.0050183; Ramirez-Nafarrate A, 2012, PHARMACOGENOMICS, P1; Roche PA, 2001, NAT REV GENET, V2, P392, DOI 10.1038/35072029; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Safran C, 2007, J AM MED INFORM ASSN, V14, P1, DOI 10.1197/jamia.M2273; Stone MA, 2005, BRIT J GEN PRACT, V55, P783; Sweeney L, 2002, INT J UNCERTAIN FUZZ, V10, P557, DOI 10.1142/S0218488502001648; Terrovitis M, 2008, PROC VLDB ENDOW, V1, P115, DOI 10.14778/1453856.1453874; Vinterbo SA, 2012, J AM MED INFORM ASSN, V19, P750, DOI 10.1136/amiajnl-2011-000459; Walker L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002788; Wasserman L, 2010, J AM STAT ASSOC, V105, P375, DOI 10.1198/jasa.2009.tm08651; Weiner MG, 2009, ANN INTERN MED, V151, P359, DOI 10.7326/0003-4819-151-5-200909010-00141; Wylie JE, 2003, TRENDS BIOTECHNOL, V21, P113, DOI 10.1016/S0167-7799(02)00039-2	51	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53875	10.1371/journal.pone.0053875	http://dx.doi.org/10.1371/journal.pone.0053875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405076	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000315153400020
J	Marrakchi-Kacem, L; Delmaire, C; Guevara, P; Poupon, F; Lecomte, S; Tucholka, A; Roca, P; Yelnik, J; Durr, A; Mangin, JF; Lehericy, S; Poupon, C				Marrakchi-Kacem, Linda; Delmaire, Christine; Guevara, Pamela; Poupon, Fabrice; Lecomte, Sophie; Tucholka, Alan; Roca, Pauline; Yelnik, Jerome; Durr, Alexandra; Mangin, Jean-Francois; Lehericy, Stephane; Poupon, Cyril			Mapping Cortico-Striatal Connectivity onto the Cortical Surface: A New Tractography-Based Approach to Study Huntington Disease	PLOS ONE			English	Article							BASAL GANGLIA; CEREBRAL-CORTEX; FIBER TRACKING; DIFFUSION; MRI; CIRCUITS; SYSTEM; BRAIN	Huntington disease (HD) is associated with early and severe damage to the basal ganglia and particularly the striatum. We investigated cortico-striatal connectivity modifications occurring in HD patients using a novel approach which focuses on the projection of the connectivity profile of the basal ganglia onto the cortex. This approach consists in computing, for each subcortical structure, surface connectivity measures representing its strength of connections to the cortex and comparing these measures across groups. In this study, we focused on Huntington disease as an application of this new approach. First, surface cortico-striatal connectivity measures of a group of healthy subjects were averaged in order to infer the "normal" connectivity profile of the striatum to the cortex. Second, a statistical analysis was performed from the surface connectivity measures of healthy subjects and HD patients in order to detect the cortical gyri presenting altered cortico-striatal connectivity in HD. Lastly, percentage differences of connectivity between healthy subjects and patients were inferred, for each nucleus of the striatum, from the connectivity measures of the cortical gyri presenting a significant connectivity difference between the two groups. These percentage differences characterize the axonal disruptions between the striatum and the cortex occurring in HD. We found selective region-specific degeneration of cortical connections predominating for associative and primary sensorimotor connections and with relative preservation of limbic connections. Our method can be used to infer novel connectivity-based markers of HD pathological process.	[Marrakchi-Kacem, Linda; Guevara, Pamela; Poupon, Fabrice; Lecomte, Sophie; Roca, Pauline; Mangin, Jean-Francois; Poupon, Cyril] CEA, NeuroSpin, Gif Sur Yvette, France; [Marrakchi-Kacem, Linda; Guevara, Pamela; Poupon, Fabrice; Lecomte, Sophie; Roca, Pauline; Mangin, Jean-Francois; Poupon, Cyril] IFR49, Inst Federatif Rech, Gif Sur Yvette, France; [Delmaire, Christine] Ctr Hosp Reg & Univ Lille, Dept Neuroradiol, F-59037 Lille, France; [Delmaire, Christine; Lehericy, Stephane] Hop La Pitie Salpetriere, AP HP, CENIR, Ctr Neuroimagerie Rech, Paris, France; [Guevara, Pamela] Univ Concepcion, Concepcion, Chile; [Tucholka, Alan] Univ Montreal, Notre Dame Hosp, CHUM, Dept Radiol, Montreal, PQ H3C 3J7, Canada; [Yelnik, Jerome; Durr, Alexandra; Lehericy, Stephane] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Yelnik, Jerome; Durr, Alexandra; Lehericy, Stephane] INSERM, U975, Paris, France; [Yelnik, Jerome; Durr, Alexandra; Lehericy, Stephane] CNRS, UMR 7225, Paris, France; [Yelnik, Jerome; Durr, Alexandra; Lehericy, Stephane] ICM Inst Cerveau & Moelle Epiniere, Paris, France; [Yelnik, Jerome] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Ctr Invest Clin, Paris, France; [Durr, Alexandra] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, Paris, France	CEA; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidad de Concepcion; Universite de Montreal; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Marrakchi-Kacem, L (corresponding author), CEA, NeuroSpin, Gif Sur Yvette, France.	linda.marrakchi@gmail.com	Mangin, Jean-Francois/AAI-8983-2020; Yelnik, Jérôme/F-7153-2013; Guevara, Pamela/AAZ-6221-2021; Guevara, Pamela/B-2300-2019	Guevara, Pamela/0000-0001-9988-400X; Guevara, Pamela/0000-0001-9988-400X; Tucholka, Alan/0000-0002-8880-2707; Roca, Pauline/0000-0003-2089-6636; YELNIK, Jerome/0000-0003-4814-708X	Child Health and Development Institute CHDI/High Q Foundation; Ecole des Neurosciences Paris-Ile-de-France (NucleiPark project); NucleiPark project [ANR/MNP/2009]; Association France Parkinson	Child Health and Development Institute CHDI/High Q Foundation; Ecole des Neurosciences Paris-Ile-de-France (NucleiPark project); NucleiPark project; Association France Parkinson	TRACK-HD is supported by the Child Health and Development Institute CHDI/High Q Foundation, a not for profit organization dedicated to finding treatments for Huntington disease. This work was also supported by the Ecole des Neurosciences Paris-Ile-de-France (NucleiPark project), by the ANR/MNP/2009 (NucleiPark project) and by the Association France Parkinson (NucleiPark project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Argall BD, 2006, HUM BRAIN MAPP, V27, P14, DOI 10.1002/hbm.20158; Backman L, 1997, BRAIN, V120, P2207, DOI 10.1093/brain/120.12.2207; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bohanna I, 2011, NEUROBIOL DIS; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Dubois J, 2010, PROCEEDINGS OF THE I; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Guevara P, 2011, PROCEEDINGS OF THE I; Kloppel S, 2008, BRAIN, V131, P196, DOI 10.1093/brain/awm275; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Leh SE, 2007, NEUROSCI LETT, V419, P113, DOI 10.1016/j.neulet.2007.04.049; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2004, CEREB CORTEX, V14, P1302, DOI 10.1093/cercor/bhh091; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marrakchi-Kacem L, 2010, I S BIOMED IMAGING, P61, DOI 10.1109/ISBI.2010.5490415; Nave RD, 2010, AM J NEURORADIOL, V31, P1675; Nopoulos PC, 2010, NEUROBIOL DIS, V40, P544, DOI 10.1016/j.nbd.2010.07.014; Perrin M, 2005, LECT NOTES COMPUT SC, V3565, P52; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Reading SAJ, 2005, PSYCHIAT RES-NEUROIM, V140, P55, DOI 10.1016/j.pscychresns.2005.05.011; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Roca P, 2009, LECT NOTES COMPUT SC, V5761, P935, DOI 10.1007/978-3-642-04268-3_115; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Rosas HD, 2006, MOVEMENT DISORD, V21, P1317, DOI 10.1002/mds.20979; Rosas HD, 2010, NEUROIMAGE, V49, P2995, DOI 10.1016/j.neuroimage.2009.10.015; Rosas HD, 2005, NEUROLOGY, V65, P745, DOI 10.1212/01.wnl.0000174432.87383.87; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Solomon AC, 2008, MOVEMENT DISORD, V23, P1830, DOI 10.1002/mds.22097; Stoffers D, 2010, NEUROLOGY, V74, P1208, DOI 10.1212/WNL.0b013e3181d8c20a; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6	36	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e53135	10.1371/journal.pone.0053135	http://dx.doi.org/10.1371/journal.pone.0053135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405066	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400009
J	Al-Kashi, A; Montero-Melendez, T; Moradi-Bidhendi, N; Gilligan, JP; Mehta, N; Perretti, M				Al-Kashi, Adam; Montero-Melendez, Trinidad; Moradi-Bidhendi, Niloufar; Gilligan, James P.; Mehta, Nozer; Perretti, Mauro			The Calcitonin and Glucocorticoids Combination: Mechanistic Insights into Their Class-Effect Synergy in Experimental Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; SALMON-CALCITONIN; KAPPA-B; BONE; PREDNISOLONE; EFFICACY; RELEASE; SAFETY; MMP-2; NEUTROPHILS	Introduction: Previous work reported the anti-arthritic synergy afforded by combining calcitonin (CT) and glucocorticoids (GC). Here we focus on the pairing of elcatonin (eCT) and dexamethasone (Dex), querying whether: i) this was a class-effect action; ii) mechanistic insights could be unveiled; iii) the synergy affected canonical GC adverse effects. Methods: Using the rat collagen-induced arthritis model, different combinations of eCT and Dex, were administered from disease onset to peak (day 11 to 18). Macroscopic disease score was monitored throughout, with biochemical and histological analyses conducted on plasma and tissues at day 18. The effect on acute hyperglycaemia and liver enzyme message were also assessed. Results: Whilst eCT alone was inactive, it synergised at 1 mu g/kg with low doses of Dex (7.5 or 15 mu g/kg) to yield an anti-arthritic efficacy equivalent to a 4- to 7-fold higher Dex dose. Mechanistically, the anti-arthritic synergy corresponded to a marked attenuation in RA-relevant analytes. CXCL5 expression, in both plasma and joint, was markedly inhibited by the co-therapy. Finally, co-administration of eCT did not exacerbate metrics of GC adverse effects, and rescued some of them. Conclusions: We present evidence of a class-effect action for the anti-arthritic synergy of CT/GC combination, underpinned by the powerful inhibition of joint destruction markers. Furthermore, we identify CXCL5 as a marker for the combination therapy with potential diagnostic and prognostic utility. Substantial GC dose reduction, together with the absence of exacerbated adverse effects, indicated a significant clinical potential for this co-therapy in RA and beyond.	[Al-Kashi, Adam; Montero-Melendez, Trinidad; Moradi-Bidhendi, Niloufar; Perretti, Mauro] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England; [Gilligan, James P.] Tarsa Therapeut, Philadelphia, PA USA; [Mehta, Nozer] Unigene Corp, Fairfield, CT USA	University of London; Queen Mary University London	Perretti, M (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England.	m.perretti@qmul.ac.uk	Montero-Melendez, Trinidad/AAF-6345-2020	Montero-Melendez, Trinidad/0000-0002-3563-376X	Unigene Corporation of London; Queen Mary University of London; William Harvey Research Foundation	Unigene Corporation of London; Queen Mary University of London; William Harvey Research Foundation	This study was funded by a collaborative project between Unigene Corporation and Queen Mary University of London and, in part, by The William Harvey Research Foundation. The authors could operate freely in design the experiments, analyse data and prepare the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAHI SE, 1977, AGENTS ACTIONS, V7, P533, DOI 10.1007/BF02111126; AIDA S, 1993, CLIN EXP RHEUMATOL, V11, P503; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes PJ, 1998, AM J RESP CRIT CARE, V157, pS1, DOI 10.1164/ajrccm.157.3.157315; Binkley N, 2009, OSTEOPOROSIS INT, V20, P1595, DOI 10.1007/s00198-008-0827-4; BODY JJ, 1990, J CLIN ENDOCR METAB, V71, P675, DOI 10.1210/jcem-71-3-675; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Buttgereit F, 2008, LANCET, V371, P205, DOI 10.1016/S0140-6736(08)60132-4; Chang YH, 2008, CLIN BIOCHEM, V41, P955, DOI 10.1016/j.clinbiochem.2008.04.012; Cidlowski John A, 2009, Retina, V29, pS21, DOI 10.1097/IAE.0b013e3181ad2636; COCHRAN M, 1970, BRIT MED J, V1, P135, DOI 10.1136/bmj.1.5689.135; COPP DH, 1961, SCIENCE, V134, P2038, DOI 10.1126/science.134.3495.2038; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; Di Filippo C, 2004, J PHARMACOL EXP THER, V310, P1133, DOI 10.1124/jpet.104.068726; Edwards MR, 2006, AM J RESP CELL MOL, V34, P616, DOI 10.1165/rcmb.2005-0385OC; Fredin MF, 2005, PHARMACOL RES, V52, P422, DOI 10.1016/j.phrs.2005.06.003; Gannon C, 2010, PALLIATIVE MED, V24, P737, DOI 10.1177/0269216310377816; GRIEDER A, 1990, AGENTS ACTIONS, V29, P308, DOI 10.1007/BF01966462; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P681, DOI 10.1007/s00198-006-0286-8; Janckila AJ, 2009, CALCIFIED TISSUE INT, V85, P465, DOI 10.1007/s00223-009-9309-8; Joe B, 1999, MOL MED TODAY, V5, P367, DOI 10.1016/S1357-4310(99)01528-2; Karsdal MA, 2008, BIODRUGS, V22, P137, DOI 10.2165/00063030-200822030-00001; Karsdal MA, 2007, ANN NY ACAD SCI, V1117, P181, DOI 10.1196/annals.1402.041; Kim KS, 2011, RHEUMATOL INT, V31, P543, DOI 10.1007/s00296-010-1592-1; KOCH AE, 1994, J CLIN INVEST, V94, P1012, DOI 10.1172/JCI117414; MACINTYRE I, 1980, ARTHRITIS RHEUM-US, V23, P1139, DOI 10.1002/art.1780231011; Mancini L, 2007, AM J PATHOL, V170, P1018, DOI 10.2353/ajpath.2007.060830; MITCHELL DR, 1990, J GERONTOL, V45, pM153, DOI 10.1093/geronj/45.5.M153; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; Nathan RA, 2001, ANN ALLERG ASTHMA IM, V86, P203, DOI 10.1016/S1081-1206(10)62692-0; Paul-Clark M, 2000, BRIT J PHARMACOL, V131, P1345, DOI 10.1038/sj.bjp.0703704; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Schacke H, 2002, E SCHERING RES FDN W, V40, P357; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Smith E, 2008, ARTHRITIS RHEUM, V58, P1968, DOI 10.1002/art.23545; Smith JB, 1997, METHOD ENZYMOL, V287, P250; Smolian H, 2001, BIOL CHEM, V382, P1491, DOI 10.1515/BC.2001.183; Sondergaard BC, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-62; STUART JM, 1982, AGENTS ACTIONS, V12, P671, DOI 10.1007/BF01965077; van Wetering S, 2002, INFLAMM RES, V51, P8, DOI 10.1007/PL00000282; Whitworth JA, 2001, CLIN EXP PHARMACOL P, V28, P993, DOI 10.1046/j.1440-1681.2001.03584.x; YAMAGUCHI M, 1983, ACTA ENDOCRINOL-COP, V102, P572, DOI 10.1530/acta.0.1020572; YAMAGUCHI M, 1981, ENDOCRINOL JAPON, V28, P709; YAMAGUCHI M, 1981, ENDOCRINOL JAPON, V28, P51; ZAIDI M, 1988, Q J EXP PHYSIOL CMS, V73, P471, DOI 10.1113/expphysiol.1988.sp003168; Zimmermann GR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2602	50	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54299	10.1371/journal.pone.0054299	http://dx.doi.org/10.1371/journal.pone.0054299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393556	gold, Green Published, Green Submitted			2022-12-25	WOS:000314692800010
J	Bessonneau, V; Mosqueron, L; Berrube, A; Mukensturm, G; Buffet-Bataillon, S; Gangneux, JP; Thomas, O				Bessonneau, Vincent; Mosqueron, Luc; Berrube, Adele; Mukensturm, Gael; Buffet-Bataillon, Sylvie; Gangneux, Jean-Pierre; Thomas, Olivier			VOC Contamination in Hospital, from Stationary Sampling of a Large Panel of Compounds, in View of Healthcare Workers and Patients Exposure Assessment	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; ADSORPTION PERFORMANCE; CARBONYL-COMPOUNDS; ETHYL GLUCURONIDE; GLYCOL ETHERS; CARBOXEN 569; AIR-QUALITY; CARBOPACK X; INDOOR AIR; HAND RUBS	Background: We aimed to assess, for the first time, the nature of the indoor air contamination of hospitals. Methods and Findings: More than 40 volatile organic compounds (VOCs) including aliphatic, aromatic and halogenated hydrocarbons, aldehydes, alcohols, ketones, ethers and terpenes were measured in a teaching hospital in France, from sampling in six sampling sites - reception hall, patient room, nursing care, post-anesthesia care unit, parasitology-mycology laboratory and flexible endoscope disinfection unit - in the morning and in the afternoon, during three consecutive days. Our results showed that the main compounds found in indoor air were alcohols (arithmetic means +/- SD: 928 +/- 958 mu g/m(3) and 47.9 +/- 52.2 mu g/m(3) for ethanol and isopropanol, respectively), ethers (75.6 +/- 157 mu g/m(3) for ether) and ketones (22.6 +/- 20.6 mu g/m(3) for acetone). Concentrations levels of aromatic and halogenated hydrocarbons, ketones, aldehydes and limonene were widely variable between sampling sites, due to building age and type of products used according to health activities conducted in each site. A high temporal variability was observed in concentrations of alcohols, probably due to the intensive use of alcohol-based hand rubs in all sites. Qualitative analysis of air samples led to the identification of other compounds, including siloxanes (hexamethyldisiloxane, octamethyltrisiloxane, decamethylcyclopentasiloxane), anesthetic gases (sevoflurane, desflurane), aliphatic hydrocarbons (butane), esters (ethylacetate), terpenes (camphor, a-bisabolol), aldehydes (benzaldehyde) and organic acids (benzoic acid) depending on sites. Conclusion: For all compounds, concentrations measured were lower than concentrations known to be harmful in humans. However, results showed that indoor air of sampling locations contains a complex mixture of VOCs. Further multicenter studies are required to compare these results. A full understanding of the exposure of healthcare workers and patients to complex mixtures of chemical compounds can then be related to potential health outcomes.	[Bessonneau, Vincent; Thomas, Olivier] Adv Sch Publ Hlth, Environm & Hlth Res Lab, Rennes, France; [Bessonneau, Vincent; Gangneux, Jean-Pierre; Thomas, Olivier] Univ Rennes 1, Inst Res Environm & Occupat Hlth U 1085, Rennes, France; [Mosqueron, Luc; Berrube, Adele; Mukensturm, Gael] Veolia Environm Res & Innovat, Rueil Malmaison, France; [Buffet-Bataillon, Sylvie] Ctr Hosp Univ Rennes, Operat Staff Hosp Hyg, Rennes, France; [Gangneux, Jean-Pierre] Ctr Hosp Univ Rennes, Parasitol Mycol Lab, Rennes, France	Universite de Rennes; Veolia; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Thomas, O (corresponding author), Adv Sch Publ Hlth, Environm & Hlth Res Lab, Rennes, France.	olivier.thomas@ehesp.fr	Bessonneau, Vincent/A-5642-2015; Gangneux, Jean-Pierre/J-2960-2015	Bessonneau, Vincent/0000-0003-3442-5026; Gangneux, Jean-Pierre/0000-0002-4974-5607	French Agency for Food, Environmental and Occupational Health and Safety (ANSES) [EST-2010/2/113]	French Agency for Food, Environmental and Occupational Health and Safety (ANSES)(French National Research Agency (ANR))	d This study was funded by the French Agency for Food, Environmental and Occupational Health and Safety (ANSES, project EST-2010/2/113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrube A, 2011, MEMOIRE INGENIEUR GE; Bessonneau V, 2012, INT J ENV RES PUB HE, V9, P868, DOI 10.3390/ijerph9030868; Bessonneau V, 2010, INT J ENV RES PUB HE, V7, P3038, DOI 10.3390/ijerph7083038; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Bruno P, 2008, INDOOR AIR, V18, P250, DOI 10.1111/j.1600-0668.2008.00528.x; Dascalaki EG, 2008, BUILD ENVIRON, V43, P1945, DOI 10.1016/j.buildenv.2007.11.015; Dascalaki EG, 2009, ENERG BUILDINGS, V41, P551, DOI 10.1016/j.enbuild.2008.11.023; Di Stefano F, 1999, ALLERGY, V54, P1105, DOI 10.1034/j.1398-9995.1999.00239.x; Dutch Expert Committee on Occupational Standards, 2006, ETH ETH ALC EV HLTH; Gallego E, 2011, TALANTA, V85, P662, DOI 10.1016/j.talanta.2011.04.043; Gallego E, 2010, TALANTA, V81, P916, DOI 10.1016/j.talanta.2010.01.037; Geiss O, 2011, ATMOS ENVIRON, V45, P3676, DOI 10.1016/j.atmosenv.2011.04.037; Ghasemkhani M, 2005, IND HEALTH, V43, P703, DOI 10.2486/indhealth.43.703; Glumbakaite E, 2003, INDOOR BUILT ENVIRON, V12, P105, DOI 10.1177/1420326X03012001017; Hellgren UM, 2008, SCAND J WORK ENV HEA, P58; Hellgren UM, 2011, INT J OCCUP MED ENV, V24, P48, DOI 10.2478/s13382-011-0011-5; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; ISIAQ (International Society of Indoor Air Quality and Climate), 2003, REV IND AIR QUAL HOS; Kang Moon-Soo, 2008, Korean Journal of Internal Medicine, V23, P111, DOI 10.3904/kjim.2008.23.3.111; Kirchner S, 2006, NATL SURVEY INDOOR A; Koda S, 1999, ACTA MED OKAYAMA, V53, P217; Korpi A, 2009, CRIT REV TOXICOL, V39, P139, DOI [10.1080/10408440802291497 , 10.1080/10408440802291497]; Kramer A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-117; Lu HX, 2006, SCI TOTAL ENVIRON, V368, P574, DOI 10.1016/j.scitotenv.2006.03.044; Lu Y, 2010, ENVIRON SCI TECHNOL, V44, P6081, DOI 10.1021/es101368n; Lu HX, 2010, J HAZARD MATER, V178, P673, DOI 10.1016/j.jhazmat.2010.01.138; Miller MA, 2006, AM J EMERG MED, V24, P815, DOI 10.1016/j.ajem.2006.05.006; Mosqueron L., 2004, INVENTAIRE DONNEES F; Norliana S., 2009, AM J PHARM TOXICOLOG, V4, P98, DOI [10.3844/ajptsp.2009.98.106, DOI 10.3844/ajptsp.2009.98.106, DOI 10.3844/AJPTSP.2009.98.106]; Ohura T, 2006, SCI TOTAL ENVIRON, V366, P485, DOI 10.1016/j.scitotenv.2005.10.005; Pacenti M, 2006, INDOOR BUILT ENVIRON, V15, P63, DOI 10.1177/1420326X06061706; Plieninger P, 2001, GEFAHRST REINHALT L, V61, P521; Redlich CA, 1997, LANCET, V349, P1013, DOI 10.1016/S0140-6736(96)07220-0; Reisfield GM, 2011, J ANAL TOXICOL, V35, P264, DOI 10.1093/anatox/35.5.264; Reisfield GM, 2011, J ANAL TOXICOL, V35, P85, DOI 10.1093/anatox/35.2.85; Ribes A, 2007, J CHROMATOGR A, V1140, P44, DOI 10.1016/j.chroma.2006.11.062; Ras MR, 2009, TRAC-TREND ANAL CHEM, V28, P347, DOI 10.1016/j.trac.2008.10.009; Saad SG, 2003, INDOOR BUILT ENVIRON, V12, P93, DOI 10.1177/1420326X03012001015; Singer BC, 2006, INDOOR AIR, V16, P179, DOI 10.1111/j.1600-0668.2005.00414.x; Sobaszek A, 1999, J OCCUP ENVIRON MED, V41, P492, DOI 10.1097/00043764-199906000-00016; Takigawa T, 2004, ENVIRON TOXICOL, V19, P280, DOI 10.1002/tox.20035; Tsigonia A, 2010, INT J ENV RES PUB HE, V7, P314, DOI 10.3390/ijerph7010314; World Health Organization, 2010, WHO GUID IND AIR QUA; Xhauflaire-Uhoda Emmanuelle, 2008, J Occup Med Toxicol, V3, P15, DOI 10.1186/1745-6673-3-15; Zabiegala B, 2006, POL J ENVIRON STUD, V15, P383	45	53	53	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55535	10.1371/journal.pone.0055535	http://dx.doi.org/10.1371/journal.pone.0055535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393590	gold, Green Published, Green Submitted			2022-12-25	WOS:000314692800044
J	Promkan, M; Dakeng, S; Chakrabarty, S; Bogler, O; Patmasiriwat, P				Promkan, Moltira; Dakeng, Sumana; Chakrabarty, Subhas; Boegler, Oliver; Patmasiriwat, Pimpicha			The Effectiveness of Cucurbitacin B in BRCA1 Defective Breast Cancer Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; C-MYC; IN-VITRO; EXPRESSION; APOPTOSIS; SURVIVIN; PATHWAY; STAT3; PROLIFERATION; TRANSCRIPTION	Cucurbitacin B (CuB) is one of the potential agents for long term anticancer chemoprevention. Cumulative evidences has shown that cucurbitacin B provides potent cellular biological activities such as hepatoprotective, anti-inflammatory and antimicrobial effects, but the precise mechanism of this agent is not clearly understood. We examine the biological effects on cancer cells of cucurbitacin B extracted from a Thai herb, Trichosanthes cucumerina L. The wild type (wt) BRCA1, mutant BRCA1, BRCA1 knocked-down and BRCA1 overexpressed breast cancer cells were treated with the cucurbitacin B and determined for the inhibitory effects on the cell proliferation, migration, invasion, anchorage-independent growth. The gene expressions in the treated cells were analyzed for p21/(Waf1), p27(Kip1) and survivin. Our previous study revealed that loss of BRCA1 expression leads to an increase in survivin expression, which is responsible for a reduction in sensitivity to paclitaxel. In this work, we showed that cucurbitacin B obviously inhibited knocked-down and mutant BRCA1 breast cancer cells rather than the wild type BRCA1 breast cancer cells in regards to the cellular proliferation, migration, invasion and anchorage-independent growth. Furthermore, forcing the cells to overexpress wild type BRCA1 significantly reduced effectiveness of cucurbitacin B on growth inhibition of the endogenous mutant BRCA1 cells. Interestingly, cucurbitacin B promotes the expression of p21/(Waf1) and p27(Kip1) but inhibit the expression of survivin. We suggest that survivin could be an important target of cucurbitacin B in BRCA1 defective breast cancer cells.	[Promkan, Moltira; Dakeng, Sumana] Mahidol Univ, Fac Med Technol, Ctr Innovat Dev & Technol Transfer, Salaya, Nakhon Pathom, Thailand; [Promkan, Moltira; Chakrabarty, Subhas] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL USA; [Promkan, Moltira; Chakrabarty, Subhas] Simmons Canc Inst, Springfield, IL USA; [Dakeng, Sumana; Boegler, Oliver] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Patmasiriwat, Pimpicha] Mahidol Univ, Fac Med Technol, Dept Clin Microscopy, Salaya, Nakhon Pathom, Thailand	Mahidol University; Southern Illinois University System; Southern Illinois University; University of Texas System; UTMD Anderson Cancer Center; Mahidol University	Patmasiriwat, P (corresponding author), Mahidol Univ, Fac Med Technol, Dept Clin Microscopy, Salaya, Nakhon Pathom, Thailand.	mtppm@mahidol.ac.th		Bogler, Oliver/0000-0002-3700-0480	Mahidol University Research Fund (National Budget) [49439]; Simmons Cancer Institute, Southern Illinois; National Cancer Institute/National Institutes of Health grant [RO1CA128991]; NATIONAL CANCER INSTITUTE [R01CA128991] Funding Source: NIH RePORTER	Mahidol University Research Fund (National Budget); Simmons Cancer Institute, Southern Illinois; National Cancer Institute/National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by (1) Mahidol University Research Fund (National Budget), project # 49439 granted to PP; (2) SC was supported by Simmons Cancer Institute, Southern Illinois and (3) The National Cancer Institute/National Institutes of Health grant RO1CA128991 to OB, University of Texas M. D. Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agil A, 1999, PLANTA MED, V65, P673, DOI 10.1055/s-2006-960847; Atipairin A, 2011, BREAST CANCER-BASIC, V5, P201, DOI 10.4137/BCBCR.S8184; Blagosklonny MV, 2005, CELL DEATH DIFFER, V12, P592, DOI 10.1038/sj.cdd.4401610; Blaskovich MA, 2003, CANCER RES, V63, P1270; Brown AMC, 2001, BREAST CANCER RES, V3, P351, DOI 10.1186/bcr321; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Chan KT, 2010, CANCER LETT, V289, P46, DOI 10.1016/j.canlet.2009.07.015; Chen JC, 2005, NAT PROD REP, V22, P386, DOI 10.1039/b418841c; Dakeng S, 2012, J CELL BIOCHEM, V113, P49, DOI 10.1002/jcb.23326; Deng CX, 2003, HUM MOL GENET, V12, pR113, DOI 10.1093/hmg/ddg082; Duangmano S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-185; Duangmano S, 2010, INT J MOL SCI, V11, P5323, DOI 10.3390/ijms11125323; DUBIK D, 1987, CANCER RES, V47, P6517; Duncan KLK, 1996, BIOCHEM PHARMACOL, V52, P1553, DOI 10.1016/S0006-2952(96)00557-6; Efferth T, 2008, MOL CANCER THER, V7, P152, DOI 10.1158/1535-7163.MCT-07-0073; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fan WM, 1999, BIOCHEM PHARMACOL, V57, P1215; FARIAS MR, 1993, PLANTA MED, V59, P272, DOI 10.1055/s-2006-959668; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; Foulkes WD, 2000, ANN ONCOL, V11, P307, DOI 10.1023/A:1008340723974; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; IRELAND CM, 1995, BIOCHEM PHARMACOL, V49, P1491, DOI 10.1016/0006-2952(95)00030-4; James CR, 2007, ONCOLOGIST, V12, P142, DOI 10.1634/theoncologist.12-2-142; Jiratchariyakul W, 1999, THAI J PHYTOPHARM, V6, P1; Khan S, 2009, BRIT J CANCER, V100, P1073, DOI 10.1038/sj.bjc.6604978; Kongtun S, 2009, PLANTA MED, V75, P839, DOI 10.1055/s-0029-1185455; Lacroix M, 2005, BREAST CANCER RES TR, V89, P297, DOI 10.1007/s10549-004-2172-4; Lee DH, 2010, THESCIENTIFICWORLDJO, V10, P413, DOI 10.1100/tsw.2010.44; Lim CP, 2006, ONCOGENE, V25, P5416, DOI 10.1038/sj.onc.1209531; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Ma XH, 2009, DRUG DISCOV TODAY, V14, P1136, DOI 10.1016/j.drudis.2009.09.006; Patmasiriwat P, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9049; Polakis P, 2000, GENE DEV, V14, P1837; Promkan M, 2011, CELL CALCIUM, V49, P79, DOI 10.1016/j.ceca.2011.01.003; Promkan M, 2009, INT J CANCER, V125, P2820, DOI 10.1002/ijc.24684; Reynolds S, 2000, CLIN EXP METASTAS, V18, P309, DOI 10.1023/A:1011071907047; Shimura T, 2004, CANCER RES, V64, P6363, DOI 10.1158/0008-5472.CAN-04-1816; Shimura T, 2005, CANCER RES, V65, P3535, DOI 10.1158/0008-5472.CAN-05-0104; Span PN, 2004, CLIN CHEM, V50, P1986, DOI 10.1373/clinchem.2004.039149; Sun CY, 2010, J CANCER RES CLIN, V136, P603, DOI 10.1007/s00432-009-0698-x; Sun JZ, 2005, ONCOGENE, V24, P3236, DOI 10.1038/sj.onc.1208470; Szabo CI, 2001, P AM ASS CANC RES, P42; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Tannin-Spitz T, 2007, BIOCHEM PHARMACOL, V73, P56, DOI 10.1016/j.bcp.2006.09.012; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Thompson C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-62; Wakimoto N, 2008, CANCER SCI, V99, P1793, DOI 10.1111/j.1349-7006.2008.00899.x; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; WOODS CM, 1995, MOL MED, V1, P506, DOI 10.1007/BF03401588; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yang L, 2007, CANCER LETT, V256, P267, DOI 10.1016/j.canlet.2007.06.018; Yasuda S, 2010, MOL NUTR FOOD RES, V54, P559, DOI 10.1002/mnfr.200900165; Zhang MX, 2010, PANCREAS, V39, P923, DOI 10.1097/MPA.0b013e3181ce719e	58	34	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55732	10.1371/journal.pone.0055732	http://dx.doi.org/10.1371/journal.pone.0055732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393598	Green Published, gold, Green Submitted			2022-12-25	WOS:000314692800052
J	Raeder, MB; Birkeland, E; Trovik, J; Krakstad, C; Shehata, S; Schumacher, S; Zack, TI; Krohn, A; Werner, HMJ; Moody, SE; Wik, E; Stefansson, IM; Holst, F; Oyan, AM; Tamayo, P; Mesirov, JP; Kalland, KH; Akslen, LA; Simon, R; Beroukhim, R; Salvesen, HB				Raeder, Maria B.; Birkeland, Even; Trovik, Jone; Krakstad, Camilla; Shehata, Shyemaa; Schumacher, Steven; Zack, Travis I.; Krohn, Antje; Werner, Henrica M. J.; Moody, Susan E.; Wik, Elisabeth; Stefansson, Ingunn M.; Holst, Frederik; Oyan, Anne M.; Tamayo, Pablo; Mesirov, Jill P.; Kalland, Karl H.; Akslen, Lars A.; Simon, Ronald; Beroukhim, Rameen; Salvesen, Helga B.			Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers	PLOS ONE			English	Article							PROGNOSTIC IMPACT; GENE; MARKERS; BREAST; INHIBITION; EXPRESSION; CARCINOMA; STRATEGY; TARGETS; ANCCA	Chromosome 8q24 is the most commonly amplified region across multiple cancer types, and the typical length of the amplification suggests that it may target additional genes to MYC. To explore the roles of the genes most frequently included in 8q24 amplifications, we analyzed the relation between copy number alterations and gene expression in three sets of endometrial cancers (N = 252); and in glioblastoma, ovarian, and breast cancers profiled by TCGA. Among the genes neighbouring MYC, expression of the bromodomain-containing gene ATAD2 was the most associated with amplification. Bromodomain-containing genes have been implicated as mediators of MYC transcriptional function, and indeed ATAD2 expression was more closely associated with expression of genes known to be upregulated by MYC than was MYC itself. Amplifications of 8q24, expression of genes downstream from MYC, and overexpression of ATAD2 predicted poor outcome and increased from primary to metastatic lesions. Knockdown of ATAD2 and MYC in seven endometrial and 21 breast cancer cell lines demonstrated that cell lines that were dependent on MYC also depended upon ATAD2. These same cell lines were also the most sensitive to the histone deacetylase (HDAC) inhibitor Trichostatin-A, consistent with prior studies identifying bromodomain-containing proteins as targets of inhibition by HDAC inhibitors. Our data indicate high ATAD2 expression is a marker of aggressive endometrial cancers, and suggest specific inhibitors of ATAD2 may have therapeutic utility in these and other MYC-dependent cancers.	[Raeder, Maria B.; Birkeland, Even; Trovik, Jone; Krakstad, Camilla; Werner, Henrica M. J.; Wik, Elisabeth; Salvesen, Helga B.] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Raeder, Maria B.; Birkeland, Even; Trovik, Jone; Krakstad, Camilla; Werner, Henrica M. J.; Wik, Elisabeth; Salvesen, Helga B.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Raeder, Maria B.; Shehata, Shyemaa; Schumacher, Steven; Zack, Travis I.; Moody, Susan E.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Raeder, Maria B.; Shehata, Shyemaa; Schumacher, Steven; Zack, Travis I.; Moody, Susan E.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Schumacher, Steven; Zack, Travis I.; Moody, Susan E.; Tamayo, Pablo; Mesirov, Jill P.; Beroukhim, Rameen] Broad Inst, Cambridge, MA USA; [Zack, Travis I.] Harvard Univ, Dept Biophys, Boston, MA 02115 USA; [Krohn, Antje; Holst, Frederik; Simon, Ronald] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany; [Stefansson, Ingunn M.; Oyan, Anne M.; Kalland, Karl H.; Akslen, Lars A.] Univ Bergen, Gade Inst, Bergen, Norway; [Stefansson, Ingunn M.; Akslen, Lars A.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Oyan, Anne M.; Kalland, Karl H.] Haukeland Hosp, Dept Microbiol & Immunol, N-5021 Bergen, Norway; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	University of Bergen; Haukeland University Hospital; University of Bergen; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Raeder, MB (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway.	Maria.Rader@uib.no	Wik, E./AAA-9105-2020; Kalland, Karl-Henning/B-9445-2017; salvesen, Helga B/C-1187-2017; Mesirov, Jill/AGF-7626-2022; Schumacher, Steven/E-9821-2013; Akslen, Lars A/C-1202-2017; Krakstad, Camilla/AAB-5138-2020; Holst, Frederik/H-3149-2019; Akslen, Lars A./AAG-6097-2021; Werner, henrica/ABG-1235-2021	Kalland, Karl-Henning/0000-0003-4486-2334; salvesen, Helga B/0000-0002-4438-8831; Schumacher, Steven/0000-0002-6819-5647; Akslen, Lars A/0000-0003-2710-9543; Krakstad, Camilla/0000-0002-0174-8139; Holst, Frederik/0000-0002-5928-2175; Akslen, Lars A./0000-0003-2710-9543; Werner, henrica/0000-0001-5186-8369; Simon, Ronald/0000-0003-0158-4258	Helse Vest [990172, 911351, 911624, 911626]; University of Bergen; Norwegian Cancer Society; Research Council of Norway [205404, 193373]; National Cancer Institute [K08CA122833, U54CA143798]; V Foundation Scholarship; NATIONAL CANCER INSTITUTE [U54CA143798, K08CA122833, R01CA121941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074024] Funding Source: NIH RePORTER	Helse Vest; University of Bergen; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support: Helse Vest Grants 990172 (MBR), 911351, 911624, and 911626 (HBS); the University of Bergen; the Norwegian Cancer Society; the Research Council of Norway Grants 205404 and 193373 (HBS); the National Cancer Institute (K08CA122833 and U54CA143798); and a V Foundation Scholarship (RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Caron C, 2010, ONCOGENE, V29, P5171, DOI 10.1038/onc.2010.259; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Engelsen IB, 2009, APMIS, V117, P693, DOI 10.1111/j.1600-0463.2009.02467.x; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Hsia EYC, 2010, MOL CANCER RES, V8, P183, DOI 10.1158/1541-7786.MCR-09-0095; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kalashnikova EV, 2010, CANCER RES, V70, P9402, DOI 10.1158/0008-5472.CAN-10-1199; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Ma O, 2009, CANCER RES, V69, P2559, DOI 10.1158/0008-5472.CAN-08-2929; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; Rose PG, 1996, NEW ENGL J MED, V335, P640, DOI 10.1056/NEJM199608293350907; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Schwartz BE, 2011, CANCER RES, V71, P2686, DOI 10.1158/0008-5472.CAN-10-3513; Stefansson IM, 2004, J CLIN ONCOL, V22, P1242, DOI 10.1200/JCO.2004.09.034; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zitterbart K, 2011, J NEURO-ONCOL, V102, P25, DOI 10.1007/s11060-010-0289-3; Zou JX, 2007, P NATL ACAD SCI USA, V104, P18067, DOI 10.1073/pnas.0705814104	30	66	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e54873	10.1371/journal.pone.0054873	http://dx.doi.org/10.1371/journal.pone.0054873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393560	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800014
J	Hurst, DR; Xie, Y; Thomas, JW; Liu, JZ; Edmonds, MD; Stewart, MD; Welch, DR				Hurst, Douglas R.; Xie, Yi; Thomas, John W.; Liu, Jianzhong; Edmonds, Mick D.; Stewart, Mark D.; Welch, Danny R.			The C-Terminal Putative Nuclear Localization Sequence of BReast cancer Metastasis Suppressor 1, BRMS1, Is Necessary for Metastasis Suppression	PLOS ONE			English	Article							CARCINOMA METASTASIS; GENE-EXPRESSION; IDENTIFICATION; SIN3; MECHANISMS; COMMUNICATION; COREPRESSOR; MDA-MB-435; COMPONENT; PROTEINS	Breast cancer metastasis suppressor 1 (BRMS1) is a predominantly nuclear protein that suppresses metastasis in multiple human and murine carcinoma cell lines. BRMS1 interacts with several nuclear proteins including SIN3:HDAC chromatin remodeling complexes that are involved in repressing transcription. However, recent reports suggest BRMS1 may function in the cytoplasm. BRMS1 has two predicted nuclear localization sequences (NLS) that are located near the C-terminus (amino acids 198-205 and 238-244, NLS1 and NLS2 respectively). We hypothesized that nuclear localization sequences of BRMS1 were essential for BRMS1 mediated metastasis suppression. Replacement of NLS2 with NLS1 (BRMS1(NLS1,1)), truncation at 238 (BRMS1(Delta NLS2)), or switching the location of NLS1 and NLS2 (BRMS1(NLS2,1)) did not affect nuclear localization; but, replacement of NLS1 with NLS2 (BRMS1(NLS2,2)) or truncation at 197 (BRMS1(Delta NLS) which removes both NLS) promoted cytoplasmic localization. MDA-MB-231 human metastatic breast cancer cells transduced with BRMS1(NLS1,1), BRMS1(NLS2,2) or BRMS1(NLS2,1) were evaluated for metastasis suppression in an experimental xenograft mouse model. Interestingly, while NLS2 was not necessary for nuclear localization, it was found to be important for metastasis suppression since BRMS1(NLS2,2) suppressed metastasis by 85%. In contrast, BRMS1(NLS2,1) and BRMS1(NLS1,1) did not significantly suppress metastasis. Both BRMS1 and BRMS1(NLS2,2) co-immunoprecipitated with SIN3A in the nucleus and cytoplasm; however, BRMS1(NLS1,1) and BRMS1(NLS2,1) were associated with SIN3A in the nucleus only. Moreover, BRMS1 and BRMS1(NLS2,2), but not BRMS1(NLS1,1) and BRMS1(NLS2,1), down-regulated the pro-metastatic microRNA, miR-10b. Together, these data demonstrate an important role for NLS2 in the cytoplasm that is critical for metastasis suppression and is distinct from nuclear localization.	[Hurst, Douglas R.; Xie, Yi; Thomas, John W.; Liu, Jianzhong; Edmonds, Mick D.; Stewart, Mark D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Hurst, Douglas R.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL USA; [Welch, Danny R.] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Kansas; University of Kansas Medical Center	Hurst, DR (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	DHurst@uab.edu; DWelch@kumc.edu	Welch, Danny R/B-7310-2009	Welch, Danny R/0000-0002-1951-4947; Hurst, Douglas/0000-0002-1296-2210	NIH [CA87728, CA134981]; National Foundation for Cancer Research; Susan G. Komen for the Cure [SAC11037]; American Cancer Society [RSG-11-259-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA134981, R01CA087728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants CA87728 and CA134981 (DRW), National Foundation for Cancer Research (DRW), Susan G. Komen for the Cure SAC11037 (DRW) and the American Cancer Society RSG-11-259-01-CSM (DRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027339; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bodenstine TM, 2010, CANCER RES, V70, P10002, DOI 10.1158/0008-5472.CAN-10-2606; Champine PJ, 2007, CLIN EXP METASTAS, V24, P551, DOI 10.1007/s10585-007-9092-8; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; Cicek M, 2009, CLIN EXP METASTAS, V26, P229, DOI 10.1007/s10585-009-9235-1; Cook LM, 2012, CLIN EXP METASTAS, V29, P315, DOI 10.1007/s10585-012-9452-x; DeWald DB, 2005, CANCER RES, V65, P713; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Edmonds MD, 2009, INT J CANCER, V125, P1778, DOI 10.1002/ijc.24616; Edmonds MD, 2009, CELL CYCLE, V8, P2673, DOI 10.4161/cc.8.17.9303; Frolova N, 2009, TUMOR BIOL, V30, P148, DOI 10.1159/000228908; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hurst DR, 2008, J BIOL CHEM, V283, P7438, DOI 10.1074/jbc.M709446200; Hurst DR, 2006, BIOCHEM BIOPH RES CO, V348, P1429, DOI 10.1016/j.bbrc.2006.08.005; Hurst DR, 2012, CANCER METAST REV, V31, P641, DOI 10.1007/s10555-012-9363-y; Hurst DR, 2011, FEBS LETT, V585, P3185, DOI 10.1016/j.febslet.2011.07.045; Hurst DR, 2011, INT REV CEL MOL BIO, V286, P107, DOI 10.1016/B978-0-12-385859-7.00003-3; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Hurst DR, 2009, CLIN EXP METASTAS, V26, P89, DOI 10.1007/s10585-008-9216-9; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Kapoor P, 2004, INT J CANCER, V111, P693, DOI 10.1002/ijc.20318; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Le Guezennec X, 2006, NUCLEIC ACIDS RES, V34, P3929, DOI 10.1093/nar/gkl537; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; McDonel P, 2012, DEV BIOL, V363, P62, DOI 10.1016/j.ydbio.2011.12.019; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Phadke PA, 2008, AM J PATHOL, V172, P809, DOI 10.2353/ajpath.2008.070772; Riker AI, 2012, BMC MED, V10, DOI [10.1186/PREACCEPT-2032291833666638, 10.1186/1741-7015-10-19]; Rivera J, 2007, J PROTEOME RES, V6, P4006, DOI 10.1021/pr0703167; Rivera J, 2010, J CELL BIOCHEM, V111, P1464, DOI 10.1002/jcb.22874; Rivera J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006433; Samant RS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-6; Samant RS, 2001, CLIN EXP METASTAS, V18, P683, DOI 10.1023/A:1013124725690; Saunders MM, 2001, CANCER RES, V61, P1765; Seraj MJ, 2000, CANCER RES, V60, P2764; Shevde LA, 2002, EXP CELL RES, V273, P229, DOI 10.1006/excr.2001.5452; Shiio Y, 2006, MOL CELL BIOL, V26, P1386, DOI 10.1128/MCB.26.4.1386-1397.2006; Silveira AC, 2009, CANCER LETT, V276, P32, DOI 10.1016/j.canlet.2008.10.024; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Slipicevic A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-73; Smith KT, 2010, CHEM BIOL, V17, P65, DOI 10.1016/j.chembiol.2009.12.010; Vaidya KS, 2008, J BIOL CHEM, V283, P28354, DOI 10.1074/jbc.M710068200; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Zhang S, 2006, INT J GYNECOL CANCER, V16, P522, DOI 10.1111/j.1525-1438.2006.00547.x	49	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55966	10.1371/journal.pone.0055966	http://dx.doi.org/10.1371/journal.pone.0055966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390556	Green Submitted, gold, Green Published			2022-12-25	WOS:000314691100072
J	Lee, HK; Bier, A; Cazacu, S; Finniss, S; Xiang, CL; Twito, H; Poisson, LM; Mikkelsen, T; Slavin, S; Jacoby, E; Yalon, M; Toren, A; Rempel, SA; Brodie, C				Lee, Hae Kyung; Bier, Ariel; Cazacu, Simona; Finniss, Susan; Xiang, Cunli; Twito, Hodaya; Poisson, Laila M.; Mikkelsen, Tom; Slavin, Shimon; Jacoby, Elad; Yalon, Michal; Toren, Amos; Rempel, Sandra A.; Brodie, Chaya			MicroRNA-145 Is Downregulated in Glial Tumors and Regulates Glioma Cell Migration by Targeting Connective Tissue Growth Factor	PLOS ONE			English	Article							FACTOR CTGF; MALIGNANT GLIOMA; STEM-CELLS; CANCER; EXPRESSION; INVASION; MIR-145; SURVIVAL; DIFFERENTIATION; TUMORIGENICITY	Glioblastomas (GBM), the most common and aggressive type of malignant glioma, are characterized by increased invasion into the surrounding brain tissues. Despite intensive therapeutic strategies, the median survival of GBM patients has remained dismal over the last decades. In this study we examined the expression of miR-145 in glial tumors and its function in glioma cells. Using TCGA analysis and real-time PCR we found that the expression of miR-145/143 cluster was downregulated in astrocytic tumors compared to normal brain specimens and in glioma cells and glioma stem cells (GSCs) compared to normal astrocytes and neural stem cells. Moreover, the low expression of both miR-145 and miR-143 in GBM was correlated with poor patient prognosis. Transfection of glioma cells with miR-145 mimic or transduction with a lentivirus vector expressing pre-miR 145 significantly decreased the migration and invasion of glioma cells. We identified connective tissue growth factor (CTGF) as a novel target of miR-145 in glioma cells; transfection of the cells with this miRNA decreased the expression of CTGF as determined by Western blot analysis and the expression of its 3'-UTR fused to luciferase. Overexpression of a CTGF plasmid lacking the 3'-UTR and administration of recombinant CTGF protein abrogated the inhibitory effect of miR-145 on glioma cell migration. Similarly, we found that silencing of CTGF decreased the migration of glioma cells. CTGF silencing also decreased the expression of SPARC, phospho-FAK and FAK and overexpression of SPARC abrogated the inhibitory effect of CTGF silencing on cell migration. These results demonstrate that miR-145 is downregulated in glial tumors and its low expression in GBM predicts poor patient prognosis. In addition miR-145 regulates glioma cell migration by targeting CTGF which downregulates SPARC expression. Therefore, miR-145 is an attractive therapeutic target for anti-invasive treatment of astrocytic tumors.	[Lee, Hae Kyung; Cazacu, Simona; Finniss, Susan; Xiang, Cunli; Mikkelsen, Tom; Brodie, Chaya] Henry Ford Hosp, Dept Neurosurg, Hermelin Brain Tumor Ctr, Davidson Lab Cell Signaling & Tumorigenesis, Detroit, MI 48202 USA; [Bier, Ariel; Twito, Hodaya; Brodie, Chaya] Bar Ilan Univ, Everard & Mina Goodman Fac Life Sci, Ramat Gan, Israel; [Poisson, Laila M.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Slavin, Shimon] Int Ctr Cell Therapy & Canc Immunotherapy CTCI, Tel Aviv, Israel; [Jacoby, Elad; Yalon, Michal; Toren, Amos] Edmond & Lilly Safra Childrens Hosp, Chaim Sheba Med Ctr, Tel Hashomer, Israel; [Jacoby, Elad; Yalon, Michal; Toren, Amos] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Rempel, Sandra A.] Henry Ford Hosp, Dept Neurosurg, Barbara Jane Levy Lab Mol Neurooncol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Bar Ilan University; Henry Ford Health System; Henry Ford Hospital; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Henry Ford Health System; Henry Ford Hospital	Brodie, C (corresponding author), Henry Ford Hosp, Dept Neurosurg, Hermelin Brain Tumor Ctr, Davidson Lab Cell Signaling & Tumorigenesis, Detroit, MI 48202 USA.	nscha@neuro.hfh.edu		Jacoby, Elad/0000-0003-1411-8942	William and Karen Davidson Fund; Lori and Alan Zekelman Fund	William and Karen Davidson Fund; Lori and Alan Zekelman Fund	This work was supported by the William and Karen Davidson and the Lori and Alan Zekelman Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; DeCarvalho AC, 2010, STEM CELLS, V28, P181, DOI 10.1002/stem.264; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Desjardins A, 2005, FRONT BIOSCI-LANDMRK, V10, P2645, DOI 10.2741/1727; Dhar A., 2010, Experimental Oncology, V32, P2; Edwards LA, 2011, JNCI-J NATL CANCER I, V103, P1162, DOI 10.1093/jnci/djr224; Emdad L, 2012, FUTURE ONCOL, V8, P343, DOI [10.2217/FON.12.16, 10.2217/fon.12.16]; Ernst A, 2010, ONCOGENE, V29, P3411, DOI 10.1038/onc.2010.83; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao P., 2012, ONCOGENE; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Golembieski WA, 2008, GLIA, V56, P1061, DOI 10.1002/glia.20679; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jia YS, 2012, ONCOL REP, V27, P1865, DOI 10.3892/or.2012.1701; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kwon S, 2007, INT J ONCOL, V31, P693; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Li XH, 2011, ONCOL REP, V26, P1431, DOI 10.3892/or.2011.1437; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Litofsky N S, 1997, Neurosurg Focus, V3, pe4; Liu DP, 2007, INT J ONCOL, V30, P865; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; Lu Y, 2013, ONCOL REP, V29, P67, DOI 10.3892/or.2012.2084; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Maher EA, 2005, GENE DEV, V15, P1311; Noda SE, 2009, SEMIN RADIAT ONCOL, V19, P171, DOI 10.1016/j.semradonc.2009.02.005; Pan LH, 2002, NEUROL RES, V24, P677, DOI 10.1179/016164102101200573; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Quintavalle C, 2012, ONCOGENE, V31, P858, DOI 10.1038/onc.2011.280; Rosenzweig T, 2006, CANCER RES, V66, P4139, DOI 10.1158/0008-5472.CAN-05-2851; Sachdeva M, 2012, NUCL ACIDS RES; Sachdeva M, 2010, AM J TRANSL RES, V2, P170; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sala-Torra O, 2007, BLOOD, V109, P3080, DOI 10.1182/blood-2006-06-031096; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Schultz C, 2002, CANCER RES, V62, P6270; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suh SO, 2011, CARCINOGENESIS, V32, P772, DOI 10.1093/carcin/bgr036; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tan TW, 2009, J CELL BIOCHEM, V107, P345, DOI 10.1002/jcb.22132; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Wang JC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2973; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu Q, 2012, NUCLEIC ACIDS RES, V40, P761, DOI 10.1093/nar/gkr730; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yin D, 2010, INT J CANCER, V127, P2257, DOI 10.1002/ijc.25257; Zaman MS, 2010, BRIT J CANCER, V103, P256, DOI 10.1038/sj.bjc.6605742; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang J, 2012, ONCOGENE; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211; Zhu HY, 2011, MOL CANCER RES, V9, P960, DOI 10.1158/1541-7786.MCR-10-0531; Zhu L, 2011, AM J CANCER RES, V1, P574; Ziv-Av A, 2011, CELL SIGNAL, V23, P1936, DOI 10.1016/j.cellsig.2011.07.001	72	69	70	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54652	10.1371/journal.pone.0054652	http://dx.doi.org/10.1371/journal.pone.0054652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390502	gold, Green Published, Green Submitted			2022-12-25	WOS:000314691100018
J	Mouchnino, L; Blouin, J				Mouchnino, Laurence; Blouin, Jean			When Standing on a Moving Support, Cutaneous Inputs Provide Sufficient Information to Plan the Anticipatory Postural Adjustments for Gait Initiation	PLOS ONE			English	Article							PERTURBED STEP INITIATION; CEREBELLAR SUBJECTS; PARKINSONS-DISEASE; RESPONSES; HUMANS; TRANSLATION; THRESHOLDS; PERCEPTION; LOCOMOTION; AFFERENTS	Gait initiation is preceded by initial postural adjustments whose goal is to set up the condition required for the execution of the focal stepping movement. For instance, the step is preceded by a shift of the body's center of mass towards the stance foot unloading the stepping leg. This displacement is produced by exerting forces on the ground (i.e., thrust) while the body is still motionless. The purpose of this study was to identify whether the mere cutaneous inputs from the feet soles evoked by a lateral translation of the support could be used to scale the initial postural adjustments. Participants stood with their eyes closed on a force platform that could be moved laterally with a low acceleration (between 0.14 m/s(2) and 0.30 m/s(2)) to reach a constant velocity of 0.02 m/s. This translation resulted in a change in the somatosensory cues from the feet soles without modifying vestibular inputs. Participants were instructed to produce a step with the right foot as soon as they felt the platform start to move (on either side) or heard an auditory cue. In the latter case, the platform stayed stationary. We found that the thrust duration was lengthened when the platform moved towards the supporting foot. In this condition, the cutaneous stimulation provided information related to a body shift towards the stepping leg. This increased thrust duration likely helped overcoming the non-functional body shift perceived towards the stepping leg. This result highlights the accuracy with which the actual standing position can be determined from foot sole cutaneous cues in the absence of visual and vestibular or proprioceptive inputs.	[Mouchnino, Laurence; Blouin, Jean] Aix Marseille Univ, CNRS, Cognit Neurosci Lab, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Mouchnino, L (corresponding author), Aix Marseille Univ, CNRS, Cognit Neurosci Lab, Marseille, France.	laurence.mouchnino@univ-amu.fr		Blouin, Jean/0000-0002-8118-8994	Centre National d'Etudes Spatiales	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	This study was funded by the Centre National d'Etudes Spatiales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bent LR, 2002, EXP BRAIN RES, V143, P100, DOI 10.1007/s00221-001-0967-7; Bernier PM, 2009, CEREB CORTEX, V19, P2106, DOI 10.1093/cercor/bhn233; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3625, DOI 10.1152/jn.00496.2003; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; BRENIERE Y, 1991, J MOTOR BEHAV, V23, P235, DOI 10.1080/00222895.1991.9942034; BURLEIGH AL, 1994, J NEUROPHYSIOL, V72, P2892, DOI 10.1152/jn.1994.72.6.2892; Chapman CE, 2006, J NEUROPHYSIOL, V96, P1664, DOI 10.1152/jn.00214.2006; DO MC, 1990, EXP BRAIN RES, V79, P319, DOI 10.1007/BF00608241; Eils E, 2002, J BIOMECH, V35, P1307, DOI 10.1016/S0021-9290(02)00168-9; Fiolkowski P, 2002, NEUROSCI LETT, V323, P167, DOI 10.1016/S0304-3940(02)00158-1; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; Gianna C, 1996, BRAIN RES BULL, V40, P443, DOI 10.1016/0361-9230(96)00140-2; Honeycutt CF, 2009, J NEUROPHYSIOL, V101, P2751, DOI 10.1152/jn.91040.2008; INGLIS JT, 1994, EXP BRAIN RES, V101, P159; INGLIS JT, 1995, J NEUROPHYSIOL, V73, P1181, DOI 10.1152/jn.1995.73.3.1181; Kavounoudias A, 1998, NEUROREPORT, V9, P3247, DOI 10.1097/00001756-199810050-00021; Kelly LA, 2012, CLIN BIOMECH, V27, P46, DOI 10.1016/j.clinbiomech.2011.07.013; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Lowrey CR, 2012, J NEUROPHYS IN PRESS; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; Mille ML, 2007, MOVEMENT DISORD, V22, P20, DOI 10.1002/mds.21139; Mille ML, 2009, J NEUROL PHYS THER, V33, P88, DOI 10.1097/NPT.0b013e3181a3360d; Mille ML, 1998, NEUROSCI LETT, V242, P61, DOI 10.1016/S0304-3940(98)00047-0; Mouchnino L, 2012, GAIT POSTURE, V35, P616, DOI 10.1016/j.gaitpost.2011.12.009; Nurse MA, 2001, CLIN BIOMECH, V16, P719, DOI 10.1016/S0268-0033(01)00090-0; Robinovitch SN, 2012, LANCET IN PRESS; Ruget H, 2008, NEUROSCIENCE, V155, P640, DOI 10.1016/j.neuroscience.2008.06.021; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; Timmann D, 1998, EXP BRAIN RES, V119, P73, DOI 10.1007/s002210050321; Timmann D, 2001, EXP BRAIN RES, V141, P110, DOI 10.1007/s002210100858; Tokuno CD, 2006, EXP BRAIN RES, V174, P19, DOI 10.1007/s00221-006-0414-x; Voss M, 2006, NAT NEUROSCI, V9, P26, DOI 10.1038/nn1592	35	22	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55081	10.1371/journal.pone.0055081	http://dx.doi.org/10.1371/journal.pone.0055081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390513	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100029
J	Bringhenti, I; Moraes-Teixeira, JA; Cunha, MR; Ornellas, F; Mandarim-de-Lacerda, CA; Aguila, MB				Bringhenti, Isabele; Moraes-Teixeira, Jessica Andrade; Cunha, Michelle Rabello; Ornellas, Fernanda; Mandarim-de-Lacerda, Carlos Alberto; Aguila, Marcia Barbosa			Maternal Obesity during the Preconception and Early Life Periods Alters Pancreatic Development in Early and Adult Life in Male Mouse Offspring	PLOS ONE			English	Article							HIGH-FAT DIET; BETA-CELL MASS; INDUCED INSULIN-SECRETION; METABOLIC SYNDROME; ENDOCRINE PANCREAS; DIABETES-MELLITUS; SKELETAL-MUSCLE; C57BL/6 MICE; RICH DIET; IN-UTERO	Maternal obesity induced by a high fat (HF) diet may program susceptibility in offspring, altering pancreatic development and causing later development of chronic degenerative diseases, such as obesity and diabetes. Female mice were fed standard chow (SC) or an HF diet for 8 weeks prior to mating and during the gestational and lactational periods. The male offspring were assessed at birth, at 10 days, and at 3 months of age. The body mass (BM) gain was 50% greater before pregnancy and 80% greater during pregnancy in HF dams than SC dams. Dams fed an HF diet showed higher oral glucose tolerance test (OGTT), blood pressure, serum corticosterone, and insulin levels than dams fed SC. At 10 days of age and at 3 mo old the HF offspring showed greater BM and higher blood glucose levels than the SC offspring. The mean diameter of the islets had increased by 37% in the SC offspring and by 155% in the HF offspring at 10 days of age. The islet mass ratio (IM/PM) was 88% greater in the HF offspring at 10 days of age, and 107% greater at 3 mo of age, compared to the values obtained at birth. The HF offspring had a beta cell mass (BCM)/PM ratio 54% lower than SC offspring at birth. However, HF offspring displayed a 146% increase in the BCM/PM ratio at 10 days of age, and 112% increase at 3 months of age than values at birth. A 3 mo of age, the HF offspring showed a greater OGTT and higher levels of than SC offspring. In conclusion, a maternal HF diet consumed during the preconceptional period and throughout the gestational and lactational periods in mice results in dramatic alterations in the pancreata of the offspring.	[Bringhenti, Isabele; Moraes-Teixeira, Jessica Andrade; Cunha, Michelle Rabello; Ornellas, Fernanda; Mandarim-de-Lacerda, Carlos Alberto; Aguila, Marcia Barbosa] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Mandarim-de-Lacerda, CA (corresponding author), Univ Estado Rio De Janeiro, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil.	mandarim@uerj.br	Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019; Aguila, Marcia Barbosa/ABF-6505-2020; Aguila, Marcia/P-2349-2019; Mandarim-de-Lacerda, Carlos A/F-7125-2012	Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Aguila, Marcia Barbosa/0000-0003-3994-4589; 	Brazilian Government (CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [302154/2001-6]; State of Rio de Janeiro (FAPERJ, Fundacao do Amparo a Pesquisa do Estado do Rio de Janeiro) [E-26/110.549/2010]	Brazilian Government (CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Rio de Janeiro (FAPERJ, Fundacao do Amparo a Pesquisa do Estado do Rio de Janeiro)	This work was supported by the Brazilian Government (CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant 302154/2001-6 to CAML) and the State of Rio de Janeiro (FAPERJ, Fundacao do Amparo a Pesquisa do Estado do Rio de Janeiro, grant E-26/110.549/2010 to MBA and CAML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Aguila MB, 2010, OLIVES AND OLIVE OIL IN HEALTH AND DISEASE PREVENTION, P787, DOI 10.1016/B978-0-12-374420-3.00082-6; Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Barbosa-da-Silva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039837; Barker G, 2012, J MATERN-FETAL NEO M, V25, P2274, DOI 10.3109/14767058.2012.686540; Bernard-Kargar C, 2001, DIABETES, V50, pS30, DOI 10.2337/diabetes.50.2007.S30; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Bringhenti I, 2011, J NUTR BIOCHEM, V22, P1009, DOI 10.1016/j.jnutbio.2010.08.013; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Cerf ME, 2007, PANCREAS, V34, P347, DOI 10.1097/MPA.0b013e31802ee9ae; Cerf ME, 2007, MED SCI MONITOR, V13, pRA12; Cerf ME, 2010, ADV EXP MED BIOL, V654, P77, DOI 10.1007/978-90-481-3271-3_5; Cerf ME, 2006, BRIT J NUTR, V95, P391, DOI 10.1079/BJN20051632; Cerf ME, 2005, AM J PHYSIOL-REG I, V288, pR1122, DOI 10.1152/ajpregu.00335.2004; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Frantz EDC, 2011, MECH AGEING DEV, V132, P110, DOI 10.1016/j.mad.2011.01.003; Dhawan S, 2007, CURR OPIN CELL BIOL, V19, P634, DOI 10.1016/j.ceb.2007.09.015; Dobrian AD, 2000, HYPERTENSION, V35, P1009, DOI 10.1161/01.HYP.35.4.1009; DONOVAN DS, 1993, AM J PHYSIOL, V264, pE730, DOI 10.1152/ajpendo.1993.264.5.E730; Foot VL, 2010, HORM METAB RES, V42, P923, DOI 10.1055/s-0030-1267225; Frangioudakis G, 2005, ENDOCRINOLOGY, V146, P5596, DOI 10.1210/en.2005-0481; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Gallou-Kabani C, 2005, DIABETES, V54, P1899, DOI 10.2337/diabetes.54.7.1899; Gardner DS, 2005, AM J PHYSIOL-REG I, V289, pR947, DOI 10.1152/ajpregu.00120.2005; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gregorio BM, 2013, EUR J NUTR, V52, P759, DOI 10.1007/s00394-012-0382-9; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Halseth AE, 2000, AM J PHYSIOL-ENDOC M, V279, pE1064, DOI 10.1152/ajpendo.2000.279.5.E1064; Holemans K, 2004, AM J OBSTET GYNECOL, V190, P858, DOI 10.1016/j.ajog.2003.09.025; Hotchkiss AK, 2005, CONTEMP TOP LAB ANIM, V44, P46; Hull RL, 2003, DIABETES, V52, P372, DOI 10.2337/diabetes.52.2.372; Jetton TL, 2008, AM J PHYSIOL-ENDOC M, V294, pE679, DOI 10.1152/ajpendo.00569.2007; KARNIK AM, 1990, BRIT J CLIN PRACT, V44, P699; KARNIK PS, 1990, J BIOL CHEM, V265, P2550; LangleyEvans SC, 1996, CLIN SCI, V91, P607, DOI 10.1042/cs0910607; Leonardi O, 2003, EUR J ENDOCRINOL, V149, P99, DOI 10.1530/eje.0.1490099; Levin BE, 2000, OBES RES, V8, P342, DOI 10.1038/oby.2000.41; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; Mandarim-de-Lacerda CA, 2010, METHODS MOL BIOL, V611, P211, DOI 10.1007/978-1-60327-345-9_17; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Masiello P, 2006, INT J BIOCHEM CELL B, V38, P873, DOI 10.1016/j.biocel.2005.09.007; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; Nascimento FAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041740; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Plagemann A, 2008, NESTLE NUTR WORKS SE, V61, P91, DOI 10.1159/0000113179; PLAGEMANN A, 1992, EXP CLIN ENDOCRINOL, V99, P91, DOI 10.1055/s-0029-1211143; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Souza-Mello V, 2011, PANCREAS, V40, P715, DOI 10.1097/MPA.0b013e3182153922; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; STOFFEL M, 1995, GENOMICS, V28, P125, DOI 10.1006/geno.1995.1120; Symonds ME, 2009, P NUTR SOC, V68, P416, DOI 10.1017/S0029665109990152; Tannenbaum BM, 1997, AM J PHYSIOL-ENDOC M, V273, pE1168, DOI 10.1152/ajpendo.1997.273.6.E1168; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wilkes JJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE679, DOI 10.1152/ajpendo.1998.275.4.E679; Yeh J, 2005, AM J OBSTET GYNECOL, V193, P1994, DOI 10.1016/j.ajog.2005.05.001; Zhang L, 2011, DOMEST ANIM ENDOCRIN, V40, P30, DOI 10.1016/j.domaniend.2010.08.004; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	68	31	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55711	10.1371/journal.pone.0055711	http://dx.doi.org/10.1371/journal.pone.0055711			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383269	Green Published, gold, Green Submitted			2022-12-25	WOS:000314610600149
J	Gao, M; Liang, J; Lu, Y; Guo, H; German, P; Bai, S; Jonasch, E; Yang, X; Mills, GB; Ding, Z				Gao, M.; Liang, J.; Lu, Y.; Guo, H.; German, P.; Bai, S.; Jonasch, E.; Yang, X.; Mills, G. B.; Ding, Z.			Site-specific activation of AKT protects cells from death induced by glucose deprivation	ONCOGENE			English	Article						glucose deprivation; site-specific AKT phosphorylation; substrate-specific AKT activation; cell survival	GROWTH-FACTORS; IN-VITRO; KINASE; PATHWAY; PHOSPHORYLATION; INHIBITOR; TARGET; SURVIVAL; IDENTIFICATION; PHOSPHATASE	The serine/threonine kinase AKT is a key mediator of cancer cell survival. We demonstrate that transient glucose deprivation modestly induces AKT phosphorylation at both Thr308 and Ser473. In contrast, prolonged glucose deprivation induces selective AKTThr308 phosphorylation and phosphorylation of a distinct subset of AKT downstream targets leading to cell survival under metabolic stress. Glucose-deprivation-induced AKTThr308 phosphorylation is dependent on PDK1 and PI3K but not EGF receptor or IGF1R. Prolonged glucose deprivation induces the formation of a complex of AKT, PDK1 and the GRP78 chaperone protein, directing phosphorylation of AKTThr308 but not AKTSer473. Our results reveal a novel mechanism of AKT activation under prolonged glucose deprivation that protects cells from metabolic stress. The selective activation of AKTThr308 phosphorylation that occurs during prolonged nutrient deprivation may provide an unexpected opportunity for the development and implementation of drugs targeting cell metabolism and aberrant AKT signaling.	[Gao, M.; Yang, X.] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Peoples R China; [Gao, M.; Liang, J.; Lu, Y.; Guo, H.; Mills, G. B.; Ding, Z.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [German, P.; Bai, S.; Jonasch, E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	Shandong University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Mills, GB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gmills@mdanderson.org; zding@mdanderson.org			National Institutes of Health (NIH) [5R21CA126700]; University of Texas MD Anderson Cancer Center Kidney Cancer Multidisciplinary Research Program; AstraZeneca; GlaxoSmithKline; NIH [CA016672];  [P01CA099031];  [P50CA083639];  [SU2C-AACR-DT0209]; NATIONAL CANCER INSTITUTE [R21CA126700, P50CA098258, P01CA099031, P50CA083639, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center Kidney Cancer Multidisciplinary Research Program; AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Qinghua Yu and Nancy Shih for technical assistance for RPPA experiments. The work was supported by National Institutes of Health (NIH) grant 5R21CA126700, a grant from The University of Texas MD Anderson Cancer Center Kidney Cancer Multidisciplinary Research Program and research support from AstraZeneca to ZD, and P01CA099031, P50CA083639, SU2C-AACR-DT0209 and research support from AstraZeneca and GlaxoSmithKline to GBM. RPPA was performed at the MD Anderson RPPA Core Facility (supported by NIH grant CA016672).	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Ding ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009910; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Folkman J, 2003, SEMIN CANCER BIOL, V13, P159, DOI 10.1016/S1044-579X(02)00133-5; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hennessy BT, 2009, CLIN CANCER RES, V15, P417, DOI 10.1158/1078-0432.CCR-08-2620; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim KY, 2009, CANCER RES, V69, P4018, DOI 10.1158/0008-5472.CAN-08-2641; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lu Y, 2011, ONCOGENE, V30, P4567, DOI 10.1038/onc.2011.164; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; MacDonald ML, 2006, NAT CHEM BIOL, V2, P329, DOI 10.1038/nchembio790; Macias AT, 2011, J MED CHEM, V54, P4034, DOI 10.1021/jm101625x; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Roberts HR, 2011, CARCINOGENESIS, V32, P1741, DOI 10.1093/carcin/bgr210; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; von der Crone S, 2000, EUR J CELL BIOL, V79, P943, DOI 10.1078/0171-9335-00118; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Worster DT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001986; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559; Zhong DS, 2009, J BIOL CHEM, V284, P23225, DOI 10.1074/jbc.M109.005280	48	44	44	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 6	2014	33	6					745	755		10.1038/onc.2013.2	http://dx.doi.org/10.1038/onc.2013.2			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5IL	23396361	Green Accepted			2022-12-25	WOS:000331129200009
J	Hossain, MI; Roulston, CL; Kamaruddin, MA; Chu, PWY; Ng, DCH; Dusting, GJ; Bjorge, JD; Williamson, NA; Fujita, DJ; Cheung, SN; Chan, TO; Hill, AF; Cheng, HC				Hossain, M. Iqbal; Roulston, Carli L.; Kamaruddin, M. Aizuddin; Chu, Percy W. Y.; Ng, Dominic C. H.; Dusting, Gregory J.; Bjorge, Jeffrey D.; Williamson, Nicholas A.; Fujita, Donald J.; Cheung, Steve N.; Chan, Tung O.; Hill, Andrew F.; Cheng, Heung-Chin			A Truncated Fragment of Src Protein Kinase Generated by Calpain-mediated Cleavage Is a Mediator of Neuronal Death in Excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-INDUCED INJURY; C-SRC; BRAIN ISCHEMIA; CELL-DEATH; CEREBRAL-ISCHEMIA; NMDA RECEPTORS; ACTIVATED SRC; STROKE; NEURODEGENERATION; CALCINEURIN	Excitotoxicity resulting from overstimulation of glutamate receptors is a major cause of neuronal death in cerebral ischemic stroke. The overstimulated ionotropic glutamate receptors exert their neurotoxic effects in part by overactivation of calpains, which induce neuronal death by catalyzing limited proteolysis of specific cellular proteins. Here, we report that in cultured cortical neurons and in vivo in a rat model of focal ischemic stroke, the tyrosine kinase Src is cleaved by calpains at a site in the N-terminal unique domain. This generates a truncated Src fragment of similar to 52 kDa, which we localized predominantly to the cytosol. A cell membrane-permeable fusion peptide derived from the unique domain of Src prevents calpain from cleaving Src in neurons and protects against excitotoxic neuronal death. To explore the role of the truncated Src fragment in neuronal death, we expressed a recombinant truncated Src fragment in cultured neurons and examined how it affects neuronal survival. Expression of this fragment, which lacks the myristoylation motif and unique domain, was sufficient to induce neuronal death. Furthermore, inactivation of the prosurvival kinase Akt is a key step in its neurotoxic signaling pathway. Because Src maintains neuronal survival, our results implicate calpain cleavage as a molecular switch converting Src from a promoter of cell survival to a mediator of neuronal death in excitotoxicity. Besides unveiling a new pathological action of Src, our discovery of the neurotoxic action of the truncated Src fragment suggests new therapeutic strategies with the potential to minimize brain damage in ischemic stroke.	[Hossain, M. Iqbal; Kamaruddin, M. Aizuddin; Chu, Percy W. Y.; Ng, Dominic C. H.; Williamson, Nicholas A.; Hill, Andrew F.; Cheng, Heung-Chin] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Roulston, Carli L.; Dusting, Gregory J.] OBrien Inst, Fitzroy, Vic 3065, Australia; [Roulston, Carli L.; Dusting, Gregory J.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; [Bjorge, Jeffrey D.; Fujita, Donald J.] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Hlth Sci Ctr, Calgary, AB T2N 4N1, Canada; [Cheung, Steve N.] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Burwood, Vic 3125, Australia; [Chan, Tung O.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	University of Melbourne; Centre for Eye Research Australia; University of Melbourne; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; Deakin University; Jefferson University	Cheng, HC (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Parkville, Vic 3010, Australia.	heung@unimelb.edu.au	Ng, Dominic/C-7291-2015; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F/B-4527-2009; Hill, Andrew F./AAH-2854-2020; Williamson, Nicholas A/O-9812-2016	Ng, Dominic/0000-0003-4657-159X; Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Williamson, Nicholas A/0000-0002-2173-3452; Cheng, Heung-Chin/0000-0002-4965-7148	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by project grants from the National Health and Medical Research Council of Australia.; Supported by Future Fellowships of the Australian Research Council.	Ardizzone TD, 2007, STROKE, V38, P1621, DOI 10.1161/STROKEAHA.106.478966; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bernocco S, 2008, PROTEOMICS, V8, P930, DOI 10.1002/pmic.200700738; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Cao X, 2009, BIOCHEM J, V424, P201, DOI 10.1042/BJ20090643; Chan CB, 2011, J NEUROSCI, V31, P8083, DOI 10.1523/JNEUROSCI.1129-11.2011; Chan TO, 2011, P NATL ACAD SCI USA, V108, pE1120, DOI 10.1073/pnas.1109879108; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; Du WL, 2010, J CLIN INVEST, V120, P3480, DOI 10.1172/JCI43165; Dutta S, 2002, BIOL CHEM, V383, P785, DOI 10.1515/BC.2002.082; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; FEDER D, 1990, J BIOL CHEM, V265, P8205; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hou XY, 2007, NEUROSCI LETT, V420, P235, DOI 10.1016/j.neulet.2007.03.048; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Jiang XN, 2008, ANN NEUROL, V63, P632, DOI 10.1002/ana.21365; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Lennmyr F, 2004, ACTA NEUROL SCAND, V110, P175, DOI 10.1111/j.1600-0404.2004.00306.x; Liang S, 2009, J PHARMACOL EXP THER, V331, P827, DOI 10.1124/jpet.109.156562; Liu DZ, 2008, NEUROBIOL DIS, V30, P201, DOI 10.1016/j.nbd.2008.01.006; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Markowitz Alison J B, 2007, Cellscience, V4, P111; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Moskowitz MA, 2010, STROKE, V41, pS85, DOI 10.1161/STROKEAHA.110.598458; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Mukalyama H, 2008, BIOORGAN MED CHEM, V16, P909, DOI 10.1016/j.bmc.2007.10.068; Mukherjee A, 2011, CURR OPIN CELL BIOL, V23, P223, DOI 10.1016/j.ceb.2010.12.006; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Roulston CL, 2008, EUR J PHARMACOL, V584, P100, DOI 10.1016/j.ejphar.2008.01.046; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; SHARKEY J, 1993, J CEREBR BLOOD F MET, V13, P865, DOI 10.1038/jcbfm.1993.108; Shioda N, 2007, J NEUROCHEM, V102, P1506, DOI 10.1111/j.1471-4159.2007.04600.x; Takadera T, 2012, NEUROTOX RES, V21, P309, DOI 10.1007/s12640-011-9284-5; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8	58	34	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9696	9709		10.1074/jbc.M112.419713	http://dx.doi.org/10.1074/jbc.M112.419713			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23400779	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000317114000012
J	Adkins, DE; Souza, RP; Aberg, K; Clark, SL; McClay, JL; Sullivan, PF; van den Oord, EJCG				Adkins, Daniel E.; Souza, Renan P.; Aberg, Karolina; Clark, Shaunna L.; McClay, Joseph L.; Sullivan, Patrick F.; van den Oord, Edwin J. C. G.			Genotype-Based Ancestral Background Consistently Predicts Efficacy and Side Effects across Treatments in CATIE and STAR*D	PLOS ONE			English	Article							NUCLEOTIDE-POLYMORPHISM PANEL; FALSE DISCOVERY RATE; GENOMEWIDE ASSOCIATION; SCHIZOPHRENIA; OUTCOMES; RACE; CARE	Only a subset of patients will typically respond to any given prescribed drug. The time it takes clinicians to declare a treatment ineffective leaves the patient in an impaired state and at unnecessary risk for adverse drug effects. Thus, diagnostic tests robustly predicting the most effective and safe medication for each patient prior to starting pharmacotherapy would have tremendous clinical value. In this article, we evaluated the use of genetic markers to estimate ancestry as a predictive component of such diagnostic tests. We first estimated each patient's unique mosaic of ancestral backgrounds using genome-wide SNP data collected in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) (n = 765) and the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) (n = 1892). Next, we performed multiple regression analyses to estimate the predictive power of these ancestral dimensions. For 136/89 treatment-outcome combinations tested in CATIE/STAR*D, results indicated 1.67/1.84 times higher median test statistics than expected under the null hypothesis assuming no predictive power (p<0.01, both samples). Thus, ancestry showed robust and pervasive correlations with drug efficacy and side effects in both CATIE and STAR*D. Comparison of the marginal predictive power of MDS ancestral dimensions and self-reported race indicated significant improvements to model fit with the inclusion of MDS dimensions, but mixed evidence for self-reported race. Knowledge of each patient's unique mosaic of ancestral backgrounds provides a potent immediate starting point for developing algorithms identifying the most effective and safe medication for a wide variety of drug-treatment response combinations. As relatively few new psychiatric drugs are currently under development, such personalized medicine offers a promising approach toward optimizing pharmacotherapy for psychiatric conditions.	[Adkins, Daniel E.; Souza, Renan P.; Aberg, Karolina; Clark, Shaunna L.; McClay, Joseph L.; van den Oord, Edwin J. C. G.] Virginia Commonwealth Univ, Med Coll Virginia, Sch Pharm, Ctr Biomarker Res & Personalized Med, Richmond, VA 23298 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet	van den Oord, EJCG (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Sch Pharm, Ctr Biomarker Res & Personalized Med, Richmond, VA 23298 USA.	ejvandenoord@vcu.edu	Souza, Renan Pedra de/G-8394-2011; Aberg, Karolina/A-6772-2010; McClay, Joseph/C-9931-2009	Souza, Renan Pedra de/0000-0002-9479-4432; Aberg, Karolina/0000-0001-6103-5168; McClay, Joseph/0000-0002-3628-2447	National Institute of Mental Health (NIMH) [R01MH078069, K01MH093731, R01MH080403, MH080403]; Eli Lily; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078069, R01MH080403, K01MH093731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA021266] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eli Lily; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	EvdO is partially supported by grants R01MH078069, DEA by K01MH093731 and PFS by R01MH080403 from the National Institute of Mental Health (NIMH). Eli Lily funded part of the genotyping conducted in the CATIE sample. PFS reports receiving research funding from Eli Lilly. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. EvdO is partially supported by grants R01MH078069 and PFS by MH080403 from the National Institute of Mental Health (NIMH). Eli Lily funded part of the genotyping conducted in the CATIE sample. PFS reports receiving research funding from Eli Lilly. No additional external funding was received for this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aberg K, 2010, PHARMACOGENOMICS J; Aberg K, 2010, BIOL PSYCHIAT, V67, P279, DOI 10.1016/j.biopsych.2009.08.036; Adkins DE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.57; Adkins DE, 2011, MOL PSYCHIATR, V16, P321, DOI 10.1038/mp.2010.14; Adkins DE, 2012, SCHIZOPHR RES, V135, P200, DOI 10.1016/j.schres.2011.11.002; Adkins Daniel E, 2010, Biol Psychiatry, V68, pe25, DOI 10.1016/j.biopsych.2010.05.018; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braff DL, 2008, AM J PSYCHIAT, V165, P952, DOI 10.1176/appi.ajp.2008.08050717; Clark SL, 2012, PSYCHOL MED, V42, P1151, DOI 10.1017/S003329171100239X; Clark SL, 2011, SCHIZOPHR RES, V132, P114, DOI 10.1016/j.schres.2011.07.031; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Couzin J, 2008, SCIENCE, V319, P274, DOI 10.1126/science.319.5861.274; Crowley JJ, 2009, PHARMACOGENOMICS, V10, P161, DOI 10.2217/14622416.10.2.161; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Garriock HA, 2010, BIOL PSYCHIAT, V67, P133, DOI 10.1016/j.biopsych.2009.08.029; Holden C, 2003, SCIENCE, V302, P594, DOI 10.1126/science.302.5645.594; Karter AJ, 2003, INT J EPIDEMIOL, V32, P26, DOI 10.1093/ije/dyg033; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; McClay JL, 2011, MOL PSYCHIATR, V16, P76, DOI 10.1038/mp.2009.89; McClay JL, 2011, NEUROPSYCHOPHARMACOL, V36, P616, DOI 10.1038/npp.2010.193; Mountain JL, 2004, NAT GENET, V36, pS48, DOI 10.1038/ng1456; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Paul D, 2008, ANN STAT, V36, P1595, DOI 10.1214/009053607000000578; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson GK., 1991, STAT SCI, V6, P18, DOI DOI 10.1214/SS/1177011926; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Simon GE, 2001, ARCH GEN PSYCHIAT, V58, P395, DOI 10.1001/archpsyc.58.4.395; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Stroup TS, 2003, SCHIZOPHRENIA BULL, V29, P15, DOI 10.1093/oxfordjournals.schbul.a006986; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; van den Oord EJCG, 2009, SCHIZOPHR RES, V107, P13, DOI 10.1016/j.schres.2008.09.009; Williams DR, 2010, J HEALTH SOC BEHAV, V51, pS15, DOI 10.1177/0022146510383838; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	43	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55239	10.1371/journal.pone.0055239	http://dx.doi.org/10.1371/journal.pone.0055239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405125	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400070
J	Gianforcaro, A; Solomon, JA; Hamadeh, MJ				Gianforcaro, Alexandro; Solomon, Jesse A.; Hamadeh, Mazen J.			Vitamin D-3 at 50x AI Attenuates the Decline in Paw Grip Endurance, but Not Disease Outcomes, in the G93A Mouse Model of ALS, and Is Toxic in Females	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; RECEPTOR KNOCKOUT MICE; CENTRAL-NERVOUS-SYSTEM; 1,25-DIHYDROXYVITAMIN D-3; CALCIUM SUPPLEMENTATION; CALORIC RESTRICTION; MESSENGER-RNA; GROWTH-FACTOR	Background: We previously demonstrated that dietary vitamin D-3 at 10x the adequate intake (AI) attenuates the decline in functional capacity in the G93A mouse model of ALS. We hypothesized that higher doses would elicit more robust changes in functional and disease outcomes. Objective: To determine the effects of dietary vitamin D-3 at 50xAI on functional outcomes (motor performance, paw grip endurance) and disease severity (clinical score), as well as disease onset, disease progression and lifespan in the transgenic G93A mouse model of ALS. Methods: Starting at age 25 d, 100 G93A mice (55 M, 45 F) were provided ad libitum with either an adequate (AI; 1 IU D-3/g feed) or high (HiD; 50 IU D-3/g feed) vitamin D-3 diet. Results: HiD females consumed 9% less food corrected for body weight vs. AI females (P = 0.010). HiD mice had a 12% greater paw grip endurance over time between age 60-141 d (P = 0.015), and a 37% greater score during disease progression (P = 0.042) vs. AI mice. Although HiD females had a non-significant 31% greater CS prior to disease onset vs. AI females, they exhibited a significant 20% greater paw grip endurance AUC (P = 0.020) when corrected for clinical score. Conclusion: Dietary D-3 supplementation at 50x the adequate intake attenuated the decline in paw grip endurance, but did not influence age at disease onset, hindlimb paralysis or endpoint in the transgenic G93A mouse model of ALS. Furthermore, females may have reached the threshold for vitamin D-3 toxicity as evidence by reduced food intake and greater disease severity prior to disease onset.	[Gianforcaro, Alexandro; Solomon, Jesse A.; Hamadeh, Mazen J.] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Gianforcaro, Alexandro; Solomon, Jesse A.; Hamadeh, Mazen J.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Hamadeh, Mazen J.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	York University - Canada; York University - Canada; McMaster University	Hamadeh, MJ (corresponding author), York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	hamadeh@yorku.ca		Hamadeh, Mazen/0000-0002-3511-4345	Natural Sciences and Engineering Research Council of Canada [341445]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding provided by the Natural Sciences and Engineering Research Council of Canada - #341445. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIERI JG, 1977, J NUTR, V107, P1394; BIRGE SJ, 1975, J CLIN INVEST, V56, P1100, DOI 10.1172/JCI108184; Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343; Bischoff HA, 2001, HISTOCHEM J, V33, P19, DOI 10.1023/A:1017535728844; Broe KE, 2007, J AM GERIATR SOC, V55, P234, DOI 10.1111/j.1532-5415.2007.01048.x; Burne THJ, 2006, BRAIN RES BULL, V69, P74, DOI 10.1016/j.brainresbull.2005.10.014; Burne THJ, 2005, BEHAV BRAIN RES, V157, P299, DOI 10.1016/j.bbr.2004.07.008; Cantorna MT, 1999, J NUTR, V129, P1966, DOI 10.1093/jn/129.11.1966; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Cornet A, 1998, J NEUROSCI RES, V53, P742, DOI 10.1002/(SICI)1097-4547(19980915)53:6<742::AID-JNR11>3.0.CO;2-#; Endo I, 2003, ENDOCRINOLOGY, V144, P5138, DOI 10.1210/en.2003-0502; Enomoto T, 2010, J BONE MINER METAB; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Fleet JC, 2008, J NUTR, V138, P1114, DOI 10.1093/jn/138.6.1114; Garcion E, 1997, MOL BRAIN RES, V45, P255, DOI 10.1016/S0169-328X(96)00260-4; Gianforcaro A, 2012, CNS NEUROSCI THER, V18, P547, DOI 10.1111/j.1755-5949.2012.00316.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; Hamadeh MJ, 2006, MUSCLE NERVE, V34, P709, DOI 10.1002/mus.20630; Hamadeh MJ, 2005, MUSCLE NERVE, V31, P214, DOI 10.1002/mus.20255; Hamden K, 2009, J NUTR SCI VITAMINOL, V55, P215, DOI 10.3177/jnsv.55.215; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; HUGHES MR, 1977, ENDOCRINOLOGY, V100, P799, DOI 10.1210/endo-100-3-799; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Minasyan A, 2009, J STEROID BIOCHEM, V114, P161, DOI 10.1016/j.jsbmb.2009.01.020; Nashold FE, 2009, J IMMUNOL, V183, P3672, DOI 10.4049/jimmunol.0901351; Nataf S, 1996, J NEUROPATH EXP NEUR, V55, P904, DOI 10.1097/00005072-199608000-00006; National Research Council (NRC), 1995, NUTR REQ LAB AN, DOI [10.17226/4758, DOI 10.17226/4758]; Naveilhan P, 1996, NEUROREPORT, V7, P2171, DOI 10.1097/00001756-199609020-00023; NEVEU I, 1994, MOL BRAIN RES, V24, P70, DOI 10.1016/0169-328X(94)90119-8; Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386; Patel BP, 2009, CLIN NUTR, V28, P604, DOI 10.1016/j.clnu.2009.06.002; Pfeifer M, 2009, OSTEOPOROSIS INT, V20, P315, DOI 10.1007/s00198-008-0662-7; Pfeifer M, 2000, J BONE MINER RES, V15, P1113, DOI 10.1359/jbmr.2000.15.6.1113; Prufer K, 1999, J CHEM NEUROANAT, V16, P135, DOI 10.1016/S0891-0618(99)00002-2; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ross AC, 2011, J AM DIET ASSOC, V111, P524, DOI 10.1016/j.jada.2011.01.004; Rowling MJ, 2007, J NUTR, V137, P2608, DOI 10.1093/jn/137.12.2608; Sanchez B, 2002, MOL BRAIN RES, V108, P143, DOI 10.1016/S0169-328X(02)00545-4; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; SAPORITO MS, 1994, BRAIN RES, V633, P189, DOI 10.1016/0006-8993(94)91539-3; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; SILVA ME, 1993, COMP BIOCHEM PHYS A, V104, P175, DOI 10.1016/0300-9629(93)90026-Z; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029354; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020582; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Taniura H, 2006, J NEUROSCI RES, V83, P1179, DOI 10.1002/jnr.20824; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Veenstra TD, 1997, BIOCHEM BIOPH RES CO, V235, P15, DOI 10.1006/bbrc.1997.6718; Vieth R, 2000, J NUTR, V130, P578, DOI 10.1093/jn/130.3.578; Vucic S, 2009, CURR MOL MED, V9, P255, DOI 10.2174/156652409787847173; Wang JY, 2001, BRAIN RES, V904, P67, DOI 10.1016/S0006-8993(01)02450-7; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Zhang ZL, 2011, ENDOCR RES, V36, P101, DOI 10.3109/07435800.2010.542415	56	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e30243	10.1371/journal.pone.0030243	http://dx.doi.org/10.1371/journal.pone.0030243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405058	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400001
J	Loucoubar, C; Grange, L; Paul, R; Huret, A; Tall, A; Telle, O; Roussilhon, C; Faye, J; Diene-Sarr, F; Trape, JF; Mercereau-Puijalon, O; Sakuntabhai, A; Bureau, JF				Loucoubar, Cheikh; Grange, Laura; Paul, Richard; Huret, Augustin; Tall, Adama; Telle, Olivier; Roussilhon, Christian; Faye, Joseph; Diene-Sarr, Fatoumata; Trape, Jean-Francois; Mercereau-Puijalon, Odile; Sakuntabhai, Anavaj; Bureau, Jean-Francois			High Number of Previous Plasmodium falciparum Clinical Episodes Increases Risk of Future Episodes in a Sub-Group of Individuals	PLOS ONE			English	Article							NATURALLY ACQUIRED-IMMUNITY; COMBATING MALARIA; TRANSMISSION; AGE; SUSCEPTIBILITY; MECHANISMS; MORBIDITY; AREA	There exists great disparity in the number of clinical P. falciparum episodes among children of the same age and living in similar conditions. The epidemiological determinants of such disparity are unclear. We used a data-mining approach to explore a nineteen-year longitudinal malaria cohort study dataset from Senegal and identify variables associated with increased risk of malaria episodes. These were then verified using classical statistics and replicated in a second cohort. In addition to age, we identified a novel high-risk group of children in whom the history of P. falciparum clinical episodes greatly increased risk of further episodes. Age and a high number of previous falciparum clinical episodes not only play major roles in explaining the risk of P. falciparum episodes but also are risk factors for different groups of people. Combined, they explain the majority of falciparum clinical attacks. Contrary to what is widely believed, clinical immunity to P. falciparum does not de facto occur following many P. falciparum clinical episodes. There exist a sub-group of children who suffer repeated clinical episodes. In addition to posing an important challenge for population stratification during clinical trials, this sub-group disproportionally contributes to the disease burden and may necessitate specific prevention and control measures.	[Loucoubar, Cheikh; Grange, Laura; Paul, Richard; Telle, Olivier; Roussilhon, Christian; Sakuntabhai, Anavaj; Bureau, Jean-Francois] Inst Pasteur, Dept Genome & Genet, Unite Genet Fonct Malad Infect, Paris, France; [Loucoubar, Cheikh; Grange, Laura; Paul, Richard; Telle, Olivier; Roussilhon, Christian; Sakuntabhai, Anavaj; Bureau, Jean-Francois] Ctr Natl Rech Sci, Unite Rech Associee 3012, Paris, France; [Loucoubar, Cheikh; Tall, Adama; Faye, Joseph; Diene-Sarr, Fatoumata] Inst Pasteur, Unite Epidemiol Malad Infect, Dakar, Senegal; [Loucoubar, Cheikh] Univ Paris 05, Unite Mixte Rech Ctr Natl Rech Sci 8145, Paris, France; [Loucoubar, Cheikh] Ecole Hautes Etud Sante Publ, Rennes, France; [Huret, Augustin] Inst Hlth & Sci, Paris, France; [Trape, Jean-Francois] Inst Rech Dev, Unite Pathogenie Afrotrop, Unite Mixte Rech 198, Dakar, Senegal; [Mercereau-Puijalon, Odile] Inst Pasteur, Dept Parasitol, Unite Immunol Mol Parasites, Paris, France; [Sakuntabhai, Anavaj] Mahidol Univ, Fac Sci, Syst Biol Dis Unit, Bangkok 10400, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University	Sakuntabhai, A (corresponding author), Inst Pasteur, Dept Genome & Genet, Unite Genet Fonct Malad Infect, Paris, France.	anavaj@pasteur.fr	Mercereau-Puijalon, Odile/AAA-2242-2020	Telle, Olivier/0000-0002-9473-8406; Bureau, Jean-Francois/0000-0003-1945-1883; Paul, Richard/0000-0002-0665-5089	Institut Pasteur, Paris; Institut Pasteur de Dakar; Institut de Recherche pour le Developpement; Institute of Health Science;  [ANR-11-BSV1-027-01]	Institut Pasteur, Paris; Institut Pasteur de Dakar; Institut de Recherche pour le Developpement; Institute of Health Science; 	Funding was provided by Institut Pasteur, Paris, Institut Pasteur de Dakar, Institut de Recherche pour le Developpement, and Institute of Health & Science. This article is linked to a project funded by ANR-11-BSV1-027-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Baird JK, 2003, ANN TROP MED PARASIT, V97, P557, DOI 10.1179/000349803225001472; BAIRD JK, 1995, PARASITOL TODAY, V11, P105, DOI 10.1016/0169-4758(95)80167-7; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Creasey A, 2004, PARASITOLOGY, V129, P263, DOI 10.1017/S0031182004005724; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Filion GJP, 2006, TRENDS PARASITOL, V22, P345, DOI 10.1016/j.pt.2006.06.005; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; HOGH B, 1994, ACTA TROP, V57, P265, DOI 10.1016/0001-706X(94)90072-8; Loucoubar C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024085; Marsh K, 1997, PHILOS T R SOC B, V352, P1385, DOI 10.1098/rstb.1997.0124; Menendez C, 2006, CURR MOL MED, V6, P269, DOI 10.2174/156652406776055186; Mwangi TW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002196; PERIGNON JL, 1994, MEM I OSWALDO CRUZ, V89, P51, DOI 10.1590/S0074-02761994000600013; PLAYFAIR JHL, 1990, IMMUNOL TODAY, V11, P25; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Sergent Ed., 1935, Arch Inst Pasteur Alger, V13, P279; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Smith T, 2012, TRENDS PARASITOL, V28, P3, DOI 10.1016/j.pt.2011.09.002; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1998, J INFECT DIS, V177, P819, DOI 10.1086/517818; Sokhna CS, 2000, AM J TROP MED HYG, V62, P266, DOI 10.4269/ajtmh.2000.62.266; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Trape JF, 2002, TRENDS PARASITOL, V18, P224, DOI 10.1016/S1471-4922(02)02249-3; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Vazquez AI, 2010, J ANIM SCI, V88, P497, DOI 10.2527/jas.2009-1952; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; WILLIAMSON WA, 1978, LANCET, V1, P1328	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55666	10.1371/journal.pone.0055666	http://dx.doi.org/10.1371/journal.pone.0055666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405191	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400136
J	Berghoff, AS; Spanberger, T; Ilhan-Mutlu, A; Magerle, M; Hutterer, M; Woehrer, A; Hackl, M; Widhalm, G; Dieckmann, K; Marosi, C; Birner, P; Prayer, D; Preusser, M				Berghoff, Anna Sophie; Spanberger, Thomas; Ilhan-Mutlu, Ayseguel; Magerle, Manuel; Hutterer, Markus; Woehrer, Adelheid; Hackl, Monika; Widhalm, Georg; Dieckmann, Karin; Marosi, Christine; Birner, Peter; Prayer, Daniela; Preusser, Matthias			Preoperative Diffusion-Weighted Imaging of Single Brain Metastases Correlates with Patient Survival Times	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; TUMOR-STROMA RATIO; PROGNOSTIC VALUE; MRI; COEFFICIENT; CARCINOMA; CELLULARITY; DIAGNOSIS; PERFUSION; GLIOMAS	Background: MRI-based diffusion-weighted imaging (DWI) visualizes the local differences in water diffusion in vivo. The prognostic value of DWI signal intensities on the source images and apparent diffusion coefficient (ADC) maps respectively has not yet been studied in brain metastases (BM). Methods: We included into this retrospective analysis all patients operated for single BM at our institution between 2002 and 2010, in whom presurgical DWI and BM tissue samples were available. We recorded relevant clinical data, assessed DWI signal intensity and apparent diffusion coefficient (ADC) values and performed histopathological analysis of BM tissues. Statistical analyses including uni- and multivariate survival analyses were performed. Results: 65 patients (34 female, 31 male) with a median overall survival time (OS) of 15 months (range 0-99 months) were available for this study. 19 (29.2%) patients presented with hyper-, 3 (4.6%) with iso-, and 43 (66.2%) with hypointense DWI. ADCmean values could be determined in 32 (49.2%) patients, ranged from 456.4 to 1691.8*10(-6) mm(2)/s (median 969.5) and showed a highly significant correlation with DWI signal intensity. DWI hyperintensity correlated significantly with high amount of interstitial reticulin deposition. In univariate analysis, patients with hyperintense DWI (5 months) and low ADCmean values (7 months) had significantly worse OS than patients with iso/hypointense DWI (16 months) and high ADCmean values (30 months), respectively. In multivariate survival analysis, high ADCmean values retained independent statistical significance. Conclusions: Preoperative DWI findings strongly and independently correlate with OS in patients operated for single BM and are related to interstitial fibrosis. Inclusion of DWI parameters into established risk stratification scores for BM patients should be considered.	[Berghoff, Anna Sophie; Woehrer, Adelheid] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Spanberger, Thomas; Prayer, Daniela] Med Univ Vienna, Div Neuroradiol, Dept Radiol, Vienna, Austria; [Ilhan-Mutlu, Ayseguel; Magerle, Manuel; Marosi, Christine; Preusser, Matthias] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Hutterer, Markus] Univ Hosp Regensburg, Wilhelm Sander NeuroOncol Therapy Unit, Dept Neurol, Regensburg, Germany; [Hackl, Monika] Stat Austria, Austrian Natl Canc Registry, Vienna, Austria; [Widhalm, Georg] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Dieckmann, Karin] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria; [Birner, Peter] Med Univ Vienna, Clin Inst Clin Pathol, Vienna, Austria; [Berghoff, Anna Sophie; Spanberger, Thomas; Ilhan-Mutlu, Ayseguel; Magerle, Manuel; Woehrer, Adelheid; Widhalm, Georg; Dieckmann, Karin; Marosi, Christine; Birner, Peter; Prayer, Daniela; Preusser, Matthias] Med Univ Vienna, Ctr Comprehens Canc, CNS Tumors Unit, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Regensburg; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Preusser, M (corresponding author), Med Univ Vienna, Dept Med 1, Vienna, Austria.	Matthias.preusser@meduniwien.ac.at	Widhalm, Georg/AFK-1669-2022; Preusser, Matthias/C-8530-2011; Hutterer, Markus/AAG-4535-2020	Widhalm, Georg/0000-0001-6014-0273; Preusser, Matthias/0000-0003-3541-2315; Berghoff, Anna Sophie/0000-0001-9379-6797; Woehrer, Adelheid/0000-0001-8435-8189	Austrian National Bank [13457]; scholarship program for scientific research of the city of Vienna [MA7-49139/13]	Austrian National Bank; scholarship program for scientific research of the city of Vienna	This study was supported by grant number 13457 of the Austrian National Bank (principle investigator: Matthias Preusser) and grant number MA7-49139/13 of the scholarship program for scientific research of the city of Vienna (recipient: Anna Sophie Berghoff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi T, 2012, EUR RADIOL, V22, P1172, DOI 10.1007/s00330-011-2359-0; Arvinda HR, 2009, J NEURO-ONCOL, V94, P87, DOI 10.1007/s11060-009-9807-6; Barajas RF, 2010, AM J NEURORADIOL, V31, P60, DOI 10.3174/ajnr.A1750; Berghoff AS, 2012, BRIT J CANCER, V107, P1454, DOI 10.1038/bjc.2012.440; Boxerman JL, 2010, AM J ROENTGENOL, V195, P720, DOI 10.2214/AJR.09.4128; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; Curvo-Semedo L, 2012, J MAGN RESON IMAGING, V35, P1365, DOI 10.1002/jmri.23589; de Kruijf EM, 2011, BREAST CANCER RES TR, V125, P687, DOI 10.1007/s10549-010-0855-6; Duygulu G, 2010, EUR J RADIOL, V74, P117, DOI 10.1016/j.ejrad.2009.03.004; Fan GG, 2006, BRIT J RADIOL, V79, P652, DOI 10.1259/bjr/25349497; Frisk G, 2012, BRIT J CANCER, V106, P1850, DOI 10.1038/bjc.2012.163; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Gaspar L E, 2000, Radiology, V215 Suppl, P1105; Hayashida Y, 2006, AM J NEURORADIOL, V27, P1419; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Lee EK, 2012, ACTA RADIOL IN PRESS; Mesker WE, 2007, CELL ONCOL, V29, P387; Moorman AM, 2012, EJSO-EUR J SURG ONC, V38, P307, DOI 10.1016/j.ejso.2012.01.002; Nakajo M, 2010, EUR J NUCL MED MOL I, V37, P2011, DOI 10.1007/s00259-010-1529-7; Ohno Y, 2012, AM J ROENTGENOL, V198, P75, DOI 10.2214/AJR.11.6525; Pillai S, 2011, CHILD NERV SYST, V27, P1407, DOI 10.1007/s00381-011-1499-5; Preusser M, 2012, EUR J CANC IN PRESS; Preusser M, 2012, CURR OPIN N IN PRESS; Preusser M, 2012, HISTOPATHOLOGY, V60, P885, DOI 10.1111/j.1365-2559.2011.04134.x; Sasaki M, 2008, RADIOLOGY, V249, P624, DOI 10.1148/radiol.2492071681; Schouten LJ, 2002, CANCER, V94, P2698, DOI 10.1002/cncr.10541; Silvera S, 2005, AM J NEURORADIOL, V26, P236; Soffietti R, 2006, EUR J NEUROL, V13, P674, DOI 10.1111/j.1468-1331.2006.01506.x; Sperduto PW, 2008, INT J RADIAT ONCOL, V70, P510, DOI 10.1016/j.ijrobp.2007.06.074; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Wang S, 2011, AM J NEURORADIOL, V32, P507, DOI 10.3174/ajnr.A2333; Wohrer A, 2009, J NEURO-ONCOL, V95, P401, DOI 10.1007/s11060-009-9938-9	33	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55464	10.1371/journal.pone.0055464	http://dx.doi.org/10.1371/journal.pone.0055464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393579	gold, Green Published, Green Submitted			2022-12-25	WOS:000314692800033
J	Bunthi, C; Thamthitiwat, S; Baggett, HC; Akarasewi, P; Ruangchira-urai, R; Maloney, SA; Ungchusak, K				Bunthi, Charatdao; Thamthitiwat, Somsak; Baggett, Henry C.; Akarasewi, Pasakorn; Ruangchira-urai, Ruchira; Maloney, Susan A.; Ungchusak, Kumnuan			Influenza A(H1N1)pdm09-Associated Pneumonia Deaths in Thailand	PLOS ONE			English	Article							PANDEMIC H1N1 2009; CRITICALLY-ILL PATIENTS; RISK-FACTORS; UNITED-STATES; INFECTION; VIRUS; HOSPITALIZATION; A(H1N1)	Background: The first human infections with influenza A(H1N1)pdm09 virus were confirmed in April 2009. We describe the clinical and epidemiological characteristics of influenza A(H1N1)pdm09-associated pneumonia deaths in Thailand from May 2009-January 2010. Methods: We identified influenza A(H1N1)pdm09-associated pneumonia deaths from a national influenza surveillance system and performed detailed reviews of a subset. Results: Of 198 deaths reported, 49% were male and the median age was 37 years; 146 (73%) were 20-60 years. Among 90 deaths with records available for review, 46% had no identified risk factors for severe influenza. Eighty-eight patients (98%) received antiviral treatment, but only 16 (18%) initiated therapy within 48 hours of symptom onset. Conclusions: Most influenza A(H1N1)pdm09 pneumonia fatalities in Thailand occurred in adults aged 20-60 years. Nearly half lacked high-risk conditions. Antiviral treatment recommendations may be especially important early in a pandemic before vaccine is available. Treatment should be considered as soon as influenza is suspected.	[Bunthi, Charatdao; Thamthitiwat, Somsak; Baggett, Henry C.; Maloney, Susan A.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Global Dis Detect Reg Ctr, Int Emerging Infect Program, Nonthaburi, Thailand; [Akarasewi, Pasakorn; Ungchusak, Kumnuan] Thailand Minist Publ Hlth, Bur Epidemiol, Nonthaburi, Thailand; [Ruangchira-urai, Ruchira] Mahidol Univ, Dept Pathol, Siriraj Hosp, Bangkok 10700, Thailand	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Mahidol University	Bunthi, C (corresponding author), US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Global Dis Detect Reg Ctr, Int Emerging Infect Program, Nonthaburi, Thailand.	charatdaob@th.cdc.gov			Thailand Ministry Of Public Health; U.S. Centers for Disease Control and Prevention (CDC)	Thailand Ministry Of Public Health; U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded primarily by the Thailand Ministry Of Public Health with additional support from the U.S. Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO REC PAND H1N1 20; Bassetti M, 2011, CLIN MICROBIOL INFEC, V17, P247, DOI 10.1111/j.1469-0691.2010.03275.x; Bassetti M, 2010, CLIN MICROBIOL INFEC; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P435; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Champunot R, 2010, JPN J INFECT DIS, V63, P251; Cox CM, 2011, CLIN INFECT DIS, V52, pS69, DOI 10.1093/cid/ciq011; Cui W, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-145; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESILVA UC, 2009, EURO SURVEILL, V14; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Dulyachai W, 2010, EMERG INFECT DIS, V16, P343, DOI 10.3201/eid1602.091733; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fowlkes AL, 2011, CLIN INFECT DIS, V52, pS60, DOI 10.1093/cid/ciq022; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Iamsirithaworn S., 2011, Siriraj Medical Journal, V63, P64; Ismail HIM, 2011, EMERG INFECT DIS, V17, P708, DOI 10.3201/eid1704.101212; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Lee C, 2011, HAEMOPHILIA, V17, P1, DOI 10.1111/j.1365-2516.2010.02478.x; Lees CH, 2011, EMERG INFECT DIS, V17, P1479, DOI 10.3201/eid1708.101914; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Cortes JMM, 2010, REV ESP SALUD PUBLIC, V84, P517, DOI 10.1590/S1135-57272010000500006; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Palache A, 2011, VACCINE, V29, P9459, DOI 10.1016/j.vaccine.2011.10.030; Pebody RG, 2010, EUROSURVEILLANCE, V15; Reichert T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-5; Restrepo Marcos I, 2010, Arch Bronconeumol, V46 Suppl 2, P13, DOI 10.1016/S0300-2896(10)70015-6; Santa-Olalla Peralta P, 2010, EUROSURVEILLANCE, V15; Peralta PS, 2010, REV ESP SALUD PUBLIC, V84, P547, DOI [10.1590/S1135-57272010000500008, 10.1590/s1135-57272010000500008]; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Tutuncu EE, 2010, SAUDI MED J, V31, P993; Ungchusak K, 2012, EMERG INFECT DIS, V18, P1058, DOI 10.3201/eid1807.110976; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; World Health Organization, 2009, CLIN MAN HUM INF PAN; Yokota RTC, 2011, EMERG INFECT DIS, V17, P1467, DOI 10.3201/eid1708.101233; Yokoyama T, 2010, INTERNAL MED, V49, P427, DOI 10.2169/internalmedicine.49.3022	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e54946	10.1371/journal.pone.0054946	http://dx.doi.org/10.1371/journal.pone.0054946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390508	Green Published, Green Submitted, gold			2022-12-25	WOS:000314691100024
J	Tuul, M; Kitao, H; Iimori, M; Matsuoka, K; Kiyonari, S; Saeki, H; Oki, E; Morita, M; Maehara, Y				Tuul, Munkhbold; Kitao, Hiroyuki; Iimori, Makoto; Matsuoka, Kazuaki; Kiyonari, Shinichi; Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko			Rad9, Rad17, TopBP1 and Claspin Play Essential Roles in Heat-Induced Activation of ATR Kinase and Heat Tolerance	PLOS ONE			English	Article							XENOPUS EGG EXTRACTS; DOUBLE-STRAND BREAKS; DNA-DAMAGE; FANCONI-ANEMIA; HISTONE H2AX; HOMOLOGOUS RECOMBINATION; CHECKPOINT ACTIVATION; CELLULAR-RESPONSE; GENOME INTEGRITY; S-PHASE	Hyperthermia is widely used to treat patients with cancer, especially in combination with other treatments such as radiation therapy. Heat treatment per se activates DNA damage responses mediated by the ATR-Chk1 and ATM-Chk2 pathways but it is not fully understood how these DNA damage responses are activated and affect heat tolerance. By performing a genetic analysis of human HeLa cells and chicken B lymphoma DT40 cells, we found that heat-induced Chk1 Ser345 phosphorylation by ATR was largely dependent on Rad9, Rad17, TopBP1 and Claspin. Activation of the ATR-Chk1 pathway by heat, however, was not associated with FancD2 monoubiquitination or RPA32 phosphorylation, which are known as downstream events of ATR kinase activation when replication forks are stalled. Downregulation of ATR, Rad9, Rad17, TopBP1 or Claspin drastically reduced clonogenic cell viability upon hyperthermia, while gene knockout or inhibition of ATM kinase reduced clonogenic viability only modestly. Suppression of the ATR-Chk1 pathway activation enhanced heat-induced phosphorylation of Chk2 Thr68 and simultaneous inhibition of ATR and ATM kinases rendered severe heat cytotoxicity. These data indicate that essential factors for activation of the ATR-Chk1 pathway at stalled replication forks are also required for heat-induced activation of ATR kinase, which predominantly contributes to heat tolerance in a non-overlapping manner with ATM kinase.	[Tuul, Munkhbold; Kitao, Hiroyuki; Iimori, Makoto] Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Fukuoka, Japan; [Tuul, Munkhbold; Saeki, Hiroshi; Oki, Eiji; Morita, Masaru; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan; [Kitao, Hiroyuki; Matsuoka, Kazuaki; Kiyonari, Shinichi; Maehara, Yoshihiko] Kyushu Univ, Innovat Anticanc Strategy Therapeut & Diag Grp, Innovat Ctr Med Redox Nav, Fukuoka, Japan; [Matsuoka, Kazuaki] Taiho Pharmaceut Co Ltd, Tokushima Res Ctr, Tokushima, Japan	Kyushu University; Kyushu University; Kyushu University; Taiho Pharmaceutical	Kitao, H (corresponding author), Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Fukuoka, Japan.	hkitao@surg2.med.kyushu-u.ac.jp	Kiyonari, Shinichi/I-7329-2014	Iimori, Makoto/0000-0003-1697-0178	Ministry of Education, Culture, Sports, Science and Technology of Japan; Science and Technology Incubation Program in Advanced Regions; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Incubation Program in Advanced Regions; Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (HK, HS, MM and YM). This work was also supported by the Science and Technology Incubation Program in Advanced Regions from the funding program 'Creation of Innovation Centers for Advanced Interdisciplinary Research Areas' from the Japan Science and Technology Agency, commissioned by the Ministry of Education, Culture, Sports, Science and Technology (YM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAI H, 1988, CANCER LETT, V40, P33, DOI 10.1016/0304-3835(88)90259-5; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Fujinaka Y, 2012, DNA REPAIR, V11, P247, DOI 10.1016/j.dnarep.2011.11.005; Furusawa Y, 2012, APOPTOSIS, V17, P102, DOI 10.1007/s10495-011-0660-7; Horsman MR, 2007, CLIN ONCOL-UK, V19, P418, DOI 10.1016/j.clon.2007.03.015; Hunt CR, 2007, CANCER RES, V67, P3010, DOI 10.1158/0008-5472.CAN-06-4328; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Kampinga HH, 2001, INT J RADIAT BIOL, V77, P399, DOI 10.1080/09553000010024687; Kaneko H, 2005, BIOCHEM BIOPH RES CO, V328, P1101, DOI 10.1016/j.bbrc.2005.01.073; Kim JE, 2005, MOL CELL BIOL, V25, P10907, DOI 10.1128/MCB.25.24.10907-10915.2005; Kim SM, 2005, J BIOL CHEM, V280, P38355, DOI 10.1074/jbc.M508673200; Kitao H, 2011, INT J HEMATOL, V93, P417, DOI 10.1007/s12185-011-0777-z; Kobayashi M, 2004, GENES CELLS, V9, P291, DOI 10.1111/j.1356-9597.2004.00728.x; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Laszlo A, 2009, CANCER RES, V69, P2042, DOI 10.1158/0008-5472.CAN-08-1639; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Matsuura K, 2008, J BIOL CHEM, V283, P25485, DOI 10.1074/jbc.M803111200; Medhurst AL, 2008, J CELL SCI, V121, P3933, DOI 10.1242/jcs.033688; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morita M, 2001, INT J RADIAT ONCOL, V49, P1259, DOI 10.1016/S0360-3016(00)01465-6; Ohno S, 1997, DIS COLON RECTUM, V40, P401, DOI 10.1007/BF02258383; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shigechi T, 2012, CANCER RES, V72, P1149, DOI 10.1158/0008-5472.CAN-11-2904; Sleeth KM, 2007, J MOL BIOL, V373, P38, DOI 10.1016/j.jmb.2007.07.068; Takahashi A, 2004, CANCER RES, V64, P8839, DOI 10.1158/0008-5472.CAN-04-1876; Takao N, 1999, ONCOGENE, V18, P7002, DOI 10.1038/sj.onc.1203172; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang YZ, 2001, J BIOL CHEM, V276, P20579, DOI 10.1074/jbc.M100874200; WARTERS RL, 1982, CANCER RES, V42, P4427; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yan S, 2009, CELL CYCLE, V8, P2877, DOI 10.4161/cc.8.18.9485; Yang XH, 2008, GENE DEV, V22, P1147, DOI 10.1101/gad.1632808; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	38	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55361	10.1371/journal.pone.0055361	http://dx.doi.org/10.1371/journal.pone.0055361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383325	Green Published, gold, Green Submitted			2022-12-25	WOS:000314597900032
J	Berryhill, ME; Wiener, M; Stephens, JA; Lohoff, FW; Coslett, HB				Berryhill, Marian E.; Wiener, Martin; Stephens, Jaclyn A.; Lohoff, Falk W.; Coslett, H. Branch			COMT and ANKK1-Taq-Ia Genetic Polymorphisms Influence Visual Working Memory	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; D2 RECEPTOR GENE; TRAUMATIC BRAIN-INJURY; RIGHT PARIETAL LOBE; VAL(158)MET POLYMORPHISM; PREFRONTAL CORTEX; BASAL GANGLIA; HEALTHY-VOLUNTEERS; EXECUTIVE FUNCTION; MESSENGER-RNA	Complex cognitive tasks such as visual working memory (WM) involve networks of interacting brain regions. Several neurotransmitters, including an appropriate dopamine concentration, are important for WM performance. A number of gene polymorphisms are associated with individual differences in cognitive task performance. COMT, for example, encodes catechol-o-methyl transferase the enzyme primarily responsible for catabolizing dopamine in the prefrontal cortex. Striatal dopamine function, linked with cognitive tasks as well as habit learning, is influenced by the Taq-Ia polymorphism of the DRD2/ANKK1 gene complex; this gene influences the density of dopamine receptors in the striatum. Here, we investigated the effects of these polymorphisms on a WM task requiring the maintenance of 4 or 6 items over delay durations of 1 or 5 seconds. We explored main effects and interactions between the COMT and DRD2/ANKK1-Taq-Ia polymorphisms on WM performance. Participants were genotyped for COMT (Val(158) Met) and DRD2/ANKK1-Taq-Ia (A1+, A1-) polymorphisms. There was a significant main effect of both polymorphisms. Participants' WM reaction times slowed with increased Val loading such that the Val/Val homozygotes made the slowest responses and the Met/Met homozygotes were the fastest. Similarly, WM reaction times were slower and more variable for the DRD2/ANKK1-Taq-Ia A1+ group than the A1- group. The main effect of COMT was only apparent in the DRD2/ANKK1-Taq-Ia A1- group. These findings link WM performance with slower dopaminergic metabolism in the prefrontal cortex as well as a greater density of dopamine receptors in the striatum.	[Berryhill, Marian E.; Stephens, Jaclyn A.] Univ Nevada, Dept Psychol, Memory & Brain Lab, Reno, NV 89557 USA; [Wiener, Martin; Coslett, H. Branch] Univ Penn, Dept Neurol, Perelman Sch Med, Lab Cognit & Neural Stimulat, Philadelphia, PA 19104 USA; [Lohoff, Falk W.] Univ Penn, Dept Psychiat, Perelman Sch Med, Translat Res Lab,Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Berryhill, ME (corresponding author), Univ Nevada, Dept Psychol, Memory & Brain Lab, Reno, NV 89557 USA.	mberryhill@unr.edu	Lohoff, Falk W/M-7951-2016	Berryhill, Marian/0000-0002-8218-6587	University of Nevada; COBRE [1P20GM103650-01, R15EY022775]; NATIONAL EYE INSTITUTE [R15EY022775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103650] Funding Source: NIH RePORTER	University of Nevada; COBRE; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by faculty start-up funds generously provided by the University of Nevada to MB and by COBRE 1P20GM103650-01 (PI M. Webster, project PI MB) and R15EY022775 to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2008, AM J MED GENET B, V147B, P898, DOI 10.1002/ajmg.b.30705; Allen RJ, 2012, Q J EXP PSYCHOL, V65, P2369, DOI 10.1080/17470218.2012.687384; Anderson DE, 2012, J COGNITIVE NEUROSCI, V24, P1069, DOI 10.1162/jocn_a_00207; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Backman L, 2011, SCIENCE, V333, P718, DOI 10.1126/science.1204978; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1775, DOI 10.1016/j.neuropsychologia.2008.03.005; Berryhill ME, 2008, NEUROPSYCHOLOGIA, V46, P1767, DOI 10.1016/j.neuropsychologia.2008.01.009; Berryhill ME, 2010, NEUROSCI LETT, V479, P312, DOI 10.1016/j.neulet.2010.05.087; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Boscarino JA, 2012, NEUROPSYCH DIS TREAT, V8, P131, DOI 10.2147/NDT.S29508; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; CAMPS M, 1989, NEUROSCIENCE, V28, P275, DOI 10.1016/0306-4522(89)90179-6; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Colzato LS, 2010, NEUROPSYCHOLOGIA, V48, P2764, DOI 10.1016/j.neuropsychologia.2010.04.023; Cools R, 2008, J NEUROSCI, V28, P1208, DOI 10.1523/JNEUROSCI.4475-07.2008; Cools R, 2011, CURR OPIN NEUROBIOL, V21, P402, DOI 10.1016/j.conb.2011.04.002; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; de Frias CM, 2005, J COGNITIVE NEUROSCI, V17, P1018, DOI 10.1162/0898929054475136; Diamond A, 2007, CEREB CORTEX, V17, pI161, DOI [10.1093/cercor/bhm082, 10.1093/cercor/blini082]; Diaz-Asper CM, 2008, BIOL PSYCHIAT, V63, P72, DOI 10.1016/j.biopsych.2007.03.031; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Gruber AJ, 2006, J COMPUT NEUROSCI, V20, P153, DOI 10.1007/s10827-005-5705-x; Hazy TE, 2006, NEUROSCIENCE, V139, P105, DOI 10.1016/j.neuroscience.2005.04.067; Hirvonen MM, 2009, PROG NEURO-PSYCHOPH, V33, P630, DOI 10.1016/j.pnpbp.2009.02.021; Ho T, 2012, J NEUROSCI, V32, P7992, DOI 10.1523/JNEUROSCI.0340-12.2012; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Nagel IE, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.001.2008; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Noble E P, 2000, Pharmacogenomics, V1, P309, DOI 10.1517/14622416.1.3.309; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Oroszi G, 2004, PHARMACOGENOMICS, V5, P1037, DOI 10.1517/14622416.5.8.1037; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Schellekens AF, 2012, ADDICTION BIOL; Slifstein M, 2008, MOL PSYCHIATR, V13, P821, DOI 10.1038/mp.2008.19; Stefanis NC, 2005, AM J PSYCHIAT, V162, P1752, DOI 10.1176/appi.ajp.162.9.1752; Stelzel C, 2009, EUR J NEUROSCI, V29, P1056, DOI 10.1111/j.1460-9568.2009.06647.x; Stormer VS, 2012, DEV PSYCHOL, V48, P875, DOI 10.1037/a0026198; Tammimaki AE, 2010, PHARMACOGENET GENOM, V20, P717, DOI 10.1097/FPC.0b013e328340bdf2; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Tunbridge EM, 2012, CNS NEUROLOGICAL DIS; Wiener M, 2011, J COGNITIVE NEUROSCI, V23, P2811, DOI 10.1162/jocn.2011.21626; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; Wishart HA, 2011, J INT NEUROPSYCH SOC, V17, P174, DOI 10.1017/S1355617710001402	62	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55862	10.1371/journal.pone.0055862	http://dx.doi.org/10.1371/journal.pone.0055862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383291	gold, Green Submitted, Green Published			2022-12-25	WOS:000314610600166
J	Diaz, MR; Wadleigh, A; Kumar, S; De Schutter, E; Valenzuela, CF				Diaz, Marvin R.; Wadleigh, Aya; Kumar, Shyam; De Schutter, Erik; Valenzuela, C. Fernando			Na+/K+-ATPase Inhibition Partially Mimics the Ethanol-Induced Increase of the Golgi Cell-Dependent Component of the Tonic GABAergic Current in Rat Cerebellar Granule Cells	PLOS ONE			English	Article							GABA(A) RECEPTORS; SIMULATED ISCHEMIA; HIPPOCAMPAL CA1; TRANSMISSION; SPILLOVER; ACTIVATION; NEURONS; SUBUNIT; RELEASE; CORTEX	Cerebellar granule cells (CGNs) are one of many neurons that express phasic and tonic GABAergic conductances. Although it is well established that Golgi cells (GoCs) mediate phasic GABAergic currents in CGNs, their role in mediating tonic currents in CGNs (CGN-I-tonic) is controversial. Earlier studies suggested that GoCs mediate a component of CGN-I-tonic that is present only in preparations from immature rodents. However, more recent studies have detected a GoC-dependent component of CGN-I-tonic in preparations of mature rodents. In addition, acute exposure to ethanol was shown to potentiate the GoC component of CGN-I-tonic and to induce a parallel increase in spontaneous inhibitory postsynaptic current frequency at CGNs. Here, we tested the hypothesis that these effects of ethanol on GABAergic transmission in CGNs are mediated by inhibition of the Na+/K+-ATPase. We used whole-cell patch-clamp electrophysiology techniques in cerebellar slices of male rats (postnatal day 23-30). Under these conditions, we reliably detected a GoC-dependent component of CGN-I-tonic that could be blocked with tetrodotoxin. Further analysis revealed a positive correlation between basal sIPSC frequency and the magnitude of the GoC-dependent component of CGN-I-tonic. Inhibition of the Na+/K+-ATPase with a submaximal concentration of ouabain partially mimicked the ethanol-induced potentiation of both phasic and tonic GABAergic currents in CGNs. Modeling studies suggest that selective inhibition of the Na+/K+-ATPase in GoCs can, in part, explain these effects of ethanol. These findings establish a novel mechanism of action of ethanol on GABAergic transmission in the central nervous system.	[Diaz, Marvin R.; Wadleigh, Aya; Valenzuela, C. Fernando] Univ New Mexico, Dept Neurosci, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Kumar, Shyam; De Schutter, Erik] Okinawa Inst Sci & Technol, Computat Neurosci Unit, Onna, Okinawa, Japan; [De Schutter, Erik] Univ Antwerp, Dept Theoret Neurobiol, Antwerp, Belgium	University of New Mexico; University of New Mexico's Health Sciences Center; Okinawa Institute of Science & Technology Graduate University; University of Antwerp	Valenzuela, CF (corresponding author), Univ New Mexico, Dept Neurosci, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	fvalenzuela@salud.unm.edu	Sudhakar, Shyam Kumar/K-9321-2019; De Schutter, Erik/G-8460-2011; Zucca, Aya/G-2458-2015	De Schutter, Erik/0000-0001-8618-5138; Zucca, Aya/0000-0001-8613-8315; Diaz, Marvin/0000-0002-6786-5709	National Institutes of Health grant [AA14973]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014973, R56AA014973] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by National Institutes of Health grant AA14973. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN PG, 1995, J NEUROSCI METH, V59, P139, DOI 10.1016/0165-0270(94)00204-T; Allen NJ, 2004, J PHYSIOL-LONDON, V561, P485, DOI 10.1113/jphysiol.2004.070490; Allen NJ, 2004, J NEUROSCI, V24, P3837, DOI 10.1523/JNEUROSCI.5539-03.2004; Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; Botta P, 2011, ALCOHOLISM CLIN EXPT; Botta P, 2010, NEUROPSYCHOPHARMACOL, V35, P1984, DOI 10.1038/npp.2010.76; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Bright DP, 2011, J NEUROSCI, V31, P753, DOI 10.1523/JNEUROSCI.2996-10.2011; Capogna M, 2011, TRENDS NEUROSCI, V34, P101, DOI 10.1016/j.tins.2010.10.005; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Carta M, 2004, J NEUROSCI, V24, P3746, DOI 10.1523/JNEUROSCI.0067-04.2004; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Crowley JJ, 2009, NEURON, V63, P843, DOI 10.1016/j.neuron.2009.09.004; Diaz MR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2011.00148; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Diwakar S, 2009, J NEUROPHYSIOL, V101, P519, DOI 10.1152/jn.90382.2008; Dugue GP, 2009, NEURON, V61, P126, DOI 10.1016/j.neuron.2008.11.028; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Hamada L, 2003, BRIT J PHARMACOL, V138, P1517, DOI 10.1038/sj.bjp.0705170; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Huang CM, 2007, ALCOHOL CLIN EXP RES, V31, P336, DOI 10.1111/j.1530-0277.2006.00309.x; Huang J, 2012, ALCOHOLISM CLIN EXPT; Hull C, 2012, NEURON, V73, P149, DOI 10.1016/j.neuron.2011.10.030; Ito M, 1984, CEREBELLUM NEURAL CO; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Koch U, 2009, CURR OPIN NEUROBIOL, V19, P305, DOI 10.1016/j.conb.2009.03.006; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Li KC, 2011, NEURON, V69, P974, DOI 10.1016/j.neuron.2011.01.022; Mitchell SJ, 2000, J NEUROSCI, V20, P8651; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Ransom CB, 2010, J NEUROSCI, V30, P7672, DOI 10.1523/JNEUROSCI.0290-10.2010; Richards KS, 2007, J PHYSIOL-LONDON, V585, P491, DOI 10.1113/jphysiol.2007.144733; Rojas H, 2004, JPN J PHYSIOL, V54, P249, DOI 10.2170/jjphysiol.54.249; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; SAXENA NC, 1994, J NEUROSCI, V14, P7077; Simoes de Souza Fabio M, 2011, Neural Syst Circuits, V1, P7, DOI 10.1186/2042-1001-1-7; Solinas S, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.002.2007; Szapiro G, 2009, NEUROSCIENCE, V162, P644, DOI 10.1016/j.neuroscience.2009.03.077; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Takeuchi A, 2006, J GEN PHYSIOL, V128, P495, DOI 10.1085/jgp.200609646; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Yamada J, 2007, CEREB CORTEX, V17, P1782, DOI 10.1093/cercor/bhl087; Yoon BE, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-42	50	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55673	10.1371/journal.pone.0055673	http://dx.doi.org/10.1371/journal.pone.0055673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23383260	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600143
J	Boscoe, FP; Schymura, MJ; Zhang, XL; Kramer, RA				Boscoe, Francis P.; Schymura, Maria J.; Zhang, Xiuling; Kramer, Rachel A.			Heuristic Algorithms for Assigning Hispanic Ethnicity	PLOS ONE			English	Article							MEDICARE ADMINISTRATIVE DATA; RACE; DISPARITIES; IDENTIFICATION; RACE/ETHNICITY; WHITE	We compared several techniques for assigning Hispanic ethnicity to records in data systems where this information may be missing, variously making use of country of origin, surname, race, and county of residence. We considered an algorithm in use by the North American Association of Central Cancer Registries (NAACCR), a variation of this developed by the authors, a "fast and frugal'' algorithm developed with the aid of recursive partitioning methods, and conventional logistic regression. With the exception of logistic regression, each approach was rule-based: if specific criteria were met, an ethnicity assignment was made; otherwise, the next criterion was considered, until all records were assigned. We evaluated the algorithms on a sample of over 500,000 female clients from the New York State Cancer Services Program for whom self-reported Hispanic ethnicity was known. We found that all approaches yielded similarly high accuracy, sensitivity, and positive predictive value in all parts of the state, from areas with very low to very high Hispanic populations. An advantage of the fast and frugal method is that it consists of a small number of easily remembered steps.	[Boscoe, Francis P.; Schymura, Maria J.; Zhang, Xiuling] New York State Dept Hlth, New York State Canc Registry, Albany, NY 12201 USA; [Kramer, Rachel A.] New York State Dept Hlth, New York State Canc Serv Program, Albany, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) System	Boscoe, FP (corresponding author), New York State Dept Hlth, New York State Canc Registry, Albany, NY 12201 USA.	fpb01@health.state.ny.us			Centers for Disease Control and Prevention's Cooperative Agreement [U58/DP000783]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000783] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention's Cooperative Agreement; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported in part by the Centers for Disease Control and Prevention's Cooperative Agreement U58/DP000783 (http://www.cdc.gov/), awarded to the New York State Department of Health through the National Program of Cancer Registries. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 2011, J PUBLIC HEALTH MAN, V17, P167, DOI 10.1097/PHH.0b013e3181f5426c; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Comstock RD, 2004, AM J EPIDEMIOL, V159, P611, DOI 10.1093/aje/kwh084; COOK EF, 1984, J CHRON DIS, V37, P721, DOI 10.1016/0021-9681(84)90041-9; Czerlinski Jean, 1999, SIMPLE HEURISTICS MA, P97, DOI DOI 10.1002/(SICI)1099-0771(200004/06)13:2<161::AID-BDM348>3.0.CO;2-P; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Elliott MN, 2008, HEALTH SERV RES, V43, P1722, DOI 10.1111/j.1475-6773.2008.00854.x; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P75; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; Lin SS, 2000, EPIDEMIOL REV, V22, P187, DOI 10.1093/oxfordjournals.epirev.a018032; Ma IWY, 2007, J CLIN EPIDEMIOL, V60, P572, DOI 10.1016/j.jclinepi.2006.11.009; Marrow H, 2003, ETHNICITIES, V3, P427, DOI DOI 10.1177/1468796803003004001; McAlpine DD, 2007, HEALTH SERV RES, V42, P2373, DOI 10.1111/j.1475-6773.2007.00771.x; Morgan RO, 2004, MED CARE, V42, P810, DOI 10.1097/01.mlr.0000132392.49176.5a; NAACCR Race and Ethnicity Work Group, 2011, NAACCR GUID ENH HISP; NAACCR Race and Ethnicity Work Group, 2010, NAACCR AS PAC ISL ID; National Research Council, 2004, ELIMINATING HLTH DIS, DOI [10.17226/10979, DOI 10.17226/10979]; North American Association of Central Cancer Registries, 2012, CINA DEL AN FIL; Passel Jeffrey, 2009, WHOS HISPANIC; Perkins RC., 1993, EVALUATING PASSEL WO; Rebbeck TR, 2006, J CLIN ONCOL, V24, P2164, DOI 10.1200/JCO.2005.05.1656; Smith DP, 2006, AM J PUBLIC HEALTH, V96, P1686, DOI 10.2105/AJPH.2003.035378; Stroupe KT, 2010, J REHABIL RES DEV, V47, P781, DOI 10.1682/JRRD.2009.08.0122; Thornton M, 2009, STANDARDS CANC REGIS, VII; Wei II, 2006, HEALTH SERV RES, V41, P1469, DOI 10.1111/j.1475-6773.2006.00550.x; Word DL, 2007, FREQUENTLY OCCURRING	26	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55689	10.1371/journal.pone.0055689	http://dx.doi.org/10.1371/journal.pone.0055689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092WJ	23405197	Green Published, gold			2022-12-25	WOS:000315153400142
J	Chiodin, M; Borve, A; Berezikov, E; Ladurner, P; Martinez, P; Hejnol, A				Chiodin, Marta; Borve, Aina; Berezikov, Eugene; Ladurner, Peter; Martinez, Pedro; Hejnol, Andreas			Mesodermal Gene Expression in the Acoel Isodiametra pulchra Indicates a Low Number of Mesodermal Cell Types and the Endomesodermal Origin of the Gonads	PLOS ONE			English	Article							SEA-URCHIN EMBRYO; CNIDARIAN NEMATOSTELLA-VECTENSIS; LEFT-RIGHT ASYMMETRY; MUSCLE LIM PROTEIN; STEM-CELLS; TRANSCRIPTION FACTORS; FOX GENES; DEVELOPMENTAL EXPRESSION; INDEPENDENT EVOLUTION; AMPHIOXUS DEVELOPMENT	Acoelomorphs are bilaterally symmetric small marine worms that lack a coelom and possess a digestive system with a single opening. Two alternative phylogenetic positions of this group within the animal tree are currently debated. In one view, Acoelomorpha is the sister group to all remaining Bilateria and as such, is a morphologically simple stepping stone in bilaterian evolution. In the other, the group is a lineage within the Deuterostomia, and therefore, has derived a simple morphology from a more complex ancestor. Acoels and the closely related Nemertodermatida and Xenoturbellida, which together form the Acoelomorpha, possess a very limited number of cell types. To further investigate the diversity and origin of mesodermal cell types we describe the expression pattern of 12 orthologs of bilaterian mesodermal markers including Six1/2, Twist, FoxC, GATA4/5/6, in the acoel Isodiametra pulchra. All the genes are expressed in stem cells (neoblasts), gonads, and at least subsets of the acoel musculature. Most are expressed in endomesodermal compartments of I. pulchra developing embryos similar to what has been described in cnidarians. Our molecular evidence indicates a very limited number of mesodermal cell types and suggests an endomesodermal origin of the gonads and the stem cell system. We discuss our results in light of the two prevailing phylogenetic positions of Acoelomorpha.	[Chiodin, Marta; Martinez, Pedro] Univ Barcelona, Dept Genet, Barcelona, Spain; [Borve, Aina; Hejnol, Andreas] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Ladurner, Peter] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Ladurner, Peter] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Berezikov, Eugene] Hubrecht Inst, Utrecht, Netherlands; [Martinez, Pedro] ICREA, Barcelona, Spain	University of Barcelona; University of Bergen; University of Innsbruck; University of Innsbruck; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); ICREA	Hejnol, A (corresponding author), Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway.	andreas.hejnol@sars.uib.no	Martinez, Pedro/O-5025-2014; Berezikov, Eugene/D-3363-2013; Hejnol, Andreas/C-5577-2012	Martinez, Pedro/0000-0003-3956-7541; Berezikov, Eugene/0000-0002-1145-2884; Hejnol, Andreas/0000-0003-2196-8507; Ladurner, Peter/0000-0002-0323-9266	FP7 Marie Curie International Re-integration Grant (IRG) [246450]; Spanish Ministry of Science and Innovation [BFU2006-00898/BMC]; Austrian Science Fund (FWF) [18099]; ICREA Funding Source: Custom	FP7 Marie Curie International Re-integration Grant (IRG); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ICREA(ICREA)	The work was supported by the following funding agencies: FP7 Marie Curie International Re-integration Grant (IRG) "Mesoderm Evolution" (246450) to AH (http://tinyurl.com/9covbsz); the Spanish Ministry of Science and Innovation to MC and PM (BFU2006-00898/BMC) (http://www.idi.mineco.gob.es); Austrian Science Fund (FWF) (http://www.fwf.ac.at) 18099 to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Arenas-Mena C, 2008, J EXP ZOOL PART B, V310B, P567, DOI 10.1002/jez.b.21225; Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Ax P, 1996, MULTICELLULAR ANIMAL; Azzaria M, 1996, DEV BIOL, V178, P289, DOI 10.1006/dbio.1996.0219; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Boone M, 2010, ACTA ZOOLOGICA, V92, P101; Boone M, 2011, ZOOMORPHOLOGY, V130, P273, DOI 10.1007/s00435-011-0137-9; Boorman CJ, 2002, EVOL DEV, V4, P354, DOI 10.1046/j.1525-142X.2002.02021.x; Boyer BC, 1996, DEV BIOL, V179, P329, DOI 10.1006/dbio.1996.0264; Boyle MJ, 2008, EVOL DEV, V10, P89, DOI 10.1111/j.1525-142X.2007.00216.x; Boyle MJ, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-2; Bresslau E., 1909, Verhandlungen der Deutschen Zoologischen Gesellschaft Leipzig, V19; Burton PM, 2008, J EXP ZOOL PART B, V310B, P5, DOI 10.1002/jez.b.21150; Cannon HG, 1925, NATURE, V115, P458, DOI 10.1038/115458a0; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; Chiodin M, 2011, J EXP ZOOL PART B, V316B, P427, DOI 10.1002/jez.b.21416; Ciglar L, 2009, CURR OPIN CELL BIOL, V21, P754, DOI 10.1016/j.ceb.2009.10.001; Clark R. B., 1964, DYNAMICS METAZOAN EV; Croce J, 2001, MECH DEVELOP, V107, P159, DOI 10.1016/S0925-4773(01)00470-1; De Mulder K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-69; De Mulder K, 2009, DEV BIOL, V334, P198, DOI 10.1016/j.ydbio.2009.07.019; De-Leon SBT, 2010, P NATL ACAD SCI USA, V107, P10103, DOI 10.1073/pnas.1004824107; Dolmatov IY, 2007, CELL TISSUE RES, V327, P371, DOI 10.1007/s00441-006-0314-1; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Edgecombe GD, 2011, ORG DIVERS EVOL, V11, P151, DOI 10.1007/s13127-011-0044-4; Egger B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005502; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; FRANSEN ME, 1980, ZOOMORPHOLOGIE, V95, P235, DOI 10.1007/BF00998124; Fritzenwanker JH, 2004, DEV BIOL, V275, P389, DOI 10.1016/j.ydbio.2004.08.014; Gardiner EG, 1895, J MORPHOL, V11, P155; Genikhovich G, 2011, DEVELOPMENT, V138, P4911, DOI 10.1242/dev.068122; Graff Ludwig von, 1891, ORG TURBELLARIA ACOE; Gschwentner R, 2001, CELL TISSUE RES, V304, P401, DOI 10.1007/s004410100375; Harada Y, 1996, MECH DEVELOP, V60, P163, DOI 10.1016/S0925-4773(96)00608-9; Haszprunar G, 1996, J ZOOL SYST EVOL RES, V34, P41; Hejnol A, 2008, NATURE, V456, P382, DOI 10.1038/nature07309; Hejnol A, 2008, PHILOS T R SOC B, V363, P1493, DOI 10.1098/rstb.2007.2239; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Henry JQ, 2000, DEV BIOL, V220, P285, DOI 10.1006/dbio.2000.9628; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Hooge MD, 2005, J ZOOL SYST EVOL RES, V43, P100, DOI 10.1111/j.1439-0469.2005.00301.x; Hooge MD, 2002, MOL PHYLOGENET EVOL, V24, P333, DOI 10.1016/S1055-7903(02)00236-1; Hooge MD, 2001, J MORPHOL, V249, P171, DOI 10.1002/jmor.1048; Horton AC, 2002, J EXP ZOOL, V294, P112, DOI 10.1002/jez.10151; Hyman LH, 1951, PLATYHELMINTHES RHYN; Jondelius U, 2011, SYST BIOL, V60, P845, DOI 10.1093/sysbio/syr073; Koinuma S, 2000, GENE, V259, P171, DOI 10.1016/S0378-1119(00)00426-1; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; Kozmik Z, 2007, DEV BIOL, V306, P143, DOI 10.1016/j.ydbio.2007.03.009; Ladurner P, 2000, DEV BIOL, V222, P359, DOI 10.1006/dbio.2000.9715; Lee PY, 2007, DEV BIOL, V307, P434, DOI 10.1016/j.ydbio.2007.05.005; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; Martin-Duran JM, 2010, DEV BIOL, V340, P145, DOI 10.1016/j.ydbio.2010.01.018; Martindale MQ, 1999, DEV BIOL, V214, P243, DOI 10.1006/dbio.1999.9427; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Mazet F, 2006, CURR BIOL, V16, pR314, DOI 10.1016/j.cub.2006.03.088; Moreno E, 2010, EVOL DEV, V12, P258, DOI 10.1111/j.1525-142X.2010.00411.x; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Obst M, 2011, ACTA ZOOL-STOCKHOLM, V92, P109, DOI 10.1111/j.1463-6395.2010.00496.x; Pfister D, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-9; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Remane A., 1950, VERH DTSCH ZOOL GES, V14, P16; Remane A., 1963, LOWER METAZOA, P78; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Rieger R, 1985, ORIGINS RELATIONSHIP, P101; RIEGER RM, 1987, ZOOMORPHOLOGY, V107, P191, DOI 10.1007/BF00312261; Rieger RM, 2005, HYDROBIOLOGIA, V535, P127, DOI 10.1007/s10750-004-4381-6; Rieger RM, 2003, INTEGR COMP BIOL, V43, P47, DOI 10.1093/icb/43.1.47; Rieger RM, 1991, MICROSCOPIC ANATOMY, V3, P7; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rossi L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r62; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; Ruppert EE, 1991, MICROSCOPIC ANATOMY, V4, P1; Salvini-Plawen L, 1978, J ZOOL SYST EVOL, P16; SALVINIPLAWEN LV, 1979, Z ZOOL SYST EVOL, V17, P10; Satoh G, 2002, J EXP ZOOL, V294, P136, DOI 10.1002/jez.10149; Schmidt-Rhaesa A, 2007, EVOLUTION ORGAN SYST; Scholz CB, 2003, DEV GENES EVOL, V212, P563, DOI 10.1007/s00427-002-0272-x; SCHUCHERT P, 1990, ACTA ZOOL-STOCKHOLM, V71, P5, DOI 10.1111/j.1463-6395.1990.tb01175.x; Seipel K, 2005, DEV BIOL, V282, P14, DOI 10.1016/j.ydbio.2005.03.032; Seipel K, 2004, INT J DEV BIOL, V48, P1, DOI 10.1387/ijdb.15005568; Seipel K, 2006, INT J DEV BIOL, V50, P589, DOI 10.1387/ijdb.062150ks; Semmler H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-14; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shankland M., 1997, EMBRYOLOGY CONSTRUCT; Shimeld SM, 2010, DEV BIOL, V340, P234, DOI 10.1016/j.ydbio.2010.01.015; SMITH JPS, 1991, T AM MICROSC SOC, V110, P12; SMITH PR, 1986, J MORPHOL, V188, P257, DOI 10.1002/jmor.1051880302; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; Stach T, 2002, ACTA ZOOL-STOCKHOLM, V83, P25, DOI 10.1046/j.1463-6395.2002.00097.x; Steinmetz PRH, 2012, NATURE, V487, P231, DOI 10.1038/nature11180; Stierwald M, 2004, DEV BIOL, V274, P70, DOI 10.1016/j.ydbio.2004.06.018; STORCH V, 1989, T AM MICROSC SOC, V108, P245, DOI 10.2307/3226343; Stronach BE, 1999, MOL BIOL CELL, V10, P2329, DOI 10.1091/mbc.10.7.2329; Tagawa K, 2000, J EXP ZOOL, V288, P23, DOI 10.1002/(SICI)1097-010X(20000415)288:1<23::AID-JEZ3>3.0.CO;2-H; Technau U, 2003, INT J DEV BIOL, V47, P531; Tu Q, 2006, DEV BIOL, V300, P49, DOI 10.1016/j.ydbio.2006.09.031; Tyler S, 1999, ZOOMORPHOLOGY, V119, P127, DOI 10.1007/s004350050087; Tyler S, 2001, INTERRELATIONSHIPS P, P3; Tyler S, 1985, ORIGINS RELATIONSHIP, P123; Wagner DE, 2012, CELL STEM CELL, V10, P299, DOI 10.1016/j.stem.2012.01.016; Wang YY, 2010, GENE DEV, V24, P2081, DOI 10.1101/gad.1951010; Worsaae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048529; Wotton KR, 2008, DEV DYNAM, V237, P1590, DOI 10.1002/dvdy.21553; Yankura KA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-143; Yasui K, 1998, DEV BIOL, V195, P49, DOI 10.1006/dbio.1997.8834; Yasui K, 2000, DEVELOPMENT, V127, P187; Zhang Y, 2007, SCI CHINA SER C, V50, P637, DOI 10.1007/s11427-007-0082-5	113	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55499	10.1371/journal.pone.0055499	http://dx.doi.org/10.1371/journal.pone.0055499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405161	Green Submitted, gold, Green Published			2022-12-25	WOS:000315153400106
J	Lachaud, CC; Pezzolla, D; Dominguez-Rodriguez, A; Smani, T; Soria, B; Hmadcha, A				Claude Lachaud, Christian; Pezzolla, Daniela; Dominguez-Rodriguez, Alejandro; Smani, Tarik; Soria, Bernat; Hmadcha, Abdelkrim			Functional Vascular Smooth Muscle-like Cells Derived from Adult Mouse Uterine Mesothelial Cells	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; IN-VITRO; IMMUNOHISTOCHEMICAL MARKERS; DIFFERENTIAL EXPRESSION; SEROSAL MESOTHELIUM; PERITONEAL-DIALYSIS; EPICARDIAL CELLS; H-CALDESMON; STEM-CELLS; MYOFIBROBLASTS	In mammalian visceral organs, vascular smooth muscle cells (VSMCs) originate from an epithelial-to-mesenchymal transition (EMT) of embryonic mesothelial cells (MCs). The ability of adult MCs to recapitulate EMT and to acquire smooth muscle (SM) markers upon provasculogenic culture suggested they might retain embryonic vasculogenic differentiation potential. However, it remains unknown whether adult MCs-derived SM-like cells may acquire specific vascular SM lineage markers and the functionality of differentiated contractile VSMCs. Here, we describe how a gentle trypsinization of adult mouse uterine cords could selectively detach their outermost uterine mesothelial layer cells. As other MCs; uterine MCs (UtMCs) uniformly expressed the epithelial markers beta-catenin, ZO-1, E-cadherin, CD54, CD29, and CK18. When cultured in a modified SM differentiation media (SMDM) UtMCs initiated a loss of epithelial characteristics and gained markers expression of EMT (Twist, Snail, and Slug), stem and progenitor (Nanog, Sox2, C-kit, Gata-4, Isl-1, and nestin), SM (alpha-SMA, calponin, caldesmon, SM22 alpha, desmin, SM-MHC, and smoothelin-B) and cardiac (BMP2, BMP4, ACTC1, sACTN, cTnI, cTnT, ANF, Cx43, and MLC2a). UtMCs repeatedly subcultured in SMDM acquired differentiated VSM-like characteristics and expressed smoothelin-B in the typical stress-fiber pattern expression of contractile VSMCs. Relevantly, UtMCs-derived VSM-like cells could generate "mechanical force" to compact collagen lattices and displayed in diverse degree voltage (K+) and receptor (endothelin-1, oxytocin, norepinephrine, carbachol and vasopressin)-induced [Ca2+](i) rises and contraction. Thus, we show for the first time that UtMCs could recapitulate in vitro differentiative events of early cardiovascular differentiation and transdifferentiate in cells exhibiting molecular and functional characteristics of VSMCs.	[Claude Lachaud, Christian; Pezzolla, Daniela; Soria, Bernat; Hmadcha, Abdelkrim] Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain; [Dominguez-Rodriguez, Alejandro; Smani, Tarik] Inst Biomed Sevilla Fisiopatol Cardiovasc, Seville, Spain; [Soria, Bernat; Hmadcha, Abdelkrim] CIBER Diabet & Enfermedades Metabol Asociadas CIB, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Soria, B (corresponding author), Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain.	bernat.soria@cabimer.es; karim.hmadcha@cabimer.es	Lachaud, Christian Claude/C-2036-2017; IBIS, CARDIOVASCULAR/P-3910-2015; , Bernat/AAL-6470-2021; Hmadcha, Abdelkrim/T-1173-2019; Hajami, Tarik Smani/D-5372-2016	Lachaud, Christian Claude/0000-0001-8698-4589; Hmadcha, Abdelkrim/0000-0002-4105-3702; Hajami, Tarik Smani/0000-0002-1877-7438; , Daniela/0000-0001-8060-3706; Dominguez Rodriguez, Alejandro/0000-0002-3508-8538; Soria, Bernat/0000-0002-2356-0380	Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia [PI-0022/2008]; Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia [CTS-6505, INP-2011-1615-900000]; FEDER; Instituto de Salud Carlos III [RD06/0010/0025, PI10/00964]; Ministry of Health and Consumer Affairs [TRA-120]	Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); FEDER(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministry of Health and Consumer Affairs	Authors are supported by the Fundacion Progreso y Salud, Consejeria de Salud, Junta de Andalucia (Grant PI-0022/2008); Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia (Grant CTS-6505; INP-2011-1615-900000); FEDER co-funded grants from Instituto de Salud Carlos III (Red TerCel-Grant RD06/0010/0025; PI10/00964) and the Ministry of Health and Consumer Affairs (Advanced Therapies Program Grant TRA-120). CIBERDEM is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Boselli C, 2002, J UROLOGY, V168, P2672, DOI 10.1016/S0022-5347(05)64242-5; Brown DJ, 2005, J VASC SURG, V41, P509, DOI 10.1016/j.jvs.2004.12.024; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Ceballos KM, 2000, AM J CLIN PATHOL, V114, P746, DOI 10.1309/K5JP-A9EN-UWN7-B5GG; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; Chen YL, 1999, EUR J PHARMACOL, V376, P45, DOI 10.1016/S0014-2999(99)00351-9; Chiavegato A, 1999, J MUSCLE RES CELL M, V20, P133, DOI 10.1023/A:1005411201187; Comin CE, 2007, AM J SURG PATHOL, V31, P1139, DOI 10.1097/PAS.0b013e318033e7a8; Council L, 2009, MODERN PATHOL, V22, P639, DOI 10.1038/modpathol.2009.9; Deruiter MC, 2001, DEV DYNAM, V221, P460, DOI 10.1002/dvdy.1156; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; FUKURODA T, 1994, BRIT J PHARMACOL, V113, P336, DOI 10.1111/j.1476-5381.1994.tb16901.x; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Hegde SS, 1997, BRIT J PHARMACOL, V120, P1409, DOI 10.1038/sj.bjp.0701048; Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622; Ijpenberg A, 2007, DEV BIOL, V312, P157, DOI 10.1016/j.ydbio.2007.09.014; Jain M, 1996, J CLIN INVEST, V98, P877; Jankowski M, 2000, P NATL ACAD SCI USA, V97, P6207, DOI 10.1073/pnas.110137497; Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280; Kawaguchi M, 2007, DEV DYNAM, V236, P2973, DOI 10.1002/dvdy.21334; Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107; Kim MR, 2009, STEM CELLS, V27, P191, DOI 10.1634/stemcells.2008-0363; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Liu JD, 2010, CIRC RES, V106, P1818, DOI 10.1161/CIRCRESAHA.110.217950; Liu QH, 2008, PERITON DIALYSIS INT, V28, pS88; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Masaki T, 2004, TRENDS PHARMACOL SCI, V25, P219, DOI 10.1016/j.tips.2004.02.008; Matsubara D, 2009, MODERN PATHOL, V22, P776, DOI 10.1038/modpathol.2009.27; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mutsaers S E, 2007, Cancer Treat Res, V134, P1; Mutsaers SE, 1997, EUR J CELL BIOL, V72, P24; Nasreen N, 2009, AM J PHYSIOL-LUNG C, V297, pL115, DOI 10.1152/ajplung.90587.2008; Oikawa H, 2010, EXP CELL RES, V316, P940, DOI 10.1016/j.yexcr.2009.10.025; Oishi K, 2000, AM J PHYSIOL-CELL PH, V279, pC1432, DOI 10.1152/ajpcell.2000.279.5.C1432; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pacini S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009861; Patel P, 2010, MATRIX BIOL, V29, P97, DOI 10.1016/j.matbio.2009.10.004; Patel P, 2010, KIDNEY INT, V77, P319, DOI 10.1038/ki.2009.436; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Qiu XF, 2008, HUM PATHOL, V39, P846, DOI 10.1016/j.humpath.2007.10.010; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rensen SS, 2008, CIRCULATION, V118, P828, DOI 10.1161/CIRCULATIONAHA.107.743690; Schlueter J, 2006, DEV BIOL, V295, P546, DOI 10.1016/j.ydbio.2006.03.036; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2007, CIRC RES, V101, P1194, DOI 10.1161/CIRCRESAHA.107.159053; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Eys GJ, 2007, TRENDS CARDIOVAS MED, V17, P26, DOI 10.1016/j.tcm.2006.11.001; van Tuyn J, 2007, STEM CELLS, V25, P271, DOI 10.1634/stemcells.2006-0366; Vedernikov YP, 2006, AM J OBSTET GYNECOL, V194, P252, DOI 10.1016/j.ajog.2005.05.006; Wada AM, 2003, CIRC RES, V92, P525, DOI 10.1161/01.RES.0000060484.11032.0B; Wang J, 2010, DEV CELL, V19, P903, DOI 10.1016/j.devcel.2010.10.022; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	68	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55181	10.1371/journal.pone.0055181	http://dx.doi.org/10.1371/journal.pone.0055181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405120	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400064
J	Gai, SP; Zhang, YX; Liu, CY; Zhang, Y; Zheng, GS				Gai, Shupeng; Zhang, Yuxi; Liu, Chunying; Zhang, Yang; Zheng, Guosheng			Transcript Profiling of Paoenia ostii during Artificial Chilling Induced Dormancy Release Identifies Activation of GA Pathway and Carbohydrate Metabolism	PLOS ONE			English	Article							HISTONE H2B MONOUBIQUITINATION; BUD DORMANCY; GENE-EXPRESSION; LEAFY SPURGE; CROWN BUDS; CELL-CYCLE; GIBBERELLIN BIOSYNTHESIS; PAEONIA-SUFFRUTICOSA; HYDROGEN CYANAMIDE; RESPONSE PATHWAYS	Endo-dormant flower buds must pass through a period of chilling to reinitiate growth and subsequent flowering, which is a major obstacle to the forcing culture of tree peony in winter. Customized cDNA microarray (8x15 K element) was used to investigate gene expression profiling in tree peony 'Feng Dan Bai' buds during 24 d chilling treatment at 0-4 degrees C. According to the morphological changes after the whole plants were transferred to green house, endo-dormancy was released after 18 d chilling treatment, and prolonged chilling treatment increased bud break rate. Pearson correlation hierarchical clustering of sample groups was highly consistent with the dormancy transitions revealed by morphological changes. Totally 3,174 significantly differentially-expressed genes (P<0.05) were observed through endo-dormancy release process, of which the number of up-regulated (1,611) and that of down-regulated (1,563) was almost the same. Functional annotation of differentially-expressed genes revealed that cellular process, metabolic process, response to stimulus, regulation of biological process and development process were well-represented. Hierarchical clustering indicated that activation of genes involved in carbohydrate metabolism (Glycolysis, Citrate cycle and Pentose phosphate pathway), energy metabolism and cell growth. Based on the results of GO analysis, totally 51 probes presented in the microarray were associated with GA response and GA signaling pathway, and 22 of them were differently expressed. The expression profiles also revealed that the genes of GA biosynthesis, signaling and response involved in endo-dormancy release. We hypothesized that activation of GA pathway played a central role in the regulation of dormancy release in tree peony.	[Gai, Shupeng; Zhang, Yuxi; Liu, Chunying; Zhang, Yang; Zheng, Guosheng] Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Univ Shandong Prov, Qingdao, Peoples R China	Qingdao Agricultural University	Zheng, GS (corresponding author), Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Univ Shandong Prov, Qingdao, Peoples R China.	gszheng@qau.edu.cn			National Natural Science Foundation of China [30871728, 31071828, 31101577]; National Natural Science Foundation of Shandong province [ZR2009DM002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shandong province	This work was supported by grants from National Natural Science Foundation of China (30871728, 31071828 and 31101577) and National Natural Science Foundation of Shandong province (ZR2009DM002). The funders have very important role in material collection and reserve, study design, data collection and analysis, amending of the manuscript and decision to publish.	Anderson JV, 2005, PLANT CELL ENVIRON, V28, P1567, DOI 10.1111/j.1365-3040.2005.01393.x; Bonhomme M, 2000, TREE PHYSIOL, V20, P615; Campbell MA, 1996, PHYSIOL PLANTARUM, V98, P743, DOI 10.1111/j.1399-3054.1996.tb06680.x; DEVITT ML, 1995, PLANT MOL BIOL, V29, P255, DOI 10.1007/BF00043650; Dogramaci M, 2010, PLANT MOL BIOL, V73, P207, DOI 10.1007/s11103-010-9621-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erez A, 1995, ACTA HORTIC, P81, DOI 10.17660/ActaHortic.1995.395.7; Espinosa-Ruiz A, 2004, PLANT J, V38, P603, DOI 10.1111/j.1365-313X.2004.02070.x; Santamaria ME, 2011, ANN BOT-LONDON, V108, P485, DOI 10.1093/aob/mcr185; FLORE JA, 1996, PHOTOASSIMILATE DIST, P797; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Francis D, 2001, PLANT GROWTH REGUL, V33, P1, DOI 10.1023/A:1010762111585; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Halaly T, 2008, PLANTA, V228, P79, DOI 10.1007/s00425-008-0720-6; Hartweck LM, 2008, PLANTA, V229, P1, DOI 10.1007/s00425-008-0830-1; Hedley PE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-202; Hewezi T, 2006, J EXP BOT, V57, P3109, DOI 10.1093/jxb/erl080; Horvath DP, 2006, WEED SCI, V54, P821, DOI 10.1614/WS-06-06R1.1; Horvath DP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-536; Horvath DP, 2002, PLANT PHYSIOL, V128, P1439, DOI 10.1104/pp.010885; Huang X, 2008, ACTA PHYSIOL PLANT, V30, P797, DOI 10.1007/s11738-008-0184-0; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Jiang C, 2007, CURR OPIN PLANT BIOL, V10, P461, DOI 10.1016/j.pbi.2007.08.011; Keilin T, 2007, PLANT SCI, V173, P446, DOI 10.1016/j.plantsci.2007.07.004; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; LANG GA, 1987, HORTSCIENCE, V22, P371; Liu Bo, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P1635; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Luo YR, 2008, J HEFEI U, V18, P78; Marquat C, 1999, SCI HORTIC-AMSTERDAM, V79, P151, DOI 10.1016/S0304-4238(98)00203-9; Mathiason K, 2009, FUNCT INTEGR GENOMIC, V9, P81, DOI 10.1007/s10142-008-0090-y; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Ophir R, 2009, PLANT MOL BIOL, V71, P403, DOI 10.1007/s11103-009-9531-9; Or E, 2000, PLANT MOL BIOL, V43, P483, DOI 10.1023/A:1006450516982; Or E., 2009, GRAPEVINE MOL PHYSL, P1, DOI DOI 10.1007/978-90-481-2305-6_1; Pang XQ, 2007, J EXP BOT, V58, P3249, DOI 10.1093/jxb/erm172; Panneerselvam R, 2007, COLLOID SURFACE B, V59, P59, DOI 10.1016/j.colsurfb.2007.04.006; Perez FJ, 2007, FUNCT PLANT BIOL, V34, P624, DOI 10.1071/FP06272; Rinne PLH, 2011, PLANT CELL, V23, P130, DOI 10.1105/tpc.110.081307; Rodrigo MJ, 2006, J EXP BOT, V57, P633, DOI 10.1093/jxb/erj048; Rohde A, 2000, FOR SCI, V64, P89; Ruonala R, 2006, PLANT J, V46, P628, DOI 10.1111/j.1365-313X.2006.02722.x; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saure M. C., 1985, Horticultural Reviews, V7, P239, DOI 10.1002/9781118060735.ch6; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Smalle J, 1997, PHYSIOL PLANTARUM, V100, P593, DOI 10.1034/j.1399-3054.1997.1000322.x; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sozzi G. O., 2004, Ciencia e Investigacion Agraria, V31, P101; Walton EF, 2009, J EXP BOT, V60, P3835, DOI 10.1093/jxb/erp231; WANG SY, 1991, PHYSIOL PLANTARUM, V82, P231, DOI 10.1111/j.1399-3054.1991.tb00086.x; Wang ZongZheng, 1996, Acta Horticulturae Sinica, V23, P307; Wu CT, 2001, PLANT PHYSIOL, V126, P1299, DOI 10.1104/pp.126.3.1299; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Zheng GuoSheng, 2009, Scientia Silvae Sinicae, V45, P48; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	64	47	60	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55297	10.1371/journal.pone.0055297	http://dx.doi.org/10.1371/journal.pone.0055297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405132	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400077
J	Goldenberg, DM; Gold, DV; Loo, M; Liu, DL; Chang, CH; Jaffe, ES				Goldenberg, David M.; Gold, David V.; Loo, Meiyu; Liu, Donglin; Chang, Chien-Hsing; Jaffe, Elaine S.			Horizontal Transmission of Malignancy: In-Vivo Fusion of Human Lymphomas with Hamster Stroma Produces Tumors Retaining Human Genes and Lymphoid Pathology	PLOS ONE			English	Article							REED-STERNBERG CELLS; HODGKINS-DISEASE; NUDE-MICE; B-CELL; METASTATIC PHENOTYPE; HOST-CELLS; CANCER; TRANSFORMATION; CHROMOSOME; BIOLOGY	We report the in-vivo fusion of two Hodgkin lymphomas with golden hamster cheek pouch cells, resulting in serially transplanted (over 5-6 years) GW-532 and GW-584 heterosynkaryon tumor cells displaying both human and hamster DNA (by FISH), lymphoma-like morphology, aggressive metastasis, and retention of 7 human genes (CD74, CXCR4, CD19, CD20, CD71, CD79b, and VIM) out of 24 tested by PCR. The prevalence of B-cell restricted genes (CD19, CD20, and CD79b) suggests that this uniform population may be the clonal initiating (malignant) cells of Hodgkin lymphoma, despite their not showing translation to their respective proteins by immunohistochemical analysis. This is believed to be the first report of in-vivo cell-cell fusion of human lymphoma and rodent host cells, and may be a method to disclose genes regulating both organoid and metastasis signatures, suggesting that the horizontal transfer of tumor DNA to adjacent stromal cells may be implicated in tumor heterogeneity and progression. The B-cell gene signature of the hybrid xenografts suggests that Hodgkin lymphoma, or its initiating cells, is a B-cell malignancy.	[Goldenberg, David M.; Gold, David V.] Garden State Canc Ctr, Ctr Mol Med & Immunol, Morris Plains, NJ USA; [Loo, Meiyu; Liu, Donglin; Chang, Chien-Hsing] Immunomedics Inc, Morris Plains, NJ USA; [Jaffe, Elaine S.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Immunomedics Inc; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Goldenberg, DM (corresponding author), Garden State Canc Ctr, Ctr Mol Med & Immunol, Morris Plains, NJ USA.	dmg.gscancer@att.net	Jaffe, Elaine/G-8981-2014	Jaffe, Elaine/0000-0003-4632-0301	National Cancer Institute, National Institutes of Health; National Institutes of Health [CA11327]; NATIONAL CANCER INSTITUTE [ZIASC000550] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the intramural research program of the National Cancer Institute, National Institutes of Health (ESJ), and USPHS grant CA11327 from the National Institutes of Health (DMG) for establishing the original GW-532 and GW-584 tumors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TL, 2007, J PATHOL, V211, P10, DOI 10.1002/path.2078; Apolant, 1905, BERL KLIN WSCHR, V42, P871; BERNSTEIN SC, 1985, P NATL ACAD SCI USA, V82, P1726, DOI 10.1073/pnas.82.6.1726; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Brauninger A, 2006, INT J CANCER, V118, P1853, DOI 10.1002/ijc.21716; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; DIEHL V, 1982, CANCER TREAT REP, V66, P615; DOHNER H, 1992, GENE CHROMOSOME CANC, V5, P392, DOI 10.1002/gcc.2870050415; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; EPSTEIN AL, 1976, CANCER, V37, P2158, DOI 10.1002/1097-0142(197605)37:5<2158::AID-CNCR2820370503>3.0.CO;2-F; FIDLER IJ, 1986, CANCER METAST REV, V5, P29, DOI 10.1007/BF00049529; FISHER ER, 1970, CANCER-AM CANCER SOC, V25, P1286, DOI 10.1002/1097-0142(197006)25:6<1286::AID-CNCR2820250606>3.0.CO;2-U; Garcia-Olmo DC, 2012, EXPERT OPIN BIOL TH, V12, pS199, DOI 10.1517/14712598.2012.681370; Garcia-Olmo DC, 2010, CANCER RES, V70, P560, DOI 10.1158/0008-5472.CAN-09-3513; GOLDENBE.DM, 1971, EXP MOL PATHOL, V14, P134, DOI 10.1016/0014-4800(71)90059-1; Goldenberg DM, 2012, EXPERT OPIN BIOL TH, V12, pS133, DOI 10.1517/14712598.2012.671807; Goldenberg DM, 2012, INT J CANCER, V131, P49, DOI 10.1002/ijc.26327; GOLDENBERG DM, 1974, NATURE, V250, P649, DOI 10.1038/250649a0; GOLDENBERG DM, 1971, CANCER RES, V31, P1148; GOLDENBERG DM, 1977, CANCER LETT, V2, P195, DOI 10.1016/S0304-3835(77)80021-9; GOLDENBERG DM, 1981, SCIENCE, V212, P65, DOI 10.1126/science.7209521; GOTZ H, 1968, EXPERIENTIA, V24, P957, DOI 10.1007/BF02138681; GREENE HSN, 1952, CANCER, V5, P24, DOI 10.1002/1097-0142(195201)5:1<24::AID-CNCR2820050106>3.0.CO;2-O; Hartmann S, 2008, HAEMATOL-HEMATOL J, V93, P1318, DOI 10.3324/haematol.12875; Holmgren L, 2002, VOX SANG, V83, P305, DOI 10.1111/j.1423-0410.2002.tb05323.x; Jacobsen BM, 2006, CANCER RES, V66, P8274, DOI 10.1158/0008-5472.CAN-06-1456; JONASSON J, 1977, J CELL SCI, V24, P217; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; KAPLAN HS, 1977, INT J CANCER, V19, P511, DOI 10.1002/ijc.2910190412; KAPLAN HS, 1977, P NATL ACAD SCI USA, V74, P2564, DOI 10.1073/pnas.74.6.2564; KAPP U, 1993, BLOOD, V82, P1247; KOVACS G, 1985, INT J CANCER, V36, P637, DOI 10.1002/ijc.2910360602; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; LAGARDE AE, 1985, BIOCHIM BIOPHYS ACTA, V823, P81, DOI 10.1016/0304-419X(85)90008-3; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; Moinfar F., 2000, CANCER RES, V60, P2652; NEWCOM SR, 1988, INT J CELL CLONING, V6, P417, DOI 10.1002/stem.5530060606; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pelham RJ, 2006, P NATL ACAD SCI USA, V103, P19848, DOI 10.1073/pnas.0609635104; ROBERTS AN, 1978, CANCER RES, V38, P3033; RUDDLE FH, 1981, NATURE, V294, P115, DOI 10.1038/294115a0; SCHOUTEN HC, 1989, BLOOD, V73, P2149; STOLER A, 1985, P NATL ACAD SCI USA, V82, P570, DOI 10.1073/pnas.82.2.570; TILLY H, 1991, BLOOD, V77, P1298; Ushmorov A, 2006, BLOOD, V107, P2493, DOI 10.1182/blood-2005-09-3765; Watanabe K, 2000, HISTOPATHOLOGY, V36, P353; Yan Y, 1996, BLOOD, V88, P3137, DOI 10.1182/blood.V88.8.3137.bloodjournal8883137	49	14	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55324	10.1371/journal.pone.0055324	http://dx.doi.org/10.1371/journal.pone.0055324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405135	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400080
J	Melbourne-Thomas, J; Constable, A; Wotherspoon, S; Raymond, B				Melbourne-Thomas, Jessica; Constable, Andrew; Wotherspoon, Simon; Raymond, Ben			Testing Paradigms of Ecosystem Change under Climate Warming in Antarctica	PLOS ONE			English	Article							KRILL EUPHAUSIA-SUPERBA; SOUTH SHETLAND ISLANDS; SEA-ICE EXTENT; QUALITATIVE-ANALYSIS; PENINSULA REGION; FOOD-WEB; PENGUIN POPULATIONS; MARINE; VARIABILITY; GROWTH	Antarctic marine ecosystems have undergone significant changes as a result of human activities in the past and are now responding in varied and often complicated ways to climate change impacts. Recent years have seen the emergence of large-scale mechanistic explanations-or "paradigms of change"-that attempt to synthesize our understanding of past and current changes. In many cases, these paradigms are based on observations that are spatially and temporally patchy. The West Antarctic Peninsula (WAP), one of Earth's most rapidly changing regions, has been an area of particular research focus. A recently proposed mechanistic explanation for observed changes in the WAP region relates changes in penguin populations to variability in krill biomass and regional warming. While this scheme is attractive for its simplicity and chronology, it may not account for complex spatio-temporal processes that drive ecosystem dynamics in the region. It might also be difficult to apply to other Antarctic regions that are experiencing some, though not all, of the changes documented for the WAP. We use qualitative network models of differing levels of complexity to test paradigms of change for the WAP ecosystem. Importantly, our approach captures the emergent effects of feedback processes in complex ecological networks and provides a means to identify and incorporate uncertain linkages between network elements. Our findings highlight key areas of uncertainty in the drivers of documented trends, and suggest that a greater level of model complexity is needed in devising explanations for ecosystem change in the Southern Ocean. We suggest that our network approach to evaluating a recent and widely cited paradigm of change for the Antarctic region could be broadly applied in hypothesis testing for other regions and research fields.	[Melbourne-Thomas, Jessica; Constable, Andrew; Raymond, Ben] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Constable, Andrew; Wotherspoon, Simon; Raymond, Ben] Australian Antarctic Div, Dept Sustainabil Environm Water Populat & Communi, Kingston, Tas, Australia; [Wotherspoon, Simon] Univ Tasmania, Inst Marine & Antarct Studies, Hobart, Tas, Australia	Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Australian Antarctic Division; University of Tasmania	Melbourne-Thomas, J (corresponding author), Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia.	Jessica.MelbourneThomas@utas.edu.au	Melbourne-Thomas, Jess/N-2437-2019; Wotherspoon, Simon J/B-2390-2013	Melbourne-Thomas, Jess/0000-0001-6585-876X; Wotherspoon, Simon J/0000-0002-6947-4445	Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystems Cooperative Research Centre (ACE CRC); Pew Fellowship in Marine Conservation	Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystems Cooperative Research Centre (ACE CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Pew Fellowship in Marine Conservation	This work was supported by the Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystems Cooperative Research Centre (ACE CRC; http://www.acecrc.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Thank you to Stuart Corney, Louise Emmerson, So Kawaguchi and Colin Southwell for helpful comments on model formulation, and on the manuscript (S. Corney). AJC was supported in part by a Pew Fellowship in Marine Conservation.	Ainley DG, 2009, FISH FISH, V10, P13, DOI 10.1111/j.1467-2979.2008.00293.x; Atkinson A, 2006, LIMNOL OCEANOGR, V51, P973, DOI 10.4319/lo.2006.51.2.0973; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Barbosa A, 2012, POLAR BIOL, V35, P1453, DOI 10.1007/s00300-012-1196-1; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Bernard KS, 2012, DEEP-SEA RES PT I, V62, P111, DOI 10.1016/j.dsr.2011.12.015; Branch T. A., 2011, Journal of Cetacean Research and Management, P53; Chapman EW, 2011, MAR ECOL PROG SER, V436, P273, DOI 10.3354/meps09242; CROXALL JP, 1992, PHILOS T ROY SOC B, V338, P319, DOI 10.1098/rstb.1992.0152; Daly KL, 2004, POLAR BIOL, V28, P72, DOI 10.1007/s00300-004-0660-y; Dambacher JM, 2005, MATH BIOSCI, V197, P1, DOI 10.1016/j.mbs.2005.06.001; Dambacher JM, 1999, OIKOS, V84, P530, DOI 10.2307/3546432; Ducklow Hugh, 2012, P121; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Emslie SD, 2007, P NATL ACAD SCI USA, V104, P11666, DOI 10.1073/pnas.0608477104; FRASER WR, 1992, POLAR BIOL, V11, P525; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Hinke JT, 2012, MAR ECOL PROG SER, V454, P91, DOI 10.3354/meps09633; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027331; Hucke-Gaete R, 2004, POLAR BIOL, V27, P304, DOI 10.1007/s00300-003-0587-8; Kravchenko VO, 2011, ANTARCT SCI, V23, P614, DOI 10.1017/S0954102011000423; LEVINS R, 1974, ANN NY ACAD SCI, V231, P123, DOI 10.1111/j.1749-6632.1974.tb20562.x; Liu JP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018732; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Lynch HJ, 2012, ECOLOGY, V93, P1367; Lynch HJ, 2012, MAR ECOL PROG SER, V454, P135, DOI 10.3354/meps09252; Marschoff ER, 2012, FISH RES, V125, P206, DOI 10.1016/j.fishres.2012.02.017; Marzloff MP, 2011, ECOL MODEL, V222, P2651, DOI 10.1016/j.ecolmodel.2011.03.040; McClintock J, 2008, AM SCI, V96, P302; Melbourne-Thomas J, 2012, ECOL MONOGR, V82, P505, DOI 10.1890/12-0207.1; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Naveen R, 2012, POLAR BIOL, V35, P1879, DOI 10.1007/s00300-012-1230-3; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Puccia C.J., 1985, QUALITATIVE MODELING; Raymond B, 2011, J APPL ECOL, V48, P181, DOI 10.1111/j.1365-2664.2010.01916.x; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; Ross RM, 2008, DEEP-SEA RES PT II, V55, P2086, DOI 10.1016/j.dsr2.2008.04.037; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Smith RC, 2001, ANN GLACIOL-SER, V33, P493, DOI 10.3189/172756401781818662; Thorpe SE, 2007, DEEP-SEA RES PT I, V54, P792, DOI 10.1016/j.dsr.2007.01.008; Trathan PN, 2012, ECOGRAPHY, V35, P983, DOI 10.1111/j.1600-0587.2012.07330.x; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Wiedenmann J, 2009, LIMNOL OCEANOGR, V54, P799, DOI 10.4319/lo.2009.54.3.0799	48	31	32	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55093	10.1371/journal.pone.0055093	http://dx.doi.org/10.1371/journal.pone.0055093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405116	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400060
J	Saraiya, AA; Li, W; Wang, CC				Saraiya, Ashesh A.; Li, Wei; Wang, Ching C.			Transition of a microRNA from Repressing to Activating Translation Depending on the Extent of Base Pairing with the Target	PLOS ONE			English	Article							GIARDIA-LAMBLIA; PROTEIN-STRUCTURE; MESSENGER-RNA; HUMAN ARGONAUTE2; STRUCTURAL BASIS; GENE-EXPRESSION; HUMAN CANCERS; UP-REGULATION; RECOGNITION; CLEAVAGE	MicroRNAs are major post-transcriptional regulators of gene expression. Here we show in the ancient protozoan Giardia lamblia a snoRNA-derived 26-nucleotide microRNA, miR3, which represses the translation of histone H2A mRNA containing an imperfect target but enhances translation when the target is made fully complementary. A stepwise mutational analysis of the fully complementary target showed that the activating effect of miR3 was significantly reduced when a single nucleotide at the 5'-end of the target was altered. The effect of miR3 became repressive when 12 of the nucleotides lost their complementation to miR3 with maximum repression reached when only 8 base-pairs remained between the miR3 seed sequence and the target. A synthetic 8-nucleotide RNA oligomer of the miR3 seed sequence was found capable of exerting a similar Argonaute-dependent translational repression. This is the first report showing a correlation between the extent of base-pairing with the target and a change in miRNA function.	[Saraiya, Ashesh A.; Li, Wei; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Wang, CC (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu			National Institutes of Health [AI30475]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [AI30475 to CCW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Horwich MD, 2008, NAT PROTOC, V3, P1537, DOI 10.1038/nprot.2008.145; Houzet L, 2012, NUCLEIC ACIDS RES, V40, P11684, DOI 10.1093/nar/gks912; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LEBLANCQ SM, 1994, PARASITOL TODAY, V10, P177, DOI 10.1016/0169-4758(94)90021-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li W, 2012, CELL MICROBIOL, V14, P1455, DOI 10.1111/j.1462-5822.2012.01811.x; Li W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001338; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russo A, 2011, FEBS LETT, V585, P2551, DOI 10.1016/j.febslet.2011.07.015; Saraiya AA, 2011, RNA, V17, P2152, DOI 10.1261/rna.028118.111; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; Sun CH, 2000, MOL BIOCHEM PARASIT, V105, P51, DOI 10.1016/S0166-6851(99)00163-2; Triana O, 2001, J CELL BIOCHEM, V82, P573, DOI 10.1002/jcb.1159; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Upcroft JA, 1996, MOL BIOCHEM PARASIT, V76, P135, DOI 10.1016/0166-6851(95)02554-5; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wu LG, 2008, CURR BIOL, V18, P1327, DOI 10.1016/j.cub.2008.07.072; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	52	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55672	10.1371/journal.pone.0055672	http://dx.doi.org/10.1371/journal.pone.0055672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405193	Green Published, Green Submitted, gold			2022-12-25	WOS:000315153400138
J	Trombetta, DM; Cardoso, SC; Facure, A; da Silva, AX; da Rosa, LAR				Trombetta, Debora M.; Cardoso, Simone C.; Facure, Alessandro; da Silva, Ademir X.; da Rosa, Luiz Antonio R.			Influence of the Presence of Tissue Expanders on Energy Deposition for Post-Mastectomy Radiotherapy	PLOS ONE			English	Article							BREAST RECONSTRUCTION; POSTOPERATIVE RADIOTHERAPY; CANCER; COMPLICATIONS; PHANTOMS; IMPLANT	An increasing number of studies have shown that post-mastectomy radiotherapy presents benefits associated with the patients survival and a significant fraction of the treated patients makes use of tissue expanders for breast reconstruction. Some models of tissue expanders have a magnetic disk on their surface that constitutes heterogeneity in the radiation field, which can affect the dose distribution during the radiotherapy treatment. In this study, the influence of a metallic heterogeneity positioned in a breast tissue expander was evaluated by means of Monte Carlo simulations using the MCNPX code and using Eclipse treatment planning system. Deposited energy values were calculated in structures which have clinical importance for the treatment. Additionally, the effect in the absorbed energy due to backscattering and attenuation of the incident beam caused by the heterogeneity, as well as due to the expansion of the prosthesis, was evaluated in target structures for a 6 MV photon beam by simulations. The dose distributions for a breast treatment were calculated using a convolution/superposition algorithm from the Eclipse treatment planning system. When compared with the smallest breast expander volume, underdosage of 7% was found for the largest volume of breast implant, in the case of frontal irradiation of the chest wall, by Monte Carlo simulations. No significant changes were found in dose distributions for the presence of the heterogeneity during the treatment planning of irradiation with an opposed pair of beams. Even considering the limitation of the treatment planning system, the results obtained with its use confirm those ones found by Monte Carlo simulations for a tangent beam irradiation. The presence of a heterogeneity didnt alters the dose distributions on treatment structures. The underdosage of 7% observed with Monte Carlo simulations were found for irradiation at 0 degrees, not used frequently in a clinical routine.	[Trombetta, Debora M.; da Silva, Ademir X.] Univ Fed Rio de Janeiro, Programa Engn Nucl, Inst Alberto Luiz Coimbra Posgrad & Pesquisa Engn, Rio De Janeiro, RJ, Brazil; [Trombetta, Debora M.; Cardoso, Simone C.] Univ Fed Rio de Janeiro, Inst Fis, Lab Fis Radica Gama, Rio De Janeiro, RJ, Brazil; [Facure, Alessandro] Comissao Nacl Energia Nucl CNEN, Rio De Janeiro, RJ, Brazil; [da Rosa, Luiz Antonio R.] Comissao Nacl Energia Nucl CNEN, IRD, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Comissao Nacional de Energia Nuclear (CNEN); Comissao Nacional de Energia Nuclear (CNEN); Instituto de Radioprotecao e Dosimetria	Cardoso, SC (corresponding author), Univ Fed Rio de Janeiro, Inst Fis, Lab Fis Radica Gama, Rio De Janeiro, RJ, Brazil.	simone@if.ufrj.br	Cardoso, Simone/AAH-4274-2021; Cardoso, Simone/V-2514-2019	Montano Trombetta, Debora/0000-0002-3473-3750; cardoso, simone/0000-0001-6216-202X	National Counsel of Technological and Scientific Development (CNPq); Rio de Janeiro Research Assistance Foundation (FAPERJ)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro Research Assistance Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by National Counsel of Technological and Scientific Development (CNPq) and Rio de Janeiro Research Assistance Foundation (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ECL ALG REF GUID P N; [Anonymous], 2008, ALD PHANT; Chatzigiannis C, 2005, J APPL CLIN MED PHYS, V12, P58; Damast S, 2006, INT J RADIAT ONCOL, V66, P305, DOI 10.1016/j.ijrobp.2006.05.017; Dang J, 2009, IEEE NUCL SCI CONF R, P3088, DOI 10.1109/NSSMIC.2009.5401670; Freedma GM, 2005, BREAST CANC ONLINE, V8, pe44; ICRU, 1992, J INT COMM RAD UN ME, P1; Krueger EA, 2000, INT J RADIAT ONCOL, V3, P713; Lai CJ, 2007, MED PHYS, V34, P2995, DOI 10.1118/1.2745921; McCarthy CM, 2005, PLAST RECONSTR SURG, V116, P1642, DOI 10.1097/01.prs.0000187794.79464.23; Moni Janaki, 2004, Med Dosim, V29, P49, DOI 10.1016/j.meddos.2003.10.005; Nahabedian MY, 2003, PLAST RECONSTR SURG, V112, P467, DOI 10.1097/01.PRS.0000070727.02992.54; Nava MB, 2011, PLAST RECONSTR SURG, V128, P353, DOI 10.1097/PRS.0b013e31821e6c10; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Ozden BC, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-44; Pelowitz D. B., 2005, LACP050369 LOS AL NA; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; RAMON Y, 1991, Harefuah, V121, P1; Raylman RR, 2001, J NUCL MED, V42, P960; Rodrigues ASHV, 2011, THESIS U TECNICA LIS; Schechter NR, 2005, AM J CLIN ONCOL-CANC, V28, P485, DOI 10.1097/01.coc.0000170582.38634.b6; Senkus-Konefka E, 2004, CANCER TREAT REV, V30, P671, DOI 10.1016/j.ctrv.2004.06.008; Sheikh-Bagheri D, 2002, MED PHYS, V29, P391, DOI 10.1118/1.1445413; Tallet AV, 2003, INT J RADIAT ONCOL, V57, P136, DOI 10.1016/S0360-3016(03)00526-1; Thompson RCA, 2005, MED PHYS, V32, P1640, DOI 10.1118/1.1914545; Trombetta DM, 2010, REV BRAS FIS, V4, P7; Weinstein SP, 2002, RADIOLOGY, V224, P265, DOI 10.1148/radiol.2241010511	28	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55430	10.1371/journal.pone.0055430	http://dx.doi.org/10.1371/journal.pone.0055430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405149	Green Published, gold, Green Submitted			2022-12-25	WOS:000315153400094
J	Vincent-Chong, VK; Anwar, A; Karen-Ng, LP; Cheong, SC; Yang, YH; Pradeep, PJ; Rahman, ZAA; Ismail, SM; Zaini, ZM; Prepageran, N; Kallarakkal, TG; Ramanathan, A; Mohayadi, NABM; Rosli, NSBM; Mustafa, WMW; Abraham, MT; Tay, KK; Zain, RB				Vincent-Chong, Vui King; Anwar, Arif; Karen-Ng, Lee Peng; Cheong, Sok Ching; Yang, Yi-Hsin; Pradeep, Padmaja Jayaprasad; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah; Zaini, Zuraiza Mohamad; Prepageran, Narayanan; Kallarakkal, Thomas George; Ramanathan, Anand; Mohayadi, Nur Aaina Binti Mohd; Rosli, Nurul Shielawati Binti Mohamed; Mustafa, Wan Mahadzir Wan; Abraham, Mannil Thomas; Tay, Keng Kiong; Zain, Rosnah Binti			Genome Wide Analysis of Chromosomal Alterations in Oral Squamous Cell Carcinomas Revealed over Expression of MGAM and ADAM9	PLOS ONE			English	Article							COPY NUMBER; GENE-EXPRESSION; CANCER; ARRAY; HYBRIDIZATION; MICROARRAY; AMPLIFICATION; INSTABILITY; PROGRESSION; MIGRATION	Despite the advances in diagnosis and treatment of oral squamous cell carcinoma (OSCC), mortality and morbidity rates have not improved over the past decade. A major drawback in diagnosis and treatment of OSCC is the lack of knowledge relating to how genetic instability in oral cancer genomes affects oral carcinogenesis. Hence, the key aim of this study was to identify copy number alterations (CNAs) that may be cancer associated in OSCC using high-resolution array comparative genomic hybridization (aCGH). To our knowledge this is the first study to use ultra-high density aCGH microarrays to profile a large number of OSCC genomes (n = 46). The most frequently amplified CNAs were located on chromosome 11q11(52%), 2p22.3(52%), 1q21.3-q22(54%), 6p21.32(59%), 20p13(61%), 7q34(52% and 72%), 8p11.23-p11.22(80%), 8q11.1-q24.4(54%), 9q13-q34.3(54%), 11q23.3-q25(57%); 14q21.3-q31.1(54%); 14q31.3-q32.33(57%), 20p13-p12.3(54%) and 20q11.21-q13.33(52%). The most frequently deleted chromosome region was located on 3q26.1 (54%). In order to verify the CNAs from aCGH using quantitative polymerase chain reaction (qPCR), the three top most amplified regions and their associated genes, namely ADAM5P (8p11.23-p11.22), MGAM (7q34) and SIRPB1 (20p13.1), were selected in this study. The ADAM5P locus was found to be amplified in 39 samples and deleted in one; MGAM (24 amplifications and 3 deletions); and SIRPB1 (12 amplifications, others undetermined). On the basis of putative cancer-related annotations, two genes, namely ADAM metallopeptidase domain 9 (ADAM9) and maltase-glucoamylase alpha-glucosidase (MGAM), that mapped to CNA regions were selected for further evaluation of their mRNA expression using reverse transcriptase qPCR. The over-expression of MGAM was confirmed with a 6.6 fold increase in expression at the mRNA level whereas the fold change in ADAM9 demonstrated a 1.6 fold increase. This study has identified significant regions in the OSCC genome that were amplified and resulted in consequent over-expression of the MGAM and ADAM9 genes that may be utilized as biological markers for OSCC.	[Vincent-Chong, Vui King; Karen-Ng, Lee Peng; Pradeep, Padmaja Jayaprasad; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah; Zaini, Zuraiza Mohamad; Prepageran, Narayanan; Kallarakkal, Thomas George; Ramanathan, Anand; Zain, Rosnah Binti] Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia; [Vincent-Chong, Vui King; Cheong, Sok Ching; Rahman, Zainal Ariff Abdul; Ismail, Siti Mazlipah] Univ Malaya, Fac Dent, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Anwar, Arif; Mohayadi, Nur Aaina Binti Mohd; Rosli, Nurul Shielawati Binti Mohamed] Sengen Sdn Bhd, Petaling Jaya, Selangor Darul, Malaysia; [Cheong, Sok Ching] Canc Res Initiat Fdn, Oral Canc Res Team, Selangor Darul Ehsan, Malaysia; [Yang, Yi-Hsin] Kaohsiung Med Univ, Coll Dent Med, Dept Dent Hyg, Kaohsiung, Taiwan; [Zaini, Zuraiza Mohamad; Kallarakkal, Thomas George; Ramanathan, Anand; Zain, Rosnah Binti] Univ Malaya, Fac Dent, Dept Oral Pathol Oral Med & Periodontol, Kuala Lumpur, Malaysia; [Prepageran, Narayanan] Univ Malaya, Fac Med, Dept Otorhinolaringol, Kuala Lumpur, Malaysia; [Mustafa, Wan Mahadzir Wan; Abraham, Mannil Thomas; Tay, Keng Kiong] Minist Hlth, Oral Hlth Div, Putrajaya, Malaysia	Universiti Malaya; Universiti Malaya; Kaohsiung Medical University; Universiti Malaya; Universiti Malaya; Kementerian Kesihatan Malaysia	Zain, RB (corresponding author), Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia.	rosnahbz12@yahoo.com	Ramanathan, Anand/J-2943-2014; Karen-Ng, Lee Peng/AAD-3810-2020; Prepageran, Narayanan/ABC-7933-2021; George, Thomas/B-7774-2010; Yang, Yi-Hsin/D-6471-2012; Narayanan, Prepageran A/L/P-2359-2014; ABDUL RAHMAN, ZAINAL ARIFF/C-1120-2010; Zain, Rosnah/B-8054-2010; Zaini, Zuraiza/B-5375-2010	Ramanathan, Anand/0000-0001-6496-7139; Karen-Ng, Lee Peng/0000-0002-3511-4791; George, Thomas/0000-0002-5986-6170; Yang, Yi-Hsin/0000-0002-9581-2778; Zaini, Zuraiza/0000-0002-9160-9625; Prepageran, Narayanan/0000-0001-5670-9340	University of Malaya High Impact Research Grant [J-00000-73561]; Ministry of Higher Education High Impact Research Grant [H-18001-00-C000008]; Ministry of Science, Technology and Innovation E-science grant [02-01-03SF0385]	University of Malaya High Impact Research Grant; Ministry of Higher Education High Impact Research Grant; Ministry of Science, Technology and Innovation E-science grant	This study was supported by a University of Malaya High Impact Research Grant (J-00000-73561), a Ministry of Higher Education High Impact Research Grant (H-18001-00-C000008) and a Ministry of Science, Technology and Innovation E-science grant (02-01-03SF0385). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Ambatipudi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017250; Baldwin C, 2005, CANCER RES, V65, P7561, DOI 10.1158/0008-5472.CAN-05-1513; Bhatnagar R, 2012, ORAL ONCOL, V48, P831, DOI 10.1016/j.oraloncology.2012.03.007; Birnbaum D, 2003, LANCET ONCOL, V4, P639, DOI 10.1016/S1470-2045(03)01225-7; Bronstad I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-111; Bueno R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010612; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Choi P, 2008, ARCH OTOLARYNGOL, V134, P539, DOI 10.1001/archotol.134.5.539; Chu SH, 2012, MOL BIOL RE IN PRESS; Cooke SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-288; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Flossbach L, 2012, INT J CANC IN PRESS; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Garnis C, 2004, ORAL ONCOL, V40, P511, DOI 10.1016/j.oraloncology.2003.10.006; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Hamada T, 2012, CANCER IN PRESS; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Hossini AM, 2008, BIOCHEM PHARMACOL, V76, P1612, DOI 10.1016/j.bcp.2008.08.013; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Kohn KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035716; Kornberg LJ, 1998, HEAD NECK-J SCI SPEC, V20, P745, DOI 10.1002/(SICI)1097-0347(199812)20:8<745::AID-HED14>3.0.CO;2-Z; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Li Jian, 2010, BMC Res Notes, V3, P321, DOI 10.1186/1756-0500-3-321; Liu CJ, 2006, MOL CARCINOGEN, V45, P721, DOI 10.1002/mc.20213; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohavanichbutr P, 2009, ARCH OTOLARYNGOL, V135, P180, DOI 10.1001/archoto.2008.540; Lopez-Nieva P, 2012, CARCINOGENESIS, V33, P452, DOI 10.1093/carcin/bgr271; Martin-Ezquerra G, 2011, HISTOL HISTOPATHOL, V26, P71, DOI 10.14670/HH-26.71; Miller DA, 2008, FILM QUART, V62, P12, DOI 10.1525/FQ.2008.62.2.12; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Nagaraj NS, 2007, TOXICOL LETT, V170, P134, DOI 10.1016/j.toxlet.2007.02.014; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Przybytkowski E, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-16; Ramsay AG, 2007, CANCER RES, V67, P5275, DOI 10.1158/0008-5472.CAN-07-0318; Reshmi SC, 2005, J DENT RES, V84, P107, DOI 10.1177/154405910508400203; Romer MU, 2012, MOL ONCOL IN PRESS; Rotger M, 2007, PHARMACOGENET GENOM, V17, P885, DOI 10.1097/FPC.0b013e3282ef5cd1; Roymans D, 2001, EUR J BIOCHEM, V268, P487, DOI 10.1046/j.1432-1327.2001.01936.x; Shah JP, 2003, ORAL CANC, P3; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Sparano A, 2006, LARYNGOSCOPE, V116, P735, DOI 10.1097/01.mlg.0000205141.54471.7f; Sriram KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030398; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tan DSP, 2007, LAB INVEST, V87, P737, DOI 10.1038/labinvest.3700593; Thean LF, 2010, GENE CHROMOSOME CANC, V49, P99, DOI 10.1002/gcc.20724; Trebinska A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-76; Tsui IFL, 2010, HEAD NECK-J SCI SPEC, V32, P1143, DOI 10.1002/hed.21311; Tsui IFL, 2009, INT J CANCER, V125, P2219, DOI 10.1002/ijc.24611; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Viet CT, 2010, HEAD NECK-J SCI SPEC, V32, P1246, DOI 10.1002/hed.21358; Vincent-Chong VK, 2012, ORAL DIS, V18, P469, DOI 10.1111/j.1601-0825.2011.01894.x; Visani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027560; Xu C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-143; Yang SH, 2007, INT J MOL MED, V20, P225; Zain RB, 2012, CELL TISSUE IN PRESS; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	69	20	20	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e54705	10.1371/journal.pone.0054705	http://dx.doi.org/10.1371/journal.pone.0054705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405089	Green Submitted, gold, Green Published			2022-12-25	WOS:000315153400033
J	Wu, YX; Wang, L; Lin, C; Lin, Y; Zhou, M; Chen, L; Connolly, B; Zhang, YQ; Chen, TB; Shaw, C				Wu, Yuxin; Wang, Lei; Lin, Chen; Lin, Yan; Zhou, Mei; Chen, Liang; Connolly, Brian; Zhang, Yingqi; Chen, Tianbao; Shaw, Chris			Vasorelaxin: A Novel Arterial Smooth Muscle-Relaxing Eicosapeptide from the Skin Secretion of the Chinese Piebald Odorous Frog (Odorrana schmackeri)	PLOS ONE			English	Article							TRYPSIN-INHIBITOR; AMPHIBIAN SKIN; PEPTIDES; RECEPTORS; SCORPION; RELEASE; TOAD	The defensive skin secretions of amphibians are a rich resource for the discovery of novel, bioactive peptides. Here we report the identification of a novel vascular smooth muscle-relaxing peptide, named vasorelaxin, from the skin secretion of the Chinese piebald odorous frog, Odorrana schmackeri. Vasorelaxin consists of 20 amino acid residues, SRVVKCSGFRPGSPDSREFC, with a disulfide-bridge between Cys-6 and Cys-20. The structure of its biosynthetic precursor was deduced from cloned skin cDNA and consists of 67 amino acid residues encoding a single copy of vasorelaxin (vasorelaxin, accession number: HE860494). Synthetic vasorelaxin caused a profound relaxation of rat arterial smooth muscle with an EC50 of 6.76 nM.	[Wu, Yuxin; Wang, Lei; Lin, Chen; Lin, Yan; Zhou, Mei; Chen, Liang; Connolly, Brian; Zhang, Yingqi; Chen, Tianbao; Shaw, Chris] Queens Univ, Sch Pharm, Nat Drug Discovery Grp, Belfast, Antrim, North Ireland; [Zhang, Yingqi] Tangshan Gongren Hosp, Tangshan City, Hebei Province, Peoples R China	Queens University Belfast	Zhang, YQ (corresponding author), Queens Univ, Sch Pharm, Nat Drug Discovery Grp, Belfast, Antrim, North Ireland.	zhangyingqi08@sina.com; chris.shaw@qub.ac.uk	Wu, Yuxin/E-5612-2014	Wu, Yuxin/0000-0002-2657-8498; Wang, Lei/0000-0002-8811-8489				Almaaytah A, 2012, PEPTIDES, V35, P291, DOI 10.1016/j.peptides.2012.03.016; BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; Chen H, 2011, MOL IMMUNOL, V48, P442, DOI 10.1016/j.molimm.2010.09.018; Chen TB, 2002, EUR J BIOCHEM, V269, P4693, DOI 10.1046/j.1432-1033.2002.03174.x; Conlon JM, 1999, REGUL PEPTIDES, V79, P71, DOI 10.1016/S0167-0115(98)00160-8; Davidson MB, 2005, NAT REV DRUG DISCOV, V4, P713, DOI 10.1038/nrd1828; Erspamer V., 1994, AMPHIBIAN BIOL, V1, P179; Galas L, 2009, GEN COMP ENDOCR, V164, P40, DOI 10.1016/j.ygcen.2009.05.003; Gale EAM, 2001, LANCET, V357, P1870, DOI 10.1016/S0140-6736(00)04960-6; LAZARUS LH, 1993, PROG NEUROBIOL, V41, P473, DOI 10.1016/0301-0082(93)90027-P; Li RJ, 2012, BIOCHIMIE, V94, P1376, DOI 10.1016/j.biochi.2012.03.009; Li XH, 2011, BIOCHIMIE, V93, P1537, DOI 10.1016/j.biochi.2011.05.009; Liu L, 2005, PEPTIDES, V26, P1369, DOI 10.1016/j.peptides.2005.03.027; Pal Sanjoy Kumar, 2002, Indian Journal of Experimental Biology, V40, P1353; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; Patlak M, 2004, FASEB J, V18, DOI 10.1096/fj.03-1398bkt; Raufman JP, 1996, REGUL PEPTIDES, V61, P1, DOI 10.1016/0167-0115(96)00135-8; Rinaldi AC, 2002, CURR OPIN CHEM BIOL, V6, P799, DOI 10.1016/S1367-5931(02)00401-5; Spindel ER, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P277, DOI 10.1016/B978-012369442-3/50045-3; Srinivasan KN, 2002, TOXICON, V40, P23, DOI 10.1016/S0041-0101(01)00182-9; TYLER MJ, 1992, J PHARMACOL TOXICOL, V28, P199, DOI 10.1016/1056-8719(92)90004-K; Wang H, 2012, BIOCHIMIE, V94, P891, DOI 10.1016/j.biochi.2011.12.008; Wang L, 2009, BIOCHEM BIOPH RES CO, V383, P240, DOI 10.1016/j.bbrc.2009.04.003; Wang M, 2012, PEPTIDES, V33, P245, DOI 10.1016/j.peptides.2012.01.003; WOLL PJ, 1988, P NATL ACAD SCI USA, V85, P1859, DOI 10.1073/pnas.85.6.1859; Wu YJ, 2011, BIOCHIMIE, V93, P981, DOI 10.1016/j.biochi.2011.03.003	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55739	10.1371/journal.pone.0055739	http://dx.doi.org/10.1371/journal.pone.0055739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405205	gold, Green Published, Green Submitted			2022-12-25	WOS:000315153400150
J	Cohen, D; Bogeat-Triboulot, MB; Vialet-Chabrand, S; Merret, R; Courty, PE; Moretti, S; Bizet, F; Guilliot, A; Hummel, I				Cohen, David; Bogeat-Triboulot, Marie-Beatrice; Vialet-Chabrand, Silvere; Merret, Remy; Courty, Pierre-Emmanuel; Moretti, Sebastien; Bizet, Francois; Guilliot, Agnes; Hummel, Irene			Developmental and Environmental Regulation of Aquaporin Gene Expression across Populus Species: Divergence or Redundancy?	PLOS ONE			English	Article							INTRINSIC PROTEINS; PLANT AQUAPORINS; WATER TRANSPORT; POPLAR LEAVES; DROUGHT; GENOME; TRICHOCARPA; EVOLUTION; LOCALIZATION; SUBFAMILY	Aquaporins (AQPs) are membrane channels belonging to the major intrinsic proteins family and are known for their ability to facilitate water movement. While in Populus trichocarpa, AQP proteins form a large family encompassing fifty-five genes, most of the experimental work focused on a few genes or subfamilies. The current work was undertaken to develop a comprehensive picture of the whole AQP gene family in Populus species by delineating gene expression domain and distinguishing responsiveness to developmental and environmental cues. Since duplication events amplified the poplar AQP family, we addressed the question of expression redundancy between gene duplicates. On these purposes, we carried a meta-analysis of all publicly available Affymetrix experiments. Our in-silico strategy controlled for previously identified biases in cross-species transcriptomics, a necessary step for any comparative transcriptomics based on multispecies design chips. Three poplar AQPs were not supported by any expression data, even in a large collection of situations (abiotic and biotic constraints, temporal oscillations and mutants). The expression of 11 AQPs was never or poorly regulated whatever the wideness of their expression domain and their expression level. Our work highlighted that PtTIP1;4 was the most responsive gene of the AQP family. A high functional divergence between gene duplicates was detected across species and in response to tested cues, except for the root-expressed PtTIP2;3/PtTIP2;4 pair exhibiting 80% convergent responses. Our meta-analysis assessed key features of aquaporin expression which had remained hidden in single experiments, such as expression wideness, response specificity and genotype and environment interactions. By consolidating expression profiles using independent experimental series, we showed that the large expansion of AQP family in poplar was accompanied with a strong divergence of gene expression, even if some cases of functional redundancy could be suspected.	[Cohen, David; Bogeat-Triboulot, Marie-Beatrice; Vialet-Chabrand, Silvere; Merret, Remy; Bizet, Francois; Guilliot, Agnes; Hummel, Irene] INRA, Ecol & Ecophysiol Forestieres UMR1137, Champenoux, France; [Cohen, David; Bogeat-Triboulot, Marie-Beatrice; Vialet-Chabrand, Silvere; Merret, Remy; Bizet, Francois; Guilliot, Agnes; Hummel, Irene] Univ Lorraine, Ecol & Ecophysiol Forestieres UMR1137, Fac Sci, Vandoeuvre Les Nancy, France; [Courty, Pierre-Emmanuel] Univ Basel, Inst Bot, Zurich Basel Plant Sci Ctr, CH-4056 Basel, Switzerland; [Moretti, Sebastien] SIB Swiss Inst Bioinformat, Vital IT, Lausanne, Switzerland; [Moretti, Sebastien] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	INRAE; Universite de Lorraine; Universite de Lorraine; University of Basel; Swiss Institute of Bioinformatics; University of Lausanne	Bogeat-Triboulot, MB (corresponding author), INRA, Ecol & Ecophysiol Forestieres UMR1137, Champenoux, France.	triboulo@nancy.inra.fr	MERRET, Rémy/J-6512-2019; Vialet-Chabrand, Silvere/Y-1642-2019	Vialet-Chabrand, Silvere/0000-0002-2105-2825; MERRET, Remy/0000-0002-3790-1115; Cohen, David/0000-0002-0320-8865; Bogeat-Triboulot, Marie-Beatrice/0000-0003-3015-488X; Moretti, Sebastien/0000-0003-3947-488X; COURTY, Pierre-Emmanuel/0000-0003-2789-7818	Laboratory of Excellence ARBRE [ANR-11-LABX-02-01]; French Research Agency [POPSEC] [ANR-Genoplante GPLA06028G]; Region Lorraine [12000158]; European Regional Development Fund [3709]	Laboratory of Excellence ARBRE; French Research Agency [POPSEC]; Region Lorraine(Region Grand-Est); European Regional Development Fund(European Commission)	This work was supported by the Laboratory of Excellence ARBRE [ANR-11-LABX-02-01], the French Research Agency [POPSEC-project number ANR-Genoplante GPLA06028G] and the Region Lorraine [grant number 12000158]. DC was supported by the European Regional Development Fund [project number 3709]. PEC is an Ambizione fellow of the Swiss National Science Foundation [PZ00P3_136651]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Almeida-Rodriguez AM, 2010, PHYSIOL PLANTARUM, V140, P321, DOI 10.1111/j.1399-3054.2010.01405.x; Almeida-Rodriguez AM, 2011, PLANT CELL ENVIRON, V34, P1318, DOI 10.1111/j.1365-3040.2011.02331.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aroca R, 2012, J EXP BOT, V63, P43, DOI 10.1093/jxb/err266; Bae EK, 2011, GENE, V483, P43, DOI 10.1016/j.gene.2011.05.015; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; Besse M, 2011, J EXP BOT, V62, P4127, DOI 10.1093/jxb/err175; Bienert GP, 2011, SIGNAL COMMUN PLANTS, P3, DOI 10.1007/978-3-642-14369-4_1; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Cohen D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-630; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gattolin S, 2011, MOL PLANT, V4, P180, DOI 10.1093/mp/ssq051; Gehring CA, 2006, OECOLOGIA, V149, P158, DOI 10.1007/s00442-006-0437-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Goue N, 2008, NEW PHYTOL, V180, P45, DOI 10.1111/j.1469-8137.2008.02556.x; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Hacke UG, 2010, TREE PHYSIOL, V30, P1016, DOI 10.1093/treephys/tpq058; Hu RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031149; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janz D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-150; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; JOHNSON KD, 1989, PLANT PHYSIOL, V91, P1006, DOI 10.1104/pp.91.3.1006; Kohler A, 2003, FEBS LETT, V542, P37, DOI 10.1016/S0014-5793(03)00334-X; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Lopez D, 2012, J EXP BOT, V63, P2217, DOI 10.1093/jxb/err404; Luu DT, 2005, PLANT CELL ENVIRON, V28, P85, DOI 10.1111/j.1365-3040.2004.01295.x; Madsen SS, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00056; MAESHIMA M, 1994, PLANT PHYSIOL, V106, P61, DOI 10.1104/pp.106.1.61; Marjanovic Z, 2005, PLANTA, V222, P258, DOI 10.1007/s00425-005-1539-z; Maurel C, 2001, PLANT PHYSIOL, V125, P135, DOI 10.1104/pp.125.1.135; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Oliviusson P, 2001, PLANT MOL BIOL, V46, P289, DOI 10.1023/A:1010611605142; Parent B, 2009, PLANT PHYSIOL, V149, P2000, DOI 10.1104/pp.108.130682; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Quesada T, 2008, NEW PHYTOL, V180, P408, DOI 10.1111/j.1469-8137.2008.02586.x; Raj S, 2011, P NATL ACAD SCI USA, V108, P12521, DOI 10.1073/pnas.1103341108; Raldua D, 2008, AM J PHYSIOL-REG I, V294, pR993, DOI 10.1152/ajpregu.00695.2007; Rinaldi C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/pp.106.094987; Rodgers-Melnick E, 2012, GENOME RES, V22, P95, DOI 10.1101/gr.125146.111; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Schneider A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-134; Secchi F, 2010, PLANT CELL ENVIRON, V33, P1285, DOI 10.1111/j.1365-3040.2010.02147.x; Secchi F, 2009, TREE PHYSIOL, V29, P1467, DOI 10.1093/treephys/tpp060; Siemens JA, 2008, MYCORRHIZA, V18, P393, DOI 10.1007/s00572-008-0193-2; Song DL, 2011, PLANT MOL BIOL, V76, P97, DOI 10.1007/s11103-011-9771-3; Soto G, 2010, PLANT J, V64, P1038, DOI 10.1111/j.1365-313X.2010.04395.x; Stalteri MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-13; Street NR, 2011, ENVIRON POLLUT, V159, P45, DOI 10.1016/j.envpol.2010.09.027; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Vander Willigen C, 2006, PLANT CELL PHYSIOL, V47, P1241, DOI 10.1093/pcp/pcj094; Voicu MC, 2011, TREES-STRUCT FUNCT, V25, P485, DOI 10.1007/s00468-010-0524-8; Wilkins O, 2009, PLANT J, V60, P703, DOI 10.1111/j.1365-313X.2009.03993.x; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	62	29	29	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55506	10.1371/journal.pone.0055506	http://dx.doi.org/10.1371/journal.pone.0055506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23393587	Green Submitted, Green Published, gold			2022-12-25	WOS:000314692800041
J	Camacho, EF; Boszczowski, I; Freire, MP; Pinto, FCG; Guimaraes, T; Teixeira, MJ; Costa, SF				Camacho, Eduardo Fernandes; Boszczowski, Icaro; Freire, Maristela Pinheiro; Gomes Pinto, Fernando Campos; Guimaraes, Thais; Teixeira, Manuel Jacobsen; Costa, Silvia Figueiredo			Impact of an Educational Intervention Implanted in a Neurological Intensive Care Unit on Rates of Infection Related to External Ventricular Drains	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; RISK-FACTORS	Background: Studies on the implantation of care routines showed reduction on EVD catheter-related infections rates; however zero tolerance is difficult to be achieved. The objective of this study was to assess the impact of an educational intervention on the maximal reduction on rates of EVD-related infections. Methodology/Principal Findings: The quasi-experimental (before-after intervention) study occurred in two phases: pre-intervention, from April 2007 to July 2008, and intervention, from August 2008 to July 2010. Patients were followed for 30 days after the removal of the EVD, and EVD-related infections were considered as only those with laboratorial confirmation in the CSF. Observations were made of the care of the EVD and compliance with Hygiene of the Hands (HH), a routine of care was drawn up, training was given, and intervention was made to reduce the time the EVD catheter remained in place. Results: during the study, 178 patients were submitted to 194 procedures, corresponding to 1217 EVD catheters-day. Gram-negative agents were identified in 71.4% of the infections during the pre-intervention period and in 60% during the intervention period. During the study, EVD-related infection rates were reduced from 9.5% to 4.8% per patient, from 8.8% to 4.4% per procedure, and the incidence density dropped from 14.0 to 6.9 infections per 1000 catheters-day (p = 0.027). The mortality reduced 12% (from 42% to 30%). Conclusions/Significance: During one year after the fourth intervention, no microbiologically identified infection was documented. In light of these results, educational intervention proved to be a useful tool in reducing these rates and showed also impact on mortality.	[Camacho, Eduardo Fernandes; Boszczowski, Icaro; Freire, Maristela Pinheiro; Guimaraes, Thais; Costa, Silvia Figueiredo] Univ Sao Paulo, Sch Med, Hosp Clin, Div Infect Dis, Sao Paulo, Brazil; [Gomes Pinto, Fernando Campos; Teixeira, Manuel Jacobsen] Univ Sao Paulo, Sch Med, Hosp Clin, Div Neurosurg, Sao Paulo, Brazil; [Costa, Silvia Figueiredo] Univ Sao Paulo, Sch Med, Med Res Lab LIM 54, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Costa, SF (corresponding author), Univ Sao Paulo, Sch Med, Hosp Clin, Div Infect Dis, Sao Paulo, Brazil.	costasilviaf@ig.com.br	Boszczowski, Icaro/AAF-9675-2022; Costa, Silvia F/K-4768-2012; Freire, Maristela P/B-5262-2014; Figueiredo Costa, silvia/ABC-7704-2021; Boszczowski, Icaro/ACH-0889-2022; Pinto, Fernando Gomes/F-6094-2012; Teixeira, Manuel AC/AAZ-7251-2020; Guimarães, Thais/C-7134-2014	Costa, Silvia F/0000-0003-1087-752X; Figueiredo Costa, silvia/0000-0003-1087-752X; Teixeira, Manuel AC/0000-0002-1959-0624; Guimarães, Thais/0000-0002-7282-5453; PINTO, FERNANDO/0000-0003-2384-2190; freire, maristela p/0000-0002-9691-192X	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superor)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superor)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superor). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabi Y, 2005, AM J INFECT CONTROL, V33, P137, DOI 10.1016/j.ajic.2004.11.008; BOGDAHN U, 1992, NEUROSURGERY, V31, P898, DOI 10.1227/00006123-199211000-00011; Bota DP, 2005, J NEUROSURG, V103, P468, DOI 10.3171/jns.2005.103.3.0468; Chi H, 2010, INT J INFECT DIS, V14, pE216, DOI 10.1016/j.ijid.2009.04.006; Clinical and Laboratory Standards Institute (CLSI), 2014, CLIN LAB STANDARDS I; Dasic D, 2006, BRIT J NEUROSURG, V20, P296, DOI 10.1080/02688690600999901; Girao E, 2008, INT J INFECT DIS, V12, pE145, DOI 10.1016/j.ijid.2008.03.011; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Honda H, 2010, INFECT CONT HOSP EP, V31, P1078, DOI 10.1086/656377; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Korinek AM, 2005, ACTA NEUROCHIR, V147, P39, DOI 10.1007/s00701-004-0416-z; Kro V, 2009, J HOSP INFECT, V71, P176, DOI 10.1016/j.jhin.2008.09.018; Leverstein-van Hall MA, 2010, J NEUROSURG, V112, P345, DOI 10.3171/2009.6.JNS09223; Levin AS, 1999, CLIN INFECT DIS, V28, P1008, DOI 10.1086/514732; Lietard C, 2008, J NEUROSURG, V109, P729, DOI 10.3171/JNS/2008/109/10/0729; Lobo RD, 2005, AM J INFECT CONTROL, V33, P83, DOI 10.1016/j.ajic.2004.05.003; Lobo RD, 2010, AM J INFECT CONTROL, V38, P440, DOI 10.1016/j.ajic.2009.09.013; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Park P, 2004, NEUROSURGERY, V55, P594, DOI 10.1227/01.NEU.0000134289.04500.EE; Pfisterer W, 2003, J NEUROL NEUROSUR PS, V74, P929, DOI 10.1136/jnnp.74.7.929; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Schade RP, 2005, J NEUROSURG, V102, P229, DOI 10.3171/jns.2005.102.2.0229	25	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e50708	10.1371/journal.pone.0050708	http://dx.doi.org/10.1371/journal.pone.0050708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390486	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100002
J	Wu, K; Taki, Y; Sato, K; Hashizume, H; Sassa, Y; Takeuchi, H; Thyreau, B; He, Y; Evans, AC; Li, XB; Kawashima, R; Fukuda, H				Wu, Kai; Taki, Yasuyuki; Sato, Kazunori; Hashizume, Hiroshi; Sassa, Yuko; Takeuchi, Hikaru; Thyreau, Benjamin; He, Yong; Evans, Alan C.; Li, Xiaobo; Kawashima, Ryuta; Fukuda, Hiroshi			Topological Organization of Functional Brain Networks in Healthy Children: Differences in Relation to Age, Sex, and Intelligence	PLOS ONE			English	Article							GENDER-RELATED DIFFERENCES; GRAY-MATTER VOLUME; SMALL-WORLD; CORTICAL NETWORKS; DEVELOPMENTAL TRAJECTORIES; UNDERLYING INTELLIGENCE; CONNECTIVITY PATTERNS; ANATOMICAL NETWORKS; STRUCTURAL NETWORKS; LOW-FREQUENCY	Recent studies have demonstrated developmental changes of functional brain networks derived from functional connectivity using graph theoretical analysis, which has been rapidly translated to studies of brain network organization. However, little is known about sex- and IQ-related differences in the topological organization of functional brain networks during development. In this study, resting-state fMRI (rs-fMRI) was used to map the functional brain networks in 51 healthy children. We then investigated the effects of age, sex, and IQ on economic small-world properties and regional nodal properties of the functional brain networks. At a global level of whole networks, we found significant age-related increases in the small-worldness and local efficiency, significant higher values of the global efficiency in boys compared with girls, and no significant IQ-related difference. Age-related increases in the regional nodal properties were found predominately in the frontal brain regions, whereas the parietal, temporal, and occipital brain regions showed age-related decreases. Significant sex- related differences in the regional nodal properties were found in various brain regions, primarily related to the default mode, language, and vision systems. Positive correlations between IQ and the regional nodal properties were found in several brain regions related to the attention system, whereas negative correlations were found in various brain regions primarily involved in the default mode, emotion, and language systems. Together, our findings of the network topology of the functional brain networks in healthy children and its relationship with age, sex, and IQ bring new insights into the understanding of brain maturation and cognitive development during childhood and adolescence.	[Wu, Kai; Taki, Yasuyuki; Sato, Kazunori; Fukuda, Hiroshi] Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Hashizume, Hiroshi; Sassa, Yuko; Thyreau, Benjamin; Kawashima, Ryuta] Tohoku Univ, Div Dev Cognit Neurosci, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Takeuchi, Hikaru; Kawashima, Ryuta] Tohoku Univ, Smart Ageing Int Res Ctr, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Dept Funct Brain Imaging, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Wu, Kai] S China Univ Technol, Dept Biomed Engn, Sch Mat Sci & Engn, Guangzhou, Guangdong, Peoples R China; [He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Evans, Alan C.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Li, Xiaobo] Yeshiva Univ Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10461 USA	Tohoku University; Tohoku University; Tohoku University; Tohoku University; South China University of Technology; Beijing Normal University; McGill University; Yeshiva University; Albert Einstein College of Medicine	Wu, K (corresponding author), Tohoku Univ, Dept Nucl Med & Radiol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	kai.wu.22@gmail.com	He, Yong/C-2161-2009; wu, kai/G-1229-2014; Evans, Alan C/B-2373-2013; Takeuchi, Hikaru/D-1057-2011; He, Yong/Q-5756-2018	wu, kai/0000-0003-4467-1597; Evans, Alan C/0000-0003-3841-6098; He, Yong/0000-0002-7039-2850; Takeuchi, Hikaru/0000-0002-8022-9694	Ministry of Education, Culture, Sports, Science and Technology [20790875, 24103701, 23240056]; Tohoku University Global COE Program "Global Nano-Biomedical Engineering Education and Research Network Centre''; Guangdong Natural Science Foundation, China [S2012040007743]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tohoku University Global COE Program "Global Nano-Biomedical Engineering Education and Research Network Centre''(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Guangdong Natural Science Foundation, China(National Natural Science Foundation of Guangdong Province)	This study was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (20790875, 24103701, and 23240056) and the 2007 Tohoku University Global COE Program "Global Nano-Biomedical Engineering Education and Research Network Centre''. This study was also supported by Guangdong Natural Science Foundation (S2012040007743), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bussey K, 1999, PSYCHOL REV, V106, P676, DOI 10.1037/0033-295X.106.4.676; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Clayden JD, 2012, CEREB CORTEX, V22, P1738, DOI 10.1093/cercor/bhr243; Clements AM, 2006, BRAIN LANG, V98, P150, DOI 10.1016/j.bandl.2006.04.007; Cohen RZ, 1999, AM J PSYCHIAT, V156, P1059; CORBETTA M, 1993, J NEUROSCI, V13, P1202; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Fangmeier T, 2006, J COGNITIVE NEUROSCI, V18, P320, DOI 10.1162/jocn.2006.18.3.320; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Fujita K, 2006, JAPANESE WECHSLER AD; Gao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025278; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Ikeda Y, 2010, PROG NEURO-PSYCHOPH, V34, P244, DOI 10.1016/j.pnpbp.2009.10.010; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee KH, 2006, NEUROIMAGE, V29, P578, DOI 10.1016/j.neuroimage.2005.07.036; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Milham M F X, 2012, 18 ANN M ORG HUM BRA; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rubia K, 2010, NEUROIMAGE, V51, P817, DOI 10.1016/j.neuroimage.2010.02.058; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schmithorst VJ, 2007, NEUROIMAGE, V35, P406, DOI 10.1016/j.neuroimage.2006.11.046; Schmithorst VJ, 2006, NEUROIMAGE, V31, P1366, DOI 10.1016/j.neuroimage.2006.01.010; Schmithorst VJ, 2009, INTELLIGENCE, V37, P164, DOI 10.1016/j.intell.2008.07.001; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Sporns Olaf, 2001, Complexity, V7, P28, DOI 10.1002/cplx.10015; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Taki Y, 2012, NEUROIMAGE, V60, P471, DOI 10.1016/j.neuroimage.2011.11.072; Taki Y, 2012, NEUROIMAGE, V59, P1023, DOI 10.1016/j.neuroimage.2011.08.092; Taki Y, 2011, NEUROIMAGE, V58, P709, DOI 10.1016/j.neuroimage.2011.07.020; Taki Y, 2011, HUM BRAIN MAPP, V32, P1973, DOI 10.1002/hbm.21163; Taki Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015213; Talairach J., 1988, COPLANAR STEREOTAXIC; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Ueno K, 1998, WECHSLER INTELLIGENC, V3rd; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019608; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yap PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024678; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	112	106	107	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2013	8	2							e55347	10.1371/journal.pone.0055347	http://dx.doi.org/10.1371/journal.pone.0055347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NH	23390528	Green Published, gold, Green Submitted			2022-12-25	WOS:000314691100044
J	Cafri, G; Sharbi-Yunger, A; Tzehoval, E; Eisenbach, L				Cafri, Gal; Sharbi-Yunger, Adi; Tzehoval, Esther; Eisenbach, Lea			Production of LacZ Inducible T Cell Hybridoma Specific for Human and Mouse gp100(25-33) Peptides	PLOS ONE			English	Article							CLASS-I; ANTIGEN; ACTIVATION; EXPRESSION	Identification and quantification of immunogenic peptides and tumor-derived epitopes presented on MHC-I molecules are essential for basic studies and vaccines generation. Although lymphocytes derived from transgenic mice can serve as sensitive detectors of processes of antigen presentation and recognition, they are not always available. The use of cell lines might be extremely useful. In this study, we generated a lacZ inducible CD8(+) hybridoma (BUSA14) capable of recognizing both human and mouse gp100(25-33) melanoma antigens presented on dendritic and tumor cell lines. This hybridoma expresses a variety of membranal T cell markers and secretes IL-2 and TNF alpha. Thus, BUSA14 offers a quantifiable, cheap and straightforward tool for studying peptide presentation by MHC-I molecules on the cell surface.	[Cafri, Gal; Sharbi-Yunger, Adi; Tzehoval, Esther; Eisenbach, Lea] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Eisenbach, L (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	lea.eisenbach@weizmann.ac.il		Eisenbach, Lea R/0000-0002-4816-1968; Cafri, Gal/0000-0002-9427-0479				DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; KATZ A, 1992, J IMMUNOL METHODS, V149, P255, DOI 10.1016/0022-1759(92)90257-T; Malarkannan S, 2000, METH MOL B, V156, P265; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; PORGADOR A, 1995, CANCER RES, V55, P4941; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shen ZH, 1997, J IMMUNOL, V158, P2723	11	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55583	10.1371/journal.pone.0055583	http://dx.doi.org/10.1371/journal.pone.0055583			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383339	Green Published, gold, Green Submitted			2022-12-25	WOS:000314597900046
J	van Nierop, BJ; van Assen, HC; van Deel, ED; Niesen, LBP; Duncker, DJ; Strijkers, GJ; Nicolay, K				van Nierop, Bastiaan J.; van Assen, Hans C.; van Deel, Elza D.; Niesen, Leonie B. P.; Duncker, Dirk J.; Strijkers, Gustav J.; Nicolay, Klaas			Phenotyping of Left and Right Ventricular Function in Mouse Models of Compensated Hypertrophy and Heart Failure with Cardiac MRI	PLOS ONE			English	Article							MURINE MODEL; MECHANISMS; MICE; SEGMENTATION; TRANSITION; DISEASE	Background: Left ventricular (LV) and right ventricular (RV) function have an important impact on symptom occurrence, disease progression and exercise tolerance in pressure overload-induced heart failure, but particularly RV functional changes are not well described in the relevant aortic banding mouse model. Therefore, we quantified time-dependent alterations in the ventricular morphology and function in two models of hypertrophy and heart failure and we studied the relationship between RV and LV function during the transition from hypertrophy to heart failure. Methods: MRI was used to quantify RV and LV function and morphology in healthy (n = 4) and sham operated (n = 3) C57BL/6 mice, and animals with a mild (n = 5) and a severe aortic constriction (n = 10). Results: Mice subjected to a mild constriction showed increased LV mass (P < 0.01) and depressed LV ejection fraction (EF) (P < 0.05) as compared to controls, but had similar RVEF (P > 0.05). Animals with a severe constriction progressively developed LV hypertrophy (P < 0.001), depressed LVEF (P < 0.001), followed by a declining RVEF (P < 0.001) and the development of pulmonary remodeling, as compared to controls during a 10-week follow-up. Myocardial strain, as a measure for local cardiac function, decreased in mice with a severe constriction compared to controls (P < 0.05). Conclusions: Relevant changes in mouse RV and LV function following an aortic constriction could be quantified using MRI. The well-controlled models described here open opportunities to assess the added value of new MRI techniques for the diagnosis of heart failure and to study the impact of new therapeutic strategies on disease progression and symptom occurrence.	[van Nierop, Bastiaan J.; Niesen, Leonie B. P.; Strijkers, Gustav J.; Nicolay, Klaas] Eindhoven Univ Technol, Biomed NMR, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [van Assen, Hans C.] Eindhoven Univ Technol, Dept Elect Engn, NL-5600 MB Eindhoven, Netherlands; [van Deel, Elza D.; Duncker, Dirk J.] Univ Med Ctr Rotterdam, Erasmus MC, Thoraxctr, Rotterdam, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Erasmus University Rotterdam; Erasmus MC	van Nierop, BJ (corresponding author), Eindhoven Univ Technol, Biomed NMR, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.	b.j.v.nierop@tue.nl	van Assen, Hans C./F-4593-2016	van Assen, Hans C./0000-0003-4907-904X; Strijkers, Gustav/0000-0001-6700-5058; Nicolay, Klaas/0000-0002-4179-616X	Center for Translational Molecular Medicine; project TRIUMPH [01C-103]; Netherlands Heart Foundation	Center for Translational Molecular Medicine; project TRIUMPH; Netherlands Heart Foundation(Netherlands Heart Foundation)	This work was supported by the Center for Translational Molecular Medicine (www.ctmm.nl), project TRIUMPH (grant 01C-103), and by the Netherlands Heart Foundation (http://www.hartstichting.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee Dipanjan, 2010, Curr Heart Fail Rep, V7, P202, DOI 10.1007/s11897-010-0031-7; Berry JM, 2007, DRUG DISCOV TODAY DI, V4, P197, DOI [DOI 10.1016/J.DDM0D.2007.06.003, 10.1016/j.ddmod.2007.06.003]; Bottomley PA., 2007, ENCY MAGNETIC RESONA; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chen YJ, 2012, HYPERTENSION, V59, P1170, DOI 10.1161/HYPERTENSIONAHA.111.186072; Cokkinos DV, 2011, HEART FAIL REV, V16, P1, DOI 10.1007/s10741-010-9192-4; Coolen BF, 2011, NMR BIOMED, V24, P154, DOI 10.1002/nbm.1566; Costandi PN, 2006, AM J PHYSIOL-HEART C, V291, pH2971, DOI 10.1152/ajpheart.00571.2006; de Couto G, 2010, NAT REV CARDIOL, V7, P334, DOI 10.1038/nrcardio.2010.51; DENOLIN H, 1983, EUR HEART J, V4, P445, DOI 10.1093/oxfordjournals.eurheartj.a061500; FISCHER SE, 1993, MAGNET RESON MED, V30, P191, DOI 10.1002/mrm.1910300207; Florack L., 2007, 2007 IEEE 11 INT C C, P1; Florack L, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/341242; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Garot J, 2000, CIRCULATION, V101, P981, DOI 10.1161/01.CIR.101.9.981; Gupta A, 2009, AM J PHYSIOL-HEART C, V297, pH59, DOI 10.1152/ajpheart.00178.2009; Hankiewicz JH, 2008, AM J PHYSIOL-HEART C, V294, pH330, DOI 10.1152/ajpheart.01109.2007; Heijman E, 2008, J MAGN RESON IMAGING, V27, P86, DOI 10.1002/jmri.21236; Iles L, 2008, J AM COLL CARDIOL, V52, P1574, DOI 10.1016/j.jacc.2008.06.049; Jacoby C, 2006, BASIC RES CARDIOL, V101, P87, DOI 10.1007/s00395-005-0542-7; Juenger J, 2002, HEART, V87, P235, DOI 10.1136/heart.87.3.235; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; Kee K, 2010, CIRC J, V74, P2507, DOI 10.1253/circj.CJ-10-0869; Le Tourneau T, 2011, MINERVA CARDIOANGIOL, V59, P349; Lemon DD, 2011, J MOL CELL CARDIOL, V51, P41, DOI 10.1016/j.yjmcc.2011.04.005; Lindqvist P, 2008, EUR J ECHOCARDIOGR, V9, P225, DOI 10.1016/j.euje.2007.04.002; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lygate C, 2006, DRUG DISCOV TODAY DI, V3, P283, DOI 10.1016/j.ddmod.2006.10.002; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; MANNING WJ, 1994, AM J PHYSIOL, V266, pH1672, DOI 10.1152/ajpheart.1994.266.4.H1672; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Qu JX, 2009, CIRC RES, V104, P365, DOI 10.1161/CIRCRESAHA.108.184044; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rothermel BA, 2005, PHYSIOL GENOMICS, V23, P18, DOI 10.1152/physiolgenomics.00061.2005; van Deel ED, 2011, J MOL CELL CARDIOL, V50, P1017, DOI 10.1016/j.yjmcc.2011.01.016; van Nierop BJ, 2013, MAGN RESON MED, V69, P1735, DOI 10.1002/mrm.24424; Vandsburger MH, 2010, MAGN RESON MED, V63, P648, DOI 10.1002/mrm.22280; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Wiesmann F, 2002, AM J PHYSIOL-HEART C, V283, pH1065, DOI 10.1152/ajpheart.00802.2001	42	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55424	10.1371/journal.pone.0055424	http://dx.doi.org/10.1371/journal.pone.0055424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23383329	Green Published, Green Submitted, gold			2022-12-25	WOS:000314597900036
J	Ye, XM; Guo, Y; Zhang, Q; Chen, WJ; Hua, XF; Liu, W; Yang, Y; Chen, GH				Ye, Xiaoming; Guo, Yu; Zhang, Qi; Chen, Wenjie; Hua, Xuefeng; Liu, Wei; Yang, Yang; Chen, Guihua			beta Klotho Suppresses Tumor Growth in Hepatocellular Carcinoma by Regulating Akt/GSK-3 beta/Cyclin D1 Signaling Pathway	PLOS ONE			English	Article							BILE-ACID SYNTHESIS; CYCLIN D1; CELL-CYCLE; RECEPTOR; EXPRESSION; CANCER; OVEREXPRESSION; APOPTOSIS; FAMILY; TARGET	beta Klotho is a regulator in multiple metabolic processes, while its role in cancer remains unclear. We found the expression of beta Klotho was down-regulated in human hepatocellular carcinoma tissues compared with that in paired adjacent non-tumourous liver tissues. Hepatoma cells also showed decreased expression of beta Klotho compared with normal hepatocyte cells. Reintroduction of beta Klotho into hepatoma cells inhibited their proliferation. The anti-proliferative effect of beta Klotho might be linked with G1 to S phase arrest, which was mediated by Akt/GSK-3 beta/cyclin D1 signaling, since forced expression beta Klotho reduced the phosphorylation level of Akt and GSK-3 beta and induced down-regulation of cyclin D1. Furthermore, beta Klotho overexpression could inhibit tumorgenesis, while constitutively activated Akt could override the suppressive effects of beta Klotho in vivo. These data suggest beta Klotho suppresses tumor growth in hepatocellular carcinoma.	[Ye, Xiaoming; Guo, Yu; Yang, Yang; Chen, Guihua] Sun Yat Sen Univ, Dept Gen Surg, Lingnan Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Ye, Xiaoming; Guo, Yu; Zhang, Qi; Chen, Wenjie; Hua, Xuefeng; Yang, Yang; Chen, Guihua] Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Guangdong, Peoples R China; [Ye, Xiaoming; Guo, Yu; Zhang, Qi; Chen, Wenjie; Liu, Wei; Yang, Yang; Chen, Guihua] Sun Yat Sen Univ, Hepatol Lab, Hosp Liver Dis, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yang, Y (corresponding author), Sun Yat Sen Univ, Dept Gen Surg, Lingnan Hosp, Guangzhou 510275, Guangdong, Peoples R China.	yysysu@163.com; chgh1955@263.net	yang, yang/GVT-5210-2022; Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022; Liu, Wei/AAH-5037-2020	Liu, Wei/0000-0002-4935-7591; Guo, Yu/0000-0002-8886-0106	National Basic Research Program of China (973 Program) [2009CB522404]; National Natural Science Foundation of China [30972915, 81170451, U0932006]; Science and Technology Planning Project of Guangdong Province [2011B031300016]; Specialized Research Fund for the Doctoral Program of Higher Education [20110171120091]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from National Basic Research Program of China (973 Program, 2009CB522404, http://www.973.gov.cn/), National Natural Science Foundation of China (30972915, 81170451 and U0932006, http://www.nsfc.gov.cn), Science and Technology Planning Project of Guangdong Province (2011B031300016, http://pro.gdstc.gov.cn) and Specialized Research Fund for the Doctoral Program of Higher Education (20110171120091, http://www.cutech.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese Marco, 2006, Hepatology, V43, P191, DOI 10.1002/hep.21022; Chen W, 2011, CANCER LETT, V307, P93, DOI 10.1016/j.canlet.2011.03.021; Deane NG, 2001, CANCER RES, V61, P5389; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Huang XQ, 2009, MOL CARCINOGEN, V48, P553, DOI 10.1002/mc.20494; Hui AM, 1998, HEPATO-GASTROENTEROL, V45, P1635; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Kim ND, 2006, CURR CANCER DRUG TAR, V6, P681; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Luo YD, 2010, J BIOL CHEM, V285, P30069, DOI 10.1074/jbc.M110.148288; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; NISHIDA N, 1994, CANCER RES, V54, P3107; Poh WJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-14; Sato Y, 1999, J GASTROENTEROL, V34, P486, DOI 10.1007/s005350050301; Scharf JG, 2003, HORM METAB RES, V35, P685; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tashiro E, 2007, CANCER SCI, V98, P629, DOI 10.1111/j.1349-7006.2007.00449.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Weinstein IB, 1996, J CELL BIOCHEM, P23; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482; Zhao HC, 2007, WORLD J GASTROENTERO, V13, P683, DOI 10.3748/wjg.v13.i5.683	32	43	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2013	8	1							e55615	10.1371/journal.pone.0055615	http://dx.doi.org/10.1371/journal.pone.0055615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098QM	23383245	Green Submitted, Green Published, gold			2022-12-25	WOS:000315563800175
J	Liu, HP; Liu, ZH; Chen, JX; Chen, L; He, X; Zheng, RJ; Yang, H; Song, P; Weng, D; Hu, HL; Fan, L; Xiao, HP; Kaufmann, SHE; Ernst, J; Ge, BX				Liu, Haipeng; Liu, Zhonghua; Chen, Jianxia; Chen, Ling; He, Xin; Zheng, Ruijuan; Yang, Hong; Song, Peng; Weng, Dong; Hu, Haili; Fan, Lin; Xiao, Heping; Kaufmann, Stefan H. E.; Ernst, Joel; Ge, Baoxue			Induction of CCL8/MCP-2 by Mycobacteria through the Activation of TLR2/PI3K/Akt Signaling Pathway	PLOS ONE			English	Article							TUBERCULOUS PLEURAL EFFUSIONS; HELPER T-CELLS; INTERFERON-GAMMA; DIAGNOSTIC UTILITY; UP-REGULATION; HOST DISEASE; PLASMA CCL8; EXPRESSION; MCP-2; RECRUITMENT	Pleural tuberculosis (TB), together with lymphatic TB, constitutes more than half of all extrapulmonary cases. Pleural effusions (PEs) in TB are representative of lymphocytic PEs which are dominated by T cells. However, the mechanism underlying T lymphocytes homing and accumulation in PEs is still incompletely understood. Here we performed a comparative analysis of cytokine abundance in PEs from TB patients and non-TB patients by protein array analysis and observed that MCP-2/CCL8 is highly expressed in the TB-PEs as compared to peripheral blood. Meanwhile, we observed that CCR5, the primary receptor used by MCP-2/CCL8, is mostly expressed on pleural CD4(+) T lymphocytes. Furthermore, we found that infection with either Mycobacterium bovis Bacillus Calmette-Guerin (BCG) or Mycobacterium tuberculosis H37Rv induced production of MCP-2/CCL8 at both transcriptional and protein level in Raw264.7 and THP-1 macrophage cells, mouse peritoneal macrophages as well as human PBMC monocyte-derived macrophages (MDMs). The induction of MCP-2/CCL8 by mycobacteria is dependent on the activation of TLR2/PI3K/Akt and p38 signaling pathway. We conclude that accumulation of MCP-2/CCL8 in TB-PEs may function as a biomarker for TB diagnosis.	[Liu, Haipeng; Liu, Zhonghua; Chen, Jianxia; Zheng, Ruijuan; Ge, Baoxue] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai TB Key Lab, Shanghai 200092, Peoples R China; [Liu, Haipeng; Yang, Hong; Song, Peng; Weng, Dong; Ge, Baoxue] Tongji Univ, Sch Med, Dept Microbiol & Immunol, Shanghai 200092, Peoples R China; [Liu, Haipeng; Chen, Jianxia; Chen, Ling; He, Xin; Yang, Hong; Song, Peng; Weng, Dong; Ge, Baoxue] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Clin Translat Res Ctr, Shanghai 200092, Peoples R China; [Hu, Haili; Fan, Lin; Xiao, Heping] Tongji Univ, Sch Med, Shanghai Pulm Hosp, TB Dept, Shanghai 200092, Peoples R China; [Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Ernst, Joel] NYU, Sch Med, Div Infect Dis, New York, NY USA	Tongji University; Tongji University; Tongji University; Tongji University; Max Planck Society; New York University	Ge, BX (corresponding author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai TB Key Lab, Shanghai 200092, Peoples R China.	baoxue_ge@tongji.edu.cn	; Kaufmann, Stefan HE/I-5454-2014	Liu, Haipeng/0000-0002-3338-6291; Kaufmann, Stefan HE/0000-0001-9866-8268	National Natural Science Foundation of China [81200003]; National Basic Research Program of China (973 Program) [2012CB518700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported in part by a grant from the National Natural Science Foundation of China (81200003); in part by a grant from the National Basic Research Program of China (973 Program 2012CB518700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameglio F, 2005, INT J TUBERC LUNG D, V9, P98; ANTONY VB, 1985, J CLIN INVEST, V76, P1514, DOI 10.1172/JCI112131; ANTONY VB, 1983, ACTA CYTOL, V27, P355; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; BARNES PF, 1989, J IMMUNOL, V142, P1114; Baumann MH, 2007, CHEST, V131, P1125, DOI 10.1378/chest.06-2352; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; BOSSINK AWJ, 1995, BLOOD, V86, P3841, DOI 10.1182/blood.V86.10.3841.bloodjournal86103841; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Gong XQ, 1997, J BIOL CHEM, V272, P11682, DOI 10.1074/jbc.272.18.11682; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Hamm H, 1997, EUR RESPIR J, V10, P1150, DOI 10.1183/09031936.97.10051150; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; Kohmo S, 2012, TUBERCULOSIS, V92, P248, DOI 10.1016/j.tube.2012.01.001; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; Maddocks S, 2009, TUBERCULOSIS, V89, P285, DOI 10.1016/j.tube.2009.05.003; Mege JL, 2011, CURR OPIN INFECT DIS, V24, P230, DOI 10.1097/QCO.0b013e328344b73e; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Ota A, 2009, EXP HEMATOL, V37, P525, DOI 10.1016/j.exphem.2008.12.006; Pierer M, 2004, J IMMUNOL, V172, P1256, DOI 10.4049/jimmunol.172.2.1256; Pokkali S, 2008, CYTOKINE, V41, P307, DOI 10.1016/j.cyto.2007.12.009; Porcel JM, 2009, LUNG, V187, P263, DOI 10.1007/s00408-009-9165-3; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Ruffing N, 1998, CELL IMMUNOL, V189, P160, DOI 10.1006/cimm.1998.1379; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Sun XG, 2006, INFECT IMMUN, V74, P5943, DOI 10.1128/IAI.00082-06; Supriya P, 2008, DIAGN MICR INFEC DIS, V62, P186, DOI 10.1016/j.diagmicrobio.2008.05.011; Trajman A, 2008, EUR RESPIR J, V31, P1098, DOI 10.1183/09031936.00147507; VANDAMME J, 1994, J IMMUNOL, V152, P5495; Villena V, 2002, ARCH BRONCONEUMOL, V38, P21, DOI 10.1016/S0300-2896(02)75142-9; Wang Ting-ting, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P592; WANGOO A, 1993, CLIN EXP IMMUNOL, V94, P43; Wu C, 2010, RESPIROLOGY, V15, P522, DOI 10.1111/j.1440-1843.2010.01719.x; Yamamoto M, 2011, EXP HEMATOL, V39, P1101, DOI 10.1016/j.exphem.2011.07.006; Yang WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040450; Ye ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031710; Ye ZJ, 2012, AM J RESP CRIT CARE, V185, P660, DOI 10.1164/rccm.201107-1198OC	46	58	61	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56815	10.1371/journal.pone.0056815	http://dx.doi.org/10.1371/journal.pone.0056815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418602	Green Published, gold			2022-12-25	WOS:000315970300195
J	Liu, ZY; Li, W; Wang, J; Pan, J; Sun, SP; Yu, YH; Zhao, B; Ma, YZ; Zhang, TJ; Qi, J; Liu, GJ; Lu, FM				Liu, Zhiyuan; Li, Wei; Wang, Jie; Pan, Jian; Sun, Shipeng; Yu, Yanhua; Zhao, Bing; Ma, Yuzhi; Zhang, Tingju; Qi, Jie; Liu, Guijian; Lu, Fengmin			Identification and Characterization of the First Escherichia coli Strain Carrying NDM-1 Gene in China	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ACINETOBACTER-BAUMANNII; EMERGENCE; ENTEROBACTERIACEAE; RESISTANCE; CARBAPENEMASES; DISSEMINATION; WORLDWIDE; INFECTION; SPREAD	New Delhi metallo-beta-lactamase-1 (NDM-1), an acquired class B carbapenemase, is a significant clinical threat due to its extended hydrolysis of beta-lactams including carbapenems. In this study, we identified the first confirmed clinical isolate of Escherichia coli BJ01 harboring bla(NDM-1) in China. The isolate is highly resistant to all tested antimicrobials except polymyxin. bla(NDM-1), bla(CTX-M-57), and bla(TEM-1) were identified in the isolate. bla(NDM-1) was transferable to E. coli EC600 and DH5 alpha in both plasmid conjugation experiments and plasmid transformation tests. BJ01 was identified as a new sequence type, ST224, by multilocus sequence typing. Analysis of genetic environment shows complex transposon-like structures surrounding the blaNDM-1 gene. Genetic analysis revealed that the region flanking blaNDM-1 was very similar to previously identified NDM-positive Acinetobacter spp. isolated in China. The findings of this study raise attention to the emergence and spread of NDM-1-carrying Enterobacteriaceae in China.	[Liu, Zhiyuan; Wang, Jie; Pan, Jian; Sun, Shipeng; Zhao, Bing; Ma, Yuzhi; Zhang, Tingju; Qi, Jie; Liu, Guijian] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China; [Liu, Zhiyuan; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Ctr Infect Dis, Beijing 100871, Peoples R China; [Li, Wei] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China; [Yu, Yanhua] Capital Med Univ, Beijing Youan Hosp, Dept Clin Lab, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Peking University; Capital Medical University; Capital Medical University	Liu, GJ (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China.	GuijianLiu234@gmail.com; Fengmingqqq@gmail.com	Li, Wei/I-8060-2014; Liu, ZH/H-7536-2012; Yang, Jian/H-3169-2011	Liu, ZH/0000-0002-0086-5659; Yang, Jian/0000-0002-2170-589X; He, Hong S./0000-0002-3983-2512; Li, Wei/0000-0002-9991-7892; Liu, Zhiyuan/0000-0002-4253-1753	Guang'anmen Hospital [2011S242]; Beijing You'an Project for Liver diseases and AIDS [JYAN-2011-064]	Guang'anmen Hospital; Beijing You'an Project for Liver diseases and AIDS	This work was supported by Internal Funding of Guang'anmen Hospital (Grant# 2011S242) and Beijing You'an Project for Liver diseases and AIDS ( Grant# JYAN-2011-064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birgy A, 2012, J CLIN MICROBIOL, V50, P1295, DOI 10.1128/JCM.06131-11; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bonomo RA, 2011, CLIN INFECT DIS, V52, P485, DOI 10.1093/cid/ciq179; Chen SD, 2011, AM J INFECT CONTROL, V39, pE55, DOI 10.1016/j.ajic.2011.02.009; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Chen Y, 2012, J BACTERIOL, V194, P204, DOI 10.1128/JB.06202-11; Clinical and Laboratory Standards Institute (CLSI), 1999, M26A CLSI, V19, P1; CLSI, 2012, M100S22 CLSI; D'Andrea MM, 2011, J CLIN MICROBIOL, V49, P2755, DOI 10.1128/JCM.00016-11; Espinal P, 2011, ANTIMICROB AGENTS CH, V55, P5396, DOI 10.1128/AAC.00679-11; Fang H, 2008, J CLIN MICROBIOL, V46, P707, DOI 10.1128/JCM.01943-07; Fu Y, 2012, J ANTIMICROB CHEMOTH; Gaibani P, 2011, EUROSURVEILLANCE, V16, P2; Ho PL, 2012, J ANTIMICROB CHEMOTH, DOI [10.1093/jac/dks095, DOI 10.1093/JAC/DKS095.EPUB]; Hopkins TA, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2903479; Hu FP, 2012, J MED MICROBIOL, V61, P132, DOI 10.1099/jmm.0.036483-0; Hu HY, 2012, ANTIMICROB AGENTS CH, V56, P1698, DOI 10.1128/AAC.06199-11; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lascols C, 2011, J ANTIMICROB CHEMOTH, V66, P1992, DOI 10.1093/jac/dkr240; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Mulvey MR, 2011, EMERG INFECT DIS, V17, P103, DOI 10.3201/eid1701.101358; Nielsen J, 2012, FEMS YEAST RES, V12, P1, DOI [10.1111/j.1567-1364.2011.00764.x, 10.1111/j.1574-6941.2011.01260.x]; OBRIEN TF, 1985, SCIENCE, V230, P87, DOI 10.1126/science.2994226; Pfeifer Y, 2011, ANTIMICROB AGENTS CH, V55, P1318, DOI 10.1128/AAC.01585-10; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P4914, DOI 10.1128/AAC.00878-10; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Shakil S, 2011, J CHEMOTHERAPY, V23, P263, DOI 10.1179/joc.2011.23.5.263; Shi DS, 2012, EUR J CLIN MICROBIOL, V31, P797, DOI 10.1007/s10096-011-1377-9; Shibata N, 2003, J CLIN MICROBIOL, V41, P5407, DOI 10.1128/JCM.41.12.5407-5413.2003; Sowmiya M, 2012, INVEST OPHTH VIS SCI, V53, P5251, DOI 10.1167/iovs.12-10467; Struelens MJ, 2010, EUROSURVEILLANCE, V15, P9; Wang XS, 2013, CLIN INFECT DIS, V56, P161, DOI 10.1093/cid/cis782; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037152; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Wilson ME, 2012, CURR INFECT DIS REP, V14, P213, DOI 10.1007/s11908-012-0252-x; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang R, 2011, J MED MICROBIOL, V60, P977, DOI 10.1099/jmm.0.015826-0; Zhou ZW, 2012, CAN J MICROBIOL, V58, P112, DOI [10.1139/W11-112, 10.1139/w11-112]	41	246	257	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66666	10.1371/journal.pone.0066666	http://dx.doi.org/10.1371/journal.pone.0066666			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762496	Green Published, Green Submitted, gold			2022-12-25	WOS:000320440500069
J	Liu, HJ; Xu, YF; Lin, XJ; Shi, J; Chen, SY				Liu, Hongjie; Xu, Yongfang; Lin, Xinjin; Shi, Jian; Chen, Shiyi			Associations between Perceived HIV Stigma and Quality of Life at the Dyadic Lvel: The Actor-Partner Interdependence Model	PLOS ONE			English	Article							YOUNG ADOLESCENTS; CAREGIVERS; SCHIZOPHRENIA; INDIVIDUALISM; COLLECTIVISM; PERSPECTIVES; SEROSTATUS; INFECTION; HIV/AIDS; DISEASE	Background: Few studies have investigated the relationship between HIV-related stigma and quality life at the dyadic level. The objective of this study was to examine the actor and partner effects of stigma that was perceived by people living with HIV/AIDS (PLWHAs) and caregivers on quality of life at the dyadic level. Method: A survey was conducted among 148 dyads consisting of one PLWHA and one caregiver (296 participants) in Nanning, China. The interdependent relationship between a pair of dyadic members that influences the associations between stigma and quality of life was analyzed, using an innovative dyadic analysis technique: the Actor-Partner Interdependence Model (APIM). Results: We found in this dyadic analysis that (1) PLWHAs compared to their caregivers exhibited a higher level of perceived HIV stigma and lower level of quality of life measured in four domains; (2) both PLWHAs' and caregivers' perceived HIV stigma influenced their own quality of life; (3) The quality of life was not substantially influenced by their partners' perceived stigma; and (4) Both actor and partner effects of stigma on quality of life were similar among PLWHAs and their caregivers. Conclusion: As HIV stigma and quality of life are complex phenomena rooted in cultures, intervention programs should be carefully planned based on social or cognitive theories and should be culturally adopted.	[Liu, Hongjie] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Xu, Yongfang; Lin, Xinjin; Shi, Jian; Chen, Shiyi] Nanning Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China	University System of Maryland; University of Maryland College Park	Liu, HJ (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA.	hliu1210@umd.edu	; Kaufmann, Stefan HE/I-5454-2014	Liu, Haipeng/0000-0002-3338-6291; Kaufmann, Stefan HE/0000-0001-9866-8268	National Institutes of Health-National Institute of Child Health and Human Development [R01 HD068305-01]; Virginia Commonwealth University School of Medicine	National Institutes of Health-National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Virginia Commonwealth University School of Medicine	This work was partially supported by a research grant (R01 HD068305-01) from the National Institutes of Health-National Institute of Child Health and Human Development and a research grant from the Virginia Commonwealth University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasiubong F, 2011, AIDS CARE, V23, P494, DOI 10.1080/09540121.2010.516340; Andrinopoulos K, 2011, AIDS EDUC PREV, V23, P367, DOI 10.1521/aeap.2011.23.4.367; Aranda-Naranjo B, 2004, J ASSOC NURSE AIDS C, V15, p20S, DOI 10.1177/1055329004269183; Boyer L, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-42; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Caqueo-Urizar A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-84; Chinese Ministry of Health, 2012, CHIN AIDS RESP PROGR; Cook WL, 2005, INT J BEHAV DEV, V29, P101, DOI 10.1080/01650250444000405; Feaster DJ, 2002, PSYCHOL HEALTH, V17, P339, DOI 10.1080/08870440290029584; Flaskerud J H, 1998, Health Care Women Int, V19, P23, DOI 10.1080/073993398246557; Goffman E., 1963, BEHAV PUBLIC PLACES; Goffman E., 1968, STIGMA NOTES MANAGEM; Group W, 1996, WHOQOL BREF INTR ADM; Ha TH, 2012, AIDS CARE, V24, P39, DOI 10.1080/09540121.2011.592820; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Holzemer WL, 2009, J ASSOC NURSE AIDS C, V20, P161, DOI 10.1016/j.jana.2009.02.002; HUI CH, 1986, J CROSS CULT PSYCHOL, V17, P225, DOI 10.1177/0022002186017002006; Kelley H.H., 1978, INTERPERSONAL RELATI; Kenny D. A., 2006, DYADIC DATA ANAL; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Laursen B, 2005, INT J BEHAV DEV, V29, P97, DOI 10.1080/01650250444000450; Lee SJ, 2007, AM J PUBLIC HEALTH, V97, P1820, DOI 10.2105/AJPH.2005.084871; Li Li, 2008, Fam Syst Health, V26, P431; Li XH, 2011, AIDS PATIENT CARE ST, V25, P665, DOI 10.1089/apc.2011.0174; Lin T. Y., 1981, NORMAL ABNORMAL BEHA, P387, DOI DOI 10.1007/978-94-017-4986-2_20; Liu H, 2009, SEX TRANSM INFECT, V85, P65, DOI 10.1136/sti.2008.032714; Liu HJ, 2006, AIDS PATIENT CARE ST, V20, P133, DOI 10.1089/apc.2006.20.133; Liu HJ, 2002, SEX TRANSM DIS, V29, P335, DOI 10.1097/00007435-200206000-00005; Liu HJ, 2012, AIDS PATIENT CARE ST, V26, P565, DOI 10.1089/apc.2012.0227; Liu Hongjie, 2011, Stigma Res Action, V1, P27; Liu HJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-563; Mitchell MM, 2009, AIDS PATIENT CARE ST, V23, P611, DOI 10.1089/apc.2008.0279; Muth?n L.K., 2010, MPLUS USERS GUIDE V; Nelms TP, 2002, J FAMILY NURSING, V8, P282; Poindexter CC, 1999, SOC WORK, V44, P46, DOI 10.1093/sw/44.1.46; Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059; Scambler G, 1998, LANCET, V352, P1054, DOI 10.1016/S0140-6736(98)08068-4; Shan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021839; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Thibaut J., 1959, SOCIAL PSYCHOL GROUP; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; WHOQOL Group, 2004, WHO QUAL LIF WHOQOL; Wight RG, 2006, SOC SCI MED, V62, P444, DOI 10.1016/j.socscimed.2005.06.004; Yang LH, 2008, SOC SCI MED, V67, P398, DOI 10.1016/j.socscimed.2008.03.011; Zendjidjian X, 2012, J AFFECT DISORDERS, V136, P660, DOI 10.1016/j.jad.2011.10.011	45	58	61	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55680	10.1371/journal.pone.0055680	http://dx.doi.org/10.1371/journal.pone.0055680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085EU	23418602	gold, Green Submitted, Green Published			2022-12-25	WOS:000314597900050
J	Park, SG; Long, MX; Kang, JA; Kim, WS; Lee, CR; Im, SH; Strickland, I; Schulze-Luehrmann, J; Hayden, MS; Ghosh, S				Park, Sung-Gyoo; Long, Meixiao; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog; Strickland, Ian; Schulze-Luehrmann, Jan; Hayden, Matthew S.; Ghosh, Sankar			The Kinase PDK1 Is Essential for B-Cell Receptor Mediated Survival Signaling	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE; ANTIGEN-RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; ACTIVATION; PHOSPHORYLATION; IMMUNODEFICIENCY; PROLIFERATION; REGULATOR; RICTOR	Phosphoinositide-dependent kinase 1 (PDK1) plays an important role in integrating the T cell antigen receptor (TCR) and CD28 signals to achieve efficient NF-kappa B activation. PDK1 is also an important regulator of T cell development, mediating pre-TCR induced proliferation signals. However, the role of PDK1 in B cell antigen receptor (BCR) signaling and B cell development remains largely unknown. In this study we provide genetic evidence supporting the role of PDK1 in B cell survival. We found PDK1 is required for BCR mediated survival in resting B cells, likely through regulation of Foxo activation. PDK1-dependent signaling to NF-kappa B is not crucial to resting B cell viability. However, PDK1 is necessary for triggering NF-kappa B during B cell activation and is required for activated B cell survival. Together these studies demonstrate that PDK1 is essential for BCR-induced signal transduction to Foxo and NF-kappa B and is indispensable for both resting and activated B cell survival.	[Park, Sung-Gyoo; Long, Meixiao; Strickland, Ian; Schulze-Luehrmann, Jan; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10027 USA; [Park, Sung-Gyoo; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog] GIST, Sch Life Sci, Kwangju, South Korea; [Park, Sung-Gyoo; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog] GIST, Immune Synapse Res Ctr, Kwangju, South Korea; [Hayden, Matthew S.] Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY USA	Columbia University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Columbia University	Park, SG (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10027 USA.	sgpark@gist.ac.kr; sg2715@columbia.edu	Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013; Park, Sung-Gyoo/H-8652-2019	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Hayden, Matthew/0000-0003-1670-6430; Park, Sung-Gyoo/0000-0003-3702-5765	National Institutes of Health [NIH R37-AI33443, RO1-AI068977]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0029942, 2011-0005477]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI068977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work in this study was supported by grants from the National Institutes of Health (NIH R37-AI33443 and RO1-AI068977) and by the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0029942 and 2011-0005477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; delPeso L, 1997, SCIENCE, V278, P687; Donahue AC, 2004, SEMIN CELL DEV BIOL, V15, P183, DOI 10.1016/j.semcdb.2003.12.024; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hayashi T, 2007, P NATL ACAD SCI USA, V104, P18619, DOI 10.1073/pnas.0709261104; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hess KL, 2004, EUR J IMMUNOL, V34, P2968, DOI 10.1002/eji.200425326; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Kloo B, 2011, P NATL ACAD SCI USA, V108, P272, DOI 10.1073/pnas.1008969108; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Mok CL, 1999, J EXP MED, V189, P575, DOI 10.1084/jem.189.3.575; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki Y, 2007, ADV EXP MED BIOL, V596, P149; SCHRIEVER F, 1989, J EXP MED, V169, P2043, DOI 10.1084/jem.169.6.2043; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	33	64	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55378	10.1371/journal.pone.0055378	http://dx.doi.org/10.1371/journal.pone.0055378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23437331	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800025
J	Wang, PH; Gu, ZH; Wan, DH; Zhu, WB; Qiu, W; Weng, SP; Yu, XQ; He, JG				Wang, Pei-Hui; Gu, Zhi-Hua; Wan, Ding-Hui; Zhu, Wei-Bin; Qiu, Wei; Weng, Shao-Ping; Yu, Xiao-Qiang; He, Jian-Guo			Litopenaeus vannamei Sterile-Alpha and Armadillo Motif Containing Protein (LvSARM) Is Involved in Regulation of Penaeidins and antilipopolysaccharide factors	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE GENES; TOLL SIGNALING PATHWAY; SHRIMP PENAEUS-MONODON; BLACK TIGER SHRIMP; INNATE IMMUNITY; CAENORHABDITIS-ELEGANS; DROSOPHILA; SARM; INFECTION; RECEPTORS	The Toll-like receptor (TLR)-mediated NF-kappa B pathway is tightly controlled because overactivation may result in severe damage to the host, such as in the case of chronic inflammatory diseases and cancer. In mammals, sterile-alpha and armadillo motif-containing protein (SARM) plays an important role in negatively regulating this pathway. While Caenorhabditis elegans SARM is crucial for an efficient immune response against bacterial and fungal infections, it is still unknown whether Drosophila SARM participates in immune responses. Here, Litopenaeus vannamei SARM (LvSARM) was cloned and functionally characterized. LvSARM shared signature domains with and exhibited significant similarities to mammalian SARM. Real-time quantitative PCR analysis indicated that the expression of LvSARM was responsive to Vibrio alginolyticus and white spot syndrome virus (WSSV) infections in the hemocyte, gill, hepatopancreas and intestine. In Drosophila S2 cells, LvSARM was widely distributed in the cytoplasm and could significantly inhibit the promoters of the NF-kappa B pathway-controlled antimicrobial peptide genes (AMPs). Silencing of LvSARM using dsRNA-mediated RNA interference increased the expression levels of Penaeidins and antilipopolysaccharide factors, which are L. vannamei AMPs, and increased the mortality rate after V. alginolyticus infection. Taken together, our results reveal that LvSARM may be a novel component of the shrimp Toll pathway that negatively regulates shrimp AMPs, particularly Penaeidins and antilipopolysaccharide factors.	[Wang, Pei-Hui; Gu, Zhi-Hua; Wan, Ding-Hui; Zhu, Wei-Bin; Qiu, Wei; Weng, Shao-Ping; He, Jian-Guo] Sch Life Sci, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [He, Jian-Guo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA	Sun Yat Sen University; University of Missouri System; University of Missouri Kansas City	Wang, PH (corresponding author), Sch Life Sci, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.	wph326@gmail.com; lsshjg@mail.sysu.edu.cn	YU, XiaoQiang/GRJ-1077-2022; Wang, Pei-Hui/F-7682-2014; YU, XIAO-QIANG/AAL-1797-2021	Wang, Pei-Hui/0000-0001-6853-2423; YU, XIAO-QIANG/0000-0003-1419-9009; Munthe, Else/0000-0003-3859-1582	National Natural Science Foundation of China [U1131002]; National High Technology Research and Development Program of China (973 Program) [2012CB114401]; China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest [201103034]; Foundation of Administration of Ocean and Fisheries of Guangdong Province [A201101B02]; Open Project of the State Key Laboratory of Biocontrol [SKLBC09K04]; Foundation of Science and Technology Bureau of Guangdong Province [2011A 020102002, 2009A 020102002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (973 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest; Foundation of Administration of Ocean and Fisheries of Guangdong Province; Open Project of the State Key Laboratory of Biocontrol; Foundation of Science and Technology Bureau of Guangdong Province	This research was supported by the National Natural Science Foundation of China under Grant No. U1131002, the National High Technology Research and Development Program of China (973 Program) 2012CB114401, the China Agriculture Research System, the Special Fund for Agro-scientific Research in the Public Interest 201103034, the Foundation of Administration of Ocean and Fisheries of Guangdong Province A201101B02, the Open Project of the State Key Laboratory of Biocontrol (SKLBC09K04) and the Foundation of Science and Technology Bureau of Guangdong Province (2011A 020102002 and 2009A 020102002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; Bachere E, 2000, AQUACULTURE, V191, P3, DOI 10.1016/S0044-8486(00)00413-0; Belinda LWC, 2008, MOL IMMUNOL, V45, P1732, DOI 10.1016/j.molimm.2007.09.030; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chen CY, 2011, J CELL BIOL, V193, P769, DOI 10.1083/jcb.201008050; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Cuthbertson BJ, 2008, DEV COMP IMMUNOL, V32, P167, DOI 10.1016/j.dci.2007.06.009; de la Vega E, 2008, MOL IMMUNOL, V45, P1916, DOI 10.1016/j.molimm.2007.10.039; de Lorgeril J, 2008, MOL IMMUNOL, V45, P3438, DOI 10.1016/j.molimm.2008.04.002; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ho SH, 2009, FISH SHELLFISH IMMUN, V27, P73, DOI 10.1016/j.fsi.2009.05.001; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Kadowaki T, 2011, IN VIVO, V25, P741; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Labreuche Y, 2009, DEV COMP IMMUNOL, V33, P806, DOI 10.1016/j.dci.2009.02.005; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leu JH, 2009, CURR TOP MICROBIOL, V328, P197; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Li CY, 2010, FISH SHELLFISH IMMUN, V29, P1044, DOI 10.1016/j.fsi.2010.08.020; Li CY, 2010, FISH SHELLFISH IMMUN, V28, P1, DOI 10.1016/j.fsi.2009.09.003; Li FH, 2010, DEV COMP IMMUNOL, V34, P874, DOI 10.1016/j.dci.2010.03.008; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; O'Leary NA, 2006, GENE, V371, P75, DOI 10.1016/j.gene.2005.11.028; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Ragab A, 2011, EMBO J, V30, P1123, DOI 10.1038/emboj.2011.4; Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006; Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007; Somboonwiwat K, 2005, DEV COMP IMMUNOL, V29, P841, DOI 10.1016/j.dci.2005.02.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wang KCHC, 2010, DEV COMP IMMUNOL, V34, P49, DOI 10.1016/j.dci.2009.08.003; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2012, DEV COMP IMMUNOL, V36, P39, DOI 10.1016/j.dci.2011.06.002; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang PH, 2009, MOL IMMUNOL, V46, P1897, DOI 10.1016/j.molimm.2009.01.005; Woramongkolchai N, 2011, DEV COMP IMMUNOL, V35, P530, DOI 10.1016/j.dci.2010.12.016; Yuan SC, 2010, J IMMUNOL, V184, P6874, DOI 10.4049/jimmunol.0903675; Zhang Q, 2011, DEV COMP IMMUNOL, V35, P461, DOI 10.1016/j.dci.2010.11.013	51	112	112	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e52088	10.1371/journal.pone.0052088	http://dx.doi.org/10.1371/journal.pone.0052088			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23405063	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400006
J	Liu, ZH; Yang, J; He, HS				Liu, Zhihua; Yang, Jian; He, Hong S.			Identifying the Threshold of Dominant Controls on Fire Spread in a Boreal Forest Landscape of Northeast China	PLOS ONE			English	Article							ENVIRONMENTAL CONTROLS; CLIMATE-CHANGE; WILDFIRE; MIXEDWOOD; AREA; FREQUENCY; PATTERNS; BEHAVIOR; WEATHER; REGIMES	The relative importance of fuel, topography, and weather on fire spread varies at different spatial scales, but how the relative importance of these controls respond to changing spatial scales is poorly understood. We designed a "moving window'' resampling technique that allowed us to quantify the relative importance of controls on fire spread at continuous spatial scales using boosted regression trees methods. This quantification allowed us to identify the threshold value for fire size at which the dominant control switches from fuel at small sizes to weather at large sizes. Topography had a fluctuating effect on fire spread across the spatial scales, explaining 20-30% of relative importance. With increasing fire size, the dominant control switched from bottom-up controls (fuel and topography) to top-down controls (weather). Our analysis suggested that there is a threshold for fire size, above which fires are driven primarily by weather and more likely lead to larger fire size. We suggest that this threshold, which may be ecosystem-specific, can be identified using our "moving window'' resampling technique. Although the threshold derived from this analytical method may rely heavily on the sampling technique, our study introduced an easily implemented approach to identify scale thresholds in wildfire regimes.	[Liu, Zhihua; Yang, Jian; He, Hong S.] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [He, Hong S.] Univ Missouri, Sch Nat Resources, Columbia, MO USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Missouri System; University of Missouri Columbia	Yang, J (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	yangjian@iae.ac.cn	Li, Wei/I-8060-2014; Liu, ZH/H-7536-2012; Yang, Jian/H-3169-2011	Liu, ZH/0000-0002-0086-5659; Yang, Jian/0000-0002-2170-589X; He, Hong S./0000-0002-3983-2512; Li, Wei/0000-0002-9991-7892; Liu, Zhiyuan/0000-0002-4253-1753	National Natural Science Foundation of China [31100345, 41071121]; Hundred Talent Program of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by National Natural Science Foundation of China (31100345 & 41071121) and the Hundred Talent Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Arienti MC, 2009, INT J WILDLAND FIRE, V18, P970, DOI 10.1071/WF08011; Bergeron Y, 2004, ECOLOGY, V85, P1916, DOI 10.1890/02-0716; Bergeron Y, 2002, SILVA FENN, V36, P81, DOI 10.14214/sf.553; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Chang Y, 2007, INT J WILDLAND FIRE, V16, P34, DOI 10.1071/WF05093; Cumming SG, 2001, ECOL APPL, V11, P97, DOI 10.1890/1051-0761(2001)011[0097:FTAWIT]2.0.CO;2; Cyr D, 2007, LANDSCAPE ECOL, V22, P1325, DOI 10.1007/s10980-007-9109-3; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Falk DA, 2011, FRONT ECOL ENVIRON, V9, P446, DOI 10.1890/100052; Franklin J., 2000, TERRAIN ANAL PRINCIP; Hargrove WW, 2000, ECOL MODEL, V135, P243, DOI 10.1016/S0304-3800(00)00368-9; Hely C, 2000, J VEG SCI, V11, P813, DOI 10.2307/3236551; Hely C, 2010, INT J WILDLAND FIRE, V19, P1099, DOI 10.1071/WF09112; Johnson E.A., 1996, FIRE VEGETATION DYNA; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Larsen CPS, 1997, J BIOGEOGR, V24, P663, DOI 10.1111/j.1365-2699.1997.tb00076.x; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Liu Zhi-hua, 2008, Yingyong Shengtai Xuebao, V19, P487; Liu ZH, 2012, J VEG SCI, V23, P782, DOI 10.1111/j.1654-1103.2012.01397.x; Liu ZH, 2012, GLOBAL CHANGE BIOL, V18, P2041, DOI 10.1111/j.1365-2486.2012.02649.x; Liu ZH, 2010, FOREST ECOL MANAG, V259, P1255, DOI 10.1016/j.foreco.2009.12.022; McKenzie D, 2011, NATURE PRECED; Parisien MA, 2011, ECOL APPL, V21, P789, DOI 10.1890/10-0326.1; Parisien MA, 2009, ECOL MONOGR, V79, P127, DOI 10.1890/07-1289.1; Parks SA, 2011, INT J WILDLAND FIRE, V20, P815, DOI 10.1071/WF10051; Peters DPC, 2004, P NATL ACAD SCI USA, V101, P15130, DOI 10.1073/pnas.0403822101; Peterson GD, 2002, ECOSYSTEMS, V5, P329, DOI 10.1007/s10021-001-0077-1; Podur JJ, 2009, ECOL APPL, V19, P1246, DOI 10.1890/08-0790.1; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Ridgeway G., 2006, GEN BOOSTED REGRESSI, P5; Rollins MG, 2002, LANDSCAPE ECOL, V17, P539, DOI 10.1023/A:1021584519109; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Slocum MG, 2010, ECOSYSTEMS, V13, P828, DOI 10.1007/s10021-010-9357-y; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Van Wagner CE, 1987, FTR35 PET NAT FOR I; Wotton BM, 2010, INT J WILDLAND FIRE, V19, P253, DOI 10.1071/WF09002; Wu ZW, 2011, ENVIRON MANAGE, V48, P1148, DOI 10.1007/s00267-011-9707-3; Xu C. H., 1997, ACTA ECOLOGICA SINIC, V17, P3; Xu HC, 1998, FOREST GREAT XING MO, P1; Yang J, 2008, ECOL APPL, V18, P1212, DOI 10.1890/07-0825.1; Zhou YL, 1991, VEGETATION GREAT XIN, P1	48	246	257	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55618	10.1371/journal.pone.0055618	http://dx.doi.org/10.1371/journal.pone.0055618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23762496	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600137
J	Yu, HC; Hou, DR; Liu, CY; Lin, CS; Shiau, CW; Cheng, AL; Chen, KF				Yu, Hui-Chuan; Hou, Duen-Ren; Liu, Chun-Yu; Lin, Chen-Si; Shiau, Chung-Wai; Cheng, Ann-Lii; Chen, Kuen-Feng			Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TUMOR-SUPPRESSOR; CIP2A EXPRESSION; CELL-SURVIVAL; PP2A; UBIQUITIN; AKT; APOPTOSIS; PHOSPHORYLATION	Previously, we reported that cancerous inhibitor of protein phosphatase 2A (CIP2A) mediates the apoptotic effect of bortezomib in hepatocellular carcinoma (HCC). Here, we report a proteasome-independent mechanism by which bortezomib induces autophagy in HCC. Our data indicate that bortezomib activated autophagy in a dose-and time-dependent manner in HCC cell lines including Huh-7, Sk-Hep1, and Hep3B. Bortezomib downregulated CIP2A, phospho-Akt (P-Akt) and phospho-4EBP1 (P-4EBP1) in a dose-and time-dependent manner in all tested HCC cells. Ectopic expression of CIP2A abolished the effect of bortezomib on autophagy. Co-treatment of bortezomib and calyculin A, a PP2A inhibitor, reduced the effect of bortezomib on P-Akt, P-4EBP1, and autophagy. Increased phosphorylation of either Akt or 4EBP1 by ectopic overexpression protected cells from bortezomib-induced autophagy. Furthermore, we examined the effect of Delta Btz, a bortezomib derivative that closely resembles bortezomib structurally but has no proteasome activity, in HCC. Interestingly, Delta Btz demonstrated similar effects to bortezomib on autophagy, CIP2A, P-Akt and P-4EBP1, suggesting that the effect of bortezomib on autophagy is independent of proteasome inhibition. Moreover, our in vivo data showed that both bortezomib and Delta Btz inhibited tumor growth, downregulated CIP2A, P-Akt and induced autophagy in Huh-7 tumors. In conclusion, bortezomib induces autophagy in HCC through a CIP2A-PP2A-Akt-4EBP1 pathway.	[Yu, Hui-Chuan; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Yu, Hui-Chuan; Cheng, Ann-Lii; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei, Taiwan; [Lin, Chen-Si; Chen, Kuen-Feng] Natl Taiwan Univ, Sch Vet Med, Taipei 10764, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Hou, Duen-Ren] Natl Cent Univ, Dept Chem, Tao Yuan, Taiwan; [Liu, Chun-Yu] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Shiau, Chung-Wai] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, KF (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan.	kfchen1970@ntu.edu.tw	Lin, Chen-Si/AAD-3733-2019	Lin, Chen-Si/0000-0003-2254-8344; Chen, Kuen-Feng/0000-0002-4686-7019; HOU, Duen-Ren/0000-0003-1072-2915; Yu, Hongbo/0000-0002-3384-7772; Liu, Jinting/0000-0003-2136-8560; Cheng, Ann-Lii/0000-0002-9152-6512; Suiyi, Zhu/0000-0002-9784-2698	National Taiwan University Hospital [NTUH 101P01]; National Science Council, Taiwan [NSC99-2314-B-002-017-MY2, NSC100-2325-B- 002-036]	National Taiwan University Hospital(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study is supported by grants, NTUH 101P01 (KFC) from National Taiwan University Hospital; NSC99-2314-B-002-017-MY2 (KFC), and NSC100-2325-B- 002-036 (KFC) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2002, ONCOLOGIST, V7, P9, DOI 10.1634/theoncologist.7-1-9; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Eskelinen EL, 2005, CELL DEATH DIFFER, V12, P1468, DOI 10.1038/sj.cdd.4401721; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Katz J, 2010, CANCER BIOL THER, V10, P694, DOI 10.4161/cbt.10.7.12895; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Li CY, 2012, CANCER LETT, V314, P102, DOI 10.1016/j.canlet.2011.09.020; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Ling YH, 2002, MOL CANCER THER, V1, P841; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Qu W, 2010, MED ONCOL; Richardson Paul G, 2003, Cancer Control, V10, P361; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Roy S, 2010, SEMIN IMMUNOPATHOL, V32, P383, DOI 10.1007/s00281-010-0213-0; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Verslype C, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp281; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Wang J, 2011, INT J LAB HEMATOL, V33, P290, DOI 10.1111/j.1751-553X.2010.01288.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhu Keyi, 2009, Proceedings of the American Association for Cancer Research Annual Meeting, V50, P451, DOI 10.1038/onc.2009.343	50	88	89	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55705	10.1371/journal.pone.0055705	http://dx.doi.org/10.1371/journal.pone.0055705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085EU	23799106	Green Submitted, gold, Green Published			2022-12-25	WOS:000314597900052
